data_1ckk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ckk _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 40.2 mt-30 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.256 0.551 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.1 mt -49.24 -52.19 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 110.391 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -50.61 -42.02 55.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 110.313 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 29.6 tt0 -59.3 -48.2 82.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -66.23 -41.61 89.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -55.21 -34.77 64.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.187 -0.945 . . . . 0.0 109.44 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 49.8 mt-10 -67.55 -49.19 64.45 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.396 -0.815 . . . . 0.0 109.533 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.3 99.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.365 -0.835 . . . . 0.0 109.608 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.616 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 73.9 t80 -62.0 -26.53 68.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.354 -0.841 . . . . 0.0 109.408 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.45 -35.47 23.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.46 -0.775 . . . . 0.0 109.742 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -54.35 -46.13 72.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 109.623 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.556 ' CD1' HD11 ' A' ' 32' ' ' LEU . 63.4 m-85 -70.02 -48.59 57.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.244 -0.91 . . . . 0.0 110.1 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -66.3 66.26 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.384 -0.823 . . . . 0.0 109.958 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -41.89 -51.82 4.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.6 p-10 -72.89 -41.4 64.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 109.701 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.91 45.21 3.67 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 26' ' ' THR . 33.1 p30 -96.03 -4.85 42.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -1.196 . . . . 0.0 110.342 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 87.49 28.33 24.88 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 11.7 p -160.03 111.3 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -1.154 . . . . 0.0 110.394 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.54 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 14.9 mt -78.66 124.91 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.048 -1.032 . . . . 0.0 109.707 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.441 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 1.2 p -100.17 -179.9 4.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.628 -0.67 . . . . 0.0 110.136 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -70.72 -33.99 71.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.727 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.89 -50.51 41.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 109.903 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' OE2' ' OG1' ' A' ' 28' ' ' THR . 57.8 mt-10 -51.36 -70.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.892 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.556 HD11 ' CD1' ' A' ' 19' ' ' PHE . 15.7 tp -51.24 -33.62 28.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.592 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -61.58 -41.33 99.55 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.0 m -61.04 -41.84 97.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.384 -1.068 . . . . 0.0 109.813 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.8 t -65.44 -46.49 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.294 -0.879 . . . . 0.0 109.705 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -19.68 65.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.062 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 1.2 ttp180 -91.48 -17.2 26.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.9 . . . . 0.0 110.053 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.89 -43.1 13.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 110.113 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.474 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -50.96 -26.4 5.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 110.337 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.65 35.99 0.94 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.44 -166.62 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -1.151 . . . . 0.0 110.348 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -149.08 97.75 3.59 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.855 . . . . 0.0 110.094 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.539 ' HA ' ' CD1' ' B' ' 4' ' ' ILE . 41.9 Cg_endo -68.18 149.17 76.1 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.904 1.476 . . . . 0.0 110.574 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 52.9 m -97.58 135.2 39.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.304 -0.873 . . . . 0.0 110.425 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -44.68 -44.99 9.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.184 -0.947 . . . . 0.0 110.196 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.27 -57.28 6.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 72.1 mm-40 -55.59 -47.68 76.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.897 . . . . 0.0 110.175 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.8 OUTLIER -48.61 -62.6 1.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.986 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 tp60 -51.1 -44.02 61.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.428 -0.795 . . . . 0.0 109.942 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -64.96 -28.29 69.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.818 . . . . 0.0 109.644 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -49.44 16.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.449 -0.782 . . . . 0.0 109.832 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.485 HG13 HD21 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -70.36 -10.03 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -85.78 -19.41 30.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.409 -0.807 . . . . 0.0 109.698 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -57.02 6.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.389 -0.819 . . . . 0.0 110.104 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.588 HG22 ' CD1' ' B' ' 7' ' ' TRP . 18.5 t -69.75 -31.72 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.274 -0.891 . . . . 0.0 109.862 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -59.15 79.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.428 -0.795 . . . . 0.0 110.034 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.86 -21.95 60.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.802 . . . . 0.0 110.621 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -71.56 -38.83 70.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.048 -1.033 . . . . 0.0 110.434 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.21 12.93 32.42 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.1 p-10 -82.89 -44.48 15.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.395 -1.062 . . . . 0.0 110.528 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.33 11.27 9.86 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.493 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 14.2 p -138.56 143.32 39.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.354 -1.086 . . . . 0.0 109.869 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.54 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 15.8 mm -87.08 150.77 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.062 -1.023 . . . . 0.0 109.924 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.516 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 1.2 m-20 -129.74 165.03 22.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.14 -0.975 . . . . 0.0 110.981 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.616 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 14.5 t80 -50.81 -47.43 85.94 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.491 -0.756 . . . . 0.0 111.139 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -67.93 -40.88 8.56 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 O-C-N 123.176 1.093 . . . . 0.0 109.912 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -56.68 -29.89 62.83 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.193 -0.942 . . . . 0.0 108.857 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.494 ' O ' ' HG2' ' A' ' 71' ' ' MET . 0.1 OUTLIER -66.91 -63.34 1.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.543 -0.723 . . . . 0.0 109.523 178.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -48.26 -22.21 0.63 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.274 -0.891 . . . . 0.0 109.968 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.5 m -100.59 -9.99 21.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.189 -0.944 . . . . 0.0 111.357 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.528 ' HG3' ' N ' ' A' ' 72' ' ' MET . 9.5 ptm -86.05 -43.52 13.04 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.799 -1.188 . . . . 0.0 110.554 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.528 ' N ' ' HG3' ' A' ' 71' ' ' MET . 89.3 mmm -65.34 -10.04 29.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.055 -1.028 . . . . 0.0 110.539 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.0 -10.54 21.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.074 -1.016 . . . . 0.0 111.043 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.75 -10.72 22.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.941 -1.1 . . . . 0.0 110.519 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.533 ' CB ' HG23 ' B' ' 8' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.183 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.267 0.556 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -84.33 -21.57 30.91 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 14.8 pt-20 -73.17 -27.57 61.72 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.57 -0.706 . . . . 0.0 110.051 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.416 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 53.1 mt -73.98 -40.82 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.606 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -32.75 73.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 109.364 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.541 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 17.2 mt-10 -70.09 -56.58 6.54 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' B' ' 12' ' ' LEU . . . -48.85 -35.98 15.88 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.25 -0.906 . . . . 0.0 108.557 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 90' ' ' ARG . 26.8 t80 -62.72 -56.09 20.76 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.628 -0.67 . . . . 0.0 109.473 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -43.03 -47.32 5.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.578 -0.701 . . . . 0.0 109.425 179.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.503 ' CG1' HG12 ' B' ' 13' ' ' VAL . 41.2 t -51.08 -49.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.363 -0.836 . . . . 0.0 109.359 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.522 ' CE1' HD22 ' A' ' 105' ' ' LEU . 54.8 m-85 -68.85 -44.66 72.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 110.38 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.438 ' OD2' ' HA2' ' A' ' 96' ' ' GLY . 34.2 t0 -92.28 60.9 3.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.062 -1.024 . . . . 0.0 110.39 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.3 -46.84 62.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.284 -0.885 . . . . 0.0 110.301 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 6.5 p30 -66.04 -26.0 67.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.319 -0.863 . . . . 0.0 110.384 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 67.52 50.99 39.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -96.97 -18.41 19.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.191 -1.182 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.542 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 109.4 24.63 5.84 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -169.92 158.75 7.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -1.113 . . . . 0.0 110.139 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.502 HG23 HD11 ' A' ' 100' ' ' ILE . 34.4 mt -117.04 148.91 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.033 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 102' ' ' ALA . 19.3 t -127.75 146.73 50.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.958 . . . . 0.0 109.876 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.18 -29.54 0.25 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 109.975 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.68 -56.08 14.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.823 . . . . 0.0 109.598 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 15.7 mt-10 -53.54 -38.13 63.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 0.0 109.707 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.522 HD22 ' CE1' ' A' ' 92' ' ' PHE . 1.4 mt -69.87 -39.2 76.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.436 -0.79 . . . . 0.0 109.607 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.0 ttp85 -62.58 -34.17 76.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.304 -0.872 . . . . 0.0 109.415 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -66.49 -51.51 55.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.362 -0.836 . . . . 0.0 109.449 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.484 HG12 ' CG1' ' B' ' 13' ' ' VAL . 28.3 t -57.89 -37.42 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.524 -0.735 . . . . 0.0 109.506 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.541 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -52.1 -64.07 0.94 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.609 -0.682 . . . . 0.0 110.77 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.426 HG22 ' HG2' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -64.22 -15.35 59.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' ' 39' ' ' LEU . 0.9 OUTLIER -79.09 -19.63 50.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.016 . . . . 0.0 109.565 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.55 HD12 ' CA ' ' B' ' 14' ' ' LYS . 15.8 mt -107.28 -27.03 10.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.484 -0.76 . . . . 0.0 109.862 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.433 ' O ' ' HE3' ' A' ' 115' ' ' LYS . . . 147.57 -74.32 0.29 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.735 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.443 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 1.8 tt0 -71.68 149.0 45.91 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.241 -1.152 . . . . 0.0 111.332 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -130.48 81.98 2.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.522 -0.736 . . . . 0.0 109.302 179.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.483 ' HB2' ' CE ' ' A' ' 109' ' ' MET . 8.0 mp -36.71 143.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.588 -0.695 . . . . 0.0 111.083 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -58.02 -153.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 110.072 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 119' ' ' GLU . 1.2 m-20 -98.8 -66.0 0.93 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.892 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' ASP . 15.1 mt-10 -44.39 -47.46 9.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.56 -54.8 43.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.369 -0.832 . . . . 0.0 109.317 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 117' ' ' THR . 39.1 t -55.47 -39.59 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 109.678 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.58 -44.52 86.41 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.375 -0.828 . . . . 0.0 109.719 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -70.59 -36.7 73.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.353 -0.842 . . . . 0.0 109.678 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.43 ' HE1' ' O ' ' B' ' 21' ' ' SER . 24.4 ttt -56.76 -37.45 71.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -0.826 . . . . 0.0 109.788 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.522 ' CD1' HD13 ' A' ' 105' ' ' LEU . 27.5 mm -82.38 -31.23 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 110.084 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -36.67 80.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 110.248 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -30.44 69.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.87 . . . . 0.0 110.061 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -82.96 -29.24 29.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 110.031 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 82.9 m-20 -63.68 72.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.908 . . . . 0.0 110.342 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 128' ' ' ALA . 3.4 mt -58.05 -21.93 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 109.893 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 35.6 p-10 -98.78 -17.16 18.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.83 61.21 3.61 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 1.6 p30 -111.03 2.87 18.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -1.191 . . . . 0.0 110.098 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 85.32 -1.67 88.44 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 86.3 mt-30 -153.83 168.28 26.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.156 -1.202 . . . . 0.0 110.221 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 50.4 t -100.0 143.15 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -0.912 . . . . 0.0 110.075 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.511 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 32.7 t30 -111.2 -173.74 2.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 0.0 110.332 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -69.84 -52.86 21.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.348 -0.845 . . . . 0.0 110.5 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -45.24 -52.66 9.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -56.24 -58.89 6.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 110.022 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.419 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 20.4 t80 -46.39 -25.16 0.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.461 ' CG1' HG22 ' A' ' 146' ' ' THR . 38.3 t -99.99 -54.03 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.299 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.77 -24.31 0.36 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.201 -0.937 . . . . 0.0 110.312 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmm -83.93 -23.83 30.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.266 -0.896 . . . . 0.0 110.313 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.537 ' HE3' ' CD2' ' B' ' 12' ' ' LEU . 0.1 OUTLIER -100.16 -11.49 20.41 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.269 -0.894 . . . . 0.0 110.51 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.461 HG22 ' CG1' ' A' ' 142' ' ' VAL . 82.4 p . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.539 ' CD1' ' HA ' ' A' ' 43' ' ' PRO . 5.6 mt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.956 0.408 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.51 ' HD2' HG22 ' B' ' 4' ' ' ILE . 42.6 Cg_endo -70.12 132.46 22.81 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.958 1.504 . . . . 0.0 110.112 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 12.3 p -69.46 -167.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.86 . . . . 0.0 110.799 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.588 ' CD1' HG22 ' A' ' 55' ' ' VAL . 5.4 m95 -73.11 -77.71 0.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.536 -0.728 . . . . 0.0 110.707 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 75' ' ' LYS . 20.5 p -40.87 -26.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.964 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.541 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 84.0 m -61.36 -63.55 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 110.001 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.571 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 4.6 m -50.79 -27.45 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.421 HG12 ' O ' ' B' ' 7' ' ' TRP . 15.0 mm -79.09 -24.79 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.468 -0.77 . . . . 0.0 109.327 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.537 ' CD2' ' HE3' ' A' ' 145' ' ' MET . 1.4 mt -68.99 -49.76 55.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.576 -0.702 . . . . 0.0 110.087 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.503 HG12 ' CG1' ' A' ' 91' ' ' VAL . 97.5 t -67.53 -40.11 83.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.38 -0.825 . . . . 0.0 110.36 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.55 ' CA ' HD12 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -64.95 -45.74 84.48 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.918 -1.114 . . . . 0.0 109.506 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.463 ' HB3' ' ND2' ' B' ' 24' ' ' ASN . 4.7 t -57.67 -36.88 72.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.324 -0.86 . . . . 0.0 108.9 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' B' ' 13' ' ' VAL . 2.9 mmt -60.04 -34.47 73.43 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 108.833 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.541 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 6.3 mp -72.59 56.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.651 -0.655 . . . . 0.0 109.418 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -83.66 0.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.69 . . . . 0.0 110.289 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' B' ' 20' ' ' ARG . 9.0 tmtt? -133.39 -85.03 0.45 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.61 -1.306 . . . . 0.0 110.387 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -142.3 23.91 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.871 -1.143 . . . . 0.0 110.115 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.43 ' O ' ' HE1' ' A' ' 124' ' ' MET . 0.6 OUTLIER -114.46 178.86 4.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.497 -0.752 . . . . 0.0 109.583 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.402 ' CE2' ' HG2' ' A' ' 124' ' ' MET . 0.2 OUTLIER -137.57 148.25 45.74 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.79 146.08 17.63 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.53 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 8.8 m120 -119.26 134.83 23.71 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.224 -1.162 . . . . 0.0 110.304 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 26' ' ' PHE . 46.0 Cg_endo -72.41 -44.38 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.024 1.539 . . . . 0.0 110.048 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' B' ' 25' ' ' PRO . 1.6 m-30 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.42 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 13.6 pt20 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.286 0.565 . . . . 0.0 109.836 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.7 mt -67.32 -29.76 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.464 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.51 -55.78 24.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.315 -0.866 . . . . 0.0 109.634 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 13.1 pt-20 -56.94 -34.67 68.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 109.389 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.525 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 13.8 m-85 -73.6 -46.01 49.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.28 -0.888 . . . . 0.0 109.358 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 17' ' ' SER . 32.6 tptt -60.27 -44.07 95.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.287 -0.883 . . . . 0.0 109.212 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.32 -44.3 75.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.179 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.92 -56.69 18.94 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.42 -0.8 . . . . 0.0 109.531 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.548 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 15.2 t80 -55.81 -45.53 78.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.218 -0.926 . . . . 0.0 109.439 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -61.78 -38.49 88.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -0.76 . . . . 0.0 109.254 179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.544 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 10.1 tt -59.09 -27.74 65.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.495 -0.753 . . . . 0.0 109.624 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.538 ' CD1' HD21 ' A' ' 18' ' ' LEU . 4.7 m-85 -90.81 -49.87 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.95 76.99 1.67 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.5 -0.75 . . . . 0.0 110.228 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -52.27 -69.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.908 . . . . 0.0 110.183 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 6.8 p-10 -45.29 -29.19 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 54.83 6.04 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.467 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 2.0 p-10 -106.68 -34.17 7.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.179 -1.189 . . . . 0.0 110.185 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 26' ' ' THR . . . 124.56 7.79 6.1 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 32.0 p -141.85 117.62 10.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.217 -1.167 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.528 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 16.5 mt -76.87 128.67 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 110.336 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.16 161.59 14.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.411 -0.806 . . . . 0.0 110.264 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.468 HG21 HG13 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -58.56 -39.23 79.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.0 110.4 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 31' ' ' GLU . 3.7 tmtt? -65.66 -52.87 48.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.0 110.275 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' LYS . 10.1 mt-10 -43.15 -61.37 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 109.903 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.7 tp -56.25 -37.98 70.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.92 . . . . 0.0 109.668 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.51 -40.29 98.5 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 m -58.34 -41.63 85.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -1.061 . . . . 0.0 109.625 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.18 -53.2 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.44 ' HE1' ' HG2' ' B' ' 5' ' ' PRO . 36.7 mtt -55.66 -31.13 62.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.207 -0.933 . . . . 0.0 109.731 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.433 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -74.27 -25.61 59.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 109.82 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.507 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -76.58 -47.36 22.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.209 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mt -56.31 -53.02 62.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 110.254 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.44 58.93 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.511 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 1.5 mm-40 -139.33 -169.76 2.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.158 -1.201 . . . . 0.0 110.233 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 13.7 m120 -143.85 75.85 15.78 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.25 -0.906 . . . . 0.0 110.438 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HA ' HD13 ' B' ' 4' ' ' ILE . 47.3 Cg_endo -74.27 119.76 5.95 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.013 1.533 . . . . 0.0 110.274 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -76.36 154.31 35.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.283 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.34 -49.24 72.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.54 -54.3 47.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.321 -0.862 . . . . 0.0 110.143 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 5.0 mt-10 -56.64 -34.83 67.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -0.906 . . . . 0.0 110.042 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.0 mt -55.78 -54.3 46.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.063 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -31.0 69.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 109.775 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 95.3 m-20 -69.12 -41.51 77.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 110.068 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.447 ' CE ' ' CD1' ' B' ' 7' ' ' TRP . 1.9 ttp -73.6 -38.93 64.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.245 -0.91 . . . . 0.0 110.023 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.505 HD11 HG22 ' A' ' 52' ' ' ILE . 5.5 mm -66.18 -25.1 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.75 0.72 22.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.295 -0.878 . . . . 0.0 110.187 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.77 -13.18 25.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 110.079 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 57' ' ' ALA . 16.3 t -113.63 -35.12 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -45.44 89.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.474 -0.766 . . . . 0.0 110.371 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -85.63 -31.44 22.58 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.236 -0.915 . . . . 0.0 110.754 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 29.4 p-10 -83.13 -39.98 20.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.029 -1.044 . . . . 0.0 110.425 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 108.54 24.12 6.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' CG ' ' OD2' ' A' ' 58' ' ' ASP . 19.9 p-10 -95.12 -14.57 24.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -1.151 . . . . 0.0 110.177 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.82 -63.76 0.3 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 1.3 p -76.54 165.02 25.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -1.115 . . . . 0.0 110.171 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.528 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 20.6 mm -90.81 149.8 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.548 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 24.6 t0 -115.3 162.36 17.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.933 . . . . 0.0 110.659 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.583 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 74.3 t80 -49.23 -46.16 76.5 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 0.0 111.333 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -69.93 -39.63 5.97 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.285 1.15 . . . . 0.0 110.406 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.454 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 1.9 mt-10 -57.58 -27.07 62.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.965 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.544 ' CZ ' HD11 ' B' ' 11' ' ' ILE . 45.4 t80 -83.27 -40.99 18.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.374 -0.829 . . . . 0.0 110.411 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.514 HD12 ' CE2' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -67.62 -15.78 63.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.275 -0.891 . . . . 0.0 110.819 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 p -100.23 -41.19 7.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.059 -1.026 . . . . 0.0 110.924 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 3.3 ppp? -66.49 -34.45 77.96 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.27 -0.894 . . . . 0.0 111.227 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.589 ' HE3' ' CZ ' ' B' ' 26' ' ' PHE . 13.2 tpt -66.67 -9.4 35.62 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.128 -0.983 . . . . 0.0 111.077 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.6 -9.85 13.19 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.978 -1.076 . . . . 0.0 111.11 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -97.1 -32.79 11.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.98 -1.075 . . . . 0.0 110.741 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.049 -1.032 . . . . 0.0 110.695 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.165 0.507 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 36.1 mt-10 -66.95 -56.69 9.1 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.197 -0.94 . . . . 0.0 110.417 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -53.07 -28.51 25.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -0.93 . . . . 0.0 110.508 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' A' ' 141' ' ' PHE . 72.9 mt -66.78 -28.35 42.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.133 -0.98 . . . . 0.0 109.21 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 3.9 ttt-85 -66.52 -30.26 70.55 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.641 -0.662 . . . . 0.0 109.539 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.53 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 8.3 mt-10 -73.59 -48.99 28.52 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.343 -0.848 . . . . 0.0 109.496 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.431 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.62 -30.75 71.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -66.46 -49.91 65.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -31.49 69.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.383 -0.823 . . . . 0.0 109.544 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 11.6 t -61.06 -47.5 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.373 -0.829 . . . . 0.0 109.631 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 45.0 m-85 -67.96 -31.71 71.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.851 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 94' ' ' LYS . 7.2 t0 -80.77 55.35 2.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.2 -0.938 . . . . 0.0 110.173 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 93' ' ' ASP . 2.5 tmtt? -42.73 -32.28 0.58 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.33 -0.857 . . . . 0.0 110.538 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 4.8 p30 -90.08 -31.07 17.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.172 -0.955 . . . . 0.0 110.342 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 84.15 20.13 59.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 48.5 p30 -75.04 -15.33 60.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.042 -1.269 . . . . 0.0 109.97 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.568 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 92.79 33.17 7.56 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 33.5 m-85 -161.92 107.21 1.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -1.123 . . . . 0.0 110.233 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mt -69.19 124.98 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 110.11 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.56 161.94 17.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.973 . . . . 0.0 110.164 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.93 -37.28 66.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.101 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.5 -53.15 60.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.841 . . . . 0.0 110.033 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 24.0 mt-10 -56.19 -39.68 72.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.54 ' CD1' HD13 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -60.27 -38.5 83.76 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.301 -0.874 . . . . 0.0 109.486 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -36.78 82.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.556 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -64.99 -52.58 55.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 109.76 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.1 t -61.84 -28.58 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 109.159 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.499 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -67.51 -59.22 3.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.398 -0.814 . . . . 0.0 109.845 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -29.07 70.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.89 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 38' ' ' SER . 3.0 m120 -77.76 -6.52 54.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.422 -0.799 . . . . 0.0 110.064 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 12.7 mt -117.5 7.97 12.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -0.925 . . . . 0.0 110.869 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.16 -68.33 0.24 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.256 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 109' ' ' MET . 26.8 tt0 -92.03 161.91 14.58 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.046 -1.267 . . . . 0.0 111.532 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.459 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.0 OUTLIER -141.62 82.82 1.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.64 -0.663 . . . . 0.0 109.489 179.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 117' ' ' THR . 6.3 mp -38.29 140.11 0.33 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.451 -0.781 . . . . 0.0 111.1 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 116' ' ' LEU . 2.6 m -52.24 -171.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.427 -0.796 . . . . 0.0 110.08 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -83.21 -54.4 5.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 110.228 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -30.26 65.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 109.704 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.62 -52.9 11.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.211 -0.931 . . . . 0.0 108.929 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.411 HG21 ' CE ' ' A' ' 109' ' ' MET . 40.4 t -57.85 -34.67 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.423 -0.798 . . . . 0.0 109.466 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -62.17 -44.15 97.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.433 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 5.6 mm-40 -69.43 -29.15 66.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.399 -0.813 . . . . 0.0 109.519 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.593 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 10.2 ttt -65.94 -44.46 85.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.531 -0.731 . . . . 0.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.54 HD13 ' CD1' ' A' ' 105' ' ' LEU . 17.7 mm -75.98 -49.59 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.274 -0.891 . . . . 0.0 109.785 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -56.61 -47.83 78.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.89 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.5 mm-40 -61.73 -43.89 97.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.792 . . . . 0.0 109.917 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.25 -32.17 72.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.884 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.494 ' HB3' ' HA2' ' A' ' 132' ' ' GLY . 5.3 m-20 -71.6 100.69 2.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.384 -0.823 . . . . 0.0 110.051 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.434 HG13 ' OE1' ' A' ' 143' ' ' GLN . 40.0 mm -51.74 -36.53 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.217 -0.927 . . . . 0.0 110.243 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.421 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 17.3 p-10 -99.45 -25.1 14.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.295 -0.878 . . . . 0.0 110.383 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 69.62 51.91 23.3 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 5.7 p30 -85.46 -23.85 27.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.185 -1.185 . . . . 0.0 110.21 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 142.17 -10.26 2.51 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.28 166.58 10.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.028 -1.278 . . . . 0.0 110.698 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.523 HG11 ' CB ' ' A' ' 140' ' ' GLU . 2.9 t -102.54 154.43 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.397 -0.814 . . . . 0.0 109.871 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.454 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 17.0 p-10 -123.27 -145.71 0.35 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.186 -0.946 . . . . 0.0 110.399 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.85 -68.81 0.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 110.618 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -45.3 -46.28 12.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.219 -0.926 . . . . 0.0 110.653 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.523 ' CB ' HG11 ' A' ' 136' ' ' VAL . 35.7 mt-10 -61.02 -57.08 14.09 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.4 ' CE2' HG21 ' A' ' 85' ' ' ILE . 71.0 t80 -50.74 -20.71 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 145' ' ' MET . 73.2 t -93.9 -58.72 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.207 -0.933 . . . . 0.0 110.436 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.434 ' OE1' HG13 ' A' ' 130' ' ' ILE . 40.3 tt0 -42.12 -30.38 0.29 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.217 -0.927 . . . . 0.0 110.176 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.461 ' O ' ' N ' ' B' ' 24' ' ' ASN . 64.9 mtp -69.51 -30.96 68.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.052 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 142' ' ' VAL . 23.5 ttm -94.13 -28.66 15.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.355 -0.841 . . . . 0.0 110.391 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.411 -179.84 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.512 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 12.0 mt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.853 0.359 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.512 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 42.5 Cg_endo -71.68 139.64 34.3 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.642 1.338 . . . . 0.0 110.24 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.534 ' O ' ' N ' ' B' ' 8' ' ' THR . 46.4 t -90.33 64.09 5.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.306 -0.871 . . . . 0.0 111.036 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.538 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.3 OUTLIER 51.3 -85.43 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.209 -0.932 . . . . 0.0 110.659 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.534 ' N ' ' O ' ' B' ' 6' ' ' SER . 0.6 OUTLIER -43.46 -40.55 3.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.158 -0.964 . . . . 0.0 109.657 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 84.3 m -51.3 -53.5 35.18 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.438 -0.789 . . . . 0.0 109.51 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' B' ' 5' ' ' PRO . 18.6 t -52.79 -38.56 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.342 -0.849 . . . . 0.0 109.632 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.544 HD11 ' CZ ' ' A' ' 68' ' ' PHE . 12.1 mt -73.48 -25.77 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.281 -0.887 . . . . 0.0 109.727 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -48.69 65.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.4 -0.813 . . . . 0.0 109.668 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 86.4 t -63.77 -48.18 87.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.5 -0.75 . . . . 0.0 110.449 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.439 ' O ' ' HD2' ' B' ' 14' ' ' LYS . 30.4 tptt -54.98 -39.24 68.79 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.956 -1.09 . . . . 0.0 109.599 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 1.7 t -59.45 -40.07 85.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 109.61 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.498 ' CE ' ' HG3' ' B' ' 25' ' ' PRO . 0.2 OUTLIER -64.71 -27.85 69.19 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.39 -0.819 . . . . 0.0 110.087 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.499 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 6.3 mp -76.0 60.37 1.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.406 -0.808 . . . . 0.0 110.23 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -133.01 67.7 1.53 Allowed 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.53 -0.731 . . . . 0.0 111.36 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.529 ' CD ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER 60.97 -62.71 0.07 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.395 0.617 . . . . 0.0 111.478 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' B' ' 18' ' ' ARG . 1.2 ptm180 -143.79 4.35 1.31 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 111.023 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' B' ' 18' ' ' ARG . 23.0 m -64.23 86.59 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.815 -1.178 . . . . 0.0 109.893 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.593 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -126.43 -10.57 6.31 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.341 -0.849 . . . . 0.0 110.526 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' B' ' 24' ' ' ASN . . . -110.61 122.2 6.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 144' ' ' MET . 9.3 t-20 40.74 77.43 0.43 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.403 -1.057 . . . . 0.0 110.839 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.498 ' HG3' ' CE ' ' B' ' 16' ' ' MET . 47.7 Cg_endo -77.36 -9.71 17.53 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.0 1.526 . . . . 0.0 110.143 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.589 ' CZ ' ' HE3' ' A' ' 72' ' ' MET . 72.2 m-85 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.213 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.296 0.569 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.2 mt -59.08 -48.85 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 110.122 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.6 -45.41 38.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.842 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 2.8 tt0 -57.25 -56.81 17.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.85 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 9.0 m-85 -53.95 -33.07 55.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.337 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 3.7 tttp -64.25 -43.08 96.0 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.328 -0.858 . . . . 0.0 109.199 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 16.0 mt-10 -53.41 -49.5 67.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 109.61 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.99 -52.0 58.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.362 -0.836 . . . . 0.0 109.573 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.422 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 65.4 t80 -54.66 -40.83 69.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.601 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -71.82 -25.79 62.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.383 -0.823 . . . . 0.0 109.565 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 112' ' ' LEU . 2.7 tt -62.42 -39.64 93.94 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.364 -0.835 . . . . 0.0 109.706 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.434 ' CD1' HD13 ' A' ' 32' ' ' LEU . 49.8 m-85 -86.06 -27.66 24.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.382 -0.824 . . . . 0.0 110.305 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 66.0 t0 -92.19 100.12 12.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.171 -0.956 . . . . 0.0 110.394 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.37 -70.31 0.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.031 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.3 p-10 -52.69 -21.61 4.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 110.049 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.5 37.24 93.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.467 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 19.8 p-10 -80.09 -36.49 35.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.108 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 128.51 25.55 1.03 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 70.2 p -157.49 126.8 5.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.071 -1.252 . . . . 0.0 110.323 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.532 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 18.1 mt -97.55 122.12 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.141 -0.974 . . . . 0.0 110.015 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.8 p -90.46 175.86 6.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.811 . . . . 0.0 110.022 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.46 ' O ' HD12 ' A' ' 48' ' ' LEU . 34.5 p -69.59 -28.92 66.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 110.175 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -77.11 -50.77 12.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.096 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -48.24 -67.44 0.27 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.321 -0.862 . . . . 0.0 109.916 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 ' CZ2' ' B' ' 7' ' ' TRP . 22.5 tp -55.57 -43.62 76.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 109.794 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.43 -41.73 17.77 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.3 m -66.0 -54.87 20.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -1.066 . . . . 0.0 109.935 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.0 t -49.4 -39.0 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 109.801 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.448 ' HG3' ' HG3' ' A' ' 43' ' ' PRO . 5.2 mmt -62.74 -46.67 87.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.849 . . . . 0.0 109.274 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -51.8 -27.24 11.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.394 179.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -50.1 47.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.849 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 mt -54.55 -31.11 55.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.041 -1.037 . . . . 0.0 110.331 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.32 2.64 2.92 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.945 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -130.71 158.12 40.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.811 -1.405 . . . . 0.0 110.94 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -123.15 98.73 41.5 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 110.094 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.448 ' HG3' ' HG3' ' A' ' 36' ' ' MET . 43.0 Cg_endo -71.88 112.85 3.49 Favored 'Trans proline' 0 C--N 1.296 -2.232 0 O-C-N 124.148 1.604 . . . . 0.0 110.32 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.538 ' CG2' ' HG3' ' A' ' 47' ' ' GLU . 1.8 t -64.25 -166.59 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.677 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.447 ' N ' ' OG1' ' A' ' 44' ' ' THR . 0.1 OUTLIER -70.99 -60.94 1.96 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.424 -0.798 . . . . 0.0 110.219 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.56 -55.46 4.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.948 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.538 ' HG3' ' CG2' ' A' ' 44' ' ' THR . 2.2 mm-40 -55.68 -57.66 11.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.165 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 29' ' ' THR . 17.6 mt -45.53 -65.02 0.6 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.342 -0.849 . . . . 0.0 110.357 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -50.54 -25.29 3.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 110.325 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.12 -39.17 55.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.976 . . . . 0.0 110.081 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.571 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 1.7 mmm -80.67 -32.11 36.13 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.286 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 52' ' ' ILE . 10.7 mm -70.09 -36.77 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.073 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 56' ' ' ASP . 0.7 OUTLIER -54.19 -67.87 0.23 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.327 -0.858 . . . . 0.0 110.701 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 53' ' ' ASN . 27.1 mt-10 -41.17 -40.33 1.53 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.42 -0.8 . . . . 0.0 110.656 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.668 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 48.8 t -83.55 -16.29 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.928 . . . . 0.0 110.412 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASN . 33.7 t0 -66.04 66.78 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.534 ' HA ' ' NH2' ' A' ' 74' ' ' ARG . . . -41.74 -44.24 3.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.367 -0.833 . . . . 0.0 110.385 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 3.9 m-20 -80.49 -35.68 34.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.33 -0.856 . . . . 0.0 110.039 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.453 ' HA2' ' OD2' ' A' ' 56' ' ' ASP . . . 92.42 28.45 12.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 24.7 p30 -95.41 -32.63 12.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.327 -1.102 . . . . 0.0 110.318 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 117.12 30.96 1.81 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.53 147.57 20.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -1.192 . . . . 0.0 110.106 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.538 HD11 ' CG1' ' A' ' 55' ' ' VAL . 6.9 mm -97.39 124.84 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.335 -0.853 . . . . 0.0 110.14 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -107.76 169.84 8.35 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.233 -0.917 . . . . 0.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.595 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 11.0 t80 -58.69 -47.75 98.14 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.27 -0.894 . . . . 0.0 110.895 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.0 Cg_endo -68.09 -37.02 15.58 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 O-C-N 123.263 1.138 . . . . 0.0 109.648 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.444 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 5.1 tt0 -60.87 -34.07 74.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.029 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.499 ' O ' ' HG3' ' A' ' 71' ' ' MET . 5.7 t80 -63.83 -51.5 64.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.464 -0.773 . . . . 0.0 109.258 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.79 -15.2 52.74 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.247 -0.908 . . . . 0.0 109.419 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 6.8 m -90.81 -50.77 5.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 110.594 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.509 ' HE1' ' N ' ' A' ' 72' ' ' MET . 0.1 OUTLIER -58.26 -24.97 61.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.054 -1.029 . . . . 0.0 109.68 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.567 ' HE2' ' CE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -65.53 -13.83 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 109.88 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.31 -14.76 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.534 ' NH2' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -86.81 -29.06 22.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.242 -0.911 . . . . 0.0 110.175 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HG2' HG22 ' B' ' 8' ' ' THR . 32.1 tptt . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.138 -0.976 . . . . 0.0 109.959 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 120.929 0.395 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 84' ' ' GLU . 6.9 pt-20 -76.18 -25.63 55.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.944 -1.098 . . . . 0.0 110.509 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 10.4 pt-20 -69.43 -37.21 77.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.157 -0.965 . . . . 0.0 110.31 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.492 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 20.6 mt -68.76 -37.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.108 -0.995 . . . . 0.0 109.011 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.67 -26.25 61.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HB3' ' OG1' ' B' ' 9' ' ' THR . 1.1 mt-10 -73.16 -58.44 3.31 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.464 -0.773 . . . . 0.0 109.185 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.87 -29.17 62.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.026 . . . . 0.0 109.2 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 4.7 t80 -64.81 -49.27 71.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.317 -0.864 . . . . 0.0 109.127 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -33.37 42.53 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.492 -0.755 . . . . 0.0 109.241 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.453 HG13 HG23 ' A' ' 108' ' ' VAL . 41.3 t -72.61 -33.25 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.533 -0.729 . . . . 0.0 110.361 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 141' ' ' PHE . 23.5 m-85 -75.29 -57.7 3.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.034 -1.041 . . . . 0.0 110.011 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 96' ' ' GLY . 20.6 t0 -84.53 53.41 2.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 110.437 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 93' ' ' ASP . 3.6 mtmt -46.39 -26.56 0.86 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.074 -1.016 . . . . 0.0 108.895 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 1.3 t0 -66.66 -35.55 80.43 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 67.37 35.29 87.23 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.489 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 33.2 p-10 -91.66 -24.12 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.043 -1.269 . . . . 0.0 109.741 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.544 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 120.65 15.93 4.75 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 2.9 m-85 -161.25 150.24 16.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.161 -1.199 . . . . 0.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 9.7 mt -107.86 131.84 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.379 -0.826 . . . . 0.0 110.273 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 102' ' ' ALA . 20.2 p -115.13 145.94 41.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.111 -0.993 . . . . 0.0 110.008 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.1 -28.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.35 -0.844 . . . . 0.0 110.043 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -69.44 -51.28 37.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.295 -0.878 . . . . 0.0 109.619 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.16 -39.12 71.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.24 -0.913 . . . . 0.0 109.454 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.573 HD22 ' CE1' ' A' ' 92' ' ' PHE . 1.2 mt -70.07 -36.34 74.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.437 -0.79 . . . . 0.0 109.785 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.45 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 17.3 ttt85 -66.36 -29.87 70.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.744 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -76.36 -33.6 58.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.806 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.453 HG23 HG13 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -79.85 -37.52 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.582 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.508 ' HG3' ' N ' ' A' ' 110' ' ' THR . 6.1 ptp -68.14 -36.48 79.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.508 ' N ' ' HG3' ' A' ' 109' ' ' MET . 68.1 m -70.18 -39.76 75.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.327 -0.858 . . . . 0.0 109.631 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -72.5 -14.48 61.67 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.355 -0.841 . . . . 0.0 109.437 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.466 ' O ' HD13 ' A' ' 18' ' ' LEU . 10.1 mt -86.57 -46.86 9.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.403 -0.81 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.29 -9.88 0.83 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.836 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp10 -127.65 150.48 49.72 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.734 -1.45 . . . . 0.0 110.857 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 116' ' ' LEU . 2.2 mttp -132.2 74.58 1.59 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.421 -0.8 . . . . 0.0 109.454 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.501 ' CG ' ' OE2' ' A' ' 120' ' ' GLU . 5.4 mp -38.64 144.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 110.652 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -57.47 -144.61 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.559 -0.713 . . . . 0.0 110.57 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -111.71 -38.58 4.83 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.019 -1.051 . . . . 0.0 111.212 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 4.8 pt-20 -70.87 -32.17 69.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.996 -1.065 . . . . 0.0 110.46 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.532 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 12.0 pt-20 -78.41 -40.47 35.9 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.13 -0.981 . . . . 0.0 109.4 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.496 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 9.7 t -63.37 -36.25 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.211 -0.931 . . . . 0.0 109.423 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.25 -48.4 65.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 0.0 109.434 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 2.3 mm-40 -63.25 -19.63 64.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.39 -0.819 . . . . 0.0 109.407 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.487 ' HE1' ' CD2' ' B' ' 22' ' ' PHE . 0.1 OUTLIER -77.88 -56.95 4.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -0.836 . . . . 0.0 109.791 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.532 HD13 ' CD1' ' A' ' 105' ' ' LEU . 22.8 mm -61.5 -43.5 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 109.483 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -64.21 -37.54 87.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.436 -0.79 . . . . 0.0 110.007 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 17.2 tp10 -70.9 -15.64 62.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.783 . . . . 0.0 110.111 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -94.57 -42.04 9.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 110.358 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 135' ' ' GLN . 0.4 OUTLIER -56.03 80.59 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.442 -0.786 . . . . 0.0 110.361 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 128' ' ' ALA . 13.0 mt -50.31 -41.41 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.099 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.441 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 12.0 p-10 -80.39 -34.91 35.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.424 -0.798 . . . . 0.0 110.048 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.92 68.16 1.14 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 3.0 p30 -117.3 -14.15 10.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -1.202 . . . . 0.0 110.186 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.76 5.39 29.4 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 11.1 pt20 -170.05 169.26 8.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.225 -1.162 . . . . 0.0 110.445 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 26.0 t -100.34 159.1 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.212 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.566 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 57.5 t30 -128.63 173.3 10.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.257 -0.902 . . . . 0.0 110.243 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.53 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 38.4 t80 -55.71 -61.95 2.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 0.0 110.087 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.36 -31.73 15.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.401 ' HB3' HG11 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -81.43 -50.88 8.92 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.182 -0.949 . . . . 0.0 110.248 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.573 ' CE1' ' CD2' ' A' ' 92' ' ' PHE . 63.3 t80 -54.93 -17.78 4.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.995 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.444 ' O ' HG21 ' A' ' 146' ' ' THR . 14.7 t -97.4 -36.68 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 0.0 110.261 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -11.47 60.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.21 -0.931 . . . . 0.0 110.425 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.43 ' HE3' ' HA ' ' A' ' 128' ' ' ALA . 17.8 mmm -91.75 -25.69 18.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.174 -0.954 . . . . 0.0 110.267 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.493 ' HE1' ' CB ' ' B' ' 24' ' ' ASN . 6.5 mtp -98.79 -30.28 12.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.226 -0.921 . . . . 0.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.444 HG21 ' O ' ' A' ' 142' ' ' VAL . 35.0 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.508 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 10.6 mt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.006 0.432 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.508 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 40.5 Cg_endo -66.71 -164.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 124.06 1.558 . . . . 0.0 110.996 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.429 ' C ' ' SD ' ' A' ' 51' ' ' MET . 0.1 OUTLIER -115.65 -148.89 0.44 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.311 -0.868 . . . . 0.0 110.797 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.668 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -91.7 -74.49 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 110.778 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.466 HG22 ' HG2' ' A' ' 75' ' ' LYS . 14.3 p -44.28 -43.25 7.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 110.094 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 87' ' ' GLU . 17.1 m -45.18 -54.03 7.43 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 109.777 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.03 -38.66 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.247 -0.908 . . . . 0.0 109.343 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.423 HD12 ' N ' ' B' ' 11' ' ' ILE . 5.3 mm -67.72 -39.27 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.361 -0.837 . . . . 0.0 109.957 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.578 HD22 ' CD2' ' B' ' 26' ' ' PHE . 12.7 mt -52.63 -56.09 17.82 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.347 -0.845 . . . . 0.0 109.958 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.504 ' O ' HD12 ' B' ' 17' ' ' LEU . 73.4 t -54.51 -54.7 19.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 110.33 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.413 ' HA ' HD23 ' B' ' 17' ' ' LEU . 3.7 tptt -55.71 -41.67 74.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.809 -1.182 . . . . 0.0 109.71 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 17.8 t -72.91 -6.0 42.27 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 109.865 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.579 ' SD ' ' CD1' ' B' ' 22' ' ' PHE . 35.0 tpp -83.97 -45.13 13.48 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.256 -0.902 . . . . 0.0 110.138 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.539 ' N ' HD21 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -96.06 33.67 1.68 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 118.383 -1.327 . . . . 0.0 110.234 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' B' ' 19' ' ' LYS . 1.5 ttt85 -42.5 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.49 0.662 . . . . 0.0 109.992 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.568 ' HD2' ' CG ' ' B' ' 20' ' ' ARG . 2.9 tmtm? -103.69 -84.66 0.47 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.141 -0.974 . . . . 0.0 110.387 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.568 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.4 OUTLIER -146.1 12.41 1.24 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.697 -1.252 . . . . 0.0 110.021 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.53 174.06 6.04 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.351 -0.843 . . . . 0.0 110.775 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.579 ' CD1' ' SD ' ' B' ' 16' ' ' MET . 0.2 OUTLIER -130.32 66.15 1.51 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.47 -0.769 . . . . 0.0 110.061 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.29 -173.97 13.24 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.493 ' CB ' ' HE1' ' A' ' 145' ' ' MET . 0.4 OUTLIER -176.71 118.59 0.28 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.369 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -79.74 35.69 0.58 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.829 1.437 . . . . 0.0 111.216 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.578 ' CD2' HD22 ' B' ' 12' ' ' LEU . 8.3 m-85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.901 -1.125 . . . . 0.0 110.388 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.237 0.542 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.9 mt -55.7 -54.45 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.191 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.72 -48.63 10.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.166 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.98 -49.01 74.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -0.926 . . . . 0.0 110.048 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.444 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 20.9 m-30 -63.69 -40.53 97.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.915 . . . . 0.0 110.112 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -54.91 -52.23 63.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.769 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 9.3 tp10 -60.04 -30.55 69.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.543 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 12' ' ' PHE . . . -69.28 -50.47 46.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.466 -0.771 . . . . 0.0 110.155 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.474 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 16.9 t80 -63.15 -36.93 85.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.607 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.2 m -75.36 -15.32 60.48 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.331 -0.856 . . . . 0.0 109.4 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.568 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 7.8 tt -74.21 -48.27 30.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.449 -0.782 . . . . 0.0 110.096 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.421 ' HB3' HG21 ' A' ' 27' ' ' ILE . 54.5 m-85 -69.57 -47.37 63.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.293 -0.879 . . . . 0.0 109.988 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 4.4 t0 -57.55 95.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.13 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -52.44 -56.08 17.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.175 -0.953 . . . . 0.0 110.15 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 18.6 p-10 -76.62 -33.78 58.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.84 . . . . 0.0 110.328 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 95.06 41.34 4.06 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 32.3 p-10 -97.09 8.98 43.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.153 -1.204 . . . . 0.0 110.308 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.533 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 74.07 38.28 47.98 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 21.7 p -156.52 111.38 2.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.173 -1.192 . . . . 0.0 110.293 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.529 ' CD1' HG23 ' A' ' 63' ' ' ILE . 17.5 mt -86.85 123.14 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.085 -1.009 . . . . 0.0 110.365 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -100.43 164.87 11.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.4 -0.812 . . . . 0.0 109.543 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.497 HG22 ' NE2' ' A' ' 49' ' ' GLN . 18.7 p -65.75 -25.11 67.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.984 -1.073 . . . . 0.0 109.885 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.36 -45.0 49.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 109.994 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 35' ' ' VAL . 46.6 mt-10 -63.25 -66.16 0.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 109.992 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.421 ' HA ' HG22 ' A' ' 35' ' ' VAL . 21.2 tp -47.74 -45.03 28.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 110.06 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.28 -54.89 9.5 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 59.3 m -61.08 -36.32 79.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -1.055 . . . . 0.0 110.036 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 31' ' ' GLU . 19.3 t -62.69 -43.94 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.92 . . . . 0.0 110.084 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.5 mmm -66.48 -28.72 68.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.283 -0.886 . . . . 0.0 110.041 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 tpt85 -72.5 -29.43 63.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.324 -0.86 . . . . 0.0 110.245 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -58.39 -48.9 79.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 110.555 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.411 HD22 HG23 ' A' ' 108' ' ' VAL . 2.6 mt -57.25 -23.47 48.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.182 -0.949 . . . . 0.0 110.2 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.403 ' O ' ' OE1' ' A' ' 41' ' ' GLN . . . 106.34 70.87 0.76 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.403 ' OE1' ' O ' ' A' ' 40' ' ' GLY . 13.7 mm100 -153.26 -172.14 4.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.233 -1.157 . . . . 0.0 110.153 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.05 78.88 45.91 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.207 -0.933 . . . . 0.0 110.533 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.22 135.69 25.33 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.074 1.565 . . . . 0.0 110.228 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.1 m -97.98 146.1 25.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -0.927 . . . . 0.0 110.237 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -49.42 -47.55 47.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.15 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.47 -48.21 74.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.951 . . . . 0.0 110.193 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.22 -32.79 74.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.951 . . . . 0.0 110.247 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.9 mt -61.07 -51.04 70.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 110.406 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.497 ' NE2' HG22 ' A' ' 29' ' ' THR . 0.1 OUTLIER -62.92 -36.91 84.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.336 -0.852 . . . . 0.0 110.203 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -71.15 -32.05 68.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 109.871 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.635 ' CE ' ' CD1' ' B' ' 7' ' ' TRP . 3.9 mmm -69.47 -36.03 76.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 109.965 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.527 HG12 ' CD1' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -89.69 -12.05 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.626 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.67 -37.17 72.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.0 110.254 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.04 -32.48 15.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.409 -0.807 . . . . 0.0 110.464 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.648 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 15.6 t -69.74 -31.51 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.093 -1.005 . . . . 0.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.4 t0 -76.84 49.41 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.127 -0.983 . . . . 0.0 110.217 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -44.05 -29.82 0.65 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 110.377 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 2.7 t0 -61.93 -61.83 2.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.725 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.18 25.19 3.92 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 54.8 p30 -99.04 -14.62 19.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.943 -1.327 . . . . 0.0 110.112 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 105.75 -34.42 5.78 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.515 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 12.7 p -106.44 161.06 14.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.157 -1.202 . . . . 0.0 110.414 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.529 HG23 ' CD1' ' A' ' 27' ' ' ILE . 25.6 mm -86.44 144.29 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.295 -0.878 . . . . 0.0 110.578 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 6.7 t70 -122.25 165.42 16.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.489 -0.757 . . . . 0.0 110.046 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.588 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 14.8 t80 -59.07 -43.35 97.24 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.235 -0.916 . . . . 0.0 111.625 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.4 Cg_endo -72.82 -30.31 11.53 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.37 1.194 . . . . 0.0 110.555 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 64' ' ' ASP . 17.0 mt-10 -68.64 -44.39 74.25 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.081 -1.012 . . . . 0.0 109.534 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CZ ' HG13 ' B' ' 11' ' ' ILE . 33.9 t80 -61.02 -45.23 95.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 0.0 110.036 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.6 -36.28 75.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.192 -0.942 . . . . 0.0 110.421 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -71.79 -26.91 62.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.249 -0.907 . . . . 0.0 110.576 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -71.5 -62.26 1.47 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 110.555 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.541 ' HE2' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -50.46 -20.47 1.14 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.222 -0.924 . . . . 0.0 110.157 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.4 -21.69 20.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.191 -0.943 . . . . 0.0 110.268 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtt85 -98.36 -20.07 17.38 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.194 -0.941 . . . . 0.0 110.503 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 tptm . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.933 . . . . 0.0 109.927 179.752 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.097 0.475 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' O ' ' OE2' ' A' ' 87' ' ' GLU . 3.9 pt-20 -84.79 -9.74 57.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.142 -0.973 . . . . 0.0 110.469 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.49 -27.36 25.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.084 -1.01 . . . . 0.0 110.088 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.547 ' CD1' ' CG2' ' A' ' 146' ' ' THR . 5.3 mt -73.25 -38.0 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.082 -1.011 . . . . 0.0 109.024 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -57.2 -31.46 65.49 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.446 ' OE2' ' O ' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -67.69 -58.89 3.87 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.556 -0.715 . . . . 0.0 109.293 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.17 -30.09 48.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 109.426 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -74.34 -31.49 62.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -0.888 . . . . 0.0 109.216 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.47 -22.42 64.56 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.534 -0.729 . . . . 0.0 109.467 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.5 ' CG1' HG22 ' A' ' 108' ' ' VAL . 23.6 t -91.12 -28.75 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 0.0 110.476 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.601 ' CE1' HG12 ' A' ' 108' ' ' VAL . 4.0 m-85 -77.92 -30.05 50.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.076 -1.015 . . . . 0.0 109.964 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -96.36 63.27 2.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.315 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ASP . 5.6 mmpp? -41.12 -28.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.512 -0.742 . . . . 0.0 110.079 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.479 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 7.9 m-20 -82.96 -39.47 21.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.357 -0.839 . . . . 0.0 109.686 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 77.23 26.61 61.41 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.479 ' OD1' ' HB2' ' A' ' 95' ' ' ASP . 5.9 p-10 -86.65 -44.18 12.05 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -1.22 . . . . 0.0 109.931 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.591 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 143.62 27.61 0.13 Allowed Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.827 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 41.3 m-85 -161.2 136.92 7.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.924 -1.339 . . . . 0.0 110.174 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 11.1 mt -101.0 123.24 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.257 -0.902 . . . . 0.0 109.969 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 61.8 p -105.19 140.61 38.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.38 -34.81 0.87 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.383 -0.823 . . . . 0.0 109.999 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.6 -51.04 70.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.855 . . . . 0.0 109.761 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.421 ' CD ' ' OD2' ' A' ' 95' ' ' ASP . 11.7 mt-10 -57.08 -43.1 81.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.78 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 109' ' ' MET . 0.7 OUTLIER -58.94 -37.35 76.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.768 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -61.35 -37.38 83.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -63.82 -44.32 93.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.459 -0.775 . . . . 0.0 109.808 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.601 HG12 ' CE1' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -82.62 -28.67 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.442 -0.786 . . . . 0.0 109.284 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.492 ' HE3' HG21 ' A' ' 121' ' ' VAL . 31.7 ttm -65.51 -57.06 9.15 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.578 -0.701 . . . . 0.0 110.14 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 m -67.53 -32.4 73.16 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.248 -0.907 . . . . 0.0 110.316 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 6.4 m120 -76.81 1.79 16.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.002 -1.061 . . . . 0.0 109.29 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.581 ' CD1' ' CG1' ' B' ' 13' ' ' VAL . 7.0 mt -111.75 4.37 18.41 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.372 -0.83 . . . . 0.0 110.601 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.76 -75.97 0.41 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.609 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp10 -94.6 154.27 17.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -1.133 . . . . 0.0 111.099 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 1.3 pttm -129.45 74.43 1.58 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' A' ' 115' ' ' LYS . 5.9 mp -34.27 154.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.391 0.615 . . . . 0.0 110.965 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -59.81 -144.23 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.299 -0.876 . . . . 0.0 110.097 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -108.53 -59.34 1.88 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.218 -0.926 . . . . 0.0 110.139 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -48.87 -45.24 40.75 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.069 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.31 -50.58 73.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.89 . . . . 0.0 109.924 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.492 HG21 ' HE3' ' A' ' 109' ' ' MET . 43.5 t -57.64 -38.26 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.86 -45.61 70.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.902 . . . . 0.0 109.796 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 1.8 tt0 -64.84 -23.18 67.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.456 -0.778 . . . . 0.0 109.89 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.403 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 1.8 ttt -73.06 -43.79 61.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.843 . . . . 0.0 109.945 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.459 HD13 HD13 ' A' ' 105' ' ' LEU . 45.0 mm -69.93 -42.13 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 110.185 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.453 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 33.9 mtt-85 -66.25 -44.55 83.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.266 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 7.6 mm-40 -48.19 -32.15 6.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.392 -0.818 . . . . 0.0 110.25 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -100.69 -30.57 11.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 110.162 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.484 ' OD2' ' OD1' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -56.72 83.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.343 -0.848 . . . . 0.0 110.613 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -65.28 -42.35 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.9 p-10 -70.68 -33.5 70.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 109.844 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 87.02 56.55 2.17 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 25.7 p30 -112.98 0.12 14.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -1.211 . . . . 0.0 109.864 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 135' ' ' GLN . . . 76.71 -1.72 61.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.478 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 33.0 mt-30 -139.55 138.52 36.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.142 -1.21 . . . . 0.0 110.25 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 t -89.37 154.74 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.108 -0.995 . . . . 0.0 109.724 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.43 ' OD1' ' HG3' ' A' ' 139' ' ' GLU . 55.9 p30 -130.09 -142.32 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 110.581 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.71 -68.58 0.69 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.391 -0.818 . . . . 0.0 110.697 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -46.74 -25.06 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.23 -0.919 . . . . 0.0 110.792 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.474 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 38.0 mt-10 -83.13 -61.09 1.95 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.008 . . . . 0.0 109.726 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -51.23 -19.52 1.25 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 110.29 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 144' ' ' MET . 55.5 t -100.93 -70.21 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.264 -0.898 . . . . 0.0 111.455 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.532 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -39.74 -24.73 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.103 -0.998 . . . . 0.0 111.787 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.532 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 77.7 mmm -88.62 -39.25 14.21 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.745 -1.222 . . . . 0.0 111.395 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.49 ' HE3' ' HB3' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.39 -9.69 21.96 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.989 -1.069 . . . . 0.0 111.895 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.547 ' CG2' ' CD1' ' A' ' 85' ' ' ILE . 1.3 p . . . . . 0 N--CA 1.491 1.617 0 O-C-N 120.721 -1.237 . . . . 0.0 111.06 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.513 HD11 ' HD2' ' B' ' 5' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.513 ' HD2' HD11 ' B' ' 4' ' ' ILE . 38.5 Cg_endo -65.9 -155.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.825 1.434 . . . . 0.0 110.176 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.466 ' O ' HG22 ' B' ' 10' ' ' VAL . 6.6 m -121.94 -147.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.933 -1.104 . . . . 0.0 111.333 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.648 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 4.8 m95 -81.91 -76.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.547 0.689 . . . . 0.0 111.282 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.407 ' O ' ' C ' ' B' ' 9' ' ' THR . 30.2 p -43.86 -42.82 5.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.811 . . . . 0.0 110.3 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 87' ' ' GLU . 53.6 m -46.29 -41.41 13.13 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 109.292 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.466 HG22 ' O ' ' B' ' 6' ' ' SER . 46.2 t -69.32 -41.06 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.359 -0.838 . . . . 0.0 109.863 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.495 HD12 ' N ' ' B' ' 11' ' ' ILE . 5.6 mm -72.76 -25.69 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.248 -0.907 . . . . 0.0 109.874 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.591 ' CD1' ' CD2' ' B' ' 26' ' ' PHE . 1.3 mm? -65.97 -53.41 39.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.694 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.581 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 53.2 t -61.02 -48.9 86.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.152 -0.968 . . . . 0.0 109.766 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -35.69 43.17 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.844 -1.16 . . . . 0.0 108.965 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 5.3 t -65.24 -34.85 79.33 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.514 -0.741 . . . . 0.0 109.365 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.412 ' CG ' ' CE1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -57.32 -43.81 83.65 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.401 -0.812 . . . . 0.0 109.518 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 19' ' ' LYS . 4.1 mp -58.16 -94.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 109.688 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 58.15 -76.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.518 -0.739 . . . . 0.0 110.6 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER 175.63 107.59 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.887 -0.508 . . . . 0.0 110.842 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.7 OUTLIER 40.16 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.464 -0.773 . . . . 0.0 110.947 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.518 ' N ' ' O ' ' B' ' 19' ' ' LYS . 2.2 m -107.62 141.16 39.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.983 -1.073 . . . . 0.0 110.29 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.412 ' CE1' ' CG ' ' B' ' 16' ' ' MET . 0.1 OUTLIER -142.21 12.67 1.99 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.196 -0.94 . . . . 0.0 110.208 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' B' ' 24' ' ' ASN . . . -77.96 -61.44 2.53 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.49 ' HB3' ' HE3' ' A' ' 145' ' ' MET . 1.8 m-80 55.4 69.06 2.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.3 -1.118 . . . . 0.0 110.068 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.45 62.47 4.43 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 O-C-N 123.967 1.509 . . . . 0.0 110.04 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.591 ' CD2' ' CD1' ' B' ' 12' ' ' LEU . 1.1 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.189 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.226 0.536 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.07 -39.58 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.45 -51.82 65.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.484 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -48.91 -49.11 41.53 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.363 -0.835 . . . . 0.0 109.256 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -60.59 -44.79 95.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.386 -0.821 . . . . 0.0 109.345 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 10.6 tptm -57.26 -36.6 71.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.368 -0.833 . . . . 0.0 109.227 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.428 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -59.74 -52.56 64.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.604 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -52.61 -41.88 64.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 0.0 109.492 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 31.8 t80 -65.62 -43.66 88.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.491 -0.756 . . . . 0.0 109.509 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -69.87 -25.35 63.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 109.615 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 112' ' ' LEU . 10.3 tt -67.47 -42.29 83.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.447 -0.783 . . . . 0.0 109.798 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.16 -39.22 65.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 109.762 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -62.94 89.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.412 -0.805 . . . . 0.0 110.226 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -88.33 30.66 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.224 -0.922 . . . . 0.0 110.133 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 9.4 p-10 -143.65 -41.53 0.29 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.241 -0.912 . . . . 0.0 110.325 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 102.93 90.94 2.17 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.1 p-10 -164.07 -43.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.195 -1.179 . . . . 0.0 110.409 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.4 17.65 6.53 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -143.85 119.52 10.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.194 -1.18 . . . . 0.0 110.351 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.462 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 5.9 mt -82.09 115.97 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.083 -1.011 . . . . 0.0 109.943 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 9.0 p -80.35 -174.29 4.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.678 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.0 -49.88 26.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.159 -0.963 . . . . 0.0 110.179 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' GLU . 4.8 ttmt -68.32 -40.9 81.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.484 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 8.2 mt-10 -43.98 -48.78 8.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.13 -0.981 . . . . 0.0 109.594 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.39 -34.52 70.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.314 -0.867 . . . . 0.0 109.366 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -59.45 -46.81 93.32 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 99.5 m -58.71 -54.35 48.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -1.094 . . . . 0.0 109.159 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 t -56.76 -35.47 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.37 -0.831 . . . . 0.0 109.363 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.0 mmt -63.56 -49.56 72.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.461 -0.774 . . . . 0.0 109.697 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -54.09 -30.46 48.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.876 . . . . 0.0 109.5 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.446 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 1.3 m -54.96 -50.17 69.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.439 -0.788 . . . . 0.0 110.132 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.1 mt -52.15 -36.64 52.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.109 -0.995 . . . . 0.0 109.673 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.468 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 117.45 64.87 0.33 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 40' ' ' GLY . 6.3 mt-30 -156.81 -166.28 2.06 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.227 -1.161 . . . . 0.0 110.376 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -126.6 82.0 67.51 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.224 -0.922 . . . . 0.0 110.667 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.481 ' HA ' HD12 ' B' ' 4' ' ' ILE . 46.3 Cg_endo -73.9 102.58 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.908 1.478 . . . . 0.0 110.438 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.49 ' CG2' ' HG3' ' A' ' 47' ' ' GLU . 11.4 t -79.63 172.09 14.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.187 -0.946 . . . . 0.0 110.084 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -78.78 -25.67 44.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.158 -0.964 . . . . 0.0 110.482 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.09 -65.43 0.7 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.034 -1.041 . . . . 0.0 110.178 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' HG3' ' CG2' ' A' ' 44' ' ' THR . 0.9 OUTLIER -52.7 -44.96 66.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 109.879 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.7 OUTLIER -50.96 -42.94 60.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.907 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -45.64 92.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.423 -0.798 . . . . 0.0 109.8 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.76 -13.97 62.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 110.062 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.576 ' HE2' ' CG ' ' B' ' 7' ' ' TRP . 2.4 mmm -94.26 -46.37 7.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.439 HG21 ' N ' ' A' ' 53' ' ' ASN . 1.2 tp -60.69 -37.96 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.242 -0.911 . . . . 0.0 110.035 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.439 ' N ' HG21 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -51.11 -29.78 14.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 110.284 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -65.24 -56.33 13.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.024 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.513 HG13 ' CG2' ' A' ' 63' ' ' ILE . 15.2 t -70.78 -14.49 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.126 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.4 77.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 110.384 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . . . -56.9 -63.81 1.08 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 0.0 110.32 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 7.0 p-10 -66.4 -43.9 84.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.97 . . . . 0.0 110.191 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.68 41.09 1.64 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 34.9 p-10 -99.51 -42.72 6.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.093 -1.239 . . . . 0.0 110.27 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 136.23 -14.34 4.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 22.0 p -118.36 160.89 20.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.135 -1.215 . . . . 0.0 110.538 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.513 ' CG2' HG13 ' A' ' 55' ' ' VAL . 8.0 mm -97.85 152.63 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 109.905 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 2.0 m-20 -131.57 148.22 52.6 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.188 -0.945 . . . . 0.0 110.535 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.625 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 37.6 t80 -40.58 -51.22 6.8 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.281 -0.887 . . . . 0.0 111.172 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.9 Cg_endo -66.09 -33.07 42.14 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.325 1.171 . . . . 0.0 110.04 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HG2' ' CB ' ' A' ' 57' ' ' ALA . 3.2 mt-10 -69.84 -30.03 67.42 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.312 -0.868 . . . . 0.0 109.467 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 56.8 t80 -65.54 -54.71 24.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.468 -0.77 . . . . 0.0 109.978 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.468 ' CD1' ' O ' ' A' ' 65' ' ' PHE . 1.3 mp -53.6 -48.75 68.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.383 -0.823 . . . . 0.0 110.066 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -27.99 69.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 110.247 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.574 ' CE ' ' HB3' ' B' ' 7' ' ' TRP . 0.1 OUTLIER -61.88 -60.41 3.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.42 -0.8 . . . . 0.0 111.023 -179.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.648 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 41.1 mmm -51.5 -16.51 0.61 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.101 -1.0 . . . . 0.0 111.076 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.73 -9.37 54.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.808 -1.182 . . . . 0.0 110.452 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -95.78 -42.62 8.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.094 -1.004 . . . . 0.0 111.375 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.519 ' CB ' HG23 ' B' ' 8' ' ' THR . 4.8 mmtp . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.088 -1.007 . . . . 0.0 111.04 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.438 ' HG2' ' OG1' ' A' ' 146' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.067 0.461 . . . . 0.0 110.593 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.456 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -59.84 -15.37 20.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.05 -1.032 . . . . 0.0 109.919 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.541 ' HG2' ' CD2' ' B' ' 12' ' ' LEU . 10.8 tt0 -68.63 -33.83 74.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.497 -0.752 . . . . 0.0 110.561 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.528 ' CD1' ' HB ' ' A' ' 146' ' ' THR . 49.9 mt -60.61 -30.53 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.214 -0.929 . . . . 0.0 109.174 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -63.41 -33.57 75.83 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.737 -0.602 . . . . 0.0 110.21 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.561 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 1.2 mp0 -73.25 -48.06 37.98 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.105 -0.997 . . . . 0.0 109.901 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -60.83 -27.68 68.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.032 . . . . 0.0 109.948 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.587 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 64.4 t80 -70.21 -49.13 53.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.929 -1.107 . . . . 0.0 108.949 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -52.12 -30.19 25.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.484 -0.76 . . . . 0.0 109.078 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 40.8 t -69.34 -47.79 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.498 -0.751 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.562 ' CZ ' ' HE2' ' B' ' 16' ' ' MET . 52.2 m-85 -62.4 -43.48 98.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.917 -1.115 . . . . 0.0 110.263 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -68.41 58.03 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 0.0 110.096 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 92' ' ' PHE . 7.2 tttm -40.89 -62.53 0.8 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 110.515 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 30.2 p-10 -63.64 -41.43 98.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.207 -0.933 . . . . 0.0 110.214 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 100.07 40.36 3.08 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -99.08 -21.07 16.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.233 -1.157 . . . . 0.0 110.265 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.56 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 101.36 33.87 4.69 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.56 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 53.3 m-85 -159.22 149.27 19.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.312 -1.111 . . . . 0.0 110.113 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 11.5 mt -116.55 153.78 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.125 -0.985 . . . . 0.0 110.543 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 102' ' ' ALA . 12.0 t -145.8 154.18 41.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.437 -0.789 . . . . 0.0 109.76 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.42 -28.81 0.6 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.955 . . . . 0.0 110.083 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.5 -51.34 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.803 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 92' ' ' PHE . 21.1 mt-10 -58.77 -35.91 73.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.879 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.57 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 0.8 OUTLIER -65.16 -41.15 94.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.611 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.443 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 1.5 tpp180 -64.33 -24.13 67.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -79.28 -31.68 43.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.45 -0.781 . . . . 0.0 110.217 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.423 HG22 HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -85.4 -30.62 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.266 -0.897 . . . . 0.0 109.995 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.552 ' CB ' HD22 ' B' ' 17' ' ' LEU . 5.0 ptp -74.41 -40.9 61.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.505 ' N ' ' HG3' ' A' ' 109' ' ' MET . 93.9 m -71.62 -23.45 61.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.134 -0.979 . . . . 0.0 109.62 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 38' ' ' SER . 22.3 m-20 -84.98 -8.48 58.72 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.194 -0.941 . . . . 0.0 109.848 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.49 ' CD1' HG11 ' B' ' 13' ' ' VAL . 6.4 mt -97.78 -38.29 9.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 110.316 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.74 -26.99 1.18 Allowed Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.586 -1.292 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 109' ' ' MET . 21.1 tt0 -113.56 166.02 11.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.887 -1.361 . . . . 0.0 110.826 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -146.12 72.19 1.29 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.493 -0.754 . . . . 0.0 109.234 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 117' ' ' THR . 2.9 mp -36.47 148.09 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.466 0.65 . . . . 0.0 111.16 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -56.46 -157.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.524 -0.735 . . . . 0.0 110.01 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -95.47 -68.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.03 -1.044 . . . . 0.0 110.312 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -43.5 -46.27 6.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.012 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -59.79 -52.11 66.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.714 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 117' ' ' THR . 83.0 t -60.18 -38.26 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 0.0 110.175 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -66.27 -63.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.0 109.875 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 122' ' ' ASP . 13.3 mm-40 -46.11 -26.57 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.365 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.64 ' CE ' ' CD2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.44 -55.12 17.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.499 -0.751 . . . . 0.0 110.183 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.57 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 44.5 mm -62.85 -22.58 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.414 -0.804 . . . . 0.0 110.244 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.427 ' C ' ' HD3' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -81.43 -38.98 25.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.194 -0.941 . . . . 0.0 110.158 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.34 -7.04 33.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 110.057 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -112.89 -32.09 6.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.19 -0.944 . . . . 0.0 110.334 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.452 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -54.94 83.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.313 -0.867 . . . . 0.0 110.513 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 128' ' ' ALA . 0.9 OUTLIER -61.67 -28.94 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 0.0 109.461 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD2' ' CD ' ' A' ' 140' ' ' GLU . 6.3 m-20 -85.53 -25.24 26.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.611 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.68 57.59 7.87 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 18.2 p-10 -120.88 -28.15 4.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -1.126 . . . . 0.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.404 ' C ' ' OE1' ' A' ' 135' ' ' GLN . . . 126.37 9.04 4.69 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.154 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.467 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 1.6 pm0 -165.14 166.86 18.73 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.931 -1.335 . . . . 0.0 110.381 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 24.1 t -110.1 168.42 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 110.413 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -141.91 173.34 11.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.382 -0.824 . . . . 0.0 109.694 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 139' ' ' GLU . 12.3 t80 -53.31 -56.89 13.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.107 -0.996 . . . . 0.0 109.965 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 2.8 tt0 -44.08 -47.87 8.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.429 ' CD ' ' OD2' ' A' ' 131' ' ' ASP . 51.4 mt-10 -69.51 -57.09 5.66 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.319 -0.863 . . . . 0.0 110.324 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.587 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 45.7 t80 -51.96 -19.76 1.99 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.291 -0.881 . . . . 0.0 110.326 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.595 ' CG1' ' CG2' ' A' ' 146' ' ' THR . 44.6 t -97.86 -43.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.212 -0.93 . . . . 0.0 110.483 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -65.32 -9.89 28.2 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.041 -1.037 . . . . 0.0 110.146 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.523 ' HE3' ' CD1' ' A' ' 130' ' ' ILE . 2.2 ttm -92.8 -37.96 12.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.669 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.46 -62.17 1.28 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.211 -0.93 . . . . 0.0 111.198 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.595 ' CG2' ' CG1' ' A' ' 142' ' ' VAL . 15.2 t . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.151 -0.968 . . . . 0.0 111.151 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 81.5 mt . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 120.767 0.318 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 49.5 Cg_endo -74.78 -157.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 124.148 1.604 . . . . 0.0 109.403 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.546 ' CB ' ' OG1' ' B' ' 9' ' ' THR . 0.2 OUTLIER -123.47 -175.04 3.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.975 -1.078 . . . . 0.0 110.648 179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.576 ' CG ' ' HE2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -80.35 -79.1 0.15 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.565 -0.709 . . . . 0.0 111.094 -179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.519 HG23 ' CB ' ' A' ' 75' ' ' LYS . 6.6 p -45.16 -23.74 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.866 -1.146 . . . . 0.0 110.043 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.561 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -63.46 -60.19 3.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.072 -1.017 . . . . 0.0 109.154 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.565 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 32.9 m -48.89 -28.36 2.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.736 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.498 ' N ' HG21 ' B' ' 10' ' ' VAL . 6.8 mm -79.77 -33.8 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.541 ' CD2' ' HG2' ' A' ' 84' ' ' GLU . 4.2 mp -60.39 -60.96 2.99 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.673 -0.642 . . . . 0.0 109.989 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.49 HG11 ' CD1' ' A' ' 112' ' ' LEU . 78.6 t -60.14 -38.88 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -67.53 -21.78 65.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.83 -1.168 . . . . 0.0 110.214 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.44 -36.68 33.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.562 ' HE2' ' CZ ' ' A' ' 92' ' ' PHE . 0.2 OUTLIER -75.19 -20.65 59.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.226 -0.921 . . . . 0.0 110.255 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.552 HD22 ' CB ' ' A' ' 109' ' ' MET . 3.3 mp -75.69 1.83 13.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.177 -0.952 . . . . 0.0 110.514 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' B' ' 17' ' ' LEU . 14.2 ttm180 -35.61 -69.71 0.1 Allowed 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.208 0.527 . . . . 0.0 110.782 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -154.0 -69.1 0.14 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.084 -1.01 . . . . 0.0 110.362 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.519 ' N ' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -133.42 12.29 4.15 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 109.841 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 4.5 t -80.84 142.41 33.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.421 -0.799 . . . . 0.0 110.175 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.64 ' CD2' ' CE ' ' A' ' 124' ' ' MET . 0.4 OUTLIER -143.88 -33.8 0.41 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.343 -0.848 . . . . 0.0 110.411 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.476 ' HA2' ' HG2' ' A' ' 144' ' ' MET . . . -64.9 -100.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -112.56 101.66 53.01 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.207 -1.172 . . . . 0.0 110.543 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.15 -18.9 12.47 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.126 1.593 . . . . 0.0 110.215 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.648 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 34.9 m-85 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.362 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.307 0.575 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mt -66.28 -35.86 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.82 88.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -0.892 . . . . 0.0 109.834 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 33.2 tp10 -64.62 -52.41 57.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.611 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -56.11 -31.19 63.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -37.33 83.33 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.302 -0.874 . . . . 0.0 109.211 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 17.0 mm-40 -58.33 -48.85 79.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.438 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -59.09 -51.56 69.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 109.648 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.613 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 25.4 t80 -52.58 -28.31 20.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -28.1 38.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.422 -0.799 . . . . 0.0 109.885 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 9.8 tt -63.66 -43.32 97.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.893 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.21 -41.0 50.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.41 -0.806 . . . . 0.0 110.333 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.74 100.03 2.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.039 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -86.13 -29.0 23.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.146 -0.971 . . . . 0.0 110.168 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.5 -33.35 54.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.12 12.49 58.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 29.7 p-10 -83.91 -27.83 28.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -1.177 . . . . 0.0 110.23 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 102.99 37.71 3.08 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 81.9 p -153.02 113.13 3.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.383 -1.069 . . . . 0.0 110.139 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.534 HD13 ' CG2' ' A' ' 63' ' ' ILE . 30.5 mt -82.83 116.24 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.42 176.27 6.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.6 p -63.41 -35.52 80.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 110.06 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.19 -56.33 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 110.295 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 30' ' ' LYS . 44.4 mt-10 -43.35 -64.8 0.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.166 -0.959 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.76 -37.15 75.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 109.938 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.77 -42.82 91.89 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 m -62.29 -47.69 83.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -1.17 . . . . 0.0 110.017 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 t -55.69 -29.74 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.688 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -31.57 60.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.916 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.14 -18.01 58.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 110.101 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.7 m -77.3 -51.48 10.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.46 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.71 -18.26 29.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.126 -0.984 . . . . 0.0 110.171 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.25 69.96 0.97 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.512 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 5.3 mm-40 -142.23 -162.74 1.46 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.278 -1.13 . . . . 0.0 109.831 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -159.58 88.46 2.0 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.128 -0.982 . . . . 0.0 110.767 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.46 127.47 13.3 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.095 1.577 . . . . 0.0 110.039 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 46' ' ' ALA . 6.2 t -86.36 30.29 0.71 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.124 -0.985 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 44' ' ' THR . 0.3 OUTLIER 67.05 -57.37 0.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 110.302 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 44' ' ' THR . . . -51.34 -40.02 58.24 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.324 -0.86 . . . . 0.0 109.927 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.53 -52.42 39.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.698 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.56 -57.52 3.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 110.064 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.5 mm-40 -55.74 -47.89 76.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.73 -36.65 72.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.456 -0.778 . . . . 0.0 109.759 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.494 ' HE1' ' N ' ' B' ' 7' ' ' TRP . 7.3 mtp -75.86 -47.03 27.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.433 -0.792 . . . . 0.0 109.534 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.6 mm -66.06 -30.11 48.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.416 -0.802 . . . . 0.0 109.972 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.4 m-80 -72.26 -16.61 61.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.181 -0.95 . . . . 0.0 110.029 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -87.48 -49.35 7.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 110.377 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.571 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 21.9 t -72.25 -13.74 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.114 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.06 79.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.089 -1.007 . . . . 0.0 110.264 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.481 ' N ' ' OE1' ' A' ' 67' ' ' GLU . . . -63.88 -39.37 94.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.666 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 37.8 p-10 -93.73 -32.12 14.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.16 -0.962 . . . . 0.0 110.793 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 97.61 38.71 4.11 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -99.81 -8.96 23.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -1.13 . . . . 0.0 110.322 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.44 -1.55 82.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.401 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 24.4 p -138.76 146.35 41.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -1.201 . . . . 0.0 110.376 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.534 ' CG2' HD13 ' A' ' 27' ' ' ILE . 48.4 mm -77.54 138.38 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.34 -0.85 . . . . 0.0 110.33 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 9.1 t0 -111.43 169.31 8.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 110.792 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 15.9 t80 -55.08 -45.46 99.84 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.35 -0.844 . . . . 0.0 111.41 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.4 Cg_endo -71.12 -46.36 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.233 1.122 . . . . 0.0 110.166 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 71' ' ' MET . 29.3 mt-10 -56.97 -33.77 67.41 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 109.87 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 47.1 t80 -67.65 -56.08 10.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.184 -0.948 . . . . 0.0 110.633 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.472 ' CD1' ' O ' ' A' ' 65' ' ' PHE . 1.2 mp -51.65 -61.5 2.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.358 -0.839 . . . . 0.0 110.995 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.5 m -51.92 -58.37 6.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.33 -0.856 . . . . 0.0 111.35 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -43.74 -68.9 0.16 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.164 -0.96 . . . . 0.0 111.372 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.479 ' HG2' ' CD1' ' B' ' 11' ' ' ILE . 7.7 mmm -37.8 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.257 -0.902 . . . . 0.0 110.908 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' MET . . . -92.81 -41.46 10.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.092 -1.005 . . . . 0.0 111.271 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -67.21 -19.16 65.51 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.905 -1.122 . . . . 0.0 110.771 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.491 ' CB ' HG22 ' B' ' 8' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.044 -1.035 . . . . 0.0 110.257 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.279 0.562 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 9.6 tt0 -68.24 -42.87 79.08 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.256 -0.903 . . . . 0.0 109.312 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.474 ' HG3' HG13 ' A' ' 85' ' ' ILE . 3.2 pt-20 -52.87 -26.98 16.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.513 -0.742 . . . . 0.0 110.246 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.474 HG13 ' HG3' ' A' ' 84' ' ' GLU . 81.6 mt -79.15 -47.94 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.961 -1.087 . . . . 0.0 109.02 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -63.12 -30.54 71.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.361 -0.837 . . . . 0.0 108.804 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.487 ' OE1' ' OG1' ' B' ' 9' ' ' THR . 51.7 mt-10 -73.05 -49.48 28.42 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.14 -36.35 70.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.335 -0.853 . . . . 0.0 109.423 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.588 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 7.2 t80 -67.46 -43.99 79.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.937 . . . . 0.0 109.397 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -35.69 50.71 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.434 -0.791 . . . . 0.0 109.236 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.444 ' CG1' HG23 ' A' ' 108' ' ' VAL . 4.0 t -67.53 -41.52 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.609 ' CE1' HG12 ' A' ' 108' ' ' VAL . 28.5 m-85 -74.19 -33.21 63.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.958 . . . . 0.0 109.957 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.497 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -81.26 58.15 3.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.883 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -39.58 -62.82 0.64 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 110.492 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.2 p-10 -66.47 -38.61 87.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.327 -0.858 . . . . 0.0 110.284 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.66 52.47 3.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -99.15 -13.34 19.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.333 -1.098 . . . . 0.0 110.136 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 105.78 20.37 9.47 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 13.9 m-85 -158.35 157.4 32.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -1.083 . . . . 0.0 109.906 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 6.1 mt -120.02 135.28 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.075 -1.015 . . . . 0.0 110.448 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 p -121.06 154.01 36.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.64 -34.05 4.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.31 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.31 96.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.497 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 23.1 mt-10 -60.95 -47.52 86.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 110.065 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.511 ' CD1' HD12 ' A' ' 125' ' ' ILE . 1.1 mt -61.5 -35.66 78.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.279 -0.888 . . . . 0.0 109.495 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' MET . 8.2 ttp180 -55.94 -43.02 77.03 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.312 -0.868 . . . . 0.0 109.044 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.66 -57.8 11.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.475 -0.766 . . . . 0.0 109.724 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.609 HG12 ' CE1' ' A' ' 92' ' ' PHE . 2.5 t -60.64 -21.87 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.398 -0.814 . . . . 0.0 109.855 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.61 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 4.0 mtt -64.32 -65.01 0.73 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.294 -0.879 . . . . 0.0 110.921 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.0 m -63.97 -9.44 15.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 0.0 110.455 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -95.94 -1.57 48.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.107 -0.996 . . . . 0.0 110.782 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.603 ' CD1' ' CG1' ' B' ' 13' ' ' VAL . 11.9 mt -133.22 -0.19 3.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 111.8 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.97 -90.5 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.113 -1.518 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -116.41 -176.85 3.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -1.063 . . . . 0.0 110.573 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.552 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -127.09 17.3 7.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.281 -0.887 . . . . 0.0 110.291 179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 115' ' ' LYS . 4.7 mp 50.17 174.77 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.674 -0.642 . . . . 0.0 110.287 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.428 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -87.85 -166.29 1.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.989 . . . . 0.0 109.873 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -80.84 -51.96 8.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.827 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 2.1 mt-10 -61.08 -41.33 96.44 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.581 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.424 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -62.2 -44.25 97.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.326 -0.859 . . . . 0.0 109.664 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 117' ' ' THR . 39.2 t -62.06 -46.32 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -66.07 -40.13 90.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.706 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 0.6 OUTLIER -64.52 -33.58 76.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.822 . . . . 0.0 109.548 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.58 ' HG2' ' CE2' ' B' ' 22' ' ' PHE . 3.0 ttt -64.85 -41.62 95.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.399 -0.813 . . . . 0.0 109.921 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.511 HD12 ' CD1' ' A' ' 105' ' ' LEU . 14.5 mm -84.45 -17.59 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.005 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -76.03 -39.42 55.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 110.064 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -69.04 -23.5 64.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.46 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . -95.86 -24.68 16.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.17 -0.957 . . . . 0.0 110.703 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -72.24 80.6 0.99 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.084 -1.01 . . . . 0.0 110.679 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 mt -82.32 -20.65 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 0.0 109.552 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 1.1 p30 -94.46 -13.72 25.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.406 -0.809 . . . . 0.0 109.78 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.03 80.93 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 12.1 p-10 -139.36 7.02 2.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.334 -1.098 . . . . 0.0 110.16 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 74.55 14.12 81.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.463 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 0.9 OUTLIER -164.81 164.58 21.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.316 -1.108 . . . . 0.0 110.187 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 22.9 t -106.45 169.77 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.112 -0.992 . . . . 0.0 109.7 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.45 ' N ' ' OE1' ' A' ' 140' ' ' GLU . 9.1 t-20 -128.34 179.64 5.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.155 -0.966 . . . . 0.0 110.351 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.588 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 9.1 t80 -62.54 -56.27 19.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.84 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -44.74 -60.36 2.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 110.123 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' A' ' 137' ' ' ASN . 53.9 mt-10 -44.63 -46.33 10.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.44 ' CG ' ' HD2' ' A' ' 89' ' ' PHE . 6.4 t80 -58.26 -28.9 65.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 139' ' ' GLU . 9.4 t -100.41 -33.85 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -0.792 . . . . 0.0 110.705 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 2.8 tp60 -73.22 -9.43 58.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.05 -1.031 . . . . 0.0 110.595 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.465 ' O ' ' O ' ' B' ' 23' ' ' GLY . 30.0 mtp -106.55 -18.63 13.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 110.813 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' B' ' 23' ' ' GLY . 20.7 ttm -99.92 -54.51 2.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.127 -0.983 . . . . 0.0 110.637 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.488 ' O ' ' CG2' ' A' ' 146' ' ' THR . 10.2 t . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.229 -0.92 . . . . 0.0 110.444 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 33.6 mm . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 39.5 Cg_endo -65.49 -172.47 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.578 1.304 . . . . 0.0 110.856 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.493 ' O ' ' N ' ' B' ' 8' ' ' THR . 57.0 p -119.76 60.54 0.85 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.059 -1.025 . . . . 0.0 111.394 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.571 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 1.0 OUTLIER 58.06 -82.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.039 -1.038 . . . . 0.0 110.864 178.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.499 HG21 ' CE ' ' A' ' 71' ' ' MET . 1.0 OUTLIER -46.14 -46.13 17.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.487 ' OG1' ' OE1' ' A' ' 87' ' ' GLU . 22.3 m -46.61 -35.79 6.26 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.227 -0.92 . . . . 0.0 109.914 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.21 -41.41 58.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.477 -0.765 . . . . 0.0 109.547 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.479 ' CD1' ' HG2' ' A' ' 72' ' ' MET . 12.5 mt -72.26 -20.19 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 109.637 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' B' ' 12' ' ' LEU . 0.5 OUTLIER -72.6 -59.96 2.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.369 -0.832 . . . . 0.0 109.735 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.603 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 43.4 t -56.02 -41.7 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.717 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.483 ' HG3' HD11 ' A' ' 18' ' ' LEU . 1.6 tmtm? -62.29 -43.97 97.61 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.88 -1.138 . . . . 0.0 109.568 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' B' ' 12' ' ' LEU . 14.5 m -53.0 -35.59 59.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.58 -0.7 . . . . 0.0 110.041 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.531 ' SD ' ' CD1' ' B' ' 22' ' ' PHE . 0.1 OUTLIER -70.67 -34.3 71.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.946 . . . . 0.0 109.951 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.61 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 3.5 mp -71.5 57.2 0.26 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.25 -0.906 . . . . 0.0 110.02 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -114.73 -86.28 0.6 Allowed 'General case' 0 C--N 1.278 -2.507 0 O-C-N 121.406 -0.809 . . . . 0.0 110.679 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' B' ' 20' ' ' ARG . 0.6 OUTLIER -153.77 94.9 1.82 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.791 -1.193 . . . . 0.0 110.53 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' B' ' 19' ' ' LYS . 10.3 tmm_? 64.67 7.0 3.52 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.437 -0.79 . . . . 0.0 110.407 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.458 ' OG ' ' HB3' ' B' ' 25' ' ' PRO . 0.1 OUTLIER -69.24 138.27 53.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.296 -0.877 . . . . 0.0 110.923 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.58 ' CE2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -176.29 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 144' ' ' MET . . . -64.39 -80.87 0.13 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -142.05 75.27 20.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.092 -1.24 . . . . 0.0 110.406 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.458 ' HB3' ' OG ' ' B' ' 21' ' ' SER . 50.6 Cg_endo -79.66 11.7 2.64 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.053 1.554 . . . . 0.0 110.716 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.33 -179.71 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.259 0.552 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 mt -56.96 -46.75 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.838 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.69 -45.95 74.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.683 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -42.26 97.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 109.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -66.54 -43.61 84.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.712 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -60.21 -40.58 90.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.603 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 1.6 mm-40 -61.98 -43.41 98.9 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.219 -0.925 . . . . 0.0 109.556 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.71 -47.48 69.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.881 . . . . 0.0 109.836 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.543 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 75.0 t80 -63.45 -40.42 97.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.613 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.9 t -72.82 -28.04 62.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 0.0 109.52 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.496 ' CD2' HG12 ' A' ' 35' ' ' VAL . 10.1 tt -62.97 -41.06 99.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 109.657 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.52 ' CZ ' HG22 ' B' ' 10' ' ' VAL . 27.0 m-85 -78.27 -10.88 59.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -0.793 . . . . 0.0 110.76 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.453 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 6.5 t0 -102.36 114.88 29.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.037 -1.039 . . . . 0.0 110.321 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.518 ' N ' ' OE2' ' A' ' 31' ' ' GLU . 5.3 tptp -97.52 29.24 3.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.261 -0.9 . . . . 0.0 110.524 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -153.68 -38.85 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.082 -1.011 . . . . 0.0 110.368 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 89.84 47.22 4.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -104.45 2.51 31.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.291 -1.123 . . . . 0.0 110.199 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.466 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 73.36 33.82 58.35 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -169.25 120.58 0.72 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.269 -1.136 . . . . 0.0 110.222 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.529 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 28.7 mt -97.56 124.47 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.172 -0.955 . . . . 0.0 110.189 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -84.68 -171.56 3.7 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.389 -0.819 . . . . 0.0 110.206 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.46 HG21 HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -78.0 -34.09 50.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.882 . . . . 0.0 109.937 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -76.16 -48.83 19.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.289 -0.882 . . . . 0.0 110.042 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 21' ' ' LYS . 43.2 tt0 -45.33 -59.76 2.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.91 . . . . 0.0 109.608 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.535 HD11 ' CH2' ' B' ' 7' ' ' TRP . 10.8 tp -60.76 -34.95 75.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.535 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.06 86.7 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.5 m -65.9 -51.07 61.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.344 -1.092 . . . . 0.0 109.543 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' A' ' 18' ' ' LEU . 48.9 t -52.54 -41.99 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.206 -0.934 . . . . 0.0 109.452 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.501 ' CE ' ' HE1' ' A' ' 51' ' ' MET . 4.8 mtt -64.74 -37.54 87.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.38 -0.825 . . . . 0.0 109.42 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -30.8 68.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.159 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.5 m -61.54 -34.01 74.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.9 . . . . 0.0 110.446 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mt -82.39 -3.11 54.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 110.224 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 86.57 86.07 1.07 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 0.8 OUTLIER -167.14 175.06 7.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -1.143 . . . . 0.0 110.143 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 11.7 p30 -139.63 84.31 15.96 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 0.0 110.291 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 44.0 Cg_endo -70.46 105.48 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.055 1.555 . . . . 0.0 110.496 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.446 ' HB ' ' OE2' ' A' ' 47' ' ' GLU . 8.9 m -61.18 150.82 33.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 110.058 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -49.43 -51.49 35.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.072 -1.018 . . . . 0.0 110.225 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.62 88.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.356 -0.84 . . . . 0.0 110.205 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -65.06 -50.98 64.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.0 110.211 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -50.33 -48.88 55.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -57.7 -36.81 72.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 5.5 m-20 -65.85 -46.98 76.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 109.949 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.566 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.1 OUTLIER -67.93 -36.68 80.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.945 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 52' ' ' ILE . 5.5 mm -65.63 -26.66 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 109.732 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.39 -9.15 58.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.306 -0.871 . . . . 0.0 110.046 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -75.3 -22.53 57.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 110.124 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 57' ' ' ALA . 12.1 t -113.8 -48.42 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.187 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 55' ' ' VAL . 13.8 t0 -42.26 89.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.695 -0.628 . . . . 0.0 110.478 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -93.12 -9.56 39.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.404 -0.81 . . . . 0.0 110.637 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.455 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 66.7 m-20 -78.24 -31.58 49.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.055 -1.028 . . . . 0.0 110.421 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.82 -16.28 18.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 3.5 p30 -77.58 -93.72 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.321 -1.105 . . . . 0.0 110.106 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 165.7 46.0 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -143.28 141.8 31.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.289 -1.124 . . . . 0.0 110.204 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.537 ' CD1' ' HB ' ' A' ' 55' ' ' VAL . 11.9 mm -92.09 129.42 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.26 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.543 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 9.5 t0 -117.18 179.9 3.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.603 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 17.1 t80 -67.15 -43.14 44.3 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 0.0 111.307 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.77 -35.54 7.45 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.348 1.183 . . . . 0.0 110.25 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 48.7 mt-10 -67.9 -28.44 67.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.107 -0.996 . . . . 0.0 109.141 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.412 ' CZ ' HD13 ' B' ' 11' ' ' ILE . 18.8 t80 -69.77 -53.24 19.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.602 -0.686 . . . . 0.0 110.317 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 mt -67.89 -17.66 64.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.284 -0.885 . . . . 0.0 110.513 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 m -78.29 -42.52 30.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.125 -0.984 . . . . 0.0 110.617 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.417 ' HE3' ' HB3' ' B' ' 7' ' ' TRP . 2.3 tmm? -72.66 -42.22 64.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.149 -0.97 . . . . 0.0 110.572 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.445 ' HE3' ' CE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -64.2 -9.46 17.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.487 -0.758 . . . . 0.0 111.231 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.31 -19.27 17.14 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.012 -1.055 . . . . 0.0 111.379 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.63 -20.85 15.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.979 -1.076 . . . . 0.0 111.02 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HG2' HG23 ' B' ' 8' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.009 -1.057 . . . . 0.0 110.5 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.328 0.585 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.69 -15.61 59.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.888 . . . . 0.0 109.982 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HG2' HD12 ' B' ' 12' ' ' LEU . 19.5 tt0 -81.83 -38.34 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 109.968 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.7 mt -67.49 -33.83 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.232 -0.917 . . . . 0.0 109.081 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -60.17 -27.19 66.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.563 -0.71 . . . . 0.0 109.091 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 1.2 mt-10 -74.76 -56.71 4.5 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.466 -0.771 . . . . 0.0 109.231 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' B' ' 12' ' ' LEU . . . -59.43 -28.85 67.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 109.567 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.439 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 15.9 t80 -69.65 -47.87 61.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.02 -1.05 . . . . 0.0 108.968 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 -47.53 -36.47 10.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.496 -0.752 . . . . 0.0 109.019 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.478 HG11 HG23 ' A' ' 108' ' ' VAL . 54.5 t -74.2 -33.56 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.535 -0.728 . . . . 0.0 110.285 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.535 ' CD1' HG13 ' A' ' 108' ' ' VAL . 16.1 m-85 -80.35 -31.29 37.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.128 -0.982 . . . . 0.0 110.287 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 96' ' ' GLY . 10.9 t0 -100.04 62.83 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.209 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -43.17 -33.01 0.82 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.78 -31.93 61.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.385 -0.822 . . . . 0.0 109.655 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 69.37 13.61 68.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 23.6 p-10 -69.45 -38.84 77.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -1.12 . . . . 0.0 110.324 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.44 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 139.19 -30.27 2.46 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 33.9 m-85 -107.29 156.78 18.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -1.127 . . . . 0.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 100' ' ' ILE . 11.4 mt -124.13 145.52 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.897 . . . . 0.0 110.018 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -124.96 147.78 48.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.168 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.29 -31.1 0.93 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.665 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.79 -47.08 79.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.359 -0.838 . . . . 0.0 109.395 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 10.0 mt-10 -54.99 -50.07 69.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.199 -0.938 . . . . 0.0 109.261 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 109' ' ' MET . 1.6 mm? -57.39 -52.79 63.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.328 -0.857 . . . . 0.0 109.185 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -45.96 -26.67 0.75 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.421 -0.8 . . . . 0.0 109.453 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.411 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -80.89 -34.59 33.43 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.373 -0.829 . . . . 0.0 110.21 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG13 ' CD1' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -89.57 -27.55 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 109.946 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.571 ' CE ' ' HB2' ' A' ' 116' ' ' LEU . 2.4 mmm -63.5 -49.5 73.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 110.659 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 m -77.82 -17.24 57.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.0 110.58 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 2.0 m120 -85.81 -3.39 58.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.089 -1.007 . . . . 0.0 109.968 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.523 ' CD1' ' CG1' ' B' ' 13' ' ' VAL . 5.4 mt -102.19 -42.75 5.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 110.426 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 162.67 -36.55 0.34 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.465 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.7 tp10 -109.7 147.0 33.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.991 -1.299 . . . . 0.0 110.828 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -119.93 74.68 1.04 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.547 -0.72 . . . . 0.0 109.282 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.571 ' HB2' ' CE ' ' A' ' 109' ' ' MET . 6.8 mp -38.46 160.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.687 -0.633 . . . . 0.0 110.709 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -60.69 -146.42 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.435 -0.791 . . . . 0.0 109.366 179.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -122.3 -60.28 1.57 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.238 -0.914 . . . . 0.0 109.929 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.65 -35.65 63.72 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 9.7 mm-40 -67.31 -56.11 11.12 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.295 -0.878 . . . . 0.0 109.08 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 117' ' ' THR . 87.4 t -43.66 -36.36 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 121.361 -0.837 . . . . 0.0 109.606 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.51 -51.86 52.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -58.25 -32.49 68.41 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.403 -0.811 . . . . 0.0 109.113 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.559 ' HE1' ' CD2' ' B' ' 22' ' ' PHE . 11.0 ttt -59.49 -44.75 93.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.495 -0.753 . . . . 0.0 109.636 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 125' ' ' ILE . 20.3 mm -71.72 -31.61 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 109.714 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.4 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 45.8 ttt85 -62.62 -42.76 99.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.98 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.9 -37.52 63.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.427 ' HA ' ' HE3' ' A' ' 144' ' ' MET . . . -84.77 -25.83 27.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 0.0 110.142 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 134' ' ' GLY . 2.6 m-20 -57.64 99.54 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.859 . . . . 0.0 110.483 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 35.3 mm -74.79 -39.13 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.244 -0.91 . . . . 0.0 109.886 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 8.0 p-10 -90.4 -17.57 27.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.34 -0.85 . . . . 0.0 109.984 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.95 55.98 3.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 6.4 p30 -113.04 0.66 15.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.335 -1.097 . . . . 0.0 110.23 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.503 ' N ' ' OD2' ' A' ' 129' ' ' ASP . . . 76.16 8.53 85.3 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -142.66 147.46 35.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -1.181 . . . . 0.0 110.406 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 39.7 t -100.9 152.0 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.34 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.57 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 62.5 t30 -122.65 158.47 29.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -0.86 . . . . 0.0 110.12 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -45.8 -54.95 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.77 -41.02 56.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.301 -0.875 . . . . 0.0 109.916 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 144' ' ' MET . 9.2 mt-10 -70.87 -47.31 59.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.0 110.021 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 89' ' ' PHE . 47.5 t80 -60.79 -17.95 52.38 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.299 -0.875 . . . . 0.0 109.968 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.9 t -100.19 -47.75 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.456 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -61.89 -26.86 68.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.172 -0.955 . . . . 0.0 110.23 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 17.8 mmm -82.62 -18.32 41.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.551 ' CE ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -99.33 -56.86 2.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.444 ' O ' HG21 ' A' ' 146' ' ' THR . 6.8 t . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.226 -0.921 . . . . 0.0 110.274 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.462 HD11 ' HG3' ' A' ' 51' ' ' MET . 11.0 pt . . . . . 0 C--O 1.215 -0.732 0 CA-C-O 120.913 0.387 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.36 153.16 50.35 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.09 1.574 . . . . 0.0 110.013 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.486 ' O ' ' HB ' ' B' ' 9' ' ' THR . 8.6 m -71.19 142.05 50.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.566 ' CD1' ' SD ' ' A' ' 51' ' ' MET . 6.8 m95 -36.29 -66.01 0.24 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.764 0.793 . . . . 0.0 110.555 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.457 HG23 ' HG2' ' A' ' 75' ' ' LYS . 10.8 p -45.38 -23.65 0.22 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.464 -0.773 . . . . 0.0 111.043 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.49 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 91.5 m -70.41 -56.65 6.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.886 -1.134 . . . . 0.0 109.87 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 32.7 m -53.16 -27.4 13.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.281 -0.887 . . . . 0.0 109.193 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.532 ' N ' HG21 ' B' ' 10' ' ' VAL . 26.0 mm -75.46 -30.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.447 -0.783 . . . . 0.0 109.61 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 84' ' ' GLU . 9.9 mt -65.91 -60.47 2.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 110.034 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.523 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 41.1 t -52.95 -39.01 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.626 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.459 ' HD3' HD11 ' A' ' 18' ' ' LEU . 1.6 tptp -64.74 -47.62 77.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.963 -1.085 . . . . 0.0 109.226 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 50.2 m -50.97 -31.27 17.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.403 -0.811 . . . . 0.0 109.738 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mmt -79.87 -27.18 40.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.354 -0.841 . . . . 0.0 109.956 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.544 HD11 ' N ' ' B' ' 17' ' ' LEU . 5.9 mp -80.04 54.47 1.92 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.344 -0.848 . . . . 0.0 109.88 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -72.58 0.57 Allowed 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.679 -0.638 . . . . 0.0 110.355 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -150.3 -60.28 0.19 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.944 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.542 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -156.64 17.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 110.208 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.465 ' O ' ' HE1' ' A' ' 124' ' ' MET . 0.3 OUTLIER -93.04 -162.1 0.9 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.217 -0.927 . . . . 0.0 110.42 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.559 ' CD2' ' HE1' ' A' ' 124' ' ' MET . 0.4 OUTLIER -174.21 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.231 -0.918 . . . . 0.0 110.523 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.09 -155.76 22.69 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.551 ' CB ' ' CE ' ' A' ' 145' ' ' MET . 3.3 m-20 -178.96 117.07 0.23 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 110.206 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.04 52.61 3.5 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.935 1.492 . . . . 0.0 110.397 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.445 ' CE2' ' HE3' ' A' ' 72' ' ' MET . 4.8 m-85 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.251 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.506 0.67 . . . . 0.0 109.36 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 98.5 mt -75.2 -34.98 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.366 -0.834 . . . . 0.0 109.712 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.22 -62.46 1.85 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 109.654 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 12' ' ' PHE . 11.4 pt-20 -56.94 -38.23 72.63 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.162 -0.961 . . . . 0.0 109.058 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.688 ' CD2' ' CZ ' ' A' ' 68' ' ' PHE . 1.8 m-85 -57.91 -45.66 86.14 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.358 -0.839 . . . . 0.0 109.019 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -41.33 66.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 109.18 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -53.36 -49.21 67.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.713 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HA ' ' HD2' ' B' ' 14' ' ' LYS . . . -59.28 -52.85 63.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 109.783 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 2.3 t80 -60.59 -35.6 76.49 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.614 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -67.06 -28.22 68.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.509 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 8.4 tt -68.7 -41.81 78.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.499 -0.751 . . . . 0.0 109.881 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -74.28 -57.88 3.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.455 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 21.9 t0 -64.97 129.93 41.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.375 -0.828 . . . . 0.0 110.54 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.78 -48.5 5.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.246 -0.909 . . . . 0.0 110.157 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.2 p-10 -75.04 -35.05 61.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.78 42.34 5.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 34.8 p-10 -90.76 -28.12 18.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -1.156 . . . . 0.0 110.057 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.523 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 112.74 31.0 2.64 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 11.1 p -159.73 125.24 4.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -1.135 . . . . 0.0 110.533 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.527 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 17.9 mt -91.97 119.22 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.21 -0.931 . . . . 0.0 109.999 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.6 p -100.17 172.91 6.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.92 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.6 p -64.43 -18.24 64.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.13 -0.981 . . . . 0.0 109.899 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -49.76 17.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.395 -0.816 . . . . 0.0 110.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 21' ' ' LYS . 20.9 mt-10 -67.21 -50.37 61.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 110.365 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 52' ' ' ILE . 13.1 tp -59.75 -51.47 69.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.287 -0.883 . . . . 0.0 110.347 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.14 -49.35 24.68 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.8 m -56.26 -47.4 78.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.229 -1.159 . . . . 0.0 110.576 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 t -62.77 -45.26 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 0.0 110.293 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.52 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 16.2 mmm -64.24 -39.64 94.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 110.405 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -15.91 61.55 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.099 -1.001 . . . . 0.0 110.237 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 39' ' ' LEU . 32.2 t -75.0 -46.05 37.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 111.058 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 38' ' ' SER . 1.9 mt -45.76 -27.31 0.8 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.914 -1.116 . . . . 0.0 109.823 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.93 -32.34 2.9 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB3' HD13 ' B' ' 4' ' ' ILE . 0.8 OUTLIER -72.08 -178.59 2.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.135 -1.215 . . . . 0.0 110.684 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -131.07 93.88 29.35 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.252 -0.905 . . . . 0.0 110.317 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.52 ' HG3' ' CB ' ' A' ' 36' ' ' MET . 45.4 Cg_endo -73.16 115.97 4.54 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.004 1.529 . . . . 0.0 110.302 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.23 164.94 23.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 110.239 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 42.9 mt-10 -61.07 -42.23 98.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.276 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.12 74.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.208 -0.933 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 51' ' ' MET . 4.6 mm-40 -66.65 -32.92 74.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 110.042 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 13.0 mt -60.37 -52.16 66.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 0.0 110.123 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -62.91 -42.39 99.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 110.107 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.89 -15.41 63.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 110.012 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.485 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 1.2 mtp -86.9 -42.94 12.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.14 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.518 ' CD1' HD23 ' A' ' 32' ' ' LEU . 1.1 mp -80.27 -11.15 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.078 -1.014 . . . . 0.0 109.731 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -83.43 -18.58 38.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 110.856 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 51' ' ' MET . 21.8 pt-20 -94.48 -18.93 21.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.036 -1.04 . . . . 0.0 110.988 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.661 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 50.6 t -99.1 -31.57 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.95 -1.094 . . . . 0.0 110.061 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -47.16 89.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.539 -0.726 . . . . 0.0 110.539 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.12 -49.63 71.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.451 -0.781 . . . . 0.0 110.172 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 14.8 p-10 -75.69 -37.91 59.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 110.063 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.42 45.78 2.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 36.0 p-10 -98.5 -38.72 9.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.274 -1.133 . . . . 0.0 110.141 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 127.6 -8.09 6.95 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p -135.79 148.52 48.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -1.167 . . . . 0.0 110.189 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.527 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 31.8 mm -82.14 140.06 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.122 -0.986 . . . . 0.0 109.91 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -114.46 157.66 22.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.066 -1.021 . . . . 0.0 110.797 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.578 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 52.8 t80 -48.9 -50.34 62.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.443 -0.786 . . . . 0.0 111.187 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.9 Cg_endo -64.39 -32.27 60.87 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.258 1.136 . . . . 0.0 110.344 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 71' ' ' MET . 7.1 tt0 -59.97 -35.46 75.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.124 -0.985 . . . . 0.0 109.291 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.688 ' CZ ' ' CD2' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -76.98 -48.78 17.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 65' ' ' PHE . 3.1 mm? -43.09 -45.28 5.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 110.625 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.31 -37.44 14.91 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.073 -1.017 . . . . 0.0 110.762 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -44.04 -38.91 3.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.191 -0.943 . . . . 0.0 110.72 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.604 ' HE1' ' CE1' ' B' ' 26' ' ' PHE . 5.7 tpt -74.65 -9.76 58.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.136 -0.977 . . . . 0.0 110.542 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -101.4 -10.83 19.88 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.248 -0.908 . . . . 0.0 110.579 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -99.61 -49.64 4.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.067 -1.021 . . . . 0.0 110.407 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HG3' ' CG2' ' B' ' 8' ' ' THR . 20.2 mmtt . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.504 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.137 0.494 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -79.66 -17.04 54.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.044 -1.035 . . . . 0.0 110.409 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -81.26 -22.71 38.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.026 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.458 HG12 ' HG2' ' A' ' 145' ' ' MET . 59.8 mt -79.09 -44.14 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.859 . . . . 0.0 110.039 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.474 ' CD ' ' OH ' ' A' ' 138' ' ' TYR . 5.4 ttp180 -55.55 -34.94 65.16 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.529 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.54 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 14.1 mt-10 -71.16 -47.55 57.02 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.437 -0.789 . . . . 0.0 109.893 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.559 ' CB ' HD21 ' B' ' 12' ' ' LEU . . . -64.92 -29.05 69.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.041 -1.037 . . . . 0.0 109.828 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.01 -39.37 83.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 109.511 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -67.44 -37.95 83.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.39 -0.819 . . . . 0.0 109.503 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.424 HG11 HG22 ' A' ' 108' ' ' VAL . 11.7 t -58.51 -44.62 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.414 -0.804 . . . . 0.0 109.704 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.402 ' CD2' ' HE2' ' A' ' 141' ' ' PHE . 20.4 m-85 -66.47 -30.58 70.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.613 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.458 ' OD1' ' OD1' ' A' ' 97' ' ' ASN . 11.6 t0 -91.42 58.47 3.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.406 -0.809 . . . . 0.0 110.092 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 93' ' ' ASP . 2.3 mmmm -43.46 -32.3 0.86 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -0.962 . . . . 0.0 110.142 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.0 p30 -83.44 -34.13 25.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.181 -0.949 . . . . 0.0 110.109 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 81.39 42.41 9.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.458 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 38.2 p30 -100.07 -17.72 17.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -1.197 . . . . 0.0 110.167 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 102.59 27.96 6.53 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 94.4 m-85 -156.95 146.65 20.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -1.08 . . . . 0.0 110.004 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 100' ' ' ILE . 80.3 mt -119.74 111.98 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.16 -0.963 . . . . 0.0 110.411 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 37.4 t -95.89 149.18 21.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.22 -31.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.168 -0.958 . . . . 0.0 109.947 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.56 -51.62 64.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.855 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.461 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 28.3 mt-10 -53.39 -38.89 63.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.67 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.507 ' CD1' HD13 ' A' ' 125' ' ' ILE . 1.2 mt -59.85 -44.57 94.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.376 -0.827 . . . . 0.0 109.711 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.467 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.0 OUTLIER -65.8 -20.78 66.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 109.619 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -81.77 -32.56 31.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.422 -0.799 . . . . 0.0 109.847 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG22 HG11 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -83.17 -34.14 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.93 . . . . 0.0 109.789 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.579 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 11.2 ptp -79.42 -35.85 39.93 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.155 -0.965 . . . . 0.0 109.561 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.461 ' N ' ' HG3' ' A' ' 109' ' ' MET . 19.6 m -68.97 -30.52 68.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 108.802 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -85.91 -19.53 30.38 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.433 -0.792 . . . . 0.0 108.97 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.526 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 9.5 mt -84.46 -32.38 24.06 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.535 -0.728 . . . . 0.0 110.122 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.98 -39.87 1.51 Allowed Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.495 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.453 ' HG2' HD13 ' A' ' 116' ' ' LEU . 2.1 tt0 -94.23 157.59 15.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.995 -1.297 . . . . 0.0 110.709 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 116' ' ' LEU . 1.8 pttt -135.86 73.21 1.46 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.565 -0.709 . . . . 0.0 109.205 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 117' ' ' THR . 3.3 mp -38.79 145.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.593 -0.692 . . . . 0.0 110.794 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -56.47 -156.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 110.387 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -97.75 -48.82 5.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.224 -0.922 . . . . 0.0 110.149 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.31 -33.05 75.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.047 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.505 ' CG ' ' HB3' ' B' ' 20' ' ' ARG . 2.5 tt0 -66.16 -47.25 74.64 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.61 0.719 . . . . 0.0 109.33 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 117' ' ' THR . 19.0 t -65.0 -42.15 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.519 -0.738 . . . . 0.0 110.387 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -62.99 -65.14 0.73 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.952 . . . . 0.0 109.827 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 122' ' ' ASP . 2.0 mm-40 -44.42 -30.19 0.81 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.381 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.521 ' HE3' ' CD1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -62.91 -61.75 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 110.205 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.507 HD13 ' CD1' ' A' ' 105' ' ' LEU . 30.3 mm -59.55 -39.02 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 127' ' ' GLU . 2.8 mtt180 -60.09 -53.2 60.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.859 . . . . 0.0 110.355 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -43.3 -32.65 0.83 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.94 -26.93 13.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 110.146 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.3 OUTLIER -71.49 64.65 0.43 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.3 -0.875 . . . . 0.0 110.352 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.8 mt -63.15 -32.01 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 21.0 p-10 -77.01 -28.83 55.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.248 -0.907 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.85 64.74 1.99 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 20.4 p-10 -114.43 -23.0 9.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -1.135 . . . . 0.0 110.185 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 115.5 -6.7 20.67 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.461 ' OE1' ' HB3' ' A' ' 99' ' ' TYR . 3.3 pt20 -158.38 163.17 37.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.29 -1.124 . . . . 0.0 110.022 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 137' ' ' ASN . 61.6 t -90.76 168.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.192 -0.942 . . . . 0.0 110.649 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.491 ' N ' HG13 ' A' ' 136' ' ' VAL . 15.4 t-20 -133.06 177.35 7.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.481 -0.762 . . . . 0.0 109.976 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.474 ' OH ' ' CD ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -56.05 -69.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.152 -0.967 . . . . 0.0 110.771 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 17.2 pt-20 -43.36 -39.08 2.99 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.146 -0.971 . . . . 0.0 110.692 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 139' ' ' GLU . 57.6 mt-10 -66.5 -60.21 2.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.168 -0.957 . . . . 0.0 110.211 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 145' ' ' MET . 26.6 t80 -46.98 -22.23 0.3 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.231 -0.918 . . . . 0.0 110.35 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.29 -44.01 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.753 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -56.44 -18.19 10.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.179 -0.95 . . . . 0.0 110.631 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.417 ' HE1' ' HB3' ' A' ' 144' ' ' MET . 46.2 mmm -112.58 -10.15 13.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.151 -0.968 . . . . 0.0 110.263 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.458 ' HG2' HG12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -98.17 -9.58 25.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 110.211 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.259 -0.901 . . . . 0.0 110.35 -179.884 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.58 ' CG1' ' HD2' ' B' ' 5' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.58 ' HD2' ' CG1' ' B' ' 4' ' ' ILE . 38.1 Cg_endo -64.24 151.55 84.95 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.528 1.278 . . . . 0.0 110.473 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.444 ' O ' ' CE ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -74.65 -52.36 11.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.482 -0.761 . . . . 0.0 111.759 -178.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.661 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -172.04 -76.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.82 -1.175 . . . . 0.0 110.754 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.505 ' CG2' ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -46.11 -48.06 17.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 0.0 109.677 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.54 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 4.8 m -44.65 -51.65 8.94 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.391 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 35.2 t -51.36 -43.08 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.263 -0.898 . . . . 0.0 108.958 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 15.5 mm -66.36 -27.5 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.139 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.559 HD21 ' CB ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -63.9 -58.71 5.94 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.623 -0.673 . . . . 0.0 109.964 179.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.442 ' CG1' HD13 ' A' ' 112' ' ' LEU . 54.3 t -60.39 -39.22 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.936 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.441 ' CG ' HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -62.12 -61.29 2.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.087 -1.008 . . . . 0.0 109.722 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 74.5 m -60.74 -18.88 57.3 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.43 -0.794 . . . . 0.0 109.875 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.514 ' O ' ' CG ' ' B' ' 19' ' ' LYS . 6.2 ttt -80.1 -18.45 49.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.579 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 5.2 mp -73.76 -50.32 21.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.248 -0.907 . . . . 0.0 110.58 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.473 ' O ' ' HB3' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -65.44 60.21 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.605 -0.684 . . . . 0.0 110.4 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' B' ' 16' ' ' MET . 0.0 OUTLIER -179.98 120.54 0.06 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.505 ' HB3' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -73.01 20.53 0.08 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.662 -0.649 . . . . 0.0 112.086 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.512 ' O ' ' CD ' ' B' ' 19' ' ' LYS . 0.4 OUTLIER -128.64 175.67 8.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.934 -1.104 . . . . 0.0 109.76 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.521 ' CD1' ' HE3' ' A' ' 124' ' ' MET . 0.6 OUTLIER -112.12 177.88 4.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.023 -1.048 . . . . 0.0 110.069 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.52 140.73 0.06 OUTLIER Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.499 ' ND2' ' HD2' ' B' ' 25' ' ' PRO . 0.4 OUTLIER -121.88 140.15 31.51 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.26 . . . . 0.0 110.948 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.499 ' HD2' ' ND2' ' B' ' 24' ' ' ASN . 44.3 Cg_endo -72.25 55.99 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.046 1.551 . . . . 0.0 109.655 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.604 ' CE1' ' HE1' ' A' ' 72' ' ' MET . 1.4 m-85 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.286 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.261 0.553 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.1 mt -50.93 -42.34 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.202 -0.937 . . . . 0.0 109.381 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -50.6 -45.32 57.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.358 -0.839 . . . . 0.0 109.266 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -57.3 -48.47 78.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.33 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.433 ' HB3' HD22 ' A' ' 69' ' ' LEU . 20.1 m-30 -53.86 -46.24 71.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.307 -0.871 . . . . 0.0 109.379 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -57.81 -46.37 84.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.883 . . . . 0.0 109.289 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -60.09 -44.9 94.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.3 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.17 95.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.383 -0.823 . . . . 0.0 109.557 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.515 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 7.2 t80 -62.97 -22.27 66.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.942 . . . . 0.0 109.074 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.51 -47.68 9.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.522 -0.736 . . . . 0.0 109.588 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 10.2 tt -47.66 -41.12 21.61 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.321 -0.862 . . . . 0.0 109.504 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 41.0 m-85 -79.89 -46.16 17.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.884 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.455 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 39.5 t0 -80.46 101.94 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.451 -0.78 . . . . 0.0 110.154 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 4.32 51.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.29 -0.881 . . . . 0.0 110.431 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.427 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 33.3 m-20 -97.08 -37.8 10.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.149 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.33 27.95 10.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 10.3 p30 -102.67 -17.03 15.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -1.169 . . . . 0.0 110.195 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 91.07 22.55 32.37 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 14.1 p -138.3 122.72 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.216 -1.167 . . . . 0.0 110.468 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.492 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 13.4 mt -89.3 114.63 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.124 -0.985 . . . . 0.0 110.137 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -93.46 155.73 17.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.714 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' HD11 ' A' ' 48' ' ' LEU . 32.0 p -54.9 -22.71 15.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 110.039 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -43.62 63.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.88 . . . . 0.0 109.972 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' OE1' ' OG1' ' A' ' 28' ' ' THR . 17.0 mt-10 -64.5 -56.68 12.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 0.0 110.093 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 tp -54.54 -36.37 64.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 109.858 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.28 -40.91 99.62 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 m -58.49 -53.07 62.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -1.119 . . . . 0.0 109.819 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.0 t -56.93 -53.9 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.603 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.468 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -50.76 -41.01 56.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 109.736 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -62.91 -27.81 69.62 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 0.0 109.886 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -79.41 -59.54 2.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.821 . . . . 0.0 110.933 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.494 HD21 HG21 ' A' ' 108' ' ' VAL . 4.0 mt -44.04 -37.54 3.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.131 -0.981 . . . . 0.0 110.082 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.08 64.85 0.16 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.507 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -144.82 -168.23 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -1.178 . . . . 0.0 110.119 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.501 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 2.5 m120 -155.1 57.75 1.75 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.062 -1.024 . . . . 0.0 110.578 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 50.1 Cg_endo -80.35 135.73 10.86 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.907 1.477 . . . . 0.0 110.061 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 45' ' ' GLU . 5.1 m -97.26 163.36 12.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.206 -0.933 . . . . 0.0 110.067 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.2 mt-10 -43.05 -54.92 4.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 109.997 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.56 -55.43 33.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 110.043 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HG3' ' HB ' ' A' ' 44' ' ' THR . 21.3 mt-10 -47.46 -44.46 25.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 109.72 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 15.1 mt -55.8 -43.44 76.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.358 -0.839 . . . . 0.0 109.912 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -54.9 -41.42 70.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.441 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.06 -42.94 91.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.447 -0.783 . . . . 0.0 109.648 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.569 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.3 OUTLIER -74.95 -49.44 20.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 109.765 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 7.3 mm -52.4 -25.2 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.624 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -30.59 67.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.345 -0.847 . . . . 0.0 110.185 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 1.3 mp0 -70.24 -25.63 63.47 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.53 HG22 ' NE1' ' B' ' 7' ' ' TRP . 5.6 t -108.07 -28.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 19.2 t0 -63.85 72.17 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.312 -0.867 . . . . 0.0 110.323 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -68.65 -35.69 77.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 110.415 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 24.3 p30 -82.44 -20.15 37.56 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.141 -0.975 . . . . 0.0 110.489 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 81.07 26.49 52.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.523 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 31.8 p-10 -89.66 -30.44 18.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -1.179 . . . . 0.0 110.09 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 113.92 -24.23 12.1 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.523 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 80.7 p -112.65 157.27 21.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -1.215 . . . . 0.0 110.393 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.492 ' CG1' ' HB ' ' A' ' 27' ' ' ILE . 10.2 mm -95.72 144.28 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 110.144 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 75.8 m-20 -110.67 160.68 16.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 109.975 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.576 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 33.0 t80 -52.4 -47.73 92.11 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.289 -0.882 . . . . 0.0 111.271 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -69.42 -41.82 4.34 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.203 1.107 . . . . 0.0 110.163 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 2.9 tt0 -55.6 -45.15 77.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 110.114 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.0 -47.35 86.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 110.118 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 12' ' ' PHE . 85.4 mt -57.41 -23.05 47.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.232 -0.917 . . . . 0.0 110.156 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.3 m -90.1 -21.7 22.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.258 -0.901 . . . . 0.0 111.012 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.476 ' SD ' HG21 ' A' ' 55' ' ' VAL . 3.1 ttp -75.48 -45.37 38.82 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.959 -1.088 . . . . 0.0 109.905 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.547 ' HE2' ' CE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -53.91 -17.27 2.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.39 -0.819 . . . . 0.0 110.907 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.02 -11.69 15.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.936 -1.102 . . . . 0.0 111.324 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -96.53 -36.23 10.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.817 -1.177 . . . . 0.0 110.678 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.534 ' HB3' ' CG2' ' B' ' 8' ' ' THR . 8.9 tttp . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.239 -0.913 . . . . 0.0 110.535 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.31 -24.64 67.72 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 25.3 tt0 -55.57 -36.92 67.37 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.509 -0.745 . . . . 0.0 109.605 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.486 ' CD1' HG23 ' A' ' 146' ' ' THR . 78.1 mt -70.4 -44.96 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.269 -0.895 . . . . 0.0 109.025 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -54.98 -28.71 53.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.484 -0.76 . . . . 0.0 109.132 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 4.2 mt-10 -69.61 -58.9 3.37 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.471 -0.768 . . . . 0.0 109.445 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.35 -31.39 54.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 0.0 109.247 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.488 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 17.1 t80 -63.72 -45.05 91.7 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -60.82 -34.89 75.23 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -71.49 -42.1 72.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.496 ' CZ ' ' HA ' ' B' ' 13' ' ' VAL . 9.6 m-85 -72.25 -34.57 68.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 108.76 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 96' ' ' GLY . 14.5 t0 -95.24 61.28 2.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.56 -0.713 . . . . 0.0 109.791 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.532 ' HA ' ' CE ' ' A' ' 94' ' ' LYS . 2.1 mmpt? -43.36 -28.02 0.3 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.16 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.43 ' OD2' ' CG ' ' A' ' 97' ' ' ASN . 49.7 t0 -67.89 -41.31 82.93 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 73.11 -0.17 48.53 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.43 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 28.5 p-10 -73.01 -24.07 60.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.117 -1.225 . . . . 0.0 110.117 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.463 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 115.21 35.44 1.33 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.467 ' O ' ' OE2' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -158.51 105.38 1.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.257 -1.143 . . . . 0.0 110.231 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 100' ' ' ILE . 7.2 mt -81.37 135.47 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.248 -0.907 . . . . 0.0 110.026 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -129.29 148.84 51.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.01 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.87 -30.95 1.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 109.848 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.5 79.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.599 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 99' ' ' TYR . 35.0 mt-10 -61.57 -43.64 98.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.386 -0.821 . . . . 0.0 109.953 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 0.7 OUTLIER -59.76 -42.64 93.71 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.323 -0.86 . . . . 0.0 109.363 179.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -36.88 74.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.799 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -65.15 -44.39 88.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.823 . . . . 0.0 109.843 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.494 HG21 HD21 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -74.0 -33.62 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.803 . . . . 0.0 109.417 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.555 ' HA ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -60.82 -65.61 0.66 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 110.174 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m -51.92 -32.84 34.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.116 -0.99 . . . . 0.0 109.507 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 9.6 m120 -77.68 -20.65 53.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 109.547 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.529 ' CD1' HG11 ' B' ' 13' ' ' VAL . 2.5 mt -85.05 -40.41 16.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.511 -0.743 . . . . 0.0 110.168 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.26 -47.39 0.55 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -94.0 165.18 12.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.143 -1.21 . . . . 0.0 111.043 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' LEU . 4.0 ptpp? -140.67 62.82 1.48 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.503 -0.748 . . . . 0.0 109.358 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' B' ' 19' ' ' LYS . 1.6 mp -38.34 140.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.696 -0.628 . . . . 0.0 110.467 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.499 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -50.85 -173.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.37 -0.831 . . . . 0.0 110.478 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 119' ' ' GLU . 20.1 t70 -86.34 -62.32 1.54 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.026 -1.046 . . . . 0.0 110.361 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.508 ' HA ' ' OD2' ' A' ' 122' ' ' ASP . 3.2 tt0 -44.11 -49.61 8.86 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 109.916 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.95 -55.33 36.0 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.519 HG23 ' CE ' ' A' ' 109' ' ' MET . 46.3 t -49.52 -43.6 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.556 -0.715 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 123' ' ' GLU . 9.4 p30 -68.75 -22.53 64.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.757 -1.214 . . . . 0.0 109.966 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 40.1 mm-40 -80.56 -27.82 37.4 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.351 -0.843 . . . . 0.0 108.867 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.524 ' HE3' ' CE1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -67.79 -43.6 79.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.594 -0.691 . . . . 0.0 109.419 179.245 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.592 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 41.5 mm -67.66 -43.49 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.0 109.691 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 126' ' ' ARG . 6.7 mmm-85 -56.98 -39.43 74.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -59.45 -28.59 67.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.355 -0.841 . . . . 0.0 109.996 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.457 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -99.25 -18.25 17.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.378 -0.827 . . . . 0.0 110.022 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.453 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 1.2 m-20 -59.12 98.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.244 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 128' ' ' ALA . 13.5 mm -67.38 -44.61 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.325 -0.859 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 19.2 p-10 -90.07 -19.2 24.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 110.093 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 79.23 64.08 1.97 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.514 ' OD2' ' NE2' ' A' ' 135' ' ' GLN . 31.1 p-10 -116.04 -34.73 4.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -1.155 . . . . 0.0 110.143 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 118.34 19.5 4.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.514 ' NE2' ' OD2' ' A' ' 133' ' ' ASP . 3.9 pp0? -160.21 159.01 31.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.173 -1.192 . . . . 0.0 110.434 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.416 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 87.2 t -114.9 108.59 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -80.69 -173.25 4.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.212 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.429 ' O ' ' C ' ' A' ' 139' ' ' GLU . 25.5 t80 -67.66 -67.18 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 110.311 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 138' ' ' TYR . 2.3 tt0 -42.85 -27.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.772 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 144' ' ' MET . 1.6 tt0 -80.94 -53.15 6.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 110.356 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.488 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 69.5 t80 -58.26 -18.31 25.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 66.5 t -99.75 -62.67 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.345 -0.847 . . . . 0.0 110.568 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -52.53 -18.96 1.95 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.254 -0.904 . . . . 0.0 110.489 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.477 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -97.81 -20.94 17.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.128 -0.983 . . . . 0.0 110.165 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.476 ' HA ' ' ND2' ' B' ' 24' ' ' ASN . 8.2 ttm -100.78 -26.37 13.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.355 -0.841 . . . . 0.0 110.746 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.486 HG23 ' CD1' ' A' ' 85' ' ' ILE . 4.7 t . . . . . 0 N--CA 1.499 2.007 0 O-C-N 120.907 -1.121 . . . . 0.0 110.888 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.569 ' CG2' ' CD ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.149 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.569 ' CD ' ' CG2' ' B' ' 4' ' ' ILE . 46.4 Cg_endo -83.03 -158.16 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.559 1.294 . . . . 0.0 110.534 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.524 ' O ' ' N ' ' B' ' 8' ' ' THR . 2.4 p -136.93 56.2 1.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.98 -1.075 . . . . 0.0 111.047 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.597 ' O ' ' CG2' ' B' ' 10' ' ' VAL . 3.0 m95 54.03 -82.15 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.253 -0.904 . . . . 0.0 111.05 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.534 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 7.1 p -41.31 -25.12 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.844 -1.16 . . . . 0.0 110.633 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.496 ' N ' ' O ' ' B' ' 7' ' ' TRP . 50.6 m -64.18 -53.47 48.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 109.638 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.597 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 4.5 m -58.59 -26.34 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.296 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.48 HD11 ' HE1' ' A' ' 72' ' ' MET . 2.9 mt -75.05 -33.13 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.266 -0.897 . . . . 0.0 109.078 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.459 HD23 ' HE3' ' A' ' 145' ' ' MET . 1.3 mt -59.47 -59.57 5.23 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 110.125 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.529 HG11 ' CD1' ' A' ' 112' ' ' LEU . 61.8 t -62.66 -40.47 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 110.939 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -63.43 -31.0 72.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.965 -1.084 . . . . 0.0 110.072 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 0.5 OUTLIER -76.4 -24.23 54.05 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.363 -0.836 . . . . 0.0 110.092 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.5 ' O ' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -83.67 -17.62 40.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.272 -0.892 . . . . 0.0 111.301 -179.323 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 19' ' ' LYS . 0.3 OUTLIER -78.79 -109.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.406 -1.434 . . . . 0.0 110.081 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.47 ' C ' ' HG3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 58.58 -72.64 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.131 -0.98 . . . . 0.0 110.821 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -172.94 90.62 0.09 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.348 -0.845 . . . . 0.0 112.256 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' B' ' 19' ' ' LYS . 0.7 OUTLIER 62.1 4.67 1.25 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.534 -1.354 . . . . 0.0 110.829 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.5 ' O ' ' O ' ' B' ' 16' ' ' MET . 12.1 t -66.01 119.04 10.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.945 -1.097 . . . . 0.0 110.23 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.524 ' CE1' ' HE3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -152.57 53.68 0.78 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.095 -1.003 . . . . 0.0 110.221 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.45 -136.23 6.42 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 2.0 m120 -130.51 65.17 75.45 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.247 -1.149 . . . . 0.0 110.637 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.27 42.26 1.29 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.937 1.493 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.547 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 5.7 m-85 . . . . . 0 N--CA 1.498 1.927 0 O-C-N 121.074 -1.016 . . . . 0.0 110.293 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.301 0.572 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mt -56.97 -43.85 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.682 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.88 -51.81 62.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.682 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.511 ' OE2' ' CD ' ' B' ' 18' ' ' ARG . 16.9 tt0 -56.9 -45.98 82.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.674 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -63.04 -41.34 99.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -61.4 -41.19 96.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.433 ' O ' ' OG ' ' A' ' 17' ' ' SER . 7.6 tt0 -63.18 -48.07 79.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.249 -0.907 . . . . 0.0 109.258 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -62.5 -46.44 88.44 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.4 -0.813 . . . . 0.0 109.395 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 65' ' ' PHE . 41.0 t80 -61.26 -38.43 86.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.338 -0.851 . . . . 0.0 109.0 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 14' ' ' GLU . 77.5 p -75.19 -35.55 61.52 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.539 -0.725 . . . . 0.0 109.365 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 112' ' ' LEU . 1.1 tt -50.16 -44.86 52.83 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.815 . . . . 0.0 109.217 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -76.83 -51.53 11.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.431 -0.793 . . . . 0.0 109.472 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.458 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 46.0 t0 -77.17 78.2 3.71 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.509 -0.744 . . . . 0.0 110.009 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -68.22 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.6 p-10 -51.64 -27.52 11.66 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.431 -0.793 . . . . 0.0 110.293 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 80.21 18.61 71.37 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 53.6 p30 -62.24 -12.47 20.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -1.191 . . . . 0.0 109.962 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 86.98 29.39 23.23 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 4.2 p -152.61 118.57 5.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.268 -1.137 . . . . 0.0 110.601 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.492 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 10.7 mt -94.22 120.12 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.163 -0.96 . . . . 0.0 110.172 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.53 164.76 11.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.353 -0.842 . . . . 0.0 109.984 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.436 ' O ' HD11 ' A' ' 48' ' ' LEU . 38.6 p -56.63 -29.31 62.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.992 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -69.51 -60.83 2.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.803 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -49.06 -57.53 6.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -0.888 . . . . 0.0 110.14 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -52.86 -41.96 64.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.781 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.495 ' HA2' ' CG ' ' A' ' 43' ' ' PRO . . . -58.39 -34.88 76.63 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.7 m -62.85 -56.92 13.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -1.11 . . . . 0.0 110.035 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG12 HD22 ' A' ' 18' ' ' LEU . 16.4 t -53.71 -32.71 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.334 -0.854 . . . . 0.0 109.883 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -27.28 59.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 109.956 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.422 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 1.4 ttp180 -76.73 -21.67 54.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -0.955 . . . . 0.0 110.121 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -33.71 59.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -0.922 . . . . 0.0 110.357 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mt -74.94 -44.1 50.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.229 -0.919 . . . . 0.0 110.231 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.16 78.76 0.08 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -176.45 -174.51 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.259 -1.142 . . . . 0.0 110.283 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -142.55 93.43 6.97 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.0 110.315 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 44.5 Cg_endo -74.61 90.92 1.01 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 124.092 1.575 . . . . 0.0 110.297 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.29 145.86 52.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 110.428 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -49.07 -64.79 0.7 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.24 -0.913 . . . . 0.0 110.573 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -43.84 -51.14 7.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.939 -1.101 . . . . 0.0 110.046 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -65.13 -35.21 80.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.876 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.436 HD11 ' O ' ' A' ' 29' ' ' THR . 11.0 mt -62.38 -47.68 83.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 110.09 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -57.48 -44.85 85.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.875 . . . . 0.0 109.821 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.17 -27.15 69.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.419 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.437 ' SD ' HG22 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -74.66 -54.13 8.0 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.493 -0.754 . . . . 0.0 110.129 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -13.08 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.253 -0.904 . . . . 0.0 109.753 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.46 -24.74 63.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.187 -0.946 . . . . 0.0 109.212 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.85 -47.89 13.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.519 -0.738 . . . . 0.0 109.962 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.602 HG22 ' CD1' ' B' ' 7' ' ' TRP . 88.3 t -69.6 -18.09 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.651 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' ALA . 17.2 t0 -67.68 57.78 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.021 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -43.36 -55.58 4.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.952 . . . . 0.0 110.256 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.485 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 6.9 p-10 -64.1 -44.15 93.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.86 35.39 3.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.485 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 6.9 p-10 -98.64 -44.93 6.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -1.207 . . . . 0.0 110.137 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.448 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . 142.15 -54.88 0.6 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.28 156.56 19.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.252 -1.146 . . . . 0.0 110.701 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.52 ' CD1' HG13 ' A' ' 55' ' ' VAL . 7.9 mm -90.39 142.93 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.805 . . . . 0.0 109.378 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.457 ' OD1' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -108.64 176.82 4.98 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.031 -1.043 . . . . 0.0 110.809 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.612 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 4.1 t80 -66.99 -45.2 52.92 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.495 -0.753 . . . . 0.0 111.372 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.8 Cg_endo -69.02 -37.81 10.38 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.203 1.107 . . . . 0.0 109.938 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 3.2 mt-10 -52.93 -41.66 64.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.293 -0.88 . . . . 0.0 109.218 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 16.3 t80 -64.51 -50.33 67.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.748 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.423 ' N ' HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -51.44 -26.29 7.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.84 . . . . 0.0 110.574 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 34.8 m -98.4 -20.4 17.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 111.167 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.481 ' HE3' ' HB2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -78.99 -30.69 44.47 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.958 -1.089 . . . . 0.0 110.861 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.503 ' HE3' ' CE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -77.09 -9.08 58.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.192 -0.942 . . . . 0.0 110.839 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.58 -16.55 8.84 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.867 -1.145 . . . . 0.0 111.405 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -99.94 -9.91 22.25 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.883 -1.136 . . . . 0.0 110.491 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HB3' HG22 ' B' ' 8' ' ' THR . 6.5 tptt . . . . . 0 C--N 1.296 -1.731 0 O-C-N 121.29 -0.881 . . . . 0.0 110.618 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.19 0.519 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -67.42 -40.11 85.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.716 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -51.8 -31.79 28.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 109.911 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.412 HG22 HG21 ' A' ' 142' ' ' VAL . 62.2 mt -78.78 -50.84 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.155 -0.966 . . . . 0.0 109.313 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.449 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 14.9 ttm180 -49.38 -40.6 36.49 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 109.5 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.52 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 26.4 mt-10 -69.06 -52.77 25.06 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.292 -0.88 . . . . 0.0 109.581 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.33 -27.04 44.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.07 -1.019 . . . . 0.0 109.071 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 86' ' ' ARG . 83.3 t80 -69.75 -45.58 67.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 0.0 109.112 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -56.61 -37.47 70.71 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.591 -0.693 . . . . 0.0 109.36 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 108' ' ' VAL . 82.1 t -64.92 -41.07 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.503 -0.748 . . . . 0.0 109.748 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CE2' HD22 ' A' ' 105' ' ' LEU . 5.0 m-85 -66.42 -31.34 72.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.0 109.37 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.468 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 3.8 t0 -91.13 59.92 4.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.479 -0.763 . . . . 0.0 109.986 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -38.96 -39.8 0.58 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.441 -0.787 . . . . 0.0 110.794 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.0 p-10 -86.58 -35.06 19.68 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 0.0 110.121 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 82.55 44.6 7.27 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -94.64 -23.61 17.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -1.197 . . . . 0.0 110.177 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 114.88 29.32 2.64 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 41.8 m-85 -160.62 150.59 17.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.174 -1.192 . . . . 0.0 110.039 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.454 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 9.0 mt -119.06 118.09 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 102' ' ' ALA . 2.0 t -105.33 145.88 30.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 110.147 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.87 -33.03 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.811 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.15 82.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 109.546 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 39.6 mt-10 -55.77 -41.27 73.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.882 . . . . 0.0 109.492 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 7.7 mt -59.74 -44.67 93.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 109.601 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -57.5 -39.35 76.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -0.825 . . . . 0.0 109.592 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -63.5 -50.8 68.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 109.554 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -63.76 -25.27 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 108.898 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.528 ' HB3' ' HA ' ' A' ' 115' ' ' LYS . 2.6 mtm -69.13 -65.37 0.72 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.672 -0.643 . . . . 0.0 109.988 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -51.99 -28.88 18.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -78.55 -10.5 59.75 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.277 -0.889 . . . . 0.0 109.337 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' B' ' 14' ' ' LYS . 13.8 mt -107.34 -48.5 3.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.356 -0.84 . . . . 0.0 110.479 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.58 -59.5 0.18 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.548 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 109' ' ' MET . 2.7 tp10 -99.76 159.23 15.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.934 -1.333 . . . . 0.0 110.819 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 1.1 pttp -123.57 1.91 8.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.375 -0.828 . . . . 0.0 110.012 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 115' ' ' LYS . 4.8 mp 48.11 175.81 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.56 0.695 . . . . 0.0 110.969 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.421 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.46 178.91 6.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.138 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -50.97 9.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.96 -1.087 . . . . 0.0 110.065 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -56.79 -46.11 81.76 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 109.491 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -58.91 -52.8 64.18 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.375 -0.828 . . . . 0.0 109.409 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 117' ' ' THR . 41.3 t -50.84 -41.41 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.857 . . . . 0.0 109.669 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 1.1 m-20 -70.95 -38.83 72.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.398 -0.813 . . . . 0.0 110.029 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -68.84 -23.73 64.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -0.866 . . . . 0.0 110.05 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.657 ' CE ' ' CD1' ' B' ' 22' ' ' PHE . 22.3 ttt -74.4 -56.21 5.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.882 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 31.2 mm -60.68 -52.82 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.0 109.712 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 122' ' ' ASP . 1.5 mtp85 -50.33 -52.89 32.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 110.1 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 15.3 mm-40 -53.33 -29.04 31.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.342 -0.849 . . . . 0.0 110.193 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.54 -19.23 24.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 110.343 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.43 70.43 3.82 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.0 110.262 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.6 mt -63.57 -41.22 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.968 . . . . 0.0 109.766 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 9.7 p30 -63.55 -36.29 83.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.332 -0.855 . . . . 0.0 110.03 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 95.48 74.19 1.22 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.458 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.437 ' OD1' ' CG ' ' A' ' 131' ' ' ASP . 4.4 m-20 -133.44 2.17 3.5 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.229 -1.159 . . . . 0.0 109.976 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.508 ' O ' ' CG ' ' A' ' 135' ' ' GLN . . . 71.66 4.71 58.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.508 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 68.1 mt-30 -156.63 168.81 26.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.163 . . . . 0.0 109.773 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.417 HG22 HG21 ' A' ' 125' ' ' ILE . 14.7 t -107.16 131.47 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 109.953 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 11.6 t30 -100.39 -152.98 0.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 0.0 110.23 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.449 ' OH ' ' HG3' ' A' ' 86' ' ' ARG . 12.1 t80 -74.54 -69.45 0.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.245 -0.909 . . . . 0.0 110.087 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 143' ' ' GLN . 1.4 tt0 -46.95 -44.4 19.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.187 -0.946 . . . . 0.0 109.875 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.413 ' CD ' ' OD2' ' A' ' 131' ' ' ASP . 11.5 mt-10 -53.78 -60.56 3.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.795 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 140' ' ' GLU . 5.1 t80 -42.96 -33.0 0.71 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 110.017 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.467 ' O ' ' OG1' ' A' ' 146' ' ' THR . 37.8 t -100.09 -17.11 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.374 -0.829 . . . . 0.0 110.726 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 139' ' ' GLU . 13.7 tt0 -77.9 -27.97 49.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.173 -0.954 . . . . 0.0 110.621 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -93.51 -11.05 32.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.503 ' O ' ' HB2' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.6 -24.78 14.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.436 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 73.0 p . . . . . 0 C--N 1.305 -1.353 0 O-C-N 120.921 -1.112 . . . . 0.0 110.661 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.437 HG22 ' SD ' ' A' ' 51' ' ' MET . 12.5 mt . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.495 ' O ' ' HB ' ' B' ' 9' ' ' THR . 44.1 Cg_endo -70.87 66.39 2.42 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.98 1.516 . . . . 0.0 111.602 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.482 ' C ' ' O ' ' B' ' 5' ' ' PRO . 42.4 m 31.56 -147.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.533 0.682 . . . . 0.0 111.874 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.602 ' CD1' HG22 ' A' ' 55' ' ' VAL . 2.0 m95 -108.7 -73.87 0.67 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.886 0.851 . . . . 0.0 110.842 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.512 ' O ' ' N ' ' B' ' 12' ' ' LEU . 2.6 p -44.83 -36.59 3.34 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.498 -0.751 . . . . 0.0 110.288 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.52 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 2.6 m -44.91 -53.84 7.15 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.695 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 4.7 t -57.46 -40.12 72.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.458 HG22 ' HG2' ' A' ' 72' ' ' MET . 47.1 mt -72.75 -19.72 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.539 -0.726 . . . . 0.0 109.635 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 8' ' ' THR . 0.2 OUTLIER -73.36 -50.16 23.42 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.647 0.737 . . . . 0.0 109.768 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.454 HG13 HG23 ' A' ' 108' ' ' VAL . 89.1 t -64.91 -47.06 89.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.475 -0.766 . . . . 0.0 110.575 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.492 ' HA ' HD11 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -65.86 -32.76 74.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.066 -1.021 . . . . 0.0 109.802 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 34.2 t -78.23 -13.68 59.76 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.6 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' B' ' 12' ' ' LEU . 0.0 OUTLIER -79.67 -42.18 25.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.162 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.488 ' O ' ' C ' ' B' ' 18' ' ' ARG . 9.3 mp -44.98 -57.32 3.89 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.918 -1.114 . . . . 0.0 109.057 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.511 ' CD ' ' OE2' ' A' ' 11' ' ' GLU . 3.6 tpt85 16.38 75.24 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' B' ' 19' ' ' LYS . 2.0 tptm 44.62 73.76 0.15 Allowed 'General case' 0 C--N 1.283 -2.308 0 O-C-N 121.273 -0.892 . . . . 0.0 112.883 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.595 ' O ' ' HG2' ' B' ' 20' ' ' ARG . 0.0 OUTLIER 47.86 13.73 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.683 0 O-C-N 120.8 -1.187 . . . . 0.0 112.092 177.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' B' ' 18' ' ' ARG . 5.1 m -112.74 115.45 28.55 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 119.956 -1.715 . . . . 0.0 110.468 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.657 ' CD1' ' CE ' ' A' ' 124' ' ' MET . 0.9 OUTLIER -58.16 -35.32 71.38 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.167 -1.013 . . . . 0.0 108.779 179.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.54 147.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 1.8 p-10 -134.97 43.09 0.87 Allowed Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.479 -1.013 . . . . 0.0 110.73 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 55.2 Cg_endo -77.96 26.64 0.49 Allowed 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.481 1.253 . . . . 0.0 111.189 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.503 ' CE2' ' HE3' ' A' ' 72' ' ' MET . 15.5 m-85 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 110.354 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.317 0.58 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 47.2 mt -66.44 -40.05 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.997 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.33 -62.35 1.78 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 109.714 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.494 ' OE1' ' CA ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -48.64 -41.48 31.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.609 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.8 m-30 -52.49 -46.78 66.74 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.214 -0.929 . . . . 0.0 109.153 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -57.34 -34.52 68.86 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.329 -0.857 . . . . 0.0 109.172 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 1.7 tt0 -56.84 -51.01 70.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.397 -0.814 . . . . 0.0 109.794 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' CA ' ' HD2' ' B' ' 14' ' ' LYS . . . -60.01 -45.39 92.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.19 -0.943 . . . . 0.0 109.566 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.584 ' CZ ' ' O ' ' A' ' 64' ' ' ASP . 1.7 t80 -64.62 -45.43 86.89 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 109.841 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m -64.29 -31.33 72.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.809 . . . . 0.0 109.706 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.454 HD11 ' HG3' ' B' ' 14' ' ' LYS . 9.7 tt -61.9 -45.9 91.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.447 -0.783 . . . . 0.0 110.041 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.545 ' CE1' HG13 ' B' ' 10' ' ' VAL . 26.4 m-85 -71.42 -27.13 63.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.287 -0.883 . . . . 0.0 110.245 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.8 120.8 26.48 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.262 -0.899 . . . . 0.0 110.346 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.44 -37.09 60.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.237 -0.914 . . . . 0.0 110.304 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 17.6 p-10 -92.09 -40.9 10.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.307 -0.871 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.98 48.58 2.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 44.8 p-10 -104.69 -7.72 19.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -1.162 . . . . 0.0 110.1 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.431 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 89.71 35.78 7.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 20.0 p -155.68 107.73 2.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.292 -1.122 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.475 HD11 HG22 ' A' ' 27' ' ' ILE . 7.1 mt -95.3 119.48 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.137 -0.977 . . . . 0.0 110.326 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.532 ' CG2' ' CG2' ' A' ' 62' ' ' THR . 12.7 p -100.08 174.46 6.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.179 -0.951 . . . . 0.0 110.231 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.413 HG22 ' OE1' ' A' ' 49' ' ' GLN . 74.9 p -59.09 -31.91 69.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -55.33 9.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.153 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 39.5 mt-10 -55.02 -69.76 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.06 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.424 ' HB2' HG23 ' A' ' 27' ' ' ILE . 12.6 tp -44.94 -41.84 7.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.761 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.21 -41.99 93.12 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 m -61.07 -50.78 71.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -1.113 . . . . 0.0 109.886 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.454 HG23 ' HA ' ' A' ' 19' ' ' PHE . 12.4 t -57.92 -42.27 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 mmt -61.07 -42.34 98.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.29 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -53.04 -40.82 64.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.242 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 40' ' ' GLY . 68.3 m -71.77 -44.22 64.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.553 -0.717 . . . . 0.0 109.461 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -43.5 -26.24 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.38 -0.825 . . . . 0.0 109.69 179.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 107.85 37.91 2.12 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 10.5 mm-40 -145.98 165.64 28.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.31 -1.112 . . . . 0.0 110.535 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -126.84 88.89 53.43 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 109.64 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.06 160.81 46.52 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.113 1.586 . . . . 0.0 110.93 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.465 HG21 ' N ' ' A' ' 45' ' ' GLU . 94.9 m -99.64 164.3 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.476 -0.765 . . . . 0.0 109.879 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.465 ' N ' HG21 ' A' ' 44' ' ' THR . 0.7 OUTLIER -69.03 -69.95 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.16 -0.963 . . . . 0.0 110.073 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -43.33 -54.14 4.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.974 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.423 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 69.1 mm-40 -54.54 -41.39 69.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.014 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 3.4 mt -55.4 -42.7 74.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 0.0 109.906 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' OE1' HG22 ' A' ' 29' ' ' THR . 45.4 tp60 -67.36 -24.32 65.69 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.274 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -71.51 -46.98 58.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 109.974 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.481 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 24.7 ptm -73.21 -35.41 66.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 109.724 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.481 ' N ' ' HG3' ' A' ' 51' ' ' MET . 7.8 mm -62.32 -32.46 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 109.529 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.24 -21.06 56.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.831 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.17 -37.99 87.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 110.154 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.544 HG22 ' CD1' ' B' ' 7' ' ' TRP . 11.5 t -91.86 -31.8 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 110.176 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.1 71.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.261 -0.9 . . . . 0.0 110.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.27 -17.17 61.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.0 110.638 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.6 p30 -100.43 -31.87 11.09 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.143 -0.973 . . . . 0.0 110.609 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.54 42.48 4.82 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.426 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 12.6 m120 -84.03 -15.77 46.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.195 -1.179 . . . . 0.0 110.076 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.428 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 101.67 -8.41 56.39 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.532 ' CG2' ' CG2' ' A' ' 28' ' ' THR . 2.9 p -158.23 168.46 26.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 26' ' ' THR . 30.2 mm -82.82 136.07 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 109.943 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.584 ' O ' ' CZ ' ' A' ' 16' ' ' PHE . 2.5 m-20 -114.27 174.01 6.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.307 -0.871 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.583 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 48.2 t80 -59.4 -49.85 90.37 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.404 -0.81 . . . . 0.0 111.714 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.1 Cg_endo -65.27 -38.37 27.28 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.169 1.089 . . . . 0.0 110.268 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -53.19 -33.9 54.66 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.136 -0.977 . . . . 0.0 109.335 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.532 ' HB2' ' CE1' ' A' ' 16' ' ' PHE . 21.9 t80 -78.05 -39.26 42.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 110.345 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.46 HD22 ' O ' ' A' ' 65' ' ' PHE . 2.3 mm? -55.49 -30.09 59.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.871 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.57 -63.21 1.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.041 -1.037 . . . . 0.0 111.37 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.456 ' HG3' ' HA ' ' A' ' 55' ' ' VAL . 2.1 tmm? -44.32 -37.92 3.6 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.068 -1.02 . . . . 0.0 111.548 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.649 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -67.08 -8.56 31.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.039 -1.038 . . . . 0.0 111.317 -179.014 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.97 -9.34 9.66 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.664 -1.273 . . . . 0.0 111.687 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -17.32 30.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.78 -1.2 . . . . 0.0 111.4 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.7 tptt . . . . . 0 N--CA 1.496 1.843 0 O-C-N 120.922 -1.111 . . . . 0.0 111.314 -179.292 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.471 ' HA ' HD13 ' A' ' 85' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 121.408 0.623 . . . . 0.0 109.566 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -73.88 -34.95 64.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.067 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 31.9 mt-10 -69.08 -19.94 64.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.146 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 82' ' ' GLU . 40.7 mt -70.85 -39.42 75.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 109.053 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -27.72 63.22 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.426 -0.796 . . . . 0.0 108.959 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 5.4 mt-10 -70.94 -57.67 4.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.393 -0.817 . . . . 0.0 109.431 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -54.88 -27.54 43.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.046 -1.034 . . . . 0.0 109.173 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -66.15 -52.67 46.21 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.73 -34.53 12.28 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.871 . . . . 0.0 109.155 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.559 ' CG1' ' CG2' ' A' ' 108' ' ' VAL . 72.0 t -67.52 -42.73 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.442 -0.786 . . . . 0.0 109.59 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.581 ' CE1' HG13 ' A' ' 108' ' ' VAL . 56.5 m-85 -76.37 -24.13 54.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 96' ' ' GLY . 3.7 t0 -100.23 67.51 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.497 -0.752 . . . . 0.0 110.144 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -39.01 -44.83 1.14 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.595 -0.69 . . . . 0.0 110.351 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.8 p30 -82.64 -22.92 34.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 109.882 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 63.18 51.56 54.13 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 24.5 p-10 -99.85 -26.21 14.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -1.155 . . . . 0.0 110.166 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 122.08 18.81 3.4 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -153.35 130.99 11.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -1.145 . . . . 0.0 110.098 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 92' ' ' PHE . 22.2 mt -103.95 157.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 110.419 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.8 OUTLIER -140.33 147.3 39.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.397 -0.814 . . . . 0.0 109.704 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.16 -30.9 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.869 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.49 -45.02 73.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.311 -0.868 . . . . 0.0 109.592 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 20.7 mt-10 -63.32 -47.53 81.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.257 -0.902 . . . . 0.0 109.555 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.539 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.39 -39.28 90.12 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.286 -0.884 . . . . 0.0 109.634 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.458 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 1.4 tmt_? -60.47 -29.05 68.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.359 -0.838 . . . . 0.0 109.823 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -31.78 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 110.048 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.581 HG13 ' CE1' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -74.15 -36.71 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.979 . . . . 0.0 109.554 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.56 ' HB3' ' CD2' ' B' ' 17' ' ' LEU . 21.5 ptp -73.26 -39.99 64.98 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.552 ' N ' ' HG3' ' A' ' 109' ' ' MET . 87.1 m -69.54 -27.38 65.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.116 -0.99 . . . . 0.0 109.47 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -89.75 -13.14 37.39 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.42 -0.8 . . . . 0.0 109.302 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 39' ' ' LEU . 9.2 mt -93.89 -32.65 13.83 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.449 -0.782 . . . . 0.0 110.006 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.05 -63.82 0.33 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.267 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 109' ' ' MET . 1.8 tt0 -94.11 156.1 16.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.114 -1.227 . . . . 0.0 110.679 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 116' ' ' LEU . 9.8 pttt -124.53 13.03 8.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.532 HD11 ' CD2' ' B' ' 17' ' ' LEU . 1.0 OUTLIER 40.66 -164.1 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.512 0.672 . . . . 0.0 110.56 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -166.28 1.3 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.387 -0.82 . . . . 0.0 109.567 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.436 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -97.17 -59.56 1.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.094 -1.004 . . . . 0.0 109.694 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 4.5 pt-20 -58.91 -30.29 67.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.515 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 9.2 tp10 -69.83 -48.17 59.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.403 -0.811 . . . . 0.0 109.321 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 t -57.28 -42.12 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.432 -0.793 . . . . 0.0 109.64 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 14.4 m-20 -69.2 -41.17 77.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.89 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 2.4 mt-10 -64.08 -31.01 72.04 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 110.007 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.556 ' HG2' ' CD1' ' B' ' 22' ' ' PHE . 1.0 OUTLIER -69.6 -42.05 74.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.176 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.539 HD13 ' CD1' ' A' ' 105' ' ' LEU . 35.0 mm -74.52 -23.88 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -74.44 -40.16 62.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.23 -0.919 . . . . 0.0 110.552 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.79 -8.96 58.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 110.266 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.466 ' O ' HD13 ' A' ' 130' ' ' ILE . . . -101.26 -30.53 11.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.305 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.466 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -52.97 101.37 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.109 -0.994 . . . . 0.0 110.285 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.466 HD13 ' O ' ' A' ' 128' ' ' ALA . 1.2 mp -67.81 -27.37 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.197 -0.939 . . . . 0.0 109.813 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 41.6 p-10 -103.38 -25.48 13.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.63 72.38 1.27 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.466 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 5.5 p-10 -130.61 -0.83 4.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -1.168 . . . . 0.0 110.145 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.07 -2.7 75.9 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' HB3' ' O ' ' A' ' 100' ' ' ILE . 40.9 mt-30 -142.54 160.7 39.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -1.226 . . . . 0.0 110.2 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.1 t -107.59 120.05 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.182 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 98' ' ' GLY . 10.4 t-20 -81.31 166.44 20.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.884 . . . . 0.0 110.15 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -57.7 -48.97 78.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.106 -0.996 . . . . 0.0 110.155 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -53.2 -30.67 38.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 109.934 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.443 ' HG2' HD11 ' A' ' 130' ' ' ILE . 42.5 mt-10 -79.84 -52.63 7.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.306 -0.871 . . . . 0.0 109.813 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.527 ' CE1' ' HE3' ' B' ' 16' ' ' MET . 65.9 t80 -49.75 -21.79 1.2 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.2 -0.938 . . . . 0.0 109.593 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 146' ' ' THR . 17.1 t -94.04 -62.28 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.437 -0.789 . . . . 0.0 110.255 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -43.84 -49.55 8.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.877 . . . . 0.0 110.267 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 3.7 tpt -59.05 -19.14 41.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.869 . . . . 0.0 110.556 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.561 ' CE ' ' HB2' ' B' ' 24' ' ' ASN . 2.7 mtt -99.61 -24.63 14.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.168 -0.958 . . . . 0.0 110.501 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 142' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.147 -0.97 . . . . 0.0 110.344 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 20.0 mt . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 38.8 Cg_endo -65.27 122.63 10.41 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.843 1.444 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.526 ' O ' ' N ' ' B' ' 8' ' ' THR . 17.8 m -78.93 79.68 5.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.834 . . . . 0.0 111.015 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.544 ' CD1' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER 50.35 -86.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.329 -0.857 . . . . 0.0 111.106 179.086 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.526 ' N ' ' O ' ' B' ' 6' ' ' SER . 10.3 p -43.31 -30.05 0.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 110.733 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' B' ' 5' ' ' PRO . 83.8 m -64.86 -47.29 78.43 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.694 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.545 HG13 ' CE1' ' A' ' 19' ' ' PHE . 5.5 t -61.39 -46.88 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.721 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.53 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 76.4 mt -58.96 -30.27 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.165 -0.959 . . . . 0.0 109.488 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.609 ' HG ' ' CE2' ' B' ' 26' ' ' PHE . 3.2 tt -63.73 -56.81 12.79 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.436 -0.79 . . . . 0.0 110.26 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.497 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 67.2 t -54.38 -40.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.149 -0.969 . . . . 0.0 110.576 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.499 ' HD2' ' CA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -72.9 -44.06 61.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.944 -1.097 . . . . 0.0 109.661 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.449 ' HA ' ' HE2' ' B' ' 14' ' ' LYS . 20.7 p -67.26 -7.87 27.5 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.368 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.527 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 2.0 ttt -93.15 -60.31 1.83 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.897 . . . . 0.0 110.871 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.668 ' O ' ' CD2' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -102.51 91.88 4.42 Favored 'General case' 0 C--O 1.204 -1.315 0 CA-C-O 123.768 1.746 . . . . 0.0 110.667 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -124.87 -35.72 2.65 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.137 -0.977 . . . . 0.0 109.763 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.489 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 1.5 tmtm? -137.44 -72.46 0.43 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.201 -0.937 . . . . 0.0 110.558 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.439 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -161.23 23.54 0.13 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.138 -0.976 . . . . 0.0 109.501 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.446 ' O ' ' SD ' ' A' ' 124' ' ' MET . 3.6 m -100.97 166.42 10.83 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.65 -0.656 . . . . 0.0 110.903 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.556 ' CD1' ' HG2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -153.63 16.45 0.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.367 -0.833 . . . . 0.0 110.37 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.39 126.34 6.22 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.561 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 2.2 m-80 -112.83 135.36 21.62 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.177 -1.19 . . . . 0.0 110.951 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -81.46 11.85 2.92 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.027 1.541 . . . . 0.0 110.015 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.649 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 3.3 m-85 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.179 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 35.4 mt-30 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.269 0.557 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.1 mt -57.33 -38.64 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 109.671 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.39 79.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.588 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 26.4 mt-10 -60.23 -56.11 25.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CB ' HD22 ' A' ' 69' ' ' LEU . 31.3 m-85 -56.82 -36.12 69.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 109.466 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -42.66 98.37 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.294 -0.879 . . . . 0.0 109.045 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' SER . 4.7 tp10 -51.1 -45.26 61.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 109.149 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.86 -49.18 73.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 109.273 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.491 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 21.6 t80 -56.45 -29.38 61.6 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.418 -0.801 . . . . 0.0 109.744 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 3.6 t -68.83 -46.67 67.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 0.0 110.0 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 112' ' ' LEU . 10.4 tt -55.03 -36.9 65.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 109.629 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 62.4 m-85 -79.38 -52.71 7.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.323 -0.86 . . . . 0.0 110.004 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -68.52 111.58 4.81 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.451 -0.78 . . . . 0.0 110.305 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -90.34 -44.15 9.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -0.841 . . . . 0.0 110.178 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 22.3 p30 -72.68 -16.48 61.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.288 -0.882 . . . . 0.0 110.244 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 64.48 65.78 2.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.9 p30 -130.95 -33.13 1.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -1.127 . . . . 0.0 110.235 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 114.33 38.39 1.12 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 67.3 p -155.39 103.35 2.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.496 HD11 HG22 ' A' ' 27' ' ' ILE . 9.8 mt -88.98 110.77 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.067 -1.02 . . . . 0.0 110.0 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 p -100.79 177.39 4.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.8 p -57.65 -19.92 29.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.026 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -73.78 -55.66 5.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.214 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HG2' ' HG3' ' A' ' 21' ' ' LYS . 6.1 mt-10 -64.25 -59.84 3.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.402 ' HB2' HG23 ' A' ' 27' ' ' ILE . 7.7 tp -62.98 -25.36 68.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 110.239 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.47 -35.95 55.29 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -71.58 -46.11 60.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.233 -1.157 . . . . 0.0 110.48 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.5 -40.98 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.204 -0.935 . . . . 0.0 110.394 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.47 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 6.9 mmm -69.26 -31.96 70.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 110.36 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.6 tpt180 -79.35 -20.54 47.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.464 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 68.0 m -70.7 -44.59 66.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 110.692 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.44 -36.1 21.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.09 -1.006 . . . . 0.0 110.368 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.26 32.8 0.66 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -120.69 -169.58 1.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.2 -1.177 . . . . 0.0 110.28 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -143.9 72.13 16.85 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.263 -0.898 . . . . 0.0 110.215 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 47.3 Cg_endo -74.22 105.51 2.05 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.035 1.545 . . . . 0.0 110.309 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.4 m -53.98 153.43 4.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.172 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 8.7 tm-20 -65.42 -43.34 90.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 109.956 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.02 -63.15 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.91 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -52.0 -36.44 49.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.2 mt -58.52 -50.49 73.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.902 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.478 ' O ' HG21 ' A' ' 52' ' ' ILE . 5.3 tp60 -54.01 -35.68 62.15 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.8 -34.39 69.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.352 -0.843 . . . . 0.0 109.545 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.459 ' HE2' ' HE3' ' A' ' 36' ' ' MET . 0.2 OUTLIER -70.03 -26.17 63.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.488 -0.758 . . . . 0.0 110.104 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.478 HG21 ' O ' ' A' ' 49' ' ' GLN . 1.2 tp -78.62 -41.23 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.986 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.434 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -54.56 -21.77 11.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -57.21 6.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.858 . . . . 0.0 110.068 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 57' ' ' ALA . 17.1 t -71.69 -23.06 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.152 -0.968 . . . . 0.0 109.926 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -56.18 83.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.353 -0.842 . . . . 0.0 110.364 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.08 -71.31 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.096 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 26.2 p-10 -48.22 -42.02 29.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 101.7 41.61 2.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 1.6 p-10 -98.88 -44.34 6.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.118 -1.225 . . . . 0.0 110.077 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 143.48 -47.24 0.8 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.149 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.5 p -94.16 158.59 15.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.208 -1.172 . . . . 0.0 110.895 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 63' ' ' ILE . 12.4 mm -93.07 135.12 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.348 -0.845 . . . . 0.0 110.146 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.46 ' OD1' ' HD2' ' A' ' 66' ' ' PRO . 2.3 t70 -107.24 168.34 9.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.11 -0.994 . . . . 0.0 110.424 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.6 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 t80 -56.02 -44.82 99.88 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.397 -0.814 . . . . 0.0 111.245 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -70.26 -31.59 18.02 Favored 'Trans proline' 0 N--CA 1.482 0.83 0 O-C-N 123.298 1.157 . . . . 0.0 110.269 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.509 ' OE2' ' N ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -63.7 -34.55 78.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 109.341 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -71.61 -42.04 68.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.486 -0.759 . . . . 0.0 109.779 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.532 HD22 ' CB ' ' A' ' 12' ' ' PHE . 37.3 mt -58.16 -34.76 70.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 0.0 110.06 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -76.86 -33.74 57.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 42.1 ttp -64.84 -63.68 1.06 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.296 -0.877 . . . . 0.0 110.569 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.551 ' HE1' ' CE1' ' B' ' 26' ' ' PHE . 9.9 tpt -54.4 -16.5 2.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.141 -0.974 . . . . 0.0 110.677 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.21 -33.02 14.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.068 -1.02 . . . . 0.0 110.662 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -98.64 -9.95 24.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.159 -0.963 . . . . 0.0 110.371 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.218 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.401 0.619 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -67.04 -29.48 69.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.244 -0.91 . . . . 0.0 109.349 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' OE2' ' CD2' ' B' ' 12' ' ' LEU . 20.9 tt0 -61.71 -26.72 68.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.439 -0.788 . . . . 0.0 109.608 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.3 mt -69.64 -36.79 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.464 -0.894 . . . . 0.0 108.86 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 89' ' ' PHE . 16.0 ttt180 -59.21 -36.85 76.12 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.562 0.696 . . . . 0.0 109.124 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HB3' HG23 ' B' ' 9' ' ' THR . 6.0 mm-40 -67.09 -54.17 23.95 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.403 -0.811 . . . . 0.0 109.421 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.36 -31.28 21.65 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.136 -0.978 . . . . 0.0 108.83 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 138' ' ' TYR . 82.3 t80 -68.16 -67.1 0.49 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.418 -0.801 . . . . 0.0 109.912 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -45.25 -35.81 3.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.758 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 87' ' ' GLU . 25.2 t -56.87 -50.39 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 109.344 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.538 ' CE1' HG13 ' A' ' 108' ' ' VAL . 25.3 m-85 -60.97 -31.62 71.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.672 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD2' ' OD1' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -98.77 62.2 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.373 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -43.42 -34.29 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.91 . . . . 0.0 110.067 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.4 p30 -77.08 -41.87 40.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 84.51 52.46 3.54 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.7 p-10 -100.06 -33.83 10.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.182 -1.187 . . . . 0.0 110.115 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.587 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 125.03 22.92 1.87 Allowed Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.577 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 85.9 m-85 -157.25 141.2 16.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.985 -1.303 . . . . 0.0 110.676 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 135' ' ' GLN . 6.3 mt -109.58 143.96 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.861 . . . . 0.0 110.153 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -139.6 152.3 46.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.145 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.39 -27.03 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 109.867 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -68.92 -47.75 64.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.562 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 6.9 mt-10 -63.79 -43.63 95.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.467 -0.771 . . . . 0.0 109.806 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.484 ' CD2' ' CE1' ' A' ' 92' ' ' PHE . 2.6 mt -67.58 -34.8 77.77 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.378 -0.826 . . . . 0.0 109.581 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.462 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 43.0 ttp180 -66.87 -27.94 67.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.292 -0.88 . . . . 0.0 109.752 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.67 -23.41 31.77 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.292 -0.88 . . . . 0.0 109.953 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.538 HG13 ' CE1' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -91.34 -29.12 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 109.97 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.572 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 21.9 ptp -76.84 -34.38 57.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 110.338 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.509 ' N ' ' HG3' ' A' ' 109' ' ' MET . 5.4 m -76.66 -28.65 56.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.052 -1.03 . . . . 0.0 109.65 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 38' ' ' SER . 2.3 m120 -82.7 -23.46 34.09 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.355 -0.84 . . . . 0.0 109.917 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.545 ' CD1' HG11 ' B' ' 13' ' ' VAL . 2.0 mt -82.84 -28.69 29.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.67 -64.24 0.39 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 109' ' ' MET . 4.1 tt0 -108.01 144.81 34.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -1.17 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.494 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 0.2 OUTLIER -119.36 22.33 11.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.855 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 115' ' ' LYS . 5.1 mp 46.9 -176.59 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.566 -0.709 . . . . 0.0 110.687 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.89 -143.59 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.232 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.11 -51.0 2.12 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.169 -0.957 . . . . 0.0 110.178 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -60.93 -38.47 85.93 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 109.519 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.59 -52.87 59.05 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.294 -0.879 . . . . 0.0 109.298 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 125' ' ' ILE . 41.4 t -47.18 -42.22 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.273 -0.892 . . . . 0.0 109.74 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.63 -63.71 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.808 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -48.12 -24.8 1.22 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.397 -0.814 . . . . 0.0 109.732 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -70.1 -44.08 69.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.779 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 121' ' ' VAL . 25.9 mm -78.62 -25.39 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.365 -0.834 . . . . 0.0 110.102 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.25 -69.84 0.37 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.279 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -47.49 -25.37 1.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -78.24 -49.99 12.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CG ' ' HA2' ' A' ' 132' ' ' GLY . 34.7 t0 -41.95 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.487 -0.758 . . . . 0.0 110.547 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . 3.3 mp -75.37 -47.46 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.909 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.412 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 16.2 p-10 -77.23 -18.31 57.78 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.404 -0.81 . . . . 0.0 109.987 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.427 ' HA2' ' CG ' ' A' ' 129' ' ' ASP . . . 76.94 56.49 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 31.1 p30 -107.77 -8.51 16.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.08 17.31 56.27 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 10.2 pt20 -168.44 150.63 5.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -1.133 . . . . 0.0 109.95 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 13.0 t -89.37 125.68 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.173 -0.955 . . . . 0.0 110.435 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 9.6 t30 -93.8 -173.72 3.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.279 -0.888 . . . . 0.0 110.243 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.469 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 64.1 t80 -69.85 -56.54 6.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.181 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.68 -58.49 4.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.843 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -52.11 -45.45 64.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.317 -0.864 . . . . 0.0 109.883 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -57.86 -26.69 62.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 0.0 109.942 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.33 -39.8 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.835 . . . . 0.0 110.347 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -56.01 -46.88 78.62 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.215 -0.928 . . . . 0.0 110.062 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 77.5 mmm -63.51 -27.47 69.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.837 . . . . 0.0 110.308 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.54 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 3.9 mtt -90.18 -34.76 15.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.195 -0.941 . . . . 0.0 110.639 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.484 ' O ' ' CG2' ' A' ' 146' ' ' THR . 9.7 t . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.026 -1.046 . . . . 0.0 110.138 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.551 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 22.3 mt . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 39.6 Cg_endo -65.43 149.2 88.24 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.639 1.336 . . . . 0.0 110.272 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.576 ' O ' ' N ' ' B' ' 8' ' ' THR . 45.2 m -94.08 92.03 7.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.278 -0.889 . . . . 0.0 111.542 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' B' ' 10' ' ' VAL . 1.8 m95 37.48 -86.98 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.614 -0.679 . . . . 0.0 111.313 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.576 ' N ' ' O ' ' B' ' 6' ' ' SER . 0.8 OUTLIER -42.83 -48.62 5.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.247 -0.908 . . . . 0.0 109.802 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.52 ' CG2' ' CB ' ' B' ' 5' ' ' PRO . 41.2 m -45.79 -37.76 6.41 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.378 -0.826 . . . . 0.0 109.218 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 7' ' ' TRP . 5.7 t -67.94 -42.03 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.71 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.495 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 9.7 mm -69.47 -26.73 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.785 . . . . 0.0 110.177 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.578 HD23 ' CE2' ' B' ' 26' ' ' PHE . 1.3 mm? -67.55 -56.52 9.14 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.392 -0.817 . . . . 0.0 110.138 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.545 HG11 ' CD1' ' A' ' 112' ' ' LEU . 9.6 t -57.31 -39.98 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.309 -0.869 . . . . 0.0 110.341 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.444 ' CE ' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.01 -32.28 72.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.767 -1.208 . . . . 0.0 109.596 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -41.57 89.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.339 -0.85 . . . . 0.0 109.239 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 7.2 mtt -75.12 -25.96 58.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.905 . . . . 0.0 109.753 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.572 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 5.6 mp -81.25 49.94 1.35 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.375 -0.828 . . . . 0.0 109.697 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.454 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -126.12 -73.5 0.62 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.247 -0.908 . . . . 0.0 111.714 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -158.67 90.64 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.105 -0.997 . . . . 0.0 111.177 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' B' ' 20' ' ' ARG . 19.6 ttp180 59.94 5.2 0.7 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.211 -0.931 . . . . 0.0 110.911 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.25 84.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.851 -1.156 . . . . 0.0 110.233 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.75 54.38 1.95 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 110.35 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.97 -111.7 0.64 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 145' ' ' MET . 1.2 t-20 -128.35 73.4 80.12 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.27 -1.135 . . . . 0.0 110.044 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.74 -2.26 10.6 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.127 1.593 . . . . 0.0 110.548 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.578 ' CE2' HD23 ' B' ' 12' ' ' LEU . 22.9 m-85 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.133 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.281 0.562 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.3 mt -53.32 -48.69 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.277 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -56.46 -38.38 71.6 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.287 -0.883 . . . . 0.0 109.101 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -54.07 -52.42 60.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.411 -0.805 . . . . 0.0 109.184 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 34.4 m-85 -63.32 -40.48 97.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.237 -0.915 . . . . 0.0 109.13 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -55.89 -44.0 77.77 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.466 -0.771 . . . . 0.0 108.94 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.466 ' O ' ' OG ' ' A' ' 17' ' ' SER . 59.7 mt-10 -56.87 -46.38 81.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.451 -0.781 . . . . 0.0 109.032 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 18' ' ' LEU . . . -67.62 -51.66 47.48 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.322 -0.861 . . . . 0.0 109.281 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.598 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 19.8 t80 -45.12 -34.02 2.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.415 -0.803 . . . . 0.0 108.845 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 14' ' ' GLU . 24.9 p -81.73 -32.58 31.51 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.627 -0.671 . . . . 0.0 109.215 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 15' ' ' ALA . 6.8 tt -49.74 -34.78 20.01 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.322 -0.862 . . . . 0.0 109.177 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.422 ' HA ' HG22 ' A' ' 35' ' ' VAL . 57.7 m-85 -82.61 -46.02 13.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.447 -0.783 . . . . 0.0 109.853 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 10.0 t70 -71.0 103.65 2.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 109.951 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -91.45 -31.21 16.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 110.454 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 29.9 p-10 -75.02 -46.59 34.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.299 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 108.94 45.65 1.01 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 49.1 p30 -115.73 -18.17 10.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -1.179 . . . . 0.0 110.009 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 91.69 5.42 66.69 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 16.7 p -120.14 116.24 25.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -1.141 . . . . 0.0 110.484 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.446 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 14.2 mt -90.84 124.33 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 109.877 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 7.8 p -100.3 178.36 4.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -63.12 -32.54 73.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.105 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -71.52 -54.4 10.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.273 -0.892 . . . . 0.0 110.308 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 41.3 mt-10 -49.41 -61.98 1.8 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 0.0 110.153 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.566 HD23 ' CZ2' ' B' ' 7' ' ' TRP . 35.5 tp -57.32 -31.5 65.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.97 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.498 ' CA ' HD12 ' A' ' 48' ' ' LEU . . . -67.03 -28.12 73.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.9 m -73.72 -52.08 14.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -1.101 . . . . 0.0 109.828 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 19' ' ' PHE . 43.2 t -63.07 -35.37 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.947 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.459 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 4.1 mmt -66.26 -35.71 81.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.273 -0.892 . . . . 0.0 109.938 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.37 -24.4 60.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 110.117 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -76.15 -32.57 59.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.36 -0.837 . . . . 0.0 110.677 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 mt -53.81 -49.46 68.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.127 -0.983 . . . . 0.0 110.405 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 142.15 47.38 0.05 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 6.4 mm-40 -153.15 -167.4 2.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -1.127 . . . . 0.0 110.233 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -140.28 82.98 15.99 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.23 -0.919 . . . . 0.0 110.428 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.459 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 49.7 Cg_endo -76.79 148.63 28.76 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.978 1.515 . . . . 0.0 109.99 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.432 ' HB ' ' OE2' ' A' ' 47' ' ' GLU . 53.9 m -100.11 133.52 44.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.974 . . . . 0.0 110.227 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -42.34 -42.92 3.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.327 -0.858 . . . . 0.0 110.169 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.23 -54.4 47.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 109.742 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' OE2' ' HB ' ' A' ' 44' ' ' THR . 2.4 mt-10 -52.19 -38.02 56.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.369 -0.832 . . . . 0.0 109.681 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.498 HD12 ' CA ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -56.7 -50.78 71.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.889 . . . . 0.0 109.724 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -50.77 -45.1 58.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.528 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.83 -23.58 66.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.439 -0.788 . . . . 0.0 109.537 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.465 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 2.2 mtp -86.92 -49.38 7.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 0.0 110.083 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 tp -57.47 -29.22 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.734 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -71.78 -5.29 33.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 110.474 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 51' ' ' MET . 2.4 mt-10 -86.95 -55.57 3.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 110.19 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' B' ' 7' ' ' TRP . 38.9 t -70.25 -21.85 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 110.294 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.89 64.01 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.185 -0.947 . . . . 0.0 110.389 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -51.5 -21.34 2.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.198 -0.939 . . . . 0.0 110.23 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.436 ' CG ' ' OD1' ' A' ' 60' ' ' ASN . 1.5 p30 -100.38 -32.44 10.83 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.34 -0.85 . . . . 0.0 110.418 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.71 52.82 2.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.436 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 5.7 m120 -99.25 -32.61 11.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.179 -1.189 . . . . 0.0 109.945 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.419 ' O ' HG21 ' A' ' 62' ' ' THR . . . 117.87 -14.3 12.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 61' ' ' GLY . 27.4 p -139.66 165.14 28.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -1.07 . . . . 0.0 109.999 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.1 mm -96.83 165.89 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.319 -0.863 . . . . 0.0 110.102 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.541 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 35.2 m-20 -140.24 179.55 6.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.124 -0.985 . . . . 0.0 110.513 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.598 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 24.5 t80 -63.2 -44.27 83.15 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.33 -0.857 . . . . 0.0 111.52 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_endo -70.85 -36.04 8.51 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.359 1.189 . . . . 0.0 110.248 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -64.09 -29.32 70.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.393 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CZ ' HD12 ' B' ' 11' ' ' ILE . 0.4 OUTLIER -72.61 -50.77 23.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 65' ' ' PHE . 3.0 mm? -50.52 -50.6 52.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 0.0 110.449 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -64.21 1.03 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.232 -0.917 . . . . 0.0 110.805 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.462 ' HE2' HG22 ' B' ' 8' ' ' THR . 9.7 tpt -43.02 -62.27 1.07 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.042 -1.037 . . . . 0.0 110.696 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.548 ' HG3' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -39.16 -32.55 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.393 -0.817 . . . . 0.0 110.748 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.09 -48.26 3.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.164 -0.96 . . . . 0.0 110.474 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 75' ' ' LYS . 4.7 mtp180 -49.93 -67.39 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.256 -0.902 . . . . 0.0 110.438 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.456 ' HB2' ' SD ' ' A' ' 71' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.375 -0.828 . . . . 0.0 110.42 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.417 ' HA ' HD13 ' A' ' 85' ' ' ILE . 9.4 pt-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.207 0.527 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.52 -24.46 66.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.883 . . . . 0.0 109.678 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' B' ' 12' ' ' LEU . 9.2 mm-40 -67.7 -15.84 63.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.454 HG23 HG21 ' A' ' 142' ' ' VAL . 97.2 mt -70.68 -36.94 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.443 -0.785 . . . . 0.0 109.466 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 20.4 ttm-85 -59.71 -44.36 93.74 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.504 -0.747 . . . . 0.0 109.61 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 6.1 mm-40 -64.42 -51.6 62.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.286 -0.884 . . . . 0.0 109.609 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -60.39 -32.56 71.42 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.228 -0.92 . . . . 0.0 109.547 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.478 ' CE2' ' CG ' ' A' ' 138' ' ' TYR . 38.9 t80 -64.32 -43.12 95.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -29.04 70.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.834 . . . . 0.0 109.549 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.453 HG13 HG23 ' A' ' 108' ' ' VAL . 28.5 t -66.94 -51.94 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 0.0 110.209 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.551 ' CE1' HD22 ' A' ' 105' ' ' LEU . 11.8 m-85 -69.73 -29.71 67.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.199 -0.938 . . . . 0.0 110.013 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 94' ' ' LYS . 32.7 t0 -81.84 51.42 1.72 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 110.185 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -43.82 -30.37 0.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.214 -0.929 . . . . 0.0 110.259 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.95 -41.14 52.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.922 . . . . 0.0 110.119 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.98 -25.07 29.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.423 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 23.8 p-10 -51.03 -41.66 59.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -1.154 . . . . 0.0 110.328 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 119.02 60.13 0.27 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 1.9 m-85 -169.73 136.09 1.55 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.271 -1.135 . . . . 0.0 109.967 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.429 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 21.8 mt -112.49 106.47 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 110.58 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 102' ' ' ALA . 45.0 t -94.54 149.76 20.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.181 -0.95 . . . . 0.0 109.513 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.38 -27.25 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 0.0 109.827 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -71.95 -44.76 63.06 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 0.0 109.464 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' OE2' ' O ' ' A' ' 99' ' ' TYR . 21.6 mt-10 -60.94 -41.45 96.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 109.565 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' A' ' 92' ' ' PHE . 1.2 mt -58.34 -44.59 88.77 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.349 -0.844 . . . . 0.0 109.364 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.455 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.0 OUTLIER -58.26 -35.87 72.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.318 -0.864 . . . . 0.0 109.197 179.232 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 46.4 t60 -55.72 -52.67 63.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.43 -0.794 . . . . 0.0 109.173 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.476 ' HA ' ' HB2' ' A' ' 111' ' ' ASN . 1.5 t -74.3 -35.51 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.537 -0.727 . . . . 0.0 109.227 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.505 ' HA ' HD22 ' B' ' 17' ' ' LEU . 10.8 ttm -49.73 -60.69 2.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.553 -0.717 . . . . 0.0 110.608 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 m -78.34 -17.45 56.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.314 -0.866 . . . . 0.0 110.68 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.476 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 17.7 m-20 -75.56 -14.78 60.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.002 . . . . 0.0 110.056 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.547 ' CD1' HG11 ' B' ' 13' ' ' VAL . 3.1 mt -101.21 -52.7 3.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.627 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.74 -18.97 0.18 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.87 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 35.8 tp10 -108.1 155.99 19.79 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.843 -1.387 . . . . 0.0 111.112 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.51 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 2.2 mttm -131.25 64.36 1.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.611 -0.68 . . . . 0.0 109.521 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.495 ' HB2' ' CE ' ' A' ' 109' ' ' MET . 1.8 mp -36.18 151.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.485 0.66 . . . . 0.0 111.126 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.458 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -61.87 -174.48 0.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.778 . . . . 0.0 110.152 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.87 -59.5 2.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.208 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.88 -42.75 37.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 109.605 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -61.61 -53.7 52.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.545 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.469 HG23 ' HE3' ' A' ' 109' ' ' MET . 53.0 t -57.81 -41.11 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 109.921 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -61.63 -58.24 8.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.854 . . . . 0.0 109.845 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -54.81 -37.59 66.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.308 -0.87 . . . . 0.0 109.706 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.551 ' O ' ' CD2' ' B' ' 22' ' ' PHE . 9.4 ttt -52.42 -44.14 65.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.911 . . . . 0.0 109.515 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.448 HD12 HD13 ' A' ' 105' ' ' LEU . 38.7 mm -78.44 -53.08 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.066 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -44.11 -68.52 0.19 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.83 . . . . 0.0 110.636 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 126' ' ' ARG . 1.3 tp10 -39.02 -53.93 1.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.535 -0.728 . . . . 0.0 110.755 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -58.92 -34.88 72.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 110.382 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.456 ' OD2' ' N ' ' A' ' 135' ' ' GLN . 1.6 t0 -65.78 68.45 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.434 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -60.07 -42.36 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.27 -0.894 . . . . 0.0 109.908 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.6 -35.97 78.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.195 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.53 71.92 1.24 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.0 p30 -121.71 -25.29 5.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.308 -1.113 . . . . 0.0 110.089 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 129.6 -20.6 5.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.456 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 16.0 pt20 -154.6 170.23 22.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -1.154 . . . . 0.0 110.26 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 137' ' ' ASN . 46.5 t -79.49 164.44 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.252 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.49 ' N ' HG11 ' A' ' 136' ' ' VAL . 12.5 t-20 -133.4 173.18 11.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.305 -0.872 . . . . 0.0 110.112 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.478 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -57.38 -68.22 0.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.261 -0.899 . . . . 0.0 110.26 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 138' ' ' TYR . 10.3 mm-40 -40.81 -53.26 2.9 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.447 -0.783 . . . . 0.0 110.023 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 141' ' ' PHE . 50.3 mt-10 -55.41 -57.86 10.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 109.505 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.426 ' CD1' ' CG2' ' A' ' 85' ' ' ILE . 3.7 t80 -43.62 -27.38 0.3 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.429 -0.794 . . . . 0.0 109.5 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.454 HG21 HG23 ' A' ' 85' ' ' ILE . 73.9 t -99.56 -64.39 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 142' ' ' VAL . 28.5 tp60 -43.07 -24.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.306 -0.871 . . . . 0.0 110.604 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 142' ' ' VAL . 1.8 tpt -84.31 -32.66 24.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 111.025 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.442 ' HB3' HD12 ' A' ' 85' ' ' ILE . 2.9 mtp -100.66 -11.42 20.01 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.017 -1.052 . . . . 0.0 111.947 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' A' ' 146' ' ' THR . 9.0 t . . . . . 0 N--CA 1.497 1.884 0 O-C-N 120.705 -1.247 . . . . 0.0 111.175 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.583 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 22.1 mt . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.583 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 36.0 Cg_endo -59.38 114.61 2.11 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.303 1.159 . . . . 0.0 109.858 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.538 ' O ' ' N ' ' B' ' 8' ' ' THR . 13.5 t -78.34 90.07 4.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.573 -0.704 . . . . 0.0 112.303 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.566 ' CZ2' HD23 ' A' ' 32' ' ' LEU . 8.7 m95 43.99 -86.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.59 -0.694 . . . . 0.0 112.229 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.538 ' N ' ' O ' ' B' ' 6' ' ' SER . 63.1 p -38.57 -46.96 1.25 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.537 -0.727 . . . . 0.0 110.945 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 97.5 m -48.87 -36.9 18.09 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.242 -0.911 . . . . 0.0 109.276 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' B' ' 7' ' ' TRP . 60.5 t -73.05 -43.07 59.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.506 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 46.7 mt -70.94 -21.82 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 109.974 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -72.53 -50.62 24.46 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.547 HG11 ' CD1' ' A' ' 112' ' ' LEU . 42.7 t -71.14 -39.01 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.124 -0.985 . . . . 0.0 110.446 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.459 ' HA ' HD11 ' A' ' 112' ' ' LEU . 2.7 tmtt? -59.64 -47.54 85.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.775 -1.203 . . . . 0.0 109.263 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 35.0 p -53.52 -48.85 68.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.451 -0.781 . . . . 0.0 109.228 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.432 ' O ' ' HE2' ' A' ' 124' ' ' MET . 10.6 ttm -54.82 -27.7 43.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.314 -0.866 . . . . 0.0 109.872 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 109' ' ' MET . 7.0 mp -79.71 49.51 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.249 -0.907 . . . . 0.0 110.574 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -96.6 -83.06 0.39 Allowed 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.331 -0.856 . . . . 0.0 109.769 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.457 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -140.44 -41.14 0.42 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.365 -0.835 . . . . 0.0 109.475 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' B' ' 21' ' ' SER . 2.4 ttt-85 -149.63 -41.53 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' B' ' 22' ' ' PHE . 26.8 t 29.73 -126.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.093 0.473 . . . . 0.0 111.32 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 124' ' ' MET . 1.5 m-85 61.99 57.74 2.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 110.519 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.442 ' C ' ' HD2' ' B' ' 25' ' ' PRO . . . -142.99 -165.01 10.46 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.721 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 39.0 p-10 -107.1 -2.83 0.11 Allowed Pre-proline 0 CA--C 1.569 1.697 0 O-C-N 121.28 -1.129 . . . . 0.0 112.974 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 48.0 Cg_endo -73.46 76.92 2.63 Favored 'Trans proline' 0 N--CA 1.485 0.971 0 O-C-N 122.304 0.634 . . . . 0.0 110.498 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.45 ' CZ ' ' HE2' ' A' ' 72' ' ' MET . 12.8 t80 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.228 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.222 0.534 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.7 mt -44.7 -50.02 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.226 -0.921 . . . . 0.0 110.296 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -49.84 -51.31 40.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 12' ' ' PHE . 9.5 tm-20 -51.58 -45.46 63.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 110.089 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CD1' ' OE1' ' A' ' 11' ' ' GLU . 18.8 m-30 -55.2 -44.42 75.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 110.014 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -53.68 -49.77 67.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.936 . . . . 0.0 109.803 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.47 -47.18 66.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 110.083 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -60.96 -46.55 90.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.813 . . . . 0.0 110.235 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 65' ' ' PHE . 34.9 t80 -57.65 -45.36 85.62 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 110.041 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.0 t -70.18 -17.1 63.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.85 . . . . 0.0 110.0 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.556 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 9.0 tt -69.99 -55.42 9.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.976 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -72.43 -11.97 60.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 0.0 110.27 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 21' ' ' LYS . 25.4 t0 -97.5 69.54 2.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' ASP . 20.3 mmtt -42.47 -71.24 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.328 -0.858 . . . . 0.0 110.126 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 2.4 p-10 -51.95 -41.23 61.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.383 -0.823 . . . . 0.0 110.062 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.4 46.72 5.71 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.464 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 39.4 p-10 -103.23 6.79 38.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.202 . . . . 0.0 110.238 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.485 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 78.3 30.38 50.25 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 10.0 p -158.12 104.09 1.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -1.139 . . . . 0.0 110.28 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.52 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 9.5 mt -80.6 125.52 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.227 -0.921 . . . . 0.0 109.8 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p -100.1 165.74 11.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.385 -0.822 . . . . 0.0 110.68 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.9 p -56.47 -41.69 76.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.851 . . . . 0.0 110.214 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -62.02 -53.16 59.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 110.248 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 15.1 mt-10 -52.02 -68.74 0.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 110.092 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.44 HD22 HD21 ' A' ' 48' ' ' LEU . 23.8 tp -49.58 -32.51 12.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.898 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.97 -53.94 36.95 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.0 m -48.12 -47.17 34.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -1.151 . . . . 0.0 109.686 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.3 t -61.01 -51.49 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.352 -0.843 . . . . 0.0 109.739 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.461 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 5.2 mmt -57.88 -39.61 78.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.84 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -34.9 72.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 110.016 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 39' ' ' LEU . 1.4 m -68.07 -48.11 66.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.164 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 38' ' ' SER . 9.5 mt -44.21 -25.3 0.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.873 . . . . 0.0 110.261 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.81 50.64 0.68 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 36' ' ' MET . 0.3 OUTLIER -154.61 -163.31 1.56 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -1.127 . . . . 0.0 110.224 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -151.79 102.15 2.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.055 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.62 119.23 5.82 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.016 1.535 . . . . 0.0 110.524 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.435 ' HB ' ' CG ' ' A' ' 47' ' ' GLU . 9.1 m -76.05 155.3 34.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.301 -0.874 . . . . 0.0 110.22 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -45.64 -69.64 0.13 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 110.026 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.06 -47.28 65.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.999 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' CG ' ' HB ' ' A' ' 44' ' ' THR . 13.0 mt-10 -46.35 -55.44 7.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.265 -0.897 . . . . 0.0 110.095 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 32' ' ' LEU . 1.1 mt -53.78 -40.26 66.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -62.75 -34.7 77.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.974 179.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -41.15 97.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.838 . . . . 0.0 110.156 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.8 mtp -74.7 -41.27 60.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.316 -0.865 . . . . 0.0 110.251 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.536 HD11 ' N ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -71.15 -14.84 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.197 -0.939 . . . . 0.0 109.699 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.8 OUTLIER -83.87 -18.63 36.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.288 -0.883 . . . . 0.0 110.187 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.86 -50.95 9.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.521 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.597 HG22 ' CD1' ' B' ' 7' ' ' TRP . 10.7 t -72.95 -22.23 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.175 -0.953 . . . . 0.0 110.021 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.87 86.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.363 -0.835 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -80.31 -46.11 16.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.202 -0.936 . . . . 0.0 110.436 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 12.2 p-10 -75.94 -42.5 48.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.084 -1.01 . . . . 0.0 110.409 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.53 44.92 2.22 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 27.0 p-10 -99.48 -38.2 8.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -1.206 . . . . 0.0 110.383 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 128.78 0.95 6.02 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 61' ' ' GLY . 19.4 p -145.85 161.77 39.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -1.127 . . . . 0.0 110.072 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.52 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 17.2 mm -86.69 152.21 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.185 -0.947 . . . . 0.0 110.518 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.525 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 29.6 m-20 -127.35 -173.15 2.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 110.542 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.6 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.0 t80 -74.39 -42.07 5.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.418 -0.801 . . . . 0.0 111.326 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -72.94 -24.57 17.41 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.274 1.144 . . . . 0.0 110.395 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.472 ' CG ' ' HB1' ' A' ' 57' ' ' ALA . 3.5 mt-10 -70.82 -32.43 69.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.394 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CZ ' HD12 ' B' ' 11' ' ' ILE . 9.1 t80 -77.41 -33.81 54.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.893 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.536 HD13 ' CE1' ' A' ' 65' ' ' PHE . 85.1 mt -72.75 -26.91 61.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.339 -0.851 . . . . 0.0 111.21 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 p -89.32 -34.77 16.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.902 -1.124 . . . . 0.0 111.227 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -39.24 62.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.137 -0.977 . . . . 0.0 111.022 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.543 ' HE3' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -63.87 -22.11 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.05 -1.031 . . . . 0.0 110.879 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -94.94 -9.72 33.24 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.928 -1.107 . . . . 0.0 110.882 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -82.36 -46.88 13.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.161 -0.962 . . . . 0.0 110.747 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.05 -39.3 34.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.468 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.61 -27.0 61.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.622 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.453 HD12 HG23 ' A' ' 146' ' ' THR . 24.0 mt -72.77 -26.19 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -29.1 67.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.39 0.614 . . . . 0.0 109.444 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 24.7 mt-10 -76.57 -47.79 21.36 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.281 -0.887 . . . . 0.0 109.199 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.579 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -57.97 -33.88 69.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.083 -1.01 . . . . 0.0 108.86 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -66.76 -48.09 70.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.432 -0.792 . . . . 0.0 109.464 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -52.69 -30.89 34.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.387 -0.821 . . . . 0.0 109.573 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 63.7 t -67.72 -53.18 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.818 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 67.0 m-85 -63.02 -15.02 55.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.135 -0.978 . . . . 0.0 109.989 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -100.04 65.01 1.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 110.436 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -40.97 -72.05 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.383 -0.823 . . . . 0.0 110.486 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.1 p30 -61.03 -28.44 69.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.01 50.13 7.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -99.73 -7.27 25.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.294 -1.121 . . . . 0.0 110.357 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.7 29.58 8.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.417 ' CD1' ' CD ' ' A' ' 135' ' ' GLN . 0.9 OUTLIER -161.31 143.19 11.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -1.139 . . . . 0.0 110.081 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 92' ' ' PHE . 17.3 mt -118.71 158.26 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.522 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 102' ' ' ALA . 23.2 p -148.07 155.76 41.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.387 -0.82 . . . . 0.0 109.927 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.1 -43.1 3.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.332 -0.855 . . . . 0.0 110.205 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.78 -51.09 68.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.839 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 92' ' ' PHE . 17.9 mt-10 -58.74 -47.75 83.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 0.0 109.959 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 2.1 mt -62.62 -33.92 75.99 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.271 -0.893 . . . . 0.0 109.696 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -61.63 -34.07 75.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.248 -0.908 . . . . 0.0 109.431 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 10.0 t-80 -68.26 -43.67 77.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.402 -0.812 . . . . 0.0 109.588 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.5 HG11 HD13 ' A' ' 112' ' ' LEU . 1.2 t -64.16 -34.42 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 109.896 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.564 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 4.8 mtt -53.63 -70.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.608 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.6 m -55.38 -16.78 3.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.898 . . . . 0.0 110.554 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 9.0 m120 -94.67 -6.49 43.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.103 -0.998 . . . . 0.0 110.392 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.609 ' CD1' ' CG1' ' B' ' 13' ' ' VAL . 9.6 mt -132.06 6.95 4.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.037 -1.04 . . . . 0.0 111.686 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.3 -93.34 0.13 Allowed Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.404 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' CG ' ' N ' ' A' ' 115' ' ' LYS . 15.3 tt0 -136.53 166.07 24.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -1.076 . . . . 0.0 110.408 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -103.6 118.66 37.23 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 9.3 mp -64.83 155.31 34.4 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 121.446 -0.784 . . . . 0.0 110.336 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -49.09 178.8 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.365 -0.835 . . . . 0.0 109.274 179.436 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.79 -57.23 4.24 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.89 -1.131 . . . . 0.0 110.263 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.97 -49.01 31.91 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.195 -0.94 . . . . 0.0 109.669 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -57.69 -60.51 3.58 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 108.978 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.1 t -47.32 -44.58 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.299 -0.876 . . . . 0.0 109.416 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -50.53 71.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.292 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.52 ' HB3' ' HG3' ' B' ' 20' ' ' ARG . 0.2 OUTLIER -57.83 -31.24 66.44 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.183 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.418 ' HG2' ' CD1' ' B' ' 22' ' ' PHE . 9.3 ttt -60.1 -43.85 95.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.475 -0.766 . . . . 0.0 109.294 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.592 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 37.6 mm -84.87 -27.12 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.923 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -45.06 78.47 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.315 -0.866 . . . . 0.0 110.314 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.08 -36.18 82.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.339 -0.851 . . . . 0.0 110.165 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 136' ' ' VAL . . . -76.23 -32.45 58.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.381 -0.824 . . . . 0.0 110.124 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 0.7 OUTLIER -73.04 63.65 0.68 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.75 -58.85 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.524 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 1.7 p30 -55.07 -36.13 65.27 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.582 -0.698 . . . . 0.0 109.784 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 98.48 69.17 0.93 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 131' ' ' ASP . 3.2 m-20 -121.89 -4.59 9.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -1.192 . . . . 0.0 110.133 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.55 -9.88 63.56 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 2.8 pt20 -142.97 168.02 20.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -1.147 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.466 HG11 ' CB ' ' A' ' 140' ' ' GLU . 5.2 t -112.82 155.76 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.203 -0.936 . . . . 0.0 110.243 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.432 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 17.6 p-10 -125.79 -144.81 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.335 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -80.15 -70.08 0.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.277 -0.89 . . . . 0.0 110.547 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 143' ' ' GLN . 26.4 mt-10 -43.03 -38.43 2.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.201 -0.937 . . . . 0.0 110.429 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.466 ' CB ' HG11 ' A' ' 136' ' ' VAL . 32.8 mt-10 -68.54 -62.26 1.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.271 -0.893 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -51.93 -22.1 3.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.3 -0.875 . . . . 0.0 110.645 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.56 -52.56 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.102 -0.999 . . . . 0.0 110.838 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.466 ' CB ' ' O ' ' A' ' 139' ' ' GLU . 4.5 tp60 -57.84 -13.03 3.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.267 -0.895 . . . . 0.0 110.832 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.8 mmm -99.34 -18.21 17.64 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.001 -1.062 . . . . 0.0 110.765 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.436 ' HE3' HD22 ' B' ' 12' ' ' LEU . 38.0 mtp -100.49 -69.25 0.78 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.041 -1.037 . . . . 0.0 110.836 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.453 HG23 HD12 ' A' ' 85' ' ' ILE . 1.9 t . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.942 . . . . 0.0 110.373 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 120.687 0.279 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.73 -176.45 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.081 1.569 . . . . 0.0 110.928 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.427 ' OG ' ' OE2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -106.4 178.65 4.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.329 -0.857 . . . . 0.0 110.501 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.597 ' CD1' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -54.11 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.415 -0.803 . . . . 0.0 110.911 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.454 ' O ' ' N ' ' B' ' 11' ' ' ILE . 55.9 p -44.82 -50.58 10.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 110.151 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.533 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 37.9 m -44.01 -50.37 8.34 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.444 -0.785 . . . . 0.0 109.633 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 24.9 t -57.22 -34.83 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.191 -0.943 . . . . 0.0 109.233 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.585 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 18.4 mt -74.08 -30.49 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 108.722 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.436 HD22 ' HE3' ' A' ' 145' ' ' MET . 0.3 OUTLIER -57.74 -58.38 8.62 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.543 -0.723 . . . . 0.0 109.378 179.319 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.609 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 81.0 t -59.12 -51.19 75.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.554 -0.716 . . . . 0.0 110.373 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -51.6 -58.57 5.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.025 -1.047 . . . . 0.0 109.878 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -51.15 -25.95 6.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.403 -0.811 . . . . 0.0 110.194 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' B' ' 21' ' ' SER . 6.3 tpp -70.88 -32.78 69.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' B' ' 19' ' ' LYS . 3.9 mp -64.68 -102.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.965 -1.084 . . . . 0.0 109.838 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.523 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 55.32 -72.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.505 -0.747 . . . . 0.0 110.85 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.625 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -173.43 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.321 -0.862 . . . . 0.0 110.952 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' B' ' 19' ' ' LYS . 7.0 tmm_? 73.97 -7.1 1.69 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.892 -1.13 . . . . 0.0 110.297 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' B' ' 16' ' ' MET . 36.0 m -46.79 116.09 1.24 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.045 -1.034 . . . . 0.0 109.779 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' B' ' 23' ' ' GLY . 0.2 OUTLIER -148.51 -32.84 0.24 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.174 -0.954 . . . . 0.0 111.282 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' B' ' 22' ' ' PHE . . . -54.81 -111.41 0.01 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.46 ' OD1' ' OXT' ' B' ' 26' ' ' PHE . 4.8 t30 -116.42 96.23 47.4 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.24 -1.153 . . . . 0.0 110.242 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.5 -18.45 20.08 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.099 1.579 . . . . 0.0 110.337 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.543 ' CZ ' ' HE3' ' A' ' 72' ' ' MET . 46.0 m-85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.285 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.6 mt -53.63 -38.4 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.3 -0.875 . . . . 0.0 108.751 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -52.03 -46.95 65.22 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.284 -0.885 . . . . 0.0 108.806 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.444 ' CD ' ' HD2' ' B' ' 18' ' ' ARG . 6.0 tt0 -53.69 -53.9 45.47 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.217 -0.927 . . . . 0.0 108.819 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -55.57 -40.27 71.75 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.373 -0.829 . . . . 0.0 108.856 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -59.43 -40.38 86.55 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 17' ' ' SER . 8.3 tt0 -49.61 -55.12 14.72 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.453 -0.78 . . . . 0.0 108.95 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.05 -55.99 24.82 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.506 -0.878 . . . . 0.0 108.76 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -49.1 -26.85 2.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 3.2 m -87.85 -36.33 17.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.541 -0.724 . . . . 0.0 109.113 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' HD22 ' A' ' 18' ' ' LEU . 9.8 tt -47.98 -34.61 9.55 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.389 -0.819 . . . . 0.0 109.376 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.523 ' CE1' HG13 ' B' ' 10' ' ' VAL . 73.4 m-85 -81.8 -28.66 33.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.824 . . . . 0.0 109.986 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 5.0 t0 -87.36 81.54 7.84 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.213 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -52.56 -56.97 11.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 110.374 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.42 ' OD1' ' CG ' ' A' ' 24' ' ' ASP . 3.0 p30 -59.16 -41.17 87.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 110.373 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.86 57.6 1.7 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 35.5 p-10 -114.33 10.4 17.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.231 -1.158 . . . . 0.0 110.293 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.97 15.18 73.96 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 1.2 p -141.72 116.6 9.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -1.225 . . . . 0.0 110.275 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.407 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 13.4 mt -92.27 112.92 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.149 -0.97 . . . . 0.0 109.738 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 18.8 p -75.95 -160.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.915 . . . . 0.0 110.354 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.0 p -88.82 -45.4 9.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 110.543 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 21.5 pttt -71.63 -25.87 62.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.026 -1.046 . . . . 0.0 110.574 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 47.2 mt-10 -63.15 -44.67 94.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.031 -1.043 . . . . 0.0 109.491 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.45 ' O ' ' HG2' ' A' ' 36' ' ' MET . 2.9 tp -67.35 -48.18 68.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.332 -0.855 . . . . 0.0 109.649 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.81 -44.96 49.36 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.8 m -61.17 -57.15 13.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.353 -1.086 . . . . 0.0 109.736 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 19' ' ' PHE . 21.4 t -50.42 -40.46 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.213 -0.929 . . . . 0.0 109.655 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 4.7 mmt -60.82 -47.57 85.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.268 -0.895 . . . . 0.0 109.412 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.456 ' NE ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -47.79 -38.23 15.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.395 179.224 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -63.04 -45.27 93.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.564 -0.71 . . . . 0.0 110.705 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 3.1 mt -57.88 -34.47 69.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.165 -0.959 . . . . 0.0 110.455 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.37 63.65 0.32 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.456 ' O ' ' NE ' ' A' ' 37' ' ' ARG . 1.9 pt20 -160.75 -175.66 5.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.309 -1.112 . . . . 0.0 109.922 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -131.12 95.08 25.94 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.068 -1.02 . . . . 0.0 110.624 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 36' ' ' MET . 47.2 Cg_endo -75.34 123.49 7.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.041 1.548 . . . . 0.0 110.177 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -94.98 168.5 10.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -57.44 -56.45 21.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.121 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.37 -55.26 16.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 0.0 110.258 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -51.23 -52.86 40.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 110.006 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.0 mt -46.61 -64.28 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.81 -34.81 63.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.419 -0.801 . . . . 0.0 110.075 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.55 -33.91 69.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 110.285 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.517 ' O ' ' NE1' ' B' ' 7' ' ' TRP . 9.8 mtp -81.17 -34.59 32.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -0.85 . . . . 0.0 110.023 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 10.9 mm -74.53 -36.62 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -0.867 . . . . 0.0 109.76 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -68.04 -20.39 64.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.394 -0.816 . . . . 0.0 110.135 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.04 -42.67 66.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 110.383 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 57' ' ' ALA . 8.7 t -83.8 -51.04 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -41.76 90.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.651 . . . . 0.0 110.428 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -83.36 -36.43 24.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.462 -0.774 . . . . 0.0 110.747 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' OD2' ' CG ' ' A' ' 60' ' ' ASN . 6.5 p-10 -72.17 -48.26 44.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.032 -1.042 . . . . 0.0 110.535 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.89 35.94 1.09 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 29.2 p-10 -98.56 -46.02 5.88 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.016 -1.285 . . . . 0.0 110.314 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 118.43 13.69 6.75 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 61' ' ' GLY . 37.5 p -144.4 141.44 29.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.16 -1.2 . . . . 0.0 110.538 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.496 HD13 ' HB ' ' A' ' 55' ' ' VAL . 35.4 mm -85.21 142.25 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.219 -0.925 . . . . 0.0 109.902 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -121.81 -175.66 3.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.075 -1.015 . . . . 0.0 110.593 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.6 t80 -65.97 -45.99 63.96 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.416 -0.802 . . . . 0.0 111.54 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.2 Cg_endo -68.62 -38.86 10.01 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 O-C-N 123.092 1.048 . . . . 0.0 110.395 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.61 -30.46 69.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.112 -0.992 . . . . 0.0 109.274 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.495 ' CG ' ' HB2' ' A' ' 16' ' ' PHE . 4.1 t80 -69.92 -46.02 66.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.54 -0.725 . . . . 0.0 109.902 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 65' ' ' PHE . 3.0 mm? -53.78 -53.05 57.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.353 -0.842 . . . . 0.0 110.303 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 71' ' ' MET . 1.5 p -66.04 -63.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.269 -0.895 . . . . 0.0 110.708 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.452 ' HG3' HG23 ' A' ' 55' ' ' VAL . 6.8 tmm? -40.51 -36.87 0.62 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.642 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 7.0 tpt -61.76 -12.1 15.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.224 -0.922 . . . . 0.0 110.702 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.02 -10.01 4.82 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.04 -1.037 . . . . 0.0 111.223 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -24.61 15.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.998 -1.064 . . . . 0.0 110.363 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.419 ' HB3' ' CG2' ' B' ' 8' ' ' THR . 2.1 tppm? . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 0.0 110.414 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.489 ' OE2' HG23 ' A' ' 142' ' ' VAL . 3.8 tm-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.217 0.532 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -55.29 -43.47 74.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.069 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -45.79 -50.21 14.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.345 -0.847 . . . . 0.0 110.495 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -70.76 -38.53 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.109 -0.994 . . . . 0.0 109.397 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -58.84 -30.64 67.84 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.367 -0.833 . . . . 0.0 109.916 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 76.9 mm-40 -74.07 -55.33 6.24 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.273 -0.892 . . . . 0.0 109.665 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.42 -29.69 49.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 0.0 109.149 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -71.89 -34.5 69.2 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.159 -0.963 . . . . 0.0 109.083 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -63.84 -27.32 69.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.445 -0.784 . . . . 0.0 109.197 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.31 -43.98 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.517 -0.739 . . . . 0.0 110.151 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.445 ' HB3' HD12 ' A' ' 100' ' ' ILE . 24.1 m-85 -67.01 -35.92 80.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.157 -0.965 . . . . 0.0 110.338 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -73.29 54.66 0.43 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.326 -0.859 . . . . 0.0 110.502 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 93' ' ' ASP . 13.4 tppt? -41.65 -46.63 3.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.0 110.288 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 21.4 p-10 -87.97 -26.78 22.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.56 47.55 12.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 31.6 p-10 -94.41 -22.35 18.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -1.121 . . . . 0.0 110.099 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.482 ' C ' ' CD2' ' A' ' 99' ' ' TYR . . . 110.76 15.23 11.23 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD2' ' C ' ' A' ' 98' ' ' GLY . 91.2 m-85 -150.72 137.73 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.307 -1.113 . . . . 0.0 110.181 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 135' ' ' GLN . 7.1 mt -101.71 150.74 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.13 -0.981 . . . . 0.0 110.14 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -138.48 146.78 42.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.151 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.88 -29.08 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.93 . . . . 0.0 109.843 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.75 79.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -0.843 . . . . 0.0 109.664 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -61.85 -45.03 95.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.486 ' CD1' HD13 ' A' ' 125' ' ' ILE . 1.5 mt -66.1 -38.09 87.37 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.354 -0.841 . . . . 0.0 109.267 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.488 ' NH2' ' HG2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -55.62 -35.83 66.3 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.406 -0.809 . . . . 0.0 109.084 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -71.03 -47.6 57.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.5 -0.75 . . . . 0.0 109.363 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -60.5 -23.51 28.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.381 -0.824 . . . . 0.0 109.024 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.566 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 5.1 mtt -69.28 -63.51 1.05 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.503 -0.748 . . . . 0.0 109.812 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.3 m -56.94 -30.37 63.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.191 -0.943 . . . . 0.0 109.236 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.425 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 12.5 m120 -74.77 -17.79 60.58 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.459 -0.776 . . . . 0.0 109.671 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.525 ' CD1' HG11 ' B' ' 13' ' ' VAL . 3.9 mt -95.41 -48.08 6.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.858 . . . . 0.0 110.212 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.09 -30.12 0.22 Allowed Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.529 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 109' ' ' MET . 29.4 tt0 -125.05 171.22 10.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.873 -1.369 . . . . 0.0 110.941 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -144.98 75.7 1.46 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 117' ' ' THR . 2.4 mp -34.79 156.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.641 0.734 . . . . 0.0 111.494 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -57.1 -150.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.0 110.387 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -109.76 -53.89 2.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.236 -0.915 . . . . 0.0 110.38 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.35 -44.46 84.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.019 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.93 -42.13 97.44 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.829 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 117' ' ' THR . 71.8 t -64.62 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.947 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -60.28 -45.19 94.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -61.47 -38.07 85.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 109.582 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.578 ' HE3' ' CD1' ' B' ' 22' ' ' PHE . 0.6 OUTLIER -54.06 -49.25 69.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.162 -0.961 . . . . 0.0 109.681 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.486 HD13 ' CD1' ' A' ' 105' ' ' LEU . 37.5 mm -70.16 -26.48 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -70.14 -26.51 63.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.902 . . . . 0.0 109.917 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -71.46 -44.5 64.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.867 . . . . 0.0 110.064 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -71.44 -33.41 69.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.381 -0.824 . . . . 0.0 110.049 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -60.44 75.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.33 -0.857 . . . . 0.0 110.4 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 128' ' ' ALA . 21.5 mt -72.16 -31.34 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.968 . . . . 0.0 110.232 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 34.8 p-10 -83.94 -27.13 28.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.148 -0.97 . . . . 0.0 110.275 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.94 71.17 1.24 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 4.0 p30 -126.57 -23.37 3.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.244 -1.151 . . . . 0.0 110.468 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 104.63 -0.78 42.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 4.8 pt20 -151.18 166.67 30.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 110.204 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.484 ' CG2' ' HB2' ' A' ' 128' ' ' ALA . 53.3 t -110.68 151.77 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -131.95 -164.92 1.51 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.143 -0.973 . . . . 0.0 110.397 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.524 ' CE1' HG22 ' A' ' 142' ' ' VAL . 9.2 t80 -62.13 -65.82 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.229 -0.919 . . . . 0.0 110.72 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -41.87 -50.02 4.46 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.216 -0.927 . . . . 0.0 110.677 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -63.96 -59.99 3.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.965 . . . . 0.0 110.394 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.42 ' CE1' ' HE2' ' A' ' 92' ' ' PHE . 50.1 t80 -51.75 -20.57 2.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 110.523 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.524 HG22 ' CE1' ' A' ' 138' ' ' TYR . 41.6 t -100.51 -60.28 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.179 -0.951 . . . . 0.0 110.791 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 142' ' ' VAL . 9.5 tt0 -40.36 -45.82 2.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.31 -0.869 . . . . 0.0 110.762 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.445 ' O ' ' OD1' ' B' ' 24' ' ' ASN . 3.7 mmt -66.59 -26.8 67.28 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 110.419 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.519 ' HE3' ' CE ' ' B' ' 16' ' ' MET . 19.9 mmm -96.07 -45.99 6.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.079 -1.013 . . . . 0.0 110.937 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.116 -0.99 . . . . 0.0 110.984 -179.48 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.519 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 35.1 mm . . . . . 0 N--CA 1.506 2.329 0 CA-C-O 120.667 0.27 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 42.3 Cg_endo -69.1 -157.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.936 1.493 . . . . 0.0 111.035 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' B' ' 7' ' ' TRP . 55.7 p -132.67 57.81 1.78 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.062 -1.024 . . . . 0.0 111.449 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.517 ' NE1' ' O ' ' A' ' 51' ' ' MET . 0.7 OUTLIER 64.27 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.972 -1.08 . . . . 0.0 111.575 178.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.419 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -46.33 -46.91 18.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 110.393 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.516 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 26.0 m -45.83 -40.24 9.55 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.151 -0.968 . . . . 0.0 109.483 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.523 HG13 ' CE1' ' A' ' 19' ' ' PHE . 10.2 t -66.03 -44.04 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.528 -0.733 . . . . 0.0 110.061 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.522 ' CG2' ' SD ' ' A' ' 72' ' ' MET . 51.7 mt -69.39 -25.29 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.288 -0.883 . . . . 0.0 109.907 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.08 -49.57 64.61 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 110.34 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.525 HG11 ' CD1' ' A' ' 112' ' ' LEU . 47.9 t -65.13 -46.96 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 110.561 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' B' ' 14' ' ' LYS . 0.2 OUTLIER -58.61 -33.71 70.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.842 -1.161 . . . . 0.0 109.688 179.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 0.1 OUTLIER -63.95 -43.89 94.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.519 ' CE ' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -59.18 -32.43 69.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.0 110.114 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.566 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 6.4 mp -69.4 58.65 0.12 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.161 -0.962 . . . . 0.0 110.345 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' B' ' 20' ' ' ARG . 3.0 ttp180 -123.84 76.22 1.42 Allowed 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.891 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.493 ' CD ' ' C ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER 62.74 -57.77 0.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.605 -0.684 . . . . 0.0 111.042 179.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' B' ' 18' ' ' ARG . 0.7 OUTLIER -166.9 22.61 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.24 -0.913 . . . . 0.0 110.38 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.407 ' OG ' ' HB3' ' B' ' 18' ' ' ARG . 66.2 m -74.8 126.55 31.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.188 -0.945 . . . . 0.0 110.363 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.578 ' CD1' ' HE3' ' A' ' 124' ' ' MET . 0.1 OUTLIER -145.11 -40.64 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.118 -0.989 . . . . 0.0 110.913 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' B' ' 22' ' ' PHE . . . -46.37 -99.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' ' 145' ' ' MET . 80.5 m-20 -138.3 88.11 15.23 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.144 -1.209 . . . . 0.0 110.719 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.63 -12.28 18.43 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.847 1.446 . . . . 0.0 110.036 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.642 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 5.5 m-30 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.269 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.554 ' CG ' ' N ' ' A' ' 9' ' ' ILE . 12.8 pt20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.099 0.476 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.554 ' N ' ' CG ' ' A' ' 8' ' ' GLN . 83.8 mt -67.02 -50.43 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.023 -1.048 . . . . 0.0 109.375 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.47 64.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 109.303 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 37.8 tt0 -58.84 -52.95 63.54 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.401 -0.812 . . . . 0.0 109.478 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.574 ' CE2' ' HG3' ' A' ' 72' ' ' MET . 1.6 m-85 -53.23 -43.67 67.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.349 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -59.53 -41.69 90.57 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.765 . . . . 0.0 109.525 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -49.52 77.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.311 -0.868 . . . . 0.0 109.487 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.84 83.94 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.351 -0.843 . . . . 0.0 109.355 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.509 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 38.8 t80 -61.29 -21.68 64.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.501 -0.749 . . . . 0.0 109.575 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -89.64 -31.39 17.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.451 -0.781 . . . . 0.0 109.694 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 10.4 tt -61.33 -44.72 96.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.866 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 74.8 m-85 -74.27 -47.38 35.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 110.193 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -67.18 73.0 0.11 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 19' ' ' PHE . 9.3 mmtt -64.89 -8.99 17.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 110.389 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -93.83 -29.55 15.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.351 -0.843 . . . . 0.0 110.167 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.11 33.61 44.51 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 23.5 p30 -104.81 -15.56 15.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.19 -1.182 . . . . 0.0 110.176 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 93.61 31.0 8.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 24.7 p -156.02 118.3 4.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -1.155 . . . . 0.0 110.29 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.481 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 7.3 mt -92.9 125.74 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.014 -1.054 . . . . 0.0 110.093 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.1 p -100.5 -175.65 2.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.501 -0.749 . . . . 0.0 109.462 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.459 ' O ' HD23 ' A' ' 48' ' ' LEU . 2.9 p -76.13 -22.54 55.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.007 . . . . 0.0 109.822 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -73.03 -46.21 53.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 110.234 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.42 -62.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.428 ' HG ' ' HE1' ' A' ' 36' ' ' MET . 34.5 tp -54.88 -30.15 57.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.013 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.526 ' CA ' HD23 ' A' ' 48' ' ' LEU . . . -68.67 -32.33 74.38 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.1 m -71.88 -59.8 2.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -1.129 . . . . 0.0 110.16 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.7 t -50.79 -46.34 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.955 . . . . 0.0 110.167 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.517 ' SD ' ' CG2' ' B' ' 4' ' ' ILE . 0.3 OUTLIER -58.77 -47.59 84.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.259 -0.901 . . . . 0.0 110.098 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -24.95 58.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.883 . . . . 0.0 110.124 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.402 ' O ' ' CG ' ' A' ' 111' ' ' ASN . 36.3 t -77.98 -34.27 51.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.881 . . . . 0.0 110.513 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 HG12 ' A' ' 91' ' ' VAL . 3.5 mt -53.97 -42.85 69.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.186 -0.946 . . . . 0.0 110.276 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.49 51.21 0.06 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.98 -162.13 1.49 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -1.127 . . . . 0.0 110.225 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.54 70.92 14.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.462 ' HA ' HD12 ' B' ' 4' ' ' ILE . 44.2 Cg_endo -70.82 118.71 5.84 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.913 1.48 . . . . 0.0 110.243 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 3.1 m -82.02 152.62 26.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.888 . . . . 0.0 110.42 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -48.65 -53.74 17.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.41 -42.19 66.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.827 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' THR . 4.2 mm-40 -59.5 -52.11 66.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.861 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.526 HD23 ' CA ' ' A' ' 33' ' ' GLY . 1.7 mt -44.29 -57.21 3.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.903 . . . . 0.0 109.946 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.69 -45.47 28.43 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 109.597 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.04 -39.42 78.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.484 -0.76 . . . . 0.0 109.668 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.513 ' SD ' ' CE ' ' A' ' 36' ' ' MET . 1.6 ttp -74.96 -51.03 14.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 109.64 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.405 HG13 ' CG2' ' A' ' 29' ' ' THR . 1.9 mm -47.95 -24.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.226 -0.921 . . . . 0.0 109.221 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.22 -14.78 59.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 110.204 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -79.59 -8.42 59.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.253 -0.905 . . . . 0.0 110.428 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.644 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 54.9 t -118.34 -53.86 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.062 -1.024 . . . . 0.0 110.675 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -19.27 82.6 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.459 0.647 . . . . 0.0 112.014 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.77 -60.88 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.455 -0.778 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 13.6 p30 -68.32 -21.61 64.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.9 . . . . 0.0 109.988 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 72.11 48.0 28.05 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -97.18 -44.96 6.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.171 -1.194 . . . . 0.0 110.181 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . 139.32 -2.11 2.52 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.392 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 166.33 30.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.833 -1.392 . . . . 0.0 110.759 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.481 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 10.5 mm -101.68 122.38 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.459 -0.775 . . . . 0.0 110.037 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.503 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 p30 -110.03 -179.64 3.85 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.021 -1.049 . . . . 0.0 110.754 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.629 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 t80 -63.31 -39.55 51.13 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.287 -0.883 . . . . 0.0 112.121 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.7 Cg_endo -69.47 -29.82 24.61 Favored 'Trans proline' 0 C--N 1.32 -0.952 0 O-C-N 123.078 1.041 . . . . 0.0 109.973 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 71' ' ' MET . 23.8 mt-10 -75.2 -30.66 60.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 109.309 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.563 ' CD1' ' HE1' ' A' ' 71' ' ' MET . 10.5 t80 -66.96 -42.64 84.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.471 -0.768 . . . . 0.0 109.762 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.432 ' CD1' ' CE1' ' A' ' 65' ' ' PHE . 4.7 mt -70.11 -32.06 69.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.83 . . . . 0.0 110.326 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -87.73 -43.25 12.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.954 . . . . 0.0 110.557 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.563 ' HE1' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -59.78 -32.92 71.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.118 -0.989 . . . . 0.0 110.263 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.574 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -69.13 -11.95 61.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.882 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.77 -35.27 5.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.385 -0.822 . . . . 0.0 110.051 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -68.42 -41.14 80.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 110.135 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.1 tptt . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.82 . . . . 0.0 110.145 179.926 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.317 0.579 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 1.8 mm-40 -66.85 -9.88 42.28 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 0.0 109.929 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.4 -30.28 57.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.261 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.555 ' CD1' ' CG2' ' A' ' 146' ' ' THR . 75.1 mt -75.82 -32.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -36.82 84.09 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.438 -0.789 . . . . 0.0 109.623 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 5.7 mm-40 -69.32 -45.58 69.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' B' ' 12' ' ' LEU . . . -60.62 -34.77 74.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.143 -0.973 . . . . 0.0 110.066 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.554 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 29.5 t80 -68.44 -40.93 80.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 109.653 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -60.85 -29.7 69.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.343 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.422 HG12 HD23 ' A' ' 39' ' ' LEU . 65.6 t -72.79 -55.06 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.006 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.469 ' CZ ' ' SD ' ' B' ' 16' ' ' MET . 37.5 m-85 -53.62 -29.87 40.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.258 -0.901 . . . . 0.0 109.975 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -100.44 67.14 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.459 -0.776 . . . . 0.0 110.101 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.503 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -41.36 -25.95 0.05 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.399 -0.813 . . . . 0.0 110.415 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.503 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 15.7 p-10 -102.09 -41.69 6.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 109.961 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.22 49.86 5.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.448 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 42.0 p-10 -92.18 -23.55 19.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 124.95 26.33 1.39 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.57 ' CZ ' ' OD1' ' A' ' 137' ' ' ASN . 1.1 m-85 -170.52 158.22 6.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.974 -1.309 . . . . 0.0 110.617 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.494 HD11 HG22 ' A' ' 100' ' ' ILE . 10.0 mt -126.97 120.19 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.271 -0.893 . . . . 0.0 110.28 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -101.38 145.91 28.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -0.988 . . . . 0.0 109.802 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.84 -31.89 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 109.726 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.1 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.343 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 101' ' ' SER . 7.4 mt-10 -60.49 -48.6 81.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.442 -0.786 . . . . 0.0 109.367 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.409 HD12 ' CZ ' ' B' ' 22' ' ' PHE . 0.3 OUTLIER -59.04 -41.95 89.06 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.298 -0.876 . . . . 0.0 108.912 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -51.62 -36.7 46.91 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -60.11 -56.08 26.06 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.78 -34.73 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.333 -0.855 . . . . 0.0 108.792 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.551 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 3.7 mtt -57.35 -69.42 0.16 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.652 -0.655 . . . . 0.0 110.829 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.511 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 93.7 m -55.57 -21.68 18.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.062 -1.024 . . . . 0.0 109.876 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 38' ' ' SER . 57.1 m-20 -84.34 -10.32 57.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.169 -0.957 . . . . 0.0 109.801 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.548 ' CD1' HG11 ' B' ' 13' ' ' VAL . 6.8 mt -108.94 -40.37 5.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.304 -0.872 . . . . 0.0 110.549 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 167.12 -64.71 0.2 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.355 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.423 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 1.2 tp10 -107.93 171.45 7.39 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.201 -1.176 . . . . 0.0 110.841 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.543 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 1.3 mptp? -130.29 5.38 4.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 0.0 110.698 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.54 ' CD2' ' HA ' ' B' ' 19' ' ' LYS . 1.4 mp 57.08 152.91 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.073 0 O-C-N 121.599 -0.688 . . . . 0.0 110.469 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 116' ' ' LEU . 1.2 m -60.72 -151.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.02 -1.05 . . . . 0.0 109.478 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.38 -33.4 5.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 110.173 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -71.21 -45.2 63.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 109.97 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 124' ' ' MET . 12.6 pt-20 -68.71 -35.79 77.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.627 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 116' ' ' LEU . 23.3 t -63.14 -37.3 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.871 . . . . 0.0 109.575 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.19 -47.8 40.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 1.2 tp10 -67.22 -30.91 70.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.359 -0.838 . . . . 0.0 109.268 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.5 ' CG ' ' HA ' ' B' ' 21' ' ' SER . 1.5 ttt -61.18 -46.32 90.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.496 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 125' ' ' ILE . 22.0 mm -70.79 -56.62 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 0.0 109.821 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 127' ' ' GLU . 7.5 mtp85 -53.93 -62.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.377 -0.827 . . . . 0.0 110.014 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 123' ' ' GLU . 8.7 tp10 -42.07 -28.13 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.403 -0.811 . . . . 0.0 110.191 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.458 ' O ' HD11 ' A' ' 130' ' ' ILE . . . -90.98 -34.45 15.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.902 . . . . 0.0 110.026 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 20.1 m-20 -57.75 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.38 -0.825 . . . . 0.0 110.587 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.458 HD11 ' O ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -52.04 -34.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.954 . . . . 0.0 109.618 179.642 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 47.5 p-10 -94.48 -16.91 22.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 110.108 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 61.37 79.07 0.14 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 8.8 p30 -123.33 5.39 9.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -1.15 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.14 15.44 66.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.563 ' HG3' ' CE1' ' A' ' 99' ' ' TYR . 6.1 pt20 -169.74 169.41 8.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -1.155 . . . . 0.0 109.99 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 9.8 t -116.63 159.16 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.119 -0.988 . . . . 0.0 110.418 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.57 ' OD1' ' CZ ' ' A' ' 99' ' ' TYR . 1.2 t30 -123.56 -167.18 1.58 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.369 -0.832 . . . . 0.0 110.014 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.554 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 1.7 t80 -74.73 -64.32 1.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.184 -0.948 . . . . 0.0 109.993 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -44.36 -48.5 9.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.913 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -55.58 -56.19 23.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.34 -0.85 . . . . 0.0 110.229 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -51.87 -19.71 1.88 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.4 t -96.46 -70.32 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.062 -1.024 . . . . 0.0 110.883 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -45.36 -48.59 13.34 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.1 -1.0 . . . . 0.0 110.794 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.515 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 11.8 tpt -72.26 -10.38 59.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.722 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.1 tpp -100.69 -47.83 4.71 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.95 -1.094 . . . . 0.0 111.044 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.555 ' CG2' ' CD1' ' A' ' 85' ' ' ILE . 1.7 t . . . . . 0 N--CA 1.496 1.872 0 O-C-N 121.106 -0.996 . . . . 0.0 110.344 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.572 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 84.4 mt . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.572 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 38.0 Cg_endo -62.91 124.55 14.23 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.641 1.337 . . . . 0.0 110.217 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.486 ' O ' ' CG2' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -58.13 170.19 0.71 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.678 0.751 . . . . 0.0 111.25 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.644 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -56.13 -80.06 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.448 0.642 . . . . 0.0 110.383 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.416 ' O ' ' HB ' ' B' ' 11' ' ' ILE . 38.7 p -45.21 -40.69 7.55 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.413 -0.805 . . . . 0.0 109.755 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.575 ' HA ' ' CD2' ' B' ' 12' ' ' LEU . 94.4 m -49.92 -48.17 51.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.233 -0.917 . . . . 0.0 109.177 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' B' ' 6' ' ' SER . 15.8 t -61.06 -29.42 45.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.387 -0.821 . . . . 0.0 109.246 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 26.5 mm -77.73 -55.18 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.66 -0.65 . . . . 0.0 111.441 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.595 ' HB3' ' CE2' ' B' ' 26' ' ' PHE . 3.9 pp -56.88 -33.03 66.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.188 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.548 HG11 ' CD1' ' A' ' 112' ' ' LEU . 24.2 t -67.09 -50.33 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.952 -1.093 . . . . 0.0 108.755 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.479 ' HG3' ' CD1' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -62.07 -24.45 67.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.205 -0.935 . . . . 0.0 108.633 178.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' B' ' 18' ' ' ARG . 1.4 p -75.38 -27.52 59.14 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.434 0.635 . . . . 0.0 109.36 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.47 ' O ' ' N ' ' B' ' 18' ' ' ARG . 8.4 mtt -73.31 -32.29 64.51 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.412 -0.805 . . . . 0.0 108.968 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.551 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 6.0 mp -67.76 58.8 0.06 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.518 -0.739 . . . . 0.0 109.229 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' B' ' 16' ' ' MET . 5.7 mtm180 -84.47 -80.99 0.19 Allowed 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.769 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.54 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -176.82 -67.31 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.052 -1.03 . . . . 0.0 111.472 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.53 ' N ' ' CD ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -87.83 -21.73 24.88 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.373 -0.829 . . . . 0.0 112.074 -178.156 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.5 ' HA ' ' CG ' ' A' ' 124' ' ' MET . 4.0 m -163.71 -175.0 3.91 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.453 -1.404 . . . . 0.0 112.554 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.409 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 11.3 m-85 -78.78 -85.83 0.07 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.418 0.628 . . . . 0.0 110.567 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.45 -151.55 21.83 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 144' ' ' MET . 0.1 OUTLIER 176.93 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.201 -1.176 . . . . 0.0 110.681 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' B' ' 24' ' ' ASN . 42.6 Cg_endo -69.45 111.3 2.71 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.764 1.402 . . . . 0.0 110.195 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.595 ' CE2' ' HB3' ' B' ' 12' ' ' LEU . 2.1 t80 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.243 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.276 0.56 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.7 mt -60.16 -35.86 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.528 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.35 -56.27 22.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 110.144 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -55.72 -47.61 76.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.083 -1.011 . . . . 0.0 109.958 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -58.91 -41.82 88.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.0 109.43 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -62.1 -31.4 71.84 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.244 -0.91 . . . . 0.0 108.923 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 6.3 tp10 -57.62 -53.45 58.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.499 -0.75 . . . . 0.0 109.166 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -51.7 -55.58 18.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 109.219 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.536 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 86.5 t80 -52.99 -36.28 60.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.495 -0.753 . . . . 0.0 109.366 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.2 t -76.05 -26.95 57.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.567 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.439 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 10.1 tt -58.8 -44.16 90.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.901 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -75.22 -25.91 58.53 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.216 -0.927 . . . . 0.0 110.281 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.72 106.08 14.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.233 -0.917 . . . . 0.0 110.1 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -99.66 5.87 45.73 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.216 -0.927 . . . . 0.0 110.49 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 3.8 p30 -116.65 -51.68 2.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.155 -0.966 . . . . 0.0 110.397 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 114.08 39.87 1.02 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 13.6 p30 -111.65 -16.14 13.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.137 -1.214 . . . . 0.0 110.233 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.54 -1.18 81.39 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 68.3 p -118.46 108.94 15.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.18 -1.188 . . . . 0.0 110.37 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 27' ' ' ILE . 17.9 mt -77.82 124.49 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.289 -0.882 . . . . 0.0 109.966 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.414 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 1.1 p -97.35 -178.79 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.374 -0.829 . . . . 0.0 110.316 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.481 ' CG2' ' NE2' ' A' ' 49' ' ' GLN . 40.6 p -73.59 -33.8 64.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.122 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -43.83 86.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 0.0 110.23 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' OE2' ' OG1' ' A' ' 28' ' ' THR . 53.6 mt-10 -60.06 -60.21 4.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 tp -58.73 -32.37 69.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.89 -33.26 86.77 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.1 m -71.94 -47.93 48.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -1.141 . . . . 0.0 110.14 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.63 -55.57 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.266 -0.896 . . . . 0.0 110.566 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.482 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 3.8 mmt -55.47 -36.44 66.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 110.179 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -64.11 -33.04 74.87 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -44.63 81.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 110.689 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.458 HD23 HG12 ' A' ' 91' ' ' VAL . 10.7 mt -47.83 -37.96 14.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.006 -1.059 . . . . 0.0 109.923 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.74 17.27 19.55 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -82.05 -131.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.122 -1.222 . . . . 0.0 110.182 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.532 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 7.6 p30 -159.05 58.28 1.22 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.95 -1.094 . . . . 0.0 110.627 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 49.4 Cg_endo -82.87 83.14 2.02 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.931 1.49 . . . . 0.0 110.186 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.7 m -50.0 176.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.144 -0.972 . . . . 0.0 110.297 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.8 mm-40 -70.13 -59.54 2.83 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.267 -0.896 . . . . 0.0 110.075 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -44.2 -36.23 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.872 . . . . 0.0 109.844 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -70.71 -38.74 73.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.904 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 12.1 mt -55.78 -54.71 41.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.915 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.481 ' NE2' ' CG2' ' A' ' 29' ' ' THR . 0.0 OUTLIER -60.1 -40.4 89.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.631 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.453 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -63.98 -36.35 83.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 109.578 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.476 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -66.93 -47.01 73.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.908 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -63.56 -30.42 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 109.335 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.27 -16.99 61.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.705 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -72.72 -57.17 4.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.498 -0.751 . . . . 0.0 110.379 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.635 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 37.6 t -71.33 -29.83 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.913 -1.117 . . . . 0.0 109.936 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -48.67 88.47 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.347 -0.846 . . . . 0.0 110.565 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -69.06 -27.4 65.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.321 -0.862 . . . . 0.0 110.452 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 8.6 p-10 -95.85 -41.91 8.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.216 -0.927 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.83 47.67 1.46 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 18.8 p-10 -98.46 -44.07 6.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -1.137 . . . . 0.0 110.24 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.57 6.66 5.05 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.14 154.99 41.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.121 -1.223 . . . . 0.0 110.35 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.0 mm -97.07 166.18 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.274 -0.891 . . . . 0.0 110.122 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 4.8 t0 -148.11 169.94 18.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.125 -0.984 . . . . 0.0 110.568 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.631 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 19.9 t80 -59.39 -41.24 86.03 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.849 . . . . 0.0 111.961 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -68.73 -23.88 35.45 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 O-C-N 123.142 1.075 . . . . 0.0 110.473 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.58 -36.27 29.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -62.01 -42.91 99.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 110.239 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.62 -34.6 58.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.197 -0.939 . . . . 0.0 110.543 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 35.5 m -74.56 -12.44 60.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.062 -1.024 . . . . 0.0 110.768 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.9 tmm? -98.6 -43.68 6.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.045 -1.035 . . . . 0.0 110.76 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -10.89 6.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -0.958 . . . . 0.0 110.784 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.01 -17.23 28.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.055 -1.028 . . . . 0.0 110.927 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -97.05 -18.33 19.44 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.961 -1.087 . . . . 0.0 110.72 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HG3' ' CG2' ' B' ' 8' ' ' THR . 17.8 mmtp . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.073 -1.017 . . . . 0.0 110.537 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.225 0.536 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -72.73 -35.57 67.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HG2' ' CD1' ' B' ' 12' ' ' LEU . 8.3 tt0 -70.26 -42.09 72.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.83 . . . . 0.0 110.168 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 ' CE2' ' A' ' 141' ' ' PHE . 46.5 mt -68.63 -26.79 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.782 . . . . 0.0 109.718 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -66.9 -49.69 64.79 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.465 -0.772 . . . . 0.0 109.709 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB3' HG22 ' B' ' 9' ' ' THR . 8.4 mt-10 -59.53 -48.83 80.15 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.301 -0.875 . . . . 0.0 109.695 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -56.07 -31.63 63.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.6 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 4.7 t80 -67.99 -63.85 0.98 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.133 -0.98 . . . . 0.0 109.682 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' PHE . 3.9 mmt85 -41.34 -32.75 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.656 -0.653 . . . . 0.0 109.826 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.458 HG12 HD23 ' A' ' 39' ' ' LEU . 71.4 t -65.5 -47.02 88.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.353 -0.842 . . . . 0.0 109.465 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.569 ' CZ ' HG12 ' B' ' 13' ' ' VAL . 43.9 m-85 -68.94 -18.44 64.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.309 -0.869 . . . . 0.0 110.028 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' HA ' ' OE2' ' A' ' 104' ' ' GLU . 1.9 t0 -96.98 60.68 1.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.334 -0.854 . . . . 0.0 110.478 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -42.07 -61.26 1.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.261 -0.899 . . . . 0.0 110.278 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 9.4 p30 -55.28 -28.97 57.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.143 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 74.81 42.84 30.02 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.0 p30 -100.13 -48.96 4.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -1.181 . . . . 0.0 110.262 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 148.66 -33.7 1.17 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -95.61 153.98 17.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.146 -1.208 . . . . 0.0 110.314 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.461 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 17.0 mt -121.27 127.52 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.259 -0.901 . . . . 0.0 110.251 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.0 p -111.28 164.13 13.22 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.352 -0.842 . . . . 0.0 109.998 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.525 ' HB2' ' CG1' ' A' ' 121' ' ' VAL . . . -55.95 -33.71 65.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.53 89.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.011 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' OE2' ' HA ' ' A' ' 93' ' ' ASP . 14.3 mt-10 -58.89 -50.06 75.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.749 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.51 ' N ' HD21 ' A' ' 105' ' ' LEU . 2.5 mm? -55.61 -42.72 75.26 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.215 -0.928 . . . . 0.0 109.748 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -18.65 65.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.205 -0.934 . . . . 0.0 109.339 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 1.7 m80 -82.52 -30.15 29.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.759 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 109' ' ' MET . 0.9 OUTLIER -83.92 -41.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.306 -0.871 . . . . 0.0 109.647 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.559 ' CG ' ' HG ' ' B' ' 17' ' ' LEU . 16.8 mtt -44.35 -70.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 110.292 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 m -49.35 -46.38 46.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.445 -0.784 . . . . 0.0 109.935 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 5.2 m120 -59.04 -16.04 16.6 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.405 -0.809 . . . . 0.0 109.74 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.535 HD13 ' CG1' ' B' ' 13' ' ' VAL . 8.1 mt -106.74 -45.89 4.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.34 -0.85 . . . . 0.0 110.537 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.98 -62.51 0.24 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.772 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 109' ' ' MET . 59.6 tt0 -81.75 172.04 13.85 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.109 -1.23 . . . . 0.0 110.831 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.48 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -154.61 75.49 0.98 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.592 -0.693 . . . . 0.0 109.593 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' B' ' 19' ' ' LYS . 2.4 mp -36.26 138.55 0.2 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.7 -0.625 . . . . 0.0 110.63 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -54.63 -165.16 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.251 -0.905 . . . . 0.0 110.18 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.56 -56.69 3.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.254 -0.904 . . . . 0.0 110.288 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -56.85 -25.34 56.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 110.067 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.456 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 14.7 mm-40 -78.12 -44.18 26.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 108.971 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 102' ' ' ALA . 15.2 t -57.69 -36.72 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.676 -0.64 . . . . 0.0 109.902 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.87 -51.01 20.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.981 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -58.89 -22.71 59.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.892 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.404 ' CE ' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -75.8 -47.24 26.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -0.901 . . . . 0.0 110.108 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.7 mm -76.94 -33.46 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.209 -0.932 . . . . 0.0 110.055 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 ttp85 -64.49 -45.38 87.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.79 -20.09 65.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.2 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -85.81 -35.2 20.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.38 64.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.279 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mp -46.97 -28.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.257 -0.902 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 13.3 p-10 -88.99 -28.17 20.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.915 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.8 73.03 1.28 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 135' ' ' GLN . 18.2 p-10 -127.34 -29.22 2.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.267 -1.137 . . . . 0.0 110.255 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.12 -8.32 12.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.431 ' O ' ' OD2' ' A' ' 133' ' ' ASP . 9.4 pt20 -159.43 169.01 24.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.189 -1.183 . . . . 0.0 110.417 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.504 ' CG1' ' HB3' ' A' ' 140' ' ' GLU . 24.9 t -113.27 159.29 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.239 -0.913 . . . . 0.0 110.497 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.472 ' N ' HG11 ' A' ' 136' ' ' VAL . 10.3 p-10 -122.26 -173.38 2.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.192 -0.943 . . . . 0.0 110.325 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.6 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 6.2 t80 -57.51 -69.37 0.17 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.218 -0.926 . . . . 0.0 110.655 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.7 OUTLIER -41.0 -53.06 3.05 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.298 -0.876 . . . . 0.0 110.382 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.504 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 8.5 mt-10 -52.79 -62.32 1.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.934 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.552 ' CE1' ' HE3' ' B' ' 16' ' ' MET . 37.8 t80 -41.79 -27.51 0.11 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.266 -0.896 . . . . 0.0 109.756 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' GLU . 96.2 t -95.19 -37.7 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 0.0 110.194 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -9.48 48.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.119 -0.988 . . . . 0.0 109.872 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.474 ' O ' ' OD1' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -94.08 -23.15 18.09 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.364 -0.835 . . . . 0.0 110.42 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.5 mmt -100.61 -68.71 0.8 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.972 . . . . 0.0 111.105 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.221 -0.924 . . . . 0.0 110.797 -179.236 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.45 HG21 ' HD2' ' B' ' 5' ' ' PRO . 14.1 mt . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' B' ' 7' ' ' TRP . 44.7 Cg_endo -71.24 103.88 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.893 1.47 . . . . 0.0 109.891 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.529 ' O ' ' N ' ' B' ' 8' ' ' THR . 23.1 t -62.13 71.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.561 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.635 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 4.2 m95 50.74 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.871 . . . . 0.0 110.648 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.553 ' CG2' ' HG3' ' A' ' 75' ' ' LYS . 40.4 p -41.78 -24.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.715 -1.241 . . . . 0.0 110.42 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.507 HG22 ' HA ' ' B' ' 5' ' ' PRO . 85.6 m -70.58 -51.47 28.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 109.941 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.594 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 3.8 m -56.38 -28.31 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.85 -1.156 . . . . 0.0 108.849 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.431 HD12 ' N ' ' B' ' 11' ' ' ILE . 7.1 mm -75.8 -28.38 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.448 -0.783 . . . . 0.0 109.322 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.471 ' CD1' ' HG2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -66.08 -57.61 7.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.57 -0.706 . . . . 0.0 110.331 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.569 HG12 ' CZ ' ' A' ' 92' ' ' PHE . 42.4 t -60.35 -40.71 84.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.387 -0.82 . . . . 0.0 110.952 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.459 ' CD ' ' O ' ' B' ' 14' ' ' LYS . 1.2 tmtt? -63.07 -29.08 70.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.369 -1.457 . . . . 0.0 108.744 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' B' ' 11' ' ' ILE . 1.5 p -83.39 -15.96 47.77 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.552 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 73.1 mmm -71.64 -47.2 56.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.555 -0.716 . . . . 0.0 110.578 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.559 ' HG ' ' CG ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -99.97 37.8 1.57 Allowed 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 117.724 -1.59 . . . . 0.0 109.619 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.526 ' HG2' ' N ' ' B' ' 19' ' ' LYS . 47.7 ttp180 -48.19 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.159 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.526 ' N ' ' HG2' ' B' ' 18' ' ' ARG . 8.6 tmtt? -104.91 -73.65 0.67 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 111.047 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.464 ' HG2' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -151.82 15.45 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.998 -1.063 . . . . 0.0 110.572 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.404 ' O ' ' CE ' ' A' ' 124' ' ' MET . 3.4 m -127.34 -173.36 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.111 -0.993 . . . . 0.0 110.176 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.469 ' CD2' ' HE2' ' B' ' 16' ' ' MET . 2.6 m-85 -92.91 -55.39 3.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.189 -0.944 . . . . 0.0 110.307 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' B' ' 24' ' ' ASN . . . 145.97 176.92 20.26 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.529 ' CB ' ' HD3' ' B' ' 25' ' ' PRO . 0.1 OUTLIER 174.17 -52.39 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.458 -1.025 . . . . 0.0 110.117 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.529 ' HD3' ' CB ' ' B' ' 24' ' ' ASN . 48.9 Cg_endo -82.62 72.94 5.76 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.792 1.417 . . . . 0.0 110.404 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.172 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.301 0.572 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 10' ' ' ALA . 67.1 mt -53.13 -43.88 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.795 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -44.19 -60.19 2.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.913 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 5.0 tm-20 -52.5 -55.4 22.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.755 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -53.26 -30.07 36.4 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.162 -0.961 . . . . 0.0 109.277 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 17' ' ' SER . 17.9 ttmt -64.83 -37.05 86.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.309 -0.869 . . . . 0.0 109.089 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 3.1 mm-40 -61.36 -46.36 90.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.508 -0.745 . . . . 0.0 109.363 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . . . -60.73 -48.74 80.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.839 . . . . 0.0 109.587 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.509 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 55.3 t80 -62.78 -39.68 94.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.413 -0.804 . . . . 0.0 109.508 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -70.8 -30.27 66.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -0.801 . . . . 0.0 109.319 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.544 HD11 ' CE ' ' B' ' 14' ' ' LYS . 9.5 tt -59.46 -44.18 93.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.427 -0.796 . . . . 0.0 109.702 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.4 ' CZ ' HG13 ' B' ' 10' ' ' VAL . 61.3 m-85 -69.87 -52.76 22.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.278 -0.888 . . . . 0.0 109.963 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.28 108.42 2.73 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.398 -0.814 . . . . 0.0 110.239 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -84.8 2.26 43.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.288 -0.883 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.57 -68.65 0.9 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.157 -0.965 . . . . 0.0 110.694 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.27 35.24 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 60.0 p30 -94.12 -10.14 34.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -1.16 . . . . 0.0 110.039 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 81.37 30.39 37.22 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 77.7 p -152.76 124.44 7.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.137 -1.214 . . . . 0.0 110.709 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.558 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 4.2 mt -92.36 120.7 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.23 -0.919 . . . . 0.0 109.758 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -100.17 171.21 7.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 110.359 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.1 p -61.94 -33.44 74.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 110.033 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -70.01 -59.21 3.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 110.276 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -49.2 -66.63 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 109.881 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.3 tp -48.98 -43.95 40.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.749 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.05 -43.25 49.61 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 83.0 m -60.68 -48.57 81.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -1.137 . . . . 0.0 110.06 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.6 -43.37 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.804 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.494 ' CE ' ' HE3' ' A' ' 51' ' ' MET . 29.9 mmm -70.97 -24.6 62.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 109.882 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.09 -21.18 47.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.88 . . . . 0.0 110.14 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 39' ' ' LEU . 50.8 m -85.9 -40.89 15.45 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.255 -0.903 . . . . 0.0 110.771 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' SER . 2.4 mt -44.13 -32.23 1.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.924 -1.11 . . . . 0.0 109.799 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 41' ' ' GLN . . . 128.62 67.24 0.12 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER 179.55 -172.2 0.17 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.372 -1.075 . . . . 0.0 110.231 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -138.33 92.03 12.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.938 . . . . 0.0 110.666 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.74 126.48 11.43 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.088 1.573 . . . . 0.0 109.885 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 m -94.38 161.72 14.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.207 -0.933 . . . . 0.0 110.581 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.0 -60.69 3.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.022 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.35 -43.96 23.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.7 -42.35 74.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 0.0 109.873 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -64.22 -34.97 79.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.83 -41.16 83.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.866 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -67.17 -24.8 65.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.384 -0.823 . . . . 0.0 109.827 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.494 ' HE3' ' CE ' ' A' ' 36' ' ' MET . 4.0 mtp -77.59 -45.96 23.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 109.791 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -64.46 -35.11 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 109.845 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.418 ' N ' HG21 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -63.37 -15.07 56.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -81.42 -33.32 32.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 110.225 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 4.4 t -103.26 -14.12 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.184 -0.948 . . . . 0.0 110.256 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 12.4 t0 -60.07 80.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 0.0 109.901 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -93.14 -15.83 25.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.901 . . . . 0.0 110.368 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.431 ' OD2' ' CD ' ' A' ' 67' ' ' GLU . 5.2 m-20 -82.3 -40.37 21.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.199 -0.938 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.19 13.54 30.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 27.6 p-10 -88.04 -46.89 8.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -1.096 . . . . 0.0 110.263 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 131.38 -21.68 4.52 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.0 p -116.6 169.63 9.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -1.184 . . . . 0.0 110.148 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.558 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 11.2 mm -94.62 138.66 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.888 . . . . 0.0 110.001 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.54 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 m-20 -117.48 171.91 7.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.972 . . . . 0.0 110.695 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.627 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.2 t80 -62.97 -38.82 46.5 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 111.674 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.7 Cg_endo -70.08 -24.54 28.1 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 O-C-N 123.075 1.04 . . . . 0.0 109.589 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 3.2 mt-10 -69.49 -33.61 73.1 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.414 -0.804 . . . . 0.0 108.922 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CZ ' HG22 ' B' ' 11' ' ' ILE . 2.0 t80 -68.4 -48.21 65.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.54 -0.725 . . . . 0.0 109.571 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 3.2 mm? -55.91 -36.72 68.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 110.371 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 2.7 m -87.33 -25.45 23.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.125 -0.984 . . . . 0.0 110.61 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.522 ' HE3' ' N ' ' A' ' 72' ' ' MET . 2.2 ttp -63.07 -61.49 2.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.937 . . . . 0.0 110.209 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.671 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 2.0 tpt -47.23 -32.27 4.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.267 -0.896 . . . . 0.0 110.632 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.38 -11.23 46.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.935 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 70' ' ' THR . 0.4 OUTLIER -99.29 -10.96 21.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.99 -1.069 . . . . 0.0 110.397 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HG2' ' CG2' ' B' ' 8' ' ' THR . 2.2 mptp? . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 0.0 110.455 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.357 0.599 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.56 -47.57 69.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.498 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' B' ' 26' ' ' PHE . 17.3 pt-20 -47.59 -33.07 6.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.526 -0.734 . . . . 0.0 110.128 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.418 HG13 ' HG3' ' A' ' 84' ' ' GLU . 63.9 mt -76.32 -39.93 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.18 -0.95 . . . . 0.0 109.074 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -32.47 67.64 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HB3' HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -67.01 -62.02 1.64 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.506 ' CB ' HD23 ' B' ' 12' ' ' LEU . . . -51.93 -30.13 23.18 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.538 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.51 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 59.0 t80 -71.92 -50.56 28.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.475 -0.766 . . . . 0.0 109.598 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.74 -47.18 77.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.0 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -49.19 -45.46 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.567 -0.708 . . . . 0.0 109.29 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.573 ' CZ ' HG12 ' B' ' 13' ' ' VAL . 17.3 m-85 -71.91 -36.69 70.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 109.964 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 94' ' ' LYS . 15.7 t0 -75.13 55.49 0.74 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.198 -0.939 . . . . 0.0 110.197 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' ASP . 9.0 tttp -40.71 -66.02 0.36 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.37 -0.831 . . . . 0.0 110.532 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 21.6 p-10 -61.48 -43.35 99.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 0.0 110.231 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.97 44.82 3.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.43 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 32.5 p-10 -87.23 -28.9 22.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.187 -1.184 . . . . 0.0 110.169 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.563 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 121.49 15.34 4.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 50.8 m-85 -151.76 152.41 32.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.141 -1.211 . . . . 0.0 110.178 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.413 HD12 ' CB ' ' A' ' 92' ' ' PHE . 9.2 mt -104.98 118.91 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.922 . . . . 0.0 110.149 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 102' ' ' ALA . 12.4 t -105.52 141.97 36.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.848 . . . . 0.0 110.338 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.96 -33.85 0.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.313 -0.867 . . . . 0.0 109.833 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -55.16 -55.64 28.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 109.612 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 49.0 mt-10 -54.38 -48.4 71.56 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.352 -0.842 . . . . 0.0 109.764 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.533 ' CD1' HD12 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -58.72 -37.36 75.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.624 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 22.6 tpt85 -60.79 -41.24 95.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.307 -0.871 . . . . 0.0 109.44 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -57.99 -44.4 87.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.783 . . . . 0.0 109.422 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.556 HG13 ' CG1' ' B' ' 13' ' ' VAL . 5.9 t -73.19 -29.08 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.553 -0.717 . . . . 0.0 109.65 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.571 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 2.3 mtt -55.37 -69.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 110.7 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.6 m -64.85 -10.09 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.38 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -94.87 -6.68 42.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.523 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 10.1 mt -107.44 -30.57 8.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 110.354 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 147.47 -51.87 0.56 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.449 ' O ' HD22 ' B' ' 17' ' ' LEU . 23.0 tt0 -107.66 149.31 28.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -1.121 . . . . 0.0 109.7 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -123.62 19.17 9.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.895 . . . . 0.0 109.827 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.513 ' CD1' ' O ' ' B' ' 17' ' ' LEU . 3.5 mp 42.54 -166.51 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.55 0.69 . . . . 0.0 110.549 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.2 -144.65 0.3 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.514 -0.741 . . . . 0.0 109.144 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -117.64 -70.64 0.78 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.07 -1.018 . . . . 0.0 110.274 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -48.45 -40.98 28.07 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 109.398 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 121' ' ' VAL . 41.7 mm-40 -60.08 -53.48 57.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 109.282 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.424 HG23 ' CE ' ' A' ' 109' ' ' MET . 70.8 t -44.59 -41.52 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.418 -0.801 . . . . 0.0 109.844 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 35.8 m-20 -63.43 -60.81 2.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.856 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 4.0 tp10 -50.24 -40.98 49.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.795 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.578 ' HE3' ' CD2' ' B' ' 22' ' ' PHE . 4.5 ttt -51.7 -47.28 63.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.833 . . . . 0.0 109.841 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.533 HD12 ' CD1' ' A' ' 105' ' ' LEU . 48.9 mm -75.72 -39.02 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.932 . . . . 0.0 109.996 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.404 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -65.42 -26.7 68.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 110.275 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.42 -41.59 98.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 110.125 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.465 ' O ' HD11 ' A' ' 130' ' ' ILE . . . -86.92 -27.04 23.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.317 -0.864 . . . . 0.0 110.335 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.452 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 1.7 m-20 -58.89 88.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.328 -0.858 . . . . 0.0 110.567 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.525 HD11 ' N ' ' A' ' 130' ' ' ILE . 1.2 mp -61.82 -41.54 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.196 -0.94 . . . . 0.0 109.422 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 35.4 p30 -82.66 -17.94 42.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.422 -0.799 . . . . 0.0 110.053 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 66.02 67.86 1.86 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 30.5 p-10 -118.25 1.84 11.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -1.11 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.86 -9.44 74.27 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.459 ' HG3' ' OD2' ' A' ' 133' ' ' ASP . 1.4 pt20 -137.71 147.72 45.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -1.106 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.468 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 4.0 t -104.08 146.08 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.209 -0.932 . . . . 0.0 110.155 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.471 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 33.7 p-10 -103.46 -161.09 0.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 139' ' ' GLU . 14.8 t80 -71.81 -63.45 1.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.074 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -44.12 -56.58 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 110.009 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.471 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 68.4 mt-10 -47.52 -61.38 1.95 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 6.0 t80 -44.68 -26.97 0.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.288 -0.882 . . . . 0.0 110.282 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -99.48 -45.95 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.201 -0.937 . . . . 0.0 110.163 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -46.48 -34.7 4.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.363 -0.836 . . . . 0.0 110.45 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.475 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -86.02 -19.82 29.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.582 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 3.7 mtt -84.86 -47.32 10.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.996 -1.065 . . . . 0.0 110.489 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.063 -1.023 . . . . 0.0 110.319 -179.929 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 17.2 mm . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 40.1 Cg_endo -66.37 116.46 4.06 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.79 1.416 . . . . 0.0 110.289 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.0 m -53.2 179.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.848 . . . . 0.0 111.04 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.608 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -68.27 -66.14 0.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.596 0.713 . . . . 0.0 110.241 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.5 ' CG2' ' HG2' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -53.99 -38.86 65.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 110.083 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 87' ' ' GLU . 49.1 m -49.06 -42.05 37.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.96 . . . . 0.0 108.982 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.4 HG13 ' CZ ' ' A' ' 19' ' ' PHE . 47.3 t -65.76 -50.36 71.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.42 -0.8 . . . . 0.0 109.382 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.521 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 9.2 mm -59.45 -27.12 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.427 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.62 ' HA ' ' CZ ' ' B' ' 26' ' ' PHE . 0.5 OUTLIER -65.14 -57.05 9.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.454 -0.779 . . . . 0.0 110.533 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.573 HG12 ' CZ ' ' A' ' 92' ' ' PHE . 67.6 t -65.86 -30.57 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.945 . . . . 0.0 110.122 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.544 ' CE ' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.36 -47.27 67.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.92 . . . . 0.0 109.918 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' B' ' 18' ' ' ARG . 8.3 m -63.28 -29.85 71.09 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 110.131 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 11.6 ttm -68.22 -40.09 82.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.992 . . . . 0.0 109.95 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.571 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 3.7 mp -56.19 -16.69 5.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.277 -0.889 . . . . 0.0 110.199 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.501 ' C ' ' O ' ' B' ' 17' ' ' LEU . 52.3 ttt180 -29.73 -78.34 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 121.032 0.444 . . . . 0.0 111.291 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.488 ' CD ' ' N ' ' B' ' 20' ' ' ARG . 1.8 tmtp? -143.18 -119.83 0.09 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.272 -0.893 . . . . 0.0 109.575 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.488 ' N ' ' CD ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -99.94 8.74 43.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.691 -1.255 . . . . 0.0 110.043 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -178.09 1.04 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.362 -0.836 . . . . 0.0 110.13 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.578 ' CD2' ' HE3' ' A' ' 124' ' ' MET . 0.3 OUTLIER -176.66 -46.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.884 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 144' ' ' MET . . . -72.02 80.8 0.58 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.2 134.57 21.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.294 -1.121 . . . . 0.0 110.586 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.51 72.62 4.26 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 124.066 1.561 . . . . 0.0 110.316 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.671 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.498 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.498 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 24.1 mt-30 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.276 0.56 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.85 -32.96 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.925 . . . . 0.0 110.038 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.72 -44.14 70.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.937 . . . . 0.0 110.224 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 12' ' ' PHE . 4.6 pt-20 -65.06 -31.15 72.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CE1' ' OE2' ' A' ' 11' ' ' GLU . 19.9 m-30 -65.53 -44.1 87.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.844 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 17' ' ' SER . 0.4 OUTLIER -59.97 -43.59 95.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.179 -0.95 . . . . 0.0 109.36 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -61.54 -40.17 93.72 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.27 -0.894 . . . . 0.0 109.263 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.68 -52.07 54.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 0.0 109.489 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.536 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 7.6 t80 -58.38 -26.16 62.89 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.356 -0.84 . . . . 0.0 108.992 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -76.57 -34.82 58.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.512 -0.743 . . . . 0.0 109.32 179.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 8.1 tt -59.14 -45.47 90.86 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.371 -0.83 . . . . 0.0 109.575 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.431 ' HB3' HG22 ' A' ' 27' ' ' ILE . 41.8 m-85 -74.1 -49.71 22.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.378 -0.826 . . . . 0.0 109.589 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 8.2 t0 -67.95 71.31 0.15 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.893 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -41.3 -41.73 2.0 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.429 -0.795 . . . . 0.0 110.36 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 13.0 p-10 -85.3 -43.1 14.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.099 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.5 32.16 6.13 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 46.2 p-10 -81.6 -2.53 50.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -1.193 . . . . 0.0 110.014 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.453 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.98 29.01 35.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 13.4 p -154.98 118.73 4.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -1.113 . . . . 0.0 110.265 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.542 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 7.8 mt -90.45 124.63 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.951 . . . . 0.0 110.002 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.01 168.17 10.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 110.285 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.457 ' O ' HD12 ' A' ' 48' ' ' LEU . 82.7 p -61.41 -28.42 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.96 -44.92 60.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.165 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 35' ' ' VAL . 51.1 mt-10 -61.38 -60.65 3.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.976 . . . . 0.0 110.1 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tp -59.31 -29.42 67.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.875 . . . . 0.0 110.189 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.99 -40.0 84.52 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.5 m -69.65 -50.71 41.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -1.157 . . . . 0.0 110.094 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 38' ' ' SER . 21.3 t -60.41 -42.72 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.177 -0.952 . . . . 0.0 110.327 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.497 ' CE ' ' HE1' ' A' ' 51' ' ' MET . 2.6 mmt -66.84 -42.14 86.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 109.737 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -67.73 -14.04 62.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 110.112 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -72.11 -58.18 3.65 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.189 -0.944 . . . . 0.0 110.623 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mt -45.94 -28.59 1.17 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.12 -0.987 . . . . 0.0 110.736 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.502 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . 118.79 58.6 0.27 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.21 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 40' ' ' GLY . 64.7 mm-40 -131.9 -162.07 1.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.248 . . . . 0.0 109.928 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.548 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 t-20 -147.1 49.95 0.87 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.186 -0.947 . . . . 0.0 110.492 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 46.1 Cg_endo -74.0 73.74 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.086 1.572 . . . . 0.0 110.462 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 43' ' ' PRO . 10.9 t -54.06 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.18 -0.95 . . . . 0.0 110.556 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -66.9 -58.65 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.337 -0.852 . . . . 0.0 110.351 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -42.71 -42.82 3.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 109.835 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.489 ' OE1' HD13 ' B' ' 4' ' ' ILE . 10.6 mm-40 -71.15 -41.16 70.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.491 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 29' ' ' THR . 4.7 mt -52.74 -59.16 4.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.806 . . . . 0.0 109.95 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -53.94 -41.26 67.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.409 -0.807 . . . . 0.0 109.882 179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -61.51 -41.13 96.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.101 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.497 ' HE1' ' CE ' ' A' ' 36' ' ' MET . 0.9 OUTLIER -73.97 -44.31 55.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 4.5 mm -61.67 -30.68 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.439 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.4 OUTLIER -73.79 -2.25 22.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.367 -0.833 . . . . 0.0 110.403 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.7 OUTLIER -85.29 -31.18 23.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.183 -0.948 . . . . 0.0 110.578 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.578 HG22 ' CD1' ' B' ' 7' ' ' TRP . 13.0 t -108.05 -46.34 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.126 -0.984 . . . . 0.0 110.495 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -45.57 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 110.663 -179.302 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -85.64 -3.35 58.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.83 . . . . 0.0 110.161 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.64 -53.94 4.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.176 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.71 22.22 5.8 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.4 p-10 -87.65 -46.21 9.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -1.169 . . . . 0.0 110.18 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.92 -0.59 11.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.6 p -134.31 149.89 50.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -1.214 . . . . 0.0 110.206 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.542 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 12.0 mm -90.41 144.55 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.065 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 48.3 m-20 -119.85 169.19 10.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.252 -0.905 . . . . 0.0 110.358 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.634 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.4 t80 -63.19 -38.58 42.68 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 111.598 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.3 Cg_endo -69.78 -26.62 27.32 Favored 'Trans proline' 0 C--N 1.321 -0.881 0 O-C-N 123.025 1.013 . . . . 0.0 109.656 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 71' ' ' MET . 10.6 mt-10 -76.41 -36.46 58.03 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 108.728 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.489 ' O ' ' HB2' ' A' ' 72' ' ' MET . 3.7 t80 -61.97 -41.33 97.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.507 -0.746 . . . . 0.0 109.986 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD13 ' CE1' ' A' ' 65' ' ' PHE . 11.2 mt -66.28 -49.1 68.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.254 -0.904 . . . . 0.0 110.16 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -59.0 3.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 110.392 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 5.3 ppp? -48.77 -30.45 5.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.271 -0.893 . . . . 0.0 110.716 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.562 ' HE2' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -68.7 -9.99 53.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.019 -1.051 . . . . 0.0 110.54 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.41 -12.93 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.125 -0.984 . . . . 0.0 111.195 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -78.71 -15.79 58.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.962 -1.087 . . . . 0.0 110.766 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.42 ' CG ' HG22 ' B' ' 8' ' ' THR . 32.8 mmtp . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.071 -1.018 . . . . 0.0 110.391 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 1.4 mt-10 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.337 0.589 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.457 ' OE1' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -65.56 -57.92 7.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.295 -0.878 . . . . 0.0 109.548 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.486 ' OE2' ' OG1' ' B' ' 8' ' ' THR . 24.5 mt-10 -45.52 -27.9 0.83 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.557 -0.714 . . . . 0.0 110.383 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.574 HG21 ' CD1' ' A' ' 141' ' ' PHE . 47.8 mt -66.37 -43.29 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 121.011 -1.056 . . . . 0.0 108.988 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 ttm105 -58.54 -46.91 85.84 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HB2' HG22 ' B' ' 9' ' ' THR . 2.9 mt-10 -67.65 -50.77 56.23 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.225 -0.922 . . . . 0.0 108.869 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HA ' ' CG2' ' B' ' 13' ' ' VAL . . . -56.35 -40.0 73.77 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.533 ' HA ' ' CE2' ' A' ' 141' ' ' PHE . 11.8 t80 -66.43 -40.08 89.28 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 10.8 ttt180 -58.85 -45.63 89.64 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.52 ' CG2' HG22 ' B' ' 13' ' ' VAL . 21.4 t -48.29 -46.73 13.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.552 ' CE2' HD23 ' A' ' 105' ' ' LEU . 4.8 m-85 -71.58 -31.85 67.41 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.005 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 11.0 t0 -101.23 63.47 0.99 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.442 -0.786 . . . . 0.0 109.975 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 34.0 pttt -55.46 -25.38 36.22 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.149 -0.969 . . . . 0.0 110.508 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.523 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 11.8 p-10 -86.58 -40.33 15.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 110.371 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 85.95 50.49 3.9 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 15.1 p-10 -96.2 -24.88 16.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.196 -1.179 . . . . 0.0 110.283 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 118.99 -7.87 12.77 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 98.3 m-85 -136.86 151.83 49.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.286 -1.126 . . . . 0.0 110.152 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.494 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 8.7 mt -103.38 134.0 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.18 -0.95 . . . . 0.0 110.09 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 102' ' ' ALA . 37.6 t -112.2 136.54 51.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 110.234 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.39 -27.12 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.305 -0.872 . . . . 0.0 109.932 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -63.49 -59.65 4.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.357 -0.839 . . . . 0.0 109.671 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 89.4 mt-10 -48.16 -38.85 19.06 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.263 -0.898 . . . . 0.0 109.414 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.552 HD23 ' CE2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -54.91 -52.67 62.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.384 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.413 ' O ' ' OG1' ' A' ' 110' ' ' THR . 5.2 ttm105 -48.65 -47.97 40.09 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.251 -0.906 . . . . 0.0 109.377 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 14.0 m170 -52.95 -53.31 51.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.4 -0.812 . . . . 0.0 109.169 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.491 ' CG1' HD13 ' A' ' 112' ' ' LEU . 21.7 t -64.49 -41.63 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 108.943 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.526 ' CE ' ' HB2' ' A' ' 116' ' ' LEU . 33.6 ttm -51.81 -48.73 63.73 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.717 -0.614 . . . . 0.0 109.937 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -79.83 -32.18 40.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.0 110.253 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -72.81 -14.92 61.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.983 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.52 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 10.5 mt -99.35 -48.84 4.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.189 -0.944 . . . . 0.0 109.949 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 148.81 -31.67 1.21 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.533 ' HG2' ' CD1' ' A' ' 116' ' ' LEU . 5.2 tp10 -79.73 156.52 27.48 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.02 -1.282 . . . . 0.0 110.661 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -137.17 51.83 1.94 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.533 ' CD1' ' HG2' ' A' ' 114' ' ' GLU . 0.2 OUTLIER -36.31 153.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.566 0.698 . . . . 0.0 110.923 -179.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -57.67 -169.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.497 -0.752 . . . . 0.0 109.699 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.05 -67.28 0.85 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.162 -0.961 . . . . 0.0 109.924 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -47.19 -36.97 9.4 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.762 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.8 -54.67 35.48 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -0.92 . . . . 0.0 109.052 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.489 ' O ' HD11 ' A' ' 125' ' ' ILE . 7.7 t -47.01 -48.83 7.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -60.97 -50.4 73.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 109.818 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -59.01 -31.4 68.78 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.295 -0.878 . . . . 0.0 109.519 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -58.05 -51.2 70.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.334 -0.854 . . . . 0.0 109.855 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.535 HD12 ' CD1' ' A' ' 105' ' ' LEU . 2.7 mp -68.74 -24.44 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.212 -0.93 . . . . 0.0 110.006 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.425 ' NH1' ' HB2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.09 -42.05 89.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.133 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.425 ' HB2' ' NH1' ' A' ' 126' ' ' ARG . 13.3 tt0 -71.34 -29.61 65.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.905 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.425 ' HB2' HG21 ' A' ' 136' ' ' VAL . . . -78.61 -20.45 50.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.01 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 0.9 OUTLIER -70.67 68.17 0.39 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.193 -0.942 . . . . 0.0 110.111 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mt -54.02 -31.58 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 0.0 110.306 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -89.53 -31.99 17.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.3 -0.875 . . . . 0.0 110.38 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.79 97.14 0.92 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' ' 135' ' ' GLN . 1.2 p-10 -148.43 -38.12 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.186 -1.185 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 133.82 -1.74 4.33 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.471 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -161.22 169.73 21.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -1.235 . . . . 0.0 110.092 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.494 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 55.3 t -93.81 139.16 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.219 -0.926 . . . . 0.0 110.076 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 19.1 t30 -102.42 178.96 4.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.274 -0.891 . . . . 0.0 110.694 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.445 ' O ' ' C ' ' A' ' 139' ' ' GLU . 47.1 t80 -67.3 -68.21 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.432 -0.793 . . . . 0.0 110.298 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 143' ' ' GLN . 2.9 pt-20 -40.93 -29.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.428 -0.795 . . . . 0.0 110.094 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 3.9 mt-10 -71.62 -59.19 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.418 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.574 ' CD1' HG21 ' A' ' 85' ' ' ILE . 2.6 t80 -42.48 -29.04 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 109.377 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.528 ' CG2' HG23 ' A' ' 85' ' ' ILE . 45.3 t -99.81 -40.29 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.505 -0.747 . . . . 0.0 110.456 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' GLU . 10.7 tt0 -63.16 -12.8 30.37 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.16 -0.962 . . . . 0.0 110.599 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.9 mtp -95.54 -21.73 18.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 109.96 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.474 ' HE2' ' HB2' ' B' ' 24' ' ' ASN . 2.6 mtt -100.88 -13.38 18.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.362 -0.836 . . . . 0.0 110.462 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.1 p . . . . . 0 C--N 1.306 -1.283 0 O-C-N 121.173 -0.954 . . . . 0.0 111.057 -178.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.508 HG23 ' HD2' ' B' ' 5' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' B' ' 4' ' ' ILE . 48.2 Cg_endo -73.99 49.15 1.86 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.825 1.434 . . . . 0.0 111.282 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.472 ' C ' ' O ' ' B' ' 5' ' ' PRO . 10.3 m 32.72 -139.59 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.597 -0.69 . . . . 0.0 111.574 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.578 ' CD1' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -117.4 -74.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 110.265 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.486 ' OG1' ' OE2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -45.06 -41.7 7.9 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.803 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.529 ' O ' ' N ' ' B' ' 12' ' ' LEU . 31.4 m -51.06 -54.72 22.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 109.7 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' B' ' 9' ' ' THR . 40.6 t -47.69 -39.69 7.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.163 -0.961 . . . . 0.0 108.683 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' B' ' 8' ' ' THR . 55.0 mt -67.5 -21.81 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 0.0 109.369 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' B' ' 9' ' ' THR . 0.4 OUTLIER -71.0 -55.48 8.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.495 -0.753 . . . . 0.0 109.904 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.52 HG22 ' CG2' ' A' ' 91' ' ' VAL . 68.1 t -54.57 -40.99 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.807 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.464 ' O ' ' HD2' ' B' ' 14' ' ' LYS . 1.2 tptm -67.24 -40.7 86.35 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.023 -1.048 . . . . 0.0 109.518 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -59.67 -27.76 66.68 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.354 -0.841 . . . . 0.0 109.474 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.482 ' O ' ' N ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -72.54 -38.96 67.86 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.29 -0.881 . . . . 0.0 109.375 179.257 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 114' ' ' GLU . 6.8 mp -67.64 59.6 0.06 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.369 -0.832 . . . . 0.0 109.874 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' B' ' 16' ' ' MET . 0.1 OUTLIER -90.03 -77.88 0.38 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.376 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.478 ' O ' HD22 ' A' ' 116' ' ' LEU . 10.3 tmtt? -162.75 -68.51 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.97 -1.082 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.98 7.95 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 110.167 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.473 ' O ' ' CE ' ' A' ' 124' ' ' MET . 0.3 OUTLIER -103.7 159.79 15.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 109.639 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.421 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 0.1 OUTLIER -131.67 -34.22 1.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.158 -0.964 . . . . 0.0 110.386 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.37 171.09 33.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.474 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 0.1 OUTLIER -158.46 112.93 1.69 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.192 -1.181 . . . . 0.0 110.443 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.27 96.03 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.943 1.496 . . . . 0.0 110.468 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.562 ' CZ ' ' HE2' ' A' ' 72' ' ' MET . 1.4 m-85 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.89 -1.053 . . . . 0.0 110.565 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.108 0.48 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 10' ' ' ALA . 23.3 mt -63.23 -51.48 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -42.65 -50.18 5.46 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.235 -0.916 . . . . 0.0 109.98 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -58.03 -52.53 65.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.885 . . . . 0.0 109.555 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -56.9 -39.82 75.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.303 -0.873 . . . . 0.0 109.716 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -63.29 -41.74 99.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' O ' ' OG ' ' A' ' 17' ' ' SER . 4.5 tp10 -58.23 -28.87 65.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 109.276 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.17 -60.87 2.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.528 -0.732 . . . . 0.0 109.769 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.534 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 21.7 t80 -52.61 -33.23 45.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.21 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 14' ' ' GLU . 2.6 p -69.47 -39.3 77.79 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.487 -0.758 . . . . 0.0 109.26 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.588 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 1.4 tt -52.48 -36.86 55.91 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.423 -0.798 . . . . 0.0 108.965 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -84.14 -45.94 12.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.578 -0.701 . . . . 0.0 109.902 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.44 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 13.5 t0 -77.49 88.15 3.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.847 . . . . 0.0 110.013 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -71.92 -13.35 61.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.251 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 21.8 p-10 -111.16 -5.73 14.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.472 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.44 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 52.97 57.51 14.41 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 8.0 p-10 -111.92 -41.46 4.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.183 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.467 ' C ' ' CG2' ' A' ' 26' ' ' THR . . . 123.55 18.96 2.9 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.467 ' CG2' ' C ' ' A' ' 25' ' ' GLY . 7.6 p -149.53 107.59 3.73 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.198 -1.178 . . . . 0.0 110.344 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.537 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 16.0 mt -88.7 118.53 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.128 -0.983 . . . . 0.0 110.091 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.1 p -93.73 153.34 18.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.335 -0.853 . . . . 0.0 109.986 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 p -45.39 -28.04 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.097 -1.002 . . . . 0.0 109.964 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -66.68 -62.08 1.63 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.098 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -45.1 -66.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 109.911 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 tp -51.44 -38.29 52.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.705 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.17 -43.03 97.41 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -58.81 -49.57 77.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -1.063 . . . . 0.0 109.782 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -53.72 -47.82 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 0.0 109.723 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.451 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 9.0 mmt -61.55 -34.7 76.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 109.862 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -20.52 64.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 110.152 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.6 m -83.19 -54.35 5.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 110.379 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 mt -45.03 -31.91 1.49 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.23 -0.919 . . . . 0.0 110.057 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.7 27.02 3.68 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 5.9 mm-40 -109.9 -175.82 2.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -1.164 . . . . 0.0 110.262 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -146.36 75.64 12.43 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.273 -0.892 . . . . 0.0 110.489 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.451 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 44.1 Cg_endo -72.33 149.1 50.35 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.992 1.522 . . . . 0.0 110.08 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.535 ' CG2' ' CG ' ' A' ' 47' ' ' GLU . 7.2 t -90.54 -157.69 0.5 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.131 -0.981 . . . . 0.0 110.456 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -94.1 -44.95 7.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.314 -0.866 . . . . 0.0 110.173 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.78 84.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.178 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.535 ' CG ' ' CG2' ' A' ' 44' ' ' THR . 51.6 mm-40 -64.72 -56.51 13.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 110.32 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.2 mt -47.52 -45.23 26.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.144 -0.973 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -63.21 -39.76 95.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.805 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.45 -42.86 74.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.412 ' O ' ' NE1' ' B' ' 7' ' ' TRP . 4.6 mtp -66.12 -34.46 78.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.393 -0.817 . . . . 0.0 109.602 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 52' ' ' ILE . 7.1 mm -71.91 -36.31 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 0.7 OUTLIER -54.48 -52.05 63.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.387 -0.821 . . . . 0.0 109.977 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -43.57 -57.44 3.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.84 . . . . 0.0 109.949 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' ALA . 15.3 t -74.23 -31.11 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -0.925 . . . . 0.0 109.811 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 30.4 t70 -64.66 71.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 110.059 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -66.65 -25.24 66.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.239 -0.913 . . . . 0.0 110.389 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -75.75 -49.86 16.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.076 -1.015 . . . . 0.0 110.29 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.69 25.39 5.99 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 8.7 p30 -99.86 -32.47 10.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.211 -1.17 . . . . 0.0 110.332 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.11 9.76 10.35 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.8 p -131.09 142.07 50.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -1.13 . . . . 0.0 109.814 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.537 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 9.7 mm -88.03 143.03 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.219 -0.925 . . . . 0.0 110.279 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.534 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 1.6 m-20 -118.69 170.88 8.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.319 -0.863 . . . . 0.0 110.142 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.57 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.3 t80 -60.94 -50.6 84.17 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.108 -0.995 . . . . 0.0 111.26 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.0 Cg_endo -66.03 -25.61 51.45 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 O-C-N 123.2 1.105 . . . . 0.0 110.511 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 71' ' ' MET . 34.9 mt-10 -71.6 -34.02 69.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.132 -0.98 . . . . 0.0 109.819 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -74.51 -58.95 2.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 0.0 110.223 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.1 mt -48.98 -42.72 38.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 110.299 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 m -70.66 -30.17 66.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.197 -0.94 . . . . 0.0 110.421 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 4.0 tmm? -65.14 -63.69 1.04 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.744 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.463 ' SD ' HG23 ' B' ' 8' ' ' THR . 37.3 mmm -52.31 -19.31 2.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.995 -1.066 . . . . 0.0 110.22 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.36 -20.84 59.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.57 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -91.64 -25.75 19.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.081 -1.012 . . . . 0.0 110.762 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.538 ' HG3' ' CG2' ' B' ' 8' ' ' THR . 53.1 mmtt . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 110.584 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.113 0.482 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -79.61 -25.16 41.54 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.108 -0.995 . . . . 0.0 110.402 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -78.02 -27.29 48.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.182 -0.949 . . . . 0.0 110.117 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.569 HG21 ' CE1' ' A' ' 141' ' ' PHE . 92.6 mt -76.9 -39.24 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.96 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.433 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 51.5 ttp180 -62.79 -35.6 80.38 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 110.038 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.522 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 19.6 mm-40 -69.35 -47.46 64.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 0.0 109.666 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.519 ' HB1' ' CD1' ' B' ' 12' ' ' LEU . . . -60.86 -33.59 73.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.113 -0.992 . . . . 0.0 109.897 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.11 -45.83 90.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.579 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 2.4 mtt180 -63.65 -26.94 68.9 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.411 -0.805 . . . . 0.0 109.759 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 41.2 t -63.84 -59.08 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 110.153 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.467 ' CE2' ' SD ' ' B' ' 16' ' ' MET . 22.7 m-85 -56.63 -32.16 65.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.08 -1.013 . . . . 0.0 110.059 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.455 ' OD1' HG12 ' A' ' 100' ' ' ILE . 3.1 m-20 -90.45 61.48 4.98 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.708 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -45.14 -23.38 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.422 -0.799 . . . . 0.0 110.407 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.525 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 35.2 p-10 -96.91 -31.14 12.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 80.09 51.83 4.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 32.6 p-10 -97.94 -14.34 20.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -1.15 . . . . 0.0 110.428 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 99.42 18.56 23.35 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 52.1 m-85 -158.08 157.03 32.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.247 -1.149 . . . . 0.0 110.088 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.455 HG12 ' OD1' ' A' ' 93' ' ' ASP . 21.5 mt -128.42 130.77 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -0.99 . . . . 0.0 110.689 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 30.9 t -116.82 151.56 36.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.837 . . . . 0.0 109.583 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.05 -26.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -72.35 -43.67 63.73 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.286 -0.884 . . . . 0.0 110.143 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 14.8 mt-10 -63.48 -33.03 74.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.006 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.548 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 3.8 mt -70.95 -43.61 67.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.879 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 -62.7 -26.04 68.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 109.559 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -75.0 -39.89 60.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.0 109.942 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.52 HG11 ' N ' ' A' ' 109' ' ' MET . 0.4 OUTLIER -76.86 -33.56 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.377 179.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.53 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 3.2 mtm -54.92 -69.6 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.546 -0.721 . . . . 0.0 110.081 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -47.77 -29.05 2.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.194 -0.941 . . . . 0.0 109.714 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -85.44 -17.3 36.96 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.408 -0.808 . . . . 0.0 109.85 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.59 ' CB ' ' CD2' ' B' ' 17' ' ' LEU . 1.3 mt -94.31 -25.36 17.04 Favored 'General case' 0 C--O 1.199 -1.582 0 O-C-N 121.168 -0.957 . . . . 0.0 110.694 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.0 -50.73 0.66 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.285 -1.436 . . . . 0.0 111.214 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -117.05 158.94 23.32 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.864 -1.374 . . . . 0.0 111.549 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.0 tmtt? -131.43 73.74 1.56 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' B' ' 19' ' ' LYS . 5.6 mp -33.75 153.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.628 0.728 . . . . 0.0 111.682 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.3 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.536 -0.727 . . . . 0.0 110.375 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' GLU . 24.4 m-20 -98.79 -68.52 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.381 -0.825 . . . . 0.0 110.33 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -42.3 -47.85 4.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.432 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 124' ' ' MET . 3.3 mm-40 -60.61 -48.17 82.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 109.89 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.423 ' O ' ' HB3' ' A' ' 124' ' ' MET . 55.0 t -65.52 -38.76 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.072 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.99 -65.3 0.71 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 109.753 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 4.7 mt-10 -46.67 -26.13 0.86 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.391 -0.818 . . . . 0.0 109.52 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.469 ' HG2' ' CE1' ' B' ' 22' ' ' PHE . 18.7 ttt -66.37 -57.04 8.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.969 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.548 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 48.2 mm -61.5 -50.48 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.929 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -54.25 -25.88 25.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.178 -0.951 . . . . 0.0 109.933 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -70.92 -44.7 65.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.396 -0.815 . . . . 0.0 110.077 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -71.37 -32.09 68.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.442 -0.786 . . . . 0.0 110.062 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.423 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 88.8 m-20 -57.07 80.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.81 . . . . 0.0 110.384 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.9 mt -76.48 -37.75 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.932 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 14.6 p-10 -78.57 -31.48 47.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.056 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.61 65.75 0.97 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 26.3 p30 -124.44 -14.88 6.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -1.132 . . . . 0.0 110.46 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 90.54 17.72 51.37 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -163.23 169.78 18.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.332 -1.099 . . . . 0.0 110.019 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.465 HG23 ' HB2' ' A' ' 128' ' ' ALA . 41.1 t -112.56 168.35 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.222 -0.924 . . . . 0.0 110.614 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 17.2 p-10 -152.18 -155.1 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -69.63 -69.44 0.34 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.295 -0.878 . . . . 0.0 110.717 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 140' ' ' GLU . 8.5 tt0 -46.19 -63.87 0.89 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.128 -0.982 . . . . 0.0 110.423 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.47 ' CB ' ' OD1' ' A' ' 137' ' ' ASN . 7.1 tt0 -41.46 -57.4 2.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.236 -0.915 . . . . 0.0 110.53 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.569 ' CE1' HG21 ' A' ' 85' ' ' ILE . 12.0 t80 -49.19 -28.88 4.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.237 -0.914 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.471 HG11 HG22 ' A' ' 146' ' ' THR . 18.6 t -99.96 -38.35 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.234 -0.916 . . . . 0.0 110.607 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -33.69 69.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.201 -0.937 . . . . 0.0 110.794 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.432 ' HE3' ' O ' ' A' ' 127' ' ' GLU . 10.0 tpp -88.3 -18.26 28.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.145 -0.972 . . . . 0.0 110.747 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.546 ' CE ' ' HB2' ' B' ' 24' ' ' ASN . 2.0 ttt -92.69 -9.8 39.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.0 110.101 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.471 HG22 HG11 ' A' ' 142' ' ' VAL . 3.6 p . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 110.939 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 9.0 mt . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 40.3 Cg_endo -67.99 124.69 12.11 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.871 1.459 . . . . 0.0 110.325 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.527 ' O ' ' N ' ' B' ' 8' ' ' THR . 68.8 m -75.92 75.03 2.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.332 -0.855 . . . . 0.0 111.226 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.412 ' NE1' ' O ' ' A' ' 51' ' ' MET . 0.4 OUTLIER 53.93 -83.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.206 -0.934 . . . . 0.0 110.941 179.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.538 ' CG2' ' HG3' ' A' ' 75' ' ' LYS . 71.6 p -46.12 -46.81 17.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.38 -0.825 . . . . 0.0 110.017 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.539 ' HA ' ' CD2' ' B' ' 12' ' ' LEU . 52.7 m -52.1 -43.82 64.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.406 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.535 HG21 ' CG ' ' B' ' 5' ' ' PRO . 61.3 t -58.54 -27.38 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.259 -0.9 . . . . 0.0 108.879 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' B' ' 8' ' ' THR . 35.3 mm -78.16 -64.76 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.628 -0.67 . . . . 0.0 110.558 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.581 ' HB3' ' CE2' ' B' ' 26' ' ' PHE . 0.3 OUTLIER -46.7 -45.39 19.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.132 -0.98 . . . . 0.0 110.485 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.539 HG11 ' CD1' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -60.44 -51.86 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.914 -1.116 . . . . 0.0 109.402 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.502 ' N ' ' CG1' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -60.1 -33.04 71.56 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.993 -1.067 . . . . 0.0 109.055 178.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 6.1 t -62.69 -47.07 85.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.421 -0.799 . . . . 0.0 109.286 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.467 ' SD ' ' CE2' ' A' ' 92' ' ' PHE . 10.7 ttm -51.52 -35.88 42.47 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.389 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.59 ' CD2' ' CB ' ' A' ' 112' ' ' LEU . 7.1 mp -70.68 57.51 0.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.464 -0.773 . . . . 0.0 109.906 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.491 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 69.4 ttt-85 -122.46 -54.76 1.86 Allowed 'General case' 0 C--N 1.288 -2.069 0 O-C-N 121.404 -0.81 . . . . 0.0 111.128 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -138.74 -126.76 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.88 -1.138 . . . . 0.0 110.133 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.502 ' N ' ' HG2' ' B' ' 19' ' ' LYS . 5.0 ptp180 -119.87 41.15 3.24 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.026 -1.046 . . . . 0.0 109.918 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 8.4 t -121.52 148.7 44.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.401 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.469 ' CE1' ' HG2' ' A' ' 124' ' ' MET . 0.2 OUTLIER -117.7 -10.87 10.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.89 152.29 31.42 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.546 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -148.63 127.5 6.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.238 . . . . 0.0 110.146 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.65 57.04 2.96 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.896 1.472 . . . . 0.0 110.279 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' B' ' 12' ' ' LEU . 2.9 m-85 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.32 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.7 mt -66.52 -52.48 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.376 -0.827 . . . . 0.0 109.352 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.88 -39.6 74.64 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -57.91 -49.27 77.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.442 -0.786 . . . . 0.0 109.251 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.562 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 17.6 m-85 -61.07 -37.4 82.55 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.291 -0.881 . . . . 0.0 109.189 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 10.7 ttpt -57.23 -42.19 80.96 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.309 -0.869 . . . . 0.0 109.073 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.21 -42.35 99.27 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.469 -0.769 . . . . 0.0 109.165 179.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.15 -47.99 77.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.485 -0.759 . . . . 0.0 109.297 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -54.78 -27.74 43.79 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.401 -0.812 . . . . 0.0 109.156 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 t -84.05 -37.24 22.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.462 -0.774 . . . . 0.0 109.395 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 112' ' ' LEU . 10.4 tt -51.01 -36.65 40.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.418 -0.801 . . . . 0.0 109.244 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -82.72 -39.78 21.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.734 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.456 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 31.1 t0 -74.86 92.33 2.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.454 -0.779 . . . . 0.0 110.058 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -65.3 -31.92 73.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 110.32 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 12.4 p-10 -90.38 -29.66 17.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.355 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.44 70.79 1.22 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 9.1 p-10 -120.21 -24.59 5.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -1.156 . . . . 0.0 110.061 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.81 -8.68 11.67 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 50.9 p -134.83 127.93 31.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -1.128 . . . . 0.0 110.222 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.523 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 16.4 mt -94.06 133.37 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 p -90.53 -171.35 3.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.899 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 p -83.59 -35.58 24.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.006 . . . . 0.0 109.957 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -68.52 -35.67 77.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -56.88 -55.56 32.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.19 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.524 HD11 ' CH2' ' B' ' 7' ' ' TRP . 24.6 tp -58.92 -39.73 82.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.208 -0.932 . . . . 0.0 110.253 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.25 -43.38 89.3 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.0 m -63.42 -56.5 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -1.176 . . . . 0.0 110.032 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.7 t -55.79 -26.94 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.795 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.452 ' HE2' ' CE ' ' A' ' 51' ' ' MET . 2.4 mmt -69.71 -41.15 75.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.247 -0.908 . . . . 0.0 109.766 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -65.81 -29.41 69.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.996 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -56.39 -55.67 30.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.13 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.488 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -54.87 -39.23 68.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.8 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.77 55.86 0.14 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.52 ' HB3' ' CD1' ' B' ' 4' ' ' ILE . 40.3 mt-30 -142.35 153.92 44.23 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.169 -1.195 . . . . 0.0 110.346 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -117.76 80.31 13.9 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.227 -0.921 . . . . 0.0 110.473 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.27 146.38 40.3 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.977 1.514 . . . . 0.0 110.224 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 47' ' ' GLU . 9.6 t -100.04 -153.81 0.45 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.204 -0.935 . . . . 0.0 110.412 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -87.18 -52.28 5.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -0.907 . . . . 0.0 110.406 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.5 76.04 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.236 -0.915 . . . . 0.0 110.305 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.451 ' HB2' HG21 ' A' ' 44' ' ' THR . 37.8 mt-10 -63.67 -55.2 25.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.295 -0.878 . . . . 0.0 110.328 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' GLU . 15.0 mt -43.81 -52.73 6.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.124 -0.985 . . . . 0.0 109.963 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -59.96 -36.19 76.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.79 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.28 -42.04 76.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.879 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.472 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 0.1 OUTLIER -67.91 -36.18 79.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 179.457 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 61' ' ' GLY . 5.4 mm -73.31 -21.48 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.477 -0.764 . . . . 0.0 109.905 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -66.3 -54.68 21.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 110.501 -179.904 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 54' ' ' GLU . 2.6 tp10 -41.09 -35.32 0.54 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.46 -0.775 . . . . 0.0 110.598 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.671 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 10.5 t -96.68 -34.97 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.18 -0.95 . . . . 0.0 110.284 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 40.5 t0 -49.46 88.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.48 -0.762 . . . . 0.0 110.729 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -80.02 -32.36 39.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.224 -0.922 . . . . 0.0 110.38 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.453 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 7.6 m-20 -76.13 -47.38 24.6 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.17 -0.956 . . . . 0.0 110.448 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.55 0.13 9.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 18.7 p30 -88.77 -32.49 17.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.113 -1.228 . . . . 0.0 110.357 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 114.44 -28.64 8.1 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 p -70.3 151.47 45.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.154 -1.204 . . . . 0.0 110.359 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.523 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 9.1 mm -102.46 122.9 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' C ' ' HD2' ' A' ' 66' ' ' PRO . 21.4 t0 -99.23 157.69 16.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.559 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.4 t80 -48.81 -45.65 72.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.711 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 50.0 Cg_endo -74.64 -37.34 2.35 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 123.347 1.183 . . . . 0.0 109.815 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 57' ' ' ALA . 4.2 tt0 -51.74 -49.07 63.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.505 -0.747 . . . . 0.0 110.199 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.13 -45.61 69.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.282 -0.886 . . . . 0.0 110.21 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -59.85 -12.59 7.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 0.0 110.607 -179.731 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.8 m -95.43 -43.21 8.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -0.988 . . . . 0.0 110.865 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.457 ' HE3' ' HB3' ' B' ' 7' ' ' TRP . 11.1 tmm? -62.87 -39.81 95.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.089 -1.007 . . . . 0.0 110.993 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.562 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 9.3 tpt -61.49 -9.74 6.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.131 -0.981 . . . . 0.0 111.127 -179.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.81 -18.43 15.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.984 -1.072 . . . . 0.0 111.089 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -23.7 14.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.986 -1.071 . . . . 0.0 110.896 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.406 ' HG2' HG23 ' B' ' 8' ' ' THR . 15.8 tttt . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.043 -1.036 . . . . 0.0 110.638 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.213 0.53 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.88 -46.83 61.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 109.793 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -58.48 -20.71 47.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 110.152 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.2 mt -69.79 -45.23 77.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.136 -0.978 . . . . 0.0 109.015 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 89' ' ' PHE . 58.3 ttt180 -56.89 -31.94 65.38 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HB3' HG22 ' B' ' 9' ' ' THR . 72.4 mm-40 -70.46 -56.42 6.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.39 -0.819 . . . . 0.0 109.306 179.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.58 -22.41 13.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.196 -0.94 . . . . 0.0 108.982 179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.58 ' CE1' ' HA ' ' A' ' 138' ' ' TYR . 84.1 t80 -71.41 -63.73 1.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.375 -0.828 . . . . 0.0 109.482 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -49.25 -38.34 26.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.383 -0.823 . . . . 0.0 109.076 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.459 HG13 HG23 ' A' ' 108' ' ' VAL . 18.6 t -63.78 -35.06 71.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.559 -0.713 . . . . 0.0 109.592 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.588 ' CE2' HD22 ' A' ' 105' ' ' LEU . 2.4 m-85 -72.74 -36.83 67.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.291 -0.881 . . . . 0.0 109.307 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 96' ' ' GLY . 3.6 t70 -99.91 62.19 1.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.757 . . . . 0.0 109.964 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' ASP . 7.7 tmtm? -42.64 -54.52 3.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 109.874 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.464 ' OD2' ' HG3' ' A' ' 104' ' ' GLU . 1.1 p30 -58.53 -27.32 64.41 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.533 -0.729 . . . . 0.0 109.913 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 60.86 59.24 10.5 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 34.3 p-10 -98.02 -41.95 7.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.201 -1.176 . . . . 0.0 110.556 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 162.96 -43.58 0.34 Allowed Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.295 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 15.0 m-85 -123.2 166.55 15.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.269 . . . . 0.0 110.904 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 9.6 mt -102.69 84.33 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.34 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.473 ' N ' ' OE1' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -73.96 161.45 30.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.077 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.28 -19.4 3.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.922 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.84 -33.34 46.08 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.29 -0.881 . . . . 0.0 109.205 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 101' ' ' SER . 0.7 OUTLIER -67.51 -42.47 82.74 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.54 -0.725 . . . . 0.0 109.254 179.178 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.588 HD22 ' CE2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -63.08 -42.23 99.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.331 -0.855 . . . . 0.0 109.163 178.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -62.47 -26.82 68.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.593 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.462 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -69.95 -48.68 57.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.441 -0.787 . . . . 0.0 109.968 179.718 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.459 HG23 HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -74.13 -30.88 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.286 -0.884 . . . . 0.0 109.455 179.47 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.557 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 2.4 ttm -52.04 -70.34 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.652 -0.655 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.7 m -51.77 -26.76 10.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.14 -0.975 . . . . 0.0 110.337 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 8.7 m120 -72.33 -18.39 61.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.333 -0.855 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.492 ' CD1' HD21 ' B' ' 17' ' ' LEU . 10.2 mt -98.87 -48.84 4.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 110.423 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.42 -58.0 0.21 Allowed Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.768 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.439 ' HG2' HD13 ' A' ' 116' ' ' LEU . 8.8 tt0 -90.89 162.21 14.89 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.964 -1.315 . . . . 0.0 111.299 -178.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.99 72.92 1.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.58 -0.7 . . . . 0.0 109.52 179.39 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.517 ' HB3' ' CG2' ' A' ' 121' ' ' VAL . 4.6 mp -33.8 150.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.614 0.721 . . . . 0.0 111.525 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 116' ' ' LEU . 1.1 m -59.18 -147.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 109.82 179.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.13 -49.65 2.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.65 -51.76 66.13 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.073 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 121' ' ' VAL . 10.1 pt-20 -61.01 -44.67 97.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.55 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 73.4 t -60.36 -39.38 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.349 -0.844 . . . . 0.0 109.673 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.67 -53.54 56.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 109.725 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -57.09 -25.62 59.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.527 ' HG3' ' HA ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -64.05 -49.21 73.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.353 -0.842 . . . . 0.0 109.47 179.259 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.508 HD12 ' CD1' ' A' ' 105' ' ' LEU . 28.8 mm -73.27 -35.83 47.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.711 -0.618 . . . . 0.0 110.247 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.415 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 3.4 tmm_? -68.94 -22.74 64.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.204 -0.935 . . . . 0.0 110.063 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.57 -34.31 67.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 110.242 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -93.34 -26.4 17.3 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.356 -0.84 . . . . 0.0 110.233 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.415 ' OD2' ' HA ' ' A' ' 126' ' ' ARG . 85.9 m-20 -45.5 90.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.323 -0.861 . . . . 0.0 110.661 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -82.96 -40.82 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.158 -0.964 . . . . 0.0 109.521 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 35.2 p-10 -76.54 -24.47 53.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.929 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.477 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.99 35.05 19.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 15.9 p-10 -89.38 -15.97 32.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -1.113 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 135' ' ' GLN . . . 97.78 9.63 54.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 68.6 mt-30 -157.08 153.4 27.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.217 -1.167 . . . . 0.0 110.275 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.469 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 25.1 t -90.83 113.33 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.262 -0.899 . . . . 0.0 110.023 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -87.93 176.07 7.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.935 . . . . 0.0 110.557 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.594 ' CE1' HG22 ' A' ' 142' ' ' VAL . 5.2 t80 -57.08 -63.63 1.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.245 -0.91 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.6 OUTLIER -41.79 -49.34 4.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 0.0 109.989 179.891 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.442 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.0 mt-10 -57.08 -57.87 10.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 0.0 109.932 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.449 ' O ' ' SD ' ' A' ' 145' ' ' MET . 10.0 t80 -47.5 -24.47 0.85 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.275 -0.891 . . . . 0.0 109.962 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.594 HG22 ' CE1' ' A' ' 138' ' ' TYR . 42.5 t -99.66 -39.4 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 110.409 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -65.89 -9.89 33.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.925 . . . . 0.0 110.797 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.442 ' SD ' ' CA ' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -98.17 -26.13 14.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.029 -1.045 . . . . 0.0 110.704 -179.746 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.449 ' SD ' ' O ' ' A' ' 141' ' ' PHE . 6.5 mtp -100.48 -34.67 9.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 110.762 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 142' ' ' VAL . 69.0 p . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 0.0 110.35 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 41' ' ' GLN . 15.9 mm . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.24 -160.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.083 1.57 . . . . 0.0 111.243 -178.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.48 ' OG ' ' OG1' ' B' ' 9' ' ' THR . 10.5 p -123.03 -179.17 4.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.402 -0.811 . . . . 0.0 110.911 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.671 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 22.5 m95 -59.1 -71.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.561 0.696 . . . . 0.0 111.075 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.432 ' C ' ' O ' ' B' ' 7' ' ' TRP . 65.8 p -39.88 -28.17 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.737 -0.602 . . . . 0.0 110.493 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.48 ' OG1' ' OG ' ' B' ' 6' ' ' SER . 1.1 m -61.66 -50.11 73.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.678 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 t -63.89 -33.69 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.529 -0.732 . . . . 0.0 110.09 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.463 ' O ' ' OG ' ' B' ' 15' ' ' SER . 3.8 mm -74.18 -31.89 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.261 -0.899 . . . . 0.0 109.979 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.482 ' O ' ' OG ' ' B' ' 15' ' ' SER . 0.4 OUTLIER -62.55 -52.45 63.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.852 . . . . 0.0 110.093 179.741 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.456 ' O ' HD11 ' B' ' 17' ' ' LEU . 78.2 t -67.81 -43.78 85.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.669 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.47 ' HA ' HD11 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -59.52 -49.74 76.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.737 -1.227 . . . . 0.0 109.692 179.453 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' B' ' 12' ' ' LEU . 3.5 p -50.67 -42.27 56.46 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 26.2 tpp -73.12 -13.93 61.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.69 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.557 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 2.9 mp -89.94 62.44 5.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 110.142 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 ttp85 -118.31 -74.4 0.61 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.364 -0.835 . . . . 0.0 111.022 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.513 ' HD2' ' HB2' ' B' ' 20' ' ' ARG . 2.3 tmtm? -138.04 -75.45 0.39 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.081 -1.012 . . . . 0.0 110.952 -178.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.527 ' HA ' ' HG3' ' A' ' 124' ' ' MET . 1.0 OUTLIER -140.09 -4.21 1.36 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.714 -1.241 . . . . 0.0 111.31 -179.655 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -53.12 141.14 23.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.026 -1.046 . . . . 0.0 110.684 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.449 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -170.88 137.54 1.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.402 -0.811 . . . . 0.0 110.189 179.581 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.442 ' CA ' ' SD ' ' A' ' 144' ' ' MET . . . 126.11 -87.2 0.35 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.537 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 3.0 p30 -131.41 50.43 5.96 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.237 -1.155 . . . . 0.0 110.338 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 45.3 Cg_endo -73.48 -6.14 18.27 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.055 1.555 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.214 0.53 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 9' ' ' ILE . 53.7 mt -57.44 -59.21 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -42.56 -46.18 4.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 110.051 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.82 -54.76 33.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.015 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CG ' HD22 ' A' ' 69' ' ' LEU . 21.4 m-85 -61.13 -42.91 99.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.97 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -58.58 -34.05 70.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.185 -0.947 . . . . 0.0 109.344 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -61.78 -44.67 96.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.381 -0.825 . . . . 0.0 109.49 179.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -66.43 -52.1 49.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.462 -0.774 . . . . 0.0 110.08 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.6 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 35.7 t80 -63.73 -12.23 33.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.811 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.3 m -92.76 -25.99 17.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.882 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 112' ' ' LEU . 7.1 tt -77.67 -30.39 51.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.603 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 47.5 m-85 -80.01 -56.71 4.05 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.335 -0.853 . . . . 0.0 110.686 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -62.84 82.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.165 -0.96 . . . . 0.0 110.213 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -88.86 21.25 3.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.235 -179.973 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 23' ' ' GLY . 7.4 p-10 -140.1 18.68 2.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.459 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.9 75.76 0.15 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 1.8 t0 -132.66 -26.7 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -1.134 . . . . 0.0 110.685 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.68 -21.4 29.88 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -119.27 118.8 32.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -1.101 . . . . 0.0 109.874 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.461 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 12.3 mt -79.34 126.17 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.121 -0.987 . . . . 0.0 109.606 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.8 p -90.16 -157.68 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.795 . . . . 0.0 110.386 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.412 HG23 HG13 ' A' ' 52' ' ' ILE . 77.8 p -94.16 -33.43 13.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 13.0 ptpt -74.68 -31.07 61.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.121 -0.987 . . . . 0.0 110.288 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.527 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 14.9 mt-10 -58.17 -66.35 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.118 -0.988 . . . . 0.0 109.47 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.603 ' CD1' ' CE1' ' A' ' 19' ' ' PHE . 58.1 tp -56.75 -35.45 68.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.168 -0.958 . . . . 0.0 109.25 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.81 -37.14 93.83 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.6 m -59.44 -47.13 86.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.348 -1.089 . . . . 0.0 109.441 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.7 t -70.93 -37.35 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.592 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.534 ' CE ' ' CE ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -69.19 -44.74 71.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.385 -0.822 . . . . 0.0 109.775 179.549 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -62.57 -29.77 70.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.973 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.43 ' O ' ' CG ' ' A' ' 111' ' ' ASN . 3.3 t -79.1 -21.67 46.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 110.014 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 36' ' ' MET . 4.3 mt -68.13 -32.01 71.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.36 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.07 -60.63 0.44 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -172.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -1.199 . . . . 0.0 110.714 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -137.1 98.88 10.16 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.431 -0.793 . . . . 0.0 109.826 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 44.3 Cg_endo -71.61 124.04 9.95 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.965 1.508 . . . . 0.0 110.464 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -93.08 167.22 11.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.3 -37.08 71.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 0.0 110.108 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.07 64.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.238 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' OE1' HD11 ' B' ' 4' ' ' ILE . 20.9 mt-10 -66.78 -38.55 86.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.087 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 12.2 mt -62.08 -39.72 93.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.087 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -43.89 86.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.334 -0.854 . . . . 0.0 109.696 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.18 -38.03 89.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.35 -0.844 . . . . 0.0 109.652 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.583 ' HE2' ' CG ' ' B' ' 7' ' ' TRP . 7.4 mmm -67.26 -42.31 84.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.668 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.454 ' O ' HG21 ' A' ' 52' ' ' ILE . 4.4 mm -70.16 -19.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.35 -0.844 . . . . 0.0 109.625 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.11 -16.21 41.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.269 -0.894 . . . . 0.0 110.02 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -71.31 -31.01 66.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.42 -0.8 . . . . 0.0 110.241 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 57' ' ' ALA . 20.4 t -92.02 -37.09 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.163 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.412 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 1.4 t70 -46.68 87.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.641 . . . . 0.0 110.555 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -99.05 -26.78 14.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 0.0 110.203 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 3.1 p-10 -73.96 -43.27 58.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -0.962 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 58' ' ' ASP . . . 114.17 27.4 3.43 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 21.8 p-10 -99.53 -40.16 7.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.098 -1.236 . . . . 0.0 110.102 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 123.43 -46.76 1.07 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.2 p -95.31 166.5 11.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -1.217 . . . . 0.0 110.479 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 26' ' ' THR . 16.4 mm -88.69 142.24 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.3 -0.875 . . . . 0.0 109.894 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.478 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.2 m-20 -121.2 147.34 45.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.982 -1.073 . . . . 0.0 110.863 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.6 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 89.7 t80 -41.61 -50.78 9.44 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.453 -0.78 . . . . 0.0 111.546 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.0 Cg_endo -66.35 -43.36 8.38 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 123.252 1.133 . . . . 0.0 110.773 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.444 ' O ' ' OG1' ' A' ' 70' ' ' THR . 43.4 tt0 -60.93 -36.82 80.32 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.208 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 13.0 t80 -62.56 -45.83 91.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.997 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.59 HD22 ' CG ' ' A' ' 12' ' ' PHE . 2.7 mt -61.94 -29.91 70.55 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.319 -0.863 . . . . 0.0 110.726 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 1.7 p -79.4 -33.41 42.75 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.154 -0.966 . . . . 0.0 111.347 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.466 ' HG3' HG12 ' A' ' 55' ' ' VAL . 9.1 tmm? -69.05 -43.27 75.0 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.962 -1.087 . . . . 0.0 110.975 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.7 tpt -58.66 -10.85 2.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.189 -0.944 . . . . 0.0 111.12 -179.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.95 -9.81 16.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.865 -1.147 . . . . 0.0 111.236 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -94.4 -43.49 8.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.961 -1.087 . . . . 0.0 110.686 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.317 -0.864 . . . . 0.0 110.486 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.142 0.496 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -72.08 -17.94 61.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -0.972 . . . . 0.0 109.509 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -70.11 -23.23 63.0 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.455 -0.778 . . . . 0.0 109.871 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.482 HG21 ' CE2' ' A' ' 141' ' ' PHE . 29.6 mt -64.88 -28.99 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.2 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -32.32 73.71 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.616 -0.677 . . . . 0.0 109.807 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 13.9 mt-10 -74.16 -47.61 34.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.863 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.52 67.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.005 -1.059 . . . . 0.0 109.405 179.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CE1' ' OD2' ' A' ' 93' ' ' ASP . 11.8 t80 -71.44 -46.43 60.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -52.91 -32.35 44.95 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.436 -0.79 . . . . 0.0 109.321 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.7 t -71.27 -43.09 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.543 -0.723 . . . . 0.0 109.85 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.482 ' CE1' HG12 ' B' ' 13' ' ' VAL . 19.6 m-85 -66.58 -28.26 68.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.237 -0.914 . . . . 0.0 109.797 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.551 ' OD2' ' CE1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -88.03 62.29 6.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.388 -0.82 . . . . 0.0 109.788 179.788 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -36.29 -32.74 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.703 -0.623 . . . . 0.0 110.968 -179.553 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 12.5 p30 -111.23 -39.15 4.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.171 -0.956 . . . . 0.0 110.389 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 92.09 55.22 1.75 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 99' ' ' TYR . 52.1 p30 -97.29 0.24 47.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.178 -1.189 . . . . 0.0 110.175 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.424 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 93.68 12.56 56.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.452 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -154.14 142.31 20.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.359 -1.083 . . . . 0.0 110.03 -179.944 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 92' ' ' PHE . 5.7 mt -101.51 116.8 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.238 -0.914 . . . . 0.0 110.119 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 t -98.97 142.03 30.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.288 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.02 -35.73 3.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.832 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -58.82 -49.77 76.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 109.538 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.61 -50.02 66.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.704 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 125' ' ' ILE . 0.7 OUTLIER -59.32 -41.08 88.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.835 . . . . 0.0 109.397 179.468 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 13.2 ttt180 -56.08 -27.7 54.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.311 -0.868 . . . . 0.0 109.403 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.13 -42.5 37.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.619 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 0.7 OUTLIER -70.06 -26.89 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.292 179.588 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.544 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 0.5 OUTLIER -64.33 -64.8 0.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.361 -0.837 . . . . 0.0 110.155 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.422 HG21 ' N ' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -55.18 -33.44 63.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.903 -179.981 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 38' ' ' SER . 77.5 m-20 -75.31 -18.52 60.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 110.174 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.504 ' CD1' HG11 ' B' ' 13' ' ' VAL . 4.3 mt -92.41 -41.36 10.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 110.268 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.32 -36.75 0.81 Allowed Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.251 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 3.4 tp10 -116.09 158.24 23.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.915 -1.344 . . . . 0.0 110.981 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.525 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -139.24 83.09 1.93 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.149 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.498 HD12 ' O ' ' B' ' 17' ' ' LEU . 6.3 mp -38.34 140.76 0.28 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.591 -0.693 . . . . 0.0 111.074 -179.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -54.35 -168.52 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.541 -0.724 . . . . 0.0 109.497 179.327 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -74.95 -68.71 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.057 -1.027 . . . . 0.0 110.211 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.46 -45.16 12.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.308 -0.87 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.14 -44.28 92.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 110.049 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.461 HG23 ' HE2' ' A' ' 109' ' ' MET . 20.1 t -61.05 -40.44 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.99 -29.21 69.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.249 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -74.63 -30.61 61.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -51.26 30.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.136 -0.977 . . . . 0.0 110.248 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.515 ' CD1' HD11 ' A' ' 105' ' ' LEU . 49.8 mm -64.56 -41.26 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.25 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -27.11 67.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 110.221 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.5 OUTLIER -69.29 -21.04 63.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.88 -35.76 8.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.931 . . . . 0.0 110.271 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 5.1 t0 -43.11 105.6 0.05 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.317 -0.864 . . . . 0.0 110.411 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.462 HD12 ' HE3' ' A' ' 144' ' ' MET . 23.4 mm -74.99 -33.97 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.251 -0.906 . . . . 0.0 109.928 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 7.1 p-10 -103.72 -21.98 13.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 0.0 109.989 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.423 ' HA2' ' CG ' ' A' ' 129' ' ' ASP . . . 81.09 70.41 1.34 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 19.3 p-10 -120.68 -10.96 9.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.186 -1.185 . . . . 0.0 110.406 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.77 12.13 30.99 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.467 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -164.59 147.35 8.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.188 -1.183 . . . . 0.0 110.168 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 11.7 t -99.98 143.15 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 110.338 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 4.1 t30 -105.32 -168.23 1.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 109.89 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.407 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 41.1 t80 -76.06 -48.46 20.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.27 -41.29 65.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.9 -52.23 38.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.274 -0.891 . . . . 0.0 110.33 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.482 ' CE2' HG21 ' A' ' 85' ' ' ILE . 53.5 t80 -57.0 -17.32 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.326 -0.859 . . . . 0.0 110.631 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 145' ' ' MET . 37.3 t -100.26 -70.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.07 -1.019 . . . . 0.0 111.006 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -39.82 -37.14 0.51 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.257 -0.902 . . . . 0.0 110.7 -179.487 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.462 ' HE3' HD12 ' A' ' 130' ' ' ILE . 7.6 mmm -62.75 -29.09 70.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.154 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -100.4 -30.86 11.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.333 -0.854 . . . . 0.0 110.653 -179.898 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 142' ' ' VAL . 9.6 t . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.096 -1.003 . . . . 0.0 110.525 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 7.8 mt . . . . . 0 N--CA 1.506 2.358 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 38.9 Cg_endo -65.31 -176.35 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.844 1.444 . . . . 0.0 110.662 -179.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.472 ' O ' ' N ' ' B' ' 8' ' ' THR . 28.9 t -126.96 64.06 1.3 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.14 -0.975 . . . . 0.0 111.384 -178.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.583 ' CG ' ' HE2' ' A' ' 51' ' ' MET . 0.8 OUTLIER 58.09 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.207 -0.933 . . . . 0.0 111.188 178.688 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.472 ' N ' ' O ' ' B' ' 6' ' ' SER . 12.0 p -43.6 -42.79 5.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.992 . . . . 0.0 110.25 -179.335 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.543 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 3.8 m -52.41 -44.39 65.36 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.177 -0.952 . . . . 0.0 109.209 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.71 -37.43 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.337 -0.852 . . . . 0.0 109.381 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.433 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 4.2 mm -71.38 -25.0 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -0.797 . . . . 0.0 109.499 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' B' ' 9' ' ' THR . 2.0 mp -67.38 -60.31 2.69 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.336 -0.853 . . . . 0.0 109.645 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.504 HG11 ' CD1' ' A' ' 112' ' ' LEU . 72.7 t -57.77 -37.79 61.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.348 -0.845 . . . . 0.0 109.99 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.472 ' HD2' ' HA ' ' A' ' 15' ' ' ALA . 2.4 ttpt -59.41 -45.1 92.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.028 -1.045 . . . . 0.0 109.467 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' B' ' 18' ' ' ARG . 1.6 m -62.79 -26.28 68.64 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.339 -0.85 . . . . 0.0 109.537 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.448 ' HA ' ' HB2' ' B' ' 21' ' ' SER . 0.0 OUTLIER -70.54 -32.37 69.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.891 . . . . 0.0 109.748 179.663 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 5.9 mp -73.65 -5.56 41.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.297 -0.877 . . . . 0.0 110.489 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.9 OUTLIER -44.21 -56.45 4.1 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.152 -0.968 . . . . 0.0 109.468 179.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.513 ' CD ' ' HB3' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -171.72 -68.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.605 0.717 . . . . 0.0 109.271 179.699 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.513 ' HB3' ' CD ' ' B' ' 19' ' ' LYS . 0.8 OUTLIER -129.51 14.67 6.03 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.073 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' B' ' 22' ' ' PHE . 20.0 m -48.3 145.29 3.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.637 -0.664 . . . . 0.0 110.761 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.454 ' CG ' ' O ' ' B' ' 21' ' ' SER . 0.1 OUTLIER 171.67 -34.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.495 -0.753 . . . . 0.0 109.912 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.29 -128.82 0.03 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.643 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 43.9 t30 -131.76 34.42 0.26 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.988 -1.301 . . . . 0.0 111.723 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 51.3 Cg_endo -76.33 56.65 5.09 Favored 'Trans proline' 0 N--CA 1.481 0.788 0 O-C-N 123.185 1.097 . . . . 0.0 110.472 179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.256 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 8.2 mm100 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.374 0.607 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.432 HG22 HD11 ' A' ' 9' ' ' ILE . 37.2 mt -48.1 -43.88 11.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 109.432 179.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.01 -47.38 71.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.384 -0.822 . . . . 0.0 109.491 179.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 1.4 mt-10 -49.49 -54.19 19.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.507 179.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -59.46 -38.92 82.03 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.144 -0.973 . . . . 0.0 109.389 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -53.54 -43.62 68.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.285 -0.884 . . . . 0.0 109.173 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -56.87 -48.32 78.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 108.888 178.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.21 -54.16 50.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.412 -0.805 . . . . 0.0 109.292 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 65' ' ' PHE . 55.7 t80 -50.71 -35.64 32.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.813 . . . . 0.0 109.126 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.15 -29.39 48.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.598 -0.689 . . . . 0.0 109.396 179.258 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 112' ' ' LEU . 3.6 tt -53.04 -50.75 63.65 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.391 -0.818 . . . . 0.0 109.365 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 45.0 m-85 -69.72 -28.03 65.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.393 179.206 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.477 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 16.0 t0 -87.23 66.15 9.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.74 . . . . 0.0 110.14 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -45.25 -32.03 1.77 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.146 -0.971 . . . . 0.0 110.324 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 11.8 p-10 -89.72 -7.19 55.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.348 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 47.98 71.26 0.59 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 35.9 p-10 -116.9 -34.28 4.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -1.147 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 128.76 -0.51 6.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 21.2 p -142.4 128.28 19.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -1.159 . . . . 0.0 110.615 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.545 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 10.7 mt -91.96 129.65 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.214 -0.929 . . . . 0.0 110.054 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 p -99.64 -163.81 1.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 110.136 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.447 ' O ' HD12 ' A' ' 48' ' ' LEU . 4.5 p -91.2 -38.03 12.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.111 -0.993 . . . . 0.0 110.049 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -66.85 -33.39 75.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.994 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' A' ' 20' ' ' ASP . 2.1 mt-10 -67.05 -64.25 0.89 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.88 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.511 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 21.5 tp -52.85 -36.85 59.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 109.843 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.7 92.33 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.1 m -63.88 -52.86 58.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -1.094 . . . . 0.0 109.822 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 19' ' ' PHE . 26.3 t -52.75 -43.66 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.732 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.475 ' HE3' ' SD ' ' A' ' 51' ' ' MET . 32.2 mtt -64.18 -38.51 91.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.638 179.676 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.24 -16.37 63.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.848 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -79.0 -63.0 1.52 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.314 -0.866 . . . . 0.0 110.603 -179.879 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.456 ' O ' ' HE2' ' A' ' 94' ' ' LYS . 1.4 mt -43.48 -41.68 4.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.094 -1.004 . . . . 0.0 109.924 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 134.12 61.91 0.07 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.481 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.492 ' NE2' ' HA ' ' B' ' 4' ' ' ILE . 7.7 mt-30 -157.34 -176.36 5.91 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.125 -1.221 . . . . 0.0 109.974 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -144.17 97.44 5.24 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.109 -0.995 . . . . 0.0 110.612 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.536 ' HA ' ' CD1' ' B' ' 4' ' ' ILE . 49.2 Cg_endo -76.39 137.23 18.51 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.015 1.534 . . . . 0.0 110.539 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 47' ' ' GLU . 24.1 m -87.75 142.91 27.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 109.87 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -42.21 -64.2 0.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 110.27 179.994 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.71 -52.15 42.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 110.092 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 2.8 mm-40 -50.21 -53.05 30.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.308 -0.87 . . . . 0.0 109.985 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -44.94 -51.64 9.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 110.13 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.461 ' HA ' ' OE1' ' A' ' 49' ' ' GLN . 40.1 tp60 -57.4 -32.71 67.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -0.822 . . . . 0.0 109.999 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -68.0 -38.67 82.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 109.906 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.568 ' HE1' ' CD1' ' B' ' 7' ' ' TRP . 2.0 ttp -81.55 -27.5 34.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.398 -0.814 . . . . 0.0 110.246 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.458 HD12 HD21 ' A' ' 32' ' ' LEU . 10.7 mm -78.29 -29.9 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.302 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -77.55 0.96 20.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.18 -0.95 . . . . 0.0 110.017 179.807 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.56 -44.68 11.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.294 -0.878 . . . . 0.0 109.669 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.585 HG22 ' CE2' ' B' ' 7' ' ' TRP . 41.0 t -79.72 -20.26 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 109.928 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -51.4 87.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.347 -0.846 . . . . 0.0 110.152 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -87.01 -47.22 9.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.259 -0.901 . . . . 0.0 111.062 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.2 p-10 -57.46 -45.94 84.2 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.023 -1.048 . . . . 0.0 110.828 -179.373 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 120.16 18.24 4.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 32.8 p-10 -96.24 -46.01 6.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -1.23 . . . . 0.0 110.239 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 134.6 -43.8 1.23 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.54 168.48 16.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.258 -1.142 . . . . 0.0 110.51 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.545 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 11.4 mm -92.76 143.76 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 110.109 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -117.95 163.69 16.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.088 -1.008 . . . . 0.0 110.379 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.556 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 44.9 t80 -59.24 -50.7 86.21 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.269 -0.894 . . . . 0.0 110.483 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -69.02 -29.2 27.81 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 O-C-N 123.393 1.207 . . . . 0.0 109.517 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' HB1' ' A' ' 57' ' ' ALA . 5.9 tt0 -67.75 -31.21 70.97 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.475 -0.766 . . . . 0.0 109.06 178.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -70.06 -53.75 16.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.538 -0.726 . . . . 0.0 109.889 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.01 -35.52 62.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.387 -0.82 . . . . 0.0 110.333 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 71' ' ' MET . 1.3 m -78.04 -53.7 7.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.23 -0.919 . . . . 0.0 110.712 -179.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.523 ' HG3' ' CG1' ' A' ' 55' ' ' VAL . 5.7 tmm? -41.24 -42.69 2.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.226 -0.921 . . . . 0.0 110.553 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.562 ' HE3' ' CE2' ' B' ' 26' ' ' PHE . 0.1 OUTLIER -51.24 -17.83 0.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -0.868 . . . . 0.0 110.681 -179.741 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.48 -35.86 10.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.016 -1.052 . . . . 0.0 110.925 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -31.65 54.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.066 -1.022 . . . . 0.0 110.742 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HB3' HG23 ' B' ' 8' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' HA ' HD13 ' A' ' 85' ' ' ILE . 19.7 mt-10 . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.226 0.536 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 87' ' ' GLU . 7.3 tt0 -74.52 -44.52 50.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.096 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.64 -23.56 66.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.488 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.471 HG22 ' CE2' ' A' ' 141' ' ' PHE . 67.2 mt -78.43 -45.48 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.927 . . . . 0.0 109.816 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -53.89 -36.66 62.91 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 109.705 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 0.3 OUTLIER -69.83 -52.22 26.84 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.213 -0.929 . . . . 0.0 109.542 179.494 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.69 -35.3 65.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.093 -1.005 . . . . 0.0 109.036 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.581 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 63.3 t80 -67.28 -47.59 70.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.508 -0.745 . . . . 0.0 109.668 179.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -46.42 71.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.404 -0.81 . . . . 0.0 109.328 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 t -51.09 -48.94 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.415 -0.803 . . . . 0.0 109.418 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.43 ' HB3' HD11 ' A' ' 100' ' ' ILE . 30.6 m-85 -57.05 -38.3 73.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.131 -0.981 . . . . 0.0 110.124 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.409 ' OD1' HG12 ' A' ' 100' ' ' ILE . 68.2 m-20 -89.54 59.75 4.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.552 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 0.8 OUTLIER -52.18 -34.37 44.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.952 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 9.9 p-10 -74.02 -41.83 61.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.924 . . . . 0.0 110.112 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.69 35.08 5.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.443 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 33.5 p-10 -94.65 3.09 55.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -1.197 . . . . 0.0 110.257 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 68.23 37.72 86.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 12.8 m-85 -165.27 142.61 5.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -1.113 . . . . 0.0 110.24 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.43 HD11 ' HB3' ' A' ' 92' ' ' PHE . 9.7 mt -107.7 126.53 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.667 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' ALA . 2.8 t -117.76 147.83 42.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.825 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.15 -27.73 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.268 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -70.73 -43.98 67.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.855 . . . . 0.0 109.799 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 101' ' ' SER . 42.8 mt-10 -61.31 -40.21 93.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.923 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.527 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 2.4 mt -63.34 -44.37 95.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.405 -0.81 . . . . 0.0 109.81 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.8 ttp85 -53.87 -37.08 63.33 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.067 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.552 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -60.55 -60.94 3.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.397 -0.814 . . . . 0.0 109.573 179.292 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.68 -35.15 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.368 -0.832 . . . . 0.0 109.464 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.561 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 5.6 mtt -50.89 -65.42 0.56 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 110.395 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -63.5 -33.21 75.09 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 110.354 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.12 -8.37 49.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.105 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.564 HD11 ' HA ' ' B' ' 14' ' ' LYS . 10.1 mt -109.38 -50.88 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 110.471 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.06 -59.24 0.16 Allowed Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.585 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.442 ' HG2' HD13 ' A' ' 116' ' ' LEU . 2.6 tt0 -105.87 154.76 20.1 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.055 -1.262 . . . . 0.0 110.626 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 6.9 ptpp? -123.48 21.97 9.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.878 . . . . 0.0 110.15 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 115' ' ' LYS . 6.6 mp 41.03 -164.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.547 -0.721 . . . . 0.0 110.575 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 m -96.49 -146.59 0.29 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.433 -0.792 . . . . 0.0 109.178 179.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -115.4 -54.51 2.53 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.127 -0.983 . . . . 0.0 109.963 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -31.35 72.54 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 109.517 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -69.93 -45.26 67.9 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.298 -0.876 . . . . 0.0 109.298 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.442 HG23 ' HE2' ' A' ' 109' ' ' MET . 24.2 t -61.99 -45.73 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.082 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.29 -39.99 92.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 109.782 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 4.5 tt0 -71.71 -31.15 66.42 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.403 -0.81 . . . . 0.0 109.559 179.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.479 ' HB2' ' HA ' ' B' ' 20' ' ' ARG . 1.4 ttt -61.33 -34.59 75.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 0.0 109.603 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.527 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 35.2 mm -80.56 -63.52 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.446 -0.784 . . . . 0.0 110.816 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.06 -30.33 10.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.181 -0.949 . . . . 0.0 110.938 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 11.8 mt-10 -74.78 -29.96 61.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.103 -0.998 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -88.11 -28.66 21.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.311 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -48.6 90.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 128' ' ' ALA . 49.3 mm -59.75 -40.93 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 0.0 109.959 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -84.55 -28.79 26.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.414 -0.804 . . . . 0.0 110.092 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.7 76.65 0.97 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 48.1 p30 -135.42 8.78 3.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.216 -1.167 . . . . 0.0 110.095 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.47 13.28 73.67 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.459 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 9.5 pt20 -169.42 163.05 10.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.247 -1.149 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 87.5 t -108.38 142.9 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.111 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.47 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 4.6 t30 -110.45 -159.04 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 0.0 110.106 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 139' ' ' GLU . 30.2 t80 -72.61 -63.02 1.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 109.691 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 143' ' ' GLN . 43.1 mt-10 -42.98 -50.11 5.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.324 -0.86 . . . . 0.0 109.787 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 142' ' ' VAL . 48.8 mt-10 -55.67 -60.46 3.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 109.634 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.581 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 30.5 t80 -41.55 -28.14 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.538 -0.727 . . . . 0.0 109.537 179.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 140' ' ' GLU . 78.7 t -100.37 -28.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.559 -0.713 . . . . 0.0 110.535 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -66.04 -13.14 59.45 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.06 -1.025 . . . . 0.0 110.343 -179.792 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -103.63 -23.72 13.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.103 -0.998 . . . . 0.0 110.608 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.505 ' HE1' ' HA2' ' B' ' 23' ' ' GLY . 8.5 mtt -90.8 -32.64 16.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.17 -0.956 . . . . 0.0 109.806 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.465 ' O ' ' CG2' ' A' ' 146' ' ' THR . 8.4 t . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.362 -0.836 . . . . 0.0 110.156 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 43' ' ' PRO . 15.9 mt . . . . . 0 N--CA 1.502 2.147 0 CA-C-O 120.723 0.297 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 43.6 Cg_endo -74.06 151.77 44.94 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.954 1.502 . . . . 0.0 109.973 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.498 ' O ' ' CE ' ' A' ' 51' ' ' MET . 13.4 m -62.9 -55.36 26.75 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 110.432 -179.533 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.585 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER 169.9 -76.25 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.315 -0.866 . . . . 0.0 109.552 -179.725 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.491 ' O ' ' HB ' ' B' ' 11' ' ' ILE . 25.7 p -53.2 -27.75 23.3 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.758 . . . . 0.0 109.878 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 79.4 m -58.86 -52.18 66.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.925 -1.109 . . . . 0.0 108.464 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 15.5 t -50.79 -43.69 25.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' B' ' 11' ' ' ILE . 0.8 OUTLIER -59.57 -54.28 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.758 0.79 . . . . 0.0 109.584 179.408 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 11' ' ' ILE . 0.6 OUTLIER -40.66 -66.85 0.28 Allowed 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.657 -0.652 . . . . 0.0 110.779 -179.831 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.539 ' CG1' HD12 ' A' ' 112' ' ' LEU . 62.1 t -46.13 -43.45 5.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.643 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.564 ' HA ' HD11 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -59.05 -50.01 75.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.91 -1.119 . . . . 0.0 110.277 179.652 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.76 -28.95 37.68 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.357 -0.839 . . . . 0.0 109.89 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.492 ' O ' ' N ' ' B' ' 18' ' ' ARG . 0.2 OUTLIER -72.6 -31.17 64.98 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.244 -0.91 . . . . 0.0 110.593 -179.871 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.561 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 4.6 mp -67.2 57.64 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.071 -1.018 . . . . 0.0 110.699 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.541 ' HG3' ' CD ' ' B' ' 19' ' ' LYS . 2.0 ttp180 -91.96 -110.38 0.1 Allowed 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.478 -0.764 . . . . 0.0 109.141 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.541 ' CD ' ' HG3' ' B' ' 18' ' ' ARG . 3.0 mptt -126.53 -94.4 0.46 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.741 -1.225 . . . . 0.0 109.114 178.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.479 ' HA ' ' HB2' ' A' ' 124' ' ' MET . 0.0 OUTLIER -105.33 3.02 29.4 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.274 -0.891 . . . . 0.0 109.31 178.943 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 6.9 m -84.07 -176.07 6.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 0.0 109.712 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.474 ' O ' ' OD1' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -151.7 -150.72 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.017 . . . . 0.0 111.186 179.712 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.505 ' HA2' ' HE1' ' A' ' 145' ' ' MET . . . -43.85 156.05 0.21 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.532 ' HB3' ' HD2' ' B' ' 25' ' ' PRO . 34.8 m120 -150.17 168.1 11.68 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.457 -1.025 . . . . 0.0 110.217 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' B' ' 24' ' ' ASN . 39.7 Cg_endo -65.78 73.22 0.32 Allowed 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.637 1.335 . . . . 0.0 110.041 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.562 ' CE2' ' HE3' ' A' ' 72' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.715 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.758 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.436 ' NE2' ' OXT' ' B' ' 26' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 109.818 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 10' ' ' ALA . 88.6 mt -50.08 -59.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -44.97 -52.7 8.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -0.939 . . . . 0.0 109.514 179.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 12' ' ' PHE . 1.2 tt0 -52.49 -48.1 66.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -0.834 . . . . 0.0 109.313 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.528 ' CD1' ' HG2' ' A' ' 11' ' ' GLU . 18.9 m-30 -55.84 -47.46 77.22 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.359 -0.838 . . . . 0.0 109.904 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -48.86 -42.64 37.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.588 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -53.63 56.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 109.619 179.439 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -54.2 -40.85 67.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.829 . . . . 0.0 109.861 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -66.8 -30.05 70.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.823 . . . . 0.0 109.831 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -78.43 -20.22 51.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.639 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.469 ' CD2' HG12 ' A' ' 35' ' ' VAL . 6.4 tt -76.72 -46.33 25.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.384 -0.822 . . . . 0.0 110.05 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.44 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 69.5 m-85 -72.1 -22.77 61.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.0 110.161 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.478 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 0.8 OUTLIER -95.44 83.78 3.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.038 179.907 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -44.71 -35.8 2.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.1 p30 -97.93 -24.52 15.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 110.328 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 67.86 31.21 75.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 41.9 p-10 -79.27 -0.75 33.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -1.191 . . . . 0.0 110.111 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 87.0 27.0 29.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 18.4 p -156.51 97.41 1.74 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -1.089 . . . . 0.0 109.894 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.556 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 18.8 mt -85.32 112.32 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.033 . . . . 0.0 109.978 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.435 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -75.79 -163.72 0.3 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.313 -0.867 . . . . 0.0 109.783 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.46 ' O ' HD12 ' A' ' 48' ' ' LEU . 6.6 p -80.45 -56.09 4.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.947 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -37.98 66.13 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.44 -0.788 . . . . 0.0 110.494 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 18.9 mt-10 -48.86 -68.49 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.048 -1.033 . . . . 0.0 109.653 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.507 HD22 ' CE ' ' A' ' 51' ' ' MET . 56.0 tp -47.28 -39.33 14.27 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.309 -0.87 . . . . 0.0 109.141 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.39 96.75 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.611 -1.796 . . . . 0.0 108.611 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 m -52.53 -42.97 64.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.362 -1.081 . . . . 0.0 109.249 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.469 HG12 ' CD2' ' A' ' 18' ' ' LEU . 13.3 t -66.91 -46.96 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.398 -0.814 . . . . 0.0 109.599 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.467 ' CE ' ' HG2' ' B' ' 5' ' ' PRO . 4.8 mmt -67.13 -29.8 69.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.658 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 2.4 ttp-105 -68.46 -35.13 77.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.771 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 m -84.12 -14.35 50.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.064 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -83.17 -32.91 26.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.103 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.65 -62.93 0.18 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.555 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -100.3 175.42 5.72 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.038 -1.272 . . . . 0.0 111.315 -178.959 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -134.52 100.06 12.69 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.602 -0.686 . . . . 0.0 109.529 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.421 ' HG3' HG23 ' B' ' 4' ' ' ILE . 43.6 Cg_endo -69.97 162.74 41.02 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 O-C-N 124.065 1.56 . . . . 0.0 111.072 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 4.2 t -96.93 -149.95 0.33 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.385 -0.822 . . . . 0.0 110.725 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 38.1 mt-10 -94.22 -57.33 2.54 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 0.0 110.88 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 47' ' ' GLU . . . -43.56 -70.54 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.035 -1.041 . . . . 0.0 110.409 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 46' ' ' ALA . 6.0 mm-40 -44.78 -42.9 8.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.077 -1.015 . . . . 0.0 109.486 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.7 mt -57.22 -47.39 81.44 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -46.28 -43.28 15.57 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.38 179.436 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.45 -30.32 64.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.432 -0.792 . . . . 0.0 109.571 179.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.584 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 1.2 mmm -74.72 -36.71 62.68 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.403 -0.811 . . . . 0.0 109.497 179.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.505 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 1.5 tp -78.1 -43.75 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.273 -0.892 . . . . 0.0 110.327 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.505 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -43.43 -26.1 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.257 -0.902 . . . . 0.0 110.331 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 52' ' ' ILE . 15.6 mm-40 -67.9 -51.43 47.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 110.213 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.543 ' HB ' ' CD1' ' A' ' 63' ' ' ILE . 14.8 t -80.61 -33.38 13.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.96 82.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.348 -0.845 . . . . 0.0 110.168 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.77 -69.25 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.398 -0.814 . . . . 0.0 110.816 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 47.1 p-10 -59.02 -16.88 20.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.252 -0.905 . . . . 0.0 110.675 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 69.47 43.8 67.54 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 31.4 p-10 -94.76 -31.84 13.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.326 -1.102 . . . . 0.0 110.478 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 120.51 24.09 2.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 3.4 p -161.05 142.66 11.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -1.14 . . . . 0.0 110.247 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.556 ' CG1' ' HB ' ' A' ' 27' ' ' ILE . 14.1 mm -82.4 134.03 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.196 -0.94 . . . . 0.0 110.011 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.472 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -105.96 160.62 15.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 110.319 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.6 t80 -56.62 -50.36 88.35 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.554 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.9 Cg_endo -69.97 -31.3 19.85 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.397 1.209 . . . . 0.0 109.974 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 70' ' ' THR . 8.9 mt-10 -64.41 -34.03 77.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.32 -0.863 . . . . 0.0 110.073 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -75.45 -53.58 8.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.21 -0.932 . . . . 0.0 109.673 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mp -49.82 -29.78 8.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.883 . . . . 0.0 109.913 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -74.59 -47.89 29.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -0.849 . . . . 0.0 110.028 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.488 ' HG3' ' HA ' ' A' ' 55' ' ' VAL . 8.0 mmm -50.39 -47.45 56.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.135 -0.978 . . . . 0.0 109.572 179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.583 ' HE3' ' CZ ' ' B' ' 26' ' ' PHE . 6.1 tpt -42.19 -26.81 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.48 -0.763 . . . . 0.0 110.498 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 71' ' ' MET . . . -107.52 -21.07 13.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.193 -0.942 . . . . 0.0 110.957 -179.145 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.46 -26.01 33.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.074 -1.016 . . . . 0.0 110.394 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.524 ' CG ' HG22 ' B' ' 8' ' ' THR . 2.6 tptm . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 110.292 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.365 0.603 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -63.89 -13.17 43.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.406 -0.809 . . . . 0.0 109.51 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.512 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 3.2 mt-10 -71.28 -45.47 63.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.513 -0.742 . . . . 0.0 110.582 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.52 HG21 ' CD2' ' A' ' 141' ' ' PHE . 27.3 mt -73.74 -21.73 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 110.198 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -71.83 -53.45 13.25 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.159 -0.963 . . . . 0.0 110.298 -179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 7.8 pt-20 -62.37 -40.27 95.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.012 -1.055 . . . . 0.0 110.333 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -58.89 -37.31 76.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.504 -1.372 . . . . 0.0 108.358 178.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' HD13 ' A' ' 100' ' ' ILE . 66.6 t80 -65.49 -44.04 88.31 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -43.52 71.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.53 -0.731 . . . . 0.0 109.046 178.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.467 ' CG1' HG22 ' A' ' 108' ' ' VAL . 30.4 t -53.29 -48.57 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -0.785 . . . . 0.0 108.989 179.03 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.59 ' CE1' HG13 ' A' ' 108' ' ' VAL . 42.9 m-85 -66.59 -35.56 80.49 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 109.228 178.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.472 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 23.6 t0 -86.9 60.02 5.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.765 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' ASP . 10.2 ttpt -39.51 -50.07 2.15 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.521 -0.737 . . . . 0.0 110.252 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 10.2 p-10 -65.25 -36.56 84.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 109.652 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 83.41 45.41 6.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.374 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 52.6 p-10 -100.22 -20.71 15.8 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.058 -1.26 . . . . 0.0 110.273 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 109.28 22.08 6.99 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 24.4 m-85 -143.57 142.66 31.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.363 -1.08 . . . . 0.0 109.98 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.534 HD13 ' CD1' ' A' ' 89' ' ' PHE . 6.3 mt -113.69 96.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.498 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.2 m -90.68 152.45 20.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -0.918 . . . . 0.0 109.775 179.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.18 -40.55 11.38 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.63 -47.4 79.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.387 -0.821 . . . . 0.0 109.59 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 25.8 mt-10 -61.06 -53.66 54.38 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.304 -0.872 . . . . 0.0 109.828 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.515 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -59.34 -29.53 67.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.465 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.4 ttt-85 -70.82 -22.88 62.29 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.343 -0.848 . . . . 0.0 108.87 178.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 9.0 m80 -79.81 -46.23 17.32 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.576 -0.702 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.59 HG13 ' CE1' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -67.03 -20.73 27.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.365 -0.834 . . . . 0.0 108.857 179.144 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.471 ' HG3' HD23 ' B' ' 17' ' ' LEU . 0.3 OUTLIER -68.77 -52.07 34.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.599 -0.688 . . . . 0.0 109.956 179.638 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -35.37 73.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.894 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -74.16 -12.66 60.65 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.16 -0.962 . . . . 0.0 109.345 179.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 8.9 mt -94.64 -51.42 4.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.432 -0.792 . . . . 0.0 109.754 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.57 -59.93 0.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 20.8 tp10 -96.76 160.6 14.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.201 -1.176 . . . . 0.0 110.949 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.524 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -133.94 81.9 1.95 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.325 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.498 ' CD2' ' O ' ' B' ' 19' ' ' LYS . 6.5 mp -37.27 150.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.573 0.701 . . . . 0.0 111.268 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.79 -148.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.502 -0.749 . . . . 0.0 110.012 179.759 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.99 -44.86 5.36 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.331 -0.855 . . . . 0.0 110.135 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 17.5 pt-20 -64.89 -42.36 94.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.76 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.48 ' N ' ' CG ' ' A' ' 119' ' ' GLU . 11.1 mm-40 -63.3 -40.72 98.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.579 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 125' ' ' ILE . 40.5 t -64.89 -45.37 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.273 -0.892 . . . . 0.0 109.699 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -63.53 -35.56 80.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.436 -0.79 . . . . 0.0 109.708 179.643 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 124' ' ' MET . 45.5 mt-10 -72.87 -54.48 8.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.0 109.566 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.601 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 25.1 ttt -42.38 -43.37 3.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.476 -0.765 . . . . 0.0 109.904 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.515 HD13 ' CD1' ' A' ' 105' ' ' LEU . 15.3 mm -76.33 -60.27 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 0.0 109.961 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -47.84 -55.03 10.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.512 ' OE2' ' CZ ' ' B' ' 20' ' ' ARG . 46.2 mt-10 -52.51 -21.6 3.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 0.0 110.388 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.464 ' O ' HD13 ' A' ' 130' ' ' ILE . . . -93.28 -34.95 13.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.215 -0.928 . . . . 0.0 110.328 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 5.2 m-20 -68.43 66.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 110.237 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.464 HD13 ' O ' ' A' ' 128' ' ' ALA . 2.5 mp -46.43 -42.82 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.004 . . . . 0.0 109.88 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -70.89 -29.41 65.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.467 -0.77 . . . . 0.0 110.189 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.92 95.45 0.28 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 29.5 p-10 -144.72 -37.76 0.29 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -1.116 . . . . 0.0 110.236 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 121.49 9.44 7.11 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -165.59 149.8 8.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -1.102 . . . . 0.0 110.271 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.471 HG11 ' HB3' ' A' ' 140' ' ' GLU . 3.5 t -103.19 116.38 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 109.823 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.37 -155.03 0.3 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.345 -0.847 . . . . 0.0 110.603 -179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 139' ' ' GLU . 58.5 t80 -75.24 -60.62 2.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 138' ' ' TYR . 1.5 tt0 -42.72 -56.83 3.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.471 ' HB3' HG11 ' A' ' 136' ' ' VAL . 2.6 mt-10 -55.23 -55.62 29.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.903 . . . . 0.0 109.85 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.52 ' CD2' HG21 ' A' ' 85' ' ' ILE . 19.1 t80 -45.22 -28.8 0.84 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.376 -0.827 . . . . 0.0 109.626 179.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.94 -24.02 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.411 -0.806 . . . . 0.0 109.806 179.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.431 ' HG2' HD12 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -59.0 -30.58 68.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 109.917 179.797 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.0 mmm -92.0 -9.58 42.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.316 -0.865 . . . . 0.0 109.844 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.529 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.2 OUTLIER -98.56 -69.76 0.75 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.388 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.495 1.82 0 O-C-N 120.963 -1.086 . . . . 0.0 110.866 -179.757 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.421 HG23 ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.118 0.485 . . . . 0.0 110.656 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.547 ' HB2' ' CB ' ' B' ' 9' ' ' THR . 48.1 Cg_endo -72.26 -155.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 124.334 1.702 . . . . 0.0 111.144 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.537 ' O ' ' N ' ' B' ' 8' ' ' THR . 5.0 t -130.18 73.8 1.55 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.245 -0.91 . . . . 0.0 111.214 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.584 ' CD1' ' O ' ' A' ' 51' ' ' MET . 0.8 OUTLIER 46.96 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.698 0 O-C-N 121.49 -0.756 . . . . 0.0 111.848 178.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.537 ' N ' ' O ' ' B' ' 6' ' ' SER . 21.6 p -38.99 -26.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 110.798 -179.016 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.547 ' CB ' ' HB2' ' B' ' 5' ' ' PRO . 15.8 m -64.92 -65.81 0.62 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.076 -1.015 . . . . 0.0 109.996 179.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.571 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 4.0 m -46.68 -26.86 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 108.955 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.529 HG23 ' CE ' ' A' ' 72' ' ' MET . 49.2 mt -74.4 -47.96 37.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 121.687 0.756 . . . . 0.0 109.541 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 mt -50.32 -56.64 10.43 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.654 -0.654 . . . . 0.0 110.561 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.528 HG12 ' CZ ' ' A' ' 92' ' ' PHE . 17.2 t -62.34 -40.17 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.969 . . . . 0.0 110.958 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.451 ' HE2' HD13 ' A' ' 18' ' ' LEU . 6.5 tptp -71.54 -11.65 60.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.802 -1.186 . . . . 0.0 110.492 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -97.59 -21.83 16.85 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.191 -0.943 . . . . 0.0 109.265 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.467 ' O ' ' HE2' ' A' ' 124' ' ' MET . 6.6 tpp -78.56 -37.39 42.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.584 -0.697 . . . . 0.0 110.156 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' A' ' 109' ' ' MET . 1.3 mp -48.43 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.918 -1.114 . . . . 0.0 109.682 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER 31.62 58.07 0.31 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.652 -0.655 . . . . 0.0 112.514 179.392 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.548 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 62.5 -59.3 0.13 Allowed 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.47 -0.768 . . . . 0.0 111.753 178.155 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -155.66 8.42 0.25 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.886 -1.134 . . . . 0.0 111.752 -178.514 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' B' ' 18' ' ' ARG . 1.8 m -59.99 84.51 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.732 -1.23 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.601 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -111.93 13.55 20.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -0.954 . . . . 0.0 110.349 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.472 ' C ' ' CD ' ' B' ' 25' ' ' PRO . . . -96.24 -139.53 10.52 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.556 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 32.8 t-20 -119.78 47.58 1.03 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.196 -1.179 . . . . 0.0 110.386 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 48.5 Cg_endo -73.73 53.02 2.66 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.734 1.386 . . . . 0.0 110.268 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.583 ' CZ ' ' HE3' ' A' ' 72' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.987 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.457 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.246 0.546 . . . . 0.0 110.278 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.4 mt -48.27 -45.97 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.785 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.09 -41.66 62.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 109.738 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.564 ' OE2' ' CE1' ' A' ' 12' ' ' PHE . 1.9 tt0 -57.55 -51.51 69.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.746 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE1' ' OE2' ' A' ' 11' ' ' GLU . 21.0 m-85 -62.15 -45.07 95.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.942 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -60.17 -42.71 95.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -0.932 . . . . 0.0 109.705 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.79 -36.89 72.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.624 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . . . -75.45 -54.11 7.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.675 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.582 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 20.6 t80 -56.73 -17.15 8.0 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.417 -0.802 . . . . 0.0 109.714 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 18' ' ' LEU . 7.3 t -89.33 -56.74 3.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 7.4 tt -44.31 -30.15 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -87.64 -30.73 20.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.284 -0.885 . . . . 0.0 110.535 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 23.6 t0 -104.89 91.57 3.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 110.495 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -67.92 -48.5 65.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.18 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 5.2 p-10 -60.39 -41.98 94.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.44 -0.787 . . . . 0.0 110.434 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.429 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . 83.87 56.47 2.6 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 38.1 p-10 -107.45 -27.57 10.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.159 -1.201 . . . . 0.0 110.263 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 111.56 9.09 21.99 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 27.2 p -141.89 116.02 9.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -1.172 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.481 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.5 mt -94.76 106.45 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 110.149 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.86 152.03 23.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.792 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -45.97 -25.56 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.01 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -61.12 2.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 110.218 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.67 -57.66 10.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.226 -0.921 . . . . 0.0 110.07 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.451 HD23 ' CZ2' ' B' ' 7' ' ' TRP . 29.8 tp -52.68 -38.43 60.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.34 -40.02 96.92 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -60.29 -55.44 33.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -1.145 . . . . 0.0 109.943 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.29 -50.53 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.649 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.527 ' HB3' ' CD ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -54.38 -38.69 66.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.917 . . . . 0.0 109.871 179.657 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.492 ' HG3' ' ND2' ' A' ' 42' ' ' ASN . 2.0 ttp85 -64.25 -23.31 67.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.417 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 8.1 t -78.36 -30.23 47.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 110.656 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.74 -43.95 67.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.08 -1.013 . . . . 0.0 110.477 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.36 -16.01 0.41 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.654 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.1 mm-40 -113.2 166.0 11.87 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.832 -1.393 . . . . 0.0 110.624 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.492 ' ND2' ' HG3' ' A' ' 37' ' ' ARG . 3.8 t-20 -127.9 97.16 30.34 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.287 -0.883 . . . . 0.0 110.231 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.527 ' CD ' ' HB3' ' A' ' 36' ' ' MET . 46.6 Cg_endo -75.45 140.08 23.87 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 124.173 1.618 . . . . 0.0 110.357 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.477 HG21 ' HG2' ' A' ' 47' ' ' GLU . 14.7 t -91.58 -143.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 109.917 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 44' ' ' THR . 11.4 tp10 -100.23 -25.96 14.08 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.252 -0.905 . . . . 0.0 110.289 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.62 -70.8 0.35 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.14 -0.975 . . . . 0.0 110.387 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.477 ' HG2' HG21 ' A' ' 44' ' ' THR . 8.2 pt-20 -49.42 -40.29 36.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.0 109.624 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 1.4 mt -58.73 -43.25 90.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.079 179.195 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.99 -49.29 51.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.502 -0.749 . . . . 0.0 109.095 179.084 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -29.98 68.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.292 179.076 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.524 ' HE2' ' CE ' ' A' ' 36' ' ' MET . 1.2 ttp -75.98 -55.38 5.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 2.5 tp -56.96 -44.66 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.532 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.5 OUTLIER -40.89 -70.1 0.12 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.557 -0.714 . . . . 0.0 111.128 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -35.91 -55.08 0.75 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.722 -0.612 . . . . 0.0 110.933 -179.315 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.634 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 11.3 t -75.21 -33.84 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.745 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 5.3 t0 -58.87 77.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 0.0 110.318 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -39.72 -61.28 0.85 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.504 -0.747 . . . . 0.0 110.575 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 41.0 p-10 -76.4 -18.85 58.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 110.091 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 72.32 49.27 21.08 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.0 p-10 -99.3 -27.41 13.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -1.154 . . . . 0.0 110.302 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 119.14 23.47 3.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 81.2 p -155.65 140.36 17.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.181 -1.187 . . . . 0.0 110.051 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.526 ' CG1' HD13 ' A' ' 52' ' ' ILE . 10.4 mm -91.15 158.75 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.354 -0.842 . . . . 0.0 110.072 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 58.5 m-20 -133.7 163.32 29.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 0.0 110.059 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.585 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 11.4 t80 -56.35 -48.54 96.78 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.16 -0.962 . . . . 0.0 111.215 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.1 Cg_endo -68.73 -35.69 15.79 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.206 1.108 . . . . 0.0 110.293 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 6.8 tt0 -58.94 -41.23 86.89 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.304 -0.872 . . . . 0.0 110.143 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 36.6 t80 -69.58 -54.85 12.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.82 -24.95 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.958 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 m -97.61 -15.31 20.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 110.479 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.482 ' CE ' HG21 ' B' ' 8' ' ' THR . 5.8 ttp -74.59 -42.7 58.23 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.144 -0.972 . . . . 0.0 110.536 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.55 ' HE3' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -54.46 -15.37 1.65 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.326 -0.858 . . . . 0.0 110.85 -179.387 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.42 -12.84 18.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.049 -1.032 . . . . 0.0 111.278 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.9 -11.96 40.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.781 -1.199 . . . . 0.0 110.502 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.539 ' CB ' HG23 ' B' ' 8' ' ' THR . 17.7 mmtt . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 110.268 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.303 0.573 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.11 -27.7 62.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.891 . . . . 0.0 109.637 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.488 ' OE2' ' HB3' ' A' ' 75' ' ' LYS . 17.3 mt-10 -72.63 -42.43 64.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.827 . . . . 0.0 110.128 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.445 HG21 ' CD1' ' A' ' 141' ' ' PHE . 14.2 mt -68.69 -37.84 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.489 -0.884 . . . . 0.0 108.762 179.502 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -60.93 -27.34 68.15 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.034 178.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.444 ' HB3' HG22 ' B' ' 9' ' ' THR . 1.5 mt-10 -73.72 -54.48 7.99 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.536 -0.728 . . . . 0.0 109.146 179.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.75 -28.14 32.76 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.329 -0.857 . . . . 0.0 109.235 179.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -70.44 -46.04 64.65 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.373 -0.83 . . . . 0.0 109.514 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -28.83 65.71 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.513 -0.742 . . . . 0.0 109.621 179.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.43 ' CG1' HG23 ' A' ' 108' ' ' VAL . 15.5 t -73.75 -39.25 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.391 -0.818 . . . . 0.0 109.677 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.505 ' CE1' HD22 ' A' ' 105' ' ' LEU . 11.1 m-85 -72.78 -32.0 65.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.859 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -85.24 54.18 3.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.305 -0.872 . . . . 0.0 110.395 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.82 -28.12 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 30.8 p-10 -85.57 -43.81 13.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.186 -0.946 . . . . 0.0 110.354 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 89.75 22.75 35.35 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 33.4 p-10 -75.73 -33.84 60.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -1.132 . . . . 0.0 109.927 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 120.84 21.13 3.28 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 2.0 m-85 -164.44 130.04 2.85 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.182 -1.187 . . . . 0.0 110.263 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.513 HD11 HG22 ' A' ' 100' ' ' ILE . 29.0 mt -82.46 155.52 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.966 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -144.67 156.88 44.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.86 -38.03 21.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 0.0 110.2 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.47 -46.89 84.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 109.849 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 107' ' ' HIS . 40.3 mt-10 -57.3 -36.26 70.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 109.861 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.525 ' CD1' HD12 ' A' ' 125' ' ' ILE . 5.7 mt -61.8 -48.4 80.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.346 -0.846 . . . . 0.0 109.822 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.8 -35.63 61.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.417 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.438 ' CD2' ' N ' ' A' ' 107' ' ' HIS . 35.2 m170 -64.0 -45.22 89.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -0.799 . . . . 0.0 110.14 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.473 HG13 ' CE1' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -79.21 -23.67 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.72 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.522 ' HB3' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -68.01 -56.89 7.27 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 110.111 -179.971 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 7.3 m -60.93 -31.41 70.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.947 . . . . 0.0 109.691 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 38' ' ' SER . 7.1 m-20 -76.96 -4.7 45.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.856 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.511 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 7.0 mt -111.64 -44.68 3.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 110.374 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.96 -66.87 0.13 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.634 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 109' ' ' MET . 2.7 tt0 -103.25 166.94 10.14 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.171 -1.193 . . . . 0.0 111.137 -178.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.3 OUTLIER -124.47 16.79 8.93 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.733 0.777 . . . . 0.0 109.553 179.255 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' B' ' 19' ' ' LYS . 2.8 mp 43.62 -173.23 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.66 0.743 . . . . 0.0 111.169 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.76 -146.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.505 -0.747 . . . . 0.0 109.886 179.75 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -114.06 -70.22 0.81 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.156 -0.965 . . . . 0.0 110.517 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 120' ' ' GLU . 3.8 pt-20 -55.39 -29.23 58.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 109.743 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.477 ' OE2' ' HE2' ' B' ' 19' ' ' LYS . 6.2 mt-10 -71.73 -45.74 60.81 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 108.919 178.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 117' ' ' THR . 53.1 t -54.67 -45.71 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.491 -0.756 . . . . 0.0 109.629 179.184 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -60.37 -59.23 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 0.0 109.373 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 68.5 mm-40 -48.41 -38.66 20.17 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.393 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.482 ' HG3' ' HA ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -51.01 -56.1 14.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.252 -0.905 . . . . 0.0 109.462 179.503 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 105' ' ' LEU . 21.0 mm -56.35 -30.67 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.349 -0.844 . . . . 0.0 110.011 179.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 123' ' ' GLU . 5.7 ttt180 -64.99 -55.0 21.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.303 -0.873 . . . . 0.0 110.528 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 126' ' ' ARG . 2.6 tp10 -41.9 -42.89 2.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.305 -0.872 . . . . 0.0 110.371 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.21 -27.79 38.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.282 -0.886 . . . . 0.0 110.171 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -83.36 63.86 7.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.373 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 130' ' ' ILE . 5.7 mt -43.56 -40.07 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.747 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 21.2 p30 -67.34 -32.23 73.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.551 -0.718 . . . . 0.0 110.118 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.3 66.65 1.76 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.445 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 2.9 p-10 -115.43 -27.86 7.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -1.121 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.96 16.26 8.62 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.436 ' O ' ' OD2' ' A' ' 133' ' ' ASP . 11.7 pt20 -169.95 149.78 3.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -1.131 . . . . 0.0 110.174 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.5 HG11 ' N ' ' A' ' 137' ' ' ASN . 85.9 t -110.79 149.77 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 109.972 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.5 ' N ' HG11 ' A' ' 136' ' ' VAL . 25.3 p-10 -120.21 -157.93 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.419 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.414 ' O ' ' C ' ' A' ' 139' ' ' GLU . 11.1 t80 -70.88 -67.22 0.52 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.358 -0.839 . . . . 0.0 110.61 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 138' ' ' TYR . 4.7 mt-10 -41.65 -62.32 0.91 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.384 -0.822 . . . . 0.0 110.351 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.447 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 49.3 mt-10 -46.27 -60.29 2.4 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.21 -0.931 . . . . 0.0 110.009 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.445 ' CD1' HG21 ' A' ' 85' ' ' ILE . 24.4 t80 -42.04 -28.19 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.743 179.755 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 140' ' ' GLU . 38.2 t -100.87 -32.25 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.454 -0.779 . . . . 0.0 110.644 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.432 ' CD ' ' O ' ' A' ' 143' ' ' GLN . 4.7 tm0? -59.94 -18.43 45.16 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.147 -0.971 . . . . 0.0 110.404 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.3 mmm -112.58 -25.09 9.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 110.34 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.476 ' HE2' ' CB ' ' B' ' 24' ' ' ASN . 3.0 ttt -100.54 -9.34 22.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 111.118 -179.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 O-C-N 120.92 -1.112 . . . . 0.0 111.174 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.496 HD11 HG22 ' B' ' 4' ' ' ILE . 24.2 mm . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.533 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 39.6 Cg_endo -67.43 173.18 9.14 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.113 1.586 . . . . 0.0 111.037 -179.281 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.8 t -126.1 79.38 1.84 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.247 -0.908 . . . . 0.0 111.452 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.634 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 9.2 m95 53.99 -93.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.45 -0.781 . . . . 0.0 112.042 178.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.539 HG23 ' CB ' ' A' ' 75' ' ' LYS . 4.0 p -37.18 -29.17 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.266 -0.896 . . . . 0.0 110.517 -178.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.533 ' CG2' ' HB3' ' B' ' 5' ' ' PRO . 53.7 m -65.67 -51.29 60.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.189 -0.945 . . . . 0.0 109.697 178.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.568 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 2.7 m -63.19 -29.91 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.948 -1.095 . . . . 0.0 108.653 179.018 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.535 ' CD1' HG21 ' B' ' 10' ' ' VAL . 1.6 mp -72.34 -54.69 15.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.52 -0.737 . . . . 0.0 109.265 178.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' B' ' 11' ' ' ILE . 0.5 OUTLIER -42.23 -59.8 1.68 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.546 -0.721 . . . . 0.0 110.534 179.897 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.3 -50.15 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 110.403 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.452 ' HD3' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -56.12 -35.23 66.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.908 -1.12 . . . . 0.0 109.663 179.632 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 5.1 t -73.84 -19.9 60.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 109.866 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 1.7 tpt -75.2 -43.18 53.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' B' ' 19' ' ' LYS . 5.3 mp -53.31 -91.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.0 . . . . 0.0 109.699 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' B' ' 17' ' ' LEU . 5.7 ttt180 59.98 -69.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.401 0.619 . . . . 0.0 110.808 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.569 ' CD ' ' HB2' ' B' ' 20' ' ' ARG . 0.8 OUTLIER -176.2 -72.53 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.027 0 O-C-N 121.412 -0.805 . . . . 0.0 110.812 -179.619 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.569 ' HB2' ' CD ' ' B' ' 19' ' ' LYS . 2.2 ttt-85 -135.09 20.4 3.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.848 -1.157 . . . . 0.0 110.324 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.73 129.56 42.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.282 -0.886 . . . . 0.0 110.219 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 124' ' ' MET . 0.2 OUTLIER -130.67 -4.06 4.16 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.426 -0.796 . . . . 0.0 110.351 -179.8 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.52 -28.07 23.04 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.476 ' CB ' ' HE2' ' A' ' 145' ' ' MET . 0.1 OUTLIER 48.89 81.81 0.25 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.081 -1.246 . . . . 0.0 109.912 -179.825 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.96 -34.94 9.85 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.901 1.474 . . . . 0.0 110.64 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.55 ' CZ ' ' HE3' ' A' ' 72' ' ' MET . 1.1 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.198 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.335 0.588 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.8 mt -53.22 -27.73 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.343 -0.848 . . . . 0.0 109.759 179.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -57.4 -64.03 1.03 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.54 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -48.39 -44.42 34.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -67.2 -50.0 62.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.384 -0.822 . . . . 0.0 109.737 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -55.89 -44.0 77.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.854 179.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 41.2 mt-10 -55.38 -43.47 75.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.762 179.538 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -72.1 -50.35 28.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.401 -0.812 . . . . 0.0 109.965 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.576 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 11.2 t80 -54.29 -47.81 71.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 109.918 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -68.05 -27.77 66.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.882 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 10.2 tt -61.41 -37.97 85.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.394 -0.816 . . . . 0.0 110.085 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -80.75 -30.03 36.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 110.106 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.44 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 13.7 t0 -84.73 84.25 7.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 110.49 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -73.12 -40.05 65.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.21 -0.931 . . . . 0.0 110.032 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -71.09 -33.86 70.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.086 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 65.17 1.23 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.44 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 57.7 p30 -128.62 6.59 5.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -1.159 . . . . 0.0 110.154 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.66 13.48 51.39 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 59.5 p -136.87 115.44 11.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.276 -1.132 . . . . 0.0 110.251 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.44 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 5.1 mt -88.9 124.01 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.203 -0.936 . . . . 0.0 110.355 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.4 p -99.67 172.02 7.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.332 -0.855 . . . . 0.0 110.284 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 p -56.95 -30.06 63.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.937 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -66.83 -60.44 2.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.232 -0.918 . . . . 0.0 110.05 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -52.16 -55.65 19.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 110.024 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.453 HD12 ' CZ2' ' B' ' 7' ' ' TRP . 27.0 tp -59.51 -37.6 78.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.05 -37.19 64.19 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.9 m -61.36 -55.36 32.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -1.136 . . . . 0.0 109.942 179.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.7 -46.88 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 109.643 179.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.531 ' CE ' ' HE2' ' A' ' 51' ' ' MET . 0.9 OUTLIER -58.63 -41.82 86.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.693 179.506 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -28.78 66.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 109.924 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -55.73 3.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.337 -0.852 . . . . 0.0 110.272 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mt -44.88 -28.18 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.129 -0.982 . . . . 0.0 110.063 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 115.98 49.89 0.45 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.481 ' NE2' ' CG ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -147.44 -174.53 4.55 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.211 -1.17 . . . . 0.0 110.359 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -161.89 84.12 1.69 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.325 -0.859 . . . . 0.0 110.256 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.402 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 46.9 Cg_endo -73.19 100.67 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.042 1.548 . . . . 0.0 110.169 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.457 HG23 ' HB2' ' A' ' 47' ' ' GLU . 5.0 t -57.07 162.39 2.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.085 -1.009 . . . . 0.0 110.239 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' ALA . 2.3 mt-10 -42.98 -65.37 0.49 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 110.269 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -40.45 -51.84 2.83 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 110.227 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HB2' HG23 ' A' ' 44' ' ' THR . 5.9 mm-40 -63.85 -56.49 14.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.026 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' GLU . 5.2 mt -42.32 -42.8 3.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -0.832 . . . . 0.0 110.18 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -66.95 -41.1 87.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 0.0 110.079 179.77 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -27.42 65.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.402 -0.811 . . . . 0.0 110.186 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.531 ' HE2' ' CE ' ' A' ' 36' ' ' MET . 0.9 OUTLIER -82.54 -33.63 28.11 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.927 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 52' ' ' ILE . 4.8 mm -80.35 -31.08 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -76.82 -13.71 59.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 110.233 179.937 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -73.42 -60.99 1.99 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 0.0 110.106 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 13.8 t -69.19 -25.41 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.108 -0.995 . . . . 0.0 109.808 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -49.23 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.368 -0.832 . . . . 0.0 109.98 179.787 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -70.56 -66.88 0.55 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.41 -0.806 . . . . 0.0 110.587 -179.521 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.7 p-10 -58.35 -35.75 72.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -0.924 . . . . 0.0 110.423 -179.582 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 92.0 45.83 3.78 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 15.7 p-10 -96.48 -34.23 11.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -1.17 . . . . 0.0 110.157 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.35 -2.36 5.4 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.5 165.37 27.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -1.213 . . . . 0.0 110.15 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.527 HD11 HG22 ' A' ' 63' ' ' ILE . 34.9 mm -87.07 142.75 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.076 179.864 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.506 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.1 m-20 -130.52 153.15 49.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.922 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.576 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 34.1 t80 -39.38 -51.08 4.77 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.549 -0.72 . . . . 0.0 112.344 -179.088 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.2 Cg_endo -64.9 -27.44 58.77 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.22 1.116 . . . . 0.0 111.265 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HG3' ' CB ' ' A' ' 64' ' ' ASP . 7.3 mt-10 -73.02 -39.92 65.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.832 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -63.54 -50.86 67.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 110.303 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.81 -37.26 78.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -0.874 . . . . 0.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 7.8 m -76.91 -14.59 59.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.285 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 37.0 ttp -79.27 -58.51 3.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.199 -0.938 . . . . 0.0 110.133 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.4 tpt -53.17 -16.09 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.409 -0.807 . . . . 0.0 111.013 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.92 -45.8 8.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.878 -1.139 . . . . 0.0 110.579 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -80.7 -10.07 59.75 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.158 -0.964 . . . . 0.0 110.75 -179.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.077 -1.014 . . . . 0.0 110.427 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.068 0.461 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.73 -40.98 88.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.645 179.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 7.3 pt-20 -54.41 -23.6 16.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.992 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.459 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 51.8 mt -80.16 -61.42 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.9 . . . . 0.0 109.606 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 85' ' ' ILE . 0.4 OUTLIER -42.57 -30.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.583 -0.698 . . . . 0.0 109.524 179.549 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.531 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 4.4 mm-40 -71.91 -60.6 2.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.408 -0.808 . . . . 0.0 109.264 179.029 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.65 -28.99 6.52 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.149 179.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -70.47 -47.71 59.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 109.758 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -35.19 51.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.755 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.485 ' CG1' HG12 ' B' ' 13' ' ' VAL . 10.6 t -67.68 -45.17 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.652 179.592 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.566 ' CE2' HD23 ' A' ' 105' ' ' LEU . 5.1 m-85 -58.78 -36.76 74.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.975 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -98.8 60.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 110.161 179.831 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -42.78 -32.88 0.66 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.309 -0.87 . . . . 0.0 110.073 179.939 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.2 p30 -77.19 -31.77 55.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.415 -0.803 . . . . 0.0 109.899 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 71.95 51.35 14.99 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.1 p-10 -97.67 -33.48 11.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -1.219 . . . . 0.0 110.014 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 131.51 0.49 4.92 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.585 ' CE2' ' OD1' ' A' ' 137' ' ' ASN . 65.1 m-85 -147.95 149.05 31.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.246 . . . . 0.0 110.595 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.509 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 45.0 mt -104.44 149.28 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.117 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.458 ' N ' HG21 ' A' ' 100' ' ' ILE . 0.6 OUTLIER -139.91 160.46 39.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.016 179.73 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.35 -38.42 58.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.28 -38.73 92.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.109 -0.994 . . . . 0.0 109.811 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -63.81 -47.66 79.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.286 -0.884 . . . . 0.0 109.862 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.599 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 0.7 OUTLIER -58.9 -34.55 71.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.322 -0.862 . . . . 0.0 109.517 179.552 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 109' ' ' MET . 16.9 ttp85 -59.42 -41.52 89.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.278 -0.889 . . . . 0.0 109.151 179.187 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -54.16 40.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.47 -0.769 . . . . 0.0 109.559 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 2.5 t -51.66 -37.02 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.21 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.527 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 21.0 mtt -58.72 -62.83 1.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.34 -0.85 . . . . 0.0 109.907 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 m -58.85 -31.36 68.46 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.574 179.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -76.53 -17.5 59.21 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.328 179.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 7.0 mt -100.05 -47.68 4.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.845 . . . . 0.0 110.24 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.21 -28.52 1.23 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.791 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.553 ' HG2' ' CD1' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -109.28 134.86 51.25 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.798 -1.413 . . . . 0.0 111.248 -179.325 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 116' ' ' LEU . 6.8 tttt -117.09 78.5 1.22 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.077 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.554 ' CD1' ' O ' ' B' ' 17' ' ' LEU . 7.0 mp -40.69 164.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.612 0.72 . . . . 0.0 111.13 -179.062 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.06 -149.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.581 -0.699 . . . . 0.0 109.712 179.456 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -111.51 -70.33 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 110.144 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 23.4 pt-20 -47.54 -40.1 18.06 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.551 179.802 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 18.8 mt-10 -61.28 -55.6 30.04 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.338 -0.851 . . . . 0.0 109.148 179.027 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.462 HG23 ' HE2' ' A' ' 109' ' ' MET . 73.0 t -50.05 -47.25 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.35 -0.844 . . . . 0.0 109.737 179.266 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.71 -50.19 70.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 109.631 179.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -34.55 68.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.462 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.452 ' HE1' ' CD1' ' B' ' 22' ' ' PHE . 6.5 ttt -56.93 -54.77 42.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.472 -0.767 . . . . 0.0 109.987 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.599 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 33.0 mm -57.64 -43.13 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 109.972 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -50.7 67.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.113 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -48.61 -38.74 21.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.383 -0.823 . . . . 0.0 110.16 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.24 -24.17 37.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.395 -0.816 . . . . 0.0 110.136 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.467 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -67.66 73.93 0.17 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.3 -0.875 . . . . 0.0 110.34 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 mp -53.85 -45.21 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.245 -0.909 . . . . 0.0 110.275 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.464 ' OD2' ' OD2' ' A' ' 133' ' ' ASP . 2.4 p30 -77.38 -36.55 53.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.35 65.03 1.11 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.464 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 2.0 p30 -112.11 -28.75 7.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -1.13 . . . . 0.0 110.263 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 118.07 -6.11 15.41 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 100' ' ' ILE . 15.6 mp0 -144.52 169.88 17.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -1.133 . . . . 0.0 109.958 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.432 HG11 ' HB3' ' A' ' 140' ' ' GLU . 69.2 t -121.44 104.92 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.948 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.585 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 8.2 t30 -79.01 167.08 21.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -0.915 . . . . 0.0 110.386 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 139' ' ' GLU . 28.1 t80 -47.33 -58.82 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.334 -0.853 . . . . 0.0 110.058 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 138' ' ' TYR . 45.6 mm-40 -44.44 -42.25 6.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 109.669 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.467 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 4.5 tt0 -68.05 -54.3 19.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.813 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -45.8 -25.66 0.54 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' HG21 ' A' ' 146' ' ' THR . 12.0 t -93.69 -30.5 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 0.0 109.836 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -58.49 -38.61 78.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.065 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.485 ' SD ' ' OD1' ' B' ' 24' ' ' ASN . 1.9 mmm -64.03 -55.17 24.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 0.0 109.917 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.496 ' HA ' ' HA ' ' B' ' 24' ' ' ASN . 6.1 ttm -67.44 -21.94 65.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 146' ' ' THR . 3.8 t . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 110.298 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.484 HG22 ' HD2' ' B' ' 5' ' ' PRO . 6.1 mt . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 120.772 0.32 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' B' ' 4' ' ' ILE . 40.2 Cg_endo -69.76 129.04 16.9 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.665 1.35 . . . . 0.0 111.085 -179.064 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.543 ' O ' ' N ' ' B' ' 8' ' ' THR . 3.8 m -86.83 95.96 10.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.494 -0.754 . . . . 0.0 110.813 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.51 ' NE1' HG22 ' A' ' 55' ' ' VAL . 13.9 m95 33.92 -87.82 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.805 -0.559 . . . . 0.0 111.92 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.543 ' N ' ' O ' ' B' ' 6' ' ' SER . 1.3 p -35.38 -38.76 0.11 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.51 -0.744 . . . . 0.0 111.011 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.531 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 4.3 m -57.65 -42.21 83.02 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.571 -0.851 . . . . 0.0 109.736 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' B' ' 7' ' ' TRP . 13.3 t -68.31 -36.6 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.418 -0.801 . . . . 0.0 109.698 179.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.505 HD12 ' N ' ' B' ' 11' ' ' ILE . 2.7 mm -70.0 -19.41 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.359 -0.838 . . . . 0.0 109.442 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.441 ' O ' ' SD ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.5 -57.43 3.94 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.715 0.769 . . . . 0.0 109.527 179.282 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.485 HG12 ' CG1' ' A' ' 91' ' ' VAL . 43.2 t -62.8 -34.36 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.0 110.76 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.432 ' C ' ' HD3' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -69.7 -34.86 74.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.987 . . . . 0.0 110.304 -179.835 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 58.5 m -71.96 -25.8 62.01 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' B' ' 22' ' ' PHE . 0.2 OUTLIER -76.07 -37.49 58.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.305 -0.872 . . . . 0.0 110.828 -179.823 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.554 ' O ' ' CD1' ' A' ' 116' ' ' LEU . 4.4 mp -51.53 -19.54 1.51 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.94 -1.1 . . . . 0.0 110.509 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' B' ' 17' ' ' LEU . 0.3 OUTLIER -21.57 -72.0 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 CA-C-O 121.087 0.47 . . . . 0.0 112.127 -179.446 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.519 ' CA ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -154.08 -114.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 110.136 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.494 ' NH2' ' OE2' ' A' ' 120' ' ' GLU . 1.6 mtm180 -101.25 21.27 14.3 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.901 -1.124 . . . . 0.0 110.087 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 13.7 m -120.75 142.74 49.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.522 ' O ' ' CG ' ' B' ' 16' ' ' MET . 1.2 m-85 -88.96 -63.96 1.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.452 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.58 108.71 0.72 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.535 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 5.6 m-80 -100.58 -42.03 0.22 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.221 -1.164 . . . . 0.0 111.943 -179.342 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 47.7 Cg_endo -81.78 10.81 3.33 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.089 1.047 . . . . 0.0 110.909 -179.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 109.961 179.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.248 0.547 . . . . 0.0 110.274 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.78 -48.38 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.985 . . . . 0.0 109.982 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.77 -36.77 62.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.802 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 19.4 mt-10 -60.74 -54.05 49.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 109.619 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -59.67 -43.06 94.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.83 . . . . 0.0 109.706 179.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -36.1 77.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.808 179.642 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -65.2 -42.04 93.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.329 -0.857 . . . . 0.0 109.769 179.573 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.22 -45.18 77.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.415 -0.803 . . . . 0.0 110.002 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.635 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 34.0 t80 -61.29 -29.74 70.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.0 109.813 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 m -83.95 -22.8 31.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.402 -0.811 . . . . 0.0 109.773 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 4.1 tt -71.3 -36.06 71.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.962 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -82.94 -46.05 13.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.234 -0.916 . . . . 0.0 110.053 179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.461 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 17.1 t0 -72.61 101.33 3.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.0 110.215 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.92 -52.34 9.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.139 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -53.43 -51.04 63.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.345 -0.847 . . . . 0.0 110.166 179.905 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.07 22.86 6.67 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 46.6 p-10 -79.83 -21.95 43.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -1.192 . . . . 0.0 110.107 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 97.18 33.2 6.07 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.455 ' CG2' ' C ' ' A' ' 25' ' ' GLY . 44.2 p -153.09 132.48 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.341 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.539 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 6.0 mt -101.06 112.63 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 109.937 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 29' ' ' THR . 51.8 p -97.98 156.92 16.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 110.169 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 28' ' ' THR . 1.9 p -44.53 -27.27 0.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.178 -0.952 . . . . 0.0 109.872 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -55.28 9.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 110.033 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' A' ' 34' ' ' THR . 39.5 mt-10 -57.15 -56.09 26.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.93 . . . . 0.0 110.063 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.458 HD23 HD11 ' A' ' 52' ' ' ILE . 10.4 tp -57.65 -48.66 78.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 109.937 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -51.78 -39.6 47.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.825 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 52.6 m -59.43 -61.07 2.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -1.175 . . . . 0.0 109.715 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 34' ' ' THR . 13.8 t -45.25 -55.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.459 ' HE2' ' CE ' ' A' ' 51' ' ' MET . 0.1 OUTLIER -57.51 -26.96 62.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.809 179.559 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.0 ttm180 -74.23 -19.49 60.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.479 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 19.2 m -96.37 -38.11 10.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.275 -0.891 . . . . 0.0 110.625 -179.704 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 mt -45.67 -29.16 1.16 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.01 -1.056 . . . . 0.0 110.067 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 41' ' ' GLN . . . 125.17 58.63 0.17 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 2.2 mt-30 170.04 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.197 -1.178 . . . . 0.0 110.498 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.54 102.09 3.49 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.276 -0.89 . . . . 0.0 110.349 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.402 ' HG2' HD13 ' A' ' 48' ' ' LEU . 45.1 Cg_endo -73.18 135.77 23.34 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.093 1.575 . . . . 0.0 110.335 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 13.7 t -71.99 -161.93 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.206 -0.934 . . . . 0.0 110.224 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -84.18 -56.38 3.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.019 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.38 -51.22 11.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.016 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.37 -52.35 65.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.865 . . . . 0.0 109.99 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.7 OUTLIER -55.56 -48.69 74.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.342 -0.848 . . . . 0.0 110.23 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -62.21 -32.82 73.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.103 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -32.59 70.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.364 -0.835 . . . . 0.0 110.093 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.459 ' CE ' ' HE2' ' A' ' 36' ' ' MET . 3.1 mtp -78.02 -43.85 28.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.433 -0.792 . . . . 0.0 110.438 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.458 HD11 HD23 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -70.43 -33.82 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.212 -0.93 . . . . 0.0 109.921 -179.993 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.2 m-80 -60.62 -25.87 66.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.486 -0.759 . . . . 0.0 110.743 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -77.92 -47.05 19.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 0.0 110.579 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.588 HG23 ' CE2' ' B' ' 7' ' ' TRP . 19.2 t -71.28 -40.36 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.185 -0.947 . . . . 0.0 110.091 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -63.46 71.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.841 -179.975 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -37.94 -63.25 0.49 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.674 -0.641 . . . . 0.0 110.529 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 3.5 p30 -56.75 -38.85 73.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.102 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.98 48.72 4.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.529 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 16.7 p-10 -98.32 -40.39 8.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -1.182 . . . . 0.0 110.115 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 133.73 21.75 0.79 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.692 179.36 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.529 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 36.3 p -158.06 145.63 18.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.922 -1.34 . . . . 0.0 110.405 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.539 ' CG1' ' HB ' ' A' ' 27' ' ' ILE . 10.8 mm -89.42 144.96 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.349 -0.844 . . . . 0.0 109.803 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -120.59 147.31 45.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.128 -0.982 . . . . 0.0 110.754 -179.578 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.635 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 11.8 t80 -43.85 -49.52 20.5 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.372 -0.83 . . . . 0.0 111.098 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.8 Cg_endo -68.7 -32.49 23.62 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.281 1.148 . . . . 0.0 110.539 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -65.51 -30.17 70.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -76.96 -51.18 11.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.885 . . . . 0.0 110.236 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mp -53.62 -32.38 51.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.376 -0.827 . . . . 0.0 110.214 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.8 m -78.03 -38.34 44.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 110.563 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -67.19 0.45 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.196 -0.94 . . . . 0.0 110.533 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.45 ' SD ' HG23 ' B' ' 11' ' ' ILE . 6.8 tpt -50.5 -19.87 0.99 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.353 -0.842 . . . . 0.0 110.665 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.86 -29.14 39.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.134 -0.979 . . . . 0.0 110.648 -179.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -93.68 -15.17 25.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.491 ' HB3' HG23 ' B' ' 8' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.215 0.531 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -75.5 -46.38 32.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.981 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HG2' ' N ' ' A' ' 85' ' ' ILE . 10.2 pm0 -55.59 -23.37 26.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 110.26 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.535 ' N ' ' HG2' ' A' ' 84' ' ' GLU . 24.3 mt -84.22 -46.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 109.203 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -34.29 69.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.459 -0.776 . . . . 0.0 109.216 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 32.0 mt-10 -72.38 -48.77 38.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.223 178.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.54 -35.14 67.77 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.426 -0.797 . . . . 0.0 109.073 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.22 -39.45 78.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.368 -0.833 . . . . 0.0 108.825 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -58.67 -29.89 66.95 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.202 179.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.9 -50.47 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.485 -0.76 . . . . 0.0 109.555 179.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 61.2 m-85 -62.43 -38.49 89.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.26 55.84 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.995 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -56.2 -48.9 75.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.094 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 15.9 p-10 -57.6 -34.55 69.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 110.323 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 74.41 49.02 12.52 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.437 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 27.0 p-10 -98.28 -22.91 15.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -1.103 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.58 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 113.7 6.79 20.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.582 ' CB ' ' NE2' ' A' ' 135' ' ' GLN . 73.0 m-85 -157.71 134.98 10.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.248 -1.148 . . . . 0.0 109.841 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 100' ' ' ILE . 24.9 mt -84.49 155.62 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.1 -1.0 . . . . 0.0 110.541 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 103' ' ' ALA . 4.0 t -139.22 140.56 37.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.454 -0.778 . . . . 0.0 109.72 179.691 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.15 -27.44 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.235 -0.916 . . . . 0.0 110.375 -179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -65.59 -55.58 16.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.674 179.492 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 38.1 mt-10 -55.08 -44.68 75.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.998 179.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.522 ' CD1' HD12 ' A' ' 125' ' ' ILE . 1.1 mt -57.37 -44.93 84.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.9 . . . . 0.0 109.655 179.733 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.475 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.2 OUTLIER -55.94 -38.29 70.11 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.053 -1.029 . . . . 0.0 109.286 179.273 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -32.24 73.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.629 -0.669 . . . . 0.0 109.539 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 26.1 t -81.15 -52.56 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.475 -0.765 . . . . 0.0 110.672 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.528 ' HG3' ' N ' ' A' ' 110' ' ' THR . 11.9 ptp -58.59 -38.6 78.28 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.981 . . . . 0.0 110.389 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.528 ' N ' ' HG3' ' A' ' 109' ' ' MET . 27.1 m -71.15 -40.09 71.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.881 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 38' ' ' SER . 36.5 m-80 -80.07 -4.45 52.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.787 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 5.8 mt -98.23 -30.48 12.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 0.0 109.923 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.38 -53.11 0.59 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 109' ' ' MET . 22.7 tt0 -108.12 143.49 36.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -1.107 . . . . 0.0 110.173 -179.876 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.6 OUTLIER -120.64 18.72 11.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.945 . . . . 0.0 109.643 179.614 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' B' ' 19' ' ' LYS . 3.4 mp 40.11 -164.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.613 0.72 . . . . 0.0 110.656 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.448 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -100.19 -172.87 2.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.462 -0.774 . . . . 0.0 109.269 179.496 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.3 -50.02 8.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 0.0 109.908 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -64.7 -32.83 74.68 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 179.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' B' ' 20' ' ' ARG . 4.8 mt-10 -69.05 -50.72 45.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.359 -0.838 . . . . 0.0 109.236 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 117' ' ' THR . 15.4 t -60.22 -42.06 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.805 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -66.14 -49.98 65.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 179.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -56.11 -25.47 45.99 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.449 -0.782 . . . . 0.0 109.139 179.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.609 ' CE ' ' CD1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.65 -57.57 6.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.567 -0.708 . . . . 0.0 109.854 179.546 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.522 HD12 ' CD1' ' A' ' 105' ' ' LEU . 24.6 mm -64.31 -24.32 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.389 -0.819 . . . . 0.0 110.003 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -76.05 -51.61 11.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.955 . . . . 0.0 110.021 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -12.39 42.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.334 -0.854 . . . . 0.0 110.053 179.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -98.4 -33.25 11.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.53 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.892 . . . . 0.0 110.121 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 130' ' ' ILE . 10.3 mt -72.74 -27.64 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p-10 -96.58 -28.12 14.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 0.0 110.296 -179.892 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.38 75.57 1.14 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 21.1 p-10 -128.1 -18.09 4.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.256 -1.144 . . . . 0.0 110.551 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.64 10.04 36.48 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.582 ' NE2' ' CB ' ' A' ' 99' ' ' TYR . 1.9 pt20 -168.94 170.27 9.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.361 -1.082 . . . . 0.0 109.484 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 35.3 t -114.87 151.95 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.943 -1.098 . . . . 0.0 110.85 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 12.6 t30 -116.77 -169.6 1.67 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.513 -0.742 . . . . 0.0 109.506 179.668 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.554 ' CE1' HG22 ' A' ' 142' ' ' VAL . 8.5 t80 -67.83 -52.83 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.931 -1.105 . . . . 0.0 110.061 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -46.17 -67.46 0.28 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.319 -0.863 . . . . 0.0 110.188 179.964 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' PHE . 4.8 tt0 -43.87 -59.39 2.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 109.766 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.568 ' CE1' ' HE1' ' B' ' 16' ' ' MET . 42.9 t80 -43.48 -26.05 0.19 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.831 179.415 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.554 HG22 ' CE1' ' A' ' 138' ' ' TYR . 68.8 t -98.93 -30.77 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.369 -0.832 . . . . 0.0 110.639 -179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -65.65 -40.71 92.75 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.097 -1.002 . . . . 0.0 110.584 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -36.56 68.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.219 -0.926 . . . . 0.0 110.559 -179.708 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.56 ' CE ' ' HB2' ' B' ' 24' ' ' ASN . 3.7 mtt -85.0 -26.06 27.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.48 ' O ' ' CG2' ' A' ' 146' ' ' THR . 9.6 t . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.128 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 6.7 mm . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.04 0.448 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.68 139.07 36.25 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.543 1.286 . . . . 0.0 110.591 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.486 ' O ' ' CG2' ' B' ' 10' ' ' VAL . 40.9 t -73.11 -159.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.845 . . . . 0.0 110.724 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.588 ' CE2' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -82.3 -82.29 0.14 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.553 -0.717 . . . . 0.0 110.724 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 75' ' ' LYS . 23.9 p -40.09 -34.99 0.34 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.622 -0.674 . . . . 0.0 110.42 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.42 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 40.1 m -59.85 -53.41 58.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 109.3 179.27 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' B' ' 6' ' ' SER . 61.9 t -50.51 -41.85 20.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.301 -0.875 . . . . 0.0 109.124 178.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.478 HD11 ' O ' ' B' ' 7' ' ' TRP . 2.8 mp -61.95 -59.59 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.561 -0.712 . . . . 0.0 110.103 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.444 ' CD2' ' CE2' ' B' ' 26' ' ' PHE . 3.2 mm? -39.94 -50.64 2.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.497 -0.752 . . . . 0.0 110.992 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.497 ' O ' HD12 ' B' ' 17' ' ' LEU . 94.8 t -56.65 -51.98 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.111 -0.993 . . . . 0.0 110.531 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.479 ' HA ' HD11 ' A' ' 112' ' ' LEU . 19.3 tptt -56.02 -49.99 72.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.86 -1.15 . . . . 0.0 109.762 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.446 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.6 OUTLIER -68.74 -6.47 26.64 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 179.045 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.572 ' HE2' ' CE2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -80.13 -45.2 18.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.362 -0.836 . . . . 0.0 110.548 -179.861 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.548 ' HA ' ' HE2' ' A' ' 124' ' ' MET . 0.0 OUTLIER -100.31 32.6 2.96 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 118.515 -1.274 . . . . 0.0 110.529 179.36 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.497 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 57.0 ttt180 -44.28 -58.95 2.61 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.56 -0.713 . . . . 0.0 109.859 179.3 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.528 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -144.59 -118.09 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.221 -0.924 . . . . 0.0 110.007 179.578 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 120' ' ' GLU . 25.5 mtp180 -97.03 25.27 5.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.884 -1.135 . . . . 0.0 109.957 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.45 ' O ' ' HE1' ' A' ' 124' ' ' MET . 0.6 OUTLIER -113.04 152.97 28.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.667 -179.352 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.609 ' CD1' ' CE ' ' A' ' 124' ' ' MET . 1.2 t80 -124.13 -25.64 4.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.875 . . . . 0.0 110.317 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.87 109.84 3.9 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.56 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 1.5 m-80 -81.57 156.18 70.84 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -1.178 . . . . 0.0 109.88 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' B' ' 26' ' ' PHE . 43.3 Cg_endo -74.72 -68.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.857 1.451 . . . . 0.0 110.432 -179.804 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.491 ' CD1' ' HB3' ' B' ' 24' ' ' ASN . 15.5 m-85 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.396 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.238 0.542 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.2 mt -49.91 -48.36 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.662 179.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.7 -48.75 66.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.331 -0.856 . . . . 0.0 109.565 179.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -55.12 -52.22 63.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.612 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.415 ' HB3' HD13 ' A' ' 69' ' ' LEU . 55.1 m-85 -57.75 -45.38 85.94 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.321 -0.862 . . . . 0.0 109.427 179.467 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -33.67 57.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 109.247 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.7 -47.82 79.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.535 -0.728 . . . . 0.0 109.661 179.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -62.46 -44.32 96.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -0.85 . . . . 0.0 109.543 179.485 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.6 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 23.9 t80 -63.74 -35.59 81.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.378 -0.826 . . . . 0.0 109.708 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.2 m -78.1 -20.64 51.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -0.842 . . . . 0.0 109.854 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -69.5 -46.95 65.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.43 -0.794 . . . . 0.0 109.789 179.799 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 21' ' ' LYS . 75.5 m-85 -69.57 -59.31 3.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 109.939 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.46 91.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.343 -0.848 . . . . 0.0 110.247 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 19' ' ' PHE . 4.0 mmtp -77.49 -26.57 51.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.129 -0.982 . . . . 0.0 110.22 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.7 p-10 -97.73 -20.72 17.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.275 -0.89 . . . . 0.0 110.326 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.61 78.79 0.92 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 45.2 p-10 -139.39 8.47 2.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -1.151 . . . . 0.0 110.061 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.444 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 65.34 35.01 90.95 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -163.85 119.31 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.236 -1.155 . . . . 0.0 110.444 -179.903 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 27' ' ' ILE . 13.3 mt -83.18 134.4 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.086 -1.009 . . . . 0.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 20.1 p -98.82 179.98 4.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' HD12 ' A' ' 48' ' ' LEU . 1.2 p -70.89 -53.27 15.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -61.39 -48.8 79.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.217 -0.927 . . . . 0.0 110.455 -179.948 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OG1' ' A' ' 28' ' ' THR . 23.3 mt-10 -41.92 -69.81 0.12 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.208 -0.932 . . . . 0.0 109.947 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.435 HD12 ' CE1' ' A' ' 19' ' ' PHE . 22.5 tp -49.55 -32.43 12.5 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.125 -0.984 . . . . 0.0 109.07 179.386 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.74 95.04 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.769 -1.733 . . . . 0.0 108.769 179.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.1 m -54.76 -44.54 73.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.293 -1.122 . . . . 0.0 109.111 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.8 t -64.31 -44.72 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.446 -0.784 . . . . 0.0 109.398 179.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.411 ' HA ' HD13 ' A' ' 39' ' ' LEU . 2.0 mmt -62.28 -34.89 77.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.315 -0.866 . . . . 0.0 109.663 179.369 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -34.31 77.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.501 179.386 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -26.58 54.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.577 -0.702 . . . . 0.0 110.386 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 36' ' ' MET . 4.7 mt -69.77 -32.44 70.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.131 -0.98 . . . . 0.0 109.985 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.06 -46.98 0.7 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.382 179.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.56 -176.46 6.26 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.1 -1.235 . . . . 0.0 111.242 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 8.1 p30 -144.82 105.07 4.52 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.538 -0.726 . . . . 0.0 109.446 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.551 ' HA ' ' CD1' ' B' ' 4' ' ' ILE . 44.0 Cg_endo -72.23 151.49 54.81 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 O-C-N 124.054 1.555 . . . . 0.0 111.046 -179.304 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 56.2 m -98.16 174.62 6.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.909 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -41.83 61.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.118 -0.989 . . . . 0.0 110.451 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.17 -48.82 74.51 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.066 -1.021 . . . . 0.0 110.281 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -64.45 -49.35 71.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.348 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.489 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 6.3 mt -52.34 -49.66 63.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.965 . . . . 0.0 110.109 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -54.73 -41.44 70.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 109.669 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.84 -25.54 62.88 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.315 -0.865 . . . . 0.0 109.464 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.541 ' HE2' ' CG ' ' B' ' 7' ' ' TRP . 0.4 OUTLIER -73.63 -40.92 63.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.894 179.678 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -28.5 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.293 -0.879 . . . . 0.0 109.478 179.733 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.71 -14.15 12.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.314 -0.866 . . . . 0.0 110.113 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -85.8 -49.27 8.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 111.069 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 21.7 t -69.1 -47.5 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.877 -1.14 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -45.89 89.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.388 0.613 . . . . 0.0 110.329 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -98.0 -9.07 26.7 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.186 -0.946 . . . . 0.0 110.59 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 5.7 p30 -100.65 -32.67 10.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.961 -1.087 . . . . 0.0 110.791 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 103.57 45.91 1.48 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 23.1 m120 -100.03 -19.82 16.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.119 -1.224 . . . . 0.0 110.037 179.833 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.89 -11.68 70.55 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.99 170.09 17.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.106 . . . . 0.0 110.109 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.2 mm -89.9 124.85 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.423 -0.798 . . . . 0.0 110.493 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.535 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 4.5 m-20 -97.07 -177.43 3.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.274 -0.892 . . . . 0.0 110.639 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.6 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 17.9 t80 -68.5 -48.37 33.7 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.392 -0.817 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.9 Cg_endo -67.69 -32.58 30.04 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 O-C-N 123.294 1.155 . . . . 0.0 110.006 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE2' ' OD1' ' A' ' 64' ' ' ASP . 6.9 mt-10 -63.34 -36.65 84.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.187 -0.946 . . . . 0.0 109.105 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE1' HG22 ' B' ' 11' ' ' ILE . 5.5 t80 -64.48 -58.24 6.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.779 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.415 HD13 ' HB3' ' A' ' 12' ' ' PHE . 2.0 mp -58.01 -30.53 66.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.329 -0.857 . . . . 0.0 110.199 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.437 ' O ' HG21 ' A' ' 70' ' ' THR . 39.9 m -84.29 -21.9 30.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.182 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.474 ' HG3' HG12 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -69.45 -45.8 68.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 0.0 109.929 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.575 ' HE1' ' CE1' ' B' ' 26' ' ' PHE . 93.3 mmm -57.29 -15.0 5.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 110.222 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.26 -20.57 14.07 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.153 -0.967 . . . . 0.0 110.572 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 -27.01 20.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.026 . . . . 0.0 110.191 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.1 tptt . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.33 -179.939 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.209 0.528 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -77.38 -40.5 43.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.197 -0.94 . . . . 0.0 110.559 -179.658 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.81 -22.58 64.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 110.633 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.415 HG23 ' CG2' ' A' ' 142' ' ' VAL . 90.3 mt -76.62 -31.42 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.064 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -65.88 -37.25 85.64 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.346 -0.846 . . . . 0.0 109.651 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.536 ' CB ' HG22 ' B' ' 9' ' ' THR . 4.9 mt-10 -68.7 -52.58 29.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 179.356 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 141' ' ' PHE . . . -55.64 -29.86 59.96 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.402 -0.811 . . . . 0.0 109.649 179.63 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -69.08 -44.37 72.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 109.333 179.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -37.99 54.24 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 109.191 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 108' ' ' VAL . 54.9 t -63.48 -51.6 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.679 . . . . 0.0 109.995 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 105' ' ' LEU . 20.1 m-85 -62.29 -34.9 77.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.168 -0.958 . . . . 0.0 109.995 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -100.46 67.32 1.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.801 . . . . 0.0 109.931 179.835 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 93' ' ' ASP . 3.0 tttp -37.45 -36.87 0.17 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.66 -0.65 . . . . 0.0 110.568 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.9 p30 -83.43 -31.78 26.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.291 -0.881 . . . . 0.0 110.088 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 75.47 33.77 51.89 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 31.4 p-10 -84.73 -31.59 23.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -1.179 . . . . 0.0 110.322 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 117.24 43.55 0.6 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 1.2 m-85 -169.4 124.26 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -1.083 . . . . 0.0 109.959 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 38.1 mt -110.4 116.29 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.585 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -106.02 148.61 27.53 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 109.547 179.237 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -37.9 -34.46 0.11 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.443 -0.786 . . . . 0.0 110.516 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -63.02 -50.41 70.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 0.0 109.487 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 25.1 mt-10 -55.47 -47.65 75.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.599 179.504 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.578 HD22 ' CE2' ' A' ' 92' ' ' PHE . 2.4 mt -51.11 -41.77 60.25 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.267 -0.896 . . . . 0.0 109.267 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.487 ' HG2' HG22 ' A' ' 121' ' ' VAL . 1.1 mmm180 -60.43 -34.37 73.87 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.464 -0.772 . . . . 0.0 109.916 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 8.8 m170 -69.98 -22.25 63.16 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 92' ' ' PHE . 2.1 t -88.29 -45.28 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.168 -0.957 . . . . 0.0 110.715 -179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.543 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 13.1 ptp -63.56 -44.85 92.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.925 -1.109 . . . . 0.0 110.691 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.503 ' N ' ' CG ' ' A' ' 109' ' ' MET . 1.8 m -60.73 -27.77 68.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.038 -1.039 . . . . 0.0 109.928 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 5.8 m120 -82.53 -7.95 59.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.914 . . . . 0.0 110.159 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.564 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 16.4 mt -114.05 -8.55 13.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.43 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.59 -59.55 0.65 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.422 -1.371 . . . . 0.0 111.148 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.444 ' HG2' HD11 ' A' ' 116' ' ' LEU . 17.8 tt0 -72.12 152.55 42.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.996 -1.296 . . . . 0.0 111.28 -178.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 116' ' ' LEU . 4.1 mtmt -132.01 68.06 1.51 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.495 -0.753 . . . . 0.0 109.77 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.52 ' N ' ' SD ' ' A' ' 109' ' ' MET . 3.0 mp -40.56 119.25 1.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.295 -0.878 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.478 ' O ' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -50.82 177.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.277 -0.889 . . . . 0.0 110.455 -179.464 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -64.71 -52.28 57.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.107 -0.996 . . . . 0.0 110.088 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 10.6 pt-20 -59.92 -42.81 94.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.531 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.417 ' N ' ' CG ' ' A' ' 119' ' ' GLU . 1.8 mt-10 -61.66 -43.54 98.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.421 -0.8 . . . . 0.0 109.446 179.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 116' ' ' LEU . 52.0 t -68.02 -48.46 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.328 -0.858 . . . . 0.0 109.596 179.453 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.21 -38.07 76.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.4 OUTLIER -68.71 -33.56 74.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.855 . . . . 0.0 109.677 179.593 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.569 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 12.0 ttt -64.25 -39.99 95.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.87 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.555 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 11.0 mm -74.37 -54.37 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.232 -0.917 . . . . 0.0 109.676 179.541 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.03 -53.38 53.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 110.145 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 7.7 tp10 -51.99 -30.05 23.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.827 . . . . 0.0 110.162 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -96.81 -25.85 15.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.392 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.47 ' OD2' HG23 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -47.2 92.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.266 -0.896 . . . . 0.0 110.556 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.6 mt -80.85 -34.01 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.39 179.403 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.465 ' OD1' ' OD2' ' A' ' 133' ' ' ASP . 9.1 p-10 -87.46 -37.93 16.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.483 -0.761 . . . . 0.0 109.868 179.685 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.24 71.83 0.95 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 3.4 p30 -140.43 9.7 2.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -1.171 . . . . 0.0 109.93 179.475 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.468 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 58.13 15.12 20.71 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 15.4 mt-30 -146.64 170.18 17.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.354 -1.086 . . . . 0.0 110.341 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 54.6 t -131.47 129.91 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 109.81 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 137' ' ' ASN . 14.2 p-10 -114.01 -160.08 0.72 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.115 -0.991 . . . . 0.0 110.579 -179.462 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 139' ' ' GLU . 62.1 t80 -62.91 -63.6 1.16 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.887 . . . . 0.0 110.31 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -40.95 -67.86 0.22 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.325 -0.859 . . . . 0.0 110.311 -179.909 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.401 ' HB3' HG11 ' A' ' 136' ' ' VAL . 12.7 tt0 -44.6 -60.91 1.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 39.1 t80 -46.08 -23.91 0.37 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.29 -0.881 . . . . 0.0 110.308 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.415 ' CG2' HG23 ' A' ' 85' ' ' ILE . 91.6 t -98.75 -31.67 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 110.241 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.48 ' NE2' ' HA ' ' A' ' 143' ' ' GLN . 7.1 mm100 -66.2 -13.79 60.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.94 . . . . 0.0 110.263 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.419 ' HB3' ' HA2' ' B' ' 23' ' ' GLY . 0.9 OUTLIER -97.47 -20.31 17.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.261 -0.9 . . . . 0.0 110.475 -179.852 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.585 ' CE ' ' CD2' ' B' ' 12' ' ' LEU . 2.1 mtt -99.56 -11.28 21.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 110.218 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 146' ' ' THR . 2.7 t . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 110.072 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 43' ' ' PRO . 16.6 mt . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.465 ' HD2' HG21 ' B' ' 4' ' ' ILE . 40.7 Cg_endo -68.64 -175.65 0.97 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.963 1.507 . . . . 0.0 110.165 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.31 -169.14 1.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.075 -1.016 . . . . 0.0 110.898 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.56 ' O ' ' CG2' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -71.51 -77.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.579 -0.7 . . . . 0.0 110.658 -179.622 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.465 ' C ' ' O ' ' B' ' 7' ' ' TRP . 2.8 p -41.15 -25.78 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.025 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.536 HG22 ' CB ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -63.99 -65.38 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 179.146 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.56 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 4.8 m -47.23 -29.87 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.154 -0.966 . . . . 0.0 109.501 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.518 HG22 ' CE1' ' A' ' 68' ' ' PHE . 7.1 mm -75.7 -45.8 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.321 179.267 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.585 ' CD2' ' CE ' ' A' ' 145' ' ' MET . 0.9 OUTLIER -47.74 -56.51 7.19 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.542 0.687 . . . . 0.0 110.225 179.655 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' A' ' 92' ' ' PHE . 22.1 t -60.04 -51.94 67.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 110.734 -179.538 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.42 ' HA ' HD11 ' A' ' 112' ' ' LEU . 24.0 tptt -66.62 -14.61 62.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.926 -1.108 . . . . 0.0 109.975 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 23.3 t -77.71 -33.01 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.872 . . . . 0.0 109.962 179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.448 ' O ' ' HE2' ' A' ' 124' ' ' MET . 0.0 OUTLIER -90.67 -14.73 31.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.786 -179.743 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.543 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 3.8 mp -73.72 51.11 0.36 Allowed 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.156 -0.965 . . . . 0.0 111.201 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.469 ' HB3' ' OG ' ' B' ' 21' ' ' SER . 0.1 OUTLIER -104.2 -107.41 0.28 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.116 -0.99 . . . . 0.0 109.817 179.426 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.494 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 0.1 OUTLIER -107.48 -70.16 0.81 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.026 -1.046 . . . . 0.0 109.513 179.677 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.486 ' HB3' ' CD ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -135.45 13.4 3.49 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.36 -0.837 . . . . 0.0 109.804 179.38 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -66.41 120.3 13.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.336 -0.853 . . . . 0.0 110.297 179.866 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.569 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -144.87 26.96 1.34 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.976 . . . . 0.0 110.953 179.965 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 144' ' ' MET . . . -118.65 -119.81 2.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 145' ' ' MET . 5.2 t-20 -129.51 70.73 82.0 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.327 -1.102 . . . . 0.0 109.962 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.23 47.2 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.877 1.462 . . . . 0.0 110.21 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.575 ' CE1' ' HE1' ' A' ' 72' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.952 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.354 0.597 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.9 mt -53.67 -45.46 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -50.33 -44.8 54.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.092 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.455 ' OE1' ' HD3' ' B' ' 18' ' ' ARG . 1.6 mt-10 -59.65 -47.12 86.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.943 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -60.64 -39.08 86.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.66 97.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.957 . . . . 0.0 109.932 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.72 -38.16 80.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.304 -0.872 . . . . 0.0 109.832 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -66.36 -51.94 52.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.247 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.549 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 15.3 t80 -62.87 -34.29 77.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.199 -0.938 . . . . 0.0 109.824 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.9 t -73.19 -19.23 61.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.836 . . . . 0.0 109.812 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 112' ' ' LEU . 10.5 tt -80.76 -34.93 33.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.356 -0.84 . . . . 0.0 110.066 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.413 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 70.2 m-85 -86.4 -44.78 11.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.35 -0.844 . . . . 0.0 110.517 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -77.63 85.79 3.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.312 -0.868 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -66.84 -40.66 88.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.892 . . . . 0.0 110.124 179.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -57.1 -43.88 82.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.419 -0.8 . . . . 0.0 110.161 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.26 0.36 67.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.472 ' OD2' HG22 ' A' ' 26' ' ' THR . 6.9 p-10 -74.84 -28.29 60.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.212 -1.169 . . . . 0.0 109.975 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.482 ' C ' ' CG2' ' A' ' 26' ' ' THR . . . 110.73 37.73 1.68 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.711 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 28.3 p -152.41 109.97 3.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.152 -1.204 . . . . 0.0 110.661 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.526 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 22.3 mt -80.73 115.12 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.196 -0.94 . . . . 0.0 109.442 179.292 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -93.64 174.65 7.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.283 -0.886 . . . . 0.0 110.228 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -30.13 71.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.043 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -73.0 -54.09 9.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.879 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -50.84 -69.91 0.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 109.865 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 tp -52.77 -36.51 58.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.739 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -62.08 -40.55 99.08 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.713 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 m -58.27 -51.87 67.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -1.086 . . . . 0.0 109.799 179.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 t -60.29 -47.53 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.858 . . . . 0.0 109.963 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.479 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 2.3 mmt -59.56 -43.02 93.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.12 -0.988 . . . . 0.0 109.895 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -65.56 -20.65 66.42 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.342 -0.849 . . . . 0.0 110.109 179.805 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.8 t -77.83 -57.41 3.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.891 . . . . 0.0 110.288 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mt -46.61 -25.64 0.75 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.156 -0.965 . . . . 0.0 110.071 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.83 66.11 0.56 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -137.69 -157.63 0.79 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.174 -1.192 . . . . 0.0 110.288 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 42' ' ' ASN . 18.0 t30 -147.54 62.8 7.33 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.291 -0.881 . . . . 0.0 110.082 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.479 ' HG3' ' CB ' ' A' ' 36' ' ' MET . 48.7 Cg_endo -74.7 118.59 5.37 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.073 1.565 . . . . 0.0 110.559 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 45' ' ' GLU . 28.1 m -99.96 146.36 26.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.317 -0.864 . . . . 0.0 109.938 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' THR . 21.7 pt-20 -43.12 -44.75 5.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.17 -0.956 . . . . 0.0 110.0 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -65.31 -65.04 0.72 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 109.802 179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -46.55 -43.24 16.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.683 179.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -55.66 18.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.351 -0.843 . . . . 0.0 109.785 179.674 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -38.52 19.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.768 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -64.76 -33.69 76.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.416 -0.803 . . . . 0.0 110.104 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.552 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.5 OUTLIER -77.18 -37.9 52.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -68.94 -33.81 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.782 179.85 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.77 -46.93 42.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.342 -0.849 . . . . 0.0 110.603 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -59.56 -56.72 18.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 0.0 110.697 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 28.5 t -70.28 -42.77 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.023 -1.048 . . . . 0.0 110.252 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 60' ' ' ASN . 1.7 t70 -64.95 67.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -40.49 -51.5 2.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.551 -0.718 . . . . 0.0 110.886 -179.74 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 6.7 p-10 -67.47 -43.85 80.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 0.0 110.524 -179.621 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' CA ' ' OD2' ' A' ' 56' ' ' ASP . . . 92.72 49.03 2.81 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.53 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 19.2 p30 -100.08 -17.76 17.31 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.168 -1.195 . . . . 0.0 110.202 179.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.16 14.2 31.49 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.15 133.33 16.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.116 -1.226 . . . . 0.0 110.183 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.526 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 26.1 mm -84.57 156.27 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.386 -0.821 . . . . 0.0 110.218 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.549 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 15.2 t0 -129.82 169.06 15.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.04 -1.037 . . . . 0.0 110.453 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.616 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 51.7 t80 -61.32 -40.03 68.47 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 111.522 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.4 Cg_endo -71.91 -29.72 14.88 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 O-C-N 123.284 1.15 . . . . 0.0 110.22 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -70.48 -31.34 68.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -0.888 . . . . 0.0 109.418 179.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 23.6 t80 -72.73 -46.11 55.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.384 -0.822 . . . . 0.0 110.421 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.514 ' CD1' ' CE2' ' A' ' 65' ' ' PHE . 28.0 mt -66.92 -25.46 66.38 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.212 -0.93 . . . . 0.0 110.778 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.8 m -83.68 -28.62 28.22 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.1 -1.0 . . . . 0.0 110.893 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.42 ' SD ' ' HE3' ' A' ' 75' ' ' LYS . 5.5 tmm? -77.29 -47.59 19.68 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.134 -0.978 . . . . 0.0 111.046 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.579 ' HE1' ' CE1' ' B' ' 26' ' ' PHE . 7.3 tpt -60.31 -10.89 5.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.118 -0.989 . . . . 0.0 111.102 -179.293 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.52 -36.58 8.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.938 -1.101 . . . . 0.0 110.942 -179.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.5 ttt-85 -85.18 -11.26 55.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.133 -0.979 . . . . 0.0 110.6 -179.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.42 ' HE3' ' SD ' ' A' ' 71' ' ' MET . 1.7 tppp? . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.002 -1.061 . . . . 0.0 110.669 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.181 0.515 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -80.41 -40.1 27.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 0.0 109.919 179.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -69.36 -27.64 65.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.262 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.0 mt -78.53 -36.14 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.113 -0.992 . . . . 0.0 109.957 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -64.66 -29.84 70.85 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 109.802 179.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HB3' HG22 ' B' ' 9' ' ' THR . 9.5 mm-40 -75.43 -50.78 14.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 109.109 179.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.57 -35.73 76.78 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.338 -0.852 . . . . 0.0 109.455 179.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 17.3 t80 -64.44 -56.95 10.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 109.847 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -44.31 -38.22 3.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.402 -0.812 . . . . 0.0 109.556 179.709 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 t -65.99 -35.92 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 109.826 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.546 ' CE1' HG12 ' A' ' 108' ' ' VAL . 9.1 m-85 -68.64 -35.68 77.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.164 -0.96 . . . . 0.0 110.474 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.439 ' OD1' HG12 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -98.82 63.59 1.4 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.21 -0.931 . . . . 0.0 110.402 -179.416 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -43.31 -28.22 0.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.277 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 27.6 p-10 -96.1 -36.98 10.8 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.19 -0.944 . . . . 0.0 110.436 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.23 44.0 14.77 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.417 ' ND2' ' OD2' ' A' ' 95' ' ' ASP . 21.7 p30 -78.17 -15.31 58.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -1.145 . . . . 0.0 110.374 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.501 ' C ' ' CG ' ' A' ' 99' ' ' TYR . . . 118.37 -8.39 13.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.501 ' CG ' ' C ' ' A' ' 98' ' ' GLY . 5.3 m-85 -148.88 163.89 36.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -1.186 . . . . 0.0 110.155 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 7.1 mt -113.01 126.32 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 110.133 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.1 p -106.36 153.15 22.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.835 . . . . 0.0 110.09 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.75 -37.84 9.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.05 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.44 93.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -55.52 -43.01 75.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.849 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.526 ' CD1' HD13 ' A' ' 125' ' ' ILE . 2.7 mt -57.92 -48.05 81.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.716 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.439 ' O ' ' OG1' ' A' ' 110' ' ' THR . 0.3 OUTLIER -50.83 -42.56 58.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.838 . . . . 0.0 109.754 179.79 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.81 -48.45 81.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 109.75 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.546 HG12 ' CE1' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -74.42 -25.8 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 0.0 109.416 179.631 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.525 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 0.5 OUTLIER -71.04 -50.05 38.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 110.108 179.98 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -71.41 -31.67 67.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.187 179.934 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -72.55 -6.46 44.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.245 -0.909 . . . . 0.0 110.438 -179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.522 ' CD1' HG11 ' B' ' 13' ' ' VAL . 6.4 mt -106.53 -44.72 4.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.106 -0.996 . . . . 0.0 110.617 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.69 -46.93 0.51 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.405 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.44 ' HG2' HD11 ' A' ' 116' ' ' LEU . 14.2 tt0 -98.48 141.67 31.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.067 -1.255 . . . . 0.0 110.659 -179.613 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 116' ' ' LEU . 3.2 ptpt -119.56 16.46 12.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 109.748 179.406 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 115' ' ' LYS . 4.0 mp 39.45 -164.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.684 0.754 . . . . 0.0 110.842 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.16 -147.98 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.562 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -107.58 -48.56 3.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 109.969 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -67.24 -34.84 78.31 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.538 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.48 -44.68 82.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.272 -0.893 . . . . 0.0 109.097 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.0 t -53.25 -48.64 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.412 -0.805 . . . . 0.0 109.646 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -65.07 -56.24 14.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.75 -30.05 13.0 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.41 -0.806 . . . . 0.0 109.437 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.574 ' HE1' ' CD2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.61 -62.4 1.84 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.339 -0.851 . . . . 0.0 109.689 179.544 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.526 HD13 ' CD1' ' A' ' 105' ' ' LEU . 48.0 mm -56.33 -34.24 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -0.78 . . . . 0.0 110.258 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -66.91 -44.18 81.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 110.323 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.77 -29.66 69.67 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 0.0 110.215 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.18 -31.18 34.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -0.953 . . . . 0.0 110.015 179.799 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.469 ' HB3' ' HA2' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -65.6 106.2 1.4 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.372 -0.83 . . . . 0.0 110.483 -179.968 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.2 mm -64.3 -28.04 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 12.3 p30 -105.54 -16.43 14.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.958 179.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 64.02 59.36 8.63 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.441 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 6.3 p-10 -101.0 -23.96 14.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -1.146 . . . . 0.0 109.941 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 135' ' ' GLN . . . 131.79 -12.72 5.35 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.478 ' CG ' ' C ' ' A' ' 134' ' ' GLY . 9.7 mt-30 -151.31 161.16 43.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.152 -1.205 . . . . 0.0 110.073 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 19.3 t -105.67 157.85 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.908 179.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 1.9 p-10 -127.23 -179.54 4.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.221 -0.925 . . . . 0.0 110.445 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -61.03 -67.15 0.43 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.447 -0.783 . . . . 0.0 110.647 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 0.7 OUTLIER -45.32 -27.67 0.71 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.238 -0.914 . . . . 0.0 110.628 -179.49 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.466 ' HB2' ' ND2' ' A' ' 137' ' ' ASN . 4.2 tt0 -80.49 -52.51 7.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 69.3 t80 -54.33 -17.39 2.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.18 -0.95 . . . . 0.0 109.859 179.638 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.462 ' O ' ' OG1' ' A' ' 146' ' ' THR . 48.1 t -99.45 -55.3 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 110.637 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 0.5 OUTLIER -58.93 -13.79 7.36 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.118 -0.988 . . . . 0.0 110.78 -179.559 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.454 ' HG3' ' HA2' ' B' ' 23' ' ' GLY . 3.7 tpt -97.55 -27.27 14.48 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.166 -0.959 . . . . 0.0 110.582 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.8 ttt -100.49 -10.05 21.47 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.249 -0.907 . . . . 0.0 110.796 -179.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 47.3 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 0.0 110.967 -179.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.558 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 19.0 mm . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 38.0 Cg_endo -66.52 170.38 12.46 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.632 1.333 . . . . 0.0 110.436 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.5 ' O ' ' HB ' ' B' ' 9' ' ' THR . 0.1 OUTLIER -96.4 152.24 18.79 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.189 -0.945 . . . . 0.0 111.299 -178.913 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.582 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 4.2 m95 -48.95 -66.09 0.46 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.881 . . . . 0.0 109.641 179.036 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' B' ' 12' ' ' LEU . 23.8 p -47.73 -24.17 0.88 Allowed 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.889 -1.132 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' B' ' 6' ' ' SER . 4.1 m -64.38 -54.97 24.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.066 -1.021 . . . . 0.0 109.639 179.37 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.573 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 6.8 m -56.89 -33.71 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.908 -1.12 . . . . 0.0 108.687 179.44 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.453 HD12 ' N ' ' B' ' 11' ' ' ILE . 4.9 mm -77.45 -23.2 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 108.799 178.411 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' B' ' 8' ' ' THR . 0.3 OUTLIER -68.5 -60.78 2.18 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.613 -0.68 . . . . 0.0 109.784 179.707 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.522 HG11 ' CD1' ' A' ' 112' ' ' LEU . 35.7 t -62.82 -32.84 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.371 -0.83 . . . . 0.0 110.166 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' B' ' 10' ' ' VAL . 0.0 OUTLIER -69.35 -45.59 69.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.017 -1.052 . . . . 0.0 109.251 179.212 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 52.7 p -58.46 -35.23 71.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.418 -0.801 . . . . 0.0 109.518 179.151 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.46 ' HE2' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -65.1 -41.97 94.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.445 -0.784 . . . . 0.0 109.582 179.477 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.56 ' O ' ' C ' ' B' ' 18' ' ' ARG . 6.2 mp -60.62 -12.82 11.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.421 -0.799 . . . . 0.0 110.038 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.56 ' C ' ' O ' ' B' ' 17' ' ' LEU . 6.4 tpt85 -18.8 -68.21 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.679 0 CA-C-O 121.489 0.661 . . . . 0.0 111.161 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.497 ' HD2' ' CG ' ' B' ' 20' ' ' ARG . 1.1 tmtm? -174.44 -104.49 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.011 179.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.497 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -87.73 13.66 10.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.444 -1.41 . . . . 0.0 109.335 179.308 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -87.06 163.34 17.08 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.456 -0.777 . . . . 0.0 110.555 -179.542 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.574 ' CD2' ' HE1' ' A' ' 124' ' ' MET . 0.2 OUTLIER 179.81 -45.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.318 -0.864 . . . . 0.0 110.559 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.454 ' HA2' ' HG3' ' A' ' 144' ' ' MET . . . -69.91 -50.96 26.43 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.395 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -150.13 84.97 5.61 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.954 -1.321 . . . . 0.0 110.838 -179.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.45 ' HG3' ' HG2' ' B' ' 16' ' ' MET . 48.6 Cg_endo -80.84 -7.76 13.35 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.925 1.487 . . . . 0.0 110.109 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.579 ' CE1' ' HE1' ' A' ' 72' ' ' MET . 5.9 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.316 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.327 0.584 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.4 mt -50.11 -44.92 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.3 -45.71 69.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 109.951 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.68 -51.01 66.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.208 -0.932 . . . . 0.0 109.813 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -44.84 67.63 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.229 -0.919 . . . . 0.0 109.377 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.63 -30.56 65.47 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.344 -0.847 . . . . 0.0 108.972 178.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -58.32 9.1 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.533 -0.729 . . . . 0.0 109.293 179.21 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.77 -48.41 41.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.267 -0.896 . . . . 0.0 109.336 179.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.543 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 32.3 t80 -66.51 -35.64 80.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.327 -0.858 . . . . 0.0 109.448 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -68.32 -30.34 69.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.46 -0.775 . . . . 0.0 109.528 179.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.511 HD12 ' CD ' ' B' ' 14' ' ' LYS . 6.7 tt -65.35 -46.03 81.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.684 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -73.29 -39.15 65.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.282 -0.886 . . . . 0.0 110.384 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.461 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 1.8 t0 -78.89 82.93 5.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.211 -0.931 . . . . 0.0 109.919 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -49.17 -74.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 110.359 -179.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.1 p-10 -51.76 -39.0 57.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 110.306 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.17 15.02 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.461 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 40.8 p-10 -76.64 -12.65 60.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -1.167 . . . . 0.0 110.081 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.98 42.11 5.42 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -161.49 117.36 2.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -1.131 . . . . 0.0 110.573 -179.831 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.526 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 8.1 mt -100.07 118.22 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.218 -0.926 . . . . 0.0 110.127 179.594 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.454 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 20.4 p -94.92 153.88 17.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 109.806 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -46.31 -24.65 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.977 . . . . 0.0 109.942 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -78.54 -60.79 2.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.066 179.761 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 37.3 mt-10 -44.21 -56.64 3.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.469 HD21 ' CZ2' ' B' ' 7' ' ' TRP . 40.8 tp -57.39 -45.65 84.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.168 -0.958 . . . . 0.0 109.3 179.336 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -56.65 -39.56 86.24 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.27 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 m -53.28 -50.94 63.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -1.027 . . . . 0.0 109.363 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.4 t -57.75 -39.28 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.326 -0.859 . . . . 0.0 109.261 179.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 13.5 mmt -61.31 -39.13 89.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 179.253 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -62.25 -30.74 71.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.381 179.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 m -65.73 -61.85 1.84 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.465 -0.772 . . . . 0.0 110.051 179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.452 HD22 HG21 ' A' ' 108' ' ' VAL . 6.1 mt -47.92 -24.16 0.96 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.71 55.08 0.58 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.15 165.94 30.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -1.186 . . . . 0.0 110.482 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 42' ' ' ASN . 2.6 p30 -140.75 97.95 7.14 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.967 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.466 ' CA ' HD13 ' B' ' 4' ' ' ILE . 46.3 Cg_endo -72.7 154.33 54.31 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.9 1.474 . . . . 0.0 110.485 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.0 m -99.65 -176.74 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 46' ' ' ALA . 1.2 tm-20 -67.45 -69.52 0.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.216 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.502 ' N ' ' OE1' ' A' ' 45' ' ' GLU . . . -47.14 -46.95 23.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 56.5 mm-40 -52.54 -58.19 7.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -0.895 . . . . 0.0 110.296 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.6 mt -48.61 -43.6 36.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.254 -0.904 . . . . 0.0 110.53 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 tp60 -63.87 -35.92 82.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 110.235 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -30.65 71.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.869 . . . . 0.0 110.12 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.426 ' HE2' ' C ' ' B' ' 6' ' ' SER . 13.9 mtp -84.15 -47.58 10.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.343 -0.848 . . . . 0.0 110.09 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 10.2 mm -66.05 -30.26 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -56.5 -14.14 2.86 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.361 -0.837 . . . . 0.0 111.094 -179.504 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.38 -53.0 4.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.085 -1.009 . . . . 0.0 111.009 -179.29 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' ALA . 6.6 t -72.46 -36.69 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.093 -1.005 . . . . 0.0 111.002 -179.484 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.7 t0 -55.32 82.25 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.267 -0.896 . . . . 0.0 110.657 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.32 -58.2 3.59 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.402 -0.812 . . . . 0.0 110.65 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 30.1 p30 -63.94 -11.7 30.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.258 -0.901 . . . . 0.0 110.5 -179.708 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 61.08 46.52 94.38 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.487 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 23.1 p-10 -97.73 -32.84 11.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -1.147 . . . . 0.0 110.23 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.16 -9.42 5.66 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.487 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 31.0 p -139.18 160.6 39.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 110.032 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.526 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 15.6 mm -84.59 159.45 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 109.92 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.543 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -126.25 173.33 9.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.093 -1.004 . . . . 0.0 110.55 -179.865 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.582 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.5 t80 -67.5 -50.77 35.53 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.322 -0.862 . . . . 0.0 111.135 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.3 Cg_endo -66.53 -39.51 16.15 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.254 1.134 . . . . 0.0 110.169 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' OE2' ' HB2' ' A' ' 64' ' ' ASP . 39.3 mt-10 -53.8 -39.62 65.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.527 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.73 -47.21 72.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 109.777 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.3 mt -51.17 -30.41 16.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.997 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.9 m -93.89 -14.86 25.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.389 -0.819 . . . . 0.0 110.501 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.446 ' HG3' HG21 ' A' ' 55' ' ' VAL . 7.1 tmm? -73.18 -54.08 9.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.107 -0.995 . . . . 0.0 110.433 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.537 ' CE ' ' CE1' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -52.62 -18.12 1.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.816 . . . . 0.0 110.668 -179.604 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.45 -10.11 22.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.13 -0.981 . . . . 0.0 110.648 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.29 -34.6 9.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.119 -0.988 . . . . 0.0 110.447 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.526 ' HB3' ' CG2' ' B' ' 8' ' ' THR . 6.4 tptt . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.204 -0.935 . . . . 0.0 110.405 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 15.8 pt-20 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.199 0.523 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.486 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 1.1 pt-20 -72.64 -9.73 58.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.474 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 13.8 mm-40 -79.12 -28.0 42.89 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.497 -0.752 . . . . 0.0 109.91 179.48 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.458 HG21 ' CE1' ' A' ' 141' ' ' PHE . 77.8 mt -62.93 -39.42 85.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.205 -0.934 . . . . 0.0 108.6 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -65.51 -28.53 69.25 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.4 -53.39 7.72 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.22 -32.39 71.08 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.33 -0.856 . . . . 0.0 108.935 178.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -72.88 -45.99 55.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.067 178.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -55.25 -23.78 24.4 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.535 -0.728 . . . . 0.0 109.135 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.512 HG13 ' CG2' ' A' ' 108' ' ' VAL . 22.8 t -78.59 -44.37 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.536 -0.728 . . . . 0.0 109.735 179.462 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.587 ' CE1' HG12 ' A' ' 108' ' ' VAL . 57.3 m-85 -65.68 -42.28 91.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.889 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.458 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 30.9 t0 -100.13 61.47 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.516 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -54.31 -48.21 71.57 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.153 -0.967 . . . . 0.0 109.534 179.867 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 10.0 p-10 -54.97 -32.15 61.34 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.799 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.29 54.63 22.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.475 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 52.6 p30 -96.57 -5.43 39.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.245 -1.15 . . . . 0.0 110.101 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 99.45 13.13 39.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 2.6 m-85 -164.74 162.97 21.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.303 -1.116 . . . . 0.0 110.04 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.53 HD12 ' CB ' ' A' ' 92' ' ' PHE . 10.7 mt -119.67 132.63 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.234 -0.916 . . . . 0.0 110.414 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.467 ' OG ' ' OE1' ' A' ' 135' ' ' GLN . 0.4 OUTLIER -116.08 153.25 32.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 110.126 179.957 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.2 -32.64 1.31 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.709 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.95 84.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.406 -0.809 . . . . 0.0 109.494 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.448 ' OE1' ' OD1' ' A' ' 93' ' ' ASP . 5.7 mt-10 -54.49 -50.58 67.45 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.324 -0.86 . . . . 0.0 109.404 179.364 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.464 ' O ' ' HG3' ' A' ' 109' ' ' MET . 3.6 mm? -57.9 -52.86 63.77 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.302 -0.873 . . . . 0.0 109.5 179.349 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -50.89 -26.57 6.0 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.213 -0.93 . . . . 0.0 109.016 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.473 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 26.3 t60 -79.27 -25.45 42.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.564 -0.71 . . . . 0.0 109.69 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.587 HG12 ' CE1' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -98.8 -30.74 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.694 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.535 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -73.49 -51.7 16.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.394 -0.816 . . . . 0.0 110.196 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.7 m -68.94 -23.42 64.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 110.321 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 3.6 m120 -86.85 -14.29 42.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 109.521 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.551 HD13 ' CG1' ' B' ' 13' ' ' VAL . 4.1 mt -89.24 -34.38 16.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -0.857 . . . . 0.0 110.106 179.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.22 -56.61 0.42 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.24 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.52 158.37 17.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.999 -1.295 . . . . 0.0 110.804 -179.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 1.2 pttt -135.52 76.17 1.6 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.533 -0.729 . . . . 0.0 109.251 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' B' ' 19' ' ' LYS . 4.6 mp -37.2 146.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.671 -0.643 . . . . 0.0 111.14 -179.332 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -54.58 -164.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 0.0 110.04 179.719 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -83.86 -46.89 11.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.124 -0.985 . . . . 0.0 110.119 179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -58.38 -53.06 62.58 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.74 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.448 ' HB3' HD22 ' A' ' 116' ' ' LEU . 67.8 mm-40 -52.85 -44.2 66.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.365 -0.834 . . . . 0.0 109.582 179.51 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 117' ' ' THR . 42.7 t -58.11 -51.19 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.851 . . . . 0.0 110.154 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -61.47 -56.38 20.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 109.88 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 1.8 mt-10 -52.65 -36.65 57.12 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.687 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.595 ' HE1' ' CD1' ' B' ' 22' ' ' PHE . 0.9 OUTLIER -55.28 -50.15 70.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.811 . . . . 0.0 110.098 179.718 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 125' ' ' ILE . 37.1 mm -71.45 -46.0 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.22 -0.925 . . . . 0.0 110.321 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 127' ' ' GLU . 11.6 mmt180 -59.8 -55.32 35.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.26 -0.9 . . . . 0.0 110.446 -179.764 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.8 OUTLIER -43.69 -26.05 0.21 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 110.265 -179.958 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -98.59 -28.51 13.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.157 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.8 t70 -65.11 69.79 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.881 . . . . 0.0 110.371 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.521 HD11 ' N ' ' A' ' 130' ' ' ILE . 1.6 mp -63.21 -35.77 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.471 179.66 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 35.7 p-10 -74.97 -23.74 58.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 179.668 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 72.93 57.87 5.07 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 1.9 p30 -110.04 -15.2 14.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.214 -1.168 . . . . 0.0 110.083 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 135' ' ' GLN . . . 106.68 -4.74 36.93 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 43.7 mt-30 -155.37 158.57 38.9 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.225 -1.162 . . . . 0.0 110.119 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 14.0 t -92.72 135.97 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 110.075 179.666 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.515 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 28.1 t-20 -106.72 173.21 6.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.156 -0.965 . . . . 0.0 110.416 -179.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -54.55 -49.88 69.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.856 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -52.99 -56.37 16.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.271 -0.893 . . . . 0.0 110.229 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 141' ' ' PHE . 48.4 mt-10 -54.22 -58.67 6.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.162 -0.962 . . . . 0.0 110.076 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.464 ' O ' ' HG3' ' A' ' 145' ' ' MET . 41.7 t80 -43.51 -27.39 0.28 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 109.739 179.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.495 ' O ' ' CG2' ' A' ' 146' ' ' THR . 46.9 t -91.81 -39.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 109.965 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -57.91 -14.14 5.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.362 -0.837 . . . . 0.0 110.501 -179.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.47 ' HE2' HD13 ' A' ' 130' ' ' ILE . 2.5 mtp -107.3 -11.19 15.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.111 -0.993 . . . . 0.0 110.515 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.534 ' CE ' HD23 ' B' ' 12' ' ' LEU . 0.2 OUTLIER -99.91 -17.84 17.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.161 -0.962 . . . . 0.0 110.699 -179.708 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.495 ' CG2' ' O ' ' A' ' 142' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 O-C-N 121.163 -0.961 . . . . 0.0 110.346 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.466 HD13 ' CA ' ' A' ' 43' ' ' PRO . 19.6 mm . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.463 ' HD2' HG21 ' B' ' 4' ' ' ILE . 46.9 Cg_endo -73.81 164.64 34.16 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.062 1.559 . . . . 0.0 110.458 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.426 ' C ' ' HE2' ' A' ' 51' ' ' MET . 0.9 OUTLIER -90.42 -175.93 4.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.181 -0.949 . . . . 0.0 110.612 -179.952 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 7' ' ' TRP . . . . . 0.569 ' O ' ' CG2' ' B' ' 10' ' ' VAL . 2.1 m95 -65.12 -76.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.643 0.735 . . . . 0.0 110.707 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 13.3 p -41.72 -25.83 0.06 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.13 -0.981 . . . . 0.0 110.591 -179.305 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.455 ' N ' ' O ' ' B' ' 7' ' ' TRP . 27.1 m -61.92 -61.68 2.32 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.01 -1.056 . . . . 0.0 109.318 178.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.569 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 6.1 m -53.97 -27.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 109.037 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' B' ' 8' ' ' THR . 30.0 mm -74.3 -42.54 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.471 -0.768 . . . . 0.0 109.287 178.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.534 HD23 ' CE ' ' A' ' 145' ' ' MET . 0.5 OUTLIER -53.33 -60.61 3.07 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.647 -0.658 . . . . 0.0 110.053 179.855 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.576 HG12 ' CZ ' ' A' ' 92' ' ' PHE . 69.3 t -56.51 -40.38 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.121 -0.987 . . . . 0.0 109.78 179.682 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.511 ' CD ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.32 -42.06 84.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.147 -0.971 . . . . 0.0 109.515 179.239 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -62.25 -31.51 72.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 109.552 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.17 -27.03 60.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.497 -0.752 . . . . 0.0 109.87 179.694 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 3.3 mp -70.34 58.47 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.384 -0.822 . . . . 0.0 109.94 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.467 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 3.7 tpp180 -85.94 -70.93 0.56 Allowed 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.616 -0.677 . . . . 0.0 110.648 -179.637 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.656 ' HG2' ' N ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -165.48 -43.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.953 . . . . 0.0 110.216 -179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.656 ' N ' ' HG2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -162.5 3.73 0.05 OUTLIER 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.236 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.457 ' HB2' ' HE2' ' B' ' 19' ' ' LYS . 5.7 t -90.16 154.22 19.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.183 -0.948 . . . . 0.0 110.693 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.595 ' CD1' ' HE1' ' A' ' 124' ' ' MET . 0.1 OUTLIER -131.27 -42.3 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.367 -0.833 . . . . 0.0 109.958 179.535 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 144' ' ' MET . . . -59.34 104.05 0.49 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.485 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -102.48 105.86 46.06 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.114 -1.227 . . . . 0.0 110.658 -179.489 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.02 139.57 24.38 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.007 1.53 . . . . 0.0 109.524 179.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.537 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 1.3 m-85 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.209 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.211 0.529 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -137.82 126.36 23.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 110.269 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.28 114.82 0.87 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.066 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.413 ' O ' ' OE1' ' A' ' 8' ' ' GLN . 15.6 mt -106.83 -163.15 0.89 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -0.943 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 p -80.39 -17.68 51.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.263 -0.898 . . . . 0.0 110.55 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -99.59 -45.71 5.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.204 -0.935 . . . . 0.0 110.159 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 7.8 tp10 -48.79 -45.92 40.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.413 ' OE1' ' O ' ' A' ' 4' ' ' LEU . 40.2 mt-30 -62.74 -56.88 13.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.267 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.1 mt -49.24 -52.19 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 110.391 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -50.61 -42.02 55.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 110.313 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 29.6 tt0 -59.3 -48.2 82.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -66.23 -41.61 89.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -55.21 -34.77 64.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.187 -0.945 . . . . 0.0 109.44 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 49.8 mt-10 -67.55 -49.19 64.45 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.396 -0.815 . . . . 0.0 109.533 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.3 99.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.365 -0.835 . . . . 0.0 109.608 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.616 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 73.9 t80 -62.0 -26.53 68.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.354 -0.841 . . . . 0.0 109.408 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.45 -35.47 23.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.46 -0.775 . . . . 0.0 109.742 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -54.35 -46.13 72.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 109.623 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.556 ' CD1' HD11 ' A' ' 32' ' ' LEU . 63.4 m-85 -70.02 -48.59 57.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.244 -0.91 . . . . 0.0 110.1 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -66.3 66.26 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.384 -0.823 . . . . 0.0 109.958 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -41.89 -51.82 4.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.6 p-10 -72.89 -41.4 64.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 109.701 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.91 45.21 3.67 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 26' ' ' THR . 33.1 p30 -96.03 -4.85 42.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -1.196 . . . . 0.0 110.342 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 87.49 28.33 24.88 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 11.7 p -160.03 111.3 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -1.154 . . . . 0.0 110.394 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.54 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 14.9 mt -78.66 124.91 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.048 -1.032 . . . . 0.0 109.707 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.441 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 1.2 p -100.17 -179.9 4.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.628 -0.67 . . . . 0.0 110.136 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -70.72 -33.99 71.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.727 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.89 -50.51 41.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 109.903 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' OE2' ' OG1' ' A' ' 28' ' ' THR . 57.8 mt-10 -51.36 -70.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.892 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.556 HD11 ' CD1' ' A' ' 19' ' ' PHE . 15.7 tp -51.24 -33.62 28.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.592 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -61.58 -41.33 99.55 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.0 m -61.04 -41.84 97.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.384 -1.068 . . . . 0.0 109.813 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.8 t -65.44 -46.49 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.294 -0.879 . . . . 0.0 109.705 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -19.68 65.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.062 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 1.2 ttp180 -91.48 -17.2 26.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.9 . . . . 0.0 110.053 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.89 -43.1 13.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 110.113 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.474 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -50.96 -26.4 5.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 110.337 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.65 35.99 0.94 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.44 -166.62 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -1.151 . . . . 0.0 110.348 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -149.08 97.75 3.59 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.855 . . . . 0.0 110.094 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.539 ' HA ' ' CD1' ' B' ' 4' ' ' ILE . 41.9 Cg_endo -68.18 149.17 76.1 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.904 1.476 . . . . 0.0 110.574 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 52.9 m -97.58 135.2 39.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.304 -0.873 . . . . 0.0 110.425 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -44.68 -44.99 9.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.184 -0.947 . . . . 0.0 110.196 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.27 -57.28 6.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 72.1 mm-40 -55.59 -47.68 76.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.897 . . . . 0.0 110.175 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.8 OUTLIER -48.61 -62.6 1.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.986 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 tp60 -51.1 -44.02 61.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.428 -0.795 . . . . 0.0 109.942 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -64.96 -28.29 69.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.818 . . . . 0.0 109.644 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -49.44 16.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.449 -0.782 . . . . 0.0 109.832 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.485 HG13 HD21 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -70.36 -10.03 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -85.78 -19.41 30.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.409 -0.807 . . . . 0.0 109.698 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -57.02 6.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.389 -0.819 . . . . 0.0 110.104 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.588 HG22 ' CD1' ' B' ' 7' ' ' TRP . 18.5 t -69.75 -31.72 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.274 -0.891 . . . . 0.0 109.862 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -59.15 79.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.428 -0.795 . . . . 0.0 110.034 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.86 -21.95 60.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.802 . . . . 0.0 110.621 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -71.56 -38.83 70.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.048 -1.033 . . . . 0.0 110.434 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.21 12.93 32.42 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.1 p-10 -82.89 -44.48 15.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.395 -1.062 . . . . 0.0 110.528 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.33 11.27 9.86 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.493 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 14.2 p -138.56 143.32 39.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.354 -1.086 . . . . 0.0 109.869 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.54 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 15.8 mm -87.08 150.77 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.062 -1.023 . . . . 0.0 109.924 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.516 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 1.2 m-20 -129.74 165.03 22.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.14 -0.975 . . . . 0.0 110.981 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.616 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 14.5 t80 -50.81 -47.43 85.94 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.491 -0.756 . . . . 0.0 111.139 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -67.93 -40.88 8.56 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 O-C-N 123.176 1.093 . . . . 0.0 109.912 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -56.68 -29.89 62.83 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.193 -0.942 . . . . 0.0 108.857 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' O ' ' HG2' ' A' ' 71' ' ' MET . 0.1 OUTLIER -66.91 -63.34 1.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.543 -0.723 . . . . 0.0 109.523 178.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -48.26 -22.21 0.63 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.274 -0.891 . . . . 0.0 109.968 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.5 m -100.59 -9.99 21.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.189 -0.944 . . . . 0.0 111.357 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.528 ' HG3' ' N ' ' A' ' 72' ' ' MET . 9.5 ptm -86.05 -43.52 13.04 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.799 -1.188 . . . . 0.0 110.554 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.528 ' N ' ' HG3' ' A' ' 71' ' ' MET . 89.3 mmm -65.34 -10.04 29.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.055 -1.028 . . . . 0.0 110.539 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.0 -10.54 21.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.074 -1.016 . . . . 0.0 111.043 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.75 -10.72 22.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.941 -1.1 . . . . 0.0 110.519 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.533 ' CB ' HG23 ' B' ' 8' ' ' THR . 0.0 OUTLIER -94.93 -25.46 16.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.183 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.9 mmt -76.8 53.6 0.92 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.243 -0.91 . . . . 0.0 110.256 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -118.06 -64.2 1.32 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.07 -32.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.272 -0.893 . . . . 0.0 110.439 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -81.87 11.19 5.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.289 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.527 ' HA ' ' CG ' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -174.59 65.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.227 -0.921 . . . . 0.0 110.266 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 77.5 p -122.47 -52.23 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 109.765 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -99.82 -13.48 19.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.833 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.527 ' CG ' ' HA ' ' A' ' 80' ' ' ASP . 0.3 OUTLIER -84.33 -21.57 30.91 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 14.8 pt-20 -73.17 -27.57 61.72 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.57 -0.706 . . . . 0.0 110.051 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.416 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 53.1 mt -73.98 -40.82 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.606 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -32.75 73.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 109.364 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.541 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 17.2 mt-10 -70.09 -56.58 6.54 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' B' ' 12' ' ' LEU . . . -48.85 -35.98 15.88 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.25 -0.906 . . . . 0.0 108.557 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 90' ' ' ARG . 26.8 t80 -62.72 -56.09 20.76 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.628 -0.67 . . . . 0.0 109.473 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -43.03 -47.32 5.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.578 -0.701 . . . . 0.0 109.425 179.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.503 ' CG1' HG12 ' B' ' 13' ' ' VAL . 41.2 t -51.08 -49.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.363 -0.836 . . . . 0.0 109.359 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.522 ' CE1' HD22 ' A' ' 105' ' ' LEU . 54.8 m-85 -68.85 -44.66 72.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 110.38 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.438 ' OD2' ' HA2' ' A' ' 96' ' ' GLY . 34.2 t0 -92.28 60.9 3.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.062 -1.024 . . . . 0.0 110.39 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.3 -46.84 62.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.284 -0.885 . . . . 0.0 110.301 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 6.5 p30 -66.04 -26.0 67.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.319 -0.863 . . . . 0.0 110.384 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 67.52 50.99 39.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -96.97 -18.41 19.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.191 -1.182 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.542 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 109.4 24.63 5.84 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -169.92 158.75 7.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -1.113 . . . . 0.0 110.139 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.502 HG23 HD11 ' A' ' 100' ' ' ILE . 34.4 mt -117.04 148.91 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.033 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 102' ' ' ALA . 19.3 t -127.75 146.73 50.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.958 . . . . 0.0 109.876 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.18 -29.54 0.25 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 109.975 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.68 -56.08 14.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.823 . . . . 0.0 109.598 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 15.7 mt-10 -53.54 -38.13 63.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 0.0 109.707 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.522 HD22 ' CE1' ' A' ' 92' ' ' PHE . 1.4 mt -69.87 -39.2 76.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.436 -0.79 . . . . 0.0 109.607 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.0 ttp85 -62.58 -34.17 76.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.304 -0.872 . . . . 0.0 109.415 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -66.49 -51.51 55.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.362 -0.836 . . . . 0.0 109.449 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.484 HG12 ' CG1' ' B' ' 13' ' ' VAL . 28.3 t -57.89 -37.42 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.524 -0.735 . . . . 0.0 109.506 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.541 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -52.1 -64.07 0.94 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.609 -0.682 . . . . 0.0 110.77 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.426 HG22 ' HG2' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -64.22 -15.35 59.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' ' 39' ' ' LEU . 0.9 OUTLIER -79.09 -19.63 50.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.016 . . . . 0.0 109.565 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.55 HD12 ' CA ' ' B' ' 14' ' ' LYS . 15.8 mt -107.28 -27.03 10.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.484 -0.76 . . . . 0.0 109.862 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.433 ' O ' ' HE3' ' A' ' 115' ' ' LYS . . . 147.57 -74.32 0.29 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.735 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.443 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 1.8 tt0 -71.68 149.0 45.91 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.241 -1.152 . . . . 0.0 111.332 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -130.48 81.98 2.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.522 -0.736 . . . . 0.0 109.302 179.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.483 ' HB2' ' CE ' ' A' ' 109' ' ' MET . 8.0 mp -36.71 143.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.588 -0.695 . . . . 0.0 111.083 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -58.02 -153.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 110.072 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 119' ' ' GLU . 1.2 m-20 -98.8 -66.0 0.93 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.892 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' ASP . 15.1 mt-10 -44.39 -47.46 9.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.56 -54.8 43.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.369 -0.832 . . . . 0.0 109.317 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 117' ' ' THR . 39.1 t -55.47 -39.59 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 109.678 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.58 -44.52 86.41 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.375 -0.828 . . . . 0.0 109.719 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -70.59 -36.7 73.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.353 -0.842 . . . . 0.0 109.678 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.43 ' HE1' ' O ' ' B' ' 21' ' ' SER . 24.4 ttt -56.76 -37.45 71.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -0.826 . . . . 0.0 109.788 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.522 ' CD1' HD13 ' A' ' 105' ' ' LEU . 27.5 mm -82.38 -31.23 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 110.084 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -36.67 80.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 110.248 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -30.44 69.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.87 . . . . 0.0 110.061 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -82.96 -29.24 29.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 110.031 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -63.68 72.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.908 . . . . 0.0 110.342 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 128' ' ' ALA . 3.4 mt -58.05 -21.93 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 109.893 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 35.6 p-10 -98.78 -17.16 18.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.83 61.21 3.61 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 1.6 p30 -111.03 2.87 18.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -1.191 . . . . 0.0 110.098 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 85.32 -1.67 88.44 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 86.3 mt-30 -153.83 168.28 26.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.156 -1.202 . . . . 0.0 110.221 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 50.4 t -100.0 143.15 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -0.912 . . . . 0.0 110.075 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.511 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 32.7 t30 -111.2 -173.74 2.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 0.0 110.332 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -69.84 -52.86 21.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.348 -0.845 . . . . 0.0 110.5 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -45.24 -52.66 9.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -56.24 -58.89 6.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 110.022 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.419 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 20.4 t80 -46.39 -25.16 0.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.461 ' CG1' HG22 ' A' ' 146' ' ' THR . 38.3 t -99.99 -54.03 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.299 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.77 -24.31 0.36 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.201 -0.937 . . . . 0.0 110.312 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmm -83.93 -23.83 30.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.266 -0.896 . . . . 0.0 110.313 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.537 ' HE3' ' CD2' ' B' ' 12' ' ' LEU . 0.1 OUTLIER -100.16 -11.49 20.41 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.269 -0.894 . . . . 0.0 110.51 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.461 HG22 ' CG1' ' A' ' 142' ' ' VAL . 82.4 p -90.96 -39.28 12.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 148' ' ' LYS . . . -77.48 52.87 1.0 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.411 -0.806 . . . . 0.0 110.267 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.221 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 121.232 0.539 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.25 -170.21 2.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.052 -1.03 . . . . 0.0 110.137 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -152.05 65.51 0.84 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.214 -0.928 . . . . 0.0 109.781 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.539 ' CD1' ' HA ' ' A' ' 43' ' ' PRO . 5.6 mt 57.24 152.48 0.07 OUTLIER Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.613 -0.679 . . . . 0.0 110.528 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.51 ' HD2' HG22 ' B' ' 4' ' ' ILE . 42.6 Cg_endo -70.12 132.46 22.81 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.958 1.504 . . . . 0.0 110.112 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 12.3 p -69.46 -167.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.86 . . . . 0.0 110.799 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.588 ' CD1' HG22 ' A' ' 55' ' ' VAL . 5.4 m95 -73.11 -77.71 0.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.536 -0.728 . . . . 0.0 110.707 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 75' ' ' LYS . 20.5 p -40.87 -26.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.964 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.541 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 84.0 m -61.36 -63.55 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 110.001 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.571 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 4.6 m -50.79 -27.45 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.421 HG12 ' O ' ' B' ' 7' ' ' TRP . 15.0 mm -79.09 -24.79 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.468 -0.77 . . . . 0.0 109.327 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.537 ' CD2' ' HE3' ' A' ' 145' ' ' MET . 1.4 mt -68.99 -49.76 55.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.576 -0.702 . . . . 0.0 110.087 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.503 HG12 ' CG1' ' A' ' 91' ' ' VAL . 97.5 t -67.53 -40.11 83.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.38 -0.825 . . . . 0.0 110.36 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.55 ' CA ' HD12 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -64.95 -45.74 84.48 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.918 -1.114 . . . . 0.0 109.506 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.463 ' HB3' ' ND2' ' B' ' 24' ' ' ASN . 4.7 t -57.67 -36.88 72.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.324 -0.86 . . . . 0.0 108.9 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' B' ' 13' ' ' VAL . 2.9 mmt -60.04 -34.47 73.43 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 108.833 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.541 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 6.3 mp -72.59 56.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.651 -0.655 . . . . 0.0 109.418 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -83.66 0.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.69 . . . . 0.0 110.289 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' B' ' 20' ' ' ARG . 9.0 tmtt? -133.39 -85.03 0.45 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.61 -1.306 . . . . 0.0 110.387 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -142.3 23.91 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.871 -1.143 . . . . 0.0 110.115 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.43 ' O ' ' HE1' ' A' ' 124' ' ' MET . 0.6 OUTLIER -114.46 178.86 4.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.497 -0.752 . . . . 0.0 109.583 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.402 ' CE2' ' HG2' ' A' ' 124' ' ' MET . 0.2 OUTLIER -137.57 148.25 45.74 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.79 146.08 17.63 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.53 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 8.8 m120 -119.26 134.83 23.71 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.224 -1.162 . . . . 0.0 110.304 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 26' ' ' PHE . 46.0 Cg_endo -72.41 -44.38 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.024 1.539 . . . . 0.0 110.048 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' B' ' 25' ' ' PRO . 1.6 m-30 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.42 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.266 0.555 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.77 -22.39 43.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -56.81 101.24 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.328 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.535 ' CD1' ' HB2' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -133.17 -174.38 3.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 110.04 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.527 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 6.7 t -135.14 -5.2 2.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -0.946 . . . . 0.0 111.0 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.33 -43.52 11.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.968 -1.082 . . . . 0.0 110.507 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HB2' ' CD1' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -64.0 -63.01 1.27 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.213 -0.929 . . . . 0.0 110.234 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 13.6 pt20 -48.59 -39.38 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 109.836 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 5' ' ' THR . 12.7 mt -67.32 -29.76 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.464 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 7' ' ' GLU . . . -62.51 -55.78 24.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.315 -0.866 . . . . 0.0 109.634 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 13.1 pt-20 -56.94 -34.67 68.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 109.389 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.525 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 13.8 m-85 -73.6 -46.01 49.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.28 -0.888 . . . . 0.0 109.358 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 17' ' ' SER . 32.6 tptt -60.27 -44.07 95.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.287 -0.883 . . . . 0.0 109.212 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.32 -44.3 75.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.179 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.92 -56.69 18.94 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.42 -0.8 . . . . 0.0 109.531 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.548 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 15.2 t80 -55.81 -45.53 78.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.218 -0.926 . . . . 0.0 109.439 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -61.78 -38.49 88.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -0.76 . . . . 0.0 109.254 179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.544 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 10.1 tt -59.09 -27.74 65.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.495 -0.753 . . . . 0.0 109.624 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.538 ' CD1' HD21 ' A' ' 18' ' ' LEU . 4.7 m-85 -90.81 -49.87 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.95 76.99 1.67 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.5 -0.75 . . . . 0.0 110.228 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -52.27 -69.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.908 . . . . 0.0 110.183 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 6.8 p-10 -45.29 -29.19 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 54.83 6.04 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.467 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 2.0 p-10 -106.68 -34.17 7.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.179 -1.189 . . . . 0.0 110.185 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 26' ' ' THR . . . 124.56 7.79 6.1 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 32.0 p -141.85 117.62 10.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.217 -1.167 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.528 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 16.5 mt -76.87 128.67 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 110.336 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.16 161.59 14.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.411 -0.806 . . . . 0.0 110.264 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.468 HG21 HG13 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -58.56 -39.23 79.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.0 110.4 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 31' ' ' GLU . 3.7 tmtt? -65.66 -52.87 48.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.0 110.275 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' LYS . 10.1 mt-10 -43.15 -61.37 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 109.903 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.7 tp -56.25 -37.98 70.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.92 . . . . 0.0 109.668 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.51 -40.29 98.5 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 m -58.34 -41.63 85.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -1.061 . . . . 0.0 109.625 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.18 -53.2 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.44 ' HE1' ' HG2' ' B' ' 5' ' ' PRO . 36.7 mtt -55.66 -31.13 62.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.207 -0.933 . . . . 0.0 109.731 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.433 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -74.27 -25.61 59.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 109.82 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.507 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -76.58 -47.36 22.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.209 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mt -56.31 -53.02 62.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 110.254 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.44 58.93 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.511 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 1.5 mm-40 -139.33 -169.76 2.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.158 -1.201 . . . . 0.0 110.233 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 13.7 m120 -143.85 75.85 15.78 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.25 -0.906 . . . . 0.0 110.438 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HA ' HD13 ' B' ' 4' ' ' ILE . 47.3 Cg_endo -74.27 119.76 5.95 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.013 1.533 . . . . 0.0 110.274 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -76.36 154.31 35.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.283 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.34 -49.24 72.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.54 -54.3 47.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.321 -0.862 . . . . 0.0 110.143 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 5.0 mt-10 -56.64 -34.83 67.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -0.906 . . . . 0.0 110.042 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.0 mt -55.78 -54.3 46.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.063 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -31.0 69.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 109.775 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 95.3 m-20 -69.12 -41.51 77.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 110.068 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.447 ' CE ' ' CD1' ' B' ' 7' ' ' TRP . 1.9 ttp -73.6 -38.93 64.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.245 -0.91 . . . . 0.0 110.023 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.505 HD11 HG22 ' A' ' 52' ' ' ILE . 5.5 mm -66.18 -25.1 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.75 0.72 22.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.295 -0.878 . . . . 0.0 110.187 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.77 -13.18 25.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 110.079 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 57' ' ' ALA . 16.3 t -113.63 -35.12 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -45.44 89.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.474 -0.766 . . . . 0.0 110.371 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -85.63 -31.44 22.58 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.236 -0.915 . . . . 0.0 110.754 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 29.4 p-10 -83.13 -39.98 20.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.029 -1.044 . . . . 0.0 110.425 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 108.54 24.12 6.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' CG ' ' OD2' ' A' ' 58' ' ' ASP . 19.9 p-10 -95.12 -14.57 24.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -1.151 . . . . 0.0 110.177 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.82 -63.76 0.3 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 27' ' ' ILE . 1.3 p -76.54 165.02 25.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -1.115 . . . . 0.0 110.171 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.528 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 20.6 mm -90.81 149.8 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.548 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 24.6 t0 -115.3 162.36 17.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.933 . . . . 0.0 110.659 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.583 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 74.3 t80 -49.23 -46.16 76.5 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 0.0 111.333 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -69.93 -39.63 5.97 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.285 1.15 . . . . 0.0 110.406 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' CG ' ' HB1' ' A' ' 57' ' ' ALA . 1.9 mt-10 -57.58 -27.07 62.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.965 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.544 ' CZ ' HD11 ' B' ' 11' ' ' ILE . 45.4 t80 -83.27 -40.99 18.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.374 -0.829 . . . . 0.0 110.411 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.514 HD12 ' CE2' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -67.62 -15.78 63.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.275 -0.891 . . . . 0.0 110.819 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 p -100.23 -41.19 7.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.059 -1.026 . . . . 0.0 110.924 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 3.3 ppp? -66.49 -34.45 77.96 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.27 -0.894 . . . . 0.0 111.227 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.589 ' HE3' ' CZ ' ' B' ' 26' ' ' PHE . 13.2 tpt -66.67 -9.4 35.62 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.128 -0.983 . . . . 0.0 111.077 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.6 -9.85 13.19 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.978 -1.076 . . . . 0.0 111.11 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.441 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 1.8 ttm180 -97.1 -32.79 11.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.98 -1.075 . . . . 0.0 110.741 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -90.49 27.81 1.63 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.049 -1.032 . . . . 0.0 110.695 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.465 ' HE2' ' HE2' ' A' ' 72' ' ' MET . 0.0 OUTLIER -100.52 -79.67 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.074 -1.016 . . . . 0.0 110.627 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.34 55.45 3.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.232 -0.918 . . . . 0.0 110.702 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 74' ' ' ARG . 0.4 OUTLIER -104.88 -50.95 3.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.116 -0.99 . . . . 0.0 110.224 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.9 t -165.14 -37.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.087 -1.008 . . . . 0.0 110.392 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.27 83.51 7.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.21 -0.931 . . . . 0.0 110.234 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.8 p -79.56 -71.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.277 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -85.52 -10.06 56.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 110.445 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 36.1 mt-10 -66.95 -56.69 9.1 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.197 -0.94 . . . . 0.0 110.417 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -53.07 -28.51 25.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -0.93 . . . . 0.0 110.508 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' A' ' 141' ' ' PHE . 72.9 mt -66.78 -28.35 42.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.133 -0.98 . . . . 0.0 109.21 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 3.9 ttt-85 -66.52 -30.26 70.55 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.641 -0.662 . . . . 0.0 109.539 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 8.3 mt-10 -73.59 -48.99 28.52 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.343 -0.848 . . . . 0.0 109.496 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.431 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.62 -30.75 71.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -66.46 -49.91 65.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -31.49 69.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.383 -0.823 . . . . 0.0 109.544 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 11.6 t -61.06 -47.5 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.373 -0.829 . . . . 0.0 109.631 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 45.0 m-85 -67.96 -31.71 71.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.851 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 94' ' ' LYS . 7.2 t0 -80.77 55.35 2.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.2 -0.938 . . . . 0.0 110.173 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 93' ' ' ASP . 2.5 tmtt? -42.73 -32.28 0.58 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.33 -0.857 . . . . 0.0 110.538 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 4.8 p30 -90.08 -31.07 17.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.172 -0.955 . . . . 0.0 110.342 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 84.15 20.13 59.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 48.5 p30 -75.04 -15.33 60.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.042 -1.269 . . . . 0.0 109.97 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.568 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 92.79 33.17 7.56 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 33.5 m-85 -161.92 107.21 1.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -1.123 . . . . 0.0 110.233 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mt -69.19 124.98 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 110.11 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.56 161.94 17.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.973 . . . . 0.0 110.164 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.93 -37.28 66.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.101 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.5 -53.15 60.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.841 . . . . 0.0 110.033 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 24.0 mt-10 -56.19 -39.68 72.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.54 ' CD1' HD13 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -60.27 -38.5 83.76 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.301 -0.874 . . . . 0.0 109.486 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -36.78 82.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.556 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -64.99 -52.58 55.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 109.76 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.1 t -61.84 -28.58 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 109.159 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.499 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -67.51 -59.22 3.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.398 -0.814 . . . . 0.0 109.845 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -29.07 70.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.89 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 38' ' ' SER . 3.0 m120 -77.76 -6.52 54.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.422 -0.799 . . . . 0.0 110.064 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 12.7 mt -117.5 7.97 12.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -0.925 . . . . 0.0 110.869 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.16 -68.33 0.24 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.256 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 109' ' ' MET . 26.8 tt0 -92.03 161.91 14.58 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.046 -1.267 . . . . 0.0 111.532 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.459 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.0 OUTLIER -141.62 82.82 1.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.64 -0.663 . . . . 0.0 109.489 179.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 117' ' ' THR . 6.3 mp -38.29 140.11 0.33 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.451 -0.781 . . . . 0.0 111.1 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 116' ' ' LEU . 2.6 m -52.24 -171.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.427 -0.796 . . . . 0.0 110.08 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -83.21 -54.4 5.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 110.228 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -30.26 65.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 109.704 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.62 -52.9 11.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.211 -0.931 . . . . 0.0 108.929 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.411 HG21 ' CE ' ' A' ' 109' ' ' MET . 40.4 t -57.85 -34.67 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.423 -0.798 . . . . 0.0 109.466 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -62.17 -44.15 97.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.433 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 5.6 mm-40 -69.43 -29.15 66.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.399 -0.813 . . . . 0.0 109.519 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.593 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 10.2 ttt -65.94 -44.46 85.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.531 -0.731 . . . . 0.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.54 HD13 ' CD1' ' A' ' 105' ' ' LEU . 17.7 mm -75.98 -49.59 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.274 -0.891 . . . . 0.0 109.785 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -56.61 -47.83 78.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.89 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.5 mm-40 -61.73 -43.89 97.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.792 . . . . 0.0 109.917 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.25 -32.17 72.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.884 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.494 ' HB3' ' HA2' ' A' ' 132' ' ' GLY . 5.3 m-20 -71.6 100.69 2.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.384 -0.823 . . . . 0.0 110.051 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.434 HG13 ' OE1' ' A' ' 143' ' ' GLN . 40.0 mm -51.74 -36.53 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.217 -0.927 . . . . 0.0 110.243 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.421 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 17.3 p-10 -99.45 -25.1 14.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.295 -0.878 . . . . 0.0 110.383 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 69.62 51.91 23.3 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 5.7 p30 -85.46 -23.85 27.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.185 -1.185 . . . . 0.0 110.21 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 142.17 -10.26 2.51 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.28 166.58 10.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.028 -1.278 . . . . 0.0 110.698 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.523 HG11 ' CB ' ' A' ' 140' ' ' GLU . 2.9 t -102.54 154.43 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.397 -0.814 . . . . 0.0 109.871 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.454 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 17.0 p-10 -123.27 -145.71 0.35 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.186 -0.946 . . . . 0.0 110.399 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.85 -68.81 0.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 110.618 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -45.3 -46.28 12.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.219 -0.926 . . . . 0.0 110.653 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.523 ' CB ' HG11 ' A' ' 136' ' ' VAL . 35.7 mt-10 -61.02 -57.08 14.09 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.4 ' CE2' HG21 ' A' ' 85' ' ' ILE . 71.0 t80 -50.74 -20.71 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 145' ' ' MET . 73.2 t -93.9 -58.72 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.207 -0.933 . . . . 0.0 110.436 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.434 ' OE1' HG13 ' A' ' 130' ' ' ILE . 40.3 tt0 -42.12 -30.38 0.29 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.217 -0.927 . . . . 0.0 110.176 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.461 ' O ' ' N ' ' B' ' 24' ' ' ASN . 64.9 mtp -69.51 -30.96 68.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.052 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 142' ' ' VAL . 23.5 ttm -94.13 -28.66 15.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.355 -0.841 . . . . 0.0 110.391 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.2 p -88.78 29.99 0.97 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.411 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 148' ' ' LYS . . . -72.93 54.4 0.37 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.298 -0.876 . . . . 0.0 110.348 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.197 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.254 0.55 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -152.77 143.72 22.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -0.957 . . . . 0.0 110.538 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.495 ' O ' ' O ' ' B' ' 4' ' ' ILE . 0.1 OUTLIER -156.99 -48.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.955 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.512 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 12.0 mt 55.97 152.38 0.06 OUTLIER Pre-proline 0 N--CA 1.486 1.34 0 O-C-N 121.596 -0.69 . . . . 0.0 110.481 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.512 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 42.5 Cg_endo -71.68 139.64 34.3 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.642 1.338 . . . . 0.0 110.24 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.534 ' O ' ' N ' ' B' ' 8' ' ' THR . 46.4 t -90.33 64.09 5.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.306 -0.871 . . . . 0.0 111.036 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.538 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.3 OUTLIER 51.3 -85.43 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.209 -0.932 . . . . 0.0 110.659 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.534 ' N ' ' O ' ' B' ' 6' ' ' SER . 0.6 OUTLIER -43.46 -40.55 3.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.158 -0.964 . . . . 0.0 109.657 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 84.3 m -51.3 -53.5 35.18 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.438 -0.789 . . . . 0.0 109.51 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' B' ' 5' ' ' PRO . 18.6 t -52.79 -38.56 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.342 -0.849 . . . . 0.0 109.632 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.544 HD11 ' CZ ' ' A' ' 68' ' ' PHE . 12.1 mt -73.48 -25.77 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.281 -0.887 . . . . 0.0 109.727 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -48.69 65.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.4 -0.813 . . . . 0.0 109.668 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 86.4 t -63.77 -48.18 87.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.5 -0.75 . . . . 0.0 110.449 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.439 ' O ' ' HD2' ' B' ' 14' ' ' LYS . 30.4 tptt -54.98 -39.24 68.79 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.956 -1.09 . . . . 0.0 109.599 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 1.7 t -59.45 -40.07 85.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 109.61 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.498 ' CE ' ' HG3' ' B' ' 25' ' ' PRO . 0.2 OUTLIER -64.71 -27.85 69.19 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.39 -0.819 . . . . 0.0 110.087 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.499 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 6.3 mp -76.0 60.37 1.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.406 -0.808 . . . . 0.0 110.23 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -133.01 67.7 1.53 Allowed 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.53 -0.731 . . . . 0.0 111.36 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.529 ' CD ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER 60.97 -62.71 0.07 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.395 0.617 . . . . 0.0 111.478 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' B' ' 18' ' ' ARG . 1.2 ptm180 -143.79 4.35 1.31 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 111.023 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' B' ' 18' ' ' ARG . 23.0 m -64.23 86.59 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.815 -1.178 . . . . 0.0 109.893 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.593 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -126.43 -10.57 6.31 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.341 -0.849 . . . . 0.0 110.526 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' B' ' 24' ' ' ASN . . . -110.61 122.2 6.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 144' ' ' MET . 9.3 t-20 40.74 77.43 0.43 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.403 -1.057 . . . . 0.0 110.839 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.498 ' HG3' ' CE ' ' B' ' 16' ' ' MET . 47.7 Cg_endo -77.36 -9.71 17.53 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.0 1.526 . . . . 0.0 110.143 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.589 ' CZ ' ' HE3' ' A' ' 72' ' ' MET . 72.2 m-85 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.213 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.181 0.515 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -44.39 -31.71 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.128 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -99.9 139.39 35.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.354 -0.841 . . . . 0.0 110.16 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.98 149.62 46.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.142 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.406 HG21 HD13 ' A' ' 9' ' ' ILE . 9.5 t -55.78 135.52 51.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.469 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -99.15 -58.11 2.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.142 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 6' ' ' GLU . 3.0 tt0 -42.93 -65.34 0.49 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.256 -0.902 . . . . 0.0 110.194 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 7' ' ' GLU . 73.7 mm-40 -44.18 -61.11 1.6 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 5' ' ' THR . 48.2 mt -59.08 -48.85 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 6' ' ' GLU . . . -48.6 -45.41 38.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.842 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 2.8 tt0 -57.25 -56.81 17.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.85 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.422 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 9.0 m-85 -53.95 -33.07 55.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.337 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 3.7 tttp -64.25 -43.08 96.0 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.328 -0.858 . . . . 0.0 109.199 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 16.0 mt-10 -53.41 -49.5 67.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 109.61 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.99 -52.0 58.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.362 -0.836 . . . . 0.0 109.573 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.422 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 65.4 t80 -54.66 -40.83 69.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.601 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -71.82 -25.79 62.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.383 -0.823 . . . . 0.0 109.565 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 112' ' ' LEU . 2.7 tt -62.42 -39.64 93.94 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.364 -0.835 . . . . 0.0 109.706 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.434 ' CD1' HD13 ' A' ' 32' ' ' LEU . 49.8 m-85 -86.06 -27.66 24.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.382 -0.824 . . . . 0.0 110.305 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -92.19 100.12 12.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.171 -0.956 . . . . 0.0 110.394 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.37 -70.31 0.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.031 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.3 p-10 -52.69 -21.61 4.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 110.049 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.5 37.24 93.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.467 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 19.8 p-10 -80.09 -36.49 35.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.108 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 128.51 25.55 1.03 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 70.2 p -157.49 126.8 5.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.071 -1.252 . . . . 0.0 110.323 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.532 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 18.1 mt -97.55 122.12 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.141 -0.974 . . . . 0.0 110.015 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.8 p -90.46 175.86 6.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.811 . . . . 0.0 110.022 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.46 ' O ' HD12 ' A' ' 48' ' ' LEU . 34.5 p -69.59 -28.92 66.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 110.175 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -77.11 -50.77 12.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.096 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -48.24 -67.44 0.27 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.321 -0.862 . . . . 0.0 109.916 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 ' CZ2' ' B' ' 7' ' ' TRP . 22.5 tp -55.57 -43.62 76.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 109.794 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.43 -41.73 17.77 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.3 m -66.0 -54.87 20.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -1.066 . . . . 0.0 109.935 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.0 t -49.4 -39.0 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 109.801 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.448 ' HG3' ' HG3' ' A' ' 43' ' ' PRO . 5.2 mmt -62.74 -46.67 87.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.849 . . . . 0.0 109.274 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -51.8 -27.24 11.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.394 179.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -50.1 47.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.849 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 mt -54.55 -31.11 55.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.041 -1.037 . . . . 0.0 110.331 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.32 2.64 2.92 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.945 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -130.71 158.12 40.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.811 -1.405 . . . . 0.0 110.94 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -123.15 98.73 41.5 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 110.094 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.448 ' HG3' ' HG3' ' A' ' 36' ' ' MET . 43.0 Cg_endo -71.88 112.85 3.49 Favored 'Trans proline' 0 C--N 1.296 -2.232 0 O-C-N 124.148 1.604 . . . . 0.0 110.32 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.538 ' CG2' ' HG3' ' A' ' 47' ' ' GLU . 1.8 t -64.25 -166.59 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.677 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.447 ' N ' ' OG1' ' A' ' 44' ' ' THR . 0.1 OUTLIER -70.99 -60.94 1.96 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.424 -0.798 . . . . 0.0 110.219 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.56 -55.46 4.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.948 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.538 ' HG3' ' CG2' ' A' ' 44' ' ' THR . 2.2 mm-40 -55.68 -57.66 11.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.165 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 29' ' ' THR . 17.6 mt -45.53 -65.02 0.6 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.342 -0.849 . . . . 0.0 110.357 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -50.54 -25.29 3.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 110.325 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.12 -39.17 55.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.976 . . . . 0.0 110.081 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.571 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 1.7 mmm -80.67 -32.11 36.13 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.286 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 52' ' ' ILE . 10.7 mm -70.09 -36.77 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.073 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 56' ' ' ASP . 0.7 OUTLIER -54.19 -67.87 0.23 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.327 -0.858 . . . . 0.0 110.701 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 53' ' ' ASN . 27.1 mt-10 -41.17 -40.33 1.53 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.42 -0.8 . . . . 0.0 110.656 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.668 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 48.8 t -83.55 -16.29 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.928 . . . . 0.0 110.412 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASN . 33.7 t0 -66.04 66.78 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.534 ' HA ' ' NH2' ' A' ' 74' ' ' ARG . . . -41.74 -44.24 3.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.367 -0.833 . . . . 0.0 110.385 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.49 -35.68 34.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.33 -0.856 . . . . 0.0 110.039 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.453 ' HA2' ' OD2' ' A' ' 56' ' ' ASP . . . 92.42 28.45 12.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 24.7 p30 -95.41 -32.63 12.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.327 -1.102 . . . . 0.0 110.318 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 117.12 30.96 1.81 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.53 147.57 20.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -1.192 . . . . 0.0 110.106 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.538 HD11 ' CG1' ' A' ' 55' ' ' VAL . 6.9 mm -97.39 124.84 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.335 -0.853 . . . . 0.0 110.14 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -107.76 169.84 8.35 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.233 -0.917 . . . . 0.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.595 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 11.0 t80 -58.69 -47.75 98.14 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.27 -0.894 . . . . 0.0 110.895 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.0 Cg_endo -68.09 -37.02 15.58 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 O-C-N 123.263 1.138 . . . . 0.0 109.648 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.416 ' OE1' ' HB2' ' A' ' 57' ' ' ALA . 5.1 tt0 -60.87 -34.07 74.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.029 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.499 ' O ' ' HG3' ' A' ' 71' ' ' MET . 5.7 t80 -63.83 -51.5 64.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.464 -0.773 . . . . 0.0 109.258 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.79 -15.2 52.74 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.247 -0.908 . . . . 0.0 109.419 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 6.8 m -90.81 -50.77 5.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 110.594 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.509 ' HE1' ' N ' ' A' ' 72' ' ' MET . 0.1 OUTLIER -58.26 -24.97 61.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.054 -1.029 . . . . 0.0 109.68 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.567 ' HE2' ' CE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -65.53 -13.83 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 109.88 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 77' ' ' LYS . . . -115.31 -14.76 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 110.238 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.534 ' NH2' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -86.81 -29.06 22.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.242 -0.911 . . . . 0.0 110.175 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HG2' HG22 ' B' ' 8' ' ' THR . 32.1 tptt -80.43 -14.12 58.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.138 -0.976 . . . . 0.0 109.959 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.444 ' HE3' ' CD2' ' B' ' 26' ' ' PHE . 53.1 mtt -100.16 4.18 44.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 110.408 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 10.5 mttp -100.86 -2.88 30.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.135 -0.978 . . . . 0.0 110.297 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.54 ' O ' ' CG2' ' A' ' 79' ' ' THR . 0.7 OUTLIER -92.63 -55.15 3.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.281 -0.887 . . . . 0.0 109.754 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER 175.66 -96.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.608 -0.683 . . . . 0.0 109.305 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.55 ' HA ' ' CG ' ' A' ' 83' ' ' GLU . 13.0 m-20 33.27 75.22 0.05 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.383 -0.823 . . . . 0.0 111.489 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.43 -72.1 0.53 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.743 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -101.24 -9.44 21.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.315 -0.866 . . . . 0.0 110.828 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' CG ' ' HA ' ' A' ' 80' ' ' ASP . 6.9 pt-20 -76.18 -25.63 55.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.944 -1.098 . . . . 0.0 110.509 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 10.4 pt-20 -69.43 -37.21 77.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.157 -0.965 . . . . 0.0 110.31 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.492 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 20.6 mt -68.76 -37.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.108 -0.995 . . . . 0.0 109.011 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.67 -26.25 61.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HB3' ' OG1' ' B' ' 9' ' ' THR . 1.1 mt-10 -73.16 -58.44 3.31 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.464 -0.773 . . . . 0.0 109.185 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.87 -29.17 62.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.026 . . . . 0.0 109.2 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 4.7 t80 -64.81 -49.27 71.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.317 -0.864 . . . . 0.0 109.127 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -33.37 42.53 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.492 -0.755 . . . . 0.0 109.241 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.453 HG13 HG23 ' A' ' 108' ' ' VAL . 41.3 t -72.61 -33.25 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.533 -0.729 . . . . 0.0 110.361 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 141' ' ' PHE . 23.5 m-85 -75.29 -57.7 3.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.034 -1.041 . . . . 0.0 110.011 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 96' ' ' GLY . 20.6 t0 -84.53 53.41 2.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 110.437 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 93' ' ' ASP . 3.6 mtmt -46.39 -26.56 0.86 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.074 -1.016 . . . . 0.0 108.895 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 1.3 t0 -66.66 -35.55 80.43 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 67.37 35.29 87.23 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.489 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 33.2 p-10 -91.66 -24.12 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.043 -1.269 . . . . 0.0 109.741 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.544 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 120.65 15.93 4.75 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 2.9 m-85 -161.25 150.24 16.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.161 -1.199 . . . . 0.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 9.7 mt -107.86 131.84 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.379 -0.826 . . . . 0.0 110.273 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 102' ' ' ALA . 20.2 p -115.13 145.94 41.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.111 -0.993 . . . . 0.0 110.008 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.1 -28.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.35 -0.844 . . . . 0.0 110.043 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -69.44 -51.28 37.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.295 -0.878 . . . . 0.0 109.619 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.16 -39.12 71.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.24 -0.913 . . . . 0.0 109.454 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.573 HD22 ' CE1' ' A' ' 92' ' ' PHE . 1.2 mt -70.07 -36.34 74.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.437 -0.79 . . . . 0.0 109.785 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.45 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 17.3 ttt85 -66.36 -29.87 70.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.744 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -76.36 -33.6 58.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.806 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.453 HG23 HG13 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -79.85 -37.52 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.582 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.508 ' HG3' ' N ' ' A' ' 110' ' ' THR . 6.1 ptp -68.14 -36.48 79.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.508 ' N ' ' HG3' ' A' ' 109' ' ' MET . 68.1 m -70.18 -39.76 75.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.327 -0.858 . . . . 0.0 109.631 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -72.5 -14.48 61.67 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.355 -0.841 . . . . 0.0 109.437 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.466 ' O ' HD13 ' A' ' 18' ' ' LEU . 10.1 mt -86.57 -46.86 9.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.403 -0.81 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.29 -9.88 0.83 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.836 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp10 -127.65 150.48 49.72 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.734 -1.45 . . . . 0.0 110.857 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 116' ' ' LEU . 2.2 mttp -132.2 74.58 1.59 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.421 -0.8 . . . . 0.0 109.454 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.501 ' CG ' ' OE2' ' A' ' 120' ' ' GLU . 5.4 mp -38.64 144.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 110.652 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -57.47 -144.61 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.559 -0.713 . . . . 0.0 110.57 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -111.71 -38.58 4.83 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.019 -1.051 . . . . 0.0 111.212 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 4.8 pt-20 -70.87 -32.17 69.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.996 -1.065 . . . . 0.0 110.46 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.532 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 12.0 pt-20 -78.41 -40.47 35.9 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.13 -0.981 . . . . 0.0 109.4 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.496 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 9.7 t -63.37 -36.25 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.211 -0.931 . . . . 0.0 109.423 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.25 -48.4 65.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 0.0 109.434 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 2.3 mm-40 -63.25 -19.63 64.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.39 -0.819 . . . . 0.0 109.407 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.487 ' HE1' ' CD2' ' B' ' 22' ' ' PHE . 0.1 OUTLIER -77.88 -56.95 4.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -0.836 . . . . 0.0 109.791 179.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.532 HD13 ' CD1' ' A' ' 105' ' ' LEU . 22.8 mm -61.5 -43.5 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 109.483 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -64.21 -37.54 87.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.436 -0.79 . . . . 0.0 110.007 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 17.2 tp10 -70.9 -15.64 62.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.783 . . . . 0.0 110.111 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -94.57 -42.04 9.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 110.358 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD2' ' CG ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -56.03 80.59 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.442 -0.786 . . . . 0.0 110.361 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 128' ' ' ALA . 13.0 mt -50.31 -41.41 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.099 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.441 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 12.0 p-10 -80.39 -34.91 35.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.424 -0.798 . . . . 0.0 110.048 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.92 68.16 1.14 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 3.0 p30 -117.3 -14.15 10.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -1.202 . . . . 0.0 110.186 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.76 5.39 29.4 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 11.1 pt20 -170.05 169.26 8.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.225 -1.162 . . . . 0.0 110.445 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 26.0 t -100.34 159.1 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.212 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.566 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 57.5 t30 -128.63 173.3 10.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.257 -0.902 . . . . 0.0 110.243 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.53 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 38.4 t80 -55.71 -61.95 2.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 0.0 110.087 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.36 -31.73 15.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.401 ' HB3' HG11 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -81.43 -50.88 8.92 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.182 -0.949 . . . . 0.0 110.248 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.573 ' CE1' ' CD2' ' A' ' 92' ' ' PHE . 63.3 t80 -54.93 -17.78 4.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.995 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.444 ' O ' HG21 ' A' ' 146' ' ' THR . 14.7 t -97.4 -36.68 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 0.0 110.261 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -11.47 60.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.21 -0.931 . . . . 0.0 110.425 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.43 ' HE3' ' HA ' ' A' ' 128' ' ' ALA . 17.8 mmm -91.75 -25.69 18.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.174 -0.954 . . . . 0.0 110.267 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.493 ' HE1' ' CB ' ' B' ' 24' ' ' ASN . 6.5 mtp -98.79 -30.28 12.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.226 -0.921 . . . . 0.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.444 HG21 ' O ' ' A' ' 142' ' ' VAL . 35.0 p -85.83 19.9 2.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.72 53.84 1.9 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.367 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.235 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.437 HG22 ' O ' ' B' ' 1' ' ' VAL . 23.5 m . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.304 0.573 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.551 ' O ' ' CB ' ' B' ' 3' ' ' LEU . 21.6 mttp -68.94 118.66 12.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.287 -0.883 . . . . 0.0 110.408 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.563 ' O ' ' HB ' ' B' ' 4' ' ' ILE . 2.6 mt 160.55 94.85 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' B' ' 3' ' ' LEU . 10.6 mt 62.23 153.31 0.11 Allowed Pre-proline 0 N--CA 1.49 1.558 0 CA-C-O 121.006 0.432 . . . . 0.0 110.423 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.508 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 40.5 Cg_endo -66.71 -164.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 124.06 1.558 . . . . 0.0 110.996 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.429 ' C ' ' SD ' ' A' ' 51' ' ' MET . 0.1 OUTLIER -115.65 -148.89 0.44 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.311 -0.868 . . . . 0.0 110.797 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.668 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -91.7 -74.49 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 110.778 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.466 HG22 ' HG2' ' A' ' 75' ' ' LYS . 14.3 p -44.28 -43.25 7.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 110.094 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 87' ' ' GLU . 17.1 m -45.18 -54.03 7.43 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 109.777 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.03 -38.66 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.247 -0.908 . . . . 0.0 109.343 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.423 HD12 ' N ' ' B' ' 11' ' ' ILE . 5.3 mm -67.72 -39.27 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.361 -0.837 . . . . 0.0 109.957 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.578 HD22 ' CD2' ' B' ' 26' ' ' PHE . 12.7 mt -52.63 -56.09 17.82 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.347 -0.845 . . . . 0.0 109.958 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.504 ' O ' HD12 ' B' ' 17' ' ' LEU . 73.4 t -54.51 -54.7 19.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 110.33 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.413 ' HA ' HD23 ' B' ' 17' ' ' LEU . 3.7 tptt -55.71 -41.67 74.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.809 -1.182 . . . . 0.0 109.71 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 17.8 t -72.91 -6.0 42.27 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 109.865 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.579 ' SD ' ' CD1' ' B' ' 22' ' ' PHE . 35.0 tpp -83.97 -45.13 13.48 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.256 -0.902 . . . . 0.0 110.138 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.539 ' N ' HD21 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -96.06 33.67 1.68 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 118.383 -1.327 . . . . 0.0 110.234 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' B' ' 19' ' ' LYS . 1.5 ttt85 -42.5 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.49 0.662 . . . . 0.0 109.992 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.568 ' HD2' ' CG ' ' B' ' 20' ' ' ARG . 2.9 tmtm? -103.69 -84.66 0.47 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.141 -0.974 . . . . 0.0 110.387 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.568 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.4 OUTLIER -146.1 12.41 1.24 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.697 -1.252 . . . . 0.0 110.021 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.53 174.06 6.04 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.351 -0.843 . . . . 0.0 110.775 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.579 ' CD1' ' SD ' ' B' ' 16' ' ' MET . 0.2 OUTLIER -130.32 66.15 1.51 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.47 -0.769 . . . . 0.0 110.061 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.29 -173.97 13.24 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.493 ' CB ' ' HE1' ' A' ' 145' ' ' MET . 0.4 OUTLIER -176.71 118.59 0.28 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.369 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -79.74 35.69 0.58 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.829 1.437 . . . . 0.0 111.216 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.578 ' CD2' HD22 ' B' ' 12' ' ' LEU . 8.3 m-85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.901 -1.125 . . . . 0.0 110.388 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.214 0.53 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 2' ' ' ASP . 9.2 t70 -126.53 25.22 6.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.245 -0.909 . . . . 0.0 110.248 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -98.19 106.31 18.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.272 -0.892 . . . . 0.0 110.205 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 4' ' ' LEU . 1.1 tt -114.26 41.95 2.18 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.255 -0.903 . . . . 0.0 110.396 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.517 ' HB ' ' NE2' ' A' ' 8' ' ' GLN . 69.5 p -149.55 39.79 0.81 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.237 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -45.01 70.18 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.484 -0.76 . . . . 0.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.98 -66.5 0.38 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.517 ' NE2' ' HB ' ' A' ' 5' ' ' THR . 4.5 mt-30 -49.1 -58.39 5.03 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.255 -0.903 . . . . 0.0 110.122 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.9 mt -55.7 -54.45 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.191 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.72 -48.63 10.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.166 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.98 -49.01 74.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -0.926 . . . . 0.0 110.048 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.444 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 20.9 m-30 -63.69 -40.53 97.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.915 . . . . 0.0 110.112 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -54.91 -52.23 63.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.769 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 9.3 tp10 -60.04 -30.55 69.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.543 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 12' ' ' PHE . . . -69.28 -50.47 46.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.466 -0.771 . . . . 0.0 110.155 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.474 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 16.9 t80 -63.15 -36.93 85.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.607 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.2 m -75.36 -15.32 60.48 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.331 -0.856 . . . . 0.0 109.4 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.568 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 7.8 tt -74.21 -48.27 30.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.449 -0.782 . . . . 0.0 110.096 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.421 ' HB3' HG21 ' A' ' 27' ' ' ILE . 54.5 m-85 -69.57 -47.37 63.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.293 -0.879 . . . . 0.0 109.988 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 4.4 t0 -57.55 95.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.13 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 mmtp -52.44 -56.08 17.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.175 -0.953 . . . . 0.0 110.15 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 18.6 p-10 -76.62 -33.78 58.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.84 . . . . 0.0 110.328 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 95.06 41.34 4.06 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 32.3 p-10 -97.09 8.98 43.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.153 -1.204 . . . . 0.0 110.308 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.533 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 74.07 38.28 47.98 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 21.7 p -156.52 111.38 2.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.173 -1.192 . . . . 0.0 110.293 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.529 ' CD1' HG23 ' A' ' 63' ' ' ILE . 17.5 mt -86.85 123.14 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.085 -1.009 . . . . 0.0 110.365 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -100.43 164.87 11.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.4 -0.812 . . . . 0.0 109.543 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.497 HG22 ' NE2' ' A' ' 49' ' ' GLN . 18.7 p -65.75 -25.11 67.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.984 -1.073 . . . . 0.0 109.885 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.36 -45.0 49.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 109.994 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 35' ' ' VAL . 46.6 mt-10 -63.25 -66.16 0.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 109.992 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.421 ' HA ' HG22 ' A' ' 35' ' ' VAL . 21.2 tp -47.74 -45.03 28.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 110.06 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.28 -54.89 9.5 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 59.3 m -61.08 -36.32 79.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -1.055 . . . . 0.0 110.036 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 31' ' ' GLU . 19.3 t -62.69 -43.94 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.92 . . . . 0.0 110.084 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.5 mmm -66.48 -28.72 68.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.283 -0.886 . . . . 0.0 110.041 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 tpt85 -72.5 -29.43 63.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.324 -0.86 . . . . 0.0 110.245 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -58.39 -48.9 79.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 110.555 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.411 HD22 HG23 ' A' ' 108' ' ' VAL . 2.6 mt -57.25 -23.47 48.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.182 -0.949 . . . . 0.0 110.2 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.403 ' O ' ' OE1' ' A' ' 41' ' ' GLN . . . 106.34 70.87 0.76 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.403 ' OE1' ' O ' ' A' ' 40' ' ' GLY . 13.7 mm100 -153.26 -172.14 4.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.233 -1.157 . . . . 0.0 110.153 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.05 78.88 45.91 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.207 -0.933 . . . . 0.0 110.533 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.22 135.69 25.33 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.074 1.565 . . . . 0.0 110.228 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.1 m -97.98 146.1 25.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -0.927 . . . . 0.0 110.237 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -49.42 -47.55 47.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.15 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.47 -48.21 74.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.951 . . . . 0.0 110.193 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.22 -32.79 74.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.951 . . . . 0.0 110.247 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.9 mt -61.07 -51.04 70.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 110.406 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.497 ' NE2' HG22 ' A' ' 29' ' ' THR . 0.1 OUTLIER -62.92 -36.91 84.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.336 -0.852 . . . . 0.0 110.203 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -71.15 -32.05 68.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 109.871 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.635 ' CE ' ' CD1' ' B' ' 7' ' ' TRP . 3.9 mmm -69.47 -36.03 76.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 109.965 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.527 HG12 ' CD1' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -89.69 -12.05 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.626 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.67 -37.17 72.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.0 110.254 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.04 -32.48 15.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.409 -0.807 . . . . 0.0 110.464 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.648 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 15.6 t -69.74 -31.51 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.093 -1.005 . . . . 0.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.4 t0 -76.84 49.41 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.127 -0.983 . . . . 0.0 110.217 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -44.05 -29.82 0.65 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 110.377 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 2.7 t0 -61.93 -61.83 2.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.725 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.18 25.19 3.92 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 54.8 p30 -99.04 -14.62 19.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.943 -1.327 . . . . 0.0 110.112 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 105.75 -34.42 5.78 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.515 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 12.7 p -106.44 161.06 14.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.157 -1.202 . . . . 0.0 110.414 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.529 HG23 ' CD1' ' A' ' 27' ' ' ILE . 25.6 mm -86.44 144.29 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.295 -0.878 . . . . 0.0 110.578 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 6.7 t70 -122.25 165.42 16.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.489 -0.757 . . . . 0.0 110.046 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.588 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 14.8 t80 -59.07 -43.35 97.24 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.235 -0.916 . . . . 0.0 111.625 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.4 Cg_endo -72.82 -30.31 11.53 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.37 1.194 . . . . 0.0 110.555 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 64' ' ' ASP . 17.0 mt-10 -68.64 -44.39 74.25 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.081 -1.012 . . . . 0.0 109.534 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CZ ' HG13 ' B' ' 11' ' ' ILE . 33.9 t80 -61.02 -45.23 95.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 0.0 110.036 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.6 -36.28 75.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.192 -0.942 . . . . 0.0 110.421 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -71.79 -26.91 62.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.249 -0.907 . . . . 0.0 110.576 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -71.5 -62.26 1.47 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 110.555 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.541 ' HE2' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -50.46 -20.47 1.14 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.222 -0.924 . . . . 0.0 110.157 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.4 -21.69 20.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.191 -0.943 . . . . 0.0 110.268 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtt85 -98.36 -20.07 17.38 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.194 -0.941 . . . . 0.0 110.503 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -76.92 -35.88 57.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.933 . . . . 0.0 109.927 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.585 ' HE2' ' CD1' ' B' ' 26' ' ' PHE . 15.4 mtt -90.11 42.21 1.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.888 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -96.86 -51.05 4.41 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.358 -0.839 . . . . 0.0 110.258 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 47.7 t0 -177.19 59.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 110.394 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.41 -81.65 0.29 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.464 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 3.8 m-20 -94.23 90.9 6.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.326 -0.859 . . . . 0.0 110.152 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 m -86.57 -62.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.953 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -100.44 -9.75 21.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.285 -0.884 . . . . 0.0 110.564 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 80' ' ' ASP . 3.9 pt-20 -84.79 -9.74 57.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.142 -0.973 . . . . 0.0 110.469 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -85.49 -27.36 25.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.084 -1.01 . . . . 0.0 110.088 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.547 ' CD1' ' CG2' ' A' ' 146' ' ' THR . 5.3 mt -73.25 -38.0 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.082 -1.011 . . . . 0.0 109.024 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -57.2 -31.46 65.49 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.446 ' OE2' ' O ' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -67.69 -58.89 3.87 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.556 -0.715 . . . . 0.0 109.293 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.17 -30.09 48.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 109.426 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -74.34 -31.49 62.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -0.888 . . . . 0.0 109.216 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.47 -22.42 64.56 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.534 -0.729 . . . . 0.0 109.467 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.5 ' CG1' HG22 ' A' ' 108' ' ' VAL . 23.6 t -91.12 -28.75 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 0.0 110.476 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.601 ' CE1' HG12 ' A' ' 108' ' ' VAL . 4.0 m-85 -77.92 -30.05 50.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.076 -1.015 . . . . 0.0 109.964 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -96.36 63.27 2.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.315 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ASP . 5.6 mmpp? -41.12 -28.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.512 -0.742 . . . . 0.0 110.079 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.479 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 7.9 m-20 -82.96 -39.47 21.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.357 -0.839 . . . . 0.0 109.686 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 77.23 26.61 61.41 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.479 ' OD1' ' HB2' ' A' ' 95' ' ' ASP . 5.9 p-10 -86.65 -44.18 12.05 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -1.22 . . . . 0.0 109.931 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.591 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 143.62 27.61 0.13 Allowed Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.827 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 41.3 m-85 -161.2 136.92 7.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.924 -1.339 . . . . 0.0 110.174 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 11.1 mt -101.0 123.24 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.257 -0.902 . . . . 0.0 109.969 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 61.8 p -105.19 140.61 38.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.38 -34.81 0.87 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.383 -0.823 . . . . 0.0 109.999 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.6 -51.04 70.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.855 . . . . 0.0 109.761 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -57.08 -43.1 81.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.78 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 109' ' ' MET . 0.7 OUTLIER -58.94 -37.35 76.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.768 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -61.35 -37.38 83.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -63.82 -44.32 93.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.459 -0.775 . . . . 0.0 109.808 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.601 HG12 ' CE1' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -82.62 -28.67 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.442 -0.786 . . . . 0.0 109.284 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.492 ' HE3' HG21 ' A' ' 121' ' ' VAL . 31.7 ttm -65.51 -57.06 9.15 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.578 -0.701 . . . . 0.0 110.14 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 m -67.53 -32.4 73.16 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.248 -0.907 . . . . 0.0 110.316 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 6.4 m120 -76.81 1.79 16.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.002 -1.061 . . . . 0.0 109.29 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.581 ' CD1' ' CG1' ' B' ' 13' ' ' VAL . 7.0 mt -111.75 4.37 18.41 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.372 -0.83 . . . . 0.0 110.601 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.76 -75.97 0.41 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.609 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp10 -94.6 154.27 17.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -1.133 . . . . 0.0 111.099 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 1.3 pttm -129.45 74.43 1.58 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' A' ' 115' ' ' LYS . 5.9 mp -34.27 154.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.391 0.615 . . . . 0.0 110.965 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -59.81 -144.23 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.299 -0.876 . . . . 0.0 110.097 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -108.53 -59.34 1.88 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.218 -0.926 . . . . 0.0 110.139 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -48.87 -45.24 40.75 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.069 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.31 -50.58 73.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.89 . . . . 0.0 109.924 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.492 HG21 ' HE3' ' A' ' 109' ' ' MET . 43.5 t -57.64 -38.26 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.86 -45.61 70.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.902 . . . . 0.0 109.796 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 1.8 tt0 -64.84 -23.18 67.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.456 -0.778 . . . . 0.0 109.89 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.403 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 1.8 ttt -73.06 -43.79 61.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.843 . . . . 0.0 109.945 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.459 HD13 HD13 ' A' ' 105' ' ' LEU . 45.0 mm -69.93 -42.13 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 110.185 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.453 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 33.9 mtt-85 -66.25 -44.55 83.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.266 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 7.6 mm-40 -48.19 -32.15 6.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.392 -0.818 . . . . 0.0 110.25 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -100.69 -30.57 11.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 110.162 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -56.72 83.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.343 -0.848 . . . . 0.0 110.613 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -65.28 -42.35 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.9 p-10 -70.68 -33.5 70.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 109.844 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 87.02 56.55 2.17 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.456 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 25.7 p30 -112.98 0.12 14.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -1.211 . . . . 0.0 109.864 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 135' ' ' GLN . . . 76.71 -1.72 61.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 100' ' ' ILE . 33.0 mt-30 -139.55 138.52 36.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.142 -1.21 . . . . 0.0 110.25 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 t -89.37 154.74 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.108 -0.995 . . . . 0.0 109.724 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.43 ' OD1' ' HG3' ' A' ' 139' ' ' GLU . 55.9 p30 -130.09 -142.32 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 110.581 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.71 -68.58 0.69 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.391 -0.818 . . . . 0.0 110.697 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -46.74 -25.06 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.23 -0.919 . . . . 0.0 110.792 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.474 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 38.0 mt-10 -83.13 -61.09 1.95 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.008 . . . . 0.0 109.726 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -51.23 -19.52 1.25 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 110.29 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 144' ' ' MET . 55.5 t -100.93 -70.21 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.264 -0.898 . . . . 0.0 111.455 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.532 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -39.74 -24.73 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.103 -0.998 . . . . 0.0 111.787 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.532 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 77.7 mmm -88.62 -39.25 14.21 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.745 -1.222 . . . . 0.0 111.395 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.49 ' HE3' ' HB3' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.39 -9.69 21.96 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.989 -1.069 . . . . 0.0 111.895 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.595 ' O ' ' N ' ' A' ' 148' ' ' LYS . 1.3 p -120.47 -26.4 5.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.721 -1.237 . . . . 0.0 111.06 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 146' ' ' THR . . . -7.85 72.87 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.85 0 CA-C-O 121.677 0.751 . . . . 0.0 112.27 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 146' ' ' THR . 4.4 ptmt . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.271 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' B' ' 2' ' ' LYS . 5.6 m . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.337 0.589 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' B' ' 1' ' ' VAL . 0.0 OUTLIER 56.29 90.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.381 -0.824 . . . . 0.0 110.934 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.07 -17.83 4.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.513 HD11 ' HD2' ' B' ' 5' ' ' PRO . 0.2 OUTLIER -51.44 143.05 20.03 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.513 ' HD2' HD11 ' B' ' 4' ' ' ILE . 38.5 Cg_endo -65.9 -155.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.825 1.434 . . . . 0.0 110.176 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.466 ' O ' HG22 ' B' ' 10' ' ' VAL . 6.6 m -121.94 -147.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.933 -1.104 . . . . 0.0 111.333 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.648 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 4.8 m95 -81.91 -76.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.547 0.689 . . . . 0.0 111.282 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.407 ' O ' ' C ' ' B' ' 9' ' ' THR . 30.2 p -43.86 -42.82 5.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.811 . . . . 0.0 110.3 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 87' ' ' GLU . 53.6 m -46.29 -41.41 13.13 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 109.292 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.466 HG22 ' O ' ' B' ' 6' ' ' SER . 46.2 t -69.32 -41.06 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.359 -0.838 . . . . 0.0 109.863 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.495 HD12 ' N ' ' B' ' 11' ' ' ILE . 5.6 mm -72.76 -25.69 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.248 -0.907 . . . . 0.0 109.874 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.591 ' CD1' ' CD2' ' B' ' 26' ' ' PHE . 1.3 mm? -65.97 -53.41 39.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.694 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.581 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 53.2 t -61.02 -48.9 86.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.152 -0.968 . . . . 0.0 109.766 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -35.69 43.17 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.844 -1.16 . . . . 0.0 108.965 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 5.3 t -65.24 -34.85 79.33 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.514 -0.741 . . . . 0.0 109.365 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.412 ' CG ' ' CE1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -57.32 -43.81 83.65 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.401 -0.812 . . . . 0.0 109.518 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 19' ' ' LYS . 4.1 mp -58.16 -94.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 109.688 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 58.15 -76.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.518 -0.739 . . . . 0.0 110.6 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER 175.63 107.59 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.887 -0.508 . . . . 0.0 110.842 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.7 OUTLIER 40.16 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.464 -0.773 . . . . 0.0 110.947 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.518 ' N ' ' O ' ' B' ' 19' ' ' LYS . 2.2 m -107.62 141.16 39.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.983 -1.073 . . . . 0.0 110.29 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.412 ' CE1' ' CG ' ' B' ' 16' ' ' MET . 0.1 OUTLIER -142.21 12.67 1.99 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.196 -0.94 . . . . 0.0 110.208 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' B' ' 24' ' ' ASN . . . -77.96 -61.44 2.53 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.49 ' HB3' ' HE3' ' A' ' 145' ' ' MET . 1.8 m-80 55.4 69.06 2.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.3 -1.118 . . . . 0.0 110.068 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.45 62.47 4.43 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 O-C-N 123.967 1.509 . . . . 0.0 110.04 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.591 ' CD2' ' CD1' ' B' ' 12' ' ' LEU . 1.1 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.189 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.249 0.547 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 59.07 95.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.207 -0.933 . . . . 0.0 110.146 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -98.16 84.75 3.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.7 118.55 26.18 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.351 -0.843 . . . . 0.0 110.273 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.462 ' O ' HD11 ' A' ' 9' ' ' ILE . 2.8 p -104.33 95.43 5.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.288 -0.882 . . . . 0.0 110.324 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.51 -32.47 67.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.122 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -54.49 -52.55 61.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 109.943 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -53.19 59.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.711 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.462 HD11 ' O ' ' A' ' 5' ' ' THR . 1.5 mp -54.07 -39.58 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 7' ' ' GLU . . . -55.45 -51.82 65.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.484 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -48.91 -49.11 41.53 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.363 -0.835 . . . . 0.0 109.256 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -60.59 -44.79 95.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.386 -0.821 . . . . 0.0 109.345 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 10.6 tptm -57.26 -36.6 71.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.368 -0.833 . . . . 0.0 109.227 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -59.74 -52.56 64.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.604 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -52.61 -41.88 64.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 0.0 109.492 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 31.8 t80 -65.62 -43.66 88.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.491 -0.756 . . . . 0.0 109.509 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -69.87 -25.35 63.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 109.615 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 112' ' ' LEU . 10.3 tt -67.47 -42.29 83.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.447 -0.783 . . . . 0.0 109.798 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.16 -39.22 65.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 109.762 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -62.94 89.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.412 -0.805 . . . . 0.0 110.226 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -88.33 30.66 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.224 -0.922 . . . . 0.0 110.133 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 9.4 p-10 -143.65 -41.53 0.29 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.241 -0.912 . . . . 0.0 110.325 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 102.93 90.94 2.17 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.1 p-10 -164.07 -43.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.195 -1.179 . . . . 0.0 110.409 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.4 17.65 6.53 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -143.85 119.52 10.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.194 -1.18 . . . . 0.0 110.351 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.462 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 5.9 mt -82.09 115.97 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.083 -1.011 . . . . 0.0 109.943 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 9.0 p -80.35 -174.29 4.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.678 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.0 -49.88 26.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.159 -0.963 . . . . 0.0 110.179 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' GLU . 4.8 ttmt -68.32 -40.9 81.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.484 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 8.2 mt-10 -43.98 -48.78 8.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.13 -0.981 . . . . 0.0 109.594 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -71.39 -34.52 70.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.314 -0.867 . . . . 0.0 109.366 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -59.45 -46.81 93.32 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 99.5 m -58.71 -54.35 48.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -1.094 . . . . 0.0 109.159 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 t -56.76 -35.47 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.37 -0.831 . . . . 0.0 109.363 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.0 mmt -63.56 -49.56 72.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.461 -0.774 . . . . 0.0 109.697 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -54.09 -30.46 48.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.876 . . . . 0.0 109.5 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.446 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 1.3 m -54.96 -50.17 69.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.439 -0.788 . . . . 0.0 110.132 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.1 mt -52.15 -36.64 52.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.109 -0.995 . . . . 0.0 109.673 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.468 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 117.45 64.87 0.33 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 40' ' ' GLY . 6.3 mt-30 -156.81 -166.28 2.06 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.227 -1.161 . . . . 0.0 110.376 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -126.6 82.0 67.51 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.224 -0.922 . . . . 0.0 110.667 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.481 ' HA ' HD12 ' B' ' 4' ' ' ILE . 46.3 Cg_endo -73.9 102.58 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.908 1.478 . . . . 0.0 110.438 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.49 ' CG2' ' HG3' ' A' ' 47' ' ' GLU . 11.4 t -79.63 172.09 14.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.187 -0.946 . . . . 0.0 110.084 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -78.78 -25.67 44.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.158 -0.964 . . . . 0.0 110.482 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.09 -65.43 0.7 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.034 -1.041 . . . . 0.0 110.178 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' HG3' ' CG2' ' A' ' 44' ' ' THR . 0.9 OUTLIER -52.7 -44.96 66.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 109.879 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.7 OUTLIER -50.96 -42.94 60.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.907 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -45.64 92.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.423 -0.798 . . . . 0.0 109.8 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.76 -13.97 62.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 110.062 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.576 ' HE2' ' CG ' ' B' ' 7' ' ' TRP . 2.4 mmm -94.26 -46.37 7.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.439 HG21 ' N ' ' A' ' 53' ' ' ASN . 1.2 tp -60.69 -37.96 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.242 -0.911 . . . . 0.0 110.035 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.439 ' N ' HG21 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -51.11 -29.78 14.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 110.284 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -65.24 -56.33 13.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.024 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG13 ' CG2' ' A' ' 63' ' ' ILE . 15.2 t -70.78 -14.49 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.126 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.4 77.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 110.384 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . . . -56.9 -63.81 1.08 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 0.0 110.32 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 7.0 p-10 -66.4 -43.9 84.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.97 . . . . 0.0 110.191 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.68 41.09 1.64 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 34.9 p-10 -99.51 -42.72 6.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.093 -1.239 . . . . 0.0 110.27 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 136.23 -14.34 4.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 22.0 p -118.36 160.89 20.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.135 -1.215 . . . . 0.0 110.538 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.513 ' CG2' HG13 ' A' ' 55' ' ' VAL . 8.0 mm -97.85 152.63 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 109.905 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 2.0 m-20 -131.57 148.22 52.6 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.188 -0.945 . . . . 0.0 110.535 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.625 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 37.6 t80 -40.58 -51.22 6.8 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.281 -0.887 . . . . 0.0 111.172 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.9 Cg_endo -66.09 -33.07 42.14 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.325 1.171 . . . . 0.0 110.04 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HG2' ' CB ' ' A' ' 57' ' ' ALA . 3.2 mt-10 -69.84 -30.03 67.42 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.312 -0.868 . . . . 0.0 109.467 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 56.8 t80 -65.54 -54.71 24.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.468 -0.77 . . . . 0.0 109.978 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.468 ' CD1' ' O ' ' A' ' 65' ' ' PHE . 1.3 mp -53.6 -48.75 68.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.383 -0.823 . . . . 0.0 110.066 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -27.99 69.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 110.247 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.574 ' CE ' ' HB3' ' B' ' 7' ' ' TRP . 0.1 OUTLIER -61.88 -60.41 3.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.42 -0.8 . . . . 0.0 111.023 -179.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.648 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 41.1 mmm -51.5 -16.51 0.61 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.101 -1.0 . . . . 0.0 111.076 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.73 -9.37 54.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.808 -1.182 . . . . 0.0 110.452 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 9.4 ttt85 -95.78 -42.62 8.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.094 -1.004 . . . . 0.0 111.375 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.519 ' CB ' HG23 ' B' ' 8' ' ' THR . 4.8 mmtp -69.22 -26.24 64.71 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.088 -1.007 . . . . 0.0 111.04 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.497 ' CG ' ' O ' ' A' ' 72' ' ' MET . 19.8 mmt -65.72 -27.39 68.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.205 -0.934 . . . . 0.0 110.754 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 71.4 1.44 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -0.968 . . . . 0.0 110.168 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.436 ' O ' ' HB ' ' A' ' 79' ' ' THR . 5.3 t70 -144.16 -55.44 0.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.025 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 7.3 t -178.06 33.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.386 -0.821 . . . . 0.0 110.081 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 79' ' ' THR . 1.6 t70 -179.82 71.82 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.372 -0.83 . . . . 0.0 109.823 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 t -83.31 -64.96 1.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.384 -0.823 . . . . 0.0 110.518 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' HG2' ' OG1' ' A' ' 146' ' ' THR . 0.2 OUTLIER -85.58 -25.51 26.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.372 -0.83 . . . . 0.0 110.593 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.456 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -59.84 -15.37 20.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.05 -1.032 . . . . 0.0 109.919 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.541 ' HG2' ' CD2' ' B' ' 12' ' ' LEU . 10.8 tt0 -68.63 -33.83 74.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.497 -0.752 . . . . 0.0 110.561 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.528 ' CD1' ' HB ' ' A' ' 146' ' ' THR . 49.9 mt -60.61 -30.53 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.214 -0.929 . . . . 0.0 109.174 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -63.41 -33.57 75.83 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.737 -0.602 . . . . 0.0 110.21 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.561 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 1.2 mp0 -73.25 -48.06 37.98 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.105 -0.997 . . . . 0.0 109.901 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -60.83 -27.68 68.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.032 . . . . 0.0 109.948 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.587 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 64.4 t80 -70.21 -49.13 53.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.929 -1.107 . . . . 0.0 108.949 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -52.12 -30.19 25.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.484 -0.76 . . . . 0.0 109.078 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 40.8 t -69.34 -47.79 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.498 -0.751 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.562 ' CZ ' ' HE2' ' B' ' 16' ' ' MET . 52.2 m-85 -62.4 -43.48 98.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.917 -1.115 . . . . 0.0 110.263 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -68.41 58.03 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 0.0 110.096 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 92' ' ' PHE . 7.2 tttm -40.89 -62.53 0.8 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 110.515 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 30.2 p-10 -63.64 -41.43 98.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.207 -0.933 . . . . 0.0 110.214 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 100.07 40.36 3.08 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -99.08 -21.07 16.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.233 -1.157 . . . . 0.0 110.265 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.56 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 101.36 33.87 4.69 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.56 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 53.3 m-85 -159.22 149.27 19.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.312 -1.111 . . . . 0.0 110.113 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 11.5 mt -116.55 153.78 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.125 -0.985 . . . . 0.0 110.543 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 102' ' ' ALA . 12.0 t -145.8 154.18 41.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.437 -0.789 . . . . 0.0 109.76 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.42 -28.81 0.6 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.955 . . . . 0.0 110.083 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.5 -51.34 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.803 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 92' ' ' PHE . 21.1 mt-10 -58.77 -35.91 73.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.879 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.57 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 0.8 OUTLIER -65.16 -41.15 94.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.611 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.443 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 1.5 tpp180 -64.33 -24.13 67.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -79.28 -31.68 43.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.45 -0.781 . . . . 0.0 110.217 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.423 HG22 HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -85.4 -30.62 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.266 -0.897 . . . . 0.0 109.995 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.552 ' CB ' HD22 ' B' ' 17' ' ' LEU . 5.0 ptp -74.41 -40.9 61.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.505 ' N ' ' HG3' ' A' ' 109' ' ' MET . 93.9 m -71.62 -23.45 61.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.134 -0.979 . . . . 0.0 109.62 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 38' ' ' SER . 22.3 m-20 -84.98 -8.48 58.72 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.194 -0.941 . . . . 0.0 109.848 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.49 ' CD1' HG11 ' B' ' 13' ' ' VAL . 6.4 mt -97.78 -38.29 9.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 110.316 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.74 -26.99 1.18 Allowed Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.586 -1.292 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 109' ' ' MET . 21.1 tt0 -113.56 166.02 11.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.887 -1.361 . . . . 0.0 110.826 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -146.12 72.19 1.29 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.493 -0.754 . . . . 0.0 109.234 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 117' ' ' THR . 2.9 mp -36.47 148.09 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.466 0.65 . . . . 0.0 111.16 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -56.46 -157.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.524 -0.735 . . . . 0.0 110.01 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -95.47 -68.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.03 -1.044 . . . . 0.0 110.312 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -43.5 -46.27 6.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.012 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -59.79 -52.11 66.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.714 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 117' ' ' THR . 83.0 t -60.18 -38.26 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 0.0 110.175 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -66.27 -63.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.0 109.875 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 122' ' ' ASP . 13.3 mm-40 -46.11 -26.57 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.365 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.64 ' CE ' ' CD2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.44 -55.12 17.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.499 -0.751 . . . . 0.0 110.183 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.57 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 44.5 mm -62.85 -22.58 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.414 -0.804 . . . . 0.0 110.244 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.427 ' C ' ' HD3' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -81.43 -38.98 25.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.194 -0.941 . . . . 0.0 110.158 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.34 -7.04 33.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 110.057 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -112.89 -32.09 6.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.19 -0.944 . . . . 0.0 110.334 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.94 83.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.313 -0.867 . . . . 0.0 110.513 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 128' ' ' ALA . 0.9 OUTLIER -61.67 -28.94 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 0.0 109.461 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -85.53 -25.24 26.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.611 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.68 57.59 7.87 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 18.2 p-10 -120.88 -28.15 4.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -1.126 . . . . 0.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.404 ' C ' ' OE1' ' A' ' 135' ' ' GLN . . . 126.37 9.04 4.69 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.154 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.467 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 1.6 pm0 -165.14 166.86 18.73 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.931 -1.335 . . . . 0.0 110.381 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 24.1 t -110.1 168.42 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 110.413 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -141.91 173.34 11.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.382 -0.824 . . . . 0.0 109.694 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 139' ' ' GLU . 12.3 t80 -53.31 -56.89 13.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.107 -0.996 . . . . 0.0 109.965 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 2.8 tt0 -44.08 -47.87 8.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -69.51 -57.09 5.66 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.319 -0.863 . . . . 0.0 110.324 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.587 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 45.7 t80 -51.96 -19.76 1.99 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.291 -0.881 . . . . 0.0 110.326 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.595 ' CG1' ' CG2' ' A' ' 146' ' ' THR . 44.6 t -97.86 -43.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.212 -0.93 . . . . 0.0 110.483 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -65.32 -9.89 28.2 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.041 -1.037 . . . . 0.0 110.146 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.523 ' HE3' ' CD1' ' A' ' 130' ' ' ILE . 2.2 ttm -92.8 -37.96 12.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.669 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.46 -62.17 1.28 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.211 -0.93 . . . . 0.0 111.198 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.595 ' CG2' ' CG1' ' A' ' 142' ' ' VAL . 15.2 t -76.53 50.38 0.66 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.151 -0.968 . . . . 0.0 111.151 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.91 51.12 1.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.134 -0.978 . . . . 0.0 109.953 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.276 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.51 ' CG1' ' HD2' ' B' ' 2' ' ' LYS . 8.3 p . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.202 0.525 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.51 ' HD2' ' CG1' ' B' ' 1' ' ' VAL . 0.1 OUTLIER -66.74 111.71 3.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.243 -0.911 . . . . 0.0 109.899 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mt -136.05 -62.97 0.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 110.81 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 81.5 mt -140.6 148.82 54.77 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.127 -0.983 . . . . 0.0 110.899 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 49.5 Cg_endo -74.78 -157.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 124.148 1.604 . . . . 0.0 109.403 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.546 ' CB ' ' OG1' ' B' ' 9' ' ' THR . 0.2 OUTLIER -123.47 -175.04 3.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.975 -1.078 . . . . 0.0 110.648 179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.576 ' CG ' ' HE2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -80.35 -79.1 0.15 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.565 -0.709 . . . . 0.0 111.094 -179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.519 HG23 ' CB ' ' A' ' 75' ' ' LYS . 6.6 p -45.16 -23.74 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.866 -1.146 . . . . 0.0 110.043 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.561 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -63.46 -60.19 3.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.072 -1.017 . . . . 0.0 109.154 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.565 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 32.9 m -48.89 -28.36 2.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.736 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.498 ' N ' HG21 ' B' ' 10' ' ' VAL . 6.8 mm -79.77 -33.8 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.541 ' CD2' ' HG2' ' A' ' 84' ' ' GLU . 4.2 mp -60.39 -60.96 2.99 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.673 -0.642 . . . . 0.0 109.989 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.49 HG11 ' CD1' ' A' ' 112' ' ' LEU . 78.6 t -60.14 -38.88 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -67.53 -21.78 65.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.83 -1.168 . . . . 0.0 110.214 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.44 -36.68 33.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.562 ' HE2' ' CZ ' ' A' ' 92' ' ' PHE . 0.2 OUTLIER -75.19 -20.65 59.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.226 -0.921 . . . . 0.0 110.255 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.552 HD22 ' CB ' ' A' ' 109' ' ' MET . 3.3 mp -75.69 1.83 13.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.177 -0.952 . . . . 0.0 110.514 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' B' ' 17' ' ' LEU . 14.2 ttm180 -35.61 -69.71 0.1 Allowed 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.208 0.527 . . . . 0.0 110.782 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -154.0 -69.1 0.14 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.084 -1.01 . . . . 0.0 110.362 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.519 ' N ' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -133.42 12.29 4.15 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 109.841 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 4.5 t -80.84 142.41 33.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.421 -0.799 . . . . 0.0 110.175 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.64 ' CD2' ' CE ' ' A' ' 124' ' ' MET . 0.4 OUTLIER -143.88 -33.8 0.41 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.343 -0.848 . . . . 0.0 110.411 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.476 ' HA2' ' HG2' ' A' ' 144' ' ' MET . . . -64.9 -100.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -112.56 101.66 53.01 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.207 -1.172 . . . . 0.0 110.543 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.15 -18.9 12.47 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.126 1.593 . . . . 0.0 110.215 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.648 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 34.9 m-85 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.362 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.255 0.55 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -102.32 -88.53 0.39 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.307 -0.871 . . . . 0.0 110.218 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -74.89 102.44 4.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.226 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.438 ' C ' HG21 ' A' ' 5' ' ' THR . 23.4 mt -65.95 166.65 11.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.438 HG21 ' C ' ' A' ' 4' ' ' LEU . 70.5 p -130.02 9.1 5.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 110.063 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 7' ' ' GLU . 14.6 mt-10 -57.79 -22.0 44.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' GLU . 8.1 pt-20 -42.21 -45.26 4.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.38 -0.825 . . . . 0.0 109.957 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -62.2 -42.4 99.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.905 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mt -66.28 -35.86 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.82 88.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -0.892 . . . . 0.0 109.834 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 33.2 tp10 -64.62 -52.41 57.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.611 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -56.11 -31.19 63.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -37.33 83.33 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.302 -0.874 . . . . 0.0 109.211 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 17.0 mm-40 -58.33 -48.85 79.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.438 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -59.09 -51.56 69.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 109.648 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.613 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 25.4 t80 -52.58 -28.31 20.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -28.1 38.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.422 -0.799 . . . . 0.0 109.885 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 9.8 tt -63.66 -43.32 97.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.893 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.21 -41.0 50.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.41 -0.806 . . . . 0.0 110.333 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.74 100.03 2.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.039 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -86.13 -29.0 23.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.146 -0.971 . . . . 0.0 110.168 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.5 -33.35 54.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.12 12.49 58.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 29.7 p-10 -83.91 -27.83 28.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -1.177 . . . . 0.0 110.23 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 102.99 37.71 3.08 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 81.9 p -153.02 113.13 3.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.383 -1.069 . . . . 0.0 110.139 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.534 HD13 ' CG2' ' A' ' 63' ' ' ILE . 30.5 mt -82.83 116.24 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.42 176.27 6.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.6 p -63.41 -35.52 80.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 110.06 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.19 -56.33 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 110.295 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 30' ' ' LYS . 44.4 mt-10 -43.35 -64.8 0.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.166 -0.959 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.76 -37.15 75.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 109.938 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.77 -42.82 91.89 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 m -62.29 -47.69 83.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -1.17 . . . . 0.0 110.017 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 t -55.69 -29.74 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.688 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -31.57 60.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.916 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.14 -18.01 58.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 110.101 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.7 m -77.3 -51.48 10.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.46 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.71 -18.26 29.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.126 -0.984 . . . . 0.0 110.171 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.25 69.96 0.97 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.512 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 5.3 mm-40 -142.23 -162.74 1.46 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.278 -1.13 . . . . 0.0 109.831 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -159.58 88.46 2.0 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.128 -0.982 . . . . 0.0 110.767 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.46 127.47 13.3 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.095 1.577 . . . . 0.0 110.039 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 46' ' ' ALA . 6.2 t -86.36 30.29 0.71 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.124 -0.985 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 44' ' ' THR . 0.3 OUTLIER 67.05 -57.37 0.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 110.302 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 44' ' ' THR . . . -51.34 -40.02 58.24 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.324 -0.86 . . . . 0.0 109.927 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.53 -52.42 39.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.698 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.56 -57.52 3.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 110.064 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.5 mm-40 -55.74 -47.89 76.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.73 -36.65 72.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.456 -0.778 . . . . 0.0 109.759 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.494 ' HE1' ' N ' ' B' ' 7' ' ' TRP . 7.3 mtp -75.86 -47.03 27.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.433 -0.792 . . . . 0.0 109.534 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.6 mm -66.06 -30.11 48.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.416 -0.802 . . . . 0.0 109.972 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.4 m-80 -72.26 -16.61 61.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.181 -0.95 . . . . 0.0 110.029 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -87.48 -49.35 7.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 110.377 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.571 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 21.9 t -72.25 -13.74 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.114 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.06 79.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.089 -1.007 . . . . 0.0 110.264 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.481 ' N ' ' OE1' ' A' ' 67' ' ' GLU . . . -63.88 -39.37 94.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.666 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 37.8 p-10 -93.73 -32.12 14.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.16 -0.962 . . . . 0.0 110.793 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 97.61 38.71 4.11 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -99.81 -8.96 23.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -1.13 . . . . 0.0 110.322 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.44 -1.55 82.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.401 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 24.4 p -138.76 146.35 41.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -1.201 . . . . 0.0 110.376 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.534 ' CG2' HD13 ' A' ' 27' ' ' ILE . 48.4 mm -77.54 138.38 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.34 -0.85 . . . . 0.0 110.33 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 9.1 t0 -111.43 169.31 8.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 110.792 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 15.9 t80 -55.08 -45.46 99.84 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.35 -0.844 . . . . 0.0 111.41 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.4 Cg_endo -71.12 -46.36 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.233 1.122 . . . . 0.0 110.166 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 71' ' ' MET . 29.3 mt-10 -56.97 -33.77 67.41 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 109.87 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 47.1 t80 -67.65 -56.08 10.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.184 -0.948 . . . . 0.0 110.633 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.472 ' CD1' ' O ' ' A' ' 65' ' ' PHE . 1.2 mp -51.65 -61.5 2.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.358 -0.839 . . . . 0.0 110.995 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.5 m -51.92 -58.37 6.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.33 -0.856 . . . . 0.0 111.35 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -43.74 -68.9 0.16 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.164 -0.96 . . . . 0.0 111.372 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.479 ' HG2' ' CD1' ' B' ' 11' ' ' ILE . 7.7 mmm -37.8 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.257 -0.902 . . . . 0.0 110.908 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' MET . . . -92.81 -41.46 10.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.092 -1.005 . . . . 0.0 111.271 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -67.21 -19.16 65.51 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.905 -1.122 . . . . 0.0 110.771 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.491 ' CB ' HG22 ' B' ' 8' ' ' THR . 0.8 OUTLIER -80.3 -36.12 34.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.044 -1.035 . . . . 0.0 110.257 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.9 mtt -84.17 48.32 1.46 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 3.0 mttp -161.23 94.82 1.01 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.597 -0.689 . . . . 0.0 109.405 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 6.1 m-20 60.76 69.91 0.65 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.609 -0.682 . . . . 0.0 109.918 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -178.7 -54.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.592 -0.692 . . . . 0.0 109.526 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 75' ' ' LYS . 9.0 p-10 -176.42 81.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 0.0 110.122 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 1.9 m -100.81 -31.26 11.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.351 -0.843 . . . . 0.0 110.021 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.77 -29.99 19.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.753 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 9.6 tt0 -68.24 -42.87 79.08 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.256 -0.903 . . . . 0.0 109.312 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 81' ' ' SER . 3.2 pt-20 -52.87 -26.98 16.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.513 -0.742 . . . . 0.0 110.246 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.474 HG13 ' HG3' ' A' ' 84' ' ' GLU . 81.6 mt -79.15 -47.94 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.961 -1.087 . . . . 0.0 109.02 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -63.12 -30.54 71.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.361 -0.837 . . . . 0.0 108.804 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' OE1' ' OG1' ' B' ' 9' ' ' THR . 51.7 mt-10 -73.05 -49.48 28.42 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.14 -36.35 70.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.335 -0.853 . . . . 0.0 109.423 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.588 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 7.2 t80 -67.46 -43.99 79.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.937 . . . . 0.0 109.397 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -35.69 50.71 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.434 -0.791 . . . . 0.0 109.236 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.444 ' CG1' HG23 ' A' ' 108' ' ' VAL . 4.0 t -67.53 -41.52 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.609 ' CE1' HG12 ' A' ' 108' ' ' VAL . 28.5 m-85 -74.19 -33.21 63.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.958 . . . . 0.0 109.957 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.497 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -81.26 58.15 3.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.883 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -39.58 -62.82 0.64 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 110.492 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.2 p-10 -66.47 -38.61 87.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.327 -0.858 . . . . 0.0 110.284 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.66 52.47 3.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -99.15 -13.34 19.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.333 -1.098 . . . . 0.0 110.136 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 105.78 20.37 9.47 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 13.9 m-85 -158.35 157.4 32.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -1.083 . . . . 0.0 109.906 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 6.1 mt -120.02 135.28 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.075 -1.015 . . . . 0.0 110.448 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 p -121.06 154.01 36.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.64 -34.05 4.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.31 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.31 96.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.497 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 23.1 mt-10 -60.95 -47.52 86.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 110.065 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.511 ' CD1' HD12 ' A' ' 125' ' ' ILE . 1.1 mt -61.5 -35.66 78.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.279 -0.888 . . . . 0.0 109.495 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' MET . 8.2 ttp180 -55.94 -43.02 77.03 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.312 -0.868 . . . . 0.0 109.044 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.66 -57.8 11.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.475 -0.766 . . . . 0.0 109.724 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.609 HG12 ' CE1' ' A' ' 92' ' ' PHE . 2.5 t -60.64 -21.87 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.398 -0.814 . . . . 0.0 109.855 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.61 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 4.0 mtt -64.32 -65.01 0.73 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.294 -0.879 . . . . 0.0 110.921 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.0 m -63.97 -9.44 15.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 0.0 110.455 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -95.94 -1.57 48.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.107 -0.996 . . . . 0.0 110.782 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.603 ' CD1' ' CG1' ' B' ' 13' ' ' VAL . 11.9 mt -133.22 -0.19 3.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 111.8 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.97 -90.5 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.113 -1.518 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -116.41 -176.85 3.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -1.063 . . . . 0.0 110.573 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.552 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -127.09 17.3 7.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.281 -0.887 . . . . 0.0 110.291 179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 115' ' ' LYS . 4.7 mp 50.17 174.77 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.674 -0.642 . . . . 0.0 110.287 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.428 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -87.85 -166.29 1.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.989 . . . . 0.0 109.873 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -80.84 -51.96 8.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.827 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 2.1 mt-10 -61.08 -41.33 96.44 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.581 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.424 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -62.2 -44.25 97.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.326 -0.859 . . . . 0.0 109.664 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 117' ' ' THR . 39.2 t -62.06 -46.32 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -66.07 -40.13 90.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.706 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 0.6 OUTLIER -64.52 -33.58 76.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.822 . . . . 0.0 109.548 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.58 ' HG2' ' CE2' ' B' ' 22' ' ' PHE . 3.0 ttt -64.85 -41.62 95.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.399 -0.813 . . . . 0.0 109.921 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.511 HD12 ' CD1' ' A' ' 105' ' ' LEU . 14.5 mm -84.45 -17.59 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.005 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -76.03 -39.42 55.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 110.064 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -69.04 -23.5 64.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.46 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . -95.86 -24.68 16.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.17 -0.957 . . . . 0.0 110.703 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -72.24 80.6 0.99 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.084 -1.01 . . . . 0.0 110.679 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 mt -82.32 -20.65 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 0.0 109.552 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -94.46 -13.72 25.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.406 -0.809 . . . . 0.0 109.78 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.03 80.93 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -139.36 7.02 2.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.334 -1.098 . . . . 0.0 110.16 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 74.55 14.12 81.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 134' ' ' GLY . 0.9 OUTLIER -164.81 164.58 21.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.316 -1.108 . . . . 0.0 110.187 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 22.9 t -106.45 169.77 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.112 -0.992 . . . . 0.0 109.7 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.45 ' N ' ' OE1' ' A' ' 140' ' ' GLU . 9.1 t-20 -128.34 179.64 5.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.155 -0.966 . . . . 0.0 110.351 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.588 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 9.1 t80 -62.54 -56.27 19.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.84 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -44.74 -60.36 2.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 110.123 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' A' ' 137' ' ' ASN . 53.9 mt-10 -44.63 -46.33 10.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.44 ' CG ' ' HD2' ' A' ' 89' ' ' PHE . 6.4 t80 -58.26 -28.9 65.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 139' ' ' GLU . 9.4 t -100.41 -33.85 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -0.792 . . . . 0.0 110.705 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 2.8 tp60 -73.22 -9.43 58.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.05 -1.031 . . . . 0.0 110.595 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.465 ' O ' ' O ' ' B' ' 23' ' ' GLY . 30.0 mtp -106.55 -18.63 13.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 110.813 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' B' ' 23' ' ' GLY . 20.7 ttm -99.92 -54.51 2.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.127 -0.983 . . . . 0.0 110.637 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.488 ' O ' ' CG2' ' A' ' 146' ' ' THR . 10.2 t -155.89 90.19 1.2 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.229 -0.92 . . . . 0.0 110.444 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.24 53.66 0.66 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.281 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.27 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' B' ' 1' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.197 0.522 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.429 ' HG2' ' C ' ' B' ' 1' ' ' VAL . 1.3 mtmt -131.41 153.65 49.48 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 110.373 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 44.8 mt -110.94 -68.69 0.91 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.476 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 33.6 mm -56.92 149.83 41.95 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.835 . . . . 0.0 109.371 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 39.5 Cg_endo -65.49 -172.47 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.578 1.304 . . . . 0.0 110.856 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.493 ' O ' ' N ' ' B' ' 8' ' ' THR . 57.0 p -119.76 60.54 0.85 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.059 -1.025 . . . . 0.0 111.394 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.571 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 1.0 OUTLIER 58.06 -82.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.039 -1.038 . . . . 0.0 110.864 178.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.499 HG21 ' CE ' ' A' ' 71' ' ' MET . 1.0 OUTLIER -46.14 -46.13 17.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.487 ' OG1' ' OE1' ' A' ' 87' ' ' GLU . 22.3 m -46.61 -35.79 6.26 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.227 -0.92 . . . . 0.0 109.914 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.21 -41.41 58.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.477 -0.765 . . . . 0.0 109.547 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.479 ' CD1' ' HG2' ' A' ' 72' ' ' MET . 12.5 mt -72.26 -20.19 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 109.637 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' B' ' 12' ' ' LEU . 0.5 OUTLIER -72.6 -59.96 2.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.369 -0.832 . . . . 0.0 109.735 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.603 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 43.4 t -56.02 -41.7 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.717 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.483 ' HG3' HD11 ' A' ' 18' ' ' LEU . 1.6 tmtm? -62.29 -43.97 97.61 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.88 -1.138 . . . . 0.0 109.568 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' B' ' 12' ' ' LEU . 14.5 m -53.0 -35.59 59.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.58 -0.7 . . . . 0.0 110.041 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.531 ' SD ' ' CD1' ' B' ' 22' ' ' PHE . 0.1 OUTLIER -70.67 -34.3 71.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.946 . . . . 0.0 109.951 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.61 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 3.5 mp -71.5 57.2 0.26 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.25 -0.906 . . . . 0.0 110.02 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -114.73 -86.28 0.6 Allowed 'General case' 0 C--N 1.278 -2.507 0 O-C-N 121.406 -0.809 . . . . 0.0 110.679 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' B' ' 20' ' ' ARG . 0.6 OUTLIER -153.77 94.9 1.82 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.791 -1.193 . . . . 0.0 110.53 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' B' ' 19' ' ' LYS . 10.3 tmm_? 64.67 7.0 3.52 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.437 -0.79 . . . . 0.0 110.407 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.458 ' OG ' ' HB3' ' B' ' 25' ' ' PRO . 0.1 OUTLIER -69.24 138.27 53.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.296 -0.877 . . . . 0.0 110.923 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.58 ' CE2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -176.29 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 144' ' ' MET . . . -64.39 -80.87 0.13 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -142.05 75.27 20.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.092 -1.24 . . . . 0.0 110.406 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.458 ' HB3' ' OG ' ' B' ' 21' ' ' SER . 50.6 Cg_endo -79.66 11.7 2.64 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.053 1.554 . . . . 0.0 110.716 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.33 -179.71 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.202 0.525 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.32 106.91 14.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.947 . . . . 0.0 110.329 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -98.66 89.82 4.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.243 -0.911 . . . . 0.0 110.056 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.4 mt -125.49 129.33 49.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 110.459 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.528 ' CG2' ' CG ' ' A' ' 7' ' ' GLU . 18.7 m -113.97 105.68 13.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.344 -0.848 . . . . 0.0 110.25 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' A' ' 7' ' ' GLU . 13.0 pt-20 -65.18 -44.7 87.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.239 -0.913 . . . . 0.0 110.503 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' CG ' ' CG2' ' A' ' 5' ' ' THR . 6.9 pt-20 -45.98 -45.98 16.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.069 -1.02 . . . . 0.0 109.816 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.71 -53.98 52.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.819 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 5' ' ' THR . 5.6 mt -56.96 -46.75 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.838 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.69 -45.95 74.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.683 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -42.26 97.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 109.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -66.54 -43.61 84.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.712 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -60.21 -40.58 90.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.603 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 1.6 mm-40 -61.98 -43.41 98.9 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.219 -0.925 . . . . 0.0 109.556 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.71 -47.48 69.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.881 . . . . 0.0 109.836 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.543 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 75.0 t80 -63.45 -40.42 97.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.613 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.9 t -72.82 -28.04 62.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 0.0 109.52 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.496 ' CD2' HG12 ' A' ' 35' ' ' VAL . 10.1 tt -62.97 -41.06 99.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 109.657 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.52 ' CZ ' HG22 ' B' ' 10' ' ' VAL . 27.0 m-85 -78.27 -10.88 59.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -0.793 . . . . 0.0 110.76 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 6.5 t0 -102.36 114.88 29.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.037 -1.039 . . . . 0.0 110.321 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.518 ' N ' ' OE2' ' A' ' 31' ' ' GLU . 5.3 tptp -97.52 29.24 3.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.261 -0.9 . . . . 0.0 110.524 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -153.68 -38.85 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.082 -1.011 . . . . 0.0 110.368 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 89.84 47.22 4.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -104.45 2.51 31.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.291 -1.123 . . . . 0.0 110.199 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.466 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 73.36 33.82 58.35 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -169.25 120.58 0.72 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.269 -1.136 . . . . 0.0 110.222 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.529 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 28.7 mt -97.56 124.47 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.172 -0.955 . . . . 0.0 110.189 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -84.68 -171.56 3.7 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.389 -0.819 . . . . 0.0 110.206 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.46 HG21 HG13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -78.0 -34.09 50.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.882 . . . . 0.0 109.937 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -76.16 -48.83 19.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.289 -0.882 . . . . 0.0 110.042 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 21' ' ' LYS . 43.2 tt0 -45.33 -59.76 2.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.91 . . . . 0.0 109.608 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.535 HD11 ' CH2' ' B' ' 7' ' ' TRP . 10.8 tp -60.76 -34.95 75.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.535 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.06 86.7 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.5 m -65.9 -51.07 61.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.344 -1.092 . . . . 0.0 109.543 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.496 HG12 ' CD2' ' A' ' 18' ' ' LEU . 48.9 t -52.54 -41.99 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.206 -0.934 . . . . 0.0 109.452 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.501 ' CE ' ' HE1' ' A' ' 51' ' ' MET . 4.8 mtt -64.74 -37.54 87.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.38 -0.825 . . . . 0.0 109.42 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -30.8 68.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.159 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.5 m -61.54 -34.01 74.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.9 . . . . 0.0 110.446 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mt -82.39 -3.11 54.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 110.224 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 86.57 86.07 1.07 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 0.8 OUTLIER -167.14 175.06 7.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -1.143 . . . . 0.0 110.143 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 11.7 p30 -139.63 84.31 15.96 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 0.0 110.291 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 44.0 Cg_endo -70.46 105.48 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.055 1.555 . . . . 0.0 110.496 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.446 ' HB ' ' OE2' ' A' ' 47' ' ' GLU . 8.9 m -61.18 150.82 33.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 110.058 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -49.43 -51.49 35.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.072 -1.018 . . . . 0.0 110.225 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.62 88.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.356 -0.84 . . . . 0.0 110.205 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -65.06 -50.98 64.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.0 110.211 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -50.33 -48.88 55.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -57.7 -36.81 72.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 5.5 m-20 -65.85 -46.98 76.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 109.949 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.566 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.1 OUTLIER -67.93 -36.68 80.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.945 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 52' ' ' ILE . 5.5 mm -65.63 -26.66 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 109.732 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.39 -9.15 58.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.306 -0.871 . . . . 0.0 110.046 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -75.3 -22.53 57.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 110.124 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 57' ' ' ALA . 12.1 t -113.8 -48.42 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.187 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 55' ' ' VAL . 13.8 t0 -42.26 89.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.695 -0.628 . . . . 0.0 110.478 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -93.12 -9.56 39.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.404 -0.81 . . . . 0.0 110.637 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -78.24 -31.58 49.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.055 -1.028 . . . . 0.0 110.421 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.82 -16.28 18.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 3.5 p30 -77.58 -93.72 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.321 -1.105 . . . . 0.0 110.106 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 165.7 46.0 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -143.28 141.8 31.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.289 -1.124 . . . . 0.0 110.204 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.537 ' CD1' ' HB ' ' A' ' 55' ' ' VAL . 11.9 mm -92.09 129.42 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.26 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.543 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 9.5 t0 -117.18 179.9 3.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.603 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 17.1 t80 -67.15 -43.14 44.3 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 0.0 111.307 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.77 -35.54 7.45 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.348 1.183 . . . . 0.0 110.25 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.9 -28.44 67.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.107 -0.996 . . . . 0.0 109.141 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.412 ' CZ ' HD13 ' B' ' 11' ' ' ILE . 18.8 t80 -69.77 -53.24 19.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.602 -0.686 . . . . 0.0 110.317 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 mt -67.89 -17.66 64.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.284 -0.885 . . . . 0.0 110.513 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 m -78.29 -42.52 30.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.125 -0.984 . . . . 0.0 110.617 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.417 ' HE3' ' HB3' ' B' ' 7' ' ' TRP . 2.3 tmm? -72.66 -42.22 64.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.149 -0.97 . . . . 0.0 110.572 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.454 ' O ' ' HG3' ' A' ' 76' ' ' MET . 0.0 OUTLIER -64.2 -9.46 17.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.487 -0.758 . . . . 0.0 111.231 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.31 -19.27 17.14 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.012 -1.055 . . . . 0.0 111.379 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.63 -20.85 15.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.979 -1.076 . . . . 0.0 111.02 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HG2' HG23 ' B' ' 8' ' ' THR . 0.0 OUTLIER -99.45 29.39 4.04 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.009 -1.057 . . . . 0.0 110.5 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.557 ' HE3' ' CD2' ' B' ' 26' ' ' PHE . 2.6 mmt -100.67 -42.41 6.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.202 -0.937 . . . . 0.0 110.709 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -119.64 71.96 0.9 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.125 -0.984 . . . . 0.0 110.523 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.12 -84.85 0.55 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 0.0 109.96 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 81' ' ' SER . 48.1 m -161.5 -54.72 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.467 -0.771 . . . . 0.0 109.845 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -65.48 80.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.756 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' THR . 4.2 t -94.79 -37.85 11.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.354 -0.841 . . . . 0.0 110.275 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.57 -25.74 35.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.943 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.69 -15.61 59.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.888 . . . . 0.0 109.982 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HG2' HD12 ' B' ' 12' ' ' LEU . 19.5 tt0 -81.83 -38.34 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 109.968 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.7 mt -67.49 -33.83 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.232 -0.917 . . . . 0.0 109.081 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -60.17 -27.19 66.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.563 -0.71 . . . . 0.0 109.091 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 1.2 mt-10 -74.76 -56.71 4.5 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.466 -0.771 . . . . 0.0 109.231 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' B' ' 12' ' ' LEU . . . -59.43 -28.85 67.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 109.567 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.439 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 15.9 t80 -69.65 -47.87 61.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.02 -1.05 . . . . 0.0 108.968 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 -47.53 -36.47 10.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.496 -0.752 . . . . 0.0 109.019 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.478 HG11 HG23 ' A' ' 108' ' ' VAL . 54.5 t -74.2 -33.56 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.535 -0.728 . . . . 0.0 110.285 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.535 ' CD1' HG13 ' A' ' 108' ' ' VAL . 16.1 m-85 -80.35 -31.29 37.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.128 -0.982 . . . . 0.0 110.287 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 96' ' ' GLY . 10.9 t0 -100.04 62.83 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.209 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -43.17 -33.01 0.82 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.78 -31.93 61.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.385 -0.822 . . . . 0.0 109.655 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 69.37 13.61 68.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 23.6 p-10 -69.45 -38.84 77.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -1.12 . . . . 0.0 110.324 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.44 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 139.19 -30.27 2.46 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 33.9 m-85 -107.29 156.78 18.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -1.127 . . . . 0.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 100' ' ' ILE . 11.4 mt -124.13 145.52 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.897 . . . . 0.0 110.018 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -124.96 147.78 48.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.168 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.29 -31.1 0.93 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.665 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.79 -47.08 79.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.359 -0.838 . . . . 0.0 109.395 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 10.0 mt-10 -54.99 -50.07 69.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.199 -0.938 . . . . 0.0 109.261 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 109' ' ' MET . 1.6 mm? -57.39 -52.79 63.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.328 -0.857 . . . . 0.0 109.185 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -45.96 -26.67 0.75 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.421 -0.8 . . . . 0.0 109.453 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.411 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -80.89 -34.59 33.43 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.373 -0.829 . . . . 0.0 110.21 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG13 ' CD1' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -89.57 -27.55 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 109.946 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.571 ' CE ' ' HB2' ' A' ' 116' ' ' LEU . 2.4 mmm -63.5 -49.5 73.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 110.659 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 m -77.82 -17.24 57.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.0 110.58 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 2.0 m120 -85.81 -3.39 58.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.089 -1.007 . . . . 0.0 109.968 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.523 ' CD1' ' CG1' ' B' ' 13' ' ' VAL . 5.4 mt -102.19 -42.75 5.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 110.426 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 162.67 -36.55 0.34 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.465 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.7 tp10 -109.7 147.0 33.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.991 -1.299 . . . . 0.0 110.828 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -119.93 74.68 1.04 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.547 -0.72 . . . . 0.0 109.282 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.571 ' HB2' ' CE ' ' A' ' 109' ' ' MET . 6.8 mp -38.46 160.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.687 -0.633 . . . . 0.0 110.709 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -60.69 -146.42 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.435 -0.791 . . . . 0.0 109.366 179.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -122.3 -60.28 1.57 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.238 -0.914 . . . . 0.0 109.929 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.65 -35.65 63.72 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 9.7 mm-40 -67.31 -56.11 11.12 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.295 -0.878 . . . . 0.0 109.08 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 117' ' ' THR . 87.4 t -43.66 -36.36 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 121.361 -0.837 . . . . 0.0 109.606 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.51 -51.86 52.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -58.25 -32.49 68.41 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.403 -0.811 . . . . 0.0 109.113 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.559 ' HE1' ' CD2' ' B' ' 22' ' ' PHE . 11.0 ttt -59.49 -44.75 93.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.495 -0.753 . . . . 0.0 109.636 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 125' ' ' ILE . 20.3 mm -71.72 -31.61 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 109.714 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.4 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 45.8 ttt85 -62.62 -42.76 99.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.98 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.9 -37.52 63.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.427 ' HA ' ' HE3' ' A' ' 144' ' ' MET . . . -84.77 -25.83 27.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 0.0 110.142 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 134' ' ' GLY . 2.6 m-20 -57.64 99.54 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.859 . . . . 0.0 110.483 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 35.3 mm -74.79 -39.13 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.244 -0.91 . . . . 0.0 109.886 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 8.0 p-10 -90.4 -17.57 27.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.34 -0.85 . . . . 0.0 109.984 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.95 55.98 3.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 6.4 p30 -113.04 0.66 15.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.335 -1.097 . . . . 0.0 110.23 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.503 ' N ' ' OD2' ' A' ' 129' ' ' ASP . . . 76.16 8.53 85.3 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -142.66 147.46 35.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -1.181 . . . . 0.0 110.406 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 39.7 t -100.9 152.0 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.34 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.57 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 62.5 t30 -122.65 158.47 29.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -0.86 . . . . 0.0 110.12 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -45.8 -54.95 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.77 -41.02 56.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.301 -0.875 . . . . 0.0 109.916 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 144' ' ' MET . 9.2 mt-10 -70.87 -47.31 59.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.0 110.021 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 89' ' ' PHE . 47.5 t80 -60.79 -17.95 52.38 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.299 -0.875 . . . . 0.0 109.968 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.9 t -100.19 -47.75 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.456 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 17.7 tp60 -61.89 -26.86 68.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.172 -0.955 . . . . 0.0 110.23 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 17.8 mmm -82.62 -18.32 41.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.551 ' CE ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -99.33 -56.86 2.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.444 ' O ' HG21 ' A' ' 146' ' ' THR . 6.8 t -105.1 63.48 0.7 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.226 -0.921 . . . . 0.0 110.274 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 148' ' ' LYS . . . -96.15 30.32 2.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.218 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 147' ' ' ALA . 1.9 tptp . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.151 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.446 ' O ' ' CG1' ' B' ' 1' ' ' VAL . 14.7 p . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.423 ' O ' ' HG ' ' B' ' 3' ' ' LEU . 9.5 ttpt -141.0 140.56 34.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.873 . . . . 0.0 110.238 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' B' ' 2' ' ' LYS . 5.1 mp -145.59 -48.54 0.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.972 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.462 HD11 ' HG3' ' A' ' 51' ' ' MET . 11.0 pt -43.17 155.29 0.29 Allowed Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.281 -0.887 . . . . 0.0 110.746 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.36 153.16 50.35 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.09 1.574 . . . . 0.0 110.013 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.486 ' O ' ' HB ' ' B' ' 9' ' ' THR . 8.6 m -71.19 142.05 50.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.566 ' CD1' ' SD ' ' A' ' 51' ' ' MET . 6.8 m95 -36.29 -66.01 0.24 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.764 0.793 . . . . 0.0 110.555 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.457 HG23 ' HG2' ' A' ' 75' ' ' LYS . 10.8 p -45.38 -23.65 0.22 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.464 -0.773 . . . . 0.0 111.043 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.49 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 91.5 m -70.41 -56.65 6.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.886 -1.134 . . . . 0.0 109.87 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 32.7 m -53.16 -27.4 13.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.281 -0.887 . . . . 0.0 109.193 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.532 ' N ' HG21 ' B' ' 10' ' ' VAL . 26.0 mm -75.46 -30.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.447 -0.783 . . . . 0.0 109.61 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 84' ' ' GLU . 9.9 mt -65.91 -60.47 2.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 110.034 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.523 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 41.1 t -52.95 -39.01 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.626 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.459 ' HD3' HD11 ' A' ' 18' ' ' LEU . 1.6 tptp -64.74 -47.62 77.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.963 -1.085 . . . . 0.0 109.226 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 50.2 m -50.97 -31.27 17.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.403 -0.811 . . . . 0.0 109.738 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mmt -79.87 -27.18 40.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.354 -0.841 . . . . 0.0 109.956 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.544 HD11 ' N ' ' B' ' 17' ' ' LEU . 5.9 mp -80.04 54.47 1.92 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.344 -0.848 . . . . 0.0 109.88 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -72.58 0.57 Allowed 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.679 -0.638 . . . . 0.0 110.355 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -150.3 -60.28 0.19 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.944 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.542 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -156.64 17.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 110.208 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.465 ' O ' ' HE1' ' A' ' 124' ' ' MET . 0.3 OUTLIER -93.04 -162.1 0.9 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.217 -0.927 . . . . 0.0 110.42 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.559 ' CD2' ' HE1' ' A' ' 124' ' ' MET . 0.4 OUTLIER -174.21 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.231 -0.918 . . . . 0.0 110.523 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.09 -155.76 22.69 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.551 ' CB ' ' CE ' ' A' ' 145' ' ' MET . 3.3 m-20 -178.96 117.07 0.23 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 110.206 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.04 52.61 3.5 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.935 1.492 . . . . 0.0 110.397 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.557 ' CD2' ' HE3' ' A' ' 76' ' ' MET . 4.8 m-85 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.251 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.263 0.554 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.44 168.33 19.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.208 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.16 132.97 45.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -0.891 . . . . 0.0 110.37 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mt -77.94 122.57 25.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.263 -0.898 . . . . 0.0 110.177 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 47.84 85.95 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.214 -0.929 . . . . 0.0 110.251 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -100.31 -24.16 14.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.307 -0.871 . . . . 0.0 110.237 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 8' ' ' GLN . 7.0 pt-20 -58.03 -34.6 70.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 109.953 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.525 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -70.2 -34.87 73.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.246 -0.908 . . . . 0.0 109.36 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 98.5 mt -75.2 -34.98 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.366 -0.834 . . . . 0.0 109.712 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.22 -62.46 1.85 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 109.654 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 12' ' ' PHE . 11.4 pt-20 -56.94 -38.23 72.63 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.162 -0.961 . . . . 0.0 109.058 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.688 ' CD2' ' CZ ' ' A' ' 68' ' ' PHE . 1.8 m-85 -57.91 -45.66 86.14 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.358 -0.839 . . . . 0.0 109.019 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -41.33 66.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 109.18 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -53.36 -49.21 67.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.713 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HA ' ' HD2' ' B' ' 14' ' ' LYS . . . -59.28 -52.85 63.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 109.783 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 2.3 t80 -60.59 -35.6 76.49 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.614 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -67.06 -28.22 68.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.509 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 8.4 tt -68.7 -41.81 78.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.499 -0.751 . . . . 0.0 109.881 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -74.28 -57.88 3.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -64.97 129.93 41.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.375 -0.828 . . . . 0.0 110.54 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.78 -48.5 5.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.246 -0.909 . . . . 0.0 110.157 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.2 p-10 -75.04 -35.05 61.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.78 42.34 5.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 34.8 p-10 -90.76 -28.12 18.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -1.156 . . . . 0.0 110.057 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 112.74 31.0 2.64 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 11.1 p -159.73 125.24 4.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -1.135 . . . . 0.0 110.533 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.527 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 17.9 mt -91.97 119.22 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.21 -0.931 . . . . 0.0 109.999 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.6 p -100.17 172.91 6.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.92 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.6 p -64.43 -18.24 64.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.13 -0.981 . . . . 0.0 109.899 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -49.76 17.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.395 -0.816 . . . . 0.0 110.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 21' ' ' LYS . 20.9 mt-10 -67.21 -50.37 61.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 110.365 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 52' ' ' ILE . 13.1 tp -59.75 -51.47 69.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.287 -0.883 . . . . 0.0 110.347 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.14 -49.35 24.68 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.8 m -56.26 -47.4 78.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.229 -1.159 . . . . 0.0 110.576 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 t -62.77 -45.26 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 0.0 110.293 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.52 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 16.2 mmm -64.24 -39.64 94.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 110.405 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -15.91 61.55 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.099 -1.001 . . . . 0.0 110.237 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 39' ' ' LEU . 32.2 t -75.0 -46.05 37.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 111.058 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 38' ' ' SER . 1.9 mt -45.76 -27.31 0.8 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.914 -1.116 . . . . 0.0 109.823 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.93 -32.34 2.9 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB3' HD13 ' B' ' 4' ' ' ILE . 0.8 OUTLIER -72.08 -178.59 2.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.135 -1.215 . . . . 0.0 110.684 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -131.07 93.88 29.35 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.252 -0.905 . . . . 0.0 110.317 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.52 ' HG3' ' CB ' ' A' ' 36' ' ' MET . 45.4 Cg_endo -73.16 115.97 4.54 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.004 1.529 . . . . 0.0 110.302 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.23 164.94 23.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 110.239 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 42.9 mt-10 -61.07 -42.23 98.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.276 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.12 74.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.208 -0.933 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 51' ' ' MET . 4.6 mm-40 -66.65 -32.92 74.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 110.042 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 13.0 mt -60.37 -52.16 66.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 0.0 110.123 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -62.91 -42.39 99.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 110.107 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.89 -15.41 63.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 110.012 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.485 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 1.2 mtp -86.9 -42.94 12.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.14 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.518 ' CD1' HD23 ' A' ' 32' ' ' LEU . 1.1 mp -80.27 -11.15 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.078 -1.014 . . . . 0.0 109.731 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -83.43 -18.58 38.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 110.856 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 51' ' ' MET . 21.8 pt-20 -94.48 -18.93 21.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.036 -1.04 . . . . 0.0 110.988 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.661 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 50.6 t -99.1 -31.57 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.95 -1.094 . . . . 0.0 110.061 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -47.16 89.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.539 -0.726 . . . . 0.0 110.539 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.12 -49.63 71.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.451 -0.781 . . . . 0.0 110.172 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 14.8 p-10 -75.69 -37.91 59.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 110.063 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.42 45.78 2.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 36.0 p-10 -98.5 -38.72 9.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.274 -1.133 . . . . 0.0 110.141 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 127.6 -8.09 6.95 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p -135.79 148.52 48.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -1.167 . . . . 0.0 110.189 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.527 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 31.8 mm -82.14 140.06 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.122 -0.986 . . . . 0.0 109.91 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -114.46 157.66 22.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.066 -1.021 . . . . 0.0 110.797 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.578 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 52.8 t80 -48.9 -50.34 62.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.443 -0.786 . . . . 0.0 111.187 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.9 Cg_endo -64.39 -32.27 60.87 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.258 1.136 . . . . 0.0 110.344 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 71' ' ' MET . 7.1 tt0 -59.97 -35.46 75.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.124 -0.985 . . . . 0.0 109.291 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.688 ' CZ ' ' CD2' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -76.98 -48.78 17.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 65' ' ' PHE . 3.1 mm? -43.09 -45.28 5.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 110.625 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.31 -37.44 14.91 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.073 -1.017 . . . . 0.0 110.762 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -44.04 -38.91 3.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.191 -0.943 . . . . 0.0 110.72 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.604 ' HE1' ' CE1' ' B' ' 26' ' ' PHE . 5.7 tpt -74.65 -9.76 58.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.136 -0.977 . . . . 0.0 110.542 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 70' ' ' THR . . . -101.4 -10.83 19.88 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.248 -0.908 . . . . 0.0 110.579 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -99.61 -49.64 4.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.067 -1.021 . . . . 0.0 110.407 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HG3' ' CG2' ' B' ' 8' ' ' THR . 20.2 mmtt -46.45 -36.88 7.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.504 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.5 mtm -94.07 58.57 2.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.23 -0.919 . . . . 0.0 110.473 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 42.8 tttm -154.67 81.89 1.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 110.128 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER 66.94 54.18 0.79 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 110.252 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 78' ' ' ASP . 4.3 m -165.31 -68.75 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.204 -0.935 . . . . 0.0 110.411 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.488 ' HB3' ' CG ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -129.03 93.71 3.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.172 -0.955 . . . . 0.0 110.33 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.7 t -100.64 -54.73 2.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.204 -0.935 . . . . 0.0 110.365 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.59 -9.82 21.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 0.0 110.763 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -79.66 -17.04 54.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.044 -1.035 . . . . 0.0 110.409 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.488 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 16.0 mt-10 -81.26 -22.71 38.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.026 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.458 HG12 ' HG2' ' A' ' 145' ' ' MET . 59.8 mt -79.09 -44.14 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.859 . . . . 0.0 110.039 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.474 ' CD ' ' OH ' ' A' ' 138' ' ' TYR . 5.4 ttp180 -55.55 -34.94 65.16 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.529 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.54 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 14.1 mt-10 -71.16 -47.55 57.02 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.437 -0.789 . . . . 0.0 109.893 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.559 ' CB ' HD21 ' B' ' 12' ' ' LEU . . . -64.92 -29.05 69.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.041 -1.037 . . . . 0.0 109.828 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.01 -39.37 83.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 109.511 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -67.44 -37.95 83.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.39 -0.819 . . . . 0.0 109.503 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.424 HG11 HG22 ' A' ' 108' ' ' VAL . 11.7 t -58.51 -44.62 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.414 -0.804 . . . . 0.0 109.704 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.402 ' CD2' ' HE2' ' A' ' 141' ' ' PHE . 20.4 m-85 -66.47 -30.58 70.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.613 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 94' ' ' LYS . 11.6 t0 -91.42 58.47 3.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.406 -0.809 . . . . 0.0 110.092 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 93' ' ' ASP . 2.3 mmmm -43.46 -32.3 0.86 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -0.962 . . . . 0.0 110.142 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.0 p30 -83.44 -34.13 25.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.181 -0.949 . . . . 0.0 110.109 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 81.39 42.41 9.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 38.2 p30 -100.07 -17.72 17.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -1.197 . . . . 0.0 110.167 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 102.59 27.96 6.53 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 94.4 m-85 -156.95 146.65 20.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -1.08 . . . . 0.0 110.004 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 100' ' ' ILE . 80.3 mt -119.74 111.98 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.16 -0.963 . . . . 0.0 110.411 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 37.4 t -95.89 149.18 21.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.22 -31.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.168 -0.958 . . . . 0.0 109.947 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.56 -51.62 64.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.855 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -53.39 -38.89 63.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.67 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.507 ' CD1' HD13 ' A' ' 125' ' ' ILE . 1.2 mt -59.85 -44.57 94.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.376 -0.827 . . . . 0.0 109.711 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.467 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.0 OUTLIER -65.8 -20.78 66.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 109.619 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -81.77 -32.56 31.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.422 -0.799 . . . . 0.0 109.847 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG22 HG11 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -83.17 -34.14 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.93 . . . . 0.0 109.789 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.579 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 11.2 ptp -79.42 -35.85 39.93 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.155 -0.965 . . . . 0.0 109.561 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.461 ' N ' ' HG3' ' A' ' 109' ' ' MET . 19.6 m -68.97 -30.52 68.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 108.802 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -85.91 -19.53 30.38 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.433 -0.792 . . . . 0.0 108.97 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.526 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 9.5 mt -84.46 -32.38 24.06 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.535 -0.728 . . . . 0.0 110.122 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.98 -39.87 1.51 Allowed Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.495 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.453 ' HG2' HD13 ' A' ' 116' ' ' LEU . 2.1 tt0 -94.23 157.59 15.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.995 -1.297 . . . . 0.0 110.709 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 116' ' ' LEU . 1.8 pttt -135.86 73.21 1.46 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.565 -0.709 . . . . 0.0 109.205 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 117' ' ' THR . 3.3 mp -38.79 145.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.593 -0.692 . . . . 0.0 110.794 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -56.47 -156.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 110.387 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -97.75 -48.82 5.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.224 -0.922 . . . . 0.0 110.149 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.31 -33.05 75.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.047 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.505 ' CG ' ' HB3' ' B' ' 20' ' ' ARG . 2.5 tt0 -66.16 -47.25 74.64 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.61 0.719 . . . . 0.0 109.33 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 117' ' ' THR . 19.0 t -65.0 -42.15 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.519 -0.738 . . . . 0.0 110.387 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -62.99 -65.14 0.73 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.952 . . . . 0.0 109.827 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 122' ' ' ASP . 2.0 mm-40 -44.42 -30.19 0.81 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.381 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.521 ' HE3' ' CD1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -62.91 -61.75 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 110.205 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.507 HD13 ' CD1' ' A' ' 105' ' ' LEU . 30.3 mm -59.55 -39.02 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 127' ' ' GLU . 2.8 mtt180 -60.09 -53.2 60.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.859 . . . . 0.0 110.355 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -43.3 -32.65 0.83 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.94 -26.93 13.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 110.146 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.3 OUTLIER -71.49 64.65 0.43 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.3 -0.875 . . . . 0.0 110.352 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.8 mt -63.15 -32.01 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 21.0 p-10 -77.01 -28.83 55.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.248 -0.907 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.85 64.74 1.99 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 20.4 p-10 -114.43 -23.0 9.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -1.135 . . . . 0.0 110.185 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 115.5 -6.7 20.67 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.461 ' OE1' ' HB3' ' A' ' 99' ' ' TYR . 3.3 pt20 -158.38 163.17 37.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.29 -1.124 . . . . 0.0 110.022 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 137' ' ' ASN . 61.6 t -90.76 168.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.192 -0.942 . . . . 0.0 110.649 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.491 ' N ' HG13 ' A' ' 136' ' ' VAL . 15.4 t-20 -133.06 177.35 7.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.481 -0.762 . . . . 0.0 109.976 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.474 ' OH ' ' CD ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -56.05 -69.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.152 -0.967 . . . . 0.0 110.771 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 17.2 pt-20 -43.36 -39.08 2.99 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.146 -0.971 . . . . 0.0 110.692 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 139' ' ' GLU . 57.6 mt-10 -66.5 -60.21 2.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.168 -0.957 . . . . 0.0 110.211 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 145' ' ' MET . 26.6 t80 -46.98 -22.23 0.3 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.231 -0.918 . . . . 0.0 110.35 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.29 -44.01 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.753 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -56.44 -18.19 10.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.179 -0.95 . . . . 0.0 110.631 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.417 ' HE1' ' HB3' ' A' ' 144' ' ' MET . 46.2 mmm -112.58 -10.15 13.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.151 -0.968 . . . . 0.0 110.263 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.458 ' HG2' HG12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -98.17 -9.58 25.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 110.211 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p -90.95 -55.23 3.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.259 -0.901 . . . . 0.0 110.35 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 148' ' ' LYS . . . -90.18 57.49 3.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.37 -0.831 . . . . 0.0 110.341 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.259 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.452 HG21 ' HG2' ' B' ' 2' ' ' LYS . 3.1 m . . . . . 0 N--CA 1.5 2.053 0 CA-C-O 121.01 0.433 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.452 ' HG2' HG21 ' B' ' 1' ' ' VAL . 0.0 OUTLIER -146.68 31.17 0.97 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.947 -1.095 . . . . 0.0 110.237 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' B' ' 4' ' ' ILE . 0.3 OUTLIER -113.96 -6.27 13.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.844 . . . . 0.0 109.467 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.58 ' CG1' ' HD2' ' B' ' 5' ' ' PRO . 1.0 OUTLIER -38.92 156.0 0.13 Allowed Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.592 -0.693 . . . . 0.0 109.933 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.58 ' HD2' ' CG1' ' B' ' 4' ' ' ILE . 38.1 Cg_endo -64.24 151.55 84.95 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.528 1.278 . . . . 0.0 110.473 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.444 ' O ' ' CE ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -74.65 -52.36 11.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.482 -0.761 . . . . 0.0 111.759 -178.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.661 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -172.04 -76.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.82 -1.175 . . . . 0.0 110.754 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.505 ' CG2' ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -46.11 -48.06 17.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 0.0 109.677 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.54 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 4.8 m -44.65 -51.65 8.94 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.391 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 35.2 t -51.36 -43.08 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.263 -0.898 . . . . 0.0 108.958 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 15.5 mm -66.36 -27.5 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.139 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.559 HD21 ' CB ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -63.9 -58.71 5.94 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.623 -0.673 . . . . 0.0 109.964 179.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.442 ' CG1' HD13 ' A' ' 112' ' ' LEU . 54.3 t -60.39 -39.22 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.936 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.441 ' CG ' HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -62.12 -61.29 2.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.087 -1.008 . . . . 0.0 109.722 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 74.5 m -60.74 -18.88 57.3 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.43 -0.794 . . . . 0.0 109.875 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.514 ' O ' ' CG ' ' B' ' 19' ' ' LYS . 6.2 ttt -80.1 -18.45 49.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.579 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 5.2 mp -73.76 -50.32 21.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.248 -0.907 . . . . 0.0 110.58 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.473 ' O ' ' HB3' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -65.44 60.21 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.605 -0.684 . . . . 0.0 110.4 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' B' ' 16' ' ' MET . 0.0 OUTLIER -179.98 120.54 0.06 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.505 ' HB3' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -73.01 20.53 0.08 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.662 -0.649 . . . . 0.0 112.086 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.512 ' O ' ' CD ' ' B' ' 19' ' ' LYS . 0.4 OUTLIER -128.64 175.67 8.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.934 -1.104 . . . . 0.0 109.76 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.521 ' CD1' ' HE3' ' A' ' 124' ' ' MET . 0.6 OUTLIER -112.12 177.88 4.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.023 -1.048 . . . . 0.0 110.069 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.52 140.73 0.06 OUTLIER Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.499 ' ND2' ' HD2' ' B' ' 25' ' ' PRO . 0.4 OUTLIER -121.88 140.15 31.51 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.26 . . . . 0.0 110.948 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.499 ' HD2' ' ND2' ' B' ' 24' ' ' ASN . 44.3 Cg_endo -72.25 55.99 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.046 1.551 . . . . 0.0 109.655 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.604 ' CE1' ' HE1' ' A' ' 72' ' ' MET . 1.4 m-85 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.286 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.212 0.53 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 18.4 p-10 -115.84 43.9 2.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.245 -0.909 . . . . 0.0 110.27 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 3' ' ' GLN . 10.1 pt20 -99.97 66.52 1.36 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.285 -0.884 . . . . 0.0 110.078 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.455 HD22 ' OE1' ' A' ' 8' ' ' GLN . 57.2 mt -142.44 109.97 5.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.952 . . . . 0.0 110.218 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.17 -160.54 0.74 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.306 -0.872 . . . . 0.0 110.198 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -73.66 -21.9 60.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.15 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 8' ' ' GLN . 0.8 OUTLIER -66.43 -68.83 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.056 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.455 ' OE1' HD22 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -45.23 -54.1 7.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 109.67 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.1 mt -50.93 -42.34 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.202 -0.937 . . . . 0.0 109.381 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -50.6 -45.32 57.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.358 -0.839 . . . . 0.0 109.266 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -57.3 -48.47 78.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.33 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.433 ' HB3' HD22 ' A' ' 69' ' ' LEU . 20.1 m-30 -53.86 -46.24 71.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.307 -0.871 . . . . 0.0 109.379 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -57.81 -46.37 84.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.883 . . . . 0.0 109.289 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -60.09 -44.9 94.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.3 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.17 95.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.383 -0.823 . . . . 0.0 109.557 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.515 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 7.2 t80 -62.97 -22.27 66.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.942 . . . . 0.0 109.074 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.51 -47.68 9.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.522 -0.736 . . . . 0.0 109.588 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 10.2 tt -47.66 -41.12 21.61 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.321 -0.862 . . . . 0.0 109.504 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 41.0 m-85 -79.89 -46.16 17.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.884 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.455 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 39.5 t0 -80.46 101.94 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.451 -0.78 . . . . 0.0 110.154 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 4.32 51.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.29 -0.881 . . . . 0.0 110.431 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -97.08 -37.8 10.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.149 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.33 27.95 10.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 10.3 p30 -102.67 -17.03 15.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -1.169 . . . . 0.0 110.195 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 91.07 22.55 32.37 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 14.1 p -138.3 122.72 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.216 -1.167 . . . . 0.0 110.468 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.492 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 13.4 mt -89.3 114.63 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.124 -0.985 . . . . 0.0 110.137 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -93.46 155.73 17.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.714 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' HD11 ' A' ' 48' ' ' LEU . 32.0 p -54.9 -22.71 15.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 110.039 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -43.62 63.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.88 . . . . 0.0 109.972 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' OE1' ' OG1' ' A' ' 28' ' ' THR . 17.0 mt-10 -64.5 -56.68 12.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 0.0 110.093 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 tp -54.54 -36.37 64.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 109.858 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.28 -40.91 99.62 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 m -58.49 -53.07 62.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -1.119 . . . . 0.0 109.819 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.0 t -56.93 -53.9 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.603 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.468 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -50.76 -41.01 56.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 109.736 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -62.91 -27.81 69.62 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 0.0 109.886 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -79.41 -59.54 2.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.821 . . . . 0.0 110.933 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.494 HD21 HG21 ' A' ' 108' ' ' VAL . 4.0 mt -44.04 -37.54 3.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.131 -0.981 . . . . 0.0 110.082 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.08 64.85 0.16 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.507 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -144.82 -168.23 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -1.178 . . . . 0.0 110.119 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.501 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 2.5 m120 -155.1 57.75 1.75 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.062 -1.024 . . . . 0.0 110.578 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 50.1 Cg_endo -80.35 135.73 10.86 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.907 1.477 . . . . 0.0 110.061 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 45' ' ' GLU . 5.1 m -97.26 163.36 12.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.206 -0.933 . . . . 0.0 110.067 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.2 mt-10 -43.05 -54.92 4.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 109.997 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.56 -55.43 33.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 110.043 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HG3' ' HB ' ' A' ' 44' ' ' THR . 21.3 mt-10 -47.46 -44.46 25.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 109.72 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 15.1 mt -55.8 -43.44 76.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.358 -0.839 . . . . 0.0 109.912 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -54.9 -41.42 70.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.441 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.06 -42.94 91.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.447 -0.783 . . . . 0.0 109.648 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.569 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.3 OUTLIER -74.95 -49.44 20.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 109.765 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 7.3 mm -52.4 -25.2 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.624 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -30.59 67.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.345 -0.847 . . . . 0.0 110.185 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 1.3 mp0 -70.24 -25.63 63.47 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.53 HG22 ' NE1' ' B' ' 7' ' ' TRP . 5.6 t -108.07 -28.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 19.2 t0 -63.85 72.17 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.312 -0.867 . . . . 0.0 110.323 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -68.65 -35.69 77.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 110.415 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 24.3 p30 -82.44 -20.15 37.56 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.141 -0.975 . . . . 0.0 110.489 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 81.07 26.49 52.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.523 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 31.8 p-10 -89.66 -30.44 18.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -1.179 . . . . 0.0 110.09 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 113.92 -24.23 12.1 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.523 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 80.7 p -112.65 157.27 21.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -1.215 . . . . 0.0 110.393 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.492 ' CG1' ' HB ' ' A' ' 27' ' ' ILE . 10.2 mm -95.72 144.28 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 110.144 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 75.8 m-20 -110.67 160.68 16.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 109.975 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.576 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 33.0 t80 -52.4 -47.73 92.11 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.289 -0.882 . . . . 0.0 111.271 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -69.42 -41.82 4.34 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.203 1.107 . . . . 0.0 110.163 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 2.9 tt0 -55.6 -45.15 77.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 110.114 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.0 -47.35 86.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 110.118 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 12' ' ' PHE . 85.4 mt -57.41 -23.05 47.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.232 -0.917 . . . . 0.0 110.156 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.3 m -90.1 -21.7 22.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.258 -0.901 . . . . 0.0 111.012 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.476 ' SD ' HG21 ' A' ' 55' ' ' VAL . 3.1 ttp -75.48 -45.37 38.82 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.959 -1.088 . . . . 0.0 109.905 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.547 ' HE2' ' CE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -53.91 -17.27 2.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.39 -0.819 . . . . 0.0 110.907 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.02 -11.69 15.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.936 -1.102 . . . . 0.0 111.324 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -96.53 -36.23 10.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.817 -1.177 . . . . 0.0 110.678 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.534 ' HB3' ' CG2' ' B' ' 8' ' ' THR . 8.9 tttp -91.69 25.94 2.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.239 -0.913 . . . . 0.0 110.535 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.518 ' CE ' ' HE3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -100.27 -32.64 10.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.035 . . . . 0.0 110.453 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -134.44 72.71 1.47 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.237 -0.914 . . . . 0.0 110.176 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER 168.82 104.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.259 -0.901 . . . . 0.0 110.024 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 3.9 m 68.93 104.62 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.429 -0.795 . . . . 0.0 110.261 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 79' ' ' THR . 1.5 t70 71.74 74.02 0.17 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.458 -0.776 . . . . 0.0 110.552 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.4 m -107.06 -46.83 3.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.855 . . . . 0.0 109.738 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -90.48 -34.34 15.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.873 . . . . 0.0 109.513 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.31 -24.64 67.72 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 25.3 tt0 -55.57 -36.92 67.37 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.509 -0.745 . . . . 0.0 109.605 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.486 ' CD1' HG23 ' A' ' 146' ' ' THR . 78.1 mt -70.4 -44.96 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.269 -0.895 . . . . 0.0 109.025 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -54.98 -28.71 53.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.484 -0.76 . . . . 0.0 109.132 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 4.2 mt-10 -69.61 -58.9 3.37 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.471 -0.768 . . . . 0.0 109.445 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.35 -31.39 54.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 0.0 109.247 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.488 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 17.1 t80 -63.72 -45.05 91.7 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -60.82 -34.89 75.23 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -71.49 -42.1 72.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.496 ' CZ ' ' HA ' ' B' ' 13' ' ' VAL . 9.6 m-85 -72.25 -34.57 68.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 108.76 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 96' ' ' GLY . 14.5 t0 -95.24 61.28 2.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.56 -0.713 . . . . 0.0 109.791 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.532 ' HA ' ' CE ' ' A' ' 94' ' ' LYS . 2.1 mmpt? -43.36 -28.02 0.3 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.16 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' OD2' ' CG ' ' A' ' 97' ' ' ASN . 49.7 t0 -67.89 -41.31 82.93 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 73.11 -0.17 48.53 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.421 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 28.5 p-10 -73.01 -24.07 60.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.117 -1.225 . . . . 0.0 110.117 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.463 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 115.21 35.44 1.33 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 0.4 OUTLIER -158.51 105.38 1.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.257 -1.143 . . . . 0.0 110.231 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 100' ' ' ILE . 7.2 mt -81.37 135.47 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.248 -0.907 . . . . 0.0 110.026 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -129.29 148.84 51.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.01 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.87 -30.95 1.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 109.848 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.5 79.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.599 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -61.57 -43.64 98.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.386 -0.821 . . . . 0.0 109.953 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 0.7 OUTLIER -59.76 -42.64 93.71 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.323 -0.86 . . . . 0.0 109.363 179.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -36.88 74.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.799 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -65.15 -44.39 88.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.823 . . . . 0.0 109.843 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.494 HG21 HD21 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -74.0 -33.62 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.803 . . . . 0.0 109.417 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.555 ' HA ' HD23 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -60.82 -65.61 0.66 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 110.174 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m -51.92 -32.84 34.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.116 -0.99 . . . . 0.0 109.507 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 9.6 m120 -77.68 -20.65 53.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 109.547 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.529 ' CD1' HG11 ' B' ' 13' ' ' VAL . 2.5 mt -85.05 -40.41 16.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.511 -0.743 . . . . 0.0 110.168 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.26 -47.39 0.55 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -94.0 165.18 12.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.143 -1.21 . . . . 0.0 111.043 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' LEU . 4.0 ptpp? -140.67 62.82 1.48 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.503 -0.748 . . . . 0.0 109.358 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' B' ' 19' ' ' LYS . 1.6 mp -38.34 140.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.696 -0.628 . . . . 0.0 110.467 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.499 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -50.85 -173.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.37 -0.831 . . . . 0.0 110.478 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 119' ' ' GLU . 20.1 t70 -86.34 -62.32 1.54 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.026 -1.046 . . . . 0.0 110.361 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.508 ' HA ' ' OD2' ' A' ' 122' ' ' ASP . 3.2 tt0 -44.11 -49.61 8.86 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 109.916 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.95 -55.33 36.0 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.519 HG23 ' CE ' ' A' ' 109' ' ' MET . 46.3 t -49.52 -43.6 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.556 -0.715 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 123' ' ' GLU . 9.4 p30 -68.75 -22.53 64.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.757 -1.214 . . . . 0.0 109.966 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 40.1 mm-40 -80.56 -27.82 37.4 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.351 -0.843 . . . . 0.0 108.867 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.524 ' HE3' ' CE1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -67.79 -43.6 79.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.594 -0.691 . . . . 0.0 109.419 179.245 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.592 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 41.5 mm -67.66 -43.49 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.0 109.691 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 126' ' ' ARG . 6.7 mmm-85 -56.98 -39.43 74.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -59.45 -28.59 67.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.355 -0.841 . . . . 0.0 109.996 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.457 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -99.25 -18.25 17.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.378 -0.827 . . . . 0.0 110.022 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.437 ' HB3' ' HA2' ' A' ' 132' ' ' GLY . 1.2 m-20 -59.12 98.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.244 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 128' ' ' ALA . 13.5 mm -67.38 -44.61 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.325 -0.859 . . . . 0.0 110.049 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 19.2 p-10 -90.07 -19.2 24.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 110.093 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 79.23 64.08 1.97 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.514 ' OD2' ' NE2' ' A' ' 135' ' ' GLN . 31.1 p-10 -116.04 -34.73 4.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -1.155 . . . . 0.0 110.143 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 118.34 19.5 4.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.514 ' NE2' ' OD2' ' A' ' 133' ' ' ASP . 3.9 pp0? -160.21 159.01 31.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.173 -1.192 . . . . 0.0 110.434 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.416 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 87.2 t -114.9 108.59 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -80.69 -173.25 4.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.212 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.429 ' O ' ' C ' ' A' ' 139' ' ' GLU . 25.5 t80 -67.66 -67.18 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 110.311 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 138' ' ' TYR . 2.3 tt0 -42.85 -27.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.772 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 144' ' ' MET . 1.6 tt0 -80.94 -53.15 6.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 110.356 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.488 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 69.5 t80 -58.26 -18.31 25.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 66.5 t -99.75 -62.67 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.345 -0.847 . . . . 0.0 110.568 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -52.53 -18.96 1.95 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.254 -0.904 . . . . 0.0 110.489 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.477 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -97.81 -20.94 17.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.128 -0.983 . . . . 0.0 110.165 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.476 ' HA ' ' ND2' ' B' ' 24' ' ' ASN . 8.2 ttm -100.78 -26.37 13.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.355 -0.841 . . . . 0.0 110.746 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.486 HG23 ' CD1' ' A' ' 85' ' ' ILE . 4.7 t -164.04 92.62 0.68 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.907 -1.121 . . . . 0.0 110.888 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.38 47.0 0.99 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.292 -0.88 . . . . 0.0 110.201 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.312 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.529 ' CG1' ' N ' ' B' ' 2' ' ' LYS . 2.1 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.025 0.44 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.529 ' N ' ' CG1' ' B' ' 1' ' ' VAL . 0.0 OUTLIER 64.83 64.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.959 -1.088 . . . . 0.0 110.054 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 7.2 tp -172.23 -26.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 111.318 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.569 ' CG2' ' CD ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -97.8 -177.16 0.58 Allowed Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 120.867 -1.145 . . . . 0.0 109.483 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.569 ' CD ' ' CG2' ' B' ' 4' ' ' ILE . 46.4 Cg_endo -83.03 -158.16 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.559 1.294 . . . . 0.0 110.534 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.524 ' O ' ' N ' ' B' ' 8' ' ' THR . 2.4 p -136.93 56.2 1.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.98 -1.075 . . . . 0.0 111.047 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.597 ' O ' ' CG2' ' B' ' 10' ' ' VAL . 3.0 m95 54.03 -82.15 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.253 -0.904 . . . . 0.0 111.05 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.534 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 7.1 p -41.31 -25.12 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.844 -1.16 . . . . 0.0 110.633 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.496 ' N ' ' O ' ' B' ' 7' ' ' TRP . 50.6 m -64.18 -53.47 48.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 109.638 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.597 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 4.5 m -58.59 -26.34 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.296 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.48 HD11 ' HE1' ' A' ' 72' ' ' MET . 2.9 mt -75.05 -33.13 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.266 -0.897 . . . . 0.0 109.078 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.459 HD23 ' HE3' ' A' ' 145' ' ' MET . 1.3 mt -59.47 -59.57 5.23 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 110.125 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.529 HG11 ' CD1' ' A' ' 112' ' ' LEU . 61.8 t -62.66 -40.47 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 110.939 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -63.43 -31.0 72.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.965 -1.084 . . . . 0.0 110.072 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 0.5 OUTLIER -76.4 -24.23 54.05 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.363 -0.836 . . . . 0.0 110.092 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.5 ' O ' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -83.67 -17.62 40.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.272 -0.892 . . . . 0.0 111.301 -179.323 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 19' ' ' LYS . 0.3 OUTLIER -78.79 -109.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.406 -1.434 . . . . 0.0 110.081 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.47 ' C ' ' HG3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 58.58 -72.64 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.131 -0.98 . . . . 0.0 110.821 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -172.94 90.62 0.09 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.348 -0.845 . . . . 0.0 112.256 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' B' ' 19' ' ' LYS . 0.7 OUTLIER 62.1 4.67 1.25 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.534 -1.354 . . . . 0.0 110.829 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.5 ' O ' ' O ' ' B' ' 16' ' ' MET . 12.1 t -66.01 119.04 10.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.945 -1.097 . . . . 0.0 110.23 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.524 ' CE1' ' HE3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -152.57 53.68 0.78 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.095 -1.003 . . . . 0.0 110.221 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.45 -136.23 6.42 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' B' ' 24' ' ' ASN . 2.0 m120 -130.51 65.17 75.45 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.247 -1.149 . . . . 0.0 110.637 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.27 42.26 1.29 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.937 1.493 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.547 ' CE2' ' HE2' ' A' ' 72' ' ' MET . 5.7 m-85 . . . . . 0 N--CA 1.498 1.927 0 O-C-N 121.074 -1.016 . . . . 0.0 110.293 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.158 0.504 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.65 178.29 1.94 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -0.932 . . . . 0.0 110.333 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.429 ' O ' HD21 ' A' ' 4' ' ' LEU . 32.9 mt-30 -53.07 -176.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.245 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 59.3 mt -122.67 125.04 44.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.908 . . . . 0.0 110.178 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 t -43.05 -40.45 3.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.381 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -45.9 -25.18 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.0 110.405 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.515 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 4.2 mt-10 -68.27 -61.11 1.99 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.127 -0.983 . . . . 0.0 109.929 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 7' ' ' GLU . 1.8 mp0 -44.24 -55.93 4.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.733 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mt -56.97 -43.85 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.682 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 6' ' ' GLU . . . -53.88 -51.81 62.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.682 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.511 ' OE2' ' CD ' ' B' ' 18' ' ' ARG . 16.9 tt0 -56.9 -45.98 82.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.674 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -63.04 -41.34 99.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -61.4 -41.19 96.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' O ' ' OG ' ' A' ' 17' ' ' SER . 7.6 tt0 -63.18 -48.07 79.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.249 -0.907 . . . . 0.0 109.258 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -62.5 -46.44 88.44 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.4 -0.813 . . . . 0.0 109.395 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 65' ' ' PHE . 41.0 t80 -61.26 -38.43 86.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.338 -0.851 . . . . 0.0 109.0 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 14' ' ' GLU . 77.5 p -75.19 -35.55 61.52 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.539 -0.725 . . . . 0.0 109.365 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 112' ' ' LEU . 1.1 tt -50.16 -44.86 52.83 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.815 . . . . 0.0 109.217 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -76.83 -51.53 11.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.431 -0.793 . . . . 0.0 109.472 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.458 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 46.0 t0 -77.17 78.2 3.71 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.509 -0.744 . . . . 0.0 110.009 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -68.22 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.6 p-10 -51.64 -27.52 11.66 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.431 -0.793 . . . . 0.0 110.293 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 80.21 18.61 71.37 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 53.6 p30 -62.24 -12.47 20.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -1.191 . . . . 0.0 109.962 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 86.98 29.39 23.23 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 4.2 p -152.61 118.57 5.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.268 -1.137 . . . . 0.0 110.601 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.492 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 10.7 mt -94.22 120.12 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.163 -0.96 . . . . 0.0 110.172 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.53 164.76 11.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.353 -0.842 . . . . 0.0 109.984 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.436 ' O ' HD11 ' A' ' 48' ' ' LEU . 38.6 p -56.63 -29.31 62.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.992 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -69.51 -60.83 2.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.803 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -49.06 -57.53 6.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -0.888 . . . . 0.0 110.14 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -52.86 -41.96 64.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.781 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.495 ' HA2' ' CG ' ' A' ' 43' ' ' PRO . . . -58.39 -34.88 76.63 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.7 m -62.85 -56.92 13.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -1.11 . . . . 0.0 110.035 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG12 HD22 ' A' ' 18' ' ' LEU . 16.4 t -53.71 -32.71 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.334 -0.854 . . . . 0.0 109.883 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -27.28 59.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 109.956 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.422 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 1.4 ttp180 -76.73 -21.67 54.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -0.955 . . . . 0.0 110.121 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -33.71 59.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -0.922 . . . . 0.0 110.357 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mt -74.94 -44.1 50.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.229 -0.919 . . . . 0.0 110.231 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.16 78.76 0.08 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -176.45 -174.51 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.259 -1.142 . . . . 0.0 110.283 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -142.55 93.43 6.97 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.0 110.315 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 44.5 Cg_endo -74.61 90.92 1.01 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 124.092 1.575 . . . . 0.0 110.297 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.29 145.86 52.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 110.428 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -49.07 -64.79 0.7 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.24 -0.913 . . . . 0.0 110.573 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -43.84 -51.14 7.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.939 -1.101 . . . . 0.0 110.046 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -65.13 -35.21 80.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.876 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.436 HD11 ' O ' ' A' ' 29' ' ' THR . 11.0 mt -62.38 -47.68 83.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 110.09 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -57.48 -44.85 85.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.875 . . . . 0.0 109.821 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.17 -27.15 69.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.419 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.437 ' SD ' HG22 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -74.66 -54.13 8.0 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.493 -0.754 . . . . 0.0 110.129 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -13.08 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.253 -0.904 . . . . 0.0 109.753 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.46 -24.74 63.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.187 -0.946 . . . . 0.0 109.212 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.85 -47.89 13.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.519 -0.738 . . . . 0.0 109.962 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.602 HG22 ' CD1' ' B' ' 7' ' ' TRP . 88.3 t -69.6 -18.09 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.651 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' ALA . 17.2 t0 -67.68 57.78 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.021 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -43.36 -55.58 4.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.952 . . . . 0.0 110.256 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.485 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 6.9 p-10 -64.1 -44.15 93.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.86 35.39 3.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.485 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 6.9 p-10 -98.64 -44.93 6.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -1.207 . . . . 0.0 110.137 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.448 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . 142.15 -54.88 0.6 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.28 156.56 19.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.252 -1.146 . . . . 0.0 110.701 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.52 ' CD1' HG13 ' A' ' 55' ' ' VAL . 7.9 mm -90.39 142.93 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.805 . . . . 0.0 109.378 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.457 ' OD1' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -108.64 176.82 4.98 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.031 -1.043 . . . . 0.0 110.809 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.612 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 4.1 t80 -66.99 -45.2 52.92 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.495 -0.753 . . . . 0.0 111.372 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.8 Cg_endo -69.02 -37.81 10.38 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.203 1.107 . . . . 0.0 109.938 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.93 -41.66 64.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.293 -0.88 . . . . 0.0 109.218 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 16.3 t80 -64.51 -50.33 67.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.748 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.423 ' N ' HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -51.44 -26.29 7.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.84 . . . . 0.0 110.574 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 34.8 m -98.4 -20.4 17.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 111.167 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.481 ' HE3' ' HB2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -78.99 -30.69 44.47 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.958 -1.089 . . . . 0.0 110.861 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.503 ' HE3' ' CE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -77.09 -9.08 58.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.192 -0.942 . . . . 0.0 110.839 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.58 -16.55 8.84 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.867 -1.145 . . . . 0.0 111.405 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -99.94 -9.91 22.25 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.883 -1.136 . . . . 0.0 110.491 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HB3' HG22 ' B' ' 8' ' ' THR . 6.5 tptt -95.41 10.29 36.92 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.29 -0.881 . . . . 0.0 110.618 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.462 ' CE ' ' HE3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -97.25 -7.83 31.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.162 -0.962 . . . . 0.0 110.245 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -147.35 69.43 1.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 109.935 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.492 ' O ' ' CG2' ' A' ' 79' ' ' THR . 39.7 t0 -148.77 -47.61 0.15 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.248 -0.907 . . . . 0.0 110.416 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 78' ' ' ASP . 1.4 p -162.24 -37.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 110.415 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 3.6 m-20 -100.24 71.54 1.59 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.222 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.456 ' O ' ' OE2' ' A' ' 84' ' ' GLU . 16.0 t -85.84 -53.25 5.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.943 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.51 -20.24 16.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.39 -0.819 . . . . 0.0 110.237 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -67.42 -40.11 85.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.716 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 81' ' ' SER . 17.9 pt-20 -51.8 -31.79 28.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 109.911 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.412 HG22 HG21 ' A' ' 142' ' ' VAL . 62.2 mt -78.78 -50.84 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.155 -0.966 . . . . 0.0 109.313 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.449 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 14.9 ttm180 -49.38 -40.6 36.49 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 109.5 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.52 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 26.4 mt-10 -69.06 -52.77 25.06 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.292 -0.88 . . . . 0.0 109.581 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.33 -27.04 44.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.07 -1.019 . . . . 0.0 109.071 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 86' ' ' ARG . 83.3 t80 -69.75 -45.58 67.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 0.0 109.112 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -56.61 -37.47 70.71 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.591 -0.693 . . . . 0.0 109.36 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 108' ' ' VAL . 82.1 t -64.92 -41.07 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.503 -0.748 . . . . 0.0 109.748 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CE2' HD22 ' A' ' 105' ' ' LEU . 5.0 m-85 -66.42 -31.34 72.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.0 109.37 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 3.8 t0 -91.13 59.92 4.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.479 -0.763 . . . . 0.0 109.986 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -38.96 -39.8 0.58 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.441 -0.787 . . . . 0.0 110.794 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.0 p-10 -86.58 -35.06 19.68 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 0.0 110.121 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 82.55 44.6 7.27 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -94.64 -23.61 17.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -1.197 . . . . 0.0 110.177 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 114.88 29.32 2.64 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 41.8 m-85 -160.62 150.59 17.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.174 -1.192 . . . . 0.0 110.039 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.454 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 9.0 mt -119.06 118.09 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 102' ' ' ALA . 2.0 t -105.33 145.88 30.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 110.147 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.87 -33.03 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.811 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.15 82.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 109.546 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 39.6 mt-10 -55.77 -41.27 73.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.882 . . . . 0.0 109.492 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 7.7 mt -59.74 -44.67 93.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 109.601 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -57.5 -39.35 76.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -0.825 . . . . 0.0 109.592 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -63.5 -50.8 68.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 109.554 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -63.76 -25.27 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 108.898 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.528 ' HB3' ' HA ' ' A' ' 115' ' ' LYS . 2.6 mtm -69.13 -65.37 0.72 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.672 -0.643 . . . . 0.0 109.988 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -51.99 -28.88 18.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -78.55 -10.5 59.75 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.277 -0.889 . . . . 0.0 109.337 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' B' ' 14' ' ' LYS . 13.8 mt -107.34 -48.5 3.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.356 -0.84 . . . . 0.0 110.479 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.58 -59.5 0.18 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.548 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 109' ' ' MET . 2.7 tp10 -99.76 159.23 15.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.934 -1.333 . . . . 0.0 110.819 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 1.1 pttp -123.57 1.91 8.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.375 -0.828 . . . . 0.0 110.012 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 115' ' ' LYS . 4.8 mp 48.11 175.81 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.56 0.695 . . . . 0.0 110.969 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.421 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.46 178.91 6.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.138 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -50.97 9.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.96 -1.087 . . . . 0.0 110.065 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -56.79 -46.11 81.76 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 109.491 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -58.91 -52.8 64.18 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.375 -0.828 . . . . 0.0 109.409 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 117' ' ' THR . 41.3 t -50.84 -41.41 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.857 . . . . 0.0 109.669 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 1.1 m-20 -70.95 -38.83 72.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.398 -0.813 . . . . 0.0 110.029 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -68.84 -23.73 64.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -0.866 . . . . 0.0 110.05 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.657 ' CE ' ' CD1' ' B' ' 22' ' ' PHE . 22.3 ttt -74.4 -56.21 5.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.882 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 31.2 mm -60.68 -52.82 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.0 109.712 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 122' ' ' ASP . 1.5 mtp85 -50.33 -52.89 32.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 110.1 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 15.3 mm-40 -53.33 -29.04 31.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.342 -0.849 . . . . 0.0 110.193 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.54 -19.23 24.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 110.343 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.43 70.43 3.82 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.0 110.262 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.6 mt -63.57 -41.22 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.968 . . . . 0.0 109.766 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 9.7 p30 -63.55 -36.29 83.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.332 -0.855 . . . . 0.0 110.03 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 95.48 74.19 1.22 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.458 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -133.44 2.17 3.5 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.229 -1.159 . . . . 0.0 109.976 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.508 ' O ' ' CG ' ' A' ' 135' ' ' GLN . . . 71.66 4.71 58.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.508 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 68.1 mt-30 -156.63 168.81 26.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.163 . . . . 0.0 109.773 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.417 HG22 HG21 ' A' ' 125' ' ' ILE . 14.7 t -107.16 131.47 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 109.953 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 11.6 t30 -100.39 -152.98 0.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 0.0 110.23 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.449 ' OH ' ' HG3' ' A' ' 86' ' ' ARG . 12.1 t80 -74.54 -69.45 0.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.245 -0.909 . . . . 0.0 110.087 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 143' ' ' GLN . 1.4 tt0 -46.95 -44.4 19.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.187 -0.946 . . . . 0.0 109.875 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.413 ' CD ' ' OD2' ' A' ' 131' ' ' ASP . 11.5 mt-10 -53.78 -60.56 3.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.795 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 140' ' ' GLU . 5.1 t80 -42.96 -33.0 0.71 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 110.017 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.467 ' O ' ' OG1' ' A' ' 146' ' ' THR . 37.8 t -100.09 -17.11 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.374 -0.829 . . . . 0.0 110.726 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 139' ' ' GLU . 13.7 tt0 -77.9 -27.97 49.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.173 -0.954 . . . . 0.0 110.621 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -93.51 -11.05 32.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.503 ' O ' ' HB2' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.6 -24.78 14.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.436 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 73.0 p -122.93 -26.83 4.34 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.921 -1.112 . . . . 0.0 110.661 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -100.22 63.11 1.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.142 -0.974 . . . . 0.0 110.141 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 147' ' ' ALA . 18.7 tttp . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.383 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' B' ' 2' ' ' LYS . 1.6 p . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.105 0.479 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' B' ' 2' ' ' LYS . 0.0 OUTLIER 55.79 110.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.177 -0.952 . . . . 0.0 109.803 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.43 HD21 ' O ' ' B' ' 2' ' ' LYS . 0.2 OUTLIER -175.06 -34.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.736 -1.228 . . . . 0.0 110.457 -179.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.437 HG22 ' SD ' ' A' ' 51' ' ' MET . 12.5 mt -147.13 122.6 5.35 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 109.595 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.495 ' O ' ' HB ' ' B' ' 9' ' ' THR . 44.1 Cg_endo -70.87 66.39 2.42 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.98 1.516 . . . . 0.0 111.602 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.482 ' C ' ' O ' ' B' ' 5' ' ' PRO . 42.4 m 31.56 -147.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.533 0.682 . . . . 0.0 111.874 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.602 ' CD1' HG22 ' A' ' 55' ' ' VAL . 2.0 m95 -108.7 -73.87 0.67 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.886 0.851 . . . . 0.0 110.842 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.512 ' O ' ' N ' ' B' ' 12' ' ' LEU . 2.6 p -44.83 -36.59 3.34 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.498 -0.751 . . . . 0.0 110.288 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.52 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 2.6 m -44.91 -53.84 7.15 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.695 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 4.7 t -57.46 -40.12 72.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.458 HG22 ' HG2' ' A' ' 72' ' ' MET . 47.1 mt -72.75 -19.72 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.539 -0.726 . . . . 0.0 109.635 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' B' ' 8' ' ' THR . 0.2 OUTLIER -73.36 -50.16 23.42 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.647 0.737 . . . . 0.0 109.768 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.454 HG13 HG23 ' A' ' 108' ' ' VAL . 89.1 t -64.91 -47.06 89.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.475 -0.766 . . . . 0.0 110.575 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.492 ' HA ' HD11 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -65.86 -32.76 74.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.066 -1.021 . . . . 0.0 109.802 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 34.2 t -78.23 -13.68 59.76 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.6 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' B' ' 12' ' ' LEU . 0.0 OUTLIER -79.67 -42.18 25.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.162 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.488 ' O ' ' C ' ' B' ' 18' ' ' ARG . 9.3 mp -44.98 -57.32 3.89 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.918 -1.114 . . . . 0.0 109.057 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.511 ' CD ' ' OE2' ' A' ' 11' ' ' GLU . 3.6 tpt85 16.38 75.24 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' B' ' 19' ' ' LYS . 2.0 tptm 44.62 73.76 0.15 Allowed 'General case' 0 C--N 1.283 -2.308 0 O-C-N 121.273 -0.892 . . . . 0.0 112.883 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.595 ' O ' ' HG2' ' B' ' 20' ' ' ARG . 0.0 OUTLIER 47.86 13.73 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.683 0 O-C-N 120.8 -1.187 . . . . 0.0 112.092 177.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' B' ' 18' ' ' ARG . 5.1 m -112.74 115.45 28.55 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 119.956 -1.715 . . . . 0.0 110.468 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.657 ' CD1' ' CE ' ' A' ' 124' ' ' MET . 0.9 OUTLIER -58.16 -35.32 71.38 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.167 -1.013 . . . . 0.0 108.779 179.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.54 147.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 1.8 p-10 -134.97 43.09 0.87 Allowed Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.479 -1.013 . . . . 0.0 110.73 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 55.2 Cg_endo -77.96 26.64 0.49 Allowed 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.481 1.253 . . . . 0.0 111.189 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.503 ' CE2' ' HE3' ' A' ' 72' ' ' MET . 15.5 m-85 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 110.354 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.309 0.576 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -103.84 21.91 15.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.204 -0.935 . . . . 0.0 110.271 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -170.58 2.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.198 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -108.41 -171.95 1.96 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.35 94.4 7.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.278 -0.889 . . . . 0.0 110.226 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -96.79 -33.42 11.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.186 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.86 -47.41 80.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.167 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -66.5 -45.52 79.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 110.111 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 47.2 mt -66.44 -40.05 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.997 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.33 -62.35 1.78 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 109.714 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.494 ' OE1' ' CA ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -48.64 -41.48 31.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.609 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.8 m-30 -52.49 -46.78 66.74 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.214 -0.929 . . . . 0.0 109.153 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -57.34 -34.52 68.86 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.329 -0.857 . . . . 0.0 109.172 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 1.7 tt0 -56.84 -51.01 70.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.397 -0.814 . . . . 0.0 109.794 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' CA ' ' HD2' ' B' ' 14' ' ' LYS . . . -60.01 -45.39 92.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.19 -0.943 . . . . 0.0 109.566 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.584 ' CZ ' ' O ' ' A' ' 64' ' ' ASP . 1.7 t80 -64.62 -45.43 86.89 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 109.841 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m -64.29 -31.33 72.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.809 . . . . 0.0 109.706 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.454 HD11 ' HG3' ' B' ' 14' ' ' LYS . 9.7 tt -61.9 -45.9 91.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.447 -0.783 . . . . 0.0 110.041 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.545 ' CE1' HG13 ' B' ' 10' ' ' VAL . 26.4 m-85 -71.42 -27.13 63.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.287 -0.883 . . . . 0.0 110.245 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.8 120.8 26.48 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.262 -0.899 . . . . 0.0 110.346 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.44 -37.09 60.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.237 -0.914 . . . . 0.0 110.304 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 17.6 p-10 -92.09 -40.9 10.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.307 -0.871 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.98 48.58 2.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 44.8 p-10 -104.69 -7.72 19.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -1.162 . . . . 0.0 110.1 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.431 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 89.71 35.78 7.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 20.0 p -155.68 107.73 2.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.292 -1.122 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.475 HD11 HG22 ' A' ' 27' ' ' ILE . 7.1 mt -95.3 119.48 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.137 -0.977 . . . . 0.0 110.326 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.532 ' CG2' ' CG2' ' A' ' 62' ' ' THR . 12.7 p -100.08 174.46 6.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.179 -0.951 . . . . 0.0 110.231 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.413 HG22 ' OE1' ' A' ' 49' ' ' GLN . 74.9 p -59.09 -31.91 69.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -55.33 9.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.153 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 39.5 mt-10 -55.02 -69.76 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.06 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.424 ' HB2' HG23 ' A' ' 27' ' ' ILE . 12.6 tp -44.94 -41.84 7.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.761 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.21 -41.99 93.12 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 m -61.07 -50.78 71.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -1.113 . . . . 0.0 109.886 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.454 HG23 ' HA ' ' A' ' 19' ' ' PHE . 12.4 t -57.92 -42.27 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 mmt -61.07 -42.34 98.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.29 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -53.04 -40.82 64.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.242 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 40' ' ' GLY . 68.3 m -71.77 -44.22 64.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.553 -0.717 . . . . 0.0 109.461 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -43.5 -26.24 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.38 -0.825 . . . . 0.0 109.69 179.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 107.85 37.91 2.12 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' B' ' 3' ' ' LEU . 10.5 mm-40 -145.98 165.64 28.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.31 -1.112 . . . . 0.0 110.535 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -126.84 88.89 53.43 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 109.64 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.06 160.81 46.52 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.113 1.586 . . . . 0.0 110.93 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.465 HG21 ' N ' ' A' ' 45' ' ' GLU . 94.9 m -99.64 164.3 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.476 -0.765 . . . . 0.0 109.879 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.465 ' N ' HG21 ' A' ' 44' ' ' THR . 0.7 OUTLIER -69.03 -69.95 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.16 -0.963 . . . . 0.0 110.073 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -43.33 -54.14 4.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.974 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 69.1 mm-40 -54.54 -41.39 69.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.014 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 3.4 mt -55.4 -42.7 74.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 0.0 109.906 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' OE1' HG22 ' A' ' 29' ' ' THR . 45.4 tp60 -67.36 -24.32 65.69 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.274 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -71.51 -46.98 58.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 109.974 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.481 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 24.7 ptm -73.21 -35.41 66.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 109.724 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.481 ' N ' ' HG3' ' A' ' 51' ' ' MET . 7.8 mm -62.32 -32.46 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 109.529 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.24 -21.06 56.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.831 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.17 -37.99 87.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 110.154 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.544 HG22 ' CD1' ' B' ' 7' ' ' TRP . 11.5 t -91.86 -31.8 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 110.176 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.1 71.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.261 -0.9 . . . . 0.0 110.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.27 -17.17 61.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.0 110.638 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.6 p30 -100.43 -31.87 11.09 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.143 -0.973 . . . . 0.0 110.609 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.54 42.48 4.82 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.422 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 12.6 m120 -84.03 -15.77 46.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.195 -1.179 . . . . 0.0 110.076 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 101.67 -8.41 56.39 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.532 ' CG2' ' CG2' ' A' ' 28' ' ' THR . 2.9 p -158.23 168.46 26.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 26' ' ' THR . 30.2 mm -82.82 136.07 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 109.943 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.584 ' O ' ' CZ ' ' A' ' 16' ' ' PHE . 2.5 m-20 -114.27 174.01 6.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.307 -0.871 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.583 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 48.2 t80 -59.4 -49.85 90.37 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.404 -0.81 . . . . 0.0 111.714 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.1 Cg_endo -65.27 -38.37 27.28 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.169 1.089 . . . . 0.0 110.268 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -53.19 -33.9 54.66 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.136 -0.977 . . . . 0.0 109.335 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' HB2' ' CE1' ' A' ' 16' ' ' PHE . 21.9 t80 -78.05 -39.26 42.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 110.345 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.46 HD22 ' O ' ' A' ' 65' ' ' PHE . 2.3 mm? -55.49 -30.09 59.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.871 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.57 -63.21 1.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.041 -1.037 . . . . 0.0 111.37 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.456 ' HG3' ' HA ' ' A' ' 55' ' ' VAL . 2.1 tmm? -44.32 -37.92 3.6 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.068 -1.02 . . . . 0.0 111.548 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.649 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -67.08 -8.56 31.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.039 -1.038 . . . . 0.0 111.317 -179.014 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.97 -9.34 9.66 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.664 -1.273 . . . . 0.0 111.687 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -17.32 30.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.78 -1.2 . . . . 0.0 111.4 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -100.42 -8.3 23.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.922 -1.111 . . . . 0.0 111.314 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.58 ' HE3' ' CE2' ' B' ' 26' ' ' PHE . 2.3 mtt -100.42 26.16 6.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 0.0 110.989 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' A' ' 76' ' ' MET . 3.1 mptt -156.49 85.97 1.0 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.13 -0.981 . . . . 0.0 110.529 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -162.61 -106.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.276 -0.89 . . . . 0.0 109.984 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.462 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -142.79 6.35 1.6 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.88 -1.138 . . . . 0.0 110.543 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 79' ' ' THR . 85.1 m-20 -141.64 63.44 1.43 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.4 p -101.81 -32.61 10.17 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.428 -0.795 . . . . 0.0 109.455 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' HA ' HD13 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -67.62 -23.36 65.35 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.498 -0.751 . . . . 0.0 109.566 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -73.88 -34.95 64.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.067 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 31.9 mt-10 -69.08 -19.94 64.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.146 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 82' ' ' GLU . 40.7 mt -70.85 -39.42 75.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 109.053 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.489 ' HD2' ' CE ' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -57.72 -27.72 63.22 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.426 -0.796 . . . . 0.0 108.959 178.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 5.4 mt-10 -70.94 -57.67 4.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.393 -0.817 . . . . 0.0 109.431 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -54.88 -27.54 43.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.046 -1.034 . . . . 0.0 109.173 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -66.15 -52.67 46.21 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.73 -34.53 12.28 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.871 . . . . 0.0 109.155 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.559 ' CG1' ' CG2' ' A' ' 108' ' ' VAL . 72.0 t -67.52 -42.73 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.442 -0.786 . . . . 0.0 109.59 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.581 ' CE1' HG13 ' A' ' 108' ' ' VAL . 56.5 m-85 -76.37 -24.13 54.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 96' ' ' GLY . 3.7 t0 -100.23 67.51 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.497 -0.752 . . . . 0.0 110.144 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -39.01 -44.83 1.14 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.595 -0.69 . . . . 0.0 110.351 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.64 -22.92 34.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 109.882 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 63.18 51.56 54.13 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -99.85 -26.21 14.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -1.155 . . . . 0.0 110.166 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 122.08 18.81 3.4 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -153.35 130.99 11.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -1.145 . . . . 0.0 110.098 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 92' ' ' PHE . 22.2 mt -103.95 157.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 110.419 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.8 OUTLIER -140.33 147.3 39.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.397 -0.814 . . . . 0.0 109.704 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.16 -30.9 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.869 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.49 -45.02 73.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.311 -0.868 . . . . 0.0 109.592 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 20.7 mt-10 -63.32 -47.53 81.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.257 -0.902 . . . . 0.0 109.555 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.539 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.39 -39.28 90.12 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.286 -0.884 . . . . 0.0 109.634 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.458 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 1.4 tmt_? -60.47 -29.05 68.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.359 -0.838 . . . . 0.0 109.823 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -31.78 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 110.048 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.581 HG13 ' CE1' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -74.15 -36.71 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.979 . . . . 0.0 109.554 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.56 ' HB3' ' CD2' ' B' ' 17' ' ' LEU . 21.5 ptp -73.26 -39.99 64.98 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.552 ' N ' ' HG3' ' A' ' 109' ' ' MET . 87.1 m -69.54 -27.38 65.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.116 -0.99 . . . . 0.0 109.47 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -89.75 -13.14 37.39 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.42 -0.8 . . . . 0.0 109.302 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 39' ' ' LEU . 9.2 mt -93.89 -32.65 13.83 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.449 -0.782 . . . . 0.0 110.006 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.05 -63.82 0.33 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.267 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 109' ' ' MET . 1.8 tt0 -94.11 156.1 16.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.114 -1.227 . . . . 0.0 110.679 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 116' ' ' LEU . 9.8 pttt -124.53 13.03 8.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.532 HD11 ' CD2' ' B' ' 17' ' ' LEU . 1.0 OUTLIER 40.66 -164.1 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.512 0.672 . . . . 0.0 110.56 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -166.28 1.3 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.387 -0.82 . . . . 0.0 109.567 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.436 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -97.17 -59.56 1.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.094 -1.004 . . . . 0.0 109.694 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 4.5 pt-20 -58.91 -30.29 67.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.515 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 9.2 tp10 -69.83 -48.17 59.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.403 -0.811 . . . . 0.0 109.321 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 t -57.28 -42.12 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.432 -0.793 . . . . 0.0 109.64 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 14.4 m-20 -69.2 -41.17 77.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.89 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 2.4 mt-10 -64.08 -31.01 72.04 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 110.007 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.556 ' HG2' ' CD1' ' B' ' 22' ' ' PHE . 1.0 OUTLIER -69.6 -42.05 74.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.176 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.539 HD13 ' CD1' ' A' ' 105' ' ' LEU . 35.0 mm -74.52 -23.88 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -74.44 -40.16 62.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.23 -0.919 . . . . 0.0 110.552 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.79 -8.96 58.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 110.266 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.466 ' O ' HD13 ' A' ' 130' ' ' ILE . . . -101.26 -30.53 11.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.305 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.97 101.37 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.109 -0.994 . . . . 0.0 110.285 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.466 HD13 ' O ' ' A' ' 128' ' ' ALA . 1.2 mp -67.81 -27.37 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.197 -0.939 . . . . 0.0 109.813 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 41.6 p-10 -103.38 -25.48 13.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.63 72.38 1.27 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -130.61 -0.83 4.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -1.168 . . . . 0.0 110.145 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.07 -2.7 75.9 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' HB3' ' O ' ' A' ' 100' ' ' ILE . 40.9 mt-30 -142.54 160.7 39.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -1.226 . . . . 0.0 110.2 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.1 t -107.59 120.05 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.182 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 98' ' ' GLY . 10.4 t-20 -81.31 166.44 20.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.884 . . . . 0.0 110.15 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -57.7 -48.97 78.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.106 -0.996 . . . . 0.0 110.155 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -53.2 -30.67 38.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 109.934 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.443 ' HG2' HD11 ' A' ' 130' ' ' ILE . 42.5 mt-10 -79.84 -52.63 7.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.306 -0.871 . . . . 0.0 109.813 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.527 ' CE1' ' HE3' ' B' ' 16' ' ' MET . 65.9 t80 -49.75 -21.79 1.2 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.2 -0.938 . . . . 0.0 109.593 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 146' ' ' THR . 17.1 t -94.04 -62.28 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.437 -0.789 . . . . 0.0 110.255 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -43.84 -49.55 8.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.877 . . . . 0.0 110.267 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 3.7 tpt -59.05 -19.14 41.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.869 . . . . 0.0 110.556 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.561 ' CE ' ' HB2' ' B' ' 24' ' ' ASN . 2.7 mtt -99.61 -24.63 14.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.168 -0.958 . . . . 0.0 110.501 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 142' ' ' VAL . 1.4 t -129.85 63.78 1.52 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.147 -0.97 . . . . 0.0 110.344 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.02 37.9 1.47 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.403 ' HD2' ' OXT' ' A' ' 148' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.21 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 77.7 t . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.274 0.559 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.489 ' CE ' ' HD2' ' A' ' 86' ' ' ARG . 4.5 mptt -94.38 105.86 17.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.229 -0.919 . . . . 0.0 110.127 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.499 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.1 mt -145.56 -51.36 0.25 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.136 -0.977 . . . . 0.0 110.477 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 20.0 mt -135.45 148.21 65.03 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.316 -0.865 . . . . 0.0 109.881 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 38.8 Cg_endo -65.27 122.63 10.41 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.843 1.444 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.526 ' O ' ' N ' ' B' ' 8' ' ' THR . 17.8 m -78.93 79.68 5.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.834 . . . . 0.0 111.015 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.544 ' CD1' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER 50.35 -86.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.329 -0.857 . . . . 0.0 111.106 179.086 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.526 ' N ' ' O ' ' B' ' 6' ' ' SER . 10.3 p -43.31 -30.05 0.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 110.733 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' B' ' 5' ' ' PRO . 83.8 m -64.86 -47.29 78.43 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.694 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.545 HG13 ' CE1' ' A' ' 19' ' ' PHE . 5.5 t -61.39 -46.88 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.721 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.53 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 76.4 mt -58.96 -30.27 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.165 -0.959 . . . . 0.0 109.488 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.609 ' HG ' ' CE2' ' B' ' 26' ' ' PHE . 3.2 tt -63.73 -56.81 12.79 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.436 -0.79 . . . . 0.0 110.26 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.497 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 67.2 t -54.38 -40.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.149 -0.969 . . . . 0.0 110.576 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.499 ' HD2' ' CA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -72.9 -44.06 61.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.944 -1.097 . . . . 0.0 109.661 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.449 ' HA ' ' HE2' ' B' ' 14' ' ' LYS . 20.7 p -67.26 -7.87 27.5 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.368 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.527 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 2.0 ttt -93.15 -60.31 1.83 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.897 . . . . 0.0 110.871 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.668 ' O ' ' CD2' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -102.51 91.88 4.42 Favored 'General case' 0 C--O 1.204 -1.315 0 CA-C-O 123.768 1.746 . . . . 0.0 110.667 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -124.87 -35.72 2.65 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.137 -0.977 . . . . 0.0 109.763 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.489 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 1.5 tmtm? -137.44 -72.46 0.43 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.201 -0.937 . . . . 0.0 110.558 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.439 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -161.23 23.54 0.13 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.138 -0.976 . . . . 0.0 109.501 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.446 ' O ' ' SD ' ' A' ' 124' ' ' MET . 3.6 m -100.97 166.42 10.83 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.65 -0.656 . . . . 0.0 110.903 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.556 ' CD1' ' HG2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -153.63 16.45 0.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.367 -0.833 . . . . 0.0 110.37 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.39 126.34 6.22 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.561 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 2.2 m-80 -112.83 135.36 21.62 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.177 -1.19 . . . . 0.0 110.951 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -81.46 11.85 2.92 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.027 1.541 . . . . 0.0 110.015 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.649 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 3.3 m-85 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.179 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.161 0.505 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -104.31 -55.82 2.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 110.292 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -74.27 -164.35 0.25 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -0.976 . . . . 0.0 110.267 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 5' ' ' THR . 3.2 mt -89.1 99.08 12.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.438 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 4' ' ' LEU . 64.0 p 40.46 65.34 0.78 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.41 -0.806 . . . . 0.0 110.47 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -100.18 -34.68 9.93 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.479 -0.763 . . . . 0.0 110.22 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 8' ' ' GLN . 6.7 mm-40 -49.71 -68.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.333 -0.855 . . . . 0.0 110.442 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 35.4 mt-30 -41.81 -54.09 3.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.877 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.1 mt -57.33 -38.64 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 109.671 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.39 79.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.588 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 26.4 mt-10 -60.23 -56.11 25.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.532 ' CB ' HD22 ' A' ' 69' ' ' LEU . 31.3 m-85 -56.82 -36.12 69.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 109.466 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -42.66 98.37 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.294 -0.879 . . . . 0.0 109.045 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' SER . 4.7 tp10 -51.1 -45.26 61.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 109.149 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.86 -49.18 73.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 109.273 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.491 ' CE1' ' CD1' ' A' ' 27' ' ' ILE . 21.6 t80 -56.45 -29.38 61.6 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.418 -0.801 . . . . 0.0 109.744 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 3.6 t -68.83 -46.67 67.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 0.0 110.0 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 112' ' ' LEU . 10.4 tt -55.03 -36.9 65.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 109.629 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 62.4 m-85 -79.38 -52.71 7.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.323 -0.86 . . . . 0.0 110.004 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -68.52 111.58 4.81 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.451 -0.78 . . . . 0.0 110.305 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -90.34 -44.15 9.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -0.841 . . . . 0.0 110.178 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 22.3 p30 -72.68 -16.48 61.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.288 -0.882 . . . . 0.0 110.244 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 64.48 65.78 2.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.9 p30 -130.95 -33.13 1.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -1.127 . . . . 0.0 110.235 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 114.33 38.39 1.12 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 67.3 p -155.39 103.35 2.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.496 HD11 HG22 ' A' ' 27' ' ' ILE . 9.8 mt -88.98 110.77 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.067 -1.02 . . . . 0.0 110.0 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 p -100.79 177.39 4.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.8 p -57.65 -19.92 29.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.026 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -73.78 -55.66 5.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.214 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HG2' ' HG3' ' A' ' 21' ' ' LYS . 6.1 mt-10 -64.25 -59.84 3.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.402 ' HB2' HG23 ' A' ' 27' ' ' ILE . 7.7 tp -62.98 -25.36 68.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 110.239 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.47 -35.95 55.29 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -71.58 -46.11 60.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.233 -1.157 . . . . 0.0 110.48 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.5 -40.98 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.204 -0.935 . . . . 0.0 110.394 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.47 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 6.9 mmm -69.26 -31.96 70.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 110.36 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.6 tpt180 -79.35 -20.54 47.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.464 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 68.0 m -70.7 -44.59 66.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 110.692 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.44 -36.1 21.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.09 -1.006 . . . . 0.0 110.368 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.26 32.8 0.66 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -120.69 -169.58 1.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.2 -1.177 . . . . 0.0 110.28 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -143.9 72.13 16.85 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.263 -0.898 . . . . 0.0 110.215 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 47.3 Cg_endo -74.22 105.51 2.05 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.035 1.545 . . . . 0.0 110.309 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.4 m -53.98 153.43 4.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.172 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 8.7 tm-20 -65.42 -43.34 90.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 109.956 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.02 -63.15 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.91 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -52.0 -36.44 49.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.2 mt -58.52 -50.49 73.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.902 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.478 ' O ' HG21 ' A' ' 52' ' ' ILE . 5.3 tp60 -54.01 -35.68 62.15 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.8 -34.39 69.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.352 -0.843 . . . . 0.0 109.545 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.459 ' HE2' ' HE3' ' A' ' 36' ' ' MET . 0.2 OUTLIER -70.03 -26.17 63.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.488 -0.758 . . . . 0.0 110.104 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.478 HG21 ' O ' ' A' ' 49' ' ' GLN . 1.2 tp -78.62 -41.23 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.986 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.434 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -54.56 -21.77 11.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -57.21 6.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.858 . . . . 0.0 110.068 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 57' ' ' ALA . 17.1 t -71.69 -23.06 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.152 -0.968 . . . . 0.0 109.926 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -56.18 83.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.353 -0.842 . . . . 0.0 110.364 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.08 -71.31 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.096 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 26.2 p-10 -48.22 -42.02 29.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 101.7 41.61 2.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 1.6 p-10 -98.88 -44.34 6.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.118 -1.225 . . . . 0.0 110.077 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 143.48 -47.24 0.8 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.149 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.5 p -94.16 158.59 15.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.208 -1.172 . . . . 0.0 110.895 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 63' ' ' ILE . 12.4 mm -93.07 135.12 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.348 -0.845 . . . . 0.0 110.146 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.46 ' OD1' ' HD2' ' A' ' 66' ' ' PRO . 2.3 t70 -107.24 168.34 9.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.11 -0.994 . . . . 0.0 110.424 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.6 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 t80 -56.02 -44.82 99.88 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.397 -0.814 . . . . 0.0 111.245 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -70.26 -31.59 18.02 Favored 'Trans proline' 0 N--CA 1.482 0.83 0 O-C-N 123.298 1.157 . . . . 0.0 110.269 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.509 ' OE2' ' N ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -63.7 -34.55 78.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 109.341 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -71.61 -42.04 68.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.486 -0.759 . . . . 0.0 109.779 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.532 HD22 ' CB ' ' A' ' 12' ' ' PHE . 37.3 mt -58.16 -34.76 70.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 0.0 110.06 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -76.86 -33.74 57.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 42.1 ttp -64.84 -63.68 1.06 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.296 -0.877 . . . . 0.0 110.569 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.551 ' HE1' ' CE1' ' B' ' 26' ' ' PHE . 9.9 tpt -54.4 -16.5 2.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.141 -0.974 . . . . 0.0 110.677 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.21 -33.02 14.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.068 -1.02 . . . . 0.0 110.662 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.403 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 1.7 tpt180 -98.64 -9.95 24.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.159 -0.963 . . . . 0.0 110.371 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -83.68 -20.79 32.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.218 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.522 ' HE3' ' CE ' ' A' ' 72' ' ' MET . 2.1 ttm -94.09 48.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 110.296 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 2.1 mtmt -135.53 70.7 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.263 -0.898 . . . . 0.0 110.107 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 77' ' ' LYS . 7.8 t0 64.02 28.99 14.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.888 . . . . 0.0 109.98 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 2.9 p -132.36 78.5 1.81 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 109.908 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 79' ' ' THR . 0.2 OUTLIER 67.58 37.07 3.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.89 . . . . 0.0 110.05 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -83.88 -65.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 109.809 179.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.79 -37.1 83.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.378 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -67.04 -29.48 69.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.244 -0.91 . . . . 0.0 109.349 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' OE2' ' CD2' ' B' ' 12' ' ' LEU . 20.9 tt0 -61.71 -26.72 68.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.439 -0.788 . . . . 0.0 109.608 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.3 mt -69.64 -36.79 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.464 -0.894 . . . . 0.0 108.86 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 89' ' ' PHE . 16.0 ttt180 -59.21 -36.85 76.12 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.562 0.696 . . . . 0.0 109.124 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HB3' HG23 ' B' ' 9' ' ' THR . 6.0 mm-40 -67.09 -54.17 23.95 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.403 -0.811 . . . . 0.0 109.421 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.36 -31.28 21.65 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.136 -0.978 . . . . 0.0 108.83 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 138' ' ' TYR . 82.3 t80 -68.16 -67.1 0.49 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.418 -0.801 . . . . 0.0 109.912 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -45.25 -35.81 3.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.758 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 87' ' ' GLU . 25.2 t -56.87 -50.39 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 109.344 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.538 ' CE1' HG13 ' A' ' 108' ' ' VAL . 25.3 m-85 -60.97 -31.62 71.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.672 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -98.77 62.2 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.373 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -43.42 -34.29 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.91 . . . . 0.0 110.067 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.4 p30 -77.08 -41.87 40.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 84.51 52.46 3.54 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.7 p-10 -100.06 -33.83 10.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.182 -1.187 . . . . 0.0 110.115 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.587 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 125.03 22.92 1.87 Allowed Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.577 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 85.9 m-85 -157.25 141.2 16.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.985 -1.303 . . . . 0.0 110.676 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 135' ' ' GLN . 6.3 mt -109.58 143.96 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.861 . . . . 0.0 110.153 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -139.6 152.3 46.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.145 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.39 -27.03 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 109.867 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -68.92 -47.75 64.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.562 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 6.9 mt-10 -63.79 -43.63 95.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.467 -0.771 . . . . 0.0 109.806 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.484 ' CD2' ' CE1' ' A' ' 92' ' ' PHE . 2.6 mt -67.58 -34.8 77.77 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.378 -0.826 . . . . 0.0 109.581 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.462 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 43.0 ttp180 -66.87 -27.94 67.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.292 -0.88 . . . . 0.0 109.752 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.67 -23.41 31.77 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.292 -0.88 . . . . 0.0 109.953 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.538 HG13 ' CE1' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -91.34 -29.12 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 109.97 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.572 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 21.9 ptp -76.84 -34.38 57.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 110.338 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.509 ' N ' ' HG3' ' A' ' 109' ' ' MET . 5.4 m -76.66 -28.65 56.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.052 -1.03 . . . . 0.0 109.65 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 38' ' ' SER . 2.3 m120 -82.7 -23.46 34.09 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.355 -0.84 . . . . 0.0 109.917 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.545 ' CD1' HG11 ' B' ' 13' ' ' VAL . 2.0 mt -82.84 -28.69 29.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.67 -64.24 0.39 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 109' ' ' MET . 4.1 tt0 -108.01 144.81 34.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -1.17 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.494 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 0.2 OUTLIER -119.36 22.33 11.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.855 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 115' ' ' LYS . 5.1 mp 46.9 -176.59 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.566 -0.709 . . . . 0.0 110.687 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.89 -143.59 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.232 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.11 -51.0 2.12 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.169 -0.957 . . . . 0.0 110.178 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -60.93 -38.47 85.93 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 109.519 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.59 -52.87 59.05 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.294 -0.879 . . . . 0.0 109.298 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 125' ' ' ILE . 41.4 t -47.18 -42.22 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.273 -0.892 . . . . 0.0 109.74 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.63 -63.71 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.808 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -48.12 -24.8 1.22 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.397 -0.814 . . . . 0.0 109.732 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -70.1 -44.08 69.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.779 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 121' ' ' VAL . 25.9 mm -78.62 -25.39 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.365 -0.834 . . . . 0.0 110.102 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.25 -69.84 0.37 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.279 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -47.49 -25.37 1.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -78.24 -49.99 12.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CG ' ' HA2' ' A' ' 132' ' ' GLY . 34.7 t0 -41.95 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.487 -0.758 . . . . 0.0 110.547 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . 3.3 mp -75.37 -47.46 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.909 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.412 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 16.2 p-10 -77.23 -18.31 57.78 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.404 -0.81 . . . . 0.0 109.987 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.427 ' HA2' ' CG ' ' A' ' 129' ' ' ASP . . . 76.94 56.49 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 31.1 p30 -107.77 -8.51 16.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.08 17.31 56.27 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 10.2 pt20 -168.44 150.63 5.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -1.133 . . . . 0.0 109.95 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 13.0 t -89.37 125.68 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.173 -0.955 . . . . 0.0 110.435 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 9.6 t30 -93.8 -173.72 3.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.279 -0.888 . . . . 0.0 110.243 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.469 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 64.1 t80 -69.85 -56.54 6.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.181 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.68 -58.49 4.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.843 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -52.11 -45.45 64.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.317 -0.864 . . . . 0.0 109.883 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -57.86 -26.69 62.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 0.0 109.942 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.33 -39.8 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.835 . . . . 0.0 110.347 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -56.01 -46.88 78.62 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.215 -0.928 . . . . 0.0 110.062 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 77.5 mmm -63.51 -27.47 69.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.837 . . . . 0.0 110.308 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.54 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 3.9 mtt -90.18 -34.76 15.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.195 -0.941 . . . . 0.0 110.639 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.484 ' O ' ' CG2' ' A' ' 146' ' ' THR . 9.7 t -170.7 96.13 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.026 -1.046 . . . . 0.0 110.138 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.26 54.0 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 110.223 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.296 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.241 0.544 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.53 -148.93 0.35 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 110.223 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.96 4.11 17.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.551 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 22.3 mt -105.86 147.76 35.31 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.342 -0.848 . . . . 0.0 109.708 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 39.6 Cg_endo -65.43 149.2 88.24 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.639 1.336 . . . . 0.0 110.272 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.576 ' O ' ' N ' ' B' ' 8' ' ' THR . 45.2 m -94.08 92.03 7.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.278 -0.889 . . . . 0.0 111.542 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' B' ' 10' ' ' VAL . 1.8 m95 37.48 -86.98 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.614 -0.679 . . . . 0.0 111.313 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.576 ' N ' ' O ' ' B' ' 6' ' ' SER . 0.8 OUTLIER -42.83 -48.62 5.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.247 -0.908 . . . . 0.0 109.802 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.52 ' CG2' ' CB ' ' B' ' 5' ' ' PRO . 41.2 m -45.79 -37.76 6.41 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.378 -0.826 . . . . 0.0 109.218 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 7' ' ' TRP . 5.7 t -67.94 -42.03 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.71 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.495 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 9.7 mm -69.47 -26.73 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.785 . . . . 0.0 110.177 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.578 HD23 ' CE2' ' B' ' 26' ' ' PHE . 1.3 mm? -67.55 -56.52 9.14 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.392 -0.817 . . . . 0.0 110.138 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.545 HG11 ' CD1' ' A' ' 112' ' ' LEU . 9.6 t -57.31 -39.98 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.309 -0.869 . . . . 0.0 110.341 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.444 ' CE ' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.01 -32.28 72.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.767 -1.208 . . . . 0.0 109.596 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -41.57 89.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.339 -0.85 . . . . 0.0 109.239 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 7.2 mtt -75.12 -25.96 58.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.905 . . . . 0.0 109.753 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.572 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 5.6 mp -81.25 49.94 1.35 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.375 -0.828 . . . . 0.0 109.697 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.454 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -126.12 -73.5 0.62 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.247 -0.908 . . . . 0.0 111.714 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -158.67 90.64 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.105 -0.997 . . . . 0.0 111.177 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' B' ' 20' ' ' ARG . 19.6 ttp180 59.94 5.2 0.7 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.211 -0.931 . . . . 0.0 110.911 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.25 84.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.851 -1.156 . . . . 0.0 110.233 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.75 54.38 1.95 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 110.35 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.97 -111.7 0.64 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 145' ' ' MET . 1.2 t-20 -128.35 73.4 80.12 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.27 -1.135 . . . . 0.0 110.044 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.74 -2.26 10.6 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.127 1.593 . . . . 0.0 110.548 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.578 ' CE2' HD23 ' B' ' 12' ' ' LEU . 22.9 m-85 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.133 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.167 0.508 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 1' ' ' ALA . 1.7 t70 -43.61 154.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.123 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' LEU . 4.2 tt0 -88.61 49.08 1.72 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 110.262 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 3' ' ' GLN . 6.6 mt -55.85 -162.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.157 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.455 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 15.1 p -133.19 127.38 33.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.963 . . . . 0.0 110.398 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.55 -43.62 54.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.86 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -50.12 -53.82 24.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 109.644 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.455 ' HG3' ' CB ' ' A' ' 5' ' ' THR . 4.5 mt-30 -50.09 -52.44 34.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.54 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.3 mt -53.32 -48.69 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.277 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -56.46 -38.38 71.6 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.287 -0.883 . . . . 0.0 109.101 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -54.07 -52.42 60.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.411 -0.805 . . . . 0.0 109.184 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.548 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 34.4 m-85 -63.32 -40.48 97.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.237 -0.915 . . . . 0.0 109.13 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -55.89 -44.0 77.77 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.466 -0.771 . . . . 0.0 108.94 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' O ' ' OG ' ' A' ' 17' ' ' SER . 59.7 mt-10 -56.87 -46.38 81.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.451 -0.781 . . . . 0.0 109.032 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 18' ' ' LEU . . . -67.62 -51.66 47.48 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.322 -0.861 . . . . 0.0 109.281 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.598 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 19.8 t80 -45.12 -34.02 2.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.415 -0.803 . . . . 0.0 108.845 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 14' ' ' GLU . 24.9 p -81.73 -32.58 31.51 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.627 -0.671 . . . . 0.0 109.215 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 15' ' ' ALA . 6.8 tt -49.74 -34.78 20.01 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.322 -0.862 . . . . 0.0 109.177 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.422 ' HA ' HG22 ' A' ' 35' ' ' VAL . 57.7 m-85 -82.61 -46.02 13.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.447 -0.783 . . . . 0.0 109.853 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.0 103.65 2.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 109.951 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -91.45 -31.21 16.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 110.454 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 29.9 p-10 -75.02 -46.59 34.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.299 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 108.94 45.65 1.01 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 49.1 p30 -115.73 -18.17 10.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -1.179 . . . . 0.0 110.009 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 91.69 5.42 66.69 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 16.7 p -120.14 116.24 25.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -1.141 . . . . 0.0 110.484 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.446 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 14.2 mt -90.84 124.33 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 109.877 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 7.8 p -100.3 178.36 4.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -63.12 -32.54 73.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.105 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -71.52 -54.4 10.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.273 -0.892 . . . . 0.0 110.308 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 41.3 mt-10 -49.41 -61.98 1.8 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 0.0 110.153 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.566 HD23 ' CZ2' ' B' ' 7' ' ' TRP . 35.5 tp -57.32 -31.5 65.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.97 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.498 ' CA ' HD12 ' A' ' 48' ' ' LEU . . . -67.03 -28.12 73.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.9 m -73.72 -52.08 14.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -1.101 . . . . 0.0 109.828 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 19' ' ' PHE . 43.2 t -63.07 -35.37 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.947 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.459 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 4.1 mmt -66.26 -35.71 81.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.273 -0.892 . . . . 0.0 109.938 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.37 -24.4 60.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 110.117 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -76.15 -32.57 59.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.36 -0.837 . . . . 0.0 110.677 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 mt -53.81 -49.46 68.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.127 -0.983 . . . . 0.0 110.405 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 142.15 47.38 0.05 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 6.4 mm-40 -153.15 -167.4 2.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -1.127 . . . . 0.0 110.233 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -140.28 82.98 15.99 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.23 -0.919 . . . . 0.0 110.428 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.459 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 49.7 Cg_endo -76.79 148.63 28.76 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.978 1.515 . . . . 0.0 109.99 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.432 ' HB ' ' OE2' ' A' ' 47' ' ' GLU . 53.9 m -100.11 133.52 44.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.974 . . . . 0.0 110.227 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -42.34 -42.92 3.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.327 -0.858 . . . . 0.0 110.169 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.23 -54.4 47.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 109.742 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' OE2' ' HB ' ' A' ' 44' ' ' THR . 2.4 mt-10 -52.19 -38.02 56.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.369 -0.832 . . . . 0.0 109.681 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.498 HD12 ' CA ' ' A' ' 33' ' ' GLY . 0.5 OUTLIER -56.7 -50.78 71.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.889 . . . . 0.0 109.724 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -50.77 -45.1 58.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.528 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.83 -23.58 66.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.439 -0.788 . . . . 0.0 109.537 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.465 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 2.2 mtp -86.92 -49.38 7.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 0.0 110.083 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 tp -57.47 -29.22 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.734 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -71.78 -5.29 33.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 110.474 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 51' ' ' MET . 2.4 mt-10 -86.95 -55.57 3.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 110.19 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' B' ' 7' ' ' TRP . 38.9 t -70.25 -21.85 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 110.294 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.89 64.01 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.185 -0.947 . . . . 0.0 110.389 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -51.5 -21.34 2.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.198 -0.939 . . . . 0.0 110.23 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' CG ' ' OD1' ' A' ' 60' ' ' ASN . 1.5 p30 -100.38 -32.44 10.83 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.34 -0.85 . . . . 0.0 110.418 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.71 52.82 2.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.436 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 5.7 m120 -99.25 -32.61 11.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.179 -1.189 . . . . 0.0 109.945 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' O ' HG21 ' A' ' 62' ' ' THR . . . 117.87 -14.3 12.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 61' ' ' GLY . 27.4 p -139.66 165.14 28.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -1.07 . . . . 0.0 109.999 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.1 mm -96.83 165.89 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.319 -0.863 . . . . 0.0 110.102 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.541 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 35.2 m-20 -140.24 179.55 6.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.124 -0.985 . . . . 0.0 110.513 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.598 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 24.5 t80 -63.2 -44.27 83.15 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.33 -0.857 . . . . 0.0 111.52 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_endo -70.85 -36.04 8.51 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.359 1.189 . . . . 0.0 110.248 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -64.09 -29.32 70.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.393 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CZ ' HD12 ' B' ' 11' ' ' ILE . 0.4 OUTLIER -72.61 -50.77 23.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 65' ' ' PHE . 3.0 mm? -50.52 -50.6 52.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 0.0 110.449 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -64.21 1.03 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.232 -0.917 . . . . 0.0 110.805 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.462 ' HE2' HG22 ' B' ' 8' ' ' THR . 9.7 tpt -43.02 -62.27 1.07 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.042 -1.037 . . . . 0.0 110.696 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.548 ' HG3' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -39.16 -32.55 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.393 -0.817 . . . . 0.0 110.748 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -104.09 -48.26 3.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.164 -0.96 . . . . 0.0 110.474 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 75' ' ' LYS . 4.7 mtp180 -49.93 -67.39 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.256 -0.902 . . . . 0.0 110.438 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.456 ' HB2' ' SD ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -42.45 -44.94 4.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.375 -0.828 . . . . 0.0 110.42 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.0 mtt -98.47 48.13 0.99 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.313 -0.867 . . . . 0.0 110.325 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.86 -3.25 5.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.16 -0.963 . . . . 0.0 110.416 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -103.77 -75.52 0.61 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.247 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 p -142.79 -36.89 0.38 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.272 -0.892 . . . . 0.0 110.445 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.29 80.09 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.24 -0.912 . . . . 0.0 110.311 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.0 t -113.55 -48.89 2.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.904 . . . . 0.0 110.058 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.417 ' HA ' HD13 ' A' ' 85' ' ' ILE . 9.4 pt-20 -89.76 -18.31 26.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.52 -24.46 66.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.883 . . . . 0.0 109.678 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' B' ' 12' ' ' LEU . 9.2 mm-40 -67.7 -15.84 63.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.454 HG23 HG21 ' A' ' 142' ' ' VAL . 97.2 mt -70.68 -36.94 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.443 -0.785 . . . . 0.0 109.466 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 20.4 ttm-85 -59.71 -44.36 93.74 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.504 -0.747 . . . . 0.0 109.61 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 6.1 mm-40 -64.42 -51.6 62.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.286 -0.884 . . . . 0.0 109.609 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -60.39 -32.56 71.42 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.228 -0.92 . . . . 0.0 109.547 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.478 ' CE2' ' CG ' ' A' ' 138' ' ' TYR . 38.9 t80 -64.32 -43.12 95.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -29.04 70.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.834 . . . . 0.0 109.549 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.453 HG13 HG23 ' A' ' 108' ' ' VAL . 28.5 t -66.94 -51.94 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 0.0 110.209 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.551 ' CE1' HD22 ' A' ' 105' ' ' LEU . 11.8 m-85 -69.73 -29.71 67.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.199 -0.938 . . . . 0.0 110.013 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 94' ' ' LYS . 32.7 t0 -81.84 51.42 1.72 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 110.185 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -43.82 -30.37 0.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.214 -0.929 . . . . 0.0 110.259 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.95 -41.14 52.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.922 . . . . 0.0 110.119 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.98 -25.07 29.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.423 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 23.8 p-10 -51.03 -41.66 59.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -1.154 . . . . 0.0 110.328 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 119.02 60.13 0.27 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 1.9 m-85 -169.73 136.09 1.55 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.271 -1.135 . . . . 0.0 109.967 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.429 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 21.8 mt -112.49 106.47 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 110.58 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 102' ' ' ALA . 45.0 t -94.54 149.76 20.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.181 -0.95 . . . . 0.0 109.513 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.38 -27.25 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 0.0 109.827 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -71.95 -44.76 63.06 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 0.0 109.464 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 107' ' ' HIS . 21.6 mt-10 -60.94 -41.45 96.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 109.565 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' A' ' 92' ' ' PHE . 1.2 mt -58.34 -44.59 88.77 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.349 -0.844 . . . . 0.0 109.364 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.455 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.0 OUTLIER -58.26 -35.87 72.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.318 -0.864 . . . . 0.0 109.197 179.232 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 46.4 t60 -55.72 -52.67 63.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.43 -0.794 . . . . 0.0 109.173 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.476 ' HA ' ' HB2' ' A' ' 111' ' ' ASN . 1.5 t -74.3 -35.51 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.537 -0.727 . . . . 0.0 109.227 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.505 ' HA ' HD22 ' B' ' 17' ' ' LEU . 10.8 ttm -49.73 -60.69 2.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.553 -0.717 . . . . 0.0 110.608 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 m -78.34 -17.45 56.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.314 -0.866 . . . . 0.0 110.68 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.476 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 17.7 m-20 -75.56 -14.78 60.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.002 . . . . 0.0 110.056 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.547 ' CD1' HG11 ' B' ' 13' ' ' VAL . 3.1 mt -101.21 -52.7 3.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.627 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.74 -18.97 0.18 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.87 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 35.8 tp10 -108.1 155.99 19.79 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.843 -1.387 . . . . 0.0 111.112 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.51 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 2.2 mttm -131.25 64.36 1.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.611 -0.68 . . . . 0.0 109.521 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.495 ' HB2' ' CE ' ' A' ' 109' ' ' MET . 1.8 mp -36.18 151.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.485 0.66 . . . . 0.0 111.126 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.458 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -61.87 -174.48 0.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.778 . . . . 0.0 110.152 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.87 -59.5 2.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.208 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.88 -42.75 37.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 109.605 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -61.61 -53.7 52.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.545 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.469 HG23 ' HE3' ' A' ' 109' ' ' MET . 53.0 t -57.81 -41.11 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 109.921 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -61.63 -58.24 8.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.854 . . . . 0.0 109.845 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -54.81 -37.59 66.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.308 -0.87 . . . . 0.0 109.706 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.551 ' O ' ' CD2' ' B' ' 22' ' ' PHE . 9.4 ttt -52.42 -44.14 65.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.911 . . . . 0.0 109.515 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.448 HD12 HD13 ' A' ' 105' ' ' LEU . 38.7 mm -78.44 -53.08 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.066 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -44.11 -68.52 0.19 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.83 . . . . 0.0 110.636 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 126' ' ' ARG . 1.3 tp10 -39.02 -53.93 1.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.535 -0.728 . . . . 0.0 110.755 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -58.92 -34.88 72.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 110.382 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.456 ' OD2' ' N ' ' A' ' 135' ' ' GLN . 1.6 t0 -65.78 68.45 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.434 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -60.07 -42.36 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.27 -0.894 . . . . 0.0 109.908 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.6 -35.97 78.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.195 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.53 71.92 1.24 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.0 p30 -121.71 -25.29 5.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.308 -1.113 . . . . 0.0 110.089 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 129.6 -20.6 5.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.456 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 16.0 pt20 -154.6 170.23 22.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -1.154 . . . . 0.0 110.26 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 137' ' ' ASN . 46.5 t -79.49 164.44 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.252 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.49 ' N ' HG11 ' A' ' 136' ' ' VAL . 12.5 t-20 -133.4 173.18 11.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.305 -0.872 . . . . 0.0 110.112 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.478 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -57.38 -68.22 0.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.261 -0.899 . . . . 0.0 110.26 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 138' ' ' TYR . 10.3 mm-40 -40.81 -53.26 2.9 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.447 -0.783 . . . . 0.0 110.023 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 141' ' ' PHE . 50.3 mt-10 -55.41 -57.86 10.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 109.505 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.426 ' CD1' ' CG2' ' A' ' 85' ' ' ILE . 3.7 t80 -43.62 -27.38 0.3 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.429 -0.794 . . . . 0.0 109.5 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.454 HG21 HG23 ' A' ' 85' ' ' ILE . 73.9 t -99.56 -64.39 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 142' ' ' VAL . 28.5 tp60 -43.07 -24.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.306 -0.871 . . . . 0.0 110.604 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 142' ' ' VAL . 1.8 tpt -84.31 -32.66 24.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 111.025 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.442 ' HB3' HD12 ' A' ' 85' ' ' ILE . 2.9 mtp -100.66 -11.42 20.01 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.017 -1.052 . . . . 0.0 111.947 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' A' ' 146' ' ' THR . 9.0 t -156.06 88.84 1.11 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.705 -1.247 . . . . 0.0 111.175 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 148' ' ' LYS . . . -100.35 34.09 2.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.013 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 147' ' ' ALA . 7.9 tptp . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.136 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.459 HG11 ' O ' ' B' ' 1' ' ' VAL . 12.8 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.241 0.543 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' B' ' 1' ' ' VAL . 5.3 mttt -160.62 157.15 26.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.975 . . . . 0.0 110.44 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 9.1 mt -107.31 -17.09 14.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.862 . . . . 0.0 109.269 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.583 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 22.1 mt -146.62 157.38 48.04 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.583 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 36.0 Cg_endo -59.38 114.61 2.11 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.303 1.159 . . . . 0.0 109.858 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.538 ' O ' ' N ' ' B' ' 8' ' ' THR . 13.5 t -78.34 90.07 4.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.573 -0.704 . . . . 0.0 112.303 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.566 ' CZ2' HD23 ' A' ' 32' ' ' LEU . 8.7 m95 43.99 -86.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.59 -0.694 . . . . 0.0 112.229 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.538 ' N ' ' O ' ' B' ' 6' ' ' SER . 63.1 p -38.57 -46.96 1.25 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.537 -0.727 . . . . 0.0 110.945 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 97.5 m -48.87 -36.9 18.09 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.242 -0.911 . . . . 0.0 109.276 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' B' ' 7' ' ' TRP . 60.5 t -73.05 -43.07 59.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.506 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 46.7 mt -70.94 -21.82 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 109.974 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -72.53 -50.62 24.46 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.547 HG11 ' CD1' ' A' ' 112' ' ' LEU . 42.7 t -71.14 -39.01 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.124 -0.985 . . . . 0.0 110.446 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.459 ' HA ' HD11 ' A' ' 112' ' ' LEU . 2.7 tmtt? -59.64 -47.54 85.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.775 -1.203 . . . . 0.0 109.263 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 35.0 p -53.52 -48.85 68.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.451 -0.781 . . . . 0.0 109.228 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.432 ' O ' ' HE2' ' A' ' 124' ' ' MET . 10.6 ttm -54.82 -27.7 43.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.314 -0.866 . . . . 0.0 109.872 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 109' ' ' MET . 7.0 mp -79.71 49.51 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.249 -0.907 . . . . 0.0 110.574 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -96.6 -83.06 0.39 Allowed 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.331 -0.856 . . . . 0.0 109.769 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.457 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -140.44 -41.14 0.42 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.365 -0.835 . . . . 0.0 109.475 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' B' ' 21' ' ' SER . 2.4 ttt-85 -149.63 -41.53 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' B' ' 22' ' ' PHE . 26.8 t 29.73 -126.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.093 0.473 . . . . 0.0 111.32 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 124' ' ' MET . 1.5 m-85 61.99 57.74 2.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 110.519 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.442 ' C ' ' HD2' ' B' ' 25' ' ' PRO . . . -142.99 -165.01 10.46 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.721 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 39.0 p-10 -107.1 -2.83 0.11 Allowed Pre-proline 0 CA--C 1.569 1.697 0 O-C-N 121.28 -1.129 . . . . 0.0 112.974 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 48.0 Cg_endo -73.46 76.92 2.63 Favored 'Trans proline' 0 N--CA 1.485 0.971 0 O-C-N 122.304 0.634 . . . . 0.0 110.498 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.45 ' CZ ' ' HE2' ' A' ' 72' ' ' MET . 12.8 t80 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.228 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.252 0.549 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 6.4 t0 178.64 121.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.323 -0.861 . . . . 0.0 110.222 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -55.82 107.35 0.34 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 110.246 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.423 ' O ' HG21 ' A' ' 5' ' ' THR . 0.5 OUTLIER -51.3 132.07 28.69 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.227 -0.921 . . . . 0.0 110.38 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.518 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 3.0 p -151.29 107.53 3.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -0.881 . . . . 0.0 110.172 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 7' ' ' GLU . 1.5 tp10 -67.47 -52.81 34.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 110.695 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -43.77 -70.11 0.12 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.105 -0.997 . . . . 0.0 110.45 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.66 -58.09 4.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.211 -0.931 . . . . 0.0 110.464 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.518 ' CD1' ' O ' ' A' ' 5' ' ' THR . 97.7 mt -44.7 -50.02 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.226 -0.921 . . . . 0.0 110.296 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -49.84 -51.31 40.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 12' ' ' PHE . 9.5 tm-20 -51.58 -45.46 63.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 110.089 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CD1' ' OE1' ' A' ' 11' ' ' GLU . 18.8 m-30 -55.2 -44.42 75.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 110.014 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -53.68 -49.77 67.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.936 . . . . 0.0 109.803 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.47 -47.18 66.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 110.083 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -60.96 -46.55 90.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.813 . . . . 0.0 110.235 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 65' ' ' PHE . 34.9 t80 -57.65 -45.36 85.62 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 110.041 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.0 t -70.18 -17.1 63.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.85 . . . . 0.0 110.0 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.556 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 9.0 tt -69.99 -55.42 9.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.976 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -72.43 -11.97 60.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 0.0 110.27 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 21' ' ' LYS . 25.4 t0 -97.5 69.54 2.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' ASP . 20.3 mmtt -42.47 -71.24 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.328 -0.858 . . . . 0.0 110.126 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD2' ' CG ' ' A' ' 24' ' ' ASP . 2.4 p-10 -51.95 -41.23 61.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.383 -0.823 . . . . 0.0 110.062 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.4 46.72 5.71 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.464 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 39.4 p-10 -103.23 6.79 38.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.202 . . . . 0.0 110.238 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.485 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 78.3 30.38 50.25 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 10.0 p -158.12 104.09 1.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -1.139 . . . . 0.0 110.28 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.52 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 9.5 mt -80.6 125.52 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.227 -0.921 . . . . 0.0 109.8 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p -100.1 165.74 11.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.385 -0.822 . . . . 0.0 110.68 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.9 p -56.47 -41.69 76.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.851 . . . . 0.0 110.214 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -62.02 -53.16 59.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 110.248 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -52.02 -68.74 0.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 110.092 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.44 HD22 HD21 ' A' ' 48' ' ' LEU . 23.8 tp -49.58 -32.51 12.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.898 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.97 -53.94 36.95 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.0 m -48.12 -47.17 34.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -1.151 . . . . 0.0 109.686 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.3 t -61.01 -51.49 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.352 -0.843 . . . . 0.0 109.739 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.461 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 5.2 mmt -57.88 -39.61 78.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.84 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -34.9 72.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 110.016 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 39' ' ' LEU . 1.4 m -68.07 -48.11 66.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.164 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 38' ' ' SER . 9.5 mt -44.21 -25.3 0.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.873 . . . . 0.0 110.261 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.81 50.64 0.68 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 36' ' ' MET . 0.3 OUTLIER -154.61 -163.31 1.56 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -1.127 . . . . 0.0 110.224 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -151.79 102.15 2.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.055 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.62 119.23 5.82 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.016 1.535 . . . . 0.0 110.524 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.435 ' HB ' ' CG ' ' A' ' 47' ' ' GLU . 9.1 m -76.05 155.3 34.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.301 -0.874 . . . . 0.0 110.22 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -45.64 -69.64 0.13 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 110.026 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.06 -47.28 65.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.999 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' CG ' ' HB ' ' A' ' 44' ' ' THR . 13.0 mt-10 -46.35 -55.44 7.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.265 -0.897 . . . . 0.0 110.095 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 32' ' ' LEU . 1.1 mt -53.78 -40.26 66.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -62.75 -34.7 77.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.974 179.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -41.15 97.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.838 . . . . 0.0 110.156 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.8 mtp -74.7 -41.27 60.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.316 -0.865 . . . . 0.0 110.251 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.536 HD11 ' N ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -71.15 -14.84 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.197 -0.939 . . . . 0.0 109.699 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.8 OUTLIER -83.87 -18.63 36.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.288 -0.883 . . . . 0.0 110.187 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.86 -50.95 9.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.521 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.597 HG22 ' CD1' ' B' ' 7' ' ' TRP . 10.7 t -72.95 -22.23 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.175 -0.953 . . . . 0.0 110.021 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.87 86.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.363 -0.835 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -80.31 -46.11 16.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.202 -0.936 . . . . 0.0 110.436 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 12.2 p-10 -75.94 -42.5 48.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.084 -1.01 . . . . 0.0 110.409 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.53 44.92 2.22 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 27.0 p-10 -99.48 -38.2 8.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -1.206 . . . . 0.0 110.383 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 128.78 0.95 6.02 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 61' ' ' GLY . 19.4 p -145.85 161.77 39.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -1.127 . . . . 0.0 110.072 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.52 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 17.2 mm -86.69 152.21 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.185 -0.947 . . . . 0.0 110.518 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.525 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 29.6 m-20 -127.35 -173.15 2.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 110.542 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.6 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.0 t80 -74.39 -42.07 5.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.418 -0.801 . . . . 0.0 111.326 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -72.94 -24.57 17.41 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.274 1.144 . . . . 0.0 110.395 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.472 ' CG ' ' HB1' ' A' ' 57' ' ' ALA . 3.5 mt-10 -70.82 -32.43 69.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.394 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.585 ' CZ ' HD12 ' B' ' 11' ' ' ILE . 9.1 t80 -77.41 -33.81 54.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.893 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.536 HD13 ' CE1' ' A' ' 65' ' ' PHE . 85.1 mt -72.75 -26.91 61.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.339 -0.851 . . . . 0.0 111.21 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 p -89.32 -34.77 16.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.902 -1.124 . . . . 0.0 111.227 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -39.24 62.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.137 -0.977 . . . . 0.0 111.022 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.543 ' HE3' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -63.87 -22.11 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.05 -1.031 . . . . 0.0 110.879 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -94.94 -9.72 33.24 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.928 -1.107 . . . . 0.0 110.882 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -82.36 -46.88 13.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.161 -0.962 . . . . 0.0 110.747 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.62 -21.24 35.16 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.516 ' HE1' ' CD2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -100.51 63.19 1.08 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.17 -0.956 . . . . 0.0 110.468 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -168.34 69.25 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.238 -0.914 . . . . 0.0 110.467 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.522 ' O ' ' CG2' ' A' ' 79' ' ' THR . 0.8 OUTLIER 65.72 71.98 0.42 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 78' ' ' ASP . 17.6 p -158.66 -100.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.276 -0.89 . . . . 0.0 110.25 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.535 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -124.27 80.86 1.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.048 -1.033 . . . . 0.0 109.856 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.9 m -96.12 -43.67 7.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.367 -0.833 . . . . 0.0 109.442 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.53 -31.59 69.53 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.434 -0.792 . . . . 0.0 109.402 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.05 -39.3 34.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.468 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 80' ' ' ASP . 6.0 mm-40 -72.61 -27.0 61.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.622 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.453 HD12 HG23 ' A' ' 146' ' ' THR . 24.0 mt -72.77 -26.19 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -29.1 67.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.39 0.614 . . . . 0.0 109.444 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 24.7 mt-10 -76.57 -47.79 21.36 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.281 -0.887 . . . . 0.0 109.199 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.579 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -57.97 -33.88 69.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.083 -1.01 . . . . 0.0 108.86 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -66.76 -48.09 70.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.432 -0.792 . . . . 0.0 109.464 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -52.69 -30.89 34.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.387 -0.821 . . . . 0.0 109.573 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 63.7 t -67.72 -53.18 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.818 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 67.0 m-85 -63.02 -15.02 55.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.135 -0.978 . . . . 0.0 109.989 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -100.04 65.01 1.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 110.436 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -40.97 -72.05 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.383 -0.823 . . . . 0.0 110.486 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.1 p30 -61.03 -28.44 69.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.01 50.13 7.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -99.73 -7.27 25.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.294 -1.121 . . . . 0.0 110.357 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.7 29.58 8.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.417 ' CD1' ' CD ' ' A' ' 135' ' ' GLN . 0.9 OUTLIER -161.31 143.19 11.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -1.139 . . . . 0.0 110.081 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 92' ' ' PHE . 17.3 mt -118.71 158.26 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.522 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 102' ' ' ALA . 23.2 p -148.07 155.76 41.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.387 -0.82 . . . . 0.0 109.927 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.1 -43.1 3.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.332 -0.855 . . . . 0.0 110.205 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.78 -51.09 68.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.839 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 92' ' ' PHE . 17.9 mt-10 -58.74 -47.75 83.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 0.0 109.959 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 2.1 mt -62.62 -33.92 75.99 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.271 -0.893 . . . . 0.0 109.696 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -61.63 -34.07 75.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.248 -0.908 . . . . 0.0 109.431 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 10.0 t-80 -68.26 -43.67 77.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.402 -0.812 . . . . 0.0 109.588 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.5 HG11 HD13 ' A' ' 112' ' ' LEU . 1.2 t -64.16 -34.42 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 109.896 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.564 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 4.8 mtt -53.63 -70.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.608 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.6 m -55.38 -16.78 3.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.898 . . . . 0.0 110.554 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 9.0 m120 -94.67 -6.49 43.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.103 -0.998 . . . . 0.0 110.392 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.609 ' CD1' ' CG1' ' B' ' 13' ' ' VAL . 9.6 mt -132.06 6.95 4.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.037 -1.04 . . . . 0.0 111.686 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.3 -93.34 0.13 Allowed Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.404 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' CG ' ' N ' ' A' ' 115' ' ' LYS . 15.3 tt0 -136.53 166.07 24.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -1.076 . . . . 0.0 110.408 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -103.6 118.66 37.23 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 9.3 mp -64.83 155.31 34.4 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 121.446 -0.784 . . . . 0.0 110.336 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -49.09 178.8 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.365 -0.835 . . . . 0.0 109.274 179.436 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.79 -57.23 4.24 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.89 -1.131 . . . . 0.0 110.263 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.97 -49.01 31.91 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.195 -0.94 . . . . 0.0 109.669 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -57.69 -60.51 3.58 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 108.978 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.1 t -47.32 -44.58 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.299 -0.876 . . . . 0.0 109.416 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -50.53 71.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.292 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.52 ' HB3' ' HG3' ' B' ' 20' ' ' ARG . 0.2 OUTLIER -57.83 -31.24 66.44 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.183 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.418 ' HG2' ' CD1' ' B' ' 22' ' ' PHE . 9.3 ttt -60.1 -43.85 95.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.475 -0.766 . . . . 0.0 109.294 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.592 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 37.6 mm -84.87 -27.12 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.923 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -45.06 78.47 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.315 -0.866 . . . . 0.0 110.314 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.08 -36.18 82.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.339 -0.851 . . . . 0.0 110.165 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 136' ' ' VAL . . . -76.23 -32.45 58.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.381 -0.824 . . . . 0.0 110.124 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.04 63.65 0.68 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.75 -58.85 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.524 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 1.7 p30 -55.07 -36.13 65.27 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.582 -0.698 . . . . 0.0 109.784 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 98.48 69.17 0.93 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.412 ' OD2' ' CG ' ' A' ' 131' ' ' ASP . 3.2 m-20 -121.89 -4.59 9.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -1.192 . . . . 0.0 110.133 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.55 -9.88 63.56 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.42 ' CB ' ' O ' ' A' ' 100' ' ' ILE . 2.8 pt20 -142.97 168.02 20.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -1.147 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.466 HG11 ' CB ' ' A' ' 140' ' ' GLU . 5.2 t -112.82 155.76 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.203 -0.936 . . . . 0.0 110.243 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.432 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 17.6 p-10 -125.79 -144.81 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.335 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -80.15 -70.08 0.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.277 -0.89 . . . . 0.0 110.547 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 143' ' ' GLN . 26.4 mt-10 -43.03 -38.43 2.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.201 -0.937 . . . . 0.0 110.429 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.466 ' CB ' HG11 ' A' ' 136' ' ' VAL . 32.8 mt-10 -68.54 -62.26 1.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.271 -0.893 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -51.93 -22.1 3.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.3 -0.875 . . . . 0.0 110.645 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.56 -52.56 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.102 -0.999 . . . . 0.0 110.838 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.466 ' CB ' ' O ' ' A' ' 139' ' ' GLU . 4.5 tp60 -57.84 -13.03 3.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.267 -0.895 . . . . 0.0 110.832 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.8 mmm -99.34 -18.21 17.64 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.001 -1.062 . . . . 0.0 110.765 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.436 ' HE3' HD22 ' B' ' 12' ' ' LEU . 38.0 mtp -100.49 -69.25 0.78 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.041 -1.037 . . . . 0.0 110.836 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.453 HG23 HD12 ' A' ' 85' ' ' ILE . 1.9 t -117.39 70.72 0.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.942 . . . . 0.0 110.373 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.18 53.06 0.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.102 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.0 mttt . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.269 -179.892 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.416 ' O ' HG21 ' B' ' 1' ' ' VAL . 9.9 p . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.197 0.523 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.95 126.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.267 -0.896 . . . . 0.0 110.474 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.0 31.35 6.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.3 -0.875 . . . . 0.0 110.147 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 6.7 mt -107.11 132.3 21.03 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.121 -0.987 . . . . 0.0 110.329 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.73 -176.45 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.081 1.569 . . . . 0.0 110.928 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.427 ' OG ' ' OE2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -106.4 178.65 4.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.329 -0.857 . . . . 0.0 110.501 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.597 ' CD1' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -54.11 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.415 -0.803 . . . . 0.0 110.911 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.454 ' O ' ' N ' ' B' ' 11' ' ' ILE . 55.9 p -44.82 -50.58 10.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 110.151 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.533 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 37.9 m -44.01 -50.37 8.34 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.444 -0.785 . . . . 0.0 109.633 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 24.9 t -57.22 -34.83 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.191 -0.943 . . . . 0.0 109.233 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.585 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 18.4 mt -74.08 -30.49 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 108.722 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.436 HD22 ' HE3' ' A' ' 145' ' ' MET . 0.3 OUTLIER -57.74 -58.38 8.62 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.543 -0.723 . . . . 0.0 109.378 179.319 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.609 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 81.0 t -59.12 -51.19 75.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.554 -0.716 . . . . 0.0 110.373 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -51.6 -58.57 5.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.025 -1.047 . . . . 0.0 109.878 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -51.15 -25.95 6.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.403 -0.811 . . . . 0.0 110.194 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.468 ' O ' ' HB2' ' B' ' 21' ' ' SER . 6.3 tpp -70.88 -32.78 69.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' B' ' 19' ' ' LYS . 3.9 mp -64.68 -102.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.965 -1.084 . . . . 0.0 109.838 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.523 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 55.32 -72.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.505 -0.747 . . . . 0.0 110.85 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.625 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -173.43 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.321 -0.862 . . . . 0.0 110.952 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.536 ' CB ' ' O ' ' B' ' 19' ' ' LYS . 7.0 tmm_? 73.97 -7.1 1.69 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.892 -1.13 . . . . 0.0 110.297 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' B' ' 16' ' ' MET . 36.0 m -46.79 116.09 1.24 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.045 -1.034 . . . . 0.0 109.779 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' B' ' 23' ' ' GLY . 0.2 OUTLIER -148.51 -32.84 0.24 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.174 -0.954 . . . . 0.0 111.282 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' B' ' 22' ' ' PHE . . . -54.81 -111.41 0.01 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.46 ' OD1' ' OXT' ' B' ' 26' ' ' PHE . 4.8 t30 -116.42 96.23 47.4 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.24 -1.153 . . . . 0.0 110.242 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.5 -18.45 20.08 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.099 1.579 . . . . 0.0 110.337 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.543 ' CZ ' ' HE3' ' A' ' 72' ' ' MET . 46.0 m-85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.285 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.195 0.521 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.97 18.95 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.201 -0.937 . . . . 0.0 110.294 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.87 77.25 2.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 110.238 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 mt -78.22 -164.06 0.5 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.296 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -118.85 12.37 12.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.307 -0.871 . . . . 0.0 110.18 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 1.2 tm-20 -72.28 -40.21 67.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.23 -0.919 . . . . 0.0 110.39 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 6' ' ' GLU . 2.5 mt-10 -41.38 -70.05 0.12 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.341 -0.85 . . . . 0.0 110.134 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -46.56 -50.07 17.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.0 . . . . 0.0 109.235 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 21.6 mt -53.63 -38.4 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.3 -0.875 . . . . 0.0 108.751 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -52.03 -46.95 65.22 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.284 -0.885 . . . . 0.0 108.806 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.444 ' CD ' ' HD2' ' B' ' 18' ' ' ARG . 6.0 tt0 -53.69 -53.9 45.47 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.217 -0.927 . . . . 0.0 108.819 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -55.57 -40.27 71.75 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.373 -0.829 . . . . 0.0 108.856 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -59.43 -40.38 86.55 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 17' ' ' SER . 8.3 tt0 -49.61 -55.12 14.72 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.453 -0.78 . . . . 0.0 108.95 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.05 -55.99 24.82 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.506 -0.878 . . . . 0.0 108.76 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -49.1 -26.85 2.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 3.2 m -87.85 -36.33 17.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.541 -0.724 . . . . 0.0 109.113 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' HD22 ' A' ' 18' ' ' LEU . 9.8 tt -47.98 -34.61 9.55 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.389 -0.819 . . . . 0.0 109.376 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.523 ' CE1' HG13 ' B' ' 10' ' ' VAL . 73.4 m-85 -81.8 -28.66 33.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.824 . . . . 0.0 109.986 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 5.0 t0 -87.36 81.54 7.84 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.213 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -52.56 -56.97 11.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 110.374 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.42 ' OD1' ' CG ' ' A' ' 24' ' ' ASP . 3.0 p30 -59.16 -41.17 87.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 110.373 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.86 57.6 1.7 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 35.5 p-10 -114.33 10.4 17.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.231 -1.158 . . . . 0.0 110.293 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.97 15.18 73.96 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 1.2 p -141.72 116.6 9.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -1.225 . . . . 0.0 110.275 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.407 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 13.4 mt -92.27 112.92 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.149 -0.97 . . . . 0.0 109.738 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 18.8 p -75.95 -160.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.915 . . . . 0.0 110.354 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.0 p -88.82 -45.4 9.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 110.543 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 21.5 pttt -71.63 -25.87 62.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.026 -1.046 . . . . 0.0 110.574 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 47.2 mt-10 -63.15 -44.67 94.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.031 -1.043 . . . . 0.0 109.491 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' O ' ' HG2' ' A' ' 36' ' ' MET . 2.9 tp -67.35 -48.18 68.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.332 -0.855 . . . . 0.0 109.649 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.81 -44.96 49.36 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.8 m -61.17 -57.15 13.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.353 -1.086 . . . . 0.0 109.736 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 19' ' ' PHE . 21.4 t -50.42 -40.46 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.213 -0.929 . . . . 0.0 109.655 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 4.7 mmt -60.82 -47.57 85.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.268 -0.895 . . . . 0.0 109.412 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.456 ' NE ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -47.79 -38.23 15.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.395 179.224 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -63.04 -45.27 93.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.564 -0.71 . . . . 0.0 110.705 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 3.1 mt -57.88 -34.47 69.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.165 -0.959 . . . . 0.0 110.455 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.37 63.65 0.32 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.456 ' O ' ' NE ' ' A' ' 37' ' ' ARG . 1.9 pt20 -160.75 -175.66 5.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.309 -1.112 . . . . 0.0 109.922 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -131.12 95.08 25.94 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.068 -1.02 . . . . 0.0 110.624 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 36' ' ' MET . 47.2 Cg_endo -75.34 123.49 7.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.041 1.548 . . . . 0.0 110.177 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -94.98 168.5 10.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -57.44 -56.45 21.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.121 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.37 -55.26 16.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 0.0 110.258 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -51.23 -52.86 40.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 110.006 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.0 mt -46.61 -64.28 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.81 -34.81 63.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.419 -0.801 . . . . 0.0 110.075 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.55 -33.91 69.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 110.285 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.517 ' O ' ' NE1' ' B' ' 7' ' ' TRP . 9.8 mtp -81.17 -34.59 32.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -0.85 . . . . 0.0 110.023 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 10.9 mm -74.53 -36.62 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -0.867 . . . . 0.0 109.76 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -68.04 -20.39 64.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.394 -0.816 . . . . 0.0 110.135 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.04 -42.67 66.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 110.383 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 57' ' ' ALA . 8.7 t -83.8 -51.04 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -41.76 90.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.651 . . . . 0.0 110.428 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -83.36 -36.43 24.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.462 -0.774 . . . . 0.0 110.747 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' OD2' ' CG ' ' A' ' 60' ' ' ASN . 6.5 p-10 -72.17 -48.26 44.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.032 -1.042 . . . . 0.0 110.535 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.89 35.94 1.09 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 29.2 p-10 -98.56 -46.02 5.88 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.016 -1.285 . . . . 0.0 110.314 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 118.43 13.69 6.75 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 61' ' ' GLY . 37.5 p -144.4 141.44 29.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.16 -1.2 . . . . 0.0 110.538 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.496 HD13 ' HB ' ' A' ' 55' ' ' VAL . 35.4 mm -85.21 142.25 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.219 -0.925 . . . . 0.0 109.902 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -121.81 -175.66 3.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.075 -1.015 . . . . 0.0 110.593 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.6 t80 -65.97 -45.99 63.96 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.416 -0.802 . . . . 0.0 111.54 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.2 Cg_endo -68.62 -38.86 10.01 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 O-C-N 123.092 1.048 . . . . 0.0 110.395 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.61 -30.46 69.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.112 -0.992 . . . . 0.0 109.274 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.495 ' CG ' ' HB2' ' A' ' 16' ' ' PHE . 4.1 t80 -69.92 -46.02 66.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.54 -0.725 . . . . 0.0 109.902 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 65' ' ' PHE . 3.0 mm? -53.78 -53.05 57.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.353 -0.842 . . . . 0.0 110.303 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 71' ' ' MET . 1.5 p -66.04 -63.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.269 -0.895 . . . . 0.0 110.708 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.452 ' HG3' HG23 ' A' ' 55' ' ' VAL . 6.8 tmm? -40.51 -36.87 0.62 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.642 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 7.0 tpt -61.76 -12.1 15.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.224 -0.922 . . . . 0.0 110.702 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.02 -10.01 4.82 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.04 -1.037 . . . . 0.0 111.223 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -24.61 15.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.998 -1.064 . . . . 0.0 110.363 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.419 ' HB3' ' CG2' ' B' ' 8' ' ' THR . 2.1 tppm? -85.12 -15.58 43.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 0.0 110.414 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 10.4 mtm -99.2 -9.22 23.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 110.391 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 16.8 mmtm -110.34 51.71 0.75 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 109.996 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 5.3 t70 -178.71 98.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.293 -0.879 . . . . 0.0 110.196 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.1 m 64.92 24.94 12.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.248 -0.907 . . . . 0.0 110.352 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -155.17 59.94 0.65 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.26 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 m -83.52 -59.49 2.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 110.118 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.489 ' OE2' HG23 ' A' ' 142' ' ' VAL . 3.8 tm-20 -100.35 -25.65 14.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 110.317 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -55.29 -43.47 74.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.069 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.431 ' HB2' ' OD2' ' A' ' 80' ' ' ASP . 19.3 tp10 -45.79 -50.21 14.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.345 -0.847 . . . . 0.0 110.495 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -70.76 -38.53 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.109 -0.994 . . . . 0.0 109.397 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -58.84 -30.64 67.84 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.367 -0.833 . . . . 0.0 109.916 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 76.9 mm-40 -74.07 -55.33 6.24 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.273 -0.892 . . . . 0.0 109.665 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.42 -29.69 49.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 0.0 109.149 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -71.89 -34.5 69.2 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.159 -0.963 . . . . 0.0 109.083 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -63.84 -27.32 69.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.445 -0.784 . . . . 0.0 109.197 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.31 -43.98 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.517 -0.739 . . . . 0.0 110.151 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.445 ' HB3' HD12 ' A' ' 100' ' ' ILE . 24.1 m-85 -67.01 -35.92 80.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.157 -0.965 . . . . 0.0 110.338 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -73.29 54.66 0.43 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.326 -0.859 . . . . 0.0 110.502 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 93' ' ' ASP . 13.4 tppt? -41.65 -46.63 3.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.0 110.288 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 21.4 p-10 -87.97 -26.78 22.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.56 47.55 12.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 31.6 p-10 -94.41 -22.35 18.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -1.121 . . . . 0.0 110.099 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.482 ' C ' ' CD2' ' A' ' 99' ' ' TYR . . . 110.76 15.23 11.23 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD2' ' C ' ' A' ' 98' ' ' GLY . 91.2 m-85 -150.72 137.73 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.307 -1.113 . . . . 0.0 110.181 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 135' ' ' GLN . 7.1 mt -101.71 150.74 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.13 -0.981 . . . . 0.0 110.14 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -138.48 146.78 42.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.151 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.88 -29.08 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.93 . . . . 0.0 109.843 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.75 79.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -0.843 . . . . 0.0 109.664 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -61.85 -45.03 95.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.486 ' CD1' HD13 ' A' ' 125' ' ' ILE . 1.5 mt -66.1 -38.09 87.37 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.354 -0.841 . . . . 0.0 109.267 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.488 ' NH2' ' HG2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -55.62 -35.83 66.3 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.406 -0.809 . . . . 0.0 109.084 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -71.03 -47.6 57.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.5 -0.75 . . . . 0.0 109.363 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -60.5 -23.51 28.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.381 -0.824 . . . . 0.0 109.024 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.566 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 5.1 mtt -69.28 -63.51 1.05 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.503 -0.748 . . . . 0.0 109.812 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.3 m -56.94 -30.37 63.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.191 -0.943 . . . . 0.0 109.236 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.425 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 12.5 m120 -74.77 -17.79 60.58 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.459 -0.776 . . . . 0.0 109.671 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.525 ' CD1' HG11 ' B' ' 13' ' ' VAL . 3.9 mt -95.41 -48.08 6.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.858 . . . . 0.0 110.212 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.09 -30.12 0.22 Allowed Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.529 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 109' ' ' MET . 29.4 tt0 -125.05 171.22 10.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.873 -1.369 . . . . 0.0 110.941 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -144.98 75.7 1.46 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 117' ' ' THR . 2.4 mp -34.79 156.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.641 0.734 . . . . 0.0 111.494 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -57.1 -150.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.0 110.387 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -109.76 -53.89 2.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.236 -0.915 . . . . 0.0 110.38 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.35 -44.46 84.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.019 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.93 -42.13 97.44 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.829 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 117' ' ' THR . 71.8 t -64.62 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.947 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -60.28 -45.19 94.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -61.47 -38.07 85.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 109.582 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.578 ' HE3' ' CD1' ' B' ' 22' ' ' PHE . 0.6 OUTLIER -54.06 -49.25 69.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.162 -0.961 . . . . 0.0 109.681 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.486 HD13 ' CD1' ' A' ' 105' ' ' LEU . 37.5 mm -70.16 -26.48 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -70.14 -26.51 63.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.902 . . . . 0.0 109.917 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -71.46 -44.5 64.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.867 . . . . 0.0 110.064 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -71.44 -33.41 69.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.381 -0.824 . . . . 0.0 110.049 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -60.44 75.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.33 -0.857 . . . . 0.0 110.4 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 128' ' ' ALA . 21.5 mt -72.16 -31.34 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.968 . . . . 0.0 110.232 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 34.8 p-10 -83.94 -27.13 28.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.148 -0.97 . . . . 0.0 110.275 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.94 71.17 1.24 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 4.0 p30 -126.57 -23.37 3.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.244 -1.151 . . . . 0.0 110.468 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 104.63 -0.78 42.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 4.8 pt20 -151.18 166.67 30.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 110.204 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.484 ' CG2' ' HB2' ' A' ' 128' ' ' ALA . 53.3 t -110.68 151.77 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -131.95 -164.92 1.51 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.143 -0.973 . . . . 0.0 110.397 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.524 ' CE1' HG22 ' A' ' 142' ' ' VAL . 9.2 t80 -62.13 -65.82 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.229 -0.919 . . . . 0.0 110.72 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -41.87 -50.02 4.46 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.216 -0.927 . . . . 0.0 110.677 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -63.96 -59.99 3.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.965 . . . . 0.0 110.394 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.42 ' CE1' ' HE2' ' A' ' 92' ' ' PHE . 50.1 t80 -51.75 -20.57 2.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 110.523 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.524 HG22 ' CE1' ' A' ' 138' ' ' TYR . 41.6 t -100.51 -60.28 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.179 -0.951 . . . . 0.0 110.791 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 142' ' ' VAL . 9.5 tt0 -40.36 -45.82 2.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.31 -0.869 . . . . 0.0 110.762 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.445 ' O ' ' OD1' ' B' ' 24' ' ' ASN . 3.7 mmt -66.59 -26.8 67.28 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 110.419 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.519 ' HE3' ' CE ' ' B' ' 16' ' ' MET . 19.9 mmm -96.07 -45.99 6.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.079 -1.013 . . . . 0.0 110.937 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.5 p -84.98 38.36 0.71 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.116 -0.99 . . . . 0.0 110.984 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 148' ' ' LYS . . . -94.36 20.63 7.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 110.141 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 147' ' ' ALA . 13.1 tptt . . . . . 0 N--CA 1.501 2.11 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.806 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.42 HG11 ' O ' ' B' ' 1' ' ' VAL . 2.4 p . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.232 0.539 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.1 -159.21 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.358 -0.839 . . . . 0.0 110.298 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.537 ' CD1' HG12 ' B' ' 4' ' ' ILE . 0.3 OUTLIER -165.6 -29.46 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.17 -0.956 . . . . 0.0 111.433 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.537 HG12 ' CD1' ' B' ' 3' ' ' LEU . 35.1 mm -100.1 146.91 32.74 Favored Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 120.926 -1.109 . . . . 0.0 110.829 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 42.3 Cg_endo -69.1 -157.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.936 1.493 . . . . 0.0 111.035 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' B' ' 7' ' ' TRP . 55.7 p -132.67 57.81 1.78 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.062 -1.024 . . . . 0.0 111.449 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.517 ' NE1' ' O ' ' A' ' 51' ' ' MET . 0.7 OUTLIER 64.27 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.972 -1.08 . . . . 0.0 111.575 178.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.419 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -46.33 -46.91 18.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 110.393 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.516 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 26.0 m -45.83 -40.24 9.55 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.151 -0.968 . . . . 0.0 109.483 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.523 HG13 ' CE1' ' A' ' 19' ' ' PHE . 10.2 t -66.03 -44.04 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.528 -0.733 . . . . 0.0 110.061 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.522 ' CG2' ' SD ' ' A' ' 72' ' ' MET . 51.7 mt -69.39 -25.29 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.288 -0.883 . . . . 0.0 109.907 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.08 -49.57 64.61 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 110.34 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.525 HG11 ' CD1' ' A' ' 112' ' ' LEU . 47.9 t -65.13 -46.96 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 110.561 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' B' ' 14' ' ' LYS . 0.2 OUTLIER -58.61 -33.71 70.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.842 -1.161 . . . . 0.0 109.688 179.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 0.1 OUTLIER -63.95 -43.89 94.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.519 ' CE ' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -59.18 -32.43 69.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.0 110.114 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.566 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 6.4 mp -69.4 58.65 0.12 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.161 -0.962 . . . . 0.0 110.345 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' B' ' 20' ' ' ARG . 3.0 ttp180 -123.84 76.22 1.42 Allowed 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.891 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.493 ' CD ' ' C ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER 62.74 -57.77 0.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.605 -0.684 . . . . 0.0 111.042 179.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' B' ' 18' ' ' ARG . 0.7 OUTLIER -166.9 22.61 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.24 -0.913 . . . . 0.0 110.38 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.407 ' OG ' ' HB3' ' B' ' 18' ' ' ARG . 66.2 m -74.8 126.55 31.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.188 -0.945 . . . . 0.0 110.363 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.578 ' CD1' ' HE3' ' A' ' 124' ' ' MET . 0.1 OUTLIER -145.11 -40.64 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.118 -0.989 . . . . 0.0 110.913 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' B' ' 22' ' ' PHE . . . -46.37 -99.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' ' 145' ' ' MET . 80.5 m-20 -138.3 88.11 15.23 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.144 -1.209 . . . . 0.0 110.719 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.63 -12.28 18.43 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.847 1.446 . . . . 0.0 110.036 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.642 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 5.5 m-30 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.269 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.231 0.538 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -131.1 57.79 1.74 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.23 -0.919 . . . . 0.0 110.21 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -100.04 116.76 32.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.266 -0.896 . . . . 0.0 110.322 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 mt -95.02 128.02 41.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.212 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.443 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 1.6 t -126.94 69.28 1.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.252 -0.905 . . . . 0.0 110.24 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -99.94 -35.74 9.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 8' ' ' GLN . 5.7 tp10 -51.62 -65.12 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 110.556 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.554 ' CG ' ' N ' ' A' ' 9' ' ' ILE . 12.8 pt20 -43.49 -47.33 7.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.138 -0.976 . . . . 0.0 109.983 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.554 ' N ' ' CG ' ' A' ' 8' ' ' GLN . 83.8 mt -67.02 -50.43 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.023 -1.048 . . . . 0.0 109.375 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.47 64.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 109.303 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 37.8 tt0 -58.84 -52.95 63.54 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.401 -0.812 . . . . 0.0 109.478 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.574 ' CE2' ' HG3' ' A' ' 72' ' ' MET . 1.6 m-85 -53.23 -43.67 67.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.349 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -59.53 -41.69 90.57 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.765 . . . . 0.0 109.525 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -49.52 77.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.311 -0.868 . . . . 0.0 109.487 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.84 83.94 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.351 -0.843 . . . . 0.0 109.355 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.509 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 38.8 t80 -61.29 -21.68 64.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.501 -0.749 . . . . 0.0 109.575 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -89.64 -31.39 17.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.451 -0.781 . . . . 0.0 109.694 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 10.4 tt -61.33 -44.72 96.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.866 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 74.8 m-85 -74.27 -47.38 35.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 110.193 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -67.18 73.0 0.11 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 19' ' ' PHE . 9.3 mmtt -64.89 -8.99 17.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 110.389 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -93.83 -29.55 15.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.351 -0.843 . . . . 0.0 110.167 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.11 33.61 44.51 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 23.5 p30 -104.81 -15.56 15.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.19 -1.182 . . . . 0.0 110.176 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 93.61 31.0 8.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 24.7 p -156.02 118.3 4.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -1.155 . . . . 0.0 110.29 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.481 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 7.3 mt -92.9 125.74 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.014 -1.054 . . . . 0.0 110.093 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.1 p -100.5 -175.65 2.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.501 -0.749 . . . . 0.0 109.462 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.459 ' O ' HD23 ' A' ' 48' ' ' LEU . 2.9 p -76.13 -22.54 55.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.007 . . . . 0.0 109.822 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -73.03 -46.21 53.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 110.234 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.42 -62.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.428 ' HG ' ' HE1' ' A' ' 36' ' ' MET . 34.5 tp -54.88 -30.15 57.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.013 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' CA ' HD23 ' A' ' 48' ' ' LEU . . . -68.67 -32.33 74.38 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.1 m -71.88 -59.8 2.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -1.129 . . . . 0.0 110.16 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.7 t -50.79 -46.34 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.955 . . . . 0.0 110.167 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.517 ' SD ' ' CG2' ' B' ' 4' ' ' ILE . 0.3 OUTLIER -58.77 -47.59 84.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.259 -0.901 . . . . 0.0 110.098 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -24.95 58.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.883 . . . . 0.0 110.124 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.402 ' O ' ' CG ' ' A' ' 111' ' ' ASN . 36.3 t -77.98 -34.27 51.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.881 . . . . 0.0 110.513 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 HG12 ' A' ' 91' ' ' VAL . 3.5 mt -53.97 -42.85 69.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.186 -0.946 . . . . 0.0 110.276 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.49 51.21 0.06 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.98 -162.13 1.49 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -1.127 . . . . 0.0 110.225 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.54 70.92 14.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.462 ' HA ' HD12 ' B' ' 4' ' ' ILE . 44.2 Cg_endo -70.82 118.71 5.84 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.913 1.48 . . . . 0.0 110.243 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 3.1 m -82.02 152.62 26.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.888 . . . . 0.0 110.42 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -48.65 -53.74 17.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.41 -42.19 66.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.827 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 44' ' ' THR . 4.2 mm-40 -59.5 -52.11 66.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.861 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.526 HD23 ' CA ' ' A' ' 33' ' ' GLY . 1.7 mt -44.29 -57.21 3.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.903 . . . . 0.0 109.946 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.69 -45.47 28.43 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 109.597 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.04 -39.42 78.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.484 -0.76 . . . . 0.0 109.668 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.513 ' SD ' ' CE ' ' A' ' 36' ' ' MET . 1.6 ttp -74.96 -51.03 14.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 109.64 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.405 HG13 ' CG2' ' A' ' 29' ' ' THR . 1.9 mm -47.95 -24.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.226 -0.921 . . . . 0.0 109.221 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.22 -14.78 59.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 110.204 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -79.59 -8.42 59.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.253 -0.905 . . . . 0.0 110.428 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.644 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 54.9 t -118.34 -53.86 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.062 -1.024 . . . . 0.0 110.675 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -19.27 82.6 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.459 0.647 . . . . 0.0 112.014 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.77 -60.88 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.455 -0.778 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 13.6 p30 -68.32 -21.61 64.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.9 . . . . 0.0 109.988 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 72.11 48.0 28.05 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -97.18 -44.96 6.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.171 -1.194 . . . . 0.0 110.181 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . 139.32 -2.11 2.52 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.392 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 166.33 30.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.833 -1.392 . . . . 0.0 110.759 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.481 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 10.5 mm -101.68 122.38 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.459 -0.775 . . . . 0.0 110.037 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.503 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 p30 -110.03 -179.64 3.85 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.021 -1.049 . . . . 0.0 110.754 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.629 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 t80 -63.31 -39.55 51.13 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.287 -0.883 . . . . 0.0 112.121 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.7 Cg_endo -69.47 -29.82 24.61 Favored 'Trans proline' 0 C--N 1.32 -0.952 0 O-C-N 123.078 1.041 . . . . 0.0 109.973 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 71' ' ' MET . 23.8 mt-10 -75.2 -30.66 60.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 109.309 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.563 ' CD1' ' HE1' ' A' ' 71' ' ' MET . 10.5 t80 -66.96 -42.64 84.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.471 -0.768 . . . . 0.0 109.762 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.432 ' CD1' ' CE1' ' A' ' 65' ' ' PHE . 4.7 mt -70.11 -32.06 69.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.83 . . . . 0.0 110.326 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -87.73 -43.25 12.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.954 . . . . 0.0 110.557 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.563 ' HE1' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -59.78 -32.92 71.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.118 -0.989 . . . . 0.0 110.263 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.574 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -69.13 -11.95 61.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.882 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.77 -35.27 5.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.385 -0.822 . . . . 0.0 110.051 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -68.42 -41.14 80.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 110.135 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.86 -26.1 67.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.82 . . . . 0.0 110.145 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 72' ' ' MET . 1.4 mtt -86.0 -12.17 51.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.857 . . . . 0.0 110.202 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -115.41 58.69 0.72 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.245 -0.91 . . . . 0.0 110.112 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -147.22 -63.69 0.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 110.2 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.5 m -155.46 -43.43 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.897 . . . . 0.0 110.176 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -85.84 98.18 10.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.279 -0.888 . . . . 0.0 110.271 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m -102.18 -51.9 3.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.02 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -100.14 -11.13 20.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -0.823 . . . . 0.0 110.128 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 1.8 mm-40 -66.85 -9.88 42.28 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 0.0 109.929 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.407 ' OE1' ' SD ' ' A' ' 76' ' ' MET . 40.8 mt-10 -76.4 -30.28 57.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.261 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.555 ' CD1' ' CG2' ' A' ' 146' ' ' THR . 75.1 mt -75.82 -32.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -36.82 84.09 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.438 -0.789 . . . . 0.0 109.623 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 5.7 mm-40 -69.32 -45.58 69.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' B' ' 12' ' ' LEU . . . -60.62 -34.77 74.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.143 -0.973 . . . . 0.0 110.066 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.554 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 29.5 t80 -68.44 -40.93 80.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 109.653 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -60.85 -29.7 69.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.343 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.422 HG12 HD23 ' A' ' 39' ' ' LEU . 65.6 t -72.79 -55.06 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.006 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.469 ' CZ ' ' SD ' ' B' ' 16' ' ' MET . 37.5 m-85 -53.62 -29.87 40.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.258 -0.901 . . . . 0.0 109.975 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -100.44 67.14 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.459 -0.776 . . . . 0.0 110.101 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.503 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -41.36 -25.95 0.05 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.399 -0.813 . . . . 0.0 110.415 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.503 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 15.7 p-10 -102.09 -41.69 6.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 109.961 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.22 49.86 5.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.448 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 42.0 p-10 -92.18 -23.55 19.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 124.95 26.33 1.39 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.57 ' CZ ' ' OD1' ' A' ' 137' ' ' ASN . 1.1 m-85 -170.52 158.22 6.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.974 -1.309 . . . . 0.0 110.617 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.494 HD11 HG22 ' A' ' 100' ' ' ILE . 10.0 mt -126.97 120.19 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.271 -0.893 . . . . 0.0 110.28 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -101.38 145.91 28.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -0.988 . . . . 0.0 109.802 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.84 -31.89 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 109.726 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.1 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.343 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 101' ' ' SER . 7.4 mt-10 -60.49 -48.6 81.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.442 -0.786 . . . . 0.0 109.367 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.409 HD12 ' CZ ' ' B' ' 22' ' ' PHE . 0.3 OUTLIER -59.04 -41.95 89.06 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.298 -0.876 . . . . 0.0 108.912 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -51.62 -36.7 46.91 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -60.11 -56.08 26.06 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.78 -34.73 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.333 -0.855 . . . . 0.0 108.792 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.551 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 3.7 mtt -57.35 -69.42 0.16 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.652 -0.655 . . . . 0.0 110.829 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.511 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 93.7 m -55.57 -21.68 18.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.062 -1.024 . . . . 0.0 109.876 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 38' ' ' SER . 57.1 m-20 -84.34 -10.32 57.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.169 -0.957 . . . . 0.0 109.801 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.548 ' CD1' HG11 ' B' ' 13' ' ' VAL . 6.8 mt -108.94 -40.37 5.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.304 -0.872 . . . . 0.0 110.549 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 167.12 -64.71 0.2 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.355 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.423 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 1.2 tp10 -107.93 171.45 7.39 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.201 -1.176 . . . . 0.0 110.841 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.543 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 1.3 mptp? -130.29 5.38 4.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 0.0 110.698 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.54 ' CD2' ' HA ' ' B' ' 19' ' ' LYS . 1.4 mp 57.08 152.91 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.073 0 O-C-N 121.599 -0.688 . . . . 0.0 110.469 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 116' ' ' LEU . 1.2 m -60.72 -151.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.02 -1.05 . . . . 0.0 109.478 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.38 -33.4 5.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 110.173 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -71.21 -45.2 63.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 109.97 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 124' ' ' MET . 12.6 pt-20 -68.71 -35.79 77.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.627 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 116' ' ' LEU . 23.3 t -63.14 -37.3 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.871 . . . . 0.0 109.575 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.19 -47.8 40.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 1.2 tp10 -67.22 -30.91 70.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.359 -0.838 . . . . 0.0 109.268 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.5 ' CG ' ' HA ' ' B' ' 21' ' ' SER . 1.5 ttt -61.18 -46.32 90.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.496 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 125' ' ' ILE . 22.0 mm -70.79 -56.62 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 0.0 109.821 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 127' ' ' GLU . 7.5 mtp85 -53.93 -62.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.377 -0.827 . . . . 0.0 110.014 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 123' ' ' GLU . 8.7 tp10 -42.07 -28.13 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.403 -0.811 . . . . 0.0 110.191 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.458 ' O ' HD11 ' A' ' 130' ' ' ILE . . . -90.98 -34.45 15.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.902 . . . . 0.0 110.026 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -57.75 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.38 -0.825 . . . . 0.0 110.587 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.458 HD11 ' O ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -52.04 -34.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.954 . . . . 0.0 109.618 179.642 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 47.5 p-10 -94.48 -16.91 22.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 110.108 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 61.37 79.07 0.14 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 8.8 p30 -123.33 5.39 9.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -1.15 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.14 15.44 66.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.563 ' HG3' ' CE1' ' A' ' 99' ' ' TYR . 6.1 pt20 -169.74 169.41 8.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -1.155 . . . . 0.0 109.99 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 9.8 t -116.63 159.16 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.119 -0.988 . . . . 0.0 110.418 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.57 ' OD1' ' CZ ' ' A' ' 99' ' ' TYR . 1.2 t30 -123.56 -167.18 1.58 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.369 -0.832 . . . . 0.0 110.014 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.554 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 1.7 t80 -74.73 -64.32 1.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.184 -0.948 . . . . 0.0 109.993 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -44.36 -48.5 9.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.913 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -55.58 -56.19 23.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.34 -0.85 . . . . 0.0 110.229 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -51.87 -19.71 1.88 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.4 t -96.46 -70.32 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.062 -1.024 . . . . 0.0 110.883 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -45.36 -48.59 13.34 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.1 -1.0 . . . . 0.0 110.794 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.515 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 11.8 tpt -72.26 -10.38 59.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.722 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.1 tpp -100.69 -47.83 4.71 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.95 -1.094 . . . . 0.0 111.044 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.555 ' CG2' ' CD1' ' A' ' 85' ' ' ILE . 1.7 t -141.41 85.17 1.95 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.106 -0.996 . . . . 0.0 110.344 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.22 52.95 0.61 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.455 -0.778 . . . . 0.0 110.651 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.184 179.695 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.504 HG11 ' N ' ' B' ' 2' ' ' LYS . 11.6 p . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 121.144 0.497 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.504 ' N ' HG11 ' B' ' 1' ' ' VAL . 0.1 OUTLIER -84.39 -85.34 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.021 . . . . 0.0 110.129 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.46 -20.66 1.19 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.197 -0.939 . . . . 0.0 110.45 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.572 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 84.4 mt -112.66 150.18 42.32 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.317 -0.865 . . . . 0.0 110.052 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.572 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 38.0 Cg_endo -62.91 124.55 14.23 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.641 1.337 . . . . 0.0 110.217 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.486 ' O ' ' CG2' ' B' ' 10' ' ' VAL . 0.3 OUTLIER -58.13 170.19 0.71 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.678 0.751 . . . . 0.0 111.25 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.644 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -56.13 -80.06 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.448 0.642 . . . . 0.0 110.383 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.416 ' O ' ' HB ' ' B' ' 11' ' ' ILE . 38.7 p -45.21 -40.69 7.55 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.413 -0.805 . . . . 0.0 109.755 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.575 ' HA ' ' CD2' ' B' ' 12' ' ' LEU . 94.4 m -49.92 -48.17 51.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.233 -0.917 . . . . 0.0 109.177 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' B' ' 6' ' ' SER . 15.8 t -61.06 -29.42 45.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.387 -0.821 . . . . 0.0 109.246 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 26.5 mm -77.73 -55.18 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.66 -0.65 . . . . 0.0 111.441 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.595 ' HB3' ' CE2' ' B' ' 26' ' ' PHE . 3.9 pp -56.88 -33.03 66.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.188 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.548 HG11 ' CD1' ' A' ' 112' ' ' LEU . 24.2 t -67.09 -50.33 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.952 -1.093 . . . . 0.0 108.755 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.479 ' HG3' ' CD1' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -62.07 -24.45 67.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.205 -0.935 . . . . 0.0 108.633 178.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' B' ' 18' ' ' ARG . 1.4 p -75.38 -27.52 59.14 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.434 0.635 . . . . 0.0 109.36 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.47 ' O ' ' N ' ' B' ' 18' ' ' ARG . 8.4 mtt -73.31 -32.29 64.51 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.412 -0.805 . . . . 0.0 108.968 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.551 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 6.0 mp -67.76 58.8 0.06 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.518 -0.739 . . . . 0.0 109.229 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' B' ' 16' ' ' MET . 5.7 mtm180 -84.47 -80.99 0.19 Allowed 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.769 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.54 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -176.82 -67.31 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.052 -1.03 . . . . 0.0 111.472 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.53 ' N ' ' CD ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -87.83 -21.73 24.88 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.373 -0.829 . . . . 0.0 112.074 -178.156 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.5 ' HA ' ' CG ' ' A' ' 124' ' ' MET . 4.0 m -163.71 -175.0 3.91 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.453 -1.404 . . . . 0.0 112.554 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.409 ' CZ ' HD12 ' A' ' 105' ' ' LEU . 11.3 m-85 -78.78 -85.83 0.07 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.418 0.628 . . . . 0.0 110.567 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.45 -151.55 21.83 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 144' ' ' MET . 0.1 OUTLIER 176.93 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.201 -1.176 . . . . 0.0 110.681 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' B' ' 24' ' ' ASN . 42.6 Cg_endo -69.45 111.3 2.71 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.764 1.402 . . . . 0.0 110.195 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.595 ' CE2' ' HB3' ' B' ' 12' ' ' LEU . 2.1 t80 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.243 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.335 0.588 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.54 9.87 23.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 4' ' ' LEU . 3.6 tt0 -97.29 149.61 21.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.256 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' GLN . 1.9 mt 55.5 108.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.434 ' O ' HD11 ' A' ' 9' ' ' ILE . 10.2 t -104.23 -1.17 27.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.287 -0.883 . . . . 0.0 110.419 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -100.19 -9.84 22.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.895 . . . . 0.0 110.46 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.473 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -68.61 -69.09 0.35 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.184 -0.947 . . . . 0.0 110.373 -179.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -50.83 41.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.539 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.434 HD11 ' O ' ' A' ' 5' ' ' THR . 61.7 mt -60.16 -35.86 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.528 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 7' ' ' GLU . . . -55.35 -56.27 22.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 110.144 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -55.72 -47.61 76.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.083 -1.011 . . . . 0.0 109.958 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -58.91 -41.82 88.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.0 109.43 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -62.1 -31.4 71.84 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.244 -0.91 . . . . 0.0 108.923 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 6.3 tp10 -57.62 -53.45 58.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.499 -0.75 . . . . 0.0 109.166 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -51.7 -55.58 18.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 109.219 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.536 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 86.5 t80 -52.99 -36.28 60.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.495 -0.753 . . . . 0.0 109.366 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.2 t -76.05 -26.95 57.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.567 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.439 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 10.1 tt -58.8 -44.16 90.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.901 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -75.22 -25.91 58.53 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.216 -0.927 . . . . 0.0 110.281 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.72 106.08 14.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.233 -0.917 . . . . 0.0 110.1 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -99.66 5.87 45.73 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.216 -0.927 . . . . 0.0 110.49 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 3.8 p30 -116.65 -51.68 2.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.155 -0.966 . . . . 0.0 110.397 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 114.08 39.87 1.02 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 13.6 p30 -111.65 -16.14 13.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.137 -1.214 . . . . 0.0 110.233 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.54 -1.18 81.39 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 68.3 p -118.46 108.94 15.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.18 -1.188 . . . . 0.0 110.37 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 27' ' ' ILE . 17.9 mt -77.82 124.49 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.289 -0.882 . . . . 0.0 109.966 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.414 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 1.1 p -97.35 -178.79 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.374 -0.829 . . . . 0.0 110.316 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.481 ' CG2' ' NE2' ' A' ' 49' ' ' GLN . 40.6 p -73.59 -33.8 64.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.122 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -43.83 86.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 0.0 110.23 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' OE2' ' OG1' ' A' ' 28' ' ' THR . 53.6 mt-10 -60.06 -60.21 4.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 tp -58.73 -32.37 69.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.89 -33.26 86.77 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.1 m -71.94 -47.93 48.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -1.141 . . . . 0.0 110.14 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.63 -55.57 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.266 -0.896 . . . . 0.0 110.566 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.482 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 3.8 mmt -55.47 -36.44 66.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 110.179 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -64.11 -33.04 74.87 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -44.63 81.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 110.689 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.458 HD23 HG12 ' A' ' 91' ' ' VAL . 10.7 mt -47.83 -37.96 14.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.006 -1.059 . . . . 0.0 109.923 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.74 17.27 19.55 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.463 ' OE1' HD11 ' B' ' 3' ' ' LEU . 87.0 mm-40 -82.05 -131.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.122 -1.222 . . . . 0.0 110.182 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.532 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 7.6 p30 -159.05 58.28 1.22 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.95 -1.094 . . . . 0.0 110.627 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 49.4 Cg_endo -82.87 83.14 2.02 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.931 1.49 . . . . 0.0 110.186 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.7 m -50.0 176.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.144 -0.972 . . . . 0.0 110.297 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.8 mm-40 -70.13 -59.54 2.83 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.267 -0.896 . . . . 0.0 110.075 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -44.2 -36.23 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.872 . . . . 0.0 109.844 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -70.71 -38.74 73.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.904 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 12.1 mt -55.78 -54.71 41.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.915 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.481 ' NE2' ' CG2' ' A' ' 29' ' ' THR . 0.0 OUTLIER -60.1 -40.4 89.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.631 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.453 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -63.98 -36.35 83.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 109.578 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.476 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -66.93 -47.01 73.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.908 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -63.56 -30.42 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 109.335 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.27 -16.99 61.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.705 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -72.72 -57.17 4.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.498 -0.751 . . . . 0.0 110.379 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.635 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 37.6 t -71.33 -29.83 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.913 -1.117 . . . . 0.0 109.936 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -48.67 88.47 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.347 -0.846 . . . . 0.0 110.565 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -69.06 -27.4 65.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.321 -0.862 . . . . 0.0 110.452 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 8.6 p-10 -95.85 -41.91 8.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.216 -0.927 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.83 47.67 1.46 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 18.8 p-10 -98.46 -44.07 6.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -1.137 . . . . 0.0 110.24 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.57 6.66 5.05 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.14 154.99 41.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.121 -1.223 . . . . 0.0 110.35 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.0 mm -97.07 166.18 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.274 -0.891 . . . . 0.0 110.122 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 4.8 t0 -148.11 169.94 18.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.125 -0.984 . . . . 0.0 110.568 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.631 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 19.9 t80 -59.39 -41.24 86.03 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.849 . . . . 0.0 111.961 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -68.73 -23.88 35.45 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 O-C-N 123.142 1.075 . . . . 0.0 110.473 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.58 -36.27 29.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -62.01 -42.91 99.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 110.239 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.62 -34.6 58.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.197 -0.939 . . . . 0.0 110.543 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 35.5 m -74.56 -12.44 60.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.062 -1.024 . . . . 0.0 110.768 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.9 tmm? -98.6 -43.68 6.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.045 -1.035 . . . . 0.0 110.76 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.543 ' HE1' ' CE ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -60.81 -10.89 6.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -0.958 . . . . 0.0 110.784 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.01 -17.23 28.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.055 -1.028 . . . . 0.0 110.927 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -97.05 -18.33 19.44 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.961 -1.087 . . . . 0.0 110.72 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HG3' ' CG2' ' B' ' 8' ' ' THR . 17.8 mmtp -92.39 -28.42 16.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.073 -1.017 . . . . 0.0 110.537 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.562 ' HE3' ' CE2' ' B' ' 26' ' ' PHE . 5.0 ttm -98.03 61.31 1.5 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.19 -0.944 . . . . 0.0 110.304 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -110.58 -56.62 2.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 110.295 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 1.2 t0 177.51 -41.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.219 -0.926 . . . . 0.0 110.43 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.4 m -49.06 -81.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.203 -0.935 . . . . 0.0 110.425 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 80' ' ' ASP . 6.0 p-10 -77.9 100.61 6.45 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.197 -0.939 . . . . 0.0 110.44 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.2 p -121.81 -32.97 3.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 0.0 109.786 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -99.14 -21.61 16.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.979 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -72.73 -35.57 67.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HG2' ' CD1' ' B' ' 12' ' ' LEU . 8.3 tt0 -70.26 -42.09 72.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.83 . . . . 0.0 110.168 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 ' CE2' ' A' ' 141' ' ' PHE . 46.5 mt -68.63 -26.79 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.782 . . . . 0.0 109.718 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -66.9 -49.69 64.79 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.465 -0.772 . . . . 0.0 109.709 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB3' HG22 ' B' ' 9' ' ' THR . 8.4 mt-10 -59.53 -48.83 80.15 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.301 -0.875 . . . . 0.0 109.695 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -56.07 -31.63 63.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.6 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 4.7 t80 -67.99 -63.85 0.98 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.133 -0.98 . . . . 0.0 109.682 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' PHE . 3.9 mmt85 -41.34 -32.75 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.656 -0.653 . . . . 0.0 109.826 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.458 HG12 HD23 ' A' ' 39' ' ' LEU . 71.4 t -65.5 -47.02 88.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.353 -0.842 . . . . 0.0 109.465 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.569 ' CZ ' HG12 ' B' ' 13' ' ' VAL . 43.9 m-85 -68.94 -18.44 64.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.309 -0.869 . . . . 0.0 110.028 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' HA ' ' OE2' ' A' ' 104' ' ' GLU . 1.9 t0 -96.98 60.68 1.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.334 -0.854 . . . . 0.0 110.478 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -42.07 -61.26 1.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.261 -0.899 . . . . 0.0 110.278 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 9.4 p30 -55.28 -28.97 57.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.143 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 74.81 42.84 30.02 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.0 p30 -100.13 -48.96 4.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -1.181 . . . . 0.0 110.262 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 148.66 -33.7 1.17 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -95.61 153.98 17.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.146 -1.208 . . . . 0.0 110.314 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.461 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 17.0 mt -121.27 127.52 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.259 -0.901 . . . . 0.0 110.251 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.0 p -111.28 164.13 13.22 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.352 -0.842 . . . . 0.0 109.998 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.525 ' HB2' ' CG1' ' A' ' 121' ' ' VAL . . . -55.95 -33.71 65.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.53 89.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.011 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' OE2' ' HA ' ' A' ' 93' ' ' ASP . 14.3 mt-10 -58.89 -50.06 75.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.749 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.51 ' N ' HD21 ' A' ' 105' ' ' LEU . 2.5 mm? -55.61 -42.72 75.26 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.215 -0.928 . . . . 0.0 109.748 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -18.65 65.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.205 -0.934 . . . . 0.0 109.339 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 1.7 m80 -82.52 -30.15 29.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.759 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 109' ' ' MET . 0.9 OUTLIER -83.92 -41.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.306 -0.871 . . . . 0.0 109.647 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.559 ' CG ' ' HG ' ' B' ' 17' ' ' LEU . 16.8 mtt -44.35 -70.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 110.292 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 m -49.35 -46.38 46.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.445 -0.784 . . . . 0.0 109.935 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 5.2 m120 -59.04 -16.04 16.6 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.405 -0.809 . . . . 0.0 109.74 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.535 HD13 ' CG1' ' B' ' 13' ' ' VAL . 8.1 mt -106.74 -45.89 4.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.34 -0.85 . . . . 0.0 110.537 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.98 -62.51 0.24 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.772 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 109' ' ' MET . 59.6 tt0 -81.75 172.04 13.85 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.109 -1.23 . . . . 0.0 110.831 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.48 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -154.61 75.49 0.98 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.592 -0.693 . . . . 0.0 109.593 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' B' ' 19' ' ' LYS . 2.4 mp -36.26 138.55 0.2 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.7 -0.625 . . . . 0.0 110.63 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -54.63 -165.16 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.251 -0.905 . . . . 0.0 110.18 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.56 -56.69 3.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.254 -0.904 . . . . 0.0 110.288 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -56.85 -25.34 56.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 110.067 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.456 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 14.7 mm-40 -78.12 -44.18 26.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 108.971 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 102' ' ' ALA . 15.2 t -57.69 -36.72 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.676 -0.64 . . . . 0.0 109.902 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.87 -51.01 20.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.981 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -58.89 -22.71 59.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.892 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.404 ' CE ' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -75.8 -47.24 26.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -0.901 . . . . 0.0 110.108 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.7 mm -76.94 -33.46 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.209 -0.932 . . . . 0.0 110.055 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 ttp85 -64.49 -45.38 87.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.79 -20.09 65.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.2 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -85.81 -35.2 20.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.38 64.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.279 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mp -46.97 -28.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.257 -0.902 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 13.3 p-10 -88.99 -28.17 20.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.915 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.8 73.03 1.28 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 135' ' ' GLN . 18.2 p-10 -127.34 -29.22 2.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.267 -1.137 . . . . 0.0 110.255 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.12 -8.32 12.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.431 ' O ' ' OD2' ' A' ' 133' ' ' ASP . 9.4 pt20 -159.43 169.01 24.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.189 -1.183 . . . . 0.0 110.417 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.504 ' CG1' ' HB3' ' A' ' 140' ' ' GLU . 24.9 t -113.27 159.29 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.239 -0.913 . . . . 0.0 110.497 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.472 ' N ' HG11 ' A' ' 136' ' ' VAL . 10.3 p-10 -122.26 -173.38 2.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.192 -0.943 . . . . 0.0 110.325 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.6 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 6.2 t80 -57.51 -69.37 0.17 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.218 -0.926 . . . . 0.0 110.655 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.7 OUTLIER -41.0 -53.06 3.05 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.298 -0.876 . . . . 0.0 110.382 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.504 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 8.5 mt-10 -52.79 -62.32 1.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.934 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.552 ' CE1' ' HE3' ' B' ' 16' ' ' MET . 37.8 t80 -41.79 -27.51 0.11 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.266 -0.896 . . . . 0.0 109.756 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' GLU . 96.2 t -95.19 -37.7 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 0.0 110.194 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -68.4 -9.48 48.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.119 -0.988 . . . . 0.0 109.872 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.474 ' O ' ' OD1' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -94.08 -23.15 18.09 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.364 -0.835 . . . . 0.0 110.42 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.5 mmt -100.61 -68.71 0.8 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.972 . . . . 0.0 111.105 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.3 t -92.43 61.66 3.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.221 -0.924 . . . . 0.0 110.797 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -99.7 40.41 1.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 110.23 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.268 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 82.6 t . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -93.98 139.19 31.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 0.0 110.039 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.465 HD11 ' O ' ' B' ' 3' ' ' LEU . 0.7 OUTLIER -170.61 68.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 110.495 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.45 HG21 ' HD2' ' B' ' 5' ' ' PRO . 14.1 mt -112.89 142.36 27.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.823 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' B' ' 7' ' ' TRP . 44.7 Cg_endo -71.24 103.88 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.893 1.47 . . . . 0.0 109.891 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.529 ' O ' ' N ' ' B' ' 8' ' ' THR . 23.1 t -62.13 71.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.561 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.635 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 4.2 m95 50.74 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.871 . . . . 0.0 110.648 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.553 ' CG2' ' HG3' ' A' ' 75' ' ' LYS . 40.4 p -41.78 -24.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.715 -1.241 . . . . 0.0 110.42 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.507 HG22 ' HA ' ' B' ' 5' ' ' PRO . 85.6 m -70.58 -51.47 28.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 109.941 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.594 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 3.8 m -56.38 -28.31 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.85 -1.156 . . . . 0.0 108.849 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.431 HD12 ' N ' ' B' ' 11' ' ' ILE . 7.1 mm -75.8 -28.38 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.448 -0.783 . . . . 0.0 109.322 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.471 ' CD1' ' HG2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -66.08 -57.61 7.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.57 -0.706 . . . . 0.0 110.331 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.569 HG12 ' CZ ' ' A' ' 92' ' ' PHE . 42.4 t -60.35 -40.71 84.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.387 -0.82 . . . . 0.0 110.952 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.459 ' CD ' ' O ' ' B' ' 14' ' ' LYS . 1.2 tmtt? -63.07 -29.08 70.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.369 -1.457 . . . . 0.0 108.744 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' B' ' 11' ' ' ILE . 1.5 p -83.39 -15.96 47.77 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.552 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 73.1 mmm -71.64 -47.2 56.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.555 -0.716 . . . . 0.0 110.578 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.559 ' HG ' ' CG ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -99.97 37.8 1.57 Allowed 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 117.724 -1.59 . . . . 0.0 109.619 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.526 ' HG2' ' N ' ' B' ' 19' ' ' LYS . 47.7 ttp180 -48.19 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.159 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.526 ' N ' ' HG2' ' B' ' 18' ' ' ARG . 8.6 tmtt? -104.91 -73.65 0.67 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 111.047 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.464 ' HG2' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -151.82 15.45 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.998 -1.063 . . . . 0.0 110.572 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.404 ' O ' ' CE ' ' A' ' 124' ' ' MET . 3.4 m -127.34 -173.36 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.111 -0.993 . . . . 0.0 110.176 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.469 ' CD2' ' HE2' ' B' ' 16' ' ' MET . 2.6 m-85 -92.91 -55.39 3.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.189 -0.944 . . . . 0.0 110.307 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' B' ' 24' ' ' ASN . . . 145.97 176.92 20.26 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.529 ' CB ' ' HD3' ' B' ' 25' ' ' PRO . 0.1 OUTLIER 174.17 -52.39 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.458 -1.025 . . . . 0.0 110.117 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.529 ' HD3' ' CB ' ' B' ' 24' ' ' ASN . 48.9 Cg_endo -82.62 72.94 5.76 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.792 1.417 . . . . 0.0 110.404 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.562 ' CE2' ' HE3' ' A' ' 76' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.172 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.288 0.566 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 7.0 p-10 -154.77 40.19 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.173 -0.954 . . . . 0.0 110.188 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.422 ' OE1' ' N ' ' A' ' 3' ' ' GLN . 8.5 mp0 -74.68 151.89 39.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.082 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.83 164.19 17.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.039 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.7 p -113.55 40.94 2.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.191 -0.943 . . . . 0.0 110.135 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 7' ' ' GLU . 1.3 tp10 -48.15 -46.96 35.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.463 -0.773 . . . . 0.0 110.308 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 6' ' ' GLU . 2.2 mm-40 -41.1 -62.37 0.84 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.367 -0.833 . . . . 0.0 110.226 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -45.82 -56.15 5.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.159 -0.963 . . . . 0.0 109.575 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 10' ' ' ALA . 67.1 mt -53.13 -43.88 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.795 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -44.19 -60.19 2.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.913 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 5.0 tm-20 -52.5 -55.4 22.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.755 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -53.26 -30.07 36.4 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.162 -0.961 . . . . 0.0 109.277 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 17' ' ' SER . 17.9 ttmt -64.83 -37.05 86.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.309 -0.869 . . . . 0.0 109.089 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 3.1 mm-40 -61.36 -46.36 90.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.508 -0.745 . . . . 0.0 109.363 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . . . -60.73 -48.74 80.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.839 . . . . 0.0 109.587 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.509 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 55.3 t80 -62.78 -39.68 94.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.413 -0.804 . . . . 0.0 109.508 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -70.8 -30.27 66.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -0.801 . . . . 0.0 109.319 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.544 HD11 ' CE ' ' B' ' 14' ' ' LYS . 9.5 tt -59.46 -44.18 93.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.427 -0.796 . . . . 0.0 109.702 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.4 ' CZ ' HG13 ' B' ' 10' ' ' VAL . 61.3 m-85 -69.87 -52.76 22.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.278 -0.888 . . . . 0.0 109.963 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.28 108.42 2.73 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.398 -0.814 . . . . 0.0 110.239 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -84.8 2.26 43.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.288 -0.883 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.57 -68.65 0.9 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.157 -0.965 . . . . 0.0 110.694 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.27 35.24 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 60.0 p30 -94.12 -10.14 34.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -1.16 . . . . 0.0 110.039 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 81.37 30.39 37.22 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 77.7 p -152.76 124.44 7.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.137 -1.214 . . . . 0.0 110.709 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.558 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 4.2 mt -92.36 120.7 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.23 -0.919 . . . . 0.0 109.758 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -100.17 171.21 7.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 110.359 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.1 p -61.94 -33.44 74.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 110.033 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -70.01 -59.21 3.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 110.276 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -49.2 -66.63 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 109.881 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.3 tp -48.98 -43.95 40.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.749 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.05 -43.25 49.61 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 83.0 m -60.68 -48.57 81.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -1.137 . . . . 0.0 110.06 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.6 -43.37 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.804 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.494 ' CE ' ' HE3' ' A' ' 51' ' ' MET . 29.9 mmm -70.97 -24.6 62.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 109.882 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.09 -21.18 47.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.88 . . . . 0.0 110.14 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 39' ' ' LEU . 50.8 m -85.9 -40.89 15.45 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.255 -0.903 . . . . 0.0 110.771 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' SER . 2.4 mt -44.13 -32.23 1.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.924 -1.11 . . . . 0.0 109.799 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 41' ' ' GLN . . . 128.62 67.24 0.12 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER 179.55 -172.2 0.17 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.372 -1.075 . . . . 0.0 110.231 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -138.33 92.03 12.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.938 . . . . 0.0 110.666 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.74 126.48 11.43 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.088 1.573 . . . . 0.0 109.885 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 m -94.38 161.72 14.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.207 -0.933 . . . . 0.0 110.581 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.0 -60.69 3.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.022 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.35 -43.96 23.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.7 -42.35 74.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 0.0 109.873 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -64.22 -34.97 79.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.83 -41.16 83.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.866 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -67.17 -24.8 65.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.384 -0.823 . . . . 0.0 109.827 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.494 ' HE3' ' CE ' ' A' ' 36' ' ' MET . 4.0 mtp -77.59 -45.96 23.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 109.791 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -64.46 -35.11 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 109.845 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.418 ' N ' HG21 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -63.37 -15.07 56.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -81.42 -33.32 32.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 110.225 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 4.4 t -103.26 -14.12 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.184 -0.948 . . . . 0.0 110.256 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 12.4 t0 -60.07 80.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 0.0 109.901 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -93.14 -15.83 25.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.901 . . . . 0.0 110.368 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.3 -40.37 21.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.199 -0.938 . . . . 0.0 110.135 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.19 13.54 30.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 27.6 p-10 -88.04 -46.89 8.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -1.096 . . . . 0.0 110.263 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 131.38 -21.68 4.52 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.0 p -116.6 169.63 9.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -1.184 . . . . 0.0 110.148 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.558 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 11.2 mm -94.62 138.66 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.888 . . . . 0.0 110.001 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.54 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 m-20 -117.48 171.91 7.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.972 . . . . 0.0 110.695 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.627 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.2 t80 -62.97 -38.82 46.5 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 111.674 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.7 Cg_endo -70.08 -24.54 28.1 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 O-C-N 123.075 1.04 . . . . 0.0 109.589 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 3.2 mt-10 -69.49 -33.61 73.1 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.414 -0.804 . . . . 0.0 108.922 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CZ ' HG22 ' B' ' 11' ' ' ILE . 2.0 t80 -68.4 -48.21 65.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.54 -0.725 . . . . 0.0 109.571 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 3.2 mm? -55.91 -36.72 68.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 110.371 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 2.7 m -87.33 -25.45 23.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.125 -0.984 . . . . 0.0 110.61 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.522 ' HE3' ' N ' ' A' ' 72' ' ' MET . 2.2 ttp -63.07 -61.49 2.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.937 . . . . 0.0 110.209 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.671 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 2.0 tpt -47.23 -32.27 4.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.267 -0.896 . . . . 0.0 110.632 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.38 -11.23 46.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.935 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 70' ' ' THR . 0.4 OUTLIER -99.29 -10.96 21.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.99 -1.069 . . . . 0.0 110.397 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HG2' ' CG2' ' B' ' 8' ' ' THR . 2.2 mptp? -100.1 -22.75 15.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 0.0 110.455 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.51 ' CE ' ' HE1' ' A' ' 72' ' ' MET . 32.7 mtt -99.54 60.15 1.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.107 -0.996 . . . . 0.0 110.269 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.72 -36.0 0.4 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.864 . . . . 0.0 110.137 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' C ' ' OG1' ' A' ' 79' ' ' THR . 7.8 t70 -172.88 66.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -171.68 99.05 0.18 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 110.324 -179.725 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 79' ' ' THR . 43.8 m-20 60.22 104.53 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.423 -0.798 . . . . 0.0 110.703 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.438 ' O ' ' OE2' ' A' ' 84' ' ' GLU . 43.4 t -102.23 -49.15 3.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.648 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -98.56 -20.35 17.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.456 -0.777 . . . . 0.0 109.587 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.56 -47.57 69.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.498 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' B' ' 26' ' ' PHE . 17.3 pt-20 -47.59 -33.07 6.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.526 -0.734 . . . . 0.0 110.128 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.418 HG13 ' HG3' ' A' ' 84' ' ' GLU . 63.9 mt -76.32 -39.93 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.18 -0.95 . . . . 0.0 109.074 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -32.47 67.64 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HB3' HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -67.01 -62.02 1.64 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.506 ' CB ' HD23 ' B' ' 12' ' ' LEU . . . -51.93 -30.13 23.18 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.538 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.51 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 59.0 t80 -71.92 -50.56 28.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.475 -0.766 . . . . 0.0 109.598 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.74 -47.18 77.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.0 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -49.19 -45.46 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.567 -0.708 . . . . 0.0 109.29 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.573 ' CZ ' HG12 ' B' ' 13' ' ' VAL . 17.3 m-85 -71.91 -36.69 70.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 109.964 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 94' ' ' LYS . 15.7 t0 -75.13 55.49 0.74 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.198 -0.939 . . . . 0.0 110.197 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' ASP . 9.0 tttp -40.71 -66.02 0.36 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.37 -0.831 . . . . 0.0 110.532 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 21.6 p-10 -61.48 -43.35 99.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 0.0 110.231 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.97 44.82 3.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.43 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 32.5 p-10 -87.23 -28.9 22.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.187 -1.184 . . . . 0.0 110.169 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.563 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 121.49 15.34 4.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 50.8 m-85 -151.76 152.41 32.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.141 -1.211 . . . . 0.0 110.178 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.413 HD12 ' CB ' ' A' ' 92' ' ' PHE . 9.2 mt -104.98 118.91 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.922 . . . . 0.0 110.149 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 102' ' ' ALA . 12.4 t -105.52 141.97 36.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.848 . . . . 0.0 110.338 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.96 -33.85 0.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.313 -0.867 . . . . 0.0 109.833 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -55.16 -55.64 28.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 109.612 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 49.0 mt-10 -54.38 -48.4 71.56 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.352 -0.842 . . . . 0.0 109.764 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.533 ' CD1' HD12 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -58.72 -37.36 75.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.624 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 22.6 tpt85 -60.79 -41.24 95.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.307 -0.871 . . . . 0.0 109.44 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -57.99 -44.4 87.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.783 . . . . 0.0 109.422 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.556 HG13 ' CG1' ' B' ' 13' ' ' VAL . 5.9 t -73.19 -29.08 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.553 -0.717 . . . . 0.0 109.65 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.571 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 2.3 mtt -55.37 -69.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 110.7 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.6 m -64.85 -10.09 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.38 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -94.87 -6.68 42.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.523 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 10.1 mt -107.44 -30.57 8.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 110.354 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 147.47 -51.87 0.56 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.449 ' O ' HD22 ' B' ' 17' ' ' LEU . 23.0 tt0 -107.66 149.31 28.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -1.121 . . . . 0.0 109.7 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -123.62 19.17 9.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.895 . . . . 0.0 109.827 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.513 ' CD1' ' O ' ' B' ' 17' ' ' LEU . 3.5 mp 42.54 -166.51 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.55 0.69 . . . . 0.0 110.549 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.2 -144.65 0.3 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.514 -0.741 . . . . 0.0 109.144 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -117.64 -70.64 0.78 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.07 -1.018 . . . . 0.0 110.274 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -48.45 -40.98 28.07 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 109.398 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 121' ' ' VAL . 41.7 mm-40 -60.08 -53.48 57.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 109.282 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.424 HG23 ' CE ' ' A' ' 109' ' ' MET . 70.8 t -44.59 -41.52 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.418 -0.801 . . . . 0.0 109.844 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 35.8 m-20 -63.43 -60.81 2.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.856 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 4.0 tp10 -50.24 -40.98 49.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.795 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.578 ' HE3' ' CD2' ' B' ' 22' ' ' PHE . 4.5 ttt -51.7 -47.28 63.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.833 . . . . 0.0 109.841 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.533 HD12 ' CD1' ' A' ' 105' ' ' LEU . 48.9 mm -75.72 -39.02 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.932 . . . . 0.0 109.996 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.404 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -65.42 -26.7 68.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 110.275 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.42 -41.59 98.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 110.125 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.465 ' O ' HD11 ' A' ' 130' ' ' ILE . . . -86.92 -27.04 23.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.317 -0.864 . . . . 0.0 110.335 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' OD2' HG21 ' A' ' 125' ' ' ILE . 1.7 m-20 -58.89 88.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.328 -0.858 . . . . 0.0 110.567 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.525 HD11 ' N ' ' A' ' 130' ' ' ILE . 1.2 mp -61.82 -41.54 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.196 -0.94 . . . . 0.0 109.422 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 35.4 p30 -82.66 -17.94 42.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.422 -0.799 . . . . 0.0 110.053 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 66.02 67.86 1.86 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 30.5 p-10 -118.25 1.84 11.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -1.11 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.86 -9.44 74.27 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.459 ' HG3' ' OD2' ' A' ' 133' ' ' ASP . 1.4 pt20 -137.71 147.72 45.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -1.106 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.468 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 4.0 t -104.08 146.08 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.209 -0.932 . . . . 0.0 110.155 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.471 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 33.7 p-10 -103.46 -161.09 0.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 139' ' ' GLU . 14.8 t80 -71.81 -63.45 1.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.074 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -44.12 -56.58 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 110.009 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.471 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 68.4 mt-10 -47.52 -61.38 1.95 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 6.0 t80 -44.68 -26.97 0.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.288 -0.882 . . . . 0.0 110.282 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -99.48 -45.95 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.201 -0.937 . . . . 0.0 110.163 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -46.48 -34.7 4.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.363 -0.836 . . . . 0.0 110.45 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.475 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -86.02 -19.82 29.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.582 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 3.7 mtt -84.86 -47.32 10.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.996 -1.065 . . . . 0.0 110.489 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.9 p -83.09 -43.06 16.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.063 -1.023 . . . . 0.0 110.319 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -87.0 57.22 4.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.023 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.199 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' B' ' 2' ' ' LYS . 5.6 m . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.311 0.577 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' B' ' 1' ' ' VAL . 22.9 mmtp 60.6 17.44 7.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.943 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 23.1 mt -144.25 -69.03 0.31 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.561 -0.712 . . . . 0.0 109.632 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 17.2 mm -62.98 152.73 82.92 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.379 -0.826 . . . . 0.0 109.776 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 40.1 Cg_endo -66.37 116.46 4.06 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.79 1.416 . . . . 0.0 110.289 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.0 m -53.2 179.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.848 . . . . 0.0 111.04 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.608 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -68.27 -66.14 0.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.596 0.713 . . . . 0.0 110.241 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.5 ' CG2' ' HG2' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -53.99 -38.86 65.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 110.083 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 87' ' ' GLU . 49.1 m -49.06 -42.05 37.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.96 . . . . 0.0 108.982 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.4 HG13 ' CZ ' ' A' ' 19' ' ' PHE . 47.3 t -65.76 -50.36 71.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.42 -0.8 . . . . 0.0 109.382 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.521 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 9.2 mm -59.45 -27.12 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.427 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.62 ' HA ' ' CZ ' ' B' ' 26' ' ' PHE . 0.5 OUTLIER -65.14 -57.05 9.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.454 -0.779 . . . . 0.0 110.533 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.573 HG12 ' CZ ' ' A' ' 92' ' ' PHE . 67.6 t -65.86 -30.57 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.945 . . . . 0.0 110.122 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.544 ' CE ' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.36 -47.27 67.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.92 . . . . 0.0 109.918 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' B' ' 18' ' ' ARG . 8.3 m -63.28 -29.85 71.09 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 110.131 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 11.6 ttm -68.22 -40.09 82.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.992 . . . . 0.0 109.95 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.571 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 3.7 mp -56.19 -16.69 5.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.277 -0.889 . . . . 0.0 110.199 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.501 ' C ' ' O ' ' B' ' 17' ' ' LEU . 52.3 ttt180 -29.73 -78.34 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 121.032 0.444 . . . . 0.0 111.291 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.488 ' CD ' ' N ' ' B' ' 20' ' ' ARG . 1.8 tmtp? -143.18 -119.83 0.09 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.272 -0.893 . . . . 0.0 109.575 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.488 ' N ' ' CD ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -99.94 8.74 43.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.691 -1.255 . . . . 0.0 110.043 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -178.09 1.04 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.362 -0.836 . . . . 0.0 110.13 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.578 ' CD2' ' HE3' ' A' ' 124' ' ' MET . 0.3 OUTLIER -176.66 -46.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.884 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 144' ' ' MET . . . -72.02 80.8 0.58 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.2 134.57 21.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.294 -1.121 . . . . 0.0 110.586 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.51 72.62 4.26 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 124.066 1.561 . . . . 0.0 110.316 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.671 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.498 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.207 0.527 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -72.43 88.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 110.173 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.498 ' NE2' ' OE1' ' A' ' 6' ' ' GLU . 2.7 mm-40 -99.27 -156.8 0.56 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.248 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 12.0 mt 55.93 160.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.293 -0.879 . . . . 0.0 110.305 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 47.58 48.14 17.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 0.0 110.464 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' OE1' ' NE2' ' A' ' 3' ' ' GLN . 4.4 tt0 -100.37 -20.19 15.94 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.466 -0.771 . . . . 0.0 110.157 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -56.67 -53.26 59.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 110.245 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.498 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 24.1 mt-30 -56.53 -35.44 68.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.164 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.85 -32.96 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.925 . . . . 0.0 110.038 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.72 -44.14 70.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.937 . . . . 0.0 110.224 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 12' ' ' PHE . 4.6 pt-20 -65.06 -31.15 72.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.511 ' CE1' ' OE2' ' A' ' 11' ' ' GLU . 19.9 m-30 -65.53 -44.1 87.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.844 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 17' ' ' SER . 0.4 OUTLIER -59.97 -43.59 95.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.179 -0.95 . . . . 0.0 109.36 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -61.54 -40.17 93.72 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.27 -0.894 . . . . 0.0 109.263 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.68 -52.07 54.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 0.0 109.489 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.536 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 7.6 t80 -58.38 -26.16 62.89 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.356 -0.84 . . . . 0.0 108.992 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -76.57 -34.82 58.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.512 -0.743 . . . . 0.0 109.32 179.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 8.1 tt -59.14 -45.47 90.86 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.371 -0.83 . . . . 0.0 109.575 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.431 ' HB3' HG22 ' A' ' 27' ' ' ILE . 41.8 m-85 -74.1 -49.71 22.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.378 -0.826 . . . . 0.0 109.589 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 8.2 t0 -67.95 71.31 0.15 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.893 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -41.3 -41.73 2.0 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.429 -0.795 . . . . 0.0 110.36 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 13.0 p-10 -85.3 -43.1 14.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.099 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.5 32.16 6.13 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 46.2 p-10 -81.6 -2.53 50.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -1.193 . . . . 0.0 110.014 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.453 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 82.98 29.01 35.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 13.4 p -154.98 118.73 4.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -1.113 . . . . 0.0 110.265 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.542 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 7.8 mt -90.45 124.63 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.951 . . . . 0.0 110.002 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.01 168.17 10.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 110.285 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.457 ' O ' HD12 ' A' ' 48' ' ' LEU . 82.7 p -61.41 -28.42 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.96 -44.92 60.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.165 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 35' ' ' VAL . 51.1 mt-10 -61.38 -60.65 3.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.976 . . . . 0.0 110.1 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tp -59.31 -29.42 67.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.875 . . . . 0.0 110.189 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.99 -40.0 84.52 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.5 m -69.65 -50.71 41.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -1.157 . . . . 0.0 110.094 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 38' ' ' SER . 21.3 t -60.41 -42.72 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.177 -0.952 . . . . 0.0 110.327 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.497 ' CE ' ' HE1' ' A' ' 51' ' ' MET . 2.6 mmt -66.84 -42.14 86.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 109.737 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -67.73 -14.04 62.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 110.112 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -72.11 -58.18 3.65 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.189 -0.944 . . . . 0.0 110.623 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mt -45.94 -28.59 1.17 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.12 -0.987 . . . . 0.0 110.736 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.502 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . 118.79 58.6 0.27 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.21 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 40' ' ' GLY . 64.7 mm-40 -131.9 -162.07 1.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.248 . . . . 0.0 109.928 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.548 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 t-20 -147.1 49.95 0.87 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.186 -0.947 . . . . 0.0 110.492 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 46.1 Cg_endo -74.0 73.74 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.086 1.572 . . . . 0.0 110.462 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 43' ' ' PRO . 10.9 t -54.06 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.18 -0.95 . . . . 0.0 110.556 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -66.9 -58.65 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.337 -0.852 . . . . 0.0 110.351 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -42.71 -42.82 3.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 109.835 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.489 ' OE1' HD13 ' B' ' 4' ' ' ILE . 10.6 mm-40 -71.15 -41.16 70.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.491 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 29' ' ' THR . 4.7 mt -52.74 -59.16 4.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.806 . . . . 0.0 109.95 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -53.94 -41.26 67.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.409 -0.807 . . . . 0.0 109.882 179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -61.51 -41.13 96.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.101 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.497 ' HE1' ' CE ' ' A' ' 36' ' ' MET . 0.9 OUTLIER -73.97 -44.31 55.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 4.5 mm -61.67 -30.68 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.439 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.4 OUTLIER -73.79 -2.25 22.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.367 -0.833 . . . . 0.0 110.403 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.7 OUTLIER -85.29 -31.18 23.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.183 -0.948 . . . . 0.0 110.578 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.578 HG22 ' CD1' ' B' ' 7' ' ' TRP . 13.0 t -108.05 -46.34 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.126 -0.984 . . . . 0.0 110.495 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -45.57 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 110.663 -179.302 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -85.64 -3.35 58.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.83 . . . . 0.0 110.161 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.64 -53.94 4.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.176 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.71 22.22 5.8 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.4 p-10 -87.65 -46.21 9.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -1.169 . . . . 0.0 110.18 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.92 -0.59 11.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.6 p -134.31 149.89 50.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -1.214 . . . . 0.0 110.206 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.542 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 12.0 mm -90.41 144.55 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.065 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 48.3 m-20 -119.85 169.19 10.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.252 -0.905 . . . . 0.0 110.358 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.634 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.4 t80 -63.19 -38.58 42.68 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 111.598 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.3 Cg_endo -69.78 -26.62 27.32 Favored 'Trans proline' 0 C--N 1.321 -0.881 0 O-C-N 123.025 1.013 . . . . 0.0 109.656 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 71' ' ' MET . 10.6 mt-10 -76.41 -36.46 58.03 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 108.728 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.489 ' O ' ' HB2' ' A' ' 72' ' ' MET . 3.7 t80 -61.97 -41.33 97.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.507 -0.746 . . . . 0.0 109.986 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD13 ' CE1' ' A' ' 65' ' ' PHE . 11.2 mt -66.28 -49.1 68.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.254 -0.904 . . . . 0.0 110.16 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -59.0 3.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 110.392 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 5.3 ppp? -48.77 -30.45 5.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.271 -0.893 . . . . 0.0 110.716 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.562 ' HE2' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -68.7 -9.99 53.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.019 -1.051 . . . . 0.0 110.54 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.41 -12.93 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.125 -0.984 . . . . 0.0 111.195 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -78.71 -15.79 58.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.962 -1.087 . . . . 0.0 110.766 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.42 ' CG ' HG22 ' B' ' 8' ' ' THR . 32.8 mmtp -100.19 -40.42 7.57 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.071 -1.018 . . . . 0.0 110.391 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.577 ' HE3' ' CE1' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -98.64 62.84 1.41 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 110.463 -179.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -129.95 -31.95 1.89 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.416 -0.803 . . . . 0.0 110.379 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.83 -94.78 0.37 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.253 -0.904 . . . . 0.0 110.419 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 89.9 m -130.97 30.62 4.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.161 -0.962 . . . . 0.0 110.42 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.06 35.73 4.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.006 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.5 m -104.45 -35.25 7.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.809 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 1.4 mt-10 -69.84 -25.2 63.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.364 -0.835 . . . . 0.0 109.716 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' OE1' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -65.56 -57.92 7.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.295 -0.878 . . . . 0.0 109.548 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.541 ' OE1' ' CG ' ' A' ' 76' ' ' MET . 24.5 mt-10 -45.52 -27.9 0.83 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.557 -0.714 . . . . 0.0 110.383 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.574 HG21 ' CD1' ' A' ' 141' ' ' PHE . 47.8 mt -66.37 -43.29 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 121.011 -1.056 . . . . 0.0 108.988 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 ttm105 -58.54 -46.91 85.84 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HB2' HG22 ' B' ' 9' ' ' THR . 2.9 mt-10 -67.65 -50.77 56.23 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.225 -0.922 . . . . 0.0 108.869 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HA ' ' CG2' ' B' ' 13' ' ' VAL . . . -56.35 -40.0 73.77 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.533 ' HA ' ' CE2' ' A' ' 141' ' ' PHE . 11.8 t80 -66.43 -40.08 89.28 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.482 ' NH1' ' O ' ' B' ' 3' ' ' LEU . 10.8 ttt180 -58.85 -45.63 89.64 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.52 ' CG2' HG22 ' B' ' 13' ' ' VAL . 21.4 t -48.29 -46.73 13.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.552 ' CE2' HD23 ' A' ' 105' ' ' LEU . 4.8 m-85 -71.58 -31.85 67.41 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.005 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 11.0 t0 -101.23 63.47 0.99 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.442 -0.786 . . . . 0.0 109.975 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 34.0 pttt -55.46 -25.38 36.22 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.149 -0.969 . . . . 0.0 110.508 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.523 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 11.8 p-10 -86.58 -40.33 15.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 110.371 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 85.95 50.49 3.9 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 15.1 p-10 -96.2 -24.88 16.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.196 -1.179 . . . . 0.0 110.283 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 118.99 -7.87 12.77 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 98.3 m-85 -136.86 151.83 49.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.286 -1.126 . . . . 0.0 110.152 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.494 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 8.7 mt -103.38 134.0 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.18 -0.95 . . . . 0.0 110.09 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 102' ' ' ALA . 37.6 t -112.2 136.54 51.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 110.234 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.39 -27.12 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.305 -0.872 . . . . 0.0 109.932 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -63.49 -59.65 4.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.357 -0.839 . . . . 0.0 109.671 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 89.4 mt-10 -48.16 -38.85 19.06 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.263 -0.898 . . . . 0.0 109.414 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.552 HD23 ' CE2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -54.91 -52.67 62.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.384 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.413 ' O ' ' OG1' ' A' ' 110' ' ' THR . 5.2 ttm105 -48.65 -47.97 40.09 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.251 -0.906 . . . . 0.0 109.377 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 14.0 m170 -52.95 -53.31 51.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.4 -0.812 . . . . 0.0 109.169 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.491 ' CG1' HD13 ' A' ' 112' ' ' LEU . 21.7 t -64.49 -41.63 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 108.943 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.526 ' CE ' ' HB2' ' A' ' 116' ' ' LEU . 33.6 ttm -51.81 -48.73 63.73 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.717 -0.614 . . . . 0.0 109.937 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -79.83 -32.18 40.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.0 110.253 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -72.81 -14.92 61.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.983 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.52 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 10.5 mt -99.35 -48.84 4.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.189 -0.944 . . . . 0.0 109.949 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 148.81 -31.67 1.21 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.533 ' HG2' ' CD1' ' A' ' 116' ' ' LEU . 5.2 tp10 -79.73 156.52 27.48 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.02 -1.282 . . . . 0.0 110.661 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -137.17 51.83 1.94 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.533 ' CD1' ' HG2' ' A' ' 114' ' ' GLU . 0.2 OUTLIER -36.31 153.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.566 0.698 . . . . 0.0 110.923 -179.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -57.67 -169.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.497 -0.752 . . . . 0.0 109.699 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.05 -67.28 0.85 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.162 -0.961 . . . . 0.0 109.924 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -47.19 -36.97 9.4 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.762 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.8 -54.67 35.48 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -0.92 . . . . 0.0 109.052 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.489 ' O ' HD11 ' A' ' 125' ' ' ILE . 7.7 t -47.01 -48.83 7.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -60.97 -50.4 73.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 109.818 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -59.01 -31.4 68.78 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.295 -0.878 . . . . 0.0 109.519 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -58.05 -51.2 70.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.334 -0.854 . . . . 0.0 109.855 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.535 HD12 ' CD1' ' A' ' 105' ' ' LEU . 2.7 mp -68.74 -24.44 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.212 -0.93 . . . . 0.0 110.006 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.425 ' NH1' ' HB2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.09 -42.05 89.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.133 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.425 ' HB2' ' NH1' ' A' ' 126' ' ' ARG . 13.3 tt0 -71.34 -29.61 65.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.905 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.425 ' HB2' HG21 ' A' ' 136' ' ' VAL . . . -78.61 -20.45 50.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.01 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.67 68.17 0.39 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.193 -0.942 . . . . 0.0 110.111 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mt -54.02 -31.58 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 0.0 110.306 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -89.53 -31.99 17.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.3 -0.875 . . . . 0.0 110.38 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.79 97.14 0.92 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' ' 135' ' ' GLN . 1.2 p-10 -148.43 -38.12 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.186 -1.185 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 133.82 -1.74 4.33 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.471 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -161.22 169.73 21.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -1.235 . . . . 0.0 110.092 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.494 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 55.3 t -93.81 139.16 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.219 -0.926 . . . . 0.0 110.076 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 19.1 t30 -102.42 178.96 4.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.274 -0.891 . . . . 0.0 110.694 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.445 ' O ' ' C ' ' A' ' 139' ' ' GLU . 47.1 t80 -67.3 -68.21 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.432 -0.793 . . . . 0.0 110.298 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 143' ' ' GLN . 2.9 pt-20 -40.93 -29.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.428 -0.795 . . . . 0.0 110.094 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 3.9 mt-10 -71.62 -59.19 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.418 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.574 ' CD1' HG21 ' A' ' 85' ' ' ILE . 2.6 t80 -42.48 -29.04 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 109.377 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.528 ' CG2' HG23 ' A' ' 85' ' ' ILE . 45.3 t -99.81 -40.29 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.505 -0.747 . . . . 0.0 110.456 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' GLU . 10.7 tt0 -63.16 -12.8 30.37 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.16 -0.962 . . . . 0.0 110.599 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.9 mtp -95.54 -21.73 18.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 109.96 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.474 ' HE2' ' HB2' ' B' ' 24' ' ' ASN . 2.6 mtt -100.88 -13.38 18.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.362 -0.836 . . . . 0.0 110.462 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 148' ' ' LYS . 72.1 p -118.89 -54.65 2.23 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.173 -0.954 . . . . 0.0 111.057 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -66.87 57.6 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.172 -0.955 . . . . 0.0 110.288 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 146' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.174 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.258 0.551 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.74 144.42 34.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.424 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.482 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 71.4 mt -114.69 -9.23 12.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.329 -0.857 . . . . 0.0 110.145 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.508 HG23 ' HD2' ' B' ' 5' ' ' PRO . 0.7 OUTLIER -97.83 142.78 25.1 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.33 -0.856 . . . . 0.0 109.56 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' B' ' 4' ' ' ILE . 48.2 Cg_endo -73.99 49.15 1.86 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.825 1.434 . . . . 0.0 111.282 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.472 ' C ' ' O ' ' B' ' 5' ' ' PRO . 10.3 m 32.72 -139.59 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.597 -0.69 . . . . 0.0 111.574 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.578 ' CD1' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -117.4 -74.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 110.265 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.486 ' OG1' ' OE2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -45.06 -41.7 7.9 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.803 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.529 ' O ' ' N ' ' B' ' 12' ' ' LEU . 31.4 m -51.06 -54.72 22.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 109.7 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' B' ' 9' ' ' THR . 40.6 t -47.69 -39.69 7.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.163 -0.961 . . . . 0.0 108.683 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' B' ' 8' ' ' THR . 55.0 mt -67.5 -21.81 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 0.0 109.369 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' B' ' 9' ' ' THR . 0.4 OUTLIER -71.0 -55.48 8.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.495 -0.753 . . . . 0.0 109.904 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.52 HG22 ' CG2' ' A' ' 91' ' ' VAL . 68.1 t -54.57 -40.99 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.807 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.464 ' O ' ' HD2' ' B' ' 14' ' ' LYS . 1.2 tptm -67.24 -40.7 86.35 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.023 -1.048 . . . . 0.0 109.518 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -59.67 -27.76 66.68 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.354 -0.841 . . . . 0.0 109.474 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.482 ' O ' ' N ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -72.54 -38.96 67.86 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.29 -0.881 . . . . 0.0 109.375 179.257 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 114' ' ' GLU . 6.8 mp -67.64 59.6 0.06 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.369 -0.832 . . . . 0.0 109.874 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' B' ' 16' ' ' MET . 0.1 OUTLIER -90.03 -77.88 0.38 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.376 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.478 ' O ' HD22 ' A' ' 116' ' ' LEU . 10.3 tmtt? -162.75 -68.51 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.97 -1.082 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.98 7.95 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 110.167 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.473 ' O ' ' CE ' ' A' ' 124' ' ' MET . 0.3 OUTLIER -103.7 159.79 15.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 109.639 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.421 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 0.1 OUTLIER -131.67 -34.22 1.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.158 -0.964 . . . . 0.0 110.386 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.37 171.09 33.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.474 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 0.1 OUTLIER -158.46 112.93 1.69 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.192 -1.181 . . . . 0.0 110.443 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.27 96.03 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.943 1.496 . . . . 0.0 110.468 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.577 ' CE1' ' HE3' ' A' ' 76' ' ' MET . 1.4 m-85 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.89 -1.053 . . . . 0.0 110.565 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.217 0.532 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -139.09 7.2 2.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.441 ' O ' ' HG3' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -88.87 152.07 21.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.248 -0.908 . . . . 0.0 110.165 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.437 ' C ' HD13 ' A' ' 9' ' ' ILE . 0.9 OUTLIER -113.39 -150.56 0.47 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.923 . . . . 0.0 110.236 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 8' ' ' GLN . 9.7 p -87.08 119.58 27.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 7' ' ' GLU . 1.3 mp0 -52.15 -58.67 5.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -0.851 . . . . 0.0 110.489 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -42.16 -62.46 0.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.225 -0.922 . . . . 0.0 110.423 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.469 ' HB2' ' OG1' ' A' ' 5' ' ' THR . 35.6 mt-30 -54.64 -47.15 73.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.337 -0.852 . . . . 0.0 110.447 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.466 ' CD1' ' O ' ' A' ' 5' ' ' THR . 23.3 mt -63.23 -51.48 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -42.65 -50.18 5.46 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.235 -0.916 . . . . 0.0 109.98 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -58.03 -52.53 65.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.885 . . . . 0.0 109.555 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -56.9 -39.82 75.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.303 -0.873 . . . . 0.0 109.716 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -63.29 -41.74 99.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.288 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' O ' ' OG ' ' A' ' 17' ' ' SER . 4.5 tp10 -58.23 -28.87 65.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 109.276 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.17 -60.87 2.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.528 -0.732 . . . . 0.0 109.769 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.534 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 21.7 t80 -52.61 -33.23 45.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.21 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 14' ' ' GLU . 2.6 p -69.47 -39.3 77.79 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.487 -0.758 . . . . 0.0 109.26 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.588 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 1.4 tt -52.48 -36.86 55.91 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.423 -0.798 . . . . 0.0 108.965 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -84.14 -45.94 12.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.578 -0.701 . . . . 0.0 109.902 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.44 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 13.5 t0 -77.49 88.15 3.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.847 . . . . 0.0 110.013 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -71.92 -13.35 61.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.251 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 21.8 p-10 -111.16 -5.73 14.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.472 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.44 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 52.97 57.51 14.41 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 8.0 p-10 -111.92 -41.46 4.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.183 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.467 ' C ' ' CG2' ' A' ' 26' ' ' THR . . . 123.55 18.96 2.9 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.467 ' CG2' ' C ' ' A' ' 25' ' ' GLY . 7.6 p -149.53 107.59 3.73 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.198 -1.178 . . . . 0.0 110.344 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.537 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 16.0 mt -88.7 118.53 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.128 -0.983 . . . . 0.0 110.091 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.1 p -93.73 153.34 18.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.335 -0.853 . . . . 0.0 109.986 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 p -45.39 -28.04 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.097 -1.002 . . . . 0.0 109.964 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -66.68 -62.08 1.63 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.098 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -45.1 -66.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 109.911 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 tp -51.44 -38.29 52.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.705 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.17 -43.03 97.41 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -58.81 -49.57 77.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -1.063 . . . . 0.0 109.782 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -53.72 -47.82 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 0.0 109.723 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.451 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 9.0 mmt -61.55 -34.7 76.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 109.862 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -20.52 64.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 110.152 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.6 m -83.19 -54.35 5.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 110.379 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 mt -45.03 -31.91 1.49 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.23 -0.919 . . . . 0.0 110.057 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.7 27.02 3.68 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 5.9 mm-40 -109.9 -175.82 2.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -1.164 . . . . 0.0 110.262 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -146.36 75.64 12.43 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.273 -0.892 . . . . 0.0 110.489 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.451 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 44.1 Cg_endo -72.33 149.1 50.35 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.992 1.522 . . . . 0.0 110.08 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.535 ' CG2' ' CG ' ' A' ' 47' ' ' GLU . 7.2 t -90.54 -157.69 0.5 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.131 -0.981 . . . . 0.0 110.456 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -94.1 -44.95 7.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.314 -0.866 . . . . 0.0 110.173 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.78 84.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.178 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' CG ' ' CG2' ' A' ' 44' ' ' THR . 51.6 mm-40 -64.72 -56.51 13.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 110.32 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.2 mt -47.52 -45.23 26.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.144 -0.973 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -63.21 -39.76 95.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.805 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.45 -42.86 74.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.412 ' O ' ' NE1' ' B' ' 7' ' ' TRP . 4.6 mtp -66.12 -34.46 78.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.393 -0.817 . . . . 0.0 109.602 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 52' ' ' ILE . 7.1 mm -71.91 -36.31 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 0.7 OUTLIER -54.48 -52.05 63.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.387 -0.821 . . . . 0.0 109.977 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -43.57 -57.44 3.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.84 . . . . 0.0 109.949 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 57' ' ' ALA . 15.3 t -74.23 -31.11 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -0.925 . . . . 0.0 109.811 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 30.4 t70 -64.66 71.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 110.059 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -66.65 -25.24 66.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.239 -0.913 . . . . 0.0 110.389 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -75.75 -49.86 16.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.076 -1.015 . . . . 0.0 110.29 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.69 25.39 5.99 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 8.7 p30 -99.86 -32.47 10.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.211 -1.17 . . . . 0.0 110.332 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.11 9.76 10.35 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.8 p -131.09 142.07 50.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -1.13 . . . . 0.0 109.814 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.537 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 9.7 mm -88.03 143.03 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.219 -0.925 . . . . 0.0 110.279 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.534 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 1.6 m-20 -118.69 170.88 8.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.319 -0.863 . . . . 0.0 110.142 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.57 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.3 t80 -60.94 -50.6 84.17 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.108 -0.995 . . . . 0.0 111.26 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.0 Cg_endo -66.03 -25.61 51.45 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 O-C-N 123.2 1.105 . . . . 0.0 110.511 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 71' ' ' MET . 34.9 mt-10 -71.6 -34.02 69.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.132 -0.98 . . . . 0.0 109.819 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -74.51 -58.95 2.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 0.0 110.223 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.1 mt -48.98 -42.72 38.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 110.299 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 m -70.66 -30.17 66.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.197 -0.94 . . . . 0.0 110.421 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 4.0 tmm? -65.14 -63.69 1.04 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.744 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.47 ' HE2' ' HE2' ' A' ' 76' ' ' MET . 37.3 mmm -52.31 -19.31 2.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.995 -1.066 . . . . 0.0 110.22 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.36 -20.84 59.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.57 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -91.64 -25.75 19.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.081 -1.012 . . . . 0.0 110.762 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' HG3' ' CG2' ' B' ' 8' ' ' THR . 53.1 mmtt -81.17 -11.52 59.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 110.584 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.622 ' CE ' ' CD2' ' B' ' 26' ' ' PHE . 0.6 OUTLIER -98.69 8.65 44.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.112 -0.992 . . . . 0.0 110.389 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 1.6 ttpt -66.28 -68.24 0.39 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 110.039 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 7.0 t70 -178.44 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.323 -0.861 . . . . 0.0 110.203 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.0 -75.9 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.25 -0.907 . . . . 0.0 110.295 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -85.61 99.94 11.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.284 -0.885 . . . . 0.0 110.321 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -125.77 -33.76 2.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.828 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.62 -11.94 19.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -0.838 . . . . 0.0 110.547 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -79.61 -25.16 41.54 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.108 -0.995 . . . . 0.0 110.402 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -78.02 -27.29 48.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.182 -0.949 . . . . 0.0 110.117 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.569 HG21 ' CE1' ' A' ' 141' ' ' PHE . 92.6 mt -76.9 -39.24 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.96 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.433 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 51.5 ttp180 -62.79 -35.6 80.38 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 110.038 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.522 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 19.6 mm-40 -69.35 -47.46 64.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 0.0 109.666 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.519 ' HB1' ' CD1' ' B' ' 12' ' ' LEU . . . -60.86 -33.59 73.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.113 -0.992 . . . . 0.0 109.897 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.11 -45.83 90.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.579 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 2.4 mtt180 -63.65 -26.94 68.9 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.411 -0.805 . . . . 0.0 109.759 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 41.2 t -63.84 -59.08 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 110.153 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.467 ' CE2' ' SD ' ' B' ' 16' ' ' MET . 22.7 m-85 -56.63 -32.16 65.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.08 -1.013 . . . . 0.0 110.059 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.455 ' OD1' HG12 ' A' ' 100' ' ' ILE . 3.1 m-20 -90.45 61.48 4.98 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.708 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -45.14 -23.38 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.422 -0.799 . . . . 0.0 110.407 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.525 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 35.2 p-10 -96.91 -31.14 12.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 80.09 51.83 4.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 32.6 p-10 -97.94 -14.34 20.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -1.15 . . . . 0.0 110.428 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 99.42 18.56 23.35 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 52.1 m-85 -158.08 157.03 32.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.247 -1.149 . . . . 0.0 110.088 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.455 HG12 ' OD1' ' A' ' 93' ' ' ASP . 21.5 mt -128.42 130.77 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -0.99 . . . . 0.0 110.689 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 30.9 t -116.82 151.56 36.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.837 . . . . 0.0 109.583 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.05 -26.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -72.35 -43.67 63.73 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.286 -0.884 . . . . 0.0 110.143 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 14.8 mt-10 -63.48 -33.03 74.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.006 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.548 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 3.8 mt -70.95 -43.61 67.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.879 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 -62.7 -26.04 68.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 109.559 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -75.0 -39.89 60.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.0 109.942 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.52 HG11 ' N ' ' A' ' 109' ' ' MET . 0.4 OUTLIER -76.86 -33.56 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.377 179.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.53 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 3.2 mtm -54.92 -69.6 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.546 -0.721 . . . . 0.0 110.081 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -47.77 -29.05 2.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.194 -0.941 . . . . 0.0 109.714 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -85.44 -17.3 36.96 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.408 -0.808 . . . . 0.0 109.85 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.59 ' CB ' ' CD2' ' B' ' 17' ' ' LEU . 1.3 mt -94.31 -25.36 17.04 Favored 'General case' 0 C--O 1.199 -1.582 0 O-C-N 121.168 -0.957 . . . . 0.0 110.694 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.0 -50.73 0.66 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.285 -1.436 . . . . 0.0 111.214 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -117.05 158.94 23.32 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.864 -1.374 . . . . 0.0 111.549 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.0 tmtt? -131.43 73.74 1.56 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' B' ' 19' ' ' LYS . 5.6 mp -33.75 153.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.628 0.728 . . . . 0.0 111.682 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.3 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.536 -0.727 . . . . 0.0 110.375 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' GLU . 24.4 m-20 -98.79 -68.52 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.381 -0.825 . . . . 0.0 110.33 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -42.3 -47.85 4.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.432 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 124' ' ' MET . 3.3 mm-40 -60.61 -48.17 82.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 109.89 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.423 ' O ' ' HB3' ' A' ' 124' ' ' MET . 55.0 t -65.52 -38.76 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.072 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.99 -65.3 0.71 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 109.753 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 4.7 mt-10 -46.67 -26.13 0.86 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.391 -0.818 . . . . 0.0 109.52 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.469 ' HG2' ' CE1' ' B' ' 22' ' ' PHE . 18.7 ttt -66.37 -57.04 8.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.969 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.548 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 48.2 mm -61.5 -50.48 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.929 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -54.25 -25.88 25.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.178 -0.951 . . . . 0.0 109.933 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -70.92 -44.7 65.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.396 -0.815 . . . . 0.0 110.077 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -71.37 -32.09 68.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.442 -0.786 . . . . 0.0 110.062 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -57.07 80.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.81 . . . . 0.0 110.384 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.9 mt -76.48 -37.75 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.932 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 14.6 p-10 -78.57 -31.48 47.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.056 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.61 65.75 0.97 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 26.3 p30 -124.44 -14.88 6.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -1.132 . . . . 0.0 110.46 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 90.54 17.72 51.37 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -163.23 169.78 18.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.332 -1.099 . . . . 0.0 110.019 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.465 HG23 ' HB2' ' A' ' 128' ' ' ALA . 41.1 t -112.56 168.35 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.222 -0.924 . . . . 0.0 110.614 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 17.2 p-10 -152.18 -155.1 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -69.63 -69.44 0.34 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.295 -0.878 . . . . 0.0 110.717 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 140' ' ' GLU . 8.5 tt0 -46.19 -63.87 0.89 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.128 -0.982 . . . . 0.0 110.423 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.47 ' CB ' ' OD1' ' A' ' 137' ' ' ASN . 7.1 tt0 -41.46 -57.4 2.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.236 -0.915 . . . . 0.0 110.53 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.569 ' CE1' HG21 ' A' ' 85' ' ' ILE . 12.0 t80 -49.19 -28.88 4.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.237 -0.914 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.471 HG11 HG22 ' A' ' 146' ' ' THR . 18.6 t -99.96 -38.35 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.234 -0.916 . . . . 0.0 110.607 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -33.69 69.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.201 -0.937 . . . . 0.0 110.794 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.432 ' HE3' ' O ' ' A' ' 127' ' ' GLU . 10.0 tpp -88.3 -18.26 28.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.145 -0.972 . . . . 0.0 110.747 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.546 ' CE ' ' HB2' ' B' ' 24' ' ' ASN . 2.0 ttt -92.69 -9.8 39.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.0 110.101 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.471 HG22 HG11 ' A' ' 142' ' ' VAL . 3.6 p -106.82 -70.24 0.8 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 110.939 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.13 -125.22 0.17 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.245 -0.91 . . . . 0.0 110.271 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? . . . . . 0 C--N 1.288 -2.071 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.21 -179.688 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.311 0.576 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.47 ' N ' ' CD ' ' B' ' 2' ' ' LYS . 0.4 OUTLIER -83.89 176.98 8.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.899 . . . . 0.0 110.292 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 mp -107.79 6.45 27.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 110.238 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 9.0 mt -87.41 145.56 37.82 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 109.779 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 40.3 Cg_endo -67.99 124.69 12.11 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.871 1.459 . . . . 0.0 110.325 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.527 ' O ' ' N ' ' B' ' 8' ' ' THR . 68.8 m -75.92 75.03 2.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.332 -0.855 . . . . 0.0 111.226 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.412 ' NE1' ' O ' ' A' ' 51' ' ' MET . 0.4 OUTLIER 53.93 -83.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.206 -0.934 . . . . 0.0 110.941 179.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.538 ' CG2' ' HG3' ' A' ' 75' ' ' LYS . 71.6 p -46.12 -46.81 17.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.38 -0.825 . . . . 0.0 110.017 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.539 ' HA ' ' CD2' ' B' ' 12' ' ' LEU . 52.7 m -52.1 -43.82 64.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.406 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.535 HG21 ' CG ' ' B' ' 5' ' ' PRO . 61.3 t -58.54 -27.38 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.259 -0.9 . . . . 0.0 108.879 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' B' ' 8' ' ' THR . 35.3 mm -78.16 -64.76 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.628 -0.67 . . . . 0.0 110.558 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.581 ' HB3' ' CE2' ' B' ' 26' ' ' PHE . 0.3 OUTLIER -46.7 -45.39 19.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.132 -0.98 . . . . 0.0 110.485 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.539 HG11 ' CD1' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -60.44 -51.86 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.914 -1.116 . . . . 0.0 109.402 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.502 ' N ' ' CG1' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -60.1 -33.04 71.56 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.993 -1.067 . . . . 0.0 109.055 178.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 6.1 t -62.69 -47.07 85.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.421 -0.799 . . . . 0.0 109.286 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.467 ' SD ' ' CE2' ' A' ' 92' ' ' PHE . 10.7 ttm -51.52 -35.88 42.47 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.389 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.59 ' CD2' ' CB ' ' A' ' 112' ' ' LEU . 7.1 mp -70.68 57.51 0.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.464 -0.773 . . . . 0.0 109.906 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.491 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 69.4 ttt-85 -122.46 -54.76 1.86 Allowed 'General case' 0 C--N 1.288 -2.069 0 O-C-N 121.404 -0.81 . . . . 0.0 111.128 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -138.74 -126.76 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.88 -1.138 . . . . 0.0 110.133 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.502 ' N ' ' HG2' ' B' ' 19' ' ' LYS . 5.0 ptp180 -119.87 41.15 3.24 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.026 -1.046 . . . . 0.0 109.918 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 8.4 t -121.52 148.7 44.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.401 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.469 ' CE1' ' HG2' ' A' ' 124' ' ' MET . 0.2 OUTLIER -117.7 -10.87 10.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.89 152.29 31.42 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.546 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -148.63 127.5 6.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.238 . . . . 0.0 110.146 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.65 57.04 2.96 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.896 1.472 . . . . 0.0 110.279 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.622 ' CD2' ' CE ' ' A' ' 76' ' ' MET . 2.9 m-85 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.32 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.193 0.52 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -100.17 65.79 1.27 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.569 ' O ' ' C ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -75.4 57.18 0.9 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.279 -0.888 . . . . 0.0 110.233 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.569 ' C ' ' O ' ' A' ' 3' ' ' GLN . 10.4 mt -1.89 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.026 0 CA-C-O 121.211 0.529 . . . . 0.0 112.351 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 t -108.35 -15.47 14.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.224 -0.923 . . . . 0.0 110.183 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 7' ' ' GLU . 16.6 tt0 -57.8 -29.82 65.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.893 . . . . 0.0 110.084 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -43.5 -48.03 7.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.796 179.897 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -46.02 82.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.365 179.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.7 mt -66.52 -52.48 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.376 -0.827 . . . . 0.0 109.352 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.88 -39.6 74.64 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -57.91 -49.27 77.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.442 -0.786 . . . . 0.0 109.251 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.562 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 17.6 m-85 -61.07 -37.4 82.55 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.291 -0.881 . . . . 0.0 109.189 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 10.7 ttpt -57.23 -42.19 80.96 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.309 -0.869 . . . . 0.0 109.073 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.21 -42.35 99.27 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.469 -0.769 . . . . 0.0 109.165 179.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.15 -47.99 77.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.485 -0.759 . . . . 0.0 109.297 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -54.78 -27.74 43.79 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.401 -0.812 . . . . 0.0 109.156 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 t -84.05 -37.24 22.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.462 -0.774 . . . . 0.0 109.395 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 112' ' ' LEU . 10.4 tt -51.01 -36.65 40.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.418 -0.801 . . . . 0.0 109.244 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -82.72 -39.78 21.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.734 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -74.86 92.33 2.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.454 -0.779 . . . . 0.0 110.058 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -65.3 -31.92 73.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 110.32 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 12.4 p-10 -90.38 -29.66 17.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.355 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.44 70.79 1.22 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 9.1 p-10 -120.21 -24.59 5.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -1.156 . . . . 0.0 110.061 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.81 -8.68 11.67 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 50.9 p -134.83 127.93 31.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -1.128 . . . . 0.0 110.222 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.523 ' CD1' ' HB ' ' A' ' 63' ' ' ILE . 16.4 mt -94.06 133.37 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 p -90.53 -171.35 3.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.899 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 p -83.59 -35.58 24.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.006 . . . . 0.0 109.957 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -68.52 -35.67 77.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -56.88 -55.56 32.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.19 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.524 HD11 ' CH2' ' B' ' 7' ' ' TRP . 24.6 tp -58.92 -39.73 82.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.208 -0.932 . . . . 0.0 110.253 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.25 -43.38 89.3 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.0 m -63.42 -56.5 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -1.176 . . . . 0.0 110.032 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.7 t -55.79 -26.94 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.795 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.452 ' HE2' ' CE ' ' A' ' 51' ' ' MET . 2.4 mmt -69.71 -41.15 75.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.247 -0.908 . . . . 0.0 109.766 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -65.81 -29.41 69.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.996 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -56.39 -55.67 30.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.13 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.488 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -54.87 -39.23 68.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.8 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.77 55.86 0.14 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' HB3' ' CD1' ' B' ' 4' ' ' ILE . 40.3 mt-30 -142.35 153.92 44.23 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.169 -1.195 . . . . 0.0 110.346 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -117.76 80.31 13.9 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.227 -0.921 . . . . 0.0 110.473 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.27 146.38 40.3 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.977 1.514 . . . . 0.0 110.224 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 47' ' ' GLU . 9.6 t -100.04 -153.81 0.45 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.204 -0.935 . . . . 0.0 110.412 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -87.18 -52.28 5.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -0.907 . . . . 0.0 110.406 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.5 76.04 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.236 -0.915 . . . . 0.0 110.305 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.451 ' HB2' HG21 ' A' ' 44' ' ' THR . 37.8 mt-10 -63.67 -55.2 25.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.295 -0.878 . . . . 0.0 110.328 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' GLU . 15.0 mt -43.81 -52.73 6.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.124 -0.985 . . . . 0.0 109.963 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -59.96 -36.19 76.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.79 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.28 -42.04 76.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.879 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.472 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 0.1 OUTLIER -67.91 -36.18 79.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 179.457 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 61' ' ' GLY . 5.4 mm -73.31 -21.48 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.477 -0.764 . . . . 0.0 109.905 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -66.3 -54.68 21.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 110.501 -179.904 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 54' ' ' GLU . 2.6 tp10 -41.09 -35.32 0.54 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.46 -0.775 . . . . 0.0 110.598 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.671 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 10.5 t -96.68 -34.97 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.18 -0.95 . . . . 0.0 110.284 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 40.5 t0 -49.46 88.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.48 -0.762 . . . . 0.0 110.729 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -80.02 -32.36 39.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.224 -0.922 . . . . 0.0 110.38 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -76.13 -47.38 24.6 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.17 -0.956 . . . . 0.0 110.448 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.55 0.13 9.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 18.7 p30 -88.77 -32.49 17.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.113 -1.228 . . . . 0.0 110.357 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 114.44 -28.64 8.1 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 p -70.3 151.47 45.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.154 -1.204 . . . . 0.0 110.359 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.523 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 9.1 mm -102.46 122.9 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' C ' ' HD2' ' A' ' 66' ' ' PRO . 21.4 t0 -99.23 157.69 16.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.559 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.4 t80 -48.81 -45.65 72.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.711 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 50.0 Cg_endo -74.64 -37.34 2.35 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 123.347 1.183 . . . . 0.0 109.815 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 57' ' ' ALA . 4.2 tt0 -51.74 -49.07 63.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.505 -0.747 . . . . 0.0 110.199 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.13 -45.61 69.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.282 -0.886 . . . . 0.0 110.21 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -59.85 -12.59 7.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 0.0 110.607 -179.731 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.8 m -95.43 -43.21 8.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -0.988 . . . . 0.0 110.865 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.457 ' HE3' ' HB3' ' B' ' 7' ' ' TRP . 11.1 tmm? -62.87 -39.81 95.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.089 -1.007 . . . . 0.0 110.993 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.562 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 9.3 tpt -61.49 -9.74 6.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.131 -0.981 . . . . 0.0 111.127 -179.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.81 -18.43 15.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.984 -1.072 . . . . 0.0 111.089 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -23.7 14.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.986 -1.071 . . . . 0.0 110.896 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.406 ' HG2' HG23 ' B' ' 8' ' ' THR . 15.8 tttt -97.98 41.12 1.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.043 -1.036 . . . . 0.0 110.638 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.1 mmt -100.27 -91.76 0.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.332 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 77' ' ' LYS . 15.4 tttt -101.72 37.52 1.81 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.137 -0.977 . . . . 0.0 110.271 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.424 ' O ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -105.53 -28.12 10.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 110.243 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 78' ' ' ASP . 4.2 m -164.21 -35.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.263 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -111.39 61.61 0.61 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.931 . . . . 0.0 110.287 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.1 t -94.31 -63.25 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.281 -0.887 . . . . 0.0 110.088 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.81 -22.46 24.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.052 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.88 -46.83 61.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 109.793 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -58.48 -20.71 47.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 110.152 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.2 mt -69.79 -45.23 77.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.136 -0.978 . . . . 0.0 109.015 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 89' ' ' PHE . 58.3 ttt180 -56.89 -31.94 65.38 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HB3' HG22 ' B' ' 9' ' ' THR . 72.4 mm-40 -70.46 -56.42 6.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.39 -0.819 . . . . 0.0 109.306 179.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.58 -22.41 13.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.196 -0.94 . . . . 0.0 108.982 179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.58 ' CE1' ' HA ' ' A' ' 138' ' ' TYR . 84.1 t80 -71.41 -63.73 1.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.375 -0.828 . . . . 0.0 109.482 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -49.25 -38.34 26.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.383 -0.823 . . . . 0.0 109.076 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.459 HG13 HG23 ' A' ' 108' ' ' VAL . 18.6 t -63.78 -35.06 71.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.559 -0.713 . . . . 0.0 109.592 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.588 ' CE2' HD22 ' A' ' 105' ' ' LEU . 2.4 m-85 -72.74 -36.83 67.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.291 -0.881 . . . . 0.0 109.307 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 96' ' ' GLY . 3.6 t70 -99.91 62.19 1.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.757 . . . . 0.0 109.964 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' ASP . 7.7 tmtm? -42.64 -54.52 3.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 109.874 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.464 ' OD2' ' HG3' ' A' ' 104' ' ' GLU . 1.1 p30 -58.53 -27.32 64.41 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.533 -0.729 . . . . 0.0 109.913 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 60.86 59.24 10.5 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 34.3 p-10 -98.02 -41.95 7.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.201 -1.176 . . . . 0.0 110.556 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 162.96 -43.58 0.34 Allowed Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.295 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 15.0 m-85 -123.2 166.55 15.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.269 . . . . 0.0 110.904 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 9.6 mt -102.69 84.33 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.34 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.473 ' N ' ' OE1' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -73.96 161.45 30.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.077 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.28 -19.4 3.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.922 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.84 -33.34 46.08 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.29 -0.881 . . . . 0.0 109.205 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 101' ' ' SER . 0.7 OUTLIER -67.51 -42.47 82.74 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.54 -0.725 . . . . 0.0 109.254 179.178 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.588 HD22 ' CE2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -63.08 -42.23 99.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.331 -0.855 . . . . 0.0 109.163 178.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -62.47 -26.82 68.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.593 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.462 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -69.95 -48.68 57.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.441 -0.787 . . . . 0.0 109.968 179.718 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.459 HG23 HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -74.13 -30.88 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.286 -0.884 . . . . 0.0 109.455 179.47 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.557 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 2.4 ttm -52.04 -70.34 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.652 -0.655 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.7 m -51.77 -26.76 10.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.14 -0.975 . . . . 0.0 110.337 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 8.7 m120 -72.33 -18.39 61.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.333 -0.855 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.492 ' CD1' HD21 ' B' ' 17' ' ' LEU . 10.2 mt -98.87 -48.84 4.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 110.423 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.42 -58.0 0.21 Allowed Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.768 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.439 ' HG2' HD13 ' A' ' 116' ' ' LEU . 8.8 tt0 -90.89 162.21 14.89 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.964 -1.315 . . . . 0.0 111.299 -178.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.99 72.92 1.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.58 -0.7 . . . . 0.0 109.52 179.39 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.517 ' HB3' ' CG2' ' A' ' 121' ' ' VAL . 4.6 mp -33.8 150.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.614 0.721 . . . . 0.0 111.525 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 116' ' ' LEU . 1.1 m -59.18 -147.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 109.82 179.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.13 -49.65 2.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.65 -51.76 66.13 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.073 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 121' ' ' VAL . 10.1 pt-20 -61.01 -44.67 97.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.55 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 73.4 t -60.36 -39.38 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.349 -0.844 . . . . 0.0 109.673 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.67 -53.54 56.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 109.725 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -57.09 -25.62 59.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.527 ' HG3' ' HA ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -64.05 -49.21 73.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.353 -0.842 . . . . 0.0 109.47 179.259 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.508 HD12 ' CD1' ' A' ' 105' ' ' LEU . 28.8 mm -73.27 -35.83 47.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.711 -0.618 . . . . 0.0 110.247 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.415 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 3.4 tmm_? -68.94 -22.74 64.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.204 -0.935 . . . . 0.0 110.063 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.57 -34.31 67.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 110.242 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -93.34 -26.4 17.3 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.356 -0.84 . . . . 0.0 110.233 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.415 ' OD2' ' HA ' ' A' ' 126' ' ' ARG . 85.9 m-20 -45.5 90.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.323 -0.861 . . . . 0.0 110.661 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -82.96 -40.82 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.158 -0.964 . . . . 0.0 109.521 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 35.2 p-10 -76.54 -24.47 53.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.929 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.477 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.99 35.05 19.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 15.9 p-10 -89.38 -15.97 32.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -1.113 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 135' ' ' GLN . . . 97.78 9.63 54.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 68.6 mt-30 -157.08 153.4 27.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.217 -1.167 . . . . 0.0 110.275 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.469 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 25.1 t -90.83 113.33 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.262 -0.899 . . . . 0.0 110.023 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -87.93 176.07 7.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.935 . . . . 0.0 110.557 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.594 ' CE1' HG22 ' A' ' 142' ' ' VAL . 5.2 t80 -57.08 -63.63 1.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.245 -0.91 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.6 OUTLIER -41.79 -49.34 4.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 0.0 109.989 179.891 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.442 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.0 mt-10 -57.08 -57.87 10.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 0.0 109.932 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.449 ' O ' ' SD ' ' A' ' 145' ' ' MET . 10.0 t80 -47.5 -24.47 0.85 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.275 -0.891 . . . . 0.0 109.962 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.594 HG22 ' CE1' ' A' ' 138' ' ' TYR . 42.5 t -99.66 -39.4 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 110.409 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -65.89 -9.89 33.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.925 . . . . 0.0 110.797 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.442 ' SD ' ' CA ' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -98.17 -26.13 14.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.029 -1.045 . . . . 0.0 110.704 -179.746 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.449 ' SD ' ' O ' ' A' ' 141' ' ' PHE . 6.5 mtp -100.48 -34.67 9.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 110.762 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 142' ' ' VAL . 69.0 p -71.69 -29.08 64.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 0.0 110.35 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -82.25 53.78 2.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.187 -0.945 . . . . 0.0 110.482 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.239 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.52 ' O ' ' CG2' ' B' ' 1' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.116 0.484 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.534 ' O ' ' CD2' ' B' ' 3' ' ' LEU . 8.1 tptp -156.39 -130.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.963 -1.086 . . . . 0.0 111.035 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.613 ' O ' ' HB ' ' B' ' 4' ' ' ILE . 0.0 OUTLIER -174.43 94.43 0.08 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.623 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.613 ' HB ' ' O ' ' B' ' 3' ' ' LEU . 15.9 mm 65.36 133.41 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.24 -160.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.083 1.57 . . . . 0.0 111.243 -178.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.48 ' OG ' ' OG1' ' B' ' 9' ' ' THR . 10.5 p -123.03 -179.17 4.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.402 -0.811 . . . . 0.0 110.911 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.671 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 22.5 m95 -59.1 -71.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.561 0.696 . . . . 0.0 111.075 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.432 ' C ' ' O ' ' B' ' 7' ' ' TRP . 65.8 p -39.88 -28.17 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.737 -0.602 . . . . 0.0 110.493 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.48 ' OG1' ' OG ' ' B' ' 6' ' ' SER . 1.1 m -61.66 -50.11 73.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.678 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 t -63.89 -33.69 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.529 -0.732 . . . . 0.0 110.09 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.463 ' O ' ' OG ' ' B' ' 15' ' ' SER . 3.8 mm -74.18 -31.89 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.261 -0.899 . . . . 0.0 109.979 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.482 ' O ' ' OG ' ' B' ' 15' ' ' SER . 0.4 OUTLIER -62.55 -52.45 63.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.852 . . . . 0.0 110.093 179.741 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.456 ' O ' HD11 ' B' ' 17' ' ' LEU . 78.2 t -67.81 -43.78 85.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.669 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.47 ' HA ' HD11 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -59.52 -49.74 76.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.737 -1.227 . . . . 0.0 109.692 179.453 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' B' ' 12' ' ' LEU . 3.5 p -50.67 -42.27 56.46 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 26.2 tpp -73.12 -13.93 61.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.69 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.557 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 2.9 mp -89.94 62.44 5.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 110.142 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 ttp85 -118.31 -74.4 0.61 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.364 -0.835 . . . . 0.0 111.022 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.513 ' HD2' ' HB2' ' B' ' 20' ' ' ARG . 2.3 tmtm? -138.04 -75.45 0.39 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.081 -1.012 . . . . 0.0 110.952 -178.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.527 ' HA ' ' HG3' ' A' ' 124' ' ' MET . 1.0 OUTLIER -140.09 -4.21 1.36 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.714 -1.241 . . . . 0.0 111.31 -179.655 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -53.12 141.14 23.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.026 -1.046 . . . . 0.0 110.684 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.449 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -170.88 137.54 1.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.402 -0.811 . . . . 0.0 110.189 179.581 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.442 ' CA ' ' SD ' ' A' ' 144' ' ' MET . . . 126.11 -87.2 0.35 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.537 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 3.0 p30 -131.41 50.43 5.96 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.237 -1.155 . . . . 0.0 110.338 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 45.3 Cg_endo -73.48 -6.14 18.27 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.055 1.555 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.282 0.563 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.74 160.69 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 110.127 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -99.4 133.42 43.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 110.134 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mp -79.19 151.22 31.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.429 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.79 56.45 1.82 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.48 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.439 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -100.42 -26.17 13.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 110.086 179.802 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -54.02 -57.65 10.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 110.332 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -54.58 -53.07 59.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -0.951 . . . . 0.0 110.303 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 9' ' ' ILE . 53.7 mt -57.44 -59.21 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 6' ' ' GLU . . . -42.56 -46.18 4.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 110.051 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.82 -54.76 33.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.015 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CG ' HD22 ' A' ' 69' ' ' LEU . 21.4 m-85 -61.13 -42.91 99.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.97 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -58.58 -34.05 70.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.185 -0.947 . . . . 0.0 109.344 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -61.78 -44.67 96.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.381 -0.825 . . . . 0.0 109.49 179.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -66.43 -52.1 49.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.462 -0.774 . . . . 0.0 110.08 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.6 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 35.7 t80 -63.73 -12.23 33.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.811 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.3 m -92.76 -25.99 17.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.882 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 112' ' ' LEU . 7.1 tt -77.67 -30.39 51.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.603 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 47.5 m-85 -80.01 -56.71 4.05 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.335 -0.853 . . . . 0.0 110.686 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -62.84 82.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.165 -0.96 . . . . 0.0 110.213 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -88.86 21.25 3.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.235 -179.973 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 23' ' ' GLY . 7.4 p-10 -140.1 18.68 2.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.459 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.9 75.76 0.15 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 1.8 t0 -132.66 -26.7 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -1.134 . . . . 0.0 110.685 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.68 -21.4 29.88 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -119.27 118.8 32.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -1.101 . . . . 0.0 109.874 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.461 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 12.3 mt -79.34 126.17 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.121 -0.987 . . . . 0.0 109.606 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.8 p -90.16 -157.68 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.795 . . . . 0.0 110.386 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.412 HG23 HG13 ' A' ' 52' ' ' ILE . 77.8 p -94.16 -33.43 13.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 13.0 ptpt -74.68 -31.07 61.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.121 -0.987 . . . . 0.0 110.288 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.527 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 14.9 mt-10 -58.17 -66.35 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.118 -0.988 . . . . 0.0 109.47 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.603 ' CD1' ' CE1' ' A' ' 19' ' ' PHE . 58.1 tp -56.75 -35.45 68.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.168 -0.958 . . . . 0.0 109.25 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.81 -37.14 93.83 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.6 m -59.44 -47.13 86.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.348 -1.089 . . . . 0.0 109.441 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.7 t -70.93 -37.35 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.592 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.534 ' CE ' ' CE ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -69.19 -44.74 71.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.385 -0.822 . . . . 0.0 109.775 179.549 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -62.57 -29.77 70.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.973 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.43 ' O ' ' CG ' ' A' ' 111' ' ' ASN . 3.3 t -79.1 -21.67 46.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 110.014 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 36' ' ' MET . 4.3 mt -68.13 -32.01 71.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.36 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.07 -60.63 0.44 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -172.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -1.199 . . . . 0.0 110.714 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -137.1 98.88 10.16 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.431 -0.793 . . . . 0.0 109.826 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 44.3 Cg_endo -71.61 124.04 9.95 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.965 1.508 . . . . 0.0 110.464 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -93.08 167.22 11.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.3 -37.08 71.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 0.0 110.108 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.07 64.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.238 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' OE1' HD11 ' B' ' 4' ' ' ILE . 20.9 mt-10 -66.78 -38.55 86.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.087 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 12.2 mt -62.08 -39.72 93.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.087 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -43.89 86.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.334 -0.854 . . . . 0.0 109.696 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.18 -38.03 89.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.35 -0.844 . . . . 0.0 109.652 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.583 ' HE2' ' CG ' ' B' ' 7' ' ' TRP . 7.4 mmm -67.26 -42.31 84.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.668 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.454 ' O ' HG21 ' A' ' 52' ' ' ILE . 4.4 mm -70.16 -19.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.35 -0.844 . . . . 0.0 109.625 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.11 -16.21 41.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.269 -0.894 . . . . 0.0 110.02 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -71.31 -31.01 66.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.42 -0.8 . . . . 0.0 110.241 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 57' ' ' ALA . 20.4 t -92.02 -37.09 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.163 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.412 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 1.4 t70 -46.68 87.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.641 . . . . 0.0 110.555 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -99.05 -26.78 14.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 0.0 110.203 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 3.1 p-10 -73.96 -43.27 58.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -0.962 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 58' ' ' ASP . . . 114.17 27.4 3.43 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 21.8 p-10 -99.53 -40.16 7.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.098 -1.236 . . . . 0.0 110.102 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 123.43 -46.76 1.07 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.2 p -95.31 166.5 11.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -1.217 . . . . 0.0 110.479 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 26' ' ' THR . 16.4 mm -88.69 142.24 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.3 -0.875 . . . . 0.0 109.894 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.478 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.2 m-20 -121.2 147.34 45.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.982 -1.073 . . . . 0.0 110.863 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.6 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 89.7 t80 -41.61 -50.78 9.44 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.453 -0.78 . . . . 0.0 111.546 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.0 Cg_endo -66.35 -43.36 8.38 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 123.252 1.133 . . . . 0.0 110.773 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.444 ' O ' ' OG1' ' A' ' 70' ' ' THR . 43.4 tt0 -60.93 -36.82 80.32 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.208 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 13.0 t80 -62.56 -45.83 91.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.997 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.59 HD22 ' CG ' ' A' ' 12' ' ' PHE . 2.7 mt -61.94 -29.91 70.55 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.319 -0.863 . . . . 0.0 110.726 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 1.7 p -79.4 -33.41 42.75 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.154 -0.966 . . . . 0.0 111.347 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.466 ' HG3' HG12 ' A' ' 55' ' ' VAL . 9.1 tmm? -69.05 -43.27 75.0 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.962 -1.087 . . . . 0.0 110.975 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.444 ' O ' ' HG3' ' A' ' 76' ' ' MET . 10.7 tpt -58.66 -10.85 2.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.189 -0.944 . . . . 0.0 111.12 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.95 -9.81 16.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.865 -1.147 . . . . 0.0 111.236 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 4.1 ttt180 -94.4 -43.49 8.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.961 -1.087 . . . . 0.0 110.686 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -64.82 -8.84 16.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.317 -0.864 . . . . 0.0 110.486 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.461 ' O ' ' HB3' ' A' ' 77' ' ' LYS . 1.3 mmt -99.27 41.56 1.14 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.98 . . . . 0.0 110.113 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.489 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -178.01 30.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -127.22 -62.82 1.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.935 . . . . 0.0 110.344 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.14 -41.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.127 -0.983 . . . . 0.0 110.638 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.76 76.31 6.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.178 -0.951 . . . . 0.0 110.177 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.7 t -110.91 -48.93 3.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.979 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -99.98 -25.29 14.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 110.187 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -72.08 -17.94 61.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -0.972 . . . . 0.0 109.509 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -70.11 -23.23 63.0 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.455 -0.778 . . . . 0.0 109.871 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.482 HG21 ' CE2' ' A' ' 141' ' ' PHE . 29.6 mt -64.88 -28.99 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.2 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -32.32 73.71 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.616 -0.677 . . . . 0.0 109.807 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 13.9 mt-10 -74.16 -47.61 34.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.863 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.52 67.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.005 -1.059 . . . . 0.0 109.405 179.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CE1' ' OD2' ' A' ' 93' ' ' ASP . 11.8 t80 -71.44 -46.43 60.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -52.91 -32.35 44.95 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.436 -0.79 . . . . 0.0 109.321 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.7 t -71.27 -43.09 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.543 -0.723 . . . . 0.0 109.85 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.482 ' CE1' HG12 ' B' ' 13' ' ' VAL . 19.6 m-85 -66.58 -28.26 68.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.237 -0.914 . . . . 0.0 109.797 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.551 ' OD2' ' CE1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -88.03 62.29 6.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.388 -0.82 . . . . 0.0 109.788 179.788 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -36.29 -32.74 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.703 -0.623 . . . . 0.0 110.968 -179.553 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 12.5 p30 -111.23 -39.15 4.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.171 -0.956 . . . . 0.0 110.389 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 92.09 55.22 1.75 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 99' ' ' TYR . 52.1 p30 -97.29 0.24 47.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.178 -1.189 . . . . 0.0 110.175 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 93.68 12.56 56.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.452 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -154.14 142.31 20.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.359 -1.083 . . . . 0.0 110.03 -179.944 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 92' ' ' PHE . 5.7 mt -101.51 116.8 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.238 -0.914 . . . . 0.0 110.119 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 t -98.97 142.03 30.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.288 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.02 -35.73 3.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.832 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -58.82 -49.77 76.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 109.538 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.61 -50.02 66.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.704 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 125' ' ' ILE . 0.7 OUTLIER -59.32 -41.08 88.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.835 . . . . 0.0 109.397 179.468 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 13.2 ttt180 -56.08 -27.7 54.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.311 -0.868 . . . . 0.0 109.403 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.13 -42.5 37.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.619 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 0.7 OUTLIER -70.06 -26.89 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.292 179.588 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.544 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 0.5 OUTLIER -64.33 -64.8 0.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.361 -0.837 . . . . 0.0 110.155 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.422 HG21 ' N ' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -55.18 -33.44 63.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.903 -179.981 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 38' ' ' SER . 77.5 m-20 -75.31 -18.52 60.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 110.174 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.504 ' CD1' HG11 ' B' ' 13' ' ' VAL . 4.3 mt -92.41 -41.36 10.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 110.268 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.32 -36.75 0.81 Allowed Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.251 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 3.4 tp10 -116.09 158.24 23.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.915 -1.344 . . . . 0.0 110.981 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.525 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -139.24 83.09 1.93 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.149 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.498 HD12 ' O ' ' B' ' 17' ' ' LEU . 6.3 mp -38.34 140.76 0.28 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.591 -0.693 . . . . 0.0 111.074 -179.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -54.35 -168.52 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.541 -0.724 . . . . 0.0 109.497 179.327 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -74.95 -68.71 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.057 -1.027 . . . . 0.0 110.211 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.46 -45.16 12.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.308 -0.87 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.14 -44.28 92.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 110.049 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.461 HG23 ' HE2' ' A' ' 109' ' ' MET . 20.1 t -61.05 -40.44 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.99 -29.21 69.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.249 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -74.63 -30.61 61.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -51.26 30.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.136 -0.977 . . . . 0.0 110.248 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.515 ' CD1' HD11 ' A' ' 105' ' ' LEU . 49.8 mm -64.56 -41.26 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.25 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -27.11 67.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 110.221 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.5 OUTLIER -69.29 -21.04 63.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.88 -35.76 8.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.931 . . . . 0.0 110.271 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.423 ' CG ' ' HA2' ' A' ' 132' ' ' GLY . 5.1 t0 -43.11 105.6 0.05 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.317 -0.864 . . . . 0.0 110.411 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.462 HD12 ' HE3' ' A' ' 144' ' ' MET . 23.4 mm -74.99 -33.97 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.251 -0.906 . . . . 0.0 109.928 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 7.1 p-10 -103.72 -21.98 13.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 0.0 109.989 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.423 ' HA2' ' CG ' ' A' ' 129' ' ' ASP . . . 81.09 70.41 1.34 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 19.3 p-10 -120.68 -10.96 9.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.186 -1.185 . . . . 0.0 110.406 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.77 12.13 30.99 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.467 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -164.59 147.35 8.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.188 -1.183 . . . . 0.0 110.168 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 11.7 t -99.98 143.15 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 110.338 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 4.1 t30 -105.32 -168.23 1.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 109.89 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.407 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 41.1 t80 -76.06 -48.46 20.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.27 -41.29 65.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.9 -52.23 38.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.274 -0.891 . . . . 0.0 110.33 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.482 ' CE2' HG21 ' A' ' 85' ' ' ILE . 53.5 t80 -57.0 -17.32 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.326 -0.859 . . . . 0.0 110.631 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 145' ' ' MET . 37.3 t -100.26 -70.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.07 -1.019 . . . . 0.0 111.006 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -39.82 -37.14 0.51 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.257 -0.902 . . . . 0.0 110.7 -179.487 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.462 ' HE3' HD12 ' A' ' 130' ' ' ILE . 7.6 mmm -62.75 -29.09 70.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.154 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -100.4 -30.86 11.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.333 -0.854 . . . . 0.0 110.653 -179.898 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 142' ' ' VAL . 9.6 t -102.45 57.66 0.79 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.096 -1.003 . . . . 0.0 110.525 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -97.39 57.4 1.41 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.048 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.243 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 84.9 t . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 120.903 0.382 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.97 -22.84 1.18 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.947 -1.095 . . . . 0.0 111.621 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' B' ' 4' ' ' ILE . 10.9 tp -153.91 -72.44 0.13 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.561 -1.337 . . . . 0.0 111.411 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 7.8 mt -39.13 147.61 0.29 Allowed Pre-proline 0 N--CA 1.506 2.358 0 O-C-N 121.101 -0.999 . . . . 0.0 110.096 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 38.9 Cg_endo -65.31 -176.35 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.844 1.444 . . . . 0.0 110.662 -179.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.472 ' O ' ' N ' ' B' ' 8' ' ' THR . 28.9 t -126.96 64.06 1.3 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.14 -0.975 . . . . 0.0 111.384 -178.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.583 ' CG ' ' HE2' ' A' ' 51' ' ' MET . 0.8 OUTLIER 58.09 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.207 -0.933 . . . . 0.0 111.188 178.688 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.472 ' N ' ' O ' ' B' ' 6' ' ' SER . 12.0 p -43.6 -42.79 5.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.992 . . . . 0.0 110.25 -179.335 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.543 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 3.8 m -52.41 -44.39 65.36 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.177 -0.952 . . . . 0.0 109.209 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.71 -37.43 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.337 -0.852 . . . . 0.0 109.381 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.433 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 4.2 mm -71.38 -25.0 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -0.797 . . . . 0.0 109.499 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' B' ' 9' ' ' THR . 2.0 mp -67.38 -60.31 2.69 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.336 -0.853 . . . . 0.0 109.645 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.504 HG11 ' CD1' ' A' ' 112' ' ' LEU . 72.7 t -57.77 -37.79 61.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.348 -0.845 . . . . 0.0 109.99 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.472 ' HD2' ' HA ' ' A' ' 15' ' ' ALA . 2.4 ttpt -59.41 -45.1 92.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.028 -1.045 . . . . 0.0 109.467 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' B' ' 18' ' ' ARG . 1.6 m -62.79 -26.28 68.64 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.339 -0.85 . . . . 0.0 109.537 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.448 ' HA ' ' HB2' ' B' ' 21' ' ' SER . 0.0 OUTLIER -70.54 -32.37 69.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.891 . . . . 0.0 109.748 179.663 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 5.9 mp -73.65 -5.56 41.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.297 -0.877 . . . . 0.0 110.489 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.9 OUTLIER -44.21 -56.45 4.1 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.152 -0.968 . . . . 0.0 109.468 179.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.513 ' CD ' ' HB3' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -171.72 -68.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.605 0.717 . . . . 0.0 109.271 179.699 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.513 ' HB3' ' CD ' ' B' ' 19' ' ' LYS . 0.8 OUTLIER -129.51 14.67 6.03 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.073 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' B' ' 22' ' ' PHE . 20.0 m -48.3 145.29 3.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.637 -0.664 . . . . 0.0 110.761 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.454 ' CG ' ' O ' ' B' ' 21' ' ' SER . 0.1 OUTLIER 171.67 -34.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.495 -0.753 . . . . 0.0 109.912 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.29 -128.82 0.03 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.643 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 43.9 t30 -131.76 34.42 0.26 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.988 -1.301 . . . . 0.0 111.723 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 51.3 Cg_endo -76.33 56.65 5.09 Favored 'Trans proline' 0 N--CA 1.481 0.788 0 O-C-N 123.185 1.097 . . . . 0.0 110.472 179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.256 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.216 0.531 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.444 ' OD1' HG23 ' A' ' 5' ' ' THR . 11.9 p30 -164.63 144.61 7.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.307 -0.87 . . . . 0.0 110.19 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 4' ' ' LEU . 6.6 mt-30 -87.86 171.15 10.58 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.264 -0.897 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 3' ' ' GLN . 25.1 mt 42.08 71.91 0.19 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 0.0 110.193 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.459 ' O ' ' CG2' ' A' ' 5' ' ' THR . 7.7 t -150.41 95.06 2.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.2 -0.938 . . . . 0.0 110.536 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.23 -23.85 18.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.131 -0.98 . . . . 0.0 110.026 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.76 -39.81 92.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.302 -0.874 . . . . 0.0 110.306 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 8.2 mm100 -71.19 -59.49 2.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.061 -1.025 . . . . 0.0 109.814 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.432 HG22 HD11 ' A' ' 9' ' ' ILE . 37.2 mt -48.1 -43.88 11.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 109.432 179.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.01 -47.38 71.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.384 -0.822 . . . . 0.0 109.491 179.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 1.4 mt-10 -49.49 -54.19 19.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.507 179.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -59.46 -38.92 82.03 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.144 -0.973 . . . . 0.0 109.389 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -53.54 -43.62 68.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.285 -0.884 . . . . 0.0 109.173 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -56.87 -48.32 78.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 108.888 178.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.21 -54.16 50.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.412 -0.805 . . . . 0.0 109.292 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 65' ' ' PHE . 55.7 t80 -50.71 -35.64 32.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.813 . . . . 0.0 109.126 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.15 -29.39 48.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.598 -0.689 . . . . 0.0 109.396 179.258 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 112' ' ' LEU . 3.6 tt -53.04 -50.75 63.65 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.391 -0.818 . . . . 0.0 109.365 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 45.0 m-85 -69.72 -28.03 65.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.393 179.206 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.477 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 16.0 t0 -87.23 66.15 9.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.74 . . . . 0.0 110.14 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -45.25 -32.03 1.77 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.146 -0.971 . . . . 0.0 110.324 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 11.8 p-10 -89.72 -7.19 55.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.348 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 47.98 71.26 0.59 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 35.9 p-10 -116.9 -34.28 4.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -1.147 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 128.76 -0.51 6.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 21.2 p -142.4 128.28 19.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -1.159 . . . . 0.0 110.615 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.545 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 10.7 mt -91.96 129.65 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.214 -0.929 . . . . 0.0 110.054 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 p -99.64 -163.81 1.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 110.136 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.447 ' O ' HD12 ' A' ' 48' ' ' LEU . 4.5 p -91.2 -38.03 12.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.111 -0.993 . . . . 0.0 110.049 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -66.85 -33.39 75.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.994 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' A' ' 20' ' ' ASP . 2.1 mt-10 -67.05 -64.25 0.89 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.88 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.511 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 21.5 tp -52.85 -36.85 59.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 109.843 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.7 92.33 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.1 m -63.88 -52.86 58.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -1.094 . . . . 0.0 109.822 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 19' ' ' PHE . 26.3 t -52.75 -43.66 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.732 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.475 ' HE3' ' SD ' ' A' ' 51' ' ' MET . 32.2 mtt -64.18 -38.51 91.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.638 179.676 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.24 -16.37 63.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.848 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -79.0 -63.0 1.52 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.314 -0.866 . . . . 0.0 110.603 -179.879 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.456 ' O ' ' HE2' ' A' ' 94' ' ' LYS . 1.4 mt -43.48 -41.68 4.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.094 -1.004 . . . . 0.0 109.924 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 134.12 61.91 0.07 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.481 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.492 ' NE2' ' HA ' ' B' ' 4' ' ' ILE . 7.7 mt-30 -157.34 -176.36 5.91 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.125 -1.221 . . . . 0.0 109.974 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -144.17 97.44 5.24 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.109 -0.995 . . . . 0.0 110.612 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.536 ' HA ' ' CD1' ' B' ' 4' ' ' ILE . 49.2 Cg_endo -76.39 137.23 18.51 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.015 1.534 . . . . 0.0 110.539 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 47' ' ' GLU . 24.1 m -87.75 142.91 27.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 109.87 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -42.21 -64.2 0.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 110.27 179.994 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.71 -52.15 42.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 110.092 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 2.8 mm-40 -50.21 -53.05 30.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.308 -0.87 . . . . 0.0 109.985 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -44.94 -51.64 9.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 110.13 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.461 ' HA ' ' OE1' ' A' ' 49' ' ' GLN . 40.1 tp60 -57.4 -32.71 67.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -0.822 . . . . 0.0 109.999 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -68.0 -38.67 82.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 109.906 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.568 ' HE1' ' CD1' ' B' ' 7' ' ' TRP . 2.0 ttp -81.55 -27.5 34.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.398 -0.814 . . . . 0.0 110.246 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.458 HD12 HD21 ' A' ' 32' ' ' LEU . 10.7 mm -78.29 -29.9 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.302 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -77.55 0.96 20.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.18 -0.95 . . . . 0.0 110.017 179.807 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.56 -44.68 11.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.294 -0.878 . . . . 0.0 109.669 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.585 HG22 ' CE2' ' B' ' 7' ' ' TRP . 41.0 t -79.72 -20.26 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 109.928 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -51.4 87.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.347 -0.846 . . . . 0.0 110.152 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -87.01 -47.22 9.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.259 -0.901 . . . . 0.0 111.062 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.2 p-10 -57.46 -45.94 84.2 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.023 -1.048 . . . . 0.0 110.828 -179.373 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 120.16 18.24 4.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 32.8 p-10 -96.24 -46.01 6.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -1.23 . . . . 0.0 110.239 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 134.6 -43.8 1.23 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.54 168.48 16.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.258 -1.142 . . . . 0.0 110.51 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.545 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 11.4 mm -92.76 143.76 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 110.109 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -117.95 163.69 16.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.088 -1.008 . . . . 0.0 110.379 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.556 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 44.9 t80 -59.24 -50.7 86.21 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.269 -0.894 . . . . 0.0 110.483 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -69.02 -29.2 27.81 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 O-C-N 123.393 1.207 . . . . 0.0 109.517 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' HB1' ' A' ' 57' ' ' ALA . 5.9 tt0 -67.75 -31.21 70.97 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.475 -0.766 . . . . 0.0 109.06 178.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -70.06 -53.75 16.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.538 -0.726 . . . . 0.0 109.889 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.01 -35.52 62.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.387 -0.82 . . . . 0.0 110.333 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 71' ' ' MET . 1.3 m -78.04 -53.7 7.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.23 -0.919 . . . . 0.0 110.712 -179.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.523 ' HG3' ' CG1' ' A' ' 55' ' ' VAL . 5.7 tmm? -41.24 -42.69 2.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.226 -0.921 . . . . 0.0 110.553 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.562 ' HE3' ' CE2' ' B' ' 26' ' ' PHE . 0.1 OUTLIER -51.24 -17.83 0.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -0.868 . . . . 0.0 110.681 -179.741 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.48 -35.86 10.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.016 -1.052 . . . . 0.0 110.925 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -31.65 54.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.066 -1.022 . . . . 0.0 110.742 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HB3' HG23 ' B' ' 8' ' ' THR . 0.1 OUTLIER -64.23 -51.03 65.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 -179.789 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.438 ' HE3' ' CE ' ' A' ' 72' ' ' MET . 6.9 mtt -82.62 51.57 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.375 -0.828 . . . . 0.0 110.75 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -113.11 20.93 15.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.172 -0.955 . . . . 0.0 109.983 179.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' C ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -138.82 77.34 1.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.067 179.918 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.425 ' OG1' ' C ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 42.85 35.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.251 -0.905 . . . . 0.0 110.25 -179.922 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.75 76.98 3.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.251 -0.906 . . . . 0.0 110.24 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -115.04 -52.24 2.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' HA ' HD13 ' A' ' 85' ' ' ILE . 19.7 mt-10 -100.06 -10.43 21.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.169 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 87' ' ' GLU . 7.3 tt0 -74.52 -44.52 50.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.096 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.64 -23.56 66.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.488 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.471 HG22 ' CE2' ' A' ' 141' ' ' PHE . 67.2 mt -78.43 -45.48 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.927 . . . . 0.0 109.816 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -53.89 -36.66 62.91 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 109.705 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 0.3 OUTLIER -69.83 -52.22 26.84 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.213 -0.929 . . . . 0.0 109.542 179.494 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.69 -35.3 65.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.093 -1.005 . . . . 0.0 109.036 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.581 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 63.3 t80 -67.28 -47.59 70.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.508 -0.745 . . . . 0.0 109.668 179.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -46.42 71.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.404 -0.81 . . . . 0.0 109.328 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 t -51.09 -48.94 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.415 -0.803 . . . . 0.0 109.418 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.43 ' HB3' HD11 ' A' ' 100' ' ' ILE . 30.6 m-85 -57.05 -38.3 73.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.131 -0.981 . . . . 0.0 110.124 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.409 ' OD1' HG12 ' A' ' 100' ' ' ILE . 68.2 m-20 -89.54 59.75 4.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.552 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 0.8 OUTLIER -52.18 -34.37 44.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.952 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 9.9 p-10 -74.02 -41.83 61.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.924 . . . . 0.0 110.112 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.69 35.08 5.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.443 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 33.5 p-10 -94.65 3.09 55.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -1.197 . . . . 0.0 110.257 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 68.23 37.72 86.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 12.8 m-85 -165.27 142.61 5.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -1.113 . . . . 0.0 110.24 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.43 HD11 ' HB3' ' A' ' 92' ' ' PHE . 9.7 mt -107.7 126.53 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.667 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' ALA . 2.8 t -117.76 147.83 42.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.825 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.15 -27.73 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.268 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -70.73 -43.98 67.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.855 . . . . 0.0 109.799 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 101' ' ' SER . 42.8 mt-10 -61.31 -40.21 93.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.923 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.527 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 2.4 mt -63.34 -44.37 95.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.405 -0.81 . . . . 0.0 109.81 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.8 ttp85 -53.87 -37.08 63.33 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.067 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.552 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -60.55 -60.94 3.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.397 -0.814 . . . . 0.0 109.573 179.292 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.68 -35.15 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.368 -0.832 . . . . 0.0 109.464 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.561 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 5.6 mtt -50.89 -65.42 0.56 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 110.395 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -63.5 -33.21 75.09 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 110.354 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.12 -8.37 49.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.105 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.564 HD11 ' HA ' ' B' ' 14' ' ' LYS . 10.1 mt -109.38 -50.88 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 110.471 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.06 -59.24 0.16 Allowed Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.585 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.442 ' HG2' HD13 ' A' ' 116' ' ' LEU . 2.6 tt0 -105.87 154.76 20.1 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.055 -1.262 . . . . 0.0 110.626 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 6.9 ptpp? -123.48 21.97 9.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.878 . . . . 0.0 110.15 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 115' ' ' LYS . 6.6 mp 41.03 -164.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.547 -0.721 . . . . 0.0 110.575 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 m -96.49 -146.59 0.29 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.433 -0.792 . . . . 0.0 109.178 179.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -115.4 -54.51 2.53 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.127 -0.983 . . . . 0.0 109.963 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -31.35 72.54 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 109.517 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -69.93 -45.26 67.9 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.298 -0.876 . . . . 0.0 109.298 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.442 HG23 ' HE2' ' A' ' 109' ' ' MET . 24.2 t -61.99 -45.73 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.082 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.29 -39.99 92.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 109.782 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 4.5 tt0 -71.71 -31.15 66.42 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.403 -0.81 . . . . 0.0 109.559 179.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.479 ' HB2' ' HA ' ' B' ' 20' ' ' ARG . 1.4 ttt -61.33 -34.59 75.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 0.0 109.603 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.527 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 35.2 mm -80.56 -63.52 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.446 -0.784 . . . . 0.0 110.816 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.06 -30.33 10.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.181 -0.949 . . . . 0.0 110.938 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 11.8 mt-10 -74.78 -29.96 61.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.103 -0.998 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -88.11 -28.66 21.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.311 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.6 90.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 128' ' ' ALA . 49.3 mm -59.75 -40.93 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 0.0 109.959 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -84.55 -28.79 26.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.414 -0.804 . . . . 0.0 110.092 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.7 76.65 0.97 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.1 p30 -135.42 8.78 3.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.216 -1.167 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.47 13.28 73.67 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -169.42 163.05 10.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.247 -1.149 . . . . 0.0 110.412 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 87.5 t -108.38 142.9 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.111 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.47 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 4.6 t30 -110.45 -159.04 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 0.0 110.106 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 139' ' ' GLU . 30.2 t80 -72.61 -63.02 1.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 109.691 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 143' ' ' GLN . 43.1 mt-10 -42.98 -50.11 5.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.324 -0.86 . . . . 0.0 109.787 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 142' ' ' VAL . 48.8 mt-10 -55.67 -60.46 3.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 109.634 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.581 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 30.5 t80 -41.55 -28.14 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.538 -0.727 . . . . 0.0 109.537 179.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 140' ' ' GLU . 78.7 t -100.37 -28.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.559 -0.713 . . . . 0.0 110.535 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -66.04 -13.14 59.45 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.06 -1.025 . . . . 0.0 110.343 -179.792 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -103.63 -23.72 13.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.103 -0.998 . . . . 0.0 110.608 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.505 ' HE1' ' HA2' ' B' ' 23' ' ' GLY . 8.5 mtt -90.8 -32.64 16.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.17 -0.956 . . . . 0.0 109.806 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.465 ' O ' ' CG2' ' A' ' 146' ' ' THR . 8.4 t -170.53 95.71 0.23 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.362 -0.836 . . . . 0.0 110.156 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.46 ' HB3' ' OE1' ' A' ' 143' ' ' GLN . . . -92.24 39.48 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.201 -0.937 . . . . 0.0 110.594 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.1 mttt . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.247 179.956 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.217 0.532 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' B' ' 3' ' ' LEU . 3.3 pttt -148.86 166.3 28.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.94 . . . . 0.0 110.541 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.496 ' O ' ' C ' ' B' ' 4' ' ' ILE . 5.0 tt -178.04 62.15 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.379 -0.826 . . . . 0.0 109.243 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 43' ' ' PRO . 15.9 mt -29.46 146.39 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 122.12 -0.362 . . . . 0.0 111.18 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 43.6 Cg_endo -74.06 151.77 44.94 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.954 1.502 . . . . 0.0 109.973 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.498 ' O ' ' CE ' ' A' ' 51' ' ' MET . 13.4 m -62.9 -55.36 26.75 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 110.432 -179.533 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.585 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER 169.9 -76.25 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.315 -0.866 . . . . 0.0 109.552 -179.725 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.491 ' O ' ' HB ' ' B' ' 11' ' ' ILE . 25.7 p -53.2 -27.75 23.3 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.758 . . . . 0.0 109.878 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 79.4 m -58.86 -52.18 66.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.925 -1.109 . . . . 0.0 108.464 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 15.5 t -50.79 -43.69 25.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' B' ' 11' ' ' ILE . 0.8 OUTLIER -59.57 -54.28 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.758 0.79 . . . . 0.0 109.584 179.408 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 11' ' ' ILE . 0.6 OUTLIER -40.66 -66.85 0.28 Allowed 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.657 -0.652 . . . . 0.0 110.779 -179.831 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.539 ' CG1' HD12 ' A' ' 112' ' ' LEU . 62.1 t -46.13 -43.45 5.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.643 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.564 ' HA ' HD11 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -59.05 -50.01 75.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.91 -1.119 . . . . 0.0 110.277 179.652 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.76 -28.95 37.68 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.357 -0.839 . . . . 0.0 109.89 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.492 ' O ' ' N ' ' B' ' 18' ' ' ARG . 0.2 OUTLIER -72.6 -31.17 64.98 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.244 -0.91 . . . . 0.0 110.593 -179.871 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.561 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 4.6 mp -67.2 57.64 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.071 -1.018 . . . . 0.0 110.699 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.541 ' HG3' ' CD ' ' B' ' 19' ' ' LYS . 2.0 ttp180 -91.96 -110.38 0.1 Allowed 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.478 -0.764 . . . . 0.0 109.141 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.541 ' CD ' ' HG3' ' B' ' 18' ' ' ARG . 3.0 mptt -126.53 -94.4 0.46 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.741 -1.225 . . . . 0.0 109.114 178.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.479 ' HA ' ' HB2' ' A' ' 124' ' ' MET . 0.0 OUTLIER -105.33 3.02 29.4 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.274 -0.891 . . . . 0.0 109.31 178.943 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 6.9 m -84.07 -176.07 6.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 0.0 109.712 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.474 ' O ' ' OD1' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -151.7 -150.72 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.017 . . . . 0.0 111.186 179.712 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.505 ' HA2' ' HE1' ' A' ' 145' ' ' MET . . . -43.85 156.05 0.21 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.532 ' HB3' ' HD2' ' B' ' 25' ' ' PRO . 34.8 m120 -150.17 168.1 11.68 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.457 -1.025 . . . . 0.0 110.217 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' B' ' 24' ' ' ASN . 39.7 Cg_endo -65.78 73.22 0.32 Allowed 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.637 1.335 . . . . 0.0 110.041 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.562 ' CE2' ' HE3' ' A' ' 72' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.715 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.758 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.214 0.531 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.428 ' OD1' ' C ' ' A' ' 2' ' ' ASP . 43.9 t0 -133.87 -100.53 0.25 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 109.896 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -99.72 -176.68 3.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 109.805 179.621 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 3' ' ' GLN . 0.9 OUTLIER 61.28 136.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.079 -1.013 . . . . 0.0 109.978 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 t -68.72 146.62 52.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.155 -0.966 . . . . 0.0 110.418 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 7' ' ' GLU . 1.6 mp0 -86.88 -41.4 14.03 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.335 -0.853 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.466 ' HA ' ' OE1' ' A' ' 7' ' ' GLU . 3.5 tp10 -42.78 -46.81 5.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 109.999 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.436 ' NE2' ' OXT' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -59.71 -54.82 41.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.818 179.767 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 10' ' ' ALA . 88.6 mt -50.08 -59.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -44.97 -52.7 8.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -0.939 . . . . 0.0 109.514 179.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 12' ' ' PHE . 1.2 tt0 -52.49 -48.1 66.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -0.834 . . . . 0.0 109.313 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.528 ' CD1' ' HG2' ' A' ' 11' ' ' GLU . 18.9 m-30 -55.84 -47.46 77.22 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.359 -0.838 . . . . 0.0 109.904 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -48.86 -42.64 37.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.588 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -53.63 56.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 109.619 179.439 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -54.2 -40.85 67.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.829 . . . . 0.0 109.861 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -66.8 -30.05 70.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.823 . . . . 0.0 109.831 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -78.43 -20.22 51.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.639 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' CD2' HG12 ' A' ' 35' ' ' VAL . 6.4 tt -76.72 -46.33 25.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.384 -0.822 . . . . 0.0 110.05 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.44 ' CD2' ' O ' ' A' ' 15' ' ' ALA . 69.5 m-85 -72.1 -22.77 61.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.0 110.161 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.478 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 0.8 OUTLIER -95.44 83.78 3.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.038 179.907 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -44.71 -35.8 2.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.1 p30 -97.93 -24.52 15.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 110.328 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 67.86 31.21 75.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 41.9 p-10 -79.27 -0.75 33.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -1.191 . . . . 0.0 110.111 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 87.0 27.0 29.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 18.4 p -156.51 97.41 1.74 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -1.089 . . . . 0.0 109.894 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.556 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 18.8 mt -85.32 112.32 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.033 . . . . 0.0 109.978 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.435 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -75.79 -163.72 0.3 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.313 -0.867 . . . . 0.0 109.783 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.46 ' O ' HD12 ' A' ' 48' ' ' LEU . 6.6 p -80.45 -56.09 4.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.947 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -37.98 66.13 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.44 -0.788 . . . . 0.0 110.494 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 18.9 mt-10 -48.86 -68.49 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.048 -1.033 . . . . 0.0 109.653 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.507 HD22 ' CE ' ' A' ' 51' ' ' MET . 56.0 tp -47.28 -39.33 14.27 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.309 -0.87 . . . . 0.0 109.141 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.39 96.75 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.611 -1.796 . . . . 0.0 108.611 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.6 m -52.53 -42.97 64.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.362 -1.081 . . . . 0.0 109.249 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.469 HG12 ' CD2' ' A' ' 18' ' ' LEU . 13.3 t -66.91 -46.96 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.398 -0.814 . . . . 0.0 109.599 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.467 ' CE ' ' HG2' ' B' ' 5' ' ' PRO . 4.8 mmt -67.13 -29.8 69.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.658 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 2.4 ttp-105 -68.46 -35.13 77.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.771 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 m -84.12 -14.35 50.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.064 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -83.17 -32.91 26.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.103 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.65 -62.93 0.18 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.555 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -100.3 175.42 5.72 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.038 -1.272 . . . . 0.0 111.315 -178.959 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -134.52 100.06 12.69 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.602 -0.686 . . . . 0.0 109.529 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.421 ' HG3' HG23 ' B' ' 4' ' ' ILE . 43.6 Cg_endo -69.97 162.74 41.02 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 O-C-N 124.065 1.56 . . . . 0.0 111.072 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 45' ' ' GLU . 4.2 t -96.93 -149.95 0.33 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.385 -0.822 . . . . 0.0 110.725 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 38.1 mt-10 -94.22 -57.33 2.54 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 0.0 110.88 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 47' ' ' GLU . . . -43.56 -70.54 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.035 -1.041 . . . . 0.0 110.409 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 46' ' ' ALA . 6.0 mm-40 -44.78 -42.9 8.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.077 -1.015 . . . . 0.0 109.486 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.7 mt -57.22 -47.39 81.44 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -46.28 -43.28 15.57 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.38 179.436 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.45 -30.32 64.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.432 -0.792 . . . . 0.0 109.571 179.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.584 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 1.2 mmm -74.72 -36.71 62.68 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.403 -0.811 . . . . 0.0 109.497 179.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.505 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 1.5 tp -78.1 -43.75 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.273 -0.892 . . . . 0.0 110.327 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.505 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -43.43 -26.1 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.257 -0.902 . . . . 0.0 110.331 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 52' ' ' ILE . 15.6 mm-40 -67.9 -51.43 47.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 110.213 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.543 ' HB ' ' CD1' ' A' ' 63' ' ' ILE . 14.8 t -80.61 -33.38 13.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.96 82.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.348 -0.845 . . . . 0.0 110.168 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.77 -69.25 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.398 -0.814 . . . . 0.0 110.816 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 47.1 p-10 -59.02 -16.88 20.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.252 -0.905 . . . . 0.0 110.675 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 69.47 43.8 67.54 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 31.4 p-10 -94.76 -31.84 13.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.326 -1.102 . . . . 0.0 110.478 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 120.51 24.09 2.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 3.4 p -161.05 142.66 11.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -1.14 . . . . 0.0 110.247 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.556 ' CG1' ' HB ' ' A' ' 27' ' ' ILE . 14.1 mm -82.4 134.03 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.196 -0.94 . . . . 0.0 110.011 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.472 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -105.96 160.62 15.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 110.319 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.6 t80 -56.62 -50.36 88.35 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.554 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.9 Cg_endo -69.97 -31.3 19.85 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.397 1.209 . . . . 0.0 109.974 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 70' ' ' THR . 8.9 mt-10 -64.41 -34.03 77.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.32 -0.863 . . . . 0.0 110.073 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -75.45 -53.58 8.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.21 -0.932 . . . . 0.0 109.673 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mp -49.82 -29.78 8.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.883 . . . . 0.0 109.913 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -74.59 -47.89 29.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -0.849 . . . . 0.0 110.028 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.488 ' HG3' ' HA ' ' A' ' 55' ' ' VAL . 8.0 mmm -50.39 -47.45 56.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.135 -0.978 . . . . 0.0 109.572 179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.583 ' HE3' ' CZ ' ' B' ' 26' ' ' PHE . 6.1 tpt -42.19 -26.81 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.48 -0.763 . . . . 0.0 110.498 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 71' ' ' MET . . . -107.52 -21.07 13.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.193 -0.942 . . . . 0.0 110.957 -179.145 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.46 -26.01 33.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.074 -1.016 . . . . 0.0 110.394 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.524 ' CG ' HG22 ' B' ' 8' ' ' THR . 2.6 tptm -100.31 23.01 10.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 110.292 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.597 ' HE2' ' CE2' ' B' ' 26' ' ' PHE . 19.1 mmt -100.29 -29.76 12.26 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.219 -0.926 . . . . 0.0 110.901 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -127.93 76.85 1.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.065 -1.022 . . . . 0.0 110.649 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.45 -79.18 0.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 p -152.06 -52.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.847 . . . . 0.0 109.779 179.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -83.96 85.75 7.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 110.061 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.46 -36.78 9.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.601 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -79.37 -35.08 41.41 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.495 -0.753 . . . . 0.0 109.64 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -63.89 -13.17 43.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.406 -0.809 . . . . 0.0 109.51 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.512 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 3.2 mt-10 -71.28 -45.47 63.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.513 -0.742 . . . . 0.0 110.582 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.52 HG21 ' CD2' ' A' ' 141' ' ' PHE . 27.3 mt -73.74 -21.73 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 110.198 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -71.83 -53.45 13.25 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.159 -0.963 . . . . 0.0 110.298 -179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 84' ' ' GLU . 7.8 pt-20 -62.37 -40.27 95.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.012 -1.055 . . . . 0.0 110.333 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -58.89 -37.31 76.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.504 -1.372 . . . . 0.0 108.358 178.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' HD13 ' A' ' 100' ' ' ILE . 66.6 t80 -65.49 -44.04 88.31 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -43.52 71.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.53 -0.731 . . . . 0.0 109.046 178.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.467 ' CG1' HG22 ' A' ' 108' ' ' VAL . 30.4 t -53.29 -48.57 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -0.785 . . . . 0.0 108.989 179.03 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.59 ' CE1' HG13 ' A' ' 108' ' ' VAL . 42.9 m-85 -66.59 -35.56 80.49 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 109.228 178.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.472 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 23.6 t0 -86.9 60.02 5.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.765 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' ASP . 10.2 ttpt -39.51 -50.07 2.15 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.521 -0.737 . . . . 0.0 110.252 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 10.2 p-10 -65.25 -36.56 84.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 109.652 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 83.41 45.41 6.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.374 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 52.6 p-10 -100.22 -20.71 15.8 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.058 -1.26 . . . . 0.0 110.273 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 109.28 22.08 6.99 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 24.4 m-85 -143.57 142.66 31.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.363 -1.08 . . . . 0.0 109.98 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.534 HD13 ' CD1' ' A' ' 89' ' ' PHE . 6.3 mt -113.69 96.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.498 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.2 m -90.68 152.45 20.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -0.918 . . . . 0.0 109.775 179.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.18 -40.55 11.38 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.63 -47.4 79.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.387 -0.821 . . . . 0.0 109.59 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 25.8 mt-10 -61.06 -53.66 54.38 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.304 -0.872 . . . . 0.0 109.828 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.515 ' CD1' HD13 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -59.34 -29.53 67.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.465 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.4 ttt-85 -70.82 -22.88 62.29 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.343 -0.848 . . . . 0.0 108.87 178.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 9.0 m80 -79.81 -46.23 17.32 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.576 -0.702 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.59 HG13 ' CE1' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -67.03 -20.73 27.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.365 -0.834 . . . . 0.0 108.857 179.144 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.471 ' HG3' HD23 ' B' ' 17' ' ' LEU . 0.3 OUTLIER -68.77 -52.07 34.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.599 -0.688 . . . . 0.0 109.956 179.638 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -35.37 73.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.894 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -74.16 -12.66 60.65 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.16 -0.962 . . . . 0.0 109.345 179.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 8.9 mt -94.64 -51.42 4.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.432 -0.792 . . . . 0.0 109.754 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.57 -59.93 0.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 20.8 tp10 -96.76 160.6 14.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.201 -1.176 . . . . 0.0 110.949 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.524 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -133.94 81.9 1.95 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.325 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.498 ' CD2' ' O ' ' B' ' 19' ' ' LYS . 6.5 mp -37.27 150.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.573 0.701 . . . . 0.0 111.268 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.79 -148.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.502 -0.749 . . . . 0.0 110.012 179.759 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.99 -44.86 5.36 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.331 -0.855 . . . . 0.0 110.135 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 17.5 pt-20 -64.89 -42.36 94.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.76 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.48 ' N ' ' CG ' ' A' ' 119' ' ' GLU . 11.1 mm-40 -63.3 -40.72 98.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.579 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 125' ' ' ILE . 40.5 t -64.89 -45.37 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.273 -0.892 . . . . 0.0 109.699 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -63.53 -35.56 80.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.436 -0.79 . . . . 0.0 109.708 179.643 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 124' ' ' MET . 45.5 mt-10 -72.87 -54.48 8.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.0 109.566 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.601 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 25.1 ttt -42.38 -43.37 3.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.476 -0.765 . . . . 0.0 109.904 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.515 HD13 ' CD1' ' A' ' 105' ' ' LEU . 15.3 mm -76.33 -60.27 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 0.0 109.961 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -47.84 -55.03 10.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.512 ' OE2' ' CZ ' ' B' ' 20' ' ' ARG . 46.2 mt-10 -52.51 -21.6 3.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 0.0 110.388 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.464 ' O ' HD13 ' A' ' 130' ' ' ILE . . . -93.28 -34.95 13.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.215 -0.928 . . . . 0.0 110.328 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 5.2 m-20 -68.43 66.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 110.237 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.464 HD13 ' O ' ' A' ' 128' ' ' ALA . 2.5 mp -46.43 -42.82 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.004 . . . . 0.0 109.88 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -70.89 -29.41 65.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.467 -0.77 . . . . 0.0 110.189 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.92 95.45 0.28 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 29.5 p-10 -144.72 -37.76 0.29 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -1.116 . . . . 0.0 110.236 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 121.49 9.44 7.11 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -165.59 149.8 8.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -1.102 . . . . 0.0 110.271 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.471 HG11 ' HB3' ' A' ' 140' ' ' GLU . 3.5 t -103.19 116.38 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 109.823 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.37 -155.03 0.3 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.345 -0.847 . . . . 0.0 110.603 -179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 139' ' ' GLU . 58.5 t80 -75.24 -60.62 2.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 138' ' ' TYR . 1.5 tt0 -42.72 -56.83 3.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.471 ' HB3' HG11 ' A' ' 136' ' ' VAL . 2.6 mt-10 -55.23 -55.62 29.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.903 . . . . 0.0 109.85 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.52 ' CD2' HG21 ' A' ' 85' ' ' ILE . 19.1 t80 -45.22 -28.8 0.84 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.376 -0.827 . . . . 0.0 109.626 179.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 147' ' ' ALA . 24.3 t -98.94 -24.02 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.411 -0.806 . . . . 0.0 109.806 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.537 ' HA ' ' CB ' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -59.0 -30.58 68.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 109.917 179.797 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.0 mmm -92.0 -9.58 42.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.316 -0.865 . . . . 0.0 109.844 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.529 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.2 OUTLIER -98.56 -69.76 0.75 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.388 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 t -156.69 56.75 0.55 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.963 -1.086 . . . . 0.0 110.866 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.537 ' CB ' ' HA ' ' A' ' 143' ' ' GLN . . . -100.42 38.5 1.49 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.108 -0.995 . . . . 0.0 110.251 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.235 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.229 0.538 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -107.39 141.17 39.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.851 . . . . 0.0 110.842 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.77 25.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.053 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.421 HG23 ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -64.69 147.6 97.71 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.169 -0.957 . . . . 0.0 110.656 -179.662 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.547 ' HB2' ' CB ' ' B' ' 9' ' ' THR . 48.1 Cg_endo -72.26 -155.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 124.334 1.702 . . . . 0.0 111.144 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.537 ' O ' ' N ' ' B' ' 8' ' ' THR . 5.0 t -130.18 73.8 1.55 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.245 -0.91 . . . . 0.0 111.214 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.584 ' CD1' ' O ' ' A' ' 51' ' ' MET . 0.8 OUTLIER 46.96 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.698 0 O-C-N 121.49 -0.756 . . . . 0.0 111.848 178.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.537 ' N ' ' O ' ' B' ' 6' ' ' SER . 21.6 p -38.99 -26.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 110.798 -179.016 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.547 ' CB ' ' HB2' ' B' ' 5' ' ' PRO . 15.8 m -64.92 -65.81 0.62 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.076 -1.015 . . . . 0.0 109.996 179.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.571 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 4.0 m -46.68 -26.86 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 108.955 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.529 HG23 ' CE ' ' A' ' 72' ' ' MET . 49.2 mt -74.4 -47.96 37.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 121.687 0.756 . . . . 0.0 109.541 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 mt -50.32 -56.64 10.43 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.654 -0.654 . . . . 0.0 110.561 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.528 HG12 ' CZ ' ' A' ' 92' ' ' PHE . 17.2 t -62.34 -40.17 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.969 . . . . 0.0 110.958 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.451 ' HE2' HD13 ' A' ' 18' ' ' LEU . 6.5 tptp -71.54 -11.65 60.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.802 -1.186 . . . . 0.0 110.492 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 1.6 m -97.59 -21.83 16.85 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.191 -0.943 . . . . 0.0 109.265 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.467 ' O ' ' HE2' ' A' ' 124' ' ' MET . 6.6 tpp -78.56 -37.39 42.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.584 -0.697 . . . . 0.0 110.156 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' A' ' 109' ' ' MET . 1.3 mp -48.43 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.918 -1.114 . . . . 0.0 109.682 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER 31.62 58.07 0.31 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.652 -0.655 . . . . 0.0 112.514 179.392 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.548 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 62.5 -59.3 0.13 Allowed 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.47 -0.768 . . . . 0.0 111.753 178.155 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -155.66 8.42 0.25 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.886 -1.134 . . . . 0.0 111.752 -178.514 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' B' ' 18' ' ' ARG . 1.8 m -59.99 84.51 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.732 -1.23 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.601 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -111.93 13.55 20.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -0.954 . . . . 0.0 110.349 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.472 ' C ' ' CD ' ' B' ' 25' ' ' PRO . . . -96.24 -139.53 10.52 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.556 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 32.8 t-20 -119.78 47.58 1.03 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.196 -1.179 . . . . 0.0 110.386 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 48.5 Cg_endo -73.73 53.02 2.66 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.734 1.386 . . . . 0.0 110.268 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.597 ' CE2' ' HE2' ' A' ' 76' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.987 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.228 0.537 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -174.29 105.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.234 -0.916 . . . . 0.0 110.188 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -100.05 164.23 12.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.346 -0.846 . . . . 0.0 110.29 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.523 ' O ' ' CG2' ' A' ' 5' ' ' THR . 0.9 OUTLIER -57.86 132.08 52.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 110.158 179.867 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -168.94 -40.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.388 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 1.2 mt-10 -99.48 -22.41 15.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.145 -0.972 . . . . 0.0 110.456 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' HB2' ' CD2' ' A' ' 4' ' ' LEU . 1.2 mp0 -43.31 -56.25 3.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -0.905 . . . . 0.0 110.391 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.457 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 0.2 OUTLIER -62.99 -67.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 110.278 -179.848 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.4 mt -48.27 -45.97 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.785 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 6' ' ' GLU . . . -52.09 -41.66 62.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 109.738 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.564 ' OE2' ' CE1' ' A' ' 12' ' ' PHE . 1.9 tt0 -57.55 -51.51 69.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.746 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE1' ' OE2' ' A' ' 11' ' ' GLU . 21.0 m-85 -62.15 -45.07 95.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.942 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -60.17 -42.71 95.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -0.932 . . . . 0.0 109.705 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.79 -36.89 72.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.624 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . . . -75.45 -54.11 7.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.675 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.582 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 20.6 t80 -56.73 -17.15 8.0 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.417 -0.802 . . . . 0.0 109.714 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 18' ' ' LEU . 7.3 t -89.33 -56.74 3.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 7.4 tt -44.31 -30.15 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -87.64 -30.73 20.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.284 -0.885 . . . . 0.0 110.535 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -104.89 91.57 3.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 110.495 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -67.92 -48.5 65.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.18 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 5.2 p-10 -60.39 -41.98 94.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.44 -0.787 . . . . 0.0 110.434 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . 83.87 56.47 2.6 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 38.1 p-10 -107.45 -27.57 10.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.159 -1.201 . . . . 0.0 110.263 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 111.56 9.09 21.99 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 27.2 p -141.89 116.02 9.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -1.172 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.481 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.5 mt -94.76 106.45 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 110.149 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.86 152.03 23.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.792 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -45.97 -25.56 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.01 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -61.12 2.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 110.218 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.67 -57.66 10.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.226 -0.921 . . . . 0.0 110.07 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.451 HD23 ' CZ2' ' B' ' 7' ' ' TRP . 29.8 tp -52.68 -38.43 60.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.34 -40.02 96.92 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -60.29 -55.44 33.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -1.145 . . . . 0.0 109.943 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.29 -50.53 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.649 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.527 ' HB3' ' CD ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -54.38 -38.69 66.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.917 . . . . 0.0 109.871 179.657 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.492 ' HG3' ' ND2' ' A' ' 42' ' ' ASN . 2.0 ttp85 -64.25 -23.31 67.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.417 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 8.1 t -78.36 -30.23 47.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 110.656 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.74 -43.95 67.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.08 -1.013 . . . . 0.0 110.477 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.36 -16.01 0.41 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.654 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.1 mm-40 -113.2 166.0 11.87 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.832 -1.393 . . . . 0.0 110.624 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.492 ' ND2' ' HG3' ' A' ' 37' ' ' ARG . 3.8 t-20 -127.9 97.16 30.34 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.287 -0.883 . . . . 0.0 110.231 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.527 ' CD ' ' HB3' ' A' ' 36' ' ' MET . 46.6 Cg_endo -75.45 140.08 23.87 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 124.173 1.618 . . . . 0.0 110.357 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.477 HG21 ' HG2' ' A' ' 47' ' ' GLU . 14.7 t -91.58 -143.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 109.917 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 44' ' ' THR . 11.4 tp10 -100.23 -25.96 14.08 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.252 -0.905 . . . . 0.0 110.289 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.62 -70.8 0.35 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.14 -0.975 . . . . 0.0 110.387 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' HG2' HG21 ' A' ' 44' ' ' THR . 8.2 pt-20 -49.42 -40.29 36.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.0 109.624 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 1.4 mt -58.73 -43.25 90.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.079 179.195 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.99 -49.29 51.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.502 -0.749 . . . . 0.0 109.095 179.084 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -29.98 68.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.292 179.076 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.524 ' HE2' ' CE ' ' A' ' 36' ' ' MET . 1.2 ttp -75.98 -55.38 5.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 2.5 tp -56.96 -44.66 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.532 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.5 OUTLIER -40.89 -70.1 0.12 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.557 -0.714 . . . . 0.0 111.128 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -35.91 -55.08 0.75 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.722 -0.612 . . . . 0.0 110.933 -179.315 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.634 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 11.3 t -75.21 -33.84 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.745 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 5.3 t0 -58.87 77.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 0.0 110.318 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -39.72 -61.28 0.85 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.504 -0.747 . . . . 0.0 110.575 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 41.0 p-10 -76.4 -18.85 58.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 110.091 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 72.32 49.27 21.08 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.0 p-10 -99.3 -27.41 13.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -1.154 . . . . 0.0 110.302 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 119.14 23.47 3.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 61' ' ' GLY . 81.2 p -155.65 140.36 17.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.181 -1.187 . . . . 0.0 110.051 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.526 ' CG1' HD13 ' A' ' 52' ' ' ILE . 10.4 mm -91.15 158.75 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.354 -0.842 . . . . 0.0 110.072 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 58.5 m-20 -133.7 163.32 29.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 0.0 110.059 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.585 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 11.4 t80 -56.35 -48.54 96.78 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.16 -0.962 . . . . 0.0 111.215 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.1 Cg_endo -68.73 -35.69 15.79 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.206 1.108 . . . . 0.0 110.293 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 6.8 tt0 -58.94 -41.23 86.89 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.304 -0.872 . . . . 0.0 110.143 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 36.6 t80 -69.58 -54.85 12.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.82 -24.95 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.958 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 m -97.61 -15.31 20.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 110.479 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.482 ' CE ' HG21 ' B' ' 8' ' ' THR . 5.8 ttp -74.59 -42.7 58.23 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.144 -0.972 . . . . 0.0 110.536 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.55 ' HE3' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -54.46 -15.37 1.65 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.326 -0.858 . . . . 0.0 110.85 -179.387 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.42 -12.84 18.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.049 -1.032 . . . . 0.0 111.278 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.9 -11.96 40.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.781 -1.199 . . . . 0.0 110.502 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.539 ' CB ' HG23 ' B' ' 8' ' ' THR . 17.7 mmtt -98.39 -34.91 10.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 110.268 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.443 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 0.2 OUTLIER -91.35 53.18 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.082 -179.975 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 78' ' ' ASP . 0.9 OUTLIER -133.91 78.59 1.77 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 110.679 -179.719 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 77' ' ' LYS . 3.4 p30 37.85 44.89 0.63 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.494 -0.753 . . . . 0.0 110.781 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 77' ' ' LYS . 18.9 p -142.49 -37.57 0.38 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.236 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.476 ' O ' ' OE2' ' A' ' 84' ' ' GLU . 7.4 t0 -153.19 71.91 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 110.168 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.4 p -106.92 -38.05 6.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 109.735 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -82.28 -37.69 25.5 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.441 -0.787 . . . . 0.0 109.82 179.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' HB3' ' OD1' ' A' ' 80' ' ' ASP . 1.7 tt0 -72.11 -27.7 62.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.891 . . . . 0.0 109.637 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.488 ' OE2' ' HB3' ' A' ' 75' ' ' LYS . 17.3 mt-10 -72.63 -42.43 64.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.827 . . . . 0.0 110.128 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.445 HG21 ' CD1' ' A' ' 141' ' ' PHE . 14.2 mt -68.69 -37.84 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.489 -0.884 . . . . 0.0 108.762 179.502 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -60.93 -27.34 68.15 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.034 178.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.444 ' HB3' HG22 ' B' ' 9' ' ' THR . 1.5 mt-10 -73.72 -54.48 7.99 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.536 -0.728 . . . . 0.0 109.146 179.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.75 -28.14 32.76 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.329 -0.857 . . . . 0.0 109.235 179.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -70.44 -46.04 64.65 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.373 -0.83 . . . . 0.0 109.514 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -28.83 65.71 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.513 -0.742 . . . . 0.0 109.621 179.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.43 ' CG1' HG23 ' A' ' 108' ' ' VAL . 15.5 t -73.75 -39.25 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.391 -0.818 . . . . 0.0 109.677 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.505 ' CE1' HD22 ' A' ' 105' ' ' LEU . 11.1 m-85 -72.78 -32.0 65.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.859 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -85.24 54.18 3.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.305 -0.872 . . . . 0.0 110.395 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.82 -28.12 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 30.8 p-10 -85.57 -43.81 13.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.186 -0.946 . . . . 0.0 110.354 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 89.75 22.75 35.35 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 33.4 p-10 -75.73 -33.84 60.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -1.132 . . . . 0.0 109.927 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 120.84 21.13 3.28 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 2.0 m-85 -164.44 130.04 2.85 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.182 -1.187 . . . . 0.0 110.263 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.513 HD11 HG22 ' A' ' 100' ' ' ILE . 29.0 mt -82.46 155.52 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.966 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -144.67 156.88 44.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.86 -38.03 21.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 0.0 110.2 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.47 -46.89 84.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 109.849 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 107' ' ' HIS . 40.3 mt-10 -57.3 -36.26 70.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 109.861 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.525 ' CD1' HD12 ' A' ' 125' ' ' ILE . 5.7 mt -61.8 -48.4 80.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.346 -0.846 . . . . 0.0 109.822 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.8 -35.63 61.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.417 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.438 ' CD2' ' N ' ' A' ' 107' ' ' HIS . 35.2 m170 -64.0 -45.22 89.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -0.799 . . . . 0.0 110.14 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.473 HG13 ' CE1' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -79.21 -23.67 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.72 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.522 ' HB3' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -68.01 -56.89 7.27 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 110.111 -179.971 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 7.3 m -60.93 -31.41 70.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.947 . . . . 0.0 109.691 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 38' ' ' SER . 7.1 m-20 -76.96 -4.7 45.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.856 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.511 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 7.0 mt -111.64 -44.68 3.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 110.374 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.96 -66.87 0.13 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.634 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 109' ' ' MET . 2.7 tt0 -103.25 166.94 10.14 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.171 -1.193 . . . . 0.0 111.137 -178.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.3 OUTLIER -124.47 16.79 8.93 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.733 0.777 . . . . 0.0 109.553 179.255 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' B' ' 19' ' ' LYS . 2.8 mp 43.62 -173.23 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.66 0.743 . . . . 0.0 111.169 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.76 -146.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.505 -0.747 . . . . 0.0 109.886 179.75 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -114.06 -70.22 0.81 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.156 -0.965 . . . . 0.0 110.517 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 120' ' ' GLU . 3.8 pt-20 -55.39 -29.23 58.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 109.743 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.477 ' OE2' ' HE2' ' B' ' 19' ' ' LYS . 6.2 mt-10 -71.73 -45.74 60.81 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 108.919 178.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 117' ' ' THR . 53.1 t -54.67 -45.71 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.491 -0.756 . . . . 0.0 109.629 179.184 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -60.37 -59.23 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 0.0 109.373 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 68.5 mm-40 -48.41 -38.66 20.17 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.393 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.482 ' HG3' ' HA ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -51.01 -56.1 14.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.252 -0.905 . . . . 0.0 109.462 179.503 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 105' ' ' LEU . 21.0 mm -56.35 -30.67 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.349 -0.844 . . . . 0.0 110.011 179.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 123' ' ' GLU . 5.7 ttt180 -64.99 -55.0 21.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.303 -0.873 . . . . 0.0 110.528 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 126' ' ' ARG . 2.6 tp10 -41.9 -42.89 2.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.305 -0.872 . . . . 0.0 110.371 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.21 -27.79 38.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.282 -0.886 . . . . 0.0 110.171 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -83.36 63.86 7.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.373 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 130' ' ' ILE . 5.7 mt -43.56 -40.07 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.747 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 21.2 p30 -67.34 -32.23 73.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.551 -0.718 . . . . 0.0 110.118 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.3 66.65 1.76 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' OD1' ' OD1' ' A' ' 131' ' ' ASP . 2.9 p-10 -115.43 -27.86 7.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -1.121 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.96 16.26 8.62 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.426 ' CG ' ' OD2' ' A' ' 133' ' ' ASP . 11.7 pt20 -169.95 149.78 3.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -1.131 . . . . 0.0 110.174 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.5 HG11 ' N ' ' A' ' 137' ' ' ASN . 85.9 t -110.79 149.77 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 109.972 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.5 ' N ' HG11 ' A' ' 136' ' ' VAL . 25.3 p-10 -120.21 -157.93 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.419 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.414 ' O ' ' C ' ' A' ' 139' ' ' GLU . 11.1 t80 -70.88 -67.22 0.52 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.358 -0.839 . . . . 0.0 110.61 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 138' ' ' TYR . 4.7 mt-10 -41.65 -62.32 0.91 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.384 -0.822 . . . . 0.0 110.351 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.447 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 49.3 mt-10 -46.27 -60.29 2.4 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.21 -0.931 . . . . 0.0 110.009 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.445 ' CD1' HG21 ' A' ' 85' ' ' ILE . 24.4 t80 -42.04 -28.19 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.743 179.755 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 140' ' ' GLU . 38.2 t -100.87 -32.25 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.454 -0.779 . . . . 0.0 110.644 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.466 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 4.7 tm0? -59.94 -18.43 45.16 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.147 -0.971 . . . . 0.0 110.404 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.3 mmm -112.58 -25.09 9.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 110.34 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.476 ' HE2' ' CB ' ' B' ' 24' ' ' ASN . 3.0 ttt -100.54 -9.34 22.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 111.118 -179.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.31 -30.73 1.14 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.92 -1.112 . . . . 0.0 111.174 -179.2 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 143' ' ' GLN . . . -77.06 54.28 1.03 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.129 -0.982 . . . . 0.0 110.461 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.239 179.949 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' B' ' 2' ' ' LYS . 5.9 p . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.207 0.527 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' B' ' 1' ' ' VAL . 0.0 OUTLIER 58.69 -91.97 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.407 -0.808 . . . . 0.0 110.786 179.71 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' B' ' 4' ' ' ILE . 3.2 mp -97.68 -43.71 7.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.098 -1.001 . . . . 0.0 110.861 -179.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.496 HD11 HG22 ' B' ' 4' ' ' ILE . 24.2 mm -41.79 139.95 1.51 Allowed Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.243 -0.911 . . . . 0.0 109.947 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.533 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 39.6 Cg_endo -67.43 173.18 9.14 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.113 1.586 . . . . 0.0 111.037 -179.281 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.8 t -126.1 79.38 1.84 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.247 -0.908 . . . . 0.0 111.452 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.634 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 9.2 m95 53.99 -93.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.45 -0.781 . . . . 0.0 112.042 178.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.539 HG23 ' CB ' ' A' ' 75' ' ' LYS . 4.0 p -37.18 -29.17 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.266 -0.896 . . . . 0.0 110.517 -178.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.533 ' CG2' ' HB3' ' B' ' 5' ' ' PRO . 53.7 m -65.67 -51.29 60.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.189 -0.945 . . . . 0.0 109.697 178.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.568 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 2.7 m -63.19 -29.91 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.948 -1.095 . . . . 0.0 108.653 179.018 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.535 ' CD1' HG21 ' B' ' 10' ' ' VAL . 1.6 mp -72.34 -54.69 15.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.52 -0.737 . . . . 0.0 109.265 178.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' B' ' 11' ' ' ILE . 0.5 OUTLIER -42.23 -59.8 1.68 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.546 -0.721 . . . . 0.0 110.534 179.897 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.3 -50.15 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 110.403 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.452 ' HD3' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -56.12 -35.23 66.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.908 -1.12 . . . . 0.0 109.663 179.632 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 5.1 t -73.84 -19.9 60.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 109.866 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 1.7 tpt -75.2 -43.18 53.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' B' ' 19' ' ' LYS . 5.3 mp -53.31 -91.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.0 . . . . 0.0 109.699 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' B' ' 17' ' ' LEU . 5.7 ttt180 59.98 -69.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.401 0.619 . . . . 0.0 110.808 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.569 ' CD ' ' HB2' ' B' ' 20' ' ' ARG . 0.8 OUTLIER -176.2 -72.53 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.027 0 O-C-N 121.412 -0.805 . . . . 0.0 110.812 -179.619 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.569 ' HB2' ' CD ' ' B' ' 19' ' ' LYS . 2.2 ttt-85 -135.09 20.4 3.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.848 -1.157 . . . . 0.0 110.324 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.73 129.56 42.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.282 -0.886 . . . . 0.0 110.219 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 124' ' ' MET . 0.2 OUTLIER -130.67 -4.06 4.16 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.426 -0.796 . . . . 0.0 110.351 -179.8 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.52 -28.07 23.04 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.476 ' CB ' ' HE2' ' A' ' 145' ' ' MET . 0.1 OUTLIER 48.89 81.81 0.25 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.081 -1.246 . . . . 0.0 109.912 -179.825 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.96 -34.94 9.85 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.901 1.474 . . . . 0.0 110.64 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.55 ' CZ ' ' HE3' ' A' ' 72' ' ' MET . 1.1 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.198 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.276 0.56 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 11.3 t70 179.7 -35.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.381 -0.824 . . . . 0.0 109.971 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.403 ' O ' ' CB ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -51.23 124.33 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 110.061 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.403 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER 64.62 124.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.937 -179.816 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.434 ' O ' ' CG2' ' A' ' 5' ' ' THR . 7.4 t -84.02 100.66 11.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 110.472 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -96.45 -45.24 6.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 109.983 179.693 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 13.6 mt-10 -41.87 -69.95 0.12 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.379 -0.825 . . . . 0.0 110.16 179.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -44.8 -63.71 0.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.8 mt -53.22 -27.73 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.343 -0.848 . . . . 0.0 109.759 179.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 6' ' ' GLU . . . -57.4 -64.03 1.03 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.54 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -48.39 -44.42 34.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -67.2 -50.0 62.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.384 -0.822 . . . . 0.0 109.737 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -55.89 -44.0 77.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.854 179.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 41.2 mt-10 -55.38 -43.47 75.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.762 179.538 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -72.1 -50.35 28.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.401 -0.812 . . . . 0.0 109.965 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.576 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 11.2 t80 -54.29 -47.81 71.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 109.918 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -68.05 -27.77 66.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.882 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 10.2 tt -61.41 -37.97 85.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.394 -0.816 . . . . 0.0 110.085 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -80.75 -30.03 36.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 110.106 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -84.73 84.25 7.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 110.49 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -73.12 -40.05 65.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.21 -0.931 . . . . 0.0 110.032 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -71.09 -33.86 70.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.086 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 65.17 1.23 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' C ' ' OD1' ' A' ' 24' ' ' ASP . 57.7 p30 -128.62 6.59 5.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -1.159 . . . . 0.0 110.154 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.66 13.48 51.39 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 59.5 p -136.87 115.44 11.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.276 -1.132 . . . . 0.0 110.251 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.44 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 5.1 mt -88.9 124.01 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.203 -0.936 . . . . 0.0 110.355 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.4 p -99.67 172.02 7.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.332 -0.855 . . . . 0.0 110.284 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 p -56.95 -30.06 63.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.937 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -66.83 -60.44 2.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.232 -0.918 . . . . 0.0 110.05 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -52.16 -55.65 19.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 110.024 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.453 HD12 ' CZ2' ' B' ' 7' ' ' TRP . 27.0 tp -59.51 -37.6 78.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.05 -37.19 64.19 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.9 m -61.36 -55.36 32.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -1.136 . . . . 0.0 109.942 179.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.7 -46.88 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 109.643 179.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.531 ' CE ' ' HE2' ' A' ' 51' ' ' MET . 0.9 OUTLIER -58.63 -41.82 86.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.693 179.506 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -28.78 66.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 109.924 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -55.73 3.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.337 -0.852 . . . . 0.0 110.272 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mt -44.88 -28.18 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.129 -0.982 . . . . 0.0 110.063 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 115.98 49.89 0.45 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.481 ' NE2' ' CG ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -147.44 -174.53 4.55 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.211 -1.17 . . . . 0.0 110.359 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -161.89 84.12 1.69 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.325 -0.859 . . . . 0.0 110.256 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.402 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 46.9 Cg_endo -73.19 100.67 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.042 1.548 . . . . 0.0 110.169 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.457 HG23 ' HB2' ' A' ' 47' ' ' GLU . 5.0 t -57.07 162.39 2.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.085 -1.009 . . . . 0.0 110.239 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' ALA . 2.3 mt-10 -42.98 -65.37 0.49 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 110.269 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -40.45 -51.84 2.83 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 110.227 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HB2' HG23 ' A' ' 44' ' ' THR . 5.9 mm-40 -63.85 -56.49 14.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.026 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' GLU . 5.2 mt -42.32 -42.8 3.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -0.832 . . . . 0.0 110.18 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -66.95 -41.1 87.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 0.0 110.079 179.77 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -27.42 65.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.402 -0.811 . . . . 0.0 110.186 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.531 ' HE2' ' CE ' ' A' ' 36' ' ' MET . 0.9 OUTLIER -82.54 -33.63 28.11 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.927 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 52' ' ' ILE . 4.8 mm -80.35 -31.08 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -76.82 -13.71 59.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 110.233 179.937 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -73.42 -60.99 1.99 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 0.0 110.106 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 13.8 t -69.19 -25.41 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.108 -0.995 . . . . 0.0 109.808 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -49.23 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.368 -0.832 . . . . 0.0 109.98 179.787 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -70.56 -66.88 0.55 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.41 -0.806 . . . . 0.0 110.587 -179.521 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.7 p-10 -58.35 -35.75 72.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -0.924 . . . . 0.0 110.423 -179.582 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 92.0 45.83 3.78 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 15.7 p-10 -96.48 -34.23 11.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -1.17 . . . . 0.0 110.157 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.35 -2.36 5.4 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.5 165.37 27.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -1.213 . . . . 0.0 110.15 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.527 HD11 HG22 ' A' ' 63' ' ' ILE . 34.9 mm -87.07 142.75 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.076 179.864 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.506 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.1 m-20 -130.52 153.15 49.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.922 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.576 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 34.1 t80 -39.38 -51.08 4.77 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.549 -0.72 . . . . 0.0 112.344 -179.088 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.2 Cg_endo -64.9 -27.44 58.77 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.22 1.116 . . . . 0.0 111.265 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HG3' ' CB ' ' A' ' 64' ' ' ASP . 7.3 mt-10 -73.02 -39.92 65.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.832 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -63.54 -50.86 67.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 110.303 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.81 -37.26 78.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -0.874 . . . . 0.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 7.8 m -76.91 -14.59 59.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.285 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 37.0 ttp -79.27 -58.51 3.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.199 -0.938 . . . . 0.0 110.133 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.485 ' O ' ' HG3' ' A' ' 76' ' ' MET . 3.4 tpt -53.17 -16.09 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.409 -0.807 . . . . 0.0 111.013 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.92 -45.8 8.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.878 -1.139 . . . . 0.0 110.579 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -80.7 -10.07 59.75 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.158 -0.964 . . . . 0.0 110.75 -179.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -84.19 -14.83 49.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.077 -1.014 . . . . 0.0 110.427 -179.729 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.485 ' HG3' ' O ' ' A' ' 72' ' ' MET . 15.2 mtt -99.83 60.72 1.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.101 -1.0 . . . . 0.0 110.111 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -159.66 90.7 0.95 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.261 -0.899 . . . . 0.0 110.176 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 3.3 m-20 61.41 79.56 0.25 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.445 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -170.26 -51.69 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.319 -0.863 . . . . 0.0 110.423 -179.947 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 79' ' ' THR . 47.4 m-20 -154.97 91.28 1.35 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.211 -0.93 . . . . 0.0 110.468 -179.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 82' ' ' GLU . 93.8 p -74.02 -68.96 0.47 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' N ' ' OG ' ' A' ' 81' ' ' SER . 3.1 tt0 -100.03 -10.47 21.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 110.077 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.73 -40.98 88.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.645 179.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 7.3 pt-20 -54.41 -23.6 16.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.992 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.459 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 51.8 mt -80.16 -61.42 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.9 . . . . 0.0 109.606 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 85' ' ' ILE . 0.4 OUTLIER -42.57 -30.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.583 -0.698 . . . . 0.0 109.524 179.549 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.531 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 4.4 mm-40 -71.91 -60.6 2.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.408 -0.808 . . . . 0.0 109.264 179.029 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.65 -28.99 6.52 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.149 179.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -70.47 -47.71 59.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 109.758 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -35.19 51.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.755 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.485 ' CG1' HG12 ' B' ' 13' ' ' VAL . 10.6 t -67.68 -45.17 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.652 179.592 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.566 ' CE2' HD23 ' A' ' 105' ' ' LEU . 5.1 m-85 -58.78 -36.76 74.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.975 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -98.8 60.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 110.161 179.831 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -42.78 -32.88 0.66 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.309 -0.87 . . . . 0.0 110.073 179.939 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.2 p30 -77.19 -31.77 55.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.415 -0.803 . . . . 0.0 109.899 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 71.95 51.35 14.99 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.1 p-10 -97.67 -33.48 11.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -1.219 . . . . 0.0 110.014 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 131.51 0.49 4.92 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.585 ' CE2' ' OD1' ' A' ' 137' ' ' ASN . 65.1 m-85 -147.95 149.05 31.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.246 . . . . 0.0 110.595 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.509 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 45.0 mt -104.44 149.28 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.117 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.458 ' N ' HG21 ' A' ' 100' ' ' ILE . 0.6 OUTLIER -139.91 160.46 39.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.016 179.73 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.35 -38.42 58.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.28 -38.73 92.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.109 -0.994 . . . . 0.0 109.811 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -63.81 -47.66 79.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.286 -0.884 . . . . 0.0 109.862 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.599 ' CD1' ' CD1' ' A' ' 125' ' ' ILE . 0.7 OUTLIER -58.9 -34.55 71.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.322 -0.862 . . . . 0.0 109.517 179.552 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 109' ' ' MET . 16.9 ttp85 -59.42 -41.52 89.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.278 -0.889 . . . . 0.0 109.151 179.187 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -54.16 40.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.47 -0.769 . . . . 0.0 109.559 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 2.5 t -51.66 -37.02 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.21 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.527 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 21.0 mtt -58.72 -62.83 1.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.34 -0.85 . . . . 0.0 109.907 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 m -58.85 -31.36 68.46 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.574 179.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -76.53 -17.5 59.21 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.328 179.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 7.0 mt -100.05 -47.68 4.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.845 . . . . 0.0 110.24 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.21 -28.52 1.23 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.791 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.553 ' HG2' ' CD1' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -109.28 134.86 51.25 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.798 -1.413 . . . . 0.0 111.248 -179.325 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 116' ' ' LEU . 6.8 tttt -117.09 78.5 1.22 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.077 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.554 ' CD1' ' O ' ' B' ' 17' ' ' LEU . 7.0 mp -40.69 164.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.612 0.72 . . . . 0.0 111.13 -179.062 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.06 -149.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.581 -0.699 . . . . 0.0 109.712 179.456 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -111.51 -70.33 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 110.144 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 23.4 pt-20 -47.54 -40.1 18.06 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.551 179.802 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 18.8 mt-10 -61.28 -55.6 30.04 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.338 -0.851 . . . . 0.0 109.148 179.027 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.462 HG23 ' HE2' ' A' ' 109' ' ' MET . 73.0 t -50.05 -47.25 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.35 -0.844 . . . . 0.0 109.737 179.266 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.71 -50.19 70.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 109.631 179.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -34.55 68.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.462 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.452 ' HE1' ' CD1' ' B' ' 22' ' ' PHE . 6.5 ttt -56.93 -54.77 42.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.472 -0.767 . . . . 0.0 109.987 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.599 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 33.0 mm -57.64 -43.13 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 109.972 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -50.7 67.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.113 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -48.61 -38.74 21.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.383 -0.823 . . . . 0.0 110.16 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.24 -24.17 37.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.395 -0.816 . . . . 0.0 110.136 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.467 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -67.66 73.93 0.17 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.3 -0.875 . . . . 0.0 110.34 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 mp -53.85 -45.21 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.245 -0.909 . . . . 0.0 110.275 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.4 p30 -77.38 -36.55 53.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.35 65.03 1.11 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.0 p30 -112.11 -28.75 7.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -1.13 . . . . 0.0 110.263 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 118.07 -6.11 15.41 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 100' ' ' ILE . 15.6 mp0 -144.52 169.88 17.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -1.133 . . . . 0.0 109.958 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.432 HG11 ' HB3' ' A' ' 140' ' ' GLU . 69.2 t -121.44 104.92 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.948 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.585 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 8.2 t30 -79.01 167.08 21.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -0.915 . . . . 0.0 110.386 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 139' ' ' GLU . 28.1 t80 -47.33 -58.82 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.334 -0.853 . . . . 0.0 110.058 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 138' ' ' TYR . 45.6 mm-40 -44.44 -42.25 6.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 109.669 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.467 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 4.5 tt0 -68.05 -54.3 19.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.813 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -45.8 -25.66 0.54 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.433 ' O ' HG21 ' A' ' 146' ' ' THR . 12.0 t -93.69 -30.5 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 0.0 109.836 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -58.49 -38.61 78.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.065 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.485 ' SD ' ' OD1' ' B' ' 24' ' ' ASN . 1.9 mmm -64.03 -55.17 24.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 0.0 109.917 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.496 ' HA ' ' HA ' ' B' ' 24' ' ' ASN . 6.1 ttm -67.44 -21.94 65.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 146' ' ' THR . 3.8 t -168.92 90.79 0.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 110.298 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.67 58.52 2.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 110.121 179.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.401 ' HA ' ' HE3' ' A' ' 148' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.193 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.465 ' O ' ' CG2' ' B' ' 1' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.252 0.549 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.87 -125.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.291 -0.881 . . . . 0.0 110.042 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.497 ' O ' ' O ' ' B' ' 4' ' ' ILE . 0.2 OUTLIER -90.7 -69.6 0.72 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.044 -1.035 . . . . 0.0 110.25 179.931 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.497 ' O ' ' O ' ' B' ' 3' ' ' LEU . 6.1 mt 57.01 147.64 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.414 -0.804 . . . . 0.0 110.203 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' B' ' 4' ' ' ILE . 40.2 Cg_endo -69.76 129.04 16.9 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.665 1.35 . . . . 0.0 111.085 -179.064 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.543 ' O ' ' N ' ' B' ' 8' ' ' THR . 3.8 m -86.83 95.96 10.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.494 -0.754 . . . . 0.0 110.813 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.51 ' NE1' HG22 ' A' ' 55' ' ' VAL . 13.9 m95 33.92 -87.82 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.805 -0.559 . . . . 0.0 111.92 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.543 ' N ' ' O ' ' B' ' 6' ' ' SER . 1.3 p -35.38 -38.76 0.11 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.51 -0.744 . . . . 0.0 111.011 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.531 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 4.3 m -57.65 -42.21 83.02 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.571 -0.851 . . . . 0.0 109.736 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' B' ' 7' ' ' TRP . 13.3 t -68.31 -36.6 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.418 -0.801 . . . . 0.0 109.698 179.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.505 HD12 ' N ' ' B' ' 11' ' ' ILE . 2.7 mm -70.0 -19.41 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.359 -0.838 . . . . 0.0 109.442 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.441 ' O ' ' SD ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.5 -57.43 3.94 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.715 0.769 . . . . 0.0 109.527 179.282 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.485 HG12 ' CG1' ' A' ' 91' ' ' VAL . 43.2 t -62.8 -34.36 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.0 110.76 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.432 ' C ' ' HD3' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -69.7 -34.86 74.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.987 . . . . 0.0 110.304 -179.835 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 58.5 m -71.96 -25.8 62.01 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' B' ' 22' ' ' PHE . 0.2 OUTLIER -76.07 -37.49 58.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.305 -0.872 . . . . 0.0 110.828 -179.823 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.554 ' O ' ' CD1' ' A' ' 116' ' ' LEU . 4.4 mp -51.53 -19.54 1.51 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.94 -1.1 . . . . 0.0 110.509 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' B' ' 17' ' ' LEU . 0.3 OUTLIER -21.57 -72.0 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 CA-C-O 121.087 0.47 . . . . 0.0 112.127 -179.446 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.519 ' CA ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -154.08 -114.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 110.136 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.494 ' NH2' ' OE2' ' A' ' 120' ' ' GLU . 1.6 mtm180 -101.25 21.27 14.3 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.901 -1.124 . . . . 0.0 110.087 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 13.7 m -120.75 142.74 49.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.522 ' O ' ' CG ' ' B' ' 16' ' ' MET . 1.2 m-85 -88.96 -63.96 1.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.452 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.58 108.71 0.72 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.535 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 5.6 m-80 -100.58 -42.03 0.22 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.221 -1.164 . . . . 0.0 111.943 -179.342 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 47.7 Cg_endo -81.78 10.81 3.33 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.089 1.047 . . . . 0.0 110.909 -179.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 109.961 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.195 0.521 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -113.2 -11.83 13.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -0.89 . . . . 0.0 110.206 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.443 ' O ' ' CB ' ' A' ' 4' ' ' LEU . 54.0 mm-40 -73.72 99.92 3.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.136 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 0.8 OUTLIER 65.11 97.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.878 . . . . 0.0 110.224 179.953 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.3 m -101.36 128.69 47.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.276 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HA ' HD13 ' A' ' 9' ' ' ILE . 6.8 pt-20 -63.8 -39.17 93.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 110.213 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -47.54 -52.93 15.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.093 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -60.1 -44.09 95.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.975 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 6' ' ' GLU . 82.5 mt -59.78 -48.38 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.985 . . . . 0.0 109.982 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.77 -36.77 62.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.802 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 19.4 mt-10 -60.74 -54.05 49.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 109.619 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -59.67 -43.06 94.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.83 . . . . 0.0 109.706 179.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -36.1 77.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.808 179.642 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -65.2 -42.04 93.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.329 -0.857 . . . . 0.0 109.769 179.573 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.22 -45.18 77.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.415 -0.803 . . . . 0.0 110.002 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.635 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 34.0 t80 -61.29 -29.74 70.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.0 109.813 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 m -83.95 -22.8 31.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.402 -0.811 . . . . 0.0 109.773 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 4.1 tt -71.3 -36.06 71.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.962 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -82.94 -46.05 13.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.234 -0.916 . . . . 0.0 110.053 179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.461 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 17.1 t0 -72.61 101.33 3.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.0 110.215 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.92 -52.34 9.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.139 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.43 -51.04 63.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.345 -0.847 . . . . 0.0 110.166 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.07 22.86 6.67 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 46.6 p-10 -79.83 -21.95 43.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -1.192 . . . . 0.0 110.107 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 97.18 33.2 6.07 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.455 ' CG2' ' C ' ' A' ' 25' ' ' GLY . 44.2 p -153.09 132.48 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.341 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.539 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 6.0 mt -101.06 112.63 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 109.937 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 29' ' ' THR . 51.8 p -97.98 156.92 16.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 110.169 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 28' ' ' THR . 1.9 p -44.53 -27.27 0.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.178 -0.952 . . . . 0.0 109.872 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -55.28 9.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 110.033 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.431 ' O ' ' HB ' ' A' ' 34' ' ' THR . 39.5 mt-10 -57.15 -56.09 26.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.93 . . . . 0.0 110.063 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.458 HD23 HD11 ' A' ' 52' ' ' ILE . 10.4 tp -57.65 -48.66 78.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 109.937 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -51.78 -39.6 47.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.825 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 52.6 m -59.43 -61.07 2.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -1.175 . . . . 0.0 109.715 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 34' ' ' THR . 13.8 t -45.25 -55.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.459 ' HE2' ' CE ' ' A' ' 51' ' ' MET . 0.1 OUTLIER -57.51 -26.96 62.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.809 179.559 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.0 ttm180 -74.23 -19.49 60.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.479 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 19.2 m -96.37 -38.11 10.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.275 -0.891 . . . . 0.0 110.625 -179.704 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 mt -45.67 -29.16 1.16 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.01 -1.056 . . . . 0.0 110.067 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 41' ' ' GLN . . . 125.17 58.63 0.17 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 2.2 mt-30 170.04 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.197 -1.178 . . . . 0.0 110.498 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.54 102.09 3.49 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.276 -0.89 . . . . 0.0 110.349 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.402 ' HG2' HD13 ' A' ' 48' ' ' LEU . 45.1 Cg_endo -73.18 135.77 23.34 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.093 1.575 . . . . 0.0 110.335 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 13.7 t -71.99 -161.93 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.206 -0.934 . . . . 0.0 110.224 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -84.18 -56.38 3.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.019 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.38 -51.22 11.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.016 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.37 -52.35 65.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.865 . . . . 0.0 109.99 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.7 OUTLIER -55.56 -48.69 74.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.342 -0.848 . . . . 0.0 110.23 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -62.21 -32.82 73.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.103 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -32.59 70.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.364 -0.835 . . . . 0.0 110.093 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.459 ' CE ' ' HE2' ' A' ' 36' ' ' MET . 3.1 mtp -78.02 -43.85 28.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.433 -0.792 . . . . 0.0 110.438 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.458 HD11 HD23 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -70.43 -33.82 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.212 -0.93 . . . . 0.0 109.921 -179.993 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.2 m-80 -60.62 -25.87 66.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.486 -0.759 . . . . 0.0 110.743 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -77.92 -47.05 19.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 0.0 110.579 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.588 HG23 ' CE2' ' B' ' 7' ' ' TRP . 19.2 t -71.28 -40.36 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.185 -0.947 . . . . 0.0 110.091 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -63.46 71.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.841 -179.975 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -37.94 -63.25 0.49 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.674 -0.641 . . . . 0.0 110.529 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 3.5 p30 -56.75 -38.85 73.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.102 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.98 48.72 4.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.529 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 16.7 p-10 -98.32 -40.39 8.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -1.182 . . . . 0.0 110.115 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 62' ' ' THR . . . 133.73 21.75 0.79 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.692 179.36 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.529 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 36.3 p -158.06 145.63 18.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.922 -1.34 . . . . 0.0 110.405 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.539 ' CG1' ' HB ' ' A' ' 27' ' ' ILE . 10.8 mm -89.42 144.96 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.349 -0.844 . . . . 0.0 109.803 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -120.59 147.31 45.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.128 -0.982 . . . . 0.0 110.754 -179.578 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.635 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 11.8 t80 -43.85 -49.52 20.5 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.372 -0.83 . . . . 0.0 111.098 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.8 Cg_endo -68.7 -32.49 23.62 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.281 1.148 . . . . 0.0 110.539 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -65.51 -30.17 70.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -76.96 -51.18 11.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.885 . . . . 0.0 110.236 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mp -53.62 -32.38 51.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.376 -0.827 . . . . 0.0 110.214 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.8 m -78.03 -38.34 44.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 110.563 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -67.19 0.45 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.196 -0.94 . . . . 0.0 110.533 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.461 ' HE1' ' CE ' ' A' ' 76' ' ' MET . 6.8 tpt -50.5 -19.87 0.99 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.353 -0.842 . . . . 0.0 110.665 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.86 -29.14 39.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.134 -0.979 . . . . 0.0 110.648 -179.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -93.68 -15.17 25.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.491 ' HB3' HG23 ' B' ' 8' ' ' THR . 0.2 OUTLIER -100.77 40.52 1.26 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 110.419 -179.845 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.461 ' CE ' ' HE1' ' A' ' 72' ' ' MET . 9.9 mmt -100.22 -36.56 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.158 -0.964 . . . . 0.0 110.325 -179.827 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 51.12 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.289 -0.882 . . . . 0.0 110.369 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -120.31 -89.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 110.259 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.5 p -93.16 -16.85 24.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 110.378 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -123.99 100.91 6.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.0 110.359 -179.662 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.463 ' O ' ' OE2' ' A' ' 84' ' ' GLU . 1.6 t -114.15 -59.33 2.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.587 179.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -100.68 -9.9 21.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.904 179.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.482 ' HB2' ' OD1' ' A' ' 80' ' ' ASP . 69.6 mt-10 -75.5 -46.38 32.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.981 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HG2' ' N ' ' A' ' 85' ' ' ILE . 10.2 pm0 -55.59 -23.37 26.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 110.26 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.535 ' N ' ' HG2' ' A' ' 84' ' ' GLU . 24.3 mt -84.22 -46.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 109.203 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -34.29 69.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.459 -0.776 . . . . 0.0 109.216 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 32.0 mt-10 -72.38 -48.77 38.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.223 178.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.54 -35.14 67.77 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.426 -0.797 . . . . 0.0 109.073 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.22 -39.45 78.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.368 -0.833 . . . . 0.0 108.825 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -58.67 -29.89 66.95 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.202 179.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.9 -50.47 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.485 -0.76 . . . . 0.0 109.555 179.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 61.2 m-85 -62.43 -38.49 89.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.26 55.84 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.995 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -56.2 -48.9 75.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.094 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 15.9 p-10 -57.6 -34.55 69.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 110.323 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 74.41 49.02 12.52 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.437 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 27.0 p-10 -98.28 -22.91 15.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -1.103 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.58 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 113.7 6.79 20.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.582 ' CB ' ' NE2' ' A' ' 135' ' ' GLN . 73.0 m-85 -157.71 134.98 10.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.248 -1.148 . . . . 0.0 109.841 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 100' ' ' ILE . 24.9 mt -84.49 155.62 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.1 -1.0 . . . . 0.0 110.541 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 103' ' ' ALA . 4.0 t -139.22 140.56 37.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.454 -0.778 . . . . 0.0 109.72 179.691 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.15 -27.44 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.235 -0.916 . . . . 0.0 110.375 -179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -65.59 -55.58 16.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.674 179.492 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 38.1 mt-10 -55.08 -44.68 75.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.998 179.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.522 ' CD1' HD12 ' A' ' 125' ' ' ILE . 1.1 mt -57.37 -44.93 84.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.9 . . . . 0.0 109.655 179.733 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.475 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.2 OUTLIER -55.94 -38.29 70.11 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.053 -1.029 . . . . 0.0 109.286 179.273 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -32.24 73.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.629 -0.669 . . . . 0.0 109.539 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 26.1 t -81.15 -52.56 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.475 -0.765 . . . . 0.0 110.672 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.528 ' HG3' ' N ' ' A' ' 110' ' ' THR . 11.9 ptp -58.59 -38.6 78.28 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.981 . . . . 0.0 110.389 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.528 ' N ' ' HG3' ' A' ' 109' ' ' MET . 27.1 m -71.15 -40.09 71.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.881 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 38' ' ' SER . 36.5 m-80 -80.07 -4.45 52.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.787 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 5.8 mt -98.23 -30.48 12.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 0.0 109.923 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.38 -53.11 0.59 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 109' ' ' MET . 22.7 tt0 -108.12 143.49 36.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -1.107 . . . . 0.0 110.173 -179.876 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.6 OUTLIER -120.64 18.72 11.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.945 . . . . 0.0 109.643 179.614 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' B' ' 19' ' ' LYS . 3.4 mp 40.11 -164.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.613 0.72 . . . . 0.0 110.656 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.448 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -100.19 -172.87 2.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.462 -0.774 . . . . 0.0 109.269 179.496 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.3 -50.02 8.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 0.0 109.908 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -64.7 -32.83 74.68 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 179.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' B' ' 20' ' ' ARG . 4.8 mt-10 -69.05 -50.72 45.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.359 -0.838 . . . . 0.0 109.236 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 117' ' ' THR . 15.4 t -60.22 -42.06 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.805 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -66.14 -49.98 65.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 179.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -56.11 -25.47 45.99 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.449 -0.782 . . . . 0.0 109.139 179.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.609 ' CE ' ' CD1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.65 -57.57 6.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.567 -0.708 . . . . 0.0 109.854 179.546 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.522 HD12 ' CD1' ' A' ' 105' ' ' LEU . 24.6 mm -64.31 -24.32 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.389 -0.819 . . . . 0.0 110.003 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -76.05 -51.61 11.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.955 . . . . 0.0 110.021 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -12.39 42.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.334 -0.854 . . . . 0.0 110.053 179.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -98.4 -33.25 11.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.53 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.892 . . . . 0.0 110.121 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 130' ' ' ILE . 10.3 mt -72.74 -27.64 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p-10 -96.58 -28.12 14.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 0.0 110.296 -179.892 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.38 75.57 1.14 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 21.1 p-10 -128.1 -18.09 4.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.256 -1.144 . . . . 0.0 110.551 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.64 10.04 36.48 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.582 ' NE2' ' CB ' ' A' ' 99' ' ' TYR . 1.9 pt20 -168.94 170.27 9.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.361 -1.082 . . . . 0.0 109.484 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 35.3 t -114.87 151.95 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.943 -1.098 . . . . 0.0 110.85 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 12.6 t30 -116.77 -169.6 1.67 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.513 -0.742 . . . . 0.0 109.506 179.668 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.554 ' CE1' HG22 ' A' ' 142' ' ' VAL . 8.5 t80 -67.83 -52.83 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.931 -1.105 . . . . 0.0 110.061 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -46.17 -67.46 0.28 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.319 -0.863 . . . . 0.0 110.188 179.964 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' PHE . 4.8 tt0 -43.87 -59.39 2.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 109.766 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.568 ' CE1' ' HE1' ' B' ' 16' ' ' MET . 42.9 t80 -43.48 -26.05 0.19 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.831 179.415 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.554 HG22 ' CE1' ' A' ' 138' ' ' TYR . 68.8 t -98.93 -30.77 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.369 -0.832 . . . . 0.0 110.639 -179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -65.65 -40.71 92.75 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.097 -1.002 . . . . 0.0 110.584 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -36.56 68.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.219 -0.926 . . . . 0.0 110.559 -179.708 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.56 ' CE ' ' HB2' ' B' ' 24' ' ' ASN . 3.7 mtt -85.0 -26.06 27.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.48 ' O ' ' CG2' ' A' ' 146' ' ' THR . 9.6 t -170.05 96.87 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.128 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.44 49.53 1.39 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.349 -0.844 . . . . 0.0 110.362 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 pttp . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.241 179.941 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' B' ' 2' ' ' LYS . 24.8 t . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 121.167 0.508 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' B' ' 1' ' ' VAL . 3.9 mtmp? 54.47 103.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.036 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' B' ' 4' ' ' ILE . 2.1 mt -123.71 -90.13 0.58 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.146 -0.971 . . . . 0.0 110.062 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.53 ' O ' ' O ' ' B' ' 3' ' ' LEU . 6.7 mm 56.09 136.04 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.662 -0.649 . . . . 0.0 110.704 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.68 139.07 36.25 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.543 1.286 . . . . 0.0 110.591 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.486 ' O ' ' CG2' ' B' ' 10' ' ' VAL . 40.9 t -73.11 -159.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.845 . . . . 0.0 110.724 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.588 ' CE2' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -82.3 -82.29 0.14 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.553 -0.717 . . . . 0.0 110.724 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 75' ' ' LYS . 23.9 p -40.09 -34.99 0.34 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.622 -0.674 . . . . 0.0 110.42 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.42 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 40.1 m -59.85 -53.41 58.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 109.3 179.27 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' B' ' 6' ' ' SER . 61.9 t -50.51 -41.85 20.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.301 -0.875 . . . . 0.0 109.124 178.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.478 HD11 ' O ' ' B' ' 7' ' ' TRP . 2.8 mp -61.95 -59.59 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.561 -0.712 . . . . 0.0 110.103 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.444 ' CD2' ' CE2' ' B' ' 26' ' ' PHE . 3.2 mm? -39.94 -50.64 2.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.497 -0.752 . . . . 0.0 110.992 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.497 ' O ' HD12 ' B' ' 17' ' ' LEU . 94.8 t -56.65 -51.98 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.111 -0.993 . . . . 0.0 110.531 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.479 ' HA ' HD11 ' A' ' 112' ' ' LEU . 19.3 tptt -56.02 -49.99 72.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.86 -1.15 . . . . 0.0 109.762 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.446 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.6 OUTLIER -68.74 -6.47 26.64 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 179.045 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.572 ' HE2' ' CE2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -80.13 -45.2 18.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.362 -0.836 . . . . 0.0 110.548 -179.861 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.548 ' HA ' ' HE2' ' A' ' 124' ' ' MET . 0.0 OUTLIER -100.31 32.6 2.96 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 118.515 -1.274 . . . . 0.0 110.529 179.36 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.497 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 57.0 ttt180 -44.28 -58.95 2.61 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.56 -0.713 . . . . 0.0 109.859 179.3 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.528 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -144.59 -118.09 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.221 -0.924 . . . . 0.0 110.007 179.578 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.409 ' HD2' ' OE1' ' A' ' 120' ' ' GLU . 25.5 mtp180 -97.03 25.27 5.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.884 -1.135 . . . . 0.0 109.957 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.45 ' O ' ' HE1' ' A' ' 124' ' ' MET . 0.6 OUTLIER -113.04 152.97 28.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.667 -179.352 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.609 ' CD1' ' CE ' ' A' ' 124' ' ' MET . 1.2 t80 -124.13 -25.64 4.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.875 . . . . 0.0 110.317 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.87 109.84 3.9 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.56 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 1.5 m-80 -81.57 156.18 70.84 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -1.178 . . . . 0.0 109.88 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' B' ' 26' ' ' PHE . 43.3 Cg_endo -74.72 -68.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.857 1.451 . . . . 0.0 110.432 -179.804 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.491 ' CD1' ' HB3' ' B' ' 24' ' ' ASN . 15.5 m-85 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.396 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.145 0.497 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 3' ' ' GLN . 3.3 m-20 -113.74 -40.59 3.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.301 -0.874 . . . . 0.0 110.254 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 2' ' ' ASP . 28.2 mm-40 -42.98 107.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 5' ' ' THR . 9.7 mt -102.76 133.14 48.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.276 -0.89 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 4' ' ' LEU . 7.4 p 44.46 99.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.471 -0.768 . . . . 0.0 110.656 179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.459 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 3.5 mt-10 -82.39 -39.48 22.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.319 -0.863 . . . . 0.0 109.992 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.59 -57.76 11.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.926 179.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -49.48 -45.47 46.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.794 179.658 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 40.2 mt -49.91 -48.36 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.662 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.7 -48.75 66.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.331 -0.856 . . . . 0.0 109.565 179.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -55.12 -52.22 63.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.612 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.415 ' HB3' HD13 ' A' ' 69' ' ' LEU . 55.1 m-85 -57.75 -45.38 85.94 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.321 -0.862 . . . . 0.0 109.427 179.467 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -33.67 57.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 109.247 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.7 -47.82 79.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.535 -0.728 . . . . 0.0 109.661 179.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -62.46 -44.32 96.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -0.85 . . . . 0.0 109.543 179.485 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.6 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 23.9 t80 -63.74 -35.59 81.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.378 -0.826 . . . . 0.0 109.708 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.2 m -78.1 -20.64 51.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -0.842 . . . . 0.0 109.854 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -69.5 -46.95 65.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.43 -0.794 . . . . 0.0 109.789 179.799 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 21' ' ' LYS . 75.5 m-85 -69.57 -59.31 3.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 109.939 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.46 91.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.343 -0.848 . . . . 0.0 110.247 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 19' ' ' PHE . 4.0 mmtp -77.49 -26.57 51.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.129 -0.982 . . . . 0.0 110.22 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.7 p-10 -97.73 -20.72 17.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.275 -0.89 . . . . 0.0 110.326 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.61 78.79 0.92 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 45.2 p-10 -139.39 8.47 2.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -1.151 . . . . 0.0 110.061 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.444 ' O ' ' CG2' ' A' ' 26' ' ' THR . . . 65.34 35.01 90.95 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -163.85 119.31 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.236 -1.155 . . . . 0.0 110.444 -179.903 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 27' ' ' ILE . 13.3 mt -83.18 134.4 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.086 -1.009 . . . . 0.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 20.1 p -98.82 179.98 4.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' HD12 ' A' ' 48' ' ' LEU . 1.2 p -70.89 -53.27 15.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -61.39 -48.8 79.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.217 -0.927 . . . . 0.0 110.455 -179.948 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OG1' ' A' ' 28' ' ' THR . 23.3 mt-10 -41.92 -69.81 0.12 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.208 -0.932 . . . . 0.0 109.947 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.435 HD12 ' CE1' ' A' ' 19' ' ' PHE . 22.5 tp -49.55 -32.43 12.5 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.125 -0.984 . . . . 0.0 109.07 179.386 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.74 95.04 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.769 -1.733 . . . . 0.0 108.769 179.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.1 m -54.76 -44.54 73.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.293 -1.122 . . . . 0.0 109.111 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.8 t -64.31 -44.72 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.446 -0.784 . . . . 0.0 109.398 179.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.411 ' HA ' HD13 ' A' ' 39' ' ' LEU . 2.0 mmt -62.28 -34.89 77.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.315 -0.866 . . . . 0.0 109.663 179.369 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -34.31 77.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.501 179.386 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -26.58 54.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.577 -0.702 . . . . 0.0 110.386 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 36' ' ' MET . 4.7 mt -69.77 -32.44 70.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.131 -0.98 . . . . 0.0 109.985 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.06 -46.98 0.7 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.382 179.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.56 -176.46 6.26 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.1 -1.235 . . . . 0.0 111.242 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 8.1 p30 -144.82 105.07 4.52 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.538 -0.726 . . . . 0.0 109.446 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.551 ' HA ' ' CD1' ' B' ' 4' ' ' ILE . 44.0 Cg_endo -72.23 151.49 54.81 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 O-C-N 124.054 1.555 . . . . 0.0 111.046 -179.304 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 56.2 m -98.16 174.62 6.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.909 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -41.83 61.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.118 -0.989 . . . . 0.0 110.451 -179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.17 -48.82 74.51 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.066 -1.021 . . . . 0.0 110.281 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -64.45 -49.35 71.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.348 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.489 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 6.3 mt -52.34 -49.66 63.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.965 . . . . 0.0 110.109 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -54.73 -41.44 70.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 109.669 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.84 -25.54 62.88 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.315 -0.865 . . . . 0.0 109.464 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.541 ' HE2' ' CG ' ' B' ' 7' ' ' TRP . 0.4 OUTLIER -73.63 -40.92 63.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.894 179.678 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -28.5 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.293 -0.879 . . . . 0.0 109.478 179.733 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.71 -14.15 12.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.314 -0.866 . . . . 0.0 110.113 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -85.8 -49.27 8.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 111.069 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 21.7 t -69.1 -47.5 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.877 -1.14 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -45.89 89.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.388 0.613 . . . . 0.0 110.329 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -98.0 -9.07 26.7 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.186 -0.946 . . . . 0.0 110.59 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 5.7 p30 -100.65 -32.67 10.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.961 -1.087 . . . . 0.0 110.791 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 103.57 45.91 1.48 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 23.1 m120 -100.03 -19.82 16.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.119 -1.224 . . . . 0.0 110.037 179.833 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.89 -11.68 70.55 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.99 170.09 17.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.106 . . . . 0.0 110.109 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.2 mm -89.9 124.85 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.423 -0.798 . . . . 0.0 110.493 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.535 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 4.5 m-20 -97.07 -177.43 3.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.274 -0.892 . . . . 0.0 110.639 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.6 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 17.9 t80 -68.5 -48.37 33.7 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.392 -0.817 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.9 Cg_endo -67.69 -32.58 30.04 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 O-C-N 123.294 1.155 . . . . 0.0 110.006 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE2' ' OD1' ' A' ' 64' ' ' ASP . 6.9 mt-10 -63.34 -36.65 84.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.187 -0.946 . . . . 0.0 109.105 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE1' HG22 ' B' ' 11' ' ' ILE . 5.5 t80 -64.48 -58.24 6.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.779 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD13 ' HB3' ' A' ' 12' ' ' PHE . 2.0 mp -58.01 -30.53 66.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.329 -0.857 . . . . 0.0 110.199 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.437 ' O ' HG21 ' A' ' 70' ' ' THR . 39.9 m -84.29 -21.9 30.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.182 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.474 ' HG3' HG12 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -69.45 -45.8 68.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 0.0 109.929 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.575 ' HE1' ' CE1' ' B' ' 26' ' ' PHE . 93.3 mmm -57.29 -15.0 5.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 110.222 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.26 -20.57 14.07 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.153 -0.967 . . . . 0.0 110.572 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 -27.01 20.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.026 . . . . 0.0 110.191 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -99.85 -34.2 10.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.33 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -98.13 60.77 1.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -0.934 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 7.6 ttpp -98.13 -39.04 9.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.095 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 1.1 t70 176.07 -29.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.294 -0.879 . . . . 0.0 110.107 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -43.13 -73.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.257 -0.902 . . . . 0.0 110.579 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.479 ' O ' ' OE1' ' A' ' 84' ' ' GLU . 41.6 p-10 -102.19 115.12 29.89 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.197 -0.94 . . . . 0.0 110.651 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.15 -42.69 3.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.465 179.376 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -100.64 -11.97 19.58 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.456 -0.777 . . . . 0.0 110.035 179.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -77.38 -40.5 43.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.197 -0.94 . . . . 0.0 110.559 -179.658 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.479 ' OE1' ' O ' ' A' ' 80' ' ' ASP . 11.2 pt-20 -68.81 -22.58 64.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 110.633 -179.762 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.415 HG23 ' CG2' ' A' ' 142' ' ' VAL . 90.3 mt -76.62 -31.42 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.064 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -65.88 -37.25 85.64 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.346 -0.846 . . . . 0.0 109.651 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.536 ' CB ' HG22 ' B' ' 9' ' ' THR . 4.9 mt-10 -68.7 -52.58 29.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 179.356 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 141' ' ' PHE . . . -55.64 -29.86 59.96 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.402 -0.811 . . . . 0.0 109.649 179.63 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -69.08 -44.37 72.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 109.333 179.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -37.99 54.24 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 109.191 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 108' ' ' VAL . 54.9 t -63.48 -51.6 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.679 . . . . 0.0 109.995 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 105' ' ' LEU . 20.1 m-85 -62.29 -34.9 77.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.168 -0.958 . . . . 0.0 109.995 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -100.46 67.32 1.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.801 . . . . 0.0 109.931 179.835 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 93' ' ' ASP . 3.0 tttp -37.45 -36.87 0.17 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.66 -0.65 . . . . 0.0 110.568 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.9 p30 -83.43 -31.78 26.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.291 -0.881 . . . . 0.0 110.088 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 75.47 33.77 51.89 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 31.4 p-10 -84.73 -31.59 23.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -1.179 . . . . 0.0 110.322 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 117.24 43.55 0.6 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -169.4 124.26 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -1.083 . . . . 0.0 109.959 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 38.1 mt -110.4 116.29 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.585 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -106.02 148.61 27.53 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 109.547 179.237 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -37.9 -34.46 0.11 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.443 -0.786 . . . . 0.0 110.516 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -63.02 -50.41 70.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 0.0 109.487 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 25.1 mt-10 -55.47 -47.65 75.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.599 179.504 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.578 HD22 ' CE2' ' A' ' 92' ' ' PHE . 2.4 mt -51.11 -41.77 60.25 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.267 -0.896 . . . . 0.0 109.267 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.487 ' HG2' HG22 ' A' ' 121' ' ' VAL . 1.1 mmm180 -60.43 -34.37 73.87 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.464 -0.772 . . . . 0.0 109.916 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 8.8 m170 -69.98 -22.25 63.16 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 92' ' ' PHE . 2.1 t -88.29 -45.28 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.168 -0.957 . . . . 0.0 110.715 -179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.543 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 13.1 ptp -63.56 -44.85 92.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.925 -1.109 . . . . 0.0 110.691 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.503 ' N ' ' CG ' ' A' ' 109' ' ' MET . 1.8 m -60.73 -27.77 68.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.038 -1.039 . . . . 0.0 109.928 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 5.8 m120 -82.53 -7.95 59.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.914 . . . . 0.0 110.159 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.564 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 16.4 mt -114.05 -8.55 13.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.43 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.59 -59.55 0.65 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.422 -1.371 . . . . 0.0 111.148 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.444 ' HG2' HD11 ' A' ' 116' ' ' LEU . 17.8 tt0 -72.12 152.55 42.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.996 -1.296 . . . . 0.0 111.28 -178.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 116' ' ' LEU . 4.1 mtmt -132.01 68.06 1.51 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.495 -0.753 . . . . 0.0 109.77 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.52 ' N ' ' SD ' ' A' ' 109' ' ' MET . 3.0 mp -40.56 119.25 1.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.295 -0.878 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.478 ' O ' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -50.82 177.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.277 -0.889 . . . . 0.0 110.455 -179.464 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -64.71 -52.28 57.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.107 -0.996 . . . . 0.0 110.088 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 10.6 pt-20 -59.92 -42.81 94.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.531 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.417 ' N ' ' CG ' ' A' ' 119' ' ' GLU . 1.8 mt-10 -61.66 -43.54 98.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.421 -0.8 . . . . 0.0 109.446 179.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 116' ' ' LEU . 52.0 t -68.02 -48.46 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.328 -0.858 . . . . 0.0 109.596 179.453 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.21 -38.07 76.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.4 OUTLIER -68.71 -33.56 74.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.855 . . . . 0.0 109.677 179.593 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.569 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 12.0 ttt -64.25 -39.99 95.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.87 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.555 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 11.0 mm -74.37 -54.37 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.232 -0.917 . . . . 0.0 109.676 179.541 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.03 -53.38 53.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 110.145 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 7.7 tp10 -51.99 -30.05 23.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.827 . . . . 0.0 110.162 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -96.81 -25.85 15.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.392 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.47 ' OD2' HG23 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -47.2 92.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.266 -0.896 . . . . 0.0 110.556 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.6 mt -80.85 -34.01 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.39 179.403 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.46 ' OD2' ' OD2' ' A' ' 133' ' ' ASP . 9.1 p-10 -87.46 -37.93 16.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.483 -0.761 . . . . 0.0 109.868 179.685 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.24 71.83 0.95 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 3.4 p30 -140.43 9.7 2.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -1.171 . . . . 0.0 109.93 179.475 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.468 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 58.13 15.12 20.71 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 15.4 mt-30 -146.64 170.18 17.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.354 -1.086 . . . . 0.0 110.341 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 54.6 t -131.47 129.91 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 109.81 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 137' ' ' ASN . 14.2 p-10 -114.01 -160.08 0.72 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.115 -0.991 . . . . 0.0 110.579 -179.462 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 139' ' ' GLU . 62.1 t80 -62.91 -63.6 1.16 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.887 . . . . 0.0 110.31 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -40.95 -67.86 0.22 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.325 -0.859 . . . . 0.0 110.311 -179.909 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.401 ' HB3' HG11 ' A' ' 136' ' ' VAL . 12.7 tt0 -44.6 -60.91 1.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 88' ' ' ALA . 39.1 t80 -46.08 -23.91 0.37 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.29 -0.881 . . . . 0.0 110.308 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.415 ' CG2' HG23 ' A' ' 85' ' ' ILE . 91.6 t -98.75 -31.67 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 110.241 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.48 ' NE2' ' HA ' ' A' ' 143' ' ' GLN . 7.1 mm100 -66.2 -13.79 60.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.94 . . . . 0.0 110.263 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.419 ' HB3' ' HA2' ' B' ' 23' ' ' GLY . 0.9 OUTLIER -97.47 -20.31 17.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.261 -0.9 . . . . 0.0 110.475 -179.852 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.585 ' CE ' ' CD2' ' B' ' 12' ' ' LEU . 2.1 mtt -99.56 -11.28 21.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 110.218 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 146' ' ' THR . 2.7 t -164.95 84.42 0.39 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 110.072 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 148' ' ' LYS . . . -99.1 8.04 45.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.032 -1.043 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.551 ' CG ' ' O ' ' A' ' 147' ' ' ALA . 2.2 mttm . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.161 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 121.109 0.481 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' B' ' 2' ' ' LYS . 3.4 pttp -170.91 63.12 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.232 -0.917 . . . . 0.0 110.346 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' B' ' 4' ' ' ILE . 3.3 mm? -90.25 16.19 9.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 0.0 109.788 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 43' ' ' PRO . 16.6 mt -40.89 141.27 0.98 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.591 -0.693 . . . . 0.0 110.086 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.465 ' HD2' HG21 ' B' ' 4' ' ' ILE . 40.7 Cg_endo -68.64 -175.65 0.97 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.963 1.507 . . . . 0.0 110.165 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.31 -169.14 1.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.075 -1.016 . . . . 0.0 110.898 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.56 ' O ' ' CG2' ' B' ' 10' ' ' VAL . 0.9 OUTLIER -71.51 -77.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.579 -0.7 . . . . 0.0 110.658 -179.622 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.465 ' C ' ' O ' ' B' ' 7' ' ' TRP . 2.8 p -41.15 -25.78 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.025 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.536 HG22 ' CB ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -63.99 -65.38 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 179.146 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.56 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 4.8 m -47.23 -29.87 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.154 -0.966 . . . . 0.0 109.501 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.518 HG22 ' CE1' ' A' ' 68' ' ' PHE . 7.1 mm -75.7 -45.8 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.321 179.267 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.585 ' CD2' ' CE ' ' A' ' 145' ' ' MET . 0.9 OUTLIER -47.74 -56.51 7.19 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.542 0.687 . . . . 0.0 110.225 179.655 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' A' ' 92' ' ' PHE . 22.1 t -60.04 -51.94 67.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 110.734 -179.538 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.42 ' HA ' HD11 ' A' ' 112' ' ' LEU . 24.0 tptt -66.62 -14.61 62.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.926 -1.108 . . . . 0.0 109.975 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 23.3 t -77.71 -33.01 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.872 . . . . 0.0 109.962 179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.448 ' O ' ' HE2' ' A' ' 124' ' ' MET . 0.0 OUTLIER -90.67 -14.73 31.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.786 -179.743 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.543 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 3.8 mp -73.72 51.11 0.36 Allowed 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.156 -0.965 . . . . 0.0 111.201 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.469 ' HB3' ' OG ' ' B' ' 21' ' ' SER . 0.1 OUTLIER -104.2 -107.41 0.28 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.116 -0.99 . . . . 0.0 109.817 179.426 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.494 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 0.1 OUTLIER -107.48 -70.16 0.81 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.026 -1.046 . . . . 0.0 109.513 179.677 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.486 ' HB3' ' CD ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -135.45 13.4 3.49 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.36 -0.837 . . . . 0.0 109.804 179.38 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -66.41 120.3 13.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.336 -0.853 . . . . 0.0 110.297 179.866 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.569 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -144.87 26.96 1.34 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.976 . . . . 0.0 110.953 179.965 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 144' ' ' MET . . . -118.65 -119.81 2.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 145' ' ' MET . 5.2 t-20 -129.51 70.73 82.0 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.327 -1.102 . . . . 0.0 109.962 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.23 47.2 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.877 1.462 . . . . 0.0 110.21 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.575 ' CE1' ' HE1' ' A' ' 72' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.952 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.344 0.592 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 4' ' ' LEU . 12.0 p30 -69.33 -118.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.217 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 7.7 pt20 -62.52 74.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.992 -1.068 . . . . 0.0 110.411 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.624 ' CD1' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -41.69 167.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -0.859 . . . . 0.0 110.898 179.57 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.506 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 73.6 m 43.67 68.59 0.5 Allowed 'General case' 0 C--N 1.311 -1.09 0 O-C-N 121.44 -0.788 . . . . 0.0 110.926 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -99.59 -26.03 14.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.401 -0.812 . . . . 0.0 109.753 179.426 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.457 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 18.0 mt-10 -69.33 -63.34 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.831 . . . . 0.0 110.124 179.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -45.9 -54.5 8.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 109.923 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.506 ' CD1' ' O ' ' A' ' 5' ' ' THR . 84.9 mt -53.67 -45.46 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 7' ' ' GLU . . . -50.33 -44.8 54.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.092 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.455 ' OE1' ' HD3' ' B' ' 18' ' ' ARG . 1.6 mt-10 -59.65 -47.12 86.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.943 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -60.64 -39.08 86.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.66 97.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.957 . . . . 0.0 109.932 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.72 -38.16 80.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.304 -0.872 . . . . 0.0 109.832 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -66.36 -51.94 52.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.247 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.549 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 15.3 t80 -62.87 -34.29 77.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.199 -0.938 . . . . 0.0 109.824 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.9 t -73.19 -19.23 61.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.836 . . . . 0.0 109.812 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 112' ' ' LEU . 10.5 tt -80.76 -34.93 33.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.356 -0.84 . . . . 0.0 110.066 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.413 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 70.2 m-85 -86.4 -44.78 11.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.35 -0.844 . . . . 0.0 110.517 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -77.63 85.79 3.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.312 -0.868 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -66.84 -40.66 88.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.892 . . . . 0.0 110.124 179.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -57.1 -43.88 82.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.419 -0.8 . . . . 0.0 110.161 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.26 0.36 67.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.472 ' OD2' HG22 ' A' ' 26' ' ' THR . 6.9 p-10 -74.84 -28.29 60.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.212 -1.169 . . . . 0.0 109.975 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.482 ' C ' ' CG2' ' A' ' 26' ' ' THR . . . 110.73 37.73 1.68 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.711 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 28.3 p -152.41 109.97 3.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.152 -1.204 . . . . 0.0 110.661 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.526 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 22.3 mt -80.73 115.12 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.196 -0.94 . . . . 0.0 109.442 179.292 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -93.64 174.65 7.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.283 -0.886 . . . . 0.0 110.228 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -30.13 71.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.043 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -73.0 -54.09 9.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.879 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -50.84 -69.91 0.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 109.865 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 tp -52.77 -36.51 58.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.739 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -62.08 -40.55 99.08 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.713 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 m -58.27 -51.87 67.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -1.086 . . . . 0.0 109.799 179.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 t -60.29 -47.53 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.858 . . . . 0.0 109.963 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.479 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 2.3 mmt -59.56 -43.02 93.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.12 -0.988 . . . . 0.0 109.895 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -65.56 -20.65 66.42 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.342 -0.849 . . . . 0.0 110.109 179.805 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.8 t -77.83 -57.41 3.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.891 . . . . 0.0 110.288 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mt -46.61 -25.64 0.75 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.156 -0.965 . . . . 0.0 110.071 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.83 66.11 0.56 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -137.69 -157.63 0.79 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.174 -1.192 . . . . 0.0 110.288 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 42' ' ' ASN . 18.0 t30 -147.54 62.8 7.33 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.291 -0.881 . . . . 0.0 110.082 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.479 ' HG3' ' CB ' ' A' ' 36' ' ' MET . 48.7 Cg_endo -74.7 118.59 5.37 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.073 1.565 . . . . 0.0 110.559 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 45' ' ' GLU . 28.1 m -99.96 146.36 26.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.317 -0.864 . . . . 0.0 109.938 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 44' ' ' THR . 21.7 pt-20 -43.12 -44.75 5.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.17 -0.956 . . . . 0.0 110.0 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -65.31 -65.04 0.72 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 109.802 179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.414 ' OE1' ' CB ' ' B' ' 2' ' ' LYS . 1.1 mm-40 -46.55 -43.24 16.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.683 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -55.66 18.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.351 -0.843 . . . . 0.0 109.785 179.674 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -38.52 19.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.768 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -64.76 -33.69 76.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.416 -0.803 . . . . 0.0 110.104 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.552 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.5 OUTLIER -77.18 -37.9 52.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -68.94 -33.81 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.782 179.85 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.77 -46.93 42.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.342 -0.849 . . . . 0.0 110.603 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -59.56 -56.72 18.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 0.0 110.697 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 28.5 t -70.28 -42.77 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.023 -1.048 . . . . 0.0 110.252 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 60' ' ' ASN . 1.7 t70 -64.95 67.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -40.49 -51.5 2.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.551 -0.718 . . . . 0.0 110.886 -179.74 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 6.7 p-10 -67.47 -43.85 80.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 0.0 110.524 -179.621 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' CA ' ' OD2' ' A' ' 56' ' ' ASP . . . 92.72 49.03 2.81 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.53 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 19.2 p30 -100.08 -17.76 17.31 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.168 -1.195 . . . . 0.0 110.202 179.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.16 14.2 31.49 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.15 133.33 16.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.116 -1.226 . . . . 0.0 110.183 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.526 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 26.1 mm -84.57 156.27 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.386 -0.821 . . . . 0.0 110.218 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.549 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 15.2 t0 -129.82 169.06 15.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.04 -1.037 . . . . 0.0 110.453 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.616 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 51.7 t80 -61.32 -40.03 68.47 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 111.522 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.4 Cg_endo -71.91 -29.72 14.88 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 O-C-N 123.284 1.15 . . . . 0.0 110.22 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -70.48 -31.34 68.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -0.888 . . . . 0.0 109.418 179.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 23.6 t80 -72.73 -46.11 55.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.384 -0.822 . . . . 0.0 110.421 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.514 ' CD1' ' CE2' ' A' ' 65' ' ' PHE . 28.0 mt -66.92 -25.46 66.38 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.212 -0.93 . . . . 0.0 110.778 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.8 m -83.68 -28.62 28.22 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.1 -1.0 . . . . 0.0 110.893 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.42 ' SD ' ' HE3' ' A' ' 75' ' ' LYS . 5.5 tmm? -77.29 -47.59 19.68 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.134 -0.978 . . . . 0.0 111.046 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.579 ' HE1' ' CE1' ' B' ' 26' ' ' PHE . 7.3 tpt -60.31 -10.89 5.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.118 -0.989 . . . . 0.0 111.102 -179.293 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.52 -36.58 8.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.938 -1.101 . . . . 0.0 110.942 -179.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.5 ttt-85 -85.18 -11.26 55.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.133 -0.979 . . . . 0.0 110.6 -179.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.42 ' HE3' ' SD ' ' A' ' 71' ' ' MET . 1.7 tppp? -100.39 -12.82 19.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.002 -1.061 . . . . 0.0 110.669 -179.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.519 ' CE ' ' HE2' ' A' ' 72' ' ' MET . 0.4 OUTLIER -99.63 -36.8 9.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.114 -0.991 . . . . 0.0 110.643 -179.611 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' CA ' ' HE2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -65.34 -9.05 21.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.093 -1.004 . . . . 0.0 110.447 -179.724 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -80.48 -87.91 0.07 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.11 -0.993 . . . . 0.0 110.376 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -155.08 -107.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.86 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.468 ' N ' ' OG1' ' A' ' 79' ' ' THR . 1.0 OUTLIER 42.23 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.004 -1.06 . . . . 0.0 110.263 -179.964 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.496 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 74.3 m -125.05 -42.53 2.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 110.004 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -100.3 -20.97 15.62 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.363 -0.836 . . . . 0.0 110.154 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -80.41 -40.1 27.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 0.0 109.919 179.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 80' ' ' ASP . 22.8 pt-20 -69.36 -27.64 65.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.262 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 81' ' ' SER . 80.0 mt -78.53 -36.14 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.113 -0.992 . . . . 0.0 109.957 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -64.66 -29.84 70.85 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 109.802 179.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HB3' HG22 ' B' ' 9' ' ' THR . 9.5 mm-40 -75.43 -50.78 14.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 109.109 179.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.57 -35.73 76.78 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.338 -0.852 . . . . 0.0 109.455 179.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 17.3 t80 -64.44 -56.95 10.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 109.847 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -44.31 -38.22 3.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.402 -0.812 . . . . 0.0 109.556 179.709 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.0 t -65.99 -35.92 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 109.826 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.546 ' CE1' HG12 ' A' ' 108' ' ' VAL . 9.1 m-85 -68.64 -35.68 77.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.164 -0.96 . . . . 0.0 110.474 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.439 ' OD1' HG12 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -98.82 63.59 1.4 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.21 -0.931 . . . . 0.0 110.402 -179.416 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -43.31 -28.22 0.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.277 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 27.6 p-10 -96.1 -36.98 10.8 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.19 -0.944 . . . . 0.0 110.436 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.23 44.0 14.77 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.417 ' ND2' ' OD2' ' A' ' 95' ' ' ASP . 21.7 p30 -78.17 -15.31 58.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -1.145 . . . . 0.0 110.374 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.501 ' C ' ' CG ' ' A' ' 99' ' ' TYR . . . 118.37 -8.39 13.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.501 ' CG ' ' C ' ' A' ' 98' ' ' GLY . 5.3 m-85 -148.88 163.89 36.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -1.186 . . . . 0.0 110.155 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 7.1 mt -113.01 126.32 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 110.133 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.1 p -106.36 153.15 22.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.835 . . . . 0.0 110.09 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.75 -37.84 9.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.05 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.44 93.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -55.52 -43.01 75.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.849 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.526 ' CD1' HD13 ' A' ' 125' ' ' ILE . 2.7 mt -57.92 -48.05 81.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.716 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.439 ' O ' ' OG1' ' A' ' 110' ' ' THR . 0.3 OUTLIER -50.83 -42.56 58.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.838 . . . . 0.0 109.754 179.79 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.81 -48.45 81.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 109.75 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.546 HG12 ' CE1' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -74.42 -25.8 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 0.0 109.416 179.631 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.525 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 0.5 OUTLIER -71.04 -50.05 38.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 110.108 179.98 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -71.41 -31.67 67.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.187 179.934 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -72.55 -6.46 44.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.245 -0.909 . . . . 0.0 110.438 -179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.522 ' CD1' HG11 ' B' ' 13' ' ' VAL . 6.4 mt -106.53 -44.72 4.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.106 -0.996 . . . . 0.0 110.617 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.69 -46.93 0.51 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.405 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.44 ' HG2' HD11 ' A' ' 116' ' ' LEU . 14.2 tt0 -98.48 141.67 31.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.067 -1.255 . . . . 0.0 110.659 -179.613 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 116' ' ' LEU . 3.2 ptpt -119.56 16.46 12.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 109.748 179.406 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 115' ' ' LYS . 4.0 mp 39.45 -164.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.684 0.754 . . . . 0.0 110.842 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.16 -147.98 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.562 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -107.58 -48.56 3.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 109.969 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -67.24 -34.84 78.31 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.538 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.48 -44.68 82.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.272 -0.893 . . . . 0.0 109.097 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.0 t -53.25 -48.64 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.412 -0.805 . . . . 0.0 109.646 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -65.07 -56.24 14.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.75 -30.05 13.0 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.41 -0.806 . . . . 0.0 109.437 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.574 ' HE1' ' CD2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.61 -62.4 1.84 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.339 -0.851 . . . . 0.0 109.689 179.544 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.526 HD13 ' CD1' ' A' ' 105' ' ' LEU . 48.0 mm -56.33 -34.24 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -0.78 . . . . 0.0 110.258 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -66.91 -44.18 81.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 110.323 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.77 -29.66 69.67 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 0.0 110.215 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.18 -31.18 34.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -0.953 . . . . 0.0 110.015 179.799 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.469 ' HB3' ' HA2' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -65.6 106.2 1.4 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.372 -0.83 . . . . 0.0 110.483 -179.968 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.2 mm -64.3 -28.04 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 12.3 p30 -105.54 -16.43 14.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.958 179.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 64.02 59.36 8.63 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.441 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 6.3 p-10 -101.0 -23.96 14.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -1.146 . . . . 0.0 109.941 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 135' ' ' GLN . . . 131.79 -12.72 5.35 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.478 ' CG ' ' C ' ' A' ' 134' ' ' GLY . 9.7 mt-30 -151.31 161.16 43.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.152 -1.205 . . . . 0.0 110.073 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 19.3 t -105.67 157.85 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.908 179.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 1.9 p-10 -127.23 -179.54 4.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.221 -0.925 . . . . 0.0 110.445 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -61.03 -67.15 0.43 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.447 -0.783 . . . . 0.0 110.647 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 0.7 OUTLIER -45.32 -27.67 0.71 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.238 -0.914 . . . . 0.0 110.628 -179.49 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.466 ' HB2' ' ND2' ' A' ' 137' ' ' ASN . 4.2 tt0 -80.49 -52.51 7.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 69.3 t80 -54.33 -17.39 2.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.18 -0.95 . . . . 0.0 109.859 179.638 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.462 ' O ' ' OG1' ' A' ' 146' ' ' THR . 48.1 t -99.45 -55.3 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 110.637 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 0.5 OUTLIER -58.93 -13.79 7.36 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.118 -0.988 . . . . 0.0 110.78 -179.559 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.454 ' HG3' ' HA2' ' B' ' 23' ' ' GLY . 3.7 tpt -97.55 -27.27 14.48 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.166 -0.959 . . . . 0.0 110.582 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.8 ttt -100.49 -10.05 21.47 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.249 -0.907 . . . . 0.0 110.796 -179.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 47.3 p -106.54 -53.21 2.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 0.0 110.967 -179.335 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 148' ' ' LYS . . . -81.65 45.3 0.87 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.214 -0.929 . . . . 0.0 110.639 -179.517 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.251 179.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.244 0.545 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.466 ' O ' ' CB ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -69.81 85.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 110.03 179.817 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' B' ' 2' ' ' LYS . 8.9 tp 69.07 21.16 7.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.225 -0.922 . . . . 0.0 110.361 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.558 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 19.0 mm -92.5 148.89 37.22 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 179.55 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.558 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 38.0 Cg_endo -66.52 170.38 12.46 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.632 1.333 . . . . 0.0 110.436 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.5 ' O ' ' HB ' ' B' ' 9' ' ' THR . 0.1 OUTLIER -96.4 152.24 18.79 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.189 -0.945 . . . . 0.0 111.299 -178.913 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.582 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 4.2 m95 -48.95 -66.09 0.46 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.881 . . . . 0.0 109.641 179.036 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' B' ' 12' ' ' LEU . 23.8 p -47.73 -24.17 0.88 Allowed 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.889 -1.132 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' B' ' 6' ' ' SER . 4.1 m -64.38 -54.97 24.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.066 -1.021 . . . . 0.0 109.639 179.37 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.573 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 6.8 m -56.89 -33.71 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.908 -1.12 . . . . 0.0 108.687 179.44 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.453 HD12 ' N ' ' B' ' 11' ' ' ILE . 4.9 mm -77.45 -23.2 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 108.799 178.411 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' B' ' 8' ' ' THR . 0.3 OUTLIER -68.5 -60.78 2.18 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.613 -0.68 . . . . 0.0 109.784 179.707 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.522 HG11 ' CD1' ' A' ' 112' ' ' LEU . 35.7 t -62.82 -32.84 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.371 -0.83 . . . . 0.0 110.166 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' B' ' 10' ' ' VAL . 0.0 OUTLIER -69.35 -45.59 69.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.017 -1.052 . . . . 0.0 109.251 179.212 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 52.7 p -58.46 -35.23 71.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.418 -0.801 . . . . 0.0 109.518 179.151 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.46 ' HE2' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -65.1 -41.97 94.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.445 -0.784 . . . . 0.0 109.582 179.477 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.56 ' O ' ' C ' ' B' ' 18' ' ' ARG . 6.2 mp -60.62 -12.82 11.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.421 -0.799 . . . . 0.0 110.038 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.56 ' C ' ' O ' ' B' ' 17' ' ' LEU . 6.4 tpt85 -18.8 -68.21 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.679 0 CA-C-O 121.489 0.661 . . . . 0.0 111.161 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.497 ' HD2' ' CG ' ' B' ' 20' ' ' ARG . 1.1 tmtm? -174.44 -104.49 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.011 179.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.497 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -87.73 13.66 10.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.444 -1.41 . . . . 0.0 109.335 179.308 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -87.06 163.34 17.08 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.456 -0.777 . . . . 0.0 110.555 -179.542 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.574 ' CD2' ' HE1' ' A' ' 124' ' ' MET . 0.2 OUTLIER 179.81 -45.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.318 -0.864 . . . . 0.0 110.559 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.454 ' HA2' ' HG3' ' A' ' 144' ' ' MET . . . -69.91 -50.96 26.43 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.395 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -150.13 84.97 5.61 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.954 -1.321 . . . . 0.0 110.838 -179.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.45 ' HG3' ' HG2' ' B' ' 16' ' ' MET . 48.6 Cg_endo -80.84 -7.76 13.35 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.925 1.487 . . . . 0.0 110.109 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.579 ' CE1' ' HE1' ' A' ' 72' ' ' MET . 5.9 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.316 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.216 0.531 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -152.99 -43.37 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -0.899 . . . . 0.0 110.264 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -99.78 -155.72 0.52 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.235 -0.916 . . . . 0.0 110.091 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.35 -174.6 0.69 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 110.124 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 t -129.27 -5.54 4.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.14 -0.975 . . . . 0.0 110.5 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 48.8 tt0 -96.12 -22.18 17.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.117 -0.989 . . . . 0.0 110.139 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -42.86 -63.94 0.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.995 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -46.81 -66.6 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 109.964 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.4 mt -50.11 -44.92 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 6' ' ' GLU . . . -53.3 -45.71 69.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 109.951 179.713 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.68 -51.01 66.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.208 -0.932 . . . . 0.0 109.813 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -44.84 67.63 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.229 -0.919 . . . . 0.0 109.377 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.63 -30.56 65.47 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.344 -0.847 . . . . 0.0 108.972 178.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -58.32 9.1 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.533 -0.729 . . . . 0.0 109.293 179.21 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.77 -48.41 41.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.267 -0.896 . . . . 0.0 109.336 179.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.543 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 32.3 t80 -66.51 -35.64 80.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.327 -0.858 . . . . 0.0 109.448 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -68.32 -30.34 69.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.46 -0.775 . . . . 0.0 109.528 179.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.511 HD12 ' CD ' ' B' ' 14' ' ' LYS . 6.7 tt -65.35 -46.03 81.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.684 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -73.29 -39.15 65.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.282 -0.886 . . . . 0.0 110.384 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.89 82.93 5.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.211 -0.931 . . . . 0.0 109.919 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -49.17 -74.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 110.359 -179.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.1 p-10 -51.76 -39.0 57.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 110.306 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.17 15.02 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.453 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 40.8 p-10 -76.64 -12.65 60.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -1.167 . . . . 0.0 110.081 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.98 42.11 5.42 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -161.49 117.36 2.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -1.131 . . . . 0.0 110.573 -179.831 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.526 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 8.1 mt -100.07 118.22 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.218 -0.926 . . . . 0.0 110.127 179.594 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.454 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 20.4 p -94.92 153.88 17.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 109.806 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -46.31 -24.65 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.977 . . . . 0.0 109.942 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -78.54 -60.79 2.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.066 179.761 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 37.3 mt-10 -44.21 -56.64 3.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.469 HD21 ' CZ2' ' B' ' 7' ' ' TRP . 40.8 tp -57.39 -45.65 84.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.168 -0.958 . . . . 0.0 109.3 179.336 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -56.65 -39.56 86.24 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.27 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 m -53.28 -50.94 63.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -1.027 . . . . 0.0 109.363 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.4 t -57.75 -39.28 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.326 -0.859 . . . . 0.0 109.261 179.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 13.5 mmt -61.31 -39.13 89.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 179.253 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -62.25 -30.74 71.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.381 179.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 m -65.73 -61.85 1.84 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.465 -0.772 . . . . 0.0 110.051 179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.452 HD22 HG21 ' A' ' 108' ' ' VAL . 6.1 mt -47.92 -24.16 0.96 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.71 55.08 0.58 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.15 165.94 30.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -1.186 . . . . 0.0 110.482 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 42' ' ' ASN . 2.6 p30 -140.75 97.95 7.14 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.967 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.466 ' CA ' HD13 ' B' ' 4' ' ' ILE . 46.3 Cg_endo -72.7 154.33 54.31 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.9 1.474 . . . . 0.0 110.485 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.0 m -99.65 -176.74 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 46' ' ' ALA . 1.2 tm-20 -67.45 -69.52 0.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.216 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.502 ' N ' ' OE1' ' A' ' 45' ' ' GLU . . . -47.14 -46.95 23.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 56.5 mm-40 -52.54 -58.19 7.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -0.895 . . . . 0.0 110.296 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.6 mt -48.61 -43.6 36.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.254 -0.904 . . . . 0.0 110.53 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 tp60 -63.87 -35.92 82.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 110.235 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -30.65 71.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.869 . . . . 0.0 110.12 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.426 ' HE2' ' C ' ' B' ' 6' ' ' SER . 13.9 mtp -84.15 -47.58 10.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.343 -0.848 . . . . 0.0 110.09 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 10.2 mm -66.05 -30.26 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -56.5 -14.14 2.86 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.361 -0.837 . . . . 0.0 111.094 -179.504 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.38 -53.0 4.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.085 -1.009 . . . . 0.0 111.009 -179.29 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 57' ' ' ALA . 6.6 t -72.46 -36.69 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.093 -1.005 . . . . 0.0 111.002 -179.484 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.7 t0 -55.32 82.25 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.267 -0.896 . . . . 0.0 110.657 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.32 -58.2 3.59 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.402 -0.812 . . . . 0.0 110.65 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 30.1 p30 -63.94 -11.7 30.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.258 -0.901 . . . . 0.0 110.5 -179.708 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 61.08 46.52 94.38 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 23.1 p-10 -97.73 -32.84 11.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -1.147 . . . . 0.0 110.23 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.16 -9.42 5.66 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.487 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 31.0 p -139.18 160.6 39.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 110.032 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.526 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 15.6 mm -84.59 159.45 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 109.92 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.543 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -126.25 173.33 9.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.093 -1.004 . . . . 0.0 110.55 -179.865 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.582 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.5 t80 -67.5 -50.77 35.53 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.322 -0.862 . . . . 0.0 111.135 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.3 Cg_endo -66.53 -39.51 16.15 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.254 1.134 . . . . 0.0 110.169 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' OE2' ' HB2' ' A' ' 64' ' ' ASP . 39.3 mt-10 -53.8 -39.62 65.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.527 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.73 -47.21 72.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 109.777 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.3 mt -51.17 -30.41 16.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.997 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.9 m -93.89 -14.86 25.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.389 -0.819 . . . . 0.0 110.501 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.446 ' HG3' HG21 ' A' ' 55' ' ' VAL . 7.1 tmm? -73.18 -54.08 9.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.107 -0.995 . . . . 0.0 110.433 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.537 ' CE ' ' CE1' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -52.62 -18.12 1.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.816 . . . . 0.0 110.668 -179.604 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.45 -10.11 22.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.13 -0.981 . . . . 0.0 110.648 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.29 -34.6 9.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.119 -0.988 . . . . 0.0 110.447 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.526 ' HB3' ' CG2' ' B' ' 8' ' ' THR . 6.4 tptt -97.54 -49.77 4.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.204 -0.935 . . . . 0.0 110.405 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.602 ' CE ' ' CE2' ' B' ' 26' ' ' PHE . 4.2 mmm -77.33 54.29 1.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.355 -0.84 . . . . 0.0 110.562 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -102.25 -56.62 2.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.377 -0.827 . . . . 0.0 110.074 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 79' ' ' THR . 0.7 OUTLIER -178.36 -33.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 110.186 179.95 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -42.49 -45.81 4.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.969 . . . . 0.0 110.153 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.535 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 5.9 p-10 -144.68 70.24 1.28 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 109.807 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.1 p -109.42 -32.43 7.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.749 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 15.8 pt-20 -79.05 -37.34 39.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.372 -0.83 . . . . 0.0 109.884 179.567 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.486 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 1.1 pt-20 -72.64 -9.73 58.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 80' ' ' ASP . 13.8 mm-40 -79.12 -28.0 42.89 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.497 -0.752 . . . . 0.0 109.91 179.48 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.458 HG21 ' CE1' ' A' ' 141' ' ' PHE . 77.8 mt -62.93 -39.42 85.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.205 -0.934 . . . . 0.0 108.6 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -65.51 -28.53 69.25 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.4 -53.39 7.72 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.22 -32.39 71.08 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.33 -0.856 . . . . 0.0 108.935 178.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -72.88 -45.99 55.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.067 178.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -55.25 -23.78 24.4 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.535 -0.728 . . . . 0.0 109.135 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.512 HG13 ' CG2' ' A' ' 108' ' ' VAL . 22.8 t -78.59 -44.37 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.536 -0.728 . . . . 0.0 109.735 179.462 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.587 ' CE1' HG12 ' A' ' 108' ' ' VAL . 57.3 m-85 -65.68 -42.28 91.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.889 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.458 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 30.9 t0 -100.13 61.47 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.516 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -54.31 -48.21 71.57 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.153 -0.967 . . . . 0.0 109.534 179.867 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 10.0 p-10 -54.97 -32.15 61.34 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.799 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.29 54.63 22.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.475 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 52.6 p30 -96.57 -5.43 39.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.245 -1.15 . . . . 0.0 110.101 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 99.45 13.13 39.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 2.6 m-85 -164.74 162.97 21.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.303 -1.116 . . . . 0.0 110.04 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.53 HD12 ' CB ' ' A' ' 92' ' ' PHE . 10.7 mt -119.67 132.63 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.234 -0.916 . . . . 0.0 110.414 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.467 ' OG ' ' OE1' ' A' ' 135' ' ' GLN . 0.4 OUTLIER -116.08 153.25 32.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 110.126 179.957 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.2 -32.64 1.31 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.709 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.95 84.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.406 -0.809 . . . . 0.0 109.494 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 5.7 mt-10 -54.49 -50.58 67.45 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.324 -0.86 . . . . 0.0 109.404 179.364 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.464 ' O ' ' HG3' ' A' ' 109' ' ' MET . 3.6 mm? -57.9 -52.86 63.77 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.302 -0.873 . . . . 0.0 109.5 179.349 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -50.89 -26.57 6.0 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.213 -0.93 . . . . 0.0 109.016 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.473 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 26.3 t60 -79.27 -25.45 42.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.564 -0.71 . . . . 0.0 109.69 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.587 HG12 ' CE1' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -98.8 -30.74 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.694 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.535 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -73.49 -51.7 16.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.394 -0.816 . . . . 0.0 110.196 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.7 m -68.94 -23.42 64.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 110.321 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 3.6 m120 -86.85 -14.29 42.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 109.521 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.551 HD13 ' CG1' ' B' ' 13' ' ' VAL . 4.1 mt -89.24 -34.38 16.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -0.857 . . . . 0.0 110.106 179.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.22 -56.61 0.42 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.24 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.52 158.37 17.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.999 -1.295 . . . . 0.0 110.804 -179.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 1.2 pttt -135.52 76.17 1.6 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.533 -0.729 . . . . 0.0 109.251 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' B' ' 19' ' ' LYS . 4.6 mp -37.2 146.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.671 -0.643 . . . . 0.0 111.14 -179.332 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -54.58 -164.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 0.0 110.04 179.719 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -83.86 -46.89 11.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.124 -0.985 . . . . 0.0 110.119 179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -58.38 -53.06 62.58 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.74 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.448 ' HB3' HD22 ' A' ' 116' ' ' LEU . 67.8 mm-40 -52.85 -44.2 66.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.365 -0.834 . . . . 0.0 109.582 179.51 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 117' ' ' THR . 42.7 t -58.11 -51.19 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.851 . . . . 0.0 110.154 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -61.47 -56.38 20.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 109.88 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 1.8 mt-10 -52.65 -36.65 57.12 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.687 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.595 ' HE1' ' CD1' ' B' ' 22' ' ' PHE . 0.9 OUTLIER -55.28 -50.15 70.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.811 . . . . 0.0 110.098 179.718 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 125' ' ' ILE . 37.1 mm -71.45 -46.0 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.22 -0.925 . . . . 0.0 110.321 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 127' ' ' GLU . 11.6 mmt180 -59.8 -55.32 35.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.26 -0.9 . . . . 0.0 110.446 -179.764 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.8 OUTLIER -43.69 -26.05 0.21 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 110.265 -179.958 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -98.59 -28.51 13.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.157 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.8 t70 -65.11 69.79 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.881 . . . . 0.0 110.371 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.521 HD11 ' N ' ' A' ' 130' ' ' ILE . 1.6 mp -63.21 -35.77 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.471 179.66 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 35.7 p-10 -74.97 -23.74 58.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 179.668 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 72.93 57.87 5.07 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 1.9 p30 -110.04 -15.2 14.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.214 -1.168 . . . . 0.0 110.083 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 135' ' ' GLN . . . 106.68 -4.74 36.93 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 43.7 mt-30 -155.37 158.57 38.9 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.225 -1.162 . . . . 0.0 110.119 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 14.0 t -92.72 135.97 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 110.075 179.666 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.515 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 28.1 t-20 -106.72 173.21 6.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.156 -0.965 . . . . 0.0 110.416 -179.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -54.55 -49.88 69.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.856 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -52.99 -56.37 16.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.271 -0.893 . . . . 0.0 110.229 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 141' ' ' PHE . 48.4 mt-10 -54.22 -58.67 6.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.162 -0.962 . . . . 0.0 110.076 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.464 ' O ' ' HG3' ' A' ' 145' ' ' MET . 41.7 t80 -43.51 -27.39 0.28 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 109.739 179.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.495 ' O ' ' CG2' ' A' ' 146' ' ' THR . 46.9 t -91.81 -39.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 109.965 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.479 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 2.6 tt0 -57.91 -14.14 5.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.362 -0.837 . . . . 0.0 110.501 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.47 ' HE2' HD13 ' A' ' 130' ' ' ILE . 2.5 mtp -107.3 -11.19 15.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.111 -0.993 . . . . 0.0 110.515 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.534 ' CE ' HD23 ' B' ' 12' ' ' LEU . 0.2 OUTLIER -99.91 -17.84 17.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.161 -0.962 . . . . 0.0 110.699 -179.708 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.495 ' CG2' ' O ' ' A' ' 142' ' ' VAL . 0.4 OUTLIER -122.56 21.63 10.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.163 -0.961 . . . . 0.0 110.346 -179.947 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 143' ' ' GLN . . . -100.31 46.66 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 0.0 110.354 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.124 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.43 HG11 ' O ' ' B' ' 1' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.311 0.577 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -65.39 -86.01 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.311 -0.868 . . . . 0.0 110.382 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.425 ' C ' HG12 ' B' ' 4' ' ' ILE . 1.0 OUTLIER 61.59 37.74 15.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 110.574 179.829 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.466 HD13 ' CA ' ' A' ' 43' ' ' PRO . 19.6 mm -142.37 139.49 17.71 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.146 -0.971 . . . . 0.0 110.453 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.463 ' HD2' HG21 ' B' ' 4' ' ' ILE . 46.9 Cg_endo -73.81 164.64 34.16 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.062 1.559 . . . . 0.0 110.458 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.426 ' C ' ' HE2' ' A' ' 51' ' ' MET . 0.9 OUTLIER -90.42 -175.93 4.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.181 -0.949 . . . . 0.0 110.612 -179.952 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 7' ' ' TRP . . . . . 0.569 ' O ' ' CG2' ' B' ' 10' ' ' VAL . 2.1 m95 -65.12 -76.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.643 0.735 . . . . 0.0 110.707 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 75' ' ' LYS . 13.3 p -41.72 -25.83 0.06 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.13 -0.981 . . . . 0.0 110.591 -179.305 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.455 ' N ' ' O ' ' B' ' 7' ' ' TRP . 27.1 m -61.92 -61.68 2.32 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.01 -1.056 . . . . 0.0 109.318 178.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.569 ' CG2' ' O ' ' B' ' 7' ' ' TRP . 6.1 m -53.97 -27.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 109.037 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' B' ' 8' ' ' THR . 30.0 mm -74.3 -42.54 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.471 -0.768 . . . . 0.0 109.287 178.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.534 HD23 ' CE ' ' A' ' 145' ' ' MET . 0.5 OUTLIER -53.33 -60.61 3.07 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.647 -0.658 . . . . 0.0 110.053 179.855 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.576 HG12 ' CZ ' ' A' ' 92' ' ' PHE . 69.3 t -56.51 -40.38 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.121 -0.987 . . . . 0.0 109.78 179.682 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.511 ' CD ' HD12 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.32 -42.06 84.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.147 -0.971 . . . . 0.0 109.515 179.239 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -62.25 -31.51 72.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 109.552 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.17 -27.03 60.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.497 -0.752 . . . . 0.0 109.87 179.694 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 109' ' ' MET . 3.3 mp -70.34 58.47 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.384 -0.822 . . . . 0.0 109.94 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.467 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 3.7 tpp180 -85.94 -70.93 0.56 Allowed 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.616 -0.677 . . . . 0.0 110.648 -179.637 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.656 ' HG2' ' N ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -165.48 -43.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.953 . . . . 0.0 110.216 -179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.656 ' N ' ' HG2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -162.5 3.73 0.05 OUTLIER 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.236 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.457 ' HB2' ' HE2' ' B' ' 19' ' ' LYS . 5.7 t -90.16 154.22 19.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.183 -0.948 . . . . 0.0 110.693 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.595 ' CD1' ' HE1' ' A' ' 124' ' ' MET . 0.1 OUTLIER -131.27 -42.3 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.367 -0.833 . . . . 0.0 109.958 179.535 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 144' ' ' MET . . . -59.34 104.05 0.49 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.485 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -102.48 105.86 46.06 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.114 -1.227 . . . . 0.0 110.658 -179.489 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.02 139.57 24.38 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.007 1.53 . . . . 0.0 109.524 179.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.602 ' CE2' ' CE ' ' A' ' 76' ' ' MET . 1.3 m-85 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.209 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 40.2 mt-30 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.256 0.551 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.1 mt -49.24 -52.19 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 110.391 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -50.61 -42.02 55.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 110.313 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 29.6 tt0 -59.3 -48.2 82.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -66.23 -41.61 89.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -55.21 -34.77 64.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.187 -0.945 . . . . 0.0 109.44 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 49.8 mt-10 -67.55 -49.19 64.45 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.396 -0.815 . . . . 0.0 109.533 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.513 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -62.57 -43.3 99.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.365 -0.835 . . . . 0.0 109.608 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.616 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 73.9 t80 -62.0 -26.53 68.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.354 -0.841 . . . . 0.0 109.408 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.45 -35.47 23.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.46 -0.775 . . . . 0.0 109.742 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -54.35 -46.13 72.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 109.623 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.552 ' CD1' HD12 ' A' ' 32' ' ' LEU . 63.4 m-85 -70.02 -48.59 57.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.244 -0.91 . . . . 0.0 110.1 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -66.3 66.26 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.384 -0.823 . . . . 0.0 109.958 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -41.89 -51.82 4.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.6 p-10 -72.89 -41.4 64.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 109.701 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.91 45.21 3.67 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 26' ' ' THR . 33.1 p30 -96.03 -4.85 42.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -1.196 . . . . 0.0 110.342 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 26' ' ' THR . . . 87.49 28.33 24.88 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.714 HG23 ' O ' ' A' ' 25' ' ' GLY . 11.7 p -160.03 111.3 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -1.154 . . . . 0.0 110.394 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.65 HD12 ' HB ' ' A' ' 63' ' ' ILE . 14.9 mt -78.66 124.91 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.048 -1.032 . . . . 0.0 109.707 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.441 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 1.2 p -100.17 -179.9 4.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.628 -0.67 . . . . 0.0 110.136 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -70.72 -33.99 71.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.727 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.89 -50.51 41.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 109.903 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' OE2' ' OG1' ' A' ' 28' ' ' THR . 57.8 mt-10 -51.36 -70.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.892 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.552 HD12 ' CD1' ' A' ' 19' ' ' PHE . 15.7 tp -51.24 -33.62 28.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.592 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -61.58 -41.33 99.55 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.0 m -61.04 -41.84 97.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.384 -1.068 . . . . 0.0 109.813 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.8 t -65.44 -46.49 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.294 -0.879 . . . . 0.0 109.705 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -19.68 65.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.062 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 1.2 ttp180 -91.48 -17.2 26.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.9 . . . . 0.0 110.053 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.89 -43.1 13.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 110.113 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.516 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -50.96 -26.4 5.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 110.337 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.65 35.99 0.94 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -136.44 -166.62 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -1.151 . . . . 0.0 110.348 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 1.9 t30 -149.08 97.75 3.59 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.855 . . . . 0.0 110.094 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.728 ' HA ' HD11 ' B' ' 4' ' ' ILE . 41.9 Cg_endo -68.18 149.17 76.1 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.904 1.476 . . . . 0.0 110.574 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 52.9 m -97.58 135.2 39.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.304 -0.873 . . . . 0.0 110.425 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -44.68 -44.99 9.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.184 -0.947 . . . . 0.0 110.196 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.27 -57.28 6.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 72.1 mm-40 -55.59 -47.68 76.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.897 . . . . 0.0 110.175 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -48.61 -62.6 1.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.986 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -51.1 -44.02 61.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.428 -0.795 . . . . 0.0 109.942 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -64.96 -28.29 69.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.818 . . . . 0.0 109.644 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -49.44 16.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.449 -0.782 . . . . 0.0 109.832 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -70.36 -10.03 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -85.78 -19.41 30.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.409 -0.807 . . . . 0.0 109.698 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -57.02 6.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.389 -0.819 . . . . 0.0 110.104 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG23 ' CD1' ' B' ' 7' ' ' TRP . 18.5 t -69.75 -31.72 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.274 -0.891 . . . . 0.0 109.862 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.494 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -59.15 79.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.428 -0.795 . . . . 0.0 110.034 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.86 -21.95 60.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.802 . . . . 0.0 110.621 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -71.56 -38.83 70.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.048 -1.033 . . . . 0.0 110.434 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.21 12.93 32.42 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.1 p-10 -82.89 -44.48 15.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.395 -1.062 . . . . 0.0 110.528 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.33 11.27 9.86 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.493 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 14.2 p -138.56 143.32 39.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.354 -1.086 . . . . 0.0 109.869 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.65 ' HB ' HD12 ' A' ' 27' ' ' ILE . 15.8 mm -87.08 150.77 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.062 -1.023 . . . . 0.0 109.924 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.516 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 1.2 m-20 -129.74 165.03 22.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.14 -0.975 . . . . 0.0 110.981 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.622 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 14.5 t80 -50.81 -47.43 85.94 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.491 -0.756 . . . . 0.0 111.139 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -67.93 -40.88 8.56 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 O-C-N 123.176 1.093 . . . . 0.0 109.912 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.494 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -56.68 -29.89 62.83 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.193 -0.942 . . . . 0.0 108.857 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -66.91 -63.34 1.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.543 -0.723 . . . . 0.0 109.523 178.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -48.26 -22.21 0.63 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.274 -0.891 . . . . 0.0 109.968 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.5 m -100.59 -9.99 21.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.189 -0.944 . . . . 0.0 111.357 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.584 ' HB2' HG13 ' A' ' 55' ' ' VAL . 9.5 ptm -86.05 -43.52 13.04 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.799 -1.188 . . . . 0.0 110.554 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.553 ' N ' ' HG3' ' A' ' 71' ' ' MET . 89.3 mmm -65.34 -10.04 29.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.055 -1.028 . . . . 0.0 110.539 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.0 -10.54 21.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.074 -1.016 . . . . 0.0 111.043 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.409 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -98.75 -10.72 22.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.941 -1.1 . . . . 0.0 110.519 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.658 ' CB ' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.183 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.267 0.556 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -84.33 -21.57 30.91 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.501 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 14.8 pt-20 -73.17 -27.57 61.72 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.57 -0.706 . . . . 0.0 110.051 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.432 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 53.1 mt -73.98 -40.82 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.606 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -32.75 73.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 109.364 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.569 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 17.2 mt-10 -70.09 -56.58 6.54 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' B' ' 12' ' ' LEU . . . -48.85 -35.98 15.88 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.25 -0.906 . . . . 0.0 108.557 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 90' ' ' ARG . 26.8 t80 -62.72 -56.09 20.76 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.628 -0.67 . . . . 0.0 109.473 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -43.03 -47.32 5.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.578 -0.701 . . . . 0.0 109.425 179.378 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.912 HG11 HG11 ' B' ' 13' ' ' VAL . 41.2 t -51.08 -49.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.363 -0.836 . . . . 0.0 109.359 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.755 ' HB3' HD13 ' A' ' 100' ' ' ILE . 54.8 m-85 -68.85 -44.66 72.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 110.38 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.486 ' HA ' ' OE2' ' A' ' 104' ' ' GLU . 34.2 t0 -92.28 60.9 3.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.062 -1.024 . . . . 0.0 110.39 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.3 -46.84 62.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.284 -0.885 . . . . 0.0 110.301 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 6.5 p30 -66.04 -26.0 67.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.319 -0.863 . . . . 0.0 110.384 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 67.52 50.99 39.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -96.97 -18.41 19.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.191 -1.182 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.542 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 109.4 24.63 5.84 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -169.92 158.75 7.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -1.113 . . . . 0.0 110.139 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.755 HD13 ' HB3' ' A' ' 92' ' ' PHE . 34.4 mt -117.04 148.91 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.033 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 102' ' ' ALA . 19.3 t -127.75 146.73 50.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.958 . . . . 0.0 109.876 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.18 -29.54 0.25 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 109.975 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.68 -56.08 14.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.823 . . . . 0.0 109.598 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.486 ' OE2' ' HA ' ' A' ' 93' ' ' ASP . 15.7 mt-10 -53.54 -38.13 63.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 0.0 109.707 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.052 HD12 HD11 ' A' ' 125' ' ' ILE . 1.4 mt -69.87 -39.2 76.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.436 -0.79 . . . . 0.0 109.607 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.0 ttp85 -62.58 -34.17 76.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.304 -0.872 . . . . 0.0 109.415 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -66.49 -51.51 55.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.362 -0.836 . . . . 0.0 109.449 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.502 HG21 HG12 ' A' ' 91' ' ' VAL . 28.3 t -57.89 -37.42 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.524 -0.735 . . . . 0.0 109.506 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.889 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -52.1 -64.07 0.94 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.609 -0.682 . . . . 0.0 110.77 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.471 HG23 ' HG2' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -64.22 -15.35 59.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.516 ' OD1' ' HA ' ' A' ' 39' ' ' LEU . 0.9 OUTLIER -79.09 -19.63 50.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.016 . . . . 0.0 109.565 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' B' ' 14' ' ' LYS . 15.8 mt -107.28 -27.03 10.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.484 -0.76 . . . . 0.0 109.862 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.415 ' O ' ' HE3' ' A' ' 115' ' ' LYS . . . 147.57 -74.32 0.29 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.735 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.436 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 1.8 tt0 -71.68 149.0 45.91 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.241 -1.152 . . . . 0.0 111.332 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.471 ' HG2' HG23 ' A' ' 110' ' ' THR . 0.7 OUTLIER -130.48 81.98 2.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.522 -0.736 . . . . 0.0 109.302 179.406 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.664 HD21 ' O ' ' B' ' 19' ' ' LYS . 8.0 mp -36.71 143.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.588 -0.695 . . . . 0.0 111.083 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -58.02 -153.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 110.072 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.539 ' H ' HG22 ' A' ' 117' ' ' THR . 1.2 m-20 -98.8 -66.0 0.93 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.892 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' ASP . 15.1 mt-10 -44.39 -47.46 9.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.56 -54.8 43.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.369 -0.832 . . . . 0.0 109.317 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' A' ' 116' ' ' LEU . 39.1 t -55.47 -39.59 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 109.678 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.58 -44.52 86.41 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.375 -0.828 . . . . 0.0 109.719 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -70.59 -36.7 73.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.353 -0.842 . . . . 0.0 109.678 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.417 ' HG2' ' CE2' ' B' ' 22' ' ' PHE . 24.4 ttt -56.76 -37.45 71.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -0.826 . . . . 0.0 109.788 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.052 HD11 HD12 ' A' ' 105' ' ' LEU . 27.5 mm -82.38 -31.23 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 110.084 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -36.67 80.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 110.248 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -30.44 69.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.87 . . . . 0.0 110.061 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -82.96 -29.24 29.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 110.031 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 82.9 m-20 -63.68 72.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.908 . . . . 0.0 110.342 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 3.4 mt -58.05 -21.93 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 109.893 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 35.6 p-10 -98.78 -17.16 18.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.83 61.21 3.61 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 1.6 p30 -111.03 2.87 18.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -1.191 . . . . 0.0 110.098 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 85.32 -1.67 88.44 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 86.3 mt-30 -153.83 168.28 26.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.156 -1.202 . . . . 0.0 110.221 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.801 HG23 HG23 ' A' ' 125' ' ' ILE . 50.4 t -100.0 143.15 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -0.912 . . . . 0.0 110.075 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.5 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 32.7 t30 -111.2 -173.74 2.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 0.0 110.332 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -69.84 -52.86 21.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.348 -0.845 . . . . 0.0 110.5 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -45.24 -52.66 9.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -56.24 -58.89 6.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 110.022 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.421 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 20.4 t80 -46.39 -25.16 0.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 145' ' ' MET . 38.3 t -99.99 -54.03 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.299 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -45.77 -24.31 0.36 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.201 -0.937 . . . . 0.0 110.312 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmm -83.93 -23.83 30.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.266 -0.896 . . . . 0.0 110.313 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.735 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -100.16 -11.49 20.41 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.269 -0.894 . . . . 0.0 110.51 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 142' ' ' VAL . 82.4 p . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.744 HG23 ' HD2' ' B' ' 5' ' ' PRO . 5.6 mt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.956 0.408 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.744 ' HD2' HG23 ' B' ' 4' ' ' ILE . 42.6 Cg_endo -70.12 132.46 22.81 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.958 1.504 . . . . 0.0 110.112 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 12.3 p -69.46 -167.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.86 . . . . 0.0 110.799 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.727 ' O ' HG22 ' B' ' 10' ' ' VAL . 5.4 m95 -73.11 -77.71 0.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.536 -0.728 . . . . 0.0 110.707 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.658 HG21 ' CB ' ' A' ' 75' ' ' LYS . 20.5 p -40.87 -26.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.964 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.569 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 84.0 m -61.36 -63.55 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 110.001 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.727 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.6 m -50.79 -27.45 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.431 HG12 ' O ' ' B' ' 7' ' ' TRP . 15.0 mm -79.09 -24.79 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.468 -0.77 . . . . 0.0 109.327 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 1.4 mt -68.99 -49.76 55.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.576 -0.702 . . . . 0.0 110.087 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.912 HG11 HG11 ' A' ' 91' ' ' VAL . 97.5 t -67.53 -40.11 83.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.38 -0.825 . . . . 0.0 110.36 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.656 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -64.95 -45.74 84.48 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.918 -1.114 . . . . 0.0 109.506 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.461 ' HB3' ' ND2' ' B' ' 24' ' ' ASN . 4.7 t -57.67 -36.88 72.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.324 -0.86 . . . . 0.0 108.9 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' B' ' 13' ' ' VAL . 2.9 mmt -60.04 -34.47 73.43 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 108.833 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.889 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.3 mp -72.59 56.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.651 -0.655 . . . . 0.0 109.418 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -83.66 0.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.69 . . . . 0.0 110.289 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.664 ' O ' HD21 ' A' ' 116' ' ' LEU . 9.0 tmtt? -133.39 -85.03 0.45 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.61 -1.306 . . . . 0.0 110.387 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.534 ' N ' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -142.3 23.91 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.871 -1.143 . . . . 0.0 110.115 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.46 178.86 4.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.497 -0.752 . . . . 0.0 109.583 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.601 ' HZ ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -137.57 148.25 45.74 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.79 146.08 17.63 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.735 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 8.8 m120 -119.26 134.83 23.71 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.224 -1.162 . . . . 0.0 110.304 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 26' ' ' PHE . 46.0 Cg_endo -72.41 -44.38 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.024 1.539 . . . . 0.0 110.048 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' B' ' 25' ' ' PRO . 1.6 m-30 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.42 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 13.6 pt20 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.286 0.565 . . . . 0.0 109.836 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.7 mt -67.32 -29.76 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.464 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.51 -55.78 24.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.315 -0.866 . . . . 0.0 109.634 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.534 ' HG3' ' N ' ' A' ' 12' ' ' PHE . 13.1 pt-20 -56.94 -34.67 68.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 109.389 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.534 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 13.8 m-85 -73.6 -46.01 49.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.28 -0.888 . . . . 0.0 109.358 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 17' ' ' SER . 32.6 tptt -60.27 -44.07 95.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.287 -0.883 . . . . 0.0 109.212 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.32 -44.3 75.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.179 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.92 -56.69 18.94 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.42 -0.8 . . . . 0.0 109.531 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.548 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 15.2 t80 -55.81 -45.53 78.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.218 -0.926 . . . . 0.0 109.439 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -61.78 -38.49 88.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -0.76 . . . . 0.0 109.254 179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.573 ' O ' HD23 ' A' ' 18' ' ' LEU . 10.1 tt -59.09 -27.74 65.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.495 -0.753 . . . . 0.0 109.624 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CE1' HD22 ' A' ' 18' ' ' LEU . 4.7 m-85 -90.81 -49.87 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.95 76.99 1.67 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.5 -0.75 . . . . 0.0 110.228 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -52.27 -69.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.908 . . . . 0.0 110.183 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 6.8 p-10 -45.29 -29.19 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 54.83 6.04 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.467 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 2.0 p-10 -106.68 -34.17 7.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.179 -1.189 . . . . 0.0 110.185 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.56 7.79 6.1 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 32.0 p -141.85 117.62 10.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.217 -1.167 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.835 ' O ' HG22 ' A' ' 62' ' ' THR . 16.5 mt -76.87 128.67 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 110.336 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.603 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.5 OUTLIER -95.16 161.59 14.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.411 -0.806 . . . . 0.0 110.264 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.489 HG23 HG13 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -58.56 -39.23 79.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.0 110.4 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 31' ' ' GLU . 3.7 tmtt? -65.66 -52.87 48.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.0 110.275 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' LYS . 10.1 mt-10 -43.15 -61.37 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 109.903 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.7 tp -56.25 -37.98 70.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.92 . . . . 0.0 109.668 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.51 -40.29 98.5 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 m -58.34 -41.63 85.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -1.061 . . . . 0.0 109.625 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.18 -53.2 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.7 mtt -55.66 -31.13 62.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.207 -0.933 . . . . 0.0 109.731 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -74.27 -25.61 59.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 109.82 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.507 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -76.58 -47.36 22.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.209 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mt -56.31 -53.02 62.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 110.254 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.44 58.93 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.511 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 1.5 mm-40 -139.33 -169.76 2.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.158 -1.201 . . . . 0.0 110.233 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 13.7 m120 -143.85 75.85 15.78 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.25 -0.906 . . . . 0.0 110.438 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.574 ' HA ' HD11 ' B' ' 4' ' ' ILE . 47.3 Cg_endo -74.27 119.76 5.95 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.013 1.533 . . . . 0.0 110.274 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -76.36 154.31 35.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.283 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.34 -49.24 72.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.54 -54.3 47.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.321 -0.862 . . . . 0.0 110.143 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -56.64 -34.83 67.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -0.906 . . . . 0.0 110.042 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.0 mt -55.78 -54.3 46.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.063 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -31.0 69.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 109.775 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.12 -41.51 77.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 110.068 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.447 ' CE ' ' CD1' ' B' ' 7' ' ' TRP . 1.9 ttp -73.6 -38.93 64.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.245 -0.91 . . . . 0.0 110.023 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.489 HG13 HG23 ' A' ' 29' ' ' THR . 5.5 mm -66.18 -25.1 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.75 0.72 22.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.295 -0.878 . . . . 0.0 110.187 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.77 -13.18 25.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 110.079 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 57' ' ' ALA . 16.3 t -113.63 -35.12 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -45.44 89.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.474 -0.766 . . . . 0.0 110.371 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -85.63 -31.44 22.58 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.236 -0.915 . . . . 0.0 110.754 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 29.4 p-10 -83.13 -39.98 20.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.029 -1.044 . . . . 0.0 110.425 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 108.54 24.12 6.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' CG ' ' OD2' ' A' ' 58' ' ' ASP . 19.9 p-10 -95.12 -14.57 24.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -1.151 . . . . 0.0 110.177 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.82 -63.76 0.3 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.835 HG22 ' O ' ' A' ' 27' ' ' ILE . 1.3 p -76.54 165.02 25.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -1.115 . . . . 0.0 110.171 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.701 ' HB ' HD12 ' A' ' 27' ' ' ILE . 20.6 mm -90.81 149.8 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.548 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 24.6 t0 -115.3 162.36 17.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.933 . . . . 0.0 110.659 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.666 ' O ' HD12 ' A' ' 69' ' ' LEU . 74.3 t80 -49.23 -46.16 76.5 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 0.0 111.333 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -69.93 -39.63 5.97 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.285 1.15 . . . . 0.0 110.406 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.454 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 1.9 mt-10 -57.58 -27.07 62.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.965 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.729 ' CZ ' HD13 ' B' ' 11' ' ' ILE . 45.4 t80 -83.27 -40.99 18.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.374 -0.829 . . . . 0.0 110.411 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -67.62 -15.78 63.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.275 -0.891 . . . . 0.0 110.819 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 p -100.23 -41.19 7.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.059 -1.026 . . . . 0.0 110.924 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.438 ' HG2' ' HA ' ' A' ' 68' ' ' PHE . 3.3 ppp? -66.49 -34.45 77.96 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.27 -0.894 . . . . 0.0 111.227 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.633 ' HE2' ' CZ ' ' B' ' 26' ' ' PHE . 13.2 tpt -66.67 -9.4 35.62 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.128 -0.983 . . . . 0.0 111.077 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.6 -9.85 13.19 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.978 -1.076 . . . . 0.0 111.11 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -97.1 -32.79 11.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.98 -1.075 . . . . 0.0 110.741 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.648 ' HB3' HG21 ' B' ' 8' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.049 -1.032 . . . . 0.0 110.695 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.848 ' HA ' HD12 ' A' ' 85' ' ' ILE . 28.5 mt-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.165 0.507 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 36.1 mt-10 -66.95 -56.69 9.1 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.197 -0.94 . . . . 0.0 110.417 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 55.9 tt0 -53.07 -28.51 25.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -0.93 . . . . 0.0 110.508 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.848 HD12 ' HA ' ' A' ' 82' ' ' GLU . 72.9 mt -66.78 -28.35 42.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.133 -0.98 . . . . 0.0 109.21 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 3.9 ttt-85 -66.52 -30.26 70.55 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.641 -0.662 . . . . 0.0 109.539 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.749 ' HB3' HG21 ' B' ' 9' ' ' THR . 8.3 mt-10 -73.59 -48.99 28.52 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.343 -0.848 . . . . 0.0 109.496 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.441 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.62 -30.75 71.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -66.46 -49.91 65.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -31.49 69.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.383 -0.823 . . . . 0.0 109.544 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.496 HG11 HG21 ' B' ' 13' ' ' VAL . 11.6 t -61.06 -47.5 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.373 -0.829 . . . . 0.0 109.631 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.493 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 45.0 m-85 -67.96 -31.71 71.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.851 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 94' ' ' LYS . 7.2 t0 -80.77 55.35 2.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.2 -0.938 . . . . 0.0 110.173 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 93' ' ' ASP . 2.5 tmtt? -42.73 -32.28 0.58 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.33 -0.857 . . . . 0.0 110.538 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 4.8 p30 -90.08 -31.07 17.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.172 -0.955 . . . . 0.0 110.342 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 84.15 20.13 59.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 48.5 p30 -75.04 -15.33 60.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.042 -1.269 . . . . 0.0 109.97 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.568 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 92.79 33.17 7.56 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 33.5 m-85 -161.92 107.21 1.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -1.123 . . . . 0.0 110.233 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mt -69.19 124.98 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 110.11 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.56 161.94 17.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.973 . . . . 0.0 110.164 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.93 -37.28 66.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.101 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.5 -53.15 60.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.841 . . . . 0.0 110.033 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 24.0 mt-10 -56.19 -39.68 72.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.92 HD12 HD11 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -60.27 -38.5 83.76 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.301 -0.874 . . . . 0.0 109.486 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -36.78 82.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.556 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -64.99 -52.58 55.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 109.76 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.489 HG11 ' CE1' ' A' ' 92' ' ' PHE . 1.1 t -61.84 -28.58 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 109.159 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.769 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -67.51 -59.22 3.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.398 -0.814 . . . . 0.0 109.845 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -29.07 70.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.89 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 38' ' ' SER . 3.0 m120 -77.76 -6.52 54.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.422 -0.799 . . . . 0.0 110.064 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.566 ' CD1' HG12 ' B' ' 13' ' ' VAL . 12.7 mt -117.5 7.97 12.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -0.925 . . . . 0.0 110.869 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.16 -68.33 0.24 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.256 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 109' ' ' MET . 26.8 tt0 -92.03 161.91 14.58 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.046 -1.267 . . . . 0.0 111.532 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.0 OUTLIER -141.62 82.82 1.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.64 -0.663 . . . . 0.0 109.489 179.604 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.552 ' H ' HD12 ' A' ' 116' ' ' LEU . 6.3 mp -38.29 140.11 0.33 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.451 -0.781 . . . . 0.0 111.1 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.701 HG22 ' H ' ' A' ' 118' ' ' ASP . 2.6 m -52.24 -171.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.427 -0.796 . . . . 0.0 110.08 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.701 ' H ' HG22 ' A' ' 117' ' ' THR . 31.8 m-20 -83.21 -54.4 5.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 110.228 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -30.26 65.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 109.704 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.436 ' HG2' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -73.62 -52.9 11.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.211 -0.931 . . . . 0.0 108.929 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.421 HG22 ' CE ' ' A' ' 109' ' ' MET . 40.4 t -57.85 -34.67 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.423 -0.798 . . . . 0.0 109.466 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -62.17 -44.15 97.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.433 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 5.6 mm-40 -69.43 -29.15 66.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.399 -0.813 . . . . 0.0 109.519 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.623 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 10.2 ttt -65.94 -44.46 85.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.531 -0.731 . . . . 0.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.92 HD11 HD12 ' A' ' 105' ' ' LEU . 17.7 mm -75.98 -49.59 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.274 -0.891 . . . . 0.0 109.785 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -56.61 -47.83 78.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.89 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.5 mm-40 -61.73 -43.89 97.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.792 . . . . 0.0 109.917 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.25 -32.17 72.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.884 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.513 ' HB3' ' HA2' ' A' ' 132' ' ' GLY . 5.3 m-20 -71.6 100.69 2.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.384 -0.823 . . . . 0.0 110.051 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.445 HG13 ' OE1' ' A' ' 143' ' ' GLN . 40.0 mm -51.74 -36.53 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.217 -0.927 . . . . 0.0 110.243 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.416 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 17.3 p-10 -99.45 -25.1 14.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.295 -0.878 . . . . 0.0 110.383 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 69.62 51.91 23.3 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 5.7 p30 -85.46 -23.85 27.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.185 -1.185 . . . . 0.0 110.21 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 142.17 -10.26 2.51 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.28 166.58 10.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.028 -1.278 . . . . 0.0 110.698 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 140' ' ' GLU . 2.9 t -102.54 154.43 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.397 -0.814 . . . . 0.0 109.871 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.436 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 17.0 p-10 -123.27 -145.71 0.35 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.186 -0.946 . . . . 0.0 110.399 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.85 -68.81 0.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 110.618 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -45.3 -46.28 12.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.219 -0.926 . . . . 0.0 110.653 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.436 ' HB3' HG13 ' A' ' 136' ' ' VAL . 35.7 mt-10 -61.02 -57.08 14.09 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.462 ' CE2' HG23 ' A' ' 85' ' ' ILE . 71.0 t80 -50.74 -20.71 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 85' ' ' ILE . 73.2 t -93.9 -58.72 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.207 -0.933 . . . . 0.0 110.436 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.445 ' OE1' HG13 ' A' ' 130' ' ' ILE . 40.3 tt0 -42.12 -30.38 0.29 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.217 -0.927 . . . . 0.0 110.176 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.461 ' O ' ' N ' ' B' ' 24' ' ' ASN . 64.9 mtp -69.51 -30.96 68.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.052 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 142' ' ' VAL . 23.5 ttm -94.13 -28.66 15.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.355 -0.841 . . . . 0.0 110.391 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.408 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 73.2 p . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.411 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.851 HG23 ' HD2' ' B' ' 5' ' ' PRO . 12.0 mt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.853 0.359 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.851 ' HD2' HG23 ' B' ' 4' ' ' ILE . 42.5 Cg_endo -71.68 139.64 34.3 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.642 1.338 . . . . 0.0 110.24 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.534 ' O ' ' N ' ' B' ' 8' ' ' THR . 46.4 t -90.33 64.09 5.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.306 -0.871 . . . . 0.0 111.036 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.486 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.3 OUTLIER 51.3 -85.43 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.209 -0.932 . . . . 0.0 110.659 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.648 HG21 ' HB3' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -43.46 -40.55 3.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.158 -0.964 . . . . 0.0 109.657 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.749 HG21 ' HB3' ' A' ' 87' ' ' GLU . 84.3 m -51.3 -53.5 35.18 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.438 -0.789 . . . . 0.0 109.51 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' B' ' 5' ' ' PRO . 18.6 t -52.79 -38.56 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.342 -0.849 . . . . 0.0 109.632 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.729 HD13 ' CZ ' ' A' ' 68' ' ' PHE . 12.1 mt -73.48 -25.77 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.281 -0.887 . . . . 0.0 109.727 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -48.69 65.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.4 -0.813 . . . . 0.0 109.668 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.566 HG12 ' CD1' ' A' ' 112' ' ' LEU . 86.4 t -63.77 -48.18 87.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.5 -0.75 . . . . 0.0 110.449 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.43 ' O ' ' HD2' ' B' ' 14' ' ' LYS . 30.4 tptt -54.98 -39.24 68.79 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.956 -1.09 . . . . 0.0 109.599 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 1.7 t -59.45 -40.07 85.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 109.61 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.509 ' CE ' ' HG3' ' B' ' 25' ' ' PRO . 0.2 OUTLIER -64.71 -27.85 69.19 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.39 -0.819 . . . . 0.0 110.087 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.769 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.3 mp -76.0 60.37 1.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.406 -0.808 . . . . 0.0 110.23 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -133.01 67.7 1.53 Allowed 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.53 -0.731 . . . . 0.0 111.36 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.552 ' CD ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER 60.97 -62.71 0.07 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.395 0.617 . . . . 0.0 111.478 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' B' ' 18' ' ' ARG . 1.2 ptm180 -143.79 4.35 1.31 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 111.023 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' B' ' 18' ' ' ARG . 23.0 m -64.23 86.59 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.815 -1.178 . . . . 0.0 109.893 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.623 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -126.43 -10.57 6.31 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.341 -0.849 . . . . 0.0 110.526 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' B' ' 24' ' ' ASN . . . -110.61 122.2 6.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 144' ' ' MET . 9.3 t-20 40.74 77.43 0.43 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.403 -1.057 . . . . 0.0 110.839 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.509 ' HG3' ' CE ' ' B' ' 16' ' ' MET . 47.7 Cg_endo -77.36 -9.71 17.53 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.0 1.526 . . . . 0.0 110.143 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.633 ' CZ ' ' HE2' ' A' ' 72' ' ' MET . 72.2 m-85 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.213 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.296 0.569 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.2 mt -59.08 -48.85 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 110.122 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.6 -45.41 38.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.842 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 2.8 tt0 -57.25 -56.81 17.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.85 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 9.0 m-85 -53.95 -33.07 55.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.337 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 3.7 tttp -64.25 -43.08 96.0 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.328 -0.858 . . . . 0.0 109.199 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 16.0 mt-10 -53.41 -49.5 67.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 109.61 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . . . -64.99 -52.0 58.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.362 -0.836 . . . . 0.0 109.573 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.422 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 65.4 t80 -54.66 -40.83 69.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.601 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -71.82 -25.79 62.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.383 -0.823 . . . . 0.0 109.565 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.712 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.7 tt -62.42 -39.64 93.94 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.364 -0.835 . . . . 0.0 109.706 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.464 ' CD1' HD12 ' A' ' 32' ' ' LEU . 49.8 m-85 -86.06 -27.66 24.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.382 -0.824 . . . . 0.0 110.305 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 66.0 t0 -92.19 100.12 12.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.171 -0.956 . . . . 0.0 110.394 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.37 -70.31 0.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.031 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.3 p-10 -52.69 -21.61 4.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 110.049 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.5 37.24 93.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 19.8 p-10 -80.09 -36.49 35.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.108 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.577 ' C ' HG23 ' A' ' 26' ' ' THR . . . 128.51 25.55 1.03 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.577 HG23 ' C ' ' A' ' 25' ' ' GLY . 70.2 p -157.49 126.8 5.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.071 -1.252 . . . . 0.0 110.323 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.54 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 18.1 mt -97.55 122.12 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.141 -0.974 . . . . 0.0 110.015 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.8 p -90.46 175.86 6.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.811 . . . . 0.0 110.022 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.5 p -69.59 -28.92 66.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 110.175 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -77.11 -50.77 12.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.096 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -48.24 -67.44 0.27 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.321 -0.862 . . . . 0.0 109.916 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.464 HD12 ' CD1' ' A' ' 19' ' ' PHE . 22.5 tp -55.57 -43.62 76.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 109.794 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.43 -41.73 17.77 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.3 m -66.0 -54.87 20.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -1.066 . . . . 0.0 109.935 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.463 ' H ' HG23 ' A' ' 35' ' ' VAL . 16.0 t -49.4 -39.0 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 109.801 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.464 ' HG3' ' HG3' ' A' ' 43' ' ' PRO . 5.2 mmt -62.74 -46.67 87.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.849 . . . . 0.0 109.274 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -51.8 -27.24 11.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.394 179.165 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -50.1 47.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.849 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 mt -54.55 -31.11 55.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.041 -1.037 . . . . 0.0 110.331 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.32 2.64 2.92 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.945 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.484 ' HG2' HG12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -130.71 158.12 40.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.811 -1.405 . . . . 0.0 110.94 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 5.7 t-20 -123.15 98.73 41.5 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 110.094 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HG3' ' HG3' ' A' ' 36' ' ' MET . 43.0 Cg_endo -71.88 112.85 3.49 Favored 'Trans proline' 0 C--N 1.296 -2.232 0 O-C-N 124.148 1.604 . . . . 0.0 110.32 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.618 HG22 ' HG3' ' A' ' 47' ' ' GLU . 1.8 t -64.25 -166.59 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.677 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.447 ' N ' ' OG1' ' A' ' 44' ' ' THR . 0.1 OUTLIER -70.99 -60.94 1.96 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.424 -0.798 . . . . 0.0 110.219 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.56 -55.46 4.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.948 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.618 ' HG3' HG22 ' A' ' 44' ' ' THR . 2.2 mm-40 -55.68 -57.66 11.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.165 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 48' ' ' LEU . 17.6 mt -45.53 -65.02 0.6 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.342 -0.849 . . . . 0.0 110.357 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -50.54 -25.29 3.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 110.325 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.12 -39.17 55.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.976 . . . . 0.0 110.081 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.571 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 1.7 mmm -80.67 -32.11 36.13 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.286 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 mm -70.09 -36.77 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.073 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 56' ' ' ASP . 0.7 OUTLIER -54.19 -67.87 0.23 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.327 -0.858 . . . . 0.0 110.701 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 53' ' ' ASN . 27.1 mt-10 -41.17 -40.33 1.53 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.42 -0.8 . . . . 0.0 110.656 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.764 HG21 ' CD1' ' B' ' 7' ' ' TRP . 48.8 t -83.55 -16.29 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.928 . . . . 0.0 110.412 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASN . 33.7 t0 -66.04 66.78 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.551 ' HA ' ' NH2' ' A' ' 74' ' ' ARG . . . -41.74 -44.24 3.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.367 -0.833 . . . . 0.0 110.385 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 3.9 m-20 -80.49 -35.68 34.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.33 -0.856 . . . . 0.0 110.039 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.439 ' HA2' ' OD2' ' A' ' 56' ' ' ASP . . . 92.42 28.45 12.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 24.7 p30 -95.41 -32.63 12.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.327 -1.102 . . . . 0.0 110.318 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 62' ' ' THR . . . 117.12 30.96 1.81 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -157.53 147.57 20.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -1.192 . . . . 0.0 110.106 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 ' CG1' ' A' ' 55' ' ' VAL . 6.9 mm -97.39 124.84 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.335 -0.853 . . . . 0.0 110.14 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -107.76 169.84 8.35 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.233 -0.917 . . . . 0.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.622 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 11.0 t80 -58.69 -47.75 98.14 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.27 -0.894 . . . . 0.0 110.895 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.0 Cg_endo -68.09 -37.02 15.58 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 O-C-N 123.263 1.138 . . . . 0.0 109.648 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' A' ' 57' ' ' ALA . 5.1 tt0 -60.87 -34.07 74.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.029 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.527 ' O ' ' HG3' ' A' ' 71' ' ' MET . 5.7 t80 -63.83 -51.5 64.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.464 -0.773 . . . . 0.0 109.258 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 69' ' ' LEU . 6.2 mp -62.79 -15.2 52.74 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.247 -0.908 . . . . 0.0 109.419 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -90.81 -50.77 5.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 110.594 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.527 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -58.26 -24.97 61.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.054 -1.029 . . . . 0.0 109.68 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.471 ' N ' ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -65.53 -13.83 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 109.88 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.31 -14.76 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.551 ' NH2' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -86.81 -29.06 22.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.242 -0.911 . . . . 0.0 110.175 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HG2' HG21 ' B' ' 8' ' ' THR . 32.1 tptt . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.138 -0.976 . . . . 0.0 109.959 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 120.929 0.395 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 84' ' ' GLU . 6.9 pt-20 -76.18 -25.63 55.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.944 -1.098 . . . . 0.0 110.509 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 10.4 pt-20 -69.43 -37.21 77.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.157 -0.965 . . . . 0.0 110.31 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.509 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 20.6 mt -68.76 -37.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.108 -0.995 . . . . 0.0 109.011 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.67 -26.25 61.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' B' ' 9' ' ' THR . 1.1 mt-10 -73.16 -58.44 3.31 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.464 -0.773 . . . . 0.0 109.185 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.87 -29.17 62.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.026 . . . . 0.0 109.2 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 4.7 t80 -64.81 -49.27 71.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.317 -0.864 . . . . 0.0 109.127 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -33.37 42.53 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.492 -0.755 . . . . 0.0 109.241 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.788 HG11 HG21 ' B' ' 13' ' ' VAL . 41.3 t -72.61 -33.25 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.533 -0.729 . . . . 0.0 110.361 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.632 ' HB3' HD13 ' A' ' 100' ' ' ILE . 23.5 m-85 -75.29 -57.7 3.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.034 -1.041 . . . . 0.0 110.011 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 96' ' ' GLY . 20.6 t0 -84.53 53.41 2.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 110.437 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 93' ' ' ASP . 3.6 mtmt -46.39 -26.56 0.86 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.074 -1.016 . . . . 0.0 108.895 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 1.3 t0 -66.66 -35.55 80.43 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 67.37 35.29 87.23 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.49 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 33.2 p-10 -91.66 -24.12 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.043 -1.269 . . . . 0.0 109.741 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.544 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 120.65 15.93 4.75 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 2.9 m-85 -161.25 150.24 16.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.161 -1.199 . . . . 0.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 92' ' ' PHE . 9.7 mt -107.86 131.84 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.379 -0.826 . . . . 0.0 110.273 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 102' ' ' ALA . 20.2 p -115.13 145.94 41.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.111 -0.993 . . . . 0.0 110.008 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.1 -28.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.35 -0.844 . . . . 0.0 110.043 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -69.44 -51.28 37.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.295 -0.878 . . . . 0.0 109.619 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.16 -39.12 71.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.24 -0.913 . . . . 0.0 109.454 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.552 HD13 HD11 ' A' ' 125' ' ' ILE . 1.2 mt -70.07 -36.34 74.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.437 -0.79 . . . . 0.0 109.785 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 17.3 ttt85 -66.36 -29.87 70.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.744 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -76.36 -33.6 58.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.806 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.767 HG21 HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -79.85 -37.52 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.582 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.526 ' HG3' ' N ' ' A' ' 110' ' ' THR . 6.1 ptp -68.14 -36.48 79.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.526 ' N ' ' HG3' ' A' ' 109' ' ' MET . 68.1 m -70.18 -39.76 75.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.327 -0.858 . . . . 0.0 109.631 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -72.5 -14.48 61.67 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.355 -0.841 . . . . 0.0 109.437 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.732 HD11 HG12 ' B' ' 13' ' ' VAL . 10.1 mt -86.57 -46.86 9.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.403 -0.81 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.29 -9.88 0.83 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.836 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp10 -127.65 150.48 49.72 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.734 -1.45 . . . . 0.0 110.857 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 116' ' ' LEU . 2.2 mttp -132.2 74.58 1.59 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.421 -0.8 . . . . 0.0 109.454 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.68 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.4 mp -38.64 144.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 110.652 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -57.47 -144.61 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.559 -0.713 . . . . 0.0 110.57 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 117' ' ' THR . 8.2 m-20 -111.71 -38.58 4.83 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.019 -1.051 . . . . 0.0 111.212 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 4.8 pt-20 -70.87 -32.17 69.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.996 -1.065 . . . . 0.0 110.46 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.538 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 12.0 pt-20 -78.41 -40.47 35.9 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.13 -0.981 . . . . 0.0 109.4 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.625 HG23 ' HB3' ' A' ' 116' ' ' LEU . 9.7 t -63.37 -36.25 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.211 -0.931 . . . . 0.0 109.423 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.25 -48.4 65.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 0.0 109.434 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 2.3 mm-40 -63.25 -19.63 64.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.39 -0.819 . . . . 0.0 109.407 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.88 -56.95 4.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -0.836 . . . . 0.0 109.791 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.552 HD11 HD13 ' A' ' 105' ' ' LEU . 22.8 mm -61.5 -43.5 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 109.483 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -64.21 -37.54 87.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.436 -0.79 . . . . 0.0 110.007 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 17.2 tp10 -70.9 -15.64 62.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.783 . . . . 0.0 110.111 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -94.57 -42.04 9.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 110.358 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 135' ' ' GLN . 0.4 OUTLIER -56.03 80.59 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.442 -0.786 . . . . 0.0 110.361 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 128' ' ' ALA . 13.0 mt -50.31 -41.41 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.099 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 12.0 p-10 -80.39 -34.91 35.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.424 -0.798 . . . . 0.0 110.048 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.92 68.16 1.14 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 3.0 p30 -117.3 -14.15 10.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -1.202 . . . . 0.0 110.186 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.76 5.39 29.4 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 11.1 pt20 -170.05 169.26 8.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.225 -1.162 . . . . 0.0 110.445 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 26.0 t -100.34 159.1 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.212 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.568 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 57.5 t30 -128.63 173.3 10.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.257 -0.902 . . . . 0.0 110.243 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.492 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 38.4 t80 -55.71 -61.95 2.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 0.0 110.087 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.36 -31.73 15.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.43 -50.88 8.92 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.182 -0.949 . . . . 0.0 110.248 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.573 ' CE1' ' CD2' ' A' ' 92' ' ' PHE . 63.3 t80 -54.93 -17.78 4.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.995 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 146' ' ' THR . 14.7 t -97.4 -36.68 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 0.0 110.261 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -11.47 60.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.21 -0.931 . . . . 0.0 110.425 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.487 ' HE3' ' HB3' ' A' ' 144' ' ' MET . 17.8 mmm -91.75 -25.69 18.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.174 -0.954 . . . . 0.0 110.267 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.465 ' SD ' HG12 ' A' ' 85' ' ' ILE . 6.5 mtp -98.79 -30.28 12.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.226 -0.921 . . . . 0.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 142' ' ' VAL . 35.0 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.833 HG23 ' HD2' ' B' ' 5' ' ' PRO . 10.6 mt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.006 0.432 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.833 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.5 Cg_endo -66.71 -164.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 124.06 1.558 . . . . 0.0 110.996 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.429 ' C ' ' SD ' ' A' ' 51' ' ' MET . 0.1 OUTLIER -115.65 -148.89 0.44 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.311 -0.868 . . . . 0.0 110.797 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.764 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -91.7 -74.49 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 110.778 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.464 HG21 ' HG2' ' A' ' 75' ' ' LYS . 14.3 p -44.28 -43.25 7.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 110.094 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 87' ' ' GLU . 17.1 m -45.18 -54.03 7.43 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 109.777 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.03 -38.66 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.247 -0.908 . . . . 0.0 109.343 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.504 ' N ' HD13 ' B' ' 11' ' ' ILE . 5.3 mm -67.72 -39.27 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.361 -0.837 . . . . 0.0 109.957 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' B' ' 9' ' ' THR . 12.7 mt -52.63 -56.09 17.82 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.347 -0.845 . . . . 0.0 109.958 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.788 HG21 HG11 ' A' ' 91' ' ' VAL . 73.4 t -54.51 -54.7 19.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 110.33 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.515 ' O ' HD22 ' B' ' 17' ' ' LEU . 3.7 tptt -55.71 -41.67 74.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.809 -1.182 . . . . 0.0 109.71 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 17.8 t -72.91 -6.0 42.27 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 109.865 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.579 ' SD ' ' CD1' ' B' ' 22' ' ' PHE . 35.0 tpp -83.97 -45.13 13.48 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.256 -0.902 . . . . 0.0 110.138 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.734 ' H ' HD13 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -96.06 33.67 1.68 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 118.383 -1.327 . . . . 0.0 110.234 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.415 ' HG2' ' N ' ' B' ' 19' ' ' LYS . 1.5 ttt85 -42.5 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.49 0.662 . . . . 0.0 109.992 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.586 ' HD2' ' CG ' ' B' ' 20' ' ' ARG . 2.9 tmtm? -103.69 -84.66 0.47 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.141 -0.974 . . . . 0.0 110.387 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.586 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.4 OUTLIER -146.1 12.41 1.24 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.697 -1.252 . . . . 0.0 110.021 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.53 174.06 6.04 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.351 -0.843 . . . . 0.0 110.775 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.579 ' CD1' ' SD ' ' B' ' 16' ' ' MET . 0.2 OUTLIER -130.32 66.15 1.51 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.47 -0.769 . . . . 0.0 110.061 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.29 -173.97 13.24 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.447 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 0.4 OUTLIER -176.71 118.59 0.28 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.369 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -79.74 35.69 0.58 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.829 1.437 . . . . 0.0 111.216 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.432 ' CD1' ' OD1' ' B' ' 24' ' ' ASN . 8.3 m-85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.901 -1.125 . . . . 0.0 110.388 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.237 0.542 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.9 mt -55.7 -54.45 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.191 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.72 -48.63 10.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.166 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.98 -49.01 74.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -0.926 . . . . 0.0 110.048 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.438 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 20.9 m-30 -63.69 -40.53 97.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.915 . . . . 0.0 110.112 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -54.91 -52.23 63.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.769 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 9.3 tp10 -60.04 -30.55 69.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.543 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -69.28 -50.47 46.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.466 -0.771 . . . . 0.0 110.155 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.474 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 16.9 t80 -63.15 -36.93 85.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.607 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.2 m -75.36 -15.32 60.48 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.331 -0.856 . . . . 0.0 109.4 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.859 HD11 ' O ' ' A' ' 112' ' ' LEU . 7.8 tt -74.21 -48.27 30.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.449 -0.782 . . . . 0.0 110.096 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.549 ' HB3' HG23 ' A' ' 27' ' ' ILE . 54.5 m-85 -69.57 -47.37 63.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.293 -0.879 . . . . 0.0 109.988 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 4.4 t0 -57.55 95.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.13 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 8.2 mmtp -52.44 -56.08 17.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.175 -0.953 . . . . 0.0 110.15 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 18.6 p-10 -76.62 -33.78 58.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.84 . . . . 0.0 110.328 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 95.06 41.34 4.06 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 32.3 p-10 -97.09 8.98 43.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.153 -1.204 . . . . 0.0 110.308 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 26' ' ' THR . . . 74.07 38.28 47.98 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 25' ' ' GLY . 21.7 p -156.52 111.38 2.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.173 -1.192 . . . . 0.0 110.293 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.848 HD12 HG21 ' A' ' 63' ' ' ILE . 17.5 mt -86.85 123.14 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.085 -1.009 . . . . 0.0 110.365 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -100.43 164.87 11.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.4 -0.812 . . . . 0.0 109.543 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.406 HG21 ' OE1' ' A' ' 49' ' ' GLN . 18.7 p -65.75 -25.11 67.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.984 -1.073 . . . . 0.0 109.885 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.36 -45.0 49.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 109.994 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 35' ' ' VAL . 46.6 mt-10 -63.25 -66.16 0.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 109.992 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 tp -47.74 -45.03 28.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 110.06 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.28 -54.89 9.5 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 59.3 m -61.08 -36.32 79.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -1.055 . . . . 0.0 110.036 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 31' ' ' GLU . 19.3 t -62.69 -43.94 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.92 . . . . 0.0 110.084 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.428 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 12.5 mmm -66.48 -28.72 68.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.283 -0.886 . . . . 0.0 110.041 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 tpt85 -72.5 -29.43 63.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.324 -0.86 . . . . 0.0 110.245 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -58.39 -48.9 79.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 110.555 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.643 HD23 HG23 ' A' ' 108' ' ' VAL . 2.6 mt -57.25 -23.47 48.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.182 -0.949 . . . . 0.0 110.2 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . 106.34 70.87 0.76 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 40' ' ' GLY . 26.8 mm-40 -153.26 -172.14 4.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.233 -1.157 . . . . 0.0 110.153 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.05 78.88 45.91 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.207 -0.933 . . . . 0.0 110.533 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HG3' ' HB2' ' A' ' 36' ' ' MET . 44.0 Cg_endo -72.22 135.69 25.33 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.074 1.565 . . . . 0.0 110.228 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.1 m -97.98 146.1 25.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -0.927 . . . . 0.0 110.237 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -49.42 -47.55 47.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.15 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.47 -48.21 74.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.951 . . . . 0.0 110.193 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.22 -32.79 74.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.951 . . . . 0.0 110.247 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 48' ' ' LEU . 8.9 mt -61.07 -51.04 70.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 110.406 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' OE1' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -62.92 -36.91 84.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.336 -0.852 . . . . 0.0 110.203 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -71.15 -32.05 68.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 109.871 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.635 ' CE ' ' CD1' ' B' ' 7' ' ' TRP . 3.9 mmm -69.47 -36.03 76.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 109.965 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.895 HG12 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -89.69 -12.05 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.626 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.67 -37.17 72.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.0 110.254 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.04 -32.48 15.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.409 -0.807 . . . . 0.0 110.464 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.78 HG12 HD12 ' A' ' 63' ' ' ILE . 15.6 t -69.74 -31.51 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.093 -1.005 . . . . 0.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 57' ' ' ALA . 42.4 t0 -76.84 49.41 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.127 -0.983 . . . . 0.0 110.217 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -44.05 -29.82 0.65 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 110.377 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 2.7 t0 -61.93 -61.83 2.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.725 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.18 25.19 3.92 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 54.8 p30 -99.04 -14.62 19.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.943 -1.327 . . . . 0.0 110.112 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 105.75 -34.42 5.78 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.515 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 12.7 p -106.44 161.06 14.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.157 -1.202 . . . . 0.0 110.414 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.895 HD11 HG12 ' A' ' 52' ' ' ILE . 25.6 mm -86.44 144.29 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.295 -0.878 . . . . 0.0 110.578 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 6.7 t70 -122.25 165.42 16.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.489 -0.757 . . . . 0.0 110.046 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.616 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 14.8 t80 -59.07 -43.35 97.24 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.235 -0.916 . . . . 0.0 111.625 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.4 Cg_endo -72.82 -30.31 11.53 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.37 1.194 . . . . 0.0 110.555 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 64' ' ' ASP . 17.0 mt-10 -68.64 -44.39 74.25 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.081 -1.012 . . . . 0.0 109.534 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CD1' ' HE3' ' A' ' 71' ' ' MET . 33.9 t80 -61.02 -45.23 95.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 0.0 110.036 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.6 -36.28 75.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.192 -0.942 . . . . 0.0 110.421 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -71.79 -26.91 62.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.249 -0.907 . . . . 0.0 110.576 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.593 ' HE2' HG22 ' A' ' 55' ' ' VAL . 2.2 tmm? -71.5 -62.26 1.47 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 110.555 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -20.47 1.14 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.222 -0.924 . . . . 0.0 110.157 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.4 -21.69 20.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.191 -0.943 . . . . 0.0 110.268 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtt85 -98.36 -20.07 17.38 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.194 -0.941 . . . . 0.0 110.503 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.575 ' HG2' HG21 ' B' ' 8' ' ' THR . 1.9 tptm . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.933 . . . . 0.0 109.927 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.097 0.475 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' O ' ' OE2' ' A' ' 87' ' ' GLU . 3.9 pt-20 -84.79 -9.74 57.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.142 -0.973 . . . . 0.0 110.469 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.49 -27.36 25.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.084 -1.01 . . . . 0.0 110.088 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.618 HD13 HG21 ' A' ' 146' ' ' THR . 5.3 mt -73.25 -38.0 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.082 -1.011 . . . . 0.0 109.024 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -57.2 -31.46 65.49 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.451 ' HB3' HG23 ' B' ' 9' ' ' THR . 0.5 OUTLIER -67.69 -58.89 3.87 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.556 -0.715 . . . . 0.0 109.293 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.17 -30.09 48.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 109.426 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -74.34 -31.49 62.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -0.888 . . . . 0.0 109.216 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.47 -22.42 64.56 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.534 -0.729 . . . . 0.0 109.467 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.783 HG12 HG21 ' A' ' 108' ' ' VAL . 23.6 t -91.12 -28.75 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 0.0 110.476 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.649 ' HB3' HD13 ' A' ' 100' ' ' ILE . 4.0 m-85 -77.92 -30.05 50.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.076 -1.015 . . . . 0.0 109.964 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -96.36 63.27 2.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.315 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ASP . 5.6 mmpp? -41.12 -28.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.512 -0.742 . . . . 0.0 110.079 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.5 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 7.9 m-20 -82.96 -39.47 21.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.357 -0.839 . . . . 0.0 109.686 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 77.23 26.61 61.41 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 95' ' ' ASP . 5.9 p-10 -86.65 -44.18 12.05 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -1.22 . . . . 0.0 109.931 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.591 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 143.62 27.61 0.13 Allowed Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.827 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 41.3 m-85 -161.2 136.92 7.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.924 -1.339 . . . . 0.0 110.174 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.649 HD13 ' HB3' ' A' ' 92' ' ' PHE . 11.1 mt -101.0 123.24 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.257 -0.902 . . . . 0.0 109.969 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 61.8 p -105.19 140.61 38.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.38 -34.81 0.87 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.383 -0.823 . . . . 0.0 109.999 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.6 -51.04 70.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.855 . . . . 0.0 109.761 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.421 ' CD ' ' OD2' ' A' ' 95' ' ' ASP . 11.7 mt-10 -57.08 -43.1 81.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.78 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.819 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -58.94 -37.35 76.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.768 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 1.8 ttt-85 -61.35 -37.38 83.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.509 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -63.82 -44.32 93.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.459 -0.775 . . . . 0.0 109.808 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.783 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -82.62 -28.67 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.442 -0.786 . . . . 0.0 109.284 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.623 ' HA ' HD21 ' B' ' 17' ' ' LEU . 31.7 ttm -65.51 -57.06 9.15 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.578 -0.701 . . . . 0.0 110.14 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.682 HG23 ' HB3' ' A' ' 115' ' ' LYS . 5.8 m -67.53 -32.4 73.16 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.248 -0.907 . . . . 0.0 110.316 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 60.6 m-20 -76.81 1.79 16.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.002 -1.061 . . . . 0.0 109.29 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.888 ' CD1' HG12 ' B' ' 13' ' ' VAL . 7.0 mt -111.75 4.37 18.41 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.372 -0.83 . . . . 0.0 110.601 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.76 -75.97 0.41 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.609 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp10 -94.6 154.27 17.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -1.133 . . . . 0.0 111.099 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.682 ' HB3' HG23 ' A' ' 110' ' ' THR . 1.3 pttm -129.45 74.43 1.58 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.641 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.9 mp -34.27 154.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.391 0.615 . . . . 0.0 110.965 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.81 -144.23 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.299 -0.876 . . . . 0.0 110.097 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -108.53 -59.34 1.88 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.218 -0.926 . . . . 0.0 110.139 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -48.87 -45.24 40.75 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.069 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.31 -50.58 73.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.89 . . . . 0.0 109.924 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.605 HG22 ' CE ' ' A' ' 109' ' ' MET . 43.5 t -57.64 -38.26 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.86 -45.61 70.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.902 . . . . 0.0 109.796 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 1.8 tt0 -64.84 -23.18 67.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.456 -0.778 . . . . 0.0 109.89 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.42 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 1.8 ttt -73.06 -43.79 61.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.843 . . . . 0.0 109.945 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.819 HD11 ' CD1' ' A' ' 105' ' ' LEU . 45.0 mm -69.93 -42.13 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 110.185 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 33.9 mtt-85 -66.25 -44.55 83.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.266 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 7.6 mm-40 -48.19 -32.15 6.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.392 -0.818 . . . . 0.0 110.25 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -100.69 -30.57 11.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 110.162 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -56.72 83.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.343 -0.848 . . . . 0.0 110.613 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -65.28 -42.35 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.9 p-10 -70.68 -33.5 70.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 109.844 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 87.02 56.55 2.17 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 25.7 p30 -112.98 0.12 14.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -1.211 . . . . 0.0 109.864 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.455 ' C ' ' HG3' ' A' ' 135' ' ' GLN . . . 76.71 -1.72 61.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.478 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 33.0 mt-30 -139.55 138.52 36.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.142 -1.21 . . . . 0.0 110.25 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 125' ' ' ILE . 20.2 t -89.37 154.74 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.108 -0.995 . . . . 0.0 109.724 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.45 ' OD1' ' HG3' ' A' ' 139' ' ' GLU . 55.9 p30 -130.09 -142.32 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 110.581 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.71 -68.58 0.69 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.391 -0.818 . . . . 0.0 110.697 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -46.74 -25.06 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.23 -0.919 . . . . 0.0 110.792 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 38.0 mt-10 -83.13 -61.09 1.95 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.008 . . . . 0.0 109.726 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.515 ' CE1' HG23 ' A' ' 85' ' ' ILE . 35.4 t80 -51.23 -19.52 1.25 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 110.29 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 144' ' ' MET . 55.5 t -100.93 -70.21 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.264 -0.898 . . . . 0.0 111.455 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.52 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -39.74 -24.73 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.103 -0.998 . . . . 0.0 111.787 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.52 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 77.7 mmm -88.62 -39.25 14.21 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.745 -1.222 . . . . 0.0 111.395 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.39 -9.69 21.96 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.989 -1.069 . . . . 0.0 111.895 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.618 HG21 HD13 ' A' ' 85' ' ' ILE . 1.3 p . . . . . 0 N--CA 1.491 1.617 0 O-C-N 120.721 -1.237 . . . . 0.0 111.06 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.987 HD13 ' HD2' ' B' ' 5' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.987 ' HD2' HD13 ' B' ' 4' ' ' ILE . 38.5 Cg_endo -65.9 -155.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.825 1.434 . . . . 0.0 110.176 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.424 ' O ' HG23 ' B' ' 10' ' ' VAL . 6.6 m -121.94 -147.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.933 -1.104 . . . . 0.0 111.333 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.764 ' CD1' HG21 ' A' ' 55' ' ' VAL . 4.8 m95 -81.91 -76.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.547 0.689 . . . . 0.0 111.282 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.575 HG21 ' HG2' ' A' ' 75' ' ' LYS . 30.2 p -43.86 -42.82 5.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.811 . . . . 0.0 110.3 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.525 HG21 ' CB ' ' B' ' 5' ' ' PRO . 53.6 m -46.29 -41.41 13.13 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 109.292 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 6' ' ' SER . 46.2 t -69.32 -41.06 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.359 -0.838 . . . . 0.0 109.863 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.5 ' N ' HD13 ' B' ' 11' ' ' ILE . 5.6 mm -72.76 -25.69 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.248 -0.907 . . . . 0.0 109.874 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.636 HD13 ' CD2' ' B' ' 26' ' ' PHE . 1.3 mm? -65.97 -53.41 39.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.694 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.888 HG12 ' CD1' ' A' ' 112' ' ' LEU . 53.2 t -61.02 -48.9 86.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.152 -0.968 . . . . 0.0 109.766 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -35.69 43.17 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.844 -1.16 . . . . 0.0 108.965 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 5.3 t -65.24 -34.85 79.33 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.514 -0.741 . . . . 0.0 109.365 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.421 ' HG3' ' CE1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -57.32 -43.81 83.65 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.401 -0.812 . . . . 0.0 109.518 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 109' ' ' MET . 4.1 mp -58.16 -94.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 109.688 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 58.15 -76.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.518 -0.739 . . . . 0.0 110.6 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER 175.63 107.59 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.887 -0.508 . . . . 0.0 110.842 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.7 OUTLIER 40.16 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.464 -0.773 . . . . 0.0 110.947 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.518 ' N ' ' O ' ' B' ' 19' ' ' LYS . 2.2 m -107.62 141.16 39.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.983 -1.073 . . . . 0.0 110.29 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.605 ' HE2' HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -142.21 12.67 1.99 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.196 -0.94 . . . . 0.0 110.208 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' B' ' 24' ' ' ASN . . . -77.96 -61.44 2.53 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 145' ' ' MET . 1.8 m-80 55.4 69.06 2.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.3 -1.118 . . . . 0.0 110.068 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.45 62.47 4.43 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 O-C-N 123.967 1.509 . . . . 0.0 110.04 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.636 ' CD2' HD13 ' B' ' 12' ' ' LEU . 1.1 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.189 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.226 0.536 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.5 mp -54.07 -39.58 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.45 -51.82 65.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.484 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -48.91 -49.11 41.53 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.363 -0.835 . . . . 0.0 109.256 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -60.59 -44.79 95.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.386 -0.821 . . . . 0.0 109.345 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 10.6 tptm -57.26 -36.6 71.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.368 -0.833 . . . . 0.0 109.227 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -52.56 64.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.604 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.61 -41.88 64.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 0.0 109.492 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 31.8 t80 -65.62 -43.66 88.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.491 -0.756 . . . . 0.0 109.509 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -69.87 -25.35 63.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 109.615 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.692 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.3 tt -67.47 -42.29 83.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.447 -0.783 . . . . 0.0 109.798 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.515 ' HA ' HG21 ' A' ' 35' ' ' VAL . 24.9 m-85 -73.16 -39.22 65.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 109.762 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -62.94 89.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.412 -0.805 . . . . 0.0 110.226 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -88.33 30.66 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.224 -0.922 . . . . 0.0 110.133 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 9.4 p-10 -143.65 -41.53 0.29 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.241 -0.912 . . . . 0.0 110.325 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 102.93 90.94 2.17 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.1 p-10 -164.07 -43.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.195 -1.179 . . . . 0.0 110.409 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.4 17.65 6.53 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -143.85 119.52 10.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.194 -1.18 . . . . 0.0 110.351 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 5.9 mt -82.09 115.97 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.083 -1.011 . . . . 0.0 109.943 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 9.0 p -80.35 -174.29 4.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.678 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.0 -49.88 26.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.159 -0.963 . . . . 0.0 110.179 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' GLU . 4.8 ttmt -68.32 -40.9 81.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.484 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.2 mt-10 -43.98 -48.78 8.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.13 -0.981 . . . . 0.0 109.594 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.608 HD23 HD21 ' A' ' 48' ' ' LEU . 24.0 tp -71.39 -34.52 70.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.314 -0.867 . . . . 0.0 109.366 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -59.45 -46.81 93.32 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 99.5 m -58.71 -54.35 48.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -1.094 . . . . 0.0 109.159 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 31' ' ' GLU . 16.8 t -56.76 -35.47 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.37 -0.831 . . . . 0.0 109.363 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.0 mmt -63.56 -49.56 72.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.461 -0.774 . . . . 0.0 109.697 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -54.09 -30.46 48.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.876 . . . . 0.0 109.5 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.446 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 1.3 m -54.96 -50.17 69.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.439 -0.788 . . . . 0.0 110.132 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.1 mt -52.15 -36.64 52.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.109 -0.995 . . . . 0.0 109.673 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 117.45 64.87 0.33 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 40' ' ' GLY . 6.3 mt-30 -156.81 -166.28 2.06 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.227 -1.161 . . . . 0.0 110.376 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -126.6 82.0 67.51 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.224 -0.922 . . . . 0.0 110.667 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.9 102.58 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.908 1.478 . . . . 0.0 110.438 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.511 ' CG2' ' HG3' ' A' ' 47' ' ' GLU . 11.4 t -79.63 172.09 14.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.187 -0.946 . . . . 0.0 110.084 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -78.78 -25.67 44.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.158 -0.964 . . . . 0.0 110.482 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.09 -65.43 0.7 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.034 -1.041 . . . . 0.0 110.178 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HG3' ' CG2' ' A' ' 44' ' ' THR . 0.9 OUTLIER -52.7 -44.96 66.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 109.879 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.608 HD21 HD23 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -50.96 -42.94 60.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.907 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -45.64 92.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.423 -0.798 . . . . 0.0 109.8 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.76 -13.97 62.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 110.062 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.617 ' HE1' ' CA ' ' B' ' 7' ' ' TRP . 2.4 mmm -94.26 -46.37 7.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.52 HG13 HD11 ' A' ' 63' ' ' ILE . 1.2 tp -60.69 -37.96 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.242 -0.911 . . . . 0.0 110.035 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.408 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.8 OUTLIER -51.11 -29.78 14.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 110.284 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -65.24 -56.33 13.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.024 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.668 HG22 ' HG3' ' A' ' 71' ' ' MET . 15.2 t -70.78 -14.49 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.126 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.4 77.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 110.384 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.551 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . . . -56.9 -63.81 1.08 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 0.0 110.32 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 7.0 p-10 -66.4 -43.9 84.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.97 . . . . 0.0 110.191 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.68 41.09 1.64 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 34.9 p-10 -99.51 -42.72 6.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.093 -1.239 . . . . 0.0 110.27 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 136.23 -14.34 4.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 22.0 p -118.36 160.89 20.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.135 -1.215 . . . . 0.0 110.538 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.52 HD11 HG13 ' A' ' 52' ' ' ILE . 8.0 mm -97.85 152.63 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 109.905 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.453 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 2.0 m-20 -131.57 148.22 52.6 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.188 -0.945 . . . . 0.0 110.535 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.911 ' O ' HD12 ' A' ' 69' ' ' LEU . 37.6 t80 -40.58 -51.22 6.8 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.281 -0.887 . . . . 0.0 111.172 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.9 Cg_endo -66.09 -33.07 42.14 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.325 1.171 . . . . 0.0 110.04 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.551 ' HG2' ' CB ' ' A' ' 57' ' ' ALA . 3.2 mt-10 -69.84 -30.03 67.42 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.312 -0.868 . . . . 0.0 109.467 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.678 ' HZ ' HG23 ' B' ' 11' ' ' ILE . 56.8 t80 -65.54 -54.71 24.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.468 -0.77 . . . . 0.0 109.978 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.911 HD12 ' O ' ' A' ' 65' ' ' PHE . 1.3 mp -53.6 -48.75 68.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.383 -0.823 . . . . 0.0 110.066 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -27.99 69.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 110.247 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.668 ' HG3' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -61.88 -60.41 3.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.42 -0.8 . . . . 0.0 111.023 -179.448 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.648 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 41.1 mmm -51.5 -16.51 0.61 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.101 -1.0 . . . . 0.0 111.076 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.73 -9.37 54.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.808 -1.182 . . . . 0.0 110.452 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -95.78 -42.62 8.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.094 -1.004 . . . . 0.0 111.375 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.614 ' CB ' HG21 ' B' ' 8' ' ' THR . 4.8 mmtp . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.088 -1.007 . . . . 0.0 111.04 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HG2' ' OG1' ' A' ' 146' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.067 0.461 . . . . 0.0 110.593 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.456 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -59.84 -15.37 20.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.05 -1.032 . . . . 0.0 109.919 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.537 ' HG2' ' CD2' ' B' ' 12' ' ' LEU . 10.8 tt0 -68.63 -33.83 74.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.497 -0.752 . . . . 0.0 110.561 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.542 ' CD1' ' HB ' ' A' ' 146' ' ' THR . 49.9 mt -60.61 -30.53 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.214 -0.929 . . . . 0.0 109.174 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -63.41 -33.57 75.83 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.737 -0.602 . . . . 0.0 110.21 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.874 ' HB3' HG21 ' B' ' 9' ' ' THR . 1.2 mp0 -73.25 -48.06 37.98 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.105 -0.997 . . . . 0.0 109.901 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -60.83 -27.68 68.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.032 . . . . 0.0 109.948 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.582 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 64.4 t80 -70.21 -49.13 53.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.929 -1.107 . . . . 0.0 108.949 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -52.12 -30.19 25.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.484 -0.76 . . . . 0.0 109.078 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.658 HG12 HG21 ' A' ' 108' ' ' VAL . 40.8 t -69.34 -47.79 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.498 -0.751 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.575 ' HB3' ' CD1' ' A' ' 100' ' ' ILE . 52.2 m-85 -62.4 -43.48 98.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.917 -1.115 . . . . 0.0 110.263 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -68.41 58.03 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 0.0 110.096 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 92' ' ' PHE . 7.2 tttm -40.89 -62.53 0.8 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 110.515 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 30.2 p-10 -63.64 -41.43 98.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.207 -0.933 . . . . 0.0 110.214 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 100.07 40.36 3.08 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 30.6 p-10 -99.08 -21.07 16.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.233 -1.157 . . . . 0.0 110.265 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.56 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 101.36 33.87 4.69 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.56 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 53.3 m-85 -159.22 149.27 19.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.312 -1.111 . . . . 0.0 110.113 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 11.5 mt -116.55 153.78 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.125 -0.985 . . . . 0.0 110.543 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 102' ' ' ALA . 12.0 t -145.8 154.18 41.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.437 -0.789 . . . . 0.0 109.76 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.42 -28.81 0.6 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.955 . . . . 0.0 110.083 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.5 -51.34 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.803 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 92' ' ' PHE . 21.1 mt-10 -58.77 -35.91 73.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.879 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.026 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -65.16 -41.15 94.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.611 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.457 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 1.5 tpp180 -64.33 -24.13 67.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -79.28 -31.68 43.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.45 -0.781 . . . . 0.0 110.217 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.658 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -85.4 -30.62 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.266 -0.897 . . . . 0.0 109.995 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.689 ' HA ' HD21 ' B' ' 17' ' ' LEU . 5.0 ptp -74.41 -40.9 61.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.525 ' N ' ' HG3' ' A' ' 109' ' ' MET . 93.9 m -71.62 -23.45 61.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.134 -0.979 . . . . 0.0 109.62 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 38' ' ' SER . 22.3 m-20 -84.98 -8.48 58.72 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.194 -0.941 . . . . 0.0 109.848 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.692 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.4 mt -97.78 -38.29 9.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 110.316 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.74 -26.99 1.18 Allowed Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.586 -1.292 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 109' ' ' MET . 21.1 tt0 -113.56 166.02 11.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.887 -1.361 . . . . 0.0 110.826 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -146.12 72.19 1.29 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.493 -0.754 . . . . 0.0 109.234 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 116' ' ' LEU . 2.9 mp -36.47 148.09 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.466 0.65 . . . . 0.0 111.16 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -56.46 -157.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.524 -0.735 . . . . 0.0 110.01 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 117' ' ' THR . 0.3 OUTLIER -95.47 -68.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.03 -1.044 . . . . 0.0 110.312 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -43.5 -46.27 6.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.012 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -59.79 -52.11 66.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.714 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 117' ' ' THR . 83.0 t -60.18 -38.26 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 0.0 110.175 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -66.27 -63.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.0 109.875 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 122' ' ' ASP . 13.3 mm-40 -46.11 -26.57 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.365 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.705 ' HE2' ' CD2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.44 -55.12 17.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.499 -0.751 . . . . 0.0 110.183 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.026 HD11 ' CD1' ' A' ' 105' ' ' LEU . 44.5 mm -62.85 -22.58 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.414 -0.804 . . . . 0.0 110.244 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.408 ' C ' ' HD3' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -81.43 -38.98 25.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.194 -0.941 . . . . 0.0 110.158 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.34 -7.04 33.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 110.057 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.905 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -112.89 -32.09 6.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.19 -0.944 . . . . 0.0 110.334 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.452 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -54.94 83.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.313 -0.867 . . . . 0.0 110.513 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 128' ' ' ALA . 0.9 OUTLIER -61.67 -28.94 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 0.0 109.461 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD2' ' CD ' ' A' ' 140' ' ' GLU . 6.3 m-20 -85.53 -25.24 26.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.611 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.68 57.59 7.87 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 18.2 p-10 -120.88 -28.15 4.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -1.126 . . . . 0.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.404 ' C ' ' OE1' ' A' ' 135' ' ' GLN . . . 126.37 9.04 4.69 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.154 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.486 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 1.6 pm0 -165.14 166.86 18.73 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.931 -1.335 . . . . 0.0 110.381 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 24.1 t -110.1 168.42 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 110.413 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.466 ' N ' HG12 ' A' ' 136' ' ' VAL . 13.7 t-20 -141.91 173.34 11.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.382 -0.824 . . . . 0.0 109.694 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 139' ' ' GLU . 12.3 t80 -53.31 -56.89 13.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.107 -0.996 . . . . 0.0 109.965 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 2.8 tt0 -44.08 -47.87 8.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.429 ' CD ' ' OD2' ' A' ' 131' ' ' ASP . 51.4 mt-10 -69.51 -57.09 5.66 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.319 -0.863 . . . . 0.0 110.324 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 45.7 t80 -51.96 -19.76 1.99 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.291 -0.881 . . . . 0.0 110.326 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.957 HG13 HG21 ' A' ' 146' ' ' THR . 44.6 t -97.86 -43.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.212 -0.93 . . . . 0.0 110.483 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -65.32 -9.89 28.2 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.041 -1.037 . . . . 0.0 110.146 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.496 ' HE2' ' CD1' ' A' ' 130' ' ' ILE . 2.2 ttm -92.8 -37.96 12.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.669 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.46 -62.17 1.28 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.211 -0.93 . . . . 0.0 111.198 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.957 HG21 HG13 ' A' ' 142' ' ' VAL . 15.2 t . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.151 -0.968 . . . . 0.0 111.151 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.768 HG23 ' HD2' ' B' ' 5' ' ' PRO . 81.5 mt . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 120.767 0.318 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.768 ' HD2' HG23 ' B' ' 4' ' ' ILE . 49.5 Cg_endo -74.78 -157.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 124.148 1.604 . . . . 0.0 109.403 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.546 ' CB ' ' OG1' ' B' ' 9' ' ' THR . 0.2 OUTLIER -123.47 -175.04 3.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.975 -1.078 . . . . 0.0 110.648 179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 1.007 ' O ' HG22 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -80.35 -79.1 0.15 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.565 -0.709 . . . . 0.0 111.094 -179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.858 ' O ' HD13 ' B' ' 12' ' ' LEU . 6.6 p -45.16 -23.74 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.866 -1.146 . . . . 0.0 110.043 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.874 HG21 ' HB3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -63.46 -60.19 3.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.072 -1.017 . . . . 0.0 109.154 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 1.007 HG22 ' O ' ' B' ' 7' ' ' TRP . 32.9 m -48.89 -28.36 2.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.736 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.678 HG23 ' HZ ' ' A' ' 68' ' ' PHE . 6.8 mm -79.77 -33.8 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.858 HD13 ' O ' ' B' ' 8' ' ' THR . 4.2 mp -60.39 -60.96 2.99 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.673 -0.642 . . . . 0.0 109.989 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.576 ' O ' HD13 ' B' ' 17' ' ' LEU . 78.6 t -60.14 -38.88 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -67.53 -21.78 65.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.83 -1.168 . . . . 0.0 110.214 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.44 -36.68 33.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.516 ' HG2' ' HA ' ' B' ' 13' ' ' VAL . 0.2 OUTLIER -75.19 -20.65 59.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.226 -0.921 . . . . 0.0 110.255 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.689 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.3 mp -75.69 1.83 13.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.177 -0.952 . . . . 0.0 110.514 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' B' ' 17' ' ' LEU . 14.2 ttm180 -35.61 -69.71 0.1 Allowed 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.208 0.527 . . . . 0.0 110.782 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -154.0 -69.1 0.14 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.084 -1.01 . . . . 0.0 110.362 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.555 ' HA ' ' HG3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -133.42 12.29 4.15 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 109.841 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 4.5 t -80.84 142.41 33.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.421 -0.799 . . . . 0.0 110.175 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.705 ' CD2' ' HE2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -143.88 -33.8 0.41 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.343 -0.848 . . . . 0.0 110.411 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.486 ' HA2' ' HG2' ' A' ' 144' ' ' MET . . . -64.9 -100.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -112.56 101.66 53.01 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.207 -1.172 . . . . 0.0 110.543 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.15 -18.9 12.47 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.126 1.593 . . . . 0.0 110.215 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.648 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 34.9 m-85 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.362 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.307 0.575 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mt -66.28 -35.86 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.82 88.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -0.892 . . . . 0.0 109.834 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 33.2 tp10 -64.62 -52.41 57.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.611 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -56.11 -31.19 63.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -37.33 83.33 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.302 -0.874 . . . . 0.0 109.211 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 17.0 mm-40 -58.33 -48.85 79.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.438 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.09 -51.56 69.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 109.648 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.613 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 25.4 t80 -52.58 -28.31 20.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -28.1 38.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.422 -0.799 . . . . 0.0 109.885 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.8 tt -63.66 -43.32 97.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.893 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.21 -41.0 50.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.41 -0.806 . . . . 0.0 110.333 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.74 100.03 2.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.039 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -86.13 -29.0 23.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.146 -0.971 . . . . 0.0 110.168 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.5 -33.35 54.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.12 12.49 58.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 29.7 p-10 -83.91 -27.83 28.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -1.177 . . . . 0.0 110.23 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' HG23 ' A' ' 26' ' ' THR . . . 102.99 37.71 3.08 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.551 HG23 ' C ' ' A' ' 25' ' ' GLY . 81.9 p -153.02 113.13 3.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.383 -1.069 . . . . 0.0 110.139 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.687 HD12 ' HB ' ' A' ' 63' ' ' ILE . 30.5 mt -82.83 116.24 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.42 176.27 6.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.6 p -63.41 -35.52 80.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 110.06 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.19 -56.33 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 110.295 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 30' ' ' LYS . 44.4 mt-10 -43.35 -64.8 0.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.166 -0.959 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.76 -37.15 75.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 109.938 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.77 -42.82 91.89 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 m -62.29 -47.69 83.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -1.17 . . . . 0.0 110.017 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 t -55.69 -29.74 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.688 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -31.57 60.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.916 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.14 -18.01 58.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 110.101 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.7 m -77.3 -51.48 10.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.46 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.71 -18.26 29.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.126 -0.984 . . . . 0.0 110.171 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.25 69.96 0.97 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.497 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 5.3 mm-40 -142.23 -162.74 1.46 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.278 -1.13 . . . . 0.0 109.831 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -159.58 88.46 2.0 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.128 -0.982 . . . . 0.0 110.767 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.46 127.47 13.3 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.095 1.577 . . . . 0.0 110.039 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 46' ' ' ALA . 6.2 t -86.36 30.29 0.71 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.124 -0.985 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 44' ' ' THR . 0.3 OUTLIER 67.05 -57.37 0.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 110.302 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 44' ' ' THR . . . -51.34 -40.02 58.24 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.324 -0.86 . . . . 0.0 109.927 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.53 -52.42 39.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.698 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.56 -57.52 3.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 110.064 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.5 mm-40 -55.74 -47.89 76.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.73 -36.65 72.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.456 -0.778 . . . . 0.0 109.759 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 mtp -75.86 -47.03 27.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.433 -0.792 . . . . 0.0 109.534 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.6 mm -66.06 -30.11 48.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.416 -0.802 . . . . 0.0 109.972 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 2.1 m120 -72.26 -16.61 61.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.181 -0.95 . . . . 0.0 110.029 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -87.48 -49.35 7.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 110.377 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.784 HG22 ' SD ' ' A' ' 71' ' ' MET . 21.9 t -72.25 -13.74 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.114 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.06 79.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.089 -1.007 . . . . 0.0 110.264 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -63.88 -39.37 94.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.666 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 37.8 p-10 -93.73 -32.12 14.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.16 -0.962 . . . . 0.0 110.793 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 97.61 38.71 4.11 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -99.81 -8.96 23.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -1.13 . . . . 0.0 110.322 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.44 -1.55 82.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 24.4 p -138.76 146.35 41.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -1.201 . . . . 0.0 110.376 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.719 HD12 ' CG1' ' A' ' 55' ' ' VAL . 48.4 mm -77.54 138.38 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.34 -0.85 . . . . 0.0 110.33 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 9.1 t0 -111.43 169.31 8.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 110.792 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 15.9 t80 -55.08 -45.46 99.84 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.35 -0.844 . . . . 0.0 111.41 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.4 Cg_endo -71.12 -46.36 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.233 1.122 . . . . 0.0 110.166 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 71' ' ' MET . 29.3 mt-10 -56.97 -33.77 67.41 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 109.87 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CZ ' HD13 ' B' ' 11' ' ' ILE . 47.1 t80 -67.65 -56.08 10.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.184 -0.948 . . . . 0.0 110.633 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 65' ' ' PHE . 1.2 mp -51.65 -61.5 2.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.358 -0.839 . . . . 0.0 110.995 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.5 m -51.92 -58.37 6.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.33 -0.856 . . . . 0.0 111.35 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.784 ' SD ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -43.74 -68.9 0.16 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.164 -0.96 . . . . 0.0 111.372 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.621 ' SD ' HG22 ' B' ' 8' ' ' THR . 7.7 mmm -37.8 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.257 -0.902 . . . . 0.0 110.908 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' MET . . . -92.81 -41.46 10.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.092 -1.005 . . . . 0.0 111.271 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -67.21 -19.16 65.51 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.905 -1.122 . . . . 0.0 110.771 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HB3' HG21 ' B' ' 8' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.044 -1.035 . . . . 0.0 110.257 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.279 0.562 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 9.6 tt0 -68.24 -42.87 79.08 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.256 -0.903 . . . . 0.0 109.312 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.496 ' HG3' HG13 ' A' ' 85' ' ' ILE . 3.2 pt-20 -52.87 -26.98 16.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.513 -0.742 . . . . 0.0 110.246 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.496 HG13 ' HG3' ' A' ' 84' ' ' GLU . 81.6 mt -79.15 -47.94 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.961 -1.087 . . . . 0.0 109.02 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -63.12 -30.54 71.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.361 -0.837 . . . . 0.0 108.804 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.487 ' OE1' ' OG1' ' B' ' 9' ' ' THR . 51.7 mt-10 -73.05 -49.48 28.42 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.74 ' HB2' HD13 ' B' ' 12' ' ' LEU . . . -57.14 -36.35 70.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.335 -0.853 . . . . 0.0 109.423 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 7.2 t80 -67.46 -43.99 79.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.937 . . . . 0.0 109.397 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -35.69 50.71 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.434 -0.791 . . . . 0.0 109.236 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.609 HG12 HG21 ' A' ' 108' ' ' VAL . 4.0 t -67.53 -41.52 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.744 ' CE1' HG11 ' A' ' 108' ' ' VAL . 28.5 m-85 -74.19 -33.21 63.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.958 . . . . 0.0 109.957 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.532 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -81.26 58.15 3.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.883 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -39.58 -62.82 0.64 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 110.492 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.2 p-10 -66.47 -38.61 87.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.327 -0.858 . . . . 0.0 110.284 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.66 52.47 3.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -99.15 -13.34 19.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.333 -1.098 . . . . 0.0 110.136 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 105.78 20.37 9.47 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 13.9 m-85 -158.35 157.4 32.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -1.083 . . . . 0.0 109.906 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 6.1 mt -120.02 135.28 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.075 -1.015 . . . . 0.0 110.448 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 p -121.06 154.01 36.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.64 -34.05 4.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.31 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.31 96.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.532 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 23.1 mt-10 -60.95 -47.52 86.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 110.065 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.832 HD12 HD11 ' A' ' 125' ' ' ILE . 1.1 mt -61.5 -35.66 78.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.279 -0.888 . . . . 0.0 109.495 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 109' ' ' MET . 8.2 ttp180 -55.94 -43.02 77.03 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.312 -0.868 . . . . 0.0 109.044 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.66 -57.8 11.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.475 -0.766 . . . . 0.0 109.724 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.744 HG11 ' CE1' ' A' ' 92' ' ' PHE . 2.5 t -60.64 -21.87 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.398 -0.814 . . . . 0.0 109.855 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . 1.022 ' HA ' HD21 ' B' ' 17' ' ' LEU . 4.0 mtt -64.32 -65.01 0.73 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.294 -0.879 . . . . 0.0 110.921 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.0 m -63.97 -9.44 15.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 0.0 110.455 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -95.94 -1.57 48.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.107 -0.996 . . . . 0.0 110.782 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.846 ' CD1' HG12 ' B' ' 13' ' ' VAL . 11.9 mt -133.22 -0.19 3.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 111.8 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.97 -90.5 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.113 -1.518 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.419 ' HG2' HD12 ' A' ' 116' ' ' LEU . 1.4 pm0 -116.41 -176.85 3.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -1.063 . . . . 0.0 110.573 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -127.09 17.3 7.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.281 -0.887 . . . . 0.0 110.291 179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.9 HD23 ' HG2' ' A' ' 120' ' ' GLU . 4.7 mp 50.17 174.77 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.674 -0.642 . . . . 0.0 110.287 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -87.85 -166.29 1.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.989 . . . . 0.0 109.873 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.454 ' H ' HG22 ' A' ' 117' ' ' THR . 23.4 t70 -80.84 -51.96 8.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.827 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 2.1 mt-10 -61.08 -41.33 96.44 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.581 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.9 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.3 OUTLIER -62.2 -44.25 97.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.326 -0.859 . . . . 0.0 109.664 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 117' ' ' THR . 39.2 t -62.06 -46.32 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -66.07 -40.13 90.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.706 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 0.6 OUTLIER -64.52 -33.58 76.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.822 . . . . 0.0 109.548 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.606 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 3.0 ttt -64.85 -41.62 95.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.399 -0.813 . . . . 0.0 109.921 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.832 HD11 HD12 ' A' ' 105' ' ' LEU . 14.5 mm -84.45 -17.59 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.005 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -76.03 -39.42 55.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 110.064 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.527 ' N ' ' HD2' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -69.04 -23.5 64.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.455 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . -95.86 -24.68 16.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.17 -0.957 . . . . 0.0 110.703 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -72.24 80.6 0.99 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.084 -1.01 . . . . 0.0 110.679 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 mt -82.32 -20.65 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 0.0 109.552 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 1.1 p30 -94.46 -13.72 25.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.406 -0.809 . . . . 0.0 109.78 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.03 80.93 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 12.1 p-10 -139.36 7.02 2.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.334 -1.098 . . . . 0.0 110.16 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 74.55 14.12 81.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.463 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 0.9 OUTLIER -164.81 164.58 21.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.316 -1.108 . . . . 0.0 110.187 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 22.9 t -106.45 169.77 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.112 -0.992 . . . . 0.0 109.7 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.469 ' N ' HG12 ' A' ' 136' ' ' VAL . 25.6 t30 -128.34 179.64 5.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.155 -0.966 . . . . 0.0 110.351 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.577 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 9.1 t80 -62.54 -56.27 19.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.84 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -44.74 -60.36 2.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 110.123 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 137' ' ' ASN . 53.9 mt-10 -44.63 -46.33 10.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.4 t80 -58.26 -28.9 65.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 139' ' ' GLU . 9.4 t -100.41 -33.85 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -0.792 . . . . 0.0 110.705 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 2.8 tp60 -73.22 -9.43 58.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.05 -1.031 . . . . 0.0 110.595 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.465 ' O ' ' O ' ' B' ' 23' ' ' GLY . 30.0 mtp -106.55 -18.63 13.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 110.813 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' B' ' 23' ' ' GLY . 20.7 ttm -99.92 -54.51 2.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.127 -0.983 . . . . 0.0 110.637 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 146' ' ' THR . 10.2 t . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.229 -0.92 . . . . 0.0 110.444 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.696 HG23 ' HD2' ' B' ' 5' ' ' PRO . 33.6 mm . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.696 ' HD2' HG23 ' B' ' 4' ' ' ILE . 39.5 Cg_endo -65.49 -172.47 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.578 1.304 . . . . 0.0 110.856 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.493 ' O ' ' N ' ' B' ' 8' ' ' THR . 57.0 p -119.76 60.54 0.85 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.059 -1.025 . . . . 0.0 111.394 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.626 ' CE2' HG21 ' A' ' 55' ' ' VAL . 1.0 OUTLIER 58.06 -82.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.039 -1.038 . . . . 0.0 110.864 178.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.671 HG23 ' HE1' ' A' ' 71' ' ' MET . 1.0 OUTLIER -46.14 -46.13 17.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.487 ' OG1' ' OE1' ' A' ' 87' ' ' GLU . 22.3 m -46.61 -35.79 6.26 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.227 -0.92 . . . . 0.0 109.914 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.21 -41.41 58.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.477 -0.765 . . . . 0.0 109.547 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.569 HD12 ' HG2' ' A' ' 72' ' ' MET . 12.5 mt -72.26 -20.19 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 109.637 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.74 HD13 ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -72.6 -59.96 2.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.369 -0.832 . . . . 0.0 109.735 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.846 HG12 ' CD1' ' A' ' 112' ' ' LEU . 43.4 t -56.02 -41.7 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.717 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.504 ' HG3' HD13 ' A' ' 18' ' ' LEU . 1.6 tmtm? -62.29 -43.97 97.61 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.88 -1.138 . . . . 0.0 109.568 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' B' ' 12' ' ' LEU . 14.5 m -53.0 -35.59 59.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.58 -0.7 . . . . 0.0 110.041 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.531 ' SD ' ' CD1' ' B' ' 22' ' ' PHE . 0.1 OUTLIER -70.67 -34.3 71.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.946 . . . . 0.0 109.951 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 1.022 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.5 mp -71.5 57.2 0.26 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.25 -0.906 . . . . 0.0 110.02 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -114.73 -86.28 0.6 Allowed 'General case' 0 C--N 1.278 -2.507 0 O-C-N 121.406 -0.809 . . . . 0.0 110.679 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' B' ' 20' ' ' ARG . 0.6 OUTLIER -153.77 94.9 1.82 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.791 -1.193 . . . . 0.0 110.53 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' B' ' 19' ' ' LYS . 10.3 tmm_? 64.67 7.0 3.52 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.437 -0.79 . . . . 0.0 110.407 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' B' ' 25' ' ' PRO . 0.1 OUTLIER -69.24 138.27 53.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.296 -0.877 . . . . 0.0 110.923 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.606 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -176.29 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 144' ' ' MET . . . -64.39 -80.87 0.13 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -142.05 75.27 20.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.092 -1.24 . . . . 0.0 110.406 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.482 ' HB3' ' OG ' ' B' ' 21' ' ' SER . 50.6 Cg_endo -79.66 11.7 2.64 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.053 1.554 . . . . 0.0 110.716 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.493 ' HE1' ' HE3' ' A' ' 72' ' ' MET . 3.9 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.33 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.259 0.552 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 mt -56.96 -46.75 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.838 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.69 -45.95 74.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.683 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -42.26 97.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 109.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -66.54 -43.61 84.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.712 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -60.21 -40.58 90.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.603 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 1.6 mm-40 -61.98 -43.41 98.9 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.219 -0.925 . . . . 0.0 109.556 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.71 -47.48 69.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.881 . . . . 0.0 109.836 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.543 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 75.0 t80 -63.45 -40.42 97.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.613 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.9 t -72.82 -28.04 62.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 0.0 109.52 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.635 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.1 tt -62.97 -41.06 99.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 109.657 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.795 ' HA ' HG21 ' A' ' 35' ' ' VAL . 27.0 m-85 -78.27 -10.88 59.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -0.793 . . . . 0.0 110.76 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 6.5 t0 -102.36 114.88 29.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.037 -1.039 . . . . 0.0 110.321 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.518 ' N ' ' OE2' ' A' ' 31' ' ' GLU . 5.3 tptp -97.52 29.24 3.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.261 -0.9 . . . . 0.0 110.524 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -153.68 -38.85 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.082 -1.011 . . . . 0.0 110.368 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 89.84 47.22 4.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -104.45 2.51 31.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.291 -1.123 . . . . 0.0 110.199 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.844 ' O ' HG23 ' A' ' 26' ' ' THR . . . 73.36 33.82 58.35 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -169.25 120.58 0.72 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.269 -1.136 . . . . 0.0 110.222 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.647 HD12 ' HB ' ' A' ' 63' ' ' ILE . 28.7 mt -97.56 124.47 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.172 -0.955 . . . . 0.0 110.189 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -84.68 -171.56 3.7 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.389 -0.819 . . . . 0.0 110.206 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.486 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -78.0 -34.09 50.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.882 . . . . 0.0 109.937 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -48.83 19.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.289 -0.882 . . . . 0.0 110.042 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 21' ' ' LYS . 43.2 tt0 -45.33 -59.76 2.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.91 . . . . 0.0 109.608 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.735 HD13 ' CH2' ' B' ' 7' ' ' TRP . 10.8 tp -60.76 -34.95 75.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.535 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.06 86.7 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.5 m -65.9 -51.07 61.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.344 -1.092 . . . . 0.0 109.543 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.795 HG21 ' HA ' ' A' ' 19' ' ' PHE . 48.9 t -52.54 -41.99 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.206 -0.934 . . . . 0.0 109.452 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.528 ' HE1' ' CE ' ' A' ' 51' ' ' MET . 4.8 mtt -64.74 -37.54 87.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.38 -0.825 . . . . 0.0 109.42 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -30.8 68.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.159 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.5 m -61.54 -34.01 74.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.9 . . . . 0.0 110.446 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mt -82.39 -3.11 54.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 110.224 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 86.57 86.07 1.07 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 0.8 OUTLIER -167.14 175.06 7.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -1.143 . . . . 0.0 110.143 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 11.7 p30 -139.63 84.31 15.96 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 0.0 110.291 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 44.0 Cg_endo -70.46 105.48 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.055 1.555 . . . . 0.0 110.496 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.449 ' HB ' ' OE2' ' A' ' 47' ' ' GLU . 8.9 m -61.18 150.82 33.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 110.058 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -49.43 -51.49 35.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.072 -1.018 . . . . 0.0 110.225 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.62 88.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.356 -0.84 . . . . 0.0 110.205 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -65.06 -50.98 64.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.0 110.211 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -50.33 -48.88 55.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -57.7 -36.81 72.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 5.5 m-20 -65.85 -46.98 76.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 109.949 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.57 ' HG3' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -67.93 -36.68 80.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.945 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 52' ' ' ILE . 5.5 mm -65.63 -26.66 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 109.732 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.39 -9.15 58.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.306 -0.871 . . . . 0.0 110.046 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -75.3 -22.53 57.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 110.124 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 57' ' ' ALA . 12.1 t -113.8 -48.42 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.187 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 55' ' ' VAL . 13.8 t0 -42.26 89.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.695 -0.628 . . . . 0.0 110.478 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -93.12 -9.56 39.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.404 -0.81 . . . . 0.0 110.637 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.455 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 66.7 m-20 -78.24 -31.58 49.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.055 -1.028 . . . . 0.0 110.421 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.82 -16.28 18.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 3.5 p30 -77.58 -93.72 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.321 -1.105 . . . . 0.0 110.106 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 165.7 46.0 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.451 ' HB ' HG22 ' A' ' 26' ' ' THR . 2.8 p -143.28 141.8 31.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.289 -1.124 . . . . 0.0 110.204 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.647 ' HB ' HD12 ' A' ' 27' ' ' ILE . 11.9 mm -92.09 129.42 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.26 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.543 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 9.5 t0 -117.18 179.9 3.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.723 ' O ' HD12 ' A' ' 69' ' ' LEU . 17.1 t80 -67.15 -43.14 44.3 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 0.0 111.307 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.77 -35.54 7.45 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.348 1.183 . . . . 0.0 110.25 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 48.7 mt-10 -67.9 -28.44 67.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.107 -0.996 . . . . 0.0 109.141 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' HZ ' HD12 ' B' ' 11' ' ' ILE . 18.8 t80 -69.77 -53.24 19.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.602 -0.686 . . . . 0.0 110.317 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 65' ' ' PHE . 1.5 mt -67.89 -17.66 64.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.284 -0.885 . . . . 0.0 110.513 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 m -78.29 -42.52 30.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.125 -0.984 . . . . 0.0 110.617 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -72.66 -42.22 64.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.149 -0.97 . . . . 0.0 110.572 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -9.46 17.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.487 -0.758 . . . . 0.0 111.231 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.31 -19.27 17.14 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.012 -1.055 . . . . 0.0 111.379 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.63 -20.85 15.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.979 -1.076 . . . . 0.0 111.02 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.009 -1.057 . . . . 0.0 110.5 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.328 0.585 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.69 -15.61 59.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.888 . . . . 0.0 109.982 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.716 ' CG ' HD11 ' B' ' 12' ' ' LEU . 19.5 tt0 -81.83 -38.34 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 109.968 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.546 HG23 ' CE1' ' A' ' 141' ' ' PHE . 16.7 mt -67.49 -33.83 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.232 -0.917 . . . . 0.0 109.081 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -60.17 -27.19 66.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.563 -0.71 . . . . 0.0 109.091 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.512 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 1.2 mt-10 -74.76 -56.71 4.5 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.466 -0.771 . . . . 0.0 109.231 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.43 -28.85 67.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 109.567 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.439 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 15.9 t80 -69.65 -47.87 61.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.02 -1.05 . . . . 0.0 108.968 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 -47.53 -36.47 10.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.496 -0.752 . . . . 0.0 109.019 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.757 HG12 HG21 ' A' ' 108' ' ' VAL . 54.5 t -74.2 -33.56 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.535 -0.728 . . . . 0.0 110.285 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.563 ' CE2' HG22 ' B' ' 13' ' ' VAL . 16.1 m-85 -80.35 -31.29 37.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.128 -0.982 . . . . 0.0 110.287 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 96' ' ' GLY . 10.9 t0 -100.04 62.83 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.209 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -43.17 -33.01 0.82 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.78 -31.93 61.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.385 -0.822 . . . . 0.0 109.655 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 69.37 13.61 68.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 23.6 p-10 -69.45 -38.84 77.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -1.12 . . . . 0.0 110.324 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 139.19 -30.27 2.46 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 33.9 m-85 -107.29 156.78 18.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -1.127 . . . . 0.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' A' ' 92' ' ' PHE . 11.4 mt -124.13 145.52 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.897 . . . . 0.0 110.018 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -124.96 147.78 48.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.168 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.29 -31.1 0.93 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.665 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.79 -47.08 79.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.359 -0.838 . . . . 0.0 109.395 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.445 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 10.0 mt-10 -54.99 -50.07 69.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.199 -0.938 . . . . 0.0 109.261 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 109' ' ' MET . 1.6 mm? -57.39 -52.79 63.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.328 -0.857 . . . . 0.0 109.185 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -45.96 -26.67 0.75 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.421 -0.8 . . . . 0.0 109.453 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.551 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -80.89 -34.59 33.43 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.373 -0.829 . . . . 0.0 110.21 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.757 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -89.57 -27.55 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 109.946 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.949 ' HA ' HD21 ' B' ' 17' ' ' LEU . 2.4 mmm -63.5 -49.5 73.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 110.659 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 m -77.82 -17.24 57.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.0 110.58 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 18.6 m-20 -85.81 -3.39 58.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.089 -1.007 . . . . 0.0 109.968 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.893 ' CD1' HG12 ' B' ' 13' ' ' VAL . 5.4 mt -102.19 -42.75 5.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 110.426 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 162.67 -36.55 0.34 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.465 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.7 tp10 -109.7 147.0 33.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.991 -1.299 . . . . 0.0 110.828 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.514 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -119.93 74.68 1.04 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.547 -0.72 . . . . 0.0 109.282 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.634 HD23 ' O ' ' B' ' 19' ' ' LYS . 6.8 mp -38.46 160.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.687 -0.633 . . . . 0.0 110.709 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -60.69 -146.42 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.435 -0.791 . . . . 0.0 109.366 179.254 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.476 ' H ' HG22 ' A' ' 117' ' ' THR . 8.1 m-20 -122.3 -60.28 1.57 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.238 -0.914 . . . . 0.0 109.929 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.65 -35.65 63.72 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 9.7 mm-40 -67.31 -56.11 11.12 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.295 -0.878 . . . . 0.0 109.08 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.461 ' O ' ' HB3' ' A' ' 124' ' ' MET . 87.4 t -43.66 -36.36 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 121.361 -0.837 . . . . 0.0 109.606 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.51 -51.86 52.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -58.25 -32.49 68.41 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.403 -0.811 . . . . 0.0 109.113 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.518 ' HE3' ' O ' ' B' ' 21' ' ' SER . 11.0 ttt -59.49 -44.75 93.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.495 -0.753 . . . . 0.0 109.636 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.498 HG23 HG23 ' A' ' 136' ' ' VAL . 20.3 mm -71.72 -31.61 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 109.714 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 45.8 ttt85 -62.62 -42.76 99.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.98 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.9 -37.52 63.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.77 -25.83 27.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 0.0 110.142 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 134' ' ' GLY . 2.6 m-20 -57.64 99.54 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.859 . . . . 0.0 110.483 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 35.3 mm -74.79 -39.13 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.244 -0.91 . . . . 0.0 109.886 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 8.0 p-10 -90.4 -17.57 27.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.34 -0.85 . . . . 0.0 109.984 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.95 55.98 3.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 6.4 p30 -113.04 0.66 15.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.335 -1.097 . . . . 0.0 110.23 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.503 ' N ' ' OD2' ' A' ' 129' ' ' ASP . . . 76.16 8.53 85.3 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -142.66 147.46 35.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -1.181 . . . . 0.0 110.406 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.498 HG23 HG23 ' A' ' 125' ' ' ILE . 39.7 t -100.9 152.0 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.34 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.564 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 62.5 t30 -122.65 158.47 29.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -0.86 . . . . 0.0 110.12 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -45.8 -54.95 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.77 -41.02 56.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.301 -0.875 . . . . 0.0 109.916 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 144' ' ' MET . 9.2 mt-10 -70.87 -47.31 59.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.0 110.021 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.546 ' CE1' HG23 ' A' ' 85' ' ' ILE . 47.5 t80 -60.79 -17.95 52.38 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.299 -0.875 . . . . 0.0 109.968 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.43 ' O ' HG22 ' A' ' 146' ' ' THR . 46.9 t -100.19 -47.75 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.456 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -61.89 -26.86 68.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.172 -0.955 . . . . 0.0 110.23 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 17.8 mmm -82.62 -18.32 41.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.551 ' CE ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -99.33 -56.86 2.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 146' ' ' THR . 6.8 t . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.226 -0.921 . . . . 0.0 110.274 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.57 HD12 ' HG3' ' A' ' 51' ' ' MET . 11.0 pt . . . . . 0 C--O 1.215 -0.732 0 CA-C-O 120.913 0.387 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.36 153.16 50.35 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.09 1.574 . . . . 0.0 110.013 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.501 ' O ' ' HB ' ' B' ' 9' ' ' THR . 8.6 m -71.19 142.05 50.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.944 ' O ' HG22 ' B' ' 10' ' ' VAL . 6.8 m95 -36.29 -66.01 0.24 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.764 0.793 . . . . 0.0 110.555 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.536 HG21 ' HG2' ' A' ' 75' ' ' LYS . 10.8 p -45.38 -23.65 0.22 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.464 -0.773 . . . . 0.0 111.043 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.512 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 91.5 m -70.41 -56.65 6.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.886 -1.134 . . . . 0.0 109.87 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.944 HG22 ' O ' ' B' ' 7' ' ' TRP . 32.7 m -53.16 -27.4 13.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.281 -0.887 . . . . 0.0 109.193 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.501 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 26.0 mm -75.46 -30.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.447 -0.783 . . . . 0.0 109.61 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.716 HD11 ' CG ' ' A' ' 84' ' ' GLU . 9.9 mt -65.91 -60.47 2.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 110.034 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.893 HG12 ' CD1' ' A' ' 112' ' ' LEU . 41.1 t -52.95 -39.01 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.626 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -64.74 -47.62 77.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.963 -1.085 . . . . 0.0 109.226 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.417 ' HB2' HD22 ' B' ' 24' ' ' ASN . 50.2 m -50.97 -31.27 17.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.403 -0.811 . . . . 0.0 109.738 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mmt -79.87 -27.18 40.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.354 -0.841 . . . . 0.0 109.956 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.949 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.9 mp -80.04 54.47 1.92 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.344 -0.848 . . . . 0.0 109.88 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -72.58 0.57 Allowed 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.679 -0.638 . . . . 0.0 110.355 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.634 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -150.3 -60.28 0.19 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.944 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.561 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -156.64 17.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 110.208 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.518 ' O ' ' HE3' ' A' ' 124' ' ' MET . 0.3 OUTLIER -93.04 -162.1 0.9 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.217 -0.927 . . . . 0.0 110.42 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.445 ' CE2' ' HE2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -174.21 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.231 -0.918 . . . . 0.0 110.523 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.09 -155.76 22.69 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.551 ' CB ' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -178.96 117.07 0.23 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 110.206 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.04 52.61 3.5 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.935 1.492 . . . . 0.0 110.397 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.251 -179.792 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.506 0.67 . . . . 0.0 109.36 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 98.5 mt -75.2 -34.98 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.366 -0.834 . . . . 0.0 109.712 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.22 -62.46 1.85 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 109.654 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 12' ' ' PHE . 11.4 pt-20 -56.94 -38.23 72.63 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.162 -0.961 . . . . 0.0 109.058 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.688 ' CD2' ' CZ ' ' A' ' 68' ' ' PHE . 1.8 m-85 -57.91 -45.66 86.14 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.358 -0.839 . . . . 0.0 109.019 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -41.33 66.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 109.18 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -53.36 -49.21 67.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.713 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' B' ' 14' ' ' LYS . . . -59.28 -52.85 63.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 109.783 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 2.3 t80 -60.59 -35.6 76.49 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.614 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -67.06 -28.22 68.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.509 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.844 HD11 ' O ' ' A' ' 112' ' ' LEU . 8.4 tt -68.7 -41.81 78.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.499 -0.751 . . . . 0.0 109.881 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -74.28 -57.88 3.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.455 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 21.9 t0 -64.97 129.93 41.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.375 -0.828 . . . . 0.0 110.54 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.78 -48.5 5.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.246 -0.909 . . . . 0.0 110.157 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.2 p-10 -75.04 -35.05 61.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.78 42.34 5.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 34.8 p-10 -90.76 -28.12 18.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -1.156 . . . . 0.0 110.057 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.712 ' O ' HG23 ' A' ' 26' ' ' THR . . . 112.74 31.0 2.64 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 25' ' ' GLY . 11.1 p -159.73 125.24 4.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -1.135 . . . . 0.0 110.533 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.699 HD12 ' HB ' ' A' ' 63' ' ' ILE . 17.9 mt -91.97 119.22 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.21 -0.931 . . . . 0.0 109.999 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.6 p -100.17 172.91 6.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.92 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.6 p -64.43 -18.24 64.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.13 -0.981 . . . . 0.0 109.899 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -49.76 17.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.395 -0.816 . . . . 0.0 110.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.64 ' O ' HG23 ' A' ' 35' ' ' VAL . 20.9 mt-10 -67.21 -50.37 61.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 110.365 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.737 HD22 ' CD1' ' A' ' 52' ' ' ILE . 13.1 tp -59.75 -51.47 69.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.287 -0.883 . . . . 0.0 110.347 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.14 -49.35 24.68 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.8 m -56.26 -47.4 78.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.229 -1.159 . . . . 0.0 110.576 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 31' ' ' GLU . 11.4 t -62.77 -45.26 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 0.0 110.293 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.538 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 16.2 mmm -64.24 -39.64 94.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 110.405 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -15.91 61.55 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.099 -1.001 . . . . 0.0 110.237 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 39' ' ' LEU . 32.2 t -75.0 -46.05 37.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 111.058 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 38' ' ' SER . 1.9 mt -45.76 -27.31 0.8 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.914 -1.116 . . . . 0.0 109.823 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.93 -32.34 2.9 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.08 -178.59 2.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.135 -1.215 . . . . 0.0 110.684 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -131.07 93.88 29.35 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.252 -0.905 . . . . 0.0 110.317 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.579 ' HB3' HD13 ' B' ' 4' ' ' ILE . 45.4 Cg_endo -73.16 115.97 4.54 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.004 1.529 . . . . 0.0 110.302 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.23 164.94 23.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 110.239 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 42.9 mt-10 -61.07 -42.23 98.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.276 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.12 74.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.208 -0.933 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 51' ' ' MET . 4.6 mm-40 -66.65 -32.92 74.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 110.042 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.491 ' HA ' HD23 ' A' ' 48' ' ' LEU . 13.0 mt -60.37 -52.16 66.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 0.0 110.123 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -62.91 -42.39 99.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 110.107 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.89 -15.41 63.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 110.012 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.509 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 1.2 mtp -86.9 -42.94 12.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.14 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.737 ' CD1' HD22 ' A' ' 32' ' ' LEU . 1.1 mp -80.27 -11.15 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.078 -1.014 . . . . 0.0 109.731 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -83.43 -18.58 38.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 110.856 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.6 ' HG3' HG23 ' A' ' 55' ' ' VAL . 21.8 pt-20 -94.48 -18.93 21.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.036 -1.04 . . . . 0.0 110.988 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.685 HG21 ' CD1' ' B' ' 7' ' ' TRP . 50.6 t -99.1 -31.57 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.95 -1.094 . . . . 0.0 110.061 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -47.16 89.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.539 -0.726 . . . . 0.0 110.539 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.12 -49.63 71.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.451 -0.781 . . . . 0.0 110.172 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 14.8 p-10 -75.69 -37.91 59.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 110.063 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.42 45.78 2.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 36.0 p-10 -98.5 -38.72 9.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.274 -1.133 . . . . 0.0 110.141 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 127.6 -8.09 6.95 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p -135.79 148.52 48.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -1.167 . . . . 0.0 110.189 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.699 ' HB ' HD12 ' A' ' 27' ' ' ILE . 31.8 mm -82.14 140.06 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.122 -0.986 . . . . 0.0 109.91 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.45 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -114.46 157.66 22.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.066 -1.021 . . . . 0.0 110.797 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.598 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 52.8 t80 -48.9 -50.34 62.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.443 -0.786 . . . . 0.0 111.187 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.9 Cg_endo -64.39 -32.27 60.87 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.258 1.136 . . . . 0.0 110.344 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 71' ' ' MET . 7.1 tt0 -59.97 -35.46 75.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.124 -0.985 . . . . 0.0 109.291 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.688 ' CZ ' ' CD2' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -76.98 -48.78 17.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.1 mm? -43.09 -45.28 5.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 110.625 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.31 -37.44 14.91 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.073 -1.017 . . . . 0.0 110.762 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -44.04 -38.91 3.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.191 -0.943 . . . . 0.0 110.72 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.51 ' HE3' ' CE1' ' B' ' 26' ' ' PHE . 5.7 tpt -74.65 -9.76 58.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.136 -0.977 . . . . 0.0 110.542 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.4 -10.83 19.88 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.248 -0.908 . . . . 0.0 110.579 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -99.61 -49.64 4.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.067 -1.021 . . . . 0.0 110.407 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.686 ' CB ' HG21 ' B' ' 8' ' ' THR . 20.2 mmtt . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.504 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.137 0.494 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -79.66 -17.04 54.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.044 -1.035 . . . . 0.0 110.409 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -81.26 -22.71 38.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.026 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.465 HG23 ' HE1' ' A' ' 141' ' ' PHE . 59.8 mt -79.09 -44.14 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.859 . . . . 0.0 110.039 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.474 ' CD ' ' OH ' ' A' ' 138' ' ' TYR . 5.4 ttp180 -55.55 -34.94 65.16 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.529 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 1.061 ' HB3' HG21 ' B' ' 9' ' ' THR . 14.1 mt-10 -71.16 -47.55 57.02 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.437 -0.789 . . . . 0.0 109.893 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.55 ' HB2' HD22 ' B' ' 12' ' ' LEU . . . -64.92 -29.05 69.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.041 -1.037 . . . . 0.0 109.828 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.01 -39.37 83.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 109.511 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -67.44 -37.95 83.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.39 -0.819 . . . . 0.0 109.503 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.635 HG12 HG21 ' A' ' 108' ' ' VAL . 11.7 t -58.51 -44.62 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.414 -0.804 . . . . 0.0 109.704 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.42 ' CE1' HG11 ' A' ' 108' ' ' VAL . 20.4 m-85 -66.47 -30.58 70.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.613 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.458 ' OD1' ' OD1' ' A' ' 97' ' ' ASN . 11.6 t0 -91.42 58.47 3.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.406 -0.809 . . . . 0.0 110.092 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 93' ' ' ASP . 2.3 mmmm -43.46 -32.3 0.86 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -0.962 . . . . 0.0 110.142 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.0 p30 -83.44 -34.13 25.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.181 -0.949 . . . . 0.0 110.109 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 81.39 42.41 9.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.458 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 38.2 p30 -100.07 -17.72 17.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -1.197 . . . . 0.0 110.167 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 102.59 27.96 6.53 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 94.4 m-85 -156.95 146.65 20.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -1.08 . . . . 0.0 110.004 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 80.3 mt -119.74 111.98 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.16 -0.963 . . . . 0.0 110.411 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 37.4 t -95.89 149.18 21.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.22 -31.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.168 -0.958 . . . . 0.0 109.947 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.56 -51.62 64.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.855 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.461 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 28.3 mt-10 -53.39 -38.89 63.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.67 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.997 HD12 HD11 ' A' ' 125' ' ' ILE . 1.2 mt -59.85 -44.57 94.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.376 -0.827 . . . . 0.0 109.711 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.518 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.0 OUTLIER -65.8 -20.78 66.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 109.619 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -81.77 -32.56 31.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.422 -0.799 . . . . 0.0 109.847 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.635 HG21 HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -83.17 -34.14 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.93 . . . . 0.0 109.789 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.902 ' HA ' HD21 ' B' ' 17' ' ' LEU . 11.2 ptp -79.42 -35.85 39.93 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.155 -0.965 . . . . 0.0 109.561 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.476 ' N ' ' HG3' ' A' ' 109' ' ' MET . 19.6 m -68.97 -30.52 68.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 108.802 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -85.91 -19.53 30.38 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.433 -0.792 . . . . 0.0 108.97 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.844 ' O ' HD11 ' A' ' 18' ' ' LEU . 9.5 mt -84.46 -32.38 24.06 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.535 -0.728 . . . . 0.0 110.122 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.98 -39.87 1.51 Allowed Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.495 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 109' ' ' MET . 2.1 tt0 -94.23 157.59 15.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.995 -1.297 . . . . 0.0 110.709 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 116' ' ' LEU . 1.8 pttt -135.86 73.21 1.46 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.565 -0.709 . . . . 0.0 109.205 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.651 HD21 ' O ' ' B' ' 17' ' ' LEU . 3.3 mp -38.79 145.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.593 -0.692 . . . . 0.0 110.794 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -56.47 -156.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 110.387 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -97.75 -48.82 5.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.224 -0.922 . . . . 0.0 110.149 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.31 -33.05 75.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.047 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.524 ' CG ' ' HB3' ' B' ' 20' ' ' ARG . 2.5 tt0 -66.16 -47.25 74.64 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.61 0.719 . . . . 0.0 109.33 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 116' ' ' LEU . 19.0 t -65.0 -42.15 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.519 -0.738 . . . . 0.0 110.387 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -62.99 -65.14 0.73 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.952 . . . . 0.0 109.827 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 122' ' ' ASP . 2.0 mm-40 -44.42 -30.19 0.81 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.381 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.544 ' HE2' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -62.91 -61.75 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 110.205 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.997 HD11 HD12 ' A' ' 105' ' ' LEU . 30.3 mm -59.55 -39.02 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 127' ' ' GLU . 2.8 mtt180 -60.09 -53.2 60.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.859 . . . . 0.0 110.355 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -43.3 -32.65 0.83 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.94 -26.93 13.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 110.146 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.3 OUTLIER -71.49 64.65 0.43 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.3 -0.875 . . . . 0.0 110.352 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.8 mt -63.15 -32.01 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 21.0 p-10 -77.01 -28.83 55.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.248 -0.907 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.85 64.74 1.99 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 20.4 p-10 -114.43 -23.0 9.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -1.135 . . . . 0.0 110.185 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 115.5 -6.7 20.67 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 99' ' ' TYR . 3.3 pt20 -158.38 163.17 37.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.29 -1.124 . . . . 0.0 110.022 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 137' ' ' ASN . 61.6 t -90.76 168.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.192 -0.942 . . . . 0.0 110.649 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.524 ' N ' HG12 ' A' ' 136' ' ' VAL . 15.4 t-20 -133.06 177.35 7.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.481 -0.762 . . . . 0.0 109.976 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.474 ' OH ' ' CD ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -56.05 -69.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.152 -0.967 . . . . 0.0 110.771 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 17.2 pt-20 -43.36 -39.08 2.99 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.146 -0.971 . . . . 0.0 110.692 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 139' ' ' GLU . 57.6 mt-10 -66.5 -60.21 2.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.168 -0.957 . . . . 0.0 110.211 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.465 ' HE1' HG23 ' A' ' 85' ' ' ILE . 26.6 t80 -46.98 -22.23 0.3 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.231 -0.918 . . . . 0.0 110.35 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.29 -44.01 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.753 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -56.44 -18.19 10.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.179 -0.95 . . . . 0.0 110.631 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.2 mmm -112.58 -10.15 13.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.151 -0.968 . . . . 0.0 110.263 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.451 ' HG2' HG12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -98.17 -9.58 25.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 110.211 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.259 -0.901 . . . . 0.0 110.35 -179.884 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.597 ' CG1' ' HD2' ' B' ' 5' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.597 ' HD2' ' CG1' ' B' ' 4' ' ' ILE . 38.1 Cg_endo -64.24 151.55 84.95 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.528 1.278 . . . . 0.0 110.473 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.444 ' O ' ' CE ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -74.65 -52.36 11.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.482 -0.761 . . . . 0.0 111.759 -178.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.685 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -172.04 -76.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.82 -1.175 . . . . 0.0 110.754 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.686 HG21 ' CB ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -46.11 -48.06 17.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 0.0 109.677 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 9' ' ' THR . . . . . 1.061 HG21 ' HB3' ' A' ' 87' ' ' GLU . 4.8 m -44.65 -51.65 8.94 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.391 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.415 HG21 ' HE1' ' A' ' 36' ' ' MET . 35.2 t -51.36 -43.08 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.263 -0.898 . . . . 0.0 108.958 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.504 HG21 ' SD ' ' A' ' 72' ' ' MET . 15.5 mm -66.36 -27.5 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.139 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -63.9 -58.71 5.94 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.623 -0.673 . . . . 0.0 109.964 179.608 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.868 ' O ' HD13 ' B' ' 17' ' ' LEU . 54.3 t -60.39 -39.22 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.936 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.641 ' CG ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -62.12 -61.29 2.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.087 -1.008 . . . . 0.0 109.722 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 74.5 m -60.74 -18.88 57.3 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.43 -0.794 . . . . 0.0 109.875 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.514 ' O ' ' CG ' ' B' ' 19' ' ' LYS . 6.2 ttt -80.1 -18.45 49.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.902 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.2 mp -73.76 -50.32 21.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.248 -0.907 . . . . 0.0 110.58 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.462 ' O ' ' CG ' ' B' ' 18' ' ' ARG . 0.6 OUTLIER -65.44 60.21 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.605 -0.684 . . . . 0.0 110.4 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' B' ' 16' ' ' MET . 0.0 OUTLIER -179.98 120.54 0.06 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.524 ' HB3' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -73.01 20.53 0.08 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.662 -0.649 . . . . 0.0 112.086 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.544 ' O ' ' HE2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -128.64 175.67 8.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.934 -1.104 . . . . 0.0 109.76 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.425 ' CD1' ' HE2' ' A' ' 124' ' ' MET . 0.6 OUTLIER -112.12 177.88 4.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.023 -1.048 . . . . 0.0 110.069 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.52 140.73 0.06 OUTLIER Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.463 ' HB3' ' CD2' ' B' ' 26' ' ' PHE . 0.7 OUTLIER -121.88 140.15 31.51 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.26 . . . . 0.0 110.948 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.25 55.99 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.046 1.551 . . . . 0.0 109.655 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.51 ' CE1' ' HE3' ' A' ' 72' ' ' MET . 1.4 m-85 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.286 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.261 0.553 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.1 mt -50.93 -42.34 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.202 -0.937 . . . . 0.0 109.381 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -50.6 -45.32 57.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.358 -0.839 . . . . 0.0 109.266 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -57.3 -48.47 78.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.33 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -53.86 -46.24 71.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.307 -0.871 . . . . 0.0 109.379 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -57.81 -46.37 84.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.883 . . . . 0.0 109.289 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -60.09 -44.9 94.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.3 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -60.76 -45.17 95.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.383 -0.823 . . . . 0.0 109.557 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.515 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 7.2 t80 -62.97 -22.27 66.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.942 . . . . 0.0 109.074 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.51 -47.68 9.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.522 -0.736 . . . . 0.0 109.588 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.858 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.2 tt -47.66 -41.12 21.61 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.321 -0.862 . . . . 0.0 109.504 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 41.0 m-85 -79.89 -46.16 17.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.884 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.503 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 39.5 t0 -80.46 101.94 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.451 -0.78 . . . . 0.0 110.154 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 4.32 51.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.29 -0.881 . . . . 0.0 110.431 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.427 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 33.3 m-20 -97.08 -37.8 10.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.149 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.33 27.95 10.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 10.3 p30 -102.67 -17.03 15.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -1.169 . . . . 0.0 110.195 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 91.07 22.55 32.37 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 14.1 p -138.3 122.72 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.216 -1.167 . . . . 0.0 110.468 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.5 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 13.4 mt -89.3 114.63 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.124 -0.985 . . . . 0.0 110.137 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -93.46 155.73 17.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.714 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.567 ' O ' HD13 ' A' ' 48' ' ' LEU . 32.0 p -54.9 -22.71 15.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 110.039 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -43.62 63.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.88 . . . . 0.0 109.972 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.503 ' OE2' ' HA ' ' A' ' 20' ' ' ASP . 17.0 mt-10 -64.5 -56.68 12.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 0.0 110.093 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.859 HD23 ' CD2' ' A' ' 48' ' ' LEU . 11.5 tp -54.54 -36.37 64.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 109.858 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.28 -40.91 99.62 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 m -58.49 -53.07 62.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -1.119 . . . . 0.0 109.819 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 35' ' ' VAL . 12.0 t -56.93 -53.9 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.603 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.504 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -50.76 -41.01 56.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 109.736 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 2.1 mtm180 -62.91 -27.81 69.62 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 0.0 109.886 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -79.41 -59.54 2.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.821 . . . . 0.0 110.933 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mt -44.04 -37.54 3.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.131 -0.981 . . . . 0.0 110.082 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.08 64.85 0.16 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.539 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -144.82 -168.23 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -1.178 . . . . 0.0 110.119 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 2.5 m120 -155.1 57.75 1.75 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.062 -1.024 . . . . 0.0 110.578 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 50.1 Cg_endo -80.35 135.73 10.86 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.907 1.477 . . . . 0.0 110.061 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 45' ' ' GLU . 5.1 m -97.26 163.36 12.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.206 -0.933 . . . . 0.0 110.067 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.2 mt-10 -43.05 -54.92 4.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 109.997 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.56 -55.43 33.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 110.043 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HG3' ' HB ' ' A' ' 44' ' ' THR . 21.3 mt-10 -47.46 -44.46 25.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 109.72 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.859 ' CD2' HD23 ' A' ' 32' ' ' LEU . 15.1 mt -55.8 -43.44 76.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.358 -0.839 . . . . 0.0 109.912 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' OE1' HG21 ' A' ' 29' ' ' THR . 5.6 tp60 -54.9 -41.42 70.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.441 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.06 -42.94 91.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.447 -0.783 . . . . 0.0 109.648 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.569 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.3 OUTLIER -74.95 -49.44 20.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 109.765 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.481 HG22 ' HB2' ' A' ' 56' ' ' ASP . 7.3 mm -52.4 -25.2 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.624 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -30.59 67.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.345 -0.847 . . . . 0.0 110.185 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 1.3 mp0 -70.24 -25.63 63.47 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.832 HG22 ' SD ' ' A' ' 71' ' ' MET . 5.6 t -108.07 -28.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 52' ' ' ILE . 19.2 t0 -63.85 72.17 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.312 -0.867 . . . . 0.0 110.323 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -68.65 -35.69 77.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 110.415 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 24.3 p30 -82.44 -20.15 37.56 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.141 -0.975 . . . . 0.0 110.489 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 81.07 26.49 52.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.523 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 31.8 p-10 -89.66 -30.44 18.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -1.179 . . . . 0.0 110.09 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 113.92 -24.23 12.1 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.523 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 80.7 p -112.65 157.27 21.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -1.215 . . . . 0.0 110.393 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.581 HD12 ' CG1' ' A' ' 55' ' ' VAL . 10.2 mm -95.72 144.28 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 110.144 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 75.8 m-20 -110.67 160.68 16.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 109.975 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 33.0 t80 -52.4 -47.73 92.11 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.289 -0.882 . . . . 0.0 111.271 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -69.42 -41.82 4.34 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.203 1.107 . . . . 0.0 110.163 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 2.9 tt0 -55.6 -45.15 77.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 110.114 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.423 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 16.3 t80 -61.0 -47.35 86.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 110.118 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 65' ' ' PHE . 85.4 mt -57.41 -23.05 47.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.232 -0.917 . . . . 0.0 110.156 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.3 m -90.1 -21.7 22.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.258 -0.901 . . . . 0.0 111.012 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.832 ' SD ' HG22 ' A' ' 55' ' ' VAL . 3.1 ttp -75.48 -45.37 38.82 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.959 -1.088 . . . . 0.0 109.905 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.533 ' HE1' ' HE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -53.91 -17.27 2.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.39 -0.819 . . . . 0.0 110.907 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.02 -11.69 15.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.936 -1.102 . . . . 0.0 111.324 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -96.53 -36.23 10.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.817 -1.177 . . . . 0.0 110.678 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.709 ' HB3' HG21 ' B' ' 8' ' ' THR . 8.9 tttp . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.239 -0.913 . . . . 0.0 110.535 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.31 -24.64 67.72 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 25.3 tt0 -55.57 -36.92 67.37 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.509 -0.745 . . . . 0.0 109.605 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.661 HG23 ' SD ' ' A' ' 145' ' ' MET . 78.1 mt -70.4 -44.96 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.269 -0.895 . . . . 0.0 109.025 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -54.98 -28.71 53.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.484 -0.76 . . . . 0.0 109.132 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 4.2 mt-10 -69.61 -58.9 3.37 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.471 -0.768 . . . . 0.0 109.445 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.35 -31.39 54.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 0.0 109.247 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 17.1 t80 -63.72 -45.05 91.7 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -60.82 -34.89 75.23 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.778 ' CG1' HG21 ' B' ' 13' ' ' VAL . 24.7 t -71.49 -42.1 72.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.584 ' CE2' HG22 ' B' ' 13' ' ' VAL . 9.6 m-85 -72.25 -34.57 68.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 108.76 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 96' ' ' GLY . 14.5 t0 -95.24 61.28 2.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.56 -0.713 . . . . 0.0 109.791 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.538 ' HA ' ' CE ' ' A' ' 94' ' ' LYS . 2.1 mmpt? -43.36 -28.02 0.3 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.16 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.43 ' OD2' ' CG ' ' A' ' 97' ' ' ASN . 49.7 t0 -67.89 -41.31 82.93 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 73.11 -0.17 48.53 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.43 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 28.5 p-10 -73.01 -24.07 60.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.117 -1.225 . . . . 0.0 110.117 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.463 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 115.21 35.44 1.33 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.467 ' O ' ' OE2' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -158.51 105.38 1.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.257 -1.143 . . . . 0.0 110.231 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 92' ' ' PHE . 7.2 mt -81.37 135.47 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.248 -0.907 . . . . 0.0 110.026 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -129.29 148.84 51.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.01 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.87 -30.95 1.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 109.848 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.5 79.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.599 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 99' ' ' TYR . 35.0 mt-10 -61.57 -43.64 98.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.386 -0.821 . . . . 0.0 109.953 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.053 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -59.76 -42.64 93.71 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.323 -0.86 . . . . 0.0 109.363 179.525 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -36.88 74.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.799 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.59 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -65.15 -44.39 88.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.823 . . . . 0.0 109.843 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.481 HG21 HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -74.0 -33.62 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.803 . . . . 0.0 109.417 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.52 ' SD ' HD21 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -60.82 -65.61 0.66 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 110.174 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m -51.92 -32.84 34.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.116 -0.99 . . . . 0.0 109.507 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 63.8 m-20 -77.68 -20.65 53.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 109.547 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.861 HD11 HG12 ' B' ' 13' ' ' VAL . 2.5 mt -85.05 -40.41 16.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.511 -0.743 . . . . 0.0 110.168 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.26 -47.39 0.55 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.656 ' HG2' HD12 ' A' ' 116' ' ' LEU . 31.1 tt0 -94.0 165.18 12.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.143 -1.21 . . . . 0.0 111.043 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' LEU . 4.0 ptpp? -140.67 62.82 1.48 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.503 -0.748 . . . . 0.0 109.358 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.882 HD21 ' HA ' ' B' ' 19' ' ' LYS . 1.6 mp -38.34 140.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.696 -0.628 . . . . 0.0 110.467 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.662 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -50.85 -173.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.37 -0.831 . . . . 0.0 110.478 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 119' ' ' GLU . 20.1 t70 -86.34 -62.32 1.54 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.026 -1.046 . . . . 0.0 110.361 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.555 ' HA ' ' OD2' ' A' ' 122' ' ' ASP . 3.2 tt0 -44.11 -49.61 8.86 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 109.916 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.95 -55.33 36.0 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 117' ' ' THR . 46.3 t -49.52 -43.6 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.556 -0.715 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.555 ' OD2' ' HA ' ' A' ' 119' ' ' GLU . 9.4 p30 -68.75 -22.53 64.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.757 -1.214 . . . . 0.0 109.966 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 40.1 mm-40 -80.56 -27.82 37.4 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.351 -0.843 . . . . 0.0 108.867 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -43.6 79.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.594 -0.691 . . . . 0.0 109.419 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.053 HD11 ' CD1' ' A' ' 105' ' ' LEU . 41.5 mm -67.66 -43.49 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.0 109.691 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.471 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.7 mmm-85 -56.98 -39.43 74.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -59.45 -28.59 67.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.355 -0.841 . . . . 0.0 109.996 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB2' ' HD2' ' B' ' 22' ' ' PHE . . . -99.25 -18.25 17.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.378 -0.827 . . . . 0.0 110.022 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 126' ' ' ARG . 1.2 m-20 -59.12 98.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.244 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 mm -67.38 -44.61 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.325 -0.859 . . . . 0.0 110.049 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 19.2 p-10 -90.07 -19.2 24.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 110.093 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 79.23 64.08 1.97 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.514 ' OD2' ' NE2' ' A' ' 135' ' ' GLN . 31.1 p-10 -116.04 -34.73 4.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -1.155 . . . . 0.0 110.143 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 118.34 19.5 4.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.514 ' NE2' ' OD2' ' A' ' 133' ' ' ASP . 3.9 pp0? -160.21 159.01 31.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.173 -1.192 . . . . 0.0 110.434 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 87.2 t -114.9 108.59 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -80.69 -173.25 4.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.212 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.429 ' O ' ' C ' ' A' ' 139' ' ' GLU . 25.5 t80 -67.66 -67.18 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 110.311 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 138' ' ' TYR . 2.3 tt0 -42.85 -27.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.772 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 144' ' ' MET . 1.6 tt0 -80.94 -53.15 6.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 110.356 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 69.5 t80 -58.26 -18.31 25.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 66.5 t -99.75 -62.67 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.345 -0.847 . . . . 0.0 110.568 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -52.53 -18.96 1.95 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.254 -0.904 . . . . 0.0 110.489 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.484 ' HB3' ' O ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -97.81 -20.94 17.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.128 -0.983 . . . . 0.0 110.165 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.661 ' SD ' HG23 ' A' ' 85' ' ' ILE . 8.2 ttm -100.78 -26.37 13.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.355 -0.841 . . . . 0.0 110.746 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 146' ' ' THR . 4.7 t . . . . . 0 N--CA 1.499 2.007 0 O-C-N 120.907 -1.121 . . . . 0.0 110.888 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.904 HG22 ' CD ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.149 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.904 ' CD ' HG22 ' B' ' 4' ' ' ILE . 46.4 Cg_endo -83.03 -158.16 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.559 1.294 . . . . 0.0 110.534 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.524 ' O ' ' N ' ' B' ' 8' ' ' THR . 2.4 p -136.93 56.2 1.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.98 -1.075 . . . . 0.0 111.047 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.811 ' O ' HG22 ' B' ' 10' ' ' VAL . 3.0 m95 54.03 -82.15 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.253 -0.904 . . . . 0.0 111.05 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 75' ' ' LYS . 7.1 p -41.31 -25.12 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.844 -1.16 . . . . 0.0 110.633 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.496 ' N ' ' O ' ' B' ' 7' ' ' TRP . 50.6 m -64.18 -53.47 48.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 109.638 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.811 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.5 m -58.59 -26.34 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.296 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' B' ' 15' ' ' SER . 2.9 mt -75.05 -33.13 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.266 -0.897 . . . . 0.0 109.078 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.47 -59.57 5.23 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 110.125 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.861 HG12 HD11 ' A' ' 112' ' ' LEU . 61.8 t -62.66 -40.47 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 110.939 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -63.43 -31.0 72.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.965 -1.084 . . . . 0.0 110.072 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 0.5 OUTLIER -76.4 -24.23 54.05 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.363 -0.836 . . . . 0.0 110.092 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.589 ' HE1' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.67 -17.62 40.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.272 -0.892 . . . . 0.0 111.301 -179.323 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 19' ' ' LYS . 0.3 OUTLIER -78.79 -109.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.406 -1.434 . . . . 0.0 110.081 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.475 ' C ' ' HG3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 58.58 -72.64 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.131 -0.98 . . . . 0.0 110.821 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.882 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -172.94 90.62 0.09 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.348 -0.845 . . . . 0.0 112.256 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 123' ' ' GLU . 0.7 OUTLIER 62.1 4.67 1.25 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.534 -1.354 . . . . 0.0 110.829 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.5 ' O ' ' O ' ' B' ' 16' ' ' MET . 12.1 t -66.01 119.04 10.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.945 -1.097 . . . . 0.0 110.23 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.656 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -152.57 53.68 0.78 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.095 -1.003 . . . . 0.0 110.221 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.45 -136.23 6.42 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 145' ' ' MET . 2.0 m120 -130.51 65.17 75.45 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.247 -1.149 . . . . 0.0 110.637 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.27 42.26 1.29 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.937 1.493 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.533 ' HE2' ' HE1' ' A' ' 72' ' ' MET . 5.7 m-85 . . . . . 0 N--CA 1.498 1.927 0 O-C-N 121.074 -1.016 . . . . 0.0 110.293 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.301 0.572 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mt -56.97 -43.85 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.682 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.88 -51.81 62.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.682 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.511 ' OE2' ' CD ' ' B' ' 18' ' ' ARG . 16.9 tt0 -56.9 -45.98 82.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.674 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -63.04 -41.34 99.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -61.4 -41.19 96.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.401 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 7.6 tt0 -63.18 -48.07 79.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.249 -0.907 . . . . 0.0 109.258 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' HB1' ' HZ ' ' A' ' 68' ' ' PHE . . . -62.5 -46.44 88.44 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.4 -0.813 . . . . 0.0 109.395 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 65' ' ' PHE . 41.0 t80 -61.26 -38.43 86.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.338 -0.851 . . . . 0.0 109.0 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 14' ' ' GLU . 77.5 p -75.19 -35.55 61.52 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.539 -0.725 . . . . 0.0 109.365 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.693 HD13 ' HG3' ' B' ' 14' ' ' LYS . 1.1 tt -50.16 -44.86 52.83 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.815 . . . . 0.0 109.217 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CE1' HG11 ' B' ' 10' ' ' VAL . 52.7 m-85 -76.83 -51.53 11.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.431 -0.793 . . . . 0.0 109.472 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 46.0 t0 -77.17 78.2 3.71 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.509 -0.744 . . . . 0.0 110.009 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -68.22 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.6 p-10 -51.64 -27.52 11.66 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.431 -0.793 . . . . 0.0 110.293 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.447 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 80.21 18.61 71.37 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 53.6 p30 -62.24 -12.47 20.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -1.191 . . . . 0.0 109.962 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 86.98 29.39 23.23 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 4.2 p -152.61 118.57 5.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.268 -1.137 . . . . 0.0 110.601 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' A' ' 63' ' ' ILE . 10.7 mt -94.22 120.12 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.163 -0.96 . . . . 0.0 110.172 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.53 164.76 11.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.353 -0.842 . . . . 0.0 109.984 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.554 ' O ' HD13 ' A' ' 48' ' ' LEU . 38.6 p -56.63 -29.31 62.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.992 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -69.51 -60.83 2.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.803 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -49.06 -57.53 6.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -0.888 . . . . 0.0 110.14 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 32' ' ' LEU . 22.9 tp -52.86 -41.96 64.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.781 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.528 ' HA2' ' HG3' ' A' ' 43' ' ' PRO . . . -58.39 -34.88 76.63 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.7 m -62.85 -56.92 13.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -1.11 . . . . 0.0 110.035 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 35' ' ' VAL . 16.4 t -53.71 -32.71 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.334 -0.854 . . . . 0.0 109.883 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -27.28 59.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 109.956 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 1.4 ttp180 -76.73 -21.67 54.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -0.955 . . . . 0.0 110.121 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -33.71 59.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -0.922 . . . . 0.0 110.357 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.505 HD22 HG13 ' A' ' 91' ' ' VAL . 4.5 mt -74.94 -44.1 50.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.229 -0.919 . . . . 0.0 110.231 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.16 78.76 0.08 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -176.45 -174.51 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.259 -1.142 . . . . 0.0 110.283 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -142.55 93.43 6.97 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.0 110.315 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.528 ' HG3' ' HA2' ' A' ' 33' ' ' GLY . 44.5 Cg_endo -74.61 90.92 1.01 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 124.092 1.575 . . . . 0.0 110.297 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.29 145.86 52.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 110.428 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -49.07 -64.79 0.7 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.24 -0.913 . . . . 0.0 110.573 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -43.84 -51.14 7.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.939 -1.101 . . . . 0.0 110.046 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -65.13 -35.21 80.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.876 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 29' ' ' THR . 11.0 mt -62.38 -47.68 83.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 110.09 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -57.48 -44.85 85.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.875 . . . . 0.0 109.821 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.17 -27.15 69.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.419 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.571 ' SD ' HG21 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -74.66 -54.13 8.0 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.493 -0.754 . . . . 0.0 110.129 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.761 HG12 HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -70.16 -13.08 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.253 -0.904 . . . . 0.0 109.753 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.46 -24.74 63.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.187 -0.946 . . . . 0.0 109.212 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.85 -47.89 13.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.519 -0.738 . . . . 0.0 109.962 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.661 HG21 ' CE2' ' B' ' 7' ' ' TRP . 88.3 t -69.6 -18.09 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.651 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' ALA . 17.2 t0 -67.68 57.78 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.021 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -43.36 -55.58 4.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.952 . . . . 0.0 110.256 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.569 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 6.9 p-10 -64.1 -44.15 93.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.86 35.39 3.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.608 HD21 ' H ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -98.64 -44.93 6.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -1.207 . . . . 0.0 110.137 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' H ' ' ND2' ' A' ' 60' ' ' ASN . . . 142.15 -54.88 0.6 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.28 156.56 19.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.252 -1.146 . . . . 0.0 110.701 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.761 HD11 HG12 ' A' ' 52' ' ' ILE . 7.9 mm -90.39 142.93 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.805 . . . . 0.0 109.378 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.483 ' OD1' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -108.64 176.82 4.98 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.031 -1.043 . . . . 0.0 110.809 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.636 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 4.1 t80 -66.99 -45.2 52.92 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.495 -0.753 . . . . 0.0 111.372 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.8 Cg_endo -69.02 -37.81 10.38 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.203 1.107 . . . . 0.0 109.938 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 3.2 mt-10 -52.93 -41.66 64.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.293 -0.88 . . . . 0.0 109.218 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.401 ' HZ ' ' HB1' ' A' ' 15' ' ' ALA . 16.3 t80 -64.51 -50.33 67.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.748 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -51.44 -26.29 7.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.84 . . . . 0.0 110.574 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 34.8 m -98.4 -20.4 17.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 111.167 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.449 ' CE ' ' HB2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -78.99 -30.69 44.47 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.958 -1.089 . . . . 0.0 110.861 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.53 ' HG2' HG21 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -77.09 -9.08 58.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.192 -0.942 . . . . 0.0 110.839 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.58 -16.55 8.84 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.867 -1.145 . . . . 0.0 111.405 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -99.94 -9.91 22.25 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.883 -1.136 . . . . 0.0 110.491 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HB3' HG21 ' B' ' 8' ' ' THR . 6.5 tptt . . . . . 0 C--N 1.296 -1.731 0 O-C-N 121.29 -0.881 . . . . 0.0 110.618 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.19 0.519 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -67.42 -40.11 85.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.716 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HG3' HG13 ' A' ' 85' ' ' ILE . 17.9 pt-20 -51.8 -31.79 28.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 109.911 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.665 HG21 HG22 ' A' ' 142' ' ' VAL . 62.2 mt -78.78 -50.84 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.155 -0.966 . . . . 0.0 109.313 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 14.9 ttm180 -49.38 -40.6 36.49 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 109.5 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.774 ' HB3' HG21 ' B' ' 9' ' ' THR . 26.4 mt-10 -69.06 -52.77 25.06 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.292 -0.88 . . . . 0.0 109.581 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.33 -27.04 44.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.07 -1.019 . . . . 0.0 109.071 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' HB3' ' O ' ' A' ' 86' ' ' ARG . 83.3 t80 -69.75 -45.58 67.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 0.0 109.112 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -56.61 -37.47 70.71 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.591 -0.693 . . . . 0.0 109.36 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.619 HG12 HG21 ' A' ' 108' ' ' VAL . 82.1 t -64.92 -41.07 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.503 -0.748 . . . . 0.0 109.748 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.774 ' HE1' HG22 ' B' ' 13' ' ' VAL . 5.0 m-85 -66.42 -31.34 72.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.0 109.37 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.511 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 3.8 t0 -91.13 59.92 4.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.479 -0.763 . . . . 0.0 109.986 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -38.96 -39.8 0.58 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.441 -0.787 . . . . 0.0 110.794 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.0 p-10 -86.58 -35.06 19.68 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 0.0 110.121 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.505 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 82.55 44.6 7.27 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -94.64 -23.61 17.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -1.197 . . . . 0.0 110.177 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 114.88 29.32 2.64 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 41.8 m-85 -160.62 150.59 17.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.174 -1.192 . . . . 0.0 110.039 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.574 HD13 ' HB3' ' A' ' 92' ' ' PHE . 9.0 mt -119.06 118.09 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 102' ' ' ALA . 2.0 t -105.33 145.88 30.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 110.147 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.953 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -43.87 -33.03 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.811 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.15 82.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 109.546 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 39.6 mt-10 -55.77 -41.27 73.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.882 . . . . 0.0 109.492 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.027 ' CD1' HD11 ' A' ' 125' ' ' ILE . 7.7 mt -59.74 -44.67 93.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 109.601 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.408 ' NH1' ' HD3' ' A' ' 115' ' ' LYS . 1.2 ttm180 -57.5 -39.35 76.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -0.825 . . . . 0.0 109.592 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -63.5 -50.8 68.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 109.554 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.619 HG21 HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -63.76 -25.27 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 108.898 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.865 ' SD ' HD13 ' A' ' 116' ' ' LEU . 2.6 mtm -69.13 -65.37 0.72 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.672 -0.643 . . . . 0.0 109.988 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -51.99 -28.88 18.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -78.55 -10.5 59.75 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.277 -0.889 . . . . 0.0 109.337 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.687 HD11 HG12 ' B' ' 13' ' ' VAL . 13.8 mt -107.34 -48.5 3.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.356 -0.84 . . . . 0.0 110.479 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.58 -59.5 0.18 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.548 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 109' ' ' MET . 2.7 tp10 -99.76 159.23 15.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.934 -1.333 . . . . 0.0 110.819 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.562 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 1.1 pttp -123.57 1.91 8.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.375 -0.828 . . . . 0.0 110.012 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.865 HD13 ' SD ' ' A' ' 109' ' ' MET . 4.8 mp 48.11 175.81 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.56 0.695 . . . . 0.0 110.969 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.666 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.46 178.91 6.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.138 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -50.97 9.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.96 -1.087 . . . . 0.0 110.065 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -56.79 -46.11 81.76 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 109.491 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -58.91 -52.8 64.18 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.375 -0.828 . . . . 0.0 109.409 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.953 HG12 ' HB1' ' A' ' 102' ' ' ALA . 41.3 t -50.84 -41.41 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.857 . . . . 0.0 109.669 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 1.1 m-20 -70.95 -38.83 72.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.398 -0.813 . . . . 0.0 110.029 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -68.84 -23.73 64.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -0.866 . . . . 0.0 110.05 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.686 ' HE3' ' CD1' ' B' ' 22' ' ' PHE . 22.3 ttt -74.4 -56.21 5.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.882 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.027 HD11 ' CD1' ' A' ' 105' ' ' LEU . 31.2 mm -60.68 -52.82 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.0 109.712 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 122' ' ' ASP . 1.5 mtp85 -50.33 -52.89 32.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 110.1 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 15.3 mm-40 -53.33 -29.04 31.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.342 -0.849 . . . . 0.0 110.193 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.54 -19.23 24.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 110.343 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.43 70.43 3.82 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.0 110.262 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.6 mt -63.57 -41.22 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.968 . . . . 0.0 109.766 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 9.7 p30 -63.55 -36.29 83.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.332 -0.855 . . . . 0.0 110.03 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 95.48 74.19 1.22 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.458 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.437 ' OD1' ' CG ' ' A' ' 131' ' ' ASP . 4.4 m-20 -133.44 2.17 3.5 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.229 -1.159 . . . . 0.0 109.976 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.508 ' O ' ' CG ' ' A' ' 135' ' ' GLN . . . 71.66 4.71 58.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.508 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 68.1 mt-30 -156.63 168.81 26.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.163 . . . . 0.0 109.773 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 140' ' ' GLU . 14.7 t -107.16 131.47 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 109.953 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 11.6 t30 -100.39 -152.98 0.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 0.0 110.23 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.458 ' OH ' ' HG3' ' A' ' 86' ' ' ARG . 12.1 t80 -74.54 -69.45 0.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.245 -0.909 . . . . 0.0 110.087 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 143' ' ' GLN . 1.4 tt0 -46.95 -44.4 19.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.187 -0.946 . . . . 0.0 109.875 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.457 ' HB3' HG13 ' A' ' 136' ' ' VAL . 11.5 mt-10 -53.78 -60.56 3.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.795 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 140' ' ' GLU . 5.1 t80 -42.96 -33.0 0.71 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 110.017 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.665 HG22 HG21 ' A' ' 85' ' ' ILE . 37.8 t -100.09 -17.11 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.374 -0.829 . . . . 0.0 110.726 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 139' ' ' GLU . 13.7 tt0 -77.9 -27.97 49.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.173 -0.954 . . . . 0.0 110.621 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -93.51 -11.05 32.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.524 ' O ' ' HB2' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.6 -24.78 14.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.436 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.0 p . . . . . 0 C--N 1.305 -1.353 0 O-C-N 120.921 -1.112 . . . . 0.0 110.661 -179.537 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.571 HG21 ' SD ' ' A' ' 51' ' ' MET . 12.5 mt . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.508 ' O ' ' HB ' ' B' ' 9' ' ' THR . 44.1 Cg_endo -70.87 66.39 2.42 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.98 1.516 . . . . 0.0 111.602 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.482 ' C ' ' O ' ' B' ' 5' ' ' PRO . 42.4 m 31.56 -147.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.533 0.682 . . . . 0.0 111.874 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.661 ' CE2' HG21 ' A' ' 55' ' ' VAL . 2.0 m95 -108.7 -73.87 0.67 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.886 0.851 . . . . 0.0 110.842 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.529 ' HA ' HD12 ' B' ' 11' ' ' ILE . 2.6 p -44.83 -36.59 3.34 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.498 -0.751 . . . . 0.0 110.288 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.774 HG21 ' HB3' ' A' ' 87' ' ' GLU . 2.6 m -44.91 -53.84 7.15 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.695 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.465 HG23 ' H ' ' B' ' 10' ' ' VAL . 4.7 t -57.46 -40.12 72.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.53 HG21 ' HG2' ' A' ' 72' ' ' MET . 47.1 mt -72.75 -19.72 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.539 -0.726 . . . . 0.0 109.635 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 8' ' ' THR . 0.2 OUTLIER -73.36 -50.16 23.42 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.647 0.737 . . . . 0.0 109.768 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.774 HG22 ' HE1' ' A' ' 92' ' ' PHE . 89.1 t -64.91 -47.06 89.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.475 -0.766 . . . . 0.0 110.575 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.693 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -65.86 -32.76 74.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.066 -1.021 . . . . 0.0 109.802 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 34.2 t -78.23 -13.68 59.76 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.6 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' B' ' 12' ' ' LEU . 0.0 OUTLIER -79.67 -42.18 25.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.162 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.621 HD21 ' CG ' ' A' ' 109' ' ' MET . 9.3 mp -44.98 -57.32 3.89 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.918 -1.114 . . . . 0.0 109.057 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.511 ' CD ' ' OE2' ' A' ' 11' ' ' GLU . 3.6 tpt85 16.38 75.24 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' B' ' 19' ' ' LYS . 2.0 tptm 44.62 73.76 0.15 Allowed 'General case' 0 C--N 1.283 -2.308 0 O-C-N 121.273 -0.892 . . . . 0.0 112.883 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.691 ' H ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER 47.86 13.73 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.683 0 O-C-N 120.8 -1.187 . . . . 0.0 112.092 177.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' B' ' 18' ' ' ARG . 5.1 m -112.74 115.45 28.55 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 119.956 -1.715 . . . . 0.0 110.468 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.686 ' CD1' ' HE3' ' A' ' 124' ' ' MET . 0.9 OUTLIER -58.16 -35.32 71.38 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.167 -1.013 . . . . 0.0 108.779 179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.54 147.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.595 ' N ' ' HD3' ' B' ' 25' ' ' PRO . 1.8 p-10 -134.97 43.09 0.87 Allowed Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.479 -1.013 . . . . 0.0 110.73 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' B' ' 24' ' ' ASN . 55.2 Cg_endo -77.96 26.64 0.49 Allowed 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.481 1.253 . . . . 0.0 111.189 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.431 ' CE2' ' HE1' ' A' ' 72' ' ' MET . 15.5 m-85 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 110.354 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.317 0.58 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 47.2 mt -66.44 -40.05 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.997 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.33 -62.35 1.78 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 109.714 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.494 ' OE1' ' CA ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -48.64 -41.48 31.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.609 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.8 m-30 -52.49 -46.78 66.74 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.214 -0.929 . . . . 0.0 109.153 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -57.34 -34.52 68.86 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.329 -0.857 . . . . 0.0 109.172 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 1.7 tt0 -56.84 -51.01 70.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.397 -0.814 . . . . 0.0 109.794 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' CA ' ' HD2' ' B' ' 14' ' ' LYS . . . -60.01 -45.39 92.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.19 -0.943 . . . . 0.0 109.566 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.584 ' CZ ' ' O ' ' A' ' 64' ' ' ASP . 1.7 t80 -64.62 -45.43 86.89 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 109.841 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m -64.29 -31.33 72.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.809 . . . . 0.0 109.706 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.622 HD21 ' O ' ' A' ' 112' ' ' LEU . 9.7 tt -61.9 -45.9 91.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.447 -0.783 . . . . 0.0 110.041 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.737 ' HA ' HG21 ' A' ' 35' ' ' VAL . 26.4 m-85 -71.42 -27.13 63.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.287 -0.883 . . . . 0.0 110.245 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.8 120.8 26.48 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.262 -0.899 . . . . 0.0 110.346 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.44 -37.09 60.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.237 -0.914 . . . . 0.0 110.304 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 17.6 p-10 -92.09 -40.9 10.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.307 -0.871 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.98 48.58 2.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 44.8 p-10 -104.69 -7.72 19.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -1.162 . . . . 0.0 110.1 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 26' ' ' THR . . . 89.71 35.78 7.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 25' ' ' GLY . 20.0 p -155.68 107.73 2.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.292 -1.122 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 mt -95.3 119.48 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.137 -0.977 . . . . 0.0 110.326 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.684 HG22 HG22 ' A' ' 62' ' ' THR . 12.7 p -100.08 174.46 6.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.179 -0.951 . . . . 0.0 110.231 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.764 HG21 ' OE1' ' A' ' 49' ' ' GLN . 74.9 p -59.09 -31.91 69.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -55.33 9.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.153 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 39.5 mt-10 -55.02 -69.76 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.06 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 31' ' ' GLU . 12.6 tp -44.94 -41.84 7.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.761 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.21 -41.99 93.12 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 2.5 m -61.07 -50.78 71.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -1.113 . . . . 0.0 109.886 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.737 HG21 ' HA ' ' A' ' 19' ' ' PHE . 12.4 t -57.92 -42.27 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 mmt -61.07 -42.34 98.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.29 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 34' ' ' THR . 3.0 tpt180 -53.04 -40.82 64.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.242 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 40' ' ' GLY . 68.3 m -71.77 -44.22 64.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.553 -0.717 . . . . 0.0 109.461 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.754 ' CD2' HD21 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -43.5 -26.24 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.38 -0.825 . . . . 0.0 109.69 179.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 107.85 37.91 2.12 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 10.5 mm-40 -145.98 165.64 28.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.31 -1.112 . . . . 0.0 110.535 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -126.84 88.89 53.43 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 109.64 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.06 160.81 46.52 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.113 1.586 . . . . 0.0 110.93 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 45' ' ' GLU . 94.9 m -99.64 164.3 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.476 -0.765 . . . . 0.0 109.879 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -69.03 -69.95 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.16 -0.963 . . . . 0.0 110.073 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -43.33 -54.14 4.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.974 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.409 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 69.1 mm-40 -54.54 -41.39 69.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.014 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 51' ' ' MET . 3.4 mt -55.4 -42.7 74.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 0.0 109.906 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.764 ' OE1' HG21 ' A' ' 29' ' ' THR . 45.4 tp60 -67.36 -24.32 65.69 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.274 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -71.51 -46.98 58.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 109.974 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.496 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 24.7 ptm -73.21 -35.41 66.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 109.724 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.565 HG13 HG22 ' A' ' 29' ' ' THR . 7.8 mm -62.32 -32.46 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 109.529 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.24 -21.06 56.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.831 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.17 -37.99 87.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 110.154 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.535 HG13 ' HE2' ' A' ' 71' ' ' MET . 11.5 t -91.86 -31.8 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 110.176 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.1 71.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.261 -0.9 . . . . 0.0 110.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.27 -17.17 61.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.0 110.638 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.6 p30 -100.43 -31.87 11.09 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.143 -0.973 . . . . 0.0 110.609 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.54 42.48 4.82 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.426 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 12.6 m120 -84.03 -15.77 46.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.195 -1.179 . . . . 0.0 110.076 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 62' ' ' THR . . . 101.67 -8.41 56.39 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.684 HG22 HG22 ' A' ' 28' ' ' THR . 2.9 p -158.23 168.46 26.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.573 HG22 ' CZ ' ' A' ' 16' ' ' PHE . 30.2 mm -82.82 136.07 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 109.943 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.584 ' O ' ' CZ ' ' A' ' 16' ' ' PHE . 2.5 m-20 -114.27 174.01 6.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.307 -0.871 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.599 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 48.2 t80 -59.4 -49.85 90.37 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.404 -0.81 . . . . 0.0 111.714 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.1 Cg_endo -65.27 -38.37 27.28 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.169 1.089 . . . . 0.0 110.268 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -53.19 -33.9 54.66 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.136 -0.977 . . . . 0.0 109.335 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.549 ' HB2' ' CE1' ' A' ' 16' ' ' PHE . 21.9 t80 -78.05 -39.26 42.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 110.345 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 65' ' ' PHE . 2.3 mm? -55.49 -30.09 59.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.871 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.57 -63.21 1.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.041 -1.037 . . . . 0.0 111.37 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.535 ' HE2' HG13 ' A' ' 55' ' ' VAL . 2.1 tmm? -44.32 -37.92 3.6 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.068 -1.02 . . . . 0.0 111.548 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.649 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -67.08 -8.56 31.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.039 -1.038 . . . . 0.0 111.317 -179.014 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.97 -9.34 9.66 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.664 -1.273 . . . . 0.0 111.687 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -17.32 30.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.78 -1.2 . . . . 0.0 111.4 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.7 tptt . . . . . 0 N--CA 1.496 1.843 0 O-C-N 120.922 -1.111 . . . . 0.0 111.314 -179.292 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 85' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 121.408 0.623 . . . . 0.0 109.566 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -73.88 -34.95 64.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.067 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 31.9 mt-10 -69.08 -19.94 64.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.146 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 82' ' ' GLU . 40.7 mt -70.85 -39.42 75.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 109.053 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -27.72 63.22 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.426 -0.796 . . . . 0.0 108.959 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 5.4 mt-10 -70.94 -57.67 4.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.393 -0.817 . . . . 0.0 109.431 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.524 ' CB ' HD22 ' B' ' 12' ' ' LEU . . . -54.88 -27.54 43.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.046 -1.034 . . . . 0.0 109.173 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -66.15 -52.67 46.21 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.73 -34.53 12.28 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.871 . . . . 0.0 109.155 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.96 HG12 HG21 ' A' ' 108' ' ' VAL . 72.0 t -67.52 -42.73 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.442 -0.786 . . . . 0.0 109.59 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.675 ' HB3' HD13 ' A' ' 100' ' ' ILE . 56.5 m-85 -76.37 -24.13 54.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 96' ' ' GLY . 3.7 t0 -100.23 67.51 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.497 -0.752 . . . . 0.0 110.144 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -39.01 -44.83 1.14 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.595 -0.69 . . . . 0.0 110.351 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.8 p30 -82.64 -22.92 34.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 109.882 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 63.18 51.56 54.13 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 24.5 p-10 -99.85 -26.21 14.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -1.155 . . . . 0.0 110.166 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 122.08 18.81 3.4 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -153.35 130.99 11.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -1.145 . . . . 0.0 110.098 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.675 HD13 ' HB3' ' A' ' 92' ' ' PHE . 22.2 mt -103.95 157.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 110.419 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.8 OUTLIER -140.33 147.3 39.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.397 -0.814 . . . . 0.0 109.704 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.16 -30.9 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.869 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.49 -45.02 73.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.311 -0.868 . . . . 0.0 109.592 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 20.7 mt-10 -63.32 -47.53 81.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.257 -0.902 . . . . 0.0 109.555 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.944 HD13 HD11 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.39 -39.28 90.12 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.286 -0.884 . . . . 0.0 109.634 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.477 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 1.4 tmt_? -60.47 -29.05 68.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.359 -0.838 . . . . 0.0 109.823 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -31.78 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 110.048 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.96 HG21 HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -74.15 -36.71 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.979 . . . . 0.0 109.554 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.79 ' CB ' HD21 ' B' ' 17' ' ' LEU . 21.5 ptp -73.26 -39.99 64.98 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.566 ' N ' ' HG3' ' A' ' 109' ' ' MET . 87.1 m -69.54 -27.38 65.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.116 -0.99 . . . . 0.0 109.47 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -89.75 -13.14 37.39 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.42 -0.8 . . . . 0.0 109.302 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.754 HD21 ' CD2' ' A' ' 39' ' ' LEU . 9.2 mt -93.89 -32.65 13.83 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.449 -0.782 . . . . 0.0 110.006 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.05 -63.82 0.33 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.267 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 109' ' ' MET . 1.8 tt0 -94.11 156.1 16.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.114 -1.227 . . . . 0.0 110.679 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 116' ' ' LEU . 9.8 pttt -124.53 13.03 8.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' B' ' 17' ' ' LEU . 1.0 OUTLIER 40.66 -164.1 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.512 0.672 . . . . 0.0 110.56 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -166.28 1.3 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.387 -0.82 . . . . 0.0 109.567 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.436 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -97.17 -59.56 1.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.094 -1.004 . . . . 0.0 109.694 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 4.5 pt-20 -58.91 -30.29 67.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.515 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 9.2 tp10 -69.83 -48.17 59.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.403 -0.811 . . . . 0.0 109.321 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 t -57.28 -42.12 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.432 -0.793 . . . . 0.0 109.64 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 14.4 m-20 -69.2 -41.17 77.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.89 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 2.4 mt-10 -64.08 -31.01 72.04 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 110.007 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.608 ' HE1' ' HA ' ' B' ' 17' ' ' LEU . 1.0 OUTLIER -69.6 -42.05 74.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.176 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.944 HD11 HD13 ' A' ' 105' ' ' LEU . 35.0 mm -74.52 -23.88 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -74.44 -40.16 62.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.23 -0.919 . . . . 0.0 110.552 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.79 -8.96 58.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 110.266 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.476 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -101.26 -30.53 11.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.305 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.466 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -52.97 101.37 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.109 -0.994 . . . . 0.0 110.285 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.476 HD12 ' O ' ' A' ' 128' ' ' ALA . 1.2 mp -67.81 -27.37 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.197 -0.939 . . . . 0.0 109.813 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 41.6 p-10 -103.38 -25.48 13.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.63 72.38 1.27 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.466 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 5.5 p-10 -130.61 -0.83 4.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -1.168 . . . . 0.0 110.145 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.07 -2.7 75.9 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 40.9 mt-30 -142.54 160.7 39.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -1.226 . . . . 0.0 110.2 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 97.1 t -107.59 120.05 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.182 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 98' ' ' GLY . 10.4 t-20 -81.31 166.44 20.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.884 . . . . 0.0 110.15 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -57.7 -48.97 78.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.106 -0.996 . . . . 0.0 110.155 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -53.2 -30.67 38.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 109.934 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.84 -52.63 7.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.306 -0.871 . . . . 0.0 109.813 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.413 ' CE2' HG23 ' A' ' 85' ' ' ILE . 65.9 t80 -49.75 -21.79 1.2 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.2 -0.938 . . . . 0.0 109.593 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 146' ' ' THR . 17.1 t -94.04 -62.28 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.437 -0.789 . . . . 0.0 110.255 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -43.84 -49.55 8.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.877 . . . . 0.0 110.267 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 3.7 tpt -59.05 -19.14 41.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.869 . . . . 0.0 110.556 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . 1.057 ' HE2' ' HB2' ' B' ' 24' ' ' ASN . 2.7 mtt -99.61 -24.63 14.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.168 -0.958 . . . . 0.0 110.501 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 142' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.147 -0.97 . . . . 0.0 110.344 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.659 HG23 ' HD2' ' B' ' 5' ' ' PRO . 20.0 mt . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.659 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.8 Cg_endo -65.27 122.63 10.41 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.843 1.444 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.526 ' O ' ' N ' ' B' ' 8' ' ' THR . 17.8 m -78.93 79.68 5.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.834 . . . . 0.0 111.015 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.406 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER 50.35 -86.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.329 -0.857 . . . . 0.0 111.106 179.086 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.526 ' N ' ' O ' ' B' ' 6' ' ' SER . 10.3 p -43.31 -30.05 0.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 110.733 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' B' ' 5' ' ' PRO . 83.8 m -64.86 -47.29 78.43 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.694 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.547 HG12 ' HZ ' ' A' ' 19' ' ' PHE . 5.5 t -61.39 -46.88 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.721 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' B' ' 15' ' ' SER . 76.4 mt -58.96 -30.27 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.165 -0.959 . . . . 0.0 109.488 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.618 ' HG ' ' CE2' ' B' ' 26' ' ' PHE . 3.2 tt -63.73 -56.81 12.79 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.436 -0.79 . . . . 0.0 110.26 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.666 HG21 HG11 ' A' ' 91' ' ' VAL . 67.2 t -54.38 -40.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.149 -0.969 . . . . 0.0 110.576 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.516 ' HD2' ' CA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -72.9 -44.06 61.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.944 -1.097 . . . . 0.0 109.661 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.436 ' HA ' ' HE2' ' B' ' 14' ' ' LYS . 20.7 p -67.26 -7.87 27.5 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.368 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.496 ' HB2' ' O ' ' B' ' 12' ' ' LEU . 2.0 ttt -93.15 -60.31 1.83 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.897 . . . . 0.0 110.871 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.944 HD22 ' O ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -102.51 91.88 4.42 Favored 'General case' 0 C--O 1.204 -1.315 0 CA-C-O 123.768 1.746 . . . . 0.0 110.667 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.462 ' HG3' ' N ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -124.87 -35.72 2.65 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.137 -0.977 . . . . 0.0 109.763 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.489 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 1.5 tmtm? -137.44 -72.46 0.43 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.201 -0.937 . . . . 0.0 110.558 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.449 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -161.23 23.54 0.13 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.138 -0.976 . . . . 0.0 109.501 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.446 ' O ' ' SD ' ' A' ' 124' ' ' MET . 3.6 m -100.97 166.42 10.83 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.65 -0.656 . . . . 0.0 110.903 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.576 ' CD1' ' HG2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -153.63 16.45 0.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.367 -0.833 . . . . 0.0 110.37 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.39 126.34 6.22 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 1.057 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 3.2 m120 -112.83 135.36 21.62 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.177 -1.19 . . . . 0.0 110.951 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -81.46 11.85 2.92 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.027 1.541 . . . . 0.0 110.015 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.649 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 3.3 m-85 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.179 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 35.4 mt-30 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.269 0.557 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.1 mt -57.33 -38.64 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 109.671 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.39 79.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.588 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 26.4 mt-10 -60.23 -56.11 25.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -56.82 -36.12 69.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 109.466 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -42.66 98.37 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.294 -0.879 . . . . 0.0 109.045 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 17' ' ' SER . 4.7 tp10 -51.1 -45.26 61.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 109.149 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.86 -49.18 73.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 109.273 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.853 ' CE1' HD11 ' A' ' 27' ' ' ILE . 21.6 t80 -56.45 -29.38 61.6 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.418 -0.801 . . . . 0.0 109.744 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 3.6 t -68.83 -46.67 67.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 0.0 110.0 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.815 HD13 ' HG3' ' B' ' 14' ' ' LYS . 10.4 tt -55.03 -36.9 65.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 109.629 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 62.4 m-85 -79.38 -52.71 7.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.323 -0.86 . . . . 0.0 110.004 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -68.52 111.58 4.81 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.451 -0.78 . . . . 0.0 110.305 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -90.34 -44.15 9.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -0.841 . . . . 0.0 110.178 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 22.3 p30 -72.68 -16.48 61.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.288 -0.882 . . . . 0.0 110.244 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 64.48 65.78 2.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.9 p30 -130.95 -33.13 1.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -1.127 . . . . 0.0 110.235 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.587 ' C ' HG23 ' A' ' 26' ' ' THR . . . 114.33 38.39 1.12 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 25' ' ' GLY . 67.3 p -155.39 103.35 2.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.853 HD11 ' CE1' ' A' ' 16' ' ' PHE . 9.8 mt -88.98 110.77 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.067 -1.02 . . . . 0.0 110.0 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.928 HG22 HG22 ' A' ' 62' ' ' THR . 59.4 p -100.79 177.39 4.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.8 p -57.65 -19.92 29.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.026 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -73.78 -55.66 5.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.214 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HG2' ' HG3' ' A' ' 21' ' ' LYS . 6.1 mt-10 -64.25 -59.84 3.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.499 HD13 ' CH2' ' B' ' 7' ' ' TRP . 7.7 tp -62.98 -25.36 68.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 110.239 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.47 -35.95 55.29 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -71.58 -46.11 60.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.233 -1.157 . . . . 0.0 110.48 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.5 -40.98 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.204 -0.935 . . . . 0.0 110.394 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.508 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 6.9 mmm -69.26 -31.96 70.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 110.36 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.6 tpt180 -79.35 -20.54 47.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.464 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 68.0 m -70.7 -44.59 66.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 110.692 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.44 -36.1 21.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.09 -1.006 . . . . 0.0 110.368 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.26 32.8 0.66 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -120.69 -169.58 1.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.2 -1.177 . . . . 0.0 110.28 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -143.9 72.13 16.85 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.263 -0.898 . . . . 0.0 110.215 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.508 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 47.3 Cg_endo -74.22 105.51 2.05 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.035 1.545 . . . . 0.0 110.309 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.4 m -53.98 153.43 4.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.172 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 8.7 tm-20 -65.42 -43.34 90.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 109.956 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.02 -63.15 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.91 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -52.0 -36.44 49.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.2 mt -58.52 -50.49 73.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.902 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.502 ' O ' HG22 ' A' ' 52' ' ' ILE . 5.3 tp60 -54.01 -35.68 62.15 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.8 -34.39 69.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.352 -0.843 . . . . 0.0 109.545 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.401 ' HE3' ' CD1' ' B' ' 7' ' ' TRP . 0.2 OUTLIER -70.03 -26.17 63.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.488 -0.758 . . . . 0.0 110.104 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.623 HG13 HD11 ' A' ' 63' ' ' ILE . 1.2 tp -78.62 -41.23 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.986 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.434 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -54.56 -21.77 11.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -57.21 6.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.858 . . . . 0.0 110.068 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.679 ' HB ' HD12 ' A' ' 63' ' ' ILE . 17.1 t -71.69 -23.06 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.152 -0.968 . . . . 0.0 109.926 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -56.18 83.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.353 -0.842 . . . . 0.0 110.364 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.08 -71.31 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.096 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 26.2 p-10 -48.22 -42.02 29.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 101.7 41.61 2.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 1.6 p-10 -98.88 -44.34 6.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.118 -1.225 . . . . 0.0 110.077 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 143.48 -47.24 0.8 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.149 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.928 HG22 HG22 ' A' ' 28' ' ' THR . 26.5 p -94.16 158.59 15.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.208 -1.172 . . . . 0.0 110.895 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.679 HD12 ' HB ' ' A' ' 55' ' ' VAL . 12.4 mm -93.07 135.12 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.348 -0.845 . . . . 0.0 110.146 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.487 ' OD1' ' HD2' ' A' ' 66' ' ' PRO . 2.3 t70 -107.24 168.34 9.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.11 -0.994 . . . . 0.0 110.424 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.622 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 t80 -56.02 -44.82 99.88 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.397 -0.814 . . . . 0.0 111.245 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -70.26 -31.59 18.02 Favored 'Trans proline' 0 N--CA 1.482 0.83 0 O-C-N 123.298 1.157 . . . . 0.0 110.269 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.509 ' OE2' ' N ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -63.7 -34.55 78.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 109.341 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -71.61 -42.04 68.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.486 -0.759 . . . . 0.0 109.779 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 mt -58.16 -34.76 70.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 0.0 110.06 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -76.86 -33.74 57.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.561 ' SD ' HG22 ' A' ' 55' ' ' VAL . 42.1 ttp -64.84 -63.68 1.06 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.296 -0.877 . . . . 0.0 110.569 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.517 ' SD ' HG22 ' B' ' 8' ' ' THR . 9.9 tpt -54.4 -16.5 2.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.141 -0.974 . . . . 0.0 110.677 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.21 -33.02 14.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.068 -1.02 . . . . 0.0 110.662 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -98.64 -9.95 24.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.159 -0.963 . . . . 0.0 110.371 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.218 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HA ' HD12 ' A' ' 85' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.401 0.619 . . . . 0.0 109.378 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -67.04 -29.48 69.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.244 -0.91 . . . . 0.0 109.349 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.565 ' OE2' HD23 ' B' ' 12' ' ' LEU . 20.9 tt0 -61.71 -26.72 68.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.439 -0.788 . . . . 0.0 109.608 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 82' ' ' GLU . 65.3 mt -69.64 -36.79 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.464 -0.894 . . . . 0.0 108.86 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 89' ' ' PHE . 16.0 ttt180 -59.21 -36.85 76.12 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.562 0.696 . . . . 0.0 109.124 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.615 ' HB3' HG21 ' B' ' 9' ' ' THR . 6.0 mm-40 -67.09 -54.17 23.95 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.403 -0.811 . . . . 0.0 109.421 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.36 -31.28 21.65 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.136 -0.978 . . . . 0.0 108.83 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.46 ' HB3' ' O ' ' A' ' 86' ' ' ARG . 82.3 t80 -68.16 -67.1 0.49 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.418 -0.801 . . . . 0.0 109.912 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -45.25 -35.81 3.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.758 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.661 HG12 HG21 ' A' ' 108' ' ' VAL . 25.2 t -56.87 -50.39 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 109.344 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.629 ' CE1' HG11 ' A' ' 108' ' ' VAL . 25.3 m-85 -60.97 -31.62 71.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.672 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD2' ' OD1' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -98.77 62.2 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.373 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -43.42 -34.29 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.91 . . . . 0.0 110.067 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.4 p30 -77.08 -41.87 40.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 84.51 52.46 3.54 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.7 p-10 -100.06 -33.83 10.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.182 -1.187 . . . . 0.0 110.115 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.587 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 125.03 22.92 1.87 Allowed Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.577 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 85.9 m-85 -157.25 141.2 16.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.985 -1.303 . . . . 0.0 110.676 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 135' ' ' GLN . 6.3 mt -109.58 143.96 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.861 . . . . 0.0 110.153 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -139.6 152.3 46.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.145 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.39 -27.03 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 109.867 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -68.92 -47.75 64.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.562 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 6.9 mt-10 -63.79 -43.63 95.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.467 -0.771 . . . . 0.0 109.806 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.666 HD13 HD11 ' A' ' 125' ' ' ILE . 2.6 mt -67.58 -34.8 77.77 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.378 -0.826 . . . . 0.0 109.581 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.474 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 43.0 ttp180 -66.87 -27.94 67.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.292 -0.88 . . . . 0.0 109.752 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.67 -23.41 31.77 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.292 -0.88 . . . . 0.0 109.953 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.661 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -91.34 -29.12 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 109.97 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.555 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 21.9 ptp -76.84 -34.38 57.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 110.338 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' MET . 5.4 m -76.66 -28.65 56.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.052 -1.03 . . . . 0.0 109.65 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 38' ' ' SER . 2.3 m120 -82.7 -23.46 34.09 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.355 -0.84 . . . . 0.0 109.917 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.793 ' CD1' HG12 ' B' ' 13' ' ' VAL . 2.0 mt -82.84 -28.69 29.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.67 -64.24 0.39 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 109' ' ' MET . 4.1 tt0 -108.01 144.81 34.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -1.17 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.512 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 0.2 OUTLIER -119.36 22.33 11.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.855 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.747 HD11 ' C ' ' B' ' 17' ' ' LEU . 5.1 mp 46.9 -176.59 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.566 -0.709 . . . . 0.0 110.687 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.89 -143.59 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.232 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.11 -51.0 2.12 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.169 -0.957 . . . . 0.0 110.178 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -60.93 -38.47 85.93 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 109.519 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.59 -52.87 59.05 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.294 -0.879 . . . . 0.0 109.298 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 125' ' ' ILE . 41.4 t -47.18 -42.22 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.273 -0.892 . . . . 0.0 109.74 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.63 -63.71 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.808 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -48.12 -24.8 1.22 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.397 -0.814 . . . . 0.0 109.732 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.445 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -70.1 -44.08 69.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.779 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.666 HD11 HD13 ' A' ' 105' ' ' LEU . 25.9 mm -78.62 -25.39 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.365 -0.834 . . . . 0.0 110.102 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.25 -69.84 0.37 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.279 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -47.49 -25.37 1.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -78.24 -49.99 12.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 128' ' ' ALA . 34.7 t0 -41.95 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.487 -0.758 . . . . 0.0 110.547 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . 3.3 mp -75.37 -47.46 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.909 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.407 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 16.2 p-10 -77.23 -18.31 57.78 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.404 -0.81 . . . . 0.0 109.987 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.413 ' HA2' ' CG ' ' A' ' 129' ' ' ASP . . . 76.94 56.49 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 31.1 p30 -107.77 -8.51 16.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.08 17.31 56.27 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 10.2 pt20 -168.44 150.63 5.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -1.133 . . . . 0.0 109.95 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 13.0 t -89.37 125.68 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.173 -0.955 . . . . 0.0 110.435 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 9.6 t30 -93.8 -173.72 3.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.279 -0.888 . . . . 0.0 110.243 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 64.1 t80 -69.85 -56.54 6.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.181 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.68 -58.49 4.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.843 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' HD12 ' A' ' 130' ' ' ILE . 36.3 mt-10 -52.11 -45.45 64.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.317 -0.864 . . . . 0.0 109.883 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -57.86 -26.69 62.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 0.0 109.942 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.33 -39.8 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.835 . . . . 0.0 110.347 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -56.01 -46.88 78.62 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.215 -0.928 . . . . 0.0 110.062 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 77.5 mmm -63.51 -27.47 69.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.837 . . . . 0.0 110.308 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.54 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 3.9 mtt -90.18 -34.76 15.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.195 -0.941 . . . . 0.0 110.639 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 146' ' ' THR . 9.7 t . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.026 -1.046 . . . . 0.0 110.138 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 22.3 mt . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 39.6 Cg_endo -65.43 149.2 88.24 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.639 1.336 . . . . 0.0 110.272 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.576 ' O ' ' N ' ' B' ' 8' ' ' THR . 45.2 m -94.08 92.03 7.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.278 -0.889 . . . . 0.0 111.542 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.513 ' CE2' HG21 ' A' ' 55' ' ' VAL . 1.8 m95 37.48 -86.98 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.614 -0.679 . . . . 0.0 111.313 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.596 HG21 ' HG2' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -42.83 -48.62 5.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.247 -0.908 . . . . 0.0 109.802 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 87' ' ' GLU . 41.2 m -45.79 -37.76 6.41 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.378 -0.826 . . . . 0.0 109.218 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.462 ' H ' HG23 ' B' ' 10' ' ' VAL . 5.7 t -67.94 -42.03 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.71 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.495 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 9.7 mm -69.47 -26.73 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.785 . . . . 0.0 110.177 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.565 HD23 ' OE2' ' A' ' 84' ' ' GLU . 1.3 mm? -67.55 -56.52 9.14 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.392 -0.817 . . . . 0.0 110.138 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.793 HG12 ' CD1' ' A' ' 112' ' ' LEU . 9.6 t -57.31 -39.98 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.309 -0.869 . . . . 0.0 110.341 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.815 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.01 -32.28 72.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.767 -1.208 . . . . 0.0 109.596 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -41.57 89.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.339 -0.85 . . . . 0.0 109.239 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 7.2 mtt -75.12 -25.96 58.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.905 . . . . 0.0 109.753 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.747 ' C ' HD11 ' A' ' 116' ' ' LEU . 5.6 mp -81.25 49.94 1.35 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.375 -0.828 . . . . 0.0 109.697 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.512 ' N ' HD11 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -126.12 -73.5 0.62 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.247 -0.908 . . . . 0.0 111.714 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -158.67 90.64 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.105 -0.997 . . . . 0.0 111.177 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' B' ' 20' ' ' ARG . 19.6 ttp180 59.94 5.2 0.7 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.211 -0.931 . . . . 0.0 110.911 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.25 84.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.851 -1.156 . . . . 0.0 110.233 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.75 54.38 1.95 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 110.35 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.97 -111.7 0.64 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 145' ' ' MET . 1.2 t-20 -128.35 73.4 80.12 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.27 -1.135 . . . . 0.0 110.044 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.74 -2.26 10.6 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.127 1.593 . . . . 0.0 110.548 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.493 ' HE2' HD13 ' B' ' 12' ' ' LEU . 22.9 m-85 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.133 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.281 0.562 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.3 mt -53.32 -48.69 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.277 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -56.46 -38.38 71.6 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.287 -0.883 . . . . 0.0 109.101 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -54.07 -52.42 60.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.411 -0.805 . . . . 0.0 109.184 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.555 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 34.4 m-85 -63.32 -40.48 97.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.237 -0.915 . . . . 0.0 109.13 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -55.89 -44.0 77.77 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.466 -0.771 . . . . 0.0 108.94 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 59.7 mt-10 -56.87 -46.38 81.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.451 -0.781 . . . . 0.0 109.032 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.579 ' HB2' ' HD2' ' B' ' 14' ' ' LYS . . . -67.62 -51.66 47.48 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.322 -0.861 . . . . 0.0 109.281 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.598 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 19.8 t80 -45.12 -34.02 2.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.415 -0.803 . . . . 0.0 108.845 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.9 p -81.73 -32.58 31.51 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.627 -0.671 . . . . 0.0 109.215 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.748 ' O ' HD23 ' A' ' 18' ' ' LEU . 6.8 tt -49.74 -34.78 20.01 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.322 -0.862 . . . . 0.0 109.177 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.452 ' HA ' HG21 ' A' ' 35' ' ' VAL . 57.7 m-85 -82.61 -46.02 13.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.447 -0.783 . . . . 0.0 109.853 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 10.0 t70 -71.0 103.65 2.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 109.951 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -91.45 -31.21 16.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 110.454 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 29.9 p-10 -75.02 -46.59 34.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.299 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 108.94 45.65 1.01 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 49.1 p30 -115.73 -18.17 10.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -1.179 . . . . 0.0 110.009 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 91.69 5.42 66.69 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 16.7 p -120.14 116.24 25.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -1.141 . . . . 0.0 110.484 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.732 HD12 ' HB ' ' A' ' 63' ' ' ILE . 14.2 mt -90.84 124.33 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 109.877 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.414 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 7.8 p -100.3 178.36 4.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -63.12 -32.54 73.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.105 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 26.5 tptt -71.52 -54.4 10.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.273 -0.892 . . . . 0.0 110.308 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 41.3 mt-10 -49.41 -61.98 1.8 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 0.0 110.153 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.439 HD22 ' CZ2' ' B' ' 7' ' ' TRP . 35.5 tp -57.32 -31.5 65.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.97 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.409 ' HA2' HD11 ' A' ' 48' ' ' LEU . . . -67.03 -28.12 73.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.9 m -73.72 -52.08 14.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -1.101 . . . . 0.0 109.828 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.452 HG21 ' HA ' ' A' ' 19' ' ' PHE . 43.2 t -63.07 -35.37 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.947 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.5 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 4.1 mmt -66.26 -35.71 81.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.273 -0.892 . . . . 0.0 109.938 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.37 -24.4 60.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 110.117 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -76.15 -32.57 59.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.36 -0.837 . . . . 0.0 110.677 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 mt -53.81 -49.46 68.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.127 -0.983 . . . . 0.0 110.405 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 142.15 47.38 0.05 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 6.4 mm-40 -153.15 -167.4 2.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -1.127 . . . . 0.0 110.233 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -140.28 82.98 15.99 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.23 -0.919 . . . . 0.0 110.428 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 49.7 Cg_endo -76.79 148.63 28.76 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.978 1.515 . . . . 0.0 109.99 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.44 ' HB ' ' OE2' ' A' ' 47' ' ' GLU . 53.9 m -100.11 133.52 44.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.974 . . . . 0.0 110.227 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -42.34 -42.92 3.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.327 -0.858 . . . . 0.0 110.169 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' H ' HG22 ' A' ' 44' ' ' THR . . . -57.23 -54.4 47.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 109.742 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.44 ' OE2' ' HB ' ' A' ' 44' ' ' THR . 2.4 mt-10 -52.19 -38.02 56.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.369 -0.832 . . . . 0.0 109.681 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -56.7 -50.78 71.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.889 . . . . 0.0 109.724 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -50.77 -45.1 58.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.528 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.83 -23.58 66.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.439 -0.788 . . . . 0.0 109.537 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 2.2 mtp -86.92 -49.38 7.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 0.0 110.083 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 tp -57.47 -29.22 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.734 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -71.78 -5.29 33.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 110.474 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 51' ' ' MET . 2.4 mt-10 -86.95 -55.57 3.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 110.19 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 57' ' ' ALA . 38.9 t -70.25 -21.85 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 110.294 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.404 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 1.2 m-20 -66.89 64.01 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.185 -0.947 . . . . 0.0 110.389 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -51.5 -21.34 2.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.198 -0.939 . . . . 0.0 110.23 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.436 ' CG ' ' OD1' ' A' ' 60' ' ' ASN . 1.5 p30 -100.38 -32.44 10.83 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.34 -0.85 . . . . 0.0 110.418 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.71 52.82 2.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.436 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 5.7 m120 -99.25 -32.61 11.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.179 -1.189 . . . . 0.0 109.945 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.87 -14.3 12.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.4 p -139.66 165.14 28.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -1.07 . . . . 0.0 109.999 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.732 ' HB ' HD12 ' A' ' 27' ' ' ILE . 10.1 mm -96.83 165.89 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.319 -0.863 . . . . 0.0 110.102 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.541 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 35.2 m-20 -140.24 179.55 6.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.124 -0.985 . . . . 0.0 110.513 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.621 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 24.5 t80 -63.2 -44.27 83.15 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.33 -0.857 . . . . 0.0 111.52 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_endo -70.85 -36.04 8.51 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.359 1.189 . . . . 0.0 110.248 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 5.7 mt-10 -64.09 -29.32 70.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.393 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -50.77 23.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.0 mm? -50.52 -50.6 52.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 0.0 110.449 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.56 HG22 ' HG3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -60.79 -64.21 1.03 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.232 -0.917 . . . . 0.0 110.805 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' HB2' ' A' ' 75' ' ' LYS . 9.7 tpt -43.02 -62.27 1.07 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.042 -1.037 . . . . 0.0 110.696 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.555 ' HG3' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -39.16 -32.55 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.393 -0.817 . . . . 0.0 110.748 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.09 -48.26 3.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.164 -0.96 . . . . 0.0 110.474 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.56 ' HG3' HG22 ' A' ' 70' ' ' THR . 4.7 mtp180 -49.93 -67.39 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.256 -0.902 . . . . 0.0 110.438 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.75 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.375 -0.828 . . . . 0.0 110.42 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.207 0.527 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.52 -24.46 66.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.883 . . . . 0.0 109.678 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' HB3' ' CD1' ' B' ' 12' ' ' LEU . 9.2 mm-40 -67.7 -15.84 63.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.729 HG23 ' CE1' ' A' ' 141' ' ' PHE . 97.2 mt -70.68 -36.94 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.443 -0.785 . . . . 0.0 109.466 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 20.4 ttm-85 -59.71 -44.36 93.74 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.504 -0.747 . . . . 0.0 109.61 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.4 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 6.1 mm-40 -64.42 -51.6 62.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.286 -0.884 . . . . 0.0 109.609 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.826 ' HB2' HD22 ' B' ' 12' ' ' LEU . . . -60.39 -32.56 71.42 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.228 -0.92 . . . . 0.0 109.547 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.478 ' CE2' ' CG ' ' A' ' 138' ' ' TYR . 38.9 t80 -64.32 -43.12 95.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -29.04 70.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.834 . . . . 0.0 109.549 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.625 HG11 HG21 ' B' ' 13' ' ' VAL . 28.5 t -66.94 -51.94 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 0.0 110.209 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.706 ' CE1' HD23 ' A' ' 105' ' ' LEU . 11.8 m-85 -69.73 -29.71 67.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.199 -0.938 . . . . 0.0 110.013 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 94' ' ' LYS . 32.7 t0 -81.84 51.42 1.72 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 110.185 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -43.82 -30.37 0.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.214 -0.929 . . . . 0.0 110.259 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.95 -41.14 52.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.922 . . . . 0.0 110.119 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.98 -25.07 29.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.423 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 23.8 p-10 -51.03 -41.66 59.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -1.154 . . . . 0.0 110.328 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 119.02 60.13 0.27 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 1.9 m-85 -169.73 136.09 1.55 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.271 -1.135 . . . . 0.0 109.967 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 21.8 mt -112.49 106.47 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 110.58 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 102' ' ' ALA . 45.0 t -94.54 149.76 20.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.181 -0.95 . . . . 0.0 109.513 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.38 -27.25 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 0.0 109.827 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -71.95 -44.76 63.06 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 0.0 109.464 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' OE2' ' O ' ' A' ' 99' ' ' TYR . 21.6 mt-10 -60.94 -41.45 96.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 109.565 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.97 HD12 HD11 ' A' ' 125' ' ' ILE . 1.2 mt -58.34 -44.59 88.77 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.349 -0.844 . . . . 0.0 109.364 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.541 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.0 OUTLIER -58.26 -35.87 72.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.318 -0.864 . . . . 0.0 109.197 179.232 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.443 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 11.7 t-80 -55.72 -52.67 63.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.43 -0.794 . . . . 0.0 109.173 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.623 HG21 HG12 ' A' ' 91' ' ' VAL . 1.5 t -74.3 -35.51 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.537 -0.727 . . . . 0.0 109.227 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.596 ' HE1' ' HB2' ' A' ' 116' ' ' LEU . 10.8 ttm -49.73 -60.69 2.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.553 -0.717 . . . . 0.0 110.608 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.546 HG23 ' HE2' ' A' ' 115' ' ' LYS . 12.1 m -78.34 -17.45 56.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.314 -0.866 . . . . 0.0 110.68 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.537 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 17.7 m-20 -75.56 -14.78 60.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.002 . . . . 0.0 110.056 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' B' ' 14' ' ' LYS . 3.1 mt -101.21 -52.7 3.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.627 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.74 -18.97 0.18 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.87 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 35.8 tp10 -108.1 155.99 19.79 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.843 -1.387 . . . . 0.0 111.112 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.546 ' HE2' HG23 ' A' ' 110' ' ' THR . 2.2 mttm -131.25 64.36 1.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.611 -0.68 . . . . 0.0 109.521 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.596 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 1.8 mp -36.18 151.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.485 0.66 . . . . 0.0 111.126 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.563 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -61.87 -174.48 0.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.778 . . . . 0.0 110.152 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.87 -59.5 2.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.208 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.88 -42.75 37.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 109.605 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -61.61 -53.7 52.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.545 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 117' ' ' THR . 53.0 t -57.81 -41.11 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 109.921 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -61.63 -58.24 8.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.854 . . . . 0.0 109.845 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -54.81 -37.59 66.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.308 -0.87 . . . . 0.0 109.706 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.551 ' O ' ' CD2' ' B' ' 22' ' ' PHE . 9.4 ttt -52.42 -44.14 65.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.911 . . . . 0.0 109.515 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.97 HD11 HD12 ' A' ' 105' ' ' LEU . 38.7 mm -78.44 -53.08 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.066 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -44.11 -68.52 0.19 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.83 . . . . 0.0 110.636 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 126' ' ' ARG . 1.3 tp10 -39.02 -53.93 1.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.535 -0.728 . . . . 0.0 110.755 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.582 ' HB3' HG22 ' A' ' 136' ' ' VAL . . . -58.92 -34.88 72.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 110.382 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.456 ' OD2' ' N ' ' A' ' 135' ' ' GLN . 1.6 t0 -65.78 68.45 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.434 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -60.07 -42.36 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.27 -0.894 . . . . 0.0 109.908 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.6 -35.97 78.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.195 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.53 71.92 1.24 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.0 p30 -121.71 -25.29 5.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.308 -1.113 . . . . 0.0 110.089 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 129.6 -20.6 5.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.456 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 16.0 pt20 -154.6 170.23 22.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -1.154 . . . . 0.0 110.26 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 128' ' ' ALA . 46.5 t -79.49 164.44 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.252 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.427 ' N ' HG12 ' A' ' 136' ' ' VAL . 55.3 t30 -133.4 173.18 11.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.305 -0.872 . . . . 0.0 110.112 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.478 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -57.38 -68.22 0.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.261 -0.899 . . . . 0.0 110.26 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 143' ' ' GLN . 10.3 mm-40 -40.81 -53.26 2.9 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.447 -0.783 . . . . 0.0 110.023 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 141' ' ' PHE . 50.3 mt-10 -55.41 -57.86 10.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 109.505 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.729 ' CE1' HG23 ' A' ' 85' ' ' ILE . 3.7 t80 -43.62 -27.38 0.3 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.429 -0.794 . . . . 0.0 109.5 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 144' ' ' MET . 73.9 t -99.56 -64.39 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 139' ' ' GLU . 28.5 tp60 -43.07 -24.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.306 -0.871 . . . . 0.0 110.604 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 142' ' ' VAL . 1.8 tpt -84.31 -32.66 24.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 111.025 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.9 mtp -100.66 -11.42 20.01 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.017 -1.052 . . . . 0.0 111.947 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 146' ' ' THR . 9.0 t . . . . . 0 N--CA 1.497 1.884 0 O-C-N 120.705 -1.247 . . . . 0.0 111.175 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.893 HG23 ' HD2' ' B' ' 5' ' ' PRO . 22.1 mt . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.893 ' HD2' HG23 ' B' ' 4' ' ' ILE . 36.0 Cg_endo -59.38 114.61 2.11 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.303 1.159 . . . . 0.0 109.858 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.538 ' O ' ' N ' ' B' ' 8' ' ' THR . 13.5 t -78.34 90.07 4.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.573 -0.704 . . . . 0.0 112.303 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.481 ' O ' ' N ' ' B' ' 10' ' ' VAL . 8.7 m95 43.99 -86.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.59 -0.694 . . . . 0.0 112.229 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.75 HG21 ' HG2' ' A' ' 75' ' ' LYS . 63.1 p -38.57 -46.96 1.25 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.537 -0.727 . . . . 0.0 110.945 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 97.5 m -48.87 -36.9 18.09 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.242 -0.911 . . . . 0.0 109.276 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' B' ' 7' ' ' TRP . 60.5 t -73.05 -43.07 59.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 46.7 mt -70.94 -21.82 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 109.974 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.826 HD22 ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -72.53 -50.62 24.46 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.625 HG21 HG11 ' A' ' 91' ' ' VAL . 42.7 t -71.14 -39.01 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.124 -0.985 . . . . 0.0 110.446 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.714 ' HA ' HD13 ' A' ' 112' ' ' LEU . 2.7 tmtt? -59.64 -47.54 85.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.775 -1.203 . . . . 0.0 109.263 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 35.0 p -53.52 -48.85 68.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.451 -0.781 . . . . 0.0 109.228 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 10.6 ttm -54.82 -27.7 43.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.314 -0.866 . . . . 0.0 109.872 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.697 HD22 ' CD1' ' A' ' 112' ' ' LEU . 7.0 mp -79.71 49.51 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.249 -0.907 . . . . 0.0 110.574 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -96.6 -83.06 0.39 Allowed 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.331 -0.856 . . . . 0.0 109.769 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.466 ' O ' ' HD3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -140.44 -41.14 0.42 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.365 -0.835 . . . . 0.0 109.475 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' B' ' 21' ' ' SER . 2.4 ttt-85 -149.63 -41.53 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' B' ' 22' ' ' PHE . 26.8 t 29.73 -126.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.093 0.473 . . . . 0.0 111.32 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 124' ' ' MET . 1.5 m-85 61.99 57.74 2.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 110.519 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.468 ' C ' ' HD2' ' B' ' 25' ' ' PRO . . . -142.99 -165.01 10.46 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.721 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 39.0 p-10 -107.1 -2.83 0.11 Allowed Pre-proline 0 CA--C 1.569 1.697 0 O-C-N 121.28 -1.129 . . . . 0.0 112.974 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 48.0 Cg_endo -73.46 76.92 2.63 Favored 'Trans proline' 0 N--CA 1.485 0.971 0 O-C-N 122.304 0.634 . . . . 0.0 110.498 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.431 ' CE2' ' HG ' ' B' ' 12' ' ' LEU . 12.8 t80 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.228 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.222 0.534 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.7 mt -44.7 -50.02 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.226 -0.921 . . . . 0.0 110.296 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -49.84 -51.31 40.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 12' ' ' PHE . 9.5 tm-20 -51.58 -45.46 63.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 110.089 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CD1' ' OE1' ' A' ' 11' ' ' GLU . 18.8 m-30 -55.2 -44.42 75.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 110.014 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -53.68 -49.77 67.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.936 . . . . 0.0 109.803 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.47 -47.18 66.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 110.083 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -60.96 -46.55 90.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.813 . . . . 0.0 110.235 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.525 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 34.9 t80 -57.65 -45.36 85.62 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 110.041 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.0 t -70.18 -17.1 63.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.85 . . . . 0.0 110.0 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.923 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.0 tt -69.99 -55.42 9.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.976 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.46 ' N ' HD23 ' A' ' 18' ' ' LEU . 91.4 m-85 -72.43 -11.97 60.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 0.0 110.27 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 21' ' ' LYS . 25.4 t0 -97.5 69.54 2.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' ASP . 20.3 mmtt -42.47 -71.24 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.328 -0.858 . . . . 0.0 110.126 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 2.4 p-10 -51.95 -41.23 61.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.383 -0.823 . . . . 0.0 110.062 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.4 46.72 5.71 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.464 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 39.4 p-10 -103.23 6.79 38.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.202 . . . . 0.0 110.238 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.69 ' O ' HG23 ' A' ' 26' ' ' THR . . . 78.3 30.38 50.25 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 25' ' ' GLY . 10.0 p -158.12 104.09 1.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -1.139 . . . . 0.0 110.28 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.53 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 9.5 mt -80.6 125.52 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.227 -0.921 . . . . 0.0 109.8 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p -100.1 165.74 11.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.385 -0.822 . . . . 0.0 110.68 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.9 p -56.47 -41.69 76.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.851 . . . . 0.0 110.214 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -62.02 -53.16 59.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 110.248 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 15.1 mt-10 -52.02 -68.74 0.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 110.092 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.516 HD22 HD11 ' A' ' 52' ' ' ILE . 23.8 tp -49.58 -32.51 12.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.898 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.97 -53.94 36.95 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.0 m -48.12 -47.17 34.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -1.151 . . . . 0.0 109.686 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.444 ' H ' HG23 ' A' ' 35' ' ' VAL . 6.3 t -61.01 -51.49 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.352 -0.843 . . . . 0.0 109.739 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.466 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 5.2 mmt -57.88 -39.61 78.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.84 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -34.9 72.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 110.016 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 39' ' ' LEU . 1.4 m -68.07 -48.11 66.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.164 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 38' ' ' SER . 9.5 mt -44.21 -25.3 0.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.873 . . . . 0.0 110.261 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.81 50.64 0.68 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 36' ' ' MET . 0.3 OUTLIER -154.61 -163.31 1.56 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -1.127 . . . . 0.0 110.224 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -151.79 102.15 2.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.055 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.62 119.23 5.82 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.016 1.535 . . . . 0.0 110.524 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 47' ' ' GLU . 9.1 m -76.05 155.3 34.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.301 -0.874 . . . . 0.0 110.22 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -45.64 -69.64 0.13 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 110.026 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.06 -47.28 65.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.999 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' CG ' ' HB ' ' A' ' 44' ' ' THR . 13.0 mt-10 -46.35 -55.44 7.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.265 -0.897 . . . . 0.0 110.095 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.425 HD23 HD23 ' A' ' 32' ' ' LEU . 1.1 mt -53.78 -40.26 66.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.75 -34.7 77.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.974 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -41.15 97.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.838 . . . . 0.0 110.156 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.8 mtp -74.7 -41.27 60.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.316 -0.865 . . . . 0.0 110.251 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.516 HD11 HD22 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -71.15 -14.84 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.197 -0.939 . . . . 0.0 109.699 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.87 -18.63 36.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.288 -0.883 . . . . 0.0 110.187 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.86 -50.95 9.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.521 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 57' ' ' ALA . 10.7 t -72.95 -22.23 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.175 -0.953 . . . . 0.0 110.021 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.87 86.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.363 -0.835 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -80.31 -46.11 16.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.202 -0.936 . . . . 0.0 110.436 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 12.2 p-10 -75.94 -42.5 48.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.084 -1.01 . . . . 0.0 110.409 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.53 44.92 2.22 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 27.0 p-10 -99.48 -38.2 8.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -1.206 . . . . 0.0 110.383 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 128.78 0.95 6.02 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.4 p -145.85 161.77 39.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -1.127 . . . . 0.0 110.072 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' THR . 17.2 mm -86.69 152.21 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.185 -0.947 . . . . 0.0 110.518 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.525 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 29.6 m-20 -127.35 -173.15 2.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 110.542 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.763 ' CE1' HD11 ' A' ' 69' ' ' LEU . 5.0 t80 -74.39 -42.07 5.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.418 -0.801 . . . . 0.0 111.326 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -72.94 -24.57 17.41 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.274 1.144 . . . . 0.0 110.395 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 3.5 mt-10 -70.82 -32.43 69.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.394 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -77.41 -33.81 54.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.893 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.763 HD11 ' CE1' ' A' ' 65' ' ' PHE . 85.1 mt -72.75 -26.91 61.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.339 -0.851 . . . . 0.0 111.21 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 p -89.32 -34.77 16.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.902 -1.124 . . . . 0.0 111.227 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.419 ' HE1' HG23 ' B' ' 8' ' ' THR . 0.3 OUTLIER -74.59 -39.24 62.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.137 -0.977 . . . . 0.0 111.022 -179.272 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.844 ' SD ' HG21 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -63.87 -22.11 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.05 -1.031 . . . . 0.0 110.879 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -94.94 -9.72 33.24 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.928 -1.107 . . . . 0.0 110.882 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 27.0 tpt180 -82.36 -46.88 13.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.161 -0.962 . . . . 0.0 110.747 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.05 -39.3 34.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.468 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.61 -27.0 61.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.622 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.77 -26.19 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.404 ' HG2' ' OH ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -68.96 -29.1 67.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.39 0.614 . . . . 0.0 109.444 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.907 ' HB3' HG21 ' B' ' 9' ' ' THR . 24.7 mt-10 -76.57 -47.79 21.36 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.281 -0.887 . . . . 0.0 109.199 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.579 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -57.97 -33.88 69.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.083 -1.01 . . . . 0.0 108.86 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -66.76 -48.09 70.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.432 -0.792 . . . . 0.0 109.464 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -52.69 -30.89 34.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.387 -0.821 . . . . 0.0 109.573 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 63.7 t -67.72 -53.18 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.818 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.669 ' CB ' HD13 ' A' ' 100' ' ' ILE . 67.0 m-85 -63.02 -15.02 55.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.135 -0.978 . . . . 0.0 109.989 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -100.04 65.01 1.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 110.436 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -40.97 -72.05 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.383 -0.823 . . . . 0.0 110.486 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.1 p30 -61.03 -28.44 69.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.01 50.13 7.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -99.73 -7.27 25.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.294 -1.121 . . . . 0.0 110.357 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.7 29.58 8.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.417 ' CD1' ' CD ' ' A' ' 135' ' ' GLN . 0.9 OUTLIER -161.31 143.19 11.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -1.139 . . . . 0.0 110.081 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.669 HD13 ' CB ' ' A' ' 92' ' ' PHE . 17.3 mt -118.71 158.26 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.522 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 102' ' ' ALA . 23.2 p -148.07 155.76 41.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.387 -0.82 . . . . 0.0 109.927 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.1 -43.1 3.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.332 -0.855 . . . . 0.0 110.205 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.78 -51.09 68.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.839 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 92' ' ' PHE . 17.9 mt-10 -58.74 -47.75 83.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 0.0 109.959 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.0 HD12 ' CD1' ' A' ' 125' ' ' ILE . 2.1 mt -62.62 -33.92 75.99 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.271 -0.893 . . . . 0.0 109.696 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -61.63 -34.07 75.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.248 -0.908 . . . . 0.0 109.431 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 10.0 t-80 -68.26 -43.67 77.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.402 -0.812 . . . . 0.0 109.588 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.675 HG13 HD12 ' A' ' 112' ' ' LEU . 1.2 t -64.16 -34.42 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 109.896 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.991 ' HA ' HD21 ' B' ' 17' ' ' LEU . 4.8 mtt -53.63 -70.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.608 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.6 m -55.38 -16.78 3.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.898 . . . . 0.0 110.554 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 9.0 m120 -94.67 -6.49 43.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.103 -0.998 . . . . 0.0 110.392 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.923 ' O ' HD11 ' A' ' 18' ' ' LEU . 9.6 mt -132.06 6.95 4.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.037 -1.04 . . . . 0.0 111.686 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.3 -93.34 0.13 Allowed Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.404 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' CG ' ' N ' ' A' ' 115' ' ' LYS . 15.3 tt0 -136.53 166.07 24.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -1.076 . . . . 0.0 110.408 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -103.6 118.66 37.23 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.641 ' N ' HD12 ' A' ' 116' ' ' LEU . 9.3 mp -64.83 155.31 34.4 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 121.446 -0.784 . . . . 0.0 110.336 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.637 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -49.09 178.8 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.365 -0.835 . . . . 0.0 109.274 179.436 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.79 -57.23 4.24 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.89 -1.131 . . . . 0.0 110.263 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.97 -49.01 31.91 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.195 -0.94 . . . . 0.0 109.669 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -57.69 -60.51 3.58 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 108.978 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 117' ' ' THR . 79.1 t -47.32 -44.58 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.299 -0.876 . . . . 0.0 109.416 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -50.53 71.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.292 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.569 ' HB3' ' HG3' ' B' ' 20' ' ' ARG . 0.2 OUTLIER -57.83 -31.24 66.44 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.183 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.571 ' SD ' HD13 ' A' ' 105' ' ' LEU . 9.3 ttt -60.1 -43.85 95.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.475 -0.766 . . . . 0.0 109.294 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.0 ' CD1' HD12 ' A' ' 105' ' ' LEU . 37.6 mm -84.87 -27.12 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.923 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -45.06 78.47 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.315 -0.866 . . . . 0.0 110.314 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.08 -36.18 82.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.339 -0.851 . . . . 0.0 110.165 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.23 -32.45 58.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.381 -0.824 . . . . 0.0 110.124 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 0.7 OUTLIER -73.04 63.65 0.68 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.75 -58.85 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.524 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 1.7 p30 -55.07 -36.13 65.27 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.582 -0.698 . . . . 0.0 109.784 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 98.48 69.17 0.93 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 131' ' ' ASP . 3.2 m-20 -121.89 -4.59 9.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -1.192 . . . . 0.0 110.133 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.55 -9.88 63.56 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 2.8 pt20 -142.97 168.02 20.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -1.147 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 140' ' ' GLU . 5.2 t -112.82 155.76 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.203 -0.936 . . . . 0.0 110.243 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.431 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 17.6 p-10 -125.79 -144.81 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.335 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.404 ' OH ' ' HG2' ' A' ' 86' ' ' ARG . 1.1 t80 -80.15 -70.08 0.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.277 -0.89 . . . . 0.0 110.547 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 143' ' ' GLN . 26.4 mt-10 -43.03 -38.43 2.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.201 -0.937 . . . . 0.0 110.429 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.536 ' HB3' HG13 ' A' ' 136' ' ' VAL . 32.8 mt-10 -68.54 -62.26 1.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.271 -0.893 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -51.93 -22.1 3.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.3 -0.875 . . . . 0.0 110.645 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.56 -52.56 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.102 -0.999 . . . . 0.0 110.838 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.466 ' CB ' ' O ' ' A' ' 139' ' ' GLU . 4.5 tp60 -57.84 -13.03 3.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.267 -0.895 . . . . 0.0 110.832 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.8 mmm -99.34 -18.21 17.64 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.001 -1.062 . . . . 0.0 110.765 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.0 mtp -100.49 -69.25 0.78 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.041 -1.037 . . . . 0.0 110.836 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.942 . . . . 0.0 110.373 -179.599 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 120.687 0.279 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.73 -176.45 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.081 1.569 . . . . 0.0 110.928 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.427 ' OG ' ' OE2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -106.4 178.65 4.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.329 -0.857 . . . . 0.0 110.501 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.52 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -54.11 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.415 -0.803 . . . . 0.0 110.911 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.478 ' HA ' HD12 ' B' ' 11' ' ' ILE . 55.9 p -44.82 -50.58 10.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 110.151 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.907 HG21 ' HB3' ' A' ' 87' ' ' GLU . 37.9 m -44.01 -50.37 8.34 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.444 -0.785 . . . . 0.0 109.633 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 24.9 t -57.22 -34.83 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.191 -0.943 . . . . 0.0 109.233 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.844 HG21 ' SD ' ' A' ' 72' ' ' MET . 18.4 mt -74.08 -30.49 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 108.722 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -58.38 8.62 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.543 -0.723 . . . . 0.0 109.378 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.609 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 81.0 t -59.12 -51.19 75.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.554 -0.716 . . . . 0.0 110.373 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.448 ' HG3' HD13 ' A' ' 18' ' ' LEU . 2.4 tmtm? -51.6 -58.57 5.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.025 -1.047 . . . . 0.0 109.878 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -51.15 -25.95 6.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.403 -0.811 . . . . 0.0 110.194 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.49 ' O ' ' HB2' ' B' ' 21' ' ' SER . 6.3 tpp -70.88 -32.78 69.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.991 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.9 mp -64.68 -102.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.965 -1.084 . . . . 0.0 109.838 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.567 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 55.32 -72.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.505 -0.747 . . . . 0.0 110.85 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.636 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -173.43 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.321 -0.862 . . . . 0.0 110.952 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.569 ' HG3' ' HB3' ' A' ' 123' ' ' GLU . 7.0 tmm_? 73.97 -7.1 1.69 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.892 -1.13 . . . . 0.0 110.297 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' B' ' 16' ' ' MET . 36.0 m -46.79 116.09 1.24 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.045 -1.034 . . . . 0.0 109.779 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -148.51 -32.84 0.24 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.174 -0.954 . . . . 0.0 111.282 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' B' ' 22' ' ' PHE . . . -54.81 -111.41 0.01 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.609 ' ND2' ' OXT' ' B' ' 26' ' ' PHE . 8.2 t-20 -116.42 96.23 47.4 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.24 -1.153 . . . . 0.0 110.242 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.5 -18.45 20.08 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.099 1.579 . . . . 0.0 110.337 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.609 ' OXT' ' ND2' ' B' ' 24' ' ' ASN . 46.0 m-85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.285 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.6 mt -53.63 -38.4 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.3 -0.875 . . . . 0.0 108.751 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -52.03 -46.95 65.22 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.284 -0.885 . . . . 0.0 108.806 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.475 ' CD ' ' HD2' ' B' ' 18' ' ' ARG . 6.0 tt0 -53.69 -53.9 45.47 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.217 -0.927 . . . . 0.0 108.819 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -55.57 -40.27 71.75 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.373 -0.829 . . . . 0.0 108.856 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -59.43 -40.38 86.55 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 17' ' ' SER . 8.3 tt0 -49.61 -55.12 14.72 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.453 -0.78 . . . . 0.0 108.95 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.05 -55.99 24.82 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.506 -0.878 . . . . 0.0 108.76 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.547 ' HD1' HD11 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -49.1 -26.85 2.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 3.2 m -87.85 -36.33 17.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.541 -0.724 . . . . 0.0 109.113 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.763 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.8 tt -47.98 -34.61 9.55 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.389 -0.819 . . . . 0.0 109.376 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.751 ' HA ' HG21 ' A' ' 35' ' ' VAL . 73.4 m-85 -81.8 -28.66 33.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.824 . . . . 0.0 109.986 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 5.0 t0 -87.36 81.54 7.84 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.213 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -52.56 -56.97 11.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 110.374 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.42 ' OD1' ' CG ' ' A' ' 24' ' ' ASP . 3.0 p30 -59.16 -41.17 87.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 110.373 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.86 57.6 1.7 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 35.5 p-10 -114.33 10.4 17.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.231 -1.158 . . . . 0.0 110.293 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.97 15.18 73.96 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 1.2 p -141.72 116.6 9.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -1.225 . . . . 0.0 110.275 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.547 HD11 ' HD1' ' A' ' 16' ' ' PHE . 13.4 mt -92.27 112.92 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.149 -0.97 . . . . 0.0 109.738 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.482 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 18.8 p -75.95 -160.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.915 . . . . 0.0 110.354 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.408 ' O ' HD22 ' A' ' 48' ' ' LEU . 22.0 p -88.82 -45.4 9.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 110.543 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.549 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 21.5 pttt -71.63 -25.87 62.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.026 -1.046 . . . . 0.0 110.574 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.797 ' O ' HG23 ' A' ' 35' ' ' VAL . 47.2 mt-10 -63.15 -44.67 94.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.031 -1.043 . . . . 0.0 109.491 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 48' ' ' LEU . 2.9 tp -67.35 -48.18 68.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.332 -0.855 . . . . 0.0 109.649 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.81 -44.96 49.36 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.8 m -61.17 -57.15 13.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.353 -1.086 . . . . 0.0 109.736 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 31' ' ' GLU . 21.4 t -50.42 -40.46 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.213 -0.929 . . . . 0.0 109.655 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 4.7 mmt -60.82 -47.57 85.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.268 -0.895 . . . . 0.0 109.412 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.456 ' NE ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -47.79 -38.23 15.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.395 179.224 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -63.04 -45.27 93.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.564 -0.71 . . . . 0.0 110.705 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 3.1 mt -57.88 -34.47 69.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.165 -0.959 . . . . 0.0 110.455 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.37 63.65 0.32 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.456 ' O ' ' NE ' ' A' ' 37' ' ' ARG . 1.9 pt20 -160.75 -175.66 5.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.309 -1.112 . . . . 0.0 109.922 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -131.12 95.08 25.94 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.068 -1.02 . . . . 0.0 110.624 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HG3' ' HB2' ' A' ' 36' ' ' MET . 47.2 Cg_endo -75.34 123.49 7.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.041 1.548 . . . . 0.0 110.177 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.421 ' HB ' ' HG3' ' A' ' 47' ' ' GLU . 17.4 m -94.98 168.5 10.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' N ' HG22 ' A' ' 44' ' ' THR . 37.9 tt0 -57.44 -56.45 21.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.121 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.37 -55.26 16.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 0.0 110.258 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' A' ' 44' ' ' THR . 2.6 mm-40 -51.23 -52.86 40.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 110.006 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 32' ' ' LEU . 9.0 mt -46.61 -64.28 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.81 -34.81 63.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.419 -0.801 . . . . 0.0 110.075 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.55 -33.91 69.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 110.285 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.517 ' O ' ' NE1' ' B' ' 7' ' ' TRP . 9.8 mtp -81.17 -34.59 32.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -0.85 . . . . 0.0 110.023 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 10.9 mm -74.53 -36.62 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -0.867 . . . . 0.0 109.76 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -68.04 -20.39 64.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.394 -0.816 . . . . 0.0 110.135 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.04 -42.67 66.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 110.383 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 57' ' ' ALA . 8.7 t -83.8 -51.04 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -41.76 90.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.651 . . . . 0.0 110.428 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -83.36 -36.43 24.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.462 -0.774 . . . . 0.0 110.747 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' OD2' ' CG ' ' A' ' 60' ' ' ASN . 6.5 p-10 -72.17 -48.26 44.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.032 -1.042 . . . . 0.0 110.535 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.89 35.94 1.09 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 29.2 p-10 -98.56 -46.02 5.88 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.016 -1.285 . . . . 0.0 110.314 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 118.43 13.69 6.75 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.5 p -144.4 141.44 29.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.16 -1.2 . . . . 0.0 110.538 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.546 ' HB ' HD12 ' A' ' 27' ' ' ILE . 35.4 mm -85.21 142.25 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.219 -0.925 . . . . 0.0 109.902 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -121.81 -175.66 3.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.075 -1.015 . . . . 0.0 110.593 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.6 t80 -65.97 -45.99 63.96 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.416 -0.802 . . . . 0.0 111.54 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.2 Cg_endo -68.62 -38.86 10.01 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 O-C-N 123.092 1.048 . . . . 0.0 110.395 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.61 -30.46 69.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.112 -0.992 . . . . 0.0 109.274 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CG ' ' HB2' ' A' ' 16' ' ' PHE . 4.1 t80 -69.92 -46.02 66.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.54 -0.725 . . . . 0.0 109.902 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.0 mm? -53.78 -53.05 57.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.353 -0.842 . . . . 0.0 110.303 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 71' ' ' MET . 1.5 p -66.04 -63.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.269 -0.895 . . . . 0.0 110.708 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.46 ' HG3' HG13 ' A' ' 55' ' ' VAL . 6.8 tmm? -40.51 -36.87 0.62 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.848 ' SD ' HG21 ' B' ' 11' ' ' ILE . 7.0 tpt -61.76 -12.1 15.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.224 -0.922 . . . . 0.0 110.702 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.02 -10.01 4.82 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.04 -1.037 . . . . 0.0 111.223 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -24.61 15.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.998 -1.064 . . . . 0.0 110.363 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.653 ' HB3' HG21 ' B' ' 8' ' ' THR . 2.1 tppm? . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 0.0 110.414 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.217 0.532 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 3.6 tt0 -55.29 -43.47 74.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.069 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' HG3' HD12 ' B' ' 12' ' ' LEU . 19.3 tp10 -45.79 -50.21 14.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.345 -0.847 . . . . 0.0 110.495 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -70.76 -38.53 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.109 -0.994 . . . . 0.0 109.397 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 31.5 ttt180 -58.84 -30.64 67.84 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.367 -0.833 . . . . 0.0 109.916 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.615 ' HB3' HG21 ' B' ' 9' ' ' THR . 76.9 mm-40 -74.07 -55.33 6.24 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.273 -0.892 . . . . 0.0 109.665 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.42 -29.69 49.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 0.0 109.149 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -71.89 -34.5 69.2 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.159 -0.963 . . . . 0.0 109.083 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -63.84 -27.32 69.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.445 -0.784 . . . . 0.0 109.197 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.422 HG12 HG21 ' A' ' 108' ' ' VAL . 17.1 t -75.31 -43.98 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.517 -0.739 . . . . 0.0 110.151 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.519 ' CZ ' HG22 ' B' ' 13' ' ' VAL . 24.1 m-85 -67.01 -35.92 80.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.157 -0.965 . . . . 0.0 110.338 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -73.29 54.66 0.43 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.326 -0.859 . . . . 0.0 110.502 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 93' ' ' ASP . 13.4 tppt? -41.65 -46.63 3.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.0 110.288 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 21.4 p-10 -87.97 -26.78 22.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.56 47.55 12.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 31.6 p-10 -94.41 -22.35 18.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -1.121 . . . . 0.0 110.099 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.482 ' C ' ' CD2' ' A' ' 99' ' ' TYR . . . 110.76 15.23 11.23 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD2' ' C ' ' A' ' 98' ' ' GLY . 91.2 m-85 -150.72 137.73 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.307 -1.113 . . . . 0.0 110.181 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' GLN . 7.1 mt -101.71 150.74 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.13 -0.981 . . . . 0.0 110.14 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -138.48 146.78 42.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.151 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -44.88 -29.08 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.93 . . . . 0.0 109.843 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.75 79.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -0.843 . . . . 0.0 109.664 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.412 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 7.6 mt-10 -61.85 -45.03 95.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.494 ' CD1' HD11 ' A' ' 125' ' ' ILE . 1.5 mt -66.1 -38.09 87.37 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.354 -0.841 . . . . 0.0 109.267 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.493 ' NH2' ' HG2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -55.62 -35.83 66.3 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.406 -0.809 . . . . 0.0 109.084 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -71.03 -47.6 57.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.5 -0.75 . . . . 0.0 109.363 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG21 HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -60.5 -23.51 28.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.381 -0.824 . . . . 0.0 109.024 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.948 ' HA ' HD21 ' B' ' 17' ' ' LEU . 5.1 mtt -69.28 -63.51 1.05 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.503 -0.748 . . . . 0.0 109.812 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.3 m -56.94 -30.37 63.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.191 -0.943 . . . . 0.0 109.236 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 12.5 m120 -74.77 -17.79 60.58 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.459 -0.776 . . . . 0.0 109.671 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.875 HD11 HG12 ' B' ' 13' ' ' VAL . 3.9 mt -95.41 -48.08 6.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.858 . . . . 0.0 110.212 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.09 -30.12 0.22 Allowed Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.529 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 109' ' ' MET . 29.4 tt0 -125.05 171.22 10.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.873 -1.369 . . . . 0.0 110.941 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -144.98 75.7 1.46 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.798 HD21 ' CA ' ' B' ' 19' ' ' LYS . 2.4 mp -34.79 156.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.641 0.734 . . . . 0.0 111.494 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -57.1 -150.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.0 110.387 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.517 ' H ' HG22 ' A' ' 117' ' ' THR . 1.4 p-10 -109.76 -53.89 2.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.236 -0.915 . . . . 0.0 110.38 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.35 -44.46 84.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.019 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.93 -42.13 97.44 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.829 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.42 HG23 ' HB3' ' A' ' 116' ' ' LEU . 71.8 t -64.62 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.947 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -60.28 -45.19 94.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -61.47 -38.07 85.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 109.582 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -54.06 -49.25 69.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.162 -0.961 . . . . 0.0 109.681 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' CD1' ' A' ' 105' ' ' LEU . 37.5 mm -70.16 -26.48 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -70.14 -26.51 63.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.902 . . . . 0.0 109.917 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -71.46 -44.5 64.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.867 . . . . 0.0 110.064 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.853 ' HB2' ' HD2' ' B' ' 22' ' ' PHE . . . -71.44 -33.41 69.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.381 -0.824 . . . . 0.0 110.049 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -60.44 75.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.33 -0.857 . . . . 0.0 110.4 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 128' ' ' ALA . 21.5 mt -72.16 -31.34 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.968 . . . . 0.0 110.232 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 34.8 p-10 -83.94 -27.13 28.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.148 -0.97 . . . . 0.0 110.275 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.94 71.17 1.24 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 4.0 p30 -126.57 -23.37 3.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.244 -1.151 . . . . 0.0 110.468 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 104.63 -0.78 42.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 4.8 pt20 -151.18 166.67 30.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 110.204 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 53.3 t -110.68 151.77 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -131.95 -164.92 1.51 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.143 -0.973 . . . . 0.0 110.397 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.752 ' CE1' HG21 ' A' ' 142' ' ' VAL . 9.2 t80 -62.13 -65.82 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.229 -0.919 . . . . 0.0 110.72 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -41.87 -50.02 4.46 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.216 -0.927 . . . . 0.0 110.677 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -63.96 -59.99 3.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.965 . . . . 0.0 110.394 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.423 ' CE1' ' HE2' ' A' ' 92' ' ' PHE . 50.1 t80 -51.75 -20.57 2.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 110.523 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.752 HG21 ' CE1' ' A' ' 138' ' ' TYR . 41.6 t -100.51 -60.28 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.179 -0.951 . . . . 0.0 110.791 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 142' ' ' VAL . 9.5 tt0 -40.36 -45.82 2.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.31 -0.869 . . . . 0.0 110.762 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.445 ' O ' ' OD1' ' B' ' 24' ' ' ASN . 3.7 mmt -66.59 -26.8 67.28 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 110.419 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.485 ' N ' ' O ' ' A' ' 142' ' ' VAL . 19.9 mmm -96.07 -45.99 6.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.079 -1.013 . . . . 0.0 110.937 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.467 HG21 HG13 ' A' ' 142' ' ' VAL . 34.5 p . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.116 -0.99 . . . . 0.0 110.984 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.672 HG23 ' HD2' ' B' ' 5' ' ' PRO . 35.1 mm . . . . . 0 N--CA 1.506 2.329 0 CA-C-O 120.667 0.27 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.672 ' HD2' HG23 ' B' ' 4' ' ' ILE . 42.3 Cg_endo -69.1 -157.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.936 1.493 . . . . 0.0 111.035 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' B' ' 7' ' ' TRP . 55.7 p -132.67 57.81 1.78 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.062 -1.024 . . . . 0.0 111.449 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.517 ' NE1' ' O ' ' A' ' 51' ' ' MET . 0.7 OUTLIER 64.27 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.972 -1.08 . . . . 0.0 111.575 178.583 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -46.33 -46.91 18.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 110.393 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 87' ' ' GLU . 26.0 m -45.83 -40.24 9.55 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.151 -0.968 . . . . 0.0 109.483 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.442 HG12 ' HZ ' ' A' ' 19' ' ' PHE . 10.2 t -66.03 -44.04 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.528 -0.733 . . . . 0.0 110.061 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.848 HG21 ' SD ' ' A' ' 72' ' ' MET . 51.7 mt -69.39 -25.29 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.288 -0.883 . . . . 0.0 109.907 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.532 ' C ' HD23 ' B' ' 12' ' ' LEU . 4.8 tt -67.08 -49.57 64.61 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 110.34 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.875 HG12 HD11 ' A' ' 112' ' ' LEU . 47.9 t -65.13 -46.96 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 110.561 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.649 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -58.61 -33.71 70.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.842 -1.161 . . . . 0.0 109.688 179.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 0.1 OUTLIER -63.95 -43.89 94.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.409 ' O ' ' N ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -59.18 -32.43 69.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.0 110.114 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.948 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.4 mp -69.4 58.65 0.12 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.161 -0.962 . . . . 0.0 110.345 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' B' ' 20' ' ' ARG . 3.0 ttp180 -123.84 76.22 1.42 Allowed 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.891 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.798 ' CA ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER 62.74 -57.77 0.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.605 -0.684 . . . . 0.0 111.042 179.071 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' B' ' 18' ' ' ARG . 0.7 OUTLIER -166.9 22.61 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.24 -0.913 . . . . 0.0 110.38 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' B' ' 18' ' ' ARG . 66.2 m -74.8 126.55 31.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.188 -0.945 . . . . 0.0 110.363 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.853 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -145.11 -40.64 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.118 -0.989 . . . . 0.0 110.913 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' B' ' 22' ' ' PHE . . . -46.37 -99.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 145' ' ' MET . 80.5 m-20 -138.3 88.11 15.23 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.144 -1.209 . . . . 0.0 110.719 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.63 -12.28 18.43 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.847 1.446 . . . . 0.0 110.036 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.642 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 5.5 m-30 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.269 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.554 ' CG ' ' N ' ' A' ' 9' ' ' ILE . 12.8 pt20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.099 0.476 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.554 ' N ' ' CG ' ' A' ' 8' ' ' GLN . 83.8 mt -67.02 -50.43 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.023 -1.048 . . . . 0.0 109.375 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.47 64.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 109.303 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 37.8 tt0 -58.84 -52.95 63.54 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.401 -0.812 . . . . 0.0 109.478 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.567 ' CE2' ' HG3' ' A' ' 72' ' ' MET . 1.6 m-85 -53.23 -43.67 67.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.349 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -59.53 -41.69 90.57 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.765 . . . . 0.0 109.525 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -49.52 77.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.311 -0.868 . . . . 0.0 109.487 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.84 83.94 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.351 -0.843 . . . . 0.0 109.355 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.509 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 38.8 t80 -61.29 -21.68 64.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.501 -0.749 . . . . 0.0 109.575 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -89.64 -31.39 17.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.451 -0.781 . . . . 0.0 109.694 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.924 HD13 ' HG3' ' B' ' 14' ' ' LYS . 10.4 tt -61.33 -44.72 96.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.866 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 74.8 m-85 -74.27 -47.38 35.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 110.193 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -67.18 73.0 0.11 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 19' ' ' PHE . 9.3 mmtt -64.89 -8.99 17.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 110.389 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -93.83 -29.55 15.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.351 -0.843 . . . . 0.0 110.167 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.11 33.61 44.51 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 23.5 p30 -104.81 -15.56 15.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.19 -1.182 . . . . 0.0 110.176 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 26' ' ' THR . . . 93.61 31.0 8.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 25' ' ' GLY . 24.7 p -156.02 118.3 4.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -1.155 . . . . 0.0 110.29 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.656 HD12 ' CG2' ' A' ' 63' ' ' ILE . 7.3 mt -92.9 125.74 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.014 -1.054 . . . . 0.0 110.093 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.1 p -100.5 -175.65 2.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.501 -0.749 . . . . 0.0 109.462 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.649 ' O ' HD22 ' A' ' 48' ' ' LEU . 2.9 p -76.13 -22.54 55.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.007 . . . . 0.0 109.822 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -73.03 -46.21 53.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 110.234 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.42 -62.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.473 ' HG ' ' HE3' ' A' ' 36' ' ' MET . 34.5 tp -54.88 -30.15 57.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.013 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.655 ' CA ' HD21 ' A' ' 48' ' ' LEU . . . -68.67 -32.33 74.38 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.1 m -71.88 -59.8 2.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -1.129 . . . . 0.0 110.16 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 35' ' ' VAL . 25.7 t -50.79 -46.34 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.955 . . . . 0.0 110.167 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.594 ' HE1' ' SD ' ' A' ' 51' ' ' MET . 0.3 OUTLIER -58.77 -47.59 84.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.259 -0.901 . . . . 0.0 110.098 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -24.95 58.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.883 . . . . 0.0 110.124 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.402 ' O ' ' CG ' ' A' ' 111' ' ' ASN . 36.3 t -77.98 -34.27 51.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.881 . . . . 0.0 110.513 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.58 HD12 ' HA ' ' A' ' 36' ' ' MET . 3.5 mt -53.97 -42.85 69.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.186 -0.946 . . . . 0.0 110.276 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.49 51.21 0.06 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.98 -162.13 1.49 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -1.127 . . . . 0.0 110.225 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.54 70.92 14.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.82 118.71 5.84 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.913 1.48 . . . . 0.0 110.243 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 3.1 m -82.02 152.62 26.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.888 . . . . 0.0 110.42 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -48.65 -53.74 17.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.41 -42.19 66.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.827 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 44' ' ' THR . 4.2 mm-40 -59.5 -52.11 66.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.861 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.655 HD21 ' CA ' ' A' ' 33' ' ' GLY . 1.7 mt -44.29 -57.21 3.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.903 . . . . 0.0 109.946 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.69 -45.47 28.43 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 109.597 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.04 -39.42 78.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.484 -0.76 . . . . 0.0 109.668 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.594 ' SD ' ' HE1' ' A' ' 36' ' ' MET . 1.6 ttp -74.96 -51.03 14.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 109.64 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 52' ' ' ILE . 1.9 mm -47.95 -24.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.226 -0.921 . . . . 0.0 109.221 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.22 -14.78 59.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 110.204 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -79.59 -8.42 59.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.253 -0.905 . . . . 0.0 110.428 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.695 HG23 ' CD1' ' B' ' 7' ' ' TRP . 54.9 t -118.34 -53.86 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.062 -1.024 . . . . 0.0 110.675 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -19.27 82.6 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.459 0.647 . . . . 0.0 112.014 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.77 -60.88 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.455 -0.778 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 13.6 p30 -68.32 -21.61 64.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.9 . . . . 0.0 109.988 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 72.11 48.0 28.05 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -97.18 -44.96 6.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.171 -1.194 . . . . 0.0 110.181 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . 139.32 -2.11 2.52 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.392 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 166.33 30.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.833 -1.392 . . . . 0.0 110.759 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.656 ' CG2' HD12 ' A' ' 27' ' ' ILE . 10.5 mm -101.68 122.38 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.459 -0.775 . . . . 0.0 110.037 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 p30 -110.03 -179.64 3.85 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.021 -1.049 . . . . 0.0 110.754 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.661 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 t80 -63.31 -39.55 51.13 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.287 -0.883 . . . . 0.0 112.121 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.7 Cg_endo -69.47 -29.82 24.61 Favored 'Trans proline' 0 C--N 1.32 -0.952 0 O-C-N 123.078 1.041 . . . . 0.0 109.973 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 71' ' ' MET . 23.8 mt-10 -75.2 -30.66 60.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 109.309 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.735 ' HZ ' HD12 ' B' ' 11' ' ' ILE . 10.5 t80 -66.96 -42.64 84.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.471 -0.768 . . . . 0.0 109.762 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.644 HD11 ' CE1' ' A' ' 65' ' ' PHE . 4.7 mt -70.11 -32.06 69.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.83 . . . . 0.0 110.326 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -87.73 -43.25 12.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.954 . . . . 0.0 110.557 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -59.78 -32.92 71.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.118 -0.989 . . . . 0.0 110.263 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.567 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -69.13 -11.95 61.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.882 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.77 -35.27 5.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.385 -0.822 . . . . 0.0 110.051 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -68.42 -41.14 80.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 110.135 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.1 tptt . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.82 . . . . 0.0 110.145 179.926 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.317 0.579 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 1.8 mm-40 -66.85 -9.88 42.28 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 0.0 109.929 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.4 -30.28 57.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.261 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.773 ' CD1' HG21 ' A' ' 146' ' ' THR . 75.1 mt -75.82 -32.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -36.82 84.09 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.438 -0.789 . . . . 0.0 109.623 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.763 ' HB3' HG21 ' B' ' 9' ' ' THR . 5.7 mm-40 -69.32 -45.58 69.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.82 ' HB2' HD11 ' B' ' 12' ' ' LEU . . . -60.62 -34.77 74.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.143 -0.973 . . . . 0.0 110.066 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 29.5 t80 -68.44 -40.93 80.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 109.653 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -60.85 -29.7 69.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.343 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.548 HG12 HG21 ' A' ' 108' ' ' VAL . 65.6 t -72.79 -55.06 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.006 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.679 ' HB3' HD13 ' A' ' 100' ' ' ILE . 37.5 m-85 -53.62 -29.87 40.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.258 -0.901 . . . . 0.0 109.975 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -100.44 67.14 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.459 -0.776 . . . . 0.0 110.101 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -41.36 -25.95 0.05 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.399 -0.813 . . . . 0.0 110.415 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.5 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 15.7 p-10 -102.09 -41.69 6.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 109.961 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.22 49.86 5.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 42.0 p-10 -92.18 -23.55 19.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 124.95 26.33 1.39 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.724 ' CZ ' ' ND2' ' A' ' 137' ' ' ASN . 1.1 m-85 -170.52 158.22 6.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.974 -1.309 . . . . 0.0 110.617 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.679 HD13 ' HB3' ' A' ' 92' ' ' PHE . 10.0 mt -126.97 120.19 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.271 -0.893 . . . . 0.0 110.28 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -101.38 145.91 28.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -0.988 . . . . 0.0 109.802 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.84 -31.89 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 109.726 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.1 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.343 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 101' ' ' SER . 7.4 mt-10 -60.49 -48.6 81.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.442 -0.786 . . . . 0.0 109.367 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.865 HD11 ' HZ ' ' B' ' 22' ' ' PHE . 0.3 OUTLIER -59.04 -41.95 89.06 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.298 -0.876 . . . . 0.0 108.912 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.433 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 18.7 ttp180 -51.62 -36.7 46.91 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -60.11 -56.08 26.06 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.548 HG21 HG12 ' A' ' 91' ' ' VAL . 2.5 t -59.78 -34.73 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.333 -0.855 . . . . 0.0 108.792 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.873 ' HA ' HD21 ' B' ' 17' ' ' LEU . 3.7 mtt -57.35 -69.42 0.16 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.652 -0.655 . . . . 0.0 110.829 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.536 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 93.7 m -55.57 -21.68 18.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.062 -1.024 . . . . 0.0 109.876 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 38' ' ' SER . 57.1 m-20 -84.34 -10.32 57.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.169 -0.957 . . . . 0.0 109.801 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.914 HD11 HG12 ' B' ' 13' ' ' VAL . 6.8 mt -108.94 -40.37 5.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.304 -0.872 . . . . 0.0 110.549 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 167.12 -64.71 0.2 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.355 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.415 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 1.2 tp10 -107.93 171.45 7.39 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.201 -1.176 . . . . 0.0 110.841 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 1.3 mptp? -130.29 5.38 4.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 0.0 110.698 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.683 HD21 ' HA ' ' B' ' 19' ' ' LYS . 1.4 mp 57.08 152.91 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.073 0 O-C-N 121.599 -0.688 . . . . 0.0 110.469 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.585 HG22 ' H ' ' A' ' 118' ' ' ASP . 1.2 m -60.72 -151.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.02 -1.05 . . . . 0.0 109.478 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.585 ' H ' HG22 ' A' ' 117' ' ' THR . 6.7 p-10 -113.38 -33.4 5.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 110.173 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -71.21 -45.2 63.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 109.97 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 124' ' ' MET . 12.6 pt-20 -68.71 -35.79 77.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.627 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.574 HG23 ' HB3' ' A' ' 116' ' ' LEU . 23.3 t -63.14 -37.3 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.871 . . . . 0.0 109.575 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.19 -47.8 40.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 1.2 tp10 -67.22 -30.91 70.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.359 -0.838 . . . . 0.0 109.268 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.567 ' CG ' ' HA ' ' B' ' 21' ' ' SER . 1.5 ttt -61.18 -46.32 90.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.496 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.669 HD11 ' CD1' ' A' ' 105' ' ' LEU . 22.0 mm -70.79 -56.62 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 0.0 109.821 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 127' ' ' GLU . 7.5 mtp85 -53.93 -62.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.377 -0.827 . . . . 0.0 110.014 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 8.7 tp10 -42.07 -28.13 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.403 -0.811 . . . . 0.0 110.191 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.503 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -90.98 -34.45 15.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.902 . . . . 0.0 110.026 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 20.1 m-20 -57.75 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.38 -0.825 . . . . 0.0 110.587 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -52.04 -34.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.954 . . . . 0.0 109.618 179.642 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 47.5 p-10 -94.48 -16.91 22.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 110.108 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 61.37 79.07 0.14 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 8.8 p30 -123.33 5.39 9.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -1.15 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.14 15.44 66.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.563 ' HG3' ' CE1' ' A' ' 99' ' ' TYR . 9.6 pt20 -169.74 169.41 8.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -1.155 . . . . 0.0 109.99 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 9.8 t -116.63 159.16 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.119 -0.988 . . . . 0.0 110.418 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.724 ' ND2' ' CZ ' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -123.56 -167.18 1.58 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.369 -0.832 . . . . 0.0 110.014 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.516 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 1.7 t80 -74.73 -64.32 1.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.184 -0.948 . . . . 0.0 109.993 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -44.36 -48.5 9.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.913 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 144' ' ' MET . 3.4 tt0 -55.58 -56.19 23.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.34 -0.85 . . . . 0.0 110.229 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -51.87 -19.71 1.88 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.4 t -96.46 -70.32 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.062 -1.024 . . . . 0.0 110.883 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -45.36 -48.59 13.34 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.1 -1.0 . . . . 0.0 110.794 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.588 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 11.8 tpt -72.26 -10.38 59.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.722 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.1 tpp -100.69 -47.83 4.71 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.95 -1.094 . . . . 0.0 111.044 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.773 HG21 ' CD1' ' A' ' 85' ' ' ILE . 1.7 t . . . . . 0 N--CA 1.496 1.872 0 O-C-N 121.106 -0.996 . . . . 0.0 110.344 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.658 HG23 ' HD2' ' B' ' 5' ' ' PRO . 84.4 mt . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.658 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.0 Cg_endo -62.91 124.55 14.23 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.641 1.337 . . . . 0.0 110.217 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' SER . . . . . 1.009 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.3 OUTLIER -58.13 170.19 0.71 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.678 0.751 . . . . 0.0 111.25 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.695 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -56.13 -80.06 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.448 0.642 . . . . 0.0 110.383 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' B' ' 11' ' ' ILE . 38.7 p -45.21 -40.69 7.55 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.413 -0.805 . . . . 0.0 109.755 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 87' ' ' GLU . 94.4 m -49.92 -48.17 51.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.233 -0.917 . . . . 0.0 109.177 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 1.009 HG23 ' O ' ' B' ' 6' ' ' SER . 15.8 t -61.06 -29.42 45.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.387 -0.821 . . . . 0.0 109.246 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.735 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 26.5 mm -77.73 -55.18 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.66 -0.65 . . . . 0.0 111.441 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 88' ' ' ALA . 3.9 pp -56.88 -33.03 66.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.188 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.914 HG12 HD11 ' A' ' 112' ' ' LEU . 24.2 t -67.09 -50.33 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.952 -1.093 . . . . 0.0 108.755 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.924 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -62.07 -24.45 67.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.205 -0.935 . . . . 0.0 108.633 178.793 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' B' ' 18' ' ' ARG . 1.4 p -75.38 -27.52 59.14 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.434 0.635 . . . . 0.0 109.36 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.496 ' O ' ' N ' ' B' ' 18' ' ' ARG . 8.4 mtt -73.31 -32.29 64.51 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.412 -0.805 . . . . 0.0 108.968 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.873 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.0 mp -67.76 58.8 0.06 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.518 -0.739 . . . . 0.0 109.229 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' B' ' 16' ' ' MET . 5.7 mtm180 -84.47 -80.99 0.19 Allowed 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.769 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.683 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -176.82 -67.31 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.052 -1.03 . . . . 0.0 111.472 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.53 ' N ' ' CD ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -87.83 -21.73 24.88 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.373 -0.829 . . . . 0.0 112.074 -178.156 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.567 ' HA ' ' CG ' ' A' ' 124' ' ' MET . 4.0 m -163.71 -175.0 3.91 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.453 -1.404 . . . . 0.0 112.554 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.865 ' HZ ' HD11 ' A' ' 105' ' ' LEU . 11.3 m-85 -78.78 -85.83 0.07 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.418 0.628 . . . . 0.0 110.567 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.45 -151.55 21.83 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 144' ' ' MET . 0.6 OUTLIER 176.93 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.201 -1.176 . . . . 0.0 110.681 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' B' ' 24' ' ' ASN . 42.6 Cg_endo -69.45 111.3 2.71 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.764 1.402 . . . . 0.0 110.195 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' B' ' 12' ' ' LEU . 2.1 t80 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.243 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.276 0.56 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.7 mt -60.16 -35.86 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.528 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.35 -56.27 22.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 110.144 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -55.72 -47.61 76.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.083 -1.011 . . . . 0.0 109.958 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -58.91 -41.82 88.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.0 109.43 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -62.1 -31.4 71.84 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.244 -0.91 . . . . 0.0 108.923 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 6.3 tp10 -57.62 -53.45 58.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.499 -0.75 . . . . 0.0 109.166 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -51.7 -55.58 18.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 109.219 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.536 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 86.5 t80 -52.99 -36.28 60.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.495 -0.753 . . . . 0.0 109.366 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.2 t -76.05 -26.95 57.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.567 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.8 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.1 tt -58.8 -44.16 90.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.901 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -75.22 -25.91 58.53 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.216 -0.927 . . . . 0.0 110.281 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.72 106.08 14.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.233 -0.917 . . . . 0.0 110.1 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -99.66 5.87 45.73 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.216 -0.927 . . . . 0.0 110.49 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.8 p30 -116.65 -51.68 2.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.155 -0.966 . . . . 0.0 110.397 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 114.08 39.87 1.02 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 13.6 p30 -111.65 -16.14 13.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.137 -1.214 . . . . 0.0 110.233 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.54 -1.18 81.39 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 68.3 p -118.46 108.94 15.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.18 -1.188 . . . . 0.0 110.37 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 17.9 mt -77.82 124.49 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.289 -0.882 . . . . 0.0 109.966 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.414 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 1.1 p -97.35 -178.79 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.374 -0.829 . . . . 0.0 110.316 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.614 HG21 ' OE1' ' A' ' 49' ' ' GLN . 40.6 p -73.59 -33.8 64.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.122 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -43.83 86.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 0.0 110.23 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' OE2' ' OG1' ' A' ' 28' ' ' THR . 53.6 mt-10 -60.06 -60.21 4.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.459 HD23 ' CD2' ' A' ' 48' ' ' LEU . 3.7 tp -58.73 -32.37 69.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.89 -33.26 86.77 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.1 m -71.94 -47.93 48.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -1.141 . . . . 0.0 110.14 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.63 -55.57 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.266 -0.896 . . . . 0.0 110.566 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.533 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 3.8 mmt -55.47 -36.44 66.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 110.179 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -64.11 -33.04 74.87 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -44.63 81.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 110.689 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 91' ' ' VAL . 10.7 mt -47.83 -37.96 14.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.006 -1.059 . . . . 0.0 109.923 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.74 17.27 19.55 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -82.05 -131.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.122 -1.222 . . . . 0.0 110.182 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.541 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 0.5 OUTLIER -159.05 58.28 1.22 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.95 -1.094 . . . . 0.0 110.627 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 49.4 Cg_endo -82.87 83.14 2.02 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.931 1.49 . . . . 0.0 110.186 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 45' ' ' GLU . 2.7 m -50.0 176.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.144 -0.972 . . . . 0.0 110.297 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' H ' HG22 ' A' ' 44' ' ' THR . 3.8 mm-40 -70.13 -59.54 2.83 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.267 -0.896 . . . . 0.0 110.075 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -44.2 -36.23 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.872 . . . . 0.0 109.844 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -70.71 -38.74 73.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.904 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.459 ' CD2' HD23 ' A' ' 32' ' ' LEU . 12.1 mt -55.78 -54.71 41.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.915 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.614 ' OE1' HG21 ' A' ' 29' ' ' THR . 1.1 tp60 -60.1 -40.4 89.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.631 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.453 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -63.98 -36.35 83.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 109.578 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.49 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -66.93 -47.01 73.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.908 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -63.56 -30.42 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 109.335 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.27 -16.99 61.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.705 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -72.72 -57.17 4.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.498 -0.751 . . . . 0.0 110.379 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.675 HG23 ' CD1' ' B' ' 7' ' ' TRP . 37.6 t -71.33 -29.83 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.913 -1.117 . . . . 0.0 109.936 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -48.67 88.47 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.347 -0.846 . . . . 0.0 110.565 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -69.06 -27.4 65.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.321 -0.862 . . . . 0.0 110.452 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 8.6 p-10 -95.85 -41.91 8.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.216 -0.927 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.83 47.67 1.46 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 18.8 p-10 -98.46 -44.07 6.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -1.137 . . . . 0.0 110.24 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.57 6.66 5.05 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.14 154.99 41.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.121 -1.223 . . . . 0.0 110.35 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.0 mm -97.07 166.18 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.274 -0.891 . . . . 0.0 110.122 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 4.8 t0 -148.11 169.94 18.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.125 -0.984 . . . . 0.0 110.568 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.659 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 19.9 t80 -59.39 -41.24 86.03 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.849 . . . . 0.0 111.961 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -68.73 -23.88 35.45 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 O-C-N 123.142 1.075 . . . . 0.0 110.473 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.58 -36.27 29.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -62.01 -42.91 99.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 110.239 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.62 -34.6 58.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.197 -0.939 . . . . 0.0 110.543 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.5 m -74.56 -12.44 60.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.062 -1.024 . . . . 0.0 110.768 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.9 tmm? -98.6 -43.68 6.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.045 -1.035 . . . . 0.0 110.76 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -10.89 6.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -0.958 . . . . 0.0 110.784 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.01 -17.23 28.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.055 -1.028 . . . . 0.0 110.927 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -97.05 -18.33 19.44 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.961 -1.087 . . . . 0.0 110.72 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.948 ' HG3' HG21 ' B' ' 8' ' ' THR . 17.8 mmtp . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.073 -1.017 . . . . 0.0 110.537 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.225 0.536 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -72.73 -35.57 67.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.791 ' HG2' HD12 ' B' ' 12' ' ' LEU . 8.3 tt0 -70.26 -42.09 72.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.83 . . . . 0.0 110.168 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.675 HG23 ' CE2' ' A' ' 141' ' ' PHE . 46.5 mt -68.63 -26.79 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.782 . . . . 0.0 109.718 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -66.9 -49.69 64.79 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.465 -0.772 . . . . 0.0 109.709 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.4 mt-10 -59.53 -48.83 80.15 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.301 -0.875 . . . . 0.0 109.695 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -56.07 -31.63 63.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.588 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 4.7 t80 -67.99 -63.85 0.98 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.133 -0.98 . . . . 0.0 109.682 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' PHE . 3.9 mmt85 -41.34 -32.75 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.656 -0.653 . . . . 0.0 109.826 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.674 HG12 HG21 ' A' ' 108' ' ' VAL . 71.4 t -65.5 -47.02 88.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.353 -0.842 . . . . 0.0 109.465 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.624 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 43.9 m-85 -68.94 -18.44 64.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.309 -0.869 . . . . 0.0 110.028 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.522 ' HA ' ' OE2' ' A' ' 104' ' ' GLU . 1.9 t0 -96.98 60.68 1.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.334 -0.854 . . . . 0.0 110.478 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -42.07 -61.26 1.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.261 -0.899 . . . . 0.0 110.278 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 9.4 p30 -55.28 -28.97 57.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.143 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 74.81 42.84 30.02 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.0 p30 -100.13 -48.96 4.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -1.181 . . . . 0.0 110.262 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 148.66 -33.7 1.17 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -95.61 153.98 17.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.146 -1.208 . . . . 0.0 110.314 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.486 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 17.0 mt -121.27 127.52 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.259 -0.901 . . . . 0.0 110.251 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.0 p -111.28 164.13 13.22 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.352 -0.842 . . . . 0.0 109.998 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.699 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -55.95 -33.71 65.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.53 89.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.011 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.522 ' OE2' ' HA ' ' A' ' 93' ' ' ASP . 14.3 mt-10 -58.89 -50.06 75.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.749 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.442 ' HG ' HD11 ' A' ' 125' ' ' ILE . 2.5 mm? -55.61 -42.72 75.26 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.215 -0.928 . . . . 0.0 109.748 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -18.65 65.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.205 -0.934 . . . . 0.0 109.339 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 1.7 m80 -82.52 -30.15 29.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.759 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.674 HG21 HG12 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -83.92 -41.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.306 -0.871 . . . . 0.0 109.647 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . 1.056 ' HE2' HD13 ' A' ' 116' ' ' LEU . 16.8 mtt -44.35 -70.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 110.292 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 m -49.35 -46.38 46.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.445 -0.784 . . . . 0.0 109.935 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 5.2 m120 -59.04 -16.04 16.6 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.405 -0.809 . . . . 0.0 109.74 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.8 ' O ' HD11 ' A' ' 18' ' ' LEU . 8.1 mt -106.74 -45.89 4.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.34 -0.85 . . . . 0.0 110.537 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.98 -62.51 0.24 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.772 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 109' ' ' MET . 59.6 tt0 -81.75 172.04 13.85 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.109 -1.23 . . . . 0.0 110.831 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.48 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -154.61 75.49 0.98 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.592 -0.693 . . . . 0.0 109.593 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.056 HD13 ' HE2' ' A' ' 109' ' ' MET . 2.4 mp -36.26 138.55 0.2 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.7 -0.625 . . . . 0.0 110.63 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.547 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -54.63 -165.16 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.251 -0.905 . . . . 0.0 110.18 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.46 ' H ' HG22 ' A' ' 117' ' ' THR . 0.9 OUTLIER -83.56 -56.69 3.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.254 -0.904 . . . . 0.0 110.288 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -56.85 -25.34 56.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 110.067 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 14.7 mm-40 -78.12 -44.18 26.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 108.971 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.699 HG12 ' HB1' ' A' ' 102' ' ' ALA . 15.2 t -57.69 -36.72 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.676 -0.64 . . . . 0.0 109.902 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.87 -51.01 20.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.981 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -58.89 -22.71 59.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.892 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.404 ' CE ' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -75.8 -47.24 26.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -0.901 . . . . 0.0 110.108 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.442 HD11 ' HG ' ' A' ' 105' ' ' LEU . 11.7 mm -76.94 -33.46 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.209 -0.932 . . . . 0.0 110.055 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 ttp85 -64.49 -45.38 87.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.79 -20.09 65.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.2 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.956 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -85.81 -35.2 20.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.38 64.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.279 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.956 HD12 ' O ' ' A' ' 128' ' ' ALA . 1.5 mp -46.97 -28.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.257 -0.902 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 13.3 p-10 -88.99 -28.17 20.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.915 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.8 73.03 1.28 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 135' ' ' GLN . 18.2 p-10 -127.34 -29.22 2.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.267 -1.137 . . . . 0.0 110.255 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.12 -8.32 12.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.431 ' O ' ' OD2' ' A' ' 133' ' ' ASP . 9.4 pt20 -159.43 169.01 24.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.189 -1.183 . . . . 0.0 110.417 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.642 HG13 ' HB3' ' A' ' 140' ' ' GLU . 24.9 t -113.27 159.29 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.239 -0.913 . . . . 0.0 110.497 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.464 ' OD1' ' OE2' ' A' ' 140' ' ' GLU . 10.3 p-10 -122.26 -173.38 2.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.192 -0.943 . . . . 0.0 110.325 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.588 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 6.2 t80 -57.51 -69.37 0.17 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.218 -0.926 . . . . 0.0 110.655 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.7 OUTLIER -41.0 -53.06 3.05 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.298 -0.876 . . . . 0.0 110.382 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.642 ' HB3' HG13 ' A' ' 136' ' ' VAL . 8.5 mt-10 -52.79 -62.32 1.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.934 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.675 ' CE2' HG23 ' A' ' 85' ' ' ILE . 37.8 t80 -41.79 -27.51 0.11 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.266 -0.896 . . . . 0.0 109.756 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' GLU . 96.2 t -95.19 -37.7 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 0.0 110.194 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -68.4 -9.48 48.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.119 -0.988 . . . . 0.0 109.872 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.617 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -94.08 -23.15 18.09 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.364 -0.835 . . . . 0.0 110.42 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.5 mmt -100.61 -68.71 0.8 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.972 . . . . 0.0 111.105 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 146' ' ' THR . 5.3 t . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.221 -0.924 . . . . 0.0 110.797 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.519 HG23 ' HD2' ' B' ' 5' ' ' PRO . 14.1 mt . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.775 ' HB2' HG13 ' B' ' 10' ' ' VAL . 44.7 Cg_endo -71.24 103.88 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.893 1.47 . . . . 0.0 109.891 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.529 ' O ' ' N ' ' B' ' 8' ' ' THR . 23.1 t -62.13 71.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.561 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.78 ' O ' HG22 ' B' ' 10' ' ' VAL . 4.2 m95 50.74 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.871 . . . . 0.0 110.648 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.948 HG21 ' HG3' ' A' ' 75' ' ' LYS . 40.4 p -41.78 -24.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.715 -1.241 . . . . 0.0 110.42 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.531 HG21 ' HA ' ' B' ' 5' ' ' PRO . 85.6 m -70.58 -51.47 28.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 109.941 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.78 HG22 ' O ' ' B' ' 7' ' ' TRP . 3.8 m -56.38 -28.31 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.85 -1.156 . . . . 0.0 108.849 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.45 ' N ' HD13 ' B' ' 11' ' ' ILE . 7.1 mm -75.8 -28.38 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.448 -0.783 . . . . 0.0 109.322 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.791 HD12 ' HG2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -66.08 -57.61 7.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.57 -0.706 . . . . 0.0 110.331 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.696 HG12 ' CD1' ' A' ' 112' ' ' LEU . 42.4 t -60.35 -40.71 84.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.387 -0.82 . . . . 0.0 110.952 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.459 ' CD ' ' O ' ' B' ' 14' ' ' LYS . 1.2 tmtt? -63.07 -29.08 70.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.369 -1.457 . . . . 0.0 108.744 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' B' ' 11' ' ' ILE . 1.5 p -83.39 -15.96 47.77 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.563 ' HE2' ' CE1' ' A' ' 141' ' ' PHE . 73.1 mmm -71.64 -47.2 56.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.555 -0.716 . . . . 0.0 110.578 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.771 ' H ' HD13 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -99.97 37.8 1.57 Allowed 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 117.724 -1.59 . . . . 0.0 109.619 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.52 ' HG2' ' N ' ' B' ' 19' ' ' LYS . 47.7 ttp180 -48.19 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.159 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.805 ' O ' HD21 ' A' ' 116' ' ' LEU . 8.6 tmtt? -104.91 -73.65 0.67 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 111.047 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.494 ' HG2' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -151.82 15.45 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.998 -1.063 . . . . 0.0 110.572 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.404 ' O ' ' CE ' ' A' ' 124' ' ' MET . 3.4 m -127.34 -173.36 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.111 -0.993 . . . . 0.0 110.176 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' B' ' 16' ' ' MET . 2.6 m-85 -92.91 -55.39 3.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.189 -0.944 . . . . 0.0 110.307 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' B' ' 24' ' ' ASN . . . 145.97 176.92 20.26 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 144' ' ' MET . 1.5 t-20 174.17 -52.39 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.458 -1.025 . . . . 0.0 110.117 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 24' ' ' ASN . 48.9 Cg_endo -82.62 72.94 5.76 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.792 1.417 . . . . 0.0 110.404 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.172 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.301 0.572 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 10' ' ' ALA . 67.1 mt -53.13 -43.88 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.795 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -44.19 -60.19 2.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.913 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 5.0 tm-20 -52.5 -55.4 22.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.755 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -53.26 -30.07 36.4 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.162 -0.961 . . . . 0.0 109.277 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' SER . 17.9 ttmt -64.83 -37.05 86.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.309 -0.869 . . . . 0.0 109.089 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 3.1 mm-40 -61.36 -46.36 90.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.508 -0.745 . . . . 0.0 109.363 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 -48.74 80.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.839 . . . . 0.0 109.587 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.509 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 55.3 t80 -62.78 -39.68 94.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.413 -0.804 . . . . 0.0 109.508 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -70.8 -30.27 66.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -0.801 . . . . 0.0 109.319 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.817 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.5 tt -59.46 -44.18 93.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.427 -0.796 . . . . 0.0 109.702 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -69.87 -52.76 22.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.278 -0.888 . . . . 0.0 109.963 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -67.28 108.42 2.73 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.398 -0.814 . . . . 0.0 110.239 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -84.8 2.26 43.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.288 -0.883 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.57 -68.65 0.9 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.157 -0.965 . . . . 0.0 110.694 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.27 35.24 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 60.0 p30 -94.12 -10.14 34.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -1.16 . . . . 0.0 110.039 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.554 ' C ' HG23 ' A' ' 26' ' ' THR . . . 81.37 30.39 37.22 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.554 HG23 ' C ' ' A' ' 25' ' ' GLY . 77.7 p -152.76 124.44 7.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.137 -1.214 . . . . 0.0 110.709 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.573 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 4.2 mt -92.36 120.7 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.23 -0.919 . . . . 0.0 109.758 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -100.17 171.21 7.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 110.359 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.1 p -61.94 -33.44 74.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 110.033 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -70.01 -59.21 3.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 110.276 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 52.7 mt-10 -49.2 -66.63 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 109.881 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.3 tp -48.98 -43.95 40.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.749 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.05 -43.25 49.61 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 83.0 m -60.68 -48.57 81.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -1.137 . . . . 0.0 110.06 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.455 ' H ' HG23 ' A' ' 35' ' ' VAL . 4.2 t -64.6 -43.37 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.804 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 29.9 mmm -70.97 -24.6 62.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 109.882 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.09 -21.18 47.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.88 . . . . 0.0 110.14 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 39' ' ' LEU . 50.8 m -85.9 -40.89 15.45 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.255 -0.903 . . . . 0.0 110.771 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.43 HD23 HG22 ' A' ' 108' ' ' VAL . 2.4 mt -44.13 -32.23 1.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.924 -1.11 . . . . 0.0 109.799 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 41' ' ' GLN . . . 128.62 67.24 0.12 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER 179.55 -172.2 0.17 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.372 -1.075 . . . . 0.0 110.231 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -138.33 92.03 12.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.938 . . . . 0.0 110.666 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.74 126.48 11.43 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.088 1.573 . . . . 0.0 109.885 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 m -94.38 161.72 14.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.207 -0.933 . . . . 0.0 110.581 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.0 -60.69 3.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.022 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.35 -43.96 23.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.7 -42.35 74.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 0.0 109.873 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -64.22 -34.97 79.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.83 -41.16 83.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.866 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -67.17 -24.8 65.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.384 -0.823 . . . . 0.0 109.827 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.0 mtp -77.59 -45.96 23.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 109.791 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -64.46 -35.11 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 109.845 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.37 -15.07 56.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -81.42 -33.32 32.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 110.225 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 4.4 t -103.26 -14.12 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.184 -0.948 . . . . 0.0 110.256 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 12.4 t0 -60.07 80.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 0.0 109.901 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -93.14 -15.83 25.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.901 . . . . 0.0 110.368 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.431 ' OD2' ' CD ' ' A' ' 67' ' ' GLU . 5.2 m-20 -82.3 -40.37 21.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.199 -0.938 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.19 13.54 30.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 27.6 p-10 -88.04 -46.89 8.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -1.096 . . . . 0.0 110.263 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 131.38 -21.68 4.52 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.0 p -116.6 169.63 9.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -1.184 . . . . 0.0 110.148 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.573 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 11.2 mm -94.62 138.66 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.888 . . . . 0.0 110.001 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.542 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 m-20 -117.48 171.91 7.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.972 . . . . 0.0 110.695 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.659 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.2 t80 -62.97 -38.82 46.5 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 111.674 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.7 Cg_endo -70.08 -24.54 28.1 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 O-C-N 123.075 1.04 . . . . 0.0 109.589 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.52 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 3.2 mt-10 -69.49 -33.61 73.1 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.414 -0.804 . . . . 0.0 108.922 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.614 ' HZ ' HG23 ' B' ' 11' ' ' ILE . 2.0 t80 -68.4 -48.21 65.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.54 -0.725 . . . . 0.0 109.571 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 3.2 mm? -55.91 -36.72 68.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 110.371 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 2.7 m -87.33 -25.45 23.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.125 -0.984 . . . . 0.0 110.61 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.526 ' HE2' ' N ' ' A' ' 72' ' ' MET . 2.2 ttp -63.07 -61.49 2.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.937 . . . . 0.0 110.209 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.671 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 2.0 tpt -47.23 -32.27 4.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.267 -0.896 . . . . 0.0 110.632 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.38 -11.23 46.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.935 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 70' ' ' THR . 0.4 OUTLIER -99.29 -10.96 21.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.99 -1.069 . . . . 0.0 110.397 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.544 ' CB ' HG21 ' B' ' 8' ' ' THR . 2.2 mptp? . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 0.0 110.455 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.357 0.599 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.56 -47.57 69.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.498 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' B' ' 26' ' ' PHE . 17.3 pt-20 -47.59 -33.07 6.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.526 -0.734 . . . . 0.0 110.128 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.676 HG21 HG22 ' A' ' 142' ' ' VAL . 63.9 mt -76.32 -39.93 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.18 -0.95 . . . . 0.0 109.074 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -32.47 67.64 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HB3' HG23 ' B' ' 9' ' ' THR . 0.2 OUTLIER -67.01 -62.02 1.64 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.681 ' CB ' HD22 ' B' ' 12' ' ' LEU . . . -51.93 -30.13 23.18 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.538 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.51 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 59.0 t80 -71.92 -50.56 28.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.475 -0.766 . . . . 0.0 109.598 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.74 -47.18 77.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.0 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.54 HG11 HG21 ' B' ' 13' ' ' VAL . 0.9 OUTLIER -49.19 -45.46 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.567 -0.708 . . . . 0.0 109.29 179.087 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.561 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 17.3 m-85 -71.91 -36.69 70.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 109.964 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 94' ' ' LYS . 15.7 t0 -75.13 55.49 0.74 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.198 -0.939 . . . . 0.0 110.197 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' ASP . 9.0 tttp -40.71 -66.02 0.36 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.37 -0.831 . . . . 0.0 110.532 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 21.6 p-10 -61.48 -43.35 99.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 0.0 110.231 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 93.97 44.82 3.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 32.5 p-10 -87.23 -28.9 22.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.187 -1.184 . . . . 0.0 110.169 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.563 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 121.49 15.34 4.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 50.8 m-85 -151.76 152.41 32.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.141 -1.211 . . . . 0.0 110.178 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.98 118.91 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.922 . . . . 0.0 110.149 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 102' ' ' ALA . 12.4 t -105.52 141.97 36.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.848 . . . . 0.0 110.338 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.96 -33.85 0.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.313 -0.867 . . . . 0.0 109.833 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -55.16 -55.64 28.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 109.612 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 49.0 mt-10 -54.38 -48.4 71.56 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.352 -0.842 . . . . 0.0 109.764 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.711 HD13 HD11 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -58.72 -37.36 75.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.624 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 22.6 tpt85 -60.79 -41.24 95.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.307 -0.871 . . . . 0.0 109.44 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -57.99 -44.4 87.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.783 . . . . 0.0 109.422 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.587 HG11 ' CG1' ' B' ' 13' ' ' VAL . 5.9 t -73.19 -29.08 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.553 -0.717 . . . . 0.0 109.65 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.987 ' HA ' HD21 ' B' ' 17' ' ' LEU . 2.3 mtt -55.37 -69.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 110.7 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.6 m -64.85 -10.09 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.38 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -94.87 -6.68 42.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.817 ' O ' HD11 ' A' ' 18' ' ' LEU . 10.1 mt -107.44 -30.57 8.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 110.354 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 147.47 -51.87 0.56 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.507 ' HG2' HD12 ' A' ' 116' ' ' LEU . 23.0 tt0 -107.66 149.31 28.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -1.121 . . . . 0.0 109.7 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -123.62 19.17 9.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.895 . . . . 0.0 109.827 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.019 HD11 ' O ' ' B' ' 17' ' ' LEU . 3.5 mp 42.54 -166.51 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.55 0.69 . . . . 0.0 110.549 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.2 -144.65 0.3 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.514 -0.741 . . . . 0.0 109.144 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -117.64 -70.64 0.78 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.07 -1.018 . . . . 0.0 110.274 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -48.45 -40.98 28.07 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 109.398 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 121' ' ' VAL . 41.7 mm-40 -60.08 -53.48 57.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 109.282 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 120' ' ' GLU . 70.8 t -44.59 -41.52 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.418 -0.801 . . . . 0.0 109.844 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 35.8 m-20 -63.43 -60.81 2.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.856 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.45 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 4.0 tp10 -50.24 -40.98 49.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.795 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.449 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 4.5 ttt -51.7 -47.28 63.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.833 . . . . 0.0 109.841 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.711 HD11 HD13 ' A' ' 105' ' ' LEU . 48.9 mm -75.72 -39.02 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.932 . . . . 0.0 109.996 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -65.42 -26.7 68.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 110.275 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.42 -41.59 98.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 110.125 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.92 -27.04 23.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.317 -0.864 . . . . 0.0 110.335 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.651 ' OD2' HG22 ' A' ' 125' ' ' ILE . 1.7 m-20 -58.89 88.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.328 -0.858 . . . . 0.0 110.567 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -61.82 -41.54 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.196 -0.94 . . . . 0.0 109.422 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 35.4 p30 -82.66 -17.94 42.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.422 -0.799 . . . . 0.0 110.053 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 66.02 67.86 1.86 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 30.5 p-10 -118.25 1.84 11.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -1.11 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.86 -9.44 74.27 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 1.4 pt20 -137.71 147.72 45.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -1.106 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.49 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 4.0 t -104.08 146.08 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.209 -0.932 . . . . 0.0 110.155 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.455 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 33.7 p-10 -103.46 -161.09 0.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 139' ' ' GLU . 14.8 t80 -71.81 -63.45 1.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.074 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -44.12 -56.58 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 110.009 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 68.4 mt-10 -47.52 -61.38 1.95 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 6.0 t80 -44.68 -26.97 0.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.288 -0.882 . . . . 0.0 110.282 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.676 HG22 HG21 ' A' ' 85' ' ' ILE . 76.8 t -99.48 -45.95 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.201 -0.937 . . . . 0.0 110.163 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -46.48 -34.7 4.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.363 -0.836 . . . . 0.0 110.45 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.5 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -86.02 -19.82 29.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.582 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 3.7 mtt -84.86 -47.32 10.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.996 -1.065 . . . . 0.0 110.489 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.063 -1.023 . . . . 0.0 110.319 -179.929 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.838 HG23 ' HD2' ' B' ' 5' ' ' PRO . 17.2 mm . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.838 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.1 Cg_endo -66.37 116.46 4.06 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.79 1.416 . . . . 0.0 110.289 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 10' ' ' VAL . 3.0 m -53.2 179.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.848 . . . . 0.0 111.04 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.608 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -68.27 -66.14 0.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.596 0.713 . . . . 0.0 110.241 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.544 HG21 ' CB ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -53.99 -38.86 65.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 110.083 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 87' ' ' GLU . 49.1 m -49.06 -42.05 37.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.96 . . . . 0.0 108.982 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 6' ' ' SER . 47.3 t -65.76 -50.36 71.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.42 -0.8 . . . . 0.0 109.382 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.614 HG23 ' HZ ' ' A' ' 68' ' ' PHE . 9.2 mm -59.45 -27.12 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.427 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -65.14 -57.05 9.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.454 -0.779 . . . . 0.0 110.533 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.661 HG12 HD11 ' A' ' 112' ' ' LEU . 67.6 t -65.86 -30.57 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.945 . . . . 0.0 110.122 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.685 ' CG ' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.36 -47.27 67.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.92 . . . . 0.0 109.918 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' B' ' 18' ' ' ARG . 8.3 m -63.28 -29.85 71.09 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 110.131 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 11.6 ttm -68.22 -40.09 82.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.992 . . . . 0.0 109.95 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 1.019 ' O ' HD11 ' A' ' 116' ' ' LEU . 3.7 mp -56.19 -16.69 5.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.277 -0.889 . . . . 0.0 110.199 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.501 ' C ' ' O ' ' B' ' 17' ' ' LEU . 52.3 ttt180 -29.73 -78.34 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 121.032 0.444 . . . . 0.0 111.291 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.503 ' C ' ' HD3' ' B' ' 19' ' ' LYS . 1.8 tmtp? -143.18 -119.83 0.09 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.272 -0.893 . . . . 0.0 109.575 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.488 ' N ' ' CD ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -99.94 8.74 43.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.691 -1.255 . . . . 0.0 110.043 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -178.09 1.04 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.362 -0.836 . . . . 0.0 110.13 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.449 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.3 OUTLIER -176.66 -46.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.884 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 144' ' ' MET . . . -72.02 80.8 0.58 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -98.2 134.57 21.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.294 -1.121 . . . . 0.0 110.586 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.51 72.62 4.26 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 124.066 1.561 . . . . 0.0 110.316 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.671 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.498 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.498 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 24.1 mt-30 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.276 0.56 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.85 -32.96 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.925 . . . . 0.0 110.038 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.72 -44.14 70.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.937 . . . . 0.0 110.224 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 12' ' ' PHE . 4.6 pt-20 -65.06 -31.15 72.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.522 ' N ' ' HG2' ' A' ' 11' ' ' GLU . 19.9 m-30 -65.53 -44.1 87.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.844 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 17' ' ' SER . 0.4 OUTLIER -59.97 -43.59 95.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.179 -0.95 . . . . 0.0 109.36 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -61.54 -40.17 93.72 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.27 -0.894 . . . . 0.0 109.263 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.68 -52.07 54.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 0.0 109.489 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.536 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 7.6 t80 -58.38 -26.16 62.89 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.356 -0.84 . . . . 0.0 108.992 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -76.57 -34.82 58.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.512 -0.743 . . . . 0.0 109.32 179.272 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.787 HD11 ' O ' ' A' ' 112' ' ' LEU . 8.1 tt -59.14 -45.47 90.86 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.371 -0.83 . . . . 0.0 109.575 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' LYS . 41.8 m-85 -74.1 -49.71 22.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.378 -0.826 . . . . 0.0 109.589 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 21' ' ' LYS . 8.2 t0 -67.95 71.31 0.15 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.893 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -41.3 -41.73 2.0 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.429 -0.795 . . . . 0.0 110.36 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 13.0 p-10 -85.3 -43.1 14.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.099 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.5 32.16 6.13 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 46.2 p-10 -81.6 -2.53 50.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -1.193 . . . . 0.0 110.014 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 26' ' ' THR . . . 82.98 29.01 35.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 25' ' ' GLY . 13.4 p -154.98 118.73 4.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -1.113 . . . . 0.0 110.265 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.554 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 7.8 mt -90.45 124.63 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.951 . . . . 0.0 110.002 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.01 168.17 10.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 110.285 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.7 p -61.41 -28.42 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.96 -44.92 60.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.165 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -61.38 -60.65 3.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.976 . . . . 0.0 110.1 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.563 HD13 ' CH2' ' B' ' 7' ' ' TRP . 2.9 tp -59.31 -29.42 67.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.875 . . . . 0.0 110.189 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.99 -40.0 84.52 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.5 m -69.65 -50.71 41.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -1.157 . . . . 0.0 110.094 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 38' ' ' SER . 21.3 t -60.41 -42.72 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.177 -0.952 . . . . 0.0 110.327 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.52 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 2.6 mmt -66.84 -42.14 86.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 109.737 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -67.73 -14.04 62.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 110.112 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -72.11 -58.18 3.65 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.189 -0.944 . . . . 0.0 110.623 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mt -45.94 -28.59 1.17 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.12 -0.987 . . . . 0.0 110.736 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.502 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . 118.79 58.6 0.27 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.21 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 40' ' ' GLY . 64.7 mm-40 -131.9 -162.07 1.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.248 . . . . 0.0 109.928 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.548 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 t-20 -147.1 49.95 0.87 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.186 -0.947 . . . . 0.0 110.492 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 46.1 Cg_endo -74.0 73.74 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.086 1.572 . . . . 0.0 110.462 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 43' ' ' PRO . 10.9 t -54.06 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.18 -0.95 . . . . 0.0 110.556 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -66.9 -58.65 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.337 -0.852 . . . . 0.0 110.351 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -42.71 -42.82 3.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 109.835 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' OE1' HD11 ' B' ' 4' ' ' ILE . 10.6 mm-40 -71.15 -41.16 70.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.491 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 mt -52.74 -59.16 4.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.806 . . . . 0.0 109.95 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.94 -41.26 67.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.409 -0.807 . . . . 0.0 109.882 179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -61.51 -41.13 96.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.101 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.514 ' HE1' ' CG ' ' B' ' 7' ' ' TRP . 0.9 OUTLIER -73.97 -44.31 55.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 4.5 mm -61.67 -30.68 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.439 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -73.79 -2.25 22.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.367 -0.833 . . . . 0.0 110.403 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.7 OUTLIER -85.29 -31.18 23.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.183 -0.948 . . . . 0.0 110.578 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 71' ' ' MET . 13.0 t -108.05 -46.34 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.126 -0.984 . . . . 0.0 110.495 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -45.57 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 110.663 -179.302 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -85.64 -3.35 58.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.83 . . . . 0.0 110.161 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.64 -53.94 4.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.176 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.71 22.22 5.8 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.4 p-10 -87.65 -46.21 9.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -1.169 . . . . 0.0 110.18 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.92 -0.59 11.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.6 p -134.31 149.89 50.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -1.214 . . . . 0.0 110.206 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.554 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 12.0 mm -90.41 144.55 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.065 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 48.3 m-20 -119.85 169.19 10.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.252 -0.905 . . . . 0.0 110.358 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.668 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.4 t80 -63.19 -38.58 42.68 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 111.598 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.3 Cg_endo -69.78 -26.62 27.32 Favored 'Trans proline' 0 C--N 1.321 -0.881 0 O-C-N 123.025 1.013 . . . . 0.0 109.656 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 71' ' ' MET . 10.6 mt-10 -76.41 -36.46 58.03 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 108.728 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 72' ' ' MET . 3.7 t80 -61.97 -41.33 97.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.507 -0.746 . . . . 0.0 109.986 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.28 -49.1 68.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.254 -0.904 . . . . 0.0 110.16 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -59.0 3.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 110.392 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.566 ' HB2' HG13 ' A' ' 55' ' ' VAL . 5.3 ppp? -48.77 -30.45 5.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.271 -0.893 . . . . 0.0 110.716 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.502 ' HA ' HG22 ' B' ' 8' ' ' THR . 0.0 OUTLIER -68.7 -9.99 53.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.019 -1.051 . . . . 0.0 110.54 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.41 -12.93 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.125 -0.984 . . . . 0.0 111.195 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -78.71 -15.79 58.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.962 -1.087 . . . . 0.0 110.766 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.071 -1.018 . . . . 0.0 110.391 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 1.4 mt-10 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.337 0.589 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.457 ' OE1' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -65.56 -57.92 7.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.295 -0.878 . . . . 0.0 109.548 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.481 ' OE2' ' CB ' ' B' ' 8' ' ' THR . 24.5 mt-10 -45.52 -27.9 0.83 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.557 -0.714 . . . . 0.0 110.383 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.888 HG21 HG22 ' A' ' 142' ' ' VAL . 47.8 mt -66.37 -43.29 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 121.011 -1.056 . . . . 0.0 108.988 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 ttm105 -58.54 -46.91 85.84 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.812 ' HB3' HG21 ' B' ' 9' ' ' THR . 2.9 mt-10 -67.65 -50.77 56.23 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.225 -0.922 . . . . 0.0 108.869 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' B' ' 13' ' ' VAL . . . -56.35 -40.0 73.77 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 141' ' ' PHE . 11.8 t80 -66.43 -40.08 89.28 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 10.8 ttt180 -58.85 -45.63 89.64 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.917 HG11 HG11 ' B' ' 13' ' ' VAL . 21.4 t -48.29 -46.73 13.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.71 ' CE2' HD21 ' A' ' 105' ' ' LEU . 4.8 m-85 -71.58 -31.85 67.41 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.005 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 11.0 t0 -101.23 63.47 0.99 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.442 -0.786 . . . . 0.0 109.975 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.528 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 34.0 pttt -55.46 -25.38 36.22 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.149 -0.969 . . . . 0.0 110.508 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.528 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 11.8 p-10 -86.58 -40.33 15.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 110.371 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 85.95 50.49 3.9 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.448 ' OD1' ' OD2' ' A' ' 95' ' ' ASP . 15.1 p-10 -96.2 -24.88 16.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.196 -1.179 . . . . 0.0 110.283 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 118.99 -7.87 12.77 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 98.3 m-85 -136.86 151.83 49.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.286 -1.126 . . . . 0.0 110.152 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.514 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 8.7 mt -103.38 134.0 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.18 -0.95 . . . . 0.0 110.09 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 102' ' ' ALA . 37.6 t -112.2 136.54 51.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 110.234 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.39 -27.12 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.305 -0.872 . . . . 0.0 109.932 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -63.49 -59.65 4.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.357 -0.839 . . . . 0.0 109.671 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 89.4 mt-10 -48.16 -38.85 19.06 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.263 -0.898 . . . . 0.0 109.414 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.71 HD21 ' CE2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -54.91 -52.67 62.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.384 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.413 ' O ' ' OG1' ' A' ' 110' ' ' THR . 5.2 ttm105 -48.65 -47.97 40.09 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.251 -0.906 . . . . 0.0 109.377 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 14.0 m170 -52.95 -53.31 51.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.4 -0.812 . . . . 0.0 109.169 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.52 HG21 HG12 ' A' ' 91' ' ' VAL . 21.7 t -64.49 -41.63 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 108.943 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.787 ' HA ' HD21 ' B' ' 17' ' ' LEU . 33.6 ttm -51.81 -48.73 63.73 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.717 -0.614 . . . . 0.0 109.937 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -79.83 -32.18 40.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.0 110.253 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -72.81 -14.92 61.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.983 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.02 HD11 HG12 ' B' ' 13' ' ' VAL . 10.5 mt -99.35 -48.84 4.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.189 -0.944 . . . . 0.0 109.949 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 148.81 -31.67 1.21 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.777 ' HB3' HD23 ' B' ' 17' ' ' LEU . 5.2 tp10 -79.73 156.52 27.48 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.02 -1.282 . . . . 0.0 110.661 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.539 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.1 OUTLIER -137.17 51.83 1.94 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.776 HD12 ' HG2' ' A' ' 114' ' ' GLU . 0.2 OUTLIER -36.31 153.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.566 0.698 . . . . 0.0 110.923 -179.317 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 118' ' ' ASP . 2.0 m -57.67 -169.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.497 -0.752 . . . . 0.0 109.699 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.691 ' H ' HG22 ' A' ' 117' ' ' THR . 0.4 OUTLIER -99.05 -67.28 0.85 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.162 -0.961 . . . . 0.0 109.924 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -47.19 -36.97 9.4 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.762 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.8 -54.67 35.48 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -0.92 . . . . 0.0 109.052 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 124' ' ' MET . 7.7 t -47.01 -48.83 7.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -60.97 -50.4 73.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 109.818 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 1.5 tp10 -59.01 -31.4 68.78 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.295 -0.878 . . . . 0.0 109.519 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -58.05 -51.2 70.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.334 -0.854 . . . . 0.0 109.855 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.846 HG23 HG23 ' A' ' 136' ' ' VAL . 2.7 mp -68.74 -24.44 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.212 -0.93 . . . . 0.0 110.006 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.414 ' NH1' ' HB2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.09 -42.05 89.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.133 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HB2' ' NH1' ' A' ' 126' ' ' ARG . 13.3 tt0 -71.34 -29.61 65.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.905 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.61 -20.45 50.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.01 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 0.9 OUTLIER -70.67 68.17 0.39 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.193 -0.942 . . . . 0.0 110.111 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mt -54.02 -31.58 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 0.0 110.306 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -89.53 -31.99 17.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.3 -0.875 . . . . 0.0 110.38 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.79 97.14 0.92 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 135' ' ' GLN . 1.2 p-10 -148.43 -38.12 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.186 -1.185 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 133.82 -1.74 4.33 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.485 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 1.5 pt20 -161.22 169.73 21.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -1.235 . . . . 0.0 110.092 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.846 HG23 HG23 ' A' ' 125' ' ' ILE . 55.3 t -93.81 139.16 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.219 -0.926 . . . . 0.0 110.076 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 19.1 t30 -102.42 178.96 4.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.274 -0.891 . . . . 0.0 110.694 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.445 ' O ' ' C ' ' A' ' 139' ' ' GLU . 47.1 t80 -67.3 -68.21 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.432 -0.793 . . . . 0.0 110.298 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 140' ' ' GLU . 2.9 pt-20 -40.93 -29.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.428 -0.795 . . . . 0.0 110.094 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 3.9 mt-10 -71.62 -59.19 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.418 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.804 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.6 t80 -42.48 -29.04 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 109.377 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.888 HG22 HG21 ' A' ' 85' ' ' ILE . 45.3 t -99.81 -40.29 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.505 -0.747 . . . . 0.0 110.456 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 10.7 tt0 -63.16 -12.8 30.37 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.16 -0.962 . . . . 0.0 110.599 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.9 mtp -95.54 -21.73 18.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 109.96 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.609 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 2.6 mtt -100.88 -13.38 18.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.362 -0.836 . . . . 0.0 110.462 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.1 p . . . . . 0 C--N 1.306 -1.283 0 O-C-N 121.173 -0.954 . . . . 0.0 111.057 -178.993 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.547 HG22 ' HD2' ' B' ' 5' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' B' ' 4' ' ' ILE . 48.2 Cg_endo -73.99 49.15 1.86 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.825 1.434 . . . . 0.0 111.282 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.472 ' C ' ' O ' ' B' ' 5' ' ' PRO . 10.3 m 32.72 -139.59 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.597 -0.69 . . . . 0.0 111.574 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.563 ' CH2' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -117.4 -74.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 110.265 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.588 ' HA ' HD12 ' B' ' 11' ' ' ILE . 0.6 OUTLIER -45.06 -41.7 7.9 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.803 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.812 HG21 ' HB3' ' A' ' 87' ' ' GLU . 31.4 m -51.06 -54.72 22.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 109.7 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 5' ' ' PRO . 40.6 t -47.69 -39.69 7.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.163 -0.961 . . . . 0.0 108.683 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' B' ' 8' ' ' THR . 55.0 mt -67.5 -21.81 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 0.0 109.369 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' B' ' 9' ' ' THR . 0.4 OUTLIER -71.0 -55.48 8.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.495 -0.753 . . . . 0.0 109.904 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 1.02 HG12 HD11 ' A' ' 112' ' ' LEU . 68.1 t -54.57 -40.99 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.807 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.455 ' O ' ' HD2' ' B' ' 14' ' ' LYS . 1.2 tptm -67.24 -40.7 86.35 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.023 -1.048 . . . . 0.0 109.518 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -59.67 -27.76 66.68 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.354 -0.841 . . . . 0.0 109.474 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.482 ' O ' ' N ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -72.54 -38.96 67.86 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.29 -0.881 . . . . 0.0 109.375 179.257 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.787 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.8 mp -67.64 59.6 0.06 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.369 -0.832 . . . . 0.0 109.874 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' B' ' 16' ' ' MET . 0.1 OUTLIER -90.03 -77.88 0.38 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.376 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.464 ' HA ' HD21 ' A' ' 116' ' ' LEU . 10.3 tmtt? -162.75 -68.51 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.97 -1.082 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.98 7.95 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 110.167 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.473 ' O ' ' CE ' ' A' ' 124' ' ' MET . 0.3 OUTLIER -103.7 159.79 15.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 109.639 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 0.1 OUTLIER -131.67 -34.22 1.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.158 -0.964 . . . . 0.0 110.386 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.37 171.09 33.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.609 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER -158.46 112.93 1.69 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.192 -1.181 . . . . 0.0 110.443 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.27 96.03 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.943 1.496 . . . . 0.0 110.468 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.89 -1.053 . . . . 0.0 110.565 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.108 0.48 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 10' ' ' ALA . 23.3 mt -63.23 -51.48 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -42.65 -50.18 5.46 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.235 -0.916 . . . . 0.0 109.98 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -58.03 -52.53 65.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.885 . . . . 0.0 109.555 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 8.5 m-85 -56.9 -39.82 75.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.303 -0.873 . . . . 0.0 109.716 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.4 ' O ' ' OG ' ' A' ' 17' ' ' SER . 3.7 tttt -63.29 -41.74 99.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.288 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.506 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 4.5 tp10 -58.23 -28.87 65.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 109.276 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -72.17 -60.87 2.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.528 -0.732 . . . . 0.0 109.769 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.534 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 21.7 t80 -52.61 -33.23 45.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.21 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 14' ' ' GLU . 2.6 p -69.47 -39.3 77.79 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.487 -0.758 . . . . 0.0 109.26 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.833 HD11 ' O ' ' A' ' 112' ' ' LEU . 1.4 tt -52.48 -36.86 55.91 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.423 -0.798 . . . . 0.0 108.965 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.556 ' CD1' HD12 ' A' ' 32' ' ' LEU . 67.0 m-85 -84.14 -45.94 12.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.578 -0.701 . . . . 0.0 109.902 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.423 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 13.5 t0 -77.49 88.15 3.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.847 . . . . 0.0 110.013 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -71.92 -13.35 61.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.251 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 21.8 p-10 -111.16 -5.73 14.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.472 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 52.97 57.51 14.41 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 8.0 p-10 -111.92 -41.46 4.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.183 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.467 ' C ' ' CG2' ' A' ' 26' ' ' THR . . . 123.55 18.96 2.9 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.467 ' CG2' ' C ' ' A' ' 25' ' ' GLY . 7.6 p -149.53 107.59 3.73 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.198 -1.178 . . . . 0.0 110.344 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.702 HD12 ' HB ' ' A' ' 63' ' ' ILE . 16.0 mt -88.7 118.53 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.128 -0.983 . . . . 0.0 110.091 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.1 p -93.73 153.34 18.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.335 -0.853 . . . . 0.0 109.986 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 p -45.39 -28.04 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.097 -1.002 . . . . 0.0 109.964 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -66.68 -62.08 1.63 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.098 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -45.1 -66.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 109.911 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.556 HD12 ' CD1' ' A' ' 19' ' ' PHE . 11.9 tp -51.44 -38.29 52.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.705 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.17 -43.03 97.41 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -58.81 -49.57 77.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -1.063 . . . . 0.0 109.782 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -53.72 -47.82 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 0.0 109.723 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.467 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 9.0 mmt -61.55 -34.7 76.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 109.862 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -20.52 64.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 110.152 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.6 m -83.19 -54.35 5.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 110.379 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 mt -45.03 -31.91 1.49 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.23 -0.919 . . . . 0.0 110.057 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.7 27.02 3.68 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -109.9 -175.82 2.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -1.164 . . . . 0.0 110.262 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -146.36 75.64 12.43 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.273 -0.892 . . . . 0.0 110.489 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 44.1 Cg_endo -72.33 149.1 50.35 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.992 1.522 . . . . 0.0 110.08 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.647 HG23 ' H ' ' A' ' 47' ' ' GLU . 7.2 t -90.54 -157.69 0.5 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.131 -0.981 . . . . 0.0 110.456 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -94.1 -44.95 7.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.314 -0.866 . . . . 0.0 110.173 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.78 84.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.178 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.647 ' H ' HG23 ' A' ' 44' ' ' THR . 51.6 mm-40 -64.72 -56.51 13.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 110.32 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 48' ' ' LEU . 14.2 mt -47.52 -45.23 26.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.144 -0.973 . . . . 0.0 110.196 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -63.21 -39.76 95.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.805 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.45 -42.86 74.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.412 ' O ' ' NE1' ' B' ' 7' ' ' TRP . 4.6 mtp -66.12 -34.46 78.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.393 -0.817 . . . . 0.0 109.602 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.544 HD13 HD11 ' A' ' 63' ' ' ILE . 7.1 mm -71.91 -36.31 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 0.7 OUTLIER -54.48 -52.05 63.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.387 -0.821 . . . . 0.0 109.977 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -43.57 -57.44 3.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.84 . . . . 0.0 109.949 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.814 HG22 ' HG3' ' A' ' 71' ' ' MET . 15.3 t -74.23 -31.11 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -0.925 . . . . 0.0 109.811 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.546 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 30.4 t70 -64.66 71.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 110.059 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -66.65 -25.24 66.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.239 -0.913 . . . . 0.0 110.389 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -75.75 -49.86 16.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.076 -1.015 . . . . 0.0 110.29 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.69 25.39 5.99 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 8.7 p30 -99.86 -32.47 10.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.211 -1.17 . . . . 0.0 110.332 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.11 9.76 10.35 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.8 p -131.09 142.07 50.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -1.13 . . . . 0.0 109.814 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.731 HD12 ' HB ' ' A' ' 55' ' ' VAL . 9.7 mm -88.03 143.03 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.219 -0.925 . . . . 0.0 110.279 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.534 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 1.6 m-20 -118.69 170.88 8.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.319 -0.863 . . . . 0.0 110.142 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.3 t80 -60.94 -50.6 84.17 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.108 -0.995 . . . . 0.0 111.26 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.0 Cg_endo -66.03 -25.61 51.45 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 O-C-N 123.2 1.105 . . . . 0.0 110.511 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 71' ' ' MET . 34.9 mt-10 -71.6 -34.02 69.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.132 -0.98 . . . . 0.0 109.819 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -74.51 -58.95 2.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 0.0 110.223 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.1 mt -48.98 -42.72 38.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 110.299 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 9.7 m -70.66 -30.17 66.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.197 -0.94 . . . . 0.0 110.421 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.814 ' HG3' HG22 ' A' ' 55' ' ' VAL . 4.0 tmm? -65.14 -63.69 1.04 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.744 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.642 ' SD ' HG22 ' B' ' 8' ' ' THR . 37.3 mmm -52.31 -19.31 2.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.995 -1.066 . . . . 0.0 110.22 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 70' ' ' THR . . . -74.36 -20.84 59.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.57 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -91.64 -25.75 19.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.081 -1.012 . . . . 0.0 110.762 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.878 ' HG3' HG21 ' B' ' 8' ' ' THR . 53.1 mmtt . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 110.584 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.113 0.482 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -79.61 -25.16 41.54 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.108 -0.995 . . . . 0.0 110.402 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -78.02 -27.29 48.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.182 -0.949 . . . . 0.0 110.117 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.54 HG23 ' CE1' ' A' ' 141' ' ' PHE . 92.6 mt -76.9 -39.24 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.96 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 51.5 ttp180 -62.79 -35.6 80.38 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 110.038 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.916 ' HB3' HG21 ' B' ' 9' ' ' THR . 19.6 mm-40 -69.35 -47.46 64.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 0.0 109.666 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.957 ' HB2' ' CD1' ' B' ' 12' ' ' LEU . . . -60.86 -33.59 73.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.113 -0.992 . . . . 0.0 109.897 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.11 -45.83 90.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.579 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 2.4 mtt180 -63.65 -26.94 68.9 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.411 -0.805 . . . . 0.0 109.759 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.803 HG11 HG21 ' B' ' 13' ' ' VAL . 41.2 t -63.84 -59.08 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 110.153 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.467 ' CE2' ' SD ' ' B' ' 16' ' ' MET . 22.7 m-85 -56.63 -32.16 65.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.08 -1.013 . . . . 0.0 110.059 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.47 ' OD1' HG12 ' A' ' 100' ' ' ILE . 3.1 m-20 -90.45 61.48 4.98 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.708 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.537 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -45.14 -23.38 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.422 -0.799 . . . . 0.0 110.407 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.537 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 35.2 p-10 -96.91 -31.14 12.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 80.09 51.83 4.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 32.6 p-10 -97.94 -14.34 20.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -1.15 . . . . 0.0 110.428 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 99.42 18.56 23.35 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 52.1 m-85 -158.08 157.03 32.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.247 -1.149 . . . . 0.0 110.088 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.47 HG12 ' OD1' ' A' ' 93' ' ' ASP . 21.5 mt -128.42 130.77 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -0.99 . . . . 0.0 110.689 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 30.9 t -116.82 151.56 36.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.837 . . . . 0.0 109.583 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.05 -26.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -72.35 -43.67 63.73 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.286 -0.884 . . . . 0.0 110.143 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 14.8 mt-10 -63.48 -33.03 74.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.006 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.987 ' CD1' HD11 ' A' ' 125' ' ' ILE . 3.8 mt -70.95 -43.61 67.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.879 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 -62.7 -26.04 68.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 109.559 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -75.0 -39.89 60.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.0 109.942 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.622 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -76.86 -33.56 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.377 179.501 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.667 ' HA ' HD21 ' B' ' 17' ' ' LEU . 3.2 mtm -54.92 -69.6 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.546 -0.721 . . . . 0.0 110.081 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -47.77 -29.05 2.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.194 -0.941 . . . . 0.0 109.714 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -85.44 -17.3 36.96 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.408 -0.808 . . . . 0.0 109.85 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.886 HD11 HG13 ' B' ' 13' ' ' VAL . 1.3 mt -94.31 -25.36 17.04 Favored 'General case' 0 C--O 1.199 -1.582 0 O-C-N 121.168 -0.957 . . . . 0.0 110.694 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.0 -50.73 0.66 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.285 -1.436 . . . . 0.0 111.214 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -117.05 158.94 23.32 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.864 -1.374 . . . . 0.0 111.549 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.0 tmtt? -131.43 73.74 1.56 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.697 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.6 mp -33.75 153.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.628 0.728 . . . . 0.0 111.682 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.3 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.536 -0.727 . . . . 0.0 110.375 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' GLU . 24.4 m-20 -98.79 -68.52 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.381 -0.825 . . . . 0.0 110.33 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -42.3 -47.85 4.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.432 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 124' ' ' MET . 3.3 mm-40 -60.61 -48.17 82.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 109.89 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 124' ' ' MET . 55.0 t -65.52 -38.76 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.072 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.99 -65.3 0.71 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 109.753 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 4.7 mt-10 -46.67 -26.13 0.86 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.391 -0.818 . . . . 0.0 109.52 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.485 ' HG2' ' CE1' ' B' ' 22' ' ' PHE . 18.7 ttt -66.37 -57.04 8.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.969 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.987 HD11 ' CD1' ' A' ' 105' ' ' LEU . 48.2 mm -61.5 -50.48 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.929 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -54.25 -25.88 25.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.178 -0.951 . . . . 0.0 109.933 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -70.92 -44.7 65.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.396 -0.815 . . . . 0.0 110.077 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -71.37 -32.09 68.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.442 -0.786 . . . . 0.0 110.062 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.407 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 88.8 m-20 -57.07 80.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.81 . . . . 0.0 110.384 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.581 HD12 ' HG3' ' A' ' 140' ' ' GLU . 1.9 mt -76.48 -37.75 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.932 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 14.6 p-10 -78.57 -31.48 47.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.056 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.61 65.75 0.97 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 26.3 p30 -124.44 -14.88 6.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -1.132 . . . . 0.0 110.46 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 90.54 17.72 51.37 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -163.23 169.78 18.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.332 -1.099 . . . . 0.0 110.019 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 137' ' ' ASN . 41.1 t -112.56 168.35 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.222 -0.924 . . . . 0.0 110.614 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.484 ' OD1' ' HB2' ' A' ' 140' ' ' GLU . 17.2 p-10 -152.18 -155.1 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -69.63 -69.44 0.34 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.295 -0.878 . . . . 0.0 110.717 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 140' ' ' GLU . 8.5 tt0 -46.19 -63.87 0.89 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.128 -0.982 . . . . 0.0 110.423 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.581 ' HG3' HD12 ' A' ' 130' ' ' ILE . 7.1 tt0 -41.46 -57.4 2.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.236 -0.915 . . . . 0.0 110.53 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.54 ' CE1' HG23 ' A' ' 85' ' ' ILE . 12.0 t80 -49.19 -28.88 4.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.237 -0.914 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.505 HG22 HG21 ' A' ' 85' ' ' ILE . 18.6 t -99.96 -38.35 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.234 -0.916 . . . . 0.0 110.607 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -33.69 69.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.201 -0.937 . . . . 0.0 110.794 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.538 ' HB2' HD11 ' A' ' 130' ' ' ILE . 10.0 tpp -88.3 -18.26 28.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.145 -0.972 . . . . 0.0 110.747 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.639 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 2.0 ttt -92.69 -9.8 39.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.0 110.101 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 110.939 -179.518 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 9.0 mt . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.599 ' HB2' HG23 ' B' ' 10' ' ' VAL . 40.3 Cg_endo -67.99 124.69 12.11 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.871 1.459 . . . . 0.0 110.325 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.527 ' O ' ' N ' ' B' ' 8' ' ' THR . 68.8 m -75.92 75.03 2.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.332 -0.855 . . . . 0.0 111.226 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.412 ' NE1' ' O ' ' A' ' 51' ' ' MET . 0.4 OUTLIER 53.93 -83.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.206 -0.934 . . . . 0.0 110.941 179.183 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.878 HG21 ' HG3' ' A' ' 75' ' ' LYS . 71.6 p -46.12 -46.81 17.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.38 -0.825 . . . . 0.0 110.017 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.916 HG21 ' HB3' ' A' ' 87' ' ' GLU . 52.7 m -52.1 -43.82 64.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.406 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.599 HG23 ' HB2' ' B' ' 5' ' ' PRO . 61.3 t -58.54 -27.38 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.259 -0.9 . . . . 0.0 108.879 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.439 HG21 ' HE2' ' A' ' 72' ' ' MET . 35.3 mm -78.16 -64.76 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.628 -0.67 . . . . 0.0 110.558 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.957 ' CD1' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -46.7 -45.39 19.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.132 -0.98 . . . . 0.0 110.485 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.886 HG13 HD11 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -60.44 -51.86 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.914 -1.116 . . . . 0.0 109.402 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.541 ' N ' HG12 ' B' ' 13' ' ' VAL . 0.0 OUTLIER -60.1 -33.04 71.56 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.993 -1.067 . . . . 0.0 109.055 178.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 6.1 t -62.69 -47.07 85.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.421 -0.799 . . . . 0.0 109.286 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.467 ' SD ' ' CE2' ' A' ' 92' ' ' PHE . 10.7 ttm -51.52 -35.88 42.47 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.389 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.816 HD22 HD13 ' A' ' 112' ' ' LEU . 7.1 mp -70.68 57.51 0.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.464 -0.773 . . . . 0.0 109.906 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.513 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 69.4 ttt-85 -122.46 -54.76 1.86 Allowed 'General case' 0 C--N 1.288 -2.069 0 O-C-N 121.404 -0.81 . . . . 0.0 111.128 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -138.74 -126.76 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.88 -1.138 . . . . 0.0 110.133 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.509 ' N ' ' HG2' ' B' ' 19' ' ' LYS . 5.0 ptp180 -119.87 41.15 3.24 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.026 -1.046 . . . . 0.0 109.918 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 8.4 t -121.52 148.7 44.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.401 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.56 ' CZ ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -117.7 -10.87 10.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.89 152.29 31.42 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.639 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 4.1 m-20 -148.63 127.5 6.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.238 . . . . 0.0 110.146 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.65 57.04 2.96 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.896 1.472 . . . . 0.0 110.279 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' B' ' 12' ' ' LEU . 2.9 m-85 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.32 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.7 mt -66.52 -52.48 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.376 -0.827 . . . . 0.0 109.352 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.88 -39.6 74.64 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -57.91 -49.27 77.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.442 -0.786 . . . . 0.0 109.251 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.568 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 17.6 m-85 -61.07 -37.4 82.55 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.291 -0.881 . . . . 0.0 109.189 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 10.7 ttpt -57.23 -42.19 80.96 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.309 -0.869 . . . . 0.0 109.073 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.21 -42.35 99.27 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.469 -0.769 . . . . 0.0 109.165 179.103 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.15 -47.99 77.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.485 -0.759 . . . . 0.0 109.297 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -54.78 -27.74 43.79 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.401 -0.812 . . . . 0.0 109.156 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 t -84.05 -37.24 22.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.462 -0.774 . . . . 0.0 109.395 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.545 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.4 tt -51.01 -36.65 40.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.418 -0.801 . . . . 0.0 109.244 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.442 ' HA ' HG21 ' A' ' 35' ' ' VAL . 86.2 m-85 -82.72 -39.78 21.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.734 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.456 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 31.1 t0 -74.86 92.33 2.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.454 -0.779 . . . . 0.0 110.058 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -65.3 -31.92 73.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 110.32 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 12.4 p-10 -90.38 -29.66 17.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.355 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.44 70.79 1.22 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 9.1 p-10 -120.21 -24.59 5.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -1.156 . . . . 0.0 110.061 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.81 -8.68 11.67 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 50.9 p -134.83 127.93 31.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -1.128 . . . . 0.0 110.222 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.684 HD12 ' CB ' ' A' ' 63' ' ' ILE . 16.4 mt -94.06 133.37 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 p -90.53 -171.35 3.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.899 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 p -83.59 -35.58 24.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.006 . . . . 0.0 109.957 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -68.52 -35.67 77.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -56.88 -55.56 32.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.19 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.62 HD13 ' CH2' ' B' ' 7' ' ' TRP . 24.6 tp -58.92 -39.73 82.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.208 -0.932 . . . . 0.0 110.253 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -56.25 -43.38 89.3 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.0 m -63.42 -56.5 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -1.176 . . . . 0.0 110.032 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.481 ' H ' HG23 ' A' ' 35' ' ' VAL . 11.7 t -55.79 -26.94 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.795 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 2.4 mmt -69.71 -41.15 75.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.247 -0.908 . . . . 0.0 109.766 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -65.81 -29.41 69.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.996 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -56.39 -55.67 30.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.13 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.486 ' CD2' HG13 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -54.87 -39.23 68.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.8 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 126.77 55.86 0.14 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.534 ' HB3' ' CD1' ' B' ' 4' ' ' ILE . 40.3 mt-30 -142.35 153.92 44.23 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.169 -1.195 . . . . 0.0 110.346 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -117.76 80.31 13.9 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.227 -0.921 . . . . 0.0 110.473 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.27 146.38 40.3 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.977 1.514 . . . . 0.0 110.224 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 45' ' ' GLU . 9.6 t -100.04 -153.81 0.45 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.204 -0.935 . . . . 0.0 110.412 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.504 ' N ' HG23 ' A' ' 44' ' ' THR . 45.3 tt0 -87.18 -52.28 5.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -0.907 . . . . 0.0 110.406 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.5 76.04 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.236 -0.915 . . . . 0.0 110.305 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' LEU . 37.8 mt-10 -63.67 -55.2 25.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.295 -0.878 . . . . 0.0 110.328 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' GLU . 15.0 mt -43.81 -52.73 6.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.124 -0.985 . . . . 0.0 109.963 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -59.96 -36.19 76.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.79 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.28 -42.04 76.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.879 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.472 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 0.1 OUTLIER -67.91 -36.18 79.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 179.457 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 5.4 mm -73.31 -21.48 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.477 -0.764 . . . . 0.0 109.905 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 54' ' ' GLU . 2.6 m-20 -66.3 -54.68 21.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 110.501 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 53' ' ' ASN . 2.6 tp10 -41.09 -35.32 0.54 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.46 -0.775 . . . . 0.0 110.598 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.671 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 10.5 t -96.68 -34.97 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.18 -0.95 . . . . 0.0 110.284 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 40.5 t0 -49.46 88.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.48 -0.762 . . . . 0.0 110.729 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -80.02 -32.36 39.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.224 -0.922 . . . . 0.0 110.38 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.453 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 7.6 m-20 -76.13 -47.38 24.6 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.17 -0.956 . . . . 0.0 110.448 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.55 0.13 9.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 18.7 p30 -88.77 -32.49 17.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.113 -1.228 . . . . 0.0 110.357 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 114.44 -28.64 8.1 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 p -70.3 151.47 45.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.154 -1.204 . . . . 0.0 110.359 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.684 ' CB ' HD12 ' A' ' 27' ' ' ILE . 9.1 mm -102.46 122.9 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.449 ' C ' ' HD2' ' A' ' 66' ' ' PRO . 21.4 t0 -99.23 157.69 16.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.4 t80 -48.81 -45.65 72.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.711 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 50.0 Cg_endo -74.64 -37.34 2.35 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 123.347 1.183 . . . . 0.0 109.815 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 57' ' ' ALA . 4.2 tt0 -51.74 -49.07 63.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.505 -0.747 . . . . 0.0 110.199 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.13 -45.61 69.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.282 -0.886 . . . . 0.0 110.21 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -59.85 -12.59 7.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 0.0 110.607 -179.731 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.8 m -95.43 -43.21 8.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -0.988 . . . . 0.0 110.865 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -62.87 -39.81 95.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.089 -1.007 . . . . 0.0 110.993 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.568 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 9.3 tpt -61.49 -9.74 6.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.131 -0.981 . . . . 0.0 111.127 -179.276 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.81 -18.43 15.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.984 -1.072 . . . . 0.0 111.089 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -23.7 14.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.986 -1.071 . . . . 0.0 110.896 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HG2' HG21 ' B' ' 8' ' ' THR . 15.8 tttt . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.043 -1.036 . . . . 0.0 110.638 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.688 ' HA ' HD12 ' A' ' 85' ' ' ILE . 1.4 pt-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.213 0.53 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.88 -46.83 61.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 109.793 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -58.48 -20.71 47.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 110.152 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.688 HD12 ' HA ' ' A' ' 82' ' ' GLU . 73.2 mt -69.79 -45.23 77.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.136 -0.978 . . . . 0.0 109.015 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 89' ' ' PHE . 58.3 ttt180 -56.89 -31.94 65.38 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.46 -56.42 6.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.39 -0.819 . . . . 0.0 109.306 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' B' ' 12' ' ' LEU . . . -54.58 -22.41 13.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.196 -0.94 . . . . 0.0 108.982 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 138' ' ' TYR . 84.1 t80 -71.41 -63.73 1.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.375 -0.828 . . . . 0.0 109.482 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -49.25 -38.34 26.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.383 -0.823 . . . . 0.0 109.076 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.694 HG12 HG21 ' A' ' 108' ' ' VAL . 18.6 t -63.78 -35.06 71.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.559 -0.713 . . . . 0.0 109.592 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.741 ' CE1' HG13 ' B' ' 13' ' ' VAL . 2.4 m-85 -72.74 -36.83 67.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.291 -0.881 . . . . 0.0 109.307 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 104' ' ' GLU . 3.6 t70 -99.91 62.19 1.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.757 . . . . 0.0 109.964 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' ASP . 7.7 tmtm? -42.64 -54.52 3.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 109.874 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.483 ' OD2' ' HG3' ' A' ' 104' ' ' GLU . 1.1 p30 -58.53 -27.32 64.41 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.533 -0.729 . . . . 0.0 109.913 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 60.86 59.24 10.5 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 34.3 p-10 -98.02 -41.95 7.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.201 -1.176 . . . . 0.0 110.556 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 162.96 -43.58 0.34 Allowed Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.295 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 15.0 m-85 -123.2 166.55 15.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.269 . . . . 0.0 110.904 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 100' ' ' ILE . 9.6 mt -102.69 84.33 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.34 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.414 ' HB2' ' OE1' ' A' ' 135' ' ' GLN . 0.2 OUTLIER -73.96 161.45 30.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.077 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.28 -19.4 3.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.922 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.84 -33.34 46.08 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.29 -0.881 . . . . 0.0 109.205 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -67.51 -42.47 82.74 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.54 -0.725 . . . . 0.0 109.254 179.178 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.054 HD12 HD11 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -63.08 -42.23 99.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.331 -0.855 . . . . 0.0 109.163 178.936 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -62.47 -26.82 68.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.593 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.462 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -69.95 -48.68 57.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.441 -0.787 . . . . 0.0 109.968 179.718 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.694 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -74.13 -30.88 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.286 -0.884 . . . . 0.0 109.455 179.47 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.814 ' HA ' HD21 ' B' ' 17' ' ' LEU . 2.4 ttm -52.04 -70.34 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.652 -0.655 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.7 m -51.77 -26.76 10.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.14 -0.975 . . . . 0.0 110.337 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.48 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 8.7 m120 -72.33 -18.39 61.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.333 -0.855 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.873 HD12 HD22 ' B' ' 17' ' ' LEU . 10.2 mt -98.87 -48.84 4.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 110.423 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.42 -58.0 0.21 Allowed Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.768 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -90.89 162.21 14.89 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.964 -1.315 . . . . 0.0 111.299 -178.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.99 72.92 1.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.58 -0.7 . . . . 0.0 109.52 179.39 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 116' ' ' LEU . 4.6 mp -33.8 150.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.614 0.721 . . . . 0.0 111.525 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 118' ' ' ASP . 1.1 m -59.18 -147.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 109.82 179.268 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.545 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -113.13 -49.65 2.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 179.816 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.65 -51.76 66.13 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.073 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 121' ' ' VAL . 10.1 pt-20 -61.01 -44.67 97.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.55 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 73.4 t -60.36 -39.38 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.349 -0.844 . . . . 0.0 109.673 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.67 -53.54 56.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 109.725 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -57.09 -25.62 59.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.602 ' HG3' ' HA ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -64.05 -49.21 73.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.353 -0.842 . . . . 0.0 109.47 179.259 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.054 HD11 HD12 ' A' ' 105' ' ' LEU . 28.8 mm -73.27 -35.83 47.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.711 -0.618 . . . . 0.0 110.247 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.409 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 3.4 tmm_? -68.94 -22.74 64.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.204 -0.935 . . . . 0.0 110.063 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.57 -34.31 67.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 110.242 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -93.34 -26.4 17.3 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.356 -0.84 . . . . 0.0 110.233 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 126' ' ' ARG . 85.9 m-20 -45.5 90.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.323 -0.861 . . . . 0.0 110.661 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -82.96 -40.82 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.158 -0.964 . . . . 0.0 109.521 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 35.2 p-10 -76.54 -24.47 53.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.929 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.477 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.99 35.05 19.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 15.9 p-10 -89.38 -15.97 32.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -1.113 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 135' ' ' GLN . . . 97.78 9.63 54.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 68.6 mt-30 -157.08 153.4 27.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.217 -1.167 . . . . 0.0 110.275 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 25.1 t -90.83 113.33 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.262 -0.899 . . . . 0.0 110.023 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -87.93 176.07 7.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.935 . . . . 0.0 110.557 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 5.2 t80 -57.08 -63.63 1.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.245 -0.91 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.6 OUTLIER -41.79 -49.34 4.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 0.0 109.989 179.891 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.443 ' HG2' HD12 ' A' ' 130' ' ' ILE . 3.0 mt-10 -57.08 -57.87 10.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 0.0 109.932 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.449 ' O ' ' SD ' ' A' ' 145' ' ' MET . 10.0 t80 -47.5 -24.47 0.85 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.275 -0.891 . . . . 0.0 109.962 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.498 HG13 HG21 ' A' ' 146' ' ' THR . 42.5 t -99.66 -39.4 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 110.409 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -65.89 -9.89 33.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.925 . . . . 0.0 110.797 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.465 ' CE ' ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -98.17 -26.13 14.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.029 -1.045 . . . . 0.0 110.704 -179.746 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' SD ' ' O ' ' A' ' 141' ' ' PHE . 6.5 mtp -100.48 -34.67 9.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 110.762 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.498 HG21 HG13 ' A' ' 142' ' ' VAL . 69.0 p . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 0.0 110.35 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 41' ' ' GLN . 15.9 mm . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.24 -160.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.083 1.57 . . . . 0.0 111.243 -178.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 10.5 p -123.03 -179.17 4.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.402 -0.811 . . . . 0.0 110.911 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.671 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 22.5 m95 -59.1 -71.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.561 0.696 . . . . 0.0 111.075 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.577 HG21 ' HG2' ' A' ' 75' ' ' LYS . 65.8 p -39.88 -28.17 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.737 -0.602 . . . . 0.0 110.493 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.459 ' N ' ' O ' ' B' ' 7' ' ' TRP . 1.1 m -61.66 -50.11 73.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.678 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 t -63.89 -33.69 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.529 -0.732 . . . . 0.0 110.09 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.586 ' N ' HD13 ' B' ' 11' ' ' ILE . 3.8 mm -74.18 -31.89 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.261 -0.899 . . . . 0.0 109.979 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.482 ' O ' ' OG ' ' B' ' 15' ' ' SER . 0.4 OUTLIER -62.55 -52.45 63.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.852 . . . . 0.0 110.093 179.741 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.741 HG13 ' CE1' ' A' ' 92' ' ' PHE . 78.2 t -67.81 -43.78 85.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.669 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.425 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -59.52 -49.74 76.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.737 -1.227 . . . . 0.0 109.692 179.453 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' B' ' 12' ' ' LEU . 3.5 p -50.67 -42.27 56.46 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.42 ' SD ' ' HG3' ' B' ' 25' ' ' PRO . 26.2 tpp -73.12 -13.93 61.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.69 179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.873 HD22 HD12 ' A' ' 112' ' ' LEU . 2.9 mp -89.94 62.44 5.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 110.142 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 ttp85 -118.31 -74.4 0.61 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.364 -0.835 . . . . 0.0 111.022 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.534 ' HD2' ' HB2' ' B' ' 20' ' ' ARG . 2.3 tmtm? -138.04 -75.45 0.39 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.081 -1.012 . . . . 0.0 110.952 -178.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.602 ' HA ' ' HG3' ' A' ' 124' ' ' MET . 1.0 OUTLIER -140.09 -4.21 1.36 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.714 -1.241 . . . . 0.0 111.31 -179.655 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -53.12 141.14 23.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.026 -1.046 . . . . 0.0 110.684 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -170.88 137.54 1.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.402 -0.811 . . . . 0.0 110.189 179.581 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.465 ' HA3' ' CE ' ' A' ' 144' ' ' MET . . . 126.11 -87.2 0.35 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.537 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 3.2 p-10 -131.41 50.43 5.96 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.237 -1.155 . . . . 0.0 110.338 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 45.3 Cg_endo -73.48 -6.14 18.27 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.055 1.555 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.214 0.53 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 10' ' ' ALA . 53.7 mt -57.44 -59.21 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -42.56 -46.18 4.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 110.051 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.82 -54.76 33.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.015 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CD2' HD23 ' A' ' 69' ' ' LEU . 21.4 m-85 -61.13 -42.91 99.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.97 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -58.58 -34.05 70.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.185 -0.947 . . . . 0.0 109.344 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -61.78 -44.67 96.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.381 -0.825 . . . . 0.0 109.49 179.346 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -66.43 -52.1 49.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.462 -0.774 . . . . 0.0 110.08 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.6 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 35.7 t80 -63.73 -12.23 33.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.811 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.3 m -92.76 -25.99 17.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.882 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.729 HD13 ' HG3' ' B' ' 14' ' ' LYS . 7.1 tt -77.67 -30.39 51.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.603 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 47.5 m-85 -80.01 -56.71 4.05 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.335 -0.853 . . . . 0.0 110.686 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -62.84 82.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.165 -0.96 . . . . 0.0 110.213 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -88.86 21.25 3.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.235 -179.973 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 23' ' ' GLY . 7.4 p-10 -140.1 18.68 2.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.459 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.9 75.76 0.15 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.449 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 1.8 t0 -132.66 -26.7 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -1.134 . . . . 0.0 110.685 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.68 -21.4 29.88 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -119.27 118.8 32.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -1.101 . . . . 0.0 109.874 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.502 HD12 HG21 ' A' ' 63' ' ' ILE . 12.3 mt -79.34 126.17 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.121 -0.987 . . . . 0.0 109.606 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.8 p -90.16 -157.68 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.795 . . . . 0.0 110.386 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.49 HG22 HG13 ' A' ' 52' ' ' ILE . 77.8 p -94.16 -33.43 13.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 13.0 ptpt -74.68 -31.07 61.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.121 -0.987 . . . . 0.0 110.288 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 14.9 mt-10 -58.17 -66.35 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.118 -0.988 . . . . 0.0 109.47 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.625 HD22 ' CZ2' ' B' ' 7' ' ' TRP . 58.1 tp -56.75 -35.45 68.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.168 -0.958 . . . . 0.0 109.25 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.81 -37.14 93.83 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.387 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 96.6 m -59.44 -47.13 86.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.348 -1.089 . . . . 0.0 109.441 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 35' ' ' VAL . 14.7 t -70.93 -37.35 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.592 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.654 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -69.19 -44.74 71.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.385 -0.822 . . . . 0.0 109.775 179.549 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -62.57 -29.77 70.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.973 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.43 ' O ' ' CG ' ' A' ' 111' ' ' ASN . 3.3 t -79.1 -21.67 46.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 110.014 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 36' ' ' MET . 4.3 mt -68.13 -32.01 71.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.36 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.07 -60.63 0.44 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -172.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -1.199 . . . . 0.0 110.714 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 54.7 m-80 -137.1 98.88 10.16 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.431 -0.793 . . . . 0.0 109.826 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 44.3 Cg_endo -71.61 124.04 9.95 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.965 1.508 . . . . 0.0 110.464 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -93.08 167.22 11.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.3 -37.08 71.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 0.0 110.108 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.07 64.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.238 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.486 ' OE1' HD12 ' B' ' 4' ' ' ILE . 20.9 mt-10 -66.78 -38.55 86.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.087 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 48' ' ' LEU . 12.2 mt -62.08 -39.72 93.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.087 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -43.89 86.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.334 -0.854 . . . . 0.0 109.696 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.18 -38.03 89.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.35 -0.844 . . . . 0.0 109.652 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.595 ' HE1' ' CG ' ' B' ' 7' ' ' TRP . 7.4 mmm -67.26 -42.31 84.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.668 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.49 HG13 HG22 ' A' ' 29' ' ' THR . 4.4 mm -70.16 -19.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.35 -0.844 . . . . 0.0 109.625 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.11 -16.21 41.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.269 -0.894 . . . . 0.0 110.02 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -71.31 -31.01 66.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.42 -0.8 . . . . 0.0 110.241 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 57' ' ' ALA . 20.4 t -92.02 -37.09 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.163 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.427 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 1.4 t70 -46.68 87.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.641 . . . . 0.0 110.555 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -99.05 -26.78 14.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 0.0 110.203 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 3.1 p-10 -73.96 -43.27 58.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -0.962 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 58' ' ' ASP . . . 114.17 27.4 3.43 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 21.8 p-10 -99.53 -40.16 7.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.098 -1.236 . . . . 0.0 110.102 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 123.43 -46.76 1.07 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.2 p -95.31 166.5 11.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -1.217 . . . . 0.0 110.479 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 26' ' ' THR . 16.4 mm -88.69 142.24 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.3 -0.875 . . . . 0.0 109.894 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.2 m-20 -121.2 147.34 45.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.982 -1.073 . . . . 0.0 110.863 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.62 ' O ' HD12 ' A' ' 69' ' ' LEU . 89.7 t80 -41.61 -50.78 9.44 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.453 -0.78 . . . . 0.0 111.546 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.0 Cg_endo -66.35 -43.36 8.38 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 123.252 1.133 . . . . 0.0 110.773 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 43.4 tt0 -60.93 -36.82 80.32 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.208 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 13.0 t80 -62.56 -45.83 91.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.997 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 65' ' ' PHE . 2.7 mt -61.94 -29.91 70.55 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.319 -0.863 . . . . 0.0 110.726 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 1.7 p -79.4 -33.41 42.75 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.154 -0.966 . . . . 0.0 111.347 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.477 ' HG3' HG13 ' A' ' 55' ' ' VAL . 9.1 tmm? -69.05 -43.27 75.0 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.962 -1.087 . . . . 0.0 110.975 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.445 ' HE2' ' CZ ' ' B' ' 26' ' ' PHE . 10.7 tpt -58.66 -10.85 2.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.189 -0.944 . . . . 0.0 111.12 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.95 -9.81 16.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.865 -1.147 . . . . 0.0 111.236 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -94.4 -43.49 8.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.961 -1.087 . . . . 0.0 110.686 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.317 -0.864 . . . . 0.0 110.486 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.142 0.496 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -72.08 -17.94 61.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -0.972 . . . . 0.0 109.509 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -70.11 -23.23 63.0 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.455 -0.778 . . . . 0.0 109.871 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.6 mt -64.88 -28.99 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.2 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -32.32 73.71 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.616 -0.677 . . . . 0.0 109.807 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.799 ' HB3' HG21 ' B' ' 9' ' ' THR . 13.9 mt-10 -74.16 -47.61 34.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.863 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.52 67.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.005 -1.059 . . . . 0.0 109.405 179.537 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CE1' ' OD2' ' A' ' 93' ' ' ASP . 11.8 t80 -71.44 -46.43 60.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -52.91 -32.35 44.95 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.436 -0.79 . . . . 0.0 109.321 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.666 HG12 HG21 ' A' ' 108' ' ' VAL . 20.7 t -71.27 -43.09 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.543 -0.723 . . . . 0.0 109.85 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.617 ' HB3' HD13 ' A' ' 100' ' ' ILE . 19.6 m-85 -66.58 -28.26 68.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.237 -0.914 . . . . 0.0 109.797 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.551 ' OD2' ' CE1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -88.03 62.29 6.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.388 -0.82 . . . . 0.0 109.788 179.788 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -36.29 -32.74 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.703 -0.623 . . . . 0.0 110.968 -179.553 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 12.5 p30 -111.23 -39.15 4.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.171 -0.956 . . . . 0.0 110.389 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 92.09 55.22 1.75 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 99' ' ' TYR . 52.1 p30 -97.29 0.24 47.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.178 -1.189 . . . . 0.0 110.175 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.585 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 93.68 12.56 56.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.452 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -154.14 142.31 20.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.359 -1.083 . . . . 0.0 110.03 -179.944 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 92' ' ' PHE . 5.7 mt -101.51 116.8 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.238 -0.914 . . . . 0.0 110.119 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 t -98.97 142.03 30.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.288 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.02 -35.73 3.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.832 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -58.82 -49.77 76.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 109.538 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.61 -50.02 66.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.704 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.815 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -59.32 -41.08 88.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.835 . . . . 0.0 109.397 179.468 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 13.2 ttt180 -56.08 -27.7 54.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.311 -0.868 . . . . 0.0 109.403 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.13 -42.5 37.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.619 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.666 HG21 HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -70.06 -26.89 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.292 179.588 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 109' ' ' MET . . . . . 1.011 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.5 OUTLIER -64.33 -64.8 0.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.361 -0.837 . . . . 0.0 110.155 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.18 -33.44 63.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.903 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 38' ' ' SER . 77.5 m-20 -75.31 -18.52 60.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 110.174 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.691 HD11 HG12 ' B' ' 13' ' ' VAL . 4.3 mt -92.41 -41.36 10.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 110.268 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.32 -36.75 0.81 Allowed Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.251 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 3.4 tp10 -116.09 158.24 23.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.915 -1.344 . . . . 0.0 110.981 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -139.24 83.09 1.93 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.149 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' B' ' 19' ' ' LYS . 6.3 mp -38.34 140.76 0.28 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.591 -0.693 . . . . 0.0 111.074 -179.265 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -54.35 -168.52 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.541 -0.724 . . . . 0.0 109.497 179.327 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -74.95 -68.71 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.057 -1.027 . . . . 0.0 110.211 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.46 -45.16 12.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.308 -0.87 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.14 -44.28 92.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 110.049 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 117' ' ' THR . 20.1 t -61.05 -40.44 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.99 -29.21 69.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.249 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -74.63 -30.61 61.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.5 ' HE1' ' CE2' ' B' ' 22' ' ' PHE . 0.1 OUTLIER -70.41 -51.26 30.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.136 -0.977 . . . . 0.0 110.248 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.815 HD11 ' CD1' ' A' ' 105' ' ' LEU . 49.8 mm -64.56 -41.26 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.25 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -27.11 67.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 110.221 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.5 OUTLIER -69.29 -21.04 63.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.88 -35.76 8.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.931 . . . . 0.0 110.271 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 5.1 t0 -43.11 105.6 0.05 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.317 -0.864 . . . . 0.0 110.411 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 130' ' ' ILE . 23.4 mm -74.99 -33.97 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.251 -0.906 . . . . 0.0 109.928 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 7.1 p-10 -103.72 -21.98 13.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 0.0 109.989 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.412 ' HA2' ' CG ' ' A' ' 129' ' ' ASP . . . 81.09 70.41 1.34 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 19.3 p-10 -120.68 -10.96 9.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.186 -1.185 . . . . 0.0 110.406 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.77 12.13 30.99 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -164.59 147.35 8.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.188 -1.183 . . . . 0.0 110.168 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 11.7 t -99.98 143.15 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 110.338 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 98' ' ' GLY . 1.7 t-20 -105.32 -168.23 1.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 109.89 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.415 ' CE1' HG21 ' A' ' 142' ' ' VAL . 41.1 t80 -76.06 -48.46 20.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.27 -41.29 65.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.9 -52.23 38.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.274 -0.891 . . . . 0.0 110.33 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -57.0 -17.32 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.326 -0.859 . . . . 0.0 110.631 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.564 ' O ' HG22 ' A' ' 146' ' ' THR . 37.3 t -100.26 -70.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.07 -1.019 . . . . 0.0 111.006 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -39.82 -37.14 0.51 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.257 -0.902 . . . . 0.0 110.7 -179.487 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.6 mmm -62.75 -29.09 70.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.154 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.473 ' HA ' ' HB2' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -100.4 -30.86 11.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.333 -0.854 . . . . 0.0 110.653 -179.898 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.6 t . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.096 -1.003 . . . . 0.0 110.525 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.761 HG23 ' HD2' ' B' ' 5' ' ' PRO . 7.8 mt . . . . . 0 N--CA 1.506 2.358 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.761 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.9 Cg_endo -65.31 -176.35 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.844 1.444 . . . . 0.0 110.662 -179.074 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.472 ' O ' ' N ' ' B' ' 8' ' ' THR . 28.9 t -126.96 64.06 1.3 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.14 -0.975 . . . . 0.0 111.384 -178.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.625 ' CZ2' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER 58.09 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.207 -0.933 . . . . 0.0 111.188 178.688 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.472 ' N ' ' O ' ' B' ' 6' ' ' SER . 12.0 p -43.6 -42.79 5.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.992 . . . . 0.0 110.25 -179.335 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.799 HG21 ' HB3' ' A' ' 87' ' ' GLU . 3.8 m -52.41 -44.39 65.36 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.177 -0.952 . . . . 0.0 109.209 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.71 -37.43 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.337 -0.852 . . . . 0.0 109.381 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.583 ' N ' HD13 ' B' ' 11' ' ' ILE . 4.2 mm -71.38 -25.0 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -0.797 . . . . 0.0 109.499 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' B' ' 9' ' ' THR . 2.0 mp -67.38 -60.31 2.69 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.336 -0.853 . . . . 0.0 109.645 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.691 HG12 HD11 ' A' ' 112' ' ' LEU . 72.7 t -57.77 -37.79 61.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.348 -0.845 . . . . 0.0 109.99 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.729 ' HG3' HD13 ' A' ' 18' ' ' LEU . 2.4 ttpt -59.41 -45.1 92.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.028 -1.045 . . . . 0.0 109.467 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' B' ' 18' ' ' ARG . 1.6 m -62.79 -26.28 68.64 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.339 -0.85 . . . . 0.0 109.537 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.533 ' HA ' ' HB2' ' B' ' 21' ' ' SER . 0.0 OUTLIER -70.54 -32.37 69.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.891 . . . . 0.0 109.748 179.663 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 1.011 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.9 mp -73.65 -5.56 41.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.297 -0.877 . . . . 0.0 110.489 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.9 OUTLIER -44.21 -56.45 4.1 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.152 -0.968 . . . . 0.0 109.468 179.885 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.548 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -171.72 -68.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.605 0.717 . . . . 0.0 109.271 179.699 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.503 ' HB3' ' CD ' ' B' ' 19' ' ' LYS . 0.8 OUTLIER -129.51 14.67 6.03 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.073 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' B' ' 16' ' ' MET . 20.0 m -48.3 145.29 3.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.637 -0.664 . . . . 0.0 110.761 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.5 ' CE2' ' HE1' ' A' ' 124' ' ' MET . 0.1 OUTLIER 171.67 -34.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.495 -0.753 . . . . 0.0 109.912 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.29 -128.82 0.03 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.643 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 43.9 t30 -131.76 34.42 0.26 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.988 -1.301 . . . . 0.0 111.723 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 51.3 Cg_endo -76.33 56.65 5.09 Favored 'Trans proline' 0 N--CA 1.481 0.788 0 O-C-N 123.185 1.097 . . . . 0.0 110.472 179.549 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.445 ' CZ ' ' HE2' ' A' ' 72' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.256 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 8.2 mm100 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.374 0.607 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mt -48.1 -43.88 11.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 109.432 179.397 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -54.01 -47.38 71.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.384 -0.822 . . . . 0.0 109.491 179.418 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 1.4 mt-10 -49.49 -54.19 19.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.507 179.43 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -59.46 -38.92 82.03 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.144 -0.973 . . . . 0.0 109.389 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 10.3 ttpt -53.54 -43.62 68.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.285 -0.884 . . . . 0.0 109.173 179.165 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -56.87 -48.32 78.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 108.888 178.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.21 -54.16 50.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.412 -0.805 . . . . 0.0 109.292 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 65' ' ' PHE . 55.7 t80 -50.71 -35.64 32.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.813 . . . . 0.0 109.126 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.15 -29.39 48.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.598 -0.689 . . . . 0.0 109.396 179.258 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.616 HD11 ' O ' ' A' ' 112' ' ' LEU . 3.6 tt -53.04 -50.75 63.65 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.391 -0.818 . . . . 0.0 109.365 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 45.0 m-85 -69.72 -28.03 65.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.393 179.206 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.515 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 16.0 t0 -87.23 66.15 9.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.74 . . . . 0.0 110.14 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -45.25 -32.03 1.77 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.146 -0.971 . . . . 0.0 110.324 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 11.8 p-10 -89.72 -7.19 55.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.348 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 47.98 71.26 0.59 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 35.9 p-10 -116.9 -34.28 4.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -1.147 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 128.76 -0.51 6.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 21.2 p -142.4 128.28 19.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -1.159 . . . . 0.0 110.615 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.556 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 10.7 mt -91.96 129.65 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.214 -0.929 . . . . 0.0 110.054 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 p -99.64 -163.81 1.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 110.136 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 48' ' ' LEU . 4.5 p -91.2 -38.03 12.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.111 -0.993 . . . . 0.0 110.049 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -66.85 -33.39 75.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.994 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' OE2' ' HA ' ' A' ' 20' ' ' ASP . 2.1 mt-10 -67.05 -64.25 0.89 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.88 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.511 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 21.5 tp -52.85 -36.85 59.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 109.843 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.7 92.33 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.1 m -63.88 -52.86 58.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -1.094 . . . . 0.0 109.822 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 19' ' ' PHE . 26.3 t -52.75 -43.66 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.732 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.5 ' HE1' ' SD ' ' A' ' 51' ' ' MET . 32.2 mtt -64.18 -38.51 91.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.638 179.676 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.24 -16.37 63.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.848 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -79.0 -63.0 1.52 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.314 -0.866 . . . . 0.0 110.603 -179.879 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.472 ' O ' ' HE2' ' A' ' 94' ' ' LYS . 1.4 mt -43.48 -41.68 4.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.094 -1.004 . . . . 0.0 109.924 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 134.12 61.91 0.07 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.481 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 11.0 mt-30 -157.34 -176.36 5.91 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.125 -1.221 . . . . 0.0 109.974 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -144.17 97.44 5.24 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.109 -0.995 . . . . 0.0 110.612 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.843 ' HA ' HD11 ' B' ' 4' ' ' ILE . 49.2 Cg_endo -76.39 137.23 18.51 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.015 1.534 . . . . 0.0 110.539 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 47' ' ' GLU . 24.1 m -87.75 142.91 27.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 109.87 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -42.21 -64.2 0.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 110.27 179.994 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.71 -52.15 42.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 110.092 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 2.8 mm-40 -50.21 -53.05 30.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.308 -0.87 . . . . 0.0 109.985 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -44.94 -51.64 9.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 110.13 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 40.1 tp60 -57.4 -32.71 67.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -0.822 . . . . 0.0 109.999 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -68.0 -38.67 82.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 109.906 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.576 ' HE3' ' O ' ' B' ' 6' ' ' SER . 2.0 ttp -81.55 -27.5 34.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.398 -0.814 . . . . 0.0 110.246 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 mm -78.29 -29.9 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.302 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -77.55 0.96 20.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.18 -0.95 . . . . 0.0 110.017 179.807 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.56 -44.68 11.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.294 -0.878 . . . . 0.0 109.669 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.852 HG13 ' HG3' ' A' ' 71' ' ' MET . 41.0 t -79.72 -20.26 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 109.928 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -51.4 87.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.347 -0.846 . . . . 0.0 110.152 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -87.01 -47.22 9.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.259 -0.901 . . . . 0.0 111.062 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.2 p-10 -57.46 -45.94 84.2 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.023 -1.048 . . . . 0.0 110.828 -179.373 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 120.16 18.24 4.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 32.8 p-10 -96.24 -46.01 6.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -1.23 . . . . 0.0 110.239 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 134.6 -43.8 1.23 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.54 168.48 16.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.258 -1.142 . . . . 0.0 110.51 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.556 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 11.4 mm -92.76 143.76 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 110.109 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -117.95 163.69 16.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.088 -1.008 . . . . 0.0 110.379 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 44.9 t80 -59.24 -50.7 86.21 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.269 -0.894 . . . . 0.0 110.483 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -69.02 -29.2 27.81 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 O-C-N 123.393 1.207 . . . . 0.0 109.517 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' HG3' ' HB3' ' A' ' 57' ' ' ALA . 5.9 tt0 -67.75 -31.21 70.97 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.475 -0.766 . . . . 0.0 109.06 178.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.413 ' CZ ' HG13 ' B' ' 11' ' ' ILE . 5.6 t80 -70.06 -53.75 16.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.538 -0.726 . . . . 0.0 109.889 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -54.01 -35.52 62.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.387 -0.82 . . . . 0.0 110.333 -179.966 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 71' ' ' MET . 1.3 m -78.04 -53.7 7.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.23 -0.919 . . . . 0.0 110.712 -179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.852 ' HG3' HG13 ' A' ' 55' ' ' VAL . 5.7 tmm? -41.24 -42.69 2.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.226 -0.921 . . . . 0.0 110.553 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.467 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 0.1 OUTLIER -51.24 -17.83 0.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -0.868 . . . . 0.0 110.681 -179.741 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.48 -35.86 10.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.016 -1.052 . . . . 0.0 110.925 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -31.65 54.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.066 -1.022 . . . . 0.0 110.742 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB3' HG21 ' B' ' 8' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 85' ' ' ILE . 19.7 mt-10 . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.226 0.536 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 87' ' ' GLU . 7.3 tt0 -74.52 -44.52 50.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.096 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.64 -23.56 66.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.488 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.545 HG23 ' CE2' ' A' ' 141' ' ' PHE . 67.2 mt -78.43 -45.48 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.927 . . . . 0.0 109.816 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -53.89 -36.66 62.91 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 109.705 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.55 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 0.3 OUTLIER -69.83 -52.22 26.84 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.213 -0.929 . . . . 0.0 109.542 179.494 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.69 -35.3 65.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.093 -1.005 . . . . 0.0 109.036 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 63.3 t80 -67.28 -47.59 70.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.508 -0.745 . . . . 0.0 109.668 179.262 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -46.42 71.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.404 -0.81 . . . . 0.0 109.328 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.629 HG11 HG21 ' B' ' 13' ' ' VAL . 1.5 t -51.09 -48.94 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.415 -0.803 . . . . 0.0 109.418 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.52 ' HB3' HD13 ' A' ' 100' ' ' ILE . 30.6 m-85 -57.05 -38.3 73.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.131 -0.981 . . . . 0.0 110.124 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.432 ' OD1' HG12 ' A' ' 100' ' ' ILE . 68.2 m-20 -89.54 59.75 4.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.545 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 0.8 OUTLIER -52.18 -34.37 44.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.952 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 9.9 p-10 -74.02 -41.83 61.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.924 . . . . 0.0 110.112 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.69 35.08 5.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.431 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 33.5 p-10 -94.65 3.09 55.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -1.197 . . . . 0.0 110.257 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 68.23 37.72 86.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 12.8 m-85 -165.27 142.61 5.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -1.113 . . . . 0.0 110.24 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 92' ' ' PHE . 9.7 mt -107.7 126.53 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.667 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' ALA . 2.8 t -117.76 147.83 42.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.825 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.15 -27.73 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.268 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -70.73 -43.98 67.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.855 . . . . 0.0 109.799 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 101' ' ' SER . 42.8 mt-10 -61.31 -40.21 93.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.923 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.054 ' CD1' HD11 ' A' ' 125' ' ' ILE . 2.4 mt -63.34 -44.37 95.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.405 -0.81 . . . . 0.0 109.81 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.8 ttp85 -53.87 -37.08 63.33 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.067 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.545 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -60.55 -60.94 3.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.397 -0.814 . . . . 0.0 109.573 179.292 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.68 -35.15 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.368 -0.832 . . . . 0.0 109.464 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.946 ' HA ' HD21 ' B' ' 17' ' ' LEU . 5.6 mtt -50.89 -65.42 0.56 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 110.395 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -63.5 -33.21 75.09 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 110.354 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.12 -8.37 49.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.105 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.916 HD11 HG12 ' B' ' 13' ' ' VAL . 10.1 mt -109.38 -50.88 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 110.471 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.06 -59.24 0.16 Allowed Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.585 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -105.87 154.76 20.1 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.055 -1.262 . . . . 0.0 110.626 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 116' ' ' LEU . 6.9 ptpp? -123.48 21.97 9.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.878 . . . . 0.0 110.15 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 115' ' ' LYS . 6.6 mp 41.03 -164.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.547 -0.721 . . . . 0.0 110.575 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 118' ' ' ASP . 1.1 m -96.49 -146.59 0.29 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.433 -0.792 . . . . 0.0 109.178 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.513 ' H ' HG22 ' A' ' 117' ' ' THR . 26.1 t70 -115.4 -54.51 2.53 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.127 -0.983 . . . . 0.0 109.963 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -31.35 72.54 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 109.517 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -69.93 -45.26 67.9 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.298 -0.876 . . . . 0.0 109.298 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.2 t -61.99 -45.73 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.082 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.29 -39.99 92.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 109.782 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 4.5 tt0 -71.71 -31.15 66.42 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.403 -0.81 . . . . 0.0 109.559 179.402 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.502 ' HB2' ' HA ' ' B' ' 20' ' ' ARG . 1.4 ttt -61.33 -34.59 75.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 0.0 109.603 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.054 HD11 ' CD1' ' A' ' 105' ' ' LEU . 35.2 mm -80.56 -63.52 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.446 -0.784 . . . . 0.0 110.816 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.06 -30.33 10.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.181 -0.949 . . . . 0.0 110.938 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 11.8 mt-10 -74.78 -29.96 61.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.103 -0.998 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -88.11 -28.66 21.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.311 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -48.6 90.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 128' ' ' ALA . 49.3 mm -59.75 -40.93 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 0.0 109.959 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -84.55 -28.79 26.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.414 -0.804 . . . . 0.0 110.092 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.7 76.65 0.97 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 48.1 p30 -135.42 8.78 3.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.216 -1.167 . . . . 0.0 110.095 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.47 13.28 73.67 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.459 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 9.5 pt20 -169.42 163.05 10.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.247 -1.149 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 87.5 t -108.38 142.9 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.111 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.47 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 4.6 t30 -110.45 -159.04 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 0.0 110.106 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 139' ' ' GLU . 30.2 t80 -72.61 -63.02 1.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 109.691 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 143' ' ' GLN . 43.1 mt-10 -42.98 -50.11 5.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.324 -0.86 . . . . 0.0 109.787 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.444 ' HB3' HG13 ' A' ' 136' ' ' VAL . 48.8 mt-10 -55.67 -60.46 3.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 109.634 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 30.5 t80 -41.55 -28.14 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.538 -0.727 . . . . 0.0 109.537 179.157 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 140' ' ' GLU . 78.7 t -100.37 -28.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.559 -0.713 . . . . 0.0 110.535 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 139' ' ' GLU . 1.0 OUTLIER -66.04 -13.14 59.45 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.06 -1.025 . . . . 0.0 110.343 -179.792 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -103.63 -23.72 13.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.103 -0.998 . . . . 0.0 110.608 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.889 ' HE2' ' H ' ' B' ' 24' ' ' ASN . 8.5 mtt -90.8 -32.64 16.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.17 -0.956 . . . . 0.0 109.806 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 146' ' ' THR . 8.4 t . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.362 -0.836 . . . . 0.0 110.156 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.843 HD11 ' HA ' ' A' ' 43' ' ' PRO . 15.9 mt . . . . . 0 N--CA 1.502 2.147 0 CA-C-O 120.723 0.297 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.638 ' HD2' HG23 ' B' ' 4' ' ' ILE . 43.6 Cg_endo -74.06 151.77 44.94 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.954 1.502 . . . . 0.0 109.973 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.576 ' O ' ' HE3' ' A' ' 51' ' ' MET . 13.4 m -62.9 -55.36 26.75 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 110.432 -179.533 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.55 ' CD1' ' HE3' ' A' ' 51' ' ' MET . 0.0 OUTLIER 169.9 -76.25 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.315 -0.866 . . . . 0.0 109.552 -179.725 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.546 HG21 ' HB3' ' A' ' 75' ' ' LYS . 25.7 p -53.2 -27.75 23.3 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.758 . . . . 0.0 109.878 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.55 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 79.4 m -58.86 -52.18 66.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.925 -1.109 . . . . 0.0 108.464 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.439 ' H ' HG23 ' B' ' 10' ' ' VAL . 15.5 t -50.79 -43.69 25.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.486 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' B' ' 11' ' ' ILE . 0.8 OUTLIER -59.57 -54.28 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.758 0.79 . . . . 0.0 109.584 179.408 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 11' ' ' ILE . 0.6 OUTLIER -40.66 -66.85 0.28 Allowed 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.657 -0.652 . . . . 0.0 110.779 -179.831 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.916 HG12 HD11 ' A' ' 112' ' ' LEU . 62.1 t -46.13 -43.45 5.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.643 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.543 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -59.05 -50.01 75.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.91 -1.119 . . . . 0.0 110.277 179.652 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.76 -28.95 37.68 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.357 -0.839 . . . . 0.0 109.89 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.492 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -72.6 -31.17 64.98 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.244 -0.91 . . . . 0.0 110.593 -179.871 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.946 HD21 ' HA ' ' A' ' 109' ' ' MET . 4.6 mp -67.2 57.64 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.071 -1.018 . . . . 0.0 110.699 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.572 ' HG3' ' CD ' ' B' ' 19' ' ' LYS . 2.0 ttp180 -91.96 -110.38 0.1 Allowed 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.478 -0.764 . . . . 0.0 109.141 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.572 ' CD ' ' HG3' ' B' ' 18' ' ' ARG . 3.0 mptt -126.53 -94.4 0.46 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.741 -1.225 . . . . 0.0 109.114 178.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.502 ' HA ' ' HB2' ' A' ' 124' ' ' MET . 0.0 OUTLIER -105.33 3.02 29.4 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.274 -0.891 . . . . 0.0 109.31 178.943 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 6.9 m -84.07 -176.07 6.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 0.0 109.712 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.625 ' HE2' HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -151.7 -150.72 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.017 . . . . 0.0 111.186 179.712 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.45 ' HA2' ' SD ' ' B' ' 16' ' ' MET . . . -43.85 156.05 0.21 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.889 ' H ' ' HE2' ' A' ' 145' ' ' MET . 34.8 m120 -150.17 168.1 11.68 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.457 -1.025 . . . . 0.0 110.217 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' B' ' 24' ' ' ASN . 39.7 Cg_endo -65.78 73.22 0.32 Allowed 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.637 1.335 . . . . 0.0 110.041 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.467 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.715 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.758 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 10' ' ' ALA . 88.6 mt -50.08 -59.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -44.97 -52.7 8.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -0.939 . . . . 0.0 109.514 179.516 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.537 ' HG2' ' CD1' ' A' ' 12' ' ' PHE . 1.2 tt0 -52.49 -48.1 66.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -0.834 . . . . 0.0 109.313 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.537 ' CD1' ' HG2' ' A' ' 11' ' ' GLU . 18.9 m-30 -55.84 -47.46 77.22 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.359 -0.838 . . . . 0.0 109.904 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -48.86 -42.64 37.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.588 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -53.63 56.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 109.619 179.439 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -54.2 -40.85 67.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.829 . . . . 0.0 109.861 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -66.8 -30.05 70.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.823 . . . . 0.0 109.831 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -78.43 -20.22 51.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.639 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.481 HD12 ' HE2' ' B' ' 14' ' ' LYS . 6.4 tt -76.72 -46.33 25.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.384 -0.822 . . . . 0.0 110.05 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' HA ' HG21 ' A' ' 35' ' ' VAL . 69.5 m-85 -72.1 -22.77 61.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.0 110.161 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.487 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 0.8 OUTLIER -95.44 83.78 3.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.038 179.907 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 13.2 mmtt -44.71 -35.8 2.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.1 p30 -97.93 -24.52 15.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 110.328 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 67.86 31.21 75.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 41.9 p-10 -79.27 -0.75 33.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -1.191 . . . . 0.0 110.111 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 26' ' ' THR . . . 87.0 27.0 29.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 25' ' ' GLY . 18.4 p -156.51 97.41 1.74 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -1.089 . . . . 0.0 109.894 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.778 HD12 HG21 ' A' ' 63' ' ' ILE . 18.8 mt -85.32 112.32 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.033 . . . . 0.0 109.978 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.429 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -75.79 -163.72 0.3 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.313 -0.867 . . . . 0.0 109.783 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 p -80.45 -56.09 4.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.947 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -37.98 66.13 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.44 -0.788 . . . . 0.0 110.494 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 18.9 mt-10 -48.86 -68.49 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.048 -1.033 . . . . 0.0 109.653 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.513 HD21 ' CE ' ' A' ' 51' ' ' MET . 56.0 tp -47.28 -39.33 14.27 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.309 -0.87 . . . . 0.0 109.141 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.39 96.75 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.611 -1.796 . . . . 0.0 108.611 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.532 HG23 HH12 ' A' ' 37' ' ' ARG . 22.6 m -52.53 -42.97 64.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.362 -1.081 . . . . 0.0 109.249 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.602 HG21 ' HA ' ' A' ' 19' ' ' PHE . 13.3 t -66.91 -46.96 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.398 -0.814 . . . . 0.0 109.599 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.472 ' CE ' ' HG2' ' B' ' 5' ' ' PRO . 4.8 mmt -67.13 -29.8 69.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.658 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.532 HH12 HG23 ' A' ' 34' ' ' THR . 2.4 ttp-105 -68.46 -35.13 77.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.771 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 m -84.12 -14.35 50.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.064 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -83.17 -32.91 26.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.103 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.65 -62.93 0.18 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.555 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -100.3 175.42 5.72 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.038 -1.272 . . . . 0.0 111.315 -178.959 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -134.52 100.06 12.69 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.602 -0.686 . . . . 0.0 109.529 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' B' ' 4' ' ' ILE . 43.6 Cg_endo -69.97 162.74 41.02 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 O-C-N 124.065 1.56 . . . . 0.0 111.072 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.495 ' O ' HD12 ' A' ' 48' ' ' LEU . 4.2 t -96.93 -149.95 0.33 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.385 -0.822 . . . . 0.0 110.725 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 38.1 mt-10 -94.22 -57.33 2.54 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 0.0 110.88 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 47' ' ' GLU . . . -43.56 -70.54 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.035 -1.041 . . . . 0.0 110.409 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 46' ' ' ALA . 6.0 mm-40 -44.78 -42.9 8.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.077 -1.015 . . . . 0.0 109.486 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 44' ' ' THR . 5.7 mt -57.22 -47.39 81.44 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -46.28 -43.28 15.57 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.38 179.436 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.45 -30.32 64.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.432 -0.792 . . . . 0.0 109.571 179.273 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.584 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 1.2 mmm -74.72 -36.71 62.68 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.403 -0.811 . . . . 0.0 109.497 179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.603 HG13 HD11 ' A' ' 63' ' ' ILE . 1.5 tp -78.1 -43.75 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.273 -0.892 . . . . 0.0 110.327 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.505 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -43.43 -26.1 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.257 -0.902 . . . . 0.0 110.331 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 52' ' ' ILE . 15.6 mm-40 -67.9 -51.43 47.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 110.213 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.7 HG22 ' HG3' ' A' ' 71' ' ' MET . 14.8 t -80.61 -33.38 13.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.96 82.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.348 -0.845 . . . . 0.0 110.168 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.77 -69.25 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.398 -0.814 . . . . 0.0 110.816 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 47.1 p-10 -59.02 -16.88 20.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.252 -0.905 . . . . 0.0 110.675 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 69.47 43.8 67.54 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 31.4 p-10 -94.76 -31.84 13.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.326 -1.102 . . . . 0.0 110.478 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 62' ' ' THR . . . 120.51 24.09 2.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 61' ' ' GLY . 3.4 p -161.05 142.66 11.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -1.14 . . . . 0.0 110.247 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.778 HG21 HD12 ' A' ' 27' ' ' ILE . 14.1 mm -82.4 134.03 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.196 -0.94 . . . . 0.0 110.011 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -105.96 160.62 15.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 110.319 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.6 t80 -56.62 -50.36 88.35 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.554 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.9 Cg_endo -69.97 -31.3 19.85 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.397 1.209 . . . . 0.0 109.974 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 70' ' ' THR . 8.9 mt-10 -64.41 -34.03 77.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.32 -0.863 . . . . 0.0 110.073 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -75.45 -53.58 8.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.21 -0.932 . . . . 0.0 109.673 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mp -49.82 -29.78 8.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.883 . . . . 0.0 109.913 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -74.59 -47.89 29.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -0.849 . . . . 0.0 110.028 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.7 ' HG3' HG22 ' A' ' 55' ' ' VAL . 8.0 mmm -50.39 -47.45 56.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.135 -0.978 . . . . 0.0 109.572 179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.861 ' CE ' HG21 ' B' ' 11' ' ' ILE . 6.1 tpt -42.19 -26.81 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.48 -0.763 . . . . 0.0 110.498 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 71' ' ' MET . . . -107.52 -21.07 13.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.193 -0.942 . . . . 0.0 110.957 -179.145 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.46 -26.01 33.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.074 -1.016 . . . . 0.0 110.394 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HB3' HG21 ' B' ' 8' ' ' THR . 2.6 tptm . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 110.292 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.365 0.603 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -63.89 -13.17 43.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.406 -0.809 . . . . 0.0 109.51 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.529 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 3.2 mt-10 -71.28 -45.47 63.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.513 -0.742 . . . . 0.0 110.582 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.696 HG21 HG22 ' A' ' 142' ' ' VAL . 27.3 mt -73.74 -21.73 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 110.198 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -71.83 -53.45 13.25 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.159 -0.963 . . . . 0.0 110.298 -179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.831 ' HG3' HG23 ' B' ' 9' ' ' THR . 7.8 pt-20 -62.37 -40.27 95.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.012 -1.055 . . . . 0.0 110.333 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.435 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -58.89 -37.31 76.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.504 -1.372 . . . . 0.0 108.358 178.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -65.49 -44.04 88.31 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.535 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -43.52 71.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.53 -0.731 . . . . 0.0 109.046 178.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.903 HG12 HG21 ' A' ' 108' ' ' VAL . 30.4 t -53.29 -48.57 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -0.785 . . . . 0.0 108.989 179.03 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.945 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 42.9 m-85 -66.59 -35.56 80.49 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 109.228 178.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.472 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 23.6 t0 -86.9 60.02 5.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.765 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' ASP . 10.2 ttpt -39.51 -50.07 2.15 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.521 -0.737 . . . . 0.0 110.252 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 10.2 p-10 -65.25 -36.56 84.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 109.652 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.453 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 83.41 45.41 6.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.374 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 52.6 p-10 -100.22 -20.71 15.8 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.058 -1.26 . . . . 0.0 110.273 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 109.28 22.08 6.99 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 24.4 m-85 -143.57 142.66 31.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.363 -1.08 . . . . 0.0 109.98 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 6.3 mt -113.69 96.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.498 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.2 m -90.68 152.45 20.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -0.918 . . . . 0.0 109.775 179.341 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.18 -40.55 11.38 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.63 -47.4 79.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.387 -0.821 . . . . 0.0 109.59 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 25.8 mt-10 -61.06 -53.66 54.38 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.304 -0.872 . . . . 0.0 109.828 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.643 HD13 HD11 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -59.34 -29.53 67.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.465 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.4 ttt-85 -70.82 -22.88 62.29 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.343 -0.848 . . . . 0.0 108.87 178.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 9.0 m80 -79.81 -46.23 17.32 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.576 -0.702 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.903 HG21 HG12 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -67.03 -20.73 27.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.365 -0.834 . . . . 0.0 108.857 179.144 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.595 ' HG3' HD21 ' B' ' 17' ' ' LEU . 0.3 OUTLIER -68.77 -52.07 34.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.599 -0.688 . . . . 0.0 109.956 179.638 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -35.37 73.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.894 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -74.16 -12.66 60.65 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.16 -0.962 . . . . 0.0 109.345 179.429 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.623 HD11 HG12 ' B' ' 13' ' ' VAL . 8.9 mt -94.64 -51.42 4.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.432 -0.792 . . . . 0.0 109.754 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.57 -59.93 0.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 20.8 tp10 -96.76 160.6 14.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.201 -1.176 . . . . 0.0 110.949 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -133.94 81.9 1.95 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.325 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.617 ' H ' HD12 ' A' ' 116' ' ' LEU . 6.5 mp -37.27 150.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.573 0.701 . . . . 0.0 111.268 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.79 -148.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.502 -0.749 . . . . 0.0 110.012 179.759 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.99 -44.86 5.36 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.331 -0.855 . . . . 0.0 110.135 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.493 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 17.5 pt-20 -64.89 -42.36 94.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.76 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.493 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 11.1 mm-40 -63.3 -40.72 98.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.579 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 125' ' ' ILE . 40.5 t -64.89 -45.37 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.273 -0.892 . . . . 0.0 109.699 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -63.53 -35.56 80.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.436 -0.79 . . . . 0.0 109.708 179.643 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 124' ' ' MET . 45.5 mt-10 -72.87 -54.48 8.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.0 109.566 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.626 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 25.1 ttt -42.38 -43.37 3.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.476 -0.765 . . . . 0.0 109.904 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.643 HD11 HD13 ' A' ' 105' ' ' LEU . 15.3 mm -76.33 -60.27 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 0.0 109.961 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -47.84 -55.03 10.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.512 ' OE2' ' CZ ' ' B' ' 20' ' ' ARG . 46.2 mt-10 -52.51 -21.6 3.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 0.0 110.388 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.559 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -93.28 -34.95 13.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.215 -0.928 . . . . 0.0 110.328 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.433 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 5.2 m-20 -68.43 66.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 110.237 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 128' ' ' ALA . 2.5 mp -46.43 -42.82 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.004 . . . . 0.0 109.88 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -70.89 -29.41 65.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.467 -0.77 . . . . 0.0 110.189 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.92 95.45 0.28 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 29.5 p-10 -144.72 -37.76 0.29 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -1.116 . . . . 0.0 110.236 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 121.49 9.44 7.11 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -165.59 149.8 8.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -1.102 . . . . 0.0 110.271 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 3.5 t -103.19 116.38 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 109.823 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.37 -155.03 0.3 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.345 -0.847 . . . . 0.0 110.603 -179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 139' ' ' GLU . 58.5 t80 -75.24 -60.62 2.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 138' ' ' TYR . 1.5 tt0 -42.72 -56.83 3.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 143' ' ' GLN . 2.6 mt-10 -55.23 -55.62 29.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.903 . . . . 0.0 109.85 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -45.22 -28.8 0.84 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.376 -0.827 . . . . 0.0 109.626 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.696 HG22 HG21 ' A' ' 85' ' ' ILE . 24.3 t -98.94 -24.02 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.411 -0.806 . . . . 0.0 109.806 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -59.0 -30.58 68.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 109.917 179.797 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.0 mmm -92.0 -9.58 42.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.316 -0.865 . . . . 0.0 109.844 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.529 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.2 OUTLIER -98.56 -69.76 0.75 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.388 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.495 1.82 0 O-C-N 120.963 -1.086 . . . . 0.0 110.866 -179.757 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.652 HG21 ' HB3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.118 0.485 . . . . 0.0 110.656 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.583 ' HB2' ' CB ' ' B' ' 9' ' ' THR . 48.1 Cg_endo -72.26 -155.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 124.334 1.702 . . . . 0.0 111.144 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.537 ' O ' ' N ' ' B' ' 8' ' ' THR . 5.0 t -130.18 73.8 1.55 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.245 -0.91 . . . . 0.0 111.214 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.714 ' O ' HG22 ' B' ' 10' ' ' VAL . 0.8 OUTLIER 46.96 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.698 0 O-C-N 121.49 -0.756 . . . . 0.0 111.848 178.912 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.858 ' HA ' HD12 ' B' ' 11' ' ' ILE . 21.6 p -38.99 -26.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 110.798 -179.016 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.831 HG23 ' HG3' ' A' ' 87' ' ' GLU . 15.8 m -64.92 -65.81 0.62 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.076 -1.015 . . . . 0.0 109.996 179.065 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.714 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.0 m -46.68 -26.86 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 108.955 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.861 HG21 ' CE ' ' A' ' 72' ' ' MET . 49.2 mt -74.4 -47.96 37.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 121.687 0.756 . . . . 0.0 109.541 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 mt -50.32 -56.64 10.43 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.654 -0.654 . . . . 0.0 110.561 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.945 HG13 ' CZ ' ' A' ' 92' ' ' PHE . 17.2 t -62.34 -40.17 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.969 . . . . 0.0 110.958 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.481 ' HE2' HD12 ' A' ' 18' ' ' LEU . 6.5 tptp -71.54 -11.65 60.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.802 -1.186 . . . . 0.0 110.492 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.403 ' CB ' ' HE1' ' B' ' 26' ' ' PHE . 1.6 m -97.59 -21.83 16.85 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.191 -0.943 . . . . 0.0 109.265 179.244 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.445 ' O ' ' HE3' ' A' ' 124' ' ' MET . 6.6 tpp -78.56 -37.39 42.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.584 -0.697 . . . . 0.0 110.156 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.595 HD21 ' HG3' ' A' ' 109' ' ' MET . 1.3 mp -48.43 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.918 -1.114 . . . . 0.0 109.682 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER 31.62 58.07 0.31 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.652 -0.655 . . . . 0.0 112.514 179.392 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.548 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 62.5 -59.3 0.13 Allowed 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.47 -0.768 . . . . 0.0 111.753 178.155 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -155.66 8.42 0.25 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.886 -1.134 . . . . 0.0 111.752 -178.514 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' B' ' 18' ' ' ARG . 1.8 m -59.99 84.51 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.732 -1.23 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.626 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -111.93 13.55 20.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -0.954 . . . . 0.0 110.349 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.506 ' C ' ' HD3' ' B' ' 25' ' ' PRO . . . -96.24 -139.53 10.52 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.556 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 32.8 t-20 -119.78 47.58 1.03 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.196 -1.179 . . . . 0.0 110.386 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 48.5 Cg_endo -73.73 53.02 2.66 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.734 1.386 . . . . 0.0 110.268 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.521 ' CZ ' ' HE1' ' A' ' 72' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.987 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.246 0.546 . . . . 0.0 110.278 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.4 mt -48.27 -45.97 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.785 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.09 -41.66 62.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 109.738 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.564 ' OE2' ' CE1' ' A' ' 12' ' ' PHE . 1.9 tt0 -57.55 -51.51 69.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.746 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE1' ' OE2' ' A' ' 11' ' ' GLU . 21.0 m-85 -62.15 -45.07 95.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.942 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -60.17 -42.71 95.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -0.932 . . . . 0.0 109.705 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.79 -36.89 72.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.624 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . . . -75.45 -54.11 7.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.675 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.582 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 20.6 t80 -56.73 -17.15 8.0 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.417 -0.802 . . . . 0.0 109.714 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 18' ' ' LEU . 7.3 t -89.33 -56.74 3.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 112' ' ' LEU . 7.4 tt -44.31 -30.15 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -87.64 -30.73 20.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.284 -0.885 . . . . 0.0 110.535 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 23.6 t0 -104.89 91.57 3.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 110.495 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -67.92 -48.5 65.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.18 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 5.2 p-10 -60.39 -41.98 94.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.44 -0.787 . . . . 0.0 110.434 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.429 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . 83.87 56.47 2.6 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 38.1 p-10 -107.45 -27.57 10.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.159 -1.201 . . . . 0.0 110.263 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 111.56 9.09 21.99 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 27.2 p -141.89 116.02 9.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -1.172 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.5 mt -94.76 106.45 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 110.149 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.86 152.03 23.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.792 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -45.97 -25.56 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.01 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -61.12 2.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 110.218 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.67 -57.66 10.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.226 -0.921 . . . . 0.0 110.07 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 ' CH2' ' B' ' 7' ' ' TRP . 29.8 tp -52.68 -38.43 60.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.34 -40.02 96.92 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -60.29 -55.44 33.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -1.145 . . . . 0.0 109.943 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.443 ' H ' HG23 ' A' ' 35' ' ' VAL . 21.2 t -48.29 -50.53 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.649 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.625 ' HE3' ' HG2' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -54.38 -38.69 66.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.917 . . . . 0.0 109.871 179.657 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 2.0 ttp85 -64.25 -23.31 67.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.417 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 8.1 t -78.36 -30.23 47.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 110.656 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.74 -43.95 67.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.08 -1.013 . . . . 0.0 110.477 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.36 -16.01 0.41 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.654 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.1 mm-40 -113.2 166.0 11.87 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.832 -1.393 . . . . 0.0 110.624 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -127.9 97.16 30.34 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.287 -0.883 . . . . 0.0 110.231 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.55 ' CD ' ' HB3' ' A' ' 36' ' ' MET . 46.6 Cg_endo -75.45 140.08 23.87 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 124.173 1.618 . . . . 0.0 110.357 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.682 HG23 ' H ' ' A' ' 46' ' ' ALA . 14.7 t -91.58 -143.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 109.917 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.58 ' N ' HG23 ' A' ' 44' ' ' THR . 11.4 tp10 -100.23 -25.96 14.08 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.252 -0.905 . . . . 0.0 110.289 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.682 ' H ' HG23 ' A' ' 44' ' ' THR . . . -73.62 -70.8 0.35 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.14 -0.975 . . . . 0.0 110.387 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.596 ' HG2' HG22 ' A' ' 44' ' ' THR . 8.2 pt-20 -49.42 -40.29 36.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.0 109.624 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 1.4 mt -58.73 -43.25 90.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.079 179.195 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -49.99 -49.29 51.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.502 -0.749 . . . . 0.0 109.095 179.084 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -29.98 68.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.292 179.076 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.491 ' CE ' ' CE ' ' A' ' 36' ' ' MET . 1.2 ttp -75.98 -55.38 5.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 2.5 tp -56.96 -44.66 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.532 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.5 OUTLIER -40.89 -70.1 0.12 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.557 -0.714 . . . . 0.0 111.128 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -35.91 -55.08 0.75 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.722 -0.612 . . . . 0.0 110.933 -179.315 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.634 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 11.3 t -75.21 -33.84 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.745 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 5.3 t0 -58.87 77.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 0.0 110.318 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -39.72 -61.28 0.85 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.504 -0.747 . . . . 0.0 110.575 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 41.0 p-10 -76.4 -18.85 58.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 110.091 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 72.32 49.27 21.08 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 17.0 p-10 -99.3 -27.41 13.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -1.154 . . . . 0.0 110.302 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.587 ' C ' HG23 ' A' ' 62' ' ' THR . . . 119.14 23.47 3.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 61' ' ' GLY . 81.2 p -155.65 140.36 17.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.181 -1.187 . . . . 0.0 110.051 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.4 mm -91.15 158.75 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.354 -0.842 . . . . 0.0 110.072 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 58.5 m-20 -133.7 163.32 29.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 0.0 110.059 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.603 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 11.4 t80 -56.35 -48.54 96.78 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.16 -0.962 . . . . 0.0 111.215 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.1 Cg_endo -68.73 -35.69 15.79 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.206 1.108 . . . . 0.0 110.293 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 6.8 tt0 -58.94 -41.23 86.89 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.304 -0.872 . . . . 0.0 110.143 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 15' ' ' ALA . 36.6 t80 -69.58 -54.85 12.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.82 -24.95 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.958 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 m -97.61 -15.31 20.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 110.479 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.563 ' SD ' HG22 ' A' ' 55' ' ' VAL . 5.8 ttp -74.59 -42.7 58.23 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.144 -0.972 . . . . 0.0 110.536 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.529 ' HE1' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -54.46 -15.37 1.65 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.326 -0.858 . . . . 0.0 110.85 -179.387 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.42 -12.84 18.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.049 -1.032 . . . . 0.0 111.278 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.9 -11.96 40.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.781 -1.199 . . . . 0.0 110.502 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.73 ' CB ' HG21 ' B' ' 8' ' ' THR . 17.7 mmtt . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 110.268 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.303 0.573 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.11 -27.7 62.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.891 . . . . 0.0 109.637 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' OE2' ' HB3' ' A' ' 75' ' ' LYS . 17.3 mt-10 -72.63 -42.43 64.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.827 . . . . 0.0 110.128 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.62 HG21 HG22 ' A' ' 142' ' ' VAL . 14.2 mt -68.69 -37.84 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.489 -0.884 . . . . 0.0 108.762 179.502 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -60.93 -27.34 68.15 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.034 178.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 1.5 mt-10 -73.72 -54.48 7.99 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.536 -0.728 . . . . 0.0 109.146 179.072 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.75 -28.14 32.76 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.329 -0.857 . . . . 0.0 109.235 179.219 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -70.44 -46.04 64.65 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.373 -0.83 . . . . 0.0 109.514 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -28.83 65.71 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.513 -0.742 . . . . 0.0 109.621 179.451 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.72 HG12 HG21 ' A' ' 108' ' ' VAL . 15.5 t -73.75 -39.25 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.391 -0.818 . . . . 0.0 109.677 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.587 ' HB3' HD13 ' A' ' 100' ' ' ILE . 11.1 m-85 -72.78 -32.0 65.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.859 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -85.24 54.18 3.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.305 -0.872 . . . . 0.0 110.395 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.82 -28.12 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 30.8 p-10 -85.57 -43.81 13.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.186 -0.946 . . . . 0.0 110.354 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 89.75 22.75 35.35 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 33.4 p-10 -75.73 -33.84 60.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -1.132 . . . . 0.0 109.927 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 120.84 21.13 3.28 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 2.0 m-85 -164.44 130.04 2.85 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.182 -1.187 . . . . 0.0 110.263 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 92' ' ' PHE . 29.0 mt -82.46 155.52 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.966 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -144.67 156.88 44.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.86 -38.03 21.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 0.0 110.2 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.47 -46.89 84.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 109.849 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.3 -36.26 70.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 109.861 179.653 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.606 HD12 HD11 ' A' ' 125' ' ' ILE . 5.7 mt -61.8 -48.4 80.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.346 -0.846 . . . . 0.0 109.822 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.8 -35.63 61.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.417 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -64.0 -45.22 89.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -0.799 . . . . 0.0 110.14 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.72 HG21 HG12 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -79.21 -23.67 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.72 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.97 ' SD ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -68.01 -56.89 7.27 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 110.111 -179.971 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.417 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 7.3 m -60.93 -31.41 70.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.947 . . . . 0.0 109.691 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 38' ' ' SER . 7.1 m-20 -76.96 -4.7 45.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.856 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.79 HD11 HG12 ' B' ' 13' ' ' VAL . 7.0 mt -111.64 -44.68 3.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 110.374 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.96 -66.87 0.13 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.634 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 109' ' ' MET . 2.7 tt0 -103.25 166.94 10.14 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.171 -1.193 . . . . 0.0 111.137 -178.905 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.566 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.3 OUTLIER -124.47 16.79 8.93 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.733 0.777 . . . . 0.0 109.553 179.255 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.97 HD13 ' SD ' ' A' ' 109' ' ' MET . 2.8 mp 43.62 -173.23 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.66 0.743 . . . . 0.0 111.169 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.76 -146.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.505 -0.747 . . . . 0.0 109.886 179.75 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -114.06 -70.22 0.81 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.156 -0.965 . . . . 0.0 110.517 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 120' ' ' GLU . 3.8 pt-20 -55.39 -29.23 58.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 109.743 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.473 ' OE2' ' HE2' ' B' ' 19' ' ' LYS . 6.2 mt-10 -71.73 -45.74 60.81 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 108.919 178.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 117' ' ' THR . 53.1 t -54.67 -45.71 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.491 -0.756 . . . . 0.0 109.629 179.184 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -60.37 -59.23 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 0.0 109.373 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 68.5 mm-40 -48.41 -38.66 20.17 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.393 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -51.01 -56.1 14.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.252 -0.905 . . . . 0.0 109.462 179.503 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 105' ' ' LEU . 21.0 mm -56.35 -30.67 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.349 -0.844 . . . . 0.0 110.011 179.517 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 123' ' ' GLU . 5.7 ttt180 -64.99 -55.0 21.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.303 -0.873 . . . . 0.0 110.528 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 126' ' ' ARG . 2.6 tp10 -41.9 -42.89 2.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.305 -0.872 . . . . 0.0 110.371 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.21 -27.79 38.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.282 -0.886 . . . . 0.0 110.171 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.6 OUTLIER -83.36 63.86 7.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.373 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 129' ' ' ASP . 5.7 mt -43.56 -40.07 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.747 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 21.2 p30 -67.34 -32.23 73.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.551 -0.718 . . . . 0.0 110.118 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.3 66.65 1.76 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.445 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 2.9 p-10 -115.43 -27.86 7.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -1.121 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.96 16.26 8.62 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.436 ' O ' ' OD2' ' A' ' 133' ' ' ASP . 11.7 pt20 -169.95 149.78 3.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -1.131 . . . . 0.0 110.174 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 85.9 t -110.79 149.77 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 109.972 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.427 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 25.3 p-10 -120.21 -157.93 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.419 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.414 ' O ' ' C ' ' A' ' 139' ' ' GLU . 11.1 t80 -70.88 -67.22 0.52 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.358 -0.839 . . . . 0.0 110.61 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 138' ' ' TYR . 4.7 mt-10 -41.65 -62.32 0.91 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.384 -0.822 . . . . 0.0 110.351 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 141' ' ' PHE . 49.3 mt-10 -46.27 -60.29 2.4 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.21 -0.931 . . . . 0.0 110.009 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.605 ' CD1' HG23 ' A' ' 85' ' ' ILE . 24.4 t80 -42.04 -28.19 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.743 179.755 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.674 HG13 ' OG1' ' A' ' 146' ' ' THR . 38.2 t -100.87 -32.25 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.454 -0.779 . . . . 0.0 110.644 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.432 ' CD ' ' O ' ' A' ' 143' ' ' GLN . 4.7 tm0? -59.94 -18.43 45.16 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.147 -0.971 . . . . 0.0 110.404 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.3 mmm -112.58 -25.09 9.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 110.34 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.556 ' HE3' ' CB ' ' B' ' 24' ' ' ASN . 3.0 ttt -100.54 -9.34 22.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 111.118 -179.413 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.674 ' OG1' HG13 ' A' ' 142' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 O-C-N 120.92 -1.112 . . . . 0.0 111.174 -179.2 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.481 HG13 ' OE2' ' A' ' 47' ' ' GLU . 24.2 mm . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.833 ' HB3' HG21 ' B' ' 9' ' ' THR . 39.6 Cg_endo -67.43 173.18 9.14 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.113 1.586 . . . . 0.0 111.037 -179.281 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.8 t -126.1 79.38 1.84 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.247 -0.908 . . . . 0.0 111.452 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.671 ' O ' HG22 ' B' ' 10' ' ' VAL . 9.2 m95 53.99 -93.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.45 -0.781 . . . . 0.0 112.042 178.551 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.73 HG21 ' CB ' ' A' ' 75' ' ' LYS . 4.0 p -37.18 -29.17 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.266 -0.896 . . . . 0.0 110.517 -178.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.833 HG21 ' HB3' ' B' ' 5' ' ' PRO . 53.7 m -65.67 -51.29 60.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.189 -0.945 . . . . 0.0 109.697 178.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.822 HG23 HD12 ' B' ' 11' ' ' ILE . 2.7 m -63.19 -29.91 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.948 -1.095 . . . . 0.0 108.653 179.018 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.822 HD12 HG23 ' B' ' 10' ' ' VAL . 1.6 mp -72.34 -54.69 15.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.52 -0.737 . . . . 0.0 109.265 178.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' B' ' 11' ' ' ILE . 0.5 OUTLIER -42.23 -59.8 1.68 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.546 -0.721 . . . . 0.0 110.534 179.897 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.79 HG12 HD11 ' A' ' 112' ' ' LEU . 69.0 t -56.3 -50.15 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 110.403 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.533 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -56.12 -35.23 66.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.908 -1.12 . . . . 0.0 109.663 179.632 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 5.1 t -73.84 -19.9 60.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 109.866 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 1.7 tpt -75.2 -43.18 53.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.939 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.3 mp -53.31 -91.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.0 . . . . 0.0 109.699 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' B' ' 17' ' ' LEU . 5.7 ttt180 59.98 -69.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.401 0.619 . . . . 0.0 110.808 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.658 ' O ' HD21 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -176.2 -72.53 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.027 0 O-C-N 121.412 -0.805 . . . . 0.0 110.812 -179.619 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.594 ' HB2' ' CD ' ' B' ' 19' ' ' LYS . 2.2 ttt-85 -135.09 20.4 3.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.848 -1.157 . . . . 0.0 110.324 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.73 129.56 42.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.282 -0.886 . . . . 0.0 110.219 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 124' ' ' MET . 0.2 OUTLIER -130.67 -4.06 4.16 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.426 -0.796 . . . . 0.0 110.351 -179.8 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.52 -28.07 23.04 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.556 ' CB ' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER 48.89 81.81 0.25 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.081 -1.246 . . . . 0.0 109.912 -179.825 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.96 -34.94 9.85 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.901 1.474 . . . . 0.0 110.64 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.529 ' CZ ' ' HE1' ' A' ' 72' ' ' MET . 1.1 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.198 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.335 0.588 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.494 HG23 ' HZ ' ' A' ' 65' ' ' PHE . 46.8 mt -53.22 -27.73 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.343 -0.848 . . . . 0.0 109.759 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -57.4 -64.03 1.03 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.54 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -48.39 -44.42 34.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.363 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -67.2 -50.0 62.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.384 -0.822 . . . . 0.0 109.737 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -55.89 -44.0 77.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.854 179.71 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 41.2 mt-10 -55.38 -43.47 75.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.762 179.538 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -72.1 -50.35 28.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.401 -0.812 . . . . 0.0 109.965 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.576 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 11.2 t80 -54.29 -47.81 71.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 109.918 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -68.05 -27.77 66.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.882 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.82 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.2 tt -61.41 -37.97 85.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.394 -0.816 . . . . 0.0 110.085 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.628 ' HD1' HG21 ' A' ' 35' ' ' VAL . 44.5 m-85 -80.75 -30.03 36.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.44 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 13.7 t0 -84.73 84.25 7.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 110.49 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -73.12 -40.05 65.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.21 -0.931 . . . . 0.0 110.032 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -71.09 -33.86 70.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.086 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 65.17 1.23 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.476 ' O ' HG23 ' A' ' 26' ' ' THR . 57.7 p30 -128.62 6.59 5.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -1.159 . . . . 0.0 110.154 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.66 13.48 51.39 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 59.5 p -136.87 115.44 11.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.276 -1.132 . . . . 0.0 110.251 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.546 ' O ' HG22 ' A' ' 62' ' ' THR . 5.1 mt -88.9 124.01 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.203 -0.936 . . . . 0.0 110.355 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.4 p -99.67 172.02 7.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.332 -0.855 . . . . 0.0 110.284 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 p -56.95 -30.06 63.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.937 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -66.83 -60.44 2.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.232 -0.918 . . . . 0.0 110.05 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' O ' HG23 ' A' ' 35' ' ' VAL . 32.5 mt-10 -52.16 -55.65 19.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 110.024 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.568 HD13 ' CH2' ' B' ' 7' ' ' TRP . 27.0 tp -59.51 -37.6 78.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.05 -37.19 64.19 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.882 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.9 m -61.36 -55.36 32.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -1.136 . . . . 0.0 109.942 179.748 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.628 HG21 ' HD1' ' A' ' 19' ' ' PHE . 20.4 t -52.7 -46.88 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 109.643 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.467 ' HE1' ' SD ' ' A' ' 51' ' ' MET . 0.9 OUTLIER -58.63 -41.82 86.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.693 179.506 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -28.78 66.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 109.924 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.451 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -85.76 -55.73 3.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.337 -0.852 . . . . 0.0 110.272 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mt -44.88 -28.18 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.129 -0.982 . . . . 0.0 110.063 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 115.98 49.89 0.45 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 40' ' ' GLY . 1.1 mp0 -147.44 -174.53 4.55 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.211 -1.17 . . . . 0.0 110.359 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -161.89 84.12 1.69 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.325 -0.859 . . . . 0.0 110.256 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 46.9 Cg_endo -73.19 100.67 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.042 1.548 . . . . 0.0 110.169 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.498 HG22 ' HB2' ' A' ' 47' ' ' GLU . 5.0 t -57.07 162.39 2.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.085 -1.009 . . . . 0.0 110.239 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' ALA . 2.3 mt-10 -42.98 -65.37 0.49 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 110.269 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -40.45 -51.84 2.83 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 110.227 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.498 ' HB2' HG22 ' A' ' 44' ' ' THR . 5.9 mm-40 -63.85 -56.49 14.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.026 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 48' ' ' LEU . 5.2 mt -42.32 -42.8 3.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -0.832 . . . . 0.0 110.18 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -66.95 -41.1 87.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 0.0 110.079 179.77 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -27.42 65.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.402 -0.811 . . . . 0.0 110.186 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.467 ' SD ' ' HE1' ' A' ' 36' ' ' MET . 0.9 OUTLIER -82.54 -33.63 28.11 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.927 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 4.8 mm -80.35 -31.08 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -76.82 -13.71 59.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 110.233 179.937 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -73.42 -60.99 1.99 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 0.0 110.106 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.649 ' HB ' HD12 ' A' ' 63' ' ' ILE . 13.8 t -69.19 -25.41 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.108 -0.995 . . . . 0.0 109.808 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -49.23 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.368 -0.832 . . . . 0.0 109.98 179.787 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -70.56 -66.88 0.55 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.41 -0.806 . . . . 0.0 110.587 -179.521 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.7 p-10 -58.35 -35.75 72.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -0.924 . . . . 0.0 110.423 -179.582 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 92.0 45.83 3.78 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.465 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 15.7 p-10 -96.48 -34.23 11.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -1.17 . . . . 0.0 110.157 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.35 -2.36 5.4 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -141.5 165.37 27.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -1.213 . . . . 0.0 110.15 179.983 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.649 HD12 ' HB ' ' A' ' 55' ' ' VAL . 34.9 mm -87.07 142.75 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.076 179.864 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.498 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.1 m-20 -130.52 153.15 49.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.922 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 34.1 t80 -39.38 -51.08 4.77 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.549 -0.72 . . . . 0.0 112.344 -179.088 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.2 Cg_endo -64.9 -27.44 58.77 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.22 1.116 . . . . 0.0 111.265 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.492 ' HG3' ' CB ' ' A' ' 64' ' ' ASP . 7.3 mt-10 -73.02 -39.92 65.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.832 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.623 ' HZ ' HD12 ' B' ' 11' ' ' ILE . 36.4 t80 -63.54 -50.86 67.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 110.303 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.81 -37.26 78.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -0.874 . . . . 0.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.8 m -76.91 -14.59 59.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.285 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' HG22 ' A' ' 55' ' ' VAL . 37.0 ttp -79.27 -58.51 3.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.199 -0.938 . . . . 0.0 110.133 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.4 tpt -53.17 -16.09 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.409 -0.807 . . . . 0.0 111.013 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.92 -45.8 8.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.878 -1.139 . . . . 0.0 110.579 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -80.7 -10.07 59.75 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.158 -0.964 . . . . 0.0 110.75 -179.673 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.077 -1.014 . . . . 0.0 110.427 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.615 ' HA ' HD12 ' A' ' 85' ' ' ILE . 3.1 tt0 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.068 0.461 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.73 -40.98 88.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.645 179.648 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 7.3 pt-20 -54.41 -23.6 16.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.992 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 82' ' ' GLU . 51.8 mt -80.16 -61.42 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.9 . . . . 0.0 109.606 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 85' ' ' ILE . 0.4 OUTLIER -42.57 -30.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.583 -0.698 . . . . 0.0 109.524 179.549 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.657 ' HB3' HG21 ' B' ' 9' ' ' THR . 4.4 mm-40 -71.91 -60.6 2.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.408 -0.808 . . . . 0.0 109.264 179.029 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.65 -28.99 6.52 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.149 179.219 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -70.47 -47.71 59.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 109.758 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -35.19 51.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.755 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.651 HG11 HG11 ' B' ' 13' ' ' VAL . 10.6 t -67.68 -45.17 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.652 179.592 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.754 ' CE2' HD21 ' A' ' 105' ' ' LEU . 5.1 m-85 -58.78 -36.76 74.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.975 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -98.8 60.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 110.161 179.831 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -42.78 -32.88 0.66 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.309 -0.87 . . . . 0.0 110.073 179.939 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.2 p30 -77.19 -31.77 55.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.415 -0.803 . . . . 0.0 109.899 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 71.95 51.35 14.99 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.1 p-10 -97.67 -33.48 11.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -1.219 . . . . 0.0 110.014 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 131.51 0.49 4.92 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.585 ' CE2' ' OD1' ' A' ' 137' ' ' ASN . 65.1 m-85 -147.95 149.05 31.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.246 . . . . 0.0 110.595 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 92' ' ' PHE . 45.0 mt -104.44 149.28 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.117 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.418 ' H ' ' HB2' ' A' ' 104' ' ' GLU . 0.6 OUTLIER -139.91 160.46 39.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.016 179.73 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.35 -38.42 58.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.28 -38.73 92.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.109 -0.994 . . . . 0.0 109.811 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' A' ' 101' ' ' SER . 12.4 mt-10 -63.81 -47.66 79.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.286 -0.884 . . . . 0.0 109.862 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.023 HD12 HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -58.9 -34.55 71.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.322 -0.862 . . . . 0.0 109.517 179.552 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 109' ' ' MET . 16.9 ttp85 -59.42 -41.52 89.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.278 -0.889 . . . . 0.0 109.151 179.187 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -54.16 40.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.47 -0.769 . . . . 0.0 109.559 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 2.5 t -51.66 -37.02 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.21 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.921 ' HA ' HD21 ' B' ' 17' ' ' LEU . 21.0 mtt -58.72 -62.83 1.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.34 -0.85 . . . . 0.0 109.907 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 m -58.85 -31.36 68.46 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.574 179.6 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 38' ' ' SER . 2.9 m120 -76.53 -17.5 59.21 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.328 179.413 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.82 ' O ' HD11 ' A' ' 18' ' ' LEU . 7.0 mt -100.05 -47.68 4.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.845 . . . . 0.0 110.24 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.21 -28.52 1.23 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.791 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.573 ' HG2' ' CD1' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -109.28 134.86 51.25 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.798 -1.413 . . . . 0.0 111.248 -179.325 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 116' ' ' LEU . 6.8 tttt -117.09 78.5 1.22 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.077 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.795 HD11 ' O ' ' B' ' 17' ' ' LEU . 7.0 mp -40.69 164.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.612 0.72 . . . . 0.0 111.13 -179.062 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.06 -149.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.581 -0.699 . . . . 0.0 109.712 179.456 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -111.51 -70.33 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 110.144 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 23.4 pt-20 -47.54 -40.1 18.06 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.551 179.802 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 18.8 mt-10 -61.28 -55.6 30.04 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.338 -0.851 . . . . 0.0 109.148 179.027 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.0 t -50.05 -47.25 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.35 -0.844 . . . . 0.0 109.737 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.71 -50.19 70.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 109.631 179.569 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -34.55 68.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.462 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.474 ' HE3' ' O ' ' B' ' 16' ' ' MET . 6.5 ttt -56.93 -54.77 42.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.472 -0.767 . . . . 0.0 109.987 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.023 HD11 HD12 ' A' ' 105' ' ' LEU . 33.0 mm -57.64 -43.13 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 109.972 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -50.7 67.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.113 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -48.61 -38.74 21.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.383 -0.823 . . . . 0.0 110.16 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.709 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -81.24 -24.17 37.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.395 -0.816 . . . . 0.0 110.136 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.472 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -67.66 73.93 0.17 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.3 -0.875 . . . . 0.0 110.34 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 128' ' ' ALA . 2.8 mp -53.85 -45.21 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.245 -0.909 . . . . 0.0 110.275 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.464 ' OD2' ' OD2' ' A' ' 133' ' ' ASP . 2.4 p30 -77.38 -36.55 53.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.35 65.03 1.11 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.464 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 2.0 p30 -112.11 -28.75 7.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -1.13 . . . . 0.0 110.263 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 118.07 -6.11 15.41 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.462 ' N ' ' CD ' ' A' ' 135' ' ' GLN . 15.6 mp0 -144.52 169.88 17.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -1.133 . . . . 0.0 109.958 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 69.2 t -121.44 104.92 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.948 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.585 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 8.2 t30 -79.01 167.08 21.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -0.915 . . . . 0.0 110.386 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 139' ' ' GLU . 28.1 t80 -47.33 -58.82 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.334 -0.853 . . . . 0.0 110.058 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 138' ' ' TYR . 45.6 mm-40 -44.44 -42.25 6.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 109.669 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.472 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 4.5 tt0 -68.05 -54.3 19.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.813 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -45.8 -25.66 0.54 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.566 HG22 HG21 ' A' ' 85' ' ' ILE . 12.0 t -93.69 -30.5 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 0.0 109.836 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 140' ' ' GLU . 25.8 mt-30 -58.49 -38.61 78.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.065 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.588 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 1.9 mmm -64.03 -55.17 24.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 0.0 109.917 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' B' ' 24' ' ' ASN . 6.1 ttm -67.44 -21.94 65.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 146' ' ' THR . 3.8 t . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 110.298 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.609 HG23 ' HD2' ' B' ' 5' ' ' PRO . 6.1 mt . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 120.772 0.32 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.609 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.2 Cg_endo -69.76 129.04 16.9 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.665 1.35 . . . . 0.0 111.085 -179.064 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.543 ' O ' ' N ' ' B' ' 8' ' ' THR . 3.8 m -86.83 95.96 10.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.494 -0.754 . . . . 0.0 110.813 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.568 ' CH2' HD13 ' A' ' 32' ' ' LEU . 13.9 m95 33.92 -87.82 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.805 -0.559 . . . . 0.0 111.92 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.543 ' N ' ' O ' ' B' ' 6' ' ' SER . 1.3 p -35.38 -38.76 0.11 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.51 -0.744 . . . . 0.0 111.011 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.657 HG21 ' HB3' ' A' ' 87' ' ' GLU . 4.3 m -57.65 -42.21 83.02 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.571 -0.851 . . . . 0.0 109.736 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' B' ' 7' ' ' TRP . 13.3 t -68.31 -36.6 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.418 -0.801 . . . . 0.0 109.698 179.634 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.686 ' N ' HD13 ' B' ' 11' ' ' ILE . 2.7 mm -70.0 -19.41 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.359 -0.838 . . . . 0.0 109.442 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.441 ' O ' ' SD ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.5 -57.43 3.94 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.715 0.769 . . . . 0.0 109.527 179.282 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.651 HG11 HG11 ' A' ' 91' ' ' VAL . 43.2 t -62.8 -34.36 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.0 110.76 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.498 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -69.7 -34.86 74.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.987 . . . . 0.0 110.304 -179.835 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 58.5 m -71.96 -25.8 62.01 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' B' ' 22' ' ' PHE . 0.2 OUTLIER -76.07 -37.49 58.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.305 -0.872 . . . . 0.0 110.828 -179.823 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.921 HD21 ' HA ' ' A' ' 109' ' ' MET . 4.4 mp -51.53 -19.54 1.51 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.94 -1.1 . . . . 0.0 110.509 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' B' ' 17' ' ' LEU . 0.3 OUTLIER -21.57 -72.0 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 CA-C-O 121.087 0.47 . . . . 0.0 112.127 -179.446 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.53 ' HD2' ' HG3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -154.08 -114.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 110.136 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.494 ' NH2' ' OE2' ' A' ' 120' ' ' GLU . 1.6 mtm180 -101.25 21.27 14.3 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.901 -1.124 . . . . 0.0 110.087 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 13.7 m -120.75 142.74 49.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.552 ' HZ ' HD11 ' A' ' 105' ' ' LEU . 1.2 m-85 -88.96 -63.96 1.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.452 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.58 108.71 0.72 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 144' ' ' MET . 9.8 m120 -100.58 -42.03 0.22 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.221 -1.164 . . . . 0.0 111.943 -179.342 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' B' ' 24' ' ' ASN . 47.7 Cg_endo -81.78 10.81 3.33 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.089 1.047 . . . . 0.0 110.909 -179.081 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 109.961 179.745 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.248 0.547 . . . . 0.0 110.274 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.78 -48.38 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.985 . . . . 0.0 109.982 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.77 -36.77 62.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.802 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 19.4 mt-10 -60.74 -54.05 49.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 109.619 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -59.67 -43.06 94.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.83 . . . . 0.0 109.706 179.553 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -36.1 77.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.808 179.642 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -65.2 -42.04 93.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.329 -0.857 . . . . 0.0 109.769 179.573 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.22 -45.18 77.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.415 -0.803 . . . . 0.0 110.002 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.635 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 34.0 t80 -61.29 -29.74 70.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.0 109.813 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 m -83.95 -22.8 31.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.402 -0.811 . . . . 0.0 109.773 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.853 HD11 ' O ' ' A' ' 112' ' ' LEU . 4.1 tt -71.3 -36.06 71.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.962 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.67 ' HD1' HG21 ' A' ' 35' ' ' VAL . 53.8 m-85 -82.94 -46.05 13.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.234 -0.916 . . . . 0.0 110.053 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.461 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 17.1 t0 -72.61 101.33 3.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.0 110.215 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.92 -52.34 9.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.139 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -53.43 -51.04 63.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.345 -0.847 . . . . 0.0 110.166 179.905 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.07 22.86 6.67 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 46.6 p-10 -79.83 -21.95 43.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -1.192 . . . . 0.0 110.107 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.558 ' C ' HG23 ' A' ' 26' ' ' THR . . . 97.18 33.2 6.07 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.558 HG23 ' C ' ' A' ' 25' ' ' GLY . 44.2 p -153.09 132.48 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.341 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.611 HD12 HG21 ' A' ' 63' ' ' ILE . 6.0 mt -101.06 112.63 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 109.937 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 29' ' ' THR . 51.8 p -97.98 156.92 16.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 110.169 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 28' ' ' THR . 1.9 p -44.53 -27.27 0.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.178 -0.952 . . . . 0.0 109.872 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -55.28 9.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 110.033 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' O ' ' HB ' ' A' ' 34' ' ' THR . 39.5 mt-10 -57.15 -56.09 26.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.93 . . . . 0.0 110.063 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.504 HD22 ' CD1' ' A' ' 52' ' ' ILE . 10.4 tp -57.65 -48.66 78.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 109.937 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -51.78 -39.6 47.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.825 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 52.6 m -59.43 -61.07 2.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -1.175 . . . . 0.0 109.715 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.67 HG21 ' HD1' ' A' ' 19' ' ' PHE . 13.8 t -45.25 -55.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -57.51 -26.96 62.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.809 179.559 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.0 ttm180 -74.23 -19.49 60.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.479 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 19.2 m -96.37 -38.11 10.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.275 -0.891 . . . . 0.0 110.625 -179.704 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 mt -45.67 -29.16 1.16 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.01 -1.056 . . . . 0.0 110.067 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 41' ' ' GLN . . . 125.17 58.63 0.17 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 2.2 mt-30 170.04 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.197 -1.178 . . . . 0.0 110.498 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.54 102.09 3.49 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.276 -0.89 . . . . 0.0 110.349 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.517 ' HB3' HD12 ' B' ' 4' ' ' ILE . 45.1 Cg_endo -73.18 135.77 23.34 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.093 1.575 . . . . 0.0 110.335 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.536 HG22 ' OE2' ' A' ' 47' ' ' GLU . 13.7 t -71.99 -161.93 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.206 -0.934 . . . . 0.0 110.224 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -84.18 -56.38 3.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.019 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.38 -51.22 11.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.016 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.536 ' OE2' HG22 ' A' ' 44' ' ' THR . 48.0 mt-10 -61.37 -52.35 65.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.865 . . . . 0.0 109.99 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.7 OUTLIER -55.56 -48.69 74.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.342 -0.848 . . . . 0.0 110.23 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -62.21 -32.82 73.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.103 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -32.59 70.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.364 -0.835 . . . . 0.0 110.093 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 3.1 mtp -78.02 -43.85 28.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.433 -0.792 . . . . 0.0 110.438 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.606 HG13 HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -70.43 -33.82 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.212 -0.93 . . . . 0.0 109.921 -179.993 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.8 m120 -60.62 -25.87 66.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.486 -0.759 . . . . 0.0 110.743 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -77.92 -47.05 19.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 0.0 110.579 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.694 HG21 ' CE2' ' B' ' 7' ' ' TRP . 19.2 t -71.28 -40.36 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.185 -0.947 . . . . 0.0 110.091 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.486 ' OD1' HD13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -63.46 71.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.841 -179.975 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -37.94 -63.25 0.49 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.674 -0.641 . . . . 0.0 110.529 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 3.5 p30 -56.75 -38.85 73.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.102 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.98 48.72 4.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.529 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 16.7 p-10 -98.32 -40.39 8.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -1.182 . . . . 0.0 110.115 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 62' ' ' THR . . . 133.73 21.75 0.79 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.692 179.36 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 61' ' ' GLY . 36.3 p -158.06 145.63 18.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.922 -1.34 . . . . 0.0 110.405 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.611 HG21 HD12 ' A' ' 27' ' ' ILE . 10.8 mm -89.42 144.96 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.349 -0.844 . . . . 0.0 109.803 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -120.59 147.31 45.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.128 -0.982 . . . . 0.0 110.754 -179.578 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.635 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 11.8 t80 -43.85 -49.52 20.5 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.372 -0.83 . . . . 0.0 111.098 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.8 Cg_endo -68.7 -32.49 23.62 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.281 1.148 . . . . 0.0 110.539 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -65.51 -30.17 70.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -76.96 -51.18 11.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.885 . . . . 0.0 110.236 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 65' ' ' PHE . 2.7 mp -53.62 -32.38 51.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.376 -0.827 . . . . 0.0 110.214 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.8 m -78.03 -38.34 44.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 110.563 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -67.19 0.45 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.196 -0.94 . . . . 0.0 110.533 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.448 ' SD ' HG21 ' B' ' 11' ' ' ILE . 6.8 tpt -50.5 -19.87 0.99 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.353 -0.842 . . . . 0.0 110.665 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.86 -29.14 39.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.134 -0.979 . . . . 0.0 110.648 -179.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -93.68 -15.17 25.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.667 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.215 0.531 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -75.5 -46.38 32.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.981 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HG2' ' N ' ' A' ' 85' ' ' ILE . 10.2 pm0 -55.59 -23.37 26.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 110.26 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.667 HG21 HG22 ' A' ' 142' ' ' VAL . 24.3 mt -84.22 -46.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 109.203 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -34.29 69.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.459 -0.776 . . . . 0.0 109.216 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.45 ' HB3' HG21 ' B' ' 9' ' ' THR . 32.0 mt-10 -72.38 -48.77 38.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.223 178.936 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.54 -35.14 67.77 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.426 -0.797 . . . . 0.0 109.073 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.22 -39.45 78.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.368 -0.833 . . . . 0.0 108.825 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -58.67 -29.89 66.95 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.202 179.03 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.9 -50.47 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.485 -0.76 . . . . 0.0 109.555 179.514 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.532 ' HB3' HD13 ' A' ' 100' ' ' ILE . 61.2 m-85 -62.43 -38.49 89.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.26 55.84 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.995 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -56.2 -48.9 75.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.094 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 15.9 p-10 -57.6 -34.55 69.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 110.323 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 74.41 49.02 12.52 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.437 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 27.0 p-10 -98.28 -22.91 15.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -1.103 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.627 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 113.7 6.79 20.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 73.0 m-85 -157.71 134.98 10.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.248 -1.148 . . . . 0.0 109.841 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.532 HD13 ' HB3' ' A' ' 92' ' ' PHE . 24.9 mt -84.49 155.62 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.1 -1.0 . . . . 0.0 110.541 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 103' ' ' ALA . 4.0 t -139.22 140.56 37.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.454 -0.778 . . . . 0.0 109.72 179.691 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.15 -27.44 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.235 -0.916 . . . . 0.0 110.375 -179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -65.59 -55.58 16.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.674 179.492 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 38.1 mt-10 -55.08 -44.68 75.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.998 179.503 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.969 ' CD1' HD11 ' A' ' 125' ' ' ILE . 1.1 mt -57.37 -44.93 84.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.9 . . . . 0.0 109.655 179.733 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.2 OUTLIER -55.94 -38.29 70.11 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.053 -1.029 . . . . 0.0 109.286 179.273 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.47 -32.24 73.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.629 -0.669 . . . . 0.0 109.539 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.448 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 26.1 t -81.15 -52.56 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.475 -0.765 . . . . 0.0 110.672 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.544 ' HG3' ' N ' ' A' ' 110' ' ' THR . 11.9 ptp -58.59 -38.6 78.28 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.981 . . . . 0.0 110.389 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.544 ' N ' ' HG3' ' A' ' 109' ' ' MET . 27.1 m -71.15 -40.09 71.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.881 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 38' ' ' SER . 36.5 m-80 -80.07 -4.45 52.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.787 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.853 ' O ' HD11 ' A' ' 18' ' ' LEU . 5.8 mt -98.23 -30.48 12.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 0.0 109.923 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.38 -53.11 0.59 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 109' ' ' MET . 22.7 tt0 -108.12 143.49 36.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -1.107 . . . . 0.0 110.173 -179.876 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.6 OUTLIER -120.64 18.72 11.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.945 . . . . 0.0 109.643 179.614 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.884 HD11 ' O ' ' B' ' 17' ' ' LEU . 3.4 mp 40.11 -164.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.613 0.72 . . . . 0.0 110.656 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 -172.87 2.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.462 -0.774 . . . . 0.0 109.269 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.3 -50.02 8.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 0.0 109.908 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -64.7 -32.83 74.68 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 179.527 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.41 ' OE1' ' HD2' ' B' ' 20' ' ' ARG . 4.8 mt-10 -69.05 -50.72 45.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.359 -0.838 . . . . 0.0 109.236 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.4 t -60.22 -42.06 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.805 179.297 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -66.14 -49.98 65.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 179.379 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -56.11 -25.47 45.99 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.449 -0.782 . . . . 0.0 109.139 179.19 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.802 ' HE2' ' CD1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.65 -57.57 6.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.567 -0.708 . . . . 0.0 109.854 179.546 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.969 HD11 ' CD1' ' A' ' 105' ' ' LEU . 24.6 mm -64.31 -24.32 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.389 -0.819 . . . . 0.0 110.003 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -76.05 -51.61 11.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.955 . . . . 0.0 110.021 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -12.39 42.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.334 -0.854 . . . . 0.0 110.053 179.823 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -98.4 -33.25 11.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.53 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.892 . . . . 0.0 110.121 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 128' ' ' ALA . 10.3 mt -72.74 -27.64 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p-10 -96.58 -28.12 14.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 0.0 110.296 -179.892 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.38 75.57 1.14 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 21.1 p-10 -128.1 -18.09 4.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.256 -1.144 . . . . 0.0 110.551 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.64 10.04 36.48 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.439 ' OE1' ' CB ' ' A' ' 99' ' ' TYR . 13.1 pt20 -168.94 170.27 9.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.361 -1.082 . . . . 0.0 109.484 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 35.3 t -114.87 151.95 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.943 -1.098 . . . . 0.0 110.85 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' A' ' 98' ' ' GLY . 5.6 t-20 -116.77 -169.6 1.67 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.513 -0.742 . . . . 0.0 109.506 179.668 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.44 ' CE1' HG21 ' A' ' 142' ' ' VAL . 8.5 t80 -67.83 -52.83 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.931 -1.105 . . . . 0.0 110.061 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -46.17 -67.46 0.28 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.319 -0.863 . . . . 0.0 110.188 179.964 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' PHE . 4.8 tt0 -43.87 -59.39 2.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 109.766 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.435 ' CE1' ' CD2' ' A' ' 92' ' ' PHE . 42.9 t80 -43.48 -26.05 0.19 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.831 179.415 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.667 HG22 HG21 ' A' ' 85' ' ' ILE . 68.8 t -98.93 -30.77 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.369 -0.832 . . . . 0.0 110.639 -179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 140' ' ' GLU . 10.3 mm-40 -65.65 -40.71 92.75 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.097 -1.002 . . . . 0.0 110.584 -179.634 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -36.56 68.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.219 -0.926 . . . . 0.0 110.559 -179.708 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.683 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 3.7 mtt -85.0 -26.06 27.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 146' ' ' THR . 9.6 t . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.128 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.517 HD12 ' HB3' ' A' ' 43' ' ' PRO . 6.7 mm . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.04 0.448 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.68 139.07 36.25 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.543 1.286 . . . . 0.0 110.591 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.85 ' O ' HG23 ' B' ' 10' ' ' VAL . 40.9 t -73.11 -159.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.845 . . . . 0.0 110.724 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.694 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -82.3 -82.29 0.14 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.553 -0.717 . . . . 0.0 110.724 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.667 HG21 ' HG2' ' A' ' 75' ' ' LYS . 23.9 p -40.09 -34.99 0.34 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.622 -0.674 . . . . 0.0 110.42 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.45 HG21 ' HB3' ' A' ' 87' ' ' GLU . 40.1 m -59.85 -53.41 58.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 109.3 179.27 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.85 HG23 ' O ' ' B' ' 6' ' ' SER . 61.9 t -50.51 -41.85 20.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.301 -0.875 . . . . 0.0 109.124 178.947 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.587 ' H ' HD12 ' B' ' 11' ' ' ILE . 2.8 mp -61.95 -59.59 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.561 -0.712 . . . . 0.0 110.103 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.444 ' CD2' ' CE2' ' B' ' 26' ' ' PHE . 3.2 mm? -39.94 -50.64 2.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.497 -0.752 . . . . 0.0 110.992 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.603 HG12 HD11 ' A' ' 112' ' ' LEU . 94.8 t -56.65 -51.98 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.111 -0.993 . . . . 0.0 110.531 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.471 ' O ' HD22 ' B' ' 17' ' ' LEU . 19.3 tptt -56.02 -49.99 72.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.86 -1.15 . . . . 0.0 109.762 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.446 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.6 OUTLIER -68.74 -6.47 26.64 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 179.045 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.531 ' O ' ' HE3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -80.13 -45.2 18.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.362 -0.836 . . . . 0.0 110.548 -179.861 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.884 ' O ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -100.31 32.6 2.96 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 118.515 -1.274 . . . . 0.0 110.529 179.36 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.533 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 57.0 ttt180 -44.28 -58.95 2.61 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.56 -0.713 . . . . 0.0 109.859 179.3 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.595 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -144.59 -118.09 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.221 -0.924 . . . . 0.0 110.007 179.578 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.41 ' HD2' ' OE1' ' A' ' 120' ' ' GLU . 25.5 mtp180 -97.03 25.27 5.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.884 -1.135 . . . . 0.0 109.957 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.04 152.97 28.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.667 -179.352 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.802 ' CD1' ' HE2' ' A' ' 124' ' ' MET . 1.2 t80 -124.13 -25.64 4.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.875 . . . . 0.0 110.317 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.87 109.84 3.9 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.683 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 1.5 m-80 -81.57 156.18 70.84 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -1.178 . . . . 0.0 109.88 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' B' ' 26' ' ' PHE . 43.3 Cg_endo -74.72 -68.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.857 1.451 . . . . 0.0 110.432 -179.804 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.498 ' CD1' ' HB3' ' B' ' 24' ' ' ASN . 15.5 m-85 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.396 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.238 0.542 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.2 mt -49.91 -48.36 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.662 179.569 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.7 -48.75 66.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.331 -0.856 . . . . 0.0 109.565 179.473 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -55.12 -52.22 63.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.612 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -57.75 -45.38 85.94 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.321 -0.862 . . . . 0.0 109.427 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -33.67 57.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 109.247 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.7 -47.82 79.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.535 -0.728 . . . . 0.0 109.661 179.483 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -62.46 -44.32 96.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -0.85 . . . . 0.0 109.543 179.485 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.6 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 23.9 t80 -63.74 -35.59 81.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.378 -0.826 . . . . 0.0 109.708 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.2 m -78.1 -20.64 51.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -0.842 . . . . 0.0 109.854 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.855 HD12 ' O ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -69.5 -46.95 65.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.43 -0.794 . . . . 0.0 109.789 179.799 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 21' ' ' LYS . 75.5 m-85 -69.57 -59.31 3.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 109.939 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.46 91.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.343 -0.848 . . . . 0.0 110.247 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 19' ' ' PHE . 4.0 mmtp -77.49 -26.57 51.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.129 -0.982 . . . . 0.0 110.22 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 20.7 p-10 -97.73 -20.72 17.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.275 -0.89 . . . . 0.0 110.326 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.61 78.79 0.92 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 45.2 p-10 -139.39 8.47 2.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -1.151 . . . . 0.0 110.061 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.791 ' O ' HG23 ' A' ' 26' ' ' THR . . . 65.34 35.01 90.95 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -163.85 119.31 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.236 -1.155 . . . . 0.0 110.444 -179.903 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 19' ' ' PHE . 13.3 mt -83.18 134.4 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.086 -1.009 . . . . 0.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 20.1 p -98.82 179.98 4.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.405 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.2 p -70.89 -53.27 15.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -61.39 -48.8 79.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.217 -0.927 . . . . 0.0 110.455 -179.948 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OG1' ' A' ' 28' ' ' THR . 23.3 mt-10 -41.92 -69.81 0.12 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.208 -0.932 . . . . 0.0 109.947 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.615 HD22 ' CH2' ' B' ' 7' ' ' TRP . 22.5 tp -49.55 -32.43 12.5 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.125 -0.984 . . . . 0.0 109.07 179.386 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.74 95.04 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.769 -1.733 . . . . 0.0 108.769 179.276 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.1 m -54.76 -44.54 73.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.293 -1.122 . . . . 0.0 109.111 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 35' ' ' VAL . 24.8 t -64.31 -44.72 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.446 -0.784 . . . . 0.0 109.398 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.608 ' HA ' HD12 ' A' ' 39' ' ' LEU . 2.0 mmt -62.28 -34.89 77.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.315 -0.866 . . . . 0.0 109.663 179.369 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -34.31 77.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.501 179.386 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -26.58 54.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.577 -0.702 . . . . 0.0 110.386 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.608 HD12 ' HA ' ' A' ' 36' ' ' MET . 4.7 mt -69.77 -32.44 70.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.131 -0.98 . . . . 0.0 109.985 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.06 -46.98 0.7 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.382 179.492 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.56 -176.46 6.26 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.1 -1.235 . . . . 0.0 111.242 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 8.1 p30 -144.82 105.07 4.52 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.538 -0.726 . . . . 0.0 109.446 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.691 ' HA ' HD11 ' B' ' 4' ' ' ILE . 44.0 Cg_endo -72.23 151.49 54.81 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 O-C-N 124.054 1.555 . . . . 0.0 111.046 -179.304 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.554 HG22 ' N ' ' A' ' 45' ' ' GLU . 56.2 m -98.16 174.62 6.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.909 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.554 ' N ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -73.82 -41.83 61.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.118 -0.989 . . . . 0.0 110.451 -179.768 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.17 -48.82 74.51 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.066 -1.021 . . . . 0.0 110.281 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -64.45 -49.35 71.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.348 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.52 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 6.3 mt -52.34 -49.66 63.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.965 . . . . 0.0 110.109 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -54.73 -41.44 70.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 109.669 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.84 -25.54 62.88 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.315 -0.865 . . . . 0.0 109.464 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.436 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.4 OUTLIER -73.63 -40.92 63.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.894 179.678 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -28.5 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.293 -0.879 . . . . 0.0 109.478 179.733 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.71 -14.15 12.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.314 -0.866 . . . . 0.0 110.113 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -85.8 -49.27 8.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 111.069 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 21.7 t -69.1 -47.5 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.877 -1.14 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -45.89 89.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.388 0.613 . . . . 0.0 110.329 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -98.0 -9.07 26.7 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.186 -0.946 . . . . 0.0 110.59 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 5.7 p30 -100.65 -32.67 10.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.961 -1.087 . . . . 0.0 110.791 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 103.57 45.91 1.48 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 23.1 m120 -100.03 -19.82 16.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.119 -1.224 . . . . 0.0 110.037 179.833 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.89 -11.68 70.55 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 27' ' ' ILE . 0.6 OUTLIER -145.99 170.09 17.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.106 . . . . 0.0 110.109 -179.999 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.2 mm -89.9 124.85 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.423 -0.798 . . . . 0.0 110.493 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.535 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 4.5 m-20 -97.07 -177.43 3.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.274 -0.892 . . . . 0.0 110.639 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.61 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 17.9 t80 -68.5 -48.37 33.7 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.392 -0.817 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.9 Cg_endo -67.69 -32.58 30.04 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 O-C-N 123.294 1.155 . . . . 0.0 110.006 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE2' ' OD1' ' A' ' 64' ' ' ASP . 6.9 mt-10 -63.34 -36.65 84.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.187 -0.946 . . . . 0.0 109.105 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.727 ' HZ ' HG23 ' B' ' 11' ' ' ILE . 5.5 t80 -64.48 -58.24 6.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.779 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.01 -30.53 66.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.329 -0.857 . . . . 0.0 110.199 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 m -84.29 -21.9 30.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.182 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.45 -45.8 68.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 0.0 109.929 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.468 ' CE ' ' CE1' ' B' ' 26' ' ' PHE . 93.3 mmm -57.29 -15.0 5.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 110.222 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.26 -20.57 14.07 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.153 -0.967 . . . . 0.0 110.572 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 -27.01 20.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.026 . . . . 0.0 110.191 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.1 tptt . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.33 -179.939 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.566 ' HA ' HD12 ' A' ' 85' ' ' ILE . 5.1 tp10 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.209 0.528 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -77.38 -40.5 43.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.197 -0.94 . . . . 0.0 110.559 -179.658 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.81 -22.58 64.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 110.633 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.766 HG21 HG22 ' A' ' 142' ' ' VAL . 90.3 mt -76.62 -31.42 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.064 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -65.88 -37.25 85.64 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.346 -0.846 . . . . 0.0 109.651 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.815 ' HB3' HG21 ' B' ' 9' ' ' THR . 4.9 mt-10 -68.7 -52.58 29.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 179.356 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.432 ' HB2' HD13 ' B' ' 12' ' ' LEU . . . -55.64 -29.86 59.96 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.402 -0.811 . . . . 0.0 109.649 179.63 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -69.08 -44.37 72.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 109.333 179.186 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -37.99 54.24 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 109.191 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.939 HG11 HG11 ' B' ' 13' ' ' VAL . 54.9 t -63.48 -51.6 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.679 . . . . 0.0 109.995 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.778 ' HB3' HD13 ' A' ' 100' ' ' ILE . 20.1 m-85 -62.29 -34.9 77.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.168 -0.958 . . . . 0.0 109.995 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -100.46 67.32 1.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.801 . . . . 0.0 109.931 179.835 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 93' ' ' ASP . 3.0 tttp -37.45 -36.87 0.17 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.66 -0.65 . . . . 0.0 110.568 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.9 p30 -83.43 -31.78 26.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.291 -0.881 . . . . 0.0 110.088 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 75.47 33.77 51.89 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 31.4 p-10 -84.73 -31.59 23.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -1.179 . . . . 0.0 110.322 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 117.24 43.55 0.6 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 1.2 m-85 -169.4 124.26 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -1.083 . . . . 0.0 109.959 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.778 HD13 ' HB3' ' A' ' 92' ' ' PHE . 38.1 mt -110.4 116.29 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.585 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -106.02 148.61 27.53 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 109.547 179.237 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.561 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -37.9 -34.46 0.11 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.443 -0.786 . . . . 0.0 110.516 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -63.02 -50.41 70.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 0.0 109.487 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 25.1 mt-10 -55.47 -47.65 75.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.599 179.504 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.997 ' CD1' HD11 ' A' ' 125' ' ' ILE . 2.4 mt -51.11 -41.77 60.25 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.267 -0.896 . . . . 0.0 109.267 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HG2' HG21 ' A' ' 121' ' ' VAL . 1.1 mmm180 -60.43 -34.37 73.87 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.464 -0.772 . . . . 0.0 109.916 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 8.8 m170 -69.98 -22.25 63.16 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 92' ' ' PHE . 2.1 t -88.29 -45.28 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.168 -0.957 . . . . 0.0 110.715 -179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.572 ' HE1' ' HB2' ' A' ' 116' ' ' LEU . 13.1 ptp -63.56 -44.85 92.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.925 -1.109 . . . . 0.0 110.691 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.503 ' N ' ' CG ' ' A' ' 109' ' ' MET . 1.8 m -60.73 -27.77 68.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.038 -1.039 . . . . 0.0 109.928 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 5.8 m120 -82.53 -7.95 59.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.914 . . . . 0.0 110.159 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 18' ' ' LEU . 16.4 mt -114.05 -8.55 13.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.43 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.59 -59.55 0.65 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.422 -1.371 . . . . 0.0 111.148 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.515 ' HG2' HD12 ' A' ' 116' ' ' LEU . 17.8 tt0 -72.12 152.55 42.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.996 -1.296 . . . . 0.0 111.28 -178.809 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 116' ' ' LEU . 4.1 mtmt -132.01 68.06 1.51 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.495 -0.753 . . . . 0.0 109.77 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.572 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 3.0 mp -40.56 119.25 1.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.295 -0.878 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -50.82 177.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.277 -0.889 . . . . 0.0 110.455 -179.464 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -64.71 -52.28 57.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.107 -0.996 . . . . 0.0 110.088 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 10.6 pt-20 -59.92 -42.81 94.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.531 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.417 ' N ' ' CG ' ' A' ' 119' ' ' GLU . 1.8 mt-10 -61.66 -43.54 98.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.421 -0.8 . . . . 0.0 109.446 179.384 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.561 HG12 ' HB1' ' A' ' 102' ' ' ALA . 52.0 t -68.02 -48.46 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.328 -0.858 . . . . 0.0 109.596 179.453 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.21 -38.07 76.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.4 OUTLIER -68.71 -33.56 74.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.855 . . . . 0.0 109.677 179.593 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.575 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 12.0 ttt -64.25 -39.99 95.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.87 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.997 HD11 ' CD1' ' A' ' 105' ' ' LEU . 11.0 mm -74.37 -54.37 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.232 -0.917 . . . . 0.0 109.676 179.541 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.03 -53.38 53.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 110.145 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 7.7 tp10 -51.99 -30.05 23.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.827 . . . . 0.0 110.162 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -96.81 -25.85 15.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.392 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD2' HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -47.2 92.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.266 -0.896 . . . . 0.0 110.556 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.6 mt -80.85 -34.01 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.39 179.403 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.465 ' OD1' ' OD2' ' A' ' 133' ' ' ASP . 9.1 p-10 -87.46 -37.93 16.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.483 -0.761 . . . . 0.0 109.868 179.685 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.24 71.83 0.95 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 3.4 p30 -140.43 9.7 2.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -1.171 . . . . 0.0 109.93 179.475 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 58.13 15.12 20.71 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 15.4 mt-30 -146.64 170.18 17.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.354 -1.086 . . . . 0.0 110.341 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.512 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 54.6 t -131.47 129.91 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 109.81 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 137' ' ' ASN . 14.2 p-10 -114.01 -160.08 0.72 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.115 -0.991 . . . . 0.0 110.579 -179.462 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 139' ' ' GLU . 62.1 t80 -62.91 -63.6 1.16 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.887 . . . . 0.0 110.31 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -40.95 -67.86 0.22 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.325 -0.859 . . . . 0.0 110.311 -179.909 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 139' ' ' GLU . 12.7 tt0 -44.6 -60.91 1.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -46.08 -23.91 0.37 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.29 -0.881 . . . . 0.0 110.308 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.766 HG22 HG21 ' A' ' 85' ' ' ILE . 91.6 t -98.75 -31.67 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 110.241 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -66.2 -13.79 60.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.94 . . . . 0.0 110.263 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.409 ' HB3' ' HA2' ' B' ' 23' ' ' GLY . 0.9 OUTLIER -97.47 -20.31 17.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.261 -0.9 . . . . 0.0 110.475 -179.852 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 145' ' ' MET . . . . . 1.111 ' CE ' HD21 ' B' ' 12' ' ' LEU . 2.1 mtt -99.56 -11.28 21.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 110.218 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 146' ' ' THR . 2.7 t . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 110.072 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.691 HD11 ' HA ' ' A' ' 43' ' ' PRO . 16.6 mt . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.454 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.7 Cg_endo -68.64 -175.65 0.97 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.963 1.507 . . . . 0.0 110.165 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.31 -169.14 1.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.075 -1.016 . . . . 0.0 110.898 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.716 ' O ' HG22 ' B' ' 10' ' ' VAL . 0.9 OUTLIER -71.51 -77.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.579 -0.7 . . . . 0.0 110.658 -179.622 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.465 ' C ' ' O ' ' B' ' 7' ' ' TRP . 2.8 p -41.15 -25.78 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.025 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.815 HG21 ' HB3' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -63.99 -65.38 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 179.146 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.716 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.8 m -47.23 -29.87 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.154 -0.966 . . . . 0.0 109.501 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.727 HG23 ' HZ ' ' A' ' 68' ' ' PHE . 7.1 mm -75.7 -45.8 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.321 179.267 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 1.111 HD21 ' CE ' ' A' ' 145' ' ' MET . 0.9 OUTLIER -47.74 -56.51 7.19 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.542 0.687 . . . . 0.0 110.225 179.655 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.939 HG11 HG11 ' A' ' 91' ' ' VAL . 22.1 t -60.04 -51.94 67.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 110.734 -179.538 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' B' ' 14' ' ' LYS . 24.0 tptt -66.62 -14.61 62.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.926 -1.108 . . . . 0.0 109.975 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 23.3 t -77.71 -33.01 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.872 . . . . 0.0 109.962 179.738 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.67 -14.73 31.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.786 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.826 ' CD2' HD12 ' A' ' 112' ' ' LEU . 3.8 mp -73.72 51.11 0.36 Allowed 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.156 -0.965 . . . . 0.0 111.201 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.484 ' HB3' ' OG ' ' B' ' 21' ' ' SER . 0.1 OUTLIER -104.2 -107.41 0.28 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.116 -0.99 . . . . 0.0 109.817 179.426 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.494 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 0.1 OUTLIER -107.48 -70.16 0.81 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.026 -1.046 . . . . 0.0 109.513 179.677 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.48 ' HB3' ' CD ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -135.45 13.4 3.49 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.36 -0.837 . . . . 0.0 109.804 179.38 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -66.41 120.3 13.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.336 -0.853 . . . . 0.0 110.297 179.866 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.575 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -144.87 26.96 1.34 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.976 . . . . 0.0 110.953 179.965 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 144' ' ' MET . . . -118.65 -119.81 2.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.534 ' HB2' ' HA ' ' A' ' 145' ' ' MET . 6.5 t30 -129.51 70.73 82.0 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.327 -1.102 . . . . 0.0 109.962 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.23 47.2 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.877 1.462 . . . . 0.0 110.21 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.468 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.952 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.354 0.597 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.9 mt -53.67 -45.46 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -50.33 -44.8 54.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.092 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.442 ' OE1' ' HD3' ' B' ' 18' ' ' ARG . 1.6 mt-10 -59.65 -47.12 86.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.943 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -60.64 -39.08 86.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.66 97.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.957 . . . . 0.0 109.932 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.72 -38.16 80.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.304 -0.872 . . . . 0.0 109.832 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -66.36 -51.94 52.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.247 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.549 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 15.3 t80 -62.87 -34.29 77.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.199 -0.938 . . . . 0.0 109.824 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.9 t -73.19 -19.23 61.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.836 . . . . 0.0 109.812 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.675 HD13 ' HG3' ' B' ' 14' ' ' LYS . 10.5 tt -80.76 -34.93 33.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.356 -0.84 . . . . 0.0 110.066 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.413 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 70.2 m-85 -86.4 -44.78 11.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.35 -0.844 . . . . 0.0 110.517 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -77.63 85.79 3.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.312 -0.868 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -66.84 -40.66 88.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.892 . . . . 0.0 110.124 179.848 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -57.1 -43.88 82.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.419 -0.8 . . . . 0.0 110.161 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.26 0.36 67.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 6.9 p-10 -74.84 -28.29 60.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.212 -1.169 . . . . 0.0 109.975 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.524 ' C ' HG23 ' A' ' 26' ' ' THR . . . 110.73 37.73 1.68 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.711 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 28.3 p -152.41 109.97 3.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.152 -1.204 . . . . 0.0 110.661 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.58 HD12 ' CG2' ' A' ' 63' ' ' ILE . 22.3 mt -80.73 115.12 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.196 -0.94 . . . . 0.0 109.442 179.292 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -93.64 174.65 7.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.283 -0.886 . . . . 0.0 110.228 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.578 HG22 ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -64.05 -30.13 71.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.043 179.923 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -73.0 -54.09 9.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.879 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -50.84 -69.91 0.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 109.865 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 tp -52.77 -36.51 58.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.739 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -62.08 -40.55 99.08 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.713 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 m -58.27 -51.87 67.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -1.086 . . . . 0.0 109.799 179.726 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 t -60.29 -47.53 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.858 . . . . 0.0 109.963 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.489 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 2.3 mmt -59.56 -43.02 93.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.12 -0.988 . . . . 0.0 109.895 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -65.56 -20.65 66.42 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.342 -0.849 . . . . 0.0 110.109 179.805 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.8 t -77.83 -57.41 3.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.891 . . . . 0.0 110.288 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mt -46.61 -25.64 0.75 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.156 -0.965 . . . . 0.0 110.071 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.83 66.11 0.56 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -137.69 -157.63 0.79 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.174 -1.192 . . . . 0.0 110.288 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 42' ' ' ASN . 18.0 t30 -147.54 62.8 7.33 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.291 -0.881 . . . . 0.0 110.082 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HG3' ' CB ' ' A' ' 36' ' ' MET . 48.7 Cg_endo -74.7 118.59 5.37 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.073 1.565 . . . . 0.0 110.559 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 46' ' ' ALA . 28.1 m -99.96 146.36 26.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.317 -0.864 . . . . 0.0 109.938 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 21.7 pt-20 -43.12 -44.75 5.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.17 -0.956 . . . . 0.0 110.0 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.474 ' H ' HG22 ' A' ' 44' ' ' THR . . . -65.31 -65.04 0.72 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 109.802 179.615 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -46.55 -43.24 16.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.683 179.677 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.578 ' HB3' HG22 ' A' ' 29' ' ' THR . 0.3 OUTLIER -51.7 -55.66 18.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.351 -0.843 . . . . 0.0 109.785 179.674 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -38.52 19.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.768 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -64.76 -33.69 76.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.416 -0.803 . . . . 0.0 110.104 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.552 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.5 OUTLIER -77.18 -37.9 52.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.587 HG13 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -68.94 -33.81 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.782 179.85 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.77 -46.93 42.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.342 -0.849 . . . . 0.0 110.603 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -59.56 -56.72 18.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 0.0 110.697 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 28.5 t -70.28 -42.77 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.023 -1.048 . . . . 0.0 110.252 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 60' ' ' ASN . 1.7 t70 -64.95 67.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -40.49 -51.5 2.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.551 -0.718 . . . . 0.0 110.886 -179.74 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 6.7 p-10 -67.47 -43.85 80.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 0.0 110.524 -179.621 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' CA ' ' OD2' ' A' ' 56' ' ' ASP . . . 92.72 49.03 2.81 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.53 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 19.2 p30 -100.08 -17.76 17.31 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.168 -1.195 . . . . 0.0 110.202 179.699 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.16 14.2 31.49 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.15 133.33 16.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.116 -1.226 . . . . 0.0 110.183 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.587 HD11 HG13 ' A' ' 52' ' ' ILE . 26.1 mm -84.57 156.27 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.386 -0.821 . . . . 0.0 110.218 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.549 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 15.2 t0 -129.82 169.06 15.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.04 -1.037 . . . . 0.0 110.453 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.82 ' CE2' HD11 ' A' ' 69' ' ' LEU . 51.7 t80 -61.32 -40.03 68.47 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 111.522 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.4 Cg_endo -71.91 -29.72 14.88 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 O-C-N 123.284 1.15 . . . . 0.0 110.22 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -70.48 -31.34 68.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -0.888 . . . . 0.0 109.418 179.218 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 23.6 t80 -72.73 -46.11 55.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.384 -0.822 . . . . 0.0 110.421 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.82 HD11 ' CE2' ' A' ' 65' ' ' PHE . 28.0 mt -66.92 -25.46 66.38 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.212 -0.93 . . . . 0.0 110.778 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.8 m -83.68 -28.62 28.22 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.1 -1.0 . . . . 0.0 110.893 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.437 ' SD ' ' HE3' ' A' ' 75' ' ' LYS . 5.5 tmm? -77.29 -47.59 19.68 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.134 -0.978 . . . . 0.0 111.046 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.602 ' HE2' ' CZ ' ' B' ' 26' ' ' PHE . 7.3 tpt -60.31 -10.89 5.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.118 -0.989 . . . . 0.0 111.102 -179.293 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.52 -36.58 8.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.938 -1.101 . . . . 0.0 110.942 -179.427 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.5 ttt-85 -85.18 -11.26 55.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.133 -0.979 . . . . 0.0 110.6 -179.594 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.746 ' HG2' HG21 ' B' ' 8' ' ' THR . 1.7 tppp? . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.002 -1.061 . . . . 0.0 110.669 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.181 0.515 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -80.41 -40.1 27.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 0.0 109.919 179.763 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -69.36 -27.64 65.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.262 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.496 HG23 ' CE2' ' A' ' 141' ' ' PHE . 80.0 mt -78.53 -36.14 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.113 -0.992 . . . . 0.0 109.957 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -64.66 -29.84 70.85 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 109.802 179.762 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -75.43 -50.78 14.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 109.109 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.762 ' HB2' HD22 ' B' ' 12' ' ' LEU . . . -60.57 -35.73 76.78 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.338 -0.852 . . . . 0.0 109.455 179.208 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 17.3 t80 -64.44 -56.95 10.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 109.847 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -44.31 -38.22 3.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.402 -0.812 . . . . 0.0 109.556 179.709 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.646 HG12 HG21 ' A' ' 108' ' ' VAL . 4.0 t -65.99 -35.92 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 109.826 179.618 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.619 ' HB3' HD13 ' A' ' 100' ' ' ILE . 9.1 m-85 -68.64 -35.68 77.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.164 -0.96 . . . . 0.0 110.474 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.464 ' OD1' HG12 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -98.82 63.59 1.4 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.21 -0.931 . . . . 0.0 110.402 -179.416 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -43.31 -28.22 0.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.277 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 27.6 p-10 -96.1 -36.98 10.8 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.19 -0.944 . . . . 0.0 110.436 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.23 44.0 14.77 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.417 ' ND2' ' OD2' ' A' ' 95' ' ' ASP . 21.7 p30 -78.17 -15.31 58.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -1.145 . . . . 0.0 110.374 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.501 ' C ' ' CG ' ' A' ' 99' ' ' TYR . . . 118.37 -8.39 13.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.501 ' CG ' ' C ' ' A' ' 98' ' ' GLY . 5.3 m-85 -148.88 163.89 36.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -1.186 . . . . 0.0 110.155 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.619 HD13 ' HB3' ' A' ' 92' ' ' PHE . 7.1 mt -113.01 126.32 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 110.133 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.1 p -106.36 153.15 22.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.835 . . . . 0.0 110.09 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.75 -37.84 9.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.05 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.44 93.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -55.52 -43.01 75.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.849 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.998 HD12 HD11 ' A' ' 125' ' ' ILE . 2.7 mt -57.92 -48.05 81.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.716 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.411 ' O ' ' OG1' ' A' ' 110' ' ' THR . 0.3 OUTLIER -50.83 -42.56 58.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.838 . . . . 0.0 109.754 179.79 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.81 -48.45 81.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 109.75 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.646 HG21 HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -74.42 -25.8 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 0.0 109.416 179.631 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.97 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.5 OUTLIER -71.04 -50.05 38.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 110.108 179.98 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -71.41 -31.67 67.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.187 179.934 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -72.55 -6.46 44.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.245 -0.909 . . . . 0.0 110.438 -179.887 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.72 HD11 HG12 ' B' ' 13' ' ' VAL . 6.4 mt -106.53 -44.72 4.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.106 -0.996 . . . . 0.0 110.617 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.69 -46.93 0.51 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.405 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.742 ' HG2' HD12 ' A' ' 116' ' ' LEU . 14.2 tt0 -98.48 141.67 31.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.067 -1.255 . . . . 0.0 110.659 -179.613 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 116' ' ' LEU . 3.2 ptpt -119.56 16.46 12.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 109.748 179.406 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.742 HD12 ' HG2' ' A' ' 114' ' ' GLU . 4.0 mp 39.45 -164.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.684 0.754 . . . . 0.0 110.842 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.16 -147.98 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.562 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -107.58 -48.56 3.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 109.969 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -67.24 -34.84 78.31 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.538 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.48 -44.68 82.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.272 -0.893 . . . . 0.0 109.097 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.0 t -53.25 -48.64 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.412 -0.805 . . . . 0.0 109.646 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -65.07 -56.24 14.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.75 -30.05 13.0 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.41 -0.806 . . . . 0.0 109.437 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.616 ' HE2' ' CD2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.61 -62.4 1.84 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.339 -0.851 . . . . 0.0 109.689 179.544 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.998 HD11 HD12 ' A' ' 105' ' ' LEU . 48.0 mm -56.33 -34.24 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -0.78 . . . . 0.0 110.258 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -66.91 -44.18 81.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 110.323 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.77 -29.66 69.67 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 0.0 110.215 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.18 -31.18 34.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -0.953 . . . . 0.0 110.015 179.799 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.476 ' HB3' ' HA2' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -65.6 106.2 1.4 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.372 -0.83 . . . . 0.0 110.483 -179.968 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.2 mm -64.3 -28.04 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 12.3 p30 -105.54 -16.43 14.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.958 179.823 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 64.02 59.36 8.63 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.441 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 6.3 p-10 -101.0 -23.96 14.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -1.146 . . . . 0.0 109.941 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 135' ' ' GLN . . . 131.79 -12.72 5.35 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.478 ' CG ' ' C ' ' A' ' 134' ' ' GLY . 9.7 mt-30 -151.31 161.16 43.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.152 -1.205 . . . . 0.0 110.073 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 19.3 t -105.67 157.85 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.908 179.653 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 1.9 p-10 -127.23 -179.54 4.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.221 -0.925 . . . . 0.0 110.445 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -61.03 -67.15 0.43 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.447 -0.783 . . . . 0.0 110.647 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 0.7 OUTLIER -45.32 -27.67 0.71 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.238 -0.914 . . . . 0.0 110.628 -179.49 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.464 ' HB2' ' ND2' ' A' ' 137' ' ' ASN . 4.2 tt0 -80.49 -52.51 7.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 69.3 t80 -54.33 -17.39 2.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.18 -0.95 . . . . 0.0 109.859 179.638 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.45 -55.3 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 110.637 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 0.5 OUTLIER -58.93 -13.79 7.36 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.118 -0.988 . . . . 0.0 110.78 -179.559 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.493 ' HG3' ' HA2' ' B' ' 23' ' ' GLY . 3.7 tpt -97.55 -27.27 14.48 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.166 -0.959 . . . . 0.0 110.582 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.8 ttt -100.49 -10.05 21.47 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.249 -0.907 . . . . 0.0 110.796 -179.53 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 0.0 110.967 -179.335 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.63 HG23 ' HD2' ' B' ' 5' ' ' PRO . 19.0 mm . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.63 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.0 Cg_endo -66.52 170.38 12.46 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.632 1.333 . . . . 0.0 110.436 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.512 ' O ' ' HB ' ' B' ' 9' ' ' THR . 0.1 OUTLIER -96.4 152.24 18.79 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.189 -0.945 . . . . 0.0 111.299 -178.913 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.759 ' O ' HG22 ' B' ' 10' ' ' VAL . 4.2 m95 -48.95 -66.09 0.46 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.881 . . . . 0.0 109.641 179.036 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.746 HG21 ' HG2' ' A' ' 75' ' ' LYS . 23.8 p -47.73 -24.17 0.88 Allowed 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.889 -1.132 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' B' ' 6' ' ' SER . 4.1 m -64.38 -54.97 24.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.066 -1.021 . . . . 0.0 109.639 179.37 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.759 HG22 ' O ' ' B' ' 7' ' ' TRP . 6.8 m -56.89 -33.71 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.908 -1.12 . . . . 0.0 108.687 179.44 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.525 ' N ' HD13 ' B' ' 11' ' ' ILE . 4.9 mm -77.45 -23.2 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 108.799 178.411 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.762 HD22 ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -68.5 -60.78 2.18 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.613 -0.68 . . . . 0.0 109.784 179.707 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.72 HG12 HD11 ' A' ' 112' ' ' LEU . 35.7 t -62.82 -32.84 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.371 -0.83 . . . . 0.0 110.166 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.675 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -69.35 -45.59 69.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.017 -1.052 . . . . 0.0 109.251 179.212 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 52.7 p -58.46 -35.23 71.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.418 -0.801 . . . . 0.0 109.518 179.151 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.489 ' HG2' ' HG3' ' B' ' 25' ' ' PRO . 0.0 OUTLIER -65.1 -41.97 94.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.445 -0.784 . . . . 0.0 109.582 179.477 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.97 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.2 mp -60.62 -12.82 11.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.421 -0.799 . . . . 0.0 110.038 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.56 ' C ' ' O ' ' B' ' 17' ' ' LEU . 6.4 tpt85 -18.8 -68.21 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.679 0 CA-C-O 121.489 0.661 . . . . 0.0 111.161 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.535 ' HD2' ' HG2' ' B' ' 20' ' ' ARG . 1.1 tmtm? -174.44 -104.49 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.011 179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.535 ' HG2' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -87.73 13.66 10.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.444 -1.41 . . . . 0.0 109.335 179.308 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -87.06 163.34 17.08 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.456 -0.777 . . . . 0.0 110.555 -179.542 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.616 ' CD2' ' HE2' ' A' ' 124' ' ' MET . 0.2 OUTLIER 179.81 -45.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.318 -0.864 . . . . 0.0 110.559 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.493 ' HA2' ' HG3' ' A' ' 144' ' ' MET . . . -69.91 -50.96 26.43 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.395 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -150.13 84.97 5.61 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.954 -1.321 . . . . 0.0 110.838 -179.572 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.489 ' HG3' ' HG2' ' B' ' 16' ' ' MET . 48.6 Cg_endo -80.84 -7.76 13.35 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.925 1.487 . . . . 0.0 110.109 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.602 ' CZ ' ' HE2' ' A' ' 72' ' ' MET . 5.9 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.316 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.327 0.584 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.4 mt -50.11 -44.92 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.3 -45.71 69.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 109.951 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.68 -51.01 66.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.208 -0.932 . . . . 0.0 109.813 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -44.84 67.63 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.229 -0.919 . . . . 0.0 109.377 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.63 -30.56 65.47 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.344 -0.847 . . . . 0.0 108.972 178.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -58.32 9.1 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.533 -0.729 . . . . 0.0 109.293 179.21 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.77 -48.41 41.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.267 -0.896 . . . . 0.0 109.336 179.231 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.543 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 32.3 t80 -66.51 -35.64 80.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.327 -0.858 . . . . 0.0 109.448 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -68.32 -30.34 69.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.46 -0.775 . . . . 0.0 109.528 179.446 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.876 HD13 ' CD ' ' B' ' 14' ' ' LYS . 6.7 tt -65.35 -46.03 81.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.684 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -73.29 -39.15 65.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.282 -0.886 . . . . 0.0 110.384 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.461 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 1.8 t0 -78.89 82.93 5.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.211 -0.931 . . . . 0.0 109.919 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -49.17 -74.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 110.359 -179.746 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.1 p-10 -51.76 -39.0 57.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 110.306 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.17 15.02 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.461 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 40.8 p-10 -76.64 -12.65 60.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -1.167 . . . . 0.0 110.081 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.621 ' O ' HG23 ' A' ' 26' ' ' THR . . . 89.98 42.11 5.42 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -161.49 117.36 2.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -1.131 . . . . 0.0 110.573 -179.831 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.538 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 8.1 mt -100.07 118.22 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.218 -0.926 . . . . 0.0 110.127 179.594 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.68 HG22 HG22 ' A' ' 62' ' ' THR . 20.4 p -94.92 153.88 17.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 109.806 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -46.31 -24.65 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.977 . . . . 0.0 109.942 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -78.54 -60.79 2.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.066 179.761 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 37.3 mt-10 -44.21 -56.64 3.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.511 HD22 ' CZ2' ' B' ' 7' ' ' TRP . 40.8 tp -57.39 -45.65 84.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.168 -0.958 . . . . 0.0 109.3 179.336 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -56.65 -39.56 86.24 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.27 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 15.0 m -53.28 -50.94 63.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -1.027 . . . . 0.0 109.363 179.352 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 35' ' ' VAL . 10.4 t -57.75 -39.28 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.326 -0.859 . . . . 0.0 109.261 179.246 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 13.5 mmt -61.31 -39.13 89.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 179.253 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -62.25 -30.74 71.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.381 179.265 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 m -65.73 -61.85 1.84 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.465 -0.772 . . . . 0.0 110.051 179.687 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.1 mt -47.92 -24.16 0.96 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.71 55.08 0.58 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.15 165.94 30.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -1.186 . . . . 0.0 110.482 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 42' ' ' ASN . 2.6 p30 -140.75 97.95 7.14 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.967 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.7 154.33 54.31 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.9 1.474 . . . . 0.0 110.485 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 45' ' ' GLU . 4.0 m -99.65 -176.74 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.664 ' H ' HG22 ' A' ' 44' ' ' THR . 1.2 tm-20 -67.45 -69.52 0.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.216 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.502 ' N ' ' OE1' ' A' ' 45' ' ' GLU . . . -47.14 -46.95 23.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.417 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 56.5 mm-40 -52.54 -58.19 7.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -0.895 . . . . 0.0 110.296 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.6 mt -48.61 -43.6 36.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.254 -0.904 . . . . 0.0 110.53 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 tp60 -63.87 -35.92 82.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 110.235 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -30.65 71.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.869 . . . . 0.0 110.12 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.9 mtp -84.15 -47.58 10.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.343 -0.848 . . . . 0.0 110.09 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 63' ' ' ILE . 10.2 mm -66.05 -30.26 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -56.5 -14.14 2.86 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.361 -0.837 . . . . 0.0 111.094 -179.504 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.38 -53.0 4.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.085 -1.009 . . . . 0.0 111.009 -179.29 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.823 HG22 ' HG3' ' A' ' 71' ' ' MET . 6.6 t -72.46 -36.69 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.093 -1.005 . . . . 0.0 111.002 -179.484 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.7 t0 -55.32 82.25 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.267 -0.896 . . . . 0.0 110.657 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.32 -58.2 3.59 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.402 -0.812 . . . . 0.0 110.65 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 30.1 p30 -63.94 -11.7 30.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.258 -0.901 . . . . 0.0 110.5 -179.708 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 61.08 46.52 94.38 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.487 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 23.1 p-10 -97.73 -32.84 11.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -1.147 . . . . 0.0 110.23 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.16 -9.42 5.66 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.68 HG22 HG22 ' A' ' 28' ' ' THR . 31.0 p -139.18 160.6 39.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 110.032 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.675 HD12 ' HB ' ' A' ' 55' ' ' VAL . 15.6 mm -84.59 159.45 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 109.92 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.543 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -126.25 173.33 9.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.093 -1.004 . . . . 0.0 110.55 -179.865 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.5 t80 -67.5 -50.77 35.53 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.322 -0.862 . . . . 0.0 111.135 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.3 Cg_endo -66.53 -39.51 16.15 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.254 1.134 . . . . 0.0 110.169 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE2' ' HB2' ' A' ' 64' ' ' ASP . 39.3 mt-10 -53.8 -39.62 65.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.527 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.73 -47.21 72.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 109.777 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 66' ' ' PRO . 18.3 mt -51.17 -30.41 16.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.997 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.9 m -93.89 -14.86 25.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.389 -0.819 . . . . 0.0 110.501 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.823 ' HG3' HG22 ' A' ' 55' ' ' VAL . 7.1 tmm? -73.18 -54.08 9.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.107 -0.995 . . . . 0.0 110.433 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.537 ' CE ' ' CE1' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -52.62 -18.12 1.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.816 . . . . 0.0 110.668 -179.604 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.45 -10.11 22.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.13 -0.981 . . . . 0.0 110.648 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.29 -34.6 9.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.119 -0.988 . . . . 0.0 110.447 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.755 ' HB3' HG21 ' B' ' 8' ' ' THR . 6.4 tptt . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.204 -0.935 . . . . 0.0 110.405 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 15.8 pt-20 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.199 0.523 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.501 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 1.1 pt-20 -72.64 -9.73 58.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.448 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 13.8 mm-40 -79.12 -28.0 42.89 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.497 -0.752 . . . . 0.0 109.91 179.48 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.661 HG23 ' CE1' ' A' ' 141' ' ' PHE . 77.8 mt -62.93 -39.42 85.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.205 -0.934 . . . . 0.0 108.6 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -65.51 -28.53 69.25 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.766 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.4 -53.39 7.72 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.22 -32.39 71.08 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.33 -0.856 . . . . 0.0 108.935 178.845 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -72.88 -45.99 55.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.067 178.915 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -55.25 -23.78 24.4 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.535 -0.728 . . . . 0.0 109.135 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.829 HG12 HG21 ' A' ' 108' ' ' VAL . 22.8 t -78.59 -44.37 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.536 -0.728 . . . . 0.0 109.735 179.462 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.587 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 57.3 m-85 -65.68 -42.28 91.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.889 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.458 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 30.9 t0 -100.13 61.47 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.524 ' HA ' ' CE ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -54.31 -48.21 71.57 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.153 -0.967 . . . . 0.0 109.534 179.867 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 10.0 p-10 -54.97 -32.15 61.34 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.799 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.29 54.63 22.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.463 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 52.6 p30 -96.57 -5.43 39.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.245 -1.15 . . . . 0.0 110.101 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 99.45 13.13 39.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 2.6 m-85 -164.74 162.97 21.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.303 -1.116 . . . . 0.0 110.04 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.573 HD13 ' HB3' ' A' ' 92' ' ' PHE . 10.7 mt -119.67 132.63 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.234 -0.916 . . . . 0.0 110.414 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -116.08 153.25 32.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 110.126 179.957 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.2 -32.64 1.31 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.709 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.95 84.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.406 -0.809 . . . . 0.0 109.494 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.448 ' OE1' ' OD1' ' A' ' 93' ' ' ASP . 5.7 mt-10 -54.49 -50.58 67.45 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.324 -0.86 . . . . 0.0 109.404 179.364 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.5 ' HG ' HD11 ' A' ' 125' ' ' ILE . 3.6 mm? -57.9 -52.86 63.77 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.302 -0.873 . . . . 0.0 109.5 179.349 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -50.89 -26.57 6.0 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.213 -0.93 . . . . 0.0 109.016 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.598 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 26.3 t60 -79.27 -25.45 42.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.564 -0.71 . . . . 0.0 109.69 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.829 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -98.8 -30.74 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.694 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 109' ' ' MET . . . . . 1.009 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.2 OUTLIER -73.49 -51.7 16.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.394 -0.816 . . . . 0.0 110.196 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.7 m -68.94 -23.42 64.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 110.321 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 36.2 m-20 -86.85 -14.29 42.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 109.521 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.629 ' CD1' HG12 ' B' ' 13' ' ' VAL . 4.1 mt -89.24 -34.38 16.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -0.857 . . . . 0.0 110.106 179.672 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.22 -56.61 0.42 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.24 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.52 158.37 17.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.999 -1.295 . . . . 0.0 110.804 -179.338 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 1.2 pttt -135.52 76.17 1.6 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.533 -0.729 . . . . 0.0 109.251 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.696 HD21 ' HA ' ' B' ' 19' ' ' LYS . 4.6 mp -37.2 146.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.671 -0.643 . . . . 0.0 111.14 -179.332 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -54.58 -164.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 0.0 110.04 179.719 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 117' ' ' THR . 91.9 m-20 -83.86 -46.89 11.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.124 -0.985 . . . . 0.0 110.119 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -58.38 -53.06 62.58 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.74 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.658 ' HB3' HD23 ' A' ' 116' ' ' LEU . 67.8 mm-40 -52.85 -44.2 66.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.365 -0.834 . . . . 0.0 109.582 179.51 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 117' ' ' THR . 42.7 t -58.11 -51.19 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.851 . . . . 0.0 110.154 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -61.47 -56.38 20.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 109.88 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 1.8 mt-10 -52.65 -36.65 57.12 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.687 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.537 ' HE1' ' O ' ' B' ' 16' ' ' MET . 0.9 OUTLIER -55.28 -50.15 70.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.811 . . . . 0.0 110.098 179.718 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.5 HD11 ' HG ' ' A' ' 105' ' ' LEU . 37.1 mm -71.45 -46.0 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.22 -0.925 . . . . 0.0 110.321 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 127' ' ' GLU . 11.6 mmt180 -59.8 -55.32 35.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.26 -0.9 . . . . 0.0 110.446 -179.764 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.8 OUTLIER -43.69 -26.05 0.21 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 110.265 -179.958 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -98.59 -28.51 13.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.157 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.8 t70 -65.11 69.79 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.881 . . . . 0.0 110.371 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.6 mp -63.21 -35.77 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.471 179.66 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 35.7 p-10 -74.97 -23.74 58.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 179.668 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 72.93 57.87 5.07 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 1.9 p30 -110.04 -15.2 14.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.214 -1.168 . . . . 0.0 110.083 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 135' ' ' GLN . . . 106.68 -4.74 36.93 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 43.7 mt-30 -155.37 158.57 38.9 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.225 -1.162 . . . . 0.0 110.119 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 14.0 t -92.72 135.97 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 110.075 179.666 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.516 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 28.1 t-20 -106.72 173.21 6.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.156 -0.965 . . . . 0.0 110.416 -179.796 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -54.55 -49.88 69.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.856 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -52.99 -56.37 16.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.271 -0.893 . . . . 0.0 110.229 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 141' ' ' PHE . 48.4 mt-10 -54.22 -58.67 6.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.162 -0.962 . . . . 0.0 110.076 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.661 ' CE1' HG23 ' A' ' 85' ' ' ILE . 41.7 t80 -43.51 -27.39 0.28 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 109.739 179.648 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.838 ' O ' HG22 ' A' ' 146' ' ' THR . 46.9 t -91.81 -39.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 109.965 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -57.91 -14.14 5.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.362 -0.837 . . . . 0.0 110.501 -179.787 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.436 ' O ' ' HA2' ' B' ' 23' ' ' GLY . 2.5 mtp -107.3 -11.19 15.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.111 -0.993 . . . . 0.0 110.515 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.593 ' CE ' HD21 ' B' ' 12' ' ' LEU . 0.2 OUTLIER -99.91 -17.84 17.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.161 -0.962 . . . . 0.0 110.699 -179.708 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 142' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 O-C-N 121.163 -0.961 . . . . 0.0 110.346 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.448 HG23 ' HD2' ' B' ' 5' ' ' PRO . 19.6 mm . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.448 ' HD2' HG23 ' B' ' 4' ' ' ILE . 46.9 Cg_endo -73.81 164.64 34.16 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.062 1.559 . . . . 0.0 110.458 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -175.93 4.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.181 -0.949 . . . . 0.0 110.612 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 7' ' ' TRP . . . . . 0.718 ' O ' HG22 ' B' ' 10' ' ' VAL . 2.1 m95 -65.12 -76.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.643 0.735 . . . . 0.0 110.707 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.755 HG21 ' HB3' ' A' ' 75' ' ' LYS . 13.3 p -41.72 -25.83 0.06 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.13 -0.981 . . . . 0.0 110.591 -179.305 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.455 ' N ' ' O ' ' B' ' 7' ' ' TRP . 27.1 m -61.92 -61.68 2.32 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.01 -1.056 . . . . 0.0 109.318 178.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.718 HG22 ' O ' ' B' ' 7' ' ' TRP . 6.1 m -53.97 -27.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 109.037 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' B' ' 8' ' ' THR . 30.0 mm -74.3 -42.54 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.471 -0.768 . . . . 0.0 109.287 178.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.593 HD21 ' CE ' ' A' ' 145' ' ' MET . 0.5 OUTLIER -53.33 -60.61 3.07 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.647 -0.658 . . . . 0.0 110.053 179.855 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.629 HG12 ' CD1' ' A' ' 112' ' ' LEU . 69.3 t -56.51 -40.38 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.121 -0.987 . . . . 0.0 109.78 179.682 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.876 ' CD ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.32 -42.06 84.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.147 -0.971 . . . . 0.0 109.515 179.239 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -62.25 -31.51 72.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 109.552 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.537 ' O ' ' HE1' ' A' ' 124' ' ' MET . 0.7 OUTLIER -74.17 -27.03 60.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.497 -0.752 . . . . 0.0 109.87 179.694 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 1.009 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.3 mp -70.34 58.47 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.384 -0.822 . . . . 0.0 109.94 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.489 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 3.7 tpp180 -85.94 -70.93 0.56 Allowed 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.616 -0.677 . . . . 0.0 110.648 -179.637 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.696 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -165.48 -43.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.953 . . . . 0.0 110.216 -179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.674 ' N ' ' HG2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -162.5 3.73 0.05 OUTLIER 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.236 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.477 ' HB2' ' HE2' ' B' ' 19' ' ' LYS . 5.7 t -90.16 154.22 19.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.183 -0.948 . . . . 0.0 110.693 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.27 -42.3 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.367 -0.833 . . . . 0.0 109.958 179.535 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 144' ' ' MET . . . -59.34 104.05 0.49 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.509 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -102.48 105.86 46.06 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.114 -1.227 . . . . 0.0 110.658 -179.489 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.02 139.57 24.38 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.007 1.53 . . . . 0.0 109.524 179.286 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.537 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 1.3 m-85 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.209 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.211 0.529 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -137.82 126.36 23.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 110.269 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.28 114.82 0.87 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.066 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.529 ' O ' ' NE2' ' A' ' 8' ' ' GLN . 15.6 mt -106.83 -163.15 0.89 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -0.943 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 p -80.39 -17.68 51.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.263 -0.898 . . . . 0.0 110.55 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -99.59 -45.71 5.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.204 -0.935 . . . . 0.0 110.159 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 7' ' ' GLU . 7.8 tp10 -48.79 -45.92 40.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 4' ' ' LEU . 62.7 mt-30 -62.74 -56.88 13.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.267 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.1 mt -49.24 -52.19 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 110.391 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -50.61 -42.02 55.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 110.313 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 29.6 tt0 -59.3 -48.2 82.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -66.23 -41.61 89.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -55.21 -34.77 64.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.187 -0.945 . . . . 0.0 109.44 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 49.8 mt-10 -67.55 -49.19 64.45 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.396 -0.815 . . . . 0.0 109.533 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.513 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -62.57 -43.3 99.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.365 -0.835 . . . . 0.0 109.608 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.616 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 73.9 t80 -62.0 -26.53 68.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.354 -0.841 . . . . 0.0 109.408 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.45 -35.47 23.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.46 -0.775 . . . . 0.0 109.742 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -54.35 -46.13 72.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 109.623 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.552 ' CD1' HD12 ' A' ' 32' ' ' LEU . 63.4 m-85 -70.02 -48.59 57.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.244 -0.91 . . . . 0.0 110.1 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -66.3 66.26 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.384 -0.823 . . . . 0.0 109.958 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -41.89 -51.82 4.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.6 p-10 -72.89 -41.4 64.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 109.701 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.91 45.21 3.67 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 26' ' ' THR . 33.1 p30 -96.03 -4.85 42.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -1.196 . . . . 0.0 110.342 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 26' ' ' THR . . . 87.49 28.33 24.88 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.714 HG23 ' O ' ' A' ' 25' ' ' GLY . 11.7 p -160.03 111.3 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -1.154 . . . . 0.0 110.394 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.65 HD12 ' HB ' ' A' ' 63' ' ' ILE . 14.9 mt -78.66 124.91 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.048 -1.032 . . . . 0.0 109.707 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.441 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 1.2 p -100.17 -179.9 4.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.628 -0.67 . . . . 0.0 110.136 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -70.72 -33.99 71.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.727 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.89 -50.51 41.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 109.903 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' OE2' ' OG1' ' A' ' 28' ' ' THR . 57.8 mt-10 -51.36 -70.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.892 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.552 HD12 ' CD1' ' A' ' 19' ' ' PHE . 15.7 tp -51.24 -33.62 28.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.592 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -61.58 -41.33 99.55 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.0 m -61.04 -41.84 97.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.384 -1.068 . . . . 0.0 109.813 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.8 t -65.44 -46.49 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.294 -0.879 . . . . 0.0 109.705 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -19.68 65.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.062 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 1.2 ttp180 -91.48 -17.2 26.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.9 . . . . 0.0 110.053 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.89 -43.1 13.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 110.113 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.516 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -50.96 -26.4 5.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 110.337 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.65 35.99 0.94 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -136.44 -166.62 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -1.151 . . . . 0.0 110.348 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 1.9 t30 -149.08 97.75 3.59 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.855 . . . . 0.0 110.094 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.728 ' HA ' HD11 ' B' ' 4' ' ' ILE . 41.9 Cg_endo -68.18 149.17 76.1 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.904 1.476 . . . . 0.0 110.574 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 52.9 m -97.58 135.2 39.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.304 -0.873 . . . . 0.0 110.425 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -44.68 -44.99 9.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.184 -0.947 . . . . 0.0 110.196 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.27 -57.28 6.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 72.1 mm-40 -55.59 -47.68 76.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.897 . . . . 0.0 110.175 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -48.61 -62.6 1.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.986 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -51.1 -44.02 61.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.428 -0.795 . . . . 0.0 109.942 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -64.96 -28.29 69.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.818 . . . . 0.0 109.644 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -49.44 16.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.449 -0.782 . . . . 0.0 109.832 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -70.36 -10.03 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -85.78 -19.41 30.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.409 -0.807 . . . . 0.0 109.698 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -57.02 6.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.389 -0.819 . . . . 0.0 110.104 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.641 HG23 ' CD1' ' B' ' 7' ' ' TRP . 18.5 t -69.75 -31.72 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.274 -0.891 . . . . 0.0 109.862 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.494 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -59.15 79.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.428 -0.795 . . . . 0.0 110.034 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.86 -21.95 60.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.802 . . . . 0.0 110.621 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -71.56 -38.83 70.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.048 -1.033 . . . . 0.0 110.434 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.21 12.93 32.42 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.1 p-10 -82.89 -44.48 15.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.395 -1.062 . . . . 0.0 110.528 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.33 11.27 9.86 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.493 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 14.2 p -138.56 143.32 39.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.354 -1.086 . . . . 0.0 109.869 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.65 ' HB ' HD12 ' A' ' 27' ' ' ILE . 15.8 mm -87.08 150.77 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.062 -1.023 . . . . 0.0 109.924 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.516 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 1.2 m-20 -129.74 165.03 22.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.14 -0.975 . . . . 0.0 110.981 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.622 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 14.5 t80 -50.81 -47.43 85.94 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.491 -0.756 . . . . 0.0 111.139 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -67.93 -40.88 8.56 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 O-C-N 123.176 1.093 . . . . 0.0 109.912 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.494 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -56.68 -29.89 62.83 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.193 -0.942 . . . . 0.0 108.857 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -66.91 -63.34 1.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.543 -0.723 . . . . 0.0 109.523 178.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -48.26 -22.21 0.63 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.274 -0.891 . . . . 0.0 109.968 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.5 m -100.59 -9.99 21.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.189 -0.944 . . . . 0.0 111.357 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.584 ' HB2' HG13 ' A' ' 55' ' ' VAL . 9.5 ptm -86.05 -43.52 13.04 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.799 -1.188 . . . . 0.0 110.554 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.553 ' N ' ' HG3' ' A' ' 71' ' ' MET . 89.3 mmm -65.34 -10.04 29.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.055 -1.028 . . . . 0.0 110.539 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.0 -10.54 21.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.074 -1.016 . . . . 0.0 111.043 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.409 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -98.75 -10.72 22.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.941 -1.1 . . . . 0.0 110.519 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.658 ' CB ' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER -94.93 -25.46 16.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.183 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.9 mmt -76.8 53.6 0.92 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.243 -0.91 . . . . 0.0 110.256 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -118.06 -64.2 1.32 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.07 -32.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.272 -0.893 . . . . 0.0 110.439 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -81.87 11.19 5.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.289 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.557 ' HA ' ' CG ' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -174.59 65.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.227 -0.921 . . . . 0.0 110.266 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 77.5 p -122.47 -52.23 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 109.765 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -99.82 -13.48 19.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.833 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 80' ' ' ASP . 0.3 OUTLIER -84.33 -21.57 30.91 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.501 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 14.8 pt-20 -73.17 -27.57 61.72 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.57 -0.706 . . . . 0.0 110.051 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.432 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 53.1 mt -73.98 -40.82 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.606 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -32.75 73.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 109.364 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.569 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 17.2 mt-10 -70.09 -56.58 6.54 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' B' ' 12' ' ' LEU . . . -48.85 -35.98 15.88 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.25 -0.906 . . . . 0.0 108.557 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 90' ' ' ARG . 26.8 t80 -62.72 -56.09 20.76 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.628 -0.67 . . . . 0.0 109.473 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -43.03 -47.32 5.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.578 -0.701 . . . . 0.0 109.425 179.378 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.912 HG11 HG11 ' B' ' 13' ' ' VAL . 41.2 t -51.08 -49.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.363 -0.836 . . . . 0.0 109.359 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.755 ' HB3' HD13 ' A' ' 100' ' ' ILE . 54.8 m-85 -68.85 -44.66 72.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 110.38 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.486 ' HA ' ' OE2' ' A' ' 104' ' ' GLU . 34.2 t0 -92.28 60.9 3.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.062 -1.024 . . . . 0.0 110.39 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.3 -46.84 62.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.284 -0.885 . . . . 0.0 110.301 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 6.5 p30 -66.04 -26.0 67.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.319 -0.863 . . . . 0.0 110.384 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 67.52 50.99 39.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -96.97 -18.41 19.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.191 -1.182 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.542 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 109.4 24.63 5.84 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -169.92 158.75 7.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -1.113 . . . . 0.0 110.139 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.755 HD13 ' HB3' ' A' ' 92' ' ' PHE . 34.4 mt -117.04 148.91 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.033 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 102' ' ' ALA . 19.3 t -127.75 146.73 50.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.958 . . . . 0.0 109.876 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.18 -29.54 0.25 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 109.975 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.68 -56.08 14.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.823 . . . . 0.0 109.598 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.486 ' OE2' ' HA ' ' A' ' 93' ' ' ASP . 15.7 mt-10 -53.54 -38.13 63.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 0.0 109.707 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.052 HD12 HD11 ' A' ' 125' ' ' ILE . 1.4 mt -69.87 -39.2 76.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.436 -0.79 . . . . 0.0 109.607 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.0 ttp85 -62.58 -34.17 76.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.304 -0.872 . . . . 0.0 109.415 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -66.49 -51.51 55.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.362 -0.836 . . . . 0.0 109.449 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.502 HG21 HG12 ' A' ' 91' ' ' VAL . 28.3 t -57.89 -37.42 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.524 -0.735 . . . . 0.0 109.506 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.889 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -52.1 -64.07 0.94 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.609 -0.682 . . . . 0.0 110.77 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.471 HG23 ' HG2' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -64.22 -15.35 59.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.516 ' OD1' ' HA ' ' A' ' 39' ' ' LEU . 0.9 OUTLIER -79.09 -19.63 50.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.016 . . . . 0.0 109.565 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' B' ' 14' ' ' LYS . 15.8 mt -107.28 -27.03 10.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.484 -0.76 . . . . 0.0 109.862 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.415 ' O ' ' HE3' ' A' ' 115' ' ' LYS . . . 147.57 -74.32 0.29 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.735 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.436 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 1.8 tt0 -71.68 149.0 45.91 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.241 -1.152 . . . . 0.0 111.332 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.471 ' HG2' HG23 ' A' ' 110' ' ' THR . 0.7 OUTLIER -130.48 81.98 2.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.522 -0.736 . . . . 0.0 109.302 179.406 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.664 HD21 ' O ' ' B' ' 19' ' ' LYS . 8.0 mp -36.71 143.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.588 -0.695 . . . . 0.0 111.083 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -58.02 -153.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 110.072 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.539 ' H ' HG22 ' A' ' 117' ' ' THR . 1.2 m-20 -98.8 -66.0 0.93 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.892 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' ASP . 15.1 mt-10 -44.39 -47.46 9.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.56 -54.8 43.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.369 -0.832 . . . . 0.0 109.317 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' A' ' 116' ' ' LEU . 39.1 t -55.47 -39.59 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 109.678 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.58 -44.52 86.41 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.375 -0.828 . . . . 0.0 109.719 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -70.59 -36.7 73.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.353 -0.842 . . . . 0.0 109.678 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.417 ' HG2' ' CE2' ' B' ' 22' ' ' PHE . 24.4 ttt -56.76 -37.45 71.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -0.826 . . . . 0.0 109.788 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.052 HD11 HD12 ' A' ' 105' ' ' LEU . 27.5 mm -82.38 -31.23 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 110.084 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -36.67 80.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 110.248 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -30.44 69.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.87 . . . . 0.0 110.061 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -82.96 -29.24 29.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 110.031 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -63.68 72.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.908 . . . . 0.0 110.342 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 3.4 mt -58.05 -21.93 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 109.893 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 35.6 p-10 -98.78 -17.16 18.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.83 61.21 3.61 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 1.6 p30 -111.03 2.87 18.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -1.191 . . . . 0.0 110.098 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 85.32 -1.67 88.44 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 86.3 mt-30 -153.83 168.28 26.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.156 -1.202 . . . . 0.0 110.221 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.801 HG23 HG23 ' A' ' 125' ' ' ILE . 50.4 t -100.0 143.15 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -0.912 . . . . 0.0 110.075 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.5 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 32.7 t30 -111.2 -173.74 2.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 0.0 110.332 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -69.84 -52.86 21.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.348 -0.845 . . . . 0.0 110.5 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -45.24 -52.66 9.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -56.24 -58.89 6.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 110.022 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.421 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 20.4 t80 -46.39 -25.16 0.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 145' ' ' MET . 38.3 t -99.99 -54.03 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.299 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -45.77 -24.31 0.36 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.201 -0.937 . . . . 0.0 110.312 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmm -83.93 -23.83 30.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.266 -0.896 . . . . 0.0 110.313 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.735 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -100.16 -11.49 20.41 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.269 -0.894 . . . . 0.0 110.51 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 142' ' ' VAL . 82.4 p -90.96 -39.28 12.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 148' ' ' LYS . . . -77.48 52.87 1.0 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.411 -0.806 . . . . 0.0 110.267 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.221 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 121.232 0.539 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.25 -170.21 2.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.052 -1.03 . . . . 0.0 110.137 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.503 ' O ' ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -152.05 65.51 0.84 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.214 -0.928 . . . . 0.0 109.781 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.744 HG23 ' HD2' ' B' ' 5' ' ' PRO . 5.6 mt 57.24 152.48 0.07 OUTLIER Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.613 -0.679 . . . . 0.0 110.528 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.744 ' HD2' HG23 ' B' ' 4' ' ' ILE . 42.6 Cg_endo -70.12 132.46 22.81 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.958 1.504 . . . . 0.0 110.112 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 12.3 p -69.46 -167.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.86 . . . . 0.0 110.799 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.727 ' O ' HG22 ' B' ' 10' ' ' VAL . 5.4 m95 -73.11 -77.71 0.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.536 -0.728 . . . . 0.0 110.707 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.658 HG21 ' CB ' ' A' ' 75' ' ' LYS . 20.5 p -40.87 -26.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.964 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.569 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 84.0 m -61.36 -63.55 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 110.001 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.727 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.6 m -50.79 -27.45 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.431 HG12 ' O ' ' B' ' 7' ' ' TRP . 15.0 mm -79.09 -24.79 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.468 -0.77 . . . . 0.0 109.327 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 1.4 mt -68.99 -49.76 55.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.576 -0.702 . . . . 0.0 110.087 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.912 HG11 HG11 ' A' ' 91' ' ' VAL . 97.5 t -67.53 -40.11 83.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.38 -0.825 . . . . 0.0 110.36 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.656 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -64.95 -45.74 84.48 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.918 -1.114 . . . . 0.0 109.506 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.461 ' HB3' ' ND2' ' B' ' 24' ' ' ASN . 4.7 t -57.67 -36.88 72.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.324 -0.86 . . . . 0.0 108.9 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' B' ' 13' ' ' VAL . 2.9 mmt -60.04 -34.47 73.43 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 108.833 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.889 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.3 mp -72.59 56.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.651 -0.655 . . . . 0.0 109.418 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -83.66 0.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.69 . . . . 0.0 110.289 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.664 ' O ' HD21 ' A' ' 116' ' ' LEU . 9.0 tmtt? -133.39 -85.03 0.45 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.61 -1.306 . . . . 0.0 110.387 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.534 ' N ' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -142.3 23.91 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.871 -1.143 . . . . 0.0 110.115 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.46 178.86 4.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.497 -0.752 . . . . 0.0 109.583 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.601 ' HZ ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -137.57 148.25 45.74 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.79 146.08 17.63 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.735 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 8.8 m120 -119.26 134.83 23.71 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.224 -1.162 . . . . 0.0 110.304 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 26' ' ' PHE . 46.0 Cg_endo -72.41 -44.38 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.024 1.539 . . . . 0.0 110.048 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' B' ' 25' ' ' PRO . 1.6 m-30 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.42 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.266 0.555 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.77 -22.39 43.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -56.81 101.24 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.328 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.968 HD11 ' HB2' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -133.17 -174.38 3.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 110.04 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.641 ' O ' HD12 ' A' ' 9' ' ' ILE . 6.7 t -135.14 -5.2 2.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -0.946 . . . . 0.0 111.0 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.33 -43.52 11.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.968 -1.082 . . . . 0.0 110.507 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.968 ' HB2' HD11 ' A' ' 4' ' ' LEU . 0.8 OUTLIER -64.0 -63.01 1.27 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.213 -0.929 . . . . 0.0 110.234 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 13.6 pt20 -48.59 -39.38 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 109.836 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.641 HD12 ' O ' ' A' ' 5' ' ' THR . 12.7 mt -67.32 -29.76 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.464 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -62.51 -55.78 24.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.315 -0.866 . . . . 0.0 109.634 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.534 ' HG3' ' N ' ' A' ' 12' ' ' PHE . 13.1 pt-20 -56.94 -34.67 68.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 109.389 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.534 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 13.8 m-85 -73.6 -46.01 49.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.28 -0.888 . . . . 0.0 109.358 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 17' ' ' SER . 32.6 tptt -60.27 -44.07 95.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.287 -0.883 . . . . 0.0 109.212 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.32 -44.3 75.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.179 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.92 -56.69 18.94 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.42 -0.8 . . . . 0.0 109.531 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.548 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 15.2 t80 -55.81 -45.53 78.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.218 -0.926 . . . . 0.0 109.439 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -61.78 -38.49 88.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -0.76 . . . . 0.0 109.254 179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.573 ' O ' HD23 ' A' ' 18' ' ' LEU . 10.1 tt -59.09 -27.74 65.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.495 -0.753 . . . . 0.0 109.624 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CE1' HD22 ' A' ' 18' ' ' LEU . 4.7 m-85 -90.81 -49.87 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.95 76.99 1.67 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.5 -0.75 . . . . 0.0 110.228 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -52.27 -69.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.908 . . . . 0.0 110.183 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 6.8 p-10 -45.29 -29.19 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 54.83 6.04 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.467 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 2.0 p-10 -106.68 -34.17 7.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.179 -1.189 . . . . 0.0 110.185 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.56 7.79 6.1 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 32.0 p -141.85 117.62 10.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.217 -1.167 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.835 ' O ' HG22 ' A' ' 62' ' ' THR . 16.5 mt -76.87 128.67 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 110.336 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.603 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.5 OUTLIER -95.16 161.59 14.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.411 -0.806 . . . . 0.0 110.264 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.489 HG23 HG13 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -58.56 -39.23 79.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.0 110.4 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 31' ' ' GLU . 3.7 tmtt? -65.66 -52.87 48.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.0 110.275 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' LYS . 10.1 mt-10 -43.15 -61.37 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 109.903 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.7 tp -56.25 -37.98 70.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.92 . . . . 0.0 109.668 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.51 -40.29 98.5 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 m -58.34 -41.63 85.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -1.061 . . . . 0.0 109.625 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.18 -53.2 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.7 mtt -55.66 -31.13 62.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.207 -0.933 . . . . 0.0 109.731 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -74.27 -25.61 59.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 109.82 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.507 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -76.58 -47.36 22.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.209 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mt -56.31 -53.02 62.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 110.254 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.44 58.93 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.511 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 1.5 mm-40 -139.33 -169.76 2.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.158 -1.201 . . . . 0.0 110.233 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 13.7 m120 -143.85 75.85 15.78 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.25 -0.906 . . . . 0.0 110.438 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.574 ' HA ' HD11 ' B' ' 4' ' ' ILE . 47.3 Cg_endo -74.27 119.76 5.95 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.013 1.533 . . . . 0.0 110.274 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -76.36 154.31 35.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.283 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.34 -49.24 72.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.54 -54.3 47.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.321 -0.862 . . . . 0.0 110.143 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -56.64 -34.83 67.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -0.906 . . . . 0.0 110.042 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.0 mt -55.78 -54.3 46.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.063 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -31.0 69.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 109.775 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.12 -41.51 77.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 110.068 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.447 ' CE ' ' CD1' ' B' ' 7' ' ' TRP . 1.9 ttp -73.6 -38.93 64.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.245 -0.91 . . . . 0.0 110.023 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.489 HG13 HG23 ' A' ' 29' ' ' THR . 5.5 mm -66.18 -25.1 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.75 0.72 22.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.295 -0.878 . . . . 0.0 110.187 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.77 -13.18 25.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 110.079 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 57' ' ' ALA . 16.3 t -113.63 -35.12 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -45.44 89.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.474 -0.766 . . . . 0.0 110.371 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -85.63 -31.44 22.58 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.236 -0.915 . . . . 0.0 110.754 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 29.4 p-10 -83.13 -39.98 20.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.029 -1.044 . . . . 0.0 110.425 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 108.54 24.12 6.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' CG ' ' OD2' ' A' ' 58' ' ' ASP . 19.9 p-10 -95.12 -14.57 24.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -1.151 . . . . 0.0 110.177 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.82 -63.76 0.3 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.835 HG22 ' O ' ' A' ' 27' ' ' ILE . 1.3 p -76.54 165.02 25.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -1.115 . . . . 0.0 110.171 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.701 ' HB ' HD12 ' A' ' 27' ' ' ILE . 20.6 mm -90.81 149.8 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.548 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 24.6 t0 -115.3 162.36 17.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.933 . . . . 0.0 110.659 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.666 ' O ' HD12 ' A' ' 69' ' ' LEU . 74.3 t80 -49.23 -46.16 76.5 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 0.0 111.333 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -69.93 -39.63 5.97 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.285 1.15 . . . . 0.0 110.406 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 57' ' ' ALA . 1.9 mt-10 -57.58 -27.07 62.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.965 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.729 ' CZ ' HD13 ' B' ' 11' ' ' ILE . 45.4 t80 -83.27 -40.99 18.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.374 -0.829 . . . . 0.0 110.411 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -67.62 -15.78 63.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.275 -0.891 . . . . 0.0 110.819 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 p -100.23 -41.19 7.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.059 -1.026 . . . . 0.0 110.924 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.438 ' HG2' ' HA ' ' A' ' 68' ' ' PHE . 3.3 ppp? -66.49 -34.45 77.96 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.27 -0.894 . . . . 0.0 111.227 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.613 ' SD ' HG21 ' B' ' 11' ' ' ILE . 13.2 tpt -66.67 -9.4 35.62 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.128 -0.983 . . . . 0.0 111.077 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.6 -9.85 13.19 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.978 -1.076 . . . . 0.0 111.11 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.441 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 1.8 ttm180 -97.1 -32.79 11.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.98 -1.075 . . . . 0.0 110.741 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.648 ' HB3' HG21 ' B' ' 8' ' ' THR . 0.6 OUTLIER -90.49 27.81 1.63 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.049 -1.032 . . . . 0.0 110.695 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.498 ' HE1' ' HE1' ' A' ' 72' ' ' MET . 0.0 OUTLIER -100.52 -79.67 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.074 -1.016 . . . . 0.0 110.627 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.34 55.45 3.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.232 -0.918 . . . . 0.0 110.702 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 74' ' ' ARG . 0.4 OUTLIER -104.88 -50.95 3.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.116 -0.99 . . . . 0.0 110.224 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 80' ' ' ASP . 2.9 t -165.14 -37.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.087 -1.008 . . . . 0.0 110.392 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.429 ' N ' HG23 ' A' ' 79' ' ' THR . 0.4 OUTLIER -85.27 83.51 7.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.21 -0.931 . . . . 0.0 110.234 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.8 p -79.56 -71.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.277 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.848 ' HA ' HD12 ' A' ' 85' ' ' ILE . 28.5 mt-10 -85.52 -10.06 56.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 110.445 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 36.1 mt-10 -66.95 -56.69 9.1 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.197 -0.94 . . . . 0.0 110.417 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 55.9 tt0 -53.07 -28.51 25.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -0.93 . . . . 0.0 110.508 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.848 HD12 ' HA ' ' A' ' 82' ' ' GLU . 72.9 mt -66.78 -28.35 42.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.133 -0.98 . . . . 0.0 109.21 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 3.9 ttt-85 -66.52 -30.26 70.55 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.641 -0.662 . . . . 0.0 109.539 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.749 ' HB3' HG21 ' B' ' 9' ' ' THR . 8.3 mt-10 -73.59 -48.99 28.52 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.343 -0.848 . . . . 0.0 109.496 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.441 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.62 -30.75 71.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -66.46 -49.91 65.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -31.49 69.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.383 -0.823 . . . . 0.0 109.544 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.496 HG11 HG21 ' B' ' 13' ' ' VAL . 11.6 t -61.06 -47.5 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.373 -0.829 . . . . 0.0 109.631 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.493 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 45.0 m-85 -67.96 -31.71 71.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.851 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 94' ' ' LYS . 7.2 t0 -80.77 55.35 2.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.2 -0.938 . . . . 0.0 110.173 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 93' ' ' ASP . 2.5 tmtt? -42.73 -32.28 0.58 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.33 -0.857 . . . . 0.0 110.538 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 4.8 p30 -90.08 -31.07 17.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.172 -0.955 . . . . 0.0 110.342 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 84.15 20.13 59.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 48.5 p30 -75.04 -15.33 60.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.042 -1.269 . . . . 0.0 109.97 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.568 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 92.79 33.17 7.56 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 33.5 m-85 -161.92 107.21 1.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -1.123 . . . . 0.0 110.233 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mt -69.19 124.98 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 110.11 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.56 161.94 17.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.973 . . . . 0.0 110.164 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.93 -37.28 66.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.101 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.5 -53.15 60.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.841 . . . . 0.0 110.033 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 24.0 mt-10 -56.19 -39.68 72.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.92 HD12 HD11 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -60.27 -38.5 83.76 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.301 -0.874 . . . . 0.0 109.486 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -36.78 82.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.556 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -64.99 -52.58 55.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 109.76 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.489 HG11 ' CE1' ' A' ' 92' ' ' PHE . 1.1 t -61.84 -28.58 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 109.159 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.769 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -67.51 -59.22 3.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.398 -0.814 . . . . 0.0 109.845 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -29.07 70.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.89 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 38' ' ' SER . 3.0 m120 -77.76 -6.52 54.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.422 -0.799 . . . . 0.0 110.064 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.566 ' CD1' HG12 ' B' ' 13' ' ' VAL . 12.7 mt -117.5 7.97 12.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -0.925 . . . . 0.0 110.869 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.16 -68.33 0.24 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.256 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 109' ' ' MET . 26.8 tt0 -92.03 161.91 14.58 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.046 -1.267 . . . . 0.0 111.532 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.0 OUTLIER -141.62 82.82 1.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.64 -0.663 . . . . 0.0 109.489 179.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.552 ' H ' HD12 ' A' ' 116' ' ' LEU . 6.3 mp -38.29 140.11 0.33 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.451 -0.781 . . . . 0.0 111.1 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.701 HG22 ' H ' ' A' ' 118' ' ' ASP . 2.6 m -52.24 -171.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.427 -0.796 . . . . 0.0 110.08 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.701 ' H ' HG22 ' A' ' 117' ' ' THR . 31.8 m-20 -83.21 -54.4 5.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 110.228 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -30.26 65.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 109.704 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.436 ' HG2' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -73.62 -52.9 11.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.211 -0.931 . . . . 0.0 108.929 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.421 HG22 ' CE ' ' A' ' 109' ' ' MET . 40.4 t -57.85 -34.67 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.423 -0.798 . . . . 0.0 109.466 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -62.17 -44.15 97.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.433 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 5.6 mm-40 -69.43 -29.15 66.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.399 -0.813 . . . . 0.0 109.519 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.623 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 10.2 ttt -65.94 -44.46 85.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.531 -0.731 . . . . 0.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.92 HD11 HD12 ' A' ' 105' ' ' LEU . 17.7 mm -75.98 -49.59 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.274 -0.891 . . . . 0.0 109.785 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -56.61 -47.83 78.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.89 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.5 mm-40 -61.73 -43.89 97.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.792 . . . . 0.0 109.917 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.25 -32.17 72.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.884 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.513 ' HB3' ' HA2' ' A' ' 132' ' ' GLY . 5.3 m-20 -71.6 100.69 2.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.384 -0.823 . . . . 0.0 110.051 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.445 HG13 ' OE1' ' A' ' 143' ' ' GLN . 40.0 mm -51.74 -36.53 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.217 -0.927 . . . . 0.0 110.243 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.416 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 17.3 p-10 -99.45 -25.1 14.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.295 -0.878 . . . . 0.0 110.383 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 69.62 51.91 23.3 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 5.7 p30 -85.46 -23.85 27.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.185 -1.185 . . . . 0.0 110.21 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 142.17 -10.26 2.51 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.28 166.58 10.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.028 -1.278 . . . . 0.0 110.698 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 140' ' ' GLU . 2.9 t -102.54 154.43 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.397 -0.814 . . . . 0.0 109.871 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.436 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 17.0 p-10 -123.27 -145.71 0.35 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.186 -0.946 . . . . 0.0 110.399 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.85 -68.81 0.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 110.618 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -45.3 -46.28 12.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.219 -0.926 . . . . 0.0 110.653 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.436 ' HB3' HG13 ' A' ' 136' ' ' VAL . 35.7 mt-10 -61.02 -57.08 14.09 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.462 ' CE2' HG23 ' A' ' 85' ' ' ILE . 71.0 t80 -50.74 -20.71 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 85' ' ' ILE . 73.2 t -93.9 -58.72 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.207 -0.933 . . . . 0.0 110.436 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.445 ' OE1' HG13 ' A' ' 130' ' ' ILE . 40.3 tt0 -42.12 -30.38 0.29 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.217 -0.927 . . . . 0.0 110.176 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.461 ' O ' ' N ' ' B' ' 24' ' ' ASN . 64.9 mtp -69.51 -30.96 68.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.052 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 142' ' ' VAL . 23.5 ttm -94.13 -28.66 15.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.355 -0.841 . . . . 0.0 110.391 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.408 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 73.2 p -88.78 29.99 0.97 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.411 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 148' ' ' LYS . . . -72.93 54.4 0.37 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.298 -0.876 . . . . 0.0 110.348 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.197 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.254 0.55 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.482 ' O ' ' HD2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -152.77 143.72 22.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -0.957 . . . . 0.0 110.538 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.495 ' O ' ' O ' ' B' ' 4' ' ' ILE . 0.1 OUTLIER -156.99 -48.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.955 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.851 HG23 ' HD2' ' B' ' 5' ' ' PRO . 12.0 mt 55.97 152.38 0.06 OUTLIER Pre-proline 0 N--CA 1.486 1.34 0 O-C-N 121.596 -0.69 . . . . 0.0 110.481 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.851 ' HD2' HG23 ' B' ' 4' ' ' ILE . 42.5 Cg_endo -71.68 139.64 34.3 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.642 1.338 . . . . 0.0 110.24 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.534 ' O ' ' N ' ' B' ' 8' ' ' THR . 46.4 t -90.33 64.09 5.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.306 -0.871 . . . . 0.0 111.036 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.486 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.3 OUTLIER 51.3 -85.43 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.209 -0.932 . . . . 0.0 110.659 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.648 HG21 ' HB3' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -43.46 -40.55 3.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.158 -0.964 . . . . 0.0 109.657 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.749 HG21 ' HB3' ' A' ' 87' ' ' GLU . 84.3 m -51.3 -53.5 35.18 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.438 -0.789 . . . . 0.0 109.51 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' B' ' 5' ' ' PRO . 18.6 t -52.79 -38.56 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.342 -0.849 . . . . 0.0 109.632 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.729 HD13 ' CZ ' ' A' ' 68' ' ' PHE . 12.1 mt -73.48 -25.77 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.281 -0.887 . . . . 0.0 109.727 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -48.69 65.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.4 -0.813 . . . . 0.0 109.668 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.566 HG12 ' CD1' ' A' ' 112' ' ' LEU . 86.4 t -63.77 -48.18 87.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.5 -0.75 . . . . 0.0 110.449 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.43 ' O ' ' HD2' ' B' ' 14' ' ' LYS . 30.4 tptt -54.98 -39.24 68.79 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.956 -1.09 . . . . 0.0 109.599 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 1.7 t -59.45 -40.07 85.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 109.61 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.509 ' CE ' ' HG3' ' B' ' 25' ' ' PRO . 0.2 OUTLIER -64.71 -27.85 69.19 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.39 -0.819 . . . . 0.0 110.087 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.769 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.3 mp -76.0 60.37 1.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.406 -0.808 . . . . 0.0 110.23 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -133.01 67.7 1.53 Allowed 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.53 -0.731 . . . . 0.0 111.36 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.552 ' CD ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER 60.97 -62.71 0.07 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.395 0.617 . . . . 0.0 111.478 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' B' ' 18' ' ' ARG . 1.2 ptm180 -143.79 4.35 1.31 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 111.023 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' B' ' 18' ' ' ARG . 23.0 m -64.23 86.59 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.815 -1.178 . . . . 0.0 109.893 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.623 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -126.43 -10.57 6.31 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.341 -0.849 . . . . 0.0 110.526 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' B' ' 24' ' ' ASN . . . -110.61 122.2 6.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 144' ' ' MET . 9.3 t-20 40.74 77.43 0.43 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.403 -1.057 . . . . 0.0 110.839 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.509 ' HG3' ' CE ' ' B' ' 16' ' ' MET . 47.7 Cg_endo -77.36 -9.71 17.53 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.0 1.526 . . . . 0.0 110.143 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.569 ' CZ ' ' HE2' ' A' ' 72' ' ' MET . 72.2 m-85 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.213 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.181 0.515 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -44.39 -31.71 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.128 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -99.9 139.39 35.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.354 -0.841 . . . . 0.0 110.16 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.98 149.62 46.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.142 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.924 ' O ' HD12 ' A' ' 9' ' ' ILE . 9.5 t -55.78 135.52 51.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -99.15 -58.11 2.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.142 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 6' ' ' GLU . 3.0 tt0 -42.93 -65.34 0.49 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.256 -0.902 . . . . 0.0 110.194 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 7' ' ' GLU . 73.7 mm-40 -44.18 -61.11 1.6 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.924 HD12 ' O ' ' A' ' 5' ' ' THR . 48.2 mt -59.08 -48.85 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.6 -45.41 38.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.842 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 2.8 tt0 -57.25 -56.81 17.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.85 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 9.0 m-85 -53.95 -33.07 55.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.337 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 3.7 tttp -64.25 -43.08 96.0 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.328 -0.858 . . . . 0.0 109.199 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 16.0 mt-10 -53.41 -49.5 67.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 109.61 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . . . -64.99 -52.0 58.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.362 -0.836 . . . . 0.0 109.573 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.422 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 65.4 t80 -54.66 -40.83 69.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.601 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -71.82 -25.79 62.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.383 -0.823 . . . . 0.0 109.565 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.712 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.7 tt -62.42 -39.64 93.94 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.364 -0.835 . . . . 0.0 109.706 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.464 ' CD1' HD12 ' A' ' 32' ' ' LEU . 49.8 m-85 -86.06 -27.66 24.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.382 -0.824 . . . . 0.0 110.305 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -92.19 100.12 12.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.171 -0.956 . . . . 0.0 110.394 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.37 -70.31 0.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.031 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.3 p-10 -52.69 -21.61 4.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 110.049 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.5 37.24 93.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 19.8 p-10 -80.09 -36.49 35.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.108 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.577 ' C ' HG23 ' A' ' 26' ' ' THR . . . 128.51 25.55 1.03 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.577 HG23 ' C ' ' A' ' 25' ' ' GLY . 70.2 p -157.49 126.8 5.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.071 -1.252 . . . . 0.0 110.323 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.54 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 18.1 mt -97.55 122.12 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.141 -0.974 . . . . 0.0 110.015 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.8 p -90.46 175.86 6.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.811 . . . . 0.0 110.022 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.5 p -69.59 -28.92 66.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 110.175 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -77.11 -50.77 12.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.096 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -48.24 -67.44 0.27 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.321 -0.862 . . . . 0.0 109.916 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.464 HD12 ' CD1' ' A' ' 19' ' ' PHE . 22.5 tp -55.57 -43.62 76.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 109.794 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.43 -41.73 17.77 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.3 m -66.0 -54.87 20.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -1.066 . . . . 0.0 109.935 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.463 ' H ' HG23 ' A' ' 35' ' ' VAL . 16.0 t -49.4 -39.0 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 109.801 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.464 ' HG3' ' HG3' ' A' ' 43' ' ' PRO . 5.2 mmt -62.74 -46.67 87.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.849 . . . . 0.0 109.274 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -51.8 -27.24 11.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.394 179.165 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -50.1 47.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.849 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 mt -54.55 -31.11 55.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.041 -1.037 . . . . 0.0 110.331 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.32 2.64 2.92 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.945 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.484 ' HG2' HG12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -130.71 158.12 40.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.811 -1.405 . . . . 0.0 110.94 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 5.7 t-20 -123.15 98.73 41.5 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 110.094 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HG3' ' HG3' ' A' ' 36' ' ' MET . 43.0 Cg_endo -71.88 112.85 3.49 Favored 'Trans proline' 0 C--N 1.296 -2.232 0 O-C-N 124.148 1.604 . . . . 0.0 110.32 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.618 HG22 ' HG3' ' A' ' 47' ' ' GLU . 1.8 t -64.25 -166.59 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.677 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.447 ' N ' ' OG1' ' A' ' 44' ' ' THR . 0.1 OUTLIER -70.99 -60.94 1.96 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.424 -0.798 . . . . 0.0 110.219 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.56 -55.46 4.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.948 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.618 ' HG3' HG22 ' A' ' 44' ' ' THR . 2.2 mm-40 -55.68 -57.66 11.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.165 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 48' ' ' LEU . 17.6 mt -45.53 -65.02 0.6 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.342 -0.849 . . . . 0.0 110.357 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -50.54 -25.29 3.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 110.325 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.12 -39.17 55.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.976 . . . . 0.0 110.081 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.571 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 1.7 mmm -80.67 -32.11 36.13 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.286 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 mm -70.09 -36.77 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.073 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 56' ' ' ASP . 0.7 OUTLIER -54.19 -67.87 0.23 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.327 -0.858 . . . . 0.0 110.701 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 53' ' ' ASN . 27.1 mt-10 -41.17 -40.33 1.53 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.42 -0.8 . . . . 0.0 110.656 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.764 HG21 ' CD1' ' B' ' 7' ' ' TRP . 48.8 t -83.55 -16.29 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.928 . . . . 0.0 110.412 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASN . 33.7 t0 -66.04 66.78 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' HA ' ' NH2' ' A' ' 74' ' ' ARG . . . -41.74 -44.24 3.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.367 -0.833 . . . . 0.0 110.385 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.49 -35.68 34.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.33 -0.856 . . . . 0.0 110.039 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.439 ' HA2' ' OD2' ' A' ' 56' ' ' ASP . . . 92.42 28.45 12.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 24.7 p30 -95.41 -32.63 12.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.327 -1.102 . . . . 0.0 110.318 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 62' ' ' THR . . . 117.12 30.96 1.81 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -157.53 147.57 20.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -1.192 . . . . 0.0 110.106 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 ' CG1' ' A' ' 55' ' ' VAL . 6.9 mm -97.39 124.84 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.335 -0.853 . . . . 0.0 110.14 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -107.76 169.84 8.35 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.233 -0.917 . . . . 0.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.622 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 11.0 t80 -58.69 -47.75 98.14 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.27 -0.894 . . . . 0.0 110.895 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.0 Cg_endo -68.09 -37.02 15.58 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 O-C-N 123.263 1.138 . . . . 0.0 109.648 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' A' ' 57' ' ' ALA . 5.1 tt0 -60.87 -34.07 74.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.029 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.527 ' O ' ' HG3' ' A' ' 71' ' ' MET . 5.7 t80 -63.83 -51.5 64.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.464 -0.773 . . . . 0.0 109.258 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 69' ' ' LEU . 6.2 mp -62.79 -15.2 52.74 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.247 -0.908 . . . . 0.0 109.419 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -90.81 -50.77 5.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 110.594 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.527 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -58.26 -24.97 61.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.054 -1.029 . . . . 0.0 109.68 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.471 ' N ' ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -65.53 -13.83 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 109.88 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 77' ' ' LYS . . . -115.31 -14.76 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 110.238 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.551 ' NH2' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -86.81 -29.06 22.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.242 -0.911 . . . . 0.0 110.175 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HG2' HG21 ' B' ' 8' ' ' THR . 32.1 tptt -80.43 -14.12 58.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.138 -0.976 . . . . 0.0 109.959 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 53.1 mtt -100.16 4.18 44.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 110.408 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 10.5 mttp -100.86 -2.88 30.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.135 -0.978 . . . . 0.0 110.297 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.864 ' O ' HG23 ' A' ' 79' ' ' THR . 0.7 OUTLIER -92.63 -55.15 3.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.281 -0.887 . . . . 0.0 109.754 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.864 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER 175.66 -96.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.608 -0.683 . . . . 0.0 109.305 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.575 ' HA ' ' CG ' ' A' ' 83' ' ' GLU . 13.0 m-20 33.27 75.22 0.05 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.383 -0.823 . . . . 0.0 111.489 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.43 -72.1 0.53 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.743 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -101.24 -9.44 21.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.315 -0.866 . . . . 0.0 110.828 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.575 ' CG ' ' HA ' ' A' ' 80' ' ' ASP . 6.9 pt-20 -76.18 -25.63 55.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.944 -1.098 . . . . 0.0 110.509 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 10.4 pt-20 -69.43 -37.21 77.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.157 -0.965 . . . . 0.0 110.31 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.509 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 20.6 mt -68.76 -37.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.108 -0.995 . . . . 0.0 109.011 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.67 -26.25 61.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' B' ' 9' ' ' THR . 1.1 mt-10 -73.16 -58.44 3.31 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.464 -0.773 . . . . 0.0 109.185 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.87 -29.17 62.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.026 . . . . 0.0 109.2 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 4.7 t80 -64.81 -49.27 71.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.317 -0.864 . . . . 0.0 109.127 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -33.37 42.53 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.492 -0.755 . . . . 0.0 109.241 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.788 HG11 HG21 ' B' ' 13' ' ' VAL . 41.3 t -72.61 -33.25 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.533 -0.729 . . . . 0.0 110.361 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.632 ' HB3' HD13 ' A' ' 100' ' ' ILE . 23.5 m-85 -75.29 -57.7 3.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.034 -1.041 . . . . 0.0 110.011 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 96' ' ' GLY . 20.6 t0 -84.53 53.41 2.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 110.437 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 93' ' ' ASP . 3.6 mtmt -46.39 -26.56 0.86 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.074 -1.016 . . . . 0.0 108.895 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 1.3 t0 -66.66 -35.55 80.43 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 67.37 35.29 87.23 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.49 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 33.2 p-10 -91.66 -24.12 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.043 -1.269 . . . . 0.0 109.741 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.544 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 120.65 15.93 4.75 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 2.9 m-85 -161.25 150.24 16.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.161 -1.199 . . . . 0.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 92' ' ' PHE . 9.7 mt -107.86 131.84 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.379 -0.826 . . . . 0.0 110.273 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 102' ' ' ALA . 20.2 p -115.13 145.94 41.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.111 -0.993 . . . . 0.0 110.008 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.1 -28.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.35 -0.844 . . . . 0.0 110.043 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -69.44 -51.28 37.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.295 -0.878 . . . . 0.0 109.619 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.16 -39.12 71.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.24 -0.913 . . . . 0.0 109.454 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.552 HD13 HD11 ' A' ' 125' ' ' ILE . 1.2 mt -70.07 -36.34 74.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.437 -0.79 . . . . 0.0 109.785 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 17.3 ttt85 -66.36 -29.87 70.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.744 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -76.36 -33.6 58.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.806 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.767 HG21 HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -79.85 -37.52 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.582 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.526 ' HG3' ' N ' ' A' ' 110' ' ' THR . 6.1 ptp -68.14 -36.48 79.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.526 ' N ' ' HG3' ' A' ' 109' ' ' MET . 68.1 m -70.18 -39.76 75.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.327 -0.858 . . . . 0.0 109.631 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -72.5 -14.48 61.67 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.355 -0.841 . . . . 0.0 109.437 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.732 HD11 HG12 ' B' ' 13' ' ' VAL . 10.1 mt -86.57 -46.86 9.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.403 -0.81 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.29 -9.88 0.83 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.836 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp10 -127.65 150.48 49.72 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.734 -1.45 . . . . 0.0 110.857 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 116' ' ' LEU . 2.2 mttp -132.2 74.58 1.59 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.421 -0.8 . . . . 0.0 109.454 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.68 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.4 mp -38.64 144.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 110.652 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -57.47 -144.61 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.559 -0.713 . . . . 0.0 110.57 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 117' ' ' THR . 8.2 m-20 -111.71 -38.58 4.83 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.019 -1.051 . . . . 0.0 111.212 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 4.8 pt-20 -70.87 -32.17 69.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.996 -1.065 . . . . 0.0 110.46 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.538 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 12.0 pt-20 -78.41 -40.47 35.9 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.13 -0.981 . . . . 0.0 109.4 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.625 HG23 ' HB3' ' A' ' 116' ' ' LEU . 9.7 t -63.37 -36.25 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.211 -0.931 . . . . 0.0 109.423 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.25 -48.4 65.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 0.0 109.434 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 2.3 mm-40 -63.25 -19.63 64.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.39 -0.819 . . . . 0.0 109.407 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.88 -56.95 4.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -0.836 . . . . 0.0 109.791 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.552 HD11 HD13 ' A' ' 105' ' ' LEU . 22.8 mm -61.5 -43.5 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 109.483 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -64.21 -37.54 87.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.436 -0.79 . . . . 0.0 110.007 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 17.2 tp10 -70.9 -15.64 62.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.783 . . . . 0.0 110.111 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -94.57 -42.04 9.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 110.358 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD2' ' CG ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -56.03 80.59 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.442 -0.786 . . . . 0.0 110.361 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 128' ' ' ALA . 13.0 mt -50.31 -41.41 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.099 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 12.0 p-10 -80.39 -34.91 35.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.424 -0.798 . . . . 0.0 110.048 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.92 68.16 1.14 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 3.0 p30 -117.3 -14.15 10.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -1.202 . . . . 0.0 110.186 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.76 5.39 29.4 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 11.1 pt20 -170.05 169.26 8.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.225 -1.162 . . . . 0.0 110.445 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 26.0 t -100.34 159.1 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.212 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.568 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 57.5 t30 -128.63 173.3 10.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.257 -0.902 . . . . 0.0 110.243 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.492 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 38.4 t80 -55.71 -61.95 2.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 0.0 110.087 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.36 -31.73 15.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.43 -50.88 8.92 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.182 -0.949 . . . . 0.0 110.248 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.573 ' CE1' ' CD2' ' A' ' 92' ' ' PHE . 63.3 t80 -54.93 -17.78 4.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.995 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 146' ' ' THR . 14.7 t -97.4 -36.68 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 0.0 110.261 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -11.47 60.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.21 -0.931 . . . . 0.0 110.425 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.487 ' HE3' ' HB3' ' A' ' 144' ' ' MET . 17.8 mmm -91.75 -25.69 18.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.174 -0.954 . . . . 0.0 110.267 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.465 ' SD ' HG12 ' A' ' 85' ' ' ILE . 6.5 mtp -98.79 -30.28 12.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.226 -0.921 . . . . 0.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 142' ' ' VAL . 35.0 p -85.83 19.9 2.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.72 53.84 1.9 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.367 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.235 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 1' ' ' VAL . 23.5 m . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.304 0.573 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.551 ' O ' ' CB ' ' B' ' 3' ' ' LEU . 21.6 mttp -68.94 118.66 12.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.287 -0.883 . . . . 0.0 110.408 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.591 ' O ' ' HB ' ' B' ' 4' ' ' ILE . 2.6 mt 160.55 94.85 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.833 HG23 ' HD2' ' B' ' 5' ' ' PRO . 10.6 mt 62.23 153.31 0.11 Allowed Pre-proline 0 N--CA 1.49 1.558 0 CA-C-O 121.006 0.432 . . . . 0.0 110.423 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.833 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.5 Cg_endo -66.71 -164.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 124.06 1.558 . . . . 0.0 110.996 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.429 ' C ' ' SD ' ' A' ' 51' ' ' MET . 0.1 OUTLIER -115.65 -148.89 0.44 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.311 -0.868 . . . . 0.0 110.797 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.764 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -91.7 -74.49 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 110.778 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.464 HG21 ' HG2' ' A' ' 75' ' ' LYS . 14.3 p -44.28 -43.25 7.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 110.094 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 87' ' ' GLU . 17.1 m -45.18 -54.03 7.43 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 109.777 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.03 -38.66 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.247 -0.908 . . . . 0.0 109.343 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.504 ' N ' HD13 ' B' ' 11' ' ' ILE . 5.3 mm -67.72 -39.27 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.361 -0.837 . . . . 0.0 109.957 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' B' ' 9' ' ' THR . 12.7 mt -52.63 -56.09 17.82 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.347 -0.845 . . . . 0.0 109.958 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.788 HG21 HG11 ' A' ' 91' ' ' VAL . 73.4 t -54.51 -54.7 19.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 110.33 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.515 ' O ' HD22 ' B' ' 17' ' ' LEU . 3.7 tptt -55.71 -41.67 74.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.809 -1.182 . . . . 0.0 109.71 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 17.8 t -72.91 -6.0 42.27 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 109.865 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.579 ' SD ' ' CD1' ' B' ' 22' ' ' PHE . 35.0 tpp -83.97 -45.13 13.48 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.256 -0.902 . . . . 0.0 110.138 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.734 ' H ' HD13 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -96.06 33.67 1.68 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 118.383 -1.327 . . . . 0.0 110.234 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.415 ' HG2' ' N ' ' B' ' 19' ' ' LYS . 1.5 ttt85 -42.5 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.49 0.662 . . . . 0.0 109.992 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.586 ' HD2' ' CG ' ' B' ' 20' ' ' ARG . 2.9 tmtm? -103.69 -84.66 0.47 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.141 -0.974 . . . . 0.0 110.387 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.586 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.4 OUTLIER -146.1 12.41 1.24 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.697 -1.252 . . . . 0.0 110.021 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.53 174.06 6.04 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.351 -0.843 . . . . 0.0 110.775 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.579 ' CD1' ' SD ' ' B' ' 16' ' ' MET . 0.2 OUTLIER -130.32 66.15 1.51 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.47 -0.769 . . . . 0.0 110.061 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.29 -173.97 13.24 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.447 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 0.4 OUTLIER -176.71 118.59 0.28 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.369 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -79.74 35.69 0.58 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.829 1.437 . . . . 0.0 111.216 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.432 ' CD1' ' OD1' ' B' ' 24' ' ' ASN . 8.3 m-85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.901 -1.125 . . . . 0.0 110.388 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.214 0.53 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 2' ' ' ASP . 9.2 t70 -126.53 25.22 6.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.245 -0.909 . . . . 0.0 110.248 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -98.19 106.31 18.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.272 -0.892 . . . . 0.0 110.205 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.493 ' C ' HG23 ' A' ' 5' ' ' THR . 1.1 tt -114.26 41.95 2.18 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.255 -0.903 . . . . 0.0 110.396 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.493 HG23 ' C ' ' A' ' 4' ' ' LEU . 69.5 p -149.55 39.79 0.81 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.237 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -45.01 70.18 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.484 -0.76 . . . . 0.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.98 -66.5 0.38 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -49.1 -58.39 5.03 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.255 -0.903 . . . . 0.0 110.122 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.9 mt -55.7 -54.45 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.191 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.72 -48.63 10.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.166 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.98 -49.01 74.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -0.926 . . . . 0.0 110.048 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.438 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 20.9 m-30 -63.69 -40.53 97.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.915 . . . . 0.0 110.112 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -54.91 -52.23 63.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.769 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 9.3 tp10 -60.04 -30.55 69.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.543 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -69.28 -50.47 46.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.466 -0.771 . . . . 0.0 110.155 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.474 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 16.9 t80 -63.15 -36.93 85.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.607 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.2 m -75.36 -15.32 60.48 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.331 -0.856 . . . . 0.0 109.4 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.859 HD11 ' O ' ' A' ' 112' ' ' LEU . 7.8 tt -74.21 -48.27 30.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.449 -0.782 . . . . 0.0 110.096 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.549 ' HB3' HG23 ' A' ' 27' ' ' ILE . 54.5 m-85 -69.57 -47.37 63.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.293 -0.879 . . . . 0.0 109.988 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 4.4 t0 -57.55 95.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.13 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 8.2 mmtp -52.44 -56.08 17.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.175 -0.953 . . . . 0.0 110.15 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 18.6 p-10 -76.62 -33.78 58.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.84 . . . . 0.0 110.328 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 95.06 41.34 4.06 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 32.3 p-10 -97.09 8.98 43.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.153 -1.204 . . . . 0.0 110.308 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 26' ' ' THR . . . 74.07 38.28 47.98 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 25' ' ' GLY . 21.7 p -156.52 111.38 2.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.173 -1.192 . . . . 0.0 110.293 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.848 HD12 HG21 ' A' ' 63' ' ' ILE . 17.5 mt -86.85 123.14 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.085 -1.009 . . . . 0.0 110.365 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -100.43 164.87 11.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.4 -0.812 . . . . 0.0 109.543 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.406 HG21 ' OE1' ' A' ' 49' ' ' GLN . 18.7 p -65.75 -25.11 67.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.984 -1.073 . . . . 0.0 109.885 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.36 -45.0 49.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 109.994 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 35' ' ' VAL . 46.6 mt-10 -63.25 -66.16 0.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 109.992 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 tp -47.74 -45.03 28.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 110.06 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.28 -54.89 9.5 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 59.3 m -61.08 -36.32 79.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -1.055 . . . . 0.0 110.036 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 31' ' ' GLU . 19.3 t -62.69 -43.94 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.92 . . . . 0.0 110.084 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.428 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 12.5 mmm -66.48 -28.72 68.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.283 -0.886 . . . . 0.0 110.041 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 tpt85 -72.5 -29.43 63.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.324 -0.86 . . . . 0.0 110.245 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -58.39 -48.9 79.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 110.555 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.643 HD23 HG23 ' A' ' 108' ' ' VAL . 2.6 mt -57.25 -23.47 48.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.182 -0.949 . . . . 0.0 110.2 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . 106.34 70.87 0.76 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 40' ' ' GLY . 26.8 mm-40 -153.26 -172.14 4.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.233 -1.157 . . . . 0.0 110.153 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.05 78.88 45.91 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.207 -0.933 . . . . 0.0 110.533 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HG3' ' HB2' ' A' ' 36' ' ' MET . 44.0 Cg_endo -72.22 135.69 25.33 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.074 1.565 . . . . 0.0 110.228 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.1 m -97.98 146.1 25.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -0.927 . . . . 0.0 110.237 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -49.42 -47.55 47.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.15 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.47 -48.21 74.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.951 . . . . 0.0 110.193 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.22 -32.79 74.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.951 . . . . 0.0 110.247 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 48' ' ' LEU . 8.9 mt -61.07 -51.04 70.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 110.406 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' OE1' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -62.92 -36.91 84.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.336 -0.852 . . . . 0.0 110.203 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -71.15 -32.05 68.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 109.871 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.635 ' CE ' ' CD1' ' B' ' 7' ' ' TRP . 3.9 mmm -69.47 -36.03 76.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 109.965 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.895 HG12 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -89.69 -12.05 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.626 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.67 -37.17 72.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.0 110.254 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.04 -32.48 15.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.409 -0.807 . . . . 0.0 110.464 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.78 HG12 HD12 ' A' ' 63' ' ' ILE . 15.6 t -69.74 -31.51 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.093 -1.005 . . . . 0.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 57' ' ' ALA . 42.4 t0 -76.84 49.41 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.127 -0.983 . . . . 0.0 110.217 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -44.05 -29.82 0.65 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 110.377 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.453 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 2.7 t0 -61.93 -61.83 2.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.725 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.18 25.19 3.92 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 54.8 p30 -99.04 -14.62 19.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.943 -1.327 . . . . 0.0 110.112 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 105.75 -34.42 5.78 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.515 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 12.7 p -106.44 161.06 14.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.157 -1.202 . . . . 0.0 110.414 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.895 HD11 HG12 ' A' ' 52' ' ' ILE . 25.6 mm -86.44 144.29 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.295 -0.878 . . . . 0.0 110.578 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 6.7 t70 -122.25 165.42 16.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.489 -0.757 . . . . 0.0 110.046 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.616 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 14.8 t80 -59.07 -43.35 97.24 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.235 -0.916 . . . . 0.0 111.625 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.4 Cg_endo -72.82 -30.31 11.53 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.37 1.194 . . . . 0.0 110.555 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 64' ' ' ASP . 17.0 mt-10 -68.64 -44.39 74.25 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.081 -1.012 . . . . 0.0 109.534 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CD1' ' HE3' ' A' ' 71' ' ' MET . 33.9 t80 -61.02 -45.23 95.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 0.0 110.036 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.6 -36.28 75.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.192 -0.942 . . . . 0.0 110.421 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -71.79 -26.91 62.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.249 -0.907 . . . . 0.0 110.576 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.593 ' HE2' HG22 ' A' ' 55' ' ' VAL . 2.2 tmm? -71.5 -62.26 1.47 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 110.555 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.599 ' HE1' ' CE1' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -50.46 -20.47 1.14 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.222 -0.924 . . . . 0.0 110.157 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.4 -21.69 20.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.191 -0.943 . . . . 0.0 110.268 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtt85 -98.36 -20.07 17.38 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.194 -0.941 . . . . 0.0 110.503 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.575 ' HG2' HG21 ' B' ' 8' ' ' THR . 1.9 tptm -76.92 -35.88 57.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.933 . . . . 0.0 109.927 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.679 ' HE1' ' CD1' ' B' ' 26' ' ' PHE . 15.4 mtt -90.11 42.21 1.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.888 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -96.86 -51.05 4.41 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.358 -0.839 . . . . 0.0 110.258 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 47.7 t0 -177.19 59.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 110.394 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.41 -81.65 0.29 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.513 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 3.8 m-20 -94.23 90.9 6.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.326 -0.859 . . . . 0.0 110.152 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 m -86.57 -62.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.953 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -100.44 -9.75 21.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.285 -0.884 . . . . 0.0 110.564 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.513 ' HG2' ' HA ' ' A' ' 80' ' ' ASP . 3.9 pt-20 -84.79 -9.74 57.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.142 -0.973 . . . . 0.0 110.469 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -85.49 -27.36 25.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.084 -1.01 . . . . 0.0 110.088 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.618 HD13 HG21 ' A' ' 146' ' ' THR . 5.3 mt -73.25 -38.0 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.082 -1.011 . . . . 0.0 109.024 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -57.2 -31.46 65.49 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.451 ' HB3' HG23 ' B' ' 9' ' ' THR . 0.5 OUTLIER -67.69 -58.89 3.87 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.556 -0.715 . . . . 0.0 109.293 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.17 -30.09 48.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 109.426 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -74.34 -31.49 62.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -0.888 . . . . 0.0 109.216 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.47 -22.42 64.56 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.534 -0.729 . . . . 0.0 109.467 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.783 HG12 HG21 ' A' ' 108' ' ' VAL . 23.6 t -91.12 -28.75 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 0.0 110.476 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.649 ' HB3' HD13 ' A' ' 100' ' ' ILE . 4.0 m-85 -77.92 -30.05 50.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.076 -1.015 . . . . 0.0 109.964 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -96.36 63.27 2.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.315 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ASP . 5.6 mmpp? -41.12 -28.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.512 -0.742 . . . . 0.0 110.079 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.5 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 7.9 m-20 -82.96 -39.47 21.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.357 -0.839 . . . . 0.0 109.686 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 77.23 26.61 61.41 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 95' ' ' ASP . 5.9 p-10 -86.65 -44.18 12.05 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -1.22 . . . . 0.0 109.931 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.591 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 143.62 27.61 0.13 Allowed Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.827 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 41.3 m-85 -161.2 136.92 7.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.924 -1.339 . . . . 0.0 110.174 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.649 HD13 ' HB3' ' A' ' 92' ' ' PHE . 11.1 mt -101.0 123.24 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.257 -0.902 . . . . 0.0 109.969 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 61.8 p -105.19 140.61 38.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.38 -34.81 0.87 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.383 -0.823 . . . . 0.0 109.999 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.6 -51.04 70.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.855 . . . . 0.0 109.761 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -57.08 -43.1 81.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.78 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.819 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -58.94 -37.35 76.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.768 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 1.8 ttt-85 -61.35 -37.38 83.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.509 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -63.82 -44.32 93.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.459 -0.775 . . . . 0.0 109.808 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.783 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -82.62 -28.67 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.442 -0.786 . . . . 0.0 109.284 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.623 ' HA ' HD21 ' B' ' 17' ' ' LEU . 31.7 ttm -65.51 -57.06 9.15 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.578 -0.701 . . . . 0.0 110.14 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.682 HG23 ' HB3' ' A' ' 115' ' ' LYS . 5.8 m -67.53 -32.4 73.16 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.248 -0.907 . . . . 0.0 110.316 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 60.6 m-20 -76.81 1.79 16.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.002 -1.061 . . . . 0.0 109.29 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.888 ' CD1' HG12 ' B' ' 13' ' ' VAL . 7.0 mt -111.75 4.37 18.41 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.372 -0.83 . . . . 0.0 110.601 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.76 -75.97 0.41 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.609 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp10 -94.6 154.27 17.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -1.133 . . . . 0.0 111.099 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.682 ' HB3' HG23 ' A' ' 110' ' ' THR . 1.3 pttm -129.45 74.43 1.58 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.641 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.9 mp -34.27 154.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.391 0.615 . . . . 0.0 110.965 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.81 -144.23 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.299 -0.876 . . . . 0.0 110.097 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -108.53 -59.34 1.88 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.218 -0.926 . . . . 0.0 110.139 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -48.87 -45.24 40.75 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.069 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.31 -50.58 73.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.89 . . . . 0.0 109.924 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.605 HG22 ' CE ' ' A' ' 109' ' ' MET . 43.5 t -57.64 -38.26 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.86 -45.61 70.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.902 . . . . 0.0 109.796 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 1.8 tt0 -64.84 -23.18 67.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.456 -0.778 . . . . 0.0 109.89 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.42 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 1.8 ttt -73.06 -43.79 61.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.843 . . . . 0.0 109.945 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.819 HD11 ' CD1' ' A' ' 105' ' ' LEU . 45.0 mm -69.93 -42.13 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 110.185 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 33.9 mtt-85 -66.25 -44.55 83.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.266 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 7.6 mm-40 -48.19 -32.15 6.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.392 -0.818 . . . . 0.0 110.25 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -100.69 -30.57 11.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 110.162 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -56.72 83.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.343 -0.848 . . . . 0.0 110.613 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -65.28 -42.35 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.9 p-10 -70.68 -33.5 70.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 109.844 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 87.02 56.55 2.17 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.456 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 25.7 p30 -112.98 0.12 14.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -1.211 . . . . 0.0 109.864 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.455 ' C ' ' HG3' ' A' ' 135' ' ' GLN . . . 76.71 -1.72 61.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 100' ' ' ILE . 33.0 mt-30 -139.55 138.52 36.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.142 -1.21 . . . . 0.0 110.25 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 125' ' ' ILE . 20.2 t -89.37 154.74 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.108 -0.995 . . . . 0.0 109.724 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.45 ' OD1' ' HG3' ' A' ' 139' ' ' GLU . 55.9 p30 -130.09 -142.32 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 110.581 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.71 -68.58 0.69 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.391 -0.818 . . . . 0.0 110.697 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -46.74 -25.06 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.23 -0.919 . . . . 0.0 110.792 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 38.0 mt-10 -83.13 -61.09 1.95 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.008 . . . . 0.0 109.726 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.515 ' CE1' HG23 ' A' ' 85' ' ' ILE . 35.4 t80 -51.23 -19.52 1.25 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 110.29 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 144' ' ' MET . 55.5 t -100.93 -70.21 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.264 -0.898 . . . . 0.0 111.455 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.811 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -39.74 -24.73 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.103 -0.998 . . . . 0.0 111.787 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.52 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 77.7 mmm -88.62 -39.25 14.21 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.745 -1.222 . . . . 0.0 111.395 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.39 -9.69 21.96 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.989 -1.069 . . . . 0.0 111.895 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.618 HG21 HD13 ' A' ' 85' ' ' ILE . 1.3 p -120.47 -26.4 5.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.721 -1.237 . . . . 0.0 111.06 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -7.85 72.87 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.85 0 CA-C-O 121.677 0.751 . . . . 0.0 112.27 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 146' ' ' THR . 4.4 ptmt . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.271 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' B' ' 2' ' ' LYS . 5.6 m . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.337 0.589 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.526 ' O ' HD22 ' B' ' 3' ' ' LEU . 0.0 OUTLIER 56.29 90.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.381 -0.824 . . . . 0.0 110.934 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.526 HD22 ' O ' ' B' ' 2' ' ' LYS . 0.6 OUTLIER -127.07 -17.83 4.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.987 HD13 ' HD2' ' B' ' 5' ' ' PRO . 0.2 OUTLIER -51.44 143.05 20.03 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.987 ' HD2' HD13 ' B' ' 4' ' ' ILE . 38.5 Cg_endo -65.9 -155.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.825 1.434 . . . . 0.0 110.176 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.424 ' O ' HG23 ' B' ' 10' ' ' VAL . 6.6 m -121.94 -147.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.933 -1.104 . . . . 0.0 111.333 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.764 ' CD1' HG21 ' A' ' 55' ' ' VAL . 4.8 m95 -81.91 -76.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.547 0.689 . . . . 0.0 111.282 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.575 HG21 ' HG2' ' A' ' 75' ' ' LYS . 30.2 p -43.86 -42.82 5.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.811 . . . . 0.0 110.3 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.525 HG21 ' CB ' ' B' ' 5' ' ' PRO . 53.6 m -46.29 -41.41 13.13 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 109.292 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 6' ' ' SER . 46.2 t -69.32 -41.06 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.359 -0.838 . . . . 0.0 109.863 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.5 ' N ' HD13 ' B' ' 11' ' ' ILE . 5.6 mm -72.76 -25.69 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.248 -0.907 . . . . 0.0 109.874 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.636 HD13 ' CD2' ' B' ' 26' ' ' PHE . 1.3 mm? -65.97 -53.41 39.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.694 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.888 HG12 ' CD1' ' A' ' 112' ' ' LEU . 53.2 t -61.02 -48.9 86.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.152 -0.968 . . . . 0.0 109.766 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -35.69 43.17 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.844 -1.16 . . . . 0.0 108.965 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 5.3 t -65.24 -34.85 79.33 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.514 -0.741 . . . . 0.0 109.365 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.421 ' HG3' ' CE1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -57.32 -43.81 83.65 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.401 -0.812 . . . . 0.0 109.518 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 109' ' ' MET . 4.1 mp -58.16 -94.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 109.688 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 58.15 -76.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.518 -0.739 . . . . 0.0 110.6 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER 175.63 107.59 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.887 -0.508 . . . . 0.0 110.842 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.7 OUTLIER 40.16 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.464 -0.773 . . . . 0.0 110.947 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.518 ' N ' ' O ' ' B' ' 19' ' ' LYS . 2.2 m -107.62 141.16 39.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.983 -1.073 . . . . 0.0 110.29 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.605 ' HE2' HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -142.21 12.67 1.99 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.196 -0.94 . . . . 0.0 110.208 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' B' ' 24' ' ' ASN . . . -77.96 -61.44 2.53 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 145' ' ' MET . 1.8 m-80 55.4 69.06 2.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.3 -1.118 . . . . 0.0 110.068 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.45 62.47 4.43 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 O-C-N 123.967 1.509 . . . . 0.0 110.04 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.679 ' CD1' ' HE1' ' A' ' 76' ' ' MET . 1.1 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.189 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.249 0.547 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 59.07 95.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.207 -0.933 . . . . 0.0 110.146 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -98.16 84.75 3.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.7 118.55 26.18 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.351 -0.843 . . . . 0.0 110.273 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 p -104.33 95.43 5.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.288 -0.882 . . . . 0.0 110.324 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.51 -32.47 67.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.122 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -52.55 61.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 109.943 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -53.19 59.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.711 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.5 mp -54.07 -39.58 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.45 -51.82 65.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.484 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -48.91 -49.11 41.53 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.363 -0.835 . . . . 0.0 109.256 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -60.59 -44.79 95.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.386 -0.821 . . . . 0.0 109.345 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 10.6 tptm -57.26 -36.6 71.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.368 -0.833 . . . . 0.0 109.227 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -52.56 64.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.604 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.61 -41.88 64.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 0.0 109.492 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 31.8 t80 -65.62 -43.66 88.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.491 -0.756 . . . . 0.0 109.509 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -69.87 -25.35 63.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 109.615 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.692 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.3 tt -67.47 -42.29 83.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.447 -0.783 . . . . 0.0 109.798 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.515 ' HA ' HG21 ' A' ' 35' ' ' VAL . 24.9 m-85 -73.16 -39.22 65.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 109.762 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -62.94 89.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.412 -0.805 . . . . 0.0 110.226 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -88.33 30.66 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.224 -0.922 . . . . 0.0 110.133 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 9.4 p-10 -143.65 -41.53 0.29 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.241 -0.912 . . . . 0.0 110.325 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 102.93 90.94 2.17 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.1 p-10 -164.07 -43.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.195 -1.179 . . . . 0.0 110.409 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.4 17.65 6.53 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -143.85 119.52 10.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.194 -1.18 . . . . 0.0 110.351 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 5.9 mt -82.09 115.97 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.083 -1.011 . . . . 0.0 109.943 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 9.0 p -80.35 -174.29 4.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.678 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.0 -49.88 26.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.159 -0.963 . . . . 0.0 110.179 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' GLU . 4.8 ttmt -68.32 -40.9 81.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.484 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.2 mt-10 -43.98 -48.78 8.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.13 -0.981 . . . . 0.0 109.594 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.608 HD23 HD21 ' A' ' 48' ' ' LEU . 24.0 tp -71.39 -34.52 70.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.314 -0.867 . . . . 0.0 109.366 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -59.45 -46.81 93.32 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 99.5 m -58.71 -54.35 48.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -1.094 . . . . 0.0 109.159 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 31' ' ' GLU . 16.8 t -56.76 -35.47 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.37 -0.831 . . . . 0.0 109.363 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.0 mmt -63.56 -49.56 72.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.461 -0.774 . . . . 0.0 109.697 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -54.09 -30.46 48.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.876 . . . . 0.0 109.5 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.446 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 1.3 m -54.96 -50.17 69.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.439 -0.788 . . . . 0.0 110.132 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.1 mt -52.15 -36.64 52.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.109 -0.995 . . . . 0.0 109.673 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 117.45 64.87 0.33 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 40' ' ' GLY . 6.3 mt-30 -156.81 -166.28 2.06 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.227 -1.161 . . . . 0.0 110.376 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -126.6 82.0 67.51 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.224 -0.922 . . . . 0.0 110.667 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.9 102.58 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.908 1.478 . . . . 0.0 110.438 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.511 ' CG2' ' HG3' ' A' ' 47' ' ' GLU . 11.4 t -79.63 172.09 14.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.187 -0.946 . . . . 0.0 110.084 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -78.78 -25.67 44.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.158 -0.964 . . . . 0.0 110.482 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.09 -65.43 0.7 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.034 -1.041 . . . . 0.0 110.178 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HG3' ' CG2' ' A' ' 44' ' ' THR . 0.9 OUTLIER -52.7 -44.96 66.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 109.879 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.608 HD21 HD23 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -50.96 -42.94 60.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.907 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -45.64 92.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.423 -0.798 . . . . 0.0 109.8 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.76 -13.97 62.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 110.062 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.617 ' HE1' ' CA ' ' B' ' 7' ' ' TRP . 2.4 mmm -94.26 -46.37 7.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.52 HG13 HD11 ' A' ' 63' ' ' ILE . 1.2 tp -60.69 -37.96 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.242 -0.911 . . . . 0.0 110.035 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.408 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.8 OUTLIER -51.11 -29.78 14.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 110.284 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -65.24 -56.33 13.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.024 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.668 HG22 ' HG3' ' A' ' 71' ' ' MET . 15.2 t -70.78 -14.49 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.126 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.4 77.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 110.384 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . . . -56.9 -63.81 1.08 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 0.0 110.32 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 7.0 p-10 -66.4 -43.9 84.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.97 . . . . 0.0 110.191 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.68 41.09 1.64 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 34.9 p-10 -99.51 -42.72 6.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.093 -1.239 . . . . 0.0 110.27 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 136.23 -14.34 4.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 22.0 p -118.36 160.89 20.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.135 -1.215 . . . . 0.0 110.538 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.52 HD11 HG13 ' A' ' 52' ' ' ILE . 8.0 mm -97.85 152.63 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 109.905 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.453 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 2.0 m-20 -131.57 148.22 52.6 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.188 -0.945 . . . . 0.0 110.535 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.911 ' O ' HD12 ' A' ' 69' ' ' LEU . 37.6 t80 -40.58 -51.22 6.8 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.281 -0.887 . . . . 0.0 111.172 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.9 Cg_endo -66.09 -33.07 42.14 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.325 1.171 . . . . 0.0 110.04 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' HG2' ' CB ' ' A' ' 57' ' ' ALA . 3.2 mt-10 -69.84 -30.03 67.42 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.312 -0.868 . . . . 0.0 109.467 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.678 ' HZ ' HG23 ' B' ' 11' ' ' ILE . 56.8 t80 -65.54 -54.71 24.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.468 -0.77 . . . . 0.0 109.978 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.911 HD12 ' O ' ' A' ' 65' ' ' PHE . 1.3 mp -53.6 -48.75 68.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.383 -0.823 . . . . 0.0 110.066 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -27.99 69.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 110.247 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.668 ' HG3' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -61.88 -60.41 3.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.42 -0.8 . . . . 0.0 111.023 -179.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.648 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 41.1 mmm -51.5 -16.51 0.61 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.101 -1.0 . . . . 0.0 111.076 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.73 -9.37 54.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.808 -1.182 . . . . 0.0 110.452 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 9.4 ttt85 -95.78 -42.62 8.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.094 -1.004 . . . . 0.0 111.375 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.614 ' CB ' HG21 ' B' ' 8' ' ' THR . 4.8 mmtp -69.22 -26.24 64.71 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.088 -1.007 . . . . 0.0 111.04 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 72' ' ' MET . 19.8 mmt -65.72 -27.39 68.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.205 -0.934 . . . . 0.0 110.754 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 71.4 1.44 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -0.968 . . . . 0.0 110.168 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 5.3 t70 -144.16 -55.44 0.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.025 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 7.3 t -178.06 33.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.386 -0.821 . . . . 0.0 110.081 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' THR . 1.6 t70 -179.82 71.82 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.372 -0.83 . . . . 0.0 109.823 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 t -83.31 -64.96 1.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.384 -0.823 . . . . 0.0 110.518 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HG2' ' OG1' ' A' ' 146' ' ' THR . 0.2 OUTLIER -85.58 -25.51 26.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.372 -0.83 . . . . 0.0 110.593 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.456 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -59.84 -15.37 20.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.05 -1.032 . . . . 0.0 109.919 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' HG2' ' CD2' ' B' ' 12' ' ' LEU . 10.8 tt0 -68.63 -33.83 74.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.497 -0.752 . . . . 0.0 110.561 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.542 ' CD1' ' HB ' ' A' ' 146' ' ' THR . 49.9 mt -60.61 -30.53 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.214 -0.929 . . . . 0.0 109.174 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -63.41 -33.57 75.83 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.737 -0.602 . . . . 0.0 110.21 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.874 ' HB3' HG21 ' B' ' 9' ' ' THR . 1.2 mp0 -73.25 -48.06 37.98 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.105 -0.997 . . . . 0.0 109.901 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -60.83 -27.68 68.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.032 . . . . 0.0 109.948 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.582 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 64.4 t80 -70.21 -49.13 53.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.929 -1.107 . . . . 0.0 108.949 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -52.12 -30.19 25.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.484 -0.76 . . . . 0.0 109.078 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.658 HG12 HG21 ' A' ' 108' ' ' VAL . 40.8 t -69.34 -47.79 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.498 -0.751 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.575 ' HB3' ' CD1' ' A' ' 100' ' ' ILE . 52.2 m-85 -62.4 -43.48 98.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.917 -1.115 . . . . 0.0 110.263 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -68.41 58.03 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 0.0 110.096 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 92' ' ' PHE . 7.2 tttm -40.89 -62.53 0.8 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 110.515 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 30.2 p-10 -63.64 -41.43 98.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.207 -0.933 . . . . 0.0 110.214 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 100.07 40.36 3.08 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 30.6 p-10 -99.08 -21.07 16.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.233 -1.157 . . . . 0.0 110.265 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.56 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 101.36 33.87 4.69 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.56 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 53.3 m-85 -159.22 149.27 19.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.312 -1.111 . . . . 0.0 110.113 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 11.5 mt -116.55 153.78 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.125 -0.985 . . . . 0.0 110.543 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 102' ' ' ALA . 12.0 t -145.8 154.18 41.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.437 -0.789 . . . . 0.0 109.76 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.42 -28.81 0.6 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.955 . . . . 0.0 110.083 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.5 -51.34 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.803 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 92' ' ' PHE . 21.1 mt-10 -58.77 -35.91 73.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.879 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.026 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -65.16 -41.15 94.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.611 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.457 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 1.5 tpp180 -64.33 -24.13 67.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -79.28 -31.68 43.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.45 -0.781 . . . . 0.0 110.217 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.658 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -85.4 -30.62 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.266 -0.897 . . . . 0.0 109.995 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.689 ' HA ' HD21 ' B' ' 17' ' ' LEU . 5.0 ptp -74.41 -40.9 61.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.525 ' N ' ' HG3' ' A' ' 109' ' ' MET . 93.9 m -71.62 -23.45 61.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.134 -0.979 . . . . 0.0 109.62 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 38' ' ' SER . 22.3 m-20 -84.98 -8.48 58.72 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.194 -0.941 . . . . 0.0 109.848 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.692 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.4 mt -97.78 -38.29 9.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 110.316 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.74 -26.99 1.18 Allowed Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.586 -1.292 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 109' ' ' MET . 21.1 tt0 -113.56 166.02 11.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.887 -1.361 . . . . 0.0 110.826 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -146.12 72.19 1.29 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.493 -0.754 . . . . 0.0 109.234 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 116' ' ' LEU . 2.9 mp -36.47 148.09 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.466 0.65 . . . . 0.0 111.16 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -56.46 -157.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.524 -0.735 . . . . 0.0 110.01 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 117' ' ' THR . 0.3 OUTLIER -95.47 -68.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.03 -1.044 . . . . 0.0 110.312 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -43.5 -46.27 6.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.012 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -59.79 -52.11 66.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.714 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 117' ' ' THR . 83.0 t -60.18 -38.26 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 0.0 110.175 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -66.27 -63.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.0 109.875 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 122' ' ' ASP . 13.3 mm-40 -46.11 -26.57 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.365 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.705 ' HE2' ' CD2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.44 -55.12 17.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.499 -0.751 . . . . 0.0 110.183 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.026 HD11 ' CD1' ' A' ' 105' ' ' LEU . 44.5 mm -62.85 -22.58 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.414 -0.804 . . . . 0.0 110.244 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.408 ' C ' ' HD3' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -81.43 -38.98 25.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.194 -0.941 . . . . 0.0 110.158 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.34 -7.04 33.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 110.057 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.905 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -112.89 -32.09 6.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.19 -0.944 . . . . 0.0 110.334 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.94 83.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.313 -0.867 . . . . 0.0 110.513 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 128' ' ' ALA . 0.9 OUTLIER -61.67 -28.94 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 0.0 109.461 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -85.53 -25.24 26.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.611 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.68 57.59 7.87 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 18.2 p-10 -120.88 -28.15 4.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -1.126 . . . . 0.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.404 ' C ' ' OE1' ' A' ' 135' ' ' GLN . . . 126.37 9.04 4.69 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.154 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.486 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 1.6 pm0 -165.14 166.86 18.73 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.931 -1.335 . . . . 0.0 110.381 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 24.1 t -110.1 168.42 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 110.413 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.466 ' N ' HG12 ' A' ' 136' ' ' VAL . 13.7 t-20 -141.91 173.34 11.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.382 -0.824 . . . . 0.0 109.694 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 139' ' ' GLU . 12.3 t80 -53.31 -56.89 13.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.107 -0.996 . . . . 0.0 109.965 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 2.8 tt0 -44.08 -47.87 8.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -69.51 -57.09 5.66 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.319 -0.863 . . . . 0.0 110.324 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 45.7 t80 -51.96 -19.76 1.99 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.291 -0.881 . . . . 0.0 110.326 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.957 HG13 HG21 ' A' ' 146' ' ' THR . 44.6 t -97.86 -43.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.212 -0.93 . . . . 0.0 110.483 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -65.32 -9.89 28.2 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.041 -1.037 . . . . 0.0 110.146 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.496 ' HE2' ' CD1' ' A' ' 130' ' ' ILE . 2.2 ttm -92.8 -37.96 12.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.669 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.46 -62.17 1.28 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.211 -0.93 . . . . 0.0 111.198 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.957 HG21 HG13 ' A' ' 142' ' ' VAL . 15.2 t -76.53 50.38 0.66 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.151 -0.968 . . . . 0.0 111.151 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.91 51.12 1.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.134 -0.978 . . . . 0.0 109.953 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.276 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.531 ' CG1' ' HD2' ' B' ' 2' ' ' LYS . 8.3 p . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.202 0.525 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.531 ' HD2' ' CG1' ' B' ' 1' ' ' VAL . 0.1 OUTLIER -66.74 111.71 3.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.243 -0.911 . . . . 0.0 109.899 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mt -136.05 -62.97 0.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 110.81 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.768 HG23 ' HD2' ' B' ' 5' ' ' PRO . 81.5 mt -140.6 148.82 54.77 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.127 -0.983 . . . . 0.0 110.899 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.768 ' HD2' HG23 ' B' ' 4' ' ' ILE . 49.5 Cg_endo -74.78 -157.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 124.148 1.604 . . . . 0.0 109.403 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.546 ' CB ' ' OG1' ' B' ' 9' ' ' THR . 0.2 OUTLIER -123.47 -175.04 3.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.975 -1.078 . . . . 0.0 110.648 179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 1.007 ' O ' HG22 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -80.35 -79.1 0.15 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.565 -0.709 . . . . 0.0 111.094 -179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.858 ' O ' HD13 ' B' ' 12' ' ' LEU . 6.6 p -45.16 -23.74 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.866 -1.146 . . . . 0.0 110.043 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.874 HG21 ' HB3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -63.46 -60.19 3.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.072 -1.017 . . . . 0.0 109.154 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 1.007 HG22 ' O ' ' B' ' 7' ' ' TRP . 32.9 m -48.89 -28.36 2.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.736 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.678 HG23 ' HZ ' ' A' ' 68' ' ' PHE . 6.8 mm -79.77 -33.8 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.858 HD13 ' O ' ' B' ' 8' ' ' THR . 4.2 mp -60.39 -60.96 2.99 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.673 -0.642 . . . . 0.0 109.989 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.576 ' O ' HD13 ' B' ' 17' ' ' LEU . 78.6 t -60.14 -38.88 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -67.53 -21.78 65.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.83 -1.168 . . . . 0.0 110.214 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.44 -36.68 33.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.516 ' HG2' ' HA ' ' B' ' 13' ' ' VAL . 0.2 OUTLIER -75.19 -20.65 59.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.226 -0.921 . . . . 0.0 110.255 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.689 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.3 mp -75.69 1.83 13.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.177 -0.952 . . . . 0.0 110.514 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' B' ' 17' ' ' LEU . 14.2 ttm180 -35.61 -69.71 0.1 Allowed 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.208 0.527 . . . . 0.0 110.782 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -154.0 -69.1 0.14 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.084 -1.01 . . . . 0.0 110.362 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.555 ' HA ' ' HG3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -133.42 12.29 4.15 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 109.841 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 4.5 t -80.84 142.41 33.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.421 -0.799 . . . . 0.0 110.175 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.705 ' CD2' ' HE2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -143.88 -33.8 0.41 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.343 -0.848 . . . . 0.0 110.411 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.486 ' HA2' ' HG2' ' A' ' 144' ' ' MET . . . -64.9 -100.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -112.56 101.66 53.01 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.207 -1.172 . . . . 0.0 110.543 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.15 -18.9 12.47 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.126 1.593 . . . . 0.0 110.215 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.648 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 34.9 m-85 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.362 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.255 0.55 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -102.32 -88.53 0.39 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.307 -0.871 . . . . 0.0 110.218 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -74.89 102.44 4.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.226 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.4 mt -65.95 166.65 11.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.5 p -130.02 9.1 5.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 110.063 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 7' ' ' GLU . 14.6 mt-10 -57.79 -22.0 44.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' GLU . 8.1 pt-20 -42.21 -45.26 4.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.38 -0.825 . . . . 0.0 109.957 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -62.2 -42.4 99.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.905 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mt -66.28 -35.86 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.82 88.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -0.892 . . . . 0.0 109.834 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 33.2 tp10 -64.62 -52.41 57.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.611 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -56.11 -31.19 63.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -37.33 83.33 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.302 -0.874 . . . . 0.0 109.211 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 17.0 mm-40 -58.33 -48.85 79.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.438 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.09 -51.56 69.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 109.648 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.613 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 25.4 t80 -52.58 -28.31 20.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -28.1 38.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.422 -0.799 . . . . 0.0 109.885 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.8 tt -63.66 -43.32 97.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.893 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.21 -41.0 50.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.41 -0.806 . . . . 0.0 110.333 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.74 100.03 2.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.039 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -86.13 -29.0 23.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.146 -0.971 . . . . 0.0 110.168 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.5 -33.35 54.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.12 12.49 58.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 29.7 p-10 -83.91 -27.83 28.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -1.177 . . . . 0.0 110.23 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' HG23 ' A' ' 26' ' ' THR . . . 102.99 37.71 3.08 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.551 HG23 ' C ' ' A' ' 25' ' ' GLY . 81.9 p -153.02 113.13 3.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.383 -1.069 . . . . 0.0 110.139 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.687 HD12 ' HB ' ' A' ' 63' ' ' ILE . 30.5 mt -82.83 116.24 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.42 176.27 6.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.6 p -63.41 -35.52 80.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 110.06 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.19 -56.33 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 110.295 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 30' ' ' LYS . 44.4 mt-10 -43.35 -64.8 0.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.166 -0.959 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.76 -37.15 75.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 109.938 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.77 -42.82 91.89 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 m -62.29 -47.69 83.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -1.17 . . . . 0.0 110.017 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 t -55.69 -29.74 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.688 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -31.57 60.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.916 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.14 -18.01 58.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 110.101 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.7 m -77.3 -51.48 10.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.46 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.71 -18.26 29.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.126 -0.984 . . . . 0.0 110.171 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.25 69.96 0.97 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.497 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 5.3 mm-40 -142.23 -162.74 1.46 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.278 -1.13 . . . . 0.0 109.831 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -159.58 88.46 2.0 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.128 -0.982 . . . . 0.0 110.767 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.46 127.47 13.3 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.095 1.577 . . . . 0.0 110.039 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 46' ' ' ALA . 6.2 t -86.36 30.29 0.71 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.124 -0.985 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 44' ' ' THR . 0.3 OUTLIER 67.05 -57.37 0.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 110.302 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 44' ' ' THR . . . -51.34 -40.02 58.24 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.324 -0.86 . . . . 0.0 109.927 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.53 -52.42 39.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.698 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.56 -57.52 3.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 110.064 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.5 mm-40 -55.74 -47.89 76.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.73 -36.65 72.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.456 -0.778 . . . . 0.0 109.759 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 mtp -75.86 -47.03 27.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.433 -0.792 . . . . 0.0 109.534 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.6 mm -66.06 -30.11 48.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.416 -0.802 . . . . 0.0 109.972 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 2.1 m120 -72.26 -16.61 61.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.181 -0.95 . . . . 0.0 110.029 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -87.48 -49.35 7.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 110.377 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.784 HG22 ' SD ' ' A' ' 71' ' ' MET . 21.9 t -72.25 -13.74 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.114 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.06 79.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.089 -1.007 . . . . 0.0 110.264 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -63.88 -39.37 94.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.666 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 37.8 p-10 -93.73 -32.12 14.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.16 -0.962 . . . . 0.0 110.793 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 97.61 38.71 4.11 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -99.81 -8.96 23.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -1.13 . . . . 0.0 110.322 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.44 -1.55 82.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 24.4 p -138.76 146.35 41.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -1.201 . . . . 0.0 110.376 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.719 HD12 ' CG1' ' A' ' 55' ' ' VAL . 48.4 mm -77.54 138.38 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.34 -0.85 . . . . 0.0 110.33 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 9.1 t0 -111.43 169.31 8.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 110.792 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 15.9 t80 -55.08 -45.46 99.84 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.35 -0.844 . . . . 0.0 111.41 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.4 Cg_endo -71.12 -46.36 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.233 1.122 . . . . 0.0 110.166 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 71' ' ' MET . 29.3 mt-10 -56.97 -33.77 67.41 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 109.87 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CZ ' HD13 ' B' ' 11' ' ' ILE . 47.1 t80 -67.65 -56.08 10.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.184 -0.948 . . . . 0.0 110.633 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 65' ' ' PHE . 1.2 mp -51.65 -61.5 2.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.358 -0.839 . . . . 0.0 110.995 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.5 m -51.92 -58.37 6.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.33 -0.856 . . . . 0.0 111.35 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.784 ' SD ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -43.74 -68.9 0.16 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.164 -0.96 . . . . 0.0 111.372 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.621 ' SD ' HG22 ' B' ' 8' ' ' THR . 7.7 mmm -37.8 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.257 -0.902 . . . . 0.0 110.908 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' MET . . . -92.81 -41.46 10.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.092 -1.005 . . . . 0.0 111.271 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -67.21 -19.16 65.51 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.905 -1.122 . . . . 0.0 110.771 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HB3' HG21 ' B' ' 8' ' ' THR . 0.8 OUTLIER -80.3 -36.12 34.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.044 -1.035 . . . . 0.0 110.257 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.9 mtt -84.17 48.32 1.46 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 3.0 mttp -161.23 94.82 1.01 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.597 -0.689 . . . . 0.0 109.405 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.672 ' O ' HG23 ' A' ' 79' ' ' THR . 6.1 m-20 60.76 69.91 0.65 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.609 -0.682 . . . . 0.0 109.918 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -178.7 -54.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.592 -0.692 . . . . 0.0 109.526 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' OD1' ' HG3' ' A' ' 75' ' ' LYS . 9.0 p-10 -176.42 81.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 0.0 110.122 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 1.9 m -100.81 -31.26 11.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.351 -0.843 . . . . 0.0 110.021 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.77 -29.99 19.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.753 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 9.6 tt0 -68.24 -42.87 79.08 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.256 -0.903 . . . . 0.0 109.312 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 81' ' ' SER . 3.2 pt-20 -52.87 -26.98 16.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.513 -0.742 . . . . 0.0 110.246 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.496 HG13 ' HG3' ' A' ' 84' ' ' GLU . 81.6 mt -79.15 -47.94 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.961 -1.087 . . . . 0.0 109.02 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -63.12 -30.54 71.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.361 -0.837 . . . . 0.0 108.804 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' OE1' ' OG1' ' B' ' 9' ' ' THR . 51.7 mt-10 -73.05 -49.48 28.42 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.74 ' HB2' HD13 ' B' ' 12' ' ' LEU . . . -57.14 -36.35 70.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.335 -0.853 . . . . 0.0 109.423 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 7.2 t80 -67.46 -43.99 79.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.937 . . . . 0.0 109.397 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -35.69 50.71 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.434 -0.791 . . . . 0.0 109.236 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.609 HG12 HG21 ' A' ' 108' ' ' VAL . 4.0 t -67.53 -41.52 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.744 ' CE1' HG11 ' A' ' 108' ' ' VAL . 28.5 m-85 -74.19 -33.21 63.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.958 . . . . 0.0 109.957 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.532 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -81.26 58.15 3.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.883 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -39.58 -62.82 0.64 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 110.492 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.2 p-10 -66.47 -38.61 87.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.327 -0.858 . . . . 0.0 110.284 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.66 52.47 3.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -99.15 -13.34 19.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.333 -1.098 . . . . 0.0 110.136 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 105.78 20.37 9.47 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 13.9 m-85 -158.35 157.4 32.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -1.083 . . . . 0.0 109.906 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 6.1 mt -120.02 135.28 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.075 -1.015 . . . . 0.0 110.448 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 p -121.06 154.01 36.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.64 -34.05 4.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.31 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.31 96.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.532 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 23.1 mt-10 -60.95 -47.52 86.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 110.065 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.832 HD12 HD11 ' A' ' 125' ' ' ILE . 1.1 mt -61.5 -35.66 78.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.279 -0.888 . . . . 0.0 109.495 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 109' ' ' MET . 8.2 ttp180 -55.94 -43.02 77.03 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.312 -0.868 . . . . 0.0 109.044 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.66 -57.8 11.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.475 -0.766 . . . . 0.0 109.724 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.744 HG11 ' CE1' ' A' ' 92' ' ' PHE . 2.5 t -60.64 -21.87 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.398 -0.814 . . . . 0.0 109.855 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 1.022 ' HA ' HD21 ' B' ' 17' ' ' LEU . 4.0 mtt -64.32 -65.01 0.73 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.294 -0.879 . . . . 0.0 110.921 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.0 m -63.97 -9.44 15.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 0.0 110.455 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -95.94 -1.57 48.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.107 -0.996 . . . . 0.0 110.782 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.846 ' CD1' HG12 ' B' ' 13' ' ' VAL . 11.9 mt -133.22 -0.19 3.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 111.8 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.97 -90.5 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.113 -1.518 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.419 ' HG2' HD12 ' A' ' 116' ' ' LEU . 1.4 pm0 -116.41 -176.85 3.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -1.063 . . . . 0.0 110.573 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -127.09 17.3 7.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.281 -0.887 . . . . 0.0 110.291 179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.9 HD23 ' HG2' ' A' ' 120' ' ' GLU . 4.7 mp 50.17 174.77 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.674 -0.642 . . . . 0.0 110.287 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -87.85 -166.29 1.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.989 . . . . 0.0 109.873 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.454 ' H ' HG22 ' A' ' 117' ' ' THR . 23.4 t70 -80.84 -51.96 8.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.827 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 2.1 mt-10 -61.08 -41.33 96.44 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.581 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.9 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.3 OUTLIER -62.2 -44.25 97.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.326 -0.859 . . . . 0.0 109.664 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 117' ' ' THR . 39.2 t -62.06 -46.32 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -66.07 -40.13 90.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.706 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 0.6 OUTLIER -64.52 -33.58 76.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.822 . . . . 0.0 109.548 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.606 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 3.0 ttt -64.85 -41.62 95.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.399 -0.813 . . . . 0.0 109.921 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.832 HD11 HD12 ' A' ' 105' ' ' LEU . 14.5 mm -84.45 -17.59 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.005 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -76.03 -39.42 55.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 110.064 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.527 ' N ' ' HD2' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -69.04 -23.5 64.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.455 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . -95.86 -24.68 16.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.17 -0.957 . . . . 0.0 110.703 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -72.24 80.6 0.99 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.084 -1.01 . . . . 0.0 110.679 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 mt -82.32 -20.65 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 0.0 109.552 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -94.46 -13.72 25.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.406 -0.809 . . . . 0.0 109.78 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.03 80.93 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -139.36 7.02 2.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.334 -1.098 . . . . 0.0 110.16 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 74.55 14.12 81.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 134' ' ' GLY . 0.9 OUTLIER -164.81 164.58 21.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.316 -1.108 . . . . 0.0 110.187 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 22.9 t -106.45 169.77 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.112 -0.992 . . . . 0.0 109.7 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.469 ' N ' HG12 ' A' ' 136' ' ' VAL . 25.6 t30 -128.34 179.64 5.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.155 -0.966 . . . . 0.0 110.351 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.577 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 9.1 t80 -62.54 -56.27 19.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.84 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -44.74 -60.36 2.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 110.123 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 137' ' ' ASN . 53.9 mt-10 -44.63 -46.33 10.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.4 t80 -58.26 -28.9 65.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 139' ' ' GLU . 9.4 t -100.41 -33.85 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -0.792 . . . . 0.0 110.705 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 2.8 tp60 -73.22 -9.43 58.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.05 -1.031 . . . . 0.0 110.595 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.465 ' O ' ' O ' ' B' ' 23' ' ' GLY . 30.0 mtp -106.55 -18.63 13.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 110.813 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' B' ' 23' ' ' GLY . 20.7 ttm -99.92 -54.51 2.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.127 -0.983 . . . . 0.0 110.637 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 146' ' ' THR . 10.2 t -155.89 90.19 1.2 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.229 -0.92 . . . . 0.0 110.444 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.24 53.66 0.66 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.281 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.27 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.701 ' O ' HG13 ' B' ' 1' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.197 0.522 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.44 ' HG2' ' C ' ' B' ' 1' ' ' VAL . 1.3 mtmt -131.41 153.65 49.48 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 110.373 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 44.8 mt -110.94 -68.69 0.91 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.476 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.696 HG23 ' HD2' ' B' ' 5' ' ' PRO . 33.6 mm -56.92 149.83 41.95 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.835 . . . . 0.0 109.371 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.696 ' HD2' HG23 ' B' ' 4' ' ' ILE . 39.5 Cg_endo -65.49 -172.47 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.578 1.304 . . . . 0.0 110.856 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.493 ' O ' ' N ' ' B' ' 8' ' ' THR . 57.0 p -119.76 60.54 0.85 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.059 -1.025 . . . . 0.0 111.394 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.626 ' CE2' HG21 ' A' ' 55' ' ' VAL . 1.0 OUTLIER 58.06 -82.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.039 -1.038 . . . . 0.0 110.864 178.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.671 HG23 ' HE1' ' A' ' 71' ' ' MET . 1.0 OUTLIER -46.14 -46.13 17.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.487 ' OG1' ' OE1' ' A' ' 87' ' ' GLU . 22.3 m -46.61 -35.79 6.26 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.227 -0.92 . . . . 0.0 109.914 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.21 -41.41 58.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.477 -0.765 . . . . 0.0 109.547 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.569 HD12 ' HG2' ' A' ' 72' ' ' MET . 12.5 mt -72.26 -20.19 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 109.637 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.74 HD13 ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -72.6 -59.96 2.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.369 -0.832 . . . . 0.0 109.735 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.846 HG12 ' CD1' ' A' ' 112' ' ' LEU . 43.4 t -56.02 -41.7 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.717 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.504 ' HG3' HD13 ' A' ' 18' ' ' LEU . 1.6 tmtm? -62.29 -43.97 97.61 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.88 -1.138 . . . . 0.0 109.568 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' B' ' 12' ' ' LEU . 14.5 m -53.0 -35.59 59.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.58 -0.7 . . . . 0.0 110.041 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.531 ' SD ' ' CD1' ' B' ' 22' ' ' PHE . 0.1 OUTLIER -70.67 -34.3 71.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.946 . . . . 0.0 109.951 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 1.022 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.5 mp -71.5 57.2 0.26 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.25 -0.906 . . . . 0.0 110.02 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -114.73 -86.28 0.6 Allowed 'General case' 0 C--N 1.278 -2.507 0 O-C-N 121.406 -0.809 . . . . 0.0 110.679 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' B' ' 20' ' ' ARG . 0.6 OUTLIER -153.77 94.9 1.82 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.791 -1.193 . . . . 0.0 110.53 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' B' ' 19' ' ' LYS . 10.3 tmm_? 64.67 7.0 3.52 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.437 -0.79 . . . . 0.0 110.407 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' B' ' 25' ' ' PRO . 0.1 OUTLIER -69.24 138.27 53.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.296 -0.877 . . . . 0.0 110.923 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.606 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -176.29 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 144' ' ' MET . . . -64.39 -80.87 0.13 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -142.05 75.27 20.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.092 -1.24 . . . . 0.0 110.406 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.482 ' HB3' ' OG ' ' B' ' 21' ' ' SER . 50.6 Cg_endo -79.66 11.7 2.64 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.053 1.554 . . . . 0.0 110.716 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.33 -179.71 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.202 0.525 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.32 106.91 14.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.947 . . . . 0.0 110.329 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -98.66 89.82 4.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.243 -0.911 . . . . 0.0 110.056 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 4' ' ' LEU . 12.4 mt -125.49 129.33 49.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 110.459 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.943 HG22 ' HG2' ' A' ' 7' ' ' GLU . 18.7 m -113.97 105.68 13.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.344 -0.848 . . . . 0.0 110.25 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 7' ' ' GLU . 13.0 pt-20 -65.18 -44.7 87.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.239 -0.913 . . . . 0.0 110.503 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.943 ' HG2' HG22 ' A' ' 5' ' ' THR . 6.9 pt-20 -45.98 -45.98 16.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.069 -1.02 . . . . 0.0 109.816 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.71 -53.98 52.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.819 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 mt -56.96 -46.75 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.838 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.69 -45.95 74.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.683 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -42.26 97.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 109.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -66.54 -43.61 84.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.712 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -60.21 -40.58 90.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.603 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 1.6 mm-40 -61.98 -43.41 98.9 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.219 -0.925 . . . . 0.0 109.556 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.71 -47.48 69.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.881 . . . . 0.0 109.836 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.543 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 75.0 t80 -63.45 -40.42 97.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.613 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.9 t -72.82 -28.04 62.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 0.0 109.52 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.635 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.1 tt -62.97 -41.06 99.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 109.657 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.795 ' HA ' HG21 ' A' ' 35' ' ' VAL . 27.0 m-85 -78.27 -10.88 59.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -0.793 . . . . 0.0 110.76 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 6.5 t0 -102.36 114.88 29.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.037 -1.039 . . . . 0.0 110.321 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.518 ' N ' ' OE2' ' A' ' 31' ' ' GLU . 5.3 tptp -97.52 29.24 3.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.261 -0.9 . . . . 0.0 110.524 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -153.68 -38.85 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.082 -1.011 . . . . 0.0 110.368 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 89.84 47.22 4.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -104.45 2.51 31.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.291 -1.123 . . . . 0.0 110.199 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.844 ' O ' HG23 ' A' ' 26' ' ' THR . . . 73.36 33.82 58.35 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -169.25 120.58 0.72 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.269 -1.136 . . . . 0.0 110.222 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.647 HD12 ' HB ' ' A' ' 63' ' ' ILE . 28.7 mt -97.56 124.47 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.172 -0.955 . . . . 0.0 110.189 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -84.68 -171.56 3.7 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.389 -0.819 . . . . 0.0 110.206 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.486 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -78.0 -34.09 50.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.882 . . . . 0.0 109.937 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -48.83 19.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.289 -0.882 . . . . 0.0 110.042 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 21' ' ' LYS . 43.2 tt0 -45.33 -59.76 2.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.91 . . . . 0.0 109.608 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.735 HD13 ' CH2' ' B' ' 7' ' ' TRP . 10.8 tp -60.76 -34.95 75.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.535 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.06 86.7 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.5 m -65.9 -51.07 61.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.344 -1.092 . . . . 0.0 109.543 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.795 HG21 ' HA ' ' A' ' 19' ' ' PHE . 48.9 t -52.54 -41.99 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.206 -0.934 . . . . 0.0 109.452 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.528 ' HE1' ' CE ' ' A' ' 51' ' ' MET . 4.8 mtt -64.74 -37.54 87.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.38 -0.825 . . . . 0.0 109.42 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -30.8 68.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.159 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.5 m -61.54 -34.01 74.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.9 . . . . 0.0 110.446 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mt -82.39 -3.11 54.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 110.224 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 86.57 86.07 1.07 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 0.8 OUTLIER -167.14 175.06 7.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -1.143 . . . . 0.0 110.143 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 11.7 p30 -139.63 84.31 15.96 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 0.0 110.291 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 44.0 Cg_endo -70.46 105.48 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.055 1.555 . . . . 0.0 110.496 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.449 ' HB ' ' OE2' ' A' ' 47' ' ' GLU . 8.9 m -61.18 150.82 33.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 110.058 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -49.43 -51.49 35.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.072 -1.018 . . . . 0.0 110.225 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.62 88.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.356 -0.84 . . . . 0.0 110.205 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -65.06 -50.98 64.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.0 110.211 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -50.33 -48.88 55.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -57.7 -36.81 72.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 5.5 m-20 -65.85 -46.98 76.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 109.949 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.57 ' HG3' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -67.93 -36.68 80.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.945 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 52' ' ' ILE . 5.5 mm -65.63 -26.66 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 109.732 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.39 -9.15 58.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.306 -0.871 . . . . 0.0 110.046 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -75.3 -22.53 57.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 110.124 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 57' ' ' ALA . 12.1 t -113.8 -48.42 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.187 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 55' ' ' VAL . 13.8 t0 -42.26 89.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.695 -0.628 . . . . 0.0 110.478 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -93.12 -9.56 39.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.404 -0.81 . . . . 0.0 110.637 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -78.24 -31.58 49.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.055 -1.028 . . . . 0.0 110.421 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.82 -16.28 18.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 3.5 p30 -77.58 -93.72 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.321 -1.105 . . . . 0.0 110.106 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 165.7 46.0 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.451 ' HB ' HG22 ' A' ' 26' ' ' THR . 2.8 p -143.28 141.8 31.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.289 -1.124 . . . . 0.0 110.204 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.647 ' HB ' HD12 ' A' ' 27' ' ' ILE . 11.9 mm -92.09 129.42 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.26 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.543 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 9.5 t0 -117.18 179.9 3.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.723 ' O ' HD12 ' A' ' 69' ' ' LEU . 17.1 t80 -67.15 -43.14 44.3 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 0.0 111.307 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.77 -35.54 7.45 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.348 1.183 . . . . 0.0 110.25 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.9 -28.44 67.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.107 -0.996 . . . . 0.0 109.141 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' HZ ' HD12 ' B' ' 11' ' ' ILE . 18.8 t80 -69.77 -53.24 19.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.602 -0.686 . . . . 0.0 110.317 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 65' ' ' PHE . 1.5 mt -67.89 -17.66 64.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.284 -0.885 . . . . 0.0 110.513 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 m -78.29 -42.52 30.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.125 -0.984 . . . . 0.0 110.617 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -72.66 -42.22 64.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.149 -0.97 . . . . 0.0 110.572 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 76' ' ' MET . 0.0 OUTLIER -64.2 -9.46 17.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.487 -0.758 . . . . 0.0 111.231 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.31 -19.27 17.14 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.012 -1.055 . . . . 0.0 111.379 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.63 -20.85 15.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.979 -1.076 . . . . 0.0 111.02 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER -99.45 29.39 4.04 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.009 -1.057 . . . . 0.0 110.5 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 72' ' ' MET . 2.6 mmt -100.67 -42.41 6.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.202 -0.937 . . . . 0.0 110.709 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -119.64 71.96 0.9 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.125 -0.984 . . . . 0.0 110.523 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.12 -84.85 0.55 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 0.0 109.96 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 81' ' ' SER . 48.1 m -161.5 -54.72 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.467 -0.771 . . . . 0.0 109.845 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -65.48 80.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.756 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' THR . 4.2 t -94.79 -37.85 11.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.354 -0.841 . . . . 0.0 110.275 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.57 -25.74 35.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.943 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.69 -15.61 59.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.888 . . . . 0.0 109.982 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.716 ' CG ' HD11 ' B' ' 12' ' ' LEU . 19.5 tt0 -81.83 -38.34 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 109.968 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.546 HG23 ' CE1' ' A' ' 141' ' ' PHE . 16.7 mt -67.49 -33.83 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.232 -0.917 . . . . 0.0 109.081 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -60.17 -27.19 66.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.563 -0.71 . . . . 0.0 109.091 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.512 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 1.2 mt-10 -74.76 -56.71 4.5 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.466 -0.771 . . . . 0.0 109.231 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.43 -28.85 67.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 109.567 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.439 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 15.9 t80 -69.65 -47.87 61.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.02 -1.05 . . . . 0.0 108.968 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 -47.53 -36.47 10.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.496 -0.752 . . . . 0.0 109.019 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.757 HG12 HG21 ' A' ' 108' ' ' VAL . 54.5 t -74.2 -33.56 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.535 -0.728 . . . . 0.0 110.285 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.563 ' CE2' HG22 ' B' ' 13' ' ' VAL . 16.1 m-85 -80.35 -31.29 37.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.128 -0.982 . . . . 0.0 110.287 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 96' ' ' GLY . 10.9 t0 -100.04 62.83 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.209 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -43.17 -33.01 0.82 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.78 -31.93 61.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.385 -0.822 . . . . 0.0 109.655 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 69.37 13.61 68.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 23.6 p-10 -69.45 -38.84 77.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -1.12 . . . . 0.0 110.324 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 139.19 -30.27 2.46 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 33.9 m-85 -107.29 156.78 18.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -1.127 . . . . 0.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' A' ' 92' ' ' PHE . 11.4 mt -124.13 145.52 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.897 . . . . 0.0 110.018 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -124.96 147.78 48.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.168 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.29 -31.1 0.93 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.665 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.79 -47.08 79.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.359 -0.838 . . . . 0.0 109.395 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 10.0 mt-10 -54.99 -50.07 69.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.199 -0.938 . . . . 0.0 109.261 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 109' ' ' MET . 1.6 mm? -57.39 -52.79 63.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.328 -0.857 . . . . 0.0 109.185 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -45.96 -26.67 0.75 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.421 -0.8 . . . . 0.0 109.453 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.551 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -80.89 -34.59 33.43 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.373 -0.829 . . . . 0.0 110.21 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.757 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -89.57 -27.55 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 109.946 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.949 ' HA ' HD21 ' B' ' 17' ' ' LEU . 2.4 mmm -63.5 -49.5 73.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 110.659 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 m -77.82 -17.24 57.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.0 110.58 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.551 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 18.6 m-20 -85.81 -3.39 58.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.089 -1.007 . . . . 0.0 109.968 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.893 ' CD1' HG12 ' B' ' 13' ' ' VAL . 5.4 mt -102.19 -42.75 5.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 110.426 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 162.67 -36.55 0.34 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.465 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.7 tp10 -109.7 147.0 33.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.991 -1.299 . . . . 0.0 110.828 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.514 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -119.93 74.68 1.04 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.547 -0.72 . . . . 0.0 109.282 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.634 HD23 ' O ' ' B' ' 19' ' ' LYS . 6.8 mp -38.46 160.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.687 -0.633 . . . . 0.0 110.709 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -60.69 -146.42 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.435 -0.791 . . . . 0.0 109.366 179.254 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.476 ' H ' HG22 ' A' ' 117' ' ' THR . 8.1 m-20 -122.3 -60.28 1.57 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.238 -0.914 . . . . 0.0 109.929 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.65 -35.65 63.72 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 9.7 mm-40 -67.31 -56.11 11.12 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.295 -0.878 . . . . 0.0 109.08 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.461 ' O ' ' HB3' ' A' ' 124' ' ' MET . 87.4 t -43.66 -36.36 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 121.361 -0.837 . . . . 0.0 109.606 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.51 -51.86 52.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -58.25 -32.49 68.41 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.403 -0.811 . . . . 0.0 109.113 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.518 ' HE3' ' O ' ' B' ' 21' ' ' SER . 11.0 ttt -59.49 -44.75 93.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.495 -0.753 . . . . 0.0 109.636 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.498 HG23 HG23 ' A' ' 136' ' ' VAL . 20.3 mm -71.72 -31.61 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 109.714 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 45.8 ttt85 -62.62 -42.76 99.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.98 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.9 -37.52 63.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.77 -25.83 27.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 0.0 110.142 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 134' ' ' GLY . 2.6 m-20 -57.64 99.54 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.859 . . . . 0.0 110.483 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 35.3 mm -74.79 -39.13 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.244 -0.91 . . . . 0.0 109.886 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 8.0 p-10 -90.4 -17.57 27.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.34 -0.85 . . . . 0.0 109.984 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.95 55.98 3.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 6.4 p30 -113.04 0.66 15.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.335 -1.097 . . . . 0.0 110.23 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.503 ' N ' ' OD2' ' A' ' 129' ' ' ASP . . . 76.16 8.53 85.3 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -142.66 147.46 35.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -1.181 . . . . 0.0 110.406 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.498 HG23 HG23 ' A' ' 125' ' ' ILE . 39.7 t -100.9 152.0 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.34 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.564 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 62.5 t30 -122.65 158.47 29.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -0.86 . . . . 0.0 110.12 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -45.8 -54.95 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.77 -41.02 56.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.301 -0.875 . . . . 0.0 109.916 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 144' ' ' MET . 9.2 mt-10 -70.87 -47.31 59.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.0 110.021 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.546 ' CE1' HG23 ' A' ' 85' ' ' ILE . 47.5 t80 -60.79 -17.95 52.38 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.299 -0.875 . . . . 0.0 109.968 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.43 ' O ' HG22 ' A' ' 146' ' ' THR . 46.9 t -100.19 -47.75 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.456 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.912 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 17.7 tp60 -61.89 -26.86 68.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.172 -0.955 . . . . 0.0 110.23 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 17.8 mmm -82.62 -18.32 41.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.551 ' CE ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -99.33 -56.86 2.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 146' ' ' THR . 6.8 t -105.1 63.48 0.7 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.226 -0.921 . . . . 0.0 110.274 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.912 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -96.15 30.32 2.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.218 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 147' ' ' ALA . 1.9 tptp . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.151 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.656 ' O ' HG13 ' B' ' 1' ' ' VAL . 14.7 p . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.626 ' C ' HD12 ' B' ' 3' ' ' LEU . 9.5 ttpt -141.0 140.56 34.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.873 . . . . 0.0 110.238 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.626 HD12 ' C ' ' B' ' 2' ' ' LYS . 5.1 mp -145.59 -48.54 0.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.972 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.57 HD12 ' HG3' ' A' ' 51' ' ' MET . 11.0 pt -43.17 155.29 0.29 Allowed Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.281 -0.887 . . . . 0.0 110.746 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.36 153.16 50.35 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.09 1.574 . . . . 0.0 110.013 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.501 ' O ' ' HB ' ' B' ' 9' ' ' THR . 8.6 m -71.19 142.05 50.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.944 ' O ' HG22 ' B' ' 10' ' ' VAL . 6.8 m95 -36.29 -66.01 0.24 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.764 0.793 . . . . 0.0 110.555 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.536 HG21 ' HG2' ' A' ' 75' ' ' LYS . 10.8 p -45.38 -23.65 0.22 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.464 -0.773 . . . . 0.0 111.043 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.512 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 91.5 m -70.41 -56.65 6.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.886 -1.134 . . . . 0.0 109.87 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.944 HG22 ' O ' ' B' ' 7' ' ' TRP . 32.7 m -53.16 -27.4 13.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.281 -0.887 . . . . 0.0 109.193 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.501 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 26.0 mm -75.46 -30.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.447 -0.783 . . . . 0.0 109.61 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.716 HD11 ' CG ' ' A' ' 84' ' ' GLU . 9.9 mt -65.91 -60.47 2.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 110.034 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.893 HG12 ' CD1' ' A' ' 112' ' ' LEU . 41.1 t -52.95 -39.01 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.626 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -64.74 -47.62 77.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.963 -1.085 . . . . 0.0 109.226 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.417 ' HB2' HD22 ' B' ' 24' ' ' ASN . 50.2 m -50.97 -31.27 17.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.403 -0.811 . . . . 0.0 109.738 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mmt -79.87 -27.18 40.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.354 -0.841 . . . . 0.0 109.956 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.949 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.9 mp -80.04 54.47 1.92 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.344 -0.848 . . . . 0.0 109.88 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -72.58 0.57 Allowed 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.679 -0.638 . . . . 0.0 110.355 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.634 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -150.3 -60.28 0.19 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.944 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.561 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -156.64 17.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 110.208 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.518 ' O ' ' HE3' ' A' ' 124' ' ' MET . 0.3 OUTLIER -93.04 -162.1 0.9 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.217 -0.927 . . . . 0.0 110.42 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.445 ' CE2' ' HE2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -174.21 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.231 -0.918 . . . . 0.0 110.523 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.09 -155.76 22.69 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.551 ' CB ' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -178.96 117.07 0.23 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 110.206 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.04 52.61 3.5 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.935 1.492 . . . . 0.0 110.397 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.456 ' CD2' ' HE2' ' A' ' 76' ' ' MET . 4.8 m-85 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.251 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.263 0.554 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.44 168.33 19.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.208 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.16 132.97 45.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -0.891 . . . . 0.0 110.37 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mt -77.94 122.57 25.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.263 -0.898 . . . . 0.0 110.177 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 47.84 85.95 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.214 -0.929 . . . . 0.0 110.251 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -100.31 -24.16 14.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.307 -0.871 . . . . 0.0 110.237 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 8' ' ' GLN . 7.0 pt-20 -58.03 -34.6 70.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 109.953 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.536 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -70.2 -34.87 73.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.246 -0.908 . . . . 0.0 109.36 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 98.5 mt -75.2 -34.98 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.366 -0.834 . . . . 0.0 109.712 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.22 -62.46 1.85 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 109.654 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 12' ' ' PHE . 11.4 pt-20 -56.94 -38.23 72.63 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.162 -0.961 . . . . 0.0 109.058 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.688 ' CD2' ' CZ ' ' A' ' 68' ' ' PHE . 1.8 m-85 -57.91 -45.66 86.14 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.358 -0.839 . . . . 0.0 109.019 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -41.33 66.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 109.18 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -53.36 -49.21 67.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.713 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' B' ' 14' ' ' LYS . . . -59.28 -52.85 63.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 109.783 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 2.3 t80 -60.59 -35.6 76.49 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.614 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -67.06 -28.22 68.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.509 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.844 HD11 ' O ' ' A' ' 112' ' ' LEU . 8.4 tt -68.7 -41.81 78.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.499 -0.751 . . . . 0.0 109.881 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -74.28 -57.88 3.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -64.97 129.93 41.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.375 -0.828 . . . . 0.0 110.54 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.78 -48.5 5.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.246 -0.909 . . . . 0.0 110.157 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.2 p-10 -75.04 -35.05 61.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.78 42.34 5.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 34.8 p-10 -90.76 -28.12 18.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -1.156 . . . . 0.0 110.057 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.712 ' O ' HG23 ' A' ' 26' ' ' THR . . . 112.74 31.0 2.64 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 25' ' ' GLY . 11.1 p -159.73 125.24 4.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -1.135 . . . . 0.0 110.533 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.699 HD12 ' HB ' ' A' ' 63' ' ' ILE . 17.9 mt -91.97 119.22 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.21 -0.931 . . . . 0.0 109.999 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.6 p -100.17 172.91 6.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.92 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.6 p -64.43 -18.24 64.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.13 -0.981 . . . . 0.0 109.899 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -49.76 17.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.395 -0.816 . . . . 0.0 110.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.64 ' O ' HG23 ' A' ' 35' ' ' VAL . 20.9 mt-10 -67.21 -50.37 61.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 110.365 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.737 HD22 ' CD1' ' A' ' 52' ' ' ILE . 13.1 tp -59.75 -51.47 69.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.287 -0.883 . . . . 0.0 110.347 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.14 -49.35 24.68 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.8 m -56.26 -47.4 78.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.229 -1.159 . . . . 0.0 110.576 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 31' ' ' GLU . 11.4 t -62.77 -45.26 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 0.0 110.293 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.538 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 16.2 mmm -64.24 -39.64 94.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 110.405 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -15.91 61.55 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.099 -1.001 . . . . 0.0 110.237 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 39' ' ' LEU . 32.2 t -75.0 -46.05 37.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 111.058 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 38' ' ' SER . 1.9 mt -45.76 -27.31 0.8 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.914 -1.116 . . . . 0.0 109.823 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.93 -32.34 2.9 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.08 -178.59 2.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.135 -1.215 . . . . 0.0 110.684 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -131.07 93.88 29.35 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.252 -0.905 . . . . 0.0 110.317 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.579 ' HB3' HD13 ' B' ' 4' ' ' ILE . 45.4 Cg_endo -73.16 115.97 4.54 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.004 1.529 . . . . 0.0 110.302 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.23 164.94 23.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 110.239 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 42.9 mt-10 -61.07 -42.23 98.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.276 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.12 74.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.208 -0.933 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 51' ' ' MET . 4.6 mm-40 -66.65 -32.92 74.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 110.042 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.491 ' HA ' HD23 ' A' ' 48' ' ' LEU . 13.0 mt -60.37 -52.16 66.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 0.0 110.123 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -62.91 -42.39 99.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 110.107 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.89 -15.41 63.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 110.012 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.509 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 1.2 mtp -86.9 -42.94 12.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.14 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.737 ' CD1' HD22 ' A' ' 32' ' ' LEU . 1.1 mp -80.27 -11.15 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.078 -1.014 . . . . 0.0 109.731 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -83.43 -18.58 38.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 110.856 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.6 ' HG3' HG23 ' A' ' 55' ' ' VAL . 21.8 pt-20 -94.48 -18.93 21.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.036 -1.04 . . . . 0.0 110.988 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.685 HG21 ' CD1' ' B' ' 7' ' ' TRP . 50.6 t -99.1 -31.57 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.95 -1.094 . . . . 0.0 110.061 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -47.16 89.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.539 -0.726 . . . . 0.0 110.539 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.12 -49.63 71.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.451 -0.781 . . . . 0.0 110.172 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 14.8 p-10 -75.69 -37.91 59.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 110.063 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.42 45.78 2.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 36.0 p-10 -98.5 -38.72 9.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.274 -1.133 . . . . 0.0 110.141 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 127.6 -8.09 6.95 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p -135.79 148.52 48.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -1.167 . . . . 0.0 110.189 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.699 ' HB ' HD12 ' A' ' 27' ' ' ILE . 31.8 mm -82.14 140.06 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.122 -0.986 . . . . 0.0 109.91 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.45 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -114.46 157.66 22.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.066 -1.021 . . . . 0.0 110.797 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.598 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 52.8 t80 -48.9 -50.34 62.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.443 -0.786 . . . . 0.0 111.187 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.9 Cg_endo -64.39 -32.27 60.87 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.258 1.136 . . . . 0.0 110.344 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 71' ' ' MET . 7.1 tt0 -59.97 -35.46 75.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.124 -0.985 . . . . 0.0 109.291 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.688 ' CZ ' ' CD2' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -76.98 -48.78 17.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.1 mm? -43.09 -45.28 5.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 110.625 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.31 -37.44 14.91 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.073 -1.017 . . . . 0.0 110.762 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -44.04 -38.91 3.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.191 -0.943 . . . . 0.0 110.72 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.655 ' HE2' ' CE1' ' B' ' 26' ' ' PHE . 5.7 tpt -74.65 -9.76 58.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.136 -0.977 . . . . 0.0 110.542 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.4 -10.83 19.88 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.248 -0.908 . . . . 0.0 110.579 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -99.61 -49.64 4.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.067 -1.021 . . . . 0.0 110.407 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.686 ' CB ' HG21 ' B' ' 8' ' ' THR . 20.2 mmtt -46.45 -36.88 7.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.504 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.5 mtm -94.07 58.57 2.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.23 -0.919 . . . . 0.0 110.473 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 42.8 tttm -154.67 81.89 1.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 110.128 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER 66.94 54.18 0.79 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 110.252 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ASP . 4.3 m -165.31 -68.75 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.204 -0.935 . . . . 0.0 110.411 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.491 ' HB3' ' CG ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -129.03 93.71 3.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.172 -0.955 . . . . 0.0 110.33 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.7 t -100.64 -54.73 2.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.204 -0.935 . . . . 0.0 110.365 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.59 -9.82 21.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 0.0 110.763 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -79.66 -17.04 54.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.044 -1.035 . . . . 0.0 110.409 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 16.0 mt-10 -81.26 -22.71 38.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.026 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.465 HG23 ' HE1' ' A' ' 141' ' ' PHE . 59.8 mt -79.09 -44.14 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.859 . . . . 0.0 110.039 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.474 ' CD ' ' OH ' ' A' ' 138' ' ' TYR . 5.4 ttp180 -55.55 -34.94 65.16 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.529 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 1.061 ' HB3' HG21 ' B' ' 9' ' ' THR . 14.1 mt-10 -71.16 -47.55 57.02 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.437 -0.789 . . . . 0.0 109.893 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.55 ' HB2' HD22 ' B' ' 12' ' ' LEU . . . -64.92 -29.05 69.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.041 -1.037 . . . . 0.0 109.828 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.01 -39.37 83.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 109.511 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -67.44 -37.95 83.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.39 -0.819 . . . . 0.0 109.503 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.635 HG12 HG21 ' A' ' 108' ' ' VAL . 11.7 t -58.51 -44.62 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.414 -0.804 . . . . 0.0 109.704 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.42 ' CE1' HG11 ' A' ' 108' ' ' VAL . 20.4 m-85 -66.47 -30.58 70.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.613 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 94' ' ' LYS . 11.6 t0 -91.42 58.47 3.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.406 -0.809 . . . . 0.0 110.092 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 93' ' ' ASP . 2.3 mmmm -43.46 -32.3 0.86 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -0.962 . . . . 0.0 110.142 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.0 p30 -83.44 -34.13 25.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.181 -0.949 . . . . 0.0 110.109 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 81.39 42.41 9.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 38.2 p30 -100.07 -17.72 17.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -1.197 . . . . 0.0 110.167 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 102.59 27.96 6.53 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 94.4 m-85 -156.95 146.65 20.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -1.08 . . . . 0.0 110.004 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 80.3 mt -119.74 111.98 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.16 -0.963 . . . . 0.0 110.411 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 37.4 t -95.89 149.18 21.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.22 -31.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.168 -0.958 . . . . 0.0 109.947 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.56 -51.62 64.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.855 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 93' ' ' ASP . 28.3 mt-10 -53.39 -38.89 63.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.67 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.997 HD12 HD11 ' A' ' 125' ' ' ILE . 1.2 mt -59.85 -44.57 94.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.376 -0.827 . . . . 0.0 109.711 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.518 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.0 OUTLIER -65.8 -20.78 66.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 109.619 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -81.77 -32.56 31.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.422 -0.799 . . . . 0.0 109.847 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.635 HG21 HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -83.17 -34.14 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.93 . . . . 0.0 109.789 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.902 ' HA ' HD21 ' B' ' 17' ' ' LEU . 11.2 ptp -79.42 -35.85 39.93 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.155 -0.965 . . . . 0.0 109.561 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.476 ' N ' ' HG3' ' A' ' 109' ' ' MET . 19.6 m -68.97 -30.52 68.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 108.802 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -85.91 -19.53 30.38 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.433 -0.792 . . . . 0.0 108.97 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.844 ' O ' HD11 ' A' ' 18' ' ' LEU . 9.5 mt -84.46 -32.38 24.06 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.535 -0.728 . . . . 0.0 110.122 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.98 -39.87 1.51 Allowed Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.495 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 109' ' ' MET . 2.1 tt0 -94.23 157.59 15.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.995 -1.297 . . . . 0.0 110.709 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 116' ' ' LEU . 1.8 pttt -135.86 73.21 1.46 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.565 -0.709 . . . . 0.0 109.205 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.651 HD21 ' O ' ' B' ' 17' ' ' LEU . 3.3 mp -38.79 145.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.593 -0.692 . . . . 0.0 110.794 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -56.47 -156.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 110.387 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -97.75 -48.82 5.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.224 -0.922 . . . . 0.0 110.149 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.31 -33.05 75.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.047 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.524 ' CG ' ' HB3' ' B' ' 20' ' ' ARG . 2.5 tt0 -66.16 -47.25 74.64 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.61 0.719 . . . . 0.0 109.33 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 116' ' ' LEU . 19.0 t -65.0 -42.15 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.519 -0.738 . . . . 0.0 110.387 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -62.99 -65.14 0.73 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.952 . . . . 0.0 109.827 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 122' ' ' ASP . 2.0 mm-40 -44.42 -30.19 0.81 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.381 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.544 ' HE2' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -62.91 -61.75 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 110.205 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.997 HD11 HD12 ' A' ' 105' ' ' LEU . 30.3 mm -59.55 -39.02 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 127' ' ' GLU . 2.8 mtt180 -60.09 -53.2 60.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.859 . . . . 0.0 110.355 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -43.3 -32.65 0.83 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.94 -26.93 13.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 110.146 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.3 OUTLIER -71.49 64.65 0.43 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.3 -0.875 . . . . 0.0 110.352 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.8 mt -63.15 -32.01 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 21.0 p-10 -77.01 -28.83 55.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.248 -0.907 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.85 64.74 1.99 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 20.4 p-10 -114.43 -23.0 9.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -1.135 . . . . 0.0 110.185 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 115.5 -6.7 20.67 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 99' ' ' TYR . 3.3 pt20 -158.38 163.17 37.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.29 -1.124 . . . . 0.0 110.022 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 137' ' ' ASN . 61.6 t -90.76 168.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.192 -0.942 . . . . 0.0 110.649 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.524 ' N ' HG12 ' A' ' 136' ' ' VAL . 15.4 t-20 -133.06 177.35 7.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.481 -0.762 . . . . 0.0 109.976 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.474 ' OH ' ' CD ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -56.05 -69.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.152 -0.967 . . . . 0.0 110.771 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 17.2 pt-20 -43.36 -39.08 2.99 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.146 -0.971 . . . . 0.0 110.692 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 139' ' ' GLU . 57.6 mt-10 -66.5 -60.21 2.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.168 -0.957 . . . . 0.0 110.211 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.465 ' HE1' HG23 ' A' ' 85' ' ' ILE . 26.6 t80 -46.98 -22.23 0.3 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.231 -0.918 . . . . 0.0 110.35 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.29 -44.01 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.753 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -56.44 -18.19 10.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.179 -0.95 . . . . 0.0 110.631 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.2 mmm -112.58 -10.15 13.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.151 -0.968 . . . . 0.0 110.263 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.451 ' HG2' HG12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -98.17 -9.58 25.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 110.211 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p -90.95 -55.23 3.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.259 -0.901 . . . . 0.0 110.35 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 148' ' ' LYS . . . -90.18 57.49 3.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.37 -0.831 . . . . 0.0 110.341 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.259 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.601 HG23 ' HG2' ' B' ' 2' ' ' LYS . 3.1 m . . . . . 0 N--CA 1.5 2.053 0 CA-C-O 121.01 0.433 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.601 ' HG2' HG23 ' B' ' 1' ' ' VAL . 0.0 OUTLIER -146.68 31.17 0.97 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.947 -1.095 . . . . 0.0 110.237 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' B' ' 4' ' ' ILE . 0.3 OUTLIER -113.96 -6.27 13.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.844 . . . . 0.0 109.467 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.597 ' CG1' ' HD2' ' B' ' 5' ' ' PRO . 1.0 OUTLIER -38.92 156.0 0.13 Allowed Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.592 -0.693 . . . . 0.0 109.933 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.597 ' HD2' ' CG1' ' B' ' 4' ' ' ILE . 38.1 Cg_endo -64.24 151.55 84.95 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.528 1.278 . . . . 0.0 110.473 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.444 ' O ' ' CE ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -74.65 -52.36 11.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.482 -0.761 . . . . 0.0 111.759 -178.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.685 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -172.04 -76.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.82 -1.175 . . . . 0.0 110.754 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.686 HG21 ' CB ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -46.11 -48.06 17.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 0.0 109.677 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 9' ' ' THR . . . . . 1.061 HG21 ' HB3' ' A' ' 87' ' ' GLU . 4.8 m -44.65 -51.65 8.94 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.391 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.415 HG21 ' HE1' ' A' ' 36' ' ' MET . 35.2 t -51.36 -43.08 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.263 -0.898 . . . . 0.0 108.958 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.504 HG21 ' SD ' ' A' ' 72' ' ' MET . 15.5 mm -66.36 -27.5 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.139 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -63.9 -58.71 5.94 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.623 -0.673 . . . . 0.0 109.964 179.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.868 ' O ' HD13 ' B' ' 17' ' ' LEU . 54.3 t -60.39 -39.22 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.936 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.641 ' CG ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -62.12 -61.29 2.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.087 -1.008 . . . . 0.0 109.722 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 74.5 m -60.74 -18.88 57.3 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.43 -0.794 . . . . 0.0 109.875 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.514 ' O ' ' CG ' ' B' ' 19' ' ' LYS . 6.2 ttt -80.1 -18.45 49.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.902 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.2 mp -73.76 -50.32 21.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.248 -0.907 . . . . 0.0 110.58 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.462 ' O ' ' CG ' ' B' ' 18' ' ' ARG . 0.6 OUTLIER -65.44 60.21 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.605 -0.684 . . . . 0.0 110.4 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' B' ' 16' ' ' MET . 0.0 OUTLIER -179.98 120.54 0.06 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.524 ' HB3' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -73.01 20.53 0.08 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.662 -0.649 . . . . 0.0 112.086 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.544 ' O ' ' HE2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -128.64 175.67 8.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.934 -1.104 . . . . 0.0 109.76 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.425 ' CD1' ' HE2' ' A' ' 124' ' ' MET . 0.6 OUTLIER -112.12 177.88 4.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.023 -1.048 . . . . 0.0 110.069 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.52 140.73 0.06 OUTLIER Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.463 ' HB3' ' CD2' ' B' ' 26' ' ' PHE . 0.7 OUTLIER -121.88 140.15 31.51 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.26 . . . . 0.0 110.948 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.25 55.99 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.046 1.551 . . . . 0.0 109.655 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.655 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 1.4 m-85 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.286 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.212 0.53 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 18.4 p-10 -115.84 43.9 2.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.245 -0.909 . . . . 0.0 110.27 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -99.97 66.52 1.36 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.285 -0.884 . . . . 0.0 110.078 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 57.2 mt -142.44 109.97 5.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.952 . . . . 0.0 110.218 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.17 -160.54 0.74 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.306 -0.872 . . . . 0.0 110.198 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -73.66 -21.9 60.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.15 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.618 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -66.43 -68.83 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.056 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -45.23 -54.1 7.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 109.67 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.1 mt -50.93 -42.34 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.202 -0.937 . . . . 0.0 109.381 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -50.6 -45.32 57.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.358 -0.839 . . . . 0.0 109.266 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -57.3 -48.47 78.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.33 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -53.86 -46.24 71.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.307 -0.871 . . . . 0.0 109.379 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -57.81 -46.37 84.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.883 . . . . 0.0 109.289 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -60.09 -44.9 94.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.3 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -60.76 -45.17 95.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.383 -0.823 . . . . 0.0 109.557 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.515 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 7.2 t80 -62.97 -22.27 66.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.942 . . . . 0.0 109.074 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.51 -47.68 9.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.522 -0.736 . . . . 0.0 109.588 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.858 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.2 tt -47.66 -41.12 21.61 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.321 -0.862 . . . . 0.0 109.504 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 41.0 m-85 -79.89 -46.16 17.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.884 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.503 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 39.5 t0 -80.46 101.94 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.451 -0.78 . . . . 0.0 110.154 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 4.32 51.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.29 -0.881 . . . . 0.0 110.431 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -97.08 -37.8 10.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.149 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.33 27.95 10.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 10.3 p30 -102.67 -17.03 15.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -1.169 . . . . 0.0 110.195 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 91.07 22.55 32.37 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 14.1 p -138.3 122.72 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.216 -1.167 . . . . 0.0 110.468 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.5 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 13.4 mt -89.3 114.63 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.124 -0.985 . . . . 0.0 110.137 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -93.46 155.73 17.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.714 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.567 ' O ' HD13 ' A' ' 48' ' ' LEU . 32.0 p -54.9 -22.71 15.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 110.039 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -43.62 63.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.88 . . . . 0.0 109.972 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.503 ' OE2' ' HA ' ' A' ' 20' ' ' ASP . 17.0 mt-10 -64.5 -56.68 12.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 0.0 110.093 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.859 HD23 ' CD2' ' A' ' 48' ' ' LEU . 11.5 tp -54.54 -36.37 64.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 109.858 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.28 -40.91 99.62 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 m -58.49 -53.07 62.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -1.119 . . . . 0.0 109.819 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 35' ' ' VAL . 12.0 t -56.93 -53.9 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.603 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.504 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -50.76 -41.01 56.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 109.736 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 2.1 mtm180 -62.91 -27.81 69.62 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 0.0 109.886 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -79.41 -59.54 2.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.821 . . . . 0.0 110.933 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mt -44.04 -37.54 3.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.131 -0.981 . . . . 0.0 110.082 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.08 64.85 0.16 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.539 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -144.82 -168.23 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -1.178 . . . . 0.0 110.119 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 2.5 m120 -155.1 57.75 1.75 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.062 -1.024 . . . . 0.0 110.578 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 50.1 Cg_endo -80.35 135.73 10.86 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.907 1.477 . . . . 0.0 110.061 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 45' ' ' GLU . 5.1 m -97.26 163.36 12.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.206 -0.933 . . . . 0.0 110.067 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.2 mt-10 -43.05 -54.92 4.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 109.997 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.56 -55.43 33.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 110.043 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HG3' ' HB ' ' A' ' 44' ' ' THR . 21.3 mt-10 -47.46 -44.46 25.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 109.72 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.859 ' CD2' HD23 ' A' ' 32' ' ' LEU . 15.1 mt -55.8 -43.44 76.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.358 -0.839 . . . . 0.0 109.912 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' OE1' HG21 ' A' ' 29' ' ' THR . 5.6 tp60 -54.9 -41.42 70.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.441 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.06 -42.94 91.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.447 -0.783 . . . . 0.0 109.648 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.569 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.3 OUTLIER -74.95 -49.44 20.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 109.765 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.481 HG22 ' HB2' ' A' ' 56' ' ' ASP . 7.3 mm -52.4 -25.2 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.624 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -30.59 67.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.345 -0.847 . . . . 0.0 110.185 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 1.3 mp0 -70.24 -25.63 63.47 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.832 HG22 ' SD ' ' A' ' 71' ' ' MET . 5.6 t -108.07 -28.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 52' ' ' ILE . 19.2 t0 -63.85 72.17 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.312 -0.867 . . . . 0.0 110.323 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -68.65 -35.69 77.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 110.415 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 24.3 p30 -82.44 -20.15 37.56 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.141 -0.975 . . . . 0.0 110.489 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 81.07 26.49 52.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.523 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 31.8 p-10 -89.66 -30.44 18.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -1.179 . . . . 0.0 110.09 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 113.92 -24.23 12.1 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.523 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 80.7 p -112.65 157.27 21.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -1.215 . . . . 0.0 110.393 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.581 HD12 ' CG1' ' A' ' 55' ' ' VAL . 10.2 mm -95.72 144.28 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 110.144 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 75.8 m-20 -110.67 160.68 16.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 109.975 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 33.0 t80 -52.4 -47.73 92.11 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.289 -0.882 . . . . 0.0 111.271 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -69.42 -41.82 4.34 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.203 1.107 . . . . 0.0 110.163 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 2.9 tt0 -55.6 -45.15 77.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 110.114 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.423 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 16.3 t80 -61.0 -47.35 86.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 110.118 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 65' ' ' PHE . 85.4 mt -57.41 -23.05 47.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.232 -0.917 . . . . 0.0 110.156 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.3 m -90.1 -21.7 22.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.258 -0.901 . . . . 0.0 111.012 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.832 ' SD ' HG22 ' A' ' 55' ' ' VAL . 3.1 ttp -75.48 -45.37 38.82 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.959 -1.088 . . . . 0.0 109.905 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.594 ' HE1' ' HE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -53.91 -17.27 2.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.39 -0.819 . . . . 0.0 110.907 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.02 -11.69 15.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.936 -1.102 . . . . 0.0 111.324 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -96.53 -36.23 10.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.817 -1.177 . . . . 0.0 110.678 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.709 ' HB3' HG21 ' B' ' 8' ' ' THR . 8.9 tttp -91.69 25.94 2.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.239 -0.913 . . . . 0.0 110.535 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.56 ' HE1' ' CD2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -100.27 -32.64 10.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.035 . . . . 0.0 110.453 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -134.44 72.71 1.47 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.237 -0.914 . . . . 0.0 110.176 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER 168.82 104.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.259 -0.901 . . . . 0.0 110.024 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 3.9 m 68.93 104.62 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.429 -0.795 . . . . 0.0 110.261 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 79' ' ' THR . 1.5 t70 71.74 74.02 0.17 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.458 -0.776 . . . . 0.0 110.552 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.4 m -107.06 -46.83 3.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.855 . . . . 0.0 109.738 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -90.48 -34.34 15.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.873 . . . . 0.0 109.513 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.31 -24.64 67.72 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 25.3 tt0 -55.57 -36.92 67.37 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.509 -0.745 . . . . 0.0 109.605 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.661 HG23 ' SD ' ' A' ' 145' ' ' MET . 78.1 mt -70.4 -44.96 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.269 -0.895 . . . . 0.0 109.025 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -54.98 -28.71 53.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.484 -0.76 . . . . 0.0 109.132 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 4.2 mt-10 -69.61 -58.9 3.37 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.471 -0.768 . . . . 0.0 109.445 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.35 -31.39 54.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 0.0 109.247 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 17.1 t80 -63.72 -45.05 91.7 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -60.82 -34.89 75.23 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.778 ' CG1' HG21 ' B' ' 13' ' ' VAL . 24.7 t -71.49 -42.1 72.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.584 ' CE2' HG22 ' B' ' 13' ' ' VAL . 9.6 m-85 -72.25 -34.57 68.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 108.76 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 96' ' ' GLY . 14.5 t0 -95.24 61.28 2.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.56 -0.713 . . . . 0.0 109.791 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.538 ' HA ' ' CE ' ' A' ' 94' ' ' LYS . 2.1 mmpt? -43.36 -28.02 0.3 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.16 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' OD2' ' CG ' ' A' ' 97' ' ' ASN . 49.7 t0 -67.89 -41.31 82.93 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 73.11 -0.17 48.53 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.421 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 28.5 p-10 -73.01 -24.07 60.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.117 -1.225 . . . . 0.0 110.117 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.463 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 115.21 35.44 1.33 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 0.4 OUTLIER -158.51 105.38 1.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.257 -1.143 . . . . 0.0 110.231 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 92' ' ' PHE . 7.2 mt -81.37 135.47 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.248 -0.907 . . . . 0.0 110.026 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -129.29 148.84 51.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.01 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.87 -30.95 1.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 109.848 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.5 79.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.599 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -61.57 -43.64 98.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.386 -0.821 . . . . 0.0 109.953 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.053 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -59.76 -42.64 93.71 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.323 -0.86 . . . . 0.0 109.363 179.525 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -36.88 74.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.799 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.59 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -65.15 -44.39 88.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.823 . . . . 0.0 109.843 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.481 HG21 HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -74.0 -33.62 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.803 . . . . 0.0 109.417 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.52 ' SD ' HD21 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -60.82 -65.61 0.66 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 110.174 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m -51.92 -32.84 34.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.116 -0.99 . . . . 0.0 109.507 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 63.8 m-20 -77.68 -20.65 53.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 109.547 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.861 HD11 HG12 ' B' ' 13' ' ' VAL . 2.5 mt -85.05 -40.41 16.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.511 -0.743 . . . . 0.0 110.168 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.26 -47.39 0.55 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.656 ' HG2' HD12 ' A' ' 116' ' ' LEU . 31.1 tt0 -94.0 165.18 12.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.143 -1.21 . . . . 0.0 111.043 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' LEU . 4.0 ptpp? -140.67 62.82 1.48 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.503 -0.748 . . . . 0.0 109.358 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.882 HD21 ' HA ' ' B' ' 19' ' ' LYS . 1.6 mp -38.34 140.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.696 -0.628 . . . . 0.0 110.467 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.662 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -50.85 -173.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.37 -0.831 . . . . 0.0 110.478 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 119' ' ' GLU . 20.1 t70 -86.34 -62.32 1.54 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.026 -1.046 . . . . 0.0 110.361 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.555 ' HA ' ' OD2' ' A' ' 122' ' ' ASP . 3.2 tt0 -44.11 -49.61 8.86 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 109.916 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.95 -55.33 36.0 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 117' ' ' THR . 46.3 t -49.52 -43.6 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.556 -0.715 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.555 ' OD2' ' HA ' ' A' ' 119' ' ' GLU . 9.4 p30 -68.75 -22.53 64.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.757 -1.214 . . . . 0.0 109.966 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 40.1 mm-40 -80.56 -27.82 37.4 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.351 -0.843 . . . . 0.0 108.867 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -43.6 79.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.594 -0.691 . . . . 0.0 109.419 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.053 HD11 ' CD1' ' A' ' 105' ' ' LEU . 41.5 mm -67.66 -43.49 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.0 109.691 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.471 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.7 mmm-85 -56.98 -39.43 74.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -59.45 -28.59 67.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.355 -0.841 . . . . 0.0 109.996 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB2' ' HD2' ' B' ' 22' ' ' PHE . . . -99.25 -18.25 17.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.378 -0.827 . . . . 0.0 110.022 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 126' ' ' ARG . 1.2 m-20 -59.12 98.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.244 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 mm -67.38 -44.61 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.325 -0.859 . . . . 0.0 110.049 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 19.2 p-10 -90.07 -19.2 24.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 110.093 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 79.23 64.08 1.97 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.514 ' OD2' ' NE2' ' A' ' 135' ' ' GLN . 31.1 p-10 -116.04 -34.73 4.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -1.155 . . . . 0.0 110.143 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 118.34 19.5 4.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.514 ' NE2' ' OD2' ' A' ' 133' ' ' ASP . 3.9 pp0? -160.21 159.01 31.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.173 -1.192 . . . . 0.0 110.434 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 87.2 t -114.9 108.59 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -80.69 -173.25 4.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.212 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.429 ' O ' ' C ' ' A' ' 139' ' ' GLU . 25.5 t80 -67.66 -67.18 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 110.311 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 138' ' ' TYR . 2.3 tt0 -42.85 -27.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.772 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 144' ' ' MET . 1.6 tt0 -80.94 -53.15 6.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 110.356 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 69.5 t80 -58.26 -18.31 25.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 66.5 t -99.75 -62.67 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.345 -0.847 . . . . 0.0 110.568 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -52.53 -18.96 1.95 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.254 -0.904 . . . . 0.0 110.489 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.484 ' HB3' ' O ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -97.81 -20.94 17.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.128 -0.983 . . . . 0.0 110.165 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.661 ' SD ' HG23 ' A' ' 85' ' ' ILE . 8.2 ttm -100.78 -26.37 13.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.355 -0.841 . . . . 0.0 110.746 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 146' ' ' THR . 4.7 t -164.04 92.62 0.68 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.907 -1.121 . . . . 0.0 110.888 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.38 47.0 0.99 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.292 -0.88 . . . . 0.0 110.201 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.312 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.809 HG13 ' N ' ' B' ' 2' ' ' LYS . 2.1 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.025 0.44 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.809 ' N ' HG13 ' B' ' 1' ' ' VAL . 0.0 OUTLIER 64.83 64.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.959 -1.088 . . . . 0.0 110.054 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 7.2 tp -172.23 -26.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 111.318 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.904 HG22 ' CD ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -97.8 -177.16 0.58 Allowed Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 120.867 -1.145 . . . . 0.0 109.483 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.904 ' CD ' HG22 ' B' ' 4' ' ' ILE . 46.4 Cg_endo -83.03 -158.16 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.559 1.294 . . . . 0.0 110.534 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.524 ' O ' ' N ' ' B' ' 8' ' ' THR . 2.4 p -136.93 56.2 1.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.98 -1.075 . . . . 0.0 111.047 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.811 ' O ' HG22 ' B' ' 10' ' ' VAL . 3.0 m95 54.03 -82.15 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.253 -0.904 . . . . 0.0 111.05 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 75' ' ' LYS . 7.1 p -41.31 -25.12 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.844 -1.16 . . . . 0.0 110.633 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.496 ' N ' ' O ' ' B' ' 7' ' ' TRP . 50.6 m -64.18 -53.47 48.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 109.638 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.811 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.5 m -58.59 -26.34 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.296 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' B' ' 15' ' ' SER . 2.9 mt -75.05 -33.13 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.266 -0.897 . . . . 0.0 109.078 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.47 -59.57 5.23 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 110.125 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.861 HG12 HD11 ' A' ' 112' ' ' LEU . 61.8 t -62.66 -40.47 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 110.939 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -63.43 -31.0 72.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.965 -1.084 . . . . 0.0 110.072 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 0.5 OUTLIER -76.4 -24.23 54.05 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.363 -0.836 . . . . 0.0 110.092 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.589 ' HE1' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.67 -17.62 40.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.272 -0.892 . . . . 0.0 111.301 -179.323 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 19' ' ' LYS . 0.3 OUTLIER -78.79 -109.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.406 -1.434 . . . . 0.0 110.081 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.475 ' C ' ' HG3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 58.58 -72.64 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.131 -0.98 . . . . 0.0 110.821 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.882 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -172.94 90.62 0.09 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.348 -0.845 . . . . 0.0 112.256 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 123' ' ' GLU . 0.7 OUTLIER 62.1 4.67 1.25 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.534 -1.354 . . . . 0.0 110.829 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.5 ' O ' ' O ' ' B' ' 16' ' ' MET . 12.1 t -66.01 119.04 10.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.945 -1.097 . . . . 0.0 110.23 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.656 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -152.57 53.68 0.78 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.095 -1.003 . . . . 0.0 110.221 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.45 -136.23 6.42 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 145' ' ' MET . 2.0 m120 -130.51 65.17 75.45 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.247 -1.149 . . . . 0.0 110.637 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.27 42.26 1.29 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.937 1.493 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.594 ' HE2' ' HE1' ' A' ' 72' ' ' MET . 5.7 m-85 . . . . . 0 N--CA 1.498 1.927 0 O-C-N 121.074 -1.016 . . . . 0.0 110.293 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.158 0.504 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.65 178.29 1.94 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -0.932 . . . . 0.0 110.333 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.442 ' O ' HD23 ' A' ' 4' ' ' LEU . 32.9 mt-30 -53.07 -176.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.245 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 59.3 mt -122.67 125.04 44.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.908 . . . . 0.0 110.178 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.521 HG23 ' N ' ' A' ' 6' ' ' GLU . 5.2 t -43.05 -40.45 3.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.381 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 5' ' ' THR . 0.9 OUTLIER -45.9 -25.18 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.0 110.405 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 4.2 mt-10 -68.27 -61.11 1.99 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.127 -0.983 . . . . 0.0 109.929 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 7' ' ' GLU . 1.8 mp0 -44.24 -55.93 4.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.733 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mt -56.97 -43.85 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.682 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.88 -51.81 62.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.682 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.511 ' OE2' ' CD ' ' B' ' 18' ' ' ARG . 16.9 tt0 -56.9 -45.98 82.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.674 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -63.04 -41.34 99.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -61.4 -41.19 96.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.401 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 7.6 tt0 -63.18 -48.07 79.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.249 -0.907 . . . . 0.0 109.258 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' HB1' ' HZ ' ' A' ' 68' ' ' PHE . . . -62.5 -46.44 88.44 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.4 -0.813 . . . . 0.0 109.395 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 65' ' ' PHE . 41.0 t80 -61.26 -38.43 86.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.338 -0.851 . . . . 0.0 109.0 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 14' ' ' GLU . 77.5 p -75.19 -35.55 61.52 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.539 -0.725 . . . . 0.0 109.365 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.693 HD13 ' HG3' ' B' ' 14' ' ' LYS . 1.1 tt -50.16 -44.86 52.83 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.815 . . . . 0.0 109.217 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CE1' HG11 ' B' ' 10' ' ' VAL . 52.7 m-85 -76.83 -51.53 11.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.431 -0.793 . . . . 0.0 109.472 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 46.0 t0 -77.17 78.2 3.71 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.509 -0.744 . . . . 0.0 110.009 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -68.22 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.6 p-10 -51.64 -27.52 11.66 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.431 -0.793 . . . . 0.0 110.293 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.447 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 80.21 18.61 71.37 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 53.6 p30 -62.24 -12.47 20.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -1.191 . . . . 0.0 109.962 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 86.98 29.39 23.23 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 4.2 p -152.61 118.57 5.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.268 -1.137 . . . . 0.0 110.601 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' A' ' 63' ' ' ILE . 10.7 mt -94.22 120.12 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.163 -0.96 . . . . 0.0 110.172 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.53 164.76 11.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.353 -0.842 . . . . 0.0 109.984 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.554 ' O ' HD13 ' A' ' 48' ' ' LEU . 38.6 p -56.63 -29.31 62.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.992 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -69.51 -60.83 2.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.803 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -49.06 -57.53 6.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -0.888 . . . . 0.0 110.14 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 32' ' ' LEU . 22.9 tp -52.86 -41.96 64.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.781 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.528 ' HA2' ' HG3' ' A' ' 43' ' ' PRO . . . -58.39 -34.88 76.63 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.7 m -62.85 -56.92 13.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -1.11 . . . . 0.0 110.035 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 35' ' ' VAL . 16.4 t -53.71 -32.71 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.334 -0.854 . . . . 0.0 109.883 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -27.28 59.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 109.956 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 1.4 ttp180 -76.73 -21.67 54.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -0.955 . . . . 0.0 110.121 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -33.71 59.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -0.922 . . . . 0.0 110.357 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.505 HD22 HG13 ' A' ' 91' ' ' VAL . 4.5 mt -74.94 -44.1 50.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.229 -0.919 . . . . 0.0 110.231 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.16 78.76 0.08 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -176.45 -174.51 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.259 -1.142 . . . . 0.0 110.283 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -142.55 93.43 6.97 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.0 110.315 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.528 ' HG3' ' HA2' ' A' ' 33' ' ' GLY . 44.5 Cg_endo -74.61 90.92 1.01 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 124.092 1.575 . . . . 0.0 110.297 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.29 145.86 52.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 110.428 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -49.07 -64.79 0.7 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.24 -0.913 . . . . 0.0 110.573 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -43.84 -51.14 7.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.939 -1.101 . . . . 0.0 110.046 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -65.13 -35.21 80.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.876 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 29' ' ' THR . 11.0 mt -62.38 -47.68 83.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 110.09 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -57.48 -44.85 85.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.875 . . . . 0.0 109.821 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.17 -27.15 69.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.419 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.571 ' SD ' HG21 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -74.66 -54.13 8.0 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.493 -0.754 . . . . 0.0 110.129 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.761 HG12 HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -70.16 -13.08 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.253 -0.904 . . . . 0.0 109.753 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.46 -24.74 63.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.187 -0.946 . . . . 0.0 109.212 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.85 -47.89 13.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.519 -0.738 . . . . 0.0 109.962 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.661 HG21 ' CE2' ' B' ' 7' ' ' TRP . 88.3 t -69.6 -18.09 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.651 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' ALA . 17.2 t0 -67.68 57.78 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.021 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -43.36 -55.58 4.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.952 . . . . 0.0 110.256 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 6.9 p-10 -64.1 -44.15 93.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.86 35.39 3.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.473 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 6.9 p-10 -98.64 -44.93 6.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -1.207 . . . . 0.0 110.137 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.448 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . 142.15 -54.88 0.6 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.28 156.56 19.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.252 -1.146 . . . . 0.0 110.701 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.761 HD11 HG12 ' A' ' 52' ' ' ILE . 7.9 mm -90.39 142.93 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.805 . . . . 0.0 109.378 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' OD1' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -108.64 176.82 4.98 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.031 -1.043 . . . . 0.0 110.809 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.636 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 4.1 t80 -66.99 -45.2 52.92 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.495 -0.753 . . . . 0.0 111.372 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.8 Cg_endo -69.02 -37.81 10.38 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.203 1.107 . . . . 0.0 109.938 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.93 -41.66 64.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.293 -0.88 . . . . 0.0 109.218 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.401 ' HZ ' ' HB1' ' A' ' 15' ' ' ALA . 16.3 t80 -64.51 -50.33 67.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.748 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -51.44 -26.29 7.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.84 . . . . 0.0 110.574 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 34.8 m -98.4 -20.4 17.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 111.167 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.449 ' CE ' ' HB2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -78.99 -30.69 44.47 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.958 -1.089 . . . . 0.0 110.861 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.633 ' HE1' ' CE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -77.09 -9.08 58.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.192 -0.942 . . . . 0.0 110.839 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.58 -16.55 8.84 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.867 -1.145 . . . . 0.0 111.405 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -99.94 -9.91 22.25 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.883 -1.136 . . . . 0.0 110.491 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HB3' HG21 ' B' ' 8' ' ' THR . 6.5 tptt -95.41 10.29 36.92 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.29 -0.881 . . . . 0.0 110.618 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.25 -7.83 31.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.162 -0.962 . . . . 0.0 110.245 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -147.35 69.43 1.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 109.935 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 79' ' ' THR . 39.7 t0 -148.77 -47.61 0.15 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.248 -0.907 . . . . 0.0 110.416 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.774 HG23 ' O ' ' A' ' 78' ' ' ASP . 1.4 p -162.24 -37.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 110.415 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 3.6 m-20 -100.24 71.54 1.59 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.222 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.456 ' O ' ' OE2' ' A' ' 84' ' ' GLU . 16.0 t -85.84 -53.25 5.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.943 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.51 -20.24 16.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.39 -0.819 . . . . 0.0 110.237 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -67.42 -40.11 85.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.716 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 81' ' ' SER . 17.9 pt-20 -51.8 -31.79 28.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 109.911 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.665 HG21 HG22 ' A' ' 142' ' ' VAL . 62.2 mt -78.78 -50.84 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.155 -0.966 . . . . 0.0 109.313 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 14.9 ttm180 -49.38 -40.6 36.49 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 109.5 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.774 ' HB3' HG21 ' B' ' 9' ' ' THR . 26.4 mt-10 -69.06 -52.77 25.06 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.292 -0.88 . . . . 0.0 109.581 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.33 -27.04 44.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.07 -1.019 . . . . 0.0 109.071 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' HB3' ' O ' ' A' ' 86' ' ' ARG . 83.3 t80 -69.75 -45.58 67.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 0.0 109.112 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -56.61 -37.47 70.71 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.591 -0.693 . . . . 0.0 109.36 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.619 HG12 HG21 ' A' ' 108' ' ' VAL . 82.1 t -64.92 -41.07 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.503 -0.748 . . . . 0.0 109.748 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.774 ' HE1' HG22 ' B' ' 13' ' ' VAL . 5.0 m-85 -66.42 -31.34 72.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.0 109.37 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.511 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 3.8 t0 -91.13 59.92 4.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.479 -0.763 . . . . 0.0 109.986 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -38.96 -39.8 0.58 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.441 -0.787 . . . . 0.0 110.794 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.0 p-10 -86.58 -35.06 19.68 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 0.0 110.121 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.505 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 82.55 44.6 7.27 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -94.64 -23.61 17.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -1.197 . . . . 0.0 110.177 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 114.88 29.32 2.64 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 41.8 m-85 -160.62 150.59 17.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.174 -1.192 . . . . 0.0 110.039 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.574 HD13 ' HB3' ' A' ' 92' ' ' PHE . 9.0 mt -119.06 118.09 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 102' ' ' ALA . 2.0 t -105.33 145.88 30.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 110.147 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.953 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -43.87 -33.03 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.811 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.15 82.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 109.546 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 39.6 mt-10 -55.77 -41.27 73.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.882 . . . . 0.0 109.492 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.027 ' CD1' HD11 ' A' ' 125' ' ' ILE . 7.7 mt -59.74 -44.67 93.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 109.601 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.408 ' NH1' ' HD3' ' A' ' 115' ' ' LYS . 1.2 ttm180 -57.5 -39.35 76.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -0.825 . . . . 0.0 109.592 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -63.5 -50.8 68.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 109.554 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.619 HG21 HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -63.76 -25.27 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 108.898 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.865 ' SD ' HD13 ' A' ' 116' ' ' LEU . 2.6 mtm -69.13 -65.37 0.72 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.672 -0.643 . . . . 0.0 109.988 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -51.99 -28.88 18.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -78.55 -10.5 59.75 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.277 -0.889 . . . . 0.0 109.337 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.687 HD11 HG12 ' B' ' 13' ' ' VAL . 13.8 mt -107.34 -48.5 3.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.356 -0.84 . . . . 0.0 110.479 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.58 -59.5 0.18 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.548 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 109' ' ' MET . 2.7 tp10 -99.76 159.23 15.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.934 -1.333 . . . . 0.0 110.819 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.562 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 1.1 pttp -123.57 1.91 8.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.375 -0.828 . . . . 0.0 110.012 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.865 HD13 ' SD ' ' A' ' 109' ' ' MET . 4.8 mp 48.11 175.81 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.56 0.695 . . . . 0.0 110.969 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.666 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.46 178.91 6.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.138 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -50.97 9.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.96 -1.087 . . . . 0.0 110.065 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -56.79 -46.11 81.76 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 109.491 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -58.91 -52.8 64.18 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.375 -0.828 . . . . 0.0 109.409 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.953 HG12 ' HB1' ' A' ' 102' ' ' ALA . 41.3 t -50.84 -41.41 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.857 . . . . 0.0 109.669 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 1.1 m-20 -70.95 -38.83 72.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.398 -0.813 . . . . 0.0 110.029 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -68.84 -23.73 64.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -0.866 . . . . 0.0 110.05 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.686 ' HE3' ' CD1' ' B' ' 22' ' ' PHE . 22.3 ttt -74.4 -56.21 5.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.882 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.027 HD11 ' CD1' ' A' ' 105' ' ' LEU . 31.2 mm -60.68 -52.82 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.0 109.712 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 122' ' ' ASP . 1.5 mtp85 -50.33 -52.89 32.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 110.1 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 15.3 mm-40 -53.33 -29.04 31.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.342 -0.849 . . . . 0.0 110.193 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.54 -19.23 24.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 110.343 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.43 70.43 3.82 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.0 110.262 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.6 mt -63.57 -41.22 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.968 . . . . 0.0 109.766 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 9.7 p30 -63.55 -36.29 83.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.332 -0.855 . . . . 0.0 110.03 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 95.48 74.19 1.22 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.458 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -133.44 2.17 3.5 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.229 -1.159 . . . . 0.0 109.976 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.508 ' O ' ' CG ' ' A' ' 135' ' ' GLN . . . 71.66 4.71 58.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.508 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 68.1 mt-30 -156.63 168.81 26.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.163 . . . . 0.0 109.773 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 140' ' ' GLU . 14.7 t -107.16 131.47 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 109.953 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 11.6 t30 -100.39 -152.98 0.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 0.0 110.23 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.458 ' OH ' ' HG3' ' A' ' 86' ' ' ARG . 12.1 t80 -74.54 -69.45 0.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.245 -0.909 . . . . 0.0 110.087 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 143' ' ' GLN . 1.4 tt0 -46.95 -44.4 19.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.187 -0.946 . . . . 0.0 109.875 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.457 ' HB3' HG13 ' A' ' 136' ' ' VAL . 11.5 mt-10 -53.78 -60.56 3.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.795 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 140' ' ' GLU . 5.1 t80 -42.96 -33.0 0.71 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 110.017 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.665 HG22 HG21 ' A' ' 85' ' ' ILE . 37.8 t -100.09 -17.11 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.374 -0.829 . . . . 0.0 110.726 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.776 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 13.7 tt0 -77.9 -27.97 49.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.173 -0.954 . . . . 0.0 110.621 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -93.51 -11.05 32.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.524 ' O ' ' HB2' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.6 -24.78 14.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.436 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.0 p -122.93 -26.83 4.34 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.921 -1.112 . . . . 0.0 110.661 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -100.22 63.11 1.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.142 -0.974 . . . . 0.0 110.141 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 147' ' ' ALA . 18.7 tttp . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.383 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.758 HG13 ' N ' ' B' ' 2' ' ' LYS . 1.6 p . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.105 0.479 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.758 ' N ' HG13 ' B' ' 1' ' ' VAL . 0.0 OUTLIER 55.79 110.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.177 -0.952 . . . . 0.0 109.803 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.665 HD23 ' C ' ' B' ' 2' ' ' LYS . 0.2 OUTLIER -175.06 -34.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.736 -1.228 . . . . 0.0 110.457 -179.077 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.571 HG21 ' SD ' ' A' ' 51' ' ' MET . 12.5 mt -147.13 122.6 5.35 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 109.595 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.508 ' O ' ' HB ' ' B' ' 9' ' ' THR . 44.1 Cg_endo -70.87 66.39 2.42 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.98 1.516 . . . . 0.0 111.602 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.482 ' C ' ' O ' ' B' ' 5' ' ' PRO . 42.4 m 31.56 -147.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.533 0.682 . . . . 0.0 111.874 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.661 ' CE2' HG21 ' A' ' 55' ' ' VAL . 2.0 m95 -108.7 -73.87 0.67 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.886 0.851 . . . . 0.0 110.842 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.529 ' HA ' HD12 ' B' ' 11' ' ' ILE . 2.6 p -44.83 -36.59 3.34 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.498 -0.751 . . . . 0.0 110.288 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.774 HG21 ' HB3' ' A' ' 87' ' ' GLU . 2.6 m -44.91 -53.84 7.15 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.695 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.465 HG23 ' H ' ' B' ' 10' ' ' VAL . 4.7 t -57.46 -40.12 72.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.53 HG21 ' HG2' ' A' ' 72' ' ' MET . 47.1 mt -72.75 -19.72 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.539 -0.726 . . . . 0.0 109.635 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 8' ' ' THR . 0.2 OUTLIER -73.36 -50.16 23.42 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.647 0.737 . . . . 0.0 109.768 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.774 HG22 ' HE1' ' A' ' 92' ' ' PHE . 89.1 t -64.91 -47.06 89.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.475 -0.766 . . . . 0.0 110.575 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.693 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -65.86 -32.76 74.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.066 -1.021 . . . . 0.0 109.802 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 34.2 t -78.23 -13.68 59.76 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.6 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' B' ' 12' ' ' LEU . 0.0 OUTLIER -79.67 -42.18 25.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.162 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.621 HD21 ' CG ' ' A' ' 109' ' ' MET . 9.3 mp -44.98 -57.32 3.89 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.918 -1.114 . . . . 0.0 109.057 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.511 ' CD ' ' OE2' ' A' ' 11' ' ' GLU . 3.6 tpt85 16.38 75.24 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' B' ' 19' ' ' LYS . 2.0 tptm 44.62 73.76 0.15 Allowed 'General case' 0 C--N 1.283 -2.308 0 O-C-N 121.273 -0.892 . . . . 0.0 112.883 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.691 ' H ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER 47.86 13.73 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.683 0 O-C-N 120.8 -1.187 . . . . 0.0 112.092 177.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' B' ' 18' ' ' ARG . 5.1 m -112.74 115.45 28.55 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 119.956 -1.715 . . . . 0.0 110.468 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.686 ' CD1' ' HE3' ' A' ' 124' ' ' MET . 0.9 OUTLIER -58.16 -35.32 71.38 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.167 -1.013 . . . . 0.0 108.779 179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.54 147.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.595 ' N ' ' HD3' ' B' ' 25' ' ' PRO . 1.8 p-10 -134.97 43.09 0.87 Allowed Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.479 -1.013 . . . . 0.0 110.73 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' B' ' 24' ' ' ASN . 55.2 Cg_endo -77.96 26.64 0.49 Allowed 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.481 1.253 . . . . 0.0 111.189 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.633 ' CE2' ' HE1' ' A' ' 72' ' ' MET . 15.5 m-85 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 110.354 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.309 0.576 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -103.84 21.91 15.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.204 -0.935 . . . . 0.0 110.271 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -170.58 2.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.198 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.498 HD13 ' HA ' ' A' ' 4' ' ' LEU . 2.6 mm? -108.41 -171.95 1.96 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.443 ' O ' HD12 ' A' ' 9' ' ' ILE . 0.9 OUTLIER -97.35 94.4 7.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.278 -0.889 . . . . 0.0 110.226 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -96.79 -33.42 11.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.186 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.86 -47.41 80.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.167 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -66.5 -45.52 79.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 110.111 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 47.2 mt -66.44 -40.05 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.997 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.33 -62.35 1.78 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 109.714 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.494 ' OE1' ' CA ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -48.64 -41.48 31.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.609 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.8 m-30 -52.49 -46.78 66.74 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.214 -0.929 . . . . 0.0 109.153 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -57.34 -34.52 68.86 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.329 -0.857 . . . . 0.0 109.172 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 1.7 tt0 -56.84 -51.01 70.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.397 -0.814 . . . . 0.0 109.794 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' CA ' ' HD2' ' B' ' 14' ' ' LYS . . . -60.01 -45.39 92.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.19 -0.943 . . . . 0.0 109.566 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.584 ' CZ ' ' O ' ' A' ' 64' ' ' ASP . 1.7 t80 -64.62 -45.43 86.89 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 109.841 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m -64.29 -31.33 72.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.809 . . . . 0.0 109.706 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.622 HD21 ' O ' ' A' ' 112' ' ' LEU . 9.7 tt -61.9 -45.9 91.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.447 -0.783 . . . . 0.0 110.041 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.737 ' HA ' HG21 ' A' ' 35' ' ' VAL . 26.4 m-85 -71.42 -27.13 63.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.287 -0.883 . . . . 0.0 110.245 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.8 120.8 26.48 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.262 -0.899 . . . . 0.0 110.346 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.44 -37.09 60.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.237 -0.914 . . . . 0.0 110.304 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 17.6 p-10 -92.09 -40.9 10.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.307 -0.871 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.98 48.58 2.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 44.8 p-10 -104.69 -7.72 19.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -1.162 . . . . 0.0 110.1 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 26' ' ' THR . . . 89.71 35.78 7.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 25' ' ' GLY . 20.0 p -155.68 107.73 2.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.292 -1.122 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 mt -95.3 119.48 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.137 -0.977 . . . . 0.0 110.326 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.684 HG22 HG22 ' A' ' 62' ' ' THR . 12.7 p -100.08 174.46 6.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.179 -0.951 . . . . 0.0 110.231 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.764 HG21 ' OE1' ' A' ' 49' ' ' GLN . 74.9 p -59.09 -31.91 69.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -55.33 9.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.153 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 39.5 mt-10 -55.02 -69.76 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.06 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 31' ' ' GLU . 12.6 tp -44.94 -41.84 7.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.761 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.21 -41.99 93.12 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 2.5 m -61.07 -50.78 71.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -1.113 . . . . 0.0 109.886 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.737 HG21 ' HA ' ' A' ' 19' ' ' PHE . 12.4 t -57.92 -42.27 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 mmt -61.07 -42.34 98.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.29 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 34' ' ' THR . 3.0 tpt180 -53.04 -40.82 64.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.242 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 40' ' ' GLY . 68.3 m -71.77 -44.22 64.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.553 -0.717 . . . . 0.0 109.461 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.754 ' CD2' HD21 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -43.5 -26.24 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.38 -0.825 . . . . 0.0 109.69 179.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 107.85 37.91 2.12 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' B' ' 3' ' ' LEU . 10.5 mm-40 -145.98 165.64 28.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.31 -1.112 . . . . 0.0 110.535 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -126.84 88.89 53.43 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 109.64 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.06 160.81 46.52 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.113 1.586 . . . . 0.0 110.93 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 45' ' ' GLU . 94.9 m -99.64 164.3 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.476 -0.765 . . . . 0.0 109.879 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -69.03 -69.95 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.16 -0.963 . . . . 0.0 110.073 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -43.33 -54.14 4.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.974 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.409 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 69.1 mm-40 -54.54 -41.39 69.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.014 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 51' ' ' MET . 3.4 mt -55.4 -42.7 74.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 0.0 109.906 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.764 ' OE1' HG21 ' A' ' 29' ' ' THR . 45.4 tp60 -67.36 -24.32 65.69 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.274 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -71.51 -46.98 58.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 109.974 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.496 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 24.7 ptm -73.21 -35.41 66.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 109.724 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.565 HG13 HG22 ' A' ' 29' ' ' THR . 7.8 mm -62.32 -32.46 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 109.529 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.24 -21.06 56.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.831 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.17 -37.99 87.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 110.154 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.535 HG13 ' HE2' ' A' ' 71' ' ' MET . 11.5 t -91.86 -31.8 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 110.176 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.1 71.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.261 -0.9 . . . . 0.0 110.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.27 -17.17 61.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.0 110.638 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.6 p30 -100.43 -31.87 11.09 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.143 -0.973 . . . . 0.0 110.609 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.54 42.48 4.82 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.422 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 12.6 m120 -84.03 -15.77 46.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.195 -1.179 . . . . 0.0 110.076 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 62' ' ' THR . . . 101.67 -8.41 56.39 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.684 HG22 HG22 ' A' ' 28' ' ' THR . 2.9 p -158.23 168.46 26.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.573 HG22 ' CZ ' ' A' ' 16' ' ' PHE . 30.2 mm -82.82 136.07 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 109.943 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.584 ' O ' ' CZ ' ' A' ' 16' ' ' PHE . 2.5 m-20 -114.27 174.01 6.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.307 -0.871 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.599 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 48.2 t80 -59.4 -49.85 90.37 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.404 -0.81 . . . . 0.0 111.714 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.1 Cg_endo -65.27 -38.37 27.28 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.169 1.089 . . . . 0.0 110.268 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -53.19 -33.9 54.66 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.136 -0.977 . . . . 0.0 109.335 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.549 ' HB2' ' CE1' ' A' ' 16' ' ' PHE . 21.9 t80 -78.05 -39.26 42.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 110.345 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 65' ' ' PHE . 2.3 mm? -55.49 -30.09 59.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.871 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.57 -63.21 1.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.041 -1.037 . . . . 0.0 111.37 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.535 ' HE2' HG13 ' A' ' 55' ' ' VAL . 2.1 tmm? -44.32 -37.92 3.6 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.068 -1.02 . . . . 0.0 111.548 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.731 ' HE1' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -67.08 -8.56 31.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.039 -1.038 . . . . 0.0 111.317 -179.014 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.97 -9.34 9.66 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.664 -1.273 . . . . 0.0 111.687 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -17.32 30.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.78 -1.2 . . . . 0.0 111.4 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -100.42 -8.3 23.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.922 -1.111 . . . . 0.0 111.314 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.563 ' HE2' ' CE2' ' B' ' 26' ' ' PHE . 2.3 mtt -100.42 26.16 6.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 0.0 110.989 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' A' ' 76' ' ' MET . 3.1 mptt -156.49 85.97 1.0 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.13 -0.981 . . . . 0.0 110.529 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -162.61 -106.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.276 -0.89 . . . . 0.0 109.984 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.462 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -142.79 6.35 1.6 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.88 -1.138 . . . . 0.0 110.543 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 79' ' ' THR . 85.1 m-20 -141.64 63.44 1.43 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.4 p -101.81 -32.61 10.17 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.428 -0.795 . . . . 0.0 109.455 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -67.62 -23.36 65.35 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.498 -0.751 . . . . 0.0 109.566 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -73.88 -34.95 64.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.067 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 31.9 mt-10 -69.08 -19.94 64.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.146 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 82' ' ' GLU . 40.7 mt -70.85 -39.42 75.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 109.053 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.528 ' HD2' ' HE3' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -57.72 -27.72 63.22 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.426 -0.796 . . . . 0.0 108.959 178.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 5.4 mt-10 -70.94 -57.67 4.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.393 -0.817 . . . . 0.0 109.431 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.524 ' CB ' HD22 ' B' ' 12' ' ' LEU . . . -54.88 -27.54 43.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.046 -1.034 . . . . 0.0 109.173 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -66.15 -52.67 46.21 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.73 -34.53 12.28 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.871 . . . . 0.0 109.155 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.96 HG12 HG21 ' A' ' 108' ' ' VAL . 72.0 t -67.52 -42.73 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.442 -0.786 . . . . 0.0 109.59 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.675 ' HB3' HD13 ' A' ' 100' ' ' ILE . 56.5 m-85 -76.37 -24.13 54.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 96' ' ' GLY . 3.7 t0 -100.23 67.51 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.497 -0.752 . . . . 0.0 110.144 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -39.01 -44.83 1.14 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.595 -0.69 . . . . 0.0 110.351 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.64 -22.92 34.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 109.882 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 63.18 51.56 54.13 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -99.85 -26.21 14.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -1.155 . . . . 0.0 110.166 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 122.08 18.81 3.4 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -153.35 130.99 11.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -1.145 . . . . 0.0 110.098 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.675 HD13 ' HB3' ' A' ' 92' ' ' PHE . 22.2 mt -103.95 157.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 110.419 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.8 OUTLIER -140.33 147.3 39.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.397 -0.814 . . . . 0.0 109.704 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.16 -30.9 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.869 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.49 -45.02 73.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.311 -0.868 . . . . 0.0 109.592 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 20.7 mt-10 -63.32 -47.53 81.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.257 -0.902 . . . . 0.0 109.555 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.944 HD13 HD11 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.39 -39.28 90.12 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.286 -0.884 . . . . 0.0 109.634 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.477 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 1.4 tmt_? -60.47 -29.05 68.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.359 -0.838 . . . . 0.0 109.823 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -31.78 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 110.048 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.96 HG21 HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -74.15 -36.71 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.979 . . . . 0.0 109.554 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.79 ' CB ' HD21 ' B' ' 17' ' ' LEU . 21.5 ptp -73.26 -39.99 64.98 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.566 ' N ' ' HG3' ' A' ' 109' ' ' MET . 87.1 m -69.54 -27.38 65.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.116 -0.99 . . . . 0.0 109.47 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -89.75 -13.14 37.39 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.42 -0.8 . . . . 0.0 109.302 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.754 HD21 ' CD2' ' A' ' 39' ' ' LEU . 9.2 mt -93.89 -32.65 13.83 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.449 -0.782 . . . . 0.0 110.006 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.05 -63.82 0.33 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.267 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 109' ' ' MET . 1.8 tt0 -94.11 156.1 16.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.114 -1.227 . . . . 0.0 110.679 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 116' ' ' LEU . 9.8 pttt -124.53 13.03 8.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' B' ' 17' ' ' LEU . 1.0 OUTLIER 40.66 -164.1 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.512 0.672 . . . . 0.0 110.56 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -166.28 1.3 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.387 -0.82 . . . . 0.0 109.567 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.436 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -97.17 -59.56 1.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.094 -1.004 . . . . 0.0 109.694 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 4.5 pt-20 -58.91 -30.29 67.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.515 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 9.2 tp10 -69.83 -48.17 59.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.403 -0.811 . . . . 0.0 109.321 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 t -57.28 -42.12 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.432 -0.793 . . . . 0.0 109.64 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 14.4 m-20 -69.2 -41.17 77.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.89 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 2.4 mt-10 -64.08 -31.01 72.04 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 110.007 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.608 ' HE1' ' HA ' ' B' ' 17' ' ' LEU . 1.0 OUTLIER -69.6 -42.05 74.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.176 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.944 HD11 HD13 ' A' ' 105' ' ' LEU . 35.0 mm -74.52 -23.88 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -74.44 -40.16 62.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.23 -0.919 . . . . 0.0 110.552 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.79 -8.96 58.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 110.266 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.476 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -101.26 -30.53 11.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.305 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.97 101.37 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.109 -0.994 . . . . 0.0 110.285 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.476 HD12 ' O ' ' A' ' 128' ' ' ALA . 1.2 mp -67.81 -27.37 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.197 -0.939 . . . . 0.0 109.813 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 41.6 p-10 -103.38 -25.48 13.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.63 72.38 1.27 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -130.61 -0.83 4.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -1.168 . . . . 0.0 110.145 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.07 -2.7 75.9 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' A' ' 100' ' ' ILE . 40.9 mt-30 -142.54 160.7 39.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -1.226 . . . . 0.0 110.2 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 97.1 t -107.59 120.05 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.182 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 98' ' ' GLY . 10.4 t-20 -81.31 166.44 20.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.884 . . . . 0.0 110.15 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -57.7 -48.97 78.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.106 -0.996 . . . . 0.0 110.155 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -53.2 -30.67 38.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 109.934 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.84 -52.63 7.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.306 -0.871 . . . . 0.0 109.813 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.413 ' CE2' HG23 ' A' ' 85' ' ' ILE . 65.9 t80 -49.75 -21.79 1.2 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.2 -0.938 . . . . 0.0 109.593 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 146' ' ' THR . 17.1 t -94.04 -62.28 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.437 -0.789 . . . . 0.0 110.255 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -43.84 -49.55 8.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.877 . . . . 0.0 110.267 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 3.7 tpt -59.05 -19.14 41.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.869 . . . . 0.0 110.556 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . 1.057 ' HE2' ' HB2' ' B' ' 24' ' ' ASN . 2.7 mtt -99.61 -24.63 14.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.168 -0.958 . . . . 0.0 110.501 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 142' ' ' VAL . 1.4 t -129.85 63.78 1.52 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.147 -0.97 . . . . 0.0 110.344 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.02 37.9 1.47 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.423 ' HD2' ' OXT' ' A' ' 148' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.21 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 77.7 t . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.274 0.559 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.528 ' HE3' ' HD2' ' A' ' 86' ' ' ARG . 4.5 mptt -94.38 105.86 17.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.229 -0.919 . . . . 0.0 110.127 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.499 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.1 mt -145.56 -51.36 0.25 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.136 -0.977 . . . . 0.0 110.477 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.659 HG23 ' HD2' ' B' ' 5' ' ' PRO . 20.0 mt -135.45 148.21 65.03 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.316 -0.865 . . . . 0.0 109.881 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.659 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.8 Cg_endo -65.27 122.63 10.41 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.843 1.444 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.526 ' O ' ' N ' ' B' ' 8' ' ' THR . 17.8 m -78.93 79.68 5.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.834 . . . . 0.0 111.015 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.406 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER 50.35 -86.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.329 -0.857 . . . . 0.0 111.106 179.086 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.526 ' N ' ' O ' ' B' ' 6' ' ' SER . 10.3 p -43.31 -30.05 0.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 110.733 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' B' ' 5' ' ' PRO . 83.8 m -64.86 -47.29 78.43 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.694 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.547 HG12 ' HZ ' ' A' ' 19' ' ' PHE . 5.5 t -61.39 -46.88 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.721 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' B' ' 15' ' ' SER . 76.4 mt -58.96 -30.27 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.165 -0.959 . . . . 0.0 109.488 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.618 ' HG ' ' CE2' ' B' ' 26' ' ' PHE . 3.2 tt -63.73 -56.81 12.79 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.436 -0.79 . . . . 0.0 110.26 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.666 HG21 HG11 ' A' ' 91' ' ' VAL . 67.2 t -54.38 -40.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.149 -0.969 . . . . 0.0 110.576 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.516 ' HD2' ' CA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -72.9 -44.06 61.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.944 -1.097 . . . . 0.0 109.661 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.436 ' HA ' ' HE2' ' B' ' 14' ' ' LYS . 20.7 p -67.26 -7.87 27.5 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.368 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.496 ' HB2' ' O ' ' B' ' 12' ' ' LEU . 2.0 ttt -93.15 -60.31 1.83 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.897 . . . . 0.0 110.871 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.944 HD22 ' O ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -102.51 91.88 4.42 Favored 'General case' 0 C--O 1.204 -1.315 0 CA-C-O 123.768 1.746 . . . . 0.0 110.667 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.462 ' HG3' ' N ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -124.87 -35.72 2.65 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.137 -0.977 . . . . 0.0 109.763 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.489 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 1.5 tmtm? -137.44 -72.46 0.43 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.201 -0.937 . . . . 0.0 110.558 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.449 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -161.23 23.54 0.13 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.138 -0.976 . . . . 0.0 109.501 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.446 ' O ' ' SD ' ' A' ' 124' ' ' MET . 3.6 m -100.97 166.42 10.83 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.65 -0.656 . . . . 0.0 110.903 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.576 ' CD1' ' HG2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -153.63 16.45 0.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.367 -0.833 . . . . 0.0 110.37 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.39 126.34 6.22 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 1.057 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 3.2 m120 -112.83 135.36 21.62 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.177 -1.19 . . . . 0.0 110.951 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -81.46 11.85 2.92 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.027 1.541 . . . . 0.0 110.015 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.731 ' CZ ' ' HE1' ' A' ' 72' ' ' MET . 3.3 m-85 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.179 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.161 0.505 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -104.31 -55.82 2.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 110.292 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -74.27 -164.35 0.25 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -0.976 . . . . 0.0 110.267 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 5' ' ' THR . 3.2 mt -89.1 99.08 12.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.438 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 4' ' ' LEU . 64.0 p 40.46 65.34 0.78 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.41 -0.806 . . . . 0.0 110.47 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -100.18 -34.68 9.93 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.479 -0.763 . . . . 0.0 110.22 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 6.7 mm-40 -49.71 -68.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.333 -0.855 . . . . 0.0 110.442 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 35.4 mt-30 -41.81 -54.09 3.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.877 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 5' ' ' THR . 58.1 mt -57.33 -38.64 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 109.671 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -58.33 -39.39 79.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.588 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 26.4 mt-10 -60.23 -56.11 25.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -56.82 -36.12 69.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 109.466 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -42.66 98.37 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.294 -0.879 . . . . 0.0 109.045 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 17' ' ' SER . 4.7 tp10 -51.1 -45.26 61.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 109.149 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.86 -49.18 73.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 109.273 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.853 ' CE1' HD11 ' A' ' 27' ' ' ILE . 21.6 t80 -56.45 -29.38 61.6 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.418 -0.801 . . . . 0.0 109.744 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 3.6 t -68.83 -46.67 67.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 0.0 110.0 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.815 HD13 ' HG3' ' B' ' 14' ' ' LYS . 10.4 tt -55.03 -36.9 65.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 109.629 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 62.4 m-85 -79.38 -52.71 7.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.323 -0.86 . . . . 0.0 110.004 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -68.52 111.58 4.81 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.451 -0.78 . . . . 0.0 110.305 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -90.34 -44.15 9.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -0.841 . . . . 0.0 110.178 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 22.3 p30 -72.68 -16.48 61.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.288 -0.882 . . . . 0.0 110.244 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 64.48 65.78 2.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.9 p30 -130.95 -33.13 1.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -1.127 . . . . 0.0 110.235 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.587 ' C ' HG23 ' A' ' 26' ' ' THR . . . 114.33 38.39 1.12 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 25' ' ' GLY . 67.3 p -155.39 103.35 2.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.853 HD11 ' CE1' ' A' ' 16' ' ' PHE . 9.8 mt -88.98 110.77 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.067 -1.02 . . . . 0.0 110.0 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.928 HG22 HG22 ' A' ' 62' ' ' THR . 59.4 p -100.79 177.39 4.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.8 p -57.65 -19.92 29.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.026 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -73.78 -55.66 5.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.214 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HG2' ' HG3' ' A' ' 21' ' ' LYS . 6.1 mt-10 -64.25 -59.84 3.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.499 HD13 ' CH2' ' B' ' 7' ' ' TRP . 7.7 tp -62.98 -25.36 68.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 110.239 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.47 -35.95 55.29 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -71.58 -46.11 60.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.233 -1.157 . . . . 0.0 110.48 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.5 -40.98 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.204 -0.935 . . . . 0.0 110.394 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.508 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 6.9 mmm -69.26 -31.96 70.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 110.36 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.6 tpt180 -79.35 -20.54 47.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.464 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 68.0 m -70.7 -44.59 66.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 110.692 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.44 -36.1 21.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.09 -1.006 . . . . 0.0 110.368 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.26 32.8 0.66 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -120.69 -169.58 1.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.2 -1.177 . . . . 0.0 110.28 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -143.9 72.13 16.85 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.263 -0.898 . . . . 0.0 110.215 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.508 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 47.3 Cg_endo -74.22 105.51 2.05 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.035 1.545 . . . . 0.0 110.309 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.4 m -53.98 153.43 4.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.172 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 8.7 tm-20 -65.42 -43.34 90.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 109.956 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.02 -63.15 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.91 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -52.0 -36.44 49.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.2 mt -58.52 -50.49 73.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.902 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.502 ' O ' HG22 ' A' ' 52' ' ' ILE . 5.3 tp60 -54.01 -35.68 62.15 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.8 -34.39 69.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.352 -0.843 . . . . 0.0 109.545 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.401 ' HE3' ' CD1' ' B' ' 7' ' ' TRP . 0.2 OUTLIER -70.03 -26.17 63.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.488 -0.758 . . . . 0.0 110.104 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.623 HG13 HD11 ' A' ' 63' ' ' ILE . 1.2 tp -78.62 -41.23 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.986 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.434 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -54.56 -21.77 11.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -57.21 6.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.858 . . . . 0.0 110.068 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.679 ' HB ' HD12 ' A' ' 63' ' ' ILE . 17.1 t -71.69 -23.06 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.152 -0.968 . . . . 0.0 109.926 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -56.18 83.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.353 -0.842 . . . . 0.0 110.364 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.08 -71.31 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.096 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 26.2 p-10 -48.22 -42.02 29.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 101.7 41.61 2.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 1.6 p-10 -98.88 -44.34 6.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.118 -1.225 . . . . 0.0 110.077 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 143.48 -47.24 0.8 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.149 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.928 HG22 HG22 ' A' ' 28' ' ' THR . 26.5 p -94.16 158.59 15.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.208 -1.172 . . . . 0.0 110.895 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.679 HD12 ' HB ' ' A' ' 55' ' ' VAL . 12.4 mm -93.07 135.12 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.348 -0.845 . . . . 0.0 110.146 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.487 ' OD1' ' HD2' ' A' ' 66' ' ' PRO . 2.3 t70 -107.24 168.34 9.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.11 -0.994 . . . . 0.0 110.424 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.622 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 t80 -56.02 -44.82 99.88 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.397 -0.814 . . . . 0.0 111.245 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -70.26 -31.59 18.02 Favored 'Trans proline' 0 N--CA 1.482 0.83 0 O-C-N 123.298 1.157 . . . . 0.0 110.269 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.509 ' OE2' ' N ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -63.7 -34.55 78.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 109.341 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -71.61 -42.04 68.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.486 -0.759 . . . . 0.0 109.779 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 mt -58.16 -34.76 70.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 0.0 110.06 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -76.86 -33.74 57.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.561 ' SD ' HG22 ' A' ' 55' ' ' VAL . 42.1 ttp -64.84 -63.68 1.06 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.296 -0.877 . . . . 0.0 110.569 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.517 ' SD ' HG22 ' B' ' 8' ' ' THR . 9.9 tpt -54.4 -16.5 2.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.141 -0.974 . . . . 0.0 110.677 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.21 -33.02 14.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.068 -1.02 . . . . 0.0 110.662 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.423 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 1.7 tpt180 -98.64 -9.95 24.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.159 -0.963 . . . . 0.0 110.371 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER -83.68 -20.79 32.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.218 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.442 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 2.1 ttm -94.09 48.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 110.296 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 2.1 mtmt -135.53 70.7 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.263 -0.898 . . . . 0.0 110.107 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 77' ' ' LYS . 7.8 t0 64.02 28.99 14.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.888 . . . . 0.0 109.98 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 2.9 p -132.36 78.5 1.81 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 109.908 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER 67.58 37.07 3.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.89 . . . . 0.0 110.05 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -83.88 -65.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 109.809 179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HA ' HD12 ' A' ' 85' ' ' ILE . 1.0 OUTLIER -66.79 -37.1 83.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.378 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -67.04 -29.48 69.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.244 -0.91 . . . . 0.0 109.349 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.565 ' OE2' HD23 ' B' ' 12' ' ' LEU . 20.9 tt0 -61.71 -26.72 68.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.439 -0.788 . . . . 0.0 109.608 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 82' ' ' GLU . 65.3 mt -69.64 -36.79 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.464 -0.894 . . . . 0.0 108.86 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 89' ' ' PHE . 16.0 ttt180 -59.21 -36.85 76.12 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.562 0.696 . . . . 0.0 109.124 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.615 ' HB3' HG21 ' B' ' 9' ' ' THR . 6.0 mm-40 -67.09 -54.17 23.95 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.403 -0.811 . . . . 0.0 109.421 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.36 -31.28 21.65 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.136 -0.978 . . . . 0.0 108.83 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.46 ' HB3' ' O ' ' A' ' 86' ' ' ARG . 82.3 t80 -68.16 -67.1 0.49 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.418 -0.801 . . . . 0.0 109.912 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -45.25 -35.81 3.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.758 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.661 HG12 HG21 ' A' ' 108' ' ' VAL . 25.2 t -56.87 -50.39 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 109.344 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.629 ' CE1' HG11 ' A' ' 108' ' ' VAL . 25.3 m-85 -60.97 -31.62 71.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.672 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -98.77 62.2 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.373 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -43.42 -34.29 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.91 . . . . 0.0 110.067 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.4 p30 -77.08 -41.87 40.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 84.51 52.46 3.54 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.7 p-10 -100.06 -33.83 10.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.182 -1.187 . . . . 0.0 110.115 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.587 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 125.03 22.92 1.87 Allowed Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.577 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 85.9 m-85 -157.25 141.2 16.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.985 -1.303 . . . . 0.0 110.676 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 135' ' ' GLN . 6.3 mt -109.58 143.96 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.861 . . . . 0.0 110.153 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -139.6 152.3 46.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.145 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.39 -27.03 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 109.867 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -68.92 -47.75 64.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.562 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 6.9 mt-10 -63.79 -43.63 95.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.467 -0.771 . . . . 0.0 109.806 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.666 HD13 HD11 ' A' ' 125' ' ' ILE . 2.6 mt -67.58 -34.8 77.77 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.378 -0.826 . . . . 0.0 109.581 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.474 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 43.0 ttp180 -66.87 -27.94 67.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.292 -0.88 . . . . 0.0 109.752 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.67 -23.41 31.77 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.292 -0.88 . . . . 0.0 109.953 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.661 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -91.34 -29.12 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 109.97 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.555 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 21.9 ptp -76.84 -34.38 57.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 110.338 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' MET . 5.4 m -76.66 -28.65 56.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.052 -1.03 . . . . 0.0 109.65 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 38' ' ' SER . 2.3 m120 -82.7 -23.46 34.09 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.355 -0.84 . . . . 0.0 109.917 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.793 ' CD1' HG12 ' B' ' 13' ' ' VAL . 2.0 mt -82.84 -28.69 29.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.67 -64.24 0.39 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 109' ' ' MET . 4.1 tt0 -108.01 144.81 34.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -1.17 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.512 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 0.2 OUTLIER -119.36 22.33 11.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.855 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.747 HD11 ' C ' ' B' ' 17' ' ' LEU . 5.1 mp 46.9 -176.59 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.566 -0.709 . . . . 0.0 110.687 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.89 -143.59 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.232 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.11 -51.0 2.12 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.169 -0.957 . . . . 0.0 110.178 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -60.93 -38.47 85.93 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 109.519 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.59 -52.87 59.05 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.294 -0.879 . . . . 0.0 109.298 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 125' ' ' ILE . 41.4 t -47.18 -42.22 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.273 -0.892 . . . . 0.0 109.74 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.63 -63.71 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.808 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -48.12 -24.8 1.22 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.397 -0.814 . . . . 0.0 109.732 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.445 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -70.1 -44.08 69.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.779 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.666 HD11 HD13 ' A' ' 105' ' ' LEU . 25.9 mm -78.62 -25.39 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.365 -0.834 . . . . 0.0 110.102 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.25 -69.84 0.37 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.279 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -47.49 -25.37 1.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -78.24 -49.99 12.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 128' ' ' ALA . 34.7 t0 -41.95 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.487 -0.758 . . . . 0.0 110.547 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . 3.3 mp -75.37 -47.46 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.909 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.407 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 16.2 p-10 -77.23 -18.31 57.78 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.404 -0.81 . . . . 0.0 109.987 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.413 ' HA2' ' CG ' ' A' ' 129' ' ' ASP . . . 76.94 56.49 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 31.1 p30 -107.77 -8.51 16.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.08 17.31 56.27 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 10.2 pt20 -168.44 150.63 5.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -1.133 . . . . 0.0 109.95 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 13.0 t -89.37 125.68 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.173 -0.955 . . . . 0.0 110.435 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 9.6 t30 -93.8 -173.72 3.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.279 -0.888 . . . . 0.0 110.243 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 64.1 t80 -69.85 -56.54 6.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.181 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.68 -58.49 4.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.843 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' HD12 ' A' ' 130' ' ' ILE . 36.3 mt-10 -52.11 -45.45 64.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.317 -0.864 . . . . 0.0 109.883 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -57.86 -26.69 62.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 0.0 109.942 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.33 -39.8 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.835 . . . . 0.0 110.347 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -56.01 -46.88 78.62 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.215 -0.928 . . . . 0.0 110.062 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 77.5 mmm -63.51 -27.47 69.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.837 . . . . 0.0 110.308 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.54 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 3.9 mtt -90.18 -34.76 15.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.195 -0.941 . . . . 0.0 110.639 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 146' ' ' THR . 9.7 t -170.7 96.13 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.026 -1.046 . . . . 0.0 110.138 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.26 54.0 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 110.223 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.296 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.241 0.544 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.53 -148.93 0.35 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 110.223 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' B' ' 3' ' ' LEU . 0.7 OUTLIER -111.96 4.11 17.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 22.3 mt -105.86 147.76 35.31 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.342 -0.848 . . . . 0.0 109.708 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 39.6 Cg_endo -65.43 149.2 88.24 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.639 1.336 . . . . 0.0 110.272 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.576 ' O ' ' N ' ' B' ' 8' ' ' THR . 45.2 m -94.08 92.03 7.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.278 -0.889 . . . . 0.0 111.542 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.513 ' CE2' HG21 ' A' ' 55' ' ' VAL . 1.8 m95 37.48 -86.98 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.614 -0.679 . . . . 0.0 111.313 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.596 HG21 ' HG2' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -42.83 -48.62 5.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.247 -0.908 . . . . 0.0 109.802 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 87' ' ' GLU . 41.2 m -45.79 -37.76 6.41 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.378 -0.826 . . . . 0.0 109.218 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.462 ' H ' HG23 ' B' ' 10' ' ' VAL . 5.7 t -67.94 -42.03 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.71 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.495 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 9.7 mm -69.47 -26.73 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.785 . . . . 0.0 110.177 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.565 HD23 ' OE2' ' A' ' 84' ' ' GLU . 1.3 mm? -67.55 -56.52 9.14 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.392 -0.817 . . . . 0.0 110.138 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.793 HG12 ' CD1' ' A' ' 112' ' ' LEU . 9.6 t -57.31 -39.98 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.309 -0.869 . . . . 0.0 110.341 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.815 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.01 -32.28 72.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.767 -1.208 . . . . 0.0 109.596 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -41.57 89.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.339 -0.85 . . . . 0.0 109.239 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 7.2 mtt -75.12 -25.96 58.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.905 . . . . 0.0 109.753 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.747 ' C ' HD11 ' A' ' 116' ' ' LEU . 5.6 mp -81.25 49.94 1.35 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.375 -0.828 . . . . 0.0 109.697 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.512 ' N ' HD11 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -126.12 -73.5 0.62 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.247 -0.908 . . . . 0.0 111.714 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -158.67 90.64 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.105 -0.997 . . . . 0.0 111.177 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' B' ' 20' ' ' ARG . 19.6 ttp180 59.94 5.2 0.7 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.211 -0.931 . . . . 0.0 110.911 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.25 84.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.851 -1.156 . . . . 0.0 110.233 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.75 54.38 1.95 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 110.35 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.97 -111.7 0.64 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 145' ' ' MET . 1.2 t-20 -128.35 73.4 80.12 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.27 -1.135 . . . . 0.0 110.044 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.74 -2.26 10.6 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.127 1.593 . . . . 0.0 110.548 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.513 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 22.9 m-85 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.133 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.167 0.508 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 1' ' ' ALA . 1.7 t70 -43.61 154.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.123 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' LEU . 4.2 tt0 -88.61 49.08 1.72 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 110.262 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 3' ' ' GLN . 6.6 mt -55.85 -162.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.157 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.456 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 15.1 p -133.19 127.38 33.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.963 . . . . 0.0 110.398 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.55 -43.62 54.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.86 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -50.12 -53.82 24.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 109.644 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.456 ' HG3' ' CB ' ' A' ' 5' ' ' THR . 4.5 mt-30 -50.09 -52.44 34.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.54 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.3 mt -53.32 -48.69 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.277 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -56.46 -38.38 71.6 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.287 -0.883 . . . . 0.0 109.101 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -54.07 -52.42 60.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.411 -0.805 . . . . 0.0 109.184 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.555 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 34.4 m-85 -63.32 -40.48 97.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.237 -0.915 . . . . 0.0 109.13 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -55.89 -44.0 77.77 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.466 -0.771 . . . . 0.0 108.94 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 59.7 mt-10 -56.87 -46.38 81.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.451 -0.781 . . . . 0.0 109.032 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.579 ' HB2' ' HD2' ' B' ' 14' ' ' LYS . . . -67.62 -51.66 47.48 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.322 -0.861 . . . . 0.0 109.281 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.598 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 19.8 t80 -45.12 -34.02 2.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.415 -0.803 . . . . 0.0 108.845 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.9 p -81.73 -32.58 31.51 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.627 -0.671 . . . . 0.0 109.215 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.748 ' O ' HD23 ' A' ' 18' ' ' LEU . 6.8 tt -49.74 -34.78 20.01 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.322 -0.862 . . . . 0.0 109.177 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.452 ' HA ' HG21 ' A' ' 35' ' ' VAL . 57.7 m-85 -82.61 -46.02 13.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.447 -0.783 . . . . 0.0 109.853 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.0 103.65 2.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 109.951 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -91.45 -31.21 16.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 110.454 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 29.9 p-10 -75.02 -46.59 34.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.299 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 108.94 45.65 1.01 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 49.1 p30 -115.73 -18.17 10.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -1.179 . . . . 0.0 110.009 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 91.69 5.42 66.69 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 16.7 p -120.14 116.24 25.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -1.141 . . . . 0.0 110.484 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.732 HD12 ' HB ' ' A' ' 63' ' ' ILE . 14.2 mt -90.84 124.33 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 109.877 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.414 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 7.8 p -100.3 178.36 4.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -63.12 -32.54 73.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.105 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 26.5 tptt -71.52 -54.4 10.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.273 -0.892 . . . . 0.0 110.308 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 41.3 mt-10 -49.41 -61.98 1.8 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 0.0 110.153 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.439 HD22 ' CZ2' ' B' ' 7' ' ' TRP . 35.5 tp -57.32 -31.5 65.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.97 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' HA2' HD11 ' A' ' 48' ' ' LEU . . . -67.03 -28.12 73.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.9 m -73.72 -52.08 14.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -1.101 . . . . 0.0 109.828 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.452 HG21 ' HA ' ' A' ' 19' ' ' PHE . 43.2 t -63.07 -35.37 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.947 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.5 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 4.1 mmt -66.26 -35.71 81.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.273 -0.892 . . . . 0.0 109.938 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.37 -24.4 60.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 110.117 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -76.15 -32.57 59.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.36 -0.837 . . . . 0.0 110.677 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 mt -53.81 -49.46 68.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.127 -0.983 . . . . 0.0 110.405 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 142.15 47.38 0.05 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 6.4 mm-40 -153.15 -167.4 2.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -1.127 . . . . 0.0 110.233 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -140.28 82.98 15.99 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.23 -0.919 . . . . 0.0 110.428 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 49.7 Cg_endo -76.79 148.63 28.76 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.978 1.515 . . . . 0.0 109.99 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.44 ' HB ' ' OE2' ' A' ' 47' ' ' GLU . 53.9 m -100.11 133.52 44.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.974 . . . . 0.0 110.227 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -42.34 -42.92 3.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.327 -0.858 . . . . 0.0 110.169 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' H ' HG22 ' A' ' 44' ' ' THR . . . -57.23 -54.4 47.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 109.742 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.44 ' OE2' ' HB ' ' A' ' 44' ' ' THR . 2.4 mt-10 -52.19 -38.02 56.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.369 -0.832 . . . . 0.0 109.681 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -56.7 -50.78 71.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.889 . . . . 0.0 109.724 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -50.77 -45.1 58.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.528 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.83 -23.58 66.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.439 -0.788 . . . . 0.0 109.537 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 2.2 mtp -86.92 -49.38 7.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 0.0 110.083 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 tp -57.47 -29.22 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.734 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -71.78 -5.29 33.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 110.474 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 51' ' ' MET . 2.4 mt-10 -86.95 -55.57 3.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 110.19 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 57' ' ' ALA . 38.9 t -70.25 -21.85 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 110.294 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 1.2 m-20 -66.89 64.01 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.185 -0.947 . . . . 0.0 110.389 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -51.5 -21.34 2.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.198 -0.939 . . . . 0.0 110.23 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' CG ' ' OD1' ' A' ' 60' ' ' ASN . 1.5 p30 -100.38 -32.44 10.83 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.34 -0.85 . . . . 0.0 110.418 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.71 52.82 2.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.436 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 5.7 m120 -99.25 -32.61 11.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.179 -1.189 . . . . 0.0 109.945 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.87 -14.3 12.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.4 p -139.66 165.14 28.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -1.07 . . . . 0.0 109.999 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.732 ' HB ' HD12 ' A' ' 27' ' ' ILE . 10.1 mm -96.83 165.89 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.319 -0.863 . . . . 0.0 110.102 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.541 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 35.2 m-20 -140.24 179.55 6.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.124 -0.985 . . . . 0.0 110.513 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.621 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 24.5 t80 -63.2 -44.27 83.15 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.33 -0.857 . . . . 0.0 111.52 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_endo -70.85 -36.04 8.51 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.359 1.189 . . . . 0.0 110.248 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 5.7 mt-10 -64.09 -29.32 70.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.393 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -50.77 23.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.0 mm? -50.52 -50.6 52.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 0.0 110.449 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.56 HG22 ' HG3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -60.79 -64.21 1.03 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.232 -0.917 . . . . 0.0 110.805 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' HB2' ' A' ' 75' ' ' LYS . 9.7 tpt -43.02 -62.27 1.07 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.042 -1.037 . . . . 0.0 110.696 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.555 ' HG3' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -39.16 -32.55 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.393 -0.817 . . . . 0.0 110.748 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -104.09 -48.26 3.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.164 -0.96 . . . . 0.0 110.474 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.56 ' HG3' HG22 ' A' ' 70' ' ' THR . 4.7 mtp180 -49.93 -67.39 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.256 -0.902 . . . . 0.0 110.438 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.75 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER -42.45 -44.94 4.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.375 -0.828 . . . . 0.0 110.42 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.0 mtt -98.47 48.13 0.99 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.313 -0.867 . . . . 0.0 110.325 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.86 -3.25 5.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.16 -0.963 . . . . 0.0 110.416 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -103.77 -75.52 0.61 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.247 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 p -142.79 -36.89 0.38 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.272 -0.892 . . . . 0.0 110.445 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.29 80.09 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.24 -0.912 . . . . 0.0 110.311 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.0 t -113.55 -48.89 2.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.904 . . . . 0.0 110.058 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -89.76 -18.31 26.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.52 -24.46 66.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.883 . . . . 0.0 109.678 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' HB3' ' CD1' ' B' ' 12' ' ' LEU . 9.2 mm-40 -67.7 -15.84 63.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.729 HG23 ' CE1' ' A' ' 141' ' ' PHE . 97.2 mt -70.68 -36.94 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.443 -0.785 . . . . 0.0 109.466 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 20.4 ttm-85 -59.71 -44.36 93.74 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.504 -0.747 . . . . 0.0 109.61 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 6.1 mm-40 -64.42 -51.6 62.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.286 -0.884 . . . . 0.0 109.609 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.826 ' HB2' HD22 ' B' ' 12' ' ' LEU . . . -60.39 -32.56 71.42 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.228 -0.92 . . . . 0.0 109.547 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.478 ' CE2' ' CG ' ' A' ' 138' ' ' TYR . 38.9 t80 -64.32 -43.12 95.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -29.04 70.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.834 . . . . 0.0 109.549 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.625 HG11 HG21 ' B' ' 13' ' ' VAL . 28.5 t -66.94 -51.94 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 0.0 110.209 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.706 ' CE1' HD23 ' A' ' 105' ' ' LEU . 11.8 m-85 -69.73 -29.71 67.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.199 -0.938 . . . . 0.0 110.013 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 94' ' ' LYS . 32.7 t0 -81.84 51.42 1.72 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 110.185 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -43.82 -30.37 0.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.214 -0.929 . . . . 0.0 110.259 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.95 -41.14 52.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.922 . . . . 0.0 110.119 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.98 -25.07 29.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.423 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 23.8 p-10 -51.03 -41.66 59.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -1.154 . . . . 0.0 110.328 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 119.02 60.13 0.27 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 1.9 m-85 -169.73 136.09 1.55 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.271 -1.135 . . . . 0.0 109.967 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 21.8 mt -112.49 106.47 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 110.58 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 102' ' ' ALA . 45.0 t -94.54 149.76 20.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.181 -0.95 . . . . 0.0 109.513 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.38 -27.25 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 0.0 109.827 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -71.95 -44.76 63.06 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 0.0 109.464 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 107' ' ' HIS . 21.6 mt-10 -60.94 -41.45 96.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 109.565 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.97 HD12 HD11 ' A' ' 125' ' ' ILE . 1.2 mt -58.34 -44.59 88.77 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.349 -0.844 . . . . 0.0 109.364 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.541 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.0 OUTLIER -58.26 -35.87 72.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.318 -0.864 . . . . 0.0 109.197 179.232 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.443 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 11.7 t-80 -55.72 -52.67 63.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.43 -0.794 . . . . 0.0 109.173 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.623 HG21 HG12 ' A' ' 91' ' ' VAL . 1.5 t -74.3 -35.51 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.537 -0.727 . . . . 0.0 109.227 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.596 ' HE1' ' HB2' ' A' ' 116' ' ' LEU . 10.8 ttm -49.73 -60.69 2.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.553 -0.717 . . . . 0.0 110.608 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.546 HG23 ' HE2' ' A' ' 115' ' ' LYS . 12.1 m -78.34 -17.45 56.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.314 -0.866 . . . . 0.0 110.68 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.537 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 17.7 m-20 -75.56 -14.78 60.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.002 . . . . 0.0 110.056 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' B' ' 14' ' ' LYS . 3.1 mt -101.21 -52.7 3.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.627 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.74 -18.97 0.18 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.87 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 35.8 tp10 -108.1 155.99 19.79 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.843 -1.387 . . . . 0.0 111.112 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.546 ' HE2' HG23 ' A' ' 110' ' ' THR . 2.2 mttm -131.25 64.36 1.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.611 -0.68 . . . . 0.0 109.521 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.596 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 1.8 mp -36.18 151.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.485 0.66 . . . . 0.0 111.126 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.563 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -61.87 -174.48 0.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.778 . . . . 0.0 110.152 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.87 -59.5 2.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.208 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.88 -42.75 37.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 109.605 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -61.61 -53.7 52.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.545 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 117' ' ' THR . 53.0 t -57.81 -41.11 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 109.921 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -61.63 -58.24 8.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.854 . . . . 0.0 109.845 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -54.81 -37.59 66.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.308 -0.87 . . . . 0.0 109.706 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.551 ' O ' ' CD2' ' B' ' 22' ' ' PHE . 9.4 ttt -52.42 -44.14 65.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.911 . . . . 0.0 109.515 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.97 HD11 HD12 ' A' ' 105' ' ' LEU . 38.7 mm -78.44 -53.08 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.066 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -44.11 -68.52 0.19 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.83 . . . . 0.0 110.636 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 126' ' ' ARG . 1.3 tp10 -39.02 -53.93 1.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.535 -0.728 . . . . 0.0 110.755 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.582 ' HB3' HG22 ' A' ' 136' ' ' VAL . . . -58.92 -34.88 72.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 110.382 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.456 ' OD2' ' N ' ' A' ' 135' ' ' GLN . 1.6 t0 -65.78 68.45 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.434 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -60.07 -42.36 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.27 -0.894 . . . . 0.0 109.908 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.6 -35.97 78.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.195 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.53 71.92 1.24 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.0 p30 -121.71 -25.29 5.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.308 -1.113 . . . . 0.0 110.089 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 129.6 -20.6 5.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.456 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 16.0 pt20 -154.6 170.23 22.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -1.154 . . . . 0.0 110.26 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 128' ' ' ALA . 46.5 t -79.49 164.44 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.252 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.427 ' N ' HG12 ' A' ' 136' ' ' VAL . 55.3 t30 -133.4 173.18 11.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.305 -0.872 . . . . 0.0 110.112 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.478 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -57.38 -68.22 0.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.261 -0.899 . . . . 0.0 110.26 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 143' ' ' GLN . 10.3 mm-40 -40.81 -53.26 2.9 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.447 -0.783 . . . . 0.0 110.023 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 141' ' ' PHE . 50.3 mt-10 -55.41 -57.86 10.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 109.505 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.729 ' CE1' HG23 ' A' ' 85' ' ' ILE . 3.7 t80 -43.62 -27.38 0.3 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.429 -0.794 . . . . 0.0 109.5 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 144' ' ' MET . 73.9 t -99.56 -64.39 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 139' ' ' GLU . 28.5 tp60 -43.07 -24.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.306 -0.871 . . . . 0.0 110.604 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 142' ' ' VAL . 1.8 tpt -84.31 -32.66 24.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 111.025 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.9 mtp -100.66 -11.42 20.01 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.017 -1.052 . . . . 0.0 111.947 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 146' ' ' THR . 9.0 t -156.06 88.84 1.11 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.705 -1.247 . . . . 0.0 111.175 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 148' ' ' LYS . . . -100.35 34.09 2.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.013 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 147' ' ' ALA . 7.9 tptp . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.136 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' B' ' 2' ' ' LYS . 12.8 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.241 0.543 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' B' ' 1' ' ' VAL . 5.3 mttt -160.62 157.15 26.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.975 . . . . 0.0 110.44 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 9.1 mt -107.31 -17.09 14.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.862 . . . . 0.0 109.269 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.893 HG23 ' HD2' ' B' ' 5' ' ' PRO . 22.1 mt -146.62 157.38 48.04 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.893 ' HD2' HG23 ' B' ' 4' ' ' ILE . 36.0 Cg_endo -59.38 114.61 2.11 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.303 1.159 . . . . 0.0 109.858 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.538 ' O ' ' N ' ' B' ' 8' ' ' THR . 13.5 t -78.34 90.07 4.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.573 -0.704 . . . . 0.0 112.303 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.481 ' O ' ' N ' ' B' ' 10' ' ' VAL . 8.7 m95 43.99 -86.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.59 -0.694 . . . . 0.0 112.229 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.75 HG21 ' HG2' ' A' ' 75' ' ' LYS . 63.1 p -38.57 -46.96 1.25 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.537 -0.727 . . . . 0.0 110.945 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 97.5 m -48.87 -36.9 18.09 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.242 -0.911 . . . . 0.0 109.276 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' B' ' 7' ' ' TRP . 60.5 t -73.05 -43.07 59.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 46.7 mt -70.94 -21.82 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 109.974 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.826 HD22 ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -72.53 -50.62 24.46 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.625 HG21 HG11 ' A' ' 91' ' ' VAL . 42.7 t -71.14 -39.01 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.124 -0.985 . . . . 0.0 110.446 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.714 ' HA ' HD13 ' A' ' 112' ' ' LEU . 2.7 tmtt? -59.64 -47.54 85.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.775 -1.203 . . . . 0.0 109.263 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 35.0 p -53.52 -48.85 68.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.451 -0.781 . . . . 0.0 109.228 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 10.6 ttm -54.82 -27.7 43.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.314 -0.866 . . . . 0.0 109.872 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.697 HD22 ' CD1' ' A' ' 112' ' ' LEU . 7.0 mp -79.71 49.51 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.249 -0.907 . . . . 0.0 110.574 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -96.6 -83.06 0.39 Allowed 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.331 -0.856 . . . . 0.0 109.769 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.466 ' O ' ' HD3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -140.44 -41.14 0.42 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.365 -0.835 . . . . 0.0 109.475 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' B' ' 21' ' ' SER . 2.4 ttt-85 -149.63 -41.53 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' B' ' 22' ' ' PHE . 26.8 t 29.73 -126.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.093 0.473 . . . . 0.0 111.32 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 124' ' ' MET . 1.5 m-85 61.99 57.74 2.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 110.519 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.468 ' C ' ' HD2' ' B' ' 25' ' ' PRO . . . -142.99 -165.01 10.46 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.721 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 39.0 p-10 -107.1 -2.83 0.11 Allowed Pre-proline 0 CA--C 1.569 1.697 0 O-C-N 121.28 -1.129 . . . . 0.0 112.974 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 48.0 Cg_endo -73.46 76.92 2.63 Favored 'Trans proline' 0 N--CA 1.485 0.971 0 O-C-N 122.304 0.634 . . . . 0.0 110.498 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.431 ' CE2' ' HG ' ' B' ' 12' ' ' LEU . 12.8 t80 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.228 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.252 0.549 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 6.4 t0 178.64 121.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.323 -0.861 . . . . 0.0 110.222 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -55.82 107.35 0.34 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 110.246 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 5' ' ' THR . 0.5 OUTLIER -51.3 132.07 28.69 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.227 -0.921 . . . . 0.0 110.38 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.604 ' O ' HD12 ' A' ' 9' ' ' ILE . 3.0 p -151.29 107.53 3.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -0.881 . . . . 0.0 110.172 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 7' ' ' GLU . 1.5 tp10 -67.47 -52.81 34.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 110.695 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -43.77 -70.11 0.12 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.105 -0.997 . . . . 0.0 110.45 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.66 -58.09 4.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.211 -0.931 . . . . 0.0 110.464 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.604 HD12 ' O ' ' A' ' 5' ' ' THR . 97.7 mt -44.7 -50.02 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.226 -0.921 . . . . 0.0 110.296 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -49.84 -51.31 40.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 12' ' ' PHE . 9.5 tm-20 -51.58 -45.46 63.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 110.089 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CD1' ' OE1' ' A' ' 11' ' ' GLU . 18.8 m-30 -55.2 -44.42 75.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 110.014 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -53.68 -49.77 67.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.936 . . . . 0.0 109.803 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.47 -47.18 66.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 110.083 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -60.96 -46.55 90.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.813 . . . . 0.0 110.235 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.525 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 34.9 t80 -57.65 -45.36 85.62 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 110.041 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.0 t -70.18 -17.1 63.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.85 . . . . 0.0 110.0 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.923 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.0 tt -69.99 -55.42 9.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.976 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.46 ' N ' HD23 ' A' ' 18' ' ' LEU . 91.4 m-85 -72.43 -11.97 60.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 0.0 110.27 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 21' ' ' LYS . 25.4 t0 -97.5 69.54 2.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' ASP . 20.3 mmtt -42.47 -71.24 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.328 -0.858 . . . . 0.0 110.126 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD2' ' CG ' ' A' ' 24' ' ' ASP . 2.4 p-10 -51.95 -41.23 61.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.383 -0.823 . . . . 0.0 110.062 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.4 46.72 5.71 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.464 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 39.4 p-10 -103.23 6.79 38.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.202 . . . . 0.0 110.238 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.69 ' O ' HG23 ' A' ' 26' ' ' THR . . . 78.3 30.38 50.25 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 25' ' ' GLY . 10.0 p -158.12 104.09 1.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -1.139 . . . . 0.0 110.28 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.53 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 9.5 mt -80.6 125.52 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.227 -0.921 . . . . 0.0 109.8 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p -100.1 165.74 11.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.385 -0.822 . . . . 0.0 110.68 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.9 p -56.47 -41.69 76.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.851 . . . . 0.0 110.214 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -62.02 -53.16 59.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 110.248 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -52.02 -68.74 0.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 110.092 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.516 HD22 HD11 ' A' ' 52' ' ' ILE . 23.8 tp -49.58 -32.51 12.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.898 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.97 -53.94 36.95 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.0 m -48.12 -47.17 34.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -1.151 . . . . 0.0 109.686 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.444 ' H ' HG23 ' A' ' 35' ' ' VAL . 6.3 t -61.01 -51.49 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.352 -0.843 . . . . 0.0 109.739 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.466 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 5.2 mmt -57.88 -39.61 78.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.84 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -34.9 72.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 110.016 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 39' ' ' LEU . 1.4 m -68.07 -48.11 66.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.164 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 38' ' ' SER . 9.5 mt -44.21 -25.3 0.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.873 . . . . 0.0 110.261 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.81 50.64 0.68 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 36' ' ' MET . 0.3 OUTLIER -154.61 -163.31 1.56 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -1.127 . . . . 0.0 110.224 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -151.79 102.15 2.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.055 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.62 119.23 5.82 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.016 1.535 . . . . 0.0 110.524 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 47' ' ' GLU . 9.1 m -76.05 155.3 34.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.301 -0.874 . . . . 0.0 110.22 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -45.64 -69.64 0.13 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 110.026 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.06 -47.28 65.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.999 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' CG ' ' HB ' ' A' ' 44' ' ' THR . 13.0 mt-10 -46.35 -55.44 7.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.265 -0.897 . . . . 0.0 110.095 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.425 HD23 HD23 ' A' ' 32' ' ' LEU . 1.1 mt -53.78 -40.26 66.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.75 -34.7 77.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.974 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -41.15 97.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.838 . . . . 0.0 110.156 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.8 mtp -74.7 -41.27 60.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.316 -0.865 . . . . 0.0 110.251 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.516 HD11 HD22 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -71.15 -14.84 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.197 -0.939 . . . . 0.0 109.699 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.87 -18.63 36.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.288 -0.883 . . . . 0.0 110.187 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.86 -50.95 9.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.521 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 57' ' ' ALA . 10.7 t -72.95 -22.23 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.175 -0.953 . . . . 0.0 110.021 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.87 86.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.363 -0.835 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -80.31 -46.11 16.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.202 -0.936 . . . . 0.0 110.436 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 12.2 p-10 -75.94 -42.5 48.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.084 -1.01 . . . . 0.0 110.409 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.53 44.92 2.22 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 27.0 p-10 -99.48 -38.2 8.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -1.206 . . . . 0.0 110.383 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 128.78 0.95 6.02 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.4 p -145.85 161.77 39.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -1.127 . . . . 0.0 110.072 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' THR . 17.2 mm -86.69 152.21 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.185 -0.947 . . . . 0.0 110.518 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.525 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 29.6 m-20 -127.35 -173.15 2.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 110.542 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.763 ' CE1' HD11 ' A' ' 69' ' ' LEU . 5.0 t80 -74.39 -42.07 5.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.418 -0.801 . . . . 0.0 111.326 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -72.94 -24.57 17.41 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.274 1.144 . . . . 0.0 110.395 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 3.5 mt-10 -70.82 -32.43 69.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.394 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -77.41 -33.81 54.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.893 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.763 HD11 ' CE1' ' A' ' 65' ' ' PHE . 85.1 mt -72.75 -26.91 61.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.339 -0.851 . . . . 0.0 111.21 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 p -89.32 -34.77 16.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.902 -1.124 . . . . 0.0 111.227 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.419 ' HE1' HG23 ' B' ' 8' ' ' THR . 0.3 OUTLIER -74.59 -39.24 62.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.137 -0.977 . . . . 0.0 111.022 -179.272 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.844 ' SD ' HG21 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -63.87 -22.11 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.05 -1.031 . . . . 0.0 110.879 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -94.94 -9.72 33.24 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.928 -1.107 . . . . 0.0 110.882 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 27.0 tpt180 -82.36 -46.88 13.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.161 -0.962 . . . . 0.0 110.747 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.62 -21.24 35.16 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.556 ' SD ' ' HE3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -100.51 63.19 1.08 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.17 -0.956 . . . . 0.0 110.468 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -168.34 69.25 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.238 -0.914 . . . . 0.0 110.467 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 79' ' ' THR . 0.8 OUTLIER 65.72 71.98 0.42 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 78' ' ' ASP . 17.6 p -158.66 -100.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.276 -0.89 . . . . 0.0 110.25 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.535 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -124.27 80.86 1.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.048 -1.033 . . . . 0.0 109.856 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.9 m -96.12 -43.67 7.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.367 -0.833 . . . . 0.0 109.442 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.53 -31.59 69.53 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.434 -0.792 . . . . 0.0 109.402 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.05 -39.3 34.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.468 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 80' ' ' ASP . 6.0 mm-40 -72.61 -27.0 61.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.622 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.77 -26.19 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.404 ' HG2' ' OH ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -68.96 -29.1 67.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.39 0.614 . . . . 0.0 109.444 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.907 ' HB3' HG21 ' B' ' 9' ' ' THR . 24.7 mt-10 -76.57 -47.79 21.36 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.281 -0.887 . . . . 0.0 109.199 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.579 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -57.97 -33.88 69.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.083 -1.01 . . . . 0.0 108.86 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -66.76 -48.09 70.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.432 -0.792 . . . . 0.0 109.464 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -52.69 -30.89 34.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.387 -0.821 . . . . 0.0 109.573 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 63.7 t -67.72 -53.18 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.818 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.669 ' CB ' HD13 ' A' ' 100' ' ' ILE . 67.0 m-85 -63.02 -15.02 55.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.135 -0.978 . . . . 0.0 109.989 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -100.04 65.01 1.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 110.436 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -40.97 -72.05 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.383 -0.823 . . . . 0.0 110.486 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.1 p30 -61.03 -28.44 69.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.01 50.13 7.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -99.73 -7.27 25.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.294 -1.121 . . . . 0.0 110.357 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.7 29.58 8.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.417 ' CD1' ' CD ' ' A' ' 135' ' ' GLN . 0.9 OUTLIER -161.31 143.19 11.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -1.139 . . . . 0.0 110.081 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.669 HD13 ' CB ' ' A' ' 92' ' ' PHE . 17.3 mt -118.71 158.26 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.522 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 102' ' ' ALA . 23.2 p -148.07 155.76 41.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.387 -0.82 . . . . 0.0 109.927 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.1 -43.1 3.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.332 -0.855 . . . . 0.0 110.205 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.78 -51.09 68.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.839 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 92' ' ' PHE . 17.9 mt-10 -58.74 -47.75 83.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 0.0 109.959 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.0 HD12 ' CD1' ' A' ' 125' ' ' ILE . 2.1 mt -62.62 -33.92 75.99 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.271 -0.893 . . . . 0.0 109.696 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -61.63 -34.07 75.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.248 -0.908 . . . . 0.0 109.431 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 10.0 t-80 -68.26 -43.67 77.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.402 -0.812 . . . . 0.0 109.588 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.675 HG13 HD12 ' A' ' 112' ' ' LEU . 1.2 t -64.16 -34.42 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 109.896 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.991 ' HA ' HD21 ' B' ' 17' ' ' LEU . 4.8 mtt -53.63 -70.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.608 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.6 m -55.38 -16.78 3.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.898 . . . . 0.0 110.554 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 9.0 m120 -94.67 -6.49 43.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.103 -0.998 . . . . 0.0 110.392 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.923 ' O ' HD11 ' A' ' 18' ' ' LEU . 9.6 mt -132.06 6.95 4.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.037 -1.04 . . . . 0.0 111.686 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.3 -93.34 0.13 Allowed Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.404 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' CG ' ' N ' ' A' ' 115' ' ' LYS . 15.3 tt0 -136.53 166.07 24.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -1.076 . . . . 0.0 110.408 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -103.6 118.66 37.23 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.641 ' N ' HD12 ' A' ' 116' ' ' LEU . 9.3 mp -64.83 155.31 34.4 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 121.446 -0.784 . . . . 0.0 110.336 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.637 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -49.09 178.8 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.365 -0.835 . . . . 0.0 109.274 179.436 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.79 -57.23 4.24 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.89 -1.131 . . . . 0.0 110.263 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.97 -49.01 31.91 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.195 -0.94 . . . . 0.0 109.669 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -57.69 -60.51 3.58 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 108.978 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 117' ' ' THR . 79.1 t -47.32 -44.58 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.299 -0.876 . . . . 0.0 109.416 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -50.53 71.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.292 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.569 ' HB3' ' HG3' ' B' ' 20' ' ' ARG . 0.2 OUTLIER -57.83 -31.24 66.44 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.183 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.571 ' SD ' HD13 ' A' ' 105' ' ' LEU . 9.3 ttt -60.1 -43.85 95.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.475 -0.766 . . . . 0.0 109.294 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.0 ' CD1' HD12 ' A' ' 105' ' ' LEU . 37.6 mm -84.87 -27.12 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.923 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -45.06 78.47 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.315 -0.866 . . . . 0.0 110.314 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.08 -36.18 82.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.339 -0.851 . . . . 0.0 110.165 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.23 -32.45 58.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.381 -0.824 . . . . 0.0 110.124 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.04 63.65 0.68 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.75 -58.85 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.524 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 1.7 p30 -55.07 -36.13 65.27 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.582 -0.698 . . . . 0.0 109.784 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 98.48 69.17 0.93 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.412 ' OD2' ' CG ' ' A' ' 131' ' ' ASP . 3.2 m-20 -121.89 -4.59 9.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -1.192 . . . . 0.0 110.133 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.55 -9.88 63.56 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.42 ' CB ' ' O ' ' A' ' 100' ' ' ILE . 2.8 pt20 -142.97 168.02 20.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -1.147 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 140' ' ' GLU . 5.2 t -112.82 155.76 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.203 -0.936 . . . . 0.0 110.243 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.431 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 17.6 p-10 -125.79 -144.81 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.335 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.404 ' OH ' ' HG2' ' A' ' 86' ' ' ARG . 1.1 t80 -80.15 -70.08 0.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.277 -0.89 . . . . 0.0 110.547 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 143' ' ' GLN . 26.4 mt-10 -43.03 -38.43 2.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.201 -0.937 . . . . 0.0 110.429 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.536 ' HB3' HG13 ' A' ' 136' ' ' VAL . 32.8 mt-10 -68.54 -62.26 1.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.271 -0.893 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -51.93 -22.1 3.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.3 -0.875 . . . . 0.0 110.645 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.56 -52.56 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.102 -0.999 . . . . 0.0 110.838 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.466 ' CB ' ' O ' ' A' ' 139' ' ' GLU . 4.5 tp60 -57.84 -13.03 3.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.267 -0.895 . . . . 0.0 110.832 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.8 mmm -99.34 -18.21 17.64 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.001 -1.062 . . . . 0.0 110.765 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.0 mtp -100.49 -69.25 0.78 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.041 -1.037 . . . . 0.0 110.836 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -117.39 70.72 0.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.942 . . . . 0.0 110.373 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.18 53.06 0.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.102 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.0 mttt . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.269 -179.892 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.197 0.523 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.95 126.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.267 -0.896 . . . . 0.0 110.474 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.59 ' O ' HD12 ' B' ' 3' ' ' LEU . 0.9 OUTLIER -114.0 31.35 6.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.3 -0.875 . . . . 0.0 110.147 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 6.7 mt -107.11 132.3 21.03 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.121 -0.987 . . . . 0.0 110.329 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.73 -176.45 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.081 1.569 . . . . 0.0 110.928 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.427 ' OG ' ' OE2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -106.4 178.65 4.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.329 -0.857 . . . . 0.0 110.501 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.52 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -54.11 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.415 -0.803 . . . . 0.0 110.911 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.478 ' HA ' HD12 ' B' ' 11' ' ' ILE . 55.9 p -44.82 -50.58 10.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 110.151 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.907 HG21 ' HB3' ' A' ' 87' ' ' GLU . 37.9 m -44.01 -50.37 8.34 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.444 -0.785 . . . . 0.0 109.633 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 24.9 t -57.22 -34.83 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.191 -0.943 . . . . 0.0 109.233 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.844 HG21 ' SD ' ' A' ' 72' ' ' MET . 18.4 mt -74.08 -30.49 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 108.722 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -58.38 8.62 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.543 -0.723 . . . . 0.0 109.378 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.609 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 81.0 t -59.12 -51.19 75.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.554 -0.716 . . . . 0.0 110.373 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.448 ' HG3' HD13 ' A' ' 18' ' ' LEU . 2.4 tmtm? -51.6 -58.57 5.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.025 -1.047 . . . . 0.0 109.878 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -51.15 -25.95 6.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.403 -0.811 . . . . 0.0 110.194 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.49 ' O ' ' HB2' ' B' ' 21' ' ' SER . 6.3 tpp -70.88 -32.78 69.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.991 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.9 mp -64.68 -102.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.965 -1.084 . . . . 0.0 109.838 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.567 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 55.32 -72.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.505 -0.747 . . . . 0.0 110.85 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.636 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -173.43 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.321 -0.862 . . . . 0.0 110.952 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.569 ' HG3' ' HB3' ' A' ' 123' ' ' GLU . 7.0 tmm_? 73.97 -7.1 1.69 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.892 -1.13 . . . . 0.0 110.297 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' B' ' 16' ' ' MET . 36.0 m -46.79 116.09 1.24 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.045 -1.034 . . . . 0.0 109.779 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -148.51 -32.84 0.24 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.174 -0.954 . . . . 0.0 111.282 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' B' ' 22' ' ' PHE . . . -54.81 -111.41 0.01 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.609 ' ND2' ' OXT' ' B' ' 26' ' ' PHE . 8.2 t-20 -116.42 96.23 47.4 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.24 -1.153 . . . . 0.0 110.242 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.5 -18.45 20.08 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.099 1.579 . . . . 0.0 110.337 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.609 ' OXT' ' ND2' ' B' ' 24' ' ' ASN . 46.0 m-85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.285 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.195 0.521 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.97 18.95 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.201 -0.937 . . . . 0.0 110.294 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.87 77.25 2.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 110.238 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 mt -78.22 -164.06 0.5 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.296 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -118.85 12.37 12.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.307 -0.871 . . . . 0.0 110.18 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 1.2 tm-20 -72.28 -40.21 67.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.23 -0.919 . . . . 0.0 110.39 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.658 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.5 mt-10 -41.38 -70.05 0.12 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.341 -0.85 . . . . 0.0 110.134 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -46.56 -50.07 17.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.0 . . . . 0.0 109.235 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 21.6 mt -53.63 -38.4 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.3 -0.875 . . . . 0.0 108.751 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.03 -46.95 65.22 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.284 -0.885 . . . . 0.0 108.806 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.475 ' CD ' ' HD2' ' B' ' 18' ' ' ARG . 6.0 tt0 -53.69 -53.9 45.47 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.217 -0.927 . . . . 0.0 108.819 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -55.57 -40.27 71.75 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.373 -0.829 . . . . 0.0 108.856 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -59.43 -40.38 86.55 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 17' ' ' SER . 8.3 tt0 -49.61 -55.12 14.72 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.453 -0.78 . . . . 0.0 108.95 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.05 -55.99 24.82 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.506 -0.878 . . . . 0.0 108.76 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.547 ' HD1' HD11 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -49.1 -26.85 2.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 3.2 m -87.85 -36.33 17.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.541 -0.724 . . . . 0.0 109.113 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.763 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.8 tt -47.98 -34.61 9.55 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.389 -0.819 . . . . 0.0 109.376 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.751 ' HA ' HG21 ' A' ' 35' ' ' VAL . 73.4 m-85 -81.8 -28.66 33.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.824 . . . . 0.0 109.986 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 5.0 t0 -87.36 81.54 7.84 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.213 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -52.56 -56.97 11.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 110.374 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.42 ' OD1' ' CG ' ' A' ' 24' ' ' ASP . 3.0 p30 -59.16 -41.17 87.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 110.373 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.86 57.6 1.7 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 35.5 p-10 -114.33 10.4 17.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.231 -1.158 . . . . 0.0 110.293 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.97 15.18 73.96 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 1.2 p -141.72 116.6 9.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -1.225 . . . . 0.0 110.275 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.547 HD11 ' HD1' ' A' ' 16' ' ' PHE . 13.4 mt -92.27 112.92 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.149 -0.97 . . . . 0.0 109.738 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.482 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 18.8 p -75.95 -160.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.915 . . . . 0.0 110.354 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.408 ' O ' HD22 ' A' ' 48' ' ' LEU . 22.0 p -88.82 -45.4 9.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 110.543 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.549 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 21.5 pttt -71.63 -25.87 62.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.026 -1.046 . . . . 0.0 110.574 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.797 ' O ' HG23 ' A' ' 35' ' ' VAL . 47.2 mt-10 -63.15 -44.67 94.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.031 -1.043 . . . . 0.0 109.491 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 48' ' ' LEU . 2.9 tp -67.35 -48.18 68.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.332 -0.855 . . . . 0.0 109.649 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.81 -44.96 49.36 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.8 m -61.17 -57.15 13.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.353 -1.086 . . . . 0.0 109.736 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 31' ' ' GLU . 21.4 t -50.42 -40.46 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.213 -0.929 . . . . 0.0 109.655 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 4.7 mmt -60.82 -47.57 85.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.268 -0.895 . . . . 0.0 109.412 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.456 ' NE ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -47.79 -38.23 15.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.395 179.224 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -63.04 -45.27 93.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.564 -0.71 . . . . 0.0 110.705 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 3.1 mt -57.88 -34.47 69.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.165 -0.959 . . . . 0.0 110.455 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.37 63.65 0.32 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.456 ' O ' ' NE ' ' A' ' 37' ' ' ARG . 1.9 pt20 -160.75 -175.66 5.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.309 -1.112 . . . . 0.0 109.922 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -131.12 95.08 25.94 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.068 -1.02 . . . . 0.0 110.624 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HG3' ' HB2' ' A' ' 36' ' ' MET . 47.2 Cg_endo -75.34 123.49 7.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.041 1.548 . . . . 0.0 110.177 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.421 ' HB ' ' HG3' ' A' ' 47' ' ' GLU . 17.4 m -94.98 168.5 10.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' N ' HG22 ' A' ' 44' ' ' THR . 37.9 tt0 -57.44 -56.45 21.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.121 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.37 -55.26 16.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 0.0 110.258 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' A' ' 44' ' ' THR . 2.6 mm-40 -51.23 -52.86 40.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 110.006 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 32' ' ' LEU . 9.0 mt -46.61 -64.28 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.81 -34.81 63.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.419 -0.801 . . . . 0.0 110.075 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.55 -33.91 69.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 110.285 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.517 ' O ' ' NE1' ' B' ' 7' ' ' TRP . 9.8 mtp -81.17 -34.59 32.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -0.85 . . . . 0.0 110.023 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 10.9 mm -74.53 -36.62 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -0.867 . . . . 0.0 109.76 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -68.04 -20.39 64.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.394 -0.816 . . . . 0.0 110.135 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.04 -42.67 66.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 110.383 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 57' ' ' ALA . 8.7 t -83.8 -51.04 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -41.76 90.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.651 . . . . 0.0 110.428 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -83.36 -36.43 24.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.462 -0.774 . . . . 0.0 110.747 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' OD2' ' CG ' ' A' ' 60' ' ' ASN . 6.5 p-10 -72.17 -48.26 44.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.032 -1.042 . . . . 0.0 110.535 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.89 35.94 1.09 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 29.2 p-10 -98.56 -46.02 5.88 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.016 -1.285 . . . . 0.0 110.314 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 118.43 13.69 6.75 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.5 p -144.4 141.44 29.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.16 -1.2 . . . . 0.0 110.538 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.546 ' HB ' HD12 ' A' ' 27' ' ' ILE . 35.4 mm -85.21 142.25 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.219 -0.925 . . . . 0.0 109.902 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -121.81 -175.66 3.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.075 -1.015 . . . . 0.0 110.593 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.6 t80 -65.97 -45.99 63.96 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.416 -0.802 . . . . 0.0 111.54 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.2 Cg_endo -68.62 -38.86 10.01 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 O-C-N 123.092 1.048 . . . . 0.0 110.395 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.61 -30.46 69.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.112 -0.992 . . . . 0.0 109.274 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CG ' ' HB2' ' A' ' 16' ' ' PHE . 4.1 t80 -69.92 -46.02 66.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.54 -0.725 . . . . 0.0 109.902 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.0 mm? -53.78 -53.05 57.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.353 -0.842 . . . . 0.0 110.303 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 71' ' ' MET . 1.5 p -66.04 -63.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.269 -0.895 . . . . 0.0 110.708 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.46 ' HG3' HG13 ' A' ' 55' ' ' VAL . 6.8 tmm? -40.51 -36.87 0.62 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.848 ' SD ' HG21 ' B' ' 11' ' ' ILE . 7.0 tpt -61.76 -12.1 15.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.224 -0.922 . . . . 0.0 110.702 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.02 -10.01 4.82 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.04 -1.037 . . . . 0.0 111.223 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -24.61 15.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.998 -1.064 . . . . 0.0 110.363 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.653 ' HB3' HG21 ' B' ' 8' ' ' THR . 2.1 tppm? -85.12 -15.58 43.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 0.0 110.414 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 10.4 mtm -99.2 -9.22 23.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 110.391 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 16.8 mmtm -110.34 51.71 0.75 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 109.996 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 79' ' ' THR . 5.3 t70 -178.71 98.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.293 -0.879 . . . . 0.0 110.196 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.1 m 64.92 24.94 12.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.248 -0.907 . . . . 0.0 110.352 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -155.17 59.94 0.65 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.26 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 m -83.52 -59.49 2.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 110.118 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -100.35 -25.65 14.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 110.317 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 3.6 tt0 -55.29 -43.47 74.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.069 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' HG3' HD12 ' B' ' 12' ' ' LEU . 19.3 tp10 -45.79 -50.21 14.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.345 -0.847 . . . . 0.0 110.495 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -70.76 -38.53 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.109 -0.994 . . . . 0.0 109.397 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 31.5 ttt180 -58.84 -30.64 67.84 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.367 -0.833 . . . . 0.0 109.916 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.615 ' HB3' HG21 ' B' ' 9' ' ' THR . 76.9 mm-40 -74.07 -55.33 6.24 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.273 -0.892 . . . . 0.0 109.665 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.42 -29.69 49.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 0.0 109.149 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -71.89 -34.5 69.2 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.159 -0.963 . . . . 0.0 109.083 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -63.84 -27.32 69.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.445 -0.784 . . . . 0.0 109.197 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.422 HG12 HG21 ' A' ' 108' ' ' VAL . 17.1 t -75.31 -43.98 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.517 -0.739 . . . . 0.0 110.151 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.519 ' CZ ' HG22 ' B' ' 13' ' ' VAL . 24.1 m-85 -67.01 -35.92 80.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.157 -0.965 . . . . 0.0 110.338 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -73.29 54.66 0.43 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.326 -0.859 . . . . 0.0 110.502 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 93' ' ' ASP . 13.4 tppt? -41.65 -46.63 3.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.0 110.288 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 21.4 p-10 -87.97 -26.78 22.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.56 47.55 12.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 31.6 p-10 -94.41 -22.35 18.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -1.121 . . . . 0.0 110.099 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.482 ' C ' ' CD2' ' A' ' 99' ' ' TYR . . . 110.76 15.23 11.23 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD2' ' C ' ' A' ' 98' ' ' GLY . 91.2 m-85 -150.72 137.73 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.307 -1.113 . . . . 0.0 110.181 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' GLN . 7.1 mt -101.71 150.74 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.13 -0.981 . . . . 0.0 110.14 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -138.48 146.78 42.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.151 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -44.88 -29.08 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.93 . . . . 0.0 109.843 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.75 79.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -0.843 . . . . 0.0 109.664 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.412 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 7.6 mt-10 -61.85 -45.03 95.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.494 ' CD1' HD11 ' A' ' 125' ' ' ILE . 1.5 mt -66.1 -38.09 87.37 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.354 -0.841 . . . . 0.0 109.267 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.493 ' NH2' ' HG2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -55.62 -35.83 66.3 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.406 -0.809 . . . . 0.0 109.084 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -71.03 -47.6 57.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.5 -0.75 . . . . 0.0 109.363 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG21 HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -60.5 -23.51 28.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.381 -0.824 . . . . 0.0 109.024 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.948 ' HA ' HD21 ' B' ' 17' ' ' LEU . 5.1 mtt -69.28 -63.51 1.05 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.503 -0.748 . . . . 0.0 109.812 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.3 m -56.94 -30.37 63.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.191 -0.943 . . . . 0.0 109.236 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 12.5 m120 -74.77 -17.79 60.58 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.459 -0.776 . . . . 0.0 109.671 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.875 HD11 HG12 ' B' ' 13' ' ' VAL . 3.9 mt -95.41 -48.08 6.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.858 . . . . 0.0 110.212 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.09 -30.12 0.22 Allowed Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.529 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 109' ' ' MET . 29.4 tt0 -125.05 171.22 10.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.873 -1.369 . . . . 0.0 110.941 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -144.98 75.7 1.46 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.798 HD21 ' CA ' ' B' ' 19' ' ' LYS . 2.4 mp -34.79 156.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.641 0.734 . . . . 0.0 111.494 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -57.1 -150.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.0 110.387 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.517 ' H ' HG22 ' A' ' 117' ' ' THR . 1.4 p-10 -109.76 -53.89 2.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.236 -0.915 . . . . 0.0 110.38 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.35 -44.46 84.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.019 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.93 -42.13 97.44 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.829 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.42 HG23 ' HB3' ' A' ' 116' ' ' LEU . 71.8 t -64.62 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.947 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -60.28 -45.19 94.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -61.47 -38.07 85.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 109.582 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -54.06 -49.25 69.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.162 -0.961 . . . . 0.0 109.681 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' CD1' ' A' ' 105' ' ' LEU . 37.5 mm -70.16 -26.48 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -70.14 -26.51 63.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.902 . . . . 0.0 109.917 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -71.46 -44.5 64.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.867 . . . . 0.0 110.064 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.853 ' HB2' ' HD2' ' B' ' 22' ' ' PHE . . . -71.44 -33.41 69.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.381 -0.824 . . . . 0.0 110.049 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -60.44 75.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.33 -0.857 . . . . 0.0 110.4 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 128' ' ' ALA . 21.5 mt -72.16 -31.34 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.968 . . . . 0.0 110.232 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 34.8 p-10 -83.94 -27.13 28.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.148 -0.97 . . . . 0.0 110.275 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.94 71.17 1.24 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 4.0 p30 -126.57 -23.37 3.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.244 -1.151 . . . . 0.0 110.468 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 104.63 -0.78 42.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 4.8 pt20 -151.18 166.67 30.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 110.204 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 53.3 t -110.68 151.77 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -131.95 -164.92 1.51 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.143 -0.973 . . . . 0.0 110.397 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.752 ' CE1' HG21 ' A' ' 142' ' ' VAL . 9.2 t80 -62.13 -65.82 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.229 -0.919 . . . . 0.0 110.72 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -41.87 -50.02 4.46 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.216 -0.927 . . . . 0.0 110.677 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -63.96 -59.99 3.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.965 . . . . 0.0 110.394 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.423 ' CE1' ' HE2' ' A' ' 92' ' ' PHE . 50.1 t80 -51.75 -20.57 2.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 110.523 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.752 HG21 ' CE1' ' A' ' 138' ' ' TYR . 41.6 t -100.51 -60.28 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.179 -0.951 . . . . 0.0 110.791 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 142' ' ' VAL . 9.5 tt0 -40.36 -45.82 2.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.31 -0.869 . . . . 0.0 110.762 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.445 ' O ' ' OD1' ' B' ' 24' ' ' ASN . 3.7 mmt -66.59 -26.8 67.28 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 110.419 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.485 ' N ' ' O ' ' A' ' 142' ' ' VAL . 19.9 mmm -96.07 -45.99 6.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.079 -1.013 . . . . 0.0 110.937 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.467 HG21 HG13 ' A' ' 142' ' ' VAL . 34.5 p -84.98 38.36 0.71 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.116 -0.99 . . . . 0.0 110.984 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 148' ' ' LYS . . . -94.36 20.63 7.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 110.141 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 147' ' ' ALA . 13.1 tptt . . . . . 0 N--CA 1.501 2.11 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.806 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.475 ' O ' HG13 ' B' ' 1' ' ' VAL . 2.4 p . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.232 0.539 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.1 -159.21 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.358 -0.839 . . . . 0.0 110.298 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.718 HD12 HG12 ' B' ' 4' ' ' ILE . 0.3 OUTLIER -165.6 -29.46 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.17 -0.956 . . . . 0.0 111.433 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.718 HG12 HD12 ' B' ' 3' ' ' LEU . 35.1 mm -100.1 146.91 32.74 Favored Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 120.926 -1.109 . . . . 0.0 110.829 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.672 ' HD2' HG23 ' B' ' 4' ' ' ILE . 42.3 Cg_endo -69.1 -157.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.936 1.493 . . . . 0.0 111.035 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' B' ' 7' ' ' TRP . 55.7 p -132.67 57.81 1.78 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.062 -1.024 . . . . 0.0 111.449 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.517 ' NE1' ' O ' ' A' ' 51' ' ' MET . 0.7 OUTLIER 64.27 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.972 -1.08 . . . . 0.0 111.575 178.583 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -46.33 -46.91 18.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 110.393 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 87' ' ' GLU . 26.0 m -45.83 -40.24 9.55 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.151 -0.968 . . . . 0.0 109.483 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.442 HG12 ' HZ ' ' A' ' 19' ' ' PHE . 10.2 t -66.03 -44.04 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.528 -0.733 . . . . 0.0 110.061 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.848 HG21 ' SD ' ' A' ' 72' ' ' MET . 51.7 mt -69.39 -25.29 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.288 -0.883 . . . . 0.0 109.907 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.532 ' C ' HD23 ' B' ' 12' ' ' LEU . 4.8 tt -67.08 -49.57 64.61 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 110.34 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.875 HG12 HD11 ' A' ' 112' ' ' LEU . 47.9 t -65.13 -46.96 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 110.561 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.649 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -58.61 -33.71 70.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.842 -1.161 . . . . 0.0 109.688 179.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 0.1 OUTLIER -63.95 -43.89 94.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.409 ' O ' ' N ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -59.18 -32.43 69.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.0 110.114 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.948 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.4 mp -69.4 58.65 0.12 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.161 -0.962 . . . . 0.0 110.345 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' B' ' 20' ' ' ARG . 3.0 ttp180 -123.84 76.22 1.42 Allowed 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.891 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.798 ' CA ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER 62.74 -57.77 0.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.605 -0.684 . . . . 0.0 111.042 179.071 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' B' ' 18' ' ' ARG . 0.7 OUTLIER -166.9 22.61 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.24 -0.913 . . . . 0.0 110.38 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' B' ' 18' ' ' ARG . 66.2 m -74.8 126.55 31.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.188 -0.945 . . . . 0.0 110.363 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.853 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -145.11 -40.64 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.118 -0.989 . . . . 0.0 110.913 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' B' ' 22' ' ' PHE . . . -46.37 -99.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 145' ' ' MET . 80.5 m-20 -138.3 88.11 15.23 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.144 -1.209 . . . . 0.0 110.719 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.63 -12.28 18.43 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.847 1.446 . . . . 0.0 110.036 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.642 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 5.5 m-30 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.269 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.231 0.538 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -131.1 57.79 1.74 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.23 -0.919 . . . . 0.0 110.21 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -100.04 116.76 32.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.266 -0.896 . . . . 0.0 110.322 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 mt -95.02 128.02 41.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.212 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.443 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 1.6 t -126.94 69.28 1.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.252 -0.905 . . . . 0.0 110.24 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -99.94 -35.74 9.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 8' ' ' GLN . 5.7 tp10 -51.62 -65.12 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 110.556 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.554 ' CG ' ' N ' ' A' ' 9' ' ' ILE . 12.8 pt20 -43.49 -47.33 7.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.138 -0.976 . . . . 0.0 109.983 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.554 ' N ' ' CG ' ' A' ' 8' ' ' GLN . 83.8 mt -67.02 -50.43 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.023 -1.048 . . . . 0.0 109.375 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.47 64.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 109.303 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 37.8 tt0 -58.84 -52.95 63.54 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.401 -0.812 . . . . 0.0 109.478 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.567 ' CE2' ' HG3' ' A' ' 72' ' ' MET . 1.6 m-85 -53.23 -43.67 67.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.349 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -59.53 -41.69 90.57 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.765 . . . . 0.0 109.525 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -49.52 77.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.311 -0.868 . . . . 0.0 109.487 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.84 83.94 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.351 -0.843 . . . . 0.0 109.355 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.509 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 38.8 t80 -61.29 -21.68 64.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.501 -0.749 . . . . 0.0 109.575 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -89.64 -31.39 17.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.451 -0.781 . . . . 0.0 109.694 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.924 HD13 ' HG3' ' B' ' 14' ' ' LYS . 10.4 tt -61.33 -44.72 96.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.866 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 74.8 m-85 -74.27 -47.38 35.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 110.193 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -67.18 73.0 0.11 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 19' ' ' PHE . 9.3 mmtt -64.89 -8.99 17.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 110.389 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -93.83 -29.55 15.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.351 -0.843 . . . . 0.0 110.167 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.11 33.61 44.51 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 23.5 p30 -104.81 -15.56 15.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.19 -1.182 . . . . 0.0 110.176 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 26' ' ' THR . . . 93.61 31.0 8.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 25' ' ' GLY . 24.7 p -156.02 118.3 4.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -1.155 . . . . 0.0 110.29 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.656 HD12 ' CG2' ' A' ' 63' ' ' ILE . 7.3 mt -92.9 125.74 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.014 -1.054 . . . . 0.0 110.093 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.1 p -100.5 -175.65 2.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.501 -0.749 . . . . 0.0 109.462 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.649 ' O ' HD22 ' A' ' 48' ' ' LEU . 2.9 p -76.13 -22.54 55.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.007 . . . . 0.0 109.822 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -73.03 -46.21 53.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 110.234 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.42 -62.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.473 ' HG ' ' HE3' ' A' ' 36' ' ' MET . 34.5 tp -54.88 -30.15 57.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.013 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.655 ' CA ' HD21 ' A' ' 48' ' ' LEU . . . -68.67 -32.33 74.38 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.1 m -71.88 -59.8 2.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -1.129 . . . . 0.0 110.16 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 35' ' ' VAL . 25.7 t -50.79 -46.34 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.955 . . . . 0.0 110.167 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.594 ' HE1' ' SD ' ' A' ' 51' ' ' MET . 0.3 OUTLIER -58.77 -47.59 84.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.259 -0.901 . . . . 0.0 110.098 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -24.95 58.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.883 . . . . 0.0 110.124 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.402 ' O ' ' CG ' ' A' ' 111' ' ' ASN . 36.3 t -77.98 -34.27 51.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.881 . . . . 0.0 110.513 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.58 HD12 ' HA ' ' A' ' 36' ' ' MET . 3.5 mt -53.97 -42.85 69.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.186 -0.946 . . . . 0.0 110.276 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.49 51.21 0.06 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.98 -162.13 1.49 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -1.127 . . . . 0.0 110.225 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.54 70.92 14.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.82 118.71 5.84 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.913 1.48 . . . . 0.0 110.243 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 3.1 m -82.02 152.62 26.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.888 . . . . 0.0 110.42 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -48.65 -53.74 17.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.41 -42.19 66.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.827 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 44' ' ' THR . 4.2 mm-40 -59.5 -52.11 66.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.861 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.655 HD21 ' CA ' ' A' ' 33' ' ' GLY . 1.7 mt -44.29 -57.21 3.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.903 . . . . 0.0 109.946 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.69 -45.47 28.43 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 109.597 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.04 -39.42 78.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.484 -0.76 . . . . 0.0 109.668 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.594 ' SD ' ' HE1' ' A' ' 36' ' ' MET . 1.6 ttp -74.96 -51.03 14.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 109.64 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 52' ' ' ILE . 1.9 mm -47.95 -24.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.226 -0.921 . . . . 0.0 109.221 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.22 -14.78 59.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 110.204 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -79.59 -8.42 59.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.253 -0.905 . . . . 0.0 110.428 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.695 HG23 ' CD1' ' B' ' 7' ' ' TRP . 54.9 t -118.34 -53.86 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.062 -1.024 . . . . 0.0 110.675 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -19.27 82.6 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.459 0.647 . . . . 0.0 112.014 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.77 -60.88 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.455 -0.778 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 13.6 p30 -68.32 -21.61 64.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.9 . . . . 0.0 109.988 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 72.11 48.0 28.05 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -97.18 -44.96 6.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.171 -1.194 . . . . 0.0 110.181 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . 139.32 -2.11 2.52 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.392 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 166.33 30.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.833 -1.392 . . . . 0.0 110.759 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.656 ' CG2' HD12 ' A' ' 27' ' ' ILE . 10.5 mm -101.68 122.38 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.459 -0.775 . . . . 0.0 110.037 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 p30 -110.03 -179.64 3.85 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.021 -1.049 . . . . 0.0 110.754 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.661 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 t80 -63.31 -39.55 51.13 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.287 -0.883 . . . . 0.0 112.121 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.7 Cg_endo -69.47 -29.82 24.61 Favored 'Trans proline' 0 C--N 1.32 -0.952 0 O-C-N 123.078 1.041 . . . . 0.0 109.973 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 71' ' ' MET . 23.8 mt-10 -75.2 -30.66 60.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 109.309 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.735 ' HZ ' HD12 ' B' ' 11' ' ' ILE . 10.5 t80 -66.96 -42.64 84.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.471 -0.768 . . . . 0.0 109.762 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.644 HD11 ' CE1' ' A' ' 65' ' ' PHE . 4.7 mt -70.11 -32.06 69.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.83 . . . . 0.0 110.326 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -87.73 -43.25 12.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.954 . . . . 0.0 110.557 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -59.78 -32.92 71.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.118 -0.989 . . . . 0.0 110.263 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.658 ' HE1' ' CE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -69.13 -11.95 61.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.882 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.77 -35.27 5.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.385 -0.822 . . . . 0.0 110.051 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -68.42 -41.14 80.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 110.135 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.86 -26.1 67.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.82 . . . . 0.0 110.145 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 72' ' ' MET . 1.4 mtt -86.0 -12.17 51.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.857 . . . . 0.0 110.202 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -115.41 58.69 0.72 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.245 -0.91 . . . . 0.0 110.112 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -147.22 -63.69 0.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 110.2 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.5 m -155.46 -43.43 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.897 . . . . 0.0 110.176 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -85.84 98.18 10.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.279 -0.888 . . . . 0.0 110.271 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m -102.18 -51.9 3.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.02 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -100.14 -11.13 20.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -0.823 . . . . 0.0 110.128 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 1.8 mm-40 -66.85 -9.88 42.28 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 0.0 109.929 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.407 ' OE1' ' SD ' ' A' ' 76' ' ' MET . 40.8 mt-10 -76.4 -30.28 57.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.261 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.773 ' CD1' HG21 ' A' ' 146' ' ' THR . 75.1 mt -75.82 -32.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -36.82 84.09 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.438 -0.789 . . . . 0.0 109.623 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.763 ' HB3' HG21 ' B' ' 9' ' ' THR . 5.7 mm-40 -69.32 -45.58 69.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.82 ' HB2' HD11 ' B' ' 12' ' ' LEU . . . -60.62 -34.77 74.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.143 -0.973 . . . . 0.0 110.066 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 29.5 t80 -68.44 -40.93 80.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 109.653 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -60.85 -29.7 69.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.343 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.548 HG12 HG21 ' A' ' 108' ' ' VAL . 65.6 t -72.79 -55.06 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.006 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.679 ' HB3' HD13 ' A' ' 100' ' ' ILE . 37.5 m-85 -53.62 -29.87 40.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.258 -0.901 . . . . 0.0 109.975 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -100.44 67.14 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.459 -0.776 . . . . 0.0 110.101 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -41.36 -25.95 0.05 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.399 -0.813 . . . . 0.0 110.415 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.5 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 15.7 p-10 -102.09 -41.69 6.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 109.961 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.22 49.86 5.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 42.0 p-10 -92.18 -23.55 19.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 124.95 26.33 1.39 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.724 ' CZ ' ' ND2' ' A' ' 137' ' ' ASN . 1.1 m-85 -170.52 158.22 6.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.974 -1.309 . . . . 0.0 110.617 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.679 HD13 ' HB3' ' A' ' 92' ' ' PHE . 10.0 mt -126.97 120.19 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.271 -0.893 . . . . 0.0 110.28 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -101.38 145.91 28.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -0.988 . . . . 0.0 109.802 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.84 -31.89 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 109.726 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.1 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.343 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 101' ' ' SER . 7.4 mt-10 -60.49 -48.6 81.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.442 -0.786 . . . . 0.0 109.367 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.865 HD11 ' HZ ' ' B' ' 22' ' ' PHE . 0.3 OUTLIER -59.04 -41.95 89.06 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.298 -0.876 . . . . 0.0 108.912 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.433 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 18.7 ttp180 -51.62 -36.7 46.91 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -60.11 -56.08 26.06 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.548 HG21 HG12 ' A' ' 91' ' ' VAL . 2.5 t -59.78 -34.73 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.333 -0.855 . . . . 0.0 108.792 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.873 ' HA ' HD21 ' B' ' 17' ' ' LEU . 3.7 mtt -57.35 -69.42 0.16 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.652 -0.655 . . . . 0.0 110.829 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.536 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 93.7 m -55.57 -21.68 18.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.062 -1.024 . . . . 0.0 109.876 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 38' ' ' SER . 57.1 m-20 -84.34 -10.32 57.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.169 -0.957 . . . . 0.0 109.801 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.914 HD11 HG12 ' B' ' 13' ' ' VAL . 6.8 mt -108.94 -40.37 5.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.304 -0.872 . . . . 0.0 110.549 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 167.12 -64.71 0.2 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.355 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.415 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 1.2 tp10 -107.93 171.45 7.39 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.201 -1.176 . . . . 0.0 110.841 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 1.3 mptp? -130.29 5.38 4.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 0.0 110.698 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.683 HD21 ' HA ' ' B' ' 19' ' ' LYS . 1.4 mp 57.08 152.91 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.073 0 O-C-N 121.599 -0.688 . . . . 0.0 110.469 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.585 HG22 ' H ' ' A' ' 118' ' ' ASP . 1.2 m -60.72 -151.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.02 -1.05 . . . . 0.0 109.478 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.585 ' H ' HG22 ' A' ' 117' ' ' THR . 6.7 p-10 -113.38 -33.4 5.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 110.173 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -71.21 -45.2 63.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 109.97 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 124' ' ' MET . 12.6 pt-20 -68.71 -35.79 77.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.627 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.574 HG23 ' HB3' ' A' ' 116' ' ' LEU . 23.3 t -63.14 -37.3 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.871 . . . . 0.0 109.575 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.19 -47.8 40.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 1.2 tp10 -67.22 -30.91 70.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.359 -0.838 . . . . 0.0 109.268 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.567 ' CG ' ' HA ' ' B' ' 21' ' ' SER . 1.5 ttt -61.18 -46.32 90.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.496 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.669 HD11 ' CD1' ' A' ' 105' ' ' LEU . 22.0 mm -70.79 -56.62 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 0.0 109.821 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 127' ' ' GLU . 7.5 mtp85 -53.93 -62.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.377 -0.827 . . . . 0.0 110.014 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 8.7 tp10 -42.07 -28.13 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.403 -0.811 . . . . 0.0 110.191 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.503 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -90.98 -34.45 15.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.902 . . . . 0.0 110.026 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -57.75 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.38 -0.825 . . . . 0.0 110.587 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -52.04 -34.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.954 . . . . 0.0 109.618 179.642 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 47.5 p-10 -94.48 -16.91 22.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 110.108 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 61.37 79.07 0.14 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 8.8 p30 -123.33 5.39 9.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -1.15 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.14 15.44 66.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.563 ' HG3' ' CE1' ' A' ' 99' ' ' TYR . 9.6 pt20 -169.74 169.41 8.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -1.155 . . . . 0.0 109.99 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 9.8 t -116.63 159.16 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.119 -0.988 . . . . 0.0 110.418 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.724 ' ND2' ' CZ ' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -123.56 -167.18 1.58 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.369 -0.832 . . . . 0.0 110.014 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.516 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 1.7 t80 -74.73 -64.32 1.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.184 -0.948 . . . . 0.0 109.993 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -44.36 -48.5 9.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.913 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 144' ' ' MET . 3.4 tt0 -55.58 -56.19 23.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.34 -0.85 . . . . 0.0 110.229 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -51.87 -19.71 1.88 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.4 t -96.46 -70.32 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.062 -1.024 . . . . 0.0 110.883 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -45.36 -48.59 13.34 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.1 -1.0 . . . . 0.0 110.794 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.588 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 11.8 tpt -72.26 -10.38 59.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.722 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.1 tpp -100.69 -47.83 4.71 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.95 -1.094 . . . . 0.0 111.044 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.773 HG21 ' CD1' ' A' ' 85' ' ' ILE . 1.7 t -141.41 85.17 1.95 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.106 -0.996 . . . . 0.0 110.344 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.22 52.95 0.61 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.455 -0.778 . . . . 0.0 110.651 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.184 179.695 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.44 HG13 ' N ' ' B' ' 2' ' ' LYS . 11.6 p . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 121.144 0.497 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.44 ' N ' HG13 ' B' ' 1' ' ' VAL . 0.1 OUTLIER -84.39 -85.34 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.021 . . . . 0.0 110.129 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' B' ' 3' ' ' LEU . 0.3 OUTLIER -50.46 -20.66 1.19 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.197 -0.939 . . . . 0.0 110.45 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.658 HG23 ' HD2' ' B' ' 5' ' ' PRO . 84.4 mt -112.66 150.18 42.32 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.317 -0.865 . . . . 0.0 110.052 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.658 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.0 Cg_endo -62.91 124.55 14.23 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.641 1.337 . . . . 0.0 110.217 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' SER . . . . . 1.009 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.3 OUTLIER -58.13 170.19 0.71 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.678 0.751 . . . . 0.0 111.25 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.695 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -56.13 -80.06 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.448 0.642 . . . . 0.0 110.383 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' B' ' 11' ' ' ILE . 38.7 p -45.21 -40.69 7.55 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.413 -0.805 . . . . 0.0 109.755 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 87' ' ' GLU . 94.4 m -49.92 -48.17 51.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.233 -0.917 . . . . 0.0 109.177 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 1.009 HG23 ' O ' ' B' ' 6' ' ' SER . 15.8 t -61.06 -29.42 45.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.387 -0.821 . . . . 0.0 109.246 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.735 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 26.5 mm -77.73 -55.18 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.66 -0.65 . . . . 0.0 111.441 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 88' ' ' ALA . 3.9 pp -56.88 -33.03 66.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.188 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.914 HG12 HD11 ' A' ' 112' ' ' LEU . 24.2 t -67.09 -50.33 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.952 -1.093 . . . . 0.0 108.755 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.924 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -62.07 -24.45 67.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.205 -0.935 . . . . 0.0 108.633 178.793 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' B' ' 18' ' ' ARG . 1.4 p -75.38 -27.52 59.14 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.434 0.635 . . . . 0.0 109.36 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.496 ' O ' ' N ' ' B' ' 18' ' ' ARG . 8.4 mtt -73.31 -32.29 64.51 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.412 -0.805 . . . . 0.0 108.968 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.873 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.0 mp -67.76 58.8 0.06 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.518 -0.739 . . . . 0.0 109.229 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' B' ' 16' ' ' MET . 5.7 mtm180 -84.47 -80.99 0.19 Allowed 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.769 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.683 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -176.82 -67.31 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.052 -1.03 . . . . 0.0 111.472 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.53 ' N ' ' CD ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -87.83 -21.73 24.88 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.373 -0.829 . . . . 0.0 112.074 -178.156 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.567 ' HA ' ' CG ' ' A' ' 124' ' ' MET . 4.0 m -163.71 -175.0 3.91 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.453 -1.404 . . . . 0.0 112.554 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.865 ' HZ ' HD11 ' A' ' 105' ' ' LEU . 11.3 m-85 -78.78 -85.83 0.07 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.418 0.628 . . . . 0.0 110.567 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.45 -151.55 21.83 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 144' ' ' MET . 0.6 OUTLIER 176.93 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.201 -1.176 . . . . 0.0 110.681 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' B' ' 24' ' ' ASN . 42.6 Cg_endo -69.45 111.3 2.71 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.764 1.402 . . . . 0.0 110.195 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.658 ' CE2' ' HE1' ' A' ' 72' ' ' MET . 2.1 t80 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.243 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.335 0.588 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.54 9.87 23.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 4' ' ' LEU . 3.6 tt0 -97.29 149.61 21.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.256 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' GLN . 1.9 mt 55.5 108.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.852 ' O ' HD12 ' A' ' 9' ' ' ILE . 10.2 t -104.23 -1.17 27.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.287 -0.883 . . . . 0.0 110.419 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -100.19 -9.84 22.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.895 . . . . 0.0 110.46 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -68.61 -69.09 0.35 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.184 -0.947 . . . . 0.0 110.373 -179.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -50.83 41.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.539 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.852 HD12 ' O ' ' A' ' 5' ' ' THR . 61.7 mt -60.16 -35.86 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.528 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 6' ' ' GLU . . . -55.35 -56.27 22.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 110.144 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -55.72 -47.61 76.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.083 -1.011 . . . . 0.0 109.958 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -58.91 -41.82 88.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.0 109.43 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -62.1 -31.4 71.84 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.244 -0.91 . . . . 0.0 108.923 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 6.3 tp10 -57.62 -53.45 58.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.499 -0.75 . . . . 0.0 109.166 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -51.7 -55.58 18.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 109.219 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.536 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 86.5 t80 -52.99 -36.28 60.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.495 -0.753 . . . . 0.0 109.366 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.2 t -76.05 -26.95 57.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.567 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.8 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.1 tt -58.8 -44.16 90.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.901 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -75.22 -25.91 58.53 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.216 -0.927 . . . . 0.0 110.281 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.72 106.08 14.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.233 -0.917 . . . . 0.0 110.1 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -99.66 5.87 45.73 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.216 -0.927 . . . . 0.0 110.49 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.8 p30 -116.65 -51.68 2.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.155 -0.966 . . . . 0.0 110.397 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 114.08 39.87 1.02 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 13.6 p30 -111.65 -16.14 13.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.137 -1.214 . . . . 0.0 110.233 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.54 -1.18 81.39 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 68.3 p -118.46 108.94 15.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.18 -1.188 . . . . 0.0 110.37 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 17.9 mt -77.82 124.49 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.289 -0.882 . . . . 0.0 109.966 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.414 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 1.1 p -97.35 -178.79 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.374 -0.829 . . . . 0.0 110.316 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.614 HG21 ' OE1' ' A' ' 49' ' ' GLN . 40.6 p -73.59 -33.8 64.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.122 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -43.83 86.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 0.0 110.23 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' OE2' ' OG1' ' A' ' 28' ' ' THR . 53.6 mt-10 -60.06 -60.21 4.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.459 HD23 ' CD2' ' A' ' 48' ' ' LEU . 3.7 tp -58.73 -32.37 69.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.89 -33.26 86.77 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.1 m -71.94 -47.93 48.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -1.141 . . . . 0.0 110.14 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.63 -55.57 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.266 -0.896 . . . . 0.0 110.566 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.533 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 3.8 mmt -55.47 -36.44 66.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 110.179 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -64.11 -33.04 74.87 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -44.63 81.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 110.689 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 91' ' ' VAL . 10.7 mt -47.83 -37.96 14.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.006 -1.059 . . . . 0.0 109.923 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.74 17.27 19.55 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.492 ' OE1' HD12 ' B' ' 3' ' ' LEU . 87.0 mm-40 -82.05 -131.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.122 -1.222 . . . . 0.0 110.182 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.541 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 0.5 OUTLIER -159.05 58.28 1.22 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.95 -1.094 . . . . 0.0 110.627 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 49.4 Cg_endo -82.87 83.14 2.02 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.931 1.49 . . . . 0.0 110.186 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 45' ' ' GLU . 2.7 m -50.0 176.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.144 -0.972 . . . . 0.0 110.297 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' H ' HG22 ' A' ' 44' ' ' THR . 3.8 mm-40 -70.13 -59.54 2.83 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.267 -0.896 . . . . 0.0 110.075 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -44.2 -36.23 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.872 . . . . 0.0 109.844 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -70.71 -38.74 73.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.904 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.459 ' CD2' HD23 ' A' ' 32' ' ' LEU . 12.1 mt -55.78 -54.71 41.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.915 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.614 ' OE1' HG21 ' A' ' 29' ' ' THR . 1.1 tp60 -60.1 -40.4 89.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.631 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.453 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -63.98 -36.35 83.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 109.578 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.49 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -66.93 -47.01 73.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.908 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -63.56 -30.42 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 109.335 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.27 -16.99 61.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.705 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -72.72 -57.17 4.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.498 -0.751 . . . . 0.0 110.379 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.675 HG23 ' CD1' ' B' ' 7' ' ' TRP . 37.6 t -71.33 -29.83 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.913 -1.117 . . . . 0.0 109.936 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -48.67 88.47 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.347 -0.846 . . . . 0.0 110.565 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -69.06 -27.4 65.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.321 -0.862 . . . . 0.0 110.452 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 8.6 p-10 -95.85 -41.91 8.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.216 -0.927 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.83 47.67 1.46 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 18.8 p-10 -98.46 -44.07 6.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -1.137 . . . . 0.0 110.24 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.57 6.66 5.05 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.14 154.99 41.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.121 -1.223 . . . . 0.0 110.35 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.0 mm -97.07 166.18 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.274 -0.891 . . . . 0.0 110.122 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 4.8 t0 -148.11 169.94 18.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.125 -0.984 . . . . 0.0 110.568 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.659 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 19.9 t80 -59.39 -41.24 86.03 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.849 . . . . 0.0 111.961 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -68.73 -23.88 35.45 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 O-C-N 123.142 1.075 . . . . 0.0 110.473 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.58 -36.27 29.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -62.01 -42.91 99.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 110.239 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.62 -34.6 58.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.197 -0.939 . . . . 0.0 110.543 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.5 m -74.56 -12.44 60.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.062 -1.024 . . . . 0.0 110.768 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.9 tmm? -98.6 -43.68 6.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.045 -1.035 . . . . 0.0 110.76 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.503 ' CE ' ' CE ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -60.81 -10.89 6.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -0.958 . . . . 0.0 110.784 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.01 -17.23 28.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.055 -1.028 . . . . 0.0 110.927 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -97.05 -18.33 19.44 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.961 -1.087 . . . . 0.0 110.72 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.948 ' HG3' HG21 ' B' ' 8' ' ' THR . 17.8 mmtp -92.39 -28.42 16.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.073 -1.017 . . . . 0.0 110.537 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.543 ' HE1' ' CE2' ' B' ' 26' ' ' PHE . 5.0 ttm -98.03 61.31 1.5 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.19 -0.944 . . . . 0.0 110.304 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -110.58 -56.62 2.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 110.295 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 1.2 t0 177.51 -41.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.219 -0.926 . . . . 0.0 110.43 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.4 m -49.06 -81.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.203 -0.935 . . . . 0.0 110.425 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 80' ' ' ASP . 6.0 p-10 -77.9 100.61 6.45 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.197 -0.939 . . . . 0.0 110.44 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.2 p -121.81 -32.97 3.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 0.0 109.786 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -99.14 -21.61 16.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.979 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -72.73 -35.57 67.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.791 ' HG2' HD12 ' B' ' 12' ' ' LEU . 8.3 tt0 -70.26 -42.09 72.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.83 . . . . 0.0 110.168 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.675 HG23 ' CE2' ' A' ' 141' ' ' PHE . 46.5 mt -68.63 -26.79 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.782 . . . . 0.0 109.718 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -66.9 -49.69 64.79 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.465 -0.772 . . . . 0.0 109.709 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.4 mt-10 -59.53 -48.83 80.15 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.301 -0.875 . . . . 0.0 109.695 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -56.07 -31.63 63.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.588 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 4.7 t80 -67.99 -63.85 0.98 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.133 -0.98 . . . . 0.0 109.682 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' PHE . 3.9 mmt85 -41.34 -32.75 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.656 -0.653 . . . . 0.0 109.826 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.674 HG12 HG21 ' A' ' 108' ' ' VAL . 71.4 t -65.5 -47.02 88.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.353 -0.842 . . . . 0.0 109.465 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.624 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 43.9 m-85 -68.94 -18.44 64.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.309 -0.869 . . . . 0.0 110.028 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.522 ' HA ' ' OE2' ' A' ' 104' ' ' GLU . 1.9 t0 -96.98 60.68 1.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.334 -0.854 . . . . 0.0 110.478 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -42.07 -61.26 1.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.261 -0.899 . . . . 0.0 110.278 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 9.4 p30 -55.28 -28.97 57.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.143 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 74.81 42.84 30.02 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.0 p30 -100.13 -48.96 4.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -1.181 . . . . 0.0 110.262 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 148.66 -33.7 1.17 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -95.61 153.98 17.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.146 -1.208 . . . . 0.0 110.314 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.486 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 17.0 mt -121.27 127.52 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.259 -0.901 . . . . 0.0 110.251 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.0 p -111.28 164.13 13.22 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.352 -0.842 . . . . 0.0 109.998 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.699 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -55.95 -33.71 65.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.53 89.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.011 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.522 ' OE2' ' HA ' ' A' ' 93' ' ' ASP . 14.3 mt-10 -58.89 -50.06 75.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.749 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.442 ' HG ' HD11 ' A' ' 125' ' ' ILE . 2.5 mm? -55.61 -42.72 75.26 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.215 -0.928 . . . . 0.0 109.748 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -18.65 65.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.205 -0.934 . . . . 0.0 109.339 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 1.7 m80 -82.52 -30.15 29.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.759 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.674 HG21 HG12 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -83.92 -41.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.306 -0.871 . . . . 0.0 109.647 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . 1.056 ' HE2' HD13 ' A' ' 116' ' ' LEU . 16.8 mtt -44.35 -70.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 110.292 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 m -49.35 -46.38 46.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.445 -0.784 . . . . 0.0 109.935 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 5.2 m120 -59.04 -16.04 16.6 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.405 -0.809 . . . . 0.0 109.74 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.8 ' O ' HD11 ' A' ' 18' ' ' LEU . 8.1 mt -106.74 -45.89 4.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.34 -0.85 . . . . 0.0 110.537 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.98 -62.51 0.24 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.772 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 109' ' ' MET . 59.6 tt0 -81.75 172.04 13.85 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.109 -1.23 . . . . 0.0 110.831 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.48 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -154.61 75.49 0.98 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.592 -0.693 . . . . 0.0 109.593 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.056 HD13 ' HE2' ' A' ' 109' ' ' MET . 2.4 mp -36.26 138.55 0.2 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.7 -0.625 . . . . 0.0 110.63 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.547 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -54.63 -165.16 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.251 -0.905 . . . . 0.0 110.18 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.46 ' H ' HG22 ' A' ' 117' ' ' THR . 0.9 OUTLIER -83.56 -56.69 3.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.254 -0.904 . . . . 0.0 110.288 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -56.85 -25.34 56.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 110.067 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 14.7 mm-40 -78.12 -44.18 26.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 108.971 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.699 HG12 ' HB1' ' A' ' 102' ' ' ALA . 15.2 t -57.69 -36.72 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.676 -0.64 . . . . 0.0 109.902 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.87 -51.01 20.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.981 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -58.89 -22.71 59.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.892 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.404 ' CE ' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -75.8 -47.24 26.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -0.901 . . . . 0.0 110.108 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.442 HD11 ' HG ' ' A' ' 105' ' ' LEU . 11.7 mm -76.94 -33.46 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.209 -0.932 . . . . 0.0 110.055 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 ttp85 -64.49 -45.38 87.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.79 -20.09 65.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.2 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.956 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -85.81 -35.2 20.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.38 64.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.279 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.956 HD12 ' O ' ' A' ' 128' ' ' ALA . 1.5 mp -46.97 -28.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.257 -0.902 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 13.3 p-10 -88.99 -28.17 20.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.915 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.8 73.03 1.28 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 135' ' ' GLN . 18.2 p-10 -127.34 -29.22 2.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.267 -1.137 . . . . 0.0 110.255 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.12 -8.32 12.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.431 ' O ' ' OD2' ' A' ' 133' ' ' ASP . 9.4 pt20 -159.43 169.01 24.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.189 -1.183 . . . . 0.0 110.417 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.642 HG13 ' HB3' ' A' ' 140' ' ' GLU . 24.9 t -113.27 159.29 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.239 -0.913 . . . . 0.0 110.497 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.464 ' OD1' ' OE2' ' A' ' 140' ' ' GLU . 10.3 p-10 -122.26 -173.38 2.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.192 -0.943 . . . . 0.0 110.325 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.588 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 6.2 t80 -57.51 -69.37 0.17 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.218 -0.926 . . . . 0.0 110.655 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.7 OUTLIER -41.0 -53.06 3.05 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.298 -0.876 . . . . 0.0 110.382 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.642 ' HB3' HG13 ' A' ' 136' ' ' VAL . 8.5 mt-10 -52.79 -62.32 1.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.934 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.675 ' CE2' HG23 ' A' ' 85' ' ' ILE . 37.8 t80 -41.79 -27.51 0.11 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.266 -0.896 . . . . 0.0 109.756 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' GLU . 96.2 t -95.19 -37.7 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 0.0 110.194 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.593 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 1.1 tm0? -68.4 -9.48 48.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.119 -0.988 . . . . 0.0 109.872 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.617 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -94.08 -23.15 18.09 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.364 -0.835 . . . . 0.0 110.42 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.5 mmt -100.61 -68.71 0.8 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.972 . . . . 0.0 111.105 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 146' ' ' THR . 5.3 t -92.43 61.66 3.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.221 -0.924 . . . . 0.0 110.797 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -99.7 40.41 1.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 110.23 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.268 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 82.6 t . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -93.98 139.19 31.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 0.0 110.039 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.505 HD13 ' C ' ' B' ' 3' ' ' LEU . 0.7 OUTLIER -170.61 68.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 110.495 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.519 HG23 ' HD2' ' B' ' 5' ' ' PRO . 14.1 mt -112.89 142.36 27.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.823 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.775 ' HB2' HG13 ' B' ' 10' ' ' VAL . 44.7 Cg_endo -71.24 103.88 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.893 1.47 . . . . 0.0 109.891 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.529 ' O ' ' N ' ' B' ' 8' ' ' THR . 23.1 t -62.13 71.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.561 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.78 ' O ' HG22 ' B' ' 10' ' ' VAL . 4.2 m95 50.74 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.871 . . . . 0.0 110.648 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.948 HG21 ' HG3' ' A' ' 75' ' ' LYS . 40.4 p -41.78 -24.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.715 -1.241 . . . . 0.0 110.42 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.531 HG21 ' HA ' ' B' ' 5' ' ' PRO . 85.6 m -70.58 -51.47 28.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 109.941 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.78 HG22 ' O ' ' B' ' 7' ' ' TRP . 3.8 m -56.38 -28.31 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.85 -1.156 . . . . 0.0 108.849 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.45 ' N ' HD13 ' B' ' 11' ' ' ILE . 7.1 mm -75.8 -28.38 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.448 -0.783 . . . . 0.0 109.322 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.791 HD12 ' HG2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -66.08 -57.61 7.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.57 -0.706 . . . . 0.0 110.331 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.696 HG12 ' CD1' ' A' ' 112' ' ' LEU . 42.4 t -60.35 -40.71 84.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.387 -0.82 . . . . 0.0 110.952 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.459 ' CD ' ' O ' ' B' ' 14' ' ' LYS . 1.2 tmtt? -63.07 -29.08 70.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.369 -1.457 . . . . 0.0 108.744 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' B' ' 11' ' ' ILE . 1.5 p -83.39 -15.96 47.77 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.563 ' HE2' ' CE1' ' A' ' 141' ' ' PHE . 73.1 mmm -71.64 -47.2 56.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.555 -0.716 . . . . 0.0 110.578 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.771 ' H ' HD13 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -99.97 37.8 1.57 Allowed 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 117.724 -1.59 . . . . 0.0 109.619 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.52 ' HG2' ' N ' ' B' ' 19' ' ' LYS . 47.7 ttp180 -48.19 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.159 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.805 ' O ' HD21 ' A' ' 116' ' ' LEU . 8.6 tmtt? -104.91 -73.65 0.67 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 111.047 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.494 ' HG2' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -151.82 15.45 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.998 -1.063 . . . . 0.0 110.572 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.404 ' O ' ' CE ' ' A' ' 124' ' ' MET . 3.4 m -127.34 -173.36 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.111 -0.993 . . . . 0.0 110.176 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' B' ' 16' ' ' MET . 2.6 m-85 -92.91 -55.39 3.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.189 -0.944 . . . . 0.0 110.307 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' B' ' 24' ' ' ASN . . . 145.97 176.92 20.26 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 144' ' ' MET . 1.5 t-20 174.17 -52.39 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.458 -1.025 . . . . 0.0 110.117 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 24' ' ' ASN . 48.9 Cg_endo -82.62 72.94 5.76 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.792 1.417 . . . . 0.0 110.404 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.543 ' CE2' ' HE1' ' A' ' 76' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.172 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.288 0.566 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 7.0 p-10 -154.77 40.19 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.173 -0.954 . . . . 0.0 110.188 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.422 ' OE1' ' N ' ' A' ' 3' ' ' GLN . 8.5 mp0 -74.68 151.89 39.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.082 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.83 164.19 17.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.039 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.7 p -113.55 40.94 2.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.191 -0.943 . . . . 0.0 110.135 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 7' ' ' GLU . 1.3 tp10 -48.15 -46.96 35.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.463 -0.773 . . . . 0.0 110.308 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.615 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.2 mm-40 -41.1 -62.37 0.84 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.367 -0.833 . . . . 0.0 110.226 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -45.82 -56.15 5.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.159 -0.963 . . . . 0.0 109.575 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 10' ' ' ALA . 67.1 mt -53.13 -43.88 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.795 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -44.19 -60.19 2.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.913 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 5.0 tm-20 -52.5 -55.4 22.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.755 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -53.26 -30.07 36.4 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.162 -0.961 . . . . 0.0 109.277 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' SER . 17.9 ttmt -64.83 -37.05 86.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.309 -0.869 . . . . 0.0 109.089 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 3.1 mm-40 -61.36 -46.36 90.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.508 -0.745 . . . . 0.0 109.363 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 -48.74 80.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.839 . . . . 0.0 109.587 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.509 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 55.3 t80 -62.78 -39.68 94.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.413 -0.804 . . . . 0.0 109.508 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -70.8 -30.27 66.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -0.801 . . . . 0.0 109.319 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.817 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.5 tt -59.46 -44.18 93.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.427 -0.796 . . . . 0.0 109.702 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -69.87 -52.76 22.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.278 -0.888 . . . . 0.0 109.963 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -67.28 108.42 2.73 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.398 -0.814 . . . . 0.0 110.239 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -84.8 2.26 43.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.288 -0.883 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.57 -68.65 0.9 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.157 -0.965 . . . . 0.0 110.694 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.27 35.24 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 60.0 p30 -94.12 -10.14 34.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -1.16 . . . . 0.0 110.039 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.554 ' C ' HG23 ' A' ' 26' ' ' THR . . . 81.37 30.39 37.22 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.554 HG23 ' C ' ' A' ' 25' ' ' GLY . 77.7 p -152.76 124.44 7.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.137 -1.214 . . . . 0.0 110.709 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.573 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 4.2 mt -92.36 120.7 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.23 -0.919 . . . . 0.0 109.758 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -100.17 171.21 7.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 110.359 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.1 p -61.94 -33.44 74.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 110.033 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -70.01 -59.21 3.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 110.276 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.404 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 52.7 mt-10 -49.2 -66.63 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 109.881 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.3 tp -48.98 -43.95 40.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.749 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.05 -43.25 49.61 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 83.0 m -60.68 -48.57 81.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -1.137 . . . . 0.0 110.06 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.455 ' H ' HG23 ' A' ' 35' ' ' VAL . 4.2 t -64.6 -43.37 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.804 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 29.9 mmm -70.97 -24.6 62.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 109.882 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.09 -21.18 47.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.88 . . . . 0.0 110.14 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 39' ' ' LEU . 50.8 m -85.9 -40.89 15.45 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.255 -0.903 . . . . 0.0 110.771 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.43 HD23 HG22 ' A' ' 108' ' ' VAL . 2.4 mt -44.13 -32.23 1.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.924 -1.11 . . . . 0.0 109.799 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 41' ' ' GLN . . . 128.62 67.24 0.12 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER 179.55 -172.2 0.17 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.372 -1.075 . . . . 0.0 110.231 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -138.33 92.03 12.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.938 . . . . 0.0 110.666 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.74 126.48 11.43 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.088 1.573 . . . . 0.0 109.885 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 m -94.38 161.72 14.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.207 -0.933 . . . . 0.0 110.581 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.0 -60.69 3.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.022 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.35 -43.96 23.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.7 -42.35 74.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 0.0 109.873 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -64.22 -34.97 79.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.83 -41.16 83.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.866 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -67.17 -24.8 65.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.384 -0.823 . . . . 0.0 109.827 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.0 mtp -77.59 -45.96 23.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 109.791 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -64.46 -35.11 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 109.845 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.37 -15.07 56.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -81.42 -33.32 32.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 110.225 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 4.4 t -103.26 -14.12 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.184 -0.948 . . . . 0.0 110.256 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 12.4 t0 -60.07 80.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 0.0 109.901 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -93.14 -15.83 25.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.901 . . . . 0.0 110.368 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.3 -40.37 21.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.199 -0.938 . . . . 0.0 110.135 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.19 13.54 30.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 27.6 p-10 -88.04 -46.89 8.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -1.096 . . . . 0.0 110.263 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 131.38 -21.68 4.52 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.0 p -116.6 169.63 9.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -1.184 . . . . 0.0 110.148 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.573 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 11.2 mm -94.62 138.66 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.888 . . . . 0.0 110.001 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.542 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 m-20 -117.48 171.91 7.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.972 . . . . 0.0 110.695 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.659 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.2 t80 -62.97 -38.82 46.5 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 111.674 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.7 Cg_endo -70.08 -24.54 28.1 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 O-C-N 123.075 1.04 . . . . 0.0 109.589 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.52 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 3.2 mt-10 -69.49 -33.61 73.1 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.414 -0.804 . . . . 0.0 108.922 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.614 ' HZ ' HG23 ' B' ' 11' ' ' ILE . 2.0 t80 -68.4 -48.21 65.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.54 -0.725 . . . . 0.0 109.571 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 3.2 mm? -55.91 -36.72 68.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 110.371 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 2.7 m -87.33 -25.45 23.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.125 -0.984 . . . . 0.0 110.61 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.526 ' HE2' ' N ' ' A' ' 72' ' ' MET . 2.2 ttp -63.07 -61.49 2.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.937 . . . . 0.0 110.209 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.671 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 2.0 tpt -47.23 -32.27 4.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.267 -0.896 . . . . 0.0 110.632 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.38 -11.23 46.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.935 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 70' ' ' THR . 0.4 OUTLIER -99.29 -10.96 21.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.99 -1.069 . . . . 0.0 110.397 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.544 ' CB ' HG21 ' B' ' 8' ' ' THR . 2.2 mptp? -100.1 -22.75 15.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 0.0 110.455 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 32.7 mtt -99.54 60.15 1.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.107 -0.996 . . . . 0.0 110.269 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.72 -36.0 0.4 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.864 . . . . 0.0 110.137 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' C ' ' OG1' ' A' ' 79' ' ' THR . 7.8 t70 -172.88 66.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -171.68 99.05 0.18 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 110.324 -179.725 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 79' ' ' THR . 43.8 m-20 60.22 104.53 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.423 -0.798 . . . . 0.0 110.703 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.438 ' O ' ' OE2' ' A' ' 84' ' ' GLU . 43.4 t -102.23 -49.15 3.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.648 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -98.56 -20.35 17.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.456 -0.777 . . . . 0.0 109.587 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.56 -47.57 69.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.498 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' B' ' 26' ' ' PHE . 17.3 pt-20 -47.59 -33.07 6.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.526 -0.734 . . . . 0.0 110.128 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.676 HG21 HG22 ' A' ' 142' ' ' VAL . 63.9 mt -76.32 -39.93 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.18 -0.95 . . . . 0.0 109.074 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -32.47 67.64 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HB3' HG23 ' B' ' 9' ' ' THR . 0.2 OUTLIER -67.01 -62.02 1.64 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.681 ' CB ' HD22 ' B' ' 12' ' ' LEU . . . -51.93 -30.13 23.18 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.538 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.51 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 59.0 t80 -71.92 -50.56 28.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.475 -0.766 . . . . 0.0 109.598 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.74 -47.18 77.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.0 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.54 HG11 HG21 ' B' ' 13' ' ' VAL . 0.9 OUTLIER -49.19 -45.46 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.567 -0.708 . . . . 0.0 109.29 179.087 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.561 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 17.3 m-85 -71.91 -36.69 70.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 109.964 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 94' ' ' LYS . 15.7 t0 -75.13 55.49 0.74 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.198 -0.939 . . . . 0.0 110.197 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' ASP . 9.0 tttp -40.71 -66.02 0.36 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.37 -0.831 . . . . 0.0 110.532 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 21.6 p-10 -61.48 -43.35 99.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 0.0 110.231 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 93.97 44.82 3.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 32.5 p-10 -87.23 -28.9 22.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.187 -1.184 . . . . 0.0 110.169 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.563 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 121.49 15.34 4.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 50.8 m-85 -151.76 152.41 32.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.141 -1.211 . . . . 0.0 110.178 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.98 118.91 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.922 . . . . 0.0 110.149 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 102' ' ' ALA . 12.4 t -105.52 141.97 36.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.848 . . . . 0.0 110.338 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.96 -33.85 0.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.313 -0.867 . . . . 0.0 109.833 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -55.16 -55.64 28.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 109.612 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 49.0 mt-10 -54.38 -48.4 71.56 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.352 -0.842 . . . . 0.0 109.764 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.711 HD13 HD11 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -58.72 -37.36 75.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.624 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 22.6 tpt85 -60.79 -41.24 95.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.307 -0.871 . . . . 0.0 109.44 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -57.99 -44.4 87.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.783 . . . . 0.0 109.422 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.587 HG11 ' CG1' ' B' ' 13' ' ' VAL . 5.9 t -73.19 -29.08 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.553 -0.717 . . . . 0.0 109.65 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.987 ' HA ' HD21 ' B' ' 17' ' ' LEU . 2.3 mtt -55.37 -69.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 110.7 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.6 m -64.85 -10.09 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.38 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -94.87 -6.68 42.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.817 ' O ' HD11 ' A' ' 18' ' ' LEU . 10.1 mt -107.44 -30.57 8.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 110.354 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 147.47 -51.87 0.56 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.507 ' HG2' HD12 ' A' ' 116' ' ' LEU . 23.0 tt0 -107.66 149.31 28.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -1.121 . . . . 0.0 109.7 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -123.62 19.17 9.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.895 . . . . 0.0 109.827 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.019 HD11 ' O ' ' B' ' 17' ' ' LEU . 3.5 mp 42.54 -166.51 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.55 0.69 . . . . 0.0 110.549 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.2 -144.65 0.3 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.514 -0.741 . . . . 0.0 109.144 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -117.64 -70.64 0.78 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.07 -1.018 . . . . 0.0 110.274 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -48.45 -40.98 28.07 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 109.398 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 121' ' ' VAL . 41.7 mm-40 -60.08 -53.48 57.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 109.282 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 120' ' ' GLU . 70.8 t -44.59 -41.52 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.418 -0.801 . . . . 0.0 109.844 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 35.8 m-20 -63.43 -60.81 2.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.856 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.45 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 4.0 tp10 -50.24 -40.98 49.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.795 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.449 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 4.5 ttt -51.7 -47.28 63.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.833 . . . . 0.0 109.841 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.711 HD11 HD13 ' A' ' 105' ' ' LEU . 48.9 mm -75.72 -39.02 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.932 . . . . 0.0 109.996 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -65.42 -26.7 68.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 110.275 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.42 -41.59 98.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 110.125 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.92 -27.04 23.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.317 -0.864 . . . . 0.0 110.335 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.651 ' OD2' HG22 ' A' ' 125' ' ' ILE . 1.7 m-20 -58.89 88.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.328 -0.858 . . . . 0.0 110.567 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -61.82 -41.54 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.196 -0.94 . . . . 0.0 109.422 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 35.4 p30 -82.66 -17.94 42.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.422 -0.799 . . . . 0.0 110.053 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 66.02 67.86 1.86 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 30.5 p-10 -118.25 1.84 11.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -1.11 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.86 -9.44 74.27 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 1.4 pt20 -137.71 147.72 45.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -1.106 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.49 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 4.0 t -104.08 146.08 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.209 -0.932 . . . . 0.0 110.155 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.455 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 33.7 p-10 -103.46 -161.09 0.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 139' ' ' GLU . 14.8 t80 -71.81 -63.45 1.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.074 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -44.12 -56.58 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 110.009 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 68.4 mt-10 -47.52 -61.38 1.95 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 6.0 t80 -44.68 -26.97 0.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.288 -0.882 . . . . 0.0 110.282 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.676 HG22 HG21 ' A' ' 85' ' ' ILE . 76.8 t -99.48 -45.95 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.201 -0.937 . . . . 0.0 110.163 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.828 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 7.7 tp60 -46.48 -34.7 4.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.363 -0.836 . . . . 0.0 110.45 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.5 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -86.02 -19.82 29.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.582 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 3.7 mtt -84.86 -47.32 10.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.996 -1.065 . . . . 0.0 110.489 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.9 p -83.09 -43.06 16.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.063 -1.023 . . . . 0.0 110.319 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -87.0 57.22 4.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.023 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.199 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' B' ' 2' ' ' LYS . 5.6 m . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.311 0.577 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' B' ' 1' ' ' VAL . 22.9 mmtp 60.6 17.44 7.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.943 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' B' ' 3' ' ' LEU . 23.1 mt -144.25 -69.03 0.31 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.561 -0.712 . . . . 0.0 109.632 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.838 HG23 ' HD2' ' B' ' 5' ' ' PRO . 17.2 mm -62.98 152.73 82.92 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.379 -0.826 . . . . 0.0 109.776 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.838 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.1 Cg_endo -66.37 116.46 4.06 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.79 1.416 . . . . 0.0 110.289 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 10' ' ' VAL . 3.0 m -53.2 179.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.848 . . . . 0.0 111.04 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.608 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -68.27 -66.14 0.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.596 0.713 . . . . 0.0 110.241 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.544 HG21 ' CB ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -53.99 -38.86 65.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 110.083 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 87' ' ' GLU . 49.1 m -49.06 -42.05 37.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.96 . . . . 0.0 108.982 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 6' ' ' SER . 47.3 t -65.76 -50.36 71.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.42 -0.8 . . . . 0.0 109.382 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.614 HG23 ' HZ ' ' A' ' 68' ' ' PHE . 9.2 mm -59.45 -27.12 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.427 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -65.14 -57.05 9.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.454 -0.779 . . . . 0.0 110.533 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.661 HG12 HD11 ' A' ' 112' ' ' LEU . 67.6 t -65.86 -30.57 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.945 . . . . 0.0 110.122 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.685 ' CG ' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.36 -47.27 67.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.92 . . . . 0.0 109.918 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' B' ' 18' ' ' ARG . 8.3 m -63.28 -29.85 71.09 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 110.131 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 11.6 ttm -68.22 -40.09 82.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.992 . . . . 0.0 109.95 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 1.019 ' O ' HD11 ' A' ' 116' ' ' LEU . 3.7 mp -56.19 -16.69 5.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.277 -0.889 . . . . 0.0 110.199 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.501 ' C ' ' O ' ' B' ' 17' ' ' LEU . 52.3 ttt180 -29.73 -78.34 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 121.032 0.444 . . . . 0.0 111.291 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.503 ' C ' ' HD3' ' B' ' 19' ' ' LYS . 1.8 tmtp? -143.18 -119.83 0.09 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.272 -0.893 . . . . 0.0 109.575 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.488 ' N ' ' CD ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -99.94 8.74 43.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.691 -1.255 . . . . 0.0 110.043 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -178.09 1.04 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.362 -0.836 . . . . 0.0 110.13 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.449 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.3 OUTLIER -176.66 -46.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.884 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 144' ' ' MET . . . -72.02 80.8 0.58 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -98.2 134.57 21.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.294 -1.121 . . . . 0.0 110.586 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.51 72.62 4.26 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 124.066 1.561 . . . . 0.0 110.316 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.671 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.498 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.207 0.527 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -72.43 88.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 110.173 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.498 ' NE2' ' OE1' ' A' ' 6' ' ' GLU . 2.7 mm-40 -99.27 -156.8 0.56 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.248 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 3' ' ' GLN . 12.0 mt 55.93 160.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.293 -0.879 . . . . 0.0 110.305 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 47.58 48.14 17.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 0.0 110.464 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' OE1' ' NE2' ' A' ' 3' ' ' GLN . 4.4 tt0 -100.37 -20.19 15.94 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.466 -0.771 . . . . 0.0 110.157 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -56.67 -53.26 59.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 110.245 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.498 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 24.1 mt-30 -56.53 -35.44 68.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.164 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.85 -32.96 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.925 . . . . 0.0 110.038 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.72 -44.14 70.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.937 . . . . 0.0 110.224 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 12' ' ' PHE . 4.6 pt-20 -65.06 -31.15 72.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.522 ' N ' ' HG2' ' A' ' 11' ' ' GLU . 19.9 m-30 -65.53 -44.1 87.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.844 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 17' ' ' SER . 0.4 OUTLIER -59.97 -43.59 95.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.179 -0.95 . . . . 0.0 109.36 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -61.54 -40.17 93.72 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.27 -0.894 . . . . 0.0 109.263 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.68 -52.07 54.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 0.0 109.489 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.536 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 7.6 t80 -58.38 -26.16 62.89 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.356 -0.84 . . . . 0.0 108.992 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -76.57 -34.82 58.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.512 -0.743 . . . . 0.0 109.32 179.272 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.787 HD11 ' O ' ' A' ' 112' ' ' LEU . 8.1 tt -59.14 -45.47 90.86 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.371 -0.83 . . . . 0.0 109.575 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' LYS . 41.8 m-85 -74.1 -49.71 22.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.378 -0.826 . . . . 0.0 109.589 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 21' ' ' LYS . 8.2 t0 -67.95 71.31 0.15 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.893 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -41.3 -41.73 2.0 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.429 -0.795 . . . . 0.0 110.36 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 13.0 p-10 -85.3 -43.1 14.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.099 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.5 32.16 6.13 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 46.2 p-10 -81.6 -2.53 50.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -1.193 . . . . 0.0 110.014 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 26' ' ' THR . . . 82.98 29.01 35.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 25' ' ' GLY . 13.4 p -154.98 118.73 4.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -1.113 . . . . 0.0 110.265 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.554 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 7.8 mt -90.45 124.63 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.951 . . . . 0.0 110.002 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.01 168.17 10.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 110.285 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.7 p -61.41 -28.42 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.96 -44.92 60.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.165 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -61.38 -60.65 3.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.976 . . . . 0.0 110.1 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.563 HD13 ' CH2' ' B' ' 7' ' ' TRP . 2.9 tp -59.31 -29.42 67.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.875 . . . . 0.0 110.189 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.99 -40.0 84.52 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.5 m -69.65 -50.71 41.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -1.157 . . . . 0.0 110.094 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 38' ' ' SER . 21.3 t -60.41 -42.72 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.177 -0.952 . . . . 0.0 110.327 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.52 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 2.6 mmt -66.84 -42.14 86.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 109.737 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -67.73 -14.04 62.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 110.112 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -72.11 -58.18 3.65 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.189 -0.944 . . . . 0.0 110.623 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mt -45.94 -28.59 1.17 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.12 -0.987 . . . . 0.0 110.736 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.502 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . 118.79 58.6 0.27 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.21 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 40' ' ' GLY . 64.7 mm-40 -131.9 -162.07 1.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.248 . . . . 0.0 109.928 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.548 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 t-20 -147.1 49.95 0.87 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.186 -0.947 . . . . 0.0 110.492 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 46.1 Cg_endo -74.0 73.74 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.086 1.572 . . . . 0.0 110.462 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 43' ' ' PRO . 10.9 t -54.06 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.18 -0.95 . . . . 0.0 110.556 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -66.9 -58.65 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.337 -0.852 . . . . 0.0 110.351 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -42.71 -42.82 3.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 109.835 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' OE1' HD11 ' B' ' 4' ' ' ILE . 10.6 mm-40 -71.15 -41.16 70.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.491 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 mt -52.74 -59.16 4.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.806 . . . . 0.0 109.95 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.94 -41.26 67.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.409 -0.807 . . . . 0.0 109.882 179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -61.51 -41.13 96.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.101 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.49 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -73.97 -44.31 55.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 4.5 mm -61.67 -30.68 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.439 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -73.79 -2.25 22.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.367 -0.833 . . . . 0.0 110.403 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.7 OUTLIER -85.29 -31.18 23.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.183 -0.948 . . . . 0.0 110.578 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 71' ' ' MET . 13.0 t -108.05 -46.34 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.126 -0.984 . . . . 0.0 110.495 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -45.57 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 110.663 -179.302 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -85.64 -3.35 58.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.83 . . . . 0.0 110.161 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.64 -53.94 4.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.176 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.71 22.22 5.8 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.4 p-10 -87.65 -46.21 9.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -1.169 . . . . 0.0 110.18 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.92 -0.59 11.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.6 p -134.31 149.89 50.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -1.214 . . . . 0.0 110.206 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.554 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 12.0 mm -90.41 144.55 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.065 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 48.3 m-20 -119.85 169.19 10.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.252 -0.905 . . . . 0.0 110.358 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.668 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.4 t80 -63.19 -38.58 42.68 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 111.598 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.3 Cg_endo -69.78 -26.62 27.32 Favored 'Trans proline' 0 C--N 1.321 -0.881 0 O-C-N 123.025 1.013 . . . . 0.0 109.656 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 71' ' ' MET . 10.6 mt-10 -76.41 -36.46 58.03 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 108.728 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 72' ' ' MET . 3.7 t80 -61.97 -41.33 97.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.507 -0.746 . . . . 0.0 109.986 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.28 -49.1 68.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.254 -0.904 . . . . 0.0 110.16 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -59.0 3.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 110.392 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.566 ' HB2' HG13 ' A' ' 55' ' ' VAL . 5.3 ppp? -48.77 -30.45 5.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.271 -0.893 . . . . 0.0 110.716 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.546 ' HE2' ' CE ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -68.7 -9.99 53.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.019 -1.051 . . . . 0.0 110.54 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.41 -12.93 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.125 -0.984 . . . . 0.0 111.195 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -78.71 -15.79 58.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.962 -1.087 . . . . 0.0 110.766 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -100.19 -40.42 7.57 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.071 -1.018 . . . . 0.0 110.391 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.586 ' HE1' ' CE1' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -98.64 62.84 1.41 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 110.463 -179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -129.95 -31.95 1.89 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.416 -0.803 . . . . 0.0 110.379 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.83 -94.78 0.37 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.253 -0.904 . . . . 0.0 110.419 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 79' ' ' THR . 89.9 m -130.97 30.62 4.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.161 -0.962 . . . . 0.0 110.42 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.06 35.73 4.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.006 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.5 m -104.45 -35.25 7.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.809 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 1.4 mt-10 -69.84 -25.2 63.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.364 -0.835 . . . . 0.0 109.716 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' OE1' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -65.56 -57.92 7.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.295 -0.878 . . . . 0.0 109.548 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.541 ' OE1' ' CG ' ' A' ' 76' ' ' MET . 24.5 mt-10 -45.52 -27.9 0.83 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.557 -0.714 . . . . 0.0 110.383 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.888 HG21 HG22 ' A' ' 142' ' ' VAL . 47.8 mt -66.37 -43.29 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 121.011 -1.056 . . . . 0.0 108.988 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 ttm105 -58.54 -46.91 85.84 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.812 ' HB3' HG21 ' B' ' 9' ' ' THR . 2.9 mt-10 -67.65 -50.77 56.23 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.225 -0.922 . . . . 0.0 108.869 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' B' ' 13' ' ' VAL . . . -56.35 -40.0 73.77 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 141' ' ' PHE . 11.8 t80 -66.43 -40.08 89.28 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.482 ' NH1' ' O ' ' B' ' 3' ' ' LEU . 10.8 ttt180 -58.85 -45.63 89.64 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.917 HG11 HG11 ' B' ' 13' ' ' VAL . 21.4 t -48.29 -46.73 13.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.71 ' CE2' HD21 ' A' ' 105' ' ' LEU . 4.8 m-85 -71.58 -31.85 67.41 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.005 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 11.0 t0 -101.23 63.47 0.99 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.442 -0.786 . . . . 0.0 109.975 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.528 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 34.0 pttt -55.46 -25.38 36.22 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.149 -0.969 . . . . 0.0 110.508 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.528 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 11.8 p-10 -86.58 -40.33 15.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 110.371 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 85.95 50.49 3.9 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.448 ' OD1' ' OD2' ' A' ' 95' ' ' ASP . 15.1 p-10 -96.2 -24.88 16.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.196 -1.179 . . . . 0.0 110.283 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 118.99 -7.87 12.77 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 98.3 m-85 -136.86 151.83 49.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.286 -1.126 . . . . 0.0 110.152 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.514 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 8.7 mt -103.38 134.0 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.18 -0.95 . . . . 0.0 110.09 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 102' ' ' ALA . 37.6 t -112.2 136.54 51.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 110.234 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.39 -27.12 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.305 -0.872 . . . . 0.0 109.932 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -63.49 -59.65 4.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.357 -0.839 . . . . 0.0 109.671 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 89.4 mt-10 -48.16 -38.85 19.06 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.263 -0.898 . . . . 0.0 109.414 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.71 HD21 ' CE2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -54.91 -52.67 62.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.384 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.413 ' O ' ' OG1' ' A' ' 110' ' ' THR . 5.2 ttm105 -48.65 -47.97 40.09 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.251 -0.906 . . . . 0.0 109.377 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 14.0 m170 -52.95 -53.31 51.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.4 -0.812 . . . . 0.0 109.169 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.52 HG21 HG12 ' A' ' 91' ' ' VAL . 21.7 t -64.49 -41.63 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 108.943 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.787 ' HA ' HD21 ' B' ' 17' ' ' LEU . 33.6 ttm -51.81 -48.73 63.73 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.717 -0.614 . . . . 0.0 109.937 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -79.83 -32.18 40.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.0 110.253 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -72.81 -14.92 61.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.983 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.02 HD11 HG12 ' B' ' 13' ' ' VAL . 10.5 mt -99.35 -48.84 4.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.189 -0.944 . . . . 0.0 109.949 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 148.81 -31.67 1.21 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.777 ' HB3' HD23 ' B' ' 17' ' ' LEU . 5.2 tp10 -79.73 156.52 27.48 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.02 -1.282 . . . . 0.0 110.661 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.539 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.1 OUTLIER -137.17 51.83 1.94 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.776 HD12 ' HG2' ' A' ' 114' ' ' GLU . 0.2 OUTLIER -36.31 153.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.566 0.698 . . . . 0.0 110.923 -179.317 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 118' ' ' ASP . 2.0 m -57.67 -169.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.497 -0.752 . . . . 0.0 109.699 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.691 ' H ' HG22 ' A' ' 117' ' ' THR . 0.4 OUTLIER -99.05 -67.28 0.85 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.162 -0.961 . . . . 0.0 109.924 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -47.19 -36.97 9.4 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.762 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.8 -54.67 35.48 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -0.92 . . . . 0.0 109.052 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 124' ' ' MET . 7.7 t -47.01 -48.83 7.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -60.97 -50.4 73.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 109.818 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 1.5 tp10 -59.01 -31.4 68.78 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.295 -0.878 . . . . 0.0 109.519 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -58.05 -51.2 70.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.334 -0.854 . . . . 0.0 109.855 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.846 HG23 HG23 ' A' ' 136' ' ' VAL . 2.7 mp -68.74 -24.44 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.212 -0.93 . . . . 0.0 110.006 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.414 ' NH1' ' HB2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.09 -42.05 89.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.133 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HB2' ' NH1' ' A' ' 126' ' ' ARG . 13.3 tt0 -71.34 -29.61 65.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.905 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.61 -20.45 50.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.01 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.67 68.17 0.39 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.193 -0.942 . . . . 0.0 110.111 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mt -54.02 -31.58 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 0.0 110.306 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -89.53 -31.99 17.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.3 -0.875 . . . . 0.0 110.38 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.79 97.14 0.92 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 135' ' ' GLN . 1.2 p-10 -148.43 -38.12 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.186 -1.185 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 133.82 -1.74 4.33 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.485 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 1.5 pt20 -161.22 169.73 21.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -1.235 . . . . 0.0 110.092 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.846 HG23 HG23 ' A' ' 125' ' ' ILE . 55.3 t -93.81 139.16 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.219 -0.926 . . . . 0.0 110.076 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 19.1 t30 -102.42 178.96 4.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.274 -0.891 . . . . 0.0 110.694 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.445 ' O ' ' C ' ' A' ' 139' ' ' GLU . 47.1 t80 -67.3 -68.21 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.432 -0.793 . . . . 0.0 110.298 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 140' ' ' GLU . 2.9 pt-20 -40.93 -29.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.428 -0.795 . . . . 0.0 110.094 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 3.9 mt-10 -71.62 -59.19 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.418 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.804 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.6 t80 -42.48 -29.04 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 109.377 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.888 HG22 HG21 ' A' ' 85' ' ' ILE . 45.3 t -99.81 -40.29 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.505 -0.747 . . . . 0.0 110.456 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.62 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 10.7 tt0 -63.16 -12.8 30.37 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.16 -0.962 . . . . 0.0 110.599 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.9 mtp -95.54 -21.73 18.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 109.96 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.609 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 2.6 mtt -100.88 -13.38 18.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.362 -0.836 . . . . 0.0 110.462 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 148' ' ' LYS . 72.1 p -118.89 -54.65 2.23 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.173 -0.954 . . . . 0.0 111.057 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -66.87 57.6 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.172 -0.955 . . . . 0.0 110.288 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 146' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.174 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.258 0.551 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.74 144.42 34.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.424 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.482 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 71.4 mt -114.69 -9.23 12.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.329 -0.857 . . . . 0.0 110.145 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.547 HG22 ' HD2' ' B' ' 5' ' ' PRO . 0.7 OUTLIER -97.83 142.78 25.1 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.33 -0.856 . . . . 0.0 109.56 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' B' ' 4' ' ' ILE . 48.2 Cg_endo -73.99 49.15 1.86 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.825 1.434 . . . . 0.0 111.282 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.472 ' C ' ' O ' ' B' ' 5' ' ' PRO . 10.3 m 32.72 -139.59 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.597 -0.69 . . . . 0.0 111.574 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.563 ' CH2' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -117.4 -74.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 110.265 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.588 ' HA ' HD12 ' B' ' 11' ' ' ILE . 0.6 OUTLIER -45.06 -41.7 7.9 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.803 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.812 HG21 ' HB3' ' A' ' 87' ' ' GLU . 31.4 m -51.06 -54.72 22.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 109.7 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 5' ' ' PRO . 40.6 t -47.69 -39.69 7.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.163 -0.961 . . . . 0.0 108.683 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' B' ' 8' ' ' THR . 55.0 mt -67.5 -21.81 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 0.0 109.369 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' B' ' 9' ' ' THR . 0.4 OUTLIER -71.0 -55.48 8.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.495 -0.753 . . . . 0.0 109.904 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 1.02 HG12 HD11 ' A' ' 112' ' ' LEU . 68.1 t -54.57 -40.99 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.807 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.455 ' O ' ' HD2' ' B' ' 14' ' ' LYS . 1.2 tptm -67.24 -40.7 86.35 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.023 -1.048 . . . . 0.0 109.518 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -59.67 -27.76 66.68 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.354 -0.841 . . . . 0.0 109.474 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.482 ' O ' ' N ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -72.54 -38.96 67.86 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.29 -0.881 . . . . 0.0 109.375 179.257 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.787 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.8 mp -67.64 59.6 0.06 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.369 -0.832 . . . . 0.0 109.874 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' B' ' 16' ' ' MET . 0.1 OUTLIER -90.03 -77.88 0.38 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.376 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.464 ' HA ' HD21 ' A' ' 116' ' ' LEU . 10.3 tmtt? -162.75 -68.51 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.97 -1.082 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.98 7.95 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 110.167 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.473 ' O ' ' CE ' ' A' ' 124' ' ' MET . 0.3 OUTLIER -103.7 159.79 15.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 109.639 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 0.1 OUTLIER -131.67 -34.22 1.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.158 -0.964 . . . . 0.0 110.386 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.37 171.09 33.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.609 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER -158.46 112.93 1.69 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.192 -1.181 . . . . 0.0 110.443 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.27 96.03 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.943 1.496 . . . . 0.0 110.468 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.586 ' CE1' ' HE1' ' A' ' 76' ' ' MET . 1.4 m-85 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.89 -1.053 . . . . 0.0 110.565 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.217 0.532 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -139.09 7.2 2.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.441 ' O ' ' HG3' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -88.87 152.07 21.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.248 -0.908 . . . . 0.0 110.165 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.805 ' HB2' HD11 ' A' ' 9' ' ' ILE . 0.9 OUTLIER -113.39 -150.56 0.47 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.923 . . . . 0.0 110.236 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.601 ' C ' HD12 ' A' ' 9' ' ' ILE . 9.7 p -87.08 119.58 27.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 7' ' ' GLU . 1.3 mp0 -52.15 -58.67 5.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -0.851 . . . . 0.0 110.489 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -42.16 -62.46 0.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.225 -0.922 . . . . 0.0 110.423 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.477 ' HB2' ' OG1' ' A' ' 5' ' ' THR . 35.6 mt-30 -54.64 -47.15 73.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.337 -0.852 . . . . 0.0 110.447 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 4' ' ' LEU . 23.3 mt -63.23 -51.48 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -42.65 -50.18 5.46 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.235 -0.916 . . . . 0.0 109.98 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -58.03 -52.53 65.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.885 . . . . 0.0 109.555 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 8.5 m-85 -56.9 -39.82 75.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.303 -0.873 . . . . 0.0 109.716 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' O ' ' OG ' ' A' ' 17' ' ' SER . 3.7 tttt -63.29 -41.74 99.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.288 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.506 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 4.5 tp10 -58.23 -28.87 65.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 109.276 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -72.17 -60.87 2.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.528 -0.732 . . . . 0.0 109.769 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.534 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 21.7 t80 -52.61 -33.23 45.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.21 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 14' ' ' GLU . 2.6 p -69.47 -39.3 77.79 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.487 -0.758 . . . . 0.0 109.26 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.833 HD11 ' O ' ' A' ' 112' ' ' LEU . 1.4 tt -52.48 -36.86 55.91 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.423 -0.798 . . . . 0.0 108.965 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.556 ' CD1' HD12 ' A' ' 32' ' ' LEU . 67.0 m-85 -84.14 -45.94 12.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.578 -0.701 . . . . 0.0 109.902 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 13.5 t0 -77.49 88.15 3.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.847 . . . . 0.0 110.013 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -71.92 -13.35 61.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.251 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 21.8 p-10 -111.16 -5.73 14.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.472 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 52.97 57.51 14.41 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 8.0 p-10 -111.92 -41.46 4.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.183 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.467 ' C ' ' CG2' ' A' ' 26' ' ' THR . . . 123.55 18.96 2.9 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.467 ' CG2' ' C ' ' A' ' 25' ' ' GLY . 7.6 p -149.53 107.59 3.73 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.198 -1.178 . . . . 0.0 110.344 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.702 HD12 ' HB ' ' A' ' 63' ' ' ILE . 16.0 mt -88.7 118.53 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.128 -0.983 . . . . 0.0 110.091 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.1 p -93.73 153.34 18.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.335 -0.853 . . . . 0.0 109.986 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 p -45.39 -28.04 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.097 -1.002 . . . . 0.0 109.964 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -66.68 -62.08 1.63 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.098 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -45.1 -66.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 109.911 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.556 HD12 ' CD1' ' A' ' 19' ' ' PHE . 11.9 tp -51.44 -38.29 52.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.705 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.17 -43.03 97.41 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -58.81 -49.57 77.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -1.063 . . . . 0.0 109.782 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -53.72 -47.82 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 0.0 109.723 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.467 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 9.0 mmt -61.55 -34.7 76.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 109.862 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -20.52 64.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 110.152 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.6 m -83.19 -54.35 5.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 110.379 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 mt -45.03 -31.91 1.49 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.23 -0.919 . . . . 0.0 110.057 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.7 27.02 3.68 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -109.9 -175.82 2.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -1.164 . . . . 0.0 110.262 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -146.36 75.64 12.43 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.273 -0.892 . . . . 0.0 110.489 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 44.1 Cg_endo -72.33 149.1 50.35 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.992 1.522 . . . . 0.0 110.08 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.647 HG23 ' H ' ' A' ' 47' ' ' GLU . 7.2 t -90.54 -157.69 0.5 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.131 -0.981 . . . . 0.0 110.456 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -94.1 -44.95 7.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.314 -0.866 . . . . 0.0 110.173 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.78 84.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.178 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.647 ' H ' HG23 ' A' ' 44' ' ' THR . 51.6 mm-40 -64.72 -56.51 13.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 110.32 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 48' ' ' LEU . 14.2 mt -47.52 -45.23 26.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.144 -0.973 . . . . 0.0 110.196 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -63.21 -39.76 95.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.805 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.45 -42.86 74.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.412 ' O ' ' NE1' ' B' ' 7' ' ' TRP . 4.6 mtp -66.12 -34.46 78.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.393 -0.817 . . . . 0.0 109.602 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.544 HD13 HD11 ' A' ' 63' ' ' ILE . 7.1 mm -71.91 -36.31 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 0.7 OUTLIER -54.48 -52.05 63.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.387 -0.821 . . . . 0.0 109.977 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -43.57 -57.44 3.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.84 . . . . 0.0 109.949 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.814 HG22 ' HG3' ' A' ' 71' ' ' MET . 15.3 t -74.23 -31.11 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -0.925 . . . . 0.0 109.811 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.546 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 30.4 t70 -64.66 71.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 110.059 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -66.65 -25.24 66.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.239 -0.913 . . . . 0.0 110.389 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -75.75 -49.86 16.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.076 -1.015 . . . . 0.0 110.29 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.69 25.39 5.99 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 8.7 p30 -99.86 -32.47 10.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.211 -1.17 . . . . 0.0 110.332 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.11 9.76 10.35 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.8 p -131.09 142.07 50.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -1.13 . . . . 0.0 109.814 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.731 HD12 ' HB ' ' A' ' 55' ' ' VAL . 9.7 mm -88.03 143.03 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.219 -0.925 . . . . 0.0 110.279 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.534 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 1.6 m-20 -118.69 170.88 8.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.319 -0.863 . . . . 0.0 110.142 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.3 t80 -60.94 -50.6 84.17 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.108 -0.995 . . . . 0.0 111.26 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.0 Cg_endo -66.03 -25.61 51.45 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 O-C-N 123.2 1.105 . . . . 0.0 110.511 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 71' ' ' MET . 34.9 mt-10 -71.6 -34.02 69.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.132 -0.98 . . . . 0.0 109.819 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -74.51 -58.95 2.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 0.0 110.223 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.1 mt -48.98 -42.72 38.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 110.299 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 9.7 m -70.66 -30.17 66.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.197 -0.94 . . . . 0.0 110.421 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.814 ' HG3' HG22 ' A' ' 55' ' ' VAL . 4.0 tmm? -65.14 -63.69 1.04 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.744 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.642 ' SD ' HG22 ' B' ' 8' ' ' THR . 37.3 mmm -52.31 -19.31 2.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.995 -1.066 . . . . 0.0 110.22 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 70' ' ' THR . . . -74.36 -20.84 59.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.57 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -91.64 -25.75 19.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.081 -1.012 . . . . 0.0 110.762 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.878 ' HG3' HG21 ' B' ' 8' ' ' THR . 53.1 mmtt -81.17 -11.52 59.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 110.584 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.622 ' CE ' ' CD2' ' B' ' 26' ' ' PHE . 0.6 OUTLIER -98.69 8.65 44.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.112 -0.992 . . . . 0.0 110.389 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 1.6 ttpt -66.28 -68.24 0.39 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 110.039 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 7.0 t70 -178.44 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.323 -0.861 . . . . 0.0 110.203 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.0 -75.9 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.25 -0.907 . . . . 0.0 110.295 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -85.61 99.94 11.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.284 -0.885 . . . . 0.0 110.321 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -125.77 -33.76 2.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.828 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.62 -11.94 19.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -0.838 . . . . 0.0 110.547 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -79.61 -25.16 41.54 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.108 -0.995 . . . . 0.0 110.402 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -78.02 -27.29 48.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.182 -0.949 . . . . 0.0 110.117 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.54 HG23 ' CE1' ' A' ' 141' ' ' PHE . 92.6 mt -76.9 -39.24 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.96 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 51.5 ttp180 -62.79 -35.6 80.38 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 110.038 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.916 ' HB3' HG21 ' B' ' 9' ' ' THR . 19.6 mm-40 -69.35 -47.46 64.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 0.0 109.666 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.957 ' HB2' ' CD1' ' B' ' 12' ' ' LEU . . . -60.86 -33.59 73.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.113 -0.992 . . . . 0.0 109.897 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.11 -45.83 90.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.579 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 2.4 mtt180 -63.65 -26.94 68.9 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.411 -0.805 . . . . 0.0 109.759 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.803 HG11 HG21 ' B' ' 13' ' ' VAL . 41.2 t -63.84 -59.08 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 110.153 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.467 ' CE2' ' SD ' ' B' ' 16' ' ' MET . 22.7 m-85 -56.63 -32.16 65.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.08 -1.013 . . . . 0.0 110.059 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.47 ' OD1' HG12 ' A' ' 100' ' ' ILE . 3.1 m-20 -90.45 61.48 4.98 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.708 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.537 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -45.14 -23.38 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.422 -0.799 . . . . 0.0 110.407 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.537 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 35.2 p-10 -96.91 -31.14 12.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 80.09 51.83 4.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 32.6 p-10 -97.94 -14.34 20.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -1.15 . . . . 0.0 110.428 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 99.42 18.56 23.35 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 52.1 m-85 -158.08 157.03 32.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.247 -1.149 . . . . 0.0 110.088 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.47 HG12 ' OD1' ' A' ' 93' ' ' ASP . 21.5 mt -128.42 130.77 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -0.99 . . . . 0.0 110.689 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 30.9 t -116.82 151.56 36.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.837 . . . . 0.0 109.583 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.05 -26.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -72.35 -43.67 63.73 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.286 -0.884 . . . . 0.0 110.143 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 14.8 mt-10 -63.48 -33.03 74.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.006 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.987 ' CD1' HD11 ' A' ' 125' ' ' ILE . 3.8 mt -70.95 -43.61 67.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.879 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 -62.7 -26.04 68.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 109.559 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -75.0 -39.89 60.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.0 109.942 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.622 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -76.86 -33.56 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.377 179.501 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.667 ' HA ' HD21 ' B' ' 17' ' ' LEU . 3.2 mtm -54.92 -69.6 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.546 -0.721 . . . . 0.0 110.081 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -47.77 -29.05 2.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.194 -0.941 . . . . 0.0 109.714 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -85.44 -17.3 36.96 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.408 -0.808 . . . . 0.0 109.85 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.886 HD11 HG13 ' B' ' 13' ' ' VAL . 1.3 mt -94.31 -25.36 17.04 Favored 'General case' 0 C--O 1.199 -1.582 0 O-C-N 121.168 -0.957 . . . . 0.0 110.694 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.0 -50.73 0.66 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.285 -1.436 . . . . 0.0 111.214 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -117.05 158.94 23.32 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.864 -1.374 . . . . 0.0 111.549 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.0 tmtt? -131.43 73.74 1.56 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.697 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.6 mp -33.75 153.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.628 0.728 . . . . 0.0 111.682 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.3 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.536 -0.727 . . . . 0.0 110.375 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' GLU . 24.4 m-20 -98.79 -68.52 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.381 -0.825 . . . . 0.0 110.33 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -42.3 -47.85 4.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.432 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 124' ' ' MET . 3.3 mm-40 -60.61 -48.17 82.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 109.89 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 124' ' ' MET . 55.0 t -65.52 -38.76 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.072 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.99 -65.3 0.71 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 109.753 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 4.7 mt-10 -46.67 -26.13 0.86 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.391 -0.818 . . . . 0.0 109.52 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.485 ' HG2' ' CE1' ' B' ' 22' ' ' PHE . 18.7 ttt -66.37 -57.04 8.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.969 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.987 HD11 ' CD1' ' A' ' 105' ' ' LEU . 48.2 mm -61.5 -50.48 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.929 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -54.25 -25.88 25.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.178 -0.951 . . . . 0.0 109.933 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -70.92 -44.7 65.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.396 -0.815 . . . . 0.0 110.077 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -71.37 -32.09 68.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.442 -0.786 . . . . 0.0 110.062 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -57.07 80.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.81 . . . . 0.0 110.384 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.581 HD12 ' HG3' ' A' ' 140' ' ' GLU . 1.9 mt -76.48 -37.75 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.932 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 14.6 p-10 -78.57 -31.48 47.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.056 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.61 65.75 0.97 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 26.3 p30 -124.44 -14.88 6.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -1.132 . . . . 0.0 110.46 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 90.54 17.72 51.37 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -163.23 169.78 18.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.332 -1.099 . . . . 0.0 110.019 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 137' ' ' ASN . 41.1 t -112.56 168.35 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.222 -0.924 . . . . 0.0 110.614 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.484 ' OD1' ' HB2' ' A' ' 140' ' ' GLU . 17.2 p-10 -152.18 -155.1 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -69.63 -69.44 0.34 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.295 -0.878 . . . . 0.0 110.717 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 140' ' ' GLU . 8.5 tt0 -46.19 -63.87 0.89 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.128 -0.982 . . . . 0.0 110.423 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.581 ' HG3' HD12 ' A' ' 130' ' ' ILE . 7.1 tt0 -41.46 -57.4 2.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.236 -0.915 . . . . 0.0 110.53 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.54 ' CE1' HG23 ' A' ' 85' ' ' ILE . 12.0 t80 -49.19 -28.88 4.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.237 -0.914 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.505 HG22 HG21 ' A' ' 85' ' ' ILE . 18.6 t -99.96 -38.35 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.234 -0.916 . . . . 0.0 110.607 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -33.69 69.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.201 -0.937 . . . . 0.0 110.794 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.538 ' HB2' HD11 ' A' ' 130' ' ' ILE . 10.0 tpp -88.3 -18.26 28.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.145 -0.972 . . . . 0.0 110.747 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.639 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 2.0 ttt -92.69 -9.8 39.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.0 110.101 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.6 p -106.82 -70.24 0.8 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 110.939 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.13 -125.22 0.17 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.245 -0.91 . . . . 0.0 110.271 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? . . . . . 0 C--N 1.288 -2.071 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.21 -179.688 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.473 ' O ' HG13 ' B' ' 1' ' ' VAL . 2.3 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.311 0.576 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.47 ' N ' ' CD ' ' B' ' 2' ' ' LYS . 0.4 OUTLIER -83.89 176.98 8.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.899 . . . . 0.0 110.292 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 mp -107.79 6.45 27.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 110.238 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 9.0 mt -87.41 145.56 37.82 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 109.779 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.599 ' HB2' HG23 ' B' ' 10' ' ' VAL . 40.3 Cg_endo -67.99 124.69 12.11 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.871 1.459 . . . . 0.0 110.325 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.527 ' O ' ' N ' ' B' ' 8' ' ' THR . 68.8 m -75.92 75.03 2.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.332 -0.855 . . . . 0.0 111.226 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.412 ' NE1' ' O ' ' A' ' 51' ' ' MET . 0.4 OUTLIER 53.93 -83.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.206 -0.934 . . . . 0.0 110.941 179.183 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.878 HG21 ' HG3' ' A' ' 75' ' ' LYS . 71.6 p -46.12 -46.81 17.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.38 -0.825 . . . . 0.0 110.017 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.916 HG21 ' HB3' ' A' ' 87' ' ' GLU . 52.7 m -52.1 -43.82 64.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.406 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.599 HG23 ' HB2' ' B' ' 5' ' ' PRO . 61.3 t -58.54 -27.38 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.259 -0.9 . . . . 0.0 108.879 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.564 HG21 ' HE2' ' A' ' 72' ' ' MET . 35.3 mm -78.16 -64.76 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.628 -0.67 . . . . 0.0 110.558 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.957 ' CD1' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -46.7 -45.39 19.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.132 -0.98 . . . . 0.0 110.485 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.886 HG13 HD11 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -60.44 -51.86 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.914 -1.116 . . . . 0.0 109.402 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.541 ' N ' HG12 ' B' ' 13' ' ' VAL . 0.0 OUTLIER -60.1 -33.04 71.56 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.993 -1.067 . . . . 0.0 109.055 178.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 6.1 t -62.69 -47.07 85.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.421 -0.799 . . . . 0.0 109.286 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.467 ' SD ' ' CE2' ' A' ' 92' ' ' PHE . 10.7 ttm -51.52 -35.88 42.47 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.389 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.816 HD22 HD13 ' A' ' 112' ' ' LEU . 7.1 mp -70.68 57.51 0.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.464 -0.773 . . . . 0.0 109.906 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.513 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 69.4 ttt-85 -122.46 -54.76 1.86 Allowed 'General case' 0 C--N 1.288 -2.069 0 O-C-N 121.404 -0.81 . . . . 0.0 111.128 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -138.74 -126.76 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.88 -1.138 . . . . 0.0 110.133 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.509 ' N ' ' HG2' ' B' ' 19' ' ' LYS . 5.0 ptp180 -119.87 41.15 3.24 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.026 -1.046 . . . . 0.0 109.918 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 8.4 t -121.52 148.7 44.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.401 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.56 ' CZ ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -117.7 -10.87 10.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.89 152.29 31.42 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.639 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 4.1 m-20 -148.63 127.5 6.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.238 . . . . 0.0 110.146 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.65 57.04 2.96 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.896 1.472 . . . . 0.0 110.279 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.622 ' CD2' ' CE ' ' A' ' 76' ' ' MET . 2.9 m-85 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.32 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.193 0.52 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -100.17 65.79 1.27 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.569 ' O ' ' C ' ' A' ' 4' ' ' LEU . 3.4 tp60 -75.4 57.18 0.9 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.279 -0.888 . . . . 0.0 110.233 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.569 ' C ' ' O ' ' A' ' 3' ' ' GLN . 10.4 mt -1.89 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.026 0 CA-C-O 121.211 0.529 . . . . 0.0 112.351 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 t -108.35 -15.47 14.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.224 -0.923 . . . . 0.0 110.183 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.743 ' HA ' HD12 ' A' ' 9' ' ' ILE . 16.6 tt0 -57.8 -29.82 65.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.893 . . . . 0.0 110.084 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -43.5 -48.03 7.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.796 179.897 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -46.02 82.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.365 179.391 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.743 HD12 ' HA ' ' A' ' 6' ' ' GLU . 14.7 mt -66.52 -52.48 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.376 -0.827 . . . . 0.0 109.352 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.88 -39.6 74.64 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -57.91 -49.27 77.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.442 -0.786 . . . . 0.0 109.251 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.568 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 17.6 m-85 -61.07 -37.4 82.55 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.291 -0.881 . . . . 0.0 109.189 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 10.7 ttpt -57.23 -42.19 80.96 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.309 -0.869 . . . . 0.0 109.073 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.21 -42.35 99.27 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.469 -0.769 . . . . 0.0 109.165 179.103 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.15 -47.99 77.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.485 -0.759 . . . . 0.0 109.297 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -54.78 -27.74 43.79 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.401 -0.812 . . . . 0.0 109.156 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 t -84.05 -37.24 22.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.462 -0.774 . . . . 0.0 109.395 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.545 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.4 tt -51.01 -36.65 40.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.418 -0.801 . . . . 0.0 109.244 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.442 ' HA ' HG21 ' A' ' 35' ' ' VAL . 86.2 m-85 -82.72 -39.78 21.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.734 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -74.86 92.33 2.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.454 -0.779 . . . . 0.0 110.058 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -65.3 -31.92 73.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 110.32 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 12.4 p-10 -90.38 -29.66 17.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.355 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.44 70.79 1.22 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 9.1 p-10 -120.21 -24.59 5.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -1.156 . . . . 0.0 110.061 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.81 -8.68 11.67 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 50.9 p -134.83 127.93 31.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -1.128 . . . . 0.0 110.222 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.684 HD12 ' CB ' ' A' ' 63' ' ' ILE . 16.4 mt -94.06 133.37 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 p -90.53 -171.35 3.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.899 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 p -83.59 -35.58 24.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.006 . . . . 0.0 109.957 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -68.52 -35.67 77.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -56.88 -55.56 32.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.19 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.62 HD13 ' CH2' ' B' ' 7' ' ' TRP . 24.6 tp -58.92 -39.73 82.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.208 -0.932 . . . . 0.0 110.253 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -56.25 -43.38 89.3 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.0 m -63.42 -56.5 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -1.176 . . . . 0.0 110.032 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.481 ' H ' HG23 ' A' ' 35' ' ' VAL . 11.7 t -55.79 -26.94 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.795 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 2.4 mmt -69.71 -41.15 75.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.247 -0.908 . . . . 0.0 109.766 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -65.81 -29.41 69.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.996 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -56.39 -55.67 30.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.13 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.486 ' CD2' HG13 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -54.87 -39.23 68.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.8 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 126.77 55.86 0.14 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.534 ' HB3' ' CD1' ' B' ' 4' ' ' ILE . 40.3 mt-30 -142.35 153.92 44.23 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.169 -1.195 . . . . 0.0 110.346 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -117.76 80.31 13.9 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.227 -0.921 . . . . 0.0 110.473 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.27 146.38 40.3 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.977 1.514 . . . . 0.0 110.224 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 45' ' ' GLU . 9.6 t -100.04 -153.81 0.45 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.204 -0.935 . . . . 0.0 110.412 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.504 ' N ' HG23 ' A' ' 44' ' ' THR . 45.3 tt0 -87.18 -52.28 5.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -0.907 . . . . 0.0 110.406 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.5 76.04 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.236 -0.915 . . . . 0.0 110.305 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' LEU . 37.8 mt-10 -63.67 -55.2 25.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.295 -0.878 . . . . 0.0 110.328 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' GLU . 15.0 mt -43.81 -52.73 6.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.124 -0.985 . . . . 0.0 109.963 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -59.96 -36.19 76.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.79 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.28 -42.04 76.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.879 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.472 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 0.1 OUTLIER -67.91 -36.18 79.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 179.457 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 5.4 mm -73.31 -21.48 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.477 -0.764 . . . . 0.0 109.905 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 54' ' ' GLU . 2.6 m-20 -66.3 -54.68 21.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 110.501 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 53' ' ' ASN . 2.6 tp10 -41.09 -35.32 0.54 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.46 -0.775 . . . . 0.0 110.598 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.671 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 10.5 t -96.68 -34.97 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.18 -0.95 . . . . 0.0 110.284 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 40.5 t0 -49.46 88.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.48 -0.762 . . . . 0.0 110.729 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -80.02 -32.36 39.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.224 -0.922 . . . . 0.0 110.38 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -76.13 -47.38 24.6 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.17 -0.956 . . . . 0.0 110.448 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.55 0.13 9.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 18.7 p30 -88.77 -32.49 17.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.113 -1.228 . . . . 0.0 110.357 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 114.44 -28.64 8.1 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 p -70.3 151.47 45.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.154 -1.204 . . . . 0.0 110.359 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.684 ' CB ' HD12 ' A' ' 27' ' ' ILE . 9.1 mm -102.46 122.9 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' C ' ' HD2' ' A' ' 66' ' ' PRO . 21.4 t0 -99.23 157.69 16.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.4 t80 -48.81 -45.65 72.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.711 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 50.0 Cg_endo -74.64 -37.34 2.35 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 123.347 1.183 . . . . 0.0 109.815 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 57' ' ' ALA . 4.2 tt0 -51.74 -49.07 63.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.505 -0.747 . . . . 0.0 110.199 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.13 -45.61 69.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.282 -0.886 . . . . 0.0 110.21 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -59.85 -12.59 7.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 0.0 110.607 -179.731 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.8 m -95.43 -43.21 8.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -0.988 . . . . 0.0 110.865 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -62.87 -39.81 95.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.089 -1.007 . . . . 0.0 110.993 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.568 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 9.3 tpt -61.49 -9.74 6.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.131 -0.981 . . . . 0.0 111.127 -179.276 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.81 -18.43 15.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.984 -1.072 . . . . 0.0 111.089 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -23.7 14.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.986 -1.071 . . . . 0.0 110.896 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HG2' HG21 ' B' ' 8' ' ' THR . 15.8 tttt -97.98 41.12 1.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.043 -1.036 . . . . 0.0 110.638 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.1 mmt -100.27 -91.76 0.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.332 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 77' ' ' LYS . 15.4 tttt -101.72 37.52 1.81 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.137 -0.977 . . . . 0.0 110.271 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.424 ' O ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -105.53 -28.12 10.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 110.243 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 78' ' ' ASP . 4.2 m -164.21 -35.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.263 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -111.39 61.61 0.61 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.931 . . . . 0.0 110.287 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.411 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 1.1 t -94.31 -63.25 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.281 -0.887 . . . . 0.0 110.088 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.688 ' HA ' HD12 ' A' ' 85' ' ' ILE . 1.4 pt-20 -87.81 -22.46 24.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.052 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.88 -46.83 61.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 109.793 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 81' ' ' SER . 17.5 pt-20 -58.48 -20.71 47.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 110.152 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.688 HD12 ' HA ' ' A' ' 82' ' ' GLU . 73.2 mt -69.79 -45.23 77.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.136 -0.978 . . . . 0.0 109.015 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 89' ' ' PHE . 58.3 ttt180 -56.89 -31.94 65.38 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.46 -56.42 6.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.39 -0.819 . . . . 0.0 109.306 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' B' ' 12' ' ' LEU . . . -54.58 -22.41 13.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.196 -0.94 . . . . 0.0 108.982 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 138' ' ' TYR . 84.1 t80 -71.41 -63.73 1.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.375 -0.828 . . . . 0.0 109.482 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -49.25 -38.34 26.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.383 -0.823 . . . . 0.0 109.076 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.694 HG12 HG21 ' A' ' 108' ' ' VAL . 18.6 t -63.78 -35.06 71.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.559 -0.713 . . . . 0.0 109.592 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.741 ' CE1' HG13 ' B' ' 13' ' ' VAL . 2.4 m-85 -72.74 -36.83 67.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.291 -0.881 . . . . 0.0 109.307 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 104' ' ' GLU . 3.6 t70 -99.91 62.19 1.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.757 . . . . 0.0 109.964 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' ASP . 7.7 tmtm? -42.64 -54.52 3.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 109.874 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.483 ' OD2' ' HG3' ' A' ' 104' ' ' GLU . 1.1 p30 -58.53 -27.32 64.41 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.533 -0.729 . . . . 0.0 109.913 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 60.86 59.24 10.5 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 34.3 p-10 -98.02 -41.95 7.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.201 -1.176 . . . . 0.0 110.556 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 162.96 -43.58 0.34 Allowed Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.295 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 15.0 m-85 -123.2 166.55 15.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.269 . . . . 0.0 110.904 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 100' ' ' ILE . 9.6 mt -102.69 84.33 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.34 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.414 ' HB2' ' OE1' ' A' ' 135' ' ' GLN . 0.2 OUTLIER -73.96 161.45 30.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.077 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.28 -19.4 3.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.922 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.84 -33.34 46.08 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.29 -0.881 . . . . 0.0 109.205 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -67.51 -42.47 82.74 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.54 -0.725 . . . . 0.0 109.254 179.178 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.054 HD12 HD11 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -63.08 -42.23 99.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.331 -0.855 . . . . 0.0 109.163 178.936 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -62.47 -26.82 68.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.593 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.462 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -69.95 -48.68 57.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.441 -0.787 . . . . 0.0 109.968 179.718 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.694 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -74.13 -30.88 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.286 -0.884 . . . . 0.0 109.455 179.47 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.814 ' HA ' HD21 ' B' ' 17' ' ' LEU . 2.4 ttm -52.04 -70.34 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.652 -0.655 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.7 m -51.77 -26.76 10.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.14 -0.975 . . . . 0.0 110.337 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.48 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 8.7 m120 -72.33 -18.39 61.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.333 -0.855 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.873 HD12 HD22 ' B' ' 17' ' ' LEU . 10.2 mt -98.87 -48.84 4.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 110.423 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.42 -58.0 0.21 Allowed Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.768 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -90.89 162.21 14.89 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.964 -1.315 . . . . 0.0 111.299 -178.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.99 72.92 1.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.58 -0.7 . . . . 0.0 109.52 179.39 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 116' ' ' LEU . 4.6 mp -33.8 150.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.614 0.721 . . . . 0.0 111.525 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 118' ' ' ASP . 1.1 m -59.18 -147.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 109.82 179.268 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.545 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -113.13 -49.65 2.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 179.816 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.65 -51.76 66.13 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.073 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 121' ' ' VAL . 10.1 pt-20 -61.01 -44.67 97.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.55 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 73.4 t -60.36 -39.38 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.349 -0.844 . . . . 0.0 109.673 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.67 -53.54 56.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 109.725 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -57.09 -25.62 59.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.602 ' HG3' ' HA ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -64.05 -49.21 73.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.353 -0.842 . . . . 0.0 109.47 179.259 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.054 HD11 HD12 ' A' ' 105' ' ' LEU . 28.8 mm -73.27 -35.83 47.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.711 -0.618 . . . . 0.0 110.247 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.409 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 3.4 tmm_? -68.94 -22.74 64.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.204 -0.935 . . . . 0.0 110.063 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.57 -34.31 67.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 110.242 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -93.34 -26.4 17.3 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.356 -0.84 . . . . 0.0 110.233 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 126' ' ' ARG . 85.9 m-20 -45.5 90.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.323 -0.861 . . . . 0.0 110.661 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -82.96 -40.82 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.158 -0.964 . . . . 0.0 109.521 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 35.2 p-10 -76.54 -24.47 53.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.929 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.477 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.99 35.05 19.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 15.9 p-10 -89.38 -15.97 32.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -1.113 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 135' ' ' GLN . . . 97.78 9.63 54.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 68.6 mt-30 -157.08 153.4 27.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.217 -1.167 . . . . 0.0 110.275 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 25.1 t -90.83 113.33 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.262 -0.899 . . . . 0.0 110.023 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -87.93 176.07 7.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.935 . . . . 0.0 110.557 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 5.2 t80 -57.08 -63.63 1.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.245 -0.91 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.6 OUTLIER -41.79 -49.34 4.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 0.0 109.989 179.891 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.443 ' HG2' HD12 ' A' ' 130' ' ' ILE . 3.0 mt-10 -57.08 -57.87 10.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 0.0 109.932 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.449 ' O ' ' SD ' ' A' ' 145' ' ' MET . 10.0 t80 -47.5 -24.47 0.85 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.275 -0.891 . . . . 0.0 109.962 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.498 HG13 HG21 ' A' ' 146' ' ' THR . 42.5 t -99.66 -39.4 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 110.409 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -65.89 -9.89 33.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.925 . . . . 0.0 110.797 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.465 ' CE ' ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -98.17 -26.13 14.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.029 -1.045 . . . . 0.0 110.704 -179.746 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' SD ' ' O ' ' A' ' 141' ' ' PHE . 6.5 mtp -100.48 -34.67 9.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 110.762 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.498 HG21 HG13 ' A' ' 142' ' ' VAL . 69.0 p -71.69 -29.08 64.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 0.0 110.35 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -82.25 53.78 2.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.187 -0.945 . . . . 0.0 110.482 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.239 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.789 HG23 ' O ' ' B' ' 1' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.116 0.484 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.677 ' O ' HD22 ' B' ' 3' ' ' LEU . 8.1 tptp -156.39 -130.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.963 -1.086 . . . . 0.0 111.035 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.677 HD22 ' O ' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -174.43 94.43 0.08 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.623 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' B' ' 3' ' ' LEU . 15.9 mm 65.36 133.41 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.24 -160.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.083 1.57 . . . . 0.0 111.243 -178.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 10.5 p -123.03 -179.17 4.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.402 -0.811 . . . . 0.0 110.911 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.671 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 22.5 m95 -59.1 -71.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.561 0.696 . . . . 0.0 111.075 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.577 HG21 ' HG2' ' A' ' 75' ' ' LYS . 65.8 p -39.88 -28.17 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.737 -0.602 . . . . 0.0 110.493 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.459 ' N ' ' O ' ' B' ' 7' ' ' TRP . 1.1 m -61.66 -50.11 73.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.678 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 t -63.89 -33.69 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.529 -0.732 . . . . 0.0 110.09 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.586 ' N ' HD13 ' B' ' 11' ' ' ILE . 3.8 mm -74.18 -31.89 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.261 -0.899 . . . . 0.0 109.979 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.482 ' O ' ' OG ' ' B' ' 15' ' ' SER . 0.4 OUTLIER -62.55 -52.45 63.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.852 . . . . 0.0 110.093 179.741 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.741 HG13 ' CE1' ' A' ' 92' ' ' PHE . 78.2 t -67.81 -43.78 85.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.669 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.425 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -59.52 -49.74 76.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.737 -1.227 . . . . 0.0 109.692 179.453 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' B' ' 12' ' ' LEU . 3.5 p -50.67 -42.27 56.46 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.42 ' SD ' ' HG3' ' B' ' 25' ' ' PRO . 26.2 tpp -73.12 -13.93 61.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.69 179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.873 HD22 HD12 ' A' ' 112' ' ' LEU . 2.9 mp -89.94 62.44 5.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 110.142 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 ttp85 -118.31 -74.4 0.61 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.364 -0.835 . . . . 0.0 111.022 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.534 ' HD2' ' HB2' ' B' ' 20' ' ' ARG . 2.3 tmtm? -138.04 -75.45 0.39 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.081 -1.012 . . . . 0.0 110.952 -178.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.602 ' HA ' ' HG3' ' A' ' 124' ' ' MET . 1.0 OUTLIER -140.09 -4.21 1.36 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.714 -1.241 . . . . 0.0 111.31 -179.655 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -53.12 141.14 23.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.026 -1.046 . . . . 0.0 110.684 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -170.88 137.54 1.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.402 -0.811 . . . . 0.0 110.189 179.581 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.465 ' HA3' ' CE ' ' A' ' 144' ' ' MET . . . 126.11 -87.2 0.35 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.537 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 3.2 p-10 -131.41 50.43 5.96 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.237 -1.155 . . . . 0.0 110.338 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 45.3 Cg_endo -73.48 -6.14 18.27 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.055 1.555 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.518 ' CZ ' ' HE1' ' A' ' 72' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.278 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.282 0.563 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.74 160.69 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 110.127 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -99.4 133.42 43.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 110.134 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mp -79.19 151.22 31.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.429 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.79 56.45 1.82 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.48 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.42 -26.17 13.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 110.086 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -54.02 -57.65 10.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 110.332 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -54.58 -53.07 59.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -0.951 . . . . 0.0 110.303 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 10' ' ' ALA . 53.7 mt -57.44 -59.21 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -42.56 -46.18 4.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 110.051 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.82 -54.76 33.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.015 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CD2' HD23 ' A' ' 69' ' ' LEU . 21.4 m-85 -61.13 -42.91 99.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.97 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -58.58 -34.05 70.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.185 -0.947 . . . . 0.0 109.344 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -61.78 -44.67 96.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.381 -0.825 . . . . 0.0 109.49 179.346 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -66.43 -52.1 49.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.462 -0.774 . . . . 0.0 110.08 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.6 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 35.7 t80 -63.73 -12.23 33.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.811 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.3 m -92.76 -25.99 17.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.882 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.729 HD13 ' HG3' ' B' ' 14' ' ' LYS . 7.1 tt -77.67 -30.39 51.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.603 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 47.5 m-85 -80.01 -56.71 4.05 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.335 -0.853 . . . . 0.0 110.686 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -62.84 82.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.165 -0.96 . . . . 0.0 110.213 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -88.86 21.25 3.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.235 -179.973 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 23' ' ' GLY . 7.4 p-10 -140.1 18.68 2.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.459 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.9 75.76 0.15 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.449 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 1.8 t0 -132.66 -26.7 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -1.134 . . . . 0.0 110.685 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.68 -21.4 29.88 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -119.27 118.8 32.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -1.101 . . . . 0.0 109.874 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.502 HD12 HG21 ' A' ' 63' ' ' ILE . 12.3 mt -79.34 126.17 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.121 -0.987 . . . . 0.0 109.606 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.8 p -90.16 -157.68 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.795 . . . . 0.0 110.386 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.49 HG22 HG13 ' A' ' 52' ' ' ILE . 77.8 p -94.16 -33.43 13.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 13.0 ptpt -74.68 -31.07 61.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.121 -0.987 . . . . 0.0 110.288 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 14.9 mt-10 -58.17 -66.35 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.118 -0.988 . . . . 0.0 109.47 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.625 HD22 ' CZ2' ' B' ' 7' ' ' TRP . 58.1 tp -56.75 -35.45 68.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.168 -0.958 . . . . 0.0 109.25 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.81 -37.14 93.83 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 96.6 m -59.44 -47.13 86.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.348 -1.089 . . . . 0.0 109.441 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 35' ' ' VAL . 14.7 t -70.93 -37.35 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.592 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.654 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -69.19 -44.74 71.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.385 -0.822 . . . . 0.0 109.775 179.549 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -62.57 -29.77 70.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.973 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.43 ' O ' ' CG ' ' A' ' 111' ' ' ASN . 3.3 t -79.1 -21.67 46.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 110.014 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 36' ' ' MET . 4.3 mt -68.13 -32.01 71.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.36 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.07 -60.63 0.44 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -172.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -1.199 . . . . 0.0 110.714 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 54.7 m-80 -137.1 98.88 10.16 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.431 -0.793 . . . . 0.0 109.826 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 44.3 Cg_endo -71.61 124.04 9.95 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.965 1.508 . . . . 0.0 110.464 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -93.08 167.22 11.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.3 -37.08 71.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 0.0 110.108 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.07 64.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.238 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.486 ' OE1' HD12 ' B' ' 4' ' ' ILE . 20.9 mt-10 -66.78 -38.55 86.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.087 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 48' ' ' LEU . 12.2 mt -62.08 -39.72 93.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.087 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -43.89 86.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.334 -0.854 . . . . 0.0 109.696 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.18 -38.03 89.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.35 -0.844 . . . . 0.0 109.652 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.595 ' HE1' ' CG ' ' B' ' 7' ' ' TRP . 7.4 mmm -67.26 -42.31 84.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.668 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.49 HG13 HG22 ' A' ' 29' ' ' THR . 4.4 mm -70.16 -19.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.35 -0.844 . . . . 0.0 109.625 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.11 -16.21 41.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.269 -0.894 . . . . 0.0 110.02 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -71.31 -31.01 66.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.42 -0.8 . . . . 0.0 110.241 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 57' ' ' ALA . 20.4 t -92.02 -37.09 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.163 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.427 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 1.4 t70 -46.68 87.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.641 . . . . 0.0 110.555 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -99.05 -26.78 14.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 0.0 110.203 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 3.1 p-10 -73.96 -43.27 58.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -0.962 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 58' ' ' ASP . . . 114.17 27.4 3.43 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 21.8 p-10 -99.53 -40.16 7.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.098 -1.236 . . . . 0.0 110.102 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 123.43 -46.76 1.07 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.2 p -95.31 166.5 11.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -1.217 . . . . 0.0 110.479 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 26' ' ' THR . 16.4 mm -88.69 142.24 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.3 -0.875 . . . . 0.0 109.894 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.2 m-20 -121.2 147.34 45.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.982 -1.073 . . . . 0.0 110.863 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.62 ' O ' HD12 ' A' ' 69' ' ' LEU . 89.7 t80 -41.61 -50.78 9.44 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.453 -0.78 . . . . 0.0 111.546 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.0 Cg_endo -66.35 -43.36 8.38 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 123.252 1.133 . . . . 0.0 110.773 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 43.4 tt0 -60.93 -36.82 80.32 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.208 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 13.0 t80 -62.56 -45.83 91.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.997 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 65' ' ' PHE . 2.7 mt -61.94 -29.91 70.55 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.319 -0.863 . . . . 0.0 110.726 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 1.7 p -79.4 -33.41 42.75 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.154 -0.966 . . . . 0.0 111.347 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.477 ' HG3' HG13 ' A' ' 55' ' ' VAL . 9.1 tmm? -69.05 -43.27 75.0 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.962 -1.087 . . . . 0.0 110.975 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.482 ' HE2' ' CE1' ' B' ' 26' ' ' PHE . 10.7 tpt -58.66 -10.85 2.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.189 -0.944 . . . . 0.0 111.12 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.95 -9.81 16.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.865 -1.147 . . . . 0.0 111.236 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 4.1 ttt180 -94.4 -43.49 8.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.961 -1.087 . . . . 0.0 110.686 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -64.82 -8.84 16.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.317 -0.864 . . . . 0.0 110.486 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 72' ' ' MET . 1.3 mmt -99.27 41.56 1.14 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.98 . . . . 0.0 110.113 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.489 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -178.01 30.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -127.22 -62.82 1.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.935 . . . . 0.0 110.344 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.14 -41.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.127 -0.983 . . . . 0.0 110.638 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.76 76.31 6.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.178 -0.951 . . . . 0.0 110.177 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.7 t -110.91 -48.93 3.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.979 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -99.98 -25.29 14.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 110.187 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -72.08 -17.94 61.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -0.972 . . . . 0.0 109.509 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -70.11 -23.23 63.0 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.455 -0.778 . . . . 0.0 109.871 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.6 mt -64.88 -28.99 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.2 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -32.32 73.71 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.616 -0.677 . . . . 0.0 109.807 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.799 ' HB3' HG21 ' B' ' 9' ' ' THR . 13.9 mt-10 -74.16 -47.61 34.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.863 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.52 67.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.005 -1.059 . . . . 0.0 109.405 179.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CE1' ' OD2' ' A' ' 93' ' ' ASP . 11.8 t80 -71.44 -46.43 60.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -52.91 -32.35 44.95 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.436 -0.79 . . . . 0.0 109.321 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.666 HG12 HG21 ' A' ' 108' ' ' VAL . 20.7 t -71.27 -43.09 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.543 -0.723 . . . . 0.0 109.85 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.617 ' HB3' HD13 ' A' ' 100' ' ' ILE . 19.6 m-85 -66.58 -28.26 68.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.237 -0.914 . . . . 0.0 109.797 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.551 ' OD2' ' CE1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -88.03 62.29 6.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.388 -0.82 . . . . 0.0 109.788 179.788 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -36.29 -32.74 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.703 -0.623 . . . . 0.0 110.968 -179.553 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 12.5 p30 -111.23 -39.15 4.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.171 -0.956 . . . . 0.0 110.389 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 92.09 55.22 1.75 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 99' ' ' TYR . 52.1 p30 -97.29 0.24 47.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.178 -1.189 . . . . 0.0 110.175 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.585 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 93.68 12.56 56.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.452 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -154.14 142.31 20.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.359 -1.083 . . . . 0.0 110.03 -179.944 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 92' ' ' PHE . 5.7 mt -101.51 116.8 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.238 -0.914 . . . . 0.0 110.119 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 t -98.97 142.03 30.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.288 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.02 -35.73 3.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.832 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -58.82 -49.77 76.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 109.538 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.61 -50.02 66.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.704 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.815 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -59.32 -41.08 88.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.835 . . . . 0.0 109.397 179.468 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 13.2 ttt180 -56.08 -27.7 54.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.311 -0.868 . . . . 0.0 109.403 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.13 -42.5 37.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.619 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.666 HG21 HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -70.06 -26.89 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.292 179.588 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 109' ' ' MET . . . . . 1.011 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.5 OUTLIER -64.33 -64.8 0.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.361 -0.837 . . . . 0.0 110.155 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.18 -33.44 63.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.903 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 38' ' ' SER . 77.5 m-20 -75.31 -18.52 60.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 110.174 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.691 HD11 HG12 ' B' ' 13' ' ' VAL . 4.3 mt -92.41 -41.36 10.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 110.268 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.32 -36.75 0.81 Allowed Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.251 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 3.4 tp10 -116.09 158.24 23.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.915 -1.344 . . . . 0.0 110.981 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -139.24 83.09 1.93 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.149 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' B' ' 19' ' ' LYS . 6.3 mp -38.34 140.76 0.28 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.591 -0.693 . . . . 0.0 111.074 -179.265 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -54.35 -168.52 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.541 -0.724 . . . . 0.0 109.497 179.327 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -74.95 -68.71 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.057 -1.027 . . . . 0.0 110.211 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.46 -45.16 12.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.308 -0.87 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.14 -44.28 92.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 110.049 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 117' ' ' THR . 20.1 t -61.05 -40.44 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.99 -29.21 69.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.249 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -74.63 -30.61 61.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.5 ' HE1' ' CE2' ' B' ' 22' ' ' PHE . 0.1 OUTLIER -70.41 -51.26 30.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.136 -0.977 . . . . 0.0 110.248 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.815 HD11 ' CD1' ' A' ' 105' ' ' LEU . 49.8 mm -64.56 -41.26 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.25 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -27.11 67.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 110.221 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.5 OUTLIER -69.29 -21.04 63.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.88 -35.76 8.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.931 . . . . 0.0 110.271 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.412 ' CG ' ' HA2' ' A' ' 132' ' ' GLY . 5.1 t0 -43.11 105.6 0.05 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.317 -0.864 . . . . 0.0 110.411 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 130' ' ' ILE . 23.4 mm -74.99 -33.97 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.251 -0.906 . . . . 0.0 109.928 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 7.1 p-10 -103.72 -21.98 13.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 0.0 109.989 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.412 ' HA2' ' CG ' ' A' ' 129' ' ' ASP . . . 81.09 70.41 1.34 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 19.3 p-10 -120.68 -10.96 9.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.186 -1.185 . . . . 0.0 110.406 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.77 12.13 30.99 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -164.59 147.35 8.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.188 -1.183 . . . . 0.0 110.168 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 11.7 t -99.98 143.15 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 110.338 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 98' ' ' GLY . 1.7 t-20 -105.32 -168.23 1.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 109.89 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.415 ' CE1' HG21 ' A' ' 142' ' ' VAL . 41.1 t80 -76.06 -48.46 20.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.27 -41.29 65.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.9 -52.23 38.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.274 -0.891 . . . . 0.0 110.33 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -57.0 -17.32 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.326 -0.859 . . . . 0.0 110.631 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.564 ' O ' HG22 ' A' ' 146' ' ' THR . 37.3 t -100.26 -70.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.07 -1.019 . . . . 0.0 111.006 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -39.82 -37.14 0.51 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.257 -0.902 . . . . 0.0 110.7 -179.487 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.6 mmm -62.75 -29.09 70.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.154 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.473 ' HA ' ' HB2' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -100.4 -30.86 11.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.333 -0.854 . . . . 0.0 110.653 -179.898 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.6 t -102.45 57.66 0.79 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.096 -1.003 . . . . 0.0 110.525 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -97.39 57.4 1.41 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.048 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.243 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.402 ' O ' HG12 ' B' ' 1' ' ' VAL . 84.9 t . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 120.903 0.382 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.97 -22.84 1.18 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.947 -1.095 . . . . 0.0 111.621 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' B' ' 4' ' ' ILE . 10.9 tp -153.91 -72.44 0.13 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.561 -1.337 . . . . 0.0 111.411 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.761 HG23 ' HD2' ' B' ' 5' ' ' PRO . 7.8 mt -39.13 147.61 0.29 Allowed Pre-proline 0 N--CA 1.506 2.358 0 O-C-N 121.101 -0.999 . . . . 0.0 110.096 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.761 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.9 Cg_endo -65.31 -176.35 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.844 1.444 . . . . 0.0 110.662 -179.074 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.472 ' O ' ' N ' ' B' ' 8' ' ' THR . 28.9 t -126.96 64.06 1.3 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.14 -0.975 . . . . 0.0 111.384 -178.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.625 ' CZ2' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER 58.09 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.207 -0.933 . . . . 0.0 111.188 178.688 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.472 ' N ' ' O ' ' B' ' 6' ' ' SER . 12.0 p -43.6 -42.79 5.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.992 . . . . 0.0 110.25 -179.335 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.799 HG21 ' HB3' ' A' ' 87' ' ' GLU . 3.8 m -52.41 -44.39 65.36 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.177 -0.952 . . . . 0.0 109.209 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.71 -37.43 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.337 -0.852 . . . . 0.0 109.381 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.583 ' N ' HD13 ' B' ' 11' ' ' ILE . 4.2 mm -71.38 -25.0 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -0.797 . . . . 0.0 109.499 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' B' ' 9' ' ' THR . 2.0 mp -67.38 -60.31 2.69 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.336 -0.853 . . . . 0.0 109.645 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.691 HG12 HD11 ' A' ' 112' ' ' LEU . 72.7 t -57.77 -37.79 61.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.348 -0.845 . . . . 0.0 109.99 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.729 ' HG3' HD13 ' A' ' 18' ' ' LEU . 2.4 ttpt -59.41 -45.1 92.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.028 -1.045 . . . . 0.0 109.467 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' B' ' 18' ' ' ARG . 1.6 m -62.79 -26.28 68.64 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.339 -0.85 . . . . 0.0 109.537 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.533 ' HA ' ' HB2' ' B' ' 21' ' ' SER . 0.0 OUTLIER -70.54 -32.37 69.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.891 . . . . 0.0 109.748 179.663 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 1.011 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.9 mp -73.65 -5.56 41.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.297 -0.877 . . . . 0.0 110.489 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.9 OUTLIER -44.21 -56.45 4.1 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.152 -0.968 . . . . 0.0 109.468 179.885 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.548 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -171.72 -68.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.605 0.717 . . . . 0.0 109.271 179.699 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.503 ' HB3' ' CD ' ' B' ' 19' ' ' LYS . 0.8 OUTLIER -129.51 14.67 6.03 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.073 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' B' ' 16' ' ' MET . 20.0 m -48.3 145.29 3.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.637 -0.664 . . . . 0.0 110.761 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.5 ' CE2' ' HE1' ' A' ' 124' ' ' MET . 0.1 OUTLIER 171.67 -34.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.495 -0.753 . . . . 0.0 109.912 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.29 -128.82 0.03 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.643 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 43.9 t30 -131.76 34.42 0.26 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.988 -1.301 . . . . 0.0 111.723 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 51.3 Cg_endo -76.33 56.65 5.09 Favored 'Trans proline' 0 N--CA 1.481 0.788 0 O-C-N 123.185 1.097 . . . . 0.0 110.472 179.549 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.256 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.216 0.531 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.554 ' OD1' HG21 ' A' ' 5' ' ' THR . 11.9 p30 -164.63 144.61 7.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.307 -0.87 . . . . 0.0 110.19 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 4' ' ' LEU . 6.6 mt-30 -87.86 171.15 10.58 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.264 -0.897 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 3' ' ' GLN . 25.1 mt 42.08 71.91 0.19 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 0.0 110.193 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 5' ' ' THR . 7.7 t -150.41 95.06 2.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.2 -0.938 . . . . 0.0 110.536 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.23 -23.85 18.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.131 -0.98 . . . . 0.0 110.026 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.76 -39.81 92.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.302 -0.874 . . . . 0.0 110.306 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 8.2 mm100 -71.19 -59.49 2.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.061 -1.025 . . . . 0.0 109.814 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mt -48.1 -43.88 11.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 109.432 179.397 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -54.01 -47.38 71.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.384 -0.822 . . . . 0.0 109.491 179.418 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 1.4 mt-10 -49.49 -54.19 19.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.507 179.43 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -59.46 -38.92 82.03 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.144 -0.973 . . . . 0.0 109.389 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 10.3 ttpt -53.54 -43.62 68.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.285 -0.884 . . . . 0.0 109.173 179.165 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -56.87 -48.32 78.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 108.888 178.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.21 -54.16 50.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.412 -0.805 . . . . 0.0 109.292 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 65' ' ' PHE . 55.7 t80 -50.71 -35.64 32.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.813 . . . . 0.0 109.126 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.15 -29.39 48.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.598 -0.689 . . . . 0.0 109.396 179.258 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.616 HD11 ' O ' ' A' ' 112' ' ' LEU . 3.6 tt -53.04 -50.75 63.65 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.391 -0.818 . . . . 0.0 109.365 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 45.0 m-85 -69.72 -28.03 65.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.393 179.206 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.515 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 16.0 t0 -87.23 66.15 9.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.74 . . . . 0.0 110.14 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -45.25 -32.03 1.77 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.146 -0.971 . . . . 0.0 110.324 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 11.8 p-10 -89.72 -7.19 55.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.348 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 47.98 71.26 0.59 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 35.9 p-10 -116.9 -34.28 4.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -1.147 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 128.76 -0.51 6.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 21.2 p -142.4 128.28 19.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -1.159 . . . . 0.0 110.615 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.556 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 10.7 mt -91.96 129.65 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.214 -0.929 . . . . 0.0 110.054 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 p -99.64 -163.81 1.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 110.136 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 48' ' ' LEU . 4.5 p -91.2 -38.03 12.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.111 -0.993 . . . . 0.0 110.049 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -66.85 -33.39 75.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.994 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' OE2' ' HA ' ' A' ' 20' ' ' ASP . 2.1 mt-10 -67.05 -64.25 0.89 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.88 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.511 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 21.5 tp -52.85 -36.85 59.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 109.843 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.7 92.33 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.1 m -63.88 -52.86 58.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -1.094 . . . . 0.0 109.822 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 19' ' ' PHE . 26.3 t -52.75 -43.66 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.732 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.5 ' HE1' ' SD ' ' A' ' 51' ' ' MET . 32.2 mtt -64.18 -38.51 91.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.638 179.676 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.24 -16.37 63.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.848 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -79.0 -63.0 1.52 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.314 -0.866 . . . . 0.0 110.603 -179.879 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.472 ' O ' ' HE2' ' A' ' 94' ' ' LYS . 1.4 mt -43.48 -41.68 4.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.094 -1.004 . . . . 0.0 109.924 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 134.12 61.91 0.07 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.481 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' B' ' 4' ' ' ILE . 7.7 mt-30 -157.34 -176.36 5.91 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.125 -1.221 . . . . 0.0 109.974 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -144.17 97.44 5.24 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.109 -0.995 . . . . 0.0 110.612 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.843 ' HA ' HD11 ' B' ' 4' ' ' ILE . 49.2 Cg_endo -76.39 137.23 18.51 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.015 1.534 . . . . 0.0 110.539 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 47' ' ' GLU . 24.1 m -87.75 142.91 27.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 109.87 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -42.21 -64.2 0.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 110.27 179.994 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.71 -52.15 42.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 110.092 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 2.8 mm-40 -50.21 -53.05 30.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.308 -0.87 . . . . 0.0 109.985 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -44.94 -51.64 9.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 110.13 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 40.1 tp60 -57.4 -32.71 67.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -0.822 . . . . 0.0 109.999 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -68.0 -38.67 82.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 109.906 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.576 ' HE3' ' O ' ' B' ' 6' ' ' SER . 2.0 ttp -81.55 -27.5 34.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.398 -0.814 . . . . 0.0 110.246 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 mm -78.29 -29.9 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.302 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -77.55 0.96 20.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.18 -0.95 . . . . 0.0 110.017 179.807 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.56 -44.68 11.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.294 -0.878 . . . . 0.0 109.669 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.852 HG13 ' HG3' ' A' ' 71' ' ' MET . 41.0 t -79.72 -20.26 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 109.928 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -51.4 87.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.347 -0.846 . . . . 0.0 110.152 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -87.01 -47.22 9.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.259 -0.901 . . . . 0.0 111.062 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.2 p-10 -57.46 -45.94 84.2 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.023 -1.048 . . . . 0.0 110.828 -179.373 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 120.16 18.24 4.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 32.8 p-10 -96.24 -46.01 6.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -1.23 . . . . 0.0 110.239 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 134.6 -43.8 1.23 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.54 168.48 16.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.258 -1.142 . . . . 0.0 110.51 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.556 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 11.4 mm -92.76 143.76 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 110.109 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -117.95 163.69 16.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.088 -1.008 . . . . 0.0 110.379 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 44.9 t80 -59.24 -50.7 86.21 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.269 -0.894 . . . . 0.0 110.483 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -69.02 -29.2 27.81 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 O-C-N 123.393 1.207 . . . . 0.0 109.517 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' HG3' ' HB3' ' A' ' 57' ' ' ALA . 5.9 tt0 -67.75 -31.21 70.97 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.475 -0.766 . . . . 0.0 109.06 178.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.413 ' CZ ' HG13 ' B' ' 11' ' ' ILE . 5.6 t80 -70.06 -53.75 16.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.538 -0.726 . . . . 0.0 109.889 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -54.01 -35.52 62.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.387 -0.82 . . . . 0.0 110.333 -179.966 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 71' ' ' MET . 1.3 m -78.04 -53.7 7.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.23 -0.919 . . . . 0.0 110.712 -179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.852 ' HG3' HG13 ' A' ' 55' ' ' VAL . 5.7 tmm? -41.24 -42.69 2.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.226 -0.921 . . . . 0.0 110.553 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.55 ' HE1' ' CZ ' ' B' ' 26' ' ' PHE . 0.1 OUTLIER -51.24 -17.83 0.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -0.868 . . . . 0.0 110.681 -179.741 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.48 -35.86 10.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.016 -1.052 . . . . 0.0 110.925 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -31.65 54.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.066 -1.022 . . . . 0.0 110.742 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB3' HG21 ' B' ' 8' ' ' THR . 0.1 OUTLIER -64.23 -51.03 65.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 -179.789 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 6.9 mtt -82.62 51.57 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.375 -0.828 . . . . 0.0 110.75 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -113.11 20.93 15.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.172 -0.955 . . . . 0.0 109.983 179.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' C ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -138.82 77.34 1.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.067 179.918 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.425 ' OG1' ' C ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 42.85 35.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.251 -0.905 . . . . 0.0 110.25 -179.922 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.75 76.98 3.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.251 -0.906 . . . . 0.0 110.24 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -115.04 -52.24 2.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 85' ' ' ILE . 19.7 mt-10 -100.06 -10.43 21.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.169 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 87' ' ' GLU . 7.3 tt0 -74.52 -44.52 50.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.096 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.64 -23.56 66.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.488 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.545 HG23 ' CE2' ' A' ' 141' ' ' PHE . 67.2 mt -78.43 -45.48 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.927 . . . . 0.0 109.816 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -53.89 -36.66 62.91 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 109.705 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.55 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 0.3 OUTLIER -69.83 -52.22 26.84 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.213 -0.929 . . . . 0.0 109.542 179.494 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.69 -35.3 65.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.093 -1.005 . . . . 0.0 109.036 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 63.3 t80 -67.28 -47.59 70.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.508 -0.745 . . . . 0.0 109.668 179.262 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -46.42 71.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.404 -0.81 . . . . 0.0 109.328 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.629 HG11 HG21 ' B' ' 13' ' ' VAL . 1.5 t -51.09 -48.94 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.415 -0.803 . . . . 0.0 109.418 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.52 ' HB3' HD13 ' A' ' 100' ' ' ILE . 30.6 m-85 -57.05 -38.3 73.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.131 -0.981 . . . . 0.0 110.124 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.432 ' OD1' HG12 ' A' ' 100' ' ' ILE . 68.2 m-20 -89.54 59.75 4.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.545 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 0.8 OUTLIER -52.18 -34.37 44.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.952 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 9.9 p-10 -74.02 -41.83 61.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.924 . . . . 0.0 110.112 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.69 35.08 5.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.431 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 33.5 p-10 -94.65 3.09 55.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -1.197 . . . . 0.0 110.257 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 68.23 37.72 86.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 12.8 m-85 -165.27 142.61 5.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -1.113 . . . . 0.0 110.24 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 92' ' ' PHE . 9.7 mt -107.7 126.53 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.667 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' ALA . 2.8 t -117.76 147.83 42.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.825 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.15 -27.73 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.268 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -70.73 -43.98 67.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.855 . . . . 0.0 109.799 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 101' ' ' SER . 42.8 mt-10 -61.31 -40.21 93.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.923 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.054 ' CD1' HD11 ' A' ' 125' ' ' ILE . 2.4 mt -63.34 -44.37 95.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.405 -0.81 . . . . 0.0 109.81 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.8 ttp85 -53.87 -37.08 63.33 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.067 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.545 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -60.55 -60.94 3.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.397 -0.814 . . . . 0.0 109.573 179.292 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.68 -35.15 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.368 -0.832 . . . . 0.0 109.464 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.946 ' HA ' HD21 ' B' ' 17' ' ' LEU . 5.6 mtt -50.89 -65.42 0.56 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 110.395 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -63.5 -33.21 75.09 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 110.354 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.12 -8.37 49.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.105 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.916 HD11 HG12 ' B' ' 13' ' ' VAL . 10.1 mt -109.38 -50.88 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 110.471 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.06 -59.24 0.16 Allowed Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.585 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -105.87 154.76 20.1 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.055 -1.262 . . . . 0.0 110.626 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 116' ' ' LEU . 6.9 ptpp? -123.48 21.97 9.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.878 . . . . 0.0 110.15 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 115' ' ' LYS . 6.6 mp 41.03 -164.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.547 -0.721 . . . . 0.0 110.575 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 118' ' ' ASP . 1.1 m -96.49 -146.59 0.29 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.433 -0.792 . . . . 0.0 109.178 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.513 ' H ' HG22 ' A' ' 117' ' ' THR . 26.1 t70 -115.4 -54.51 2.53 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.127 -0.983 . . . . 0.0 109.963 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -31.35 72.54 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 109.517 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -69.93 -45.26 67.9 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.298 -0.876 . . . . 0.0 109.298 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.2 t -61.99 -45.73 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.082 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.29 -39.99 92.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 109.782 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 4.5 tt0 -71.71 -31.15 66.42 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.403 -0.81 . . . . 0.0 109.559 179.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.502 ' HB2' ' HA ' ' B' ' 20' ' ' ARG . 1.4 ttt -61.33 -34.59 75.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 0.0 109.603 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.054 HD11 ' CD1' ' A' ' 105' ' ' LEU . 35.2 mm -80.56 -63.52 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.446 -0.784 . . . . 0.0 110.816 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.06 -30.33 10.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.181 -0.949 . . . . 0.0 110.938 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 11.8 mt-10 -74.78 -29.96 61.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.103 -0.998 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -88.11 -28.66 21.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.311 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.6 90.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 128' ' ' ALA . 49.3 mm -59.75 -40.93 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 0.0 109.959 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -84.55 -28.79 26.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.414 -0.804 . . . . 0.0 110.092 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.7 76.65 0.97 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.1 p30 -135.42 8.78 3.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.216 -1.167 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.47 13.28 73.67 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -169.42 163.05 10.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.247 -1.149 . . . . 0.0 110.412 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 87.5 t -108.38 142.9 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.111 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.47 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 4.6 t30 -110.45 -159.04 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 0.0 110.106 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 139' ' ' GLU . 30.2 t80 -72.61 -63.02 1.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 109.691 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 143' ' ' GLN . 43.1 mt-10 -42.98 -50.11 5.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.324 -0.86 . . . . 0.0 109.787 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.444 ' HB3' HG13 ' A' ' 136' ' ' VAL . 48.8 mt-10 -55.67 -60.46 3.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 109.634 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 30.5 t80 -41.55 -28.14 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.538 -0.727 . . . . 0.0 109.537 179.157 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 140' ' ' GLU . 78.7 t -100.37 -28.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.559 -0.713 . . . . 0.0 110.535 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -66.04 -13.14 59.45 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.06 -1.025 . . . . 0.0 110.343 -179.792 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -103.63 -23.72 13.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.103 -0.998 . . . . 0.0 110.608 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.889 ' HE2' ' H ' ' B' ' 24' ' ' ASN . 8.5 mtt -90.8 -32.64 16.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.17 -0.956 . . . . 0.0 109.806 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 146' ' ' THR . 8.4 t -170.53 95.71 0.23 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.362 -0.836 . . . . 0.0 110.156 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.24 39.48 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.201 -0.937 . . . . 0.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.1 mttt . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.247 179.956 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.217 0.532 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' B' ' 3' ' ' LEU . 3.3 pttt -148.86 166.3 28.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.94 . . . . 0.0 110.541 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.677 ' O ' HD23 ' B' ' 3' ' ' LEU . 5.0 tt -178.04 62.15 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.379 -0.826 . . . . 0.0 109.243 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.843 HD11 ' HA ' ' A' ' 43' ' ' PRO . 15.9 mt -29.46 146.39 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 122.12 -0.362 . . . . 0.0 111.18 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.638 ' HD2' HG23 ' B' ' 4' ' ' ILE . 43.6 Cg_endo -74.06 151.77 44.94 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.954 1.502 . . . . 0.0 109.973 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.576 ' O ' ' HE3' ' A' ' 51' ' ' MET . 13.4 m -62.9 -55.36 26.75 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 110.432 -179.533 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.55 ' CD1' ' HE3' ' A' ' 51' ' ' MET . 0.0 OUTLIER 169.9 -76.25 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.315 -0.866 . . . . 0.0 109.552 -179.725 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.546 HG21 ' HB3' ' A' ' 75' ' ' LYS . 25.7 p -53.2 -27.75 23.3 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.758 . . . . 0.0 109.878 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.55 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 79.4 m -58.86 -52.18 66.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.925 -1.109 . . . . 0.0 108.464 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.439 ' H ' HG23 ' B' ' 10' ' ' VAL . 15.5 t -50.79 -43.69 25.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.486 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' B' ' 11' ' ' ILE . 0.8 OUTLIER -59.57 -54.28 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.758 0.79 . . . . 0.0 109.584 179.408 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 11' ' ' ILE . 0.6 OUTLIER -40.66 -66.85 0.28 Allowed 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.657 -0.652 . . . . 0.0 110.779 -179.831 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.916 HG12 HD11 ' A' ' 112' ' ' LEU . 62.1 t -46.13 -43.45 5.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.643 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.543 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -59.05 -50.01 75.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.91 -1.119 . . . . 0.0 110.277 179.652 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.76 -28.95 37.68 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.357 -0.839 . . . . 0.0 109.89 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.492 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -72.6 -31.17 64.98 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.244 -0.91 . . . . 0.0 110.593 -179.871 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.946 HD21 ' HA ' ' A' ' 109' ' ' MET . 4.6 mp -67.2 57.64 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.071 -1.018 . . . . 0.0 110.699 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.572 ' HG3' ' CD ' ' B' ' 19' ' ' LYS . 2.0 ttp180 -91.96 -110.38 0.1 Allowed 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.478 -0.764 . . . . 0.0 109.141 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.572 ' CD ' ' HG3' ' B' ' 18' ' ' ARG . 3.0 mptt -126.53 -94.4 0.46 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.741 -1.225 . . . . 0.0 109.114 178.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.502 ' HA ' ' HB2' ' A' ' 124' ' ' MET . 0.0 OUTLIER -105.33 3.02 29.4 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.274 -0.891 . . . . 0.0 109.31 178.943 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 6.9 m -84.07 -176.07 6.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 0.0 109.712 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.625 ' HE2' HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -151.7 -150.72 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.017 . . . . 0.0 111.186 179.712 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.45 ' HA2' ' SD ' ' B' ' 16' ' ' MET . . . -43.85 156.05 0.21 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.889 ' H ' ' HE2' ' A' ' 145' ' ' MET . 34.8 m120 -150.17 168.1 11.68 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.457 -1.025 . . . . 0.0 110.217 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' B' ' 24' ' ' ASN . 39.7 Cg_endo -65.78 73.22 0.32 Allowed 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.637 1.335 . . . . 0.0 110.041 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.55 ' CZ ' ' HE1' ' A' ' 72' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.715 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.758 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.214 0.531 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.428 ' OD1' ' C ' ' A' ' 2' ' ' ASP . 43.9 t0 -133.87 -100.53 0.25 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 109.896 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -99.72 -176.68 3.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 109.805 179.621 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 3' ' ' GLN . 0.9 OUTLIER 61.28 136.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.079 -1.013 . . . . 0.0 109.978 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.604 HG23 ' HB2' ' A' ' 8' ' ' GLN . 2.2 t -68.72 146.62 52.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.155 -0.966 . . . . 0.0 110.418 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 7' ' ' GLU . 1.6 mp0 -86.88 -41.4 14.03 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.335 -0.853 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 7' ' ' GLU . 3.5 tp10 -42.78 -46.81 5.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 109.999 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.604 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -59.71 -54.82 41.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.818 179.767 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 10' ' ' ALA . 88.6 mt -50.08 -59.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -44.97 -52.7 8.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -0.939 . . . . 0.0 109.514 179.516 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.537 ' HG2' ' CD1' ' A' ' 12' ' ' PHE . 1.2 tt0 -52.49 -48.1 66.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -0.834 . . . . 0.0 109.313 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.537 ' CD1' ' HG2' ' A' ' 11' ' ' GLU . 18.9 m-30 -55.84 -47.46 77.22 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.359 -0.838 . . . . 0.0 109.904 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -48.86 -42.64 37.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.588 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -53.63 56.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 109.619 179.439 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -54.2 -40.85 67.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.829 . . . . 0.0 109.861 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -66.8 -30.05 70.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.823 . . . . 0.0 109.831 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -78.43 -20.22 51.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.639 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.481 HD12 ' HE2' ' B' ' 14' ' ' LYS . 6.4 tt -76.72 -46.33 25.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.384 -0.822 . . . . 0.0 110.05 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' HA ' HG21 ' A' ' 35' ' ' VAL . 69.5 m-85 -72.1 -22.77 61.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.0 110.161 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.487 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 0.8 OUTLIER -95.44 83.78 3.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.038 179.907 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 13.2 mmtt -44.71 -35.8 2.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.1 p30 -97.93 -24.52 15.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 110.328 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 67.86 31.21 75.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 41.9 p-10 -79.27 -0.75 33.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -1.191 . . . . 0.0 110.111 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 26' ' ' THR . . . 87.0 27.0 29.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 25' ' ' GLY . 18.4 p -156.51 97.41 1.74 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -1.089 . . . . 0.0 109.894 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.778 HD12 HG21 ' A' ' 63' ' ' ILE . 18.8 mt -85.32 112.32 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.033 . . . . 0.0 109.978 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.429 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -75.79 -163.72 0.3 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.313 -0.867 . . . . 0.0 109.783 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 p -80.45 -56.09 4.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.947 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -37.98 66.13 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.44 -0.788 . . . . 0.0 110.494 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 18.9 mt-10 -48.86 -68.49 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.048 -1.033 . . . . 0.0 109.653 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD21 ' CE ' ' A' ' 51' ' ' MET . 56.0 tp -47.28 -39.33 14.27 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.309 -0.87 . . . . 0.0 109.141 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.39 96.75 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.611 -1.796 . . . . 0.0 108.611 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.532 HG23 HH12 ' A' ' 37' ' ' ARG . 22.6 m -52.53 -42.97 64.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.362 -1.081 . . . . 0.0 109.249 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.602 HG21 ' HA ' ' A' ' 19' ' ' PHE . 13.3 t -66.91 -46.96 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.398 -0.814 . . . . 0.0 109.599 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.472 ' CE ' ' HG2' ' B' ' 5' ' ' PRO . 4.8 mmt -67.13 -29.8 69.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.658 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.532 HH12 HG23 ' A' ' 34' ' ' THR . 2.4 ttp-105 -68.46 -35.13 77.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.771 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 m -84.12 -14.35 50.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.064 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -83.17 -32.91 26.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.103 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.65 -62.93 0.18 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.555 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -100.3 175.42 5.72 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.038 -1.272 . . . . 0.0 111.315 -178.959 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -134.52 100.06 12.69 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.602 -0.686 . . . . 0.0 109.529 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' B' ' 4' ' ' ILE . 43.6 Cg_endo -69.97 162.74 41.02 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 O-C-N 124.065 1.56 . . . . 0.0 111.072 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.495 ' O ' HD12 ' A' ' 48' ' ' LEU . 4.2 t -96.93 -149.95 0.33 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.385 -0.822 . . . . 0.0 110.725 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 38.1 mt-10 -94.22 -57.33 2.54 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 0.0 110.88 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 47' ' ' GLU . . . -43.56 -70.54 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.035 -1.041 . . . . 0.0 110.409 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 46' ' ' ALA . 6.0 mm-40 -44.78 -42.9 8.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.077 -1.015 . . . . 0.0 109.486 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 44' ' ' THR . 5.7 mt -57.22 -47.39 81.44 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -46.28 -43.28 15.57 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.38 179.436 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.45 -30.32 64.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.432 -0.792 . . . . 0.0 109.571 179.273 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.584 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 1.2 mmm -74.72 -36.71 62.68 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.403 -0.811 . . . . 0.0 109.497 179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.603 HG13 HD11 ' A' ' 63' ' ' ILE . 1.5 tp -78.1 -43.75 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.273 -0.892 . . . . 0.0 110.327 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.505 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -43.43 -26.1 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.257 -0.902 . . . . 0.0 110.331 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 52' ' ' ILE . 15.6 mm-40 -67.9 -51.43 47.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 110.213 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.7 HG22 ' HG3' ' A' ' 71' ' ' MET . 14.8 t -80.61 -33.38 13.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.96 82.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.348 -0.845 . . . . 0.0 110.168 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.77 -69.25 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.398 -0.814 . . . . 0.0 110.816 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 47.1 p-10 -59.02 -16.88 20.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.252 -0.905 . . . . 0.0 110.675 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 69.47 43.8 67.54 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 31.4 p-10 -94.76 -31.84 13.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.326 -1.102 . . . . 0.0 110.478 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 62' ' ' THR . . . 120.51 24.09 2.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 61' ' ' GLY . 3.4 p -161.05 142.66 11.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -1.14 . . . . 0.0 110.247 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.778 HG21 HD12 ' A' ' 27' ' ' ILE . 14.1 mm -82.4 134.03 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.196 -0.94 . . . . 0.0 110.011 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -105.96 160.62 15.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 110.319 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.6 t80 -56.62 -50.36 88.35 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.554 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.9 Cg_endo -69.97 -31.3 19.85 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.397 1.209 . . . . 0.0 109.974 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 70' ' ' THR . 8.9 mt-10 -64.41 -34.03 77.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.32 -0.863 . . . . 0.0 110.073 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -75.45 -53.58 8.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.21 -0.932 . . . . 0.0 109.673 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mp -49.82 -29.78 8.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.883 . . . . 0.0 109.913 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -74.59 -47.89 29.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -0.849 . . . . 0.0 110.028 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.7 ' HG3' HG22 ' A' ' 55' ' ' VAL . 8.0 mmm -50.39 -47.45 56.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.135 -0.978 . . . . 0.0 109.572 179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.861 ' CE ' HG21 ' B' ' 11' ' ' ILE . 6.1 tpt -42.19 -26.81 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.48 -0.763 . . . . 0.0 110.498 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 71' ' ' MET . . . -107.52 -21.07 13.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.193 -0.942 . . . . 0.0 110.957 -179.145 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.46 -26.01 33.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.074 -1.016 . . . . 0.0 110.394 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HB3' HG21 ' B' ' 8' ' ' THR . 2.6 tptm -100.31 23.01 10.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 110.292 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.488 ' CG ' ' O ' ' A' ' 72' ' ' MET . 19.1 mmt -100.29 -29.76 12.26 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.219 -0.926 . . . . 0.0 110.901 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -127.93 76.85 1.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.065 -1.022 . . . . 0.0 110.649 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' HG23 ' A' ' 79' ' ' THR . 0.2 OUTLIER -124.45 -79.18 0.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.758 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 78' ' ' ASP . 1.9 p -152.06 -52.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.847 . . . . 0.0 109.779 179.677 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -83.96 85.75 7.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 110.061 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -98.46 -36.78 9.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.601 179.806 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -79.37 -35.08 41.41 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.495 -0.753 . . . . 0.0 109.64 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -63.89 -13.17 43.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.406 -0.809 . . . . 0.0 109.51 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.529 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 3.2 mt-10 -71.28 -45.47 63.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.513 -0.742 . . . . 0.0 110.582 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.696 HG21 HG22 ' A' ' 142' ' ' VAL . 27.3 mt -73.74 -21.73 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 110.198 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -71.83 -53.45 13.25 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.159 -0.963 . . . . 0.0 110.298 -179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.831 ' HG3' HG23 ' B' ' 9' ' ' THR . 7.8 pt-20 -62.37 -40.27 95.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.012 -1.055 . . . . 0.0 110.333 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -58.89 -37.31 76.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.504 -1.372 . . . . 0.0 108.358 178.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -65.49 -44.04 88.31 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.535 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -43.52 71.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.53 -0.731 . . . . 0.0 109.046 178.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.903 HG12 HG21 ' A' ' 108' ' ' VAL . 30.4 t -53.29 -48.57 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -0.785 . . . . 0.0 108.989 179.03 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.945 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 42.9 m-85 -66.59 -35.56 80.49 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 109.228 178.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.472 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 23.6 t0 -86.9 60.02 5.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.765 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' ASP . 10.2 ttpt -39.51 -50.07 2.15 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.521 -0.737 . . . . 0.0 110.252 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 10.2 p-10 -65.25 -36.56 84.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 109.652 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.453 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 83.41 45.41 6.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.374 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 52.6 p-10 -100.22 -20.71 15.8 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.058 -1.26 . . . . 0.0 110.273 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 109.28 22.08 6.99 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 24.4 m-85 -143.57 142.66 31.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.363 -1.08 . . . . 0.0 109.98 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 6.3 mt -113.69 96.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.498 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.2 m -90.68 152.45 20.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -0.918 . . . . 0.0 109.775 179.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.18 -40.55 11.38 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.63 -47.4 79.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.387 -0.821 . . . . 0.0 109.59 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 25.8 mt-10 -61.06 -53.66 54.38 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.304 -0.872 . . . . 0.0 109.828 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.643 HD13 HD11 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -59.34 -29.53 67.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.465 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.4 ttt-85 -70.82 -22.88 62.29 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.343 -0.848 . . . . 0.0 108.87 178.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 9.0 m80 -79.81 -46.23 17.32 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.576 -0.702 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.903 HG21 HG12 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -67.03 -20.73 27.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.365 -0.834 . . . . 0.0 108.857 179.144 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.595 ' HG3' HD21 ' B' ' 17' ' ' LEU . 0.3 OUTLIER -68.77 -52.07 34.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.599 -0.688 . . . . 0.0 109.956 179.638 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -35.37 73.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.894 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -74.16 -12.66 60.65 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.16 -0.962 . . . . 0.0 109.345 179.429 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.623 HD11 HG12 ' B' ' 13' ' ' VAL . 8.9 mt -94.64 -51.42 4.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.432 -0.792 . . . . 0.0 109.754 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.57 -59.93 0.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 20.8 tp10 -96.76 160.6 14.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.201 -1.176 . . . . 0.0 110.949 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -133.94 81.9 1.95 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.325 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.617 ' H ' HD12 ' A' ' 116' ' ' LEU . 6.5 mp -37.27 150.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.573 0.701 . . . . 0.0 111.268 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.79 -148.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.502 -0.749 . . . . 0.0 110.012 179.759 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.99 -44.86 5.36 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.331 -0.855 . . . . 0.0 110.135 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.493 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 17.5 pt-20 -64.89 -42.36 94.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.76 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.493 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 11.1 mm-40 -63.3 -40.72 98.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.579 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 125' ' ' ILE . 40.5 t -64.89 -45.37 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.273 -0.892 . . . . 0.0 109.699 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -63.53 -35.56 80.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.436 -0.79 . . . . 0.0 109.708 179.643 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 124' ' ' MET . 45.5 mt-10 -72.87 -54.48 8.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.0 109.566 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.626 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 25.1 ttt -42.38 -43.37 3.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.476 -0.765 . . . . 0.0 109.904 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.643 HD11 HD13 ' A' ' 105' ' ' LEU . 15.3 mm -76.33 -60.27 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 0.0 109.961 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -47.84 -55.03 10.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.512 ' OE2' ' CZ ' ' B' ' 20' ' ' ARG . 46.2 mt-10 -52.51 -21.6 3.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 0.0 110.388 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.559 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -93.28 -34.95 13.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.215 -0.928 . . . . 0.0 110.328 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.433 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 5.2 m-20 -68.43 66.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 110.237 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 128' ' ' ALA . 2.5 mp -46.43 -42.82 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.004 . . . . 0.0 109.88 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -70.89 -29.41 65.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.467 -0.77 . . . . 0.0 110.189 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.92 95.45 0.28 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 29.5 p-10 -144.72 -37.76 0.29 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -1.116 . . . . 0.0 110.236 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 121.49 9.44 7.11 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -165.59 149.8 8.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -1.102 . . . . 0.0 110.271 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 3.5 t -103.19 116.38 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 109.823 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.37 -155.03 0.3 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.345 -0.847 . . . . 0.0 110.603 -179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 139' ' ' GLU . 58.5 t80 -75.24 -60.62 2.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 138' ' ' TYR . 1.5 tt0 -42.72 -56.83 3.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 143' ' ' GLN . 2.6 mt-10 -55.23 -55.62 29.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.903 . . . . 0.0 109.85 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -45.22 -28.8 0.84 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.376 -0.827 . . . . 0.0 109.626 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.806 HG12 ' HB2' ' A' ' 147' ' ' ALA . 24.3 t -98.94 -24.02 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.411 -0.806 . . . . 0.0 109.806 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.739 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -59.0 -30.58 68.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 109.917 179.797 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.0 mmm -92.0 -9.58 42.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.316 -0.865 . . . . 0.0 109.844 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.529 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.2 OUTLIER -98.56 -69.76 0.75 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.388 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 t -156.69 56.75 0.55 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.963 -1.086 . . . . 0.0 110.866 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.806 ' HB2' HG12 ' A' ' 142' ' ' VAL . . . -100.42 38.5 1.49 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.108 -0.995 . . . . 0.0 110.251 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.235 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.428 ' O ' HG12 ' B' ' 1' ' ' VAL . 41.5 t . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.229 0.538 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -107.39 141.17 39.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.851 . . . . 0.0 110.842 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.77 25.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.053 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.652 HG21 ' HB3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -64.69 147.6 97.71 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.169 -0.957 . . . . 0.0 110.656 -179.662 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.583 ' HB2' ' CB ' ' B' ' 9' ' ' THR . 48.1 Cg_endo -72.26 -155.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 124.334 1.702 . . . . 0.0 111.144 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.537 ' O ' ' N ' ' B' ' 8' ' ' THR . 5.0 t -130.18 73.8 1.55 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.245 -0.91 . . . . 0.0 111.214 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.714 ' O ' HG22 ' B' ' 10' ' ' VAL . 0.8 OUTLIER 46.96 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.698 0 O-C-N 121.49 -0.756 . . . . 0.0 111.848 178.912 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.858 ' HA ' HD12 ' B' ' 11' ' ' ILE . 21.6 p -38.99 -26.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 110.798 -179.016 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.831 HG23 ' HG3' ' A' ' 87' ' ' GLU . 15.8 m -64.92 -65.81 0.62 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.076 -1.015 . . . . 0.0 109.996 179.065 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.714 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.0 m -46.68 -26.86 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 108.955 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.861 HG21 ' CE ' ' A' ' 72' ' ' MET . 49.2 mt -74.4 -47.96 37.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 121.687 0.756 . . . . 0.0 109.541 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 mt -50.32 -56.64 10.43 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.654 -0.654 . . . . 0.0 110.561 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.945 HG13 ' CZ ' ' A' ' 92' ' ' PHE . 17.2 t -62.34 -40.17 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.969 . . . . 0.0 110.958 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.481 ' HE2' HD12 ' A' ' 18' ' ' LEU . 6.5 tptp -71.54 -11.65 60.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.802 -1.186 . . . . 0.0 110.492 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.403 ' CB ' ' HE1' ' B' ' 26' ' ' PHE . 1.6 m -97.59 -21.83 16.85 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.191 -0.943 . . . . 0.0 109.265 179.244 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.445 ' O ' ' HE3' ' A' ' 124' ' ' MET . 6.6 tpp -78.56 -37.39 42.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.584 -0.697 . . . . 0.0 110.156 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.595 HD21 ' HG3' ' A' ' 109' ' ' MET . 1.3 mp -48.43 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.918 -1.114 . . . . 0.0 109.682 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER 31.62 58.07 0.31 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.652 -0.655 . . . . 0.0 112.514 179.392 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.548 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 62.5 -59.3 0.13 Allowed 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.47 -0.768 . . . . 0.0 111.753 178.155 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -155.66 8.42 0.25 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.886 -1.134 . . . . 0.0 111.752 -178.514 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' B' ' 18' ' ' ARG . 1.8 m -59.99 84.51 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.732 -1.23 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.626 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -111.93 13.55 20.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -0.954 . . . . 0.0 110.349 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.506 ' C ' ' HD3' ' B' ' 25' ' ' PRO . . . -96.24 -139.53 10.52 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.556 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 32.8 t-20 -119.78 47.58 1.03 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.196 -1.179 . . . . 0.0 110.386 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 48.5 Cg_endo -73.73 53.02 2.66 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.734 1.386 . . . . 0.0 110.268 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.481 ' HE2' ' HE1' ' A' ' 76' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.987 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.228 0.537 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -174.29 105.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.234 -0.916 . . . . 0.0 110.188 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -100.05 164.23 12.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.346 -0.846 . . . . 0.0 110.29 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.89 ' O ' HG23 ' A' ' 5' ' ' THR . 0.9 OUTLIER -57.86 132.08 52.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 110.158 179.867 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -168.94 -40.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.388 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 1.2 mt-10 -99.48 -22.41 15.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.145 -0.972 . . . . 0.0 110.456 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.604 ' HB2' HD23 ' A' ' 4' ' ' LEU . 1.2 mp0 -43.31 -56.25 3.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -0.905 . . . . 0.0 110.391 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 0.2 OUTLIER -62.99 -67.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 110.278 -179.848 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.4 mt -48.27 -45.97 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.785 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 6' ' ' GLU . . . -52.09 -41.66 62.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 109.738 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.564 ' OE2' ' CE1' ' A' ' 12' ' ' PHE . 1.9 tt0 -57.55 -51.51 69.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.746 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE1' ' OE2' ' A' ' 11' ' ' GLU . 21.0 m-85 -62.15 -45.07 95.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.942 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -60.17 -42.71 95.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -0.932 . . . . 0.0 109.705 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.79 -36.89 72.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.624 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . . . -75.45 -54.11 7.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.675 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.582 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 20.6 t80 -56.73 -17.15 8.0 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.417 -0.802 . . . . 0.0 109.714 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 18' ' ' LEU . 7.3 t -89.33 -56.74 3.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 112' ' ' LEU . 7.4 tt -44.31 -30.15 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -87.64 -30.73 20.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.284 -0.885 . . . . 0.0 110.535 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -104.89 91.57 3.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 110.495 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -67.92 -48.5 65.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.18 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 5.2 p-10 -60.39 -41.98 94.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.44 -0.787 . . . . 0.0 110.434 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . 83.87 56.47 2.6 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 38.1 p-10 -107.45 -27.57 10.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.159 -1.201 . . . . 0.0 110.263 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 111.56 9.09 21.99 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 27.2 p -141.89 116.02 9.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -1.172 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.5 mt -94.76 106.45 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 110.149 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.86 152.03 23.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.792 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -45.97 -25.56 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.01 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -61.12 2.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 110.218 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.67 -57.66 10.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.226 -0.921 . . . . 0.0 110.07 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 ' CH2' ' B' ' 7' ' ' TRP . 29.8 tp -52.68 -38.43 60.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.34 -40.02 96.92 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -60.29 -55.44 33.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -1.145 . . . . 0.0 109.943 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.443 ' H ' HG23 ' A' ' 35' ' ' VAL . 21.2 t -48.29 -50.53 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.649 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.625 ' HE3' ' HG2' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -54.38 -38.69 66.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.917 . . . . 0.0 109.871 179.657 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 2.0 ttp85 -64.25 -23.31 67.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.417 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 8.1 t -78.36 -30.23 47.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 110.656 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.74 -43.95 67.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.08 -1.013 . . . . 0.0 110.477 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.36 -16.01 0.41 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.654 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.1 mm-40 -113.2 166.0 11.87 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.832 -1.393 . . . . 0.0 110.624 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -127.9 97.16 30.34 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.287 -0.883 . . . . 0.0 110.231 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.55 ' CD ' ' HB3' ' A' ' 36' ' ' MET . 46.6 Cg_endo -75.45 140.08 23.87 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 124.173 1.618 . . . . 0.0 110.357 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.682 HG23 ' H ' ' A' ' 46' ' ' ALA . 14.7 t -91.58 -143.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 109.917 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.58 ' N ' HG23 ' A' ' 44' ' ' THR . 11.4 tp10 -100.23 -25.96 14.08 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.252 -0.905 . . . . 0.0 110.289 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.682 ' H ' HG23 ' A' ' 44' ' ' THR . . . -73.62 -70.8 0.35 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.14 -0.975 . . . . 0.0 110.387 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.596 ' HG2' HG22 ' A' ' 44' ' ' THR . 8.2 pt-20 -49.42 -40.29 36.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.0 109.624 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 1.4 mt -58.73 -43.25 90.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.079 179.195 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -49.99 -49.29 51.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.502 -0.749 . . . . 0.0 109.095 179.084 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -29.98 68.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.292 179.076 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.491 ' CE ' ' CE ' ' A' ' 36' ' ' MET . 1.2 ttp -75.98 -55.38 5.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 2.5 tp -56.96 -44.66 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.532 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.5 OUTLIER -40.89 -70.1 0.12 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.557 -0.714 . . . . 0.0 111.128 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -35.91 -55.08 0.75 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.722 -0.612 . . . . 0.0 110.933 -179.315 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.634 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 11.3 t -75.21 -33.84 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.745 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 5.3 t0 -58.87 77.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 0.0 110.318 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -39.72 -61.28 0.85 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.504 -0.747 . . . . 0.0 110.575 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 41.0 p-10 -76.4 -18.85 58.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 110.091 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 72.32 49.27 21.08 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 17.0 p-10 -99.3 -27.41 13.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -1.154 . . . . 0.0 110.302 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.587 ' C ' HG23 ' A' ' 62' ' ' THR . . . 119.14 23.47 3.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 61' ' ' GLY . 81.2 p -155.65 140.36 17.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.181 -1.187 . . . . 0.0 110.051 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.4 mm -91.15 158.75 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.354 -0.842 . . . . 0.0 110.072 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 58.5 m-20 -133.7 163.32 29.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 0.0 110.059 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.603 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 11.4 t80 -56.35 -48.54 96.78 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.16 -0.962 . . . . 0.0 111.215 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.1 Cg_endo -68.73 -35.69 15.79 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.206 1.108 . . . . 0.0 110.293 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 6.8 tt0 -58.94 -41.23 86.89 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.304 -0.872 . . . . 0.0 110.143 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 15' ' ' ALA . 36.6 t80 -69.58 -54.85 12.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.82 -24.95 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.958 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 m -97.61 -15.31 20.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 110.479 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.563 ' SD ' HG22 ' A' ' 55' ' ' VAL . 5.8 ttp -74.59 -42.7 58.23 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.144 -0.972 . . . . 0.0 110.536 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.489 ' SD ' HG21 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -54.46 -15.37 1.65 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.326 -0.858 . . . . 0.0 110.85 -179.387 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.42 -12.84 18.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.049 -1.032 . . . . 0.0 111.278 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.9 -11.96 40.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.781 -1.199 . . . . 0.0 110.502 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.73 ' CB ' HG21 ' B' ' 8' ' ' THR . 17.7 mmtt -98.39 -34.91 10.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 110.268 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.484 ' HE1' ' HG3' ' A' ' 72' ' ' MET . 0.2 OUTLIER -91.35 53.18 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.082 -179.975 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.751 ' O ' HG23 ' A' ' 79' ' ' THR . 0.9 OUTLIER -133.91 78.59 1.77 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 110.679 -179.719 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 77' ' ' LYS . 3.4 p30 37.85 44.89 0.63 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.494 -0.753 . . . . 0.0 110.781 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 77' ' ' LYS . 18.9 p -142.49 -37.57 0.38 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.236 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.476 ' O ' ' OE2' ' A' ' 84' ' ' GLU . 7.4 t0 -153.19 71.91 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 110.168 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.4 p -106.92 -38.05 6.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 109.735 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -82.28 -37.69 25.5 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.441 -0.787 . . . . 0.0 109.82 179.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.47 ' HB3' ' OD1' ' A' ' 80' ' ' ASP . 1.7 tt0 -72.11 -27.7 62.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.891 . . . . 0.0 109.637 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' OE2' ' HB3' ' A' ' 75' ' ' LYS . 17.3 mt-10 -72.63 -42.43 64.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.827 . . . . 0.0 110.128 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.62 HG21 HG22 ' A' ' 142' ' ' VAL . 14.2 mt -68.69 -37.84 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.489 -0.884 . . . . 0.0 108.762 179.502 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -60.93 -27.34 68.15 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.034 178.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 1.5 mt-10 -73.72 -54.48 7.99 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.536 -0.728 . . . . 0.0 109.146 179.072 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.75 -28.14 32.76 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.329 -0.857 . . . . 0.0 109.235 179.219 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -70.44 -46.04 64.65 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.373 -0.83 . . . . 0.0 109.514 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -28.83 65.71 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.513 -0.742 . . . . 0.0 109.621 179.451 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.72 HG12 HG21 ' A' ' 108' ' ' VAL . 15.5 t -73.75 -39.25 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.391 -0.818 . . . . 0.0 109.677 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.587 ' HB3' HD13 ' A' ' 100' ' ' ILE . 11.1 m-85 -72.78 -32.0 65.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.859 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -85.24 54.18 3.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.305 -0.872 . . . . 0.0 110.395 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.82 -28.12 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 30.8 p-10 -85.57 -43.81 13.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.186 -0.946 . . . . 0.0 110.354 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 89.75 22.75 35.35 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 33.4 p-10 -75.73 -33.84 60.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -1.132 . . . . 0.0 109.927 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 120.84 21.13 3.28 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 2.0 m-85 -164.44 130.04 2.85 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.182 -1.187 . . . . 0.0 110.263 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 92' ' ' PHE . 29.0 mt -82.46 155.52 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.966 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -144.67 156.88 44.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.86 -38.03 21.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 0.0 110.2 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.47 -46.89 84.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 109.849 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.3 -36.26 70.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 109.861 179.653 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.606 HD12 HD11 ' A' ' 125' ' ' ILE . 5.7 mt -61.8 -48.4 80.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.346 -0.846 . . . . 0.0 109.822 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.8 -35.63 61.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.417 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -64.0 -45.22 89.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -0.799 . . . . 0.0 110.14 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.72 HG21 HG12 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -79.21 -23.67 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.72 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.97 ' SD ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -68.01 -56.89 7.27 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 110.111 -179.971 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.417 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 7.3 m -60.93 -31.41 70.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.947 . . . . 0.0 109.691 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 38' ' ' SER . 7.1 m-20 -76.96 -4.7 45.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.856 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.79 HD11 HG12 ' B' ' 13' ' ' VAL . 7.0 mt -111.64 -44.68 3.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 110.374 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.96 -66.87 0.13 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.634 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 109' ' ' MET . 2.7 tt0 -103.25 166.94 10.14 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.171 -1.193 . . . . 0.0 111.137 -178.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.566 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.3 OUTLIER -124.47 16.79 8.93 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.733 0.777 . . . . 0.0 109.553 179.255 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.97 HD13 ' SD ' ' A' ' 109' ' ' MET . 2.8 mp 43.62 -173.23 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.66 0.743 . . . . 0.0 111.169 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.76 -146.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.505 -0.747 . . . . 0.0 109.886 179.75 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -114.06 -70.22 0.81 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.156 -0.965 . . . . 0.0 110.517 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 120' ' ' GLU . 3.8 pt-20 -55.39 -29.23 58.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 109.743 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.473 ' OE2' ' HE2' ' B' ' 19' ' ' LYS . 6.2 mt-10 -71.73 -45.74 60.81 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 108.919 178.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 117' ' ' THR . 53.1 t -54.67 -45.71 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.491 -0.756 . . . . 0.0 109.629 179.184 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -60.37 -59.23 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 0.0 109.373 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 68.5 mm-40 -48.41 -38.66 20.17 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.393 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -51.01 -56.1 14.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.252 -0.905 . . . . 0.0 109.462 179.503 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 105' ' ' LEU . 21.0 mm -56.35 -30.67 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.349 -0.844 . . . . 0.0 110.011 179.517 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 123' ' ' GLU . 5.7 ttt180 -64.99 -55.0 21.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.303 -0.873 . . . . 0.0 110.528 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 126' ' ' ARG . 2.6 tp10 -41.9 -42.89 2.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.305 -0.872 . . . . 0.0 110.371 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.21 -27.79 38.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.282 -0.886 . . . . 0.0 110.171 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.6 OUTLIER -83.36 63.86 7.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.373 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 129' ' ' ASP . 5.7 mt -43.56 -40.07 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.747 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 21.2 p30 -67.34 -32.23 73.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.551 -0.718 . . . . 0.0 110.118 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.3 66.65 1.76 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.435 ' OD2' ' HG3' ' A' ' 135' ' ' GLN . 2.9 p-10 -115.43 -27.86 7.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -1.121 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.96 16.26 8.62 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.435 ' HG3' ' OD2' ' A' ' 133' ' ' ASP . 11.7 pt20 -169.95 149.78 3.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -1.131 . . . . 0.0 110.174 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 85.9 t -110.79 149.77 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 109.972 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.427 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 25.3 p-10 -120.21 -157.93 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.419 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.414 ' O ' ' C ' ' A' ' 139' ' ' GLU . 11.1 t80 -70.88 -67.22 0.52 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.358 -0.839 . . . . 0.0 110.61 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 138' ' ' TYR . 4.7 mt-10 -41.65 -62.32 0.91 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.384 -0.822 . . . . 0.0 110.351 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 141' ' ' PHE . 49.3 mt-10 -46.27 -60.29 2.4 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.21 -0.931 . . . . 0.0 110.009 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.605 ' CD1' HG23 ' A' ' 85' ' ' ILE . 24.4 t80 -42.04 -28.19 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.743 179.755 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.674 HG13 ' OG1' ' A' ' 146' ' ' THR . 38.2 t -100.87 -32.25 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.454 -0.779 . . . . 0.0 110.644 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.678 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 4.7 tm0? -59.94 -18.43 45.16 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.147 -0.971 . . . . 0.0 110.404 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.3 mmm -112.58 -25.09 9.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 110.34 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.556 ' HE3' ' CB ' ' B' ' 24' ' ' ASN . 3.0 ttt -100.54 -9.34 22.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 111.118 -179.413 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.674 ' OG1' HG13 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -134.31 -30.73 1.14 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.92 -1.112 . . . . 0.0 111.174 -179.2 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -77.06 54.28 1.03 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.129 -0.982 . . . . 0.0 110.461 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.239 179.949 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' B' ' 2' ' ' LYS . 5.9 p . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.207 0.527 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' B' ' 1' ' ' VAL . 0.0 OUTLIER 58.69 -91.97 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.407 -0.808 . . . . 0.0 110.786 179.71 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' B' ' 4' ' ' ILE . 3.2 mp -97.68 -43.71 7.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.098 -1.001 . . . . 0.0 110.861 -179.304 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.481 HG13 ' OE2' ' A' ' 47' ' ' GLU . 24.2 mm -41.79 139.95 1.51 Allowed Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.243 -0.911 . . . . 0.0 109.947 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.833 ' HB3' HG21 ' B' ' 9' ' ' THR . 39.6 Cg_endo -67.43 173.18 9.14 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.113 1.586 . . . . 0.0 111.037 -179.281 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.8 t -126.1 79.38 1.84 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.247 -0.908 . . . . 0.0 111.452 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.671 ' O ' HG22 ' B' ' 10' ' ' VAL . 9.2 m95 53.99 -93.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.45 -0.781 . . . . 0.0 112.042 178.551 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.73 HG21 ' CB ' ' A' ' 75' ' ' LYS . 4.0 p -37.18 -29.17 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.266 -0.896 . . . . 0.0 110.517 -178.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.833 HG21 ' HB3' ' B' ' 5' ' ' PRO . 53.7 m -65.67 -51.29 60.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.189 -0.945 . . . . 0.0 109.697 178.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.822 HG23 HD12 ' B' ' 11' ' ' ILE . 2.7 m -63.19 -29.91 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.948 -1.095 . . . . 0.0 108.653 179.018 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.822 HD12 HG23 ' B' ' 10' ' ' VAL . 1.6 mp -72.34 -54.69 15.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.52 -0.737 . . . . 0.0 109.265 178.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' B' ' 11' ' ' ILE . 0.5 OUTLIER -42.23 -59.8 1.68 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.546 -0.721 . . . . 0.0 110.534 179.897 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.79 HG12 HD11 ' A' ' 112' ' ' LEU . 69.0 t -56.3 -50.15 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 110.403 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.533 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -56.12 -35.23 66.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.908 -1.12 . . . . 0.0 109.663 179.632 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 5.1 t -73.84 -19.9 60.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 109.866 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 1.7 tpt -75.2 -43.18 53.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.939 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.3 mp -53.31 -91.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.0 . . . . 0.0 109.699 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' B' ' 17' ' ' LEU . 5.7 ttt180 59.98 -69.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.401 0.619 . . . . 0.0 110.808 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.658 ' O ' HD21 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -176.2 -72.53 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.027 0 O-C-N 121.412 -0.805 . . . . 0.0 110.812 -179.619 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.594 ' HB2' ' CD ' ' B' ' 19' ' ' LYS . 2.2 ttt-85 -135.09 20.4 3.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.848 -1.157 . . . . 0.0 110.324 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.73 129.56 42.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.282 -0.886 . . . . 0.0 110.219 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 124' ' ' MET . 0.2 OUTLIER -130.67 -4.06 4.16 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.426 -0.796 . . . . 0.0 110.351 -179.8 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.52 -28.07 23.04 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.556 ' CB ' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER 48.89 81.81 0.25 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.081 -1.246 . . . . 0.0 109.912 -179.825 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.96 -34.94 9.85 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.901 1.474 . . . . 0.0 110.64 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.445 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 1.1 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.198 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.276 0.56 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 11.3 t70 179.7 -35.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.381 -0.824 . . . . 0.0 109.971 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.403 ' O ' ' CB ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -51.23 124.33 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 110.061 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.403 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER 64.62 124.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.937 -179.816 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 5' ' ' THR . 7.4 t -84.02 100.66 11.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 110.472 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -96.45 -45.24 6.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 109.983 179.693 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.809 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 13.6 mt-10 -41.87 -69.95 0.12 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.379 -0.825 . . . . 0.0 110.16 179.911 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -44.8 -63.71 0.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 5' ' ' THR . 46.8 mt -53.22 -27.73 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.343 -0.848 . . . . 0.0 109.759 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -57.4 -64.03 1.03 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.54 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -48.39 -44.42 34.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.363 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -67.2 -50.0 62.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.384 -0.822 . . . . 0.0 109.737 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -55.89 -44.0 77.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.854 179.71 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 41.2 mt-10 -55.38 -43.47 75.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.762 179.538 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -72.1 -50.35 28.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.401 -0.812 . . . . 0.0 109.965 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.576 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 11.2 t80 -54.29 -47.81 71.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 109.918 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -68.05 -27.77 66.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.882 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.82 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.2 tt -61.41 -37.97 85.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.394 -0.816 . . . . 0.0 110.085 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.628 ' HD1' HG21 ' A' ' 35' ' ' VAL . 44.5 m-85 -80.75 -30.03 36.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -84.73 84.25 7.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 110.49 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -73.12 -40.05 65.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.21 -0.931 . . . . 0.0 110.032 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -71.09 -33.86 70.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.086 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 65.17 1.23 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.476 ' O ' HG23 ' A' ' 26' ' ' THR . 57.7 p30 -128.62 6.59 5.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -1.159 . . . . 0.0 110.154 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.66 13.48 51.39 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 59.5 p -136.87 115.44 11.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.276 -1.132 . . . . 0.0 110.251 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.546 ' O ' HG22 ' A' ' 62' ' ' THR . 5.1 mt -88.9 124.01 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.203 -0.936 . . . . 0.0 110.355 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.4 p -99.67 172.02 7.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.332 -0.855 . . . . 0.0 110.284 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 p -56.95 -30.06 63.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.937 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -66.83 -60.44 2.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.232 -0.918 . . . . 0.0 110.05 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' O ' HG23 ' A' ' 35' ' ' VAL . 32.5 mt-10 -52.16 -55.65 19.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 110.024 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.568 HD13 ' CH2' ' B' ' 7' ' ' TRP . 27.0 tp -59.51 -37.6 78.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.05 -37.19 64.19 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.882 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.9 m -61.36 -55.36 32.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -1.136 . . . . 0.0 109.942 179.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.628 HG21 ' HD1' ' A' ' 19' ' ' PHE . 20.4 t -52.7 -46.88 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 109.643 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.467 ' HE1' ' SD ' ' A' ' 51' ' ' MET . 0.9 OUTLIER -58.63 -41.82 86.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.693 179.506 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -28.78 66.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 109.924 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.451 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -85.76 -55.73 3.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.337 -0.852 . . . . 0.0 110.272 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mt -44.88 -28.18 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.129 -0.982 . . . . 0.0 110.063 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 115.98 49.89 0.45 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 40' ' ' GLY . 1.1 mp0 -147.44 -174.53 4.55 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.211 -1.17 . . . . 0.0 110.359 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -161.89 84.12 1.69 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.325 -0.859 . . . . 0.0 110.256 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 46.9 Cg_endo -73.19 100.67 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.042 1.548 . . . . 0.0 110.169 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.498 HG22 ' HB2' ' A' ' 47' ' ' GLU . 5.0 t -57.07 162.39 2.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.085 -1.009 . . . . 0.0 110.239 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' ALA . 2.3 mt-10 -42.98 -65.37 0.49 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 110.269 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -40.45 -51.84 2.83 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 110.227 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' HB2' HG22 ' A' ' 44' ' ' THR . 5.9 mm-40 -63.85 -56.49 14.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.026 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 48' ' ' LEU . 5.2 mt -42.32 -42.8 3.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -0.832 . . . . 0.0 110.18 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -66.95 -41.1 87.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 0.0 110.079 179.77 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -27.42 65.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.402 -0.811 . . . . 0.0 110.186 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.467 ' SD ' ' HE1' ' A' ' 36' ' ' MET . 0.9 OUTLIER -82.54 -33.63 28.11 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.927 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 4.8 mm -80.35 -31.08 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -76.82 -13.71 59.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 110.233 179.937 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -73.42 -60.99 1.99 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 0.0 110.106 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.649 ' HB ' HD12 ' A' ' 63' ' ' ILE . 13.8 t -69.19 -25.41 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.108 -0.995 . . . . 0.0 109.808 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -49.23 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.368 -0.832 . . . . 0.0 109.98 179.787 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -70.56 -66.88 0.55 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.41 -0.806 . . . . 0.0 110.587 -179.521 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.7 p-10 -58.35 -35.75 72.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -0.924 . . . . 0.0 110.423 -179.582 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 92.0 45.83 3.78 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.465 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 15.7 p-10 -96.48 -34.23 11.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -1.17 . . . . 0.0 110.157 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.35 -2.36 5.4 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -141.5 165.37 27.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -1.213 . . . . 0.0 110.15 179.983 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.649 HD12 ' HB ' ' A' ' 55' ' ' VAL . 34.9 mm -87.07 142.75 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.076 179.864 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.498 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.1 m-20 -130.52 153.15 49.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.922 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 34.1 t80 -39.38 -51.08 4.77 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.549 -0.72 . . . . 0.0 112.344 -179.088 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.2 Cg_endo -64.9 -27.44 58.77 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.22 1.116 . . . . 0.0 111.265 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.492 ' HG3' ' CB ' ' A' ' 64' ' ' ASP . 7.3 mt-10 -73.02 -39.92 65.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.832 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.623 ' HZ ' HD12 ' B' ' 11' ' ' ILE . 36.4 t80 -63.54 -50.86 67.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 110.303 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.81 -37.26 78.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -0.874 . . . . 0.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.8 m -76.91 -14.59 59.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.285 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' HG22 ' A' ' 55' ' ' VAL . 37.0 ttp -79.27 -58.51 3.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.199 -0.938 . . . . 0.0 110.133 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.494 ' O ' ' HG3' ' A' ' 76' ' ' MET . 3.4 tpt -53.17 -16.09 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.409 -0.807 . . . . 0.0 111.013 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.92 -45.8 8.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.878 -1.139 . . . . 0.0 110.579 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -80.7 -10.07 59.75 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.158 -0.964 . . . . 0.0 110.75 -179.673 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -84.19 -14.83 49.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.077 -1.014 . . . . 0.0 110.427 -179.729 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.494 ' HG3' ' O ' ' A' ' 72' ' ' MET . 15.2 mtt -99.83 60.72 1.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.101 -1.0 . . . . 0.0 110.111 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -159.66 90.7 0.95 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.261 -0.899 . . . . 0.0 110.176 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 3.3 m-20 61.41 79.56 0.25 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.445 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -170.26 -51.69 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.319 -0.863 . . . . 0.0 110.423 -179.947 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 79' ' ' THR . 47.4 m-20 -154.97 91.28 1.35 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.211 -0.93 . . . . 0.0 110.468 -179.759 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 82' ' ' GLU . 93.8 p -74.02 -68.96 0.47 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.615 ' HA ' HD12 ' A' ' 85' ' ' ILE . 3.1 tt0 -100.03 -10.47 21.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 110.077 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.73 -40.98 88.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.645 179.648 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 7.3 pt-20 -54.41 -23.6 16.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.992 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 82' ' ' GLU . 51.8 mt -80.16 -61.42 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.9 . . . . 0.0 109.606 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 85' ' ' ILE . 0.4 OUTLIER -42.57 -30.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.583 -0.698 . . . . 0.0 109.524 179.549 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.657 ' HB3' HG21 ' B' ' 9' ' ' THR . 4.4 mm-40 -71.91 -60.6 2.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.408 -0.808 . . . . 0.0 109.264 179.029 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.65 -28.99 6.52 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.149 179.219 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -70.47 -47.71 59.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 109.758 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -35.19 51.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.755 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.651 HG11 HG11 ' B' ' 13' ' ' VAL . 10.6 t -67.68 -45.17 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.652 179.592 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.754 ' CE2' HD21 ' A' ' 105' ' ' LEU . 5.1 m-85 -58.78 -36.76 74.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.975 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -98.8 60.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 110.161 179.831 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -42.78 -32.88 0.66 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.309 -0.87 . . . . 0.0 110.073 179.939 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.2 p30 -77.19 -31.77 55.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.415 -0.803 . . . . 0.0 109.899 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 71.95 51.35 14.99 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.1 p-10 -97.67 -33.48 11.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -1.219 . . . . 0.0 110.014 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 131.51 0.49 4.92 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.585 ' CE2' ' OD1' ' A' ' 137' ' ' ASN . 65.1 m-85 -147.95 149.05 31.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.246 . . . . 0.0 110.595 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 92' ' ' PHE . 45.0 mt -104.44 149.28 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.117 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.418 ' H ' ' HB2' ' A' ' 104' ' ' GLU . 0.6 OUTLIER -139.91 160.46 39.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.016 179.73 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.35 -38.42 58.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.28 -38.73 92.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.109 -0.994 . . . . 0.0 109.811 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' A' ' 101' ' ' SER . 12.4 mt-10 -63.81 -47.66 79.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.286 -0.884 . . . . 0.0 109.862 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.023 HD12 HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -58.9 -34.55 71.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.322 -0.862 . . . . 0.0 109.517 179.552 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 109' ' ' MET . 16.9 ttp85 -59.42 -41.52 89.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.278 -0.889 . . . . 0.0 109.151 179.187 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -54.16 40.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.47 -0.769 . . . . 0.0 109.559 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 2.5 t -51.66 -37.02 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.21 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.921 ' HA ' HD21 ' B' ' 17' ' ' LEU . 21.0 mtt -58.72 -62.83 1.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.34 -0.85 . . . . 0.0 109.907 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 m -58.85 -31.36 68.46 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.574 179.6 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 38' ' ' SER . 2.9 m120 -76.53 -17.5 59.21 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.328 179.413 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.82 ' O ' HD11 ' A' ' 18' ' ' LEU . 7.0 mt -100.05 -47.68 4.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.845 . . . . 0.0 110.24 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.21 -28.52 1.23 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.791 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.573 ' HG2' ' CD1' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -109.28 134.86 51.25 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.798 -1.413 . . . . 0.0 111.248 -179.325 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 116' ' ' LEU . 6.8 tttt -117.09 78.5 1.22 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.077 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.795 HD11 ' O ' ' B' ' 17' ' ' LEU . 7.0 mp -40.69 164.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.612 0.72 . . . . 0.0 111.13 -179.062 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.06 -149.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.581 -0.699 . . . . 0.0 109.712 179.456 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -111.51 -70.33 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 110.144 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 23.4 pt-20 -47.54 -40.1 18.06 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.551 179.802 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 18.8 mt-10 -61.28 -55.6 30.04 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.338 -0.851 . . . . 0.0 109.148 179.027 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.0 t -50.05 -47.25 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.35 -0.844 . . . . 0.0 109.737 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.71 -50.19 70.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 109.631 179.569 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -34.55 68.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.462 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.474 ' HE3' ' O ' ' B' ' 16' ' ' MET . 6.5 ttt -56.93 -54.77 42.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.472 -0.767 . . . . 0.0 109.987 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.023 HD11 HD12 ' A' ' 105' ' ' LEU . 33.0 mm -57.64 -43.13 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 109.972 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -50.7 67.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.113 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -48.61 -38.74 21.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.383 -0.823 . . . . 0.0 110.16 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.709 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -81.24 -24.17 37.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.395 -0.816 . . . . 0.0 110.136 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.472 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -67.66 73.93 0.17 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.3 -0.875 . . . . 0.0 110.34 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 128' ' ' ALA . 2.8 mp -53.85 -45.21 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.245 -0.909 . . . . 0.0 110.275 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.4 p30 -77.38 -36.55 53.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.35 65.03 1.11 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.0 p30 -112.11 -28.75 7.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -1.13 . . . . 0.0 110.263 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 118.07 -6.11 15.41 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.462 ' N ' ' CD ' ' A' ' 135' ' ' GLN . 15.6 mp0 -144.52 169.88 17.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -1.133 . . . . 0.0 109.958 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 69.2 t -121.44 104.92 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.948 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.585 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 8.2 t30 -79.01 167.08 21.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -0.915 . . . . 0.0 110.386 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 139' ' ' GLU . 28.1 t80 -47.33 -58.82 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.334 -0.853 . . . . 0.0 110.058 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 138' ' ' TYR . 45.6 mm-40 -44.44 -42.25 6.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 109.669 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.472 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 4.5 tt0 -68.05 -54.3 19.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.813 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -45.8 -25.66 0.54 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.566 HG22 HG21 ' A' ' 85' ' ' ILE . 12.0 t -93.69 -30.5 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 0.0 109.836 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.602 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 25.8 mt-30 -58.49 -38.61 78.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.065 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.588 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 1.9 mmm -64.03 -55.17 24.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 0.0 109.917 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' B' ' 24' ' ' ASN . 6.1 ttm -67.44 -21.94 65.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 146' ' ' THR . 3.8 t -168.92 90.79 0.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 110.298 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -93.67 58.52 2.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 110.121 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.193 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.717 HG22 ' O ' ' B' ' 1' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.252 0.549 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.87 -125.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.291 -0.881 . . . . 0.0 110.042 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.497 HD23 ' OE1' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -90.7 -69.6 0.72 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.044 -1.035 . . . . 0.0 110.25 179.931 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.609 HG23 ' HD2' ' B' ' 5' ' ' PRO . 6.1 mt 57.01 147.64 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.414 -0.804 . . . . 0.0 110.203 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.609 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.2 Cg_endo -69.76 129.04 16.9 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.665 1.35 . . . . 0.0 111.085 -179.064 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.543 ' O ' ' N ' ' B' ' 8' ' ' THR . 3.8 m -86.83 95.96 10.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.494 -0.754 . . . . 0.0 110.813 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.568 ' CH2' HD13 ' A' ' 32' ' ' LEU . 13.9 m95 33.92 -87.82 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.805 -0.559 . . . . 0.0 111.92 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.543 ' N ' ' O ' ' B' ' 6' ' ' SER . 1.3 p -35.38 -38.76 0.11 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.51 -0.744 . . . . 0.0 111.011 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.657 HG21 ' HB3' ' A' ' 87' ' ' GLU . 4.3 m -57.65 -42.21 83.02 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.571 -0.851 . . . . 0.0 109.736 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' B' ' 7' ' ' TRP . 13.3 t -68.31 -36.6 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.418 -0.801 . . . . 0.0 109.698 179.634 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.686 ' N ' HD13 ' B' ' 11' ' ' ILE . 2.7 mm -70.0 -19.41 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.359 -0.838 . . . . 0.0 109.442 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.441 ' O ' ' SD ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.5 -57.43 3.94 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.715 0.769 . . . . 0.0 109.527 179.282 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.651 HG11 HG11 ' A' ' 91' ' ' VAL . 43.2 t -62.8 -34.36 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.0 110.76 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.498 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -69.7 -34.86 74.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.987 . . . . 0.0 110.304 -179.835 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 58.5 m -71.96 -25.8 62.01 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' B' ' 22' ' ' PHE . 0.2 OUTLIER -76.07 -37.49 58.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.305 -0.872 . . . . 0.0 110.828 -179.823 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.921 HD21 ' HA ' ' A' ' 109' ' ' MET . 4.4 mp -51.53 -19.54 1.51 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.94 -1.1 . . . . 0.0 110.509 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' B' ' 17' ' ' LEU . 0.3 OUTLIER -21.57 -72.0 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 CA-C-O 121.087 0.47 . . . . 0.0 112.127 -179.446 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.53 ' HD2' ' HG3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -154.08 -114.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 110.136 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.494 ' NH2' ' OE2' ' A' ' 120' ' ' GLU . 1.6 mtm180 -101.25 21.27 14.3 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.901 -1.124 . . . . 0.0 110.087 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 13.7 m -120.75 142.74 49.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.552 ' HZ ' HD11 ' A' ' 105' ' ' LEU . 1.2 m-85 -88.96 -63.96 1.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.452 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.58 108.71 0.72 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 144' ' ' MET . 9.8 m120 -100.58 -42.03 0.22 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.221 -1.164 . . . . 0.0 111.943 -179.342 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' B' ' 24' ' ' ASN . 47.7 Cg_endo -81.78 10.81 3.33 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.089 1.047 . . . . 0.0 110.909 -179.081 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 109.961 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.195 0.521 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -113.2 -11.83 13.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -0.89 . . . . 0.0 110.206 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.443 ' O ' ' CB ' ' A' ' 4' ' ' LEU . 54.0 mm-40 -73.72 99.92 3.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.136 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 0.8 OUTLIER 65.11 97.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.878 . . . . 0.0 110.224 179.953 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.3 m -101.36 128.69 47.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.276 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.669 ' HA ' HD12 ' A' ' 9' ' ' ILE . 6.8 pt-20 -63.8 -39.17 93.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 110.213 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -47.54 -52.93 15.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.093 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 0.1 OUTLIER -60.1 -44.09 95.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.975 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 6' ' ' GLU . 82.5 mt -59.78 -48.38 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.985 . . . . 0.0 109.982 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.77 -36.77 62.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.802 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 19.4 mt-10 -60.74 -54.05 49.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 109.619 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -59.67 -43.06 94.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.83 . . . . 0.0 109.706 179.553 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -36.1 77.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.808 179.642 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -65.2 -42.04 93.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.329 -0.857 . . . . 0.0 109.769 179.573 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.22 -45.18 77.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.415 -0.803 . . . . 0.0 110.002 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.635 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 34.0 t80 -61.29 -29.74 70.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.0 109.813 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 m -83.95 -22.8 31.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.402 -0.811 . . . . 0.0 109.773 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.853 HD11 ' O ' ' A' ' 112' ' ' LEU . 4.1 tt -71.3 -36.06 71.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.962 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.67 ' HD1' HG21 ' A' ' 35' ' ' VAL . 53.8 m-85 -82.94 -46.05 13.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.234 -0.916 . . . . 0.0 110.053 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.461 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 17.1 t0 -72.61 101.33 3.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.0 110.215 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.92 -52.34 9.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.139 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.43 -51.04 63.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.345 -0.847 . . . . 0.0 110.166 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.07 22.86 6.67 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 46.6 p-10 -79.83 -21.95 43.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -1.192 . . . . 0.0 110.107 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.558 ' C ' HG23 ' A' ' 26' ' ' THR . . . 97.18 33.2 6.07 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.558 HG23 ' C ' ' A' ' 25' ' ' GLY . 44.2 p -153.09 132.48 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.341 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.611 HD12 HG21 ' A' ' 63' ' ' ILE . 6.0 mt -101.06 112.63 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 109.937 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 29' ' ' THR . 51.8 p -97.98 156.92 16.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 110.169 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 28' ' ' THR . 1.9 p -44.53 -27.27 0.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.178 -0.952 . . . . 0.0 109.872 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -55.28 9.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 110.033 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' O ' ' HB ' ' A' ' 34' ' ' THR . 39.5 mt-10 -57.15 -56.09 26.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.93 . . . . 0.0 110.063 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.504 HD22 ' CD1' ' A' ' 52' ' ' ILE . 10.4 tp -57.65 -48.66 78.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 109.937 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -51.78 -39.6 47.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.825 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 52.6 m -59.43 -61.07 2.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -1.175 . . . . 0.0 109.715 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.67 HG21 ' HD1' ' A' ' 19' ' ' PHE . 13.8 t -45.25 -55.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -57.51 -26.96 62.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.809 179.559 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.0 ttm180 -74.23 -19.49 60.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.479 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 19.2 m -96.37 -38.11 10.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.275 -0.891 . . . . 0.0 110.625 -179.704 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 mt -45.67 -29.16 1.16 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.01 -1.056 . . . . 0.0 110.067 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 41' ' ' GLN . . . 125.17 58.63 0.17 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 2.2 mt-30 170.04 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.197 -1.178 . . . . 0.0 110.498 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.54 102.09 3.49 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.276 -0.89 . . . . 0.0 110.349 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.517 ' HB3' HD12 ' B' ' 4' ' ' ILE . 45.1 Cg_endo -73.18 135.77 23.34 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.093 1.575 . . . . 0.0 110.335 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.536 HG22 ' OE2' ' A' ' 47' ' ' GLU . 13.7 t -71.99 -161.93 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.206 -0.934 . . . . 0.0 110.224 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -84.18 -56.38 3.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.019 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.38 -51.22 11.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.016 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.536 ' OE2' HG22 ' A' ' 44' ' ' THR . 48.0 mt-10 -61.37 -52.35 65.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.865 . . . . 0.0 109.99 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.7 OUTLIER -55.56 -48.69 74.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.342 -0.848 . . . . 0.0 110.23 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -62.21 -32.82 73.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.103 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -32.59 70.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.364 -0.835 . . . . 0.0 110.093 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 3.1 mtp -78.02 -43.85 28.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.433 -0.792 . . . . 0.0 110.438 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.606 HG13 HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -70.43 -33.82 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.212 -0.93 . . . . 0.0 109.921 -179.993 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.8 m120 -60.62 -25.87 66.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.486 -0.759 . . . . 0.0 110.743 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -77.92 -47.05 19.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 0.0 110.579 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.694 HG21 ' CE2' ' B' ' 7' ' ' TRP . 19.2 t -71.28 -40.36 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.185 -0.947 . . . . 0.0 110.091 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.486 ' OD1' HD13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -63.46 71.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.841 -179.975 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -37.94 -63.25 0.49 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.674 -0.641 . . . . 0.0 110.529 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 3.5 p30 -56.75 -38.85 73.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.102 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.98 48.72 4.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.529 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 16.7 p-10 -98.32 -40.39 8.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -1.182 . . . . 0.0 110.115 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 62' ' ' THR . . . 133.73 21.75 0.79 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.692 179.36 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 61' ' ' GLY . 36.3 p -158.06 145.63 18.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.922 -1.34 . . . . 0.0 110.405 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.611 HG21 HD12 ' A' ' 27' ' ' ILE . 10.8 mm -89.42 144.96 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.349 -0.844 . . . . 0.0 109.803 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -120.59 147.31 45.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.128 -0.982 . . . . 0.0 110.754 -179.578 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.635 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 11.8 t80 -43.85 -49.52 20.5 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.372 -0.83 . . . . 0.0 111.098 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.8 Cg_endo -68.7 -32.49 23.62 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.281 1.148 . . . . 0.0 110.539 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -65.51 -30.17 70.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -76.96 -51.18 11.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.885 . . . . 0.0 110.236 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 65' ' ' PHE . 2.7 mp -53.62 -32.38 51.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.376 -0.827 . . . . 0.0 110.214 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.8 m -78.03 -38.34 44.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 110.563 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -67.19 0.45 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.196 -0.94 . . . . 0.0 110.533 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.518 ' HE1' ' CD2' ' B' ' 12' ' ' LEU . 6.8 tpt -50.5 -19.87 0.99 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.353 -0.842 . . . . 0.0 110.665 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.86 -29.14 39.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.134 -0.979 . . . . 0.0 110.648 -179.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -93.68 -15.17 25.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.667 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.2 OUTLIER -100.77 40.52 1.26 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 110.419 -179.845 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 72' ' ' MET . 9.9 mmt -100.22 -36.56 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.158 -0.964 . . . . 0.0 110.325 -179.827 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 51.12 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.289 -0.882 . . . . 0.0 110.369 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -120.31 -89.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 110.259 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.5 p -93.16 -16.85 24.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 110.378 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.508 ' OD1' ' HB2' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -123.99 100.91 6.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.0 110.359 -179.662 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.467 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 1.6 t -114.15 -59.33 2.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.587 179.442 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -100.68 -9.9 21.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.904 179.469 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' HB2' ' OD1' ' A' ' 80' ' ' ASP . 69.6 mt-10 -75.5 -46.38 32.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.981 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HG2' ' N ' ' A' ' 85' ' ' ILE . 10.2 pm0 -55.59 -23.37 26.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 110.26 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.667 HG21 HG22 ' A' ' 142' ' ' VAL . 24.3 mt -84.22 -46.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 109.203 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -34.29 69.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.459 -0.776 . . . . 0.0 109.216 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.45 ' HB3' HG21 ' B' ' 9' ' ' THR . 32.0 mt-10 -72.38 -48.77 38.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.223 178.936 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.54 -35.14 67.77 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.426 -0.797 . . . . 0.0 109.073 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.22 -39.45 78.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.368 -0.833 . . . . 0.0 108.825 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -58.67 -29.89 66.95 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.202 179.03 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.9 -50.47 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.485 -0.76 . . . . 0.0 109.555 179.514 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.532 ' HB3' HD13 ' A' ' 100' ' ' ILE . 61.2 m-85 -62.43 -38.49 89.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.26 55.84 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.995 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -56.2 -48.9 75.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.094 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 15.9 p-10 -57.6 -34.55 69.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 110.323 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 74.41 49.02 12.52 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.437 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 27.0 p-10 -98.28 -22.91 15.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -1.103 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.627 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 113.7 6.79 20.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 73.0 m-85 -157.71 134.98 10.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.248 -1.148 . . . . 0.0 109.841 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.532 HD13 ' HB3' ' A' ' 92' ' ' PHE . 24.9 mt -84.49 155.62 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.1 -1.0 . . . . 0.0 110.541 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 103' ' ' ALA . 4.0 t -139.22 140.56 37.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.454 -0.778 . . . . 0.0 109.72 179.691 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.15 -27.44 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.235 -0.916 . . . . 0.0 110.375 -179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -65.59 -55.58 16.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.674 179.492 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 38.1 mt-10 -55.08 -44.68 75.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.998 179.503 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.969 ' CD1' HD11 ' A' ' 125' ' ' ILE . 1.1 mt -57.37 -44.93 84.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.9 . . . . 0.0 109.655 179.733 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.2 OUTLIER -55.94 -38.29 70.11 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.053 -1.029 . . . . 0.0 109.286 179.273 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.47 -32.24 73.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.629 -0.669 . . . . 0.0 109.539 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.448 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 26.1 t -81.15 -52.56 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.475 -0.765 . . . . 0.0 110.672 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.544 ' HG3' ' N ' ' A' ' 110' ' ' THR . 11.9 ptp -58.59 -38.6 78.28 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.981 . . . . 0.0 110.389 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.544 ' N ' ' HG3' ' A' ' 109' ' ' MET . 27.1 m -71.15 -40.09 71.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.881 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 38' ' ' SER . 36.5 m-80 -80.07 -4.45 52.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.787 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.853 ' O ' HD11 ' A' ' 18' ' ' LEU . 5.8 mt -98.23 -30.48 12.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 0.0 109.923 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.38 -53.11 0.59 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 109' ' ' MET . 22.7 tt0 -108.12 143.49 36.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -1.107 . . . . 0.0 110.173 -179.876 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.6 OUTLIER -120.64 18.72 11.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.945 . . . . 0.0 109.643 179.614 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.884 HD11 ' O ' ' B' ' 17' ' ' LEU . 3.4 mp 40.11 -164.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.613 0.72 . . . . 0.0 110.656 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 -172.87 2.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.462 -0.774 . . . . 0.0 109.269 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.3 -50.02 8.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 0.0 109.908 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -64.7 -32.83 74.68 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 179.527 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.41 ' OE1' ' HD2' ' B' ' 20' ' ' ARG . 4.8 mt-10 -69.05 -50.72 45.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.359 -0.838 . . . . 0.0 109.236 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.4 t -60.22 -42.06 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.805 179.297 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -66.14 -49.98 65.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 179.379 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -56.11 -25.47 45.99 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.449 -0.782 . . . . 0.0 109.139 179.19 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.802 ' HE2' ' CD1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.65 -57.57 6.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.567 -0.708 . . . . 0.0 109.854 179.546 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.969 HD11 ' CD1' ' A' ' 105' ' ' LEU . 24.6 mm -64.31 -24.32 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.389 -0.819 . . . . 0.0 110.003 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -76.05 -51.61 11.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.955 . . . . 0.0 110.021 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -12.39 42.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.334 -0.854 . . . . 0.0 110.053 179.823 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -98.4 -33.25 11.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.53 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.892 . . . . 0.0 110.121 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 128' ' ' ALA . 10.3 mt -72.74 -27.64 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p-10 -96.58 -28.12 14.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 0.0 110.296 -179.892 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.38 75.57 1.14 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 21.1 p-10 -128.1 -18.09 4.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.256 -1.144 . . . . 0.0 110.551 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.64 10.04 36.48 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' OE1' ' CB ' ' A' ' 99' ' ' TYR . 13.1 pt20 -168.94 170.27 9.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.361 -1.082 . . . . 0.0 109.484 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 35.3 t -114.87 151.95 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.943 -1.098 . . . . 0.0 110.85 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' A' ' 98' ' ' GLY . 5.6 t-20 -116.77 -169.6 1.67 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.513 -0.742 . . . . 0.0 109.506 179.668 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.44 ' CE1' HG21 ' A' ' 142' ' ' VAL . 8.5 t80 -67.83 -52.83 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.931 -1.105 . . . . 0.0 110.061 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -46.17 -67.46 0.28 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.319 -0.863 . . . . 0.0 110.188 179.964 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' PHE . 4.8 tt0 -43.87 -59.39 2.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 109.766 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.435 ' CE1' ' CD2' ' A' ' 92' ' ' PHE . 42.9 t80 -43.48 -26.05 0.19 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.831 179.415 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.667 HG22 HG21 ' A' ' 85' ' ' ILE . 68.8 t -98.93 -30.77 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.369 -0.832 . . . . 0.0 110.639 -179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 140' ' ' GLU . 10.3 mm-40 -65.65 -40.71 92.75 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.097 -1.002 . . . . 0.0 110.584 -179.634 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -36.56 68.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.219 -0.926 . . . . 0.0 110.559 -179.708 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.683 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 3.7 mtt -85.0 -26.06 27.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 146' ' ' THR . 9.6 t -170.05 96.87 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.128 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.44 49.53 1.39 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.349 -0.844 . . . . 0.0 110.362 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 pttp . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.241 179.941 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' B' ' 2' ' ' LYS . 24.8 t . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 121.167 0.508 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' B' ' 1' ' ' VAL . 3.9 mtmp? 54.47 103.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.036 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' B' ' 4' ' ' ILE . 2.1 mt -123.71 -90.13 0.58 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.146 -0.971 . . . . 0.0 110.062 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.53 ' O ' ' O ' ' B' ' 3' ' ' LEU . 6.7 mm 56.09 136.04 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.662 -0.649 . . . . 0.0 110.704 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.68 139.07 36.25 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.543 1.286 . . . . 0.0 110.591 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.85 ' O ' HG23 ' B' ' 10' ' ' VAL . 40.9 t -73.11 -159.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.845 . . . . 0.0 110.724 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.694 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -82.3 -82.29 0.14 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.553 -0.717 . . . . 0.0 110.724 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.667 HG21 ' HG2' ' A' ' 75' ' ' LYS . 23.9 p -40.09 -34.99 0.34 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.622 -0.674 . . . . 0.0 110.42 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.45 HG21 ' HB3' ' A' ' 87' ' ' GLU . 40.1 m -59.85 -53.41 58.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 109.3 179.27 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.85 HG23 ' O ' ' B' ' 6' ' ' SER . 61.9 t -50.51 -41.85 20.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.301 -0.875 . . . . 0.0 109.124 178.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.587 ' H ' HD12 ' B' ' 11' ' ' ILE . 2.8 mp -61.95 -59.59 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.561 -0.712 . . . . 0.0 110.103 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.518 ' CD2' ' HE1' ' A' ' 72' ' ' MET . 3.2 mm? -39.94 -50.64 2.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.497 -0.752 . . . . 0.0 110.992 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.603 HG12 HD11 ' A' ' 112' ' ' LEU . 94.8 t -56.65 -51.98 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.111 -0.993 . . . . 0.0 110.531 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.471 ' O ' HD22 ' B' ' 17' ' ' LEU . 19.3 tptt -56.02 -49.99 72.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.86 -1.15 . . . . 0.0 109.762 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.446 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.6 OUTLIER -68.74 -6.47 26.64 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 179.045 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.531 ' O ' ' HE3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -80.13 -45.2 18.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.362 -0.836 . . . . 0.0 110.548 -179.861 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.884 ' O ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -100.31 32.6 2.96 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 118.515 -1.274 . . . . 0.0 110.529 179.36 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.533 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 57.0 ttt180 -44.28 -58.95 2.61 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.56 -0.713 . . . . 0.0 109.859 179.3 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.595 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -144.59 -118.09 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.221 -0.924 . . . . 0.0 110.007 179.578 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.41 ' HD2' ' OE1' ' A' ' 120' ' ' GLU . 25.5 mtp180 -97.03 25.27 5.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.884 -1.135 . . . . 0.0 109.957 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.04 152.97 28.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.667 -179.352 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.802 ' CD1' ' HE2' ' A' ' 124' ' ' MET . 1.2 t80 -124.13 -25.64 4.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.875 . . . . 0.0 110.317 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.87 109.84 3.9 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.683 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 1.5 m-80 -81.57 156.18 70.84 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -1.178 . . . . 0.0 109.88 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' B' ' 26' ' ' PHE . 43.3 Cg_endo -74.72 -68.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.857 1.451 . . . . 0.0 110.432 -179.804 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.498 ' CD1' ' HB3' ' B' ' 24' ' ' ASN . 15.5 m-85 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.396 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.145 0.497 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 3' ' ' GLN . 3.3 m-20 -113.74 -40.59 3.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.301 -0.874 . . . . 0.0 110.254 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 2' ' ' ASP . 28.2 mm-40 -42.98 107.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 5' ' ' THR . 9.7 mt -102.76 133.14 48.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.276 -0.89 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 4' ' ' LEU . 7.4 p 44.46 99.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.471 -0.768 . . . . 0.0 110.656 179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.5 mt-10 -82.39 -39.48 22.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.319 -0.863 . . . . 0.0 109.992 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.59 -57.76 11.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.926 179.721 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -49.48 -45.47 46.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.794 179.658 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.611 HD12 ' HA ' ' A' ' 6' ' ' GLU . 40.2 mt -49.91 -48.36 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.662 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.7 -48.75 66.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.331 -0.856 . . . . 0.0 109.565 179.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -55.12 -52.22 63.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.612 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -57.75 -45.38 85.94 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.321 -0.862 . . . . 0.0 109.427 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -33.67 57.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 109.247 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.7 -47.82 79.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.535 -0.728 . . . . 0.0 109.661 179.483 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -62.46 -44.32 96.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -0.85 . . . . 0.0 109.543 179.485 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.6 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 23.9 t80 -63.74 -35.59 81.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.378 -0.826 . . . . 0.0 109.708 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.2 m -78.1 -20.64 51.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -0.842 . . . . 0.0 109.854 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.855 HD12 ' O ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -69.5 -46.95 65.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.43 -0.794 . . . . 0.0 109.789 179.799 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 21' ' ' LYS . 75.5 m-85 -69.57 -59.31 3.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 109.939 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.46 91.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.343 -0.848 . . . . 0.0 110.247 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 19' ' ' PHE . 4.0 mmtp -77.49 -26.57 51.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.129 -0.982 . . . . 0.0 110.22 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 20.7 p-10 -97.73 -20.72 17.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.275 -0.89 . . . . 0.0 110.326 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.61 78.79 0.92 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 45.2 p-10 -139.39 8.47 2.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -1.151 . . . . 0.0 110.061 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.791 ' O ' HG23 ' A' ' 26' ' ' THR . . . 65.34 35.01 90.95 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -163.85 119.31 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.236 -1.155 . . . . 0.0 110.444 -179.903 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 19' ' ' PHE . 13.3 mt -83.18 134.4 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.086 -1.009 . . . . 0.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 20.1 p -98.82 179.98 4.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.405 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.2 p -70.89 -53.27 15.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -61.39 -48.8 79.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.217 -0.927 . . . . 0.0 110.455 -179.948 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OG1' ' A' ' 28' ' ' THR . 23.3 mt-10 -41.92 -69.81 0.12 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.208 -0.932 . . . . 0.0 109.947 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.615 HD22 ' CH2' ' B' ' 7' ' ' TRP . 22.5 tp -49.55 -32.43 12.5 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.125 -0.984 . . . . 0.0 109.07 179.386 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.74 95.04 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.769 -1.733 . . . . 0.0 108.769 179.276 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.1 m -54.76 -44.54 73.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.293 -1.122 . . . . 0.0 109.111 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 35' ' ' VAL . 24.8 t -64.31 -44.72 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.446 -0.784 . . . . 0.0 109.398 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.608 ' HA ' HD12 ' A' ' 39' ' ' LEU . 2.0 mmt -62.28 -34.89 77.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.315 -0.866 . . . . 0.0 109.663 179.369 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -34.31 77.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.501 179.386 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -26.58 54.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.577 -0.702 . . . . 0.0 110.386 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.608 HD12 ' HA ' ' A' ' 36' ' ' MET . 4.7 mt -69.77 -32.44 70.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.131 -0.98 . . . . 0.0 109.985 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.06 -46.98 0.7 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.382 179.492 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.56 -176.46 6.26 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.1 -1.235 . . . . 0.0 111.242 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 8.1 p30 -144.82 105.07 4.52 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.538 -0.726 . . . . 0.0 109.446 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.691 ' HA ' HD11 ' B' ' 4' ' ' ILE . 44.0 Cg_endo -72.23 151.49 54.81 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 O-C-N 124.054 1.555 . . . . 0.0 111.046 -179.304 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.554 HG22 ' N ' ' A' ' 45' ' ' GLU . 56.2 m -98.16 174.62 6.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.909 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.554 ' N ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -73.82 -41.83 61.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.118 -0.989 . . . . 0.0 110.451 -179.768 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.17 -48.82 74.51 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.066 -1.021 . . . . 0.0 110.281 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -64.45 -49.35 71.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.348 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.52 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 6.3 mt -52.34 -49.66 63.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.965 . . . . 0.0 110.109 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -54.73 -41.44 70.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 109.669 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.84 -25.54 62.88 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.315 -0.865 . . . . 0.0 109.464 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.436 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.4 OUTLIER -73.63 -40.92 63.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.894 179.678 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -28.5 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.293 -0.879 . . . . 0.0 109.478 179.733 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.71 -14.15 12.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.314 -0.866 . . . . 0.0 110.113 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -85.8 -49.27 8.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 111.069 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 21.7 t -69.1 -47.5 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.877 -1.14 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -45.89 89.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.388 0.613 . . . . 0.0 110.329 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -98.0 -9.07 26.7 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.186 -0.946 . . . . 0.0 110.59 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 5.7 p30 -100.65 -32.67 10.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.961 -1.087 . . . . 0.0 110.791 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 103.57 45.91 1.48 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 23.1 m120 -100.03 -19.82 16.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.119 -1.224 . . . . 0.0 110.037 179.833 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.89 -11.68 70.55 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 27' ' ' ILE . 0.6 OUTLIER -145.99 170.09 17.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.106 . . . . 0.0 110.109 -179.999 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.2 mm -89.9 124.85 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.423 -0.798 . . . . 0.0 110.493 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.535 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 4.5 m-20 -97.07 -177.43 3.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.274 -0.892 . . . . 0.0 110.639 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.61 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 17.9 t80 -68.5 -48.37 33.7 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.392 -0.817 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.9 Cg_endo -67.69 -32.58 30.04 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 O-C-N 123.294 1.155 . . . . 0.0 110.006 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE2' ' OD1' ' A' ' 64' ' ' ASP . 6.9 mt-10 -63.34 -36.65 84.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.187 -0.946 . . . . 0.0 109.105 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.727 ' HZ ' HG23 ' B' ' 11' ' ' ILE . 5.5 t80 -64.48 -58.24 6.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.779 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.01 -30.53 66.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.329 -0.857 . . . . 0.0 110.199 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 m -84.29 -21.9 30.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.182 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.45 -45.8 68.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 0.0 109.929 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.513 ' HE2' ' CE1' ' B' ' 26' ' ' PHE . 93.3 mmm -57.29 -15.0 5.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 110.222 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.26 -20.57 14.07 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.153 -0.967 . . . . 0.0 110.572 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 -27.01 20.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.026 . . . . 0.0 110.191 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -99.85 -34.2 10.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.33 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -98.13 60.77 1.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -0.934 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 7.6 ttpp -98.13 -39.04 9.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.095 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 1.1 t70 176.07 -29.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.294 -0.879 . . . . 0.0 110.107 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -43.13 -73.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.257 -0.902 . . . . 0.0 110.579 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.479 ' O ' ' OE1' ' A' ' 84' ' ' GLU . 41.6 p-10 -102.19 115.12 29.89 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.197 -0.94 . . . . 0.0 110.651 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.15 -42.69 3.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.465 179.376 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.566 ' HA ' HD12 ' A' ' 85' ' ' ILE . 5.1 tp10 -100.64 -11.97 19.58 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.456 -0.777 . . . . 0.0 110.035 179.594 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 80' ' ' ASP . 5.1 tm-20 -77.38 -40.5 43.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.197 -0.94 . . . . 0.0 110.559 -179.658 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.479 ' OE1' ' O ' ' A' ' 80' ' ' ASP . 11.2 pt-20 -68.81 -22.58 64.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 110.633 -179.762 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.766 HG21 HG22 ' A' ' 142' ' ' VAL . 90.3 mt -76.62 -31.42 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.064 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -65.88 -37.25 85.64 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.346 -0.846 . . . . 0.0 109.651 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.815 ' HB3' HG21 ' B' ' 9' ' ' THR . 4.9 mt-10 -68.7 -52.58 29.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 179.356 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.432 ' HB2' HD13 ' B' ' 12' ' ' LEU . . . -55.64 -29.86 59.96 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.402 -0.811 . . . . 0.0 109.649 179.63 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -69.08 -44.37 72.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 109.333 179.186 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -37.99 54.24 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 109.191 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.939 HG11 HG11 ' B' ' 13' ' ' VAL . 54.9 t -63.48 -51.6 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.679 . . . . 0.0 109.995 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.778 ' HB3' HD13 ' A' ' 100' ' ' ILE . 20.1 m-85 -62.29 -34.9 77.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.168 -0.958 . . . . 0.0 109.995 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -100.46 67.32 1.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.801 . . . . 0.0 109.931 179.835 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 93' ' ' ASP . 3.0 tttp -37.45 -36.87 0.17 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.66 -0.65 . . . . 0.0 110.568 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.9 p30 -83.43 -31.78 26.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.291 -0.881 . . . . 0.0 110.088 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 75.47 33.77 51.89 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 31.4 p-10 -84.73 -31.59 23.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -1.179 . . . . 0.0 110.322 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 117.24 43.55 0.6 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -169.4 124.26 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -1.083 . . . . 0.0 109.959 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.778 HD13 ' HB3' ' A' ' 92' ' ' PHE . 38.1 mt -110.4 116.29 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.585 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -106.02 148.61 27.53 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 109.547 179.237 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.561 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -37.9 -34.46 0.11 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.443 -0.786 . . . . 0.0 110.516 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -63.02 -50.41 70.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 0.0 109.487 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 25.1 mt-10 -55.47 -47.65 75.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.599 179.504 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.997 ' CD1' HD11 ' A' ' 125' ' ' ILE . 2.4 mt -51.11 -41.77 60.25 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.267 -0.896 . . . . 0.0 109.267 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HG2' HG21 ' A' ' 121' ' ' VAL . 1.1 mmm180 -60.43 -34.37 73.87 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.464 -0.772 . . . . 0.0 109.916 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 8.8 m170 -69.98 -22.25 63.16 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 92' ' ' PHE . 2.1 t -88.29 -45.28 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.168 -0.957 . . . . 0.0 110.715 -179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.572 ' HE1' ' HB2' ' A' ' 116' ' ' LEU . 13.1 ptp -63.56 -44.85 92.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.925 -1.109 . . . . 0.0 110.691 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.503 ' N ' ' CG ' ' A' ' 109' ' ' MET . 1.8 m -60.73 -27.77 68.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.038 -1.039 . . . . 0.0 109.928 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 5.8 m120 -82.53 -7.95 59.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.914 . . . . 0.0 110.159 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 18' ' ' LEU . 16.4 mt -114.05 -8.55 13.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.43 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.59 -59.55 0.65 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.422 -1.371 . . . . 0.0 111.148 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.515 ' HG2' HD12 ' A' ' 116' ' ' LEU . 17.8 tt0 -72.12 152.55 42.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.996 -1.296 . . . . 0.0 111.28 -178.809 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 116' ' ' LEU . 4.1 mtmt -132.01 68.06 1.51 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.495 -0.753 . . . . 0.0 109.77 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.572 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 3.0 mp -40.56 119.25 1.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.295 -0.878 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -50.82 177.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.277 -0.889 . . . . 0.0 110.455 -179.464 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -64.71 -52.28 57.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.107 -0.996 . . . . 0.0 110.088 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 10.6 pt-20 -59.92 -42.81 94.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.531 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.417 ' N ' ' CG ' ' A' ' 119' ' ' GLU . 1.8 mt-10 -61.66 -43.54 98.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.421 -0.8 . . . . 0.0 109.446 179.384 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.561 HG12 ' HB1' ' A' ' 102' ' ' ALA . 52.0 t -68.02 -48.46 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.328 -0.858 . . . . 0.0 109.596 179.453 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.21 -38.07 76.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.4 OUTLIER -68.71 -33.56 74.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.855 . . . . 0.0 109.677 179.593 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.575 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 12.0 ttt -64.25 -39.99 95.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.87 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.997 HD11 ' CD1' ' A' ' 105' ' ' LEU . 11.0 mm -74.37 -54.37 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.232 -0.917 . . . . 0.0 109.676 179.541 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.03 -53.38 53.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 110.145 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 7.7 tp10 -51.99 -30.05 23.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.827 . . . . 0.0 110.162 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -96.81 -25.85 15.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.392 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD2' HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -47.2 92.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.266 -0.896 . . . . 0.0 110.556 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.6 mt -80.85 -34.01 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.39 179.403 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.46 ' OD2' ' OD2' ' A' ' 133' ' ' ASP . 9.1 p-10 -87.46 -37.93 16.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.483 -0.761 . . . . 0.0 109.868 179.685 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.24 71.83 0.95 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 3.4 p30 -140.43 9.7 2.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -1.171 . . . . 0.0 109.93 179.475 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 58.13 15.12 20.71 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 15.4 mt-30 -146.64 170.18 17.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.354 -1.086 . . . . 0.0 110.341 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.512 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 54.6 t -131.47 129.91 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 109.81 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 137' ' ' ASN . 14.2 p-10 -114.01 -160.08 0.72 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.115 -0.991 . . . . 0.0 110.579 -179.462 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 139' ' ' GLU . 62.1 t80 -62.91 -63.6 1.16 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.887 . . . . 0.0 110.31 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -40.95 -67.86 0.22 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.325 -0.859 . . . . 0.0 110.311 -179.909 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 139' ' ' GLU . 12.7 tt0 -44.6 -60.91 1.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -46.08 -23.91 0.37 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.29 -0.881 . . . . 0.0 110.308 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.766 HG22 HG21 ' A' ' 85' ' ' ILE . 91.6 t -98.75 -31.67 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 110.241 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -66.2 -13.79 60.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.94 . . . . 0.0 110.263 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.409 ' HB3' ' HA2' ' B' ' 23' ' ' GLY . 0.9 OUTLIER -97.47 -20.31 17.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.261 -0.9 . . . . 0.0 110.475 -179.852 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 145' ' ' MET . . . . . 1.111 ' CE ' HD21 ' B' ' 12' ' ' LEU . 2.1 mtt -99.56 -11.28 21.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 110.218 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 146' ' ' THR . 2.7 t -164.95 84.42 0.39 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 110.072 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 148' ' ' LYS . . . -99.1 8.04 45.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.032 -1.043 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.551 ' CG ' ' O ' ' A' ' 147' ' ' ALA . 2.2 mttm . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.161 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.539 HG23 ' N ' ' B' ' 2' ' ' LYS . 16.3 m . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 121.109 0.481 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.539 ' N ' HG23 ' B' ' 1' ' ' VAL . 3.4 pttp -170.91 63.12 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.232 -0.917 . . . . 0.0 110.346 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' B' ' 3' ' ' LEU . 3.3 mm? -90.25 16.19 9.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 0.0 109.788 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.691 HD11 ' HA ' ' A' ' 43' ' ' PRO . 16.6 mt -40.89 141.27 0.98 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.591 -0.693 . . . . 0.0 110.086 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.454 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.7 Cg_endo -68.64 -175.65 0.97 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.963 1.507 . . . . 0.0 110.165 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.31 -169.14 1.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.075 -1.016 . . . . 0.0 110.898 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.716 ' O ' HG22 ' B' ' 10' ' ' VAL . 0.9 OUTLIER -71.51 -77.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.579 -0.7 . . . . 0.0 110.658 -179.622 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.465 ' C ' ' O ' ' B' ' 7' ' ' TRP . 2.8 p -41.15 -25.78 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.025 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.815 HG21 ' HB3' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -63.99 -65.38 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 179.146 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.716 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.8 m -47.23 -29.87 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.154 -0.966 . . . . 0.0 109.501 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.727 HG23 ' HZ ' ' A' ' 68' ' ' PHE . 7.1 mm -75.7 -45.8 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.321 179.267 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 1.111 HD21 ' CE ' ' A' ' 145' ' ' MET . 0.9 OUTLIER -47.74 -56.51 7.19 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.542 0.687 . . . . 0.0 110.225 179.655 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.939 HG11 HG11 ' A' ' 91' ' ' VAL . 22.1 t -60.04 -51.94 67.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 110.734 -179.538 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' B' ' 14' ' ' LYS . 24.0 tptt -66.62 -14.61 62.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.926 -1.108 . . . . 0.0 109.975 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 23.3 t -77.71 -33.01 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.872 . . . . 0.0 109.962 179.738 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.67 -14.73 31.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.786 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.826 ' CD2' HD12 ' A' ' 112' ' ' LEU . 3.8 mp -73.72 51.11 0.36 Allowed 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.156 -0.965 . . . . 0.0 111.201 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.484 ' HB3' ' OG ' ' B' ' 21' ' ' SER . 0.1 OUTLIER -104.2 -107.41 0.28 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.116 -0.99 . . . . 0.0 109.817 179.426 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.494 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 0.1 OUTLIER -107.48 -70.16 0.81 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.026 -1.046 . . . . 0.0 109.513 179.677 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.48 ' HB3' ' CD ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -135.45 13.4 3.49 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.36 -0.837 . . . . 0.0 109.804 179.38 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -66.41 120.3 13.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.336 -0.853 . . . . 0.0 110.297 179.866 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.575 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -144.87 26.96 1.34 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.976 . . . . 0.0 110.953 179.965 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 144' ' ' MET . . . -118.65 -119.81 2.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.534 ' HB2' ' HA ' ' A' ' 145' ' ' MET . 6.5 t30 -129.51 70.73 82.0 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.327 -1.102 . . . . 0.0 109.962 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.23 47.2 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.877 1.462 . . . . 0.0 110.21 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.513 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.952 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.344 0.592 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 4' ' ' LEU . 12.0 p30 -69.33 -118.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.217 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 7.7 pt20 -62.52 74.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.992 -1.068 . . . . 0.0 110.411 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.8 HD22 ' C ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -41.69 167.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -0.859 . . . . 0.0 110.898 179.57 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.777 ' HB ' HD22 ' A' ' 4' ' ' LEU . 73.6 m 43.67 68.59 0.5 Allowed 'General case' 0 C--N 1.311 -1.09 0 O-C-N 121.44 -0.788 . . . . 0.0 110.926 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -99.59 -26.03 14.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.401 -0.812 . . . . 0.0 109.753 179.426 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 18.0 mt-10 -69.33 -63.34 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.831 . . . . 0.0 110.124 179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -45.9 -54.5 8.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 109.923 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.706 HD12 ' O ' ' A' ' 5' ' ' THR . 84.9 mt -53.67 -45.46 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -50.33 -44.8 54.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.092 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.442 ' OE1' ' HD3' ' B' ' 18' ' ' ARG . 1.6 mt-10 -59.65 -47.12 86.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.943 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -60.64 -39.08 86.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.66 97.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.957 . . . . 0.0 109.932 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.72 -38.16 80.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.304 -0.872 . . . . 0.0 109.832 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -66.36 -51.94 52.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.247 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.549 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 15.3 t80 -62.87 -34.29 77.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.199 -0.938 . . . . 0.0 109.824 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.9 t -73.19 -19.23 61.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.836 . . . . 0.0 109.812 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.675 HD13 ' HG3' ' B' ' 14' ' ' LYS . 10.5 tt -80.76 -34.93 33.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.356 -0.84 . . . . 0.0 110.066 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.413 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 70.2 m-85 -86.4 -44.78 11.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.35 -0.844 . . . . 0.0 110.517 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -77.63 85.79 3.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.312 -0.868 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -66.84 -40.66 88.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.892 . . . . 0.0 110.124 179.848 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -57.1 -43.88 82.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.419 -0.8 . . . . 0.0 110.161 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.26 0.36 67.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 6.9 p-10 -74.84 -28.29 60.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.212 -1.169 . . . . 0.0 109.975 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.524 ' C ' HG23 ' A' ' 26' ' ' THR . . . 110.73 37.73 1.68 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.711 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 28.3 p -152.41 109.97 3.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.152 -1.204 . . . . 0.0 110.661 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.58 HD12 ' CG2' ' A' ' 63' ' ' ILE . 22.3 mt -80.73 115.12 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.196 -0.94 . . . . 0.0 109.442 179.292 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -93.64 174.65 7.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.283 -0.886 . . . . 0.0 110.228 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.578 HG22 ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -64.05 -30.13 71.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.043 179.923 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -73.0 -54.09 9.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.879 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -50.84 -69.91 0.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 109.865 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 tp -52.77 -36.51 58.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.739 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -62.08 -40.55 99.08 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.713 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 m -58.27 -51.87 67.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -1.086 . . . . 0.0 109.799 179.726 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 t -60.29 -47.53 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.858 . . . . 0.0 109.963 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.489 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 2.3 mmt -59.56 -43.02 93.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.12 -0.988 . . . . 0.0 109.895 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -65.56 -20.65 66.42 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.342 -0.849 . . . . 0.0 110.109 179.805 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.8 t -77.83 -57.41 3.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.891 . . . . 0.0 110.288 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mt -46.61 -25.64 0.75 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.156 -0.965 . . . . 0.0 110.071 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.83 66.11 0.56 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -137.69 -157.63 0.79 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.174 -1.192 . . . . 0.0 110.288 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 42' ' ' ASN . 18.0 t30 -147.54 62.8 7.33 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.291 -0.881 . . . . 0.0 110.082 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HG3' ' CB ' ' A' ' 36' ' ' MET . 48.7 Cg_endo -74.7 118.59 5.37 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.073 1.565 . . . . 0.0 110.559 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 46' ' ' ALA . 28.1 m -99.96 146.36 26.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.317 -0.864 . . . . 0.0 109.938 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 21.7 pt-20 -43.12 -44.75 5.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.17 -0.956 . . . . 0.0 110.0 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.474 ' H ' HG22 ' A' ' 44' ' ' THR . . . -65.31 -65.04 0.72 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 109.802 179.615 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' CD ' ' HB2' ' B' ' 2' ' ' LYS . 1.1 mm-40 -46.55 -43.24 16.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.683 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.578 ' HB3' HG22 ' A' ' 29' ' ' THR . 0.3 OUTLIER -51.7 -55.66 18.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.351 -0.843 . . . . 0.0 109.785 179.674 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -38.52 19.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.768 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -64.76 -33.69 76.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.416 -0.803 . . . . 0.0 110.104 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.552 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.5 OUTLIER -77.18 -37.9 52.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.587 HG13 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -68.94 -33.81 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.782 179.85 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.77 -46.93 42.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.342 -0.849 . . . . 0.0 110.603 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -59.56 -56.72 18.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 0.0 110.697 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 28.5 t -70.28 -42.77 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.023 -1.048 . . . . 0.0 110.252 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 60' ' ' ASN . 1.7 t70 -64.95 67.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -40.49 -51.5 2.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.551 -0.718 . . . . 0.0 110.886 -179.74 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 6.7 p-10 -67.47 -43.85 80.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 0.0 110.524 -179.621 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' CA ' ' OD2' ' A' ' 56' ' ' ASP . . . 92.72 49.03 2.81 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.53 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 19.2 p30 -100.08 -17.76 17.31 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.168 -1.195 . . . . 0.0 110.202 179.699 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.16 14.2 31.49 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.15 133.33 16.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.116 -1.226 . . . . 0.0 110.183 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.587 HD11 HG13 ' A' ' 52' ' ' ILE . 26.1 mm -84.57 156.27 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.386 -0.821 . . . . 0.0 110.218 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.549 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 15.2 t0 -129.82 169.06 15.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.04 -1.037 . . . . 0.0 110.453 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.82 ' CE2' HD11 ' A' ' 69' ' ' LEU . 51.7 t80 -61.32 -40.03 68.47 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 111.522 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.4 Cg_endo -71.91 -29.72 14.88 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 O-C-N 123.284 1.15 . . . . 0.0 110.22 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -70.48 -31.34 68.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -0.888 . . . . 0.0 109.418 179.218 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 23.6 t80 -72.73 -46.11 55.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.384 -0.822 . . . . 0.0 110.421 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.82 HD11 ' CE2' ' A' ' 65' ' ' PHE . 28.0 mt -66.92 -25.46 66.38 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.212 -0.93 . . . . 0.0 110.778 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.8 m -83.68 -28.62 28.22 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.1 -1.0 . . . . 0.0 110.893 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.437 ' SD ' ' HE3' ' A' ' 75' ' ' LYS . 5.5 tmm? -77.29 -47.59 19.68 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.134 -0.978 . . . . 0.0 111.046 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.609 ' HE2' ' HZ ' ' B' ' 26' ' ' PHE . 7.3 tpt -60.31 -10.89 5.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.118 -0.989 . . . . 0.0 111.102 -179.293 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.52 -36.58 8.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.938 -1.101 . . . . 0.0 110.942 -179.427 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.5 ttt-85 -85.18 -11.26 55.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.133 -0.979 . . . . 0.0 110.6 -179.594 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.746 ' HG2' HG21 ' B' ' 8' ' ' THR . 1.7 tppp? -100.39 -12.82 19.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.002 -1.061 . . . . 0.0 110.669 -179.786 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.63 -36.8 9.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.114 -0.991 . . . . 0.0 110.643 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -9.05 21.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.093 -1.004 . . . . 0.0 110.447 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -80.48 -87.91 0.07 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.11 -0.993 . . . . 0.0 110.376 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -155.08 -107.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.86 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.468 ' N ' ' OG1' ' A' ' 79' ' ' THR . 1.0 OUTLIER 42.23 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.004 -1.06 . . . . 0.0 110.263 -179.964 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.496 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 74.3 m -125.05 -42.53 2.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 110.004 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -100.3 -20.97 15.62 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.363 -0.836 . . . . 0.0 110.154 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -80.41 -40.1 27.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 0.0 109.919 179.763 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 80' ' ' ASP . 22.8 pt-20 -69.36 -27.64 65.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.262 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 81' ' ' SER . 80.0 mt -78.53 -36.14 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.113 -0.992 . . . . 0.0 109.957 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -64.66 -29.84 70.85 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 109.802 179.762 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -75.43 -50.78 14.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 109.109 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.762 ' HB2' HD22 ' B' ' 12' ' ' LEU . . . -60.57 -35.73 76.78 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.338 -0.852 . . . . 0.0 109.455 179.208 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 17.3 t80 -64.44 -56.95 10.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 109.847 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -44.31 -38.22 3.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.402 -0.812 . . . . 0.0 109.556 179.709 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.646 HG12 HG21 ' A' ' 108' ' ' VAL . 4.0 t -65.99 -35.92 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 109.826 179.618 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.619 ' HB3' HD13 ' A' ' 100' ' ' ILE . 9.1 m-85 -68.64 -35.68 77.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.164 -0.96 . . . . 0.0 110.474 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.464 ' OD1' HG12 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -98.82 63.59 1.4 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.21 -0.931 . . . . 0.0 110.402 -179.416 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -43.31 -28.22 0.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.277 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 27.6 p-10 -96.1 -36.98 10.8 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.19 -0.944 . . . . 0.0 110.436 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.23 44.0 14.77 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.417 ' ND2' ' OD2' ' A' ' 95' ' ' ASP . 21.7 p30 -78.17 -15.31 58.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -1.145 . . . . 0.0 110.374 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.501 ' C ' ' CG ' ' A' ' 99' ' ' TYR . . . 118.37 -8.39 13.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.501 ' CG ' ' C ' ' A' ' 98' ' ' GLY . 5.3 m-85 -148.88 163.89 36.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -1.186 . . . . 0.0 110.155 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.619 HD13 ' HB3' ' A' ' 92' ' ' PHE . 7.1 mt -113.01 126.32 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 110.133 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.1 p -106.36 153.15 22.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.835 . . . . 0.0 110.09 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.75 -37.84 9.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.05 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.44 93.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -55.52 -43.01 75.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.849 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.998 HD12 HD11 ' A' ' 125' ' ' ILE . 2.7 mt -57.92 -48.05 81.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.716 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.411 ' O ' ' OG1' ' A' ' 110' ' ' THR . 0.3 OUTLIER -50.83 -42.56 58.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.838 . . . . 0.0 109.754 179.79 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.81 -48.45 81.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 109.75 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.646 HG21 HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -74.42 -25.8 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 0.0 109.416 179.631 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.97 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.5 OUTLIER -71.04 -50.05 38.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 110.108 179.98 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -71.41 -31.67 67.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.187 179.934 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -72.55 -6.46 44.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.245 -0.909 . . . . 0.0 110.438 -179.887 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.72 HD11 HG12 ' B' ' 13' ' ' VAL . 6.4 mt -106.53 -44.72 4.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.106 -0.996 . . . . 0.0 110.617 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.69 -46.93 0.51 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.405 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.742 ' HG2' HD12 ' A' ' 116' ' ' LEU . 14.2 tt0 -98.48 141.67 31.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.067 -1.255 . . . . 0.0 110.659 -179.613 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 116' ' ' LEU . 3.2 ptpt -119.56 16.46 12.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 109.748 179.406 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.742 HD12 ' HG2' ' A' ' 114' ' ' GLU . 4.0 mp 39.45 -164.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.684 0.754 . . . . 0.0 110.842 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.16 -147.98 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.562 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -107.58 -48.56 3.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 109.969 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -67.24 -34.84 78.31 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.538 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.48 -44.68 82.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.272 -0.893 . . . . 0.0 109.097 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.0 t -53.25 -48.64 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.412 -0.805 . . . . 0.0 109.646 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -65.07 -56.24 14.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.75 -30.05 13.0 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.41 -0.806 . . . . 0.0 109.437 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.616 ' HE2' ' CD2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.61 -62.4 1.84 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.339 -0.851 . . . . 0.0 109.689 179.544 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.998 HD11 HD12 ' A' ' 105' ' ' LEU . 48.0 mm -56.33 -34.24 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -0.78 . . . . 0.0 110.258 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -66.91 -44.18 81.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 110.323 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.77 -29.66 69.67 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 0.0 110.215 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.18 -31.18 34.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -0.953 . . . . 0.0 110.015 179.799 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.476 ' HB3' ' HA2' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -65.6 106.2 1.4 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.372 -0.83 . . . . 0.0 110.483 -179.968 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.2 mm -64.3 -28.04 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 12.3 p30 -105.54 -16.43 14.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.958 179.823 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 64.02 59.36 8.63 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.441 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 6.3 p-10 -101.0 -23.96 14.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -1.146 . . . . 0.0 109.941 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 135' ' ' GLN . . . 131.79 -12.72 5.35 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.478 ' CG ' ' C ' ' A' ' 134' ' ' GLY . 9.7 mt-30 -151.31 161.16 43.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.152 -1.205 . . . . 0.0 110.073 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 19.3 t -105.67 157.85 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.908 179.653 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 1.9 p-10 -127.23 -179.54 4.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.221 -0.925 . . . . 0.0 110.445 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -61.03 -67.15 0.43 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.447 -0.783 . . . . 0.0 110.647 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 0.7 OUTLIER -45.32 -27.67 0.71 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.238 -0.914 . . . . 0.0 110.628 -179.49 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.464 ' HB2' ' ND2' ' A' ' 137' ' ' ASN . 4.2 tt0 -80.49 -52.51 7.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 69.3 t80 -54.33 -17.39 2.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.18 -0.95 . . . . 0.0 109.859 179.638 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.45 -55.3 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 110.637 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 0.5 OUTLIER -58.93 -13.79 7.36 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.118 -0.988 . . . . 0.0 110.78 -179.559 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.493 ' HG3' ' HA2' ' B' ' 23' ' ' GLY . 3.7 tpt -97.55 -27.27 14.48 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.166 -0.959 . . . . 0.0 110.582 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.8 ttt -100.49 -10.05 21.47 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.249 -0.907 . . . . 0.0 110.796 -179.53 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 p -106.54 -53.21 2.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 0.0 110.967 -179.335 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 148' ' ' LYS . . . -81.65 45.3 0.87 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.214 -0.929 . . . . 0.0 110.639 -179.517 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.251 179.767 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 1' ' ' VAL . 27.6 m . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.244 0.545 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.466 ' O ' ' CB ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -69.81 85.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 110.03 179.817 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' B' ' 3' ' ' LEU . 8.9 tp 69.07 21.16 7.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.225 -0.922 . . . . 0.0 110.361 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.63 HG23 ' HD2' ' B' ' 5' ' ' PRO . 19.0 mm -92.5 148.89 37.22 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 179.55 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.63 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.0 Cg_endo -66.52 170.38 12.46 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.632 1.333 . . . . 0.0 110.436 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.512 ' O ' ' HB ' ' B' ' 9' ' ' THR . 0.1 OUTLIER -96.4 152.24 18.79 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.189 -0.945 . . . . 0.0 111.299 -178.913 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.759 ' O ' HG22 ' B' ' 10' ' ' VAL . 4.2 m95 -48.95 -66.09 0.46 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.881 . . . . 0.0 109.641 179.036 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.746 HG21 ' HG2' ' A' ' 75' ' ' LYS . 23.8 p -47.73 -24.17 0.88 Allowed 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.889 -1.132 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' B' ' 6' ' ' SER . 4.1 m -64.38 -54.97 24.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.066 -1.021 . . . . 0.0 109.639 179.37 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.759 HG22 ' O ' ' B' ' 7' ' ' TRP . 6.8 m -56.89 -33.71 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.908 -1.12 . . . . 0.0 108.687 179.44 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.525 ' N ' HD13 ' B' ' 11' ' ' ILE . 4.9 mm -77.45 -23.2 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 108.799 178.411 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.762 HD22 ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -68.5 -60.78 2.18 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.613 -0.68 . . . . 0.0 109.784 179.707 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.72 HG12 HD11 ' A' ' 112' ' ' LEU . 35.7 t -62.82 -32.84 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.371 -0.83 . . . . 0.0 110.166 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.675 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -69.35 -45.59 69.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.017 -1.052 . . . . 0.0 109.251 179.212 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 52.7 p -58.46 -35.23 71.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.418 -0.801 . . . . 0.0 109.518 179.151 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.489 ' HG2' ' HG3' ' B' ' 25' ' ' PRO . 0.0 OUTLIER -65.1 -41.97 94.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.445 -0.784 . . . . 0.0 109.582 179.477 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.97 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.2 mp -60.62 -12.82 11.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.421 -0.799 . . . . 0.0 110.038 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.56 ' C ' ' O ' ' B' ' 17' ' ' LEU . 6.4 tpt85 -18.8 -68.21 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.679 0 CA-C-O 121.489 0.661 . . . . 0.0 111.161 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.535 ' HD2' ' HG2' ' B' ' 20' ' ' ARG . 1.1 tmtm? -174.44 -104.49 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.011 179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.535 ' HG2' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -87.73 13.66 10.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.444 -1.41 . . . . 0.0 109.335 179.308 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -87.06 163.34 17.08 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.456 -0.777 . . . . 0.0 110.555 -179.542 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.616 ' CD2' ' HE2' ' A' ' 124' ' ' MET . 0.2 OUTLIER 179.81 -45.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.318 -0.864 . . . . 0.0 110.559 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.493 ' HA2' ' HG3' ' A' ' 144' ' ' MET . . . -69.91 -50.96 26.43 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.395 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -150.13 84.97 5.61 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.954 -1.321 . . . . 0.0 110.838 -179.572 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.489 ' HG3' ' HG2' ' B' ' 16' ' ' MET . 48.6 Cg_endo -80.84 -7.76 13.35 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.925 1.487 . . . . 0.0 110.109 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.609 ' HZ ' ' HE2' ' A' ' 72' ' ' MET . 5.9 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.316 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.216 0.531 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -152.99 -43.37 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -0.899 . . . . 0.0 110.264 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -99.78 -155.72 0.52 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.235 -0.916 . . . . 0.0 110.091 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.35 -174.6 0.69 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 110.124 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 t -129.27 -5.54 4.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.14 -0.975 . . . . 0.0 110.5 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 7' ' ' GLU . 48.8 tt0 -96.12 -22.18 17.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.117 -0.989 . . . . 0.0 110.139 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -42.86 -63.94 0.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.995 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -46.81 -66.6 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 109.964 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.4 mt -50.11 -44.92 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.3 -45.71 69.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 109.951 179.713 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.68 -51.01 66.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.208 -0.932 . . . . 0.0 109.813 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -44.84 67.63 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.229 -0.919 . . . . 0.0 109.377 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.63 -30.56 65.47 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.344 -0.847 . . . . 0.0 108.972 178.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -58.32 9.1 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.533 -0.729 . . . . 0.0 109.293 179.21 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.77 -48.41 41.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.267 -0.896 . . . . 0.0 109.336 179.231 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.543 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 32.3 t80 -66.51 -35.64 80.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.327 -0.858 . . . . 0.0 109.448 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -68.32 -30.34 69.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.46 -0.775 . . . . 0.0 109.528 179.446 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.876 HD13 ' CD ' ' B' ' 14' ' ' LYS . 6.7 tt -65.35 -46.03 81.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.684 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -73.29 -39.15 65.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.282 -0.886 . . . . 0.0 110.384 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.89 82.93 5.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.211 -0.931 . . . . 0.0 109.919 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -49.17 -74.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 110.359 -179.746 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.1 p-10 -51.76 -39.0 57.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 110.306 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.17 15.02 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.451 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 40.8 p-10 -76.64 -12.65 60.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -1.167 . . . . 0.0 110.081 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.621 ' O ' HG23 ' A' ' 26' ' ' THR . . . 89.98 42.11 5.42 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -161.49 117.36 2.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -1.131 . . . . 0.0 110.573 -179.831 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.538 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 8.1 mt -100.07 118.22 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.218 -0.926 . . . . 0.0 110.127 179.594 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.68 HG22 HG22 ' A' ' 62' ' ' THR . 20.4 p -94.92 153.88 17.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 109.806 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -46.31 -24.65 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.977 . . . . 0.0 109.942 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -78.54 -60.79 2.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.066 179.761 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 37.3 mt-10 -44.21 -56.64 3.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.511 HD22 ' CZ2' ' B' ' 7' ' ' TRP . 40.8 tp -57.39 -45.65 84.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.168 -0.958 . . . . 0.0 109.3 179.336 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -56.65 -39.56 86.24 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.27 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 15.0 m -53.28 -50.94 63.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -1.027 . . . . 0.0 109.363 179.352 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 35' ' ' VAL . 10.4 t -57.75 -39.28 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.326 -0.859 . . . . 0.0 109.261 179.246 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 13.5 mmt -61.31 -39.13 89.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 179.253 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -62.25 -30.74 71.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.381 179.265 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 m -65.73 -61.85 1.84 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.465 -0.772 . . . . 0.0 110.051 179.687 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.1 mt -47.92 -24.16 0.96 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.71 55.08 0.58 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.15 165.94 30.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -1.186 . . . . 0.0 110.482 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 42' ' ' ASN . 2.6 p30 -140.75 97.95 7.14 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.967 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.7 154.33 54.31 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.9 1.474 . . . . 0.0 110.485 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 45' ' ' GLU . 4.0 m -99.65 -176.74 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.664 ' H ' HG22 ' A' ' 44' ' ' THR . 1.2 tm-20 -67.45 -69.52 0.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.216 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.502 ' N ' ' OE1' ' A' ' 45' ' ' GLU . . . -47.14 -46.95 23.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.417 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 56.5 mm-40 -52.54 -58.19 7.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -0.895 . . . . 0.0 110.296 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.6 mt -48.61 -43.6 36.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.254 -0.904 . . . . 0.0 110.53 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 tp60 -63.87 -35.92 82.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 110.235 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -30.65 71.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.869 . . . . 0.0 110.12 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.9 mtp -84.15 -47.58 10.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.343 -0.848 . . . . 0.0 110.09 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 63' ' ' ILE . 10.2 mm -66.05 -30.26 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -56.5 -14.14 2.86 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.361 -0.837 . . . . 0.0 111.094 -179.504 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.38 -53.0 4.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.085 -1.009 . . . . 0.0 111.009 -179.29 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.823 HG22 ' HG3' ' A' ' 71' ' ' MET . 6.6 t -72.46 -36.69 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.093 -1.005 . . . . 0.0 111.002 -179.484 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.7 t0 -55.32 82.25 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.267 -0.896 . . . . 0.0 110.657 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.32 -58.2 3.59 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.402 -0.812 . . . . 0.0 110.65 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 30.1 p30 -63.94 -11.7 30.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.258 -0.901 . . . . 0.0 110.5 -179.708 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 61.08 46.52 94.38 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 23.1 p-10 -97.73 -32.84 11.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -1.147 . . . . 0.0 110.23 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.16 -9.42 5.66 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.68 HG22 HG22 ' A' ' 28' ' ' THR . 31.0 p -139.18 160.6 39.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 110.032 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.675 HD12 ' HB ' ' A' ' 55' ' ' VAL . 15.6 mm -84.59 159.45 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 109.92 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.543 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -126.25 173.33 9.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.093 -1.004 . . . . 0.0 110.55 -179.865 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.5 t80 -67.5 -50.77 35.53 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.322 -0.862 . . . . 0.0 111.135 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.3 Cg_endo -66.53 -39.51 16.15 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.254 1.134 . . . . 0.0 110.169 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE2' ' HB2' ' A' ' 64' ' ' ASP . 39.3 mt-10 -53.8 -39.62 65.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.527 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.73 -47.21 72.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 109.777 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 66' ' ' PRO . 18.3 mt -51.17 -30.41 16.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.997 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.9 m -93.89 -14.86 25.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.389 -0.819 . . . . 0.0 110.501 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.823 ' HG3' HG22 ' A' ' 55' ' ' VAL . 7.1 tmm? -73.18 -54.08 9.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.107 -0.995 . . . . 0.0 110.433 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.537 ' CE ' ' CE1' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -52.62 -18.12 1.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.816 . . . . 0.0 110.668 -179.604 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.45 -10.11 22.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.13 -0.981 . . . . 0.0 110.648 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.29 -34.6 9.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.119 -0.988 . . . . 0.0 110.447 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.755 ' HB3' HG21 ' B' ' 8' ' ' THR . 6.4 tptt -97.54 -49.77 4.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.204 -0.935 . . . . 0.0 110.405 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.615 ' HE3' ' CG ' ' B' ' 26' ' ' PHE . 4.2 mmm -77.33 54.29 1.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.355 -0.84 . . . . 0.0 110.562 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -102.25 -56.62 2.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.377 -0.827 . . . . 0.0 110.074 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 79' ' ' THR . 0.7 OUTLIER -178.36 -33.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 110.186 179.95 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -42.49 -45.81 4.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.969 . . . . 0.0 110.153 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.535 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 5.9 p-10 -144.68 70.24 1.28 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 109.807 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.1 p -109.42 -32.43 7.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.749 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 15.8 pt-20 -79.05 -37.34 39.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.372 -0.83 . . . . 0.0 109.884 179.567 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.501 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 1.1 pt-20 -72.64 -9.73 58.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 80' ' ' ASP . 13.8 mm-40 -79.12 -28.0 42.89 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.497 -0.752 . . . . 0.0 109.91 179.48 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.661 HG23 ' CE1' ' A' ' 141' ' ' PHE . 77.8 mt -62.93 -39.42 85.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.205 -0.934 . . . . 0.0 108.6 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -65.51 -28.53 69.25 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.766 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.4 -53.39 7.72 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.22 -32.39 71.08 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.33 -0.856 . . . . 0.0 108.935 178.845 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -72.88 -45.99 55.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.067 178.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -55.25 -23.78 24.4 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.535 -0.728 . . . . 0.0 109.135 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.829 HG12 HG21 ' A' ' 108' ' ' VAL . 22.8 t -78.59 -44.37 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.536 -0.728 . . . . 0.0 109.735 179.462 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.587 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 57.3 m-85 -65.68 -42.28 91.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.889 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.458 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 30.9 t0 -100.13 61.47 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.524 ' HA ' ' CE ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -54.31 -48.21 71.57 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.153 -0.967 . . . . 0.0 109.534 179.867 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 10.0 p-10 -54.97 -32.15 61.34 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.799 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.29 54.63 22.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.463 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 52.6 p30 -96.57 -5.43 39.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.245 -1.15 . . . . 0.0 110.101 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 99.45 13.13 39.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 2.6 m-85 -164.74 162.97 21.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.303 -1.116 . . . . 0.0 110.04 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.573 HD13 ' HB3' ' A' ' 92' ' ' PHE . 10.7 mt -119.67 132.63 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.234 -0.916 . . . . 0.0 110.414 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -116.08 153.25 32.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 110.126 179.957 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.2 -32.64 1.31 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.709 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.95 84.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.406 -0.809 . . . . 0.0 109.494 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 5.7 mt-10 -54.49 -50.58 67.45 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.324 -0.86 . . . . 0.0 109.404 179.364 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.5 ' HG ' HD11 ' A' ' 125' ' ' ILE . 3.6 mm? -57.9 -52.86 63.77 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.302 -0.873 . . . . 0.0 109.5 179.349 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -50.89 -26.57 6.0 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.213 -0.93 . . . . 0.0 109.016 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.598 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 26.3 t60 -79.27 -25.45 42.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.564 -0.71 . . . . 0.0 109.69 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.829 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -98.8 -30.74 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.694 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 109' ' ' MET . . . . . 1.009 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.2 OUTLIER -73.49 -51.7 16.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.394 -0.816 . . . . 0.0 110.196 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.7 m -68.94 -23.42 64.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 110.321 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 36.2 m-20 -86.85 -14.29 42.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 109.521 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.629 ' CD1' HG12 ' B' ' 13' ' ' VAL . 4.1 mt -89.24 -34.38 16.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -0.857 . . . . 0.0 110.106 179.672 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.22 -56.61 0.42 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.24 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.52 158.37 17.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.999 -1.295 . . . . 0.0 110.804 -179.338 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 1.2 pttt -135.52 76.17 1.6 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.533 -0.729 . . . . 0.0 109.251 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.696 HD21 ' HA ' ' B' ' 19' ' ' LYS . 4.6 mp -37.2 146.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.671 -0.643 . . . . 0.0 111.14 -179.332 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -54.58 -164.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 0.0 110.04 179.719 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 117' ' ' THR . 91.9 m-20 -83.86 -46.89 11.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.124 -0.985 . . . . 0.0 110.119 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -58.38 -53.06 62.58 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.74 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.658 ' HB3' HD23 ' A' ' 116' ' ' LEU . 67.8 mm-40 -52.85 -44.2 66.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.365 -0.834 . . . . 0.0 109.582 179.51 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 117' ' ' THR . 42.7 t -58.11 -51.19 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.851 . . . . 0.0 110.154 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -61.47 -56.38 20.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 109.88 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 1.8 mt-10 -52.65 -36.65 57.12 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.687 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.537 ' HE1' ' O ' ' B' ' 16' ' ' MET . 0.9 OUTLIER -55.28 -50.15 70.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.811 . . . . 0.0 110.098 179.718 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.5 HD11 ' HG ' ' A' ' 105' ' ' LEU . 37.1 mm -71.45 -46.0 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.22 -0.925 . . . . 0.0 110.321 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 127' ' ' GLU . 11.6 mmt180 -59.8 -55.32 35.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.26 -0.9 . . . . 0.0 110.446 -179.764 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.8 OUTLIER -43.69 -26.05 0.21 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 110.265 -179.958 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -98.59 -28.51 13.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.157 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.8 t70 -65.11 69.79 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.881 . . . . 0.0 110.371 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.6 mp -63.21 -35.77 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.471 179.66 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 35.7 p-10 -74.97 -23.74 58.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 179.668 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 72.93 57.87 5.07 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 1.9 p30 -110.04 -15.2 14.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.214 -1.168 . . . . 0.0 110.083 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 135' ' ' GLN . . . 106.68 -4.74 36.93 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 43.7 mt-30 -155.37 158.57 38.9 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.225 -1.162 . . . . 0.0 110.119 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 14.0 t -92.72 135.97 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 110.075 179.666 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.516 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 28.1 t-20 -106.72 173.21 6.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.156 -0.965 . . . . 0.0 110.416 -179.796 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -54.55 -49.88 69.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.856 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -52.99 -56.37 16.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.271 -0.893 . . . . 0.0 110.229 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 141' ' ' PHE . 48.4 mt-10 -54.22 -58.67 6.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.162 -0.962 . . . . 0.0 110.076 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.661 ' CE1' HG23 ' A' ' 85' ' ' ILE . 41.7 t80 -43.51 -27.39 0.28 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 109.739 179.648 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.838 ' O ' HG22 ' A' ' 146' ' ' THR . 46.9 t -91.81 -39.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 109.965 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 2.6 tt0 -57.91 -14.14 5.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.362 -0.837 . . . . 0.0 110.501 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.436 ' O ' ' HA2' ' B' ' 23' ' ' GLY . 2.5 mtp -107.3 -11.19 15.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.111 -0.993 . . . . 0.0 110.515 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.593 ' CE ' HD21 ' B' ' 12' ' ' LEU . 0.2 OUTLIER -99.91 -17.84 17.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.161 -0.962 . . . . 0.0 110.699 -179.708 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 142' ' ' VAL . 0.4 OUTLIER -122.56 21.63 10.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.163 -0.961 . . . . 0.0 110.346 -179.947 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -100.31 46.66 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 0.0 110.354 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.124 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.456 ' O ' HG22 ' B' ' 1' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.311 0.577 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -65.39 -86.01 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.311 -0.868 . . . . 0.0 110.382 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.414 ' O ' HD23 ' B' ' 3' ' ' LEU . 1.0 OUTLIER 61.59 37.74 15.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 110.574 179.829 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.448 HG23 ' HD2' ' B' ' 5' ' ' PRO . 19.6 mm -142.37 139.49 17.71 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.146 -0.971 . . . . 0.0 110.453 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.448 ' HD2' HG23 ' B' ' 4' ' ' ILE . 46.9 Cg_endo -73.81 164.64 34.16 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.062 1.559 . . . . 0.0 110.458 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -175.93 4.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.181 -0.949 . . . . 0.0 110.612 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 7' ' ' TRP . . . . . 0.718 ' O ' HG22 ' B' ' 10' ' ' VAL . 2.1 m95 -65.12 -76.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.643 0.735 . . . . 0.0 110.707 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.755 HG21 ' HB3' ' A' ' 75' ' ' LYS . 13.3 p -41.72 -25.83 0.06 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.13 -0.981 . . . . 0.0 110.591 -179.305 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.455 ' N ' ' O ' ' B' ' 7' ' ' TRP . 27.1 m -61.92 -61.68 2.32 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.01 -1.056 . . . . 0.0 109.318 178.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.718 HG22 ' O ' ' B' ' 7' ' ' TRP . 6.1 m -53.97 -27.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 109.037 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' B' ' 8' ' ' THR . 30.0 mm -74.3 -42.54 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.471 -0.768 . . . . 0.0 109.287 178.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.593 HD21 ' CE ' ' A' ' 145' ' ' MET . 0.5 OUTLIER -53.33 -60.61 3.07 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.647 -0.658 . . . . 0.0 110.053 179.855 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.629 HG12 ' CD1' ' A' ' 112' ' ' LEU . 69.3 t -56.51 -40.38 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.121 -0.987 . . . . 0.0 109.78 179.682 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.876 ' CD ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.32 -42.06 84.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.147 -0.971 . . . . 0.0 109.515 179.239 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -62.25 -31.51 72.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 109.552 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.537 ' O ' ' HE1' ' A' ' 124' ' ' MET . 0.7 OUTLIER -74.17 -27.03 60.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.497 -0.752 . . . . 0.0 109.87 179.694 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 1.009 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.3 mp -70.34 58.47 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.384 -0.822 . . . . 0.0 109.94 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.489 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 3.7 tpp180 -85.94 -70.93 0.56 Allowed 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.616 -0.677 . . . . 0.0 110.648 -179.637 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.696 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -165.48 -43.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.953 . . . . 0.0 110.216 -179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.674 ' N ' ' HG2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -162.5 3.73 0.05 OUTLIER 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.236 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.477 ' HB2' ' HE2' ' B' ' 19' ' ' LYS . 5.7 t -90.16 154.22 19.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.183 -0.948 . . . . 0.0 110.693 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.27 -42.3 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.367 -0.833 . . . . 0.0 109.958 179.535 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 144' ' ' MET . . . -59.34 104.05 0.49 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.509 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -102.48 105.86 46.06 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.114 -1.227 . . . . 0.0 110.658 -179.489 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.02 139.57 24.38 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.007 1.53 . . . . 0.0 109.524 179.286 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.615 ' CG ' ' HE3' ' A' ' 76' ' ' MET . 1.3 m-85 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.209 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 40.2 mt-30 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.256 0.551 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.1 mt -49.24 -52.19 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 110.391 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -50.61 -42.02 55.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 110.313 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 29.6 tt0 -59.3 -48.2 82.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -66.23 -41.61 89.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -55.21 -34.77 64.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.187 -0.945 . . . . 0.0 109.44 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 49.8 mt-10 -67.55 -49.19 64.45 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.396 -0.815 . . . . 0.0 109.533 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.513 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -62.57 -43.3 99.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.365 -0.835 . . . . 0.0 109.608 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.616 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 73.9 t80 -62.0 -26.53 68.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.354 -0.841 . . . . 0.0 109.408 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.45 -35.47 23.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.46 -0.775 . . . . 0.0 109.742 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -54.35 -46.13 72.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 109.623 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.552 ' CD1' HD12 ' A' ' 32' ' ' LEU . 63.4 m-85 -70.02 -48.59 57.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.244 -0.91 . . . . 0.0 110.1 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -66.3 66.26 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.384 -0.823 . . . . 0.0 109.958 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -41.89 -51.82 4.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.6 p-10 -72.89 -41.4 64.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 109.701 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.91 45.21 3.67 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 26' ' ' THR . 33.1 p30 -96.03 -4.85 42.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -1.196 . . . . 0.0 110.342 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 26' ' ' THR . . . 87.49 28.33 24.88 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.714 HG23 ' O ' ' A' ' 25' ' ' GLY . 11.7 p -160.03 111.3 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -1.154 . . . . 0.0 110.394 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.65 HD12 ' HB ' ' A' ' 63' ' ' ILE . 14.9 mt -78.66 124.91 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.048 -1.032 . . . . 0.0 109.707 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.441 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 1.2 p -100.17 -179.9 4.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.628 -0.67 . . . . 0.0 110.136 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -70.72 -33.99 71.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.727 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.89 -50.51 41.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 109.903 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' OE2' ' OG1' ' A' ' 28' ' ' THR . 57.8 mt-10 -51.36 -70.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.892 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.552 HD12 ' CD1' ' A' ' 19' ' ' PHE . 15.7 tp -51.24 -33.62 28.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.592 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -61.58 -41.33 99.55 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.0 m -61.04 -41.84 97.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.384 -1.068 . . . . 0.0 109.813 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.8 t -65.44 -46.49 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.294 -0.879 . . . . 0.0 109.705 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -19.68 65.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.062 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 1.2 ttp180 -91.48 -17.2 26.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.9 . . . . 0.0 110.053 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.89 -43.1 13.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 110.113 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.516 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -50.96 -26.4 5.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 110.337 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.65 35.99 0.94 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.44 -166.62 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -1.151 . . . . 0.0 110.348 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 1.9 t30 -149.08 97.75 3.59 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.855 . . . . 0.0 110.094 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.728 ' HA ' HD11 ' B' ' 4' ' ' ILE . 41.9 Cg_endo -68.18 149.17 76.1 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.904 1.476 . . . . 0.0 110.574 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 52.9 m -97.58 135.2 39.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.304 -0.873 . . . . 0.0 110.425 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -44.68 -44.99 9.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.184 -0.947 . . . . 0.0 110.196 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.27 -57.28 6.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 72.1 mm-40 -55.59 -47.68 76.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.897 . . . . 0.0 110.175 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -48.61 -62.6 1.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.986 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 tp60 -51.1 -44.02 61.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.428 -0.795 . . . . 0.0 109.942 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -64.96 -28.29 69.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.818 . . . . 0.0 109.644 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -49.44 16.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.449 -0.782 . . . . 0.0 109.832 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -70.36 -10.03 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -85.78 -19.41 30.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.409 -0.807 . . . . 0.0 109.698 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -57.02 6.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.389 -0.819 . . . . 0.0 110.104 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG23 ' CD1' ' B' ' 7' ' ' TRP . 18.5 t -69.75 -31.72 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.274 -0.891 . . . . 0.0 109.862 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.494 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -59.15 79.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.428 -0.795 . . . . 0.0 110.034 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.86 -21.95 60.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.802 . . . . 0.0 110.621 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -71.56 -38.83 70.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.048 -1.033 . . . . 0.0 110.434 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.21 12.93 32.42 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.1 p-10 -82.89 -44.48 15.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.395 -1.062 . . . . 0.0 110.528 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.33 11.27 9.86 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.493 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 14.2 p -138.56 143.32 39.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.354 -1.086 . . . . 0.0 109.869 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.65 ' HB ' HD12 ' A' ' 27' ' ' ILE . 15.8 mm -87.08 150.77 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.062 -1.023 . . . . 0.0 109.924 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.516 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 1.2 m-20 -129.74 165.03 22.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.14 -0.975 . . . . 0.0 110.981 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.622 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 14.5 t80 -50.81 -47.43 85.94 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.491 -0.756 . . . . 0.0 111.139 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -67.93 -40.88 8.56 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 O-C-N 123.176 1.093 . . . . 0.0 109.912 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.494 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -56.68 -29.89 62.83 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.193 -0.942 . . . . 0.0 108.857 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -66.91 -63.34 1.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.543 -0.723 . . . . 0.0 109.523 178.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -48.26 -22.21 0.63 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.274 -0.891 . . . . 0.0 109.968 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.5 m -100.59 -9.99 21.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.189 -0.944 . . . . 0.0 111.357 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.584 ' HB2' HG13 ' A' ' 55' ' ' VAL . 9.5 ptm -86.05 -43.52 13.04 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.799 -1.188 . . . . 0.0 110.554 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.553 ' N ' ' HG3' ' A' ' 71' ' ' MET . 89.3 mmm -65.34 -10.04 29.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.055 -1.028 . . . . 0.0 110.539 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.0 -10.54 21.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.074 -1.016 . . . . 0.0 111.043 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.409 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -98.75 -10.72 22.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.941 -1.1 . . . . 0.0 110.519 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.658 ' CB ' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.183 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.267 0.556 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -84.33 -21.57 30.91 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.501 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 14.8 pt-20 -73.17 -27.57 61.72 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.57 -0.706 . . . . 0.0 110.051 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.432 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 53.1 mt -73.98 -40.82 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.606 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -32.75 73.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 109.364 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.569 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 17.2 mt-10 -70.09 -56.58 6.54 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' B' ' 12' ' ' LEU . . . -48.85 -35.98 15.88 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.25 -0.906 . . . . 0.0 108.557 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 90' ' ' ARG . 26.8 t80 -62.72 -56.09 20.76 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.628 -0.67 . . . . 0.0 109.473 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -43.03 -47.32 5.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.578 -0.701 . . . . 0.0 109.425 179.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.912 HG11 HG11 ' B' ' 13' ' ' VAL . 41.2 t -51.08 -49.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.363 -0.836 . . . . 0.0 109.359 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.755 ' HB3' HD13 ' A' ' 100' ' ' ILE . 54.8 m-85 -68.85 -44.66 72.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 110.38 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.486 ' HA ' ' OE2' ' A' ' 104' ' ' GLU . 34.2 t0 -92.28 60.9 3.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.062 -1.024 . . . . 0.0 110.39 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.3 -46.84 62.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.284 -0.885 . . . . 0.0 110.301 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 6.5 p30 -66.04 -26.0 67.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.319 -0.863 . . . . 0.0 110.384 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 67.52 50.99 39.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -96.97 -18.41 19.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.191 -1.182 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.542 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 109.4 24.63 5.84 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -169.92 158.75 7.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -1.113 . . . . 0.0 110.139 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.755 HD13 ' HB3' ' A' ' 92' ' ' PHE . 34.4 mt -117.04 148.91 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.033 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 102' ' ' ALA . 19.3 t -127.75 146.73 50.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.958 . . . . 0.0 109.876 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.18 -29.54 0.25 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 109.975 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.68 -56.08 14.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.823 . . . . 0.0 109.598 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.486 ' OE2' ' HA ' ' A' ' 93' ' ' ASP . 15.7 mt-10 -53.54 -38.13 63.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 0.0 109.707 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.052 HD12 HD11 ' A' ' 125' ' ' ILE . 1.4 mt -69.87 -39.2 76.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.436 -0.79 . . . . 0.0 109.607 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.0 ttp85 -62.58 -34.17 76.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.304 -0.872 . . . . 0.0 109.415 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -66.49 -51.51 55.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.362 -0.836 . . . . 0.0 109.449 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.502 HG21 HG12 ' A' ' 91' ' ' VAL . 28.3 t -57.89 -37.42 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.524 -0.735 . . . . 0.0 109.506 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.889 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -52.1 -64.07 0.94 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.609 -0.682 . . . . 0.0 110.77 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.471 HG23 ' HG2' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -64.22 -15.35 59.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.516 ' OD1' ' HA ' ' A' ' 39' ' ' LEU . 0.9 OUTLIER -79.09 -19.63 50.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.016 . . . . 0.0 109.565 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' B' ' 14' ' ' LYS . 15.8 mt -107.28 -27.03 10.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.484 -0.76 . . . . 0.0 109.862 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.415 ' O ' ' HE3' ' A' ' 115' ' ' LYS . . . 147.57 -74.32 0.29 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.735 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.436 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 1.8 tt0 -71.68 149.0 45.91 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.241 -1.152 . . . . 0.0 111.332 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.471 ' HG2' HG23 ' A' ' 110' ' ' THR . 0.7 OUTLIER -130.48 81.98 2.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.522 -0.736 . . . . 0.0 109.302 179.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.664 HD21 ' O ' ' B' ' 19' ' ' LYS . 8.0 mp -36.71 143.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.588 -0.695 . . . . 0.0 111.083 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -58.02 -153.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 110.072 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.539 ' H ' HG22 ' A' ' 117' ' ' THR . 1.2 m-20 -98.8 -66.0 0.93 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.892 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' ASP . 15.1 mt-10 -44.39 -47.46 9.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.56 -54.8 43.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.369 -0.832 . . . . 0.0 109.317 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' A' ' 116' ' ' LEU . 39.1 t -55.47 -39.59 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 109.678 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.58 -44.52 86.41 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.375 -0.828 . . . . 0.0 109.719 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -70.59 -36.7 73.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.353 -0.842 . . . . 0.0 109.678 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.417 ' HG2' ' CE2' ' B' ' 22' ' ' PHE . 24.4 ttt -56.76 -37.45 71.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -0.826 . . . . 0.0 109.788 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.052 HD11 HD12 ' A' ' 105' ' ' LEU . 27.5 mm -82.38 -31.23 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 110.084 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -36.67 80.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 110.248 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -30.44 69.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.87 . . . . 0.0 110.061 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -82.96 -29.24 29.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 110.031 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 82.9 m-20 -63.68 72.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.908 . . . . 0.0 110.342 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 3.4 mt -58.05 -21.93 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 109.893 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 35.6 p-10 -98.78 -17.16 18.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.83 61.21 3.61 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 1.6 p30 -111.03 2.87 18.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -1.191 . . . . 0.0 110.098 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 85.32 -1.67 88.44 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 86.3 mt-30 -153.83 168.28 26.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.156 -1.202 . . . . 0.0 110.221 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.801 HG23 HG23 ' A' ' 125' ' ' ILE . 50.4 t -100.0 143.15 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -0.912 . . . . 0.0 110.075 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.5 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 32.7 t30 -111.2 -173.74 2.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 0.0 110.332 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -69.84 -52.86 21.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.348 -0.845 . . . . 0.0 110.5 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -45.24 -52.66 9.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -56.24 -58.89 6.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 110.022 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.421 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 20.4 t80 -46.39 -25.16 0.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 145' ' ' MET . 38.3 t -99.99 -54.03 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.299 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.77 -24.31 0.36 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.201 -0.937 . . . . 0.0 110.312 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmm -83.93 -23.83 30.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.266 -0.896 . . . . 0.0 110.313 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.735 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -100.16 -11.49 20.41 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.269 -0.894 . . . . 0.0 110.51 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 142' ' ' VAL . 82.4 p . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.744 HG23 ' HD2' ' B' ' 5' ' ' PRO . 5.6 mt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.956 0.408 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.744 ' HD2' HG23 ' B' ' 4' ' ' ILE . 42.6 Cg_endo -70.12 132.46 22.81 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.958 1.504 . . . . 0.0 110.112 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 12.3 p -69.46 -167.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.86 . . . . 0.0 110.799 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.727 ' O ' HG22 ' B' ' 10' ' ' VAL . 5.4 m95 -73.11 -77.71 0.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.536 -0.728 . . . . 0.0 110.707 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.658 HG21 ' CB ' ' A' ' 75' ' ' LYS . 20.5 p -40.87 -26.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.964 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.569 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 84.0 m -61.36 -63.55 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 110.001 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.727 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.6 m -50.79 -27.45 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.431 HG12 ' O ' ' B' ' 7' ' ' TRP . 15.0 mm -79.09 -24.79 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.468 -0.77 . . . . 0.0 109.327 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 1.4 mt -68.99 -49.76 55.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.576 -0.702 . . . . 0.0 110.087 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.912 HG11 HG11 ' A' ' 91' ' ' VAL . 97.5 t -67.53 -40.11 83.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.38 -0.825 . . . . 0.0 110.36 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.656 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -64.95 -45.74 84.48 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.918 -1.114 . . . . 0.0 109.506 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.461 ' HB3' ' ND2' ' B' ' 24' ' ' ASN . 4.7 t -57.67 -36.88 72.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.324 -0.86 . . . . 0.0 108.9 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' B' ' 13' ' ' VAL . 2.9 mmt -60.04 -34.47 73.43 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 108.833 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.889 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.3 mp -72.59 56.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.651 -0.655 . . . . 0.0 109.418 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -83.66 0.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.69 . . . . 0.0 110.289 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.664 ' O ' HD21 ' A' ' 116' ' ' LEU . 9.0 tmtt? -133.39 -85.03 0.45 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.61 -1.306 . . . . 0.0 110.387 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.534 ' N ' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -142.3 23.91 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.871 -1.143 . . . . 0.0 110.115 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.46 178.86 4.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.497 -0.752 . . . . 0.0 109.583 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.601 ' HZ ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -137.57 148.25 45.74 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.79 146.08 17.63 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.735 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 8.8 m120 -119.26 134.83 23.71 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.224 -1.162 . . . . 0.0 110.304 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 26' ' ' PHE . 46.0 Cg_endo -72.41 -44.38 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.024 1.539 . . . . 0.0 110.048 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' B' ' 25' ' ' PRO . 1.6 m-30 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.42 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 13.6 pt20 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.286 0.565 . . . . 0.0 109.836 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.7 mt -67.32 -29.76 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.464 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.51 -55.78 24.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.315 -0.866 . . . . 0.0 109.634 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.534 ' HG3' ' N ' ' A' ' 12' ' ' PHE . 13.1 pt-20 -56.94 -34.67 68.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 109.389 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.534 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 13.8 m-85 -73.6 -46.01 49.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.28 -0.888 . . . . 0.0 109.358 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 17' ' ' SER . 32.6 tptt -60.27 -44.07 95.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.287 -0.883 . . . . 0.0 109.212 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.32 -44.3 75.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.179 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.92 -56.69 18.94 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.42 -0.8 . . . . 0.0 109.531 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.548 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 15.2 t80 -55.81 -45.53 78.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.218 -0.926 . . . . 0.0 109.439 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -61.78 -38.49 88.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -0.76 . . . . 0.0 109.254 179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.573 ' O ' HD23 ' A' ' 18' ' ' LEU . 10.1 tt -59.09 -27.74 65.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.495 -0.753 . . . . 0.0 109.624 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CE1' HD22 ' A' ' 18' ' ' LEU . 4.7 m-85 -90.81 -49.87 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.95 76.99 1.67 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.5 -0.75 . . . . 0.0 110.228 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -52.27 -69.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.908 . . . . 0.0 110.183 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 6.8 p-10 -45.29 -29.19 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 54.83 6.04 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.467 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 2.0 p-10 -106.68 -34.17 7.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.179 -1.189 . . . . 0.0 110.185 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.56 7.79 6.1 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 32.0 p -141.85 117.62 10.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.217 -1.167 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.835 ' O ' HG22 ' A' ' 62' ' ' THR . 16.5 mt -76.87 128.67 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 110.336 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.603 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.5 OUTLIER -95.16 161.59 14.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.411 -0.806 . . . . 0.0 110.264 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.489 HG23 HG13 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -58.56 -39.23 79.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.0 110.4 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 31' ' ' GLU . 3.7 tmtt? -65.66 -52.87 48.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.0 110.275 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' LYS . 10.1 mt-10 -43.15 -61.37 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 109.903 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.7 tp -56.25 -37.98 70.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.92 . . . . 0.0 109.668 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.51 -40.29 98.5 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 m -58.34 -41.63 85.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -1.061 . . . . 0.0 109.625 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.18 -53.2 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.7 mtt -55.66 -31.13 62.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.207 -0.933 . . . . 0.0 109.731 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -74.27 -25.61 59.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 109.82 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.507 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -76.58 -47.36 22.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.209 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mt -56.31 -53.02 62.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 110.254 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.44 58.93 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.511 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 1.5 mm-40 -139.33 -169.76 2.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.158 -1.201 . . . . 0.0 110.233 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 13.7 m120 -143.85 75.85 15.78 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.25 -0.906 . . . . 0.0 110.438 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.574 ' HA ' HD11 ' B' ' 4' ' ' ILE . 47.3 Cg_endo -74.27 119.76 5.95 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.013 1.533 . . . . 0.0 110.274 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -76.36 154.31 35.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.283 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.34 -49.24 72.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.54 -54.3 47.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.321 -0.862 . . . . 0.0 110.143 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -56.64 -34.83 67.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -0.906 . . . . 0.0 110.042 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.0 mt -55.78 -54.3 46.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.063 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -31.0 69.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 109.775 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.12 -41.51 77.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 110.068 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.447 ' CE ' ' CD1' ' B' ' 7' ' ' TRP . 1.9 ttp -73.6 -38.93 64.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.245 -0.91 . . . . 0.0 110.023 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.489 HG13 HG23 ' A' ' 29' ' ' THR . 5.5 mm -66.18 -25.1 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.75 0.72 22.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.295 -0.878 . . . . 0.0 110.187 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.77 -13.18 25.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 110.079 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 57' ' ' ALA . 16.3 t -113.63 -35.12 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -45.44 89.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.474 -0.766 . . . . 0.0 110.371 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -85.63 -31.44 22.58 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.236 -0.915 . . . . 0.0 110.754 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 29.4 p-10 -83.13 -39.98 20.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.029 -1.044 . . . . 0.0 110.425 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 108.54 24.12 6.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' CG ' ' OD2' ' A' ' 58' ' ' ASP . 19.9 p-10 -95.12 -14.57 24.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -1.151 . . . . 0.0 110.177 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.82 -63.76 0.3 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.835 HG22 ' O ' ' A' ' 27' ' ' ILE . 1.3 p -76.54 165.02 25.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -1.115 . . . . 0.0 110.171 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.701 ' HB ' HD12 ' A' ' 27' ' ' ILE . 20.6 mm -90.81 149.8 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.548 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 24.6 t0 -115.3 162.36 17.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.933 . . . . 0.0 110.659 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.666 ' O ' HD12 ' A' ' 69' ' ' LEU . 74.3 t80 -49.23 -46.16 76.5 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 0.0 111.333 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -69.93 -39.63 5.97 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.285 1.15 . . . . 0.0 110.406 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.454 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 1.9 mt-10 -57.58 -27.07 62.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.965 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.729 ' CZ ' HD13 ' B' ' 11' ' ' ILE . 45.4 t80 -83.27 -40.99 18.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.374 -0.829 . . . . 0.0 110.411 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -67.62 -15.78 63.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.275 -0.891 . . . . 0.0 110.819 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 p -100.23 -41.19 7.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.059 -1.026 . . . . 0.0 110.924 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.438 ' HG2' ' HA ' ' A' ' 68' ' ' PHE . 3.3 ppp? -66.49 -34.45 77.96 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.27 -0.894 . . . . 0.0 111.227 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.633 ' HE2' ' CZ ' ' B' ' 26' ' ' PHE . 13.2 tpt -66.67 -9.4 35.62 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.128 -0.983 . . . . 0.0 111.077 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.6 -9.85 13.19 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.978 -1.076 . . . . 0.0 111.11 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -97.1 -32.79 11.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.98 -1.075 . . . . 0.0 110.741 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.648 ' HB3' HG21 ' B' ' 8' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.049 -1.032 . . . . 0.0 110.695 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.848 ' HA ' HD12 ' A' ' 85' ' ' ILE . 28.5 mt-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.165 0.507 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 36.1 mt-10 -66.95 -56.69 9.1 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.197 -0.94 . . . . 0.0 110.417 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 55.9 tt0 -53.07 -28.51 25.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -0.93 . . . . 0.0 110.508 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.848 HD12 ' HA ' ' A' ' 82' ' ' GLU . 72.9 mt -66.78 -28.35 42.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.133 -0.98 . . . . 0.0 109.21 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 3.9 ttt-85 -66.52 -30.26 70.55 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.641 -0.662 . . . . 0.0 109.539 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.749 ' HB3' HG21 ' B' ' 9' ' ' THR . 8.3 mt-10 -73.59 -48.99 28.52 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.343 -0.848 . . . . 0.0 109.496 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.441 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.62 -30.75 71.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -66.46 -49.91 65.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -31.49 69.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.383 -0.823 . . . . 0.0 109.544 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.496 HG11 HG21 ' B' ' 13' ' ' VAL . 11.6 t -61.06 -47.5 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.373 -0.829 . . . . 0.0 109.631 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.493 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 45.0 m-85 -67.96 -31.71 71.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.851 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 94' ' ' LYS . 7.2 t0 -80.77 55.35 2.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.2 -0.938 . . . . 0.0 110.173 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 93' ' ' ASP . 2.5 tmtt? -42.73 -32.28 0.58 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.33 -0.857 . . . . 0.0 110.538 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 4.8 p30 -90.08 -31.07 17.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.172 -0.955 . . . . 0.0 110.342 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 84.15 20.13 59.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 48.5 p30 -75.04 -15.33 60.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.042 -1.269 . . . . 0.0 109.97 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.568 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 92.79 33.17 7.56 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 33.5 m-85 -161.92 107.21 1.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -1.123 . . . . 0.0 110.233 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mt -69.19 124.98 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 110.11 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.56 161.94 17.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.973 . . . . 0.0 110.164 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.93 -37.28 66.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.101 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.5 -53.15 60.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.841 . . . . 0.0 110.033 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 24.0 mt-10 -56.19 -39.68 72.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.92 HD12 HD11 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -60.27 -38.5 83.76 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.301 -0.874 . . . . 0.0 109.486 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -36.78 82.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.556 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -64.99 -52.58 55.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 109.76 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.489 HG11 ' CE1' ' A' ' 92' ' ' PHE . 1.1 t -61.84 -28.58 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 109.159 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.769 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -67.51 -59.22 3.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.398 -0.814 . . . . 0.0 109.845 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -29.07 70.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.89 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 38' ' ' SER . 3.0 m120 -77.76 -6.52 54.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.422 -0.799 . . . . 0.0 110.064 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.566 ' CD1' HG12 ' B' ' 13' ' ' VAL . 12.7 mt -117.5 7.97 12.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -0.925 . . . . 0.0 110.869 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.16 -68.33 0.24 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.256 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 109' ' ' MET . 26.8 tt0 -92.03 161.91 14.58 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.046 -1.267 . . . . 0.0 111.532 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.0 OUTLIER -141.62 82.82 1.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.64 -0.663 . . . . 0.0 109.489 179.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.552 ' H ' HD12 ' A' ' 116' ' ' LEU . 6.3 mp -38.29 140.11 0.33 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.451 -0.781 . . . . 0.0 111.1 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.701 HG22 ' H ' ' A' ' 118' ' ' ASP . 2.6 m -52.24 -171.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.427 -0.796 . . . . 0.0 110.08 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.701 ' H ' HG22 ' A' ' 117' ' ' THR . 31.8 m-20 -83.21 -54.4 5.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 110.228 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -30.26 65.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 109.704 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.436 ' HG2' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -73.62 -52.9 11.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.211 -0.931 . . . . 0.0 108.929 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.421 HG22 ' CE ' ' A' ' 109' ' ' MET . 40.4 t -57.85 -34.67 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.423 -0.798 . . . . 0.0 109.466 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -62.17 -44.15 97.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.433 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 5.6 mm-40 -69.43 -29.15 66.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.399 -0.813 . . . . 0.0 109.519 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.623 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 10.2 ttt -65.94 -44.46 85.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.531 -0.731 . . . . 0.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.92 HD11 HD12 ' A' ' 105' ' ' LEU . 17.7 mm -75.98 -49.59 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.274 -0.891 . . . . 0.0 109.785 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -56.61 -47.83 78.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.89 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.5 mm-40 -61.73 -43.89 97.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.792 . . . . 0.0 109.917 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.25 -32.17 72.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.884 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.513 ' HB3' ' HA2' ' A' ' 132' ' ' GLY . 5.3 m-20 -71.6 100.69 2.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.384 -0.823 . . . . 0.0 110.051 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.445 HG13 ' OE1' ' A' ' 143' ' ' GLN . 40.0 mm -51.74 -36.53 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.217 -0.927 . . . . 0.0 110.243 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.416 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 17.3 p-10 -99.45 -25.1 14.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.295 -0.878 . . . . 0.0 110.383 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 69.62 51.91 23.3 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 5.7 p30 -85.46 -23.85 27.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.185 -1.185 . . . . 0.0 110.21 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 142.17 -10.26 2.51 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.28 166.58 10.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.028 -1.278 . . . . 0.0 110.698 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 140' ' ' GLU . 2.9 t -102.54 154.43 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.397 -0.814 . . . . 0.0 109.871 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.436 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 17.0 p-10 -123.27 -145.71 0.35 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.186 -0.946 . . . . 0.0 110.399 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.85 -68.81 0.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 110.618 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -45.3 -46.28 12.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.219 -0.926 . . . . 0.0 110.653 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.436 ' HB3' HG13 ' A' ' 136' ' ' VAL . 35.7 mt-10 -61.02 -57.08 14.09 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.462 ' CE2' HG23 ' A' ' 85' ' ' ILE . 71.0 t80 -50.74 -20.71 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 85' ' ' ILE . 73.2 t -93.9 -58.72 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.207 -0.933 . . . . 0.0 110.436 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.445 ' OE1' HG13 ' A' ' 130' ' ' ILE . 40.3 tt0 -42.12 -30.38 0.29 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.217 -0.927 . . . . 0.0 110.176 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.461 ' O ' ' N ' ' B' ' 24' ' ' ASN . 64.9 mtp -69.51 -30.96 68.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.052 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 142' ' ' VAL . 23.5 ttm -94.13 -28.66 15.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.355 -0.841 . . . . 0.0 110.391 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.408 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 73.2 p . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.411 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.851 HG23 ' HD2' ' B' ' 5' ' ' PRO . 12.0 mt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.853 0.359 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.851 ' HD2' HG23 ' B' ' 4' ' ' ILE . 42.5 Cg_endo -71.68 139.64 34.3 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.642 1.338 . . . . 0.0 110.24 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.534 ' O ' ' N ' ' B' ' 8' ' ' THR . 46.4 t -90.33 64.09 5.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.306 -0.871 . . . . 0.0 111.036 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.486 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.3 OUTLIER 51.3 -85.43 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.209 -0.932 . . . . 0.0 110.659 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.648 HG21 ' HB3' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -43.46 -40.55 3.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.158 -0.964 . . . . 0.0 109.657 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.749 HG21 ' HB3' ' A' ' 87' ' ' GLU . 84.3 m -51.3 -53.5 35.18 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.438 -0.789 . . . . 0.0 109.51 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' B' ' 5' ' ' PRO . 18.6 t -52.79 -38.56 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.342 -0.849 . . . . 0.0 109.632 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.729 HD13 ' CZ ' ' A' ' 68' ' ' PHE . 12.1 mt -73.48 -25.77 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.281 -0.887 . . . . 0.0 109.727 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -48.69 65.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.4 -0.813 . . . . 0.0 109.668 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.566 HG12 ' CD1' ' A' ' 112' ' ' LEU . 86.4 t -63.77 -48.18 87.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.5 -0.75 . . . . 0.0 110.449 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.43 ' HD2' ' O ' ' B' ' 14' ' ' LYS . 30.4 tptt -54.98 -39.24 68.79 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.956 -1.09 . . . . 0.0 109.599 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 1.7 t -59.45 -40.07 85.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 109.61 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.509 ' CE ' ' HG3' ' B' ' 25' ' ' PRO . 0.2 OUTLIER -64.71 -27.85 69.19 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.39 -0.819 . . . . 0.0 110.087 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.769 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.3 mp -76.0 60.37 1.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.406 -0.808 . . . . 0.0 110.23 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -133.01 67.7 1.53 Allowed 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.53 -0.731 . . . . 0.0 111.36 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.552 ' CD ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER 60.97 -62.71 0.07 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.395 0.617 . . . . 0.0 111.478 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' B' ' 18' ' ' ARG . 1.2 ptm180 -143.79 4.35 1.31 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 111.023 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' B' ' 18' ' ' ARG . 23.0 m -64.23 86.59 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.815 -1.178 . . . . 0.0 109.893 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.623 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -126.43 -10.57 6.31 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.341 -0.849 . . . . 0.0 110.526 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' B' ' 24' ' ' ASN . . . -110.61 122.2 6.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 144' ' ' MET . 9.3 t-20 40.74 77.43 0.43 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.403 -1.057 . . . . 0.0 110.839 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.509 ' HG3' ' CE ' ' B' ' 16' ' ' MET . 47.7 Cg_endo -77.36 -9.71 17.53 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.0 1.526 . . . . 0.0 110.143 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.633 ' CZ ' ' HE2' ' A' ' 72' ' ' MET . 72.2 m-85 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.213 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.296 0.569 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.2 mt -59.08 -48.85 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 110.122 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.6 -45.41 38.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.842 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 2.8 tt0 -57.25 -56.81 17.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.85 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 9.0 m-85 -53.95 -33.07 55.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.337 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 3.7 tttp -64.25 -43.08 96.0 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.328 -0.858 . . . . 0.0 109.199 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 16.0 mt-10 -53.41 -49.5 67.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 109.61 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . . . -64.99 -52.0 58.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.362 -0.836 . . . . 0.0 109.573 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.422 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 65.4 t80 -54.66 -40.83 69.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.601 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -71.82 -25.79 62.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.383 -0.823 . . . . 0.0 109.565 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.712 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.7 tt -62.42 -39.64 93.94 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.364 -0.835 . . . . 0.0 109.706 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.464 ' CD1' HD12 ' A' ' 32' ' ' LEU . 49.8 m-85 -86.06 -27.66 24.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.382 -0.824 . . . . 0.0 110.305 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 66.0 t0 -92.19 100.12 12.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.171 -0.956 . . . . 0.0 110.394 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.37 -70.31 0.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.031 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.3 p-10 -52.69 -21.61 4.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 110.049 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.5 37.24 93.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 19.8 p-10 -80.09 -36.49 35.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.108 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.577 ' C ' HG23 ' A' ' 26' ' ' THR . . . 128.51 25.55 1.03 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.577 HG23 ' C ' ' A' ' 25' ' ' GLY . 70.2 p -157.49 126.8 5.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.071 -1.252 . . . . 0.0 110.323 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.54 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 18.1 mt -97.55 122.12 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.141 -0.974 . . . . 0.0 110.015 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.8 p -90.46 175.86 6.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.811 . . . . 0.0 110.022 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.5 p -69.59 -28.92 66.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 110.175 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -77.11 -50.77 12.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.096 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -48.24 -67.44 0.27 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.321 -0.862 . . . . 0.0 109.916 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.464 HD12 ' CD1' ' A' ' 19' ' ' PHE . 22.5 tp -55.57 -43.62 76.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 109.794 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.43 -41.73 17.77 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.3 m -66.0 -54.87 20.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -1.066 . . . . 0.0 109.935 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 35' ' ' VAL . 16.0 t -49.4 -39.0 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 109.801 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.464 ' HG3' ' HG3' ' A' ' 43' ' ' PRO . 5.2 mmt -62.74 -46.67 87.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.849 . . . . 0.0 109.274 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -51.8 -27.24 11.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.394 179.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -50.1 47.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.849 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 mt -54.55 -31.11 55.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.041 -1.037 . . . . 0.0 110.331 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.32 2.64 2.92 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.945 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.484 ' HG2' HG12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -130.71 158.12 40.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.811 -1.405 . . . . 0.0 110.94 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 5.7 t-20 -123.15 98.73 41.5 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 110.094 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HG3' ' HG3' ' A' ' 36' ' ' MET . 43.0 Cg_endo -71.88 112.85 3.49 Favored 'Trans proline' 0 C--N 1.296 -2.232 0 O-C-N 124.148 1.604 . . . . 0.0 110.32 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.618 HG22 ' HG3' ' A' ' 47' ' ' GLU . 1.8 t -64.25 -166.59 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.677 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.447 ' N ' ' OG1' ' A' ' 44' ' ' THR . 0.1 OUTLIER -70.99 -60.94 1.96 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.424 -0.798 . . . . 0.0 110.219 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.56 -55.46 4.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.948 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.618 ' HG3' HG22 ' A' ' 44' ' ' THR . 2.2 mm-40 -55.68 -57.66 11.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.165 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 48' ' ' LEU . 17.6 mt -45.53 -65.02 0.6 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.342 -0.849 . . . . 0.0 110.357 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -50.54 -25.29 3.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 110.325 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.12 -39.17 55.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.976 . . . . 0.0 110.081 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.571 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 1.7 mmm -80.67 -32.11 36.13 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.286 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 mm -70.09 -36.77 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.073 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 56' ' ' ASP . 0.7 OUTLIER -54.19 -67.87 0.23 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.327 -0.858 . . . . 0.0 110.701 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 53' ' ' ASN . 27.1 mt-10 -41.17 -40.33 1.53 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.42 -0.8 . . . . 0.0 110.656 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.764 HG21 ' CD1' ' B' ' 7' ' ' TRP . 48.8 t -83.55 -16.29 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.928 . . . . 0.0 110.412 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASN . 33.7 t0 -66.04 66.78 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.551 ' HA ' ' NH2' ' A' ' 74' ' ' ARG . . . -41.74 -44.24 3.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.367 -0.833 . . . . 0.0 110.385 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' OE1' ' A' ' 67' ' ' GLU . 3.9 m-20 -80.49 -35.68 34.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.33 -0.856 . . . . 0.0 110.039 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.439 ' HA2' ' OD2' ' A' ' 56' ' ' ASP . . . 92.42 28.45 12.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 24.7 p30 -95.41 -32.63 12.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.327 -1.102 . . . . 0.0 110.318 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 62' ' ' THR . . . 117.12 30.96 1.81 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -157.53 147.57 20.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -1.192 . . . . 0.0 110.106 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 ' CG1' ' A' ' 55' ' ' VAL . 6.9 mm -97.39 124.84 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.335 -0.853 . . . . 0.0 110.14 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -107.76 169.84 8.35 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.233 -0.917 . . . . 0.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.622 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 11.0 t80 -58.69 -47.75 98.14 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.27 -0.894 . . . . 0.0 110.895 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.0 Cg_endo -68.09 -37.02 15.58 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 O-C-N 123.263 1.138 . . . . 0.0 109.648 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' A' ' 57' ' ' ALA . 5.1 tt0 -60.87 -34.07 74.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.029 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.527 ' O ' ' HG3' ' A' ' 71' ' ' MET . 5.7 t80 -63.83 -51.5 64.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.464 -0.773 . . . . 0.0 109.258 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 69' ' ' LEU . 6.2 mp -62.79 -15.2 52.74 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.247 -0.908 . . . . 0.0 109.419 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -90.81 -50.77 5.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 110.594 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.527 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -58.26 -24.97 61.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.054 -1.029 . . . . 0.0 109.68 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.471 ' N ' ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -65.53 -13.83 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 109.88 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.31 -14.76 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.551 ' NH2' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -86.81 -29.06 22.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.242 -0.911 . . . . 0.0 110.175 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HG2' HG21 ' B' ' 8' ' ' THR . 32.1 tptt . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.138 -0.976 . . . . 0.0 109.959 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 120.929 0.395 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 84' ' ' GLU . 6.9 pt-20 -76.18 -25.63 55.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.944 -1.098 . . . . 0.0 110.509 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 10.4 pt-20 -69.43 -37.21 77.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.157 -0.965 . . . . 0.0 110.31 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.509 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 20.6 mt -68.76 -37.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.108 -0.995 . . . . 0.0 109.011 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.67 -26.25 61.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' B' ' 9' ' ' THR . 1.1 mt-10 -73.16 -58.44 3.31 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.464 -0.773 . . . . 0.0 109.185 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.87 -29.17 62.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.026 . . . . 0.0 109.2 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 4.7 t80 -64.81 -49.27 71.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.317 -0.864 . . . . 0.0 109.127 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -33.37 42.53 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.492 -0.755 . . . . 0.0 109.241 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.788 HG11 HG21 ' B' ' 13' ' ' VAL . 41.3 t -72.61 -33.25 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.533 -0.729 . . . . 0.0 110.361 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.632 ' HB3' HD13 ' A' ' 100' ' ' ILE . 23.5 m-85 -75.29 -57.7 3.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.034 -1.041 . . . . 0.0 110.011 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 96' ' ' GLY . 20.6 t0 -84.53 53.41 2.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 110.437 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 93' ' ' ASP . 3.6 mtmt -46.39 -26.56 0.86 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.074 -1.016 . . . . 0.0 108.895 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 1.3 t0 -66.66 -35.55 80.43 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 67.37 35.29 87.23 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.49 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 33.2 p-10 -91.66 -24.12 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.043 -1.269 . . . . 0.0 109.741 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.544 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 120.65 15.93 4.75 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 2.9 m-85 -161.25 150.24 16.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.161 -1.199 . . . . 0.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 92' ' ' PHE . 9.7 mt -107.86 131.84 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.379 -0.826 . . . . 0.0 110.273 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 102' ' ' ALA . 20.2 p -115.13 145.94 41.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.111 -0.993 . . . . 0.0 110.008 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.1 -28.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.35 -0.844 . . . . 0.0 110.043 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -69.44 -51.28 37.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.295 -0.878 . . . . 0.0 109.619 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.16 -39.12 71.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.24 -0.913 . . . . 0.0 109.454 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.552 HD13 HD11 ' A' ' 125' ' ' ILE . 1.2 mt -70.07 -36.34 74.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.437 -0.79 . . . . 0.0 109.785 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 17.3 ttt85 -66.36 -29.87 70.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.744 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -76.36 -33.6 58.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.806 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.767 HG21 HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -79.85 -37.52 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.582 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.526 ' HG3' ' N ' ' A' ' 110' ' ' THR . 6.1 ptp -68.14 -36.48 79.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.526 ' N ' ' HG3' ' A' ' 109' ' ' MET . 68.1 m -70.18 -39.76 75.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.327 -0.858 . . . . 0.0 109.631 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -72.5 -14.48 61.67 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.355 -0.841 . . . . 0.0 109.437 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.732 HD11 HG12 ' B' ' 13' ' ' VAL . 10.1 mt -86.57 -46.86 9.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.403 -0.81 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.29 -9.88 0.83 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.836 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp10 -127.65 150.48 49.72 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.734 -1.45 . . . . 0.0 110.857 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 116' ' ' LEU . 2.2 mttp -132.2 74.58 1.59 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.421 -0.8 . . . . 0.0 109.454 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.68 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.4 mp -38.64 144.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 110.652 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -57.47 -144.61 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.559 -0.713 . . . . 0.0 110.57 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 117' ' ' THR . 8.2 m-20 -111.71 -38.58 4.83 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.019 -1.051 . . . . 0.0 111.212 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 4.8 pt-20 -70.87 -32.17 69.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.996 -1.065 . . . . 0.0 110.46 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.538 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 12.0 pt-20 -78.41 -40.47 35.9 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.13 -0.981 . . . . 0.0 109.4 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.625 HG23 ' HB3' ' A' ' 116' ' ' LEU . 9.7 t -63.37 -36.25 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.211 -0.931 . . . . 0.0 109.423 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.25 -48.4 65.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 0.0 109.434 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 2.3 mm-40 -63.25 -19.63 64.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.39 -0.819 . . . . 0.0 109.407 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.88 -56.95 4.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -0.836 . . . . 0.0 109.791 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.552 HD11 HD13 ' A' ' 105' ' ' LEU . 22.8 mm -61.5 -43.5 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 109.483 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -64.21 -37.54 87.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.436 -0.79 . . . . 0.0 110.007 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 17.2 tp10 -70.9 -15.64 62.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.783 . . . . 0.0 110.111 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -94.57 -42.04 9.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 110.358 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 135' ' ' GLN . 0.4 OUTLIER -56.03 80.59 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.442 -0.786 . . . . 0.0 110.361 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 128' ' ' ALA . 13.0 mt -50.31 -41.41 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.099 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 12.0 p-10 -80.39 -34.91 35.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.424 -0.798 . . . . 0.0 110.048 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.92 68.16 1.14 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 3.0 p30 -117.3 -14.15 10.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -1.202 . . . . 0.0 110.186 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.76 5.39 29.4 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 11.1 pt20 -170.05 169.26 8.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.225 -1.162 . . . . 0.0 110.445 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 26.0 t -100.34 159.1 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.212 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.568 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 57.5 t30 -128.63 173.3 10.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.257 -0.902 . . . . 0.0 110.243 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.492 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 38.4 t80 -55.71 -61.95 2.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 0.0 110.087 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.36 -31.73 15.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.43 -50.88 8.92 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.182 -0.949 . . . . 0.0 110.248 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.573 ' CE1' ' CD2' ' A' ' 92' ' ' PHE . 63.3 t80 -54.93 -17.78 4.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.995 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 146' ' ' THR . 14.7 t -97.4 -36.68 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 0.0 110.261 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -11.47 60.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.21 -0.931 . . . . 0.0 110.425 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.487 ' HE3' ' HB3' ' A' ' 144' ' ' MET . 17.8 mmm -91.75 -25.69 18.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.174 -0.954 . . . . 0.0 110.267 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.465 ' SD ' HG12 ' A' ' 85' ' ' ILE . 6.5 mtp -98.79 -30.28 12.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.226 -0.921 . . . . 0.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 142' ' ' VAL . 35.0 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.833 HG23 ' HD2' ' B' ' 5' ' ' PRO . 10.6 mt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.006 0.432 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.833 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.5 Cg_endo -66.71 -164.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 124.06 1.558 . . . . 0.0 110.996 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.429 ' C ' ' SD ' ' A' ' 51' ' ' MET . 0.1 OUTLIER -115.65 -148.89 0.44 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.311 -0.868 . . . . 0.0 110.797 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.764 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -91.7 -74.49 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 110.778 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.464 HG21 ' HG2' ' A' ' 75' ' ' LYS . 14.3 p -44.28 -43.25 7.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 110.094 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 87' ' ' GLU . 17.1 m -45.18 -54.03 7.43 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 109.777 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.03 -38.66 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.247 -0.908 . . . . 0.0 109.343 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.504 ' N ' HD13 ' B' ' 11' ' ' ILE . 5.3 mm -67.72 -39.27 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.361 -0.837 . . . . 0.0 109.957 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' B' ' 9' ' ' THR . 12.7 mt -52.63 -56.09 17.82 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.347 -0.845 . . . . 0.0 109.958 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.788 HG21 HG11 ' A' ' 91' ' ' VAL . 73.4 t -54.51 -54.7 19.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 110.33 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.515 ' O ' HD22 ' B' ' 17' ' ' LEU . 3.7 tptt -55.71 -41.67 74.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.809 -1.182 . . . . 0.0 109.71 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 17.8 t -72.91 -6.0 42.27 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 109.865 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.579 ' SD ' ' CD1' ' B' ' 22' ' ' PHE . 35.0 tpp -83.97 -45.13 13.48 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.256 -0.902 . . . . 0.0 110.138 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.734 HD13 ' H ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -96.06 33.67 1.68 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 118.383 -1.327 . . . . 0.0 110.234 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.415 ' HG2' ' N ' ' B' ' 19' ' ' LYS . 1.5 ttt85 -42.5 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.49 0.662 . . . . 0.0 109.992 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.586 ' HD2' ' CG ' ' B' ' 20' ' ' ARG . 2.9 tmtm? -103.69 -84.66 0.47 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.141 -0.974 . . . . 0.0 110.387 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.586 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.4 OUTLIER -146.1 12.41 1.24 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.697 -1.252 . . . . 0.0 110.021 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.53 174.06 6.04 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.351 -0.843 . . . . 0.0 110.775 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.579 ' CD1' ' SD ' ' B' ' 16' ' ' MET . 0.2 OUTLIER -130.32 66.15 1.51 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.47 -0.769 . . . . 0.0 110.061 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.29 -173.97 13.24 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.447 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 0.4 OUTLIER -176.71 118.59 0.28 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.369 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -79.74 35.69 0.58 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.829 1.437 . . . . 0.0 111.216 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.432 ' CD1' ' OD1' ' B' ' 24' ' ' ASN . 8.3 m-85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.901 -1.125 . . . . 0.0 110.388 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.237 0.542 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.9 mt -55.7 -54.45 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.191 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.72 -48.63 10.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.166 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.98 -49.01 74.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -0.926 . . . . 0.0 110.048 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.438 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 20.9 m-30 -63.69 -40.53 97.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.915 . . . . 0.0 110.112 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -54.91 -52.23 63.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.769 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 9.3 tp10 -60.04 -30.55 69.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.543 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -69.28 -50.47 46.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.466 -0.771 . . . . 0.0 110.155 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.474 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 16.9 t80 -63.15 -36.93 85.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.607 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.2 m -75.36 -15.32 60.48 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.331 -0.856 . . . . 0.0 109.4 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.859 HD11 ' O ' ' A' ' 112' ' ' LEU . 7.8 tt -74.21 -48.27 30.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.449 -0.782 . . . . 0.0 110.096 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.549 ' HB3' HG23 ' A' ' 27' ' ' ILE . 54.5 m-85 -69.57 -47.37 63.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.293 -0.879 . . . . 0.0 109.988 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 4.4 t0 -57.55 95.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.13 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 8.2 mmtp -52.44 -56.08 17.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.175 -0.953 . . . . 0.0 110.15 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 18.6 p-10 -76.62 -33.78 58.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.84 . . . . 0.0 110.328 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 95.06 41.34 4.06 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 32.3 p-10 -97.09 8.98 43.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.153 -1.204 . . . . 0.0 110.308 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 26' ' ' THR . . . 74.07 38.28 47.98 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 25' ' ' GLY . 21.7 p -156.52 111.38 2.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.173 -1.192 . . . . 0.0 110.293 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.848 HD12 HG21 ' A' ' 63' ' ' ILE . 17.5 mt -86.85 123.14 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.085 -1.009 . . . . 0.0 110.365 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -100.43 164.87 11.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.4 -0.812 . . . . 0.0 109.543 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.556 HG21 ' NE2' ' A' ' 49' ' ' GLN . 18.7 p -65.75 -25.11 67.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.984 -1.073 . . . . 0.0 109.885 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.36 -45.0 49.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 109.994 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 35' ' ' VAL . 46.6 mt-10 -63.25 -66.16 0.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 109.992 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 tp -47.74 -45.03 28.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 110.06 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.28 -54.89 9.5 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 59.3 m -61.08 -36.32 79.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -1.055 . . . . 0.0 110.036 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 31' ' ' GLU . 19.3 t -62.69 -43.94 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.92 . . . . 0.0 110.084 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.428 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 12.5 mmm -66.48 -28.72 68.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.283 -0.886 . . . . 0.0 110.041 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 tpt85 -72.5 -29.43 63.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.324 -0.86 . . . . 0.0 110.245 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -58.39 -48.9 79.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 110.555 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.643 HD23 HG23 ' A' ' 108' ' ' VAL . 2.6 mt -57.25 -23.47 48.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.182 -0.949 . . . . 0.0 110.2 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.403 ' O ' ' OE1' ' A' ' 41' ' ' GLN . . . 106.34 70.87 0.76 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.403 ' OE1' ' O ' ' A' ' 40' ' ' GLY . 13.7 mm100 -153.26 -172.14 4.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.233 -1.157 . . . . 0.0 110.153 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.05 78.88 45.91 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.207 -0.933 . . . . 0.0 110.533 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HG3' ' HB2' ' A' ' 36' ' ' MET . 44.0 Cg_endo -72.22 135.69 25.33 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.074 1.565 . . . . 0.0 110.228 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.1 m -97.98 146.1 25.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -0.927 . . . . 0.0 110.237 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -49.42 -47.55 47.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.15 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.47 -48.21 74.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.951 . . . . 0.0 110.193 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.22 -32.79 74.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.951 . . . . 0.0 110.247 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 48' ' ' LEU . 8.9 mt -61.07 -51.04 70.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 110.406 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.556 ' NE2' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -62.92 -36.91 84.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.336 -0.852 . . . . 0.0 110.203 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -71.15 -32.05 68.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 109.871 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.635 ' CE ' ' CD1' ' B' ' 7' ' ' TRP . 3.9 mmm -69.47 -36.03 76.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 109.965 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.895 HG12 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -89.69 -12.05 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.626 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.67 -37.17 72.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.0 110.254 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.04 -32.48 15.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.409 -0.807 . . . . 0.0 110.464 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.78 HG12 HD12 ' A' ' 63' ' ' ILE . 15.6 t -69.74 -31.51 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.093 -1.005 . . . . 0.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 57' ' ' ALA . 42.4 t0 -76.84 49.41 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.127 -0.983 . . . . 0.0 110.217 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -44.05 -29.82 0.65 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 110.377 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 2.7 t0 -61.93 -61.83 2.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.725 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.18 25.19 3.92 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 54.8 p30 -99.04 -14.62 19.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.943 -1.327 . . . . 0.0 110.112 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 105.75 -34.42 5.78 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.515 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 12.7 p -106.44 161.06 14.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.157 -1.202 . . . . 0.0 110.414 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.895 HD11 HG12 ' A' ' 52' ' ' ILE . 25.6 mm -86.44 144.29 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.295 -0.878 . . . . 0.0 110.578 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 6.7 t70 -122.25 165.42 16.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.489 -0.757 . . . . 0.0 110.046 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.616 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 14.8 t80 -59.07 -43.35 97.24 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.235 -0.916 . . . . 0.0 111.625 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.4 Cg_endo -72.82 -30.31 11.53 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.37 1.194 . . . . 0.0 110.555 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 64' ' ' ASP . 17.0 mt-10 -68.64 -44.39 74.25 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.081 -1.012 . . . . 0.0 109.534 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CD1' ' HE3' ' A' ' 71' ' ' MET . 33.9 t80 -61.02 -45.23 95.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 0.0 110.036 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.6 -36.28 75.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.192 -0.942 . . . . 0.0 110.421 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -71.79 -26.91 62.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.249 -0.907 . . . . 0.0 110.576 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.593 ' HE2' HG22 ' A' ' 55' ' ' VAL . 2.2 tmm? -71.5 -62.26 1.47 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 110.555 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -20.47 1.14 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.222 -0.924 . . . . 0.0 110.157 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.4 -21.69 20.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.191 -0.943 . . . . 0.0 110.268 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtt85 -98.36 -20.07 17.38 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.194 -0.941 . . . . 0.0 110.503 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.575 ' HG2' HG21 ' B' ' 8' ' ' THR . 1.9 tptm . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.933 . . . . 0.0 109.927 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.097 0.475 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' O ' ' OE2' ' A' ' 87' ' ' GLU . 3.9 pt-20 -84.79 -9.74 57.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.142 -0.973 . . . . 0.0 110.469 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.49 -27.36 25.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.084 -1.01 . . . . 0.0 110.088 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.618 HD13 HG21 ' A' ' 146' ' ' THR . 5.3 mt -73.25 -38.0 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.082 -1.011 . . . . 0.0 109.024 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -57.2 -31.46 65.49 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.451 ' HB3' HG23 ' B' ' 9' ' ' THR . 0.5 OUTLIER -67.69 -58.89 3.87 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.556 -0.715 . . . . 0.0 109.293 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.17 -30.09 48.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 109.426 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -74.34 -31.49 62.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -0.888 . . . . 0.0 109.216 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.47 -22.42 64.56 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.534 -0.729 . . . . 0.0 109.467 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.783 HG12 HG21 ' A' ' 108' ' ' VAL . 23.6 t -91.12 -28.75 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 0.0 110.476 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.649 ' HB3' HD13 ' A' ' 100' ' ' ILE . 4.0 m-85 -77.92 -30.05 50.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.076 -1.015 . . . . 0.0 109.964 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -96.36 63.27 2.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.315 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ASP . 5.6 mmpp? -41.12 -28.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.512 -0.742 . . . . 0.0 110.079 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.5 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 7.9 m-20 -82.96 -39.47 21.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.357 -0.839 . . . . 0.0 109.686 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 77.23 26.61 61.41 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 95' ' ' ASP . 5.9 p-10 -86.65 -44.18 12.05 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -1.22 . . . . 0.0 109.931 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.591 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 143.62 27.61 0.13 Allowed Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.827 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 41.3 m-85 -161.2 136.92 7.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.924 -1.339 . . . . 0.0 110.174 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.649 HD13 ' HB3' ' A' ' 92' ' ' PHE . 11.1 mt -101.0 123.24 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.257 -0.902 . . . . 0.0 109.969 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 61.8 p -105.19 140.61 38.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.38 -34.81 0.87 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.383 -0.823 . . . . 0.0 109.999 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.6 -51.04 70.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.855 . . . . 0.0 109.761 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.421 ' CD ' ' OD2' ' A' ' 95' ' ' ASP . 11.7 mt-10 -57.08 -43.1 81.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.78 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.819 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -58.94 -37.35 76.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.768 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 1.8 ttt-85 -61.35 -37.38 83.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -63.82 -44.32 93.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.459 -0.775 . . . . 0.0 109.808 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.783 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -82.62 -28.67 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.442 -0.786 . . . . 0.0 109.284 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.623 ' HA ' HD21 ' B' ' 17' ' ' LEU . 31.7 ttm -65.51 -57.06 9.15 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.578 -0.701 . . . . 0.0 110.14 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.682 HG23 ' HB3' ' A' ' 115' ' ' LYS . 5.8 m -67.53 -32.4 73.16 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.248 -0.907 . . . . 0.0 110.316 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 6.4 m120 -76.81 1.79 16.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.002 -1.061 . . . . 0.0 109.29 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.888 ' CD1' HG12 ' B' ' 13' ' ' VAL . 7.0 mt -111.75 4.37 18.41 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.372 -0.83 . . . . 0.0 110.601 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.76 -75.97 0.41 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.609 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp10 -94.6 154.27 17.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -1.133 . . . . 0.0 111.099 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.682 ' HB3' HG23 ' A' ' 110' ' ' THR . 1.3 pttm -129.45 74.43 1.58 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.641 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.9 mp -34.27 154.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.391 0.615 . . . . 0.0 110.965 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.81 -144.23 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.299 -0.876 . . . . 0.0 110.097 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -108.53 -59.34 1.88 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.218 -0.926 . . . . 0.0 110.139 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -48.87 -45.24 40.75 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.069 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.31 -50.58 73.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.89 . . . . 0.0 109.924 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.605 HG22 ' CE ' ' A' ' 109' ' ' MET . 43.5 t -57.64 -38.26 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.86 -45.61 70.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.902 . . . . 0.0 109.796 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 1.8 tt0 -64.84 -23.18 67.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.456 -0.778 . . . . 0.0 109.89 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.42 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 1.8 ttt -73.06 -43.79 61.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.843 . . . . 0.0 109.945 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.819 HD11 ' CD1' ' A' ' 105' ' ' LEU . 45.0 mm -69.93 -42.13 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 110.185 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 33.9 mtt-85 -66.25 -44.55 83.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.266 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 7.6 mm-40 -48.19 -32.15 6.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.392 -0.818 . . . . 0.0 110.25 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -100.69 -30.57 11.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 110.162 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -56.72 83.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.343 -0.848 . . . . 0.0 110.613 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -65.28 -42.35 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.9 p-10 -70.68 -33.5 70.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 109.844 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 87.02 56.55 2.17 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 25.7 p30 -112.98 0.12 14.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -1.211 . . . . 0.0 109.864 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.455 ' C ' ' HG3' ' A' ' 135' ' ' GLN . . . 76.71 -1.72 61.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.478 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 33.0 mt-30 -139.55 138.52 36.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.142 -1.21 . . . . 0.0 110.25 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 125' ' ' ILE . 20.2 t -89.37 154.74 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.108 -0.995 . . . . 0.0 109.724 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.45 ' OD1' ' HG3' ' A' ' 139' ' ' GLU . 55.9 p30 -130.09 -142.32 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 110.581 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.71 -68.58 0.69 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.391 -0.818 . . . . 0.0 110.697 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -46.74 -25.06 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.23 -0.919 . . . . 0.0 110.792 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 38.0 mt-10 -83.13 -61.09 1.95 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.008 . . . . 0.0 109.726 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.515 ' CE1' HG23 ' A' ' 85' ' ' ILE . 35.4 t80 -51.23 -19.52 1.25 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 110.29 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 144' ' ' MET . 55.5 t -100.93 -70.21 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.264 -0.898 . . . . 0.0 111.455 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.52 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -39.74 -24.73 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.103 -0.998 . . . . 0.0 111.787 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.52 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 77.7 mmm -88.62 -39.25 14.21 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.745 -1.222 . . . . 0.0 111.395 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.39 -9.69 21.96 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.989 -1.069 . . . . 0.0 111.895 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.618 HG21 HD13 ' A' ' 85' ' ' ILE . 1.3 p . . . . . 0 N--CA 1.491 1.617 0 O-C-N 120.721 -1.237 . . . . 0.0 111.06 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.987 HD13 ' HD2' ' B' ' 5' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.987 ' HD2' HD13 ' B' ' 4' ' ' ILE . 38.5 Cg_endo -65.9 -155.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.825 1.434 . . . . 0.0 110.176 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.424 ' O ' HG23 ' B' ' 10' ' ' VAL . 6.6 m -121.94 -147.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.933 -1.104 . . . . 0.0 111.333 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.764 ' CD1' HG21 ' A' ' 55' ' ' VAL . 4.8 m95 -81.91 -76.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.547 0.689 . . . . 0.0 111.282 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.575 HG21 ' HG2' ' A' ' 75' ' ' LYS . 30.2 p -43.86 -42.82 5.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.811 . . . . 0.0 110.3 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.525 HG21 ' CB ' ' B' ' 5' ' ' PRO . 53.6 m -46.29 -41.41 13.13 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 109.292 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 6' ' ' SER . 46.2 t -69.32 -41.06 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.359 -0.838 . . . . 0.0 109.863 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.5 ' N ' HD13 ' B' ' 11' ' ' ILE . 5.6 mm -72.76 -25.69 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.248 -0.907 . . . . 0.0 109.874 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.636 HD13 ' CD2' ' B' ' 26' ' ' PHE . 1.3 mm? -65.97 -53.41 39.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.694 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.888 HG12 ' CD1' ' A' ' 112' ' ' LEU . 53.2 t -61.02 -48.9 86.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.152 -0.968 . . . . 0.0 109.766 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -35.69 43.17 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.844 -1.16 . . . . 0.0 108.965 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 5.3 t -65.24 -34.85 79.33 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.514 -0.741 . . . . 0.0 109.365 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.421 ' HG3' ' CE1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -57.32 -43.81 83.65 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.401 -0.812 . . . . 0.0 109.518 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 109' ' ' MET . 4.1 mp -58.16 -94.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 109.688 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 58.15 -76.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.518 -0.739 . . . . 0.0 110.6 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER 175.63 107.59 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.887 -0.508 . . . . 0.0 110.842 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.7 OUTLIER 40.16 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.464 -0.773 . . . . 0.0 110.947 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.518 ' N ' ' O ' ' B' ' 19' ' ' LYS . 2.2 m -107.62 141.16 39.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.983 -1.073 . . . . 0.0 110.29 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.605 ' HE2' HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -142.21 12.67 1.99 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.196 -0.94 . . . . 0.0 110.208 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' B' ' 24' ' ' ASN . . . -77.96 -61.44 2.53 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 145' ' ' MET . 1.8 m-80 55.4 69.06 2.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.3 -1.118 . . . . 0.0 110.068 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.45 62.47 4.43 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 O-C-N 123.967 1.509 . . . . 0.0 110.04 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.636 ' CD2' HD13 ' B' ' 12' ' ' LEU . 1.1 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.189 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.226 0.536 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.5 mp -54.07 -39.58 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.45 -51.82 65.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.484 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -48.91 -49.11 41.53 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.363 -0.835 . . . . 0.0 109.256 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -60.59 -44.79 95.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.386 -0.821 . . . . 0.0 109.345 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 10.6 tptm -57.26 -36.6 71.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.368 -0.833 . . . . 0.0 109.227 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -52.56 64.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.604 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.61 -41.88 64.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 0.0 109.492 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 31.8 t80 -65.62 -43.66 88.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.491 -0.756 . . . . 0.0 109.509 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -69.87 -25.35 63.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 109.615 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.692 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.3 tt -67.47 -42.29 83.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.447 -0.783 . . . . 0.0 109.798 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.515 ' HA ' HG21 ' A' ' 35' ' ' VAL . 24.9 m-85 -73.16 -39.22 65.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 109.762 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -62.94 89.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.412 -0.805 . . . . 0.0 110.226 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -88.33 30.66 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.224 -0.922 . . . . 0.0 110.133 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 9.4 p-10 -143.65 -41.53 0.29 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.241 -0.912 . . . . 0.0 110.325 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 102.93 90.94 2.17 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.1 p-10 -164.07 -43.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.195 -1.179 . . . . 0.0 110.409 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.4 17.65 6.53 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -143.85 119.52 10.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.194 -1.18 . . . . 0.0 110.351 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 5.9 mt -82.09 115.97 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.083 -1.011 . . . . 0.0 109.943 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 9.0 p -80.35 -174.29 4.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.678 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.0 -49.88 26.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.159 -0.963 . . . . 0.0 110.179 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' GLU . 4.8 ttmt -68.32 -40.9 81.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.484 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.2 mt-10 -43.98 -48.78 8.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.13 -0.981 . . . . 0.0 109.594 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.608 HD23 HD21 ' A' ' 48' ' ' LEU . 24.0 tp -71.39 -34.52 70.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.314 -0.867 . . . . 0.0 109.366 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -59.45 -46.81 93.32 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 99.5 m -58.71 -54.35 48.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -1.094 . . . . 0.0 109.159 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 31' ' ' GLU . 16.8 t -56.76 -35.47 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.37 -0.831 . . . . 0.0 109.363 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.0 mmt -63.56 -49.56 72.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.461 -0.774 . . . . 0.0 109.697 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -54.09 -30.46 48.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.876 . . . . 0.0 109.5 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.446 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 1.3 m -54.96 -50.17 69.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.439 -0.788 . . . . 0.0 110.132 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.1 mt -52.15 -36.64 52.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.109 -0.995 . . . . 0.0 109.673 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 117.45 64.87 0.33 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 40' ' ' GLY . 6.3 mt-30 -156.81 -166.28 2.06 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.227 -1.161 . . . . 0.0 110.376 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -126.6 82.0 67.51 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.224 -0.922 . . . . 0.0 110.667 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.9 102.58 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.908 1.478 . . . . 0.0 110.438 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.511 ' CG2' ' HG3' ' A' ' 47' ' ' GLU . 11.4 t -79.63 172.09 14.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.187 -0.946 . . . . 0.0 110.084 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -78.78 -25.67 44.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.158 -0.964 . . . . 0.0 110.482 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.09 -65.43 0.7 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.034 -1.041 . . . . 0.0 110.178 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HG3' ' CG2' ' A' ' 44' ' ' THR . 0.9 OUTLIER -52.7 -44.96 66.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 109.879 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.608 HD21 HD23 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -50.96 -42.94 60.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.907 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -45.64 92.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.423 -0.798 . . . . 0.0 109.8 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.76 -13.97 62.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 110.062 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.617 ' HE1' ' CA ' ' B' ' 7' ' ' TRP . 2.4 mmm -94.26 -46.37 7.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.52 HG13 HD11 ' A' ' 63' ' ' ILE . 1.2 tp -60.69 -37.96 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.242 -0.911 . . . . 0.0 110.035 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.408 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.8 OUTLIER -51.11 -29.78 14.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 110.284 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -65.24 -56.33 13.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.024 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.668 HG22 ' HG3' ' A' ' 71' ' ' MET . 15.2 t -70.78 -14.49 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.126 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.4 77.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 110.384 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.551 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . . . -56.9 -63.81 1.08 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 0.0 110.32 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 7.0 p-10 -66.4 -43.9 84.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.97 . . . . 0.0 110.191 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.68 41.09 1.64 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 34.9 p-10 -99.51 -42.72 6.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.093 -1.239 . . . . 0.0 110.27 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 136.23 -14.34 4.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 22.0 p -118.36 160.89 20.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.135 -1.215 . . . . 0.0 110.538 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.52 HD11 HG13 ' A' ' 52' ' ' ILE . 8.0 mm -97.85 152.63 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 109.905 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.453 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 2.0 m-20 -131.57 148.22 52.6 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.188 -0.945 . . . . 0.0 110.535 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.911 ' O ' HD12 ' A' ' 69' ' ' LEU . 37.6 t80 -40.58 -51.22 6.8 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.281 -0.887 . . . . 0.0 111.172 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.9 Cg_endo -66.09 -33.07 42.14 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.325 1.171 . . . . 0.0 110.04 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.551 ' HG2' ' CB ' ' A' ' 57' ' ' ALA . 3.2 mt-10 -69.84 -30.03 67.42 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.312 -0.868 . . . . 0.0 109.467 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.678 ' HZ ' HG23 ' B' ' 11' ' ' ILE . 56.8 t80 -65.54 -54.71 24.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.468 -0.77 . . . . 0.0 109.978 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.911 HD12 ' O ' ' A' ' 65' ' ' PHE . 1.3 mp -53.6 -48.75 68.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.383 -0.823 . . . . 0.0 110.066 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -27.99 69.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 110.247 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.668 ' HG3' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -61.88 -60.41 3.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.42 -0.8 . . . . 0.0 111.023 -179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.648 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 41.1 mmm -51.5 -16.51 0.61 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.101 -1.0 . . . . 0.0 111.076 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.73 -9.37 54.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.808 -1.182 . . . . 0.0 110.452 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -95.78 -42.62 8.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.094 -1.004 . . . . 0.0 111.375 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.614 ' CB ' HG21 ' B' ' 8' ' ' THR . 4.8 mmtp . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.088 -1.007 . . . . 0.0 111.04 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HG2' ' OG1' ' A' ' 146' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.067 0.461 . . . . 0.0 110.593 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.456 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -59.84 -15.37 20.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.05 -1.032 . . . . 0.0 109.919 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.537 ' HG2' ' CD2' ' B' ' 12' ' ' LEU . 10.8 tt0 -68.63 -33.83 74.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.497 -0.752 . . . . 0.0 110.561 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.542 ' CD1' ' HB ' ' A' ' 146' ' ' THR . 49.9 mt -60.61 -30.53 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.214 -0.929 . . . . 0.0 109.174 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -63.41 -33.57 75.83 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.737 -0.602 . . . . 0.0 110.21 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.874 ' HB3' HG21 ' B' ' 9' ' ' THR . 1.2 mp0 -73.25 -48.06 37.98 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.105 -0.997 . . . . 0.0 109.901 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -60.83 -27.68 68.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.032 . . . . 0.0 109.948 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.582 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 64.4 t80 -70.21 -49.13 53.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.929 -1.107 . . . . 0.0 108.949 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -52.12 -30.19 25.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.484 -0.76 . . . . 0.0 109.078 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.658 HG12 HG21 ' A' ' 108' ' ' VAL . 40.8 t -69.34 -47.79 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.498 -0.751 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.575 ' HB3' ' CD1' ' A' ' 100' ' ' ILE . 52.2 m-85 -62.4 -43.48 98.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.917 -1.115 . . . . 0.0 110.263 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -68.41 58.03 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 0.0 110.096 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 92' ' ' PHE . 7.2 tttm -40.89 -62.53 0.8 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 110.515 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 30.2 p-10 -63.64 -41.43 98.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.207 -0.933 . . . . 0.0 110.214 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 100.07 40.36 3.08 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 30.6 p-10 -99.08 -21.07 16.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.233 -1.157 . . . . 0.0 110.265 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.56 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 101.36 33.87 4.69 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.56 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 53.3 m-85 -159.22 149.27 19.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.312 -1.111 . . . . 0.0 110.113 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 11.5 mt -116.55 153.78 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.125 -0.985 . . . . 0.0 110.543 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 102' ' ' ALA . 12.0 t -145.8 154.18 41.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.437 -0.789 . . . . 0.0 109.76 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.42 -28.81 0.6 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.955 . . . . 0.0 110.083 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.5 -51.34 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.803 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 92' ' ' PHE . 21.1 mt-10 -58.77 -35.91 73.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.879 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.026 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -65.16 -41.15 94.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.611 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.457 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 1.5 tpp180 -64.33 -24.13 67.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -79.28 -31.68 43.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.45 -0.781 . . . . 0.0 110.217 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.658 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -85.4 -30.62 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.266 -0.897 . . . . 0.0 109.995 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.689 ' HA ' HD21 ' B' ' 17' ' ' LEU . 5.0 ptp -74.41 -40.9 61.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.525 ' N ' ' HG3' ' A' ' 109' ' ' MET . 93.9 m -71.62 -23.45 61.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.134 -0.979 . . . . 0.0 109.62 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 38' ' ' SER . 22.3 m-20 -84.98 -8.48 58.72 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.194 -0.941 . . . . 0.0 109.848 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.692 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.4 mt -97.78 -38.29 9.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 110.316 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.74 -26.99 1.18 Allowed Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.586 -1.292 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 109' ' ' MET . 21.1 tt0 -113.56 166.02 11.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.887 -1.361 . . . . 0.0 110.826 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -146.12 72.19 1.29 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.493 -0.754 . . . . 0.0 109.234 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 116' ' ' LEU . 2.9 mp -36.47 148.09 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.466 0.65 . . . . 0.0 111.16 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -56.46 -157.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.524 -0.735 . . . . 0.0 110.01 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 117' ' ' THR . 0.3 OUTLIER -95.47 -68.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.03 -1.044 . . . . 0.0 110.312 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -43.5 -46.27 6.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.012 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -59.79 -52.11 66.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.714 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 117' ' ' THR . 83.0 t -60.18 -38.26 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 0.0 110.175 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -66.27 -63.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.0 109.875 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 122' ' ' ASP . 13.3 mm-40 -46.11 -26.57 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.365 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.705 ' HE2' ' CD2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.44 -55.12 17.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.499 -0.751 . . . . 0.0 110.183 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.026 HD11 ' CD1' ' A' ' 105' ' ' LEU . 44.5 mm -62.85 -22.58 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.414 -0.804 . . . . 0.0 110.244 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.408 ' C ' ' HD3' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -81.43 -38.98 25.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.194 -0.941 . . . . 0.0 110.158 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.34 -7.04 33.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 110.057 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.905 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -112.89 -32.09 6.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.19 -0.944 . . . . 0.0 110.334 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.452 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -54.94 83.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.313 -0.867 . . . . 0.0 110.513 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 128' ' ' ALA . 0.9 OUTLIER -61.67 -28.94 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 0.0 109.461 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD2' ' CD ' ' A' ' 140' ' ' GLU . 6.3 m-20 -85.53 -25.24 26.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.611 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.68 57.59 7.87 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 18.2 p-10 -120.88 -28.15 4.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -1.126 . . . . 0.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.404 ' C ' ' OE1' ' A' ' 135' ' ' GLN . . . 126.37 9.04 4.69 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.154 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.486 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 1.6 pm0 -165.14 166.86 18.73 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.931 -1.335 . . . . 0.0 110.381 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 24.1 t -110.1 168.42 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 110.413 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.466 ' N ' HG12 ' A' ' 136' ' ' VAL . 13.7 t-20 -141.91 173.34 11.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.382 -0.824 . . . . 0.0 109.694 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 139' ' ' GLU . 12.3 t80 -53.31 -56.89 13.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.107 -0.996 . . . . 0.0 109.965 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 2.8 tt0 -44.08 -47.87 8.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.429 ' CD ' ' OD2' ' A' ' 131' ' ' ASP . 51.4 mt-10 -69.51 -57.09 5.66 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.319 -0.863 . . . . 0.0 110.324 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 45.7 t80 -51.96 -19.76 1.99 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.291 -0.881 . . . . 0.0 110.326 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.957 HG13 HG21 ' A' ' 146' ' ' THR . 44.6 t -97.86 -43.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.212 -0.93 . . . . 0.0 110.483 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -65.32 -9.89 28.2 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.041 -1.037 . . . . 0.0 110.146 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.496 ' HE2' ' CD1' ' A' ' 130' ' ' ILE . 2.2 ttm -92.8 -37.96 12.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.669 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.46 -62.17 1.28 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.211 -0.93 . . . . 0.0 111.198 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.957 HG21 HG13 ' A' ' 142' ' ' VAL . 15.2 t . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.151 -0.968 . . . . 0.0 111.151 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.768 HG23 ' HD2' ' B' ' 5' ' ' PRO . 81.5 mt . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 120.767 0.318 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.768 ' HD2' HG23 ' B' ' 4' ' ' ILE . 49.5 Cg_endo -74.78 -157.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 124.148 1.604 . . . . 0.0 109.403 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.546 ' CB ' ' OG1' ' B' ' 9' ' ' THR . 0.2 OUTLIER -123.47 -175.04 3.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.975 -1.078 . . . . 0.0 110.648 179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 1.007 ' O ' HG22 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -80.35 -79.1 0.15 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.565 -0.709 . . . . 0.0 111.094 -179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.858 ' O ' HD13 ' B' ' 12' ' ' LEU . 6.6 p -45.16 -23.74 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.866 -1.146 . . . . 0.0 110.043 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.874 HG21 ' HB3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -63.46 -60.19 3.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.072 -1.017 . . . . 0.0 109.154 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 1.007 HG22 ' O ' ' B' ' 7' ' ' TRP . 32.9 m -48.89 -28.36 2.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.736 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.678 HG23 ' HZ ' ' A' ' 68' ' ' PHE . 6.8 mm -79.77 -33.8 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.858 HD13 ' O ' ' B' ' 8' ' ' THR . 4.2 mp -60.39 -60.96 2.99 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.673 -0.642 . . . . 0.0 109.989 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.576 ' O ' HD13 ' B' ' 17' ' ' LEU . 78.6 t -60.14 -38.88 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -67.53 -21.78 65.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.83 -1.168 . . . . 0.0 110.214 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.44 -36.68 33.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.516 ' HG2' ' HA ' ' B' ' 13' ' ' VAL . 0.2 OUTLIER -75.19 -20.65 59.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.226 -0.921 . . . . 0.0 110.255 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.689 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.3 mp -75.69 1.83 13.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.177 -0.952 . . . . 0.0 110.514 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' B' ' 17' ' ' LEU . 14.2 ttm180 -35.61 -69.71 0.1 Allowed 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.208 0.527 . . . . 0.0 110.782 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -154.0 -69.1 0.14 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.084 -1.01 . . . . 0.0 110.362 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.555 ' HA ' ' HG3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -133.42 12.29 4.15 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 109.841 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 4.5 t -80.84 142.41 33.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.421 -0.799 . . . . 0.0 110.175 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.705 ' CD2' ' HE2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -143.88 -33.8 0.41 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.343 -0.848 . . . . 0.0 110.411 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.486 ' HA2' ' HG2' ' A' ' 144' ' ' MET . . . -64.9 -100.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -112.56 101.66 53.01 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.207 -1.172 . . . . 0.0 110.543 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.15 -18.9 12.47 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.126 1.593 . . . . 0.0 110.215 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.648 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 34.9 m-85 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.362 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.307 0.575 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mt -66.28 -35.86 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.82 88.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -0.892 . . . . 0.0 109.834 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 33.2 tp10 -64.62 -52.41 57.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.611 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -56.11 -31.19 63.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -37.33 83.33 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.302 -0.874 . . . . 0.0 109.211 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 17.0 mm-40 -58.33 -48.85 79.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.438 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.09 -51.56 69.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 109.648 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.613 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 25.4 t80 -52.58 -28.31 20.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -28.1 38.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.422 -0.799 . . . . 0.0 109.885 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.8 tt -63.66 -43.32 97.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.893 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.21 -41.0 50.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.41 -0.806 . . . . 0.0 110.333 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.74 100.03 2.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.039 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -86.13 -29.0 23.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.146 -0.971 . . . . 0.0 110.168 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.5 -33.35 54.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.12 12.49 58.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 29.7 p-10 -83.91 -27.83 28.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -1.177 . . . . 0.0 110.23 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' HG23 ' A' ' 26' ' ' THR . . . 102.99 37.71 3.08 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.551 HG23 ' C ' ' A' ' 25' ' ' GLY . 81.9 p -153.02 113.13 3.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.383 -1.069 . . . . 0.0 110.139 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.687 HD12 ' HB ' ' A' ' 63' ' ' ILE . 30.5 mt -82.83 116.24 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.42 176.27 6.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.6 p -63.41 -35.52 80.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 110.06 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.19 -56.33 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 110.295 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 30' ' ' LYS . 44.4 mt-10 -43.35 -64.8 0.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.166 -0.959 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.76 -37.15 75.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 109.938 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.77 -42.82 91.89 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 m -62.29 -47.69 83.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -1.17 . . . . 0.0 110.017 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 t -55.69 -29.74 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.688 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -31.57 60.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.916 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.14 -18.01 58.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 110.101 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.7 m -77.3 -51.48 10.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.46 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.71 -18.26 29.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.126 -0.984 . . . . 0.0 110.171 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.25 69.96 0.97 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.497 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 5.3 mm-40 -142.23 -162.74 1.46 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.278 -1.13 . . . . 0.0 109.831 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -159.58 88.46 2.0 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.128 -0.982 . . . . 0.0 110.767 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.46 127.47 13.3 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.095 1.577 . . . . 0.0 110.039 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 46' ' ' ALA . 6.2 t -86.36 30.29 0.71 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.124 -0.985 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 44' ' ' THR . 0.3 OUTLIER 67.05 -57.37 0.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 110.302 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 44' ' ' THR . . . -51.34 -40.02 58.24 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.324 -0.86 . . . . 0.0 109.927 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.53 -52.42 39.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.698 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.56 -57.52 3.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 110.064 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.5 mm-40 -55.74 -47.89 76.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.73 -36.65 72.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.456 -0.778 . . . . 0.0 109.759 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 mtp -75.86 -47.03 27.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.433 -0.792 . . . . 0.0 109.534 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.6 mm -66.06 -30.11 48.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.416 -0.802 . . . . 0.0 109.972 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.4 m-80 -72.26 -16.61 61.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.181 -0.95 . . . . 0.0 110.029 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -87.48 -49.35 7.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 110.377 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.784 HG22 ' SD ' ' A' ' 71' ' ' MET . 21.9 t -72.25 -13.74 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.114 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.06 79.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.089 -1.007 . . . . 0.0 110.264 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -63.88 -39.37 94.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.666 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 37.8 p-10 -93.73 -32.12 14.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.16 -0.962 . . . . 0.0 110.793 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 97.61 38.71 4.11 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -99.81 -8.96 23.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -1.13 . . . . 0.0 110.322 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.44 -1.55 82.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 24.4 p -138.76 146.35 41.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -1.201 . . . . 0.0 110.376 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.719 HD12 ' CG1' ' A' ' 55' ' ' VAL . 48.4 mm -77.54 138.38 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.34 -0.85 . . . . 0.0 110.33 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 9.1 t0 -111.43 169.31 8.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 110.792 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 15.9 t80 -55.08 -45.46 99.84 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.35 -0.844 . . . . 0.0 111.41 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.4 Cg_endo -71.12 -46.36 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.233 1.122 . . . . 0.0 110.166 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 71' ' ' MET . 29.3 mt-10 -56.97 -33.77 67.41 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 109.87 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CZ ' HD13 ' B' ' 11' ' ' ILE . 47.1 t80 -67.65 -56.08 10.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.184 -0.948 . . . . 0.0 110.633 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 65' ' ' PHE . 1.2 mp -51.65 -61.5 2.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.358 -0.839 . . . . 0.0 110.995 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.5 m -51.92 -58.37 6.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.33 -0.856 . . . . 0.0 111.35 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.784 ' SD ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -43.74 -68.9 0.16 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.164 -0.96 . . . . 0.0 111.372 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.621 ' SD ' HG22 ' B' ' 8' ' ' THR . 7.7 mmm -37.8 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.257 -0.902 . . . . 0.0 110.908 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' MET . . . -92.81 -41.46 10.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.092 -1.005 . . . . 0.0 111.271 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -67.21 -19.16 65.51 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.905 -1.122 . . . . 0.0 110.771 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HB3' HG21 ' B' ' 8' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.044 -1.035 . . . . 0.0 110.257 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.279 0.562 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 9.6 tt0 -68.24 -42.87 79.08 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.256 -0.903 . . . . 0.0 109.312 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.496 ' HG3' HG13 ' A' ' 85' ' ' ILE . 3.2 pt-20 -52.87 -26.98 16.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.513 -0.742 . . . . 0.0 110.246 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.496 HG13 ' HG3' ' A' ' 84' ' ' GLU . 81.6 mt -79.15 -47.94 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.961 -1.087 . . . . 0.0 109.02 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -63.12 -30.54 71.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.361 -0.837 . . . . 0.0 108.804 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.487 ' OE1' ' OG1' ' B' ' 9' ' ' THR . 51.7 mt-10 -73.05 -49.48 28.42 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.74 ' HB2' HD13 ' B' ' 12' ' ' LEU . . . -57.14 -36.35 70.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.335 -0.853 . . . . 0.0 109.423 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 7.2 t80 -67.46 -43.99 79.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.937 . . . . 0.0 109.397 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -35.69 50.71 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.434 -0.791 . . . . 0.0 109.236 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.609 HG12 HG21 ' A' ' 108' ' ' VAL . 4.0 t -67.53 -41.52 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.744 ' CE1' HG11 ' A' ' 108' ' ' VAL . 28.5 m-85 -74.19 -33.21 63.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.958 . . . . 0.0 109.957 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.532 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -81.26 58.15 3.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.883 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -39.58 -62.82 0.64 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 110.492 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.2 p-10 -66.47 -38.61 87.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.327 -0.858 . . . . 0.0 110.284 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.66 52.47 3.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -99.15 -13.34 19.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.333 -1.098 . . . . 0.0 110.136 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 105.78 20.37 9.47 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 13.9 m-85 -158.35 157.4 32.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -1.083 . . . . 0.0 109.906 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 6.1 mt -120.02 135.28 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.075 -1.015 . . . . 0.0 110.448 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 p -121.06 154.01 36.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.64 -34.05 4.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.31 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.31 96.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.532 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 23.1 mt-10 -60.95 -47.52 86.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 110.065 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.832 HD12 HD11 ' A' ' 125' ' ' ILE . 1.1 mt -61.5 -35.66 78.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.279 -0.888 . . . . 0.0 109.495 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 109' ' ' MET . 8.2 ttp180 -55.94 -43.02 77.03 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.312 -0.868 . . . . 0.0 109.044 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.66 -57.8 11.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.475 -0.766 . . . . 0.0 109.724 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.744 HG11 ' CE1' ' A' ' 92' ' ' PHE . 2.5 t -60.64 -21.87 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.398 -0.814 . . . . 0.0 109.855 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 1.022 ' HA ' HD21 ' B' ' 17' ' ' LEU . 4.0 mtt -64.32 -65.01 0.73 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.294 -0.879 . . . . 0.0 110.921 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.0 m -63.97 -9.44 15.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 0.0 110.455 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -95.94 -1.57 48.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.107 -0.996 . . . . 0.0 110.782 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.846 ' CD1' HG12 ' B' ' 13' ' ' VAL . 11.9 mt -133.22 -0.19 3.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 111.8 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.97 -90.5 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.113 -1.518 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.419 ' HG2' HD12 ' A' ' 116' ' ' LEU . 1.4 pm0 -116.41 -176.85 3.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -1.063 . . . . 0.0 110.573 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -127.09 17.3 7.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.281 -0.887 . . . . 0.0 110.291 179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.9 HD23 ' HG2' ' A' ' 120' ' ' GLU . 4.7 mp 50.17 174.77 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.674 -0.642 . . . . 0.0 110.287 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -87.85 -166.29 1.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.989 . . . . 0.0 109.873 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.454 ' H ' HG22 ' A' ' 117' ' ' THR . 23.4 t70 -80.84 -51.96 8.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.827 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 2.1 mt-10 -61.08 -41.33 96.44 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.581 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.9 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.3 OUTLIER -62.2 -44.25 97.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.326 -0.859 . . . . 0.0 109.664 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 117' ' ' THR . 39.2 t -62.06 -46.32 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -66.07 -40.13 90.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.706 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 0.6 OUTLIER -64.52 -33.58 76.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.822 . . . . 0.0 109.548 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.606 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 3.0 ttt -64.85 -41.62 95.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.399 -0.813 . . . . 0.0 109.921 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.832 HD11 HD12 ' A' ' 105' ' ' LEU . 14.5 mm -84.45 -17.59 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.005 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -76.03 -39.42 55.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 110.064 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.527 ' N ' ' HD2' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -69.04 -23.5 64.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.455 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . -95.86 -24.68 16.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.17 -0.957 . . . . 0.0 110.703 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -72.24 80.6 0.99 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.084 -1.01 . . . . 0.0 110.679 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 mt -82.32 -20.65 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 0.0 109.552 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 1.1 p30 -94.46 -13.72 25.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.406 -0.809 . . . . 0.0 109.78 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.03 80.93 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 12.1 p-10 -139.36 7.02 2.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.334 -1.098 . . . . 0.0 110.16 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 74.55 14.12 81.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.463 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 0.9 OUTLIER -164.81 164.58 21.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.316 -1.108 . . . . 0.0 110.187 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 22.9 t -106.45 169.77 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.112 -0.992 . . . . 0.0 109.7 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.469 ' N ' HG12 ' A' ' 136' ' ' VAL . 9.1 t-20 -128.34 179.64 5.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.155 -0.966 . . . . 0.0 110.351 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.577 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 9.1 t80 -62.54 -56.27 19.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.84 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -44.74 -60.36 2.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 110.123 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 137' ' ' ASN . 53.9 mt-10 -44.63 -46.33 10.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.4 t80 -58.26 -28.9 65.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 139' ' ' GLU . 9.4 t -100.41 -33.85 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -0.792 . . . . 0.0 110.705 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 2.8 tp60 -73.22 -9.43 58.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.05 -1.031 . . . . 0.0 110.595 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.465 ' O ' ' O ' ' B' ' 23' ' ' GLY . 30.0 mtp -106.55 -18.63 13.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 110.813 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' B' ' 23' ' ' GLY . 20.7 ttm -99.92 -54.51 2.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.127 -0.983 . . . . 0.0 110.637 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 146' ' ' THR . 10.2 t . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.229 -0.92 . . . . 0.0 110.444 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.696 HG23 ' HD2' ' B' ' 5' ' ' PRO . 33.6 mm . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.696 ' HD2' HG23 ' B' ' 4' ' ' ILE . 39.5 Cg_endo -65.49 -172.47 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.578 1.304 . . . . 0.0 110.856 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.493 ' O ' ' N ' ' B' ' 8' ' ' THR . 57.0 p -119.76 60.54 0.85 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.059 -1.025 . . . . 0.0 111.394 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.626 ' CE2' HG21 ' A' ' 55' ' ' VAL . 1.0 OUTLIER 58.06 -82.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.039 -1.038 . . . . 0.0 110.864 178.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.671 HG23 ' HE1' ' A' ' 71' ' ' MET . 1.0 OUTLIER -46.14 -46.13 17.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.487 ' OG1' ' OE1' ' A' ' 87' ' ' GLU . 22.3 m -46.61 -35.79 6.26 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.227 -0.92 . . . . 0.0 109.914 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.21 -41.41 58.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.477 -0.765 . . . . 0.0 109.547 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.569 HD12 ' HG2' ' A' ' 72' ' ' MET . 12.5 mt -72.26 -20.19 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 109.637 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.74 HD13 ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -72.6 -59.96 2.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.369 -0.832 . . . . 0.0 109.735 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.846 HG12 ' CD1' ' A' ' 112' ' ' LEU . 43.4 t -56.02 -41.7 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.717 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.504 ' HG3' HD13 ' A' ' 18' ' ' LEU . 1.6 tmtm? -62.29 -43.97 97.61 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.88 -1.138 . . . . 0.0 109.568 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' B' ' 12' ' ' LEU . 14.5 m -53.0 -35.59 59.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.58 -0.7 . . . . 0.0 110.041 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.531 ' SD ' ' CD1' ' B' ' 22' ' ' PHE . 0.1 OUTLIER -70.67 -34.3 71.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.946 . . . . 0.0 109.951 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 1.022 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.5 mp -71.5 57.2 0.26 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.25 -0.906 . . . . 0.0 110.02 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -114.73 -86.28 0.6 Allowed 'General case' 0 C--N 1.278 -2.507 0 O-C-N 121.406 -0.809 . . . . 0.0 110.679 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' B' ' 20' ' ' ARG . 0.6 OUTLIER -153.77 94.9 1.82 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.791 -1.193 . . . . 0.0 110.53 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' B' ' 19' ' ' LYS . 10.3 tmm_? 64.67 7.0 3.52 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.437 -0.79 . . . . 0.0 110.407 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' B' ' 25' ' ' PRO . 0.1 OUTLIER -69.24 138.27 53.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.296 -0.877 . . . . 0.0 110.923 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.606 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -176.29 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 144' ' ' MET . . . -64.39 -80.87 0.13 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -142.05 75.27 20.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.092 -1.24 . . . . 0.0 110.406 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.482 ' HB3' ' OG ' ' B' ' 21' ' ' SER . 50.6 Cg_endo -79.66 11.7 2.64 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.053 1.554 . . . . 0.0 110.716 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.493 ' HE1' ' HE3' ' A' ' 72' ' ' MET . 3.9 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.33 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.259 0.552 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 mt -56.96 -46.75 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.838 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.69 -45.95 74.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.683 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -42.26 97.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 109.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -66.54 -43.61 84.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.712 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -60.21 -40.58 90.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.603 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 1.6 mm-40 -61.98 -43.41 98.9 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.219 -0.925 . . . . 0.0 109.556 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.71 -47.48 69.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.881 . . . . 0.0 109.836 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.543 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 75.0 t80 -63.45 -40.42 97.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.613 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.9 t -72.82 -28.04 62.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 0.0 109.52 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.635 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.1 tt -62.97 -41.06 99.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 109.657 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.795 ' HA ' HG21 ' A' ' 35' ' ' VAL . 27.0 m-85 -78.27 -10.88 59.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -0.793 . . . . 0.0 110.76 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 6.5 t0 -102.36 114.88 29.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.037 -1.039 . . . . 0.0 110.321 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.518 ' N ' ' OE2' ' A' ' 31' ' ' GLU . 5.3 tptp -97.52 29.24 3.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.261 -0.9 . . . . 0.0 110.524 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -153.68 -38.85 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.082 -1.011 . . . . 0.0 110.368 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 89.84 47.22 4.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -104.45 2.51 31.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.291 -1.123 . . . . 0.0 110.199 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.844 ' O ' HG23 ' A' ' 26' ' ' THR . . . 73.36 33.82 58.35 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -169.25 120.58 0.72 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.269 -1.136 . . . . 0.0 110.222 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.647 HD12 ' HB ' ' A' ' 63' ' ' ILE . 28.7 mt -97.56 124.47 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.172 -0.955 . . . . 0.0 110.189 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -84.68 -171.56 3.7 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.389 -0.819 . . . . 0.0 110.206 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.486 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -78.0 -34.09 50.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.882 . . . . 0.0 109.937 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -48.83 19.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.289 -0.882 . . . . 0.0 110.042 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 21' ' ' LYS . 43.2 tt0 -45.33 -59.76 2.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.91 . . . . 0.0 109.608 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.735 HD13 ' CH2' ' B' ' 7' ' ' TRP . 10.8 tp -60.76 -34.95 75.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.535 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.06 86.7 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.5 m -65.9 -51.07 61.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.344 -1.092 . . . . 0.0 109.543 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.795 HG21 ' HA ' ' A' ' 19' ' ' PHE . 48.9 t -52.54 -41.99 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.206 -0.934 . . . . 0.0 109.452 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.528 ' HE1' ' CE ' ' A' ' 51' ' ' MET . 4.8 mtt -64.74 -37.54 87.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.38 -0.825 . . . . 0.0 109.42 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -30.8 68.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.159 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.5 m -61.54 -34.01 74.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.9 . . . . 0.0 110.446 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mt -82.39 -3.11 54.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 110.224 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 86.57 86.07 1.07 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 0.8 OUTLIER -167.14 175.06 7.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -1.143 . . . . 0.0 110.143 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 11.7 p30 -139.63 84.31 15.96 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 0.0 110.291 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 44.0 Cg_endo -70.46 105.48 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.055 1.555 . . . . 0.0 110.496 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.449 ' HB ' ' OE2' ' A' ' 47' ' ' GLU . 8.9 m -61.18 150.82 33.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 110.058 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -49.43 -51.49 35.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.072 -1.018 . . . . 0.0 110.225 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.62 88.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.356 -0.84 . . . . 0.0 110.205 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -65.06 -50.98 64.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.0 110.211 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -50.33 -48.88 55.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -57.7 -36.81 72.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 5.5 m-20 -65.85 -46.98 76.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 109.949 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.57 ' HG3' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -67.93 -36.68 80.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.945 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 52' ' ' ILE . 5.5 mm -65.63 -26.66 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 109.732 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.39 -9.15 58.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.306 -0.871 . . . . 0.0 110.046 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -75.3 -22.53 57.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 110.124 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 57' ' ' ALA . 12.1 t -113.8 -48.42 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.187 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 55' ' ' VAL . 13.8 t0 -42.26 89.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.695 -0.628 . . . . 0.0 110.478 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -93.12 -9.56 39.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.404 -0.81 . . . . 0.0 110.637 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.455 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 66.7 m-20 -78.24 -31.58 49.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.055 -1.028 . . . . 0.0 110.421 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.82 -16.28 18.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 3.5 p30 -77.58 -93.72 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.321 -1.105 . . . . 0.0 110.106 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 165.7 46.0 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.451 ' HB ' HG22 ' A' ' 26' ' ' THR . 2.8 p -143.28 141.8 31.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.289 -1.124 . . . . 0.0 110.204 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.647 ' HB ' HD12 ' A' ' 27' ' ' ILE . 11.9 mm -92.09 129.42 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.26 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.543 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 9.5 t0 -117.18 179.9 3.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.723 ' O ' HD12 ' A' ' 69' ' ' LEU . 17.1 t80 -67.15 -43.14 44.3 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 0.0 111.307 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.77 -35.54 7.45 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.348 1.183 . . . . 0.0 110.25 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 48.7 mt-10 -67.9 -28.44 67.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.107 -0.996 . . . . 0.0 109.141 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' HZ ' HD12 ' B' ' 11' ' ' ILE . 18.8 t80 -69.77 -53.24 19.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.602 -0.686 . . . . 0.0 110.317 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 65' ' ' PHE . 1.5 mt -67.89 -17.66 64.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.284 -0.885 . . . . 0.0 110.513 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 m -78.29 -42.52 30.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.125 -0.984 . . . . 0.0 110.617 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -72.66 -42.22 64.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.149 -0.97 . . . . 0.0 110.572 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -9.46 17.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.487 -0.758 . . . . 0.0 111.231 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.31 -19.27 17.14 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.012 -1.055 . . . . 0.0 111.379 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.63 -20.85 15.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.979 -1.076 . . . . 0.0 111.02 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.009 -1.057 . . . . 0.0 110.5 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.328 0.585 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.69 -15.61 59.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.888 . . . . 0.0 109.982 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.716 ' CG ' HD11 ' B' ' 12' ' ' LEU . 19.5 tt0 -81.83 -38.34 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 109.968 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.546 HG23 ' CE1' ' A' ' 141' ' ' PHE . 16.7 mt -67.49 -33.83 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.232 -0.917 . . . . 0.0 109.081 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -60.17 -27.19 66.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.563 -0.71 . . . . 0.0 109.091 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.512 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 1.2 mt-10 -74.76 -56.71 4.5 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.466 -0.771 . . . . 0.0 109.231 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.43 -28.85 67.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 109.567 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.439 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 15.9 t80 -69.65 -47.87 61.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.02 -1.05 . . . . 0.0 108.968 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 -47.53 -36.47 10.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.496 -0.752 . . . . 0.0 109.019 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.757 HG12 HG21 ' A' ' 108' ' ' VAL . 54.5 t -74.2 -33.56 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.535 -0.728 . . . . 0.0 110.285 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.563 ' CE2' HG22 ' B' ' 13' ' ' VAL . 16.1 m-85 -80.35 -31.29 37.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.128 -0.982 . . . . 0.0 110.287 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 96' ' ' GLY . 10.9 t0 -100.04 62.83 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.209 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -43.17 -33.01 0.82 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.78 -31.93 61.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.385 -0.822 . . . . 0.0 109.655 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 69.37 13.61 68.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 23.6 p-10 -69.45 -38.84 77.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -1.12 . . . . 0.0 110.324 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 139.19 -30.27 2.46 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 33.9 m-85 -107.29 156.78 18.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -1.127 . . . . 0.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' A' ' 92' ' ' PHE . 11.4 mt -124.13 145.52 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.897 . . . . 0.0 110.018 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -124.96 147.78 48.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.168 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.29 -31.1 0.93 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.665 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.79 -47.08 79.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.359 -0.838 . . . . 0.0 109.395 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.445 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 10.0 mt-10 -54.99 -50.07 69.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.199 -0.938 . . . . 0.0 109.261 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 109' ' ' MET . 1.6 mm? -57.39 -52.79 63.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.328 -0.857 . . . . 0.0 109.185 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -45.96 -26.67 0.75 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.421 -0.8 . . . . 0.0 109.453 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.411 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -80.89 -34.59 33.43 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.373 -0.829 . . . . 0.0 110.21 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.757 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -89.57 -27.55 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 109.946 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.949 ' HA ' HD21 ' B' ' 17' ' ' LEU . 2.4 mmm -63.5 -49.5 73.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 110.659 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 m -77.82 -17.24 57.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.0 110.58 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 2.0 m120 -85.81 -3.39 58.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.089 -1.007 . . . . 0.0 109.968 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.893 ' CD1' HG12 ' B' ' 13' ' ' VAL . 5.4 mt -102.19 -42.75 5.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 110.426 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 162.67 -36.55 0.34 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.465 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.7 tp10 -109.7 147.0 33.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.991 -1.299 . . . . 0.0 110.828 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.514 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -119.93 74.68 1.04 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.547 -0.72 . . . . 0.0 109.282 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.634 HD23 ' O ' ' B' ' 19' ' ' LYS . 6.8 mp -38.46 160.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.687 -0.633 . . . . 0.0 110.709 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -60.69 -146.42 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.435 -0.791 . . . . 0.0 109.366 179.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.476 ' H ' HG22 ' A' ' 117' ' ' THR . 8.1 m-20 -122.3 -60.28 1.57 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.238 -0.914 . . . . 0.0 109.929 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.65 -35.65 63.72 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 9.7 mm-40 -67.31 -56.11 11.12 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.295 -0.878 . . . . 0.0 109.08 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.461 ' O ' ' HB3' ' A' ' 124' ' ' MET . 87.4 t -43.66 -36.36 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 121.361 -0.837 . . . . 0.0 109.606 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.51 -51.86 52.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -58.25 -32.49 68.41 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.403 -0.811 . . . . 0.0 109.113 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.518 ' HE3' ' O ' ' B' ' 21' ' ' SER . 11.0 ttt -59.49 -44.75 93.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.495 -0.753 . . . . 0.0 109.636 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.498 HG23 HG23 ' A' ' 136' ' ' VAL . 20.3 mm -71.72 -31.61 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 109.714 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 45.8 ttt85 -62.62 -42.76 99.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.98 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.9 -37.52 63.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.77 -25.83 27.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 0.0 110.142 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 134' ' ' GLY . 2.6 m-20 -57.64 99.54 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.859 . . . . 0.0 110.483 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 35.3 mm -74.79 -39.13 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.244 -0.91 . . . . 0.0 109.886 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 8.0 p-10 -90.4 -17.57 27.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.34 -0.85 . . . . 0.0 109.984 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.95 55.98 3.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 6.4 p30 -113.04 0.66 15.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.335 -1.097 . . . . 0.0 110.23 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.503 ' N ' ' OD2' ' A' ' 129' ' ' ASP . . . 76.16 8.53 85.3 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -142.66 147.46 35.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -1.181 . . . . 0.0 110.406 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.498 HG23 HG23 ' A' ' 125' ' ' ILE . 39.7 t -100.9 152.0 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.34 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.564 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 62.5 t30 -122.65 158.47 29.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -0.86 . . . . 0.0 110.12 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -45.8 -54.95 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.77 -41.02 56.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.301 -0.875 . . . . 0.0 109.916 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 144' ' ' MET . 9.2 mt-10 -70.87 -47.31 59.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.0 110.021 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.546 ' CE1' HG23 ' A' ' 85' ' ' ILE . 47.5 t80 -60.79 -17.95 52.38 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.299 -0.875 . . . . 0.0 109.968 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.43 ' O ' HG22 ' A' ' 146' ' ' THR . 46.9 t -100.19 -47.75 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.456 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -61.89 -26.86 68.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.172 -0.955 . . . . 0.0 110.23 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 17.8 mmm -82.62 -18.32 41.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.551 ' CE ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -99.33 -56.86 2.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 146' ' ' THR . 6.8 t . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.226 -0.921 . . . . 0.0 110.274 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.57 HD12 ' HG3' ' A' ' 51' ' ' MET . 11.0 pt . . . . . 0 C--O 1.215 -0.732 0 CA-C-O 120.913 0.387 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.36 153.16 50.35 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.09 1.574 . . . . 0.0 110.013 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.501 ' O ' ' HB ' ' B' ' 9' ' ' THR . 8.6 m -71.19 142.05 50.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.944 ' O ' HG22 ' B' ' 10' ' ' VAL . 6.8 m95 -36.29 -66.01 0.24 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.764 0.793 . . . . 0.0 110.555 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.536 HG21 ' HG2' ' A' ' 75' ' ' LYS . 10.8 p -45.38 -23.65 0.22 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.464 -0.773 . . . . 0.0 111.043 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.512 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 91.5 m -70.41 -56.65 6.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.886 -1.134 . . . . 0.0 109.87 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.944 HG22 ' O ' ' B' ' 7' ' ' TRP . 32.7 m -53.16 -27.4 13.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.281 -0.887 . . . . 0.0 109.193 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.501 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 26.0 mm -75.46 -30.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.447 -0.783 . . . . 0.0 109.61 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.716 HD11 ' CG ' ' A' ' 84' ' ' GLU . 9.9 mt -65.91 -60.47 2.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 110.034 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.893 HG12 ' CD1' ' A' ' 112' ' ' LEU . 41.1 t -52.95 -39.01 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.626 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -64.74 -47.62 77.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.963 -1.085 . . . . 0.0 109.226 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 50.2 m -50.97 -31.27 17.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.403 -0.811 . . . . 0.0 109.738 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mmt -79.87 -27.18 40.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.354 -0.841 . . . . 0.0 109.956 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.949 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.9 mp -80.04 54.47 1.92 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.344 -0.848 . . . . 0.0 109.88 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -72.58 0.57 Allowed 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.679 -0.638 . . . . 0.0 110.355 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.634 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -150.3 -60.28 0.19 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.944 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.561 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -156.64 17.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 110.208 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.518 ' O ' ' HE3' ' A' ' 124' ' ' MET . 0.3 OUTLIER -93.04 -162.1 0.9 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.217 -0.927 . . . . 0.0 110.42 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.445 ' CE2' ' HE2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -174.21 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.231 -0.918 . . . . 0.0 110.523 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.09 -155.76 22.69 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.551 ' CB ' ' CE ' ' A' ' 145' ' ' MET . 3.3 m-20 -178.96 117.07 0.23 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 110.206 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.04 52.61 3.5 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.935 1.492 . . . . 0.0 110.397 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.251 -179.792 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.506 0.67 . . . . 0.0 109.36 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 98.5 mt -75.2 -34.98 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.366 -0.834 . . . . 0.0 109.712 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.22 -62.46 1.85 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 109.654 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 12' ' ' PHE . 11.4 pt-20 -56.94 -38.23 72.63 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.162 -0.961 . . . . 0.0 109.058 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.688 ' CD2' ' CZ ' ' A' ' 68' ' ' PHE . 1.8 m-85 -57.91 -45.66 86.14 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.358 -0.839 . . . . 0.0 109.019 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -41.33 66.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 109.18 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -53.36 -49.21 67.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.713 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' B' ' 14' ' ' LYS . . . -59.28 -52.85 63.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 109.783 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 2.3 t80 -60.59 -35.6 76.49 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.614 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -67.06 -28.22 68.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.509 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.844 HD11 ' O ' ' A' ' 112' ' ' LEU . 8.4 tt -68.7 -41.81 78.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.499 -0.751 . . . . 0.0 109.881 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -74.28 -57.88 3.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.455 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 21.9 t0 -64.97 129.93 41.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.375 -0.828 . . . . 0.0 110.54 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.78 -48.5 5.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.246 -0.909 . . . . 0.0 110.157 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.2 p-10 -75.04 -35.05 61.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.78 42.34 5.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 34.8 p-10 -90.76 -28.12 18.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -1.156 . . . . 0.0 110.057 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.712 ' O ' HG23 ' A' ' 26' ' ' THR . . . 112.74 31.0 2.64 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 25' ' ' GLY . 11.1 p -159.73 125.24 4.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -1.135 . . . . 0.0 110.533 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.699 HD12 ' HB ' ' A' ' 63' ' ' ILE . 17.9 mt -91.97 119.22 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.21 -0.931 . . . . 0.0 109.999 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.6 p -100.17 172.91 6.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.92 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.436 HG21 HE22 ' A' ' 49' ' ' GLN . 3.6 p -64.43 -18.24 64.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.13 -0.981 . . . . 0.0 109.899 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -49.76 17.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.395 -0.816 . . . . 0.0 110.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.64 ' O ' HG23 ' A' ' 35' ' ' VAL . 20.9 mt-10 -67.21 -50.37 61.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 110.365 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.737 HD22 ' CD1' ' A' ' 52' ' ' ILE . 13.1 tp -59.75 -51.47 69.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.287 -0.883 . . . . 0.0 110.347 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.14 -49.35 24.68 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.8 m -56.26 -47.4 78.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.229 -1.159 . . . . 0.0 110.576 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 31' ' ' GLU . 11.4 t -62.77 -45.26 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 0.0 110.293 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.538 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 16.2 mmm -64.24 -39.64 94.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 110.405 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -15.91 61.55 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.099 -1.001 . . . . 0.0 110.237 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 39' ' ' LEU . 32.2 t -75.0 -46.05 37.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 111.058 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 38' ' ' SER . 1.9 mt -45.76 -27.31 0.8 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.914 -1.116 . . . . 0.0 109.823 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.93 -32.34 2.9 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.08 -178.59 2.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.135 -1.215 . . . . 0.0 110.684 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -131.07 93.88 29.35 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.252 -0.905 . . . . 0.0 110.317 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.579 ' HB3' HD13 ' B' ' 4' ' ' ILE . 45.4 Cg_endo -73.16 115.97 4.54 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.004 1.529 . . . . 0.0 110.302 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.23 164.94 23.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 110.239 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 42.9 mt-10 -61.07 -42.23 98.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.276 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.12 74.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.208 -0.933 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 51' ' ' MET . 4.6 mm-40 -66.65 -32.92 74.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 110.042 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 48' ' ' LEU . 13.0 mt -60.37 -52.16 66.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 0.0 110.123 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -62.91 -42.39 99.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 110.107 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.89 -15.41 63.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 110.012 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.509 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 1.2 mtp -86.9 -42.94 12.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.14 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.737 ' CD1' HD22 ' A' ' 32' ' ' LEU . 1.1 mp -80.27 -11.15 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.078 -1.014 . . . . 0.0 109.731 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -83.43 -18.58 38.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 110.856 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.6 ' HG3' HG23 ' A' ' 55' ' ' VAL . 21.8 pt-20 -94.48 -18.93 21.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.036 -1.04 . . . . 0.0 110.988 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.685 HG21 ' CD1' ' B' ' 7' ' ' TRP . 50.6 t -99.1 -31.57 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.95 -1.094 . . . . 0.0 110.061 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -47.16 89.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.539 -0.726 . . . . 0.0 110.539 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.12 -49.63 71.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.451 -0.781 . . . . 0.0 110.172 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 14.8 p-10 -75.69 -37.91 59.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 110.063 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.42 45.78 2.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 36.0 p-10 -98.5 -38.72 9.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.274 -1.133 . . . . 0.0 110.141 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 127.6 -8.09 6.95 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p -135.79 148.52 48.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -1.167 . . . . 0.0 110.189 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.699 ' HB ' HD12 ' A' ' 27' ' ' ILE . 31.8 mm -82.14 140.06 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.122 -0.986 . . . . 0.0 109.91 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.45 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -114.46 157.66 22.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.066 -1.021 . . . . 0.0 110.797 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.598 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 52.8 t80 -48.9 -50.34 62.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.443 -0.786 . . . . 0.0 111.187 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.9 Cg_endo -64.39 -32.27 60.87 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.258 1.136 . . . . 0.0 110.344 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 71' ' ' MET . 7.1 tt0 -59.97 -35.46 75.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.124 -0.985 . . . . 0.0 109.291 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.688 ' CZ ' ' CD2' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -76.98 -48.78 17.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.1 mm? -43.09 -45.28 5.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 110.625 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.31 -37.44 14.91 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.073 -1.017 . . . . 0.0 110.762 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -44.04 -38.91 3.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.191 -0.943 . . . . 0.0 110.72 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.51 ' HE3' ' CE1' ' B' ' 26' ' ' PHE . 5.7 tpt -74.65 -9.76 58.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.136 -0.977 . . . . 0.0 110.542 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.4 -10.83 19.88 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.248 -0.908 . . . . 0.0 110.579 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -99.61 -49.64 4.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.067 -1.021 . . . . 0.0 110.407 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.686 ' CB ' HG21 ' B' ' 8' ' ' THR . 20.2 mmtt . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.504 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.137 0.494 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -79.66 -17.04 54.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.044 -1.035 . . . . 0.0 110.409 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -81.26 -22.71 38.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.026 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.465 HG23 ' HE1' ' A' ' 141' ' ' PHE . 59.8 mt -79.09 -44.14 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.859 . . . . 0.0 110.039 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.474 ' CD ' ' OH ' ' A' ' 138' ' ' TYR . 5.4 ttp180 -55.55 -34.94 65.16 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.529 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 1.061 ' HB3' HG21 ' B' ' 9' ' ' THR . 14.1 mt-10 -71.16 -47.55 57.02 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.437 -0.789 . . . . 0.0 109.893 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.55 ' HB2' HD22 ' B' ' 12' ' ' LEU . . . -64.92 -29.05 69.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.041 -1.037 . . . . 0.0 109.828 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.01 -39.37 83.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 109.511 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -67.44 -37.95 83.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.39 -0.819 . . . . 0.0 109.503 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.635 HG12 HG21 ' A' ' 108' ' ' VAL . 11.7 t -58.51 -44.62 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.414 -0.804 . . . . 0.0 109.704 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.42 ' CE1' HG11 ' A' ' 108' ' ' VAL . 20.4 m-85 -66.47 -30.58 70.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.613 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.458 ' OD1' ' OD1' ' A' ' 97' ' ' ASN . 11.6 t0 -91.42 58.47 3.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.406 -0.809 . . . . 0.0 110.092 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 93' ' ' ASP . 2.3 mmmm -43.46 -32.3 0.86 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -0.962 . . . . 0.0 110.142 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.0 p30 -83.44 -34.13 25.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.181 -0.949 . . . . 0.0 110.109 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 81.39 42.41 9.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.458 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 38.2 p30 -100.07 -17.72 17.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -1.197 . . . . 0.0 110.167 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 102.59 27.96 6.53 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 94.4 m-85 -156.95 146.65 20.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -1.08 . . . . 0.0 110.004 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 80.3 mt -119.74 111.98 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.16 -0.963 . . . . 0.0 110.411 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 37.4 t -95.89 149.18 21.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.22 -31.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.168 -0.958 . . . . 0.0 109.947 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.56 -51.62 64.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.855 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.461 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 28.3 mt-10 -53.39 -38.89 63.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.67 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.997 HD12 HD11 ' A' ' 125' ' ' ILE . 1.2 mt -59.85 -44.57 94.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.376 -0.827 . . . . 0.0 109.711 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.518 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.0 OUTLIER -65.8 -20.78 66.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 109.619 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -81.77 -32.56 31.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.422 -0.799 . . . . 0.0 109.847 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.635 HG21 HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -83.17 -34.14 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.93 . . . . 0.0 109.789 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.902 ' HA ' HD21 ' B' ' 17' ' ' LEU . 11.2 ptp -79.42 -35.85 39.93 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.155 -0.965 . . . . 0.0 109.561 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.476 ' N ' ' HG3' ' A' ' 109' ' ' MET . 19.6 m -68.97 -30.52 68.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 108.802 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -85.91 -19.53 30.38 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.433 -0.792 . . . . 0.0 108.97 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.844 ' O ' HD11 ' A' ' 18' ' ' LEU . 9.5 mt -84.46 -32.38 24.06 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.535 -0.728 . . . . 0.0 110.122 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.98 -39.87 1.51 Allowed Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.495 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 109' ' ' MET . 2.1 tt0 -94.23 157.59 15.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.995 -1.297 . . . . 0.0 110.709 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 116' ' ' LEU . 1.8 pttt -135.86 73.21 1.46 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.565 -0.709 . . . . 0.0 109.205 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.651 HD21 ' O ' ' B' ' 17' ' ' LEU . 3.3 mp -38.79 145.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.593 -0.692 . . . . 0.0 110.794 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -56.47 -156.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 110.387 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -97.75 -48.82 5.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.224 -0.922 . . . . 0.0 110.149 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.31 -33.05 75.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.047 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.524 ' CG ' ' HB3' ' B' ' 20' ' ' ARG . 2.5 tt0 -66.16 -47.25 74.64 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.61 0.719 . . . . 0.0 109.33 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 116' ' ' LEU . 19.0 t -65.0 -42.15 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.519 -0.738 . . . . 0.0 110.387 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -62.99 -65.14 0.73 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.952 . . . . 0.0 109.827 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 122' ' ' ASP . 2.0 mm-40 -44.42 -30.19 0.81 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.381 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.544 ' HE2' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -62.91 -61.75 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 110.205 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.997 HD11 HD12 ' A' ' 105' ' ' LEU . 30.3 mm -59.55 -39.02 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 127' ' ' GLU . 2.8 mtt180 -60.09 -53.2 60.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.859 . . . . 0.0 110.355 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -43.3 -32.65 0.83 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.94 -26.93 13.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 110.146 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.3 OUTLIER -71.49 64.65 0.43 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.3 -0.875 . . . . 0.0 110.352 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.8 mt -63.15 -32.01 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 21.0 p-10 -77.01 -28.83 55.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.248 -0.907 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.85 64.74 1.99 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 20.4 p-10 -114.43 -23.0 9.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -1.135 . . . . 0.0 110.185 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 115.5 -6.7 20.67 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 99' ' ' TYR . 3.3 pt20 -158.38 163.17 37.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.29 -1.124 . . . . 0.0 110.022 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 137' ' ' ASN . 61.6 t -90.76 168.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.192 -0.942 . . . . 0.0 110.649 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.524 ' N ' HG12 ' A' ' 136' ' ' VAL . 15.4 t-20 -133.06 177.35 7.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.481 -0.762 . . . . 0.0 109.976 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.474 ' OH ' ' CD ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -56.05 -69.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.152 -0.967 . . . . 0.0 110.771 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 17.2 pt-20 -43.36 -39.08 2.99 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.146 -0.971 . . . . 0.0 110.692 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 139' ' ' GLU . 57.6 mt-10 -66.5 -60.21 2.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.168 -0.957 . . . . 0.0 110.211 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.465 ' HE1' HG23 ' A' ' 85' ' ' ILE . 26.6 t80 -46.98 -22.23 0.3 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.231 -0.918 . . . . 0.0 110.35 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.29 -44.01 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.753 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -56.44 -18.19 10.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.179 -0.95 . . . . 0.0 110.631 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.2 mmm -112.58 -10.15 13.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.151 -0.968 . . . . 0.0 110.263 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.451 ' HG2' HG12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -98.17 -9.58 25.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 110.211 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.259 -0.901 . . . . 0.0 110.35 -179.884 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.597 ' CG1' ' HD2' ' B' ' 5' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.597 ' HD2' ' CG1' ' B' ' 4' ' ' ILE . 38.1 Cg_endo -64.24 151.55 84.95 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.528 1.278 . . . . 0.0 110.473 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.444 ' O ' ' CE ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -74.65 -52.36 11.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.482 -0.761 . . . . 0.0 111.759 -178.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.685 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -172.04 -76.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.82 -1.175 . . . . 0.0 110.754 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.686 HG21 ' CB ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -46.11 -48.06 17.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 0.0 109.677 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 1.061 HG21 ' HB3' ' A' ' 87' ' ' GLU . 4.8 m -44.65 -51.65 8.94 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.391 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.415 HG21 ' HE1' ' A' ' 36' ' ' MET . 35.2 t -51.36 -43.08 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.263 -0.898 . . . . 0.0 108.958 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.504 HG21 ' SD ' ' A' ' 72' ' ' MET . 15.5 mm -66.36 -27.5 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.139 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -63.9 -58.71 5.94 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.623 -0.673 . . . . 0.0 109.964 179.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.868 ' O ' HD13 ' B' ' 17' ' ' LEU . 54.3 t -60.39 -39.22 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.936 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.641 ' CG ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -62.12 -61.29 2.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.087 -1.008 . . . . 0.0 109.722 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 74.5 m -60.74 -18.88 57.3 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.43 -0.794 . . . . 0.0 109.875 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.514 ' O ' ' CG ' ' B' ' 19' ' ' LYS . 6.2 ttt -80.1 -18.45 49.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.902 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.2 mp -73.76 -50.32 21.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.248 -0.907 . . . . 0.0 110.58 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.462 ' O ' ' CG ' ' B' ' 18' ' ' ARG . 0.6 OUTLIER -65.44 60.21 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.605 -0.684 . . . . 0.0 110.4 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' B' ' 16' ' ' MET . 0.0 OUTLIER -179.98 120.54 0.06 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.524 ' HB3' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -73.01 20.53 0.08 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.662 -0.649 . . . . 0.0 112.086 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.544 ' O ' ' HE2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -128.64 175.67 8.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.934 -1.104 . . . . 0.0 109.76 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.425 ' CD1' ' HE2' ' A' ' 124' ' ' MET . 0.6 OUTLIER -112.12 177.88 4.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.023 -1.048 . . . . 0.0 110.069 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.52 140.73 0.06 OUTLIER Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.502 ' ND2' ' HD2' ' B' ' 25' ' ' PRO . 0.4 OUTLIER -121.88 140.15 31.51 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.26 . . . . 0.0 110.948 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.502 ' HD2' ' ND2' ' B' ' 24' ' ' ASN . 44.3 Cg_endo -72.25 55.99 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.046 1.551 . . . . 0.0 109.655 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.51 ' CE1' ' HE3' ' A' ' 72' ' ' MET . 1.4 m-85 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.286 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.261 0.553 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.1 mt -50.93 -42.34 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.202 -0.937 . . . . 0.0 109.381 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -50.6 -45.32 57.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.358 -0.839 . . . . 0.0 109.266 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -57.3 -48.47 78.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.33 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -53.86 -46.24 71.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.307 -0.871 . . . . 0.0 109.379 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -57.81 -46.37 84.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.883 . . . . 0.0 109.289 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -60.09 -44.9 94.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.3 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -60.76 -45.17 95.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.383 -0.823 . . . . 0.0 109.557 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.515 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 7.2 t80 -62.97 -22.27 66.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.942 . . . . 0.0 109.074 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.51 -47.68 9.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.522 -0.736 . . . . 0.0 109.588 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.858 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.2 tt -47.66 -41.12 21.61 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.321 -0.862 . . . . 0.0 109.504 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 41.0 m-85 -79.89 -46.16 17.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.884 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.503 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 39.5 t0 -80.46 101.94 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.451 -0.78 . . . . 0.0 110.154 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 4.32 51.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.29 -0.881 . . . . 0.0 110.431 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.427 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 33.3 m-20 -97.08 -37.8 10.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.149 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.33 27.95 10.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 10.3 p30 -102.67 -17.03 15.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -1.169 . . . . 0.0 110.195 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 91.07 22.55 32.37 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 14.1 p -138.3 122.72 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.216 -1.167 . . . . 0.0 110.468 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.5 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 13.4 mt -89.3 114.63 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.124 -0.985 . . . . 0.0 110.137 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -93.46 155.73 17.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.714 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.567 ' O ' HD13 ' A' ' 48' ' ' LEU . 32.0 p -54.9 -22.71 15.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 110.039 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -43.62 63.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.88 . . . . 0.0 109.972 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.503 ' OE2' ' HA ' ' A' ' 20' ' ' ASP . 17.0 mt-10 -64.5 -56.68 12.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 0.0 110.093 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.859 HD23 ' CD2' ' A' ' 48' ' ' LEU . 11.5 tp -54.54 -36.37 64.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 109.858 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.28 -40.91 99.62 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 m -58.49 -53.07 62.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -1.119 . . . . 0.0 109.819 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 35' ' ' VAL . 12.0 t -56.93 -53.9 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.603 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.504 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -50.76 -41.01 56.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 109.736 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 2.1 mtm180 -62.91 -27.81 69.62 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 0.0 109.886 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -79.41 -59.54 2.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.821 . . . . 0.0 110.933 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mt -44.04 -37.54 3.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.131 -0.981 . . . . 0.0 110.082 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.08 64.85 0.16 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.539 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -144.82 -168.23 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -1.178 . . . . 0.0 110.119 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 2.5 m120 -155.1 57.75 1.75 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.062 -1.024 . . . . 0.0 110.578 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 50.1 Cg_endo -80.35 135.73 10.86 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.907 1.477 . . . . 0.0 110.061 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 45' ' ' GLU . 5.1 m -97.26 163.36 12.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.206 -0.933 . . . . 0.0 110.067 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.2 mt-10 -43.05 -54.92 4.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 109.997 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.56 -55.43 33.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 110.043 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HG3' ' HB ' ' A' ' 44' ' ' THR . 21.3 mt-10 -47.46 -44.46 25.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 109.72 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.859 ' CD2' HD23 ' A' ' 32' ' ' LEU . 15.1 mt -55.8 -43.44 76.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.358 -0.839 . . . . 0.0 109.912 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' OE1' HG21 ' A' ' 29' ' ' THR . 5.6 tp60 -54.9 -41.42 70.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.441 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.06 -42.94 91.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.447 -0.783 . . . . 0.0 109.648 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.569 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.3 OUTLIER -74.95 -49.44 20.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 109.765 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.481 HG22 ' HB2' ' A' ' 56' ' ' ASP . 7.3 mm -52.4 -25.2 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.624 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -30.59 67.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.345 -0.847 . . . . 0.0 110.185 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 1.3 mp0 -70.24 -25.63 63.47 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.832 HG22 ' SD ' ' A' ' 71' ' ' MET . 5.6 t -108.07 -28.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 52' ' ' ILE . 19.2 t0 -63.85 72.17 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.312 -0.867 . . . . 0.0 110.323 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -68.65 -35.69 77.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 110.415 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 24.3 p30 -82.44 -20.15 37.56 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.141 -0.975 . . . . 0.0 110.489 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 81.07 26.49 52.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.523 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 31.8 p-10 -89.66 -30.44 18.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -1.179 . . . . 0.0 110.09 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 113.92 -24.23 12.1 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.523 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 80.7 p -112.65 157.27 21.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -1.215 . . . . 0.0 110.393 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.581 HD12 ' CG1' ' A' ' 55' ' ' VAL . 10.2 mm -95.72 144.28 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 110.144 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 75.8 m-20 -110.67 160.68 16.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 109.975 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 33.0 t80 -52.4 -47.73 92.11 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.289 -0.882 . . . . 0.0 111.271 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -69.42 -41.82 4.34 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.203 1.107 . . . . 0.0 110.163 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 2.9 tt0 -55.6 -45.15 77.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 110.114 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.423 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 16.3 t80 -61.0 -47.35 86.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 110.118 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 65' ' ' PHE . 85.4 mt -57.41 -23.05 47.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.232 -0.917 . . . . 0.0 110.156 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.3 m -90.1 -21.7 22.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.258 -0.901 . . . . 0.0 111.012 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.832 ' SD ' HG22 ' A' ' 55' ' ' VAL . 3.1 ttp -75.48 -45.37 38.82 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.959 -1.088 . . . . 0.0 109.905 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.533 ' HE1' ' HE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -53.91 -17.27 2.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.39 -0.819 . . . . 0.0 110.907 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.02 -11.69 15.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.936 -1.102 . . . . 0.0 111.324 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -96.53 -36.23 10.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.817 -1.177 . . . . 0.0 110.678 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.709 ' HB3' HG21 ' B' ' 8' ' ' THR . 8.9 tttp . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.239 -0.913 . . . . 0.0 110.535 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.31 -24.64 67.72 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 25.3 tt0 -55.57 -36.92 67.37 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.509 -0.745 . . . . 0.0 109.605 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.661 HG23 ' SD ' ' A' ' 145' ' ' MET . 78.1 mt -70.4 -44.96 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.269 -0.895 . . . . 0.0 109.025 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -54.98 -28.71 53.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.484 -0.76 . . . . 0.0 109.132 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 4.2 mt-10 -69.61 -58.9 3.37 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.471 -0.768 . . . . 0.0 109.445 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.35 -31.39 54.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 0.0 109.247 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 17.1 t80 -63.72 -45.05 91.7 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -60.82 -34.89 75.23 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.778 ' CG1' HG21 ' B' ' 13' ' ' VAL . 24.7 t -71.49 -42.1 72.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.584 ' CE2' HG22 ' B' ' 13' ' ' VAL . 9.6 m-85 -72.25 -34.57 68.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 108.76 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 96' ' ' GLY . 14.5 t0 -95.24 61.28 2.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.56 -0.713 . . . . 0.0 109.791 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.538 ' CE ' ' HA ' ' A' ' 94' ' ' LYS . 2.1 mmpt? -43.36 -28.02 0.3 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.16 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.43 ' OD2' ' CG ' ' A' ' 97' ' ' ASN . 49.7 t0 -67.89 -41.31 82.93 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 73.11 -0.17 48.53 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.43 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 28.5 p-10 -73.01 -24.07 60.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.117 -1.225 . . . . 0.0 110.117 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.463 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 115.21 35.44 1.33 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.467 ' O ' ' OE2' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -158.51 105.38 1.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.257 -1.143 . . . . 0.0 110.231 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 92' ' ' PHE . 7.2 mt -81.37 135.47 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.248 -0.907 . . . . 0.0 110.026 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -129.29 148.84 51.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.01 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.87 -30.95 1.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 109.848 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.5 79.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.599 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 99' ' ' TYR . 35.0 mt-10 -61.57 -43.64 98.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.386 -0.821 . . . . 0.0 109.953 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.053 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -59.76 -42.64 93.71 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.323 -0.86 . . . . 0.0 109.363 179.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -36.88 74.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.799 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -65.15 -44.39 88.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.823 . . . . 0.0 109.843 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.481 HG21 HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -74.0 -33.62 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.803 . . . . 0.0 109.417 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.52 ' SD ' HD21 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -60.82 -65.61 0.66 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 110.174 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m -51.92 -32.84 34.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.116 -0.99 . . . . 0.0 109.507 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 9.6 m120 -77.68 -20.65 53.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 109.547 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.861 HD11 HG12 ' B' ' 13' ' ' VAL . 2.5 mt -85.05 -40.41 16.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.511 -0.743 . . . . 0.0 110.168 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.26 -47.39 0.55 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.656 ' HG2' HD12 ' A' ' 116' ' ' LEU . 31.1 tt0 -94.0 165.18 12.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.143 -1.21 . . . . 0.0 111.043 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' LEU . 4.0 ptpp? -140.67 62.82 1.48 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.503 -0.748 . . . . 0.0 109.358 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.882 HD21 ' HA ' ' B' ' 19' ' ' LYS . 1.6 mp -38.34 140.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.696 -0.628 . . . . 0.0 110.467 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.662 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -50.85 -173.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.37 -0.831 . . . . 0.0 110.478 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 119' ' ' GLU . 20.1 t70 -86.34 -62.32 1.54 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.026 -1.046 . . . . 0.0 110.361 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.555 ' HA ' ' OD2' ' A' ' 122' ' ' ASP . 3.2 tt0 -44.11 -49.61 8.86 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 109.916 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.95 -55.33 36.0 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 117' ' ' THR . 46.3 t -49.52 -43.6 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.556 -0.715 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.555 ' OD2' ' HA ' ' A' ' 119' ' ' GLU . 9.4 p30 -68.75 -22.53 64.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.757 -1.214 . . . . 0.0 109.966 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 40.1 mm-40 -80.56 -27.82 37.4 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.351 -0.843 . . . . 0.0 108.867 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -43.6 79.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.594 -0.691 . . . . 0.0 109.419 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.053 HD11 ' CD1' ' A' ' 105' ' ' LEU . 41.5 mm -67.66 -43.49 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.0 109.691 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.471 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.7 mmm-85 -56.98 -39.43 74.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -59.45 -28.59 67.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.355 -0.841 . . . . 0.0 109.996 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB2' ' HD2' ' B' ' 22' ' ' PHE . . . -99.25 -18.25 17.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.378 -0.827 . . . . 0.0 110.022 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 126' ' ' ARG . 1.2 m-20 -59.12 98.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.244 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 mm -67.38 -44.61 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.325 -0.859 . . . . 0.0 110.049 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 19.2 p-10 -90.07 -19.2 24.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 110.093 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 79.23 64.08 1.97 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.514 ' OD2' ' NE2' ' A' ' 135' ' ' GLN . 31.1 p-10 -116.04 -34.73 4.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -1.155 . . . . 0.0 110.143 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 118.34 19.5 4.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.514 ' NE2' ' OD2' ' A' ' 133' ' ' ASP . 3.9 pp0? -160.21 159.01 31.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.173 -1.192 . . . . 0.0 110.434 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 87.2 t -114.9 108.59 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -80.69 -173.25 4.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.212 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.429 ' O ' ' C ' ' A' ' 139' ' ' GLU . 25.5 t80 -67.66 -67.18 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 110.311 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 138' ' ' TYR . 2.3 tt0 -42.85 -27.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.772 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 144' ' ' MET . 1.6 tt0 -80.94 -53.15 6.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 110.356 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 69.5 t80 -58.26 -18.31 25.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 66.5 t -99.75 -62.67 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.345 -0.847 . . . . 0.0 110.568 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -52.53 -18.96 1.95 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.254 -0.904 . . . . 0.0 110.489 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.484 ' HB3' ' O ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -97.81 -20.94 17.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.128 -0.983 . . . . 0.0 110.165 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.661 ' SD ' HG23 ' A' ' 85' ' ' ILE . 8.2 ttm -100.78 -26.37 13.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.355 -0.841 . . . . 0.0 110.746 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 146' ' ' THR . 4.7 t . . . . . 0 N--CA 1.499 2.007 0 O-C-N 120.907 -1.121 . . . . 0.0 110.888 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.904 HG22 ' CD ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.149 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.904 ' CD ' HG22 ' B' ' 4' ' ' ILE . 46.4 Cg_endo -83.03 -158.16 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.559 1.294 . . . . 0.0 110.534 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.524 ' O ' ' N ' ' B' ' 8' ' ' THR . 2.4 p -136.93 56.2 1.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.98 -1.075 . . . . 0.0 111.047 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.811 ' O ' HG22 ' B' ' 10' ' ' VAL . 3.0 m95 54.03 -82.15 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.253 -0.904 . . . . 0.0 111.05 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 75' ' ' LYS . 7.1 p -41.31 -25.12 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.844 -1.16 . . . . 0.0 110.633 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.496 ' N ' ' O ' ' B' ' 7' ' ' TRP . 50.6 m -64.18 -53.47 48.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 109.638 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.811 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.5 m -58.59 -26.34 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.296 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' B' ' 15' ' ' SER . 2.9 mt -75.05 -33.13 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.266 -0.897 . . . . 0.0 109.078 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.47 -59.57 5.23 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 110.125 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.861 HG12 HD11 ' A' ' 112' ' ' LEU . 61.8 t -62.66 -40.47 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 110.939 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -63.43 -31.0 72.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.965 -1.084 . . . . 0.0 110.072 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 0.5 OUTLIER -76.4 -24.23 54.05 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.363 -0.836 . . . . 0.0 110.092 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.589 ' HE1' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.67 -17.62 40.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.272 -0.892 . . . . 0.0 111.301 -179.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 19' ' ' LYS . 0.3 OUTLIER -78.79 -109.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.406 -1.434 . . . . 0.0 110.081 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.475 ' C ' ' HG3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 58.58 -72.64 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.131 -0.98 . . . . 0.0 110.821 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.882 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -172.94 90.62 0.09 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.348 -0.845 . . . . 0.0 112.256 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 123' ' ' GLU . 0.7 OUTLIER 62.1 4.67 1.25 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.534 -1.354 . . . . 0.0 110.829 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.5 ' O ' ' O ' ' B' ' 16' ' ' MET . 12.1 t -66.01 119.04 10.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.945 -1.097 . . . . 0.0 110.23 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.656 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -152.57 53.68 0.78 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.095 -1.003 . . . . 0.0 110.221 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.45 -136.23 6.42 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 145' ' ' MET . 2.0 m120 -130.51 65.17 75.45 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.247 -1.149 . . . . 0.0 110.637 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.27 42.26 1.29 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.937 1.493 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.533 ' HE2' ' HE1' ' A' ' 72' ' ' MET . 5.7 m-85 . . . . . 0 N--CA 1.498 1.927 0 O-C-N 121.074 -1.016 . . . . 0.0 110.293 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.301 0.572 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mt -56.97 -43.85 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.682 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.88 -51.81 62.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.682 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.511 ' OE2' ' CD ' ' B' ' 18' ' ' ARG . 16.9 tt0 -56.9 -45.98 82.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.674 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -63.04 -41.34 99.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -61.4 -41.19 96.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.401 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 7.6 tt0 -63.18 -48.07 79.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.249 -0.907 . . . . 0.0 109.258 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' HB1' ' HZ ' ' A' ' 68' ' ' PHE . . . -62.5 -46.44 88.44 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.4 -0.813 . . . . 0.0 109.395 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 65' ' ' PHE . 41.0 t80 -61.26 -38.43 86.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.338 -0.851 . . . . 0.0 109.0 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 14' ' ' GLU . 77.5 p -75.19 -35.55 61.52 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.539 -0.725 . . . . 0.0 109.365 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.693 HD13 ' HG3' ' B' ' 14' ' ' LYS . 1.1 tt -50.16 -44.86 52.83 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.815 . . . . 0.0 109.217 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CE1' HG11 ' B' ' 10' ' ' VAL . 52.7 m-85 -76.83 -51.53 11.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.431 -0.793 . . . . 0.0 109.472 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 46.0 t0 -77.17 78.2 3.71 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.509 -0.744 . . . . 0.0 110.009 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -68.22 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.6 p-10 -51.64 -27.52 11.66 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.431 -0.793 . . . . 0.0 110.293 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.447 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 80.21 18.61 71.37 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 53.6 p30 -62.24 -12.47 20.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -1.191 . . . . 0.0 109.962 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 86.98 29.39 23.23 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 4.2 p -152.61 118.57 5.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.268 -1.137 . . . . 0.0 110.601 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' A' ' 63' ' ' ILE . 10.7 mt -94.22 120.12 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.163 -0.96 . . . . 0.0 110.172 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.53 164.76 11.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.353 -0.842 . . . . 0.0 109.984 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.554 ' O ' HD13 ' A' ' 48' ' ' LEU . 38.6 p -56.63 -29.31 62.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.992 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -69.51 -60.83 2.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.803 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -49.06 -57.53 6.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -0.888 . . . . 0.0 110.14 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 32' ' ' LEU . 22.9 tp -52.86 -41.96 64.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.781 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.528 ' HA2' ' HG3' ' A' ' 43' ' ' PRO . . . -58.39 -34.88 76.63 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.7 m -62.85 -56.92 13.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -1.11 . . . . 0.0 110.035 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 35' ' ' VAL . 16.4 t -53.71 -32.71 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.334 -0.854 . . . . 0.0 109.883 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -27.28 59.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 109.956 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 1.4 ttp180 -76.73 -21.67 54.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -0.955 . . . . 0.0 110.121 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -33.71 59.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -0.922 . . . . 0.0 110.357 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.505 HD22 HG13 ' A' ' 91' ' ' VAL . 4.5 mt -74.94 -44.1 50.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.229 -0.919 . . . . 0.0 110.231 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.16 78.76 0.08 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -176.45 -174.51 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.259 -1.142 . . . . 0.0 110.283 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -142.55 93.43 6.97 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.0 110.315 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.528 ' HG3' ' HA2' ' A' ' 33' ' ' GLY . 44.5 Cg_endo -74.61 90.92 1.01 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 124.092 1.575 . . . . 0.0 110.297 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.29 145.86 52.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 110.428 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -49.07 -64.79 0.7 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.24 -0.913 . . . . 0.0 110.573 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -43.84 -51.14 7.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.939 -1.101 . . . . 0.0 110.046 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -65.13 -35.21 80.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.876 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 29' ' ' THR . 11.0 mt -62.38 -47.68 83.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 110.09 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -57.48 -44.85 85.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.875 . . . . 0.0 109.821 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.17 -27.15 69.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.419 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.571 ' SD ' HG21 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -74.66 -54.13 8.0 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.493 -0.754 . . . . 0.0 110.129 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.761 HG12 HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -70.16 -13.08 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.253 -0.904 . . . . 0.0 109.753 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.46 -24.74 63.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.187 -0.946 . . . . 0.0 109.212 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.85 -47.89 13.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.519 -0.738 . . . . 0.0 109.962 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.661 HG21 ' CE2' ' B' ' 7' ' ' TRP . 88.3 t -69.6 -18.09 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.651 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' ALA . 17.2 t0 -67.68 57.78 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.021 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -43.36 -55.58 4.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.952 . . . . 0.0 110.256 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 6.9 p-10 -64.1 -44.15 93.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.86 35.39 3.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.473 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 6.9 p-10 -98.64 -44.93 6.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -1.207 . . . . 0.0 110.137 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.448 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . 142.15 -54.88 0.6 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.28 156.56 19.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.252 -1.146 . . . . 0.0 110.701 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.761 HD11 HG12 ' A' ' 52' ' ' ILE . 7.9 mm -90.39 142.93 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.805 . . . . 0.0 109.378 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.483 ' OD1' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -108.64 176.82 4.98 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.031 -1.043 . . . . 0.0 110.809 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.636 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 4.1 t80 -66.99 -45.2 52.92 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.495 -0.753 . . . . 0.0 111.372 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.8 Cg_endo -69.02 -37.81 10.38 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.203 1.107 . . . . 0.0 109.938 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' OE2' ' OD1' ' A' ' 58' ' ' ASP . 3.2 mt-10 -52.93 -41.66 64.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.293 -0.88 . . . . 0.0 109.218 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.401 ' HZ ' ' HB1' ' A' ' 15' ' ' ALA . 16.3 t80 -64.51 -50.33 67.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.748 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -51.44 -26.29 7.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.84 . . . . 0.0 110.574 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 34.8 m -98.4 -20.4 17.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 111.167 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.449 ' CE ' ' HB2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -78.99 -30.69 44.47 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.958 -1.089 . . . . 0.0 110.861 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.53 ' HG2' HG21 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -77.09 -9.08 58.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.192 -0.942 . . . . 0.0 110.839 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.58 -16.55 8.84 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.867 -1.145 . . . . 0.0 111.405 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -99.94 -9.91 22.25 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.883 -1.136 . . . . 0.0 110.491 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HB3' HG21 ' B' ' 8' ' ' THR . 6.5 tptt . . . . . 0 C--N 1.296 -1.731 0 O-C-N 121.29 -0.881 . . . . 0.0 110.618 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.19 0.519 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -67.42 -40.11 85.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.716 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HG3' HG13 ' A' ' 85' ' ' ILE . 17.9 pt-20 -51.8 -31.79 28.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 109.911 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.665 HG21 HG22 ' A' ' 142' ' ' VAL . 62.2 mt -78.78 -50.84 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.155 -0.966 . . . . 0.0 109.313 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 14.9 ttm180 -49.38 -40.6 36.49 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 109.5 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.774 ' HB3' HG21 ' B' ' 9' ' ' THR . 26.4 mt-10 -69.06 -52.77 25.06 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.292 -0.88 . . . . 0.0 109.581 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.33 -27.04 44.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.07 -1.019 . . . . 0.0 109.071 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' HB3' ' O ' ' A' ' 86' ' ' ARG . 83.3 t80 -69.75 -45.58 67.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 0.0 109.112 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -56.61 -37.47 70.71 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.591 -0.693 . . . . 0.0 109.36 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.619 HG12 HG21 ' A' ' 108' ' ' VAL . 82.1 t -64.92 -41.07 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.503 -0.748 . . . . 0.0 109.748 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.774 ' HE1' HG22 ' B' ' 13' ' ' VAL . 5.0 m-85 -66.42 -31.34 72.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.0 109.37 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.511 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 3.8 t0 -91.13 59.92 4.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.479 -0.763 . . . . 0.0 109.986 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -38.96 -39.8 0.58 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.441 -0.787 . . . . 0.0 110.794 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.0 p-10 -86.58 -35.06 19.68 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 0.0 110.121 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.505 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 82.55 44.6 7.27 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -94.64 -23.61 17.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -1.197 . . . . 0.0 110.177 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 114.88 29.32 2.64 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 41.8 m-85 -160.62 150.59 17.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.174 -1.192 . . . . 0.0 110.039 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.574 HD13 ' HB3' ' A' ' 92' ' ' PHE . 9.0 mt -119.06 118.09 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 102' ' ' ALA . 2.0 t -105.33 145.88 30.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 110.147 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.953 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -43.87 -33.03 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.811 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.15 82.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 109.546 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 39.6 mt-10 -55.77 -41.27 73.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.882 . . . . 0.0 109.492 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.027 ' CD1' HD11 ' A' ' 125' ' ' ILE . 7.7 mt -59.74 -44.67 93.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 109.601 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.408 ' NH1' ' HD3' ' A' ' 115' ' ' LYS . 1.2 ttm180 -57.5 -39.35 76.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -0.825 . . . . 0.0 109.592 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -63.5 -50.8 68.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 109.554 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.619 HG21 HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -63.76 -25.27 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 108.898 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.865 ' SD ' HD13 ' A' ' 116' ' ' LEU . 2.6 mtm -69.13 -65.37 0.72 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.672 -0.643 . . . . 0.0 109.988 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -51.99 -28.88 18.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -78.55 -10.5 59.75 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.277 -0.889 . . . . 0.0 109.337 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.687 HD11 HG12 ' B' ' 13' ' ' VAL . 13.8 mt -107.34 -48.5 3.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.356 -0.84 . . . . 0.0 110.479 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.58 -59.5 0.18 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.548 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 109' ' ' MET . 2.7 tp10 -99.76 159.23 15.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.934 -1.333 . . . . 0.0 110.819 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.562 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 1.1 pttp -123.57 1.91 8.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.375 -0.828 . . . . 0.0 110.012 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.865 HD13 ' SD ' ' A' ' 109' ' ' MET . 4.8 mp 48.11 175.81 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.56 0.695 . . . . 0.0 110.969 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.666 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.46 178.91 6.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.138 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -50.97 9.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.96 -1.087 . . . . 0.0 110.065 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -56.79 -46.11 81.76 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 109.491 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -58.91 -52.8 64.18 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.375 -0.828 . . . . 0.0 109.409 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.953 HG12 ' HB1' ' A' ' 102' ' ' ALA . 41.3 t -50.84 -41.41 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.857 . . . . 0.0 109.669 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 1.1 m-20 -70.95 -38.83 72.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.398 -0.813 . . . . 0.0 110.029 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -68.84 -23.73 64.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -0.866 . . . . 0.0 110.05 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.686 ' HE3' ' CD1' ' B' ' 22' ' ' PHE . 22.3 ttt -74.4 -56.21 5.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.882 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.027 HD11 ' CD1' ' A' ' 105' ' ' LEU . 31.2 mm -60.68 -52.82 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.0 109.712 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 122' ' ' ASP . 1.5 mtp85 -50.33 -52.89 32.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 110.1 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 15.3 mm-40 -53.33 -29.04 31.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.342 -0.849 . . . . 0.0 110.193 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.54 -19.23 24.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 110.343 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.43 70.43 3.82 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.0 110.262 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.6 mt -63.57 -41.22 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.968 . . . . 0.0 109.766 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 9.7 p30 -63.55 -36.29 83.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.332 -0.855 . . . . 0.0 110.03 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 95.48 74.19 1.22 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.458 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.437 ' OD1' ' CG ' ' A' ' 131' ' ' ASP . 4.4 m-20 -133.44 2.17 3.5 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.229 -1.159 . . . . 0.0 109.976 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.508 ' O ' ' CG ' ' A' ' 135' ' ' GLN . . . 71.66 4.71 58.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.508 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 68.1 mt-30 -156.63 168.81 26.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.163 . . . . 0.0 109.773 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 140' ' ' GLU . 14.7 t -107.16 131.47 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 109.953 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 11.6 t30 -100.39 -152.98 0.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 0.0 110.23 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.458 ' OH ' ' HG3' ' A' ' 86' ' ' ARG . 12.1 t80 -74.54 -69.45 0.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.245 -0.909 . . . . 0.0 110.087 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 143' ' ' GLN . 1.4 tt0 -46.95 -44.4 19.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.187 -0.946 . . . . 0.0 109.875 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.457 ' HB3' HG13 ' A' ' 136' ' ' VAL . 11.5 mt-10 -53.78 -60.56 3.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.795 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 140' ' ' GLU . 5.1 t80 -42.96 -33.0 0.71 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 110.017 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.665 HG22 HG21 ' A' ' 85' ' ' ILE . 37.8 t -100.09 -17.11 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.374 -0.829 . . . . 0.0 110.726 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 139' ' ' GLU . 13.7 tt0 -77.9 -27.97 49.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.173 -0.954 . . . . 0.0 110.621 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -93.51 -11.05 32.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.524 ' O ' ' HB2' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.6 -24.78 14.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.436 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.0 p . . . . . 0 C--N 1.305 -1.353 0 O-C-N 120.921 -1.112 . . . . 0.0 110.661 -179.537 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.571 HG21 ' SD ' ' A' ' 51' ' ' MET . 12.5 mt . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.508 ' O ' ' HB ' ' B' ' 9' ' ' THR . 44.1 Cg_endo -70.87 66.39 2.42 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.98 1.516 . . . . 0.0 111.602 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.482 ' C ' ' O ' ' B' ' 5' ' ' PRO . 42.4 m 31.56 -147.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.533 0.682 . . . . 0.0 111.874 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.661 ' CE2' HG21 ' A' ' 55' ' ' VAL . 2.0 m95 -108.7 -73.87 0.67 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.886 0.851 . . . . 0.0 110.842 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.529 ' HA ' HD12 ' B' ' 11' ' ' ILE . 2.6 p -44.83 -36.59 3.34 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.498 -0.751 . . . . 0.0 110.288 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.774 HG21 ' HB3' ' A' ' 87' ' ' GLU . 2.6 m -44.91 -53.84 7.15 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.695 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.465 HG23 ' H ' ' B' ' 10' ' ' VAL . 4.7 t -57.46 -40.12 72.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.53 HG21 ' HG2' ' A' ' 72' ' ' MET . 47.1 mt -72.75 -19.72 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.539 -0.726 . . . . 0.0 109.635 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 8' ' ' THR . 0.2 OUTLIER -73.36 -50.16 23.42 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.647 0.737 . . . . 0.0 109.768 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.774 HG22 ' HE1' ' A' ' 92' ' ' PHE . 89.1 t -64.91 -47.06 89.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.475 -0.766 . . . . 0.0 110.575 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.693 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -65.86 -32.76 74.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.066 -1.021 . . . . 0.0 109.802 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 34.2 t -78.23 -13.68 59.76 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.6 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' B' ' 12' ' ' LEU . 0.0 OUTLIER -79.67 -42.18 25.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.162 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.621 HD21 ' CG ' ' A' ' 109' ' ' MET . 9.3 mp -44.98 -57.32 3.89 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.918 -1.114 . . . . 0.0 109.057 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.511 ' CD ' ' OE2' ' A' ' 11' ' ' GLU . 3.6 tpt85 16.38 75.24 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.528 ' O ' ' CG ' ' B' ' 19' ' ' LYS . 2.0 tptm 44.62 73.76 0.15 Allowed 'General case' 0 C--N 1.283 -2.308 0 O-C-N 121.273 -0.892 . . . . 0.0 112.883 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.691 ' H ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER 47.86 13.73 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.683 0 O-C-N 120.8 -1.187 . . . . 0.0 112.092 177.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' B' ' 18' ' ' ARG . 5.1 m -112.74 115.45 28.55 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 119.956 -1.715 . . . . 0.0 110.468 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.686 ' CD1' ' HE3' ' A' ' 124' ' ' MET . 0.9 OUTLIER -58.16 -35.32 71.38 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.167 -1.013 . . . . 0.0 108.779 179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.54 147.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.595 ' N ' ' HD3' ' B' ' 25' ' ' PRO . 1.8 p-10 -134.97 43.09 0.87 Allowed Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.479 -1.013 . . . . 0.0 110.73 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' B' ' 24' ' ' ASN . 55.2 Cg_endo -77.96 26.64 0.49 Allowed 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.481 1.253 . . . . 0.0 111.189 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.431 ' CE2' ' HE1' ' A' ' 72' ' ' MET . 15.5 m-85 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 110.354 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.317 0.58 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 47.2 mt -66.44 -40.05 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.997 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.33 -62.35 1.78 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 109.714 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.494 ' CA ' ' OE1' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -48.64 -41.48 31.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.609 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.8 m-30 -52.49 -46.78 66.74 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.214 -0.929 . . . . 0.0 109.153 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -57.34 -34.52 68.86 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.329 -0.857 . . . . 0.0 109.172 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 1.7 tt0 -56.84 -51.01 70.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.397 -0.814 . . . . 0.0 109.794 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' CA ' ' HD2' ' B' ' 14' ' ' LYS . . . -60.01 -45.39 92.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.19 -0.943 . . . . 0.0 109.566 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.584 ' CZ ' ' O ' ' A' ' 64' ' ' ASP . 1.7 t80 -64.62 -45.43 86.89 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 109.841 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m -64.29 -31.33 72.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.809 . . . . 0.0 109.706 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.622 HD21 ' O ' ' A' ' 112' ' ' LEU . 9.7 tt -61.9 -45.9 91.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.447 -0.783 . . . . 0.0 110.041 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.737 ' HA ' HG21 ' A' ' 35' ' ' VAL . 26.4 m-85 -71.42 -27.13 63.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.287 -0.883 . . . . 0.0 110.245 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.8 120.8 26.48 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.262 -0.899 . . . . 0.0 110.346 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.44 -37.09 60.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.237 -0.914 . . . . 0.0 110.304 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 17.6 p-10 -92.09 -40.9 10.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.307 -0.871 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.98 48.58 2.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 44.8 p-10 -104.69 -7.72 19.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -1.162 . . . . 0.0 110.1 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 26' ' ' THR . . . 89.71 35.78 7.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 25' ' ' GLY . 20.0 p -155.68 107.73 2.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.292 -1.122 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 mt -95.3 119.48 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.137 -0.977 . . . . 0.0 110.326 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.684 HG22 HG22 ' A' ' 62' ' ' THR . 12.7 p -100.08 174.46 6.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.179 -0.951 . . . . 0.0 110.231 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.764 HG21 ' OE1' ' A' ' 49' ' ' GLN . 74.9 p -59.09 -31.91 69.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -55.33 9.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.153 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 39.5 mt-10 -55.02 -69.76 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.06 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 31' ' ' GLU . 12.6 tp -44.94 -41.84 7.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.761 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.21 -41.99 93.12 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 2.5 m -61.07 -50.78 71.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -1.113 . . . . 0.0 109.886 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.737 HG21 ' HA ' ' A' ' 19' ' ' PHE . 12.4 t -57.92 -42.27 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 mmt -61.07 -42.34 98.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.29 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 34' ' ' THR . 3.0 tpt180 -53.04 -40.82 64.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.242 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 40' ' ' GLY . 68.3 m -71.77 -44.22 64.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.553 -0.717 . . . . 0.0 109.461 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.754 ' CD2' HD21 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -43.5 -26.24 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.38 -0.825 . . . . 0.0 109.69 179.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 107.85 37.91 2.12 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 10.5 mm-40 -145.98 165.64 28.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.31 -1.112 . . . . 0.0 110.535 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -126.84 88.89 53.43 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 109.64 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.06 160.81 46.52 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.113 1.586 . . . . 0.0 110.93 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 45' ' ' GLU . 94.9 m -99.64 164.3 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.476 -0.765 . . . . 0.0 109.879 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -69.03 -69.95 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.16 -0.963 . . . . 0.0 110.073 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -43.33 -54.14 4.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.974 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.409 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 69.1 mm-40 -54.54 -41.39 69.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.014 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 51' ' ' MET . 3.4 mt -55.4 -42.7 74.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 0.0 109.906 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.764 ' OE1' HG21 ' A' ' 29' ' ' THR . 45.4 tp60 -67.36 -24.32 65.69 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.274 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -71.51 -46.98 58.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 109.974 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.496 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 24.7 ptm -73.21 -35.41 66.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 109.724 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.565 HG13 HG22 ' A' ' 29' ' ' THR . 7.8 mm -62.32 -32.46 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 109.529 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.24 -21.06 56.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.831 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.17 -37.99 87.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 110.154 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.535 HG13 ' HE2' ' A' ' 71' ' ' MET . 11.5 t -91.86 -31.8 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 110.176 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.1 71.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.261 -0.9 . . . . 0.0 110.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.27 -17.17 61.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.0 110.638 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.6 p30 -100.43 -31.87 11.09 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.143 -0.973 . . . . 0.0 110.609 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.54 42.48 4.82 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.426 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 12.6 m120 -84.03 -15.77 46.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.195 -1.179 . . . . 0.0 110.076 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 62' ' ' THR . . . 101.67 -8.41 56.39 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.684 HG22 HG22 ' A' ' 28' ' ' THR . 2.9 p -158.23 168.46 26.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.573 HG22 ' CZ ' ' A' ' 16' ' ' PHE . 30.2 mm -82.82 136.07 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 109.943 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.584 ' O ' ' CZ ' ' A' ' 16' ' ' PHE . 2.5 m-20 -114.27 174.01 6.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.307 -0.871 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.599 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 48.2 t80 -59.4 -49.85 90.37 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.404 -0.81 . . . . 0.0 111.714 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.1 Cg_endo -65.27 -38.37 27.28 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.169 1.089 . . . . 0.0 110.268 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -53.19 -33.9 54.66 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.136 -0.977 . . . . 0.0 109.335 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.549 ' HB2' ' CE1' ' A' ' 16' ' ' PHE . 21.9 t80 -78.05 -39.26 42.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 110.345 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 65' ' ' PHE . 2.3 mm? -55.49 -30.09 59.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.871 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.57 -63.21 1.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.041 -1.037 . . . . 0.0 111.37 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.535 ' HE2' HG13 ' A' ' 55' ' ' VAL . 2.1 tmm? -44.32 -37.92 3.6 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.068 -1.02 . . . . 0.0 111.548 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.649 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -67.08 -8.56 31.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.039 -1.038 . . . . 0.0 111.317 -179.014 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.97 -9.34 9.66 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.664 -1.273 . . . . 0.0 111.687 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -17.32 30.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.78 -1.2 . . . . 0.0 111.4 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.7 tptt . . . . . 0 N--CA 1.496 1.843 0 O-C-N 120.922 -1.111 . . . . 0.0 111.314 -179.292 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 85' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 121.408 0.623 . . . . 0.0 109.566 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -73.88 -34.95 64.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.067 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 31.9 mt-10 -69.08 -19.94 64.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.146 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 82' ' ' GLU . 40.7 mt -70.85 -39.42 75.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 109.053 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -27.72 63.22 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.426 -0.796 . . . . 0.0 108.959 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 5.4 mt-10 -70.94 -57.67 4.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.393 -0.817 . . . . 0.0 109.431 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.524 ' CB ' HD22 ' B' ' 12' ' ' LEU . . . -54.88 -27.54 43.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.046 -1.034 . . . . 0.0 109.173 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -66.15 -52.67 46.21 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.73 -34.53 12.28 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.871 . . . . 0.0 109.155 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.96 HG12 HG21 ' A' ' 108' ' ' VAL . 72.0 t -67.52 -42.73 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.442 -0.786 . . . . 0.0 109.59 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.675 ' HB3' HD13 ' A' ' 100' ' ' ILE . 56.5 m-85 -76.37 -24.13 54.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 96' ' ' GLY . 3.7 t0 -100.23 67.51 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.497 -0.752 . . . . 0.0 110.144 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -39.01 -44.83 1.14 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.595 -0.69 . . . . 0.0 110.351 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.434 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 1.8 p30 -82.64 -22.92 34.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 109.882 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 63.18 51.56 54.13 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.434 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 24.5 p-10 -99.85 -26.21 14.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -1.155 . . . . 0.0 110.166 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 122.08 18.81 3.4 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -153.35 130.99 11.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -1.145 . . . . 0.0 110.098 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.675 HD13 ' HB3' ' A' ' 92' ' ' PHE . 22.2 mt -103.95 157.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 110.419 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.8 OUTLIER -140.33 147.3 39.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.397 -0.814 . . . . 0.0 109.704 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.16 -30.9 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.869 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.49 -45.02 73.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.311 -0.868 . . . . 0.0 109.592 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 20.7 mt-10 -63.32 -47.53 81.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.257 -0.902 . . . . 0.0 109.555 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.944 HD13 HD11 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.39 -39.28 90.12 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.286 -0.884 . . . . 0.0 109.634 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.477 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 1.4 tmt_? -60.47 -29.05 68.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.359 -0.838 . . . . 0.0 109.823 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -31.78 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 110.048 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.96 HG21 HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -74.15 -36.71 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.979 . . . . 0.0 109.554 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.79 ' CB ' HD21 ' B' ' 17' ' ' LEU . 21.5 ptp -73.26 -39.99 64.98 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.566 ' N ' ' HG3' ' A' ' 109' ' ' MET . 87.1 m -69.54 -27.38 65.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.116 -0.99 . . . . 0.0 109.47 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -89.75 -13.14 37.39 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.42 -0.8 . . . . 0.0 109.302 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.754 HD21 ' CD2' ' A' ' 39' ' ' LEU . 9.2 mt -93.89 -32.65 13.83 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.449 -0.782 . . . . 0.0 110.006 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.05 -63.82 0.33 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.267 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 109' ' ' MET . 1.8 tt0 -94.11 156.1 16.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.114 -1.227 . . . . 0.0 110.679 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 116' ' ' LEU . 9.8 pttt -124.53 13.03 8.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' B' ' 17' ' ' LEU . 1.0 OUTLIER 40.66 -164.1 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.512 0.672 . . . . 0.0 110.56 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -166.28 1.3 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.387 -0.82 . . . . 0.0 109.567 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.436 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -97.17 -59.56 1.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.094 -1.004 . . . . 0.0 109.694 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 4.5 pt-20 -58.91 -30.29 67.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.515 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 9.2 tp10 -69.83 -48.17 59.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.403 -0.811 . . . . 0.0 109.321 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 t -57.28 -42.12 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.432 -0.793 . . . . 0.0 109.64 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 14.4 m-20 -69.2 -41.17 77.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.89 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 2.4 mt-10 -64.08 -31.01 72.04 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 110.007 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.608 ' HE1' ' HA ' ' B' ' 17' ' ' LEU . 1.0 OUTLIER -69.6 -42.05 74.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.176 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.944 HD11 HD13 ' A' ' 105' ' ' LEU . 35.0 mm -74.52 -23.88 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -74.44 -40.16 62.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.23 -0.919 . . . . 0.0 110.552 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.79 -8.96 58.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 110.266 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.476 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -101.26 -30.53 11.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.305 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.466 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -52.97 101.37 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.109 -0.994 . . . . 0.0 110.285 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.476 HD12 ' O ' ' A' ' 128' ' ' ALA . 1.2 mp -67.81 -27.37 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.197 -0.939 . . . . 0.0 109.813 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 41.6 p-10 -103.38 -25.48 13.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.63 72.38 1.27 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.466 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 5.5 p-10 -130.61 -0.83 4.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -1.168 . . . . 0.0 110.145 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.07 -2.7 75.9 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.435 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 40.9 mt-30 -142.54 160.7 39.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -1.226 . . . . 0.0 110.2 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 97.1 t -107.59 120.05 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.182 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 98' ' ' GLY . 10.4 t-20 -81.31 166.44 20.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.884 . . . . 0.0 110.15 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -57.7 -48.97 78.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.106 -0.996 . . . . 0.0 110.155 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -53.2 -30.67 38.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 109.934 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.84 -52.63 7.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.306 -0.871 . . . . 0.0 109.813 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.413 ' CE2' HG23 ' A' ' 85' ' ' ILE . 65.9 t80 -49.75 -21.79 1.2 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.2 -0.938 . . . . 0.0 109.593 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 146' ' ' THR . 17.1 t -94.04 -62.28 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.437 -0.789 . . . . 0.0 110.255 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -43.84 -49.55 8.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.877 . . . . 0.0 110.267 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 3.7 tpt -59.05 -19.14 41.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.869 . . . . 0.0 110.556 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 1.057 ' HE2' ' HB2' ' B' ' 24' ' ' ASN . 2.7 mtt -99.61 -24.63 14.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.168 -0.958 . . . . 0.0 110.501 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 142' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.147 -0.97 . . . . 0.0 110.344 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.659 HG23 ' HD2' ' B' ' 5' ' ' PRO . 20.0 mt . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.659 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.8 Cg_endo -65.27 122.63 10.41 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.843 1.444 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.526 ' O ' ' N ' ' B' ' 8' ' ' THR . 17.8 m -78.93 79.68 5.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.834 . . . . 0.0 111.015 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.406 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER 50.35 -86.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.329 -0.857 . . . . 0.0 111.106 179.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.526 ' N ' ' O ' ' B' ' 6' ' ' SER . 10.3 p -43.31 -30.05 0.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 110.733 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' B' ' 5' ' ' PRO . 83.8 m -64.86 -47.29 78.43 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.694 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.547 HG12 ' HZ ' ' A' ' 19' ' ' PHE . 5.5 t -61.39 -46.88 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.721 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' B' ' 15' ' ' SER . 76.4 mt -58.96 -30.27 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.165 -0.959 . . . . 0.0 109.488 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.618 ' HG ' ' CE2' ' B' ' 26' ' ' PHE . 3.2 tt -63.73 -56.81 12.79 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.436 -0.79 . . . . 0.0 110.26 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.666 HG21 HG11 ' A' ' 91' ' ' VAL . 67.2 t -54.38 -40.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.149 -0.969 . . . . 0.0 110.576 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.516 ' HD2' ' CA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -72.9 -44.06 61.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.944 -1.097 . . . . 0.0 109.661 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.436 ' HA ' ' HE2' ' B' ' 14' ' ' LYS . 20.7 p -67.26 -7.87 27.5 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.368 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.496 ' HB2' ' O ' ' B' ' 12' ' ' LEU . 2.0 ttt -93.15 -60.31 1.83 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.897 . . . . 0.0 110.871 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.944 HD22 ' O ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -102.51 91.88 4.42 Favored 'General case' 0 C--O 1.204 -1.315 0 CA-C-O 123.768 1.746 . . . . 0.0 110.667 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.462 ' HG3' ' N ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -124.87 -35.72 2.65 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.137 -0.977 . . . . 0.0 109.763 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.489 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 1.5 tmtm? -137.44 -72.46 0.43 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.201 -0.937 . . . . 0.0 110.558 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.449 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -161.23 23.54 0.13 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.138 -0.976 . . . . 0.0 109.501 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.446 ' O ' ' SD ' ' A' ' 124' ' ' MET . 3.6 m -100.97 166.42 10.83 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.65 -0.656 . . . . 0.0 110.903 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.576 ' CD1' ' HG2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -153.63 16.45 0.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.367 -0.833 . . . . 0.0 110.37 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.39 126.34 6.22 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 1.057 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 2.2 m-80 -112.83 135.36 21.62 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.177 -1.19 . . . . 0.0 110.951 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -81.46 11.85 2.92 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.027 1.541 . . . . 0.0 110.015 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.649 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 3.3 m-85 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.179 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 35.4 mt-30 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.269 0.557 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.1 mt -57.33 -38.64 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 109.671 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.39 79.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.588 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 26.4 mt-10 -60.23 -56.11 25.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -56.82 -36.12 69.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 109.466 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -42.66 98.37 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.294 -0.879 . . . . 0.0 109.045 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 17' ' ' SER . 4.7 tp10 -51.1 -45.26 61.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 109.149 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.86 -49.18 73.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 109.273 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.853 ' CE1' HD11 ' A' ' 27' ' ' ILE . 21.6 t80 -56.45 -29.38 61.6 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.418 -0.801 . . . . 0.0 109.744 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 3.6 t -68.83 -46.67 67.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 0.0 110.0 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.815 HD13 ' HG3' ' B' ' 14' ' ' LYS . 10.4 tt -55.03 -36.9 65.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 109.629 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 62.4 m-85 -79.38 -52.71 7.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.323 -0.86 . . . . 0.0 110.004 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -68.52 111.58 4.81 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.451 -0.78 . . . . 0.0 110.305 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -90.34 -44.15 9.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -0.841 . . . . 0.0 110.178 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 22.3 p30 -72.68 -16.48 61.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.288 -0.882 . . . . 0.0 110.244 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 64.48 65.78 2.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.9 p30 -130.95 -33.13 1.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -1.127 . . . . 0.0 110.235 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.587 ' C ' HG23 ' A' ' 26' ' ' THR . . . 114.33 38.39 1.12 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 25' ' ' GLY . 67.3 p -155.39 103.35 2.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.853 HD11 ' CE1' ' A' ' 16' ' ' PHE . 9.8 mt -88.98 110.77 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.067 -1.02 . . . . 0.0 110.0 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.928 HG22 HG22 ' A' ' 62' ' ' THR . 59.4 p -100.79 177.39 4.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.8 p -57.65 -19.92 29.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.026 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -73.78 -55.66 5.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.214 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HG2' ' HG3' ' A' ' 21' ' ' LYS . 6.1 mt-10 -64.25 -59.84 3.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.499 HD13 ' CH2' ' B' ' 7' ' ' TRP . 7.7 tp -62.98 -25.36 68.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 110.239 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.47 -35.95 55.29 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -71.58 -46.11 60.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.233 -1.157 . . . . 0.0 110.48 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.5 -40.98 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.204 -0.935 . . . . 0.0 110.394 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.508 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 6.9 mmm -69.26 -31.96 70.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 110.36 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.6 tpt180 -79.35 -20.54 47.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.464 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 68.0 m -70.7 -44.59 66.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 110.692 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.44 -36.1 21.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.09 -1.006 . . . . 0.0 110.368 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.26 32.8 0.66 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -120.69 -169.58 1.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.2 -1.177 . . . . 0.0 110.28 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -143.9 72.13 16.85 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.263 -0.898 . . . . 0.0 110.215 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.508 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 47.3 Cg_endo -74.22 105.51 2.05 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.035 1.545 . . . . 0.0 110.309 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.4 m -53.98 153.43 4.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.172 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 8.7 tm-20 -65.42 -43.34 90.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 109.956 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.02 -63.15 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.91 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -52.0 -36.44 49.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.2 mt -58.52 -50.49 73.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.902 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.502 ' O ' HG22 ' A' ' 52' ' ' ILE . 5.3 tp60 -54.01 -35.68 62.15 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.8 -34.39 69.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.352 -0.843 . . . . 0.0 109.545 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.401 ' HE3' ' CD1' ' B' ' 7' ' ' TRP . 0.2 OUTLIER -70.03 -26.17 63.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.488 -0.758 . . . . 0.0 110.104 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.623 HG13 HD11 ' A' ' 63' ' ' ILE . 1.2 tp -78.62 -41.23 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.986 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.434 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -54.56 -21.77 11.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -57.21 6.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.858 . . . . 0.0 110.068 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.679 ' HB ' HD12 ' A' ' 63' ' ' ILE . 17.1 t -71.69 -23.06 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.152 -0.968 . . . . 0.0 109.926 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -56.18 83.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.353 -0.842 . . . . 0.0 110.364 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.08 -71.31 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.096 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 26.2 p-10 -48.22 -42.02 29.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 101.7 41.61 2.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 1.6 p-10 -98.88 -44.34 6.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.118 -1.225 . . . . 0.0 110.077 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 143.48 -47.24 0.8 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.149 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.928 HG22 HG22 ' A' ' 28' ' ' THR . 26.5 p -94.16 158.59 15.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.208 -1.172 . . . . 0.0 110.895 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.679 HD12 ' HB ' ' A' ' 55' ' ' VAL . 12.4 mm -93.07 135.12 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.348 -0.845 . . . . 0.0 110.146 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.487 ' OD1' ' HD2' ' A' ' 66' ' ' PRO . 2.3 t70 -107.24 168.34 9.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.11 -0.994 . . . . 0.0 110.424 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.622 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 t80 -56.02 -44.82 99.88 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.397 -0.814 . . . . 0.0 111.245 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -70.26 -31.59 18.02 Favored 'Trans proline' 0 N--CA 1.482 0.83 0 O-C-N 123.298 1.157 . . . . 0.0 110.269 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.509 ' OE2' ' N ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -63.7 -34.55 78.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 109.341 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -71.61 -42.04 68.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.486 -0.759 . . . . 0.0 109.779 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 mt -58.16 -34.76 70.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 0.0 110.06 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -76.86 -33.74 57.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.561 ' SD ' HG22 ' A' ' 55' ' ' VAL . 42.1 ttp -64.84 -63.68 1.06 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.296 -0.877 . . . . 0.0 110.569 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.517 ' SD ' HG22 ' B' ' 8' ' ' THR . 9.9 tpt -54.4 -16.5 2.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.141 -0.974 . . . . 0.0 110.677 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.21 -33.02 14.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.068 -1.02 . . . . 0.0 110.662 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -98.64 -9.95 24.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.159 -0.963 . . . . 0.0 110.371 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.218 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HA ' HD12 ' A' ' 85' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.401 0.619 . . . . 0.0 109.378 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -67.04 -29.48 69.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.244 -0.91 . . . . 0.0 109.349 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.565 ' OE2' HD23 ' B' ' 12' ' ' LEU . 20.9 tt0 -61.71 -26.72 68.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.439 -0.788 . . . . 0.0 109.608 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 82' ' ' GLU . 65.3 mt -69.64 -36.79 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.464 -0.894 . . . . 0.0 108.86 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 89' ' ' PHE . 16.0 ttt180 -59.21 -36.85 76.12 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.562 0.696 . . . . 0.0 109.124 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.615 ' HB3' HG21 ' B' ' 9' ' ' THR . 6.0 mm-40 -67.09 -54.17 23.95 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.403 -0.811 . . . . 0.0 109.421 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.36 -31.28 21.65 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.136 -0.978 . . . . 0.0 108.83 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.46 ' HB3' ' O ' ' A' ' 86' ' ' ARG . 82.3 t80 -68.16 -67.1 0.49 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.418 -0.801 . . . . 0.0 109.912 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -45.25 -35.81 3.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.758 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.661 HG12 HG21 ' A' ' 108' ' ' VAL . 25.2 t -56.87 -50.39 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 109.344 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.629 ' CE1' HG11 ' A' ' 108' ' ' VAL . 25.3 m-85 -60.97 -31.62 71.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.672 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD2' ' OD1' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -98.77 62.2 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.373 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -43.42 -34.29 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.91 . . . . 0.0 110.067 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.4 p30 -77.08 -41.87 40.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 84.51 52.46 3.54 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.7 p-10 -100.06 -33.83 10.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.182 -1.187 . . . . 0.0 110.115 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.587 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 125.03 22.92 1.87 Allowed Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.577 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 85.9 m-85 -157.25 141.2 16.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.985 -1.303 . . . . 0.0 110.676 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 135' ' ' GLN . 6.3 mt -109.58 143.96 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.861 . . . . 0.0 110.153 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -139.6 152.3 46.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.145 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.39 -27.03 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 109.867 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -68.92 -47.75 64.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.562 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 6.9 mt-10 -63.79 -43.63 95.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.467 -0.771 . . . . 0.0 109.806 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.666 HD13 HD11 ' A' ' 125' ' ' ILE . 2.6 mt -67.58 -34.8 77.77 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.378 -0.826 . . . . 0.0 109.581 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.474 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 43.0 ttp180 -66.87 -27.94 67.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.292 -0.88 . . . . 0.0 109.752 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.67 -23.41 31.77 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.292 -0.88 . . . . 0.0 109.953 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.661 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -91.34 -29.12 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 109.97 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.555 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 21.9 ptp -76.84 -34.38 57.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 110.338 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' MET . 5.4 m -76.66 -28.65 56.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.052 -1.03 . . . . 0.0 109.65 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 38' ' ' SER . 2.3 m120 -82.7 -23.46 34.09 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.355 -0.84 . . . . 0.0 109.917 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.793 ' CD1' HG12 ' B' ' 13' ' ' VAL . 2.0 mt -82.84 -28.69 29.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.67 -64.24 0.39 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 109' ' ' MET . 4.1 tt0 -108.01 144.81 34.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -1.17 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.512 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 0.2 OUTLIER -119.36 22.33 11.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.855 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.747 HD11 ' C ' ' B' ' 17' ' ' LEU . 5.1 mp 46.9 -176.59 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.566 -0.709 . . . . 0.0 110.687 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.89 -143.59 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.232 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.11 -51.0 2.12 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.169 -0.957 . . . . 0.0 110.178 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -60.93 -38.47 85.93 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 109.519 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.59 -52.87 59.05 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.294 -0.879 . . . . 0.0 109.298 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 125' ' ' ILE . 41.4 t -47.18 -42.22 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.273 -0.892 . . . . 0.0 109.74 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.63 -63.71 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.808 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -48.12 -24.8 1.22 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.397 -0.814 . . . . 0.0 109.732 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.445 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -70.1 -44.08 69.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.779 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.666 HD11 HD13 ' A' ' 105' ' ' LEU . 25.9 mm -78.62 -25.39 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.365 -0.834 . . . . 0.0 110.102 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.25 -69.84 0.37 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.279 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -47.49 -25.37 1.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -78.24 -49.99 12.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 128' ' ' ALA . 34.7 t0 -41.95 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.487 -0.758 . . . . 0.0 110.547 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . 3.3 mp -75.37 -47.46 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.909 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.407 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 16.2 p-10 -77.23 -18.31 57.78 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.404 -0.81 . . . . 0.0 109.987 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.413 ' HA2' ' CG ' ' A' ' 129' ' ' ASP . . . 76.94 56.49 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 31.1 p30 -107.77 -8.51 16.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.08 17.31 56.27 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 10.2 pt20 -168.44 150.63 5.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -1.133 . . . . 0.0 109.95 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 13.0 t -89.37 125.68 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.173 -0.955 . . . . 0.0 110.435 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 9.6 t30 -93.8 -173.72 3.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.279 -0.888 . . . . 0.0 110.243 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 64.1 t80 -69.85 -56.54 6.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.181 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.68 -58.49 4.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.843 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' HD12 ' A' ' 130' ' ' ILE . 36.3 mt-10 -52.11 -45.45 64.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.317 -0.864 . . . . 0.0 109.883 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -57.86 -26.69 62.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 0.0 109.942 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.33 -39.8 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.835 . . . . 0.0 110.347 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -56.01 -46.88 78.62 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.215 -0.928 . . . . 0.0 110.062 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 77.5 mmm -63.51 -27.47 69.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.837 . . . . 0.0 110.308 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.54 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 3.9 mtt -90.18 -34.76 15.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.195 -0.941 . . . . 0.0 110.639 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 146' ' ' THR . 9.7 t . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.026 -1.046 . . . . 0.0 110.138 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 22.3 mt . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 39.6 Cg_endo -65.43 149.2 88.24 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.639 1.336 . . . . 0.0 110.272 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.576 ' O ' ' N ' ' B' ' 8' ' ' THR . 45.2 m -94.08 92.03 7.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.278 -0.889 . . . . 0.0 111.542 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.513 ' CE2' HG21 ' A' ' 55' ' ' VAL . 1.8 m95 37.48 -86.98 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.614 -0.679 . . . . 0.0 111.313 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.596 HG21 ' HG2' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -42.83 -48.62 5.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.247 -0.908 . . . . 0.0 109.802 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 87' ' ' GLU . 41.2 m -45.79 -37.76 6.41 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.378 -0.826 . . . . 0.0 109.218 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.462 ' H ' HG23 ' B' ' 10' ' ' VAL . 5.7 t -67.94 -42.03 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.71 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.495 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 9.7 mm -69.47 -26.73 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.785 . . . . 0.0 110.177 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.565 HD23 ' OE2' ' A' ' 84' ' ' GLU . 1.3 mm? -67.55 -56.52 9.14 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.392 -0.817 . . . . 0.0 110.138 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.793 HG12 ' CD1' ' A' ' 112' ' ' LEU . 9.6 t -57.31 -39.98 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.309 -0.869 . . . . 0.0 110.341 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.815 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.01 -32.28 72.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.767 -1.208 . . . . 0.0 109.596 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -41.57 89.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.339 -0.85 . . . . 0.0 109.239 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 7.2 mtt -75.12 -25.96 58.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.905 . . . . 0.0 109.753 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.747 ' C ' HD11 ' A' ' 116' ' ' LEU . 5.6 mp -81.25 49.94 1.35 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.375 -0.828 . . . . 0.0 109.697 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.512 ' N ' HD11 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -126.12 -73.5 0.62 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.247 -0.908 . . . . 0.0 111.714 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -158.67 90.64 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.105 -0.997 . . . . 0.0 111.177 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' B' ' 20' ' ' ARG . 19.6 ttp180 59.94 5.2 0.7 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.211 -0.931 . . . . 0.0 110.911 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.25 84.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.851 -1.156 . . . . 0.0 110.233 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.75 54.38 1.95 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 110.35 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.97 -111.7 0.64 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 145' ' ' MET . 1.2 t-20 -128.35 73.4 80.12 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.27 -1.135 . . . . 0.0 110.044 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.74 -2.26 10.6 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.127 1.593 . . . . 0.0 110.548 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.493 ' HE2' HD13 ' B' ' 12' ' ' LEU . 22.9 m-85 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.133 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.281 0.562 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.3 mt -53.32 -48.69 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.277 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -56.46 -38.38 71.6 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.287 -0.883 . . . . 0.0 109.101 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -54.07 -52.42 60.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.411 -0.805 . . . . 0.0 109.184 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.555 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 34.4 m-85 -63.32 -40.48 97.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.237 -0.915 . . . . 0.0 109.13 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -55.89 -44.0 77.77 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.466 -0.771 . . . . 0.0 108.94 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 59.7 mt-10 -56.87 -46.38 81.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.451 -0.781 . . . . 0.0 109.032 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.579 ' HB2' ' HD2' ' B' ' 14' ' ' LYS . . . -67.62 -51.66 47.48 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.322 -0.861 . . . . 0.0 109.281 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.598 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 19.8 t80 -45.12 -34.02 2.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.415 -0.803 . . . . 0.0 108.845 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.9 p -81.73 -32.58 31.51 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.627 -0.671 . . . . 0.0 109.215 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.748 ' O ' HD23 ' A' ' 18' ' ' LEU . 6.8 tt -49.74 -34.78 20.01 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.322 -0.862 . . . . 0.0 109.177 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.452 ' HA ' HG21 ' A' ' 35' ' ' VAL . 57.7 m-85 -82.61 -46.02 13.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.447 -0.783 . . . . 0.0 109.853 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 10.0 t70 -71.0 103.65 2.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 109.951 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -91.45 -31.21 16.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 110.454 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 29.9 p-10 -75.02 -46.59 34.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.299 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 108.94 45.65 1.01 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 49.1 p30 -115.73 -18.17 10.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -1.179 . . . . 0.0 110.009 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 91.69 5.42 66.69 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 16.7 p -120.14 116.24 25.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -1.141 . . . . 0.0 110.484 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.732 HD12 ' HB ' ' A' ' 63' ' ' ILE . 14.2 mt -90.84 124.33 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 109.877 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.414 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 7.8 p -100.3 178.36 4.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -63.12 -32.54 73.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.105 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 26.5 tptt -71.52 -54.4 10.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.273 -0.892 . . . . 0.0 110.308 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 41.3 mt-10 -49.41 -61.98 1.8 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 0.0 110.153 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.439 HD22 ' CZ2' ' B' ' 7' ' ' TRP . 35.5 tp -57.32 -31.5 65.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.97 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.409 ' HA2' HD11 ' A' ' 48' ' ' LEU . . . -67.03 -28.12 73.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.9 m -73.72 -52.08 14.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -1.101 . . . . 0.0 109.828 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.452 HG21 ' HA ' ' A' ' 19' ' ' PHE . 43.2 t -63.07 -35.37 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.947 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.5 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 4.1 mmt -66.26 -35.71 81.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.273 -0.892 . . . . 0.0 109.938 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.37 -24.4 60.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 110.117 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -76.15 -32.57 59.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.36 -0.837 . . . . 0.0 110.677 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 mt -53.81 -49.46 68.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.127 -0.983 . . . . 0.0 110.405 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 142.15 47.38 0.05 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 6.4 mm-40 -153.15 -167.4 2.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -1.127 . . . . 0.0 110.233 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -140.28 82.98 15.99 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.23 -0.919 . . . . 0.0 110.428 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 49.7 Cg_endo -76.79 148.63 28.76 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.978 1.515 . . . . 0.0 109.99 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.44 ' HB ' ' OE2' ' A' ' 47' ' ' GLU . 53.9 m -100.11 133.52 44.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.974 . . . . 0.0 110.227 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -42.34 -42.92 3.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.327 -0.858 . . . . 0.0 110.169 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' H ' HG22 ' A' ' 44' ' ' THR . . . -57.23 -54.4 47.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 109.742 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.44 ' OE2' ' HB ' ' A' ' 44' ' ' THR . 2.4 mt-10 -52.19 -38.02 56.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.369 -0.832 . . . . 0.0 109.681 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -56.7 -50.78 71.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.889 . . . . 0.0 109.724 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -50.77 -45.1 58.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.528 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.83 -23.58 66.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.439 -0.788 . . . . 0.0 109.537 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 2.2 mtp -86.92 -49.38 7.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 0.0 110.083 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 tp -57.47 -29.22 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.734 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -71.78 -5.29 33.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 110.474 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 51' ' ' MET . 2.4 mt-10 -86.95 -55.57 3.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 110.19 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 57' ' ' ALA . 38.9 t -70.25 -21.85 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 110.294 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.404 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 1.2 m-20 -66.89 64.01 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.185 -0.947 . . . . 0.0 110.389 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -51.5 -21.34 2.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.198 -0.939 . . . . 0.0 110.23 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.436 ' CG ' ' OD1' ' A' ' 60' ' ' ASN . 1.5 p30 -100.38 -32.44 10.83 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.34 -0.85 . . . . 0.0 110.418 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.71 52.82 2.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.436 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 5.7 m120 -99.25 -32.61 11.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.179 -1.189 . . . . 0.0 109.945 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.87 -14.3 12.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.4 p -139.66 165.14 28.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -1.07 . . . . 0.0 109.999 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.732 ' HB ' HD12 ' A' ' 27' ' ' ILE . 10.1 mm -96.83 165.89 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.319 -0.863 . . . . 0.0 110.102 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.541 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 35.2 m-20 -140.24 179.55 6.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.124 -0.985 . . . . 0.0 110.513 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.621 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 24.5 t80 -63.2 -44.27 83.15 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.33 -0.857 . . . . 0.0 111.52 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_endo -70.85 -36.04 8.51 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.359 1.189 . . . . 0.0 110.248 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 5.7 mt-10 -64.09 -29.32 70.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.393 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -50.77 23.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.0 mm? -50.52 -50.6 52.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 0.0 110.449 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.56 HG22 ' HG3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -60.79 -64.21 1.03 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.232 -0.917 . . . . 0.0 110.805 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' HB2' ' A' ' 75' ' ' LYS . 9.7 tpt -43.02 -62.27 1.07 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.042 -1.037 . . . . 0.0 110.696 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.555 ' HG3' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -39.16 -32.55 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.393 -0.817 . . . . 0.0 110.748 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.09 -48.26 3.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.164 -0.96 . . . . 0.0 110.474 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.56 ' HG3' HG22 ' A' ' 70' ' ' THR . 4.7 mtp180 -49.93 -67.39 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.256 -0.902 . . . . 0.0 110.438 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.75 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.375 -0.828 . . . . 0.0 110.42 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.207 0.527 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.52 -24.46 66.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.883 . . . . 0.0 109.678 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' HB3' ' CD1' ' B' ' 12' ' ' LEU . 9.2 mm-40 -67.7 -15.84 63.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.729 HG23 ' CE1' ' A' ' 141' ' ' PHE . 97.2 mt -70.68 -36.94 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.443 -0.785 . . . . 0.0 109.466 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 20.4 ttm-85 -59.71 -44.36 93.74 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.504 -0.747 . . . . 0.0 109.61 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.4 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 6.1 mm-40 -64.42 -51.6 62.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.286 -0.884 . . . . 0.0 109.609 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.826 ' HB2' HD22 ' B' ' 12' ' ' LEU . . . -60.39 -32.56 71.42 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.228 -0.92 . . . . 0.0 109.547 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.478 ' CE2' ' CG ' ' A' ' 138' ' ' TYR . 38.9 t80 -64.32 -43.12 95.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -29.04 70.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.834 . . . . 0.0 109.549 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.625 HG11 HG21 ' B' ' 13' ' ' VAL . 28.5 t -66.94 -51.94 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 0.0 110.209 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.706 ' CE1' HD23 ' A' ' 105' ' ' LEU . 11.8 m-85 -69.73 -29.71 67.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.199 -0.938 . . . . 0.0 110.013 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 94' ' ' LYS . 32.7 t0 -81.84 51.42 1.72 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 110.185 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -43.82 -30.37 0.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.214 -0.929 . . . . 0.0 110.259 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.95 -41.14 52.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.922 . . . . 0.0 110.119 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.98 -25.07 29.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.423 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 23.8 p-10 -51.03 -41.66 59.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -1.154 . . . . 0.0 110.328 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 119.02 60.13 0.27 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 1.9 m-85 -169.73 136.09 1.55 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.271 -1.135 . . . . 0.0 109.967 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 21.8 mt -112.49 106.47 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 110.58 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 102' ' ' ALA . 45.0 t -94.54 149.76 20.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.181 -0.95 . . . . 0.0 109.513 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.38 -27.25 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 0.0 109.827 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -71.95 -44.76 63.06 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 0.0 109.464 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' OE2' ' O ' ' A' ' 99' ' ' TYR . 21.6 mt-10 -60.94 -41.45 96.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 109.565 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.97 HD12 HD11 ' A' ' 125' ' ' ILE . 1.2 mt -58.34 -44.59 88.77 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.349 -0.844 . . . . 0.0 109.364 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.541 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.0 OUTLIER -58.26 -35.87 72.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.318 -0.864 . . . . 0.0 109.197 179.232 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.443 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 46.4 t60 -55.72 -52.67 63.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.43 -0.794 . . . . 0.0 109.173 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.623 HG21 HG12 ' A' ' 91' ' ' VAL . 1.5 t -74.3 -35.51 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.537 -0.727 . . . . 0.0 109.227 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.596 ' HE1' ' HB2' ' A' ' 116' ' ' LEU . 10.8 ttm -49.73 -60.69 2.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.553 -0.717 . . . . 0.0 110.608 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.546 HG23 ' HE2' ' A' ' 115' ' ' LYS . 12.1 m -78.34 -17.45 56.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.314 -0.866 . . . . 0.0 110.68 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.537 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 17.7 m-20 -75.56 -14.78 60.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.002 . . . . 0.0 110.056 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' B' ' 14' ' ' LYS . 3.1 mt -101.21 -52.7 3.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.627 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.74 -18.97 0.18 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.87 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 35.8 tp10 -108.1 155.99 19.79 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.843 -1.387 . . . . 0.0 111.112 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.546 ' HE2' HG23 ' A' ' 110' ' ' THR . 2.2 mttm -131.25 64.36 1.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.611 -0.68 . . . . 0.0 109.521 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.596 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 1.8 mp -36.18 151.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.485 0.66 . . . . 0.0 111.126 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.563 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -61.87 -174.48 0.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.778 . . . . 0.0 110.152 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.87 -59.5 2.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.208 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.88 -42.75 37.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 109.605 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -61.61 -53.7 52.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.545 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 117' ' ' THR . 53.0 t -57.81 -41.11 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 109.921 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -61.63 -58.24 8.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.854 . . . . 0.0 109.845 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -54.81 -37.59 66.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.308 -0.87 . . . . 0.0 109.706 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.551 ' O ' ' CD2' ' B' ' 22' ' ' PHE . 9.4 ttt -52.42 -44.14 65.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.911 . . . . 0.0 109.515 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.97 HD11 HD12 ' A' ' 105' ' ' LEU . 38.7 mm -78.44 -53.08 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.066 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -44.11 -68.52 0.19 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.83 . . . . 0.0 110.636 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 126' ' ' ARG . 1.3 tp10 -39.02 -53.93 1.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.535 -0.728 . . . . 0.0 110.755 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.582 ' HB3' HG22 ' A' ' 136' ' ' VAL . . . -58.92 -34.88 72.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 110.382 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.456 ' OD2' ' N ' ' A' ' 135' ' ' GLN . 1.6 t0 -65.78 68.45 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.434 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -60.07 -42.36 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.27 -0.894 . . . . 0.0 109.908 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.6 -35.97 78.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.195 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.53 71.92 1.24 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.0 p30 -121.71 -25.29 5.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.308 -1.113 . . . . 0.0 110.089 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 129.6 -20.6 5.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.456 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 16.0 pt20 -154.6 170.23 22.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -1.154 . . . . 0.0 110.26 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 128' ' ' ALA . 46.5 t -79.49 164.44 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.252 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.427 ' N ' HG12 ' A' ' 136' ' ' VAL . 12.5 t-20 -133.4 173.18 11.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.305 -0.872 . . . . 0.0 110.112 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.478 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -57.38 -68.22 0.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.261 -0.899 . . . . 0.0 110.26 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 143' ' ' GLN . 10.3 mm-40 -40.81 -53.26 2.9 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.447 -0.783 . . . . 0.0 110.023 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 141' ' ' PHE . 50.3 mt-10 -55.41 -57.86 10.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 109.505 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.729 ' CE1' HG23 ' A' ' 85' ' ' ILE . 3.7 t80 -43.62 -27.38 0.3 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.429 -0.794 . . . . 0.0 109.5 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 144' ' ' MET . 73.9 t -99.56 -64.39 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 139' ' ' GLU . 28.5 tp60 -43.07 -24.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.306 -0.871 . . . . 0.0 110.604 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 142' ' ' VAL . 1.8 tpt -84.31 -32.66 24.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 111.025 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.9 mtp -100.66 -11.42 20.01 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.017 -1.052 . . . . 0.0 111.947 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 146' ' ' THR . 9.0 t . . . . . 0 N--CA 1.497 1.884 0 O-C-N 120.705 -1.247 . . . . 0.0 111.175 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.893 HG23 ' HD2' ' B' ' 5' ' ' PRO . 22.1 mt . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.893 ' HD2' HG23 ' B' ' 4' ' ' ILE . 36.0 Cg_endo -59.38 114.61 2.11 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.303 1.159 . . . . 0.0 109.858 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.538 ' O ' ' N ' ' B' ' 8' ' ' THR . 13.5 t -78.34 90.07 4.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.573 -0.704 . . . . 0.0 112.303 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.481 ' O ' ' N ' ' B' ' 10' ' ' VAL . 8.7 m95 43.99 -86.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.59 -0.694 . . . . 0.0 112.229 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.75 HG21 ' HG2' ' A' ' 75' ' ' LYS . 63.1 p -38.57 -46.96 1.25 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.537 -0.727 . . . . 0.0 110.945 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 97.5 m -48.87 -36.9 18.09 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.242 -0.911 . . . . 0.0 109.276 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' B' ' 7' ' ' TRP . 60.5 t -73.05 -43.07 59.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 46.7 mt -70.94 -21.82 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 109.974 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.826 HD22 ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -72.53 -50.62 24.46 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.625 HG21 HG11 ' A' ' 91' ' ' VAL . 42.7 t -71.14 -39.01 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.124 -0.985 . . . . 0.0 110.446 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.714 ' HA ' HD13 ' A' ' 112' ' ' LEU . 2.7 tmtt? -59.64 -47.54 85.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.775 -1.203 . . . . 0.0 109.263 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 35.0 p -53.52 -48.85 68.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.451 -0.781 . . . . 0.0 109.228 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 10.6 ttm -54.82 -27.7 43.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.314 -0.866 . . . . 0.0 109.872 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.697 HD22 ' CD1' ' A' ' 112' ' ' LEU . 7.0 mp -79.71 49.51 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.249 -0.907 . . . . 0.0 110.574 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -96.6 -83.06 0.39 Allowed 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.331 -0.856 . . . . 0.0 109.769 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -140.44 -41.14 0.42 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.365 -0.835 . . . . 0.0 109.475 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' B' ' 21' ' ' SER . 2.4 ttt-85 -149.63 -41.53 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' B' ' 22' ' ' PHE . 26.8 t 29.73 -126.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.093 0.473 . . . . 0.0 111.32 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 124' ' ' MET . 1.5 m-85 61.99 57.74 2.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 110.519 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.468 ' C ' ' HD2' ' B' ' 25' ' ' PRO . . . -142.99 -165.01 10.46 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.721 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 39.0 p-10 -107.1 -2.83 0.11 Allowed Pre-proline 0 CA--C 1.569 1.697 0 O-C-N 121.28 -1.129 . . . . 0.0 112.974 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 48.0 Cg_endo -73.46 76.92 2.63 Favored 'Trans proline' 0 N--CA 1.485 0.971 0 O-C-N 122.304 0.634 . . . . 0.0 110.498 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.431 ' CE2' ' HG ' ' B' ' 12' ' ' LEU . 12.8 t80 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.228 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.222 0.534 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.7 mt -44.7 -50.02 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.226 -0.921 . . . . 0.0 110.296 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -49.84 -51.31 40.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 12' ' ' PHE . 9.5 tm-20 -51.58 -45.46 63.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 110.089 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CD1' ' OE1' ' A' ' 11' ' ' GLU . 18.8 m-30 -55.2 -44.42 75.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 110.014 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -53.68 -49.77 67.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.936 . . . . 0.0 109.803 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.47 -47.18 66.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 110.083 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -60.96 -46.55 90.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.813 . . . . 0.0 110.235 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.525 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 34.9 t80 -57.65 -45.36 85.62 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 110.041 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.0 t -70.18 -17.1 63.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.85 . . . . 0.0 110.0 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.923 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.0 tt -69.99 -55.42 9.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.976 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.46 ' N ' HD23 ' A' ' 18' ' ' LEU . 91.4 m-85 -72.43 -11.97 60.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 0.0 110.27 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 21' ' ' LYS . 25.4 t0 -97.5 69.54 2.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' ASP . 20.3 mmtt -42.47 -71.24 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.328 -0.858 . . . . 0.0 110.126 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 2.4 p-10 -51.95 -41.23 61.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.383 -0.823 . . . . 0.0 110.062 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.4 46.72 5.71 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.464 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 39.4 p-10 -103.23 6.79 38.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.202 . . . . 0.0 110.238 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.69 ' O ' HG23 ' A' ' 26' ' ' THR . . . 78.3 30.38 50.25 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 25' ' ' GLY . 10.0 p -158.12 104.09 1.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -1.139 . . . . 0.0 110.28 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.53 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 9.5 mt -80.6 125.52 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.227 -0.921 . . . . 0.0 109.8 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p -100.1 165.74 11.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.385 -0.822 . . . . 0.0 110.68 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.9 p -56.47 -41.69 76.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.851 . . . . 0.0 110.214 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -62.02 -53.16 59.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 110.248 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' OE2' ' OD1' ' A' ' 22' ' ' ASP . 15.1 mt-10 -52.02 -68.74 0.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 110.092 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.516 HD22 HD11 ' A' ' 52' ' ' ILE . 23.8 tp -49.58 -32.51 12.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.898 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.97 -53.94 36.95 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.0 m -48.12 -47.17 34.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -1.151 . . . . 0.0 109.686 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.444 ' H ' HG23 ' A' ' 35' ' ' VAL . 6.3 t -61.01 -51.49 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.352 -0.843 . . . . 0.0 109.739 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.466 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 5.2 mmt -57.88 -39.61 78.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.84 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -34.9 72.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 110.016 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 39' ' ' LEU . 1.4 m -68.07 -48.11 66.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.164 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 38' ' ' SER . 9.5 mt -44.21 -25.3 0.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.873 . . . . 0.0 110.261 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.81 50.64 0.68 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 36' ' ' MET . 0.3 OUTLIER -154.61 -163.31 1.56 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -1.127 . . . . 0.0 110.224 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -151.79 102.15 2.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.055 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.62 119.23 5.82 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.016 1.535 . . . . 0.0 110.524 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 47' ' ' GLU . 9.1 m -76.05 155.3 34.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.301 -0.874 . . . . 0.0 110.22 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -45.64 -69.64 0.13 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 110.026 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.06 -47.28 65.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.999 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' CG ' ' HB ' ' A' ' 44' ' ' THR . 13.0 mt-10 -46.35 -55.44 7.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.265 -0.897 . . . . 0.0 110.095 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.425 HD23 HD23 ' A' ' 32' ' ' LEU . 1.1 mt -53.78 -40.26 66.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.75 -34.7 77.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.974 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -41.15 97.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.838 . . . . 0.0 110.156 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.8 mtp -74.7 -41.27 60.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.316 -0.865 . . . . 0.0 110.251 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.516 HD11 HD22 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -71.15 -14.84 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.197 -0.939 . . . . 0.0 109.699 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.87 -18.63 36.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.288 -0.883 . . . . 0.0 110.187 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.86 -50.95 9.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.521 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 57' ' ' ALA . 10.7 t -72.95 -22.23 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.175 -0.953 . . . . 0.0 110.021 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.87 86.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.363 -0.835 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -80.31 -46.11 16.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.202 -0.936 . . . . 0.0 110.436 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 12.2 p-10 -75.94 -42.5 48.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.084 -1.01 . . . . 0.0 110.409 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.53 44.92 2.22 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 27.0 p-10 -99.48 -38.2 8.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -1.206 . . . . 0.0 110.383 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 128.78 0.95 6.02 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.4 p -145.85 161.77 39.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -1.127 . . . . 0.0 110.072 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' THR . 17.2 mm -86.69 152.21 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.185 -0.947 . . . . 0.0 110.518 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.525 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 29.6 m-20 -127.35 -173.15 2.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 110.542 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.763 ' CE1' HD11 ' A' ' 69' ' ' LEU . 5.0 t80 -74.39 -42.07 5.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.418 -0.801 . . . . 0.0 111.326 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -72.94 -24.57 17.41 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.274 1.144 . . . . 0.0 110.395 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 3.5 mt-10 -70.82 -32.43 69.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.394 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -77.41 -33.81 54.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.893 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.763 HD11 ' CE1' ' A' ' 65' ' ' PHE . 85.1 mt -72.75 -26.91 61.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.339 -0.851 . . . . 0.0 111.21 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 p -89.32 -34.77 16.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.902 -1.124 . . . . 0.0 111.227 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.419 ' HE1' HG23 ' B' ' 8' ' ' THR . 0.3 OUTLIER -74.59 -39.24 62.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.137 -0.977 . . . . 0.0 111.022 -179.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.844 ' SD ' HG21 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -63.87 -22.11 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.05 -1.031 . . . . 0.0 110.879 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -94.94 -9.72 33.24 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.928 -1.107 . . . . 0.0 110.882 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 27.0 tpt180 -82.36 -46.88 13.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.161 -0.962 . . . . 0.0 110.747 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.05 -39.3 34.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.468 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.61 -27.0 61.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.622 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.77 -26.19 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.404 ' HG2' ' OH ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -68.96 -29.1 67.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.39 0.614 . . . . 0.0 109.444 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.907 ' HB3' HG21 ' B' ' 9' ' ' THR . 24.7 mt-10 -76.57 -47.79 21.36 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.281 -0.887 . . . . 0.0 109.199 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.579 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -57.97 -33.88 69.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.083 -1.01 . . . . 0.0 108.86 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -66.76 -48.09 70.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.432 -0.792 . . . . 0.0 109.464 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -52.69 -30.89 34.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.387 -0.821 . . . . 0.0 109.573 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 63.7 t -67.72 -53.18 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.818 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.669 ' CB ' HD13 ' A' ' 100' ' ' ILE . 67.0 m-85 -63.02 -15.02 55.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.135 -0.978 . . . . 0.0 109.989 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -100.04 65.01 1.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 110.436 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -40.97 -72.05 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.383 -0.823 . . . . 0.0 110.486 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.1 p30 -61.03 -28.44 69.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.01 50.13 7.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -99.73 -7.27 25.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.294 -1.121 . . . . 0.0 110.357 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.7 29.58 8.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.417 ' CD1' ' CD ' ' A' ' 135' ' ' GLN . 0.9 OUTLIER -161.31 143.19 11.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -1.139 . . . . 0.0 110.081 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.669 HD13 ' CB ' ' A' ' 92' ' ' PHE . 17.3 mt -118.71 158.26 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.522 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 102' ' ' ALA . 23.2 p -148.07 155.76 41.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.387 -0.82 . . . . 0.0 109.927 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.1 -43.1 3.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.332 -0.855 . . . . 0.0 110.205 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.78 -51.09 68.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.839 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 92' ' ' PHE . 17.9 mt-10 -58.74 -47.75 83.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 0.0 109.959 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.0 HD12 ' CD1' ' A' ' 125' ' ' ILE . 2.1 mt -62.62 -33.92 75.99 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.271 -0.893 . . . . 0.0 109.696 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -61.63 -34.07 75.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.248 -0.908 . . . . 0.0 109.431 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 10.0 t-80 -68.26 -43.67 77.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.402 -0.812 . . . . 0.0 109.588 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.675 HG13 HD12 ' A' ' 112' ' ' LEU . 1.2 t -64.16 -34.42 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 109.896 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.991 ' HA ' HD21 ' B' ' 17' ' ' LEU . 4.8 mtt -53.63 -70.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.608 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.6 m -55.38 -16.78 3.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.898 . . . . 0.0 110.554 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 9.0 m120 -94.67 -6.49 43.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.103 -0.998 . . . . 0.0 110.392 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.923 ' O ' HD11 ' A' ' 18' ' ' LEU . 9.6 mt -132.06 6.95 4.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.037 -1.04 . . . . 0.0 111.686 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.3 -93.34 0.13 Allowed Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.404 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' CG ' ' N ' ' A' ' 115' ' ' LYS . 15.3 tt0 -136.53 166.07 24.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -1.076 . . . . 0.0 110.408 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -103.6 118.66 37.23 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.641 ' N ' HD12 ' A' ' 116' ' ' LEU . 9.3 mp -64.83 155.31 34.4 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 121.446 -0.784 . . . . 0.0 110.336 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.637 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -49.09 178.8 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.365 -0.835 . . . . 0.0 109.274 179.436 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.79 -57.23 4.24 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.89 -1.131 . . . . 0.0 110.263 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.97 -49.01 31.91 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.195 -0.94 . . . . 0.0 109.669 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -57.69 -60.51 3.58 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 108.978 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 117' ' ' THR . 79.1 t -47.32 -44.58 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.299 -0.876 . . . . 0.0 109.416 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -50.53 71.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.292 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.569 ' HB3' ' HG3' ' B' ' 20' ' ' ARG . 0.2 OUTLIER -57.83 -31.24 66.44 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.183 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.571 ' SD ' HD13 ' A' ' 105' ' ' LEU . 9.3 ttt -60.1 -43.85 95.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.475 -0.766 . . . . 0.0 109.294 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.0 ' CD1' HD12 ' A' ' 105' ' ' LEU . 37.6 mm -84.87 -27.12 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.923 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -45.06 78.47 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.315 -0.866 . . . . 0.0 110.314 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.08 -36.18 82.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.339 -0.851 . . . . 0.0 110.165 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.23 -32.45 58.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.381 -0.824 . . . . 0.0 110.124 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 0.7 OUTLIER -73.04 63.65 0.68 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.75 -58.85 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.524 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 1.7 p30 -55.07 -36.13 65.27 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.582 -0.698 . . . . 0.0 109.784 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 98.48 69.17 0.93 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 131' ' ' ASP . 3.2 m-20 -121.89 -4.59 9.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -1.192 . . . . 0.0 110.133 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.55 -9.88 63.56 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 2.8 pt20 -142.97 168.02 20.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -1.147 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 140' ' ' GLU . 5.2 t -112.82 155.76 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.203 -0.936 . . . . 0.0 110.243 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.431 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 17.6 p-10 -125.79 -144.81 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.335 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.404 ' OH ' ' HG2' ' A' ' 86' ' ' ARG . 1.1 t80 -80.15 -70.08 0.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.277 -0.89 . . . . 0.0 110.547 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 143' ' ' GLN . 26.4 mt-10 -43.03 -38.43 2.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.201 -0.937 . . . . 0.0 110.429 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.536 ' HB3' HG13 ' A' ' 136' ' ' VAL . 32.8 mt-10 -68.54 -62.26 1.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.271 -0.893 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -51.93 -22.1 3.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.3 -0.875 . . . . 0.0 110.645 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.56 -52.56 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.102 -0.999 . . . . 0.0 110.838 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.466 ' CB ' ' O ' ' A' ' 139' ' ' GLU . 4.5 tp60 -57.84 -13.03 3.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.267 -0.895 . . . . 0.0 110.832 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.8 mmm -99.34 -18.21 17.64 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.001 -1.062 . . . . 0.0 110.765 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.0 mtp -100.49 -69.25 0.78 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.041 -1.037 . . . . 0.0 110.836 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.942 . . . . 0.0 110.373 -179.599 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 120.687 0.279 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.73 -176.45 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.081 1.569 . . . . 0.0 110.928 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.427 ' OG ' ' OE2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -106.4 178.65 4.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.329 -0.857 . . . . 0.0 110.501 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.52 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -54.11 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.415 -0.803 . . . . 0.0 110.911 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.478 ' HA ' HD12 ' B' ' 11' ' ' ILE . 55.9 p -44.82 -50.58 10.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 110.151 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.907 HG21 ' HB3' ' A' ' 87' ' ' GLU . 37.9 m -44.01 -50.37 8.34 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.444 -0.785 . . . . 0.0 109.633 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 24.9 t -57.22 -34.83 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.191 -0.943 . . . . 0.0 109.233 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.844 HG21 ' SD ' ' A' ' 72' ' ' MET . 18.4 mt -74.08 -30.49 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 108.722 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -58.38 8.62 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.543 -0.723 . . . . 0.0 109.378 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.609 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 81.0 t -59.12 -51.19 75.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.554 -0.716 . . . . 0.0 110.373 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.448 ' HG3' HD13 ' A' ' 18' ' ' LEU . 2.4 tmtm? -51.6 -58.57 5.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.025 -1.047 . . . . 0.0 109.878 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -51.15 -25.95 6.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.403 -0.811 . . . . 0.0 110.194 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.49 ' O ' ' HB2' ' B' ' 21' ' ' SER . 6.3 tpp -70.88 -32.78 69.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.991 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.9 mp -64.68 -102.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.965 -1.084 . . . . 0.0 109.838 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.567 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 55.32 -72.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.505 -0.747 . . . . 0.0 110.85 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -173.43 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.321 -0.862 . . . . 0.0 110.952 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.569 ' HG3' ' HB3' ' A' ' 123' ' ' GLU . 7.0 tmm_? 73.97 -7.1 1.69 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.892 -1.13 . . . . 0.0 110.297 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' B' ' 16' ' ' MET . 36.0 m -46.79 116.09 1.24 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.045 -1.034 . . . . 0.0 109.779 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -148.51 -32.84 0.24 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.174 -0.954 . . . . 0.0 111.282 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' B' ' 22' ' ' PHE . . . -54.81 -111.41 0.01 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.46 ' OD1' ' OXT' ' B' ' 26' ' ' PHE . 4.8 t30 -116.42 96.23 47.4 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.24 -1.153 . . . . 0.0 110.242 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.5 -18.45 20.08 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.099 1.579 . . . . 0.0 110.337 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.46 ' OXT' ' OD1' ' B' ' 24' ' ' ASN . 46.0 m-85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.285 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.6 mt -53.63 -38.4 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.3 -0.875 . . . . 0.0 108.751 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -52.03 -46.95 65.22 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.284 -0.885 . . . . 0.0 108.806 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.475 ' CD ' ' HD2' ' B' ' 18' ' ' ARG . 6.0 tt0 -53.69 -53.9 45.47 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.217 -0.927 . . . . 0.0 108.819 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -55.57 -40.27 71.75 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.373 -0.829 . . . . 0.0 108.856 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -59.43 -40.38 86.55 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 17' ' ' SER . 8.3 tt0 -49.61 -55.12 14.72 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.453 -0.78 . . . . 0.0 108.95 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.05 -55.99 24.82 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.506 -0.878 . . . . 0.0 108.76 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.547 ' HD1' HD11 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -49.1 -26.85 2.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 3.2 m -87.85 -36.33 17.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.541 -0.724 . . . . 0.0 109.113 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.763 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.8 tt -47.98 -34.61 9.55 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.389 -0.819 . . . . 0.0 109.376 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.751 ' HA ' HG21 ' A' ' 35' ' ' VAL . 73.4 m-85 -81.8 -28.66 33.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.824 . . . . 0.0 109.986 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 5.0 t0 -87.36 81.54 7.84 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.213 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -52.56 -56.97 11.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 110.374 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.42 ' OD1' ' CG ' ' A' ' 24' ' ' ASP . 3.0 p30 -59.16 -41.17 87.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 110.373 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.86 57.6 1.7 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 35.5 p-10 -114.33 10.4 17.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.231 -1.158 . . . . 0.0 110.293 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.97 15.18 73.96 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 1.2 p -141.72 116.6 9.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -1.225 . . . . 0.0 110.275 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.547 HD11 ' HD1' ' A' ' 16' ' ' PHE . 13.4 mt -92.27 112.92 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.149 -0.97 . . . . 0.0 109.738 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.482 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 18.8 p -75.95 -160.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.915 . . . . 0.0 110.354 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.408 ' O ' HD22 ' A' ' 48' ' ' LEU . 22.0 p -88.82 -45.4 9.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 110.543 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.549 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 21.5 pttt -71.63 -25.87 62.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.026 -1.046 . . . . 0.0 110.574 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.797 ' O ' HG23 ' A' ' 35' ' ' VAL . 47.2 mt-10 -63.15 -44.67 94.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.031 -1.043 . . . . 0.0 109.491 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 48' ' ' LEU . 2.9 tp -67.35 -48.18 68.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.332 -0.855 . . . . 0.0 109.649 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.81 -44.96 49.36 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.8 m -61.17 -57.15 13.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.353 -1.086 . . . . 0.0 109.736 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 31' ' ' GLU . 21.4 t -50.42 -40.46 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.213 -0.929 . . . . 0.0 109.655 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 4.7 mmt -60.82 -47.57 85.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.268 -0.895 . . . . 0.0 109.412 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.456 ' NE ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -47.79 -38.23 15.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.395 179.224 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -63.04 -45.27 93.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.564 -0.71 . . . . 0.0 110.705 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 3.1 mt -57.88 -34.47 69.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.165 -0.959 . . . . 0.0 110.455 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.37 63.65 0.32 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.456 ' O ' ' NE ' ' A' ' 37' ' ' ARG . 1.9 pt20 -160.75 -175.66 5.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.309 -1.112 . . . . 0.0 109.922 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -131.12 95.08 25.94 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.068 -1.02 . . . . 0.0 110.624 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HG3' ' HB2' ' A' ' 36' ' ' MET . 47.2 Cg_endo -75.34 123.49 7.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.041 1.548 . . . . 0.0 110.177 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.421 ' HB ' ' HG3' ' A' ' 47' ' ' GLU . 17.4 m -94.98 168.5 10.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' N ' HG22 ' A' ' 44' ' ' THR . 37.9 tt0 -57.44 -56.45 21.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.121 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.37 -55.26 16.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 0.0 110.258 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' A' ' 44' ' ' THR . 2.6 mm-40 -51.23 -52.86 40.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 110.006 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 32' ' ' LEU . 9.0 mt -46.61 -64.28 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.81 -34.81 63.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.419 -0.801 . . . . 0.0 110.075 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.55 -33.91 69.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 110.285 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.517 ' O ' ' NE1' ' B' ' 7' ' ' TRP . 9.8 mtp -81.17 -34.59 32.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -0.85 . . . . 0.0 110.023 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 10.9 mm -74.53 -36.62 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -0.867 . . . . 0.0 109.76 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -68.04 -20.39 64.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.394 -0.816 . . . . 0.0 110.135 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.04 -42.67 66.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 110.383 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 57' ' ' ALA . 8.7 t -83.8 -51.04 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -41.76 90.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.651 . . . . 0.0 110.428 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -83.36 -36.43 24.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.462 -0.774 . . . . 0.0 110.747 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' OD2' ' CG ' ' A' ' 60' ' ' ASN . 6.5 p-10 -72.17 -48.26 44.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.032 -1.042 . . . . 0.0 110.535 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.89 35.94 1.09 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 29.2 p-10 -98.56 -46.02 5.88 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.016 -1.285 . . . . 0.0 110.314 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 118.43 13.69 6.75 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.5 p -144.4 141.44 29.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.16 -1.2 . . . . 0.0 110.538 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.546 ' HB ' HD12 ' A' ' 27' ' ' ILE . 35.4 mm -85.21 142.25 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.219 -0.925 . . . . 0.0 109.902 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -121.81 -175.66 3.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.075 -1.015 . . . . 0.0 110.593 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.6 t80 -65.97 -45.99 63.96 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.416 -0.802 . . . . 0.0 111.54 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.2 Cg_endo -68.62 -38.86 10.01 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 O-C-N 123.092 1.048 . . . . 0.0 110.395 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.61 -30.46 69.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.112 -0.992 . . . . 0.0 109.274 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CG ' ' HB2' ' A' ' 16' ' ' PHE . 4.1 t80 -69.92 -46.02 66.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.54 -0.725 . . . . 0.0 109.902 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.0 mm? -53.78 -53.05 57.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.353 -0.842 . . . . 0.0 110.303 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 71' ' ' MET . 1.5 p -66.04 -63.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.269 -0.895 . . . . 0.0 110.708 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.46 ' HG3' HG13 ' A' ' 55' ' ' VAL . 6.8 tmm? -40.51 -36.87 0.62 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.848 ' SD ' HG21 ' B' ' 11' ' ' ILE . 7.0 tpt -61.76 -12.1 15.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.224 -0.922 . . . . 0.0 110.702 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.02 -10.01 4.82 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.04 -1.037 . . . . 0.0 111.223 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -24.61 15.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.998 -1.064 . . . . 0.0 110.363 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.653 ' HB3' HG21 ' B' ' 8' ' ' THR . 2.1 tppm? . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 0.0 110.414 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.217 0.532 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 3.6 tt0 -55.29 -43.47 74.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.069 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' HG3' HD12 ' B' ' 12' ' ' LEU . 19.3 tp10 -45.79 -50.21 14.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.345 -0.847 . . . . 0.0 110.495 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -70.76 -38.53 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.109 -0.994 . . . . 0.0 109.397 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 31.5 ttt180 -58.84 -30.64 67.84 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.367 -0.833 . . . . 0.0 109.916 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.615 ' HB3' HG21 ' B' ' 9' ' ' THR . 76.9 mm-40 -74.07 -55.33 6.24 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.273 -0.892 . . . . 0.0 109.665 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.42 -29.69 49.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 0.0 109.149 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -71.89 -34.5 69.2 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.159 -0.963 . . . . 0.0 109.083 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -63.84 -27.32 69.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.445 -0.784 . . . . 0.0 109.197 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.422 HG12 HG21 ' A' ' 108' ' ' VAL . 17.1 t -75.31 -43.98 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.517 -0.739 . . . . 0.0 110.151 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.519 ' CZ ' HG22 ' B' ' 13' ' ' VAL . 24.1 m-85 -67.01 -35.92 80.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.157 -0.965 . . . . 0.0 110.338 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -73.29 54.66 0.43 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.326 -0.859 . . . . 0.0 110.502 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 93' ' ' ASP . 13.4 tppt? -41.65 -46.63 3.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.0 110.288 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 21.4 p-10 -87.97 -26.78 22.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.56 47.55 12.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 31.6 p-10 -94.41 -22.35 18.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -1.121 . . . . 0.0 110.099 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.482 ' C ' ' CD2' ' A' ' 99' ' ' TYR . . . 110.76 15.23 11.23 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD2' ' C ' ' A' ' 98' ' ' GLY . 91.2 m-85 -150.72 137.73 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.307 -1.113 . . . . 0.0 110.181 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' GLN . 7.1 mt -101.71 150.74 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.13 -0.981 . . . . 0.0 110.14 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -138.48 146.78 42.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.151 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -44.88 -29.08 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.93 . . . . 0.0 109.843 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.75 79.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -0.843 . . . . 0.0 109.664 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.412 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 7.6 mt-10 -61.85 -45.03 95.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.494 ' CD1' HD11 ' A' ' 125' ' ' ILE . 1.5 mt -66.1 -38.09 87.37 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.354 -0.841 . . . . 0.0 109.267 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.493 ' HG2' ' NH2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -55.62 -35.83 66.3 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.406 -0.809 . . . . 0.0 109.084 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -71.03 -47.6 57.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.5 -0.75 . . . . 0.0 109.363 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG21 HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -60.5 -23.51 28.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.381 -0.824 . . . . 0.0 109.024 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.948 ' HA ' HD21 ' B' ' 17' ' ' LEU . 5.1 mtt -69.28 -63.51 1.05 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.503 -0.748 . . . . 0.0 109.812 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.3 m -56.94 -30.37 63.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.191 -0.943 . . . . 0.0 109.236 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 12.5 m120 -74.77 -17.79 60.58 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.459 -0.776 . . . . 0.0 109.671 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.875 HD11 HG12 ' B' ' 13' ' ' VAL . 3.9 mt -95.41 -48.08 6.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.858 . . . . 0.0 110.212 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.09 -30.12 0.22 Allowed Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.529 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 109' ' ' MET . 29.4 tt0 -125.05 171.22 10.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.873 -1.369 . . . . 0.0 110.941 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -144.98 75.7 1.46 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.798 HD21 ' CA ' ' B' ' 19' ' ' LYS . 2.4 mp -34.79 156.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.641 0.734 . . . . 0.0 111.494 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -57.1 -150.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.0 110.387 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.517 ' H ' HG22 ' A' ' 117' ' ' THR . 1.4 p-10 -109.76 -53.89 2.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.236 -0.915 . . . . 0.0 110.38 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.35 -44.46 84.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.019 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.93 -42.13 97.44 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.829 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.42 HG23 ' HB3' ' A' ' 116' ' ' LEU . 71.8 t -64.62 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.947 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -60.28 -45.19 94.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -61.47 -38.07 85.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 109.582 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -54.06 -49.25 69.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.162 -0.961 . . . . 0.0 109.681 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' CD1' ' A' ' 105' ' ' LEU . 37.5 mm -70.16 -26.48 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -70.14 -26.51 63.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.902 . . . . 0.0 109.917 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -71.46 -44.5 64.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.867 . . . . 0.0 110.064 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.853 ' HB2' ' HD2' ' B' ' 22' ' ' PHE . . . -71.44 -33.41 69.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.381 -0.824 . . . . 0.0 110.049 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -60.44 75.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.33 -0.857 . . . . 0.0 110.4 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 128' ' ' ALA . 21.5 mt -72.16 -31.34 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.968 . . . . 0.0 110.232 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 34.8 p-10 -83.94 -27.13 28.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.148 -0.97 . . . . 0.0 110.275 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.94 71.17 1.24 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 4.0 p30 -126.57 -23.37 3.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.244 -1.151 . . . . 0.0 110.468 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 104.63 -0.78 42.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 4.8 pt20 -151.18 166.67 30.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 110.204 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 53.3 t -110.68 151.77 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -131.95 -164.92 1.51 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.143 -0.973 . . . . 0.0 110.397 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.752 ' CE1' HG21 ' A' ' 142' ' ' VAL . 9.2 t80 -62.13 -65.82 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.229 -0.919 . . . . 0.0 110.72 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -41.87 -50.02 4.46 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.216 -0.927 . . . . 0.0 110.677 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -63.96 -59.99 3.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.965 . . . . 0.0 110.394 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.423 ' CE1' ' HE2' ' A' ' 92' ' ' PHE . 50.1 t80 -51.75 -20.57 2.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 110.523 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.752 HG21 ' CE1' ' A' ' 138' ' ' TYR . 41.6 t -100.51 -60.28 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.179 -0.951 . . . . 0.0 110.791 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 142' ' ' VAL . 9.5 tt0 -40.36 -45.82 2.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.31 -0.869 . . . . 0.0 110.762 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.445 ' O ' ' OD1' ' B' ' 24' ' ' ASN . 3.7 mmt -66.59 -26.8 67.28 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 110.419 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.485 ' N ' ' O ' ' A' ' 142' ' ' VAL . 19.9 mmm -96.07 -45.99 6.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.079 -1.013 . . . . 0.0 110.937 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.467 HG21 HG13 ' A' ' 142' ' ' VAL . 34.5 p . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.116 -0.99 . . . . 0.0 110.984 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.672 HG23 ' HD2' ' B' ' 5' ' ' PRO . 35.1 mm . . . . . 0 N--CA 1.506 2.329 0 CA-C-O 120.667 0.27 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.672 ' HD2' HG23 ' B' ' 4' ' ' ILE . 42.3 Cg_endo -69.1 -157.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.936 1.493 . . . . 0.0 111.035 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' B' ' 7' ' ' TRP . 55.7 p -132.67 57.81 1.78 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.062 -1.024 . . . . 0.0 111.449 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.517 ' NE1' ' O ' ' A' ' 51' ' ' MET . 0.7 OUTLIER 64.27 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.972 -1.08 . . . . 0.0 111.575 178.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -46.33 -46.91 18.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 110.393 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 87' ' ' GLU . 26.0 m -45.83 -40.24 9.55 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.151 -0.968 . . . . 0.0 109.483 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.442 HG12 ' HZ ' ' A' ' 19' ' ' PHE . 10.2 t -66.03 -44.04 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.528 -0.733 . . . . 0.0 110.061 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.848 HG21 ' SD ' ' A' ' 72' ' ' MET . 51.7 mt -69.39 -25.29 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.288 -0.883 . . . . 0.0 109.907 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.532 HD23 ' C ' ' B' ' 12' ' ' LEU . 4.8 tt -67.08 -49.57 64.61 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 110.34 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.875 HG12 HD11 ' A' ' 112' ' ' LEU . 47.9 t -65.13 -46.96 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 110.561 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.649 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -58.61 -33.71 70.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.842 -1.161 . . . . 0.0 109.688 179.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 0.1 OUTLIER -63.95 -43.89 94.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.409 ' O ' ' N ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -59.18 -32.43 69.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.0 110.114 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.948 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.4 mp -69.4 58.65 0.12 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.161 -0.962 . . . . 0.0 110.345 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' B' ' 20' ' ' ARG . 3.0 ttp180 -123.84 76.22 1.42 Allowed 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.891 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.798 ' CA ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER 62.74 -57.77 0.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.605 -0.684 . . . . 0.0 111.042 179.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' B' ' 18' ' ' ARG . 0.7 OUTLIER -166.9 22.61 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.24 -0.913 . . . . 0.0 110.38 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' B' ' 18' ' ' ARG . 66.2 m -74.8 126.55 31.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.188 -0.945 . . . . 0.0 110.363 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.853 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -145.11 -40.64 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.118 -0.989 . . . . 0.0 110.913 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' B' ' 22' ' ' PHE . . . -46.37 -99.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 145' ' ' MET . 80.5 m-20 -138.3 88.11 15.23 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.144 -1.209 . . . . 0.0 110.719 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.63 -12.28 18.43 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.847 1.446 . . . . 0.0 110.036 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.642 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 5.5 m-30 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.269 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.554 ' CG ' ' N ' ' A' ' 9' ' ' ILE . 12.8 pt20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.099 0.476 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.554 ' N ' ' CG ' ' A' ' 8' ' ' GLN . 83.8 mt -67.02 -50.43 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.023 -1.048 . . . . 0.0 109.375 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.47 64.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 109.303 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 37.8 tt0 -58.84 -52.95 63.54 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.401 -0.812 . . . . 0.0 109.478 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.567 ' CE2' ' HG3' ' A' ' 72' ' ' MET . 1.6 m-85 -53.23 -43.67 67.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.349 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -59.53 -41.69 90.57 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.765 . . . . 0.0 109.525 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -49.52 77.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.311 -0.868 . . . . 0.0 109.487 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.84 83.94 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.351 -0.843 . . . . 0.0 109.355 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.509 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 38.8 t80 -61.29 -21.68 64.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.501 -0.749 . . . . 0.0 109.575 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -89.64 -31.39 17.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.451 -0.781 . . . . 0.0 109.694 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.924 HD13 ' HG3' ' B' ' 14' ' ' LYS . 10.4 tt -61.33 -44.72 96.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.866 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 74.8 m-85 -74.27 -47.38 35.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 110.193 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -67.18 73.0 0.11 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 19' ' ' PHE . 9.3 mmtt -64.89 -8.99 17.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 110.389 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -93.83 -29.55 15.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.351 -0.843 . . . . 0.0 110.167 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.11 33.61 44.51 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 23.5 p30 -104.81 -15.56 15.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.19 -1.182 . . . . 0.0 110.176 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 26' ' ' THR . . . 93.61 31.0 8.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 25' ' ' GLY . 24.7 p -156.02 118.3 4.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -1.155 . . . . 0.0 110.29 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.656 HD12 ' CG2' ' A' ' 63' ' ' ILE . 7.3 mt -92.9 125.74 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.014 -1.054 . . . . 0.0 110.093 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.1 p -100.5 -175.65 2.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.501 -0.749 . . . . 0.0 109.462 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.649 ' O ' HD22 ' A' ' 48' ' ' LEU . 2.9 p -76.13 -22.54 55.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.007 . . . . 0.0 109.822 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -73.03 -46.21 53.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 110.234 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.42 -62.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.473 ' HG ' ' HE3' ' A' ' 36' ' ' MET . 34.5 tp -54.88 -30.15 57.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.013 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.655 ' CA ' HD21 ' A' ' 48' ' ' LEU . . . -68.67 -32.33 74.38 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.1 m -71.88 -59.8 2.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -1.129 . . . . 0.0 110.16 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 35' ' ' VAL . 25.7 t -50.79 -46.34 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.955 . . . . 0.0 110.167 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.594 ' HE1' ' SD ' ' A' ' 51' ' ' MET . 0.3 OUTLIER -58.77 -47.59 84.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.259 -0.901 . . . . 0.0 110.098 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -24.95 58.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.883 . . . . 0.0 110.124 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.402 ' O ' ' CG ' ' A' ' 111' ' ' ASN . 36.3 t -77.98 -34.27 51.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.881 . . . . 0.0 110.513 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.58 HD12 ' HA ' ' A' ' 36' ' ' MET . 3.5 mt -53.97 -42.85 69.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.186 -0.946 . . . . 0.0 110.276 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.49 51.21 0.06 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.98 -162.13 1.49 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -1.127 . . . . 0.0 110.225 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.54 70.92 14.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.82 118.71 5.84 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.913 1.48 . . . . 0.0 110.243 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 3.1 m -82.02 152.62 26.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.888 . . . . 0.0 110.42 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -48.65 -53.74 17.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.41 -42.19 66.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.827 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 44' ' ' THR . 4.2 mm-40 -59.5 -52.11 66.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.861 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.655 HD21 ' CA ' ' A' ' 33' ' ' GLY . 1.7 mt -44.29 -57.21 3.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.903 . . . . 0.0 109.946 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.69 -45.47 28.43 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 109.597 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.04 -39.42 78.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.484 -0.76 . . . . 0.0 109.668 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.594 ' SD ' ' HE1' ' A' ' 36' ' ' MET . 1.6 ttp -74.96 -51.03 14.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 109.64 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 52' ' ' ILE . 1.9 mm -47.95 -24.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.226 -0.921 . . . . 0.0 109.221 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.22 -14.78 59.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 110.204 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -79.59 -8.42 59.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.253 -0.905 . . . . 0.0 110.428 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.695 HG23 ' CD1' ' B' ' 7' ' ' TRP . 54.9 t -118.34 -53.86 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.062 -1.024 . . . . 0.0 110.675 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -19.27 82.6 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.459 0.647 . . . . 0.0 112.014 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.77 -60.88 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.455 -0.778 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 13.6 p30 -68.32 -21.61 64.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.9 . . . . 0.0 109.988 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 72.11 48.0 28.05 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -97.18 -44.96 6.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.171 -1.194 . . . . 0.0 110.181 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . 139.32 -2.11 2.52 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.392 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 166.33 30.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.833 -1.392 . . . . 0.0 110.759 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.656 ' CG2' HD12 ' A' ' 27' ' ' ILE . 10.5 mm -101.68 122.38 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.459 -0.775 . . . . 0.0 110.037 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 p30 -110.03 -179.64 3.85 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.021 -1.049 . . . . 0.0 110.754 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.661 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 t80 -63.31 -39.55 51.13 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.287 -0.883 . . . . 0.0 112.121 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.7 Cg_endo -69.47 -29.82 24.61 Favored 'Trans proline' 0 C--N 1.32 -0.952 0 O-C-N 123.078 1.041 . . . . 0.0 109.973 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 71' ' ' MET . 23.8 mt-10 -75.2 -30.66 60.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 109.309 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.735 ' HZ ' HD12 ' B' ' 11' ' ' ILE . 10.5 t80 -66.96 -42.64 84.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.471 -0.768 . . . . 0.0 109.762 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.644 HD11 ' CE1' ' A' ' 65' ' ' PHE . 4.7 mt -70.11 -32.06 69.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.83 . . . . 0.0 110.326 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -87.73 -43.25 12.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.954 . . . . 0.0 110.557 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -59.78 -32.92 71.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.118 -0.989 . . . . 0.0 110.263 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.567 ' HG3' ' CE2' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -69.13 -11.95 61.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.882 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.77 -35.27 5.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.385 -0.822 . . . . 0.0 110.051 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -68.42 -41.14 80.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 110.135 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.1 tptt . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.82 . . . . 0.0 110.145 179.926 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.317 0.579 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 1.8 mm-40 -66.85 -9.88 42.28 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 0.0 109.929 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.4 -30.28 57.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.261 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.773 ' CD1' HG21 ' A' ' 146' ' ' THR . 75.1 mt -75.82 -32.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -36.82 84.09 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.438 -0.789 . . . . 0.0 109.623 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.763 ' HB3' HG21 ' B' ' 9' ' ' THR . 5.7 mm-40 -69.32 -45.58 69.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.82 ' HB2' HD11 ' B' ' 12' ' ' LEU . . . -60.62 -34.77 74.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.143 -0.973 . . . . 0.0 110.066 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 29.5 t80 -68.44 -40.93 80.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 109.653 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -60.85 -29.7 69.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.343 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.548 HG12 HG21 ' A' ' 108' ' ' VAL . 65.6 t -72.79 -55.06 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.006 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.679 ' HB3' HD13 ' A' ' 100' ' ' ILE . 37.5 m-85 -53.62 -29.87 40.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.258 -0.901 . . . . 0.0 109.975 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -100.44 67.14 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.459 -0.776 . . . . 0.0 110.101 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -41.36 -25.95 0.05 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.399 -0.813 . . . . 0.0 110.415 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.5 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 15.7 p-10 -102.09 -41.69 6.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 109.961 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.22 49.86 5.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 42.0 p-10 -92.18 -23.55 19.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 124.95 26.33 1.39 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.57 ' CZ ' ' OD1' ' A' ' 137' ' ' ASN . 1.1 m-85 -170.52 158.22 6.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.974 -1.309 . . . . 0.0 110.617 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.679 HD13 ' HB3' ' A' ' 92' ' ' PHE . 10.0 mt -126.97 120.19 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.271 -0.893 . . . . 0.0 110.28 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -101.38 145.91 28.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -0.988 . . . . 0.0 109.802 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.84 -31.89 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 109.726 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.1 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.343 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 101' ' ' SER . 7.4 mt-10 -60.49 -48.6 81.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.442 -0.786 . . . . 0.0 109.367 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.865 HD11 ' HZ ' ' B' ' 22' ' ' PHE . 0.3 OUTLIER -59.04 -41.95 89.06 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.298 -0.876 . . . . 0.0 108.912 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.433 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 18.7 ttp180 -51.62 -36.7 46.91 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -60.11 -56.08 26.06 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.548 HG21 HG12 ' A' ' 91' ' ' VAL . 2.5 t -59.78 -34.73 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.333 -0.855 . . . . 0.0 108.792 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.873 ' HA ' HD21 ' B' ' 17' ' ' LEU . 3.7 mtt -57.35 -69.42 0.16 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.652 -0.655 . . . . 0.0 110.829 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.536 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 93.7 m -55.57 -21.68 18.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.062 -1.024 . . . . 0.0 109.876 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 38' ' ' SER . 57.1 m-20 -84.34 -10.32 57.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.169 -0.957 . . . . 0.0 109.801 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.914 HD11 HG12 ' B' ' 13' ' ' VAL . 6.8 mt -108.94 -40.37 5.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.304 -0.872 . . . . 0.0 110.549 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 167.12 -64.71 0.2 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.355 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.415 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 1.2 tp10 -107.93 171.45 7.39 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.201 -1.176 . . . . 0.0 110.841 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 1.3 mptp? -130.29 5.38 4.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 0.0 110.698 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.683 HD21 ' HA ' ' B' ' 19' ' ' LYS . 1.4 mp 57.08 152.91 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.073 0 O-C-N 121.599 -0.688 . . . . 0.0 110.469 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.585 HG22 ' H ' ' A' ' 118' ' ' ASP . 1.2 m -60.72 -151.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.02 -1.05 . . . . 0.0 109.478 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.585 ' H ' HG22 ' A' ' 117' ' ' THR . 6.7 p-10 -113.38 -33.4 5.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 110.173 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -71.21 -45.2 63.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 109.97 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 124' ' ' MET . 12.6 pt-20 -68.71 -35.79 77.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.627 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.574 HG23 ' HB3' ' A' ' 116' ' ' LEU . 23.3 t -63.14 -37.3 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.871 . . . . 0.0 109.575 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.19 -47.8 40.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 1.2 tp10 -67.22 -30.91 70.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.359 -0.838 . . . . 0.0 109.268 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.567 ' CG ' ' HA ' ' B' ' 21' ' ' SER . 1.5 ttt -61.18 -46.32 90.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.496 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.669 HD11 ' CD1' ' A' ' 105' ' ' LEU . 22.0 mm -70.79 -56.62 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 0.0 109.821 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 127' ' ' GLU . 7.5 mtp85 -53.93 -62.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.377 -0.827 . . . . 0.0 110.014 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 8.7 tp10 -42.07 -28.13 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.403 -0.811 . . . . 0.0 110.191 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.503 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -90.98 -34.45 15.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.902 . . . . 0.0 110.026 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 20.1 m-20 -57.75 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.38 -0.825 . . . . 0.0 110.587 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -52.04 -34.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.954 . . . . 0.0 109.618 179.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 47.5 p-10 -94.48 -16.91 22.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 110.108 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 61.37 79.07 0.14 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 8.8 p30 -123.33 5.39 9.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -1.15 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.14 15.44 66.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.563 ' HG3' ' CE1' ' A' ' 99' ' ' TYR . 6.1 pt20 -169.74 169.41 8.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -1.155 . . . . 0.0 109.99 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 9.8 t -116.63 159.16 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.119 -0.988 . . . . 0.0 110.418 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.57 ' OD1' ' CZ ' ' A' ' 99' ' ' TYR . 1.2 t30 -123.56 -167.18 1.58 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.369 -0.832 . . . . 0.0 110.014 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.516 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 1.7 t80 -74.73 -64.32 1.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.184 -0.948 . . . . 0.0 109.993 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -44.36 -48.5 9.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.913 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 144' ' ' MET . 3.4 tt0 -55.58 -56.19 23.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.34 -0.85 . . . . 0.0 110.229 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -51.87 -19.71 1.88 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.4 t -96.46 -70.32 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.062 -1.024 . . . . 0.0 110.883 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -45.36 -48.59 13.34 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.1 -1.0 . . . . 0.0 110.794 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.515 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 11.8 tpt -72.26 -10.38 59.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.722 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.1 tpp -100.69 -47.83 4.71 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.95 -1.094 . . . . 0.0 111.044 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.773 HG21 ' CD1' ' A' ' 85' ' ' ILE . 1.7 t . . . . . 0 N--CA 1.496 1.872 0 O-C-N 121.106 -0.996 . . . . 0.0 110.344 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.658 HG23 ' HD2' ' B' ' 5' ' ' PRO . 84.4 mt . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.658 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.0 Cg_endo -62.91 124.55 14.23 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.641 1.337 . . . . 0.0 110.217 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 1.009 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.3 OUTLIER -58.13 170.19 0.71 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.678 0.751 . . . . 0.0 111.25 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.695 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -56.13 -80.06 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.448 0.642 . . . . 0.0 110.383 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' B' ' 11' ' ' ILE . 38.7 p -45.21 -40.69 7.55 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.413 -0.805 . . . . 0.0 109.755 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 87' ' ' GLU . 94.4 m -49.92 -48.17 51.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.233 -0.917 . . . . 0.0 109.177 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 1.009 HG23 ' O ' ' B' ' 6' ' ' SER . 15.8 t -61.06 -29.42 45.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.387 -0.821 . . . . 0.0 109.246 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.735 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 26.5 mm -77.73 -55.18 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.66 -0.65 . . . . 0.0 111.441 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 88' ' ' ALA . 3.9 pp -56.88 -33.03 66.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.188 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.914 HG12 HD11 ' A' ' 112' ' ' LEU . 24.2 t -67.09 -50.33 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.952 -1.093 . . . . 0.0 108.755 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.924 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -62.07 -24.45 67.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.205 -0.935 . . . . 0.0 108.633 178.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' B' ' 18' ' ' ARG . 1.4 p -75.38 -27.52 59.14 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.434 0.635 . . . . 0.0 109.36 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.496 ' O ' ' N ' ' B' ' 18' ' ' ARG . 8.4 mtt -73.31 -32.29 64.51 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.412 -0.805 . . . . 0.0 108.968 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.873 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.0 mp -67.76 58.8 0.06 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.518 -0.739 . . . . 0.0 109.229 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' B' ' 16' ' ' MET . 5.7 mtm180 -84.47 -80.99 0.19 Allowed 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.769 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.683 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -176.82 -67.31 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.052 -1.03 . . . . 0.0 111.472 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.53 ' N ' ' CD ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -87.83 -21.73 24.88 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.373 -0.829 . . . . 0.0 112.074 -178.156 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.567 ' HA ' ' CG ' ' A' ' 124' ' ' MET . 4.0 m -163.71 -175.0 3.91 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.453 -1.404 . . . . 0.0 112.554 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.865 ' HZ ' HD11 ' A' ' 105' ' ' LEU . 11.3 m-85 -78.78 -85.83 0.07 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.418 0.628 . . . . 0.0 110.567 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.45 -151.55 21.83 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.526 ' N ' ' HD2' ' B' ' 25' ' ' PRO . 0.1 OUTLIER 176.93 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.201 -1.176 . . . . 0.0 110.681 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' B' ' 24' ' ' ASN . 42.6 Cg_endo -69.45 111.3 2.71 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.764 1.402 . . . . 0.0 110.195 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.619 ' CE2' ' HB3' ' B' ' 12' ' ' LEU . 2.1 t80 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.243 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.276 0.56 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.7 mt -60.16 -35.86 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.528 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.35 -56.27 22.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 110.144 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -55.72 -47.61 76.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.083 -1.011 . . . . 0.0 109.958 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -58.91 -41.82 88.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.0 109.43 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -62.1 -31.4 71.84 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.244 -0.91 . . . . 0.0 108.923 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 6.3 tp10 -57.62 -53.45 58.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.499 -0.75 . . . . 0.0 109.166 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -51.7 -55.58 18.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 109.219 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.536 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 86.5 t80 -52.99 -36.28 60.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.495 -0.753 . . . . 0.0 109.366 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.2 t -76.05 -26.95 57.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.567 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.8 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.1 tt -58.8 -44.16 90.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.901 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -75.22 -25.91 58.53 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.216 -0.927 . . . . 0.0 110.281 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.72 106.08 14.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.233 -0.917 . . . . 0.0 110.1 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -99.66 5.87 45.73 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.216 -0.927 . . . . 0.0 110.49 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.8 p30 -116.65 -51.68 2.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.155 -0.966 . . . . 0.0 110.397 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 114.08 39.87 1.02 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 13.6 p30 -111.65 -16.14 13.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.137 -1.214 . . . . 0.0 110.233 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.54 -1.18 81.39 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 68.3 p -118.46 108.94 15.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.18 -1.188 . . . . 0.0 110.37 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 17.9 mt -77.82 124.49 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.289 -0.882 . . . . 0.0 109.966 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.414 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 1.1 p -97.35 -178.79 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.374 -0.829 . . . . 0.0 110.316 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.757 HG21 ' NE2' ' A' ' 49' ' ' GLN . 40.6 p -73.59 -33.8 64.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.122 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -43.83 86.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 0.0 110.23 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' OE2' ' OG1' ' A' ' 28' ' ' THR . 53.6 mt-10 -60.06 -60.21 4.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.459 HD23 ' CD2' ' A' ' 48' ' ' LEU . 3.7 tp -58.73 -32.37 69.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.89 -33.26 86.77 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.1 m -71.94 -47.93 48.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -1.141 . . . . 0.0 110.14 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.63 -55.57 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.266 -0.896 . . . . 0.0 110.566 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.533 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 3.8 mmt -55.47 -36.44 66.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 110.179 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -64.11 -33.04 74.87 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -44.63 81.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 110.689 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 91' ' ' VAL . 10.7 mt -47.83 -37.96 14.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.006 -1.059 . . . . 0.0 109.923 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.74 17.27 19.55 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -82.05 -131.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.122 -1.222 . . . . 0.0 110.182 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.541 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 7.6 p30 -159.05 58.28 1.22 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.95 -1.094 . . . . 0.0 110.627 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 49.4 Cg_endo -82.87 83.14 2.02 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.931 1.49 . . . . 0.0 110.186 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 45' ' ' GLU . 2.7 m -50.0 176.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.144 -0.972 . . . . 0.0 110.297 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' H ' HG22 ' A' ' 44' ' ' THR . 3.8 mm-40 -70.13 -59.54 2.83 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.267 -0.896 . . . . 0.0 110.075 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -44.2 -36.23 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.872 . . . . 0.0 109.844 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -70.71 -38.74 73.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.904 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.459 ' CD2' HD23 ' A' ' 32' ' ' LEU . 12.1 mt -55.78 -54.71 41.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.915 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.757 ' NE2' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -60.1 -40.4 89.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.631 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.453 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -63.98 -36.35 83.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 109.578 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.49 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -66.93 -47.01 73.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.908 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -63.56 -30.42 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 109.335 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.27 -16.99 61.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.705 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -72.72 -57.17 4.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.498 -0.751 . . . . 0.0 110.379 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.675 HG23 ' CD1' ' B' ' 7' ' ' TRP . 37.6 t -71.33 -29.83 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.913 -1.117 . . . . 0.0 109.936 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -48.67 88.47 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.347 -0.846 . . . . 0.0 110.565 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -69.06 -27.4 65.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.321 -0.862 . . . . 0.0 110.452 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 8.6 p-10 -95.85 -41.91 8.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.216 -0.927 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.83 47.67 1.46 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 18.8 p-10 -98.46 -44.07 6.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -1.137 . . . . 0.0 110.24 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.57 6.66 5.05 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.14 154.99 41.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.121 -1.223 . . . . 0.0 110.35 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.0 mm -97.07 166.18 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.274 -0.891 . . . . 0.0 110.122 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 4.8 t0 -148.11 169.94 18.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.125 -0.984 . . . . 0.0 110.568 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.659 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 19.9 t80 -59.39 -41.24 86.03 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.849 . . . . 0.0 111.961 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -68.73 -23.88 35.45 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 O-C-N 123.142 1.075 . . . . 0.0 110.473 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.58 -36.27 29.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -62.01 -42.91 99.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 110.239 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.62 -34.6 58.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.197 -0.939 . . . . 0.0 110.543 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.5 m -74.56 -12.44 60.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.062 -1.024 . . . . 0.0 110.768 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.9 tmm? -98.6 -43.68 6.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.045 -1.035 . . . . 0.0 110.76 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -10.89 6.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -0.958 . . . . 0.0 110.784 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.01 -17.23 28.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.055 -1.028 . . . . 0.0 110.927 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -97.05 -18.33 19.44 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.961 -1.087 . . . . 0.0 110.72 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.948 ' HG3' HG21 ' B' ' 8' ' ' THR . 17.8 mmtp . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.073 -1.017 . . . . 0.0 110.537 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.225 0.536 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -72.73 -35.57 67.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.791 ' HG2' HD12 ' B' ' 12' ' ' LEU . 8.3 tt0 -70.26 -42.09 72.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.83 . . . . 0.0 110.168 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.675 HG23 ' CE2' ' A' ' 141' ' ' PHE . 46.5 mt -68.63 -26.79 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.782 . . . . 0.0 109.718 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -66.9 -49.69 64.79 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.465 -0.772 . . . . 0.0 109.709 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.4 mt-10 -59.53 -48.83 80.15 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.301 -0.875 . . . . 0.0 109.695 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -56.07 -31.63 63.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.588 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 4.7 t80 -67.99 -63.85 0.98 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.133 -0.98 . . . . 0.0 109.682 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' PHE . 3.9 mmt85 -41.34 -32.75 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.656 -0.653 . . . . 0.0 109.826 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.674 HG12 HG21 ' A' ' 108' ' ' VAL . 71.4 t -65.5 -47.02 88.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.353 -0.842 . . . . 0.0 109.465 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.624 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 43.9 m-85 -68.94 -18.44 64.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.309 -0.869 . . . . 0.0 110.028 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.522 ' HA ' ' OE2' ' A' ' 104' ' ' GLU . 1.9 t0 -96.98 60.68 1.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.334 -0.854 . . . . 0.0 110.478 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -42.07 -61.26 1.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.261 -0.899 . . . . 0.0 110.278 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 9.4 p30 -55.28 -28.97 57.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.143 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 74.81 42.84 30.02 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.0 p30 -100.13 -48.96 4.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -1.181 . . . . 0.0 110.262 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 148.66 -33.7 1.17 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -95.61 153.98 17.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.146 -1.208 . . . . 0.0 110.314 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.486 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 17.0 mt -121.27 127.52 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.259 -0.901 . . . . 0.0 110.251 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.0 p -111.28 164.13 13.22 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.352 -0.842 . . . . 0.0 109.998 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.699 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -55.95 -33.71 65.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.53 89.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.011 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.522 ' OE2' ' HA ' ' A' ' 93' ' ' ASP . 14.3 mt-10 -58.89 -50.06 75.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.749 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.442 ' HG ' HD11 ' A' ' 125' ' ' ILE . 2.5 mm? -55.61 -42.72 75.26 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.215 -0.928 . . . . 0.0 109.748 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -18.65 65.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.205 -0.934 . . . . 0.0 109.339 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 1.7 m80 -82.52 -30.15 29.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.759 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.674 HG21 HG12 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -83.92 -41.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.306 -0.871 . . . . 0.0 109.647 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 1.056 ' HE2' HD13 ' A' ' 116' ' ' LEU . 16.8 mtt -44.35 -70.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 110.292 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 m -49.35 -46.38 46.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.445 -0.784 . . . . 0.0 109.935 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 5.2 m120 -59.04 -16.04 16.6 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.405 -0.809 . . . . 0.0 109.74 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.8 ' O ' HD11 ' A' ' 18' ' ' LEU . 8.1 mt -106.74 -45.89 4.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.34 -0.85 . . . . 0.0 110.537 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.98 -62.51 0.24 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.772 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 109' ' ' MET . 59.6 tt0 -81.75 172.04 13.85 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.109 -1.23 . . . . 0.0 110.831 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.48 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -154.61 75.49 0.98 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.592 -0.693 . . . . 0.0 109.593 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.056 HD13 ' HE2' ' A' ' 109' ' ' MET . 2.4 mp -36.26 138.55 0.2 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.7 -0.625 . . . . 0.0 110.63 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.547 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -54.63 -165.16 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.251 -0.905 . . . . 0.0 110.18 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.46 ' H ' HG22 ' A' ' 117' ' ' THR . 0.9 OUTLIER -83.56 -56.69 3.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.254 -0.904 . . . . 0.0 110.288 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -56.85 -25.34 56.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 110.067 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 14.7 mm-40 -78.12 -44.18 26.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 108.971 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.699 HG12 ' HB1' ' A' ' 102' ' ' ALA . 15.2 t -57.69 -36.72 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.676 -0.64 . . . . 0.0 109.902 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.87 -51.01 20.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.981 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -58.89 -22.71 59.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.892 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.404 ' CE ' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -75.8 -47.24 26.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -0.901 . . . . 0.0 110.108 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.442 HD11 ' HG ' ' A' ' 105' ' ' LEU . 11.7 mm -76.94 -33.46 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.209 -0.932 . . . . 0.0 110.055 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 ttp85 -64.49 -45.38 87.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.79 -20.09 65.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.2 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.956 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -85.81 -35.2 20.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.38 64.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.279 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.956 HD12 ' O ' ' A' ' 128' ' ' ALA . 1.5 mp -46.97 -28.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.257 -0.902 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 13.3 p-10 -88.99 -28.17 20.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.915 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.8 73.03 1.28 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 135' ' ' GLN . 18.2 p-10 -127.34 -29.22 2.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.267 -1.137 . . . . 0.0 110.255 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.12 -8.32 12.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.431 ' O ' ' OD2' ' A' ' 133' ' ' ASP . 9.4 pt20 -159.43 169.01 24.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.189 -1.183 . . . . 0.0 110.417 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.642 HG13 ' HB3' ' A' ' 140' ' ' GLU . 24.9 t -113.27 159.29 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.239 -0.913 . . . . 0.0 110.497 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.464 ' OD1' ' OE2' ' A' ' 140' ' ' GLU . 10.3 p-10 -122.26 -173.38 2.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.192 -0.943 . . . . 0.0 110.325 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.588 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 6.2 t80 -57.51 -69.37 0.17 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.218 -0.926 . . . . 0.0 110.655 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.7 OUTLIER -41.0 -53.06 3.05 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.298 -0.876 . . . . 0.0 110.382 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.642 ' HB3' HG13 ' A' ' 136' ' ' VAL . 8.5 mt-10 -52.79 -62.32 1.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.934 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.675 ' CE2' HG23 ' A' ' 85' ' ' ILE . 37.8 t80 -41.79 -27.51 0.11 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.266 -0.896 . . . . 0.0 109.756 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' GLU . 96.2 t -95.19 -37.7 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 0.0 110.194 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -9.48 48.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.119 -0.988 . . . . 0.0 109.872 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.474 ' O ' ' OD1' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -94.08 -23.15 18.09 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.364 -0.835 . . . . 0.0 110.42 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.5 mmt -100.61 -68.71 0.8 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.972 . . . . 0.0 111.105 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 146' ' ' THR . 5.3 t . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.221 -0.924 . . . . 0.0 110.797 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.519 HG23 ' HD2' ' B' ' 5' ' ' PRO . 14.1 mt . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.775 ' HB2' HG13 ' B' ' 10' ' ' VAL . 44.7 Cg_endo -71.24 103.88 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.893 1.47 . . . . 0.0 109.891 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.529 ' O ' ' N ' ' B' ' 8' ' ' THR . 23.1 t -62.13 71.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.561 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.78 ' O ' HG22 ' B' ' 10' ' ' VAL . 4.2 m95 50.74 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.871 . . . . 0.0 110.648 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.948 HG21 ' HG3' ' A' ' 75' ' ' LYS . 40.4 p -41.78 -24.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.715 -1.241 . . . . 0.0 110.42 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.531 HG21 ' HA ' ' B' ' 5' ' ' PRO . 85.6 m -70.58 -51.47 28.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 109.941 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.78 HG22 ' O ' ' B' ' 7' ' ' TRP . 3.8 m -56.38 -28.31 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.85 -1.156 . . . . 0.0 108.849 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.45 ' N ' HD13 ' B' ' 11' ' ' ILE . 7.1 mm -75.8 -28.38 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.448 -0.783 . . . . 0.0 109.322 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.791 HD12 ' HG2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -66.08 -57.61 7.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.57 -0.706 . . . . 0.0 110.331 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.696 HG12 ' CD1' ' A' ' 112' ' ' LEU . 42.4 t -60.35 -40.71 84.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.387 -0.82 . . . . 0.0 110.952 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.459 ' O ' ' CD ' ' B' ' 14' ' ' LYS . 1.2 tmtt? -63.07 -29.08 70.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.369 -1.457 . . . . 0.0 108.744 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' B' ' 11' ' ' ILE . 1.5 p -83.39 -15.96 47.77 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.563 ' HE2' ' CE1' ' A' ' 141' ' ' PHE . 73.1 mmm -71.64 -47.2 56.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.555 -0.716 . . . . 0.0 110.578 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.771 HD13 ' H ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -99.97 37.8 1.57 Allowed 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 117.724 -1.59 . . . . 0.0 109.619 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.52 ' HG2' ' N ' ' B' ' 19' ' ' LYS . 47.7 ttp180 -48.19 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.159 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.805 ' O ' HD21 ' A' ' 116' ' ' LEU . 8.6 tmtt? -104.91 -73.65 0.67 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 111.047 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.494 ' HG2' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -151.82 15.45 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.998 -1.063 . . . . 0.0 110.572 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.404 ' O ' ' CE ' ' A' ' 124' ' ' MET . 3.4 m -127.34 -173.36 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.111 -0.993 . . . . 0.0 110.176 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' B' ' 16' ' ' MET . 2.6 m-85 -92.91 -55.39 3.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.189 -0.944 . . . . 0.0 110.307 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' B' ' 24' ' ' ASN . . . 145.97 176.92 20.26 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.542 ' CB ' ' HD3' ' B' ' 25' ' ' PRO . 0.1 OUTLIER 174.17 -52.39 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.458 -1.025 . . . . 0.0 110.117 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 24' ' ' ASN . 48.9 Cg_endo -82.62 72.94 5.76 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.792 1.417 . . . . 0.0 110.404 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.172 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.301 0.572 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 10' ' ' ALA . 67.1 mt -53.13 -43.88 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.795 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -44.19 -60.19 2.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.913 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 5.0 tm-20 -52.5 -55.4 22.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.755 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -53.26 -30.07 36.4 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.162 -0.961 . . . . 0.0 109.277 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' SER . 17.9 ttmt -64.83 -37.05 86.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.309 -0.869 . . . . 0.0 109.089 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 3.1 mm-40 -61.36 -46.36 90.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.508 -0.745 . . . . 0.0 109.363 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 -48.74 80.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.839 . . . . 0.0 109.587 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.509 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 55.3 t80 -62.78 -39.68 94.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.413 -0.804 . . . . 0.0 109.508 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -70.8 -30.27 66.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -0.801 . . . . 0.0 109.319 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.817 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.5 tt -59.46 -44.18 93.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.427 -0.796 . . . . 0.0 109.702 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -69.87 -52.76 22.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.278 -0.888 . . . . 0.0 109.963 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -67.28 108.42 2.73 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.398 -0.814 . . . . 0.0 110.239 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -84.8 2.26 43.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.288 -0.883 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.57 -68.65 0.9 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.157 -0.965 . . . . 0.0 110.694 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.27 35.24 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 60.0 p30 -94.12 -10.14 34.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -1.16 . . . . 0.0 110.039 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.554 ' C ' HG23 ' A' ' 26' ' ' THR . . . 81.37 30.39 37.22 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.554 HG23 ' C ' ' A' ' 25' ' ' GLY . 77.7 p -152.76 124.44 7.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.137 -1.214 . . . . 0.0 110.709 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.573 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 4.2 mt -92.36 120.7 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.23 -0.919 . . . . 0.0 109.758 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -100.17 171.21 7.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 110.359 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.1 p -61.94 -33.44 74.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 110.033 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -70.01 -59.21 3.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 110.276 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 52.7 mt-10 -49.2 -66.63 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 109.881 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.3 tp -48.98 -43.95 40.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.749 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.05 -43.25 49.61 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 83.0 m -60.68 -48.57 81.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -1.137 . . . . 0.0 110.06 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 35' ' ' VAL . 4.2 t -64.6 -43.37 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.804 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 29.9 mmm -70.97 -24.6 62.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 109.882 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.09 -21.18 47.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.88 . . . . 0.0 110.14 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 39' ' ' LEU . 50.8 m -85.9 -40.89 15.45 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.255 -0.903 . . . . 0.0 110.771 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.43 HD23 HG22 ' A' ' 108' ' ' VAL . 2.4 mt -44.13 -32.23 1.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.924 -1.11 . . . . 0.0 109.799 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 41' ' ' GLN . . . 128.62 67.24 0.12 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER 179.55 -172.2 0.17 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.372 -1.075 . . . . 0.0 110.231 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -138.33 92.03 12.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.938 . . . . 0.0 110.666 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.74 126.48 11.43 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.088 1.573 . . . . 0.0 109.885 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 m -94.38 161.72 14.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.207 -0.933 . . . . 0.0 110.581 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.0 -60.69 3.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.022 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.35 -43.96 23.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.7 -42.35 74.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 0.0 109.873 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -64.22 -34.97 79.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.83 -41.16 83.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.866 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -67.17 -24.8 65.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.384 -0.823 . . . . 0.0 109.827 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.0 mtp -77.59 -45.96 23.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 109.791 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -64.46 -35.11 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 109.845 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.37 -15.07 56.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -81.42 -33.32 32.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 110.225 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 4.4 t -103.26 -14.12 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.184 -0.948 . . . . 0.0 110.256 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 12.4 t0 -60.07 80.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 0.0 109.901 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -93.14 -15.83 25.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.901 . . . . 0.0 110.368 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.431 ' OD2' ' CD ' ' A' ' 67' ' ' GLU . 5.2 m-20 -82.3 -40.37 21.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.199 -0.938 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.19 13.54 30.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 27.6 p-10 -88.04 -46.89 8.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -1.096 . . . . 0.0 110.263 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 131.38 -21.68 4.52 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.0 p -116.6 169.63 9.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -1.184 . . . . 0.0 110.148 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.573 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 11.2 mm -94.62 138.66 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.888 . . . . 0.0 110.001 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.542 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 m-20 -117.48 171.91 7.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.972 . . . . 0.0 110.695 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.659 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.2 t80 -62.97 -38.82 46.5 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 111.674 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.7 Cg_endo -70.08 -24.54 28.1 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 O-C-N 123.075 1.04 . . . . 0.0 109.589 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.52 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 3.2 mt-10 -69.49 -33.61 73.1 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.414 -0.804 . . . . 0.0 108.922 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.614 ' HZ ' HG23 ' B' ' 11' ' ' ILE . 2.0 t80 -68.4 -48.21 65.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.54 -0.725 . . . . 0.0 109.571 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 3.2 mm? -55.91 -36.72 68.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 110.371 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 2.7 m -87.33 -25.45 23.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.125 -0.984 . . . . 0.0 110.61 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.526 ' HE2' ' N ' ' A' ' 72' ' ' MET . 2.2 ttp -63.07 -61.49 2.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.937 . . . . 0.0 110.209 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.671 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 2.0 tpt -47.23 -32.27 4.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.267 -0.896 . . . . 0.0 110.632 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.38 -11.23 46.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.935 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 70' ' ' THR . 0.4 OUTLIER -99.29 -10.96 21.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.99 -1.069 . . . . 0.0 110.397 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.544 ' CB ' HG21 ' B' ' 8' ' ' THR . 2.2 mptp? . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 0.0 110.455 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.357 0.599 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.56 -47.57 69.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.498 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' B' ' 26' ' ' PHE . 17.3 pt-20 -47.59 -33.07 6.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.526 -0.734 . . . . 0.0 110.128 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.676 HG21 HG22 ' A' ' 142' ' ' VAL . 63.9 mt -76.32 -39.93 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.18 -0.95 . . . . 0.0 109.074 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -32.47 67.64 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HB3' HG23 ' B' ' 9' ' ' THR . 0.2 OUTLIER -67.01 -62.02 1.64 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.681 ' CB ' HD22 ' B' ' 12' ' ' LEU . . . -51.93 -30.13 23.18 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.538 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.51 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 59.0 t80 -71.92 -50.56 28.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.475 -0.766 . . . . 0.0 109.598 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.74 -47.18 77.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.0 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.54 HG11 HG21 ' B' ' 13' ' ' VAL . 0.9 OUTLIER -49.19 -45.46 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.567 -0.708 . . . . 0.0 109.29 179.087 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.561 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 17.3 m-85 -71.91 -36.69 70.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 109.964 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 94' ' ' LYS . 15.7 t0 -75.13 55.49 0.74 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.198 -0.939 . . . . 0.0 110.197 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' ASP . 9.0 tttp -40.71 -66.02 0.36 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.37 -0.831 . . . . 0.0 110.532 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 21.6 p-10 -61.48 -43.35 99.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 0.0 110.231 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 93.97 44.82 3.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 32.5 p-10 -87.23 -28.9 22.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.187 -1.184 . . . . 0.0 110.169 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.563 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 121.49 15.34 4.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 50.8 m-85 -151.76 152.41 32.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.141 -1.211 . . . . 0.0 110.178 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.98 118.91 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.922 . . . . 0.0 110.149 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 102' ' ' ALA . 12.4 t -105.52 141.97 36.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.848 . . . . 0.0 110.338 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.96 -33.85 0.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.313 -0.867 . . . . 0.0 109.833 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -55.16 -55.64 28.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 109.612 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 49.0 mt-10 -54.38 -48.4 71.56 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.352 -0.842 . . . . 0.0 109.764 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.711 HD13 HD11 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -58.72 -37.36 75.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.624 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 22.6 tpt85 -60.79 -41.24 95.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.307 -0.871 . . . . 0.0 109.44 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -57.99 -44.4 87.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.783 . . . . 0.0 109.422 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.587 HG11 ' CG1' ' B' ' 13' ' ' VAL . 5.9 t -73.19 -29.08 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.553 -0.717 . . . . 0.0 109.65 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.987 ' HA ' HD21 ' B' ' 17' ' ' LEU . 2.3 mtt -55.37 -69.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 110.7 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.6 m -64.85 -10.09 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.38 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -94.87 -6.68 42.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.817 ' O ' HD11 ' A' ' 18' ' ' LEU . 10.1 mt -107.44 -30.57 8.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 110.354 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 147.47 -51.87 0.56 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.507 ' HG2' HD12 ' A' ' 116' ' ' LEU . 23.0 tt0 -107.66 149.31 28.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -1.121 . . . . 0.0 109.7 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -123.62 19.17 9.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.895 . . . . 0.0 109.827 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.019 HD11 ' O ' ' B' ' 17' ' ' LEU . 3.5 mp 42.54 -166.51 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.55 0.69 . . . . 0.0 110.549 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.2 -144.65 0.3 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.514 -0.741 . . . . 0.0 109.144 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -117.64 -70.64 0.78 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.07 -1.018 . . . . 0.0 110.274 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -48.45 -40.98 28.07 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 109.398 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 121' ' ' VAL . 41.7 mm-40 -60.08 -53.48 57.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 109.282 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 120' ' ' GLU . 70.8 t -44.59 -41.52 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.418 -0.801 . . . . 0.0 109.844 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 35.8 m-20 -63.43 -60.81 2.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.856 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.45 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 4.0 tp10 -50.24 -40.98 49.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.795 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.449 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 4.5 ttt -51.7 -47.28 63.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.833 . . . . 0.0 109.841 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.711 HD11 HD13 ' A' ' 105' ' ' LEU . 48.9 mm -75.72 -39.02 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.932 . . . . 0.0 109.996 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -65.42 -26.7 68.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 110.275 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.42 -41.59 98.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 110.125 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.92 -27.04 23.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.317 -0.864 . . . . 0.0 110.335 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.651 ' OD2' HG22 ' A' ' 125' ' ' ILE . 1.7 m-20 -58.89 88.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.328 -0.858 . . . . 0.0 110.567 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -61.82 -41.54 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.196 -0.94 . . . . 0.0 109.422 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 35.4 p30 -82.66 -17.94 42.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.422 -0.799 . . . . 0.0 110.053 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 66.02 67.86 1.86 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 30.5 p-10 -118.25 1.84 11.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -1.11 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.86 -9.44 74.27 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 1.4 pt20 -137.71 147.72 45.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -1.106 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.49 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 4.0 t -104.08 146.08 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.209 -0.932 . . . . 0.0 110.155 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.455 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 33.7 p-10 -103.46 -161.09 0.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 139' ' ' GLU . 14.8 t80 -71.81 -63.45 1.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.074 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -44.12 -56.58 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 110.009 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 68.4 mt-10 -47.52 -61.38 1.95 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 6.0 t80 -44.68 -26.97 0.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.288 -0.882 . . . . 0.0 110.282 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.676 HG22 HG21 ' A' ' 85' ' ' ILE . 76.8 t -99.48 -45.95 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.201 -0.937 . . . . 0.0 110.163 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -46.48 -34.7 4.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.363 -0.836 . . . . 0.0 110.45 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.5 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -86.02 -19.82 29.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.582 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 3.7 mtt -84.86 -47.32 10.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.996 -1.065 . . . . 0.0 110.489 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.063 -1.023 . . . . 0.0 110.319 -179.929 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.838 HG23 ' HD2' ' B' ' 5' ' ' PRO . 17.2 mm . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.838 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.1 Cg_endo -66.37 116.46 4.06 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.79 1.416 . . . . 0.0 110.289 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 10' ' ' VAL . 3.0 m -53.2 179.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.848 . . . . 0.0 111.04 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.608 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -68.27 -66.14 0.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.596 0.713 . . . . 0.0 110.241 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.544 HG21 ' CB ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -53.99 -38.86 65.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 110.083 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 87' ' ' GLU . 49.1 m -49.06 -42.05 37.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.96 . . . . 0.0 108.982 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 6' ' ' SER . 47.3 t -65.76 -50.36 71.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.42 -0.8 . . . . 0.0 109.382 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.614 HG23 ' HZ ' ' A' ' 68' ' ' PHE . 9.2 mm -59.45 -27.12 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.427 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -65.14 -57.05 9.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.454 -0.779 . . . . 0.0 110.533 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.661 HG12 HD11 ' A' ' 112' ' ' LEU . 67.6 t -65.86 -30.57 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.945 . . . . 0.0 110.122 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.685 ' CG ' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.36 -47.27 67.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.92 . . . . 0.0 109.918 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' B' ' 18' ' ' ARG . 8.3 m -63.28 -29.85 71.09 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 110.131 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 11.6 ttm -68.22 -40.09 82.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.992 . . . . 0.0 109.95 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 1.019 ' O ' HD11 ' A' ' 116' ' ' LEU . 3.7 mp -56.19 -16.69 5.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.277 -0.889 . . . . 0.0 110.199 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.501 ' C ' ' O ' ' B' ' 17' ' ' LEU . 52.3 ttt180 -29.73 -78.34 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 121.032 0.444 . . . . 0.0 111.291 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.503 ' HD3' ' C ' ' B' ' 19' ' ' LYS . 1.8 tmtp? -143.18 -119.83 0.09 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.272 -0.893 . . . . 0.0 109.575 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.488 ' N ' ' CD ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -99.94 8.74 43.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.691 -1.255 . . . . 0.0 110.043 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -178.09 1.04 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.362 -0.836 . . . . 0.0 110.13 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.449 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.3 OUTLIER -176.66 -46.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.884 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 144' ' ' MET . . . -72.02 80.8 0.58 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.2 134.57 21.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.294 -1.121 . . . . 0.0 110.586 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.51 72.62 4.26 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 124.066 1.561 . . . . 0.0 110.316 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.671 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.498 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.498 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 24.1 mt-30 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.276 0.56 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.85 -32.96 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.925 . . . . 0.0 110.038 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.72 -44.14 70.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.937 . . . . 0.0 110.224 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 12' ' ' PHE . 4.6 pt-20 -65.06 -31.15 72.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.522 ' N ' ' HG2' ' A' ' 11' ' ' GLU . 19.9 m-30 -65.53 -44.1 87.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.844 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 17' ' ' SER . 0.4 OUTLIER -59.97 -43.59 95.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.179 -0.95 . . . . 0.0 109.36 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -61.54 -40.17 93.72 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.27 -0.894 . . . . 0.0 109.263 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.68 -52.07 54.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 0.0 109.489 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.536 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 7.6 t80 -58.38 -26.16 62.89 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.356 -0.84 . . . . 0.0 108.992 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -76.57 -34.82 58.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.512 -0.743 . . . . 0.0 109.32 179.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.787 HD11 ' O ' ' A' ' 112' ' ' LEU . 8.1 tt -59.14 -45.47 90.86 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.371 -0.83 . . . . 0.0 109.575 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' LYS . 41.8 m-85 -74.1 -49.71 22.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.378 -0.826 . . . . 0.0 109.589 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 21' ' ' LYS . 8.2 t0 -67.95 71.31 0.15 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.893 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -41.3 -41.73 2.0 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.429 -0.795 . . . . 0.0 110.36 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 13.0 p-10 -85.3 -43.1 14.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.099 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.5 32.16 6.13 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 46.2 p-10 -81.6 -2.53 50.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -1.193 . . . . 0.0 110.014 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 26' ' ' THR . . . 82.98 29.01 35.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 25' ' ' GLY . 13.4 p -154.98 118.73 4.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -1.113 . . . . 0.0 110.265 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.554 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 7.8 mt -90.45 124.63 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.951 . . . . 0.0 110.002 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.01 168.17 10.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 110.285 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.7 p -61.41 -28.42 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.96 -44.92 60.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.165 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -61.38 -60.65 3.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.976 . . . . 0.0 110.1 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.563 HD13 ' CH2' ' B' ' 7' ' ' TRP . 2.9 tp -59.31 -29.42 67.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.875 . . . . 0.0 110.189 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.99 -40.0 84.52 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.5 m -69.65 -50.71 41.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -1.157 . . . . 0.0 110.094 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 38' ' ' SER . 21.3 t -60.41 -42.72 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.177 -0.952 . . . . 0.0 110.327 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.52 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 2.6 mmt -66.84 -42.14 86.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 109.737 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -67.73 -14.04 62.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 110.112 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -72.11 -58.18 3.65 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.189 -0.944 . . . . 0.0 110.623 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mt -45.94 -28.59 1.17 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.12 -0.987 . . . . 0.0 110.736 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.502 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . 118.79 58.6 0.27 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.21 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 40' ' ' GLY . 64.7 mm-40 -131.9 -162.07 1.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.248 . . . . 0.0 109.928 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.548 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 t-20 -147.1 49.95 0.87 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.186 -0.947 . . . . 0.0 110.492 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 46.1 Cg_endo -74.0 73.74 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.086 1.572 . . . . 0.0 110.462 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 43' ' ' PRO . 10.9 t -54.06 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.18 -0.95 . . . . 0.0 110.556 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -66.9 -58.65 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.337 -0.852 . . . . 0.0 110.351 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -42.71 -42.82 3.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 109.835 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' OE1' HD11 ' B' ' 4' ' ' ILE . 10.6 mm-40 -71.15 -41.16 70.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.491 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 mt -52.74 -59.16 4.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.806 . . . . 0.0 109.95 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -53.94 -41.26 67.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.409 -0.807 . . . . 0.0 109.882 179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -61.51 -41.13 96.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.101 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.514 ' HE1' ' CG ' ' B' ' 7' ' ' TRP . 0.9 OUTLIER -73.97 -44.31 55.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 4.5 mm -61.67 -30.68 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.439 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.4 OUTLIER -73.79 -2.25 22.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.367 -0.833 . . . . 0.0 110.403 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.7 OUTLIER -85.29 -31.18 23.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.183 -0.948 . . . . 0.0 110.578 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 71' ' ' MET . 13.0 t -108.05 -46.34 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.126 -0.984 . . . . 0.0 110.495 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -45.57 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 110.663 -179.302 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -85.64 -3.35 58.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.83 . . . . 0.0 110.161 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.64 -53.94 4.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.176 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.71 22.22 5.8 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.4 p-10 -87.65 -46.21 9.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -1.169 . . . . 0.0 110.18 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.92 -0.59 11.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.6 p -134.31 149.89 50.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -1.214 . . . . 0.0 110.206 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.554 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 12.0 mm -90.41 144.55 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.065 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 48.3 m-20 -119.85 169.19 10.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.252 -0.905 . . . . 0.0 110.358 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.668 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.4 t80 -63.19 -38.58 42.68 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 111.598 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.3 Cg_endo -69.78 -26.62 27.32 Favored 'Trans proline' 0 C--N 1.321 -0.881 0 O-C-N 123.025 1.013 . . . . 0.0 109.656 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 71' ' ' MET . 10.6 mt-10 -76.41 -36.46 58.03 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 108.728 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 72' ' ' MET . 3.7 t80 -61.97 -41.33 97.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.507 -0.746 . . . . 0.0 109.986 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.28 -49.1 68.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.254 -0.904 . . . . 0.0 110.16 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -59.0 3.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 110.392 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.566 ' HB2' HG13 ' A' ' 55' ' ' VAL . 5.3 ppp? -48.77 -30.45 5.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.271 -0.893 . . . . 0.0 110.716 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.502 ' HA ' HG22 ' B' ' 8' ' ' THR . 0.0 OUTLIER -68.7 -9.99 53.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.019 -1.051 . . . . 0.0 110.54 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.41 -12.93 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.125 -0.984 . . . . 0.0 111.195 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -78.71 -15.79 58.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.962 -1.087 . . . . 0.0 110.766 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.071 -1.018 . . . . 0.0 110.391 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 1.4 mt-10 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.337 0.589 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.457 ' OE1' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -65.56 -57.92 7.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.295 -0.878 . . . . 0.0 109.548 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.481 ' OE2' ' CB ' ' B' ' 8' ' ' THR . 24.5 mt-10 -45.52 -27.9 0.83 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.557 -0.714 . . . . 0.0 110.383 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.888 HG21 HG22 ' A' ' 142' ' ' VAL . 47.8 mt -66.37 -43.29 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 121.011 -1.056 . . . . 0.0 108.988 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 ttm105 -58.54 -46.91 85.84 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.812 ' HB3' HG21 ' B' ' 9' ' ' THR . 2.9 mt-10 -67.65 -50.77 56.23 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.225 -0.922 . . . . 0.0 108.869 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' B' ' 13' ' ' VAL . . . -56.35 -40.0 73.77 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 141' ' ' PHE . 11.8 t80 -66.43 -40.08 89.28 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 87' ' ' GLU . 10.8 ttt180 -58.85 -45.63 89.64 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.917 HG11 HG11 ' B' ' 13' ' ' VAL . 21.4 t -48.29 -46.73 13.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.71 ' CE2' HD21 ' A' ' 105' ' ' LEU . 4.8 m-85 -71.58 -31.85 67.41 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.005 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 11.0 t0 -101.23 63.47 0.99 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.442 -0.786 . . . . 0.0 109.975 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.528 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 34.0 pttt -55.46 -25.38 36.22 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.149 -0.969 . . . . 0.0 110.508 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.528 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 11.8 p-10 -86.58 -40.33 15.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 110.371 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 85.95 50.49 3.9 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.448 ' OD1' ' OD2' ' A' ' 95' ' ' ASP . 15.1 p-10 -96.2 -24.88 16.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.196 -1.179 . . . . 0.0 110.283 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 118.99 -7.87 12.77 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 98.3 m-85 -136.86 151.83 49.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.286 -1.126 . . . . 0.0 110.152 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.514 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 8.7 mt -103.38 134.0 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.18 -0.95 . . . . 0.0 110.09 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 102' ' ' ALA . 37.6 t -112.2 136.54 51.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 110.234 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.39 -27.12 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.305 -0.872 . . . . 0.0 109.932 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -63.49 -59.65 4.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.357 -0.839 . . . . 0.0 109.671 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 89.4 mt-10 -48.16 -38.85 19.06 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.263 -0.898 . . . . 0.0 109.414 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.71 HD21 ' CE2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -54.91 -52.67 62.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.384 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.413 ' O ' ' OG1' ' A' ' 110' ' ' THR . 5.2 ttm105 -48.65 -47.97 40.09 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.251 -0.906 . . . . 0.0 109.377 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 14.0 m170 -52.95 -53.31 51.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.4 -0.812 . . . . 0.0 109.169 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.52 HG21 HG12 ' A' ' 91' ' ' VAL . 21.7 t -64.49 -41.63 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 108.943 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.787 ' HA ' HD21 ' B' ' 17' ' ' LEU . 33.6 ttm -51.81 -48.73 63.73 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.717 -0.614 . . . . 0.0 109.937 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -79.83 -32.18 40.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.0 110.253 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -72.81 -14.92 61.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.983 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.02 HD11 HG12 ' B' ' 13' ' ' VAL . 10.5 mt -99.35 -48.84 4.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.189 -0.944 . . . . 0.0 109.949 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 148.81 -31.67 1.21 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.777 ' HB3' HD23 ' B' ' 17' ' ' LEU . 5.2 tp10 -79.73 156.52 27.48 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.02 -1.282 . . . . 0.0 110.661 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.539 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.1 OUTLIER -137.17 51.83 1.94 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.776 HD12 ' HG2' ' A' ' 114' ' ' GLU . 0.2 OUTLIER -36.31 153.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.566 0.698 . . . . 0.0 110.923 -179.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 118' ' ' ASP . 2.0 m -57.67 -169.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.497 -0.752 . . . . 0.0 109.699 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.691 ' H ' HG22 ' A' ' 117' ' ' THR . 0.4 OUTLIER -99.05 -67.28 0.85 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.162 -0.961 . . . . 0.0 109.924 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -47.19 -36.97 9.4 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.762 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.8 -54.67 35.48 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -0.92 . . . . 0.0 109.052 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 124' ' ' MET . 7.7 t -47.01 -48.83 7.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -60.97 -50.4 73.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 109.818 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 1.5 tp10 -59.01 -31.4 68.78 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.295 -0.878 . . . . 0.0 109.519 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -58.05 -51.2 70.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.334 -0.854 . . . . 0.0 109.855 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.846 HG23 HG23 ' A' ' 136' ' ' VAL . 2.7 mp -68.74 -24.44 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.212 -0.93 . . . . 0.0 110.006 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.414 ' NH1' ' HB2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.09 -42.05 89.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.133 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HB2' ' NH1' ' A' ' 126' ' ' ARG . 13.3 tt0 -71.34 -29.61 65.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.905 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.61 -20.45 50.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.01 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 0.9 OUTLIER -70.67 68.17 0.39 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.193 -0.942 . . . . 0.0 110.111 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mt -54.02 -31.58 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 0.0 110.306 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -89.53 -31.99 17.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.3 -0.875 . . . . 0.0 110.38 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.79 97.14 0.92 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 135' ' ' GLN . 1.2 p-10 -148.43 -38.12 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.186 -1.185 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 133.82 -1.74 4.33 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.485 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -161.22 169.73 21.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -1.235 . . . . 0.0 110.092 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.846 HG23 HG23 ' A' ' 125' ' ' ILE . 55.3 t -93.81 139.16 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.219 -0.926 . . . . 0.0 110.076 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 19.1 t30 -102.42 178.96 4.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.274 -0.891 . . . . 0.0 110.694 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.445 ' O ' ' C ' ' A' ' 139' ' ' GLU . 47.1 t80 -67.3 -68.21 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.432 -0.793 . . . . 0.0 110.298 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 140' ' ' GLU . 2.9 pt-20 -40.93 -29.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.428 -0.795 . . . . 0.0 110.094 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 3.9 mt-10 -71.62 -59.19 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.418 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.804 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.6 t80 -42.48 -29.04 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 109.377 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.888 HG22 HG21 ' A' ' 85' ' ' ILE . 45.3 t -99.81 -40.29 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.505 -0.747 . . . . 0.0 110.456 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 10.7 tt0 -63.16 -12.8 30.37 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.16 -0.962 . . . . 0.0 110.599 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.9 mtp -95.54 -21.73 18.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 109.96 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.609 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 2.6 mtt -100.88 -13.38 18.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.362 -0.836 . . . . 0.0 110.462 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.1 p . . . . . 0 C--N 1.306 -1.283 0 O-C-N 121.173 -0.954 . . . . 0.0 111.057 -178.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.547 HG22 ' HD2' ' B' ' 5' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' B' ' 4' ' ' ILE . 48.2 Cg_endo -73.99 49.15 1.86 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.825 1.434 . . . . 0.0 111.282 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.472 ' C ' ' O ' ' B' ' 5' ' ' PRO . 10.3 m 32.72 -139.59 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.597 -0.69 . . . . 0.0 111.574 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.563 ' CH2' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -117.4 -74.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 110.265 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.588 ' HA ' HD12 ' B' ' 11' ' ' ILE . 0.6 OUTLIER -45.06 -41.7 7.9 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.803 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.812 HG21 ' HB3' ' A' ' 87' ' ' GLU . 31.4 m -51.06 -54.72 22.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 109.7 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 5' ' ' PRO . 40.6 t -47.69 -39.69 7.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.163 -0.961 . . . . 0.0 108.683 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' B' ' 8' ' ' THR . 55.0 mt -67.5 -21.81 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 0.0 109.369 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' B' ' 9' ' ' THR . 0.4 OUTLIER -71.0 -55.48 8.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.495 -0.753 . . . . 0.0 109.904 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 1.02 HG12 HD11 ' A' ' 112' ' ' LEU . 68.1 t -54.57 -40.99 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.807 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' B' ' 14' ' ' LYS . 1.2 tptm -67.24 -40.7 86.35 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.023 -1.048 . . . . 0.0 109.518 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -59.67 -27.76 66.68 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.354 -0.841 . . . . 0.0 109.474 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.482 ' O ' ' N ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -72.54 -38.96 67.86 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.29 -0.881 . . . . 0.0 109.375 179.257 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.787 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.8 mp -67.64 59.6 0.06 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.369 -0.832 . . . . 0.0 109.874 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' B' ' 16' ' ' MET . 0.1 OUTLIER -90.03 -77.88 0.38 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.376 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.464 ' HA ' HD21 ' A' ' 116' ' ' LEU . 10.3 tmtt? -162.75 -68.51 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.97 -1.082 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.98 7.95 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 110.167 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.473 ' O ' ' CE ' ' A' ' 124' ' ' MET . 0.3 OUTLIER -103.7 159.79 15.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 109.639 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 0.1 OUTLIER -131.67 -34.22 1.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.158 -0.964 . . . . 0.0 110.386 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.37 171.09 33.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.609 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER -158.46 112.93 1.69 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.192 -1.181 . . . . 0.0 110.443 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.27 96.03 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.943 1.496 . . . . 0.0 110.468 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.89 -1.053 . . . . 0.0 110.565 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.108 0.48 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 10' ' ' ALA . 23.3 mt -63.23 -51.48 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -42.65 -50.18 5.46 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.235 -0.916 . . . . 0.0 109.98 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -58.03 -52.53 65.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.885 . . . . 0.0 109.555 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 8.5 m-85 -56.9 -39.82 75.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.303 -0.873 . . . . 0.0 109.716 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.4 ' O ' ' OG ' ' A' ' 17' ' ' SER . 3.7 tttt -63.29 -41.74 99.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.288 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.506 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 4.5 tp10 -58.23 -28.87 65.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 109.276 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -72.17 -60.87 2.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.528 -0.732 . . . . 0.0 109.769 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.534 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 21.7 t80 -52.61 -33.23 45.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.21 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 14' ' ' GLU . 2.6 p -69.47 -39.3 77.79 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.487 -0.758 . . . . 0.0 109.26 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.833 HD11 ' O ' ' A' ' 112' ' ' LEU . 1.4 tt -52.48 -36.86 55.91 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.423 -0.798 . . . . 0.0 108.965 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.556 ' CD1' HD12 ' A' ' 32' ' ' LEU . 67.0 m-85 -84.14 -45.94 12.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.578 -0.701 . . . . 0.0 109.902 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.423 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 13.5 t0 -77.49 88.15 3.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.847 . . . . 0.0 110.013 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -71.92 -13.35 61.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.251 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 21.8 p-10 -111.16 -5.73 14.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.472 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 52.97 57.51 14.41 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 8.0 p-10 -111.92 -41.46 4.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.183 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.467 ' C ' ' CG2' ' A' ' 26' ' ' THR . . . 123.55 18.96 2.9 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.467 ' CG2' ' C ' ' A' ' 25' ' ' GLY . 7.6 p -149.53 107.59 3.73 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.198 -1.178 . . . . 0.0 110.344 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.702 HD12 ' HB ' ' A' ' 63' ' ' ILE . 16.0 mt -88.7 118.53 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.128 -0.983 . . . . 0.0 110.091 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.1 p -93.73 153.34 18.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.335 -0.853 . . . . 0.0 109.986 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 p -45.39 -28.04 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.097 -1.002 . . . . 0.0 109.964 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -66.68 -62.08 1.63 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.098 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -45.1 -66.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 109.911 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.556 HD12 ' CD1' ' A' ' 19' ' ' PHE . 11.9 tp -51.44 -38.29 52.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.705 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.17 -43.03 97.41 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -58.81 -49.57 77.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -1.063 . . . . 0.0 109.782 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -53.72 -47.82 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 0.0 109.723 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.467 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 9.0 mmt -61.55 -34.7 76.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 109.862 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -20.52 64.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 110.152 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.6 m -83.19 -54.35 5.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 110.379 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 mt -45.03 -31.91 1.49 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.23 -0.919 . . . . 0.0 110.057 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.7 27.02 3.68 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -109.9 -175.82 2.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -1.164 . . . . 0.0 110.262 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -146.36 75.64 12.43 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.273 -0.892 . . . . 0.0 110.489 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 44.1 Cg_endo -72.33 149.1 50.35 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.992 1.522 . . . . 0.0 110.08 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.647 HG23 ' H ' ' A' ' 47' ' ' GLU . 7.2 t -90.54 -157.69 0.5 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.131 -0.981 . . . . 0.0 110.456 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -94.1 -44.95 7.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.314 -0.866 . . . . 0.0 110.173 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.78 84.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.178 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.647 ' H ' HG23 ' A' ' 44' ' ' THR . 51.6 mm-40 -64.72 -56.51 13.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 110.32 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 48' ' ' LEU . 14.2 mt -47.52 -45.23 26.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.144 -0.973 . . . . 0.0 110.196 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -63.21 -39.76 95.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.805 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.45 -42.86 74.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.412 ' O ' ' NE1' ' B' ' 7' ' ' TRP . 4.6 mtp -66.12 -34.46 78.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.393 -0.817 . . . . 0.0 109.602 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.544 HD13 HD11 ' A' ' 63' ' ' ILE . 7.1 mm -71.91 -36.31 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 0.7 OUTLIER -54.48 -52.05 63.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.387 -0.821 . . . . 0.0 109.977 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -43.57 -57.44 3.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.84 . . . . 0.0 109.949 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.814 HG22 ' HG3' ' A' ' 71' ' ' MET . 15.3 t -74.23 -31.11 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -0.925 . . . . 0.0 109.811 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.546 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 30.4 t70 -64.66 71.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 110.059 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -66.65 -25.24 66.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.239 -0.913 . . . . 0.0 110.389 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -75.75 -49.86 16.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.076 -1.015 . . . . 0.0 110.29 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.69 25.39 5.99 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 8.7 p30 -99.86 -32.47 10.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.211 -1.17 . . . . 0.0 110.332 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.11 9.76 10.35 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.8 p -131.09 142.07 50.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -1.13 . . . . 0.0 109.814 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.731 HD12 ' HB ' ' A' ' 55' ' ' VAL . 9.7 mm -88.03 143.03 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.219 -0.925 . . . . 0.0 110.279 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.534 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 1.6 m-20 -118.69 170.88 8.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.319 -0.863 . . . . 0.0 110.142 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.3 t80 -60.94 -50.6 84.17 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.108 -0.995 . . . . 0.0 111.26 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.0 Cg_endo -66.03 -25.61 51.45 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 O-C-N 123.2 1.105 . . . . 0.0 110.511 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 71' ' ' MET . 34.9 mt-10 -71.6 -34.02 69.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.132 -0.98 . . . . 0.0 109.819 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -74.51 -58.95 2.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 0.0 110.223 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.1 mt -48.98 -42.72 38.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 110.299 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 9.7 m -70.66 -30.17 66.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.197 -0.94 . . . . 0.0 110.421 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.814 ' HG3' HG22 ' A' ' 55' ' ' VAL . 4.0 tmm? -65.14 -63.69 1.04 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.744 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.642 ' SD ' HG22 ' B' ' 8' ' ' THR . 37.3 mmm -52.31 -19.31 2.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.995 -1.066 . . . . 0.0 110.22 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 70' ' ' THR . . . -74.36 -20.84 59.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.57 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -91.64 -25.75 19.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.081 -1.012 . . . . 0.0 110.762 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.878 ' HG3' HG21 ' B' ' 8' ' ' THR . 53.1 mmtt . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 110.584 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.113 0.482 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -79.61 -25.16 41.54 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.108 -0.995 . . . . 0.0 110.402 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -78.02 -27.29 48.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.182 -0.949 . . . . 0.0 110.117 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.54 HG23 ' CE1' ' A' ' 141' ' ' PHE . 92.6 mt -76.9 -39.24 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.96 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 51.5 ttp180 -62.79 -35.6 80.38 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 110.038 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.916 ' HB3' HG21 ' B' ' 9' ' ' THR . 19.6 mm-40 -69.35 -47.46 64.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 0.0 109.666 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.957 ' HB2' ' CD1' ' B' ' 12' ' ' LEU . . . -60.86 -33.59 73.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.113 -0.992 . . . . 0.0 109.897 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.11 -45.83 90.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.579 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 2.4 mtt180 -63.65 -26.94 68.9 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.411 -0.805 . . . . 0.0 109.759 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.803 HG11 HG21 ' B' ' 13' ' ' VAL . 41.2 t -63.84 -59.08 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 110.153 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.467 ' CE2' ' SD ' ' B' ' 16' ' ' MET . 22.7 m-85 -56.63 -32.16 65.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.08 -1.013 . . . . 0.0 110.059 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.47 ' OD1' HG12 ' A' ' 100' ' ' ILE . 3.1 m-20 -90.45 61.48 4.98 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.708 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.537 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -45.14 -23.38 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.422 -0.799 . . . . 0.0 110.407 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.537 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 35.2 p-10 -96.91 -31.14 12.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 80.09 51.83 4.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 32.6 p-10 -97.94 -14.34 20.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -1.15 . . . . 0.0 110.428 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 99.42 18.56 23.35 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 52.1 m-85 -158.08 157.03 32.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.247 -1.149 . . . . 0.0 110.088 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.47 HG12 ' OD1' ' A' ' 93' ' ' ASP . 21.5 mt -128.42 130.77 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -0.99 . . . . 0.0 110.689 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 30.9 t -116.82 151.56 36.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.837 . . . . 0.0 109.583 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.05 -26.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -72.35 -43.67 63.73 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.286 -0.884 . . . . 0.0 110.143 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 14.8 mt-10 -63.48 -33.03 74.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.006 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.987 ' CD1' HD11 ' A' ' 125' ' ' ILE . 3.8 mt -70.95 -43.61 67.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.879 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 -62.7 -26.04 68.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 109.559 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -75.0 -39.89 60.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.0 109.942 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.622 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -76.86 -33.56 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.377 179.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.667 ' HA ' HD21 ' B' ' 17' ' ' LEU . 3.2 mtm -54.92 -69.6 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.546 -0.721 . . . . 0.0 110.081 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -47.77 -29.05 2.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.194 -0.941 . . . . 0.0 109.714 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -85.44 -17.3 36.96 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.408 -0.808 . . . . 0.0 109.85 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.886 HD11 HG13 ' B' ' 13' ' ' VAL . 1.3 mt -94.31 -25.36 17.04 Favored 'General case' 0 C--O 1.199 -1.582 0 O-C-N 121.168 -0.957 . . . . 0.0 110.694 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.0 -50.73 0.66 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.285 -1.436 . . . . 0.0 111.214 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -117.05 158.94 23.32 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.864 -1.374 . . . . 0.0 111.549 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 115' ' ' LYS . 8.0 tmtt? -131.43 73.74 1.56 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.697 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.6 mp -33.75 153.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.628 0.728 . . . . 0.0 111.682 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.3 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.536 -0.727 . . . . 0.0 110.375 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' GLU . 24.4 m-20 -98.79 -68.52 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.381 -0.825 . . . . 0.0 110.33 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -42.3 -47.85 4.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.432 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 124' ' ' MET . 3.3 mm-40 -60.61 -48.17 82.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 109.89 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 124' ' ' MET . 55.0 t -65.52 -38.76 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.072 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.99 -65.3 0.71 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 109.753 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 4.7 mt-10 -46.67 -26.13 0.86 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.391 -0.818 . . . . 0.0 109.52 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.485 ' HG2' ' CE1' ' B' ' 22' ' ' PHE . 18.7 ttt -66.37 -57.04 8.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.969 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.987 HD11 ' CD1' ' A' ' 105' ' ' LEU . 48.2 mm -61.5 -50.48 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.929 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -54.25 -25.88 25.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.178 -0.951 . . . . 0.0 109.933 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -70.92 -44.7 65.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.396 -0.815 . . . . 0.0 110.077 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -71.37 -32.09 68.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.442 -0.786 . . . . 0.0 110.062 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.407 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 88.8 m-20 -57.07 80.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.81 . . . . 0.0 110.384 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.581 HD12 ' HG3' ' A' ' 140' ' ' GLU . 1.9 mt -76.48 -37.75 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.932 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 14.6 p-10 -78.57 -31.48 47.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.056 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.61 65.75 0.97 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 26.3 p30 -124.44 -14.88 6.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -1.132 . . . . 0.0 110.46 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 90.54 17.72 51.37 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -163.23 169.78 18.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.332 -1.099 . . . . 0.0 110.019 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 137' ' ' ASN . 41.1 t -112.56 168.35 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.222 -0.924 . . . . 0.0 110.614 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.484 ' OD1' ' HB2' ' A' ' 140' ' ' GLU . 17.2 p-10 -152.18 -155.1 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -69.63 -69.44 0.34 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.295 -0.878 . . . . 0.0 110.717 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 140' ' ' GLU . 8.5 tt0 -46.19 -63.87 0.89 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.128 -0.982 . . . . 0.0 110.423 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.581 ' HG3' HD12 ' A' ' 130' ' ' ILE . 7.1 tt0 -41.46 -57.4 2.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.236 -0.915 . . . . 0.0 110.53 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.54 ' CE1' HG23 ' A' ' 85' ' ' ILE . 12.0 t80 -49.19 -28.88 4.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.237 -0.914 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.505 HG22 HG21 ' A' ' 85' ' ' ILE . 18.6 t -99.96 -38.35 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.234 -0.916 . . . . 0.0 110.607 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -33.69 69.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.201 -0.937 . . . . 0.0 110.794 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.538 ' HB2' HD11 ' A' ' 130' ' ' ILE . 10.0 tpp -88.3 -18.26 28.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.145 -0.972 . . . . 0.0 110.747 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.639 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 2.0 ttt -92.69 -9.8 39.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.0 110.101 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 110.939 -179.518 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 9.0 mt . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.599 ' HB2' HG23 ' B' ' 10' ' ' VAL . 40.3 Cg_endo -67.99 124.69 12.11 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.871 1.459 . . . . 0.0 110.325 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.527 ' O ' ' N ' ' B' ' 8' ' ' THR . 68.8 m -75.92 75.03 2.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.332 -0.855 . . . . 0.0 111.226 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.412 ' NE1' ' O ' ' A' ' 51' ' ' MET . 0.4 OUTLIER 53.93 -83.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.206 -0.934 . . . . 0.0 110.941 179.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.878 HG21 ' HG3' ' A' ' 75' ' ' LYS . 71.6 p -46.12 -46.81 17.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.38 -0.825 . . . . 0.0 110.017 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.916 HG21 ' HB3' ' A' ' 87' ' ' GLU . 52.7 m -52.1 -43.82 64.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.406 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.599 HG23 ' HB2' ' B' ' 5' ' ' PRO . 61.3 t -58.54 -27.38 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.259 -0.9 . . . . 0.0 108.879 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.439 HG21 ' HE2' ' A' ' 72' ' ' MET . 35.3 mm -78.16 -64.76 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.628 -0.67 . . . . 0.0 110.558 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.957 ' CD1' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -46.7 -45.39 19.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.132 -0.98 . . . . 0.0 110.485 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.886 HG13 HD11 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -60.44 -51.86 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.914 -1.116 . . . . 0.0 109.402 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.541 ' N ' HG12 ' B' ' 13' ' ' VAL . 0.0 OUTLIER -60.1 -33.04 71.56 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.993 -1.067 . . . . 0.0 109.055 178.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 6.1 t -62.69 -47.07 85.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.421 -0.799 . . . . 0.0 109.286 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.467 ' SD ' ' CE2' ' A' ' 92' ' ' PHE . 10.7 ttm -51.52 -35.88 42.47 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.389 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.816 HD22 HD13 ' A' ' 112' ' ' LEU . 7.1 mp -70.68 57.51 0.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.464 -0.773 . . . . 0.0 109.906 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.513 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 69.4 ttt-85 -122.46 -54.76 1.86 Allowed 'General case' 0 C--N 1.288 -2.069 0 O-C-N 121.404 -0.81 . . . . 0.0 111.128 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -138.74 -126.76 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.88 -1.138 . . . . 0.0 110.133 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.509 ' N ' ' HG2' ' B' ' 19' ' ' LYS . 5.0 ptp180 -119.87 41.15 3.24 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.026 -1.046 . . . . 0.0 109.918 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 8.4 t -121.52 148.7 44.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.401 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.56 ' CZ ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -117.7 -10.87 10.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.89 152.29 31.42 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.639 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 0.6 OUTLIER -148.63 127.5 6.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.238 . . . . 0.0 110.146 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.65 57.04 2.96 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.896 1.472 . . . . 0.0 110.279 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' B' ' 12' ' ' LEU . 2.9 m-85 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.32 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.7 mt -66.52 -52.48 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.376 -0.827 . . . . 0.0 109.352 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.88 -39.6 74.64 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -57.91 -49.27 77.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.442 -0.786 . . . . 0.0 109.251 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.568 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 17.6 m-85 -61.07 -37.4 82.55 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.291 -0.881 . . . . 0.0 109.189 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 10.7 ttpt -57.23 -42.19 80.96 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.309 -0.869 . . . . 0.0 109.073 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.21 -42.35 99.27 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.469 -0.769 . . . . 0.0 109.165 179.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.15 -47.99 77.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.485 -0.759 . . . . 0.0 109.297 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -54.78 -27.74 43.79 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.401 -0.812 . . . . 0.0 109.156 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 t -84.05 -37.24 22.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.462 -0.774 . . . . 0.0 109.395 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.545 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.4 tt -51.01 -36.65 40.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.418 -0.801 . . . . 0.0 109.244 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.442 ' HA ' HG21 ' A' ' 35' ' ' VAL . 86.2 m-85 -82.72 -39.78 21.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.734 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.456 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 31.1 t0 -74.86 92.33 2.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.454 -0.779 . . . . 0.0 110.058 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -65.3 -31.92 73.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 110.32 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 12.4 p-10 -90.38 -29.66 17.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.355 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.44 70.79 1.22 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 9.1 p-10 -120.21 -24.59 5.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -1.156 . . . . 0.0 110.061 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.81 -8.68 11.67 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 50.9 p -134.83 127.93 31.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -1.128 . . . . 0.0 110.222 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.684 HD12 ' CB ' ' A' ' 63' ' ' ILE . 16.4 mt -94.06 133.37 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 p -90.53 -171.35 3.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.899 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 p -83.59 -35.58 24.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.006 . . . . 0.0 109.957 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -68.52 -35.67 77.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -56.88 -55.56 32.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.19 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.62 HD13 ' CH2' ' B' ' 7' ' ' TRP . 24.6 tp -58.92 -39.73 82.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.208 -0.932 . . . . 0.0 110.253 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -56.25 -43.38 89.3 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.0 m -63.42 -56.5 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -1.176 . . . . 0.0 110.032 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 35' ' ' VAL . 11.7 t -55.79 -26.94 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.795 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 2.4 mmt -69.71 -41.15 75.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.247 -0.908 . . . . 0.0 109.766 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -65.81 -29.41 69.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.996 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -56.39 -55.67 30.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.13 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.486 ' CD2' HG13 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -54.87 -39.23 68.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.8 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 126.77 55.86 0.14 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.534 ' HB3' ' CD1' ' B' ' 4' ' ' ILE . 40.3 mt-30 -142.35 153.92 44.23 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.169 -1.195 . . . . 0.0 110.346 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -117.76 80.31 13.9 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.227 -0.921 . . . . 0.0 110.473 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.27 146.38 40.3 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.977 1.514 . . . . 0.0 110.224 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 45' ' ' GLU . 9.6 t -100.04 -153.81 0.45 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.204 -0.935 . . . . 0.0 110.412 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.504 ' N ' HG23 ' A' ' 44' ' ' THR . 45.3 tt0 -87.18 -52.28 5.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -0.907 . . . . 0.0 110.406 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.5 76.04 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.236 -0.915 . . . . 0.0 110.305 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' LEU . 37.8 mt-10 -63.67 -55.2 25.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.295 -0.878 . . . . 0.0 110.328 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' GLU . 15.0 mt -43.81 -52.73 6.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.124 -0.985 . . . . 0.0 109.963 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -59.96 -36.19 76.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.79 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.28 -42.04 76.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.879 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.472 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 0.1 OUTLIER -67.91 -36.18 79.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 179.457 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 5.4 mm -73.31 -21.48 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.477 -0.764 . . . . 0.0 109.905 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -66.3 -54.68 21.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 110.501 -179.904 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 53' ' ' ASN . 2.6 tp10 -41.09 -35.32 0.54 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.46 -0.775 . . . . 0.0 110.598 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.671 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 10.5 t -96.68 -34.97 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.18 -0.95 . . . . 0.0 110.284 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 40.5 t0 -49.46 88.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.48 -0.762 . . . . 0.0 110.729 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -80.02 -32.36 39.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.224 -0.922 . . . . 0.0 110.38 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.453 ' OD2' ' OE2' ' A' ' 67' ' ' GLU . 7.6 m-20 -76.13 -47.38 24.6 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.17 -0.956 . . . . 0.0 110.448 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.55 0.13 9.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 18.7 p30 -88.77 -32.49 17.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.113 -1.228 . . . . 0.0 110.357 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 114.44 -28.64 8.1 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 p -70.3 151.47 45.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.154 -1.204 . . . . 0.0 110.359 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.684 ' CB ' HD12 ' A' ' 27' ' ' ILE . 9.1 mm -102.46 122.9 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.449 ' C ' ' HD2' ' A' ' 66' ' ' PRO . 21.4 t0 -99.23 157.69 16.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.58 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.4 t80 -48.81 -45.65 72.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.711 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 50.0 Cg_endo -74.64 -37.34 2.35 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 123.347 1.183 . . . . 0.0 109.815 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 57' ' ' ALA . 4.2 tt0 -51.74 -49.07 63.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.505 -0.747 . . . . 0.0 110.199 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.13 -45.61 69.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.282 -0.886 . . . . 0.0 110.21 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -59.85 -12.59 7.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 0.0 110.607 -179.731 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.8 m -95.43 -43.21 8.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -0.988 . . . . 0.0 110.865 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -62.87 -39.81 95.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.089 -1.007 . . . . 0.0 110.993 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.568 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 9.3 tpt -61.49 -9.74 6.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.131 -0.981 . . . . 0.0 111.127 -179.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.81 -18.43 15.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.984 -1.072 . . . . 0.0 111.089 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -23.7 14.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.986 -1.071 . . . . 0.0 110.896 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HG2' HG21 ' B' ' 8' ' ' THR . 15.8 tttt . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.043 -1.036 . . . . 0.0 110.638 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.688 ' HA ' HD12 ' A' ' 85' ' ' ILE . 1.4 pt-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.213 0.53 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.88 -46.83 61.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 109.793 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -58.48 -20.71 47.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 110.152 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.688 HD12 ' HA ' ' A' ' 82' ' ' GLU . 73.2 mt -69.79 -45.23 77.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.136 -0.978 . . . . 0.0 109.015 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 89' ' ' PHE . 58.3 ttt180 -56.89 -31.94 65.38 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.46 -56.42 6.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.39 -0.819 . . . . 0.0 109.306 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' B' ' 12' ' ' LEU . . . -54.58 -22.41 13.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.196 -0.94 . . . . 0.0 108.982 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 138' ' ' TYR . 84.1 t80 -71.41 -63.73 1.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.375 -0.828 . . . . 0.0 109.482 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -49.25 -38.34 26.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.383 -0.823 . . . . 0.0 109.076 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.694 HG12 HG21 ' A' ' 108' ' ' VAL . 18.6 t -63.78 -35.06 71.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.559 -0.713 . . . . 0.0 109.592 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.741 ' CE1' HG13 ' B' ' 13' ' ' VAL . 2.4 m-85 -72.74 -36.83 67.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.291 -0.881 . . . . 0.0 109.307 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 104' ' ' GLU . 3.6 t70 -99.91 62.19 1.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.757 . . . . 0.0 109.964 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' ASP . 7.7 tmtm? -42.64 -54.52 3.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 109.874 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.483 ' OD2' ' HG3' ' A' ' 104' ' ' GLU . 1.1 p30 -58.53 -27.32 64.41 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.533 -0.729 . . . . 0.0 109.913 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 60.86 59.24 10.5 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 34.3 p-10 -98.02 -41.95 7.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.201 -1.176 . . . . 0.0 110.556 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 162.96 -43.58 0.34 Allowed Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.295 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 15.0 m-85 -123.2 166.55 15.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.269 . . . . 0.0 110.904 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 100' ' ' ILE . 9.6 mt -102.69 84.33 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.34 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.414 ' HB2' ' OE1' ' A' ' 135' ' ' GLN . 0.2 OUTLIER -73.96 161.45 30.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.077 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.28 -19.4 3.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.922 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.84 -33.34 46.08 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.29 -0.881 . . . . 0.0 109.205 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -67.51 -42.47 82.74 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.54 -0.725 . . . . 0.0 109.254 179.178 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.054 HD12 HD11 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -63.08 -42.23 99.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.331 -0.855 . . . . 0.0 109.163 178.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -62.47 -26.82 68.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.593 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.462 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -69.95 -48.68 57.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.441 -0.787 . . . . 0.0 109.968 179.718 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.694 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -74.13 -30.88 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.286 -0.884 . . . . 0.0 109.455 179.47 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.814 ' HA ' HD21 ' B' ' 17' ' ' LEU . 2.4 ttm -52.04 -70.34 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.652 -0.655 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.7 m -51.77 -26.76 10.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.14 -0.975 . . . . 0.0 110.337 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.48 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 8.7 m120 -72.33 -18.39 61.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.333 -0.855 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.873 HD12 HD22 ' B' ' 17' ' ' LEU . 10.2 mt -98.87 -48.84 4.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 110.423 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.42 -58.0 0.21 Allowed Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.768 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -90.89 162.21 14.89 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.964 -1.315 . . . . 0.0 111.299 -178.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.99 72.92 1.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.58 -0.7 . . . . 0.0 109.52 179.39 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 116' ' ' LEU . 4.6 mp -33.8 150.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.614 0.721 . . . . 0.0 111.525 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 118' ' ' ASP . 1.1 m -59.18 -147.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 109.82 179.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.545 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -113.13 -49.65 2.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 179.816 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.65 -51.76 66.13 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.073 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 121' ' ' VAL . 10.1 pt-20 -61.01 -44.67 97.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.55 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 73.4 t -60.36 -39.38 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.349 -0.844 . . . . 0.0 109.673 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.67 -53.54 56.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 109.725 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -57.09 -25.62 59.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.602 ' HG3' ' HA ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -64.05 -49.21 73.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.353 -0.842 . . . . 0.0 109.47 179.259 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.054 HD11 HD12 ' A' ' 105' ' ' LEU . 28.8 mm -73.27 -35.83 47.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.711 -0.618 . . . . 0.0 110.247 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.409 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 3.4 tmm_? -68.94 -22.74 64.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.204 -0.935 . . . . 0.0 110.063 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.57 -34.31 67.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 110.242 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -93.34 -26.4 17.3 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.356 -0.84 . . . . 0.0 110.233 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 126' ' ' ARG . 85.9 m-20 -45.5 90.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.323 -0.861 . . . . 0.0 110.661 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -82.96 -40.82 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.158 -0.964 . . . . 0.0 109.521 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 35.2 p-10 -76.54 -24.47 53.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.929 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.477 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.99 35.05 19.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 15.9 p-10 -89.38 -15.97 32.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -1.113 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 135' ' ' GLN . . . 97.78 9.63 54.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 68.6 mt-30 -157.08 153.4 27.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.217 -1.167 . . . . 0.0 110.275 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 25.1 t -90.83 113.33 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.262 -0.899 . . . . 0.0 110.023 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -87.93 176.07 7.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.935 . . . . 0.0 110.557 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 5.2 t80 -57.08 -63.63 1.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.245 -0.91 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.6 OUTLIER -41.79 -49.34 4.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 0.0 109.989 179.891 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.443 ' HG2' HD12 ' A' ' 130' ' ' ILE . 3.0 mt-10 -57.08 -57.87 10.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 0.0 109.932 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.449 ' O ' ' SD ' ' A' ' 145' ' ' MET . 10.0 t80 -47.5 -24.47 0.85 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.275 -0.891 . . . . 0.0 109.962 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.498 HG13 HG21 ' A' ' 146' ' ' THR . 42.5 t -99.66 -39.4 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 110.409 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -65.89 -9.89 33.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.925 . . . . 0.0 110.797 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.465 ' CE ' ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -98.17 -26.13 14.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.029 -1.045 . . . . 0.0 110.704 -179.746 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' SD ' ' O ' ' A' ' 141' ' ' PHE . 6.5 mtp -100.48 -34.67 9.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 110.762 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.498 HG21 HG13 ' A' ' 142' ' ' VAL . 69.0 p . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 0.0 110.35 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 41' ' ' GLN . 15.9 mm . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.24 -160.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.083 1.57 . . . . 0.0 111.243 -178.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 10.5 p -123.03 -179.17 4.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.402 -0.811 . . . . 0.0 110.911 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.671 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 22.5 m95 -59.1 -71.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.561 0.696 . . . . 0.0 111.075 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.577 HG21 ' HG2' ' A' ' 75' ' ' LYS . 65.8 p -39.88 -28.17 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.737 -0.602 . . . . 0.0 110.493 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.459 ' N ' ' O ' ' B' ' 7' ' ' TRP . 1.1 m -61.66 -50.11 73.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.678 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 t -63.89 -33.69 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.529 -0.732 . . . . 0.0 110.09 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.586 ' N ' HD13 ' B' ' 11' ' ' ILE . 3.8 mm -74.18 -31.89 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.261 -0.899 . . . . 0.0 109.979 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.482 ' O ' ' OG ' ' B' ' 15' ' ' SER . 0.4 OUTLIER -62.55 -52.45 63.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.852 . . . . 0.0 110.093 179.741 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.741 HG13 ' CE1' ' A' ' 92' ' ' PHE . 78.2 t -67.81 -43.78 85.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.669 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.425 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -59.52 -49.74 76.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.737 -1.227 . . . . 0.0 109.692 179.453 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' B' ' 12' ' ' LEU . 3.5 p -50.67 -42.27 56.46 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.42 ' SD ' ' HG3' ' B' ' 25' ' ' PRO . 26.2 tpp -73.12 -13.93 61.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.69 179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.873 HD22 HD12 ' A' ' 112' ' ' LEU . 2.9 mp -89.94 62.44 5.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 110.142 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 ttp85 -118.31 -74.4 0.61 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.364 -0.835 . . . . 0.0 111.022 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.534 ' HD2' ' HB2' ' B' ' 20' ' ' ARG . 2.3 tmtm? -138.04 -75.45 0.39 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.081 -1.012 . . . . 0.0 110.952 -178.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.602 ' HA ' ' HG3' ' A' ' 124' ' ' MET . 1.0 OUTLIER -140.09 -4.21 1.36 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.714 -1.241 . . . . 0.0 111.31 -179.655 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -53.12 141.14 23.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.026 -1.046 . . . . 0.0 110.684 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -170.88 137.54 1.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.402 -0.811 . . . . 0.0 110.189 179.581 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.465 ' HA3' ' CE ' ' A' ' 144' ' ' MET . . . 126.11 -87.2 0.35 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.537 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 3.0 p30 -131.41 50.43 5.96 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.237 -1.155 . . . . 0.0 110.338 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 45.3 Cg_endo -73.48 -6.14 18.27 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.055 1.555 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.214 0.53 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 10' ' ' ALA . 53.7 mt -57.44 -59.21 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -42.56 -46.18 4.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 110.051 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.82 -54.76 33.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.015 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CD2' HD23 ' A' ' 69' ' ' LEU . 21.4 m-85 -61.13 -42.91 99.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.97 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -58.58 -34.05 70.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.185 -0.947 . . . . 0.0 109.344 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -61.78 -44.67 96.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.381 -0.825 . . . . 0.0 109.49 179.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -66.43 -52.1 49.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.462 -0.774 . . . . 0.0 110.08 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.6 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 35.7 t80 -63.73 -12.23 33.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.811 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.3 m -92.76 -25.99 17.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.882 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.729 HD13 ' HG3' ' B' ' 14' ' ' LYS . 7.1 tt -77.67 -30.39 51.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.603 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 47.5 m-85 -80.01 -56.71 4.05 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.335 -0.853 . . . . 0.0 110.686 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -62.84 82.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.165 -0.96 . . . . 0.0 110.213 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -88.86 21.25 3.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.235 -179.973 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 23' ' ' GLY . 7.4 p-10 -140.1 18.68 2.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.459 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.9 75.76 0.15 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.449 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 1.8 t0 -132.66 -26.7 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -1.134 . . . . 0.0 110.685 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.68 -21.4 29.88 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -119.27 118.8 32.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -1.101 . . . . 0.0 109.874 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.502 HD12 HG21 ' A' ' 63' ' ' ILE . 12.3 mt -79.34 126.17 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.121 -0.987 . . . . 0.0 109.606 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.8 p -90.16 -157.68 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.795 . . . . 0.0 110.386 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.49 HG22 HG13 ' A' ' 52' ' ' ILE . 77.8 p -94.16 -33.43 13.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 13.0 ptpt -74.68 -31.07 61.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.121 -0.987 . . . . 0.0 110.288 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 14.9 mt-10 -58.17 -66.35 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.118 -0.988 . . . . 0.0 109.47 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.625 HD22 ' CZ2' ' B' ' 7' ' ' TRP . 58.1 tp -56.75 -35.45 68.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.168 -0.958 . . . . 0.0 109.25 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.81 -37.14 93.83 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 96.6 m -59.44 -47.13 86.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.348 -1.089 . . . . 0.0 109.441 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 35' ' ' VAL . 14.7 t -70.93 -37.35 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.592 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.654 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -69.19 -44.74 71.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.385 -0.822 . . . . 0.0 109.775 179.549 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -62.57 -29.77 70.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.973 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.43 ' O ' ' CG ' ' A' ' 111' ' ' ASN . 3.3 t -79.1 -21.67 46.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 110.014 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 36' ' ' MET . 4.3 mt -68.13 -32.01 71.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.36 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.07 -60.63 0.44 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -172.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -1.199 . . . . 0.0 110.714 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 54.7 m-80 -137.1 98.88 10.16 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.431 -0.793 . . . . 0.0 109.826 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 44.3 Cg_endo -71.61 124.04 9.95 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.965 1.508 . . . . 0.0 110.464 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -93.08 167.22 11.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.3 -37.08 71.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 0.0 110.108 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.07 64.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.238 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.486 ' OE1' HD12 ' B' ' 4' ' ' ILE . 20.9 mt-10 -66.78 -38.55 86.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.087 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 48' ' ' LEU . 12.2 mt -62.08 -39.72 93.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.087 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -43.89 86.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.334 -0.854 . . . . 0.0 109.696 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.18 -38.03 89.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.35 -0.844 . . . . 0.0 109.652 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.595 ' HE1' ' CG ' ' B' ' 7' ' ' TRP . 7.4 mmm -67.26 -42.31 84.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.668 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.49 HG13 HG22 ' A' ' 29' ' ' THR . 4.4 mm -70.16 -19.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.35 -0.844 . . . . 0.0 109.625 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.11 -16.21 41.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.269 -0.894 . . . . 0.0 110.02 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -71.31 -31.01 66.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.42 -0.8 . . . . 0.0 110.241 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 57' ' ' ALA . 20.4 t -92.02 -37.09 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.163 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.427 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 1.4 t70 -46.68 87.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.641 . . . . 0.0 110.555 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -99.05 -26.78 14.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 0.0 110.203 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' OD1' ' A' ' 60' ' ' ASN . 3.1 p-10 -73.96 -43.27 58.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -0.962 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 58' ' ' ASP . . . 114.17 27.4 3.43 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 21.8 p-10 -99.53 -40.16 7.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.098 -1.236 . . . . 0.0 110.102 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 123.43 -46.76 1.07 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.2 p -95.31 166.5 11.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -1.217 . . . . 0.0 110.479 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 26' ' ' THR . 16.4 mm -88.69 142.24 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.3 -0.875 . . . . 0.0 109.894 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.2 m-20 -121.2 147.34 45.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.982 -1.073 . . . . 0.0 110.863 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.62 ' O ' HD12 ' A' ' 69' ' ' LEU . 89.7 t80 -41.61 -50.78 9.44 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.453 -0.78 . . . . 0.0 111.546 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.0 Cg_endo -66.35 -43.36 8.38 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 123.252 1.133 . . . . 0.0 110.773 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 43.4 tt0 -60.93 -36.82 80.32 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.208 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 13.0 t80 -62.56 -45.83 91.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.997 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 65' ' ' PHE . 2.7 mt -61.94 -29.91 70.55 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.319 -0.863 . . . . 0.0 110.726 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 1.7 p -79.4 -33.41 42.75 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.154 -0.966 . . . . 0.0 111.347 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.477 ' HG3' HG13 ' A' ' 55' ' ' VAL . 9.1 tmm? -69.05 -43.27 75.0 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.962 -1.087 . . . . 0.0 110.975 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.445 ' HE2' ' CZ ' ' B' ' 26' ' ' PHE . 10.7 tpt -58.66 -10.85 2.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.189 -0.944 . . . . 0.0 111.12 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.95 -9.81 16.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.865 -1.147 . . . . 0.0 111.236 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -94.4 -43.49 8.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.961 -1.087 . . . . 0.0 110.686 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.317 -0.864 . . . . 0.0 110.486 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.142 0.496 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -72.08 -17.94 61.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -0.972 . . . . 0.0 109.509 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -70.11 -23.23 63.0 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.455 -0.778 . . . . 0.0 109.871 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.6 mt -64.88 -28.99 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.2 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -32.32 73.71 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.616 -0.677 . . . . 0.0 109.807 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.799 ' HB3' HG21 ' B' ' 9' ' ' THR . 13.9 mt-10 -74.16 -47.61 34.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.863 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.52 67.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.005 -1.059 . . . . 0.0 109.405 179.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CE1' ' OD2' ' A' ' 93' ' ' ASP . 11.8 t80 -71.44 -46.43 60.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -52.91 -32.35 44.95 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.436 -0.79 . . . . 0.0 109.321 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.666 HG12 HG21 ' A' ' 108' ' ' VAL . 20.7 t -71.27 -43.09 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.543 -0.723 . . . . 0.0 109.85 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.617 ' HB3' HD13 ' A' ' 100' ' ' ILE . 19.6 m-85 -66.58 -28.26 68.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.237 -0.914 . . . . 0.0 109.797 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.551 ' OD2' ' CE1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -88.03 62.29 6.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.388 -0.82 . . . . 0.0 109.788 179.788 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -36.29 -32.74 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.703 -0.623 . . . . 0.0 110.968 -179.553 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 12.5 p30 -111.23 -39.15 4.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.171 -0.956 . . . . 0.0 110.389 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 92.09 55.22 1.75 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 99' ' ' TYR . 52.1 p30 -97.29 0.24 47.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.178 -1.189 . . . . 0.0 110.175 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.424 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 93.68 12.56 56.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.452 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -154.14 142.31 20.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.359 -1.083 . . . . 0.0 110.03 -179.944 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 92' ' ' PHE . 5.7 mt -101.51 116.8 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.238 -0.914 . . . . 0.0 110.119 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 t -98.97 142.03 30.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.288 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.02 -35.73 3.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.832 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -58.82 -49.77 76.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 109.538 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.61 -50.02 66.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.704 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.815 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -59.32 -41.08 88.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.835 . . . . 0.0 109.397 179.468 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 13.2 ttt180 -56.08 -27.7 54.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.311 -0.868 . . . . 0.0 109.403 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.13 -42.5 37.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.619 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.666 HG21 HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -70.06 -26.89 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.292 179.588 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 1.011 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.5 OUTLIER -64.33 -64.8 0.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.361 -0.837 . . . . 0.0 110.155 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.18 -33.44 63.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.903 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 38' ' ' SER . 77.5 m-20 -75.31 -18.52 60.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 110.174 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.691 HD11 HG12 ' B' ' 13' ' ' VAL . 4.3 mt -92.41 -41.36 10.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 110.268 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.32 -36.75 0.81 Allowed Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.251 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 3.4 tp10 -116.09 158.24 23.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.915 -1.344 . . . . 0.0 110.981 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -139.24 83.09 1.93 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.149 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' B' ' 19' ' ' LYS . 6.3 mp -38.34 140.76 0.28 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.591 -0.693 . . . . 0.0 111.074 -179.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -54.35 -168.52 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.541 -0.724 . . . . 0.0 109.497 179.327 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -74.95 -68.71 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.057 -1.027 . . . . 0.0 110.211 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.46 -45.16 12.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.308 -0.87 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.14 -44.28 92.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 110.049 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 117' ' ' THR . 20.1 t -61.05 -40.44 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.99 -29.21 69.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.249 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -74.63 -30.61 61.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.5 ' HE1' ' CE2' ' B' ' 22' ' ' PHE . 0.1 OUTLIER -70.41 -51.26 30.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.136 -0.977 . . . . 0.0 110.248 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.815 HD11 ' CD1' ' A' ' 105' ' ' LEU . 49.8 mm -64.56 -41.26 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.25 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -27.11 67.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 110.221 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.5 OUTLIER -69.29 -21.04 63.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.88 -35.76 8.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.931 . . . . 0.0 110.271 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 5.1 t0 -43.11 105.6 0.05 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.317 -0.864 . . . . 0.0 110.411 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 130' ' ' ILE . 23.4 mm -74.99 -33.97 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.251 -0.906 . . . . 0.0 109.928 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 7.1 p-10 -103.72 -21.98 13.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 0.0 109.989 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.412 ' HA2' ' CG ' ' A' ' 129' ' ' ASP . . . 81.09 70.41 1.34 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 19.3 p-10 -120.68 -10.96 9.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.186 -1.185 . . . . 0.0 110.406 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.77 12.13 30.99 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -164.59 147.35 8.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.188 -1.183 . . . . 0.0 110.168 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 11.7 t -99.98 143.15 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 110.338 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 4.1 t30 -105.32 -168.23 1.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 109.89 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.415 ' CE1' HG21 ' A' ' 142' ' ' VAL . 41.1 t80 -76.06 -48.46 20.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.27 -41.29 65.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.9 -52.23 38.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.274 -0.891 . . . . 0.0 110.33 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -57.0 -17.32 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.326 -0.859 . . . . 0.0 110.631 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.564 ' O ' HG22 ' A' ' 146' ' ' THR . 37.3 t -100.26 -70.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.07 -1.019 . . . . 0.0 111.006 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -39.82 -37.14 0.51 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.257 -0.902 . . . . 0.0 110.7 -179.487 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.6 mmm -62.75 -29.09 70.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.154 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.473 ' HA ' ' HB2' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -100.4 -30.86 11.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.333 -0.854 . . . . 0.0 110.653 -179.898 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.6 t . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.096 -1.003 . . . . 0.0 110.525 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.761 HG23 ' HD2' ' B' ' 5' ' ' PRO . 7.8 mt . . . . . 0 N--CA 1.506 2.358 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.761 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.9 Cg_endo -65.31 -176.35 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.844 1.444 . . . . 0.0 110.662 -179.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.472 ' O ' ' N ' ' B' ' 8' ' ' THR . 28.9 t -126.96 64.06 1.3 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.14 -0.975 . . . . 0.0 111.384 -178.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.625 ' CZ2' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER 58.09 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.207 -0.933 . . . . 0.0 111.188 178.688 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.472 ' N ' ' O ' ' B' ' 6' ' ' SER . 12.0 p -43.6 -42.79 5.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.992 . . . . 0.0 110.25 -179.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.799 HG21 ' HB3' ' A' ' 87' ' ' GLU . 3.8 m -52.41 -44.39 65.36 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.177 -0.952 . . . . 0.0 109.209 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.71 -37.43 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.337 -0.852 . . . . 0.0 109.381 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.583 ' N ' HD13 ' B' ' 11' ' ' ILE . 4.2 mm -71.38 -25.0 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -0.797 . . . . 0.0 109.499 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' B' ' 9' ' ' THR . 2.0 mp -67.38 -60.31 2.69 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.336 -0.853 . . . . 0.0 109.645 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.691 HG12 HD11 ' A' ' 112' ' ' LEU . 72.7 t -57.77 -37.79 61.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.348 -0.845 . . . . 0.0 109.99 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.729 ' HG3' HD13 ' A' ' 18' ' ' LEU . 2.4 ttpt -59.41 -45.1 92.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.028 -1.045 . . . . 0.0 109.467 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' B' ' 18' ' ' ARG . 1.6 m -62.79 -26.28 68.64 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.339 -0.85 . . . . 0.0 109.537 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.533 ' HA ' ' HB2' ' B' ' 21' ' ' SER . 0.0 OUTLIER -70.54 -32.37 69.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.891 . . . . 0.0 109.748 179.663 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 1.011 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.9 mp -73.65 -5.56 41.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.297 -0.877 . . . . 0.0 110.489 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.9 OUTLIER -44.21 -56.45 4.1 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.152 -0.968 . . . . 0.0 109.468 179.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.548 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -171.72 -68.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.605 0.717 . . . . 0.0 109.271 179.699 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.503 ' HB3' ' CD ' ' B' ' 19' ' ' LYS . 0.8 OUTLIER -129.51 14.67 6.03 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.073 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' B' ' 16' ' ' MET . 20.0 m -48.3 145.29 3.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.637 -0.664 . . . . 0.0 110.761 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.5 ' CE2' ' HE1' ' A' ' 124' ' ' MET . 0.1 OUTLIER 171.67 -34.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.495 -0.753 . . . . 0.0 109.912 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.29 -128.82 0.03 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.643 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 43.9 t30 -131.76 34.42 0.26 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.988 -1.301 . . . . 0.0 111.723 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 51.3 Cg_endo -76.33 56.65 5.09 Favored 'Trans proline' 0 N--CA 1.481 0.788 0 O-C-N 123.185 1.097 . . . . 0.0 110.472 179.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.445 ' CZ ' ' HE2' ' A' ' 72' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.256 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 8.2 mm100 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.374 0.607 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mt -48.1 -43.88 11.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 109.432 179.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -54.01 -47.38 71.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.384 -0.822 . . . . 0.0 109.491 179.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 1.4 mt-10 -49.49 -54.19 19.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.507 179.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -59.46 -38.92 82.03 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.144 -0.973 . . . . 0.0 109.389 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 10.3 ttpt -53.54 -43.62 68.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.285 -0.884 . . . . 0.0 109.173 179.165 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -56.87 -48.32 78.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 108.888 178.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.21 -54.16 50.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.412 -0.805 . . . . 0.0 109.292 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 65' ' ' PHE . 55.7 t80 -50.71 -35.64 32.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.813 . . . . 0.0 109.126 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.15 -29.39 48.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.598 -0.689 . . . . 0.0 109.396 179.258 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.616 HD11 ' O ' ' A' ' 112' ' ' LEU . 3.6 tt -53.04 -50.75 63.65 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.391 -0.818 . . . . 0.0 109.365 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 45.0 m-85 -69.72 -28.03 65.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.393 179.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.515 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 16.0 t0 -87.23 66.15 9.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.74 . . . . 0.0 110.14 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -45.25 -32.03 1.77 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.146 -0.971 . . . . 0.0 110.324 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' OE2' ' A' ' 31' ' ' GLU . 11.8 p-10 -89.72 -7.19 55.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.348 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 47.98 71.26 0.59 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 35.9 p-10 -116.9 -34.28 4.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -1.147 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 128.76 -0.51 6.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 21.2 p -142.4 128.28 19.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -1.159 . . . . 0.0 110.615 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.556 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 10.7 mt -91.96 129.65 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.214 -0.929 . . . . 0.0 110.054 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 p -99.64 -163.81 1.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 110.136 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 48' ' ' LEU . 4.5 p -91.2 -38.03 12.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.111 -0.993 . . . . 0.0 110.049 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -66.85 -33.39 75.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.994 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' OE2' ' HA ' ' A' ' 20' ' ' ASP . 2.1 mt-10 -67.05 -64.25 0.89 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.88 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.511 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 21.5 tp -52.85 -36.85 59.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 109.843 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.7 92.33 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.1 m -63.88 -52.86 58.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -1.094 . . . . 0.0 109.822 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 19' ' ' PHE . 26.3 t -52.75 -43.66 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.732 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.5 ' HE1' ' SD ' ' A' ' 51' ' ' MET . 32.2 mtt -64.18 -38.51 91.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.638 179.676 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.24 -16.37 63.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.848 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -79.0 -63.0 1.52 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.314 -0.866 . . . . 0.0 110.603 -179.879 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.472 ' O ' ' HE2' ' A' ' 94' ' ' LYS . 1.4 mt -43.48 -41.68 4.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.094 -1.004 . . . . 0.0 109.924 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 134.12 61.91 0.07 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.481 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' B' ' 4' ' ' ILE . 7.7 mt-30 -157.34 -176.36 5.91 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.125 -1.221 . . . . 0.0 109.974 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -144.17 97.44 5.24 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.109 -0.995 . . . . 0.0 110.612 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.843 ' HA ' HD11 ' B' ' 4' ' ' ILE . 49.2 Cg_endo -76.39 137.23 18.51 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.015 1.534 . . . . 0.0 110.539 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 47' ' ' GLU . 24.1 m -87.75 142.91 27.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 109.87 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -42.21 -64.2 0.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 110.27 179.994 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.71 -52.15 42.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 110.092 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 2.8 mm-40 -50.21 -53.05 30.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.308 -0.87 . . . . 0.0 109.985 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -44.94 -51.64 9.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 110.13 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 40.1 tp60 -57.4 -32.71 67.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -0.822 . . . . 0.0 109.999 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -68.0 -38.67 82.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 109.906 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.576 ' HE3' ' O ' ' B' ' 6' ' ' SER . 2.0 ttp -81.55 -27.5 34.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.398 -0.814 . . . . 0.0 110.246 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 mm -78.29 -29.9 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.302 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -77.55 0.96 20.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.18 -0.95 . . . . 0.0 110.017 179.807 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.56 -44.68 11.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.294 -0.878 . . . . 0.0 109.669 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.852 HG13 ' HG3' ' A' ' 71' ' ' MET . 41.0 t -79.72 -20.26 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 109.928 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -51.4 87.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.347 -0.846 . . . . 0.0 110.152 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -87.01 -47.22 9.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.259 -0.901 . . . . 0.0 111.062 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.2 p-10 -57.46 -45.94 84.2 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.023 -1.048 . . . . 0.0 110.828 -179.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 120.16 18.24 4.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 32.8 p-10 -96.24 -46.01 6.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -1.23 . . . . 0.0 110.239 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 134.6 -43.8 1.23 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.54 168.48 16.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.258 -1.142 . . . . 0.0 110.51 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.556 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 11.4 mm -92.76 143.76 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 110.109 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -117.95 163.69 16.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.088 -1.008 . . . . 0.0 110.379 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 44.9 t80 -59.24 -50.7 86.21 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.269 -0.894 . . . . 0.0 110.483 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -69.02 -29.2 27.81 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 O-C-N 123.393 1.207 . . . . 0.0 109.517 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' HG3' ' HB3' ' A' ' 57' ' ' ALA . 5.9 tt0 -67.75 -31.21 70.97 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.475 -0.766 . . . . 0.0 109.06 178.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.413 ' CZ ' HG13 ' B' ' 11' ' ' ILE . 5.6 t80 -70.06 -53.75 16.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.538 -0.726 . . . . 0.0 109.889 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -54.01 -35.52 62.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.387 -0.82 . . . . 0.0 110.333 -179.966 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 71' ' ' MET . 1.3 m -78.04 -53.7 7.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.23 -0.919 . . . . 0.0 110.712 -179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.852 ' HG3' HG13 ' A' ' 55' ' ' VAL . 5.7 tmm? -41.24 -42.69 2.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.226 -0.921 . . . . 0.0 110.553 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.467 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 0.1 OUTLIER -51.24 -17.83 0.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -0.868 . . . . 0.0 110.681 -179.741 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.48 -35.86 10.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.016 -1.052 . . . . 0.0 110.925 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -31.65 54.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.066 -1.022 . . . . 0.0 110.742 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB3' HG21 ' B' ' 8' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 85' ' ' ILE . 19.7 mt-10 . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.226 0.536 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 87' ' ' GLU . 7.3 tt0 -74.52 -44.52 50.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.096 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.64 -23.56 66.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.488 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.545 HG23 ' CE2' ' A' ' 141' ' ' PHE . 67.2 mt -78.43 -45.48 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.927 . . . . 0.0 109.816 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -53.89 -36.66 62.91 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 109.705 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.55 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 0.3 OUTLIER -69.83 -52.22 26.84 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.213 -0.929 . . . . 0.0 109.542 179.494 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.69 -35.3 65.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.093 -1.005 . . . . 0.0 109.036 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 63.3 t80 -67.28 -47.59 70.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.508 -0.745 . . . . 0.0 109.668 179.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -46.42 71.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.404 -0.81 . . . . 0.0 109.328 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.629 HG11 HG21 ' B' ' 13' ' ' VAL . 1.5 t -51.09 -48.94 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.415 -0.803 . . . . 0.0 109.418 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.52 ' HB3' HD13 ' A' ' 100' ' ' ILE . 30.6 m-85 -57.05 -38.3 73.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.131 -0.981 . . . . 0.0 110.124 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.432 ' OD1' HG12 ' A' ' 100' ' ' ILE . 68.2 m-20 -89.54 59.75 4.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.545 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 0.8 OUTLIER -52.18 -34.37 44.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.952 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 9.9 p-10 -74.02 -41.83 61.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.924 . . . . 0.0 110.112 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.69 35.08 5.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.431 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 33.5 p-10 -94.65 3.09 55.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -1.197 . . . . 0.0 110.257 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 68.23 37.72 86.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 12.8 m-85 -165.27 142.61 5.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -1.113 . . . . 0.0 110.24 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 92' ' ' PHE . 9.7 mt -107.7 126.53 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.667 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' ALA . 2.8 t -117.76 147.83 42.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.825 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.15 -27.73 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.268 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -70.73 -43.98 67.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.855 . . . . 0.0 109.799 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 101' ' ' SER . 42.8 mt-10 -61.31 -40.21 93.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.923 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.054 ' CD1' HD11 ' A' ' 125' ' ' ILE . 2.4 mt -63.34 -44.37 95.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.405 -0.81 . . . . 0.0 109.81 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.8 ttp85 -53.87 -37.08 63.33 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.067 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.545 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -60.55 -60.94 3.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.397 -0.814 . . . . 0.0 109.573 179.292 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.68 -35.15 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.368 -0.832 . . . . 0.0 109.464 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.946 ' HA ' HD21 ' B' ' 17' ' ' LEU . 5.6 mtt -50.89 -65.42 0.56 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 110.395 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -63.5 -33.21 75.09 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 110.354 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.12 -8.37 49.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.105 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.916 HD11 HG12 ' B' ' 13' ' ' VAL . 10.1 mt -109.38 -50.88 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 110.471 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.06 -59.24 0.16 Allowed Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.585 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -105.87 154.76 20.1 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.055 -1.262 . . . . 0.0 110.626 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 116' ' ' LEU . 6.9 ptpp? -123.48 21.97 9.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.878 . . . . 0.0 110.15 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 115' ' ' LYS . 6.6 mp 41.03 -164.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.547 -0.721 . . . . 0.0 110.575 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 118' ' ' ASP . 1.1 m -96.49 -146.59 0.29 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.433 -0.792 . . . . 0.0 109.178 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.513 ' H ' HG22 ' A' ' 117' ' ' THR . 26.1 t70 -115.4 -54.51 2.53 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.127 -0.983 . . . . 0.0 109.963 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -31.35 72.54 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 109.517 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -69.93 -45.26 67.9 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.298 -0.876 . . . . 0.0 109.298 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.2 t -61.99 -45.73 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.082 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.29 -39.99 92.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 109.782 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 4.5 tt0 -71.71 -31.15 66.42 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.403 -0.81 . . . . 0.0 109.559 179.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.502 ' HB2' ' HA ' ' B' ' 20' ' ' ARG . 1.4 ttt -61.33 -34.59 75.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 0.0 109.603 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.054 HD11 ' CD1' ' A' ' 105' ' ' LEU . 35.2 mm -80.56 -63.52 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.446 -0.784 . . . . 0.0 110.816 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.06 -30.33 10.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.181 -0.949 . . . . 0.0 110.938 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 11.8 mt-10 -74.78 -29.96 61.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.103 -0.998 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -88.11 -28.66 21.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.311 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -48.6 90.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 128' ' ' ALA . 49.3 mm -59.75 -40.93 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 0.0 109.959 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -84.55 -28.79 26.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.414 -0.804 . . . . 0.0 110.092 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.7 76.65 0.97 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 48.1 p30 -135.42 8.78 3.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.216 -1.167 . . . . 0.0 110.095 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.47 13.28 73.67 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.459 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 9.5 pt20 -169.42 163.05 10.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.247 -1.149 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 87.5 t -108.38 142.9 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.111 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.47 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 4.6 t30 -110.45 -159.04 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 0.0 110.106 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 139' ' ' GLU . 30.2 t80 -72.61 -63.02 1.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 109.691 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 143' ' ' GLN . 43.1 mt-10 -42.98 -50.11 5.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.324 -0.86 . . . . 0.0 109.787 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.444 ' HB3' HG13 ' A' ' 136' ' ' VAL . 48.8 mt-10 -55.67 -60.46 3.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 109.634 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 30.5 t80 -41.55 -28.14 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.538 -0.727 . . . . 0.0 109.537 179.157 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 140' ' ' GLU . 78.7 t -100.37 -28.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.559 -0.713 . . . . 0.0 110.535 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -66.04 -13.14 59.45 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.06 -1.025 . . . . 0.0 110.343 -179.792 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -103.63 -23.72 13.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.103 -0.998 . . . . 0.0 110.608 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.889 ' HE2' ' H ' ' B' ' 24' ' ' ASN . 8.5 mtt -90.8 -32.64 16.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.17 -0.956 . . . . 0.0 109.806 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 146' ' ' THR . 8.4 t . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.362 -0.836 . . . . 0.0 110.156 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.843 HD11 ' HA ' ' A' ' 43' ' ' PRO . 15.9 mt . . . . . 0 N--CA 1.502 2.147 0 CA-C-O 120.723 0.297 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.638 ' HD2' HG23 ' B' ' 4' ' ' ILE . 43.6 Cg_endo -74.06 151.77 44.94 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.954 1.502 . . . . 0.0 109.973 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.576 ' O ' ' HE3' ' A' ' 51' ' ' MET . 13.4 m -62.9 -55.36 26.75 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 110.432 -179.533 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.55 ' CD1' ' HE3' ' A' ' 51' ' ' MET . 0.0 OUTLIER 169.9 -76.25 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.315 -0.866 . . . . 0.0 109.552 -179.725 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.546 HG21 ' HB3' ' A' ' 75' ' ' LYS . 25.7 p -53.2 -27.75 23.3 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.758 . . . . 0.0 109.878 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.55 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 79.4 m -58.86 -52.18 66.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.925 -1.109 . . . . 0.0 108.464 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.439 ' H ' HG23 ' B' ' 10' ' ' VAL . 15.5 t -50.79 -43.69 25.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.593 ' N ' ' CD1' ' B' ' 11' ' ' ILE . 0.8 OUTLIER -59.57 -54.28 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.758 0.79 . . . . 0.0 109.584 179.408 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 11' ' ' ILE . 0.6 OUTLIER -40.66 -66.85 0.28 Allowed 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.657 -0.652 . . . . 0.0 110.779 -179.831 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.916 HG12 HD11 ' A' ' 112' ' ' LEU . 62.1 t -46.13 -43.45 5.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.643 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.543 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -59.05 -50.01 75.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.91 -1.119 . . . . 0.0 110.277 179.652 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.76 -28.95 37.68 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.357 -0.839 . . . . 0.0 109.89 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.492 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -72.6 -31.17 64.98 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.244 -0.91 . . . . 0.0 110.593 -179.871 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.946 HD21 ' HA ' ' A' ' 109' ' ' MET . 4.6 mp -67.2 57.64 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.071 -1.018 . . . . 0.0 110.699 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.572 ' HG3' ' CD ' ' B' ' 19' ' ' LYS . 2.0 ttp180 -91.96 -110.38 0.1 Allowed 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.478 -0.764 . . . . 0.0 109.141 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.572 ' CD ' ' HG3' ' B' ' 18' ' ' ARG . 3.0 mptt -126.53 -94.4 0.46 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.741 -1.225 . . . . 0.0 109.114 178.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.502 ' HA ' ' HB2' ' A' ' 124' ' ' MET . 0.0 OUTLIER -105.33 3.02 29.4 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.274 -0.891 . . . . 0.0 109.31 178.943 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 6.9 m -84.07 -176.07 6.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 0.0 109.712 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.625 ' HE2' HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -151.7 -150.72 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.017 . . . . 0.0 111.186 179.712 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.45 ' HA2' ' SD ' ' B' ' 16' ' ' MET . . . -43.85 156.05 0.21 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.889 ' H ' ' HE2' ' A' ' 145' ' ' MET . 34.8 m120 -150.17 168.1 11.68 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.457 -1.025 . . . . 0.0 110.217 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' B' ' 24' ' ' ASN . 39.7 Cg_endo -65.78 73.22 0.32 Allowed 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.637 1.335 . . . . 0.0 110.041 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.467 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.715 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.758 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.436 ' NE2' ' OXT' ' B' ' 26' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 109.818 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 10' ' ' ALA . 88.6 mt -50.08 -59.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -44.97 -52.7 8.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -0.939 . . . . 0.0 109.514 179.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.537 ' HG2' ' CD1' ' A' ' 12' ' ' PHE . 1.2 tt0 -52.49 -48.1 66.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -0.834 . . . . 0.0 109.313 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.537 ' CD1' ' HG2' ' A' ' 11' ' ' GLU . 18.9 m-30 -55.84 -47.46 77.22 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.359 -0.838 . . . . 0.0 109.904 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -48.86 -42.64 37.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.588 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -53.63 56.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 109.619 179.439 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -54.2 -40.85 67.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.829 . . . . 0.0 109.861 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -66.8 -30.05 70.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.823 . . . . 0.0 109.831 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -78.43 -20.22 51.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.639 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.481 HD12 ' HE2' ' B' ' 14' ' ' LYS . 6.4 tt -76.72 -46.33 25.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.384 -0.822 . . . . 0.0 110.05 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' HA ' HG21 ' A' ' 35' ' ' VAL . 69.5 m-85 -72.1 -22.77 61.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.0 110.161 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.487 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 0.8 OUTLIER -95.44 83.78 3.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.038 179.907 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 13.2 mmtt -44.71 -35.8 2.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.1 p30 -97.93 -24.52 15.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 110.328 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 67.86 31.21 75.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 41.9 p-10 -79.27 -0.75 33.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -1.191 . . . . 0.0 110.111 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 26' ' ' THR . . . 87.0 27.0 29.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 25' ' ' GLY . 18.4 p -156.51 97.41 1.74 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -1.089 . . . . 0.0 109.894 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.778 HD12 HG21 ' A' ' 63' ' ' ILE . 18.8 mt -85.32 112.32 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.033 . . . . 0.0 109.978 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.429 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -75.79 -163.72 0.3 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.313 -0.867 . . . . 0.0 109.783 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 p -80.45 -56.09 4.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.947 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -37.98 66.13 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.44 -0.788 . . . . 0.0 110.494 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 18.9 mt-10 -48.86 -68.49 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.048 -1.033 . . . . 0.0 109.653 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.513 HD21 ' CE ' ' A' ' 51' ' ' MET . 56.0 tp -47.28 -39.33 14.27 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.309 -0.87 . . . . 0.0 109.141 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.39 96.75 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.611 -1.796 . . . . 0.0 108.611 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.532 HG23 HH12 ' A' ' 37' ' ' ARG . 22.6 m -52.53 -42.97 64.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.362 -1.081 . . . . 0.0 109.249 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.602 HG21 ' HA ' ' A' ' 19' ' ' PHE . 13.3 t -66.91 -46.96 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.398 -0.814 . . . . 0.0 109.599 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.472 ' CE ' ' HG2' ' B' ' 5' ' ' PRO . 4.8 mmt -67.13 -29.8 69.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.658 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.532 HH12 HG23 ' A' ' 34' ' ' THR . 2.4 ttp-105 -68.46 -35.13 77.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.771 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 m -84.12 -14.35 50.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.064 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -83.17 -32.91 26.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.103 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.65 -62.93 0.18 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.555 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -100.3 175.42 5.72 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.038 -1.272 . . . . 0.0 111.315 -178.959 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -134.52 100.06 12.69 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.602 -0.686 . . . . 0.0 109.529 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' B' ' 4' ' ' ILE . 43.6 Cg_endo -69.97 162.74 41.02 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 O-C-N 124.065 1.56 . . . . 0.0 111.072 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.495 ' O ' HD12 ' A' ' 48' ' ' LEU . 4.2 t -96.93 -149.95 0.33 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.385 -0.822 . . . . 0.0 110.725 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 38.1 mt-10 -94.22 -57.33 2.54 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 0.0 110.88 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 47' ' ' GLU . . . -43.56 -70.54 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.035 -1.041 . . . . 0.0 110.409 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 46' ' ' ALA . 6.0 mm-40 -44.78 -42.9 8.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.077 -1.015 . . . . 0.0 109.486 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 44' ' ' THR . 5.7 mt -57.22 -47.39 81.44 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -46.28 -43.28 15.57 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.38 179.436 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.45 -30.32 64.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.432 -0.792 . . . . 0.0 109.571 179.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.584 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 1.2 mmm -74.72 -36.71 62.68 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.403 -0.811 . . . . 0.0 109.497 179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.603 HG13 HD11 ' A' ' 63' ' ' ILE . 1.5 tp -78.1 -43.75 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.273 -0.892 . . . . 0.0 110.327 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.505 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -43.43 -26.1 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.257 -0.902 . . . . 0.0 110.331 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 52' ' ' ILE . 15.6 mm-40 -67.9 -51.43 47.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 110.213 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.7 HG22 ' HG3' ' A' ' 71' ' ' MET . 14.8 t -80.61 -33.38 13.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.96 82.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.348 -0.845 . . . . 0.0 110.168 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.77 -69.25 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.398 -0.814 . . . . 0.0 110.816 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 47.1 p-10 -59.02 -16.88 20.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.252 -0.905 . . . . 0.0 110.675 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 69.47 43.8 67.54 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 31.4 p-10 -94.76 -31.84 13.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.326 -1.102 . . . . 0.0 110.478 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 62' ' ' THR . . . 120.51 24.09 2.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 61' ' ' GLY . 3.4 p -161.05 142.66 11.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -1.14 . . . . 0.0 110.247 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.778 HG21 HD12 ' A' ' 27' ' ' ILE . 14.1 mm -82.4 134.03 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.196 -0.94 . . . . 0.0 110.011 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -105.96 160.62 15.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 110.319 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.6 t80 -56.62 -50.36 88.35 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.554 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.9 Cg_endo -69.97 -31.3 19.85 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.397 1.209 . . . . 0.0 109.974 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 70' ' ' THR . 8.9 mt-10 -64.41 -34.03 77.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.32 -0.863 . . . . 0.0 110.073 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -75.45 -53.58 8.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.21 -0.932 . . . . 0.0 109.673 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mp -49.82 -29.78 8.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.883 . . . . 0.0 109.913 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -74.59 -47.89 29.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -0.849 . . . . 0.0 110.028 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.7 ' HG3' HG22 ' A' ' 55' ' ' VAL . 8.0 mmm -50.39 -47.45 56.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.135 -0.978 . . . . 0.0 109.572 179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.861 ' CE ' HG21 ' B' ' 11' ' ' ILE . 6.1 tpt -42.19 -26.81 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.48 -0.763 . . . . 0.0 110.498 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 71' ' ' MET . . . -107.52 -21.07 13.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.193 -0.942 . . . . 0.0 110.957 -179.145 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.46 -26.01 33.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.074 -1.016 . . . . 0.0 110.394 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HB3' HG21 ' B' ' 8' ' ' THR . 2.6 tptm . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 110.292 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.365 0.603 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -63.89 -13.17 43.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.406 -0.809 . . . . 0.0 109.51 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.529 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 3.2 mt-10 -71.28 -45.47 63.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.513 -0.742 . . . . 0.0 110.582 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.696 HG21 HG22 ' A' ' 142' ' ' VAL . 27.3 mt -73.74 -21.73 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 110.198 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -71.83 -53.45 13.25 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.159 -0.963 . . . . 0.0 110.298 -179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.831 ' HG3' HG23 ' B' ' 9' ' ' THR . 7.8 pt-20 -62.37 -40.27 95.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.012 -1.055 . . . . 0.0 110.333 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.435 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -58.89 -37.31 76.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.504 -1.372 . . . . 0.0 108.358 178.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -65.49 -44.04 88.31 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -43.52 71.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.53 -0.731 . . . . 0.0 109.046 178.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.903 HG12 HG21 ' A' ' 108' ' ' VAL . 30.4 t -53.29 -48.57 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -0.785 . . . . 0.0 108.989 179.03 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.945 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 42.9 m-85 -66.59 -35.56 80.49 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 109.228 178.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.472 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 23.6 t0 -86.9 60.02 5.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.765 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' ASP . 10.2 ttpt -39.51 -50.07 2.15 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.521 -0.737 . . . . 0.0 110.252 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 10.2 p-10 -65.25 -36.56 84.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 109.652 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.453 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 83.41 45.41 6.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.374 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 52.6 p-10 -100.22 -20.71 15.8 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.058 -1.26 . . . . 0.0 110.273 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 109.28 22.08 6.99 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 24.4 m-85 -143.57 142.66 31.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.363 -1.08 . . . . 0.0 109.98 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 6.3 mt -113.69 96.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.498 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.2 m -90.68 152.45 20.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -0.918 . . . . 0.0 109.775 179.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.18 -40.55 11.38 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.63 -47.4 79.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.387 -0.821 . . . . 0.0 109.59 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 25.8 mt-10 -61.06 -53.66 54.38 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.304 -0.872 . . . . 0.0 109.828 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.643 HD13 HD11 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -59.34 -29.53 67.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.465 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.4 ttt-85 -70.82 -22.88 62.29 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.343 -0.848 . . . . 0.0 108.87 178.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 9.0 m80 -79.81 -46.23 17.32 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.576 -0.702 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.903 HG21 HG12 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -67.03 -20.73 27.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.365 -0.834 . . . . 0.0 108.857 179.144 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.595 ' HG3' HD21 ' B' ' 17' ' ' LEU . 0.3 OUTLIER -68.77 -52.07 34.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.599 -0.688 . . . . 0.0 109.956 179.638 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -35.37 73.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.894 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -74.16 -12.66 60.65 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.16 -0.962 . . . . 0.0 109.345 179.429 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.623 HD11 HG12 ' B' ' 13' ' ' VAL . 8.9 mt -94.64 -51.42 4.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.432 -0.792 . . . . 0.0 109.754 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.57 -59.93 0.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 20.8 tp10 -96.76 160.6 14.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.201 -1.176 . . . . 0.0 110.949 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -133.94 81.9 1.95 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.325 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.617 ' H ' HD12 ' A' ' 116' ' ' LEU . 6.5 mp -37.27 150.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.573 0.701 . . . . 0.0 111.268 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.79 -148.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.502 -0.749 . . . . 0.0 110.012 179.759 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.99 -44.86 5.36 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.331 -0.855 . . . . 0.0 110.135 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.493 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 17.5 pt-20 -64.89 -42.36 94.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.76 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.493 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 11.1 mm-40 -63.3 -40.72 98.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.579 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 125' ' ' ILE . 40.5 t -64.89 -45.37 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.273 -0.892 . . . . 0.0 109.699 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -63.53 -35.56 80.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.436 -0.79 . . . . 0.0 109.708 179.643 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 124' ' ' MET . 45.5 mt-10 -72.87 -54.48 8.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.0 109.566 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.626 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 25.1 ttt -42.38 -43.37 3.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.476 -0.765 . . . . 0.0 109.904 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.643 HD11 HD13 ' A' ' 105' ' ' LEU . 15.3 mm -76.33 -60.27 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 0.0 109.961 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -47.84 -55.03 10.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.512 ' OE2' ' CZ ' ' B' ' 20' ' ' ARG . 46.2 mt-10 -52.51 -21.6 3.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 0.0 110.388 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.559 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -93.28 -34.95 13.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.215 -0.928 . . . . 0.0 110.328 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.433 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 5.2 m-20 -68.43 66.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 110.237 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 128' ' ' ALA . 2.5 mp -46.43 -42.82 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.004 . . . . 0.0 109.88 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -70.89 -29.41 65.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.467 -0.77 . . . . 0.0 110.189 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.92 95.45 0.28 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 29.5 p-10 -144.72 -37.76 0.29 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -1.116 . . . . 0.0 110.236 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 121.49 9.44 7.11 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -165.59 149.8 8.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -1.102 . . . . 0.0 110.271 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 3.5 t -103.19 116.38 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 109.823 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.37 -155.03 0.3 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.345 -0.847 . . . . 0.0 110.603 -179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 139' ' ' GLU . 58.5 t80 -75.24 -60.62 2.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 138' ' ' TYR . 1.5 tt0 -42.72 -56.83 3.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 143' ' ' GLN . 2.6 mt-10 -55.23 -55.62 29.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.903 . . . . 0.0 109.85 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -45.22 -28.8 0.84 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.376 -0.827 . . . . 0.0 109.626 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.696 HG22 HG21 ' A' ' 85' ' ' ILE . 24.3 t -98.94 -24.02 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.411 -0.806 . . . . 0.0 109.806 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -59.0 -30.58 68.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 109.917 179.797 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.0 mmm -92.0 -9.58 42.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.316 -0.865 . . . . 0.0 109.844 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.529 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.2 OUTLIER -98.56 -69.76 0.75 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.388 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.495 1.82 0 O-C-N 120.963 -1.086 . . . . 0.0 110.866 -179.757 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.652 HG21 ' HB3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.118 0.485 . . . . 0.0 110.656 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.583 ' HB2' ' CB ' ' B' ' 9' ' ' THR . 48.1 Cg_endo -72.26 -155.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 124.334 1.702 . . . . 0.0 111.144 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.537 ' O ' ' N ' ' B' ' 8' ' ' THR . 5.0 t -130.18 73.8 1.55 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.245 -0.91 . . . . 0.0 111.214 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.714 ' O ' HG22 ' B' ' 10' ' ' VAL . 0.8 OUTLIER 46.96 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.698 0 O-C-N 121.49 -0.756 . . . . 0.0 111.848 178.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.858 ' HA ' HD12 ' B' ' 11' ' ' ILE . 21.6 p -38.99 -26.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 110.798 -179.016 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.831 HG23 ' HG3' ' A' ' 87' ' ' GLU . 15.8 m -64.92 -65.81 0.62 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.076 -1.015 . . . . 0.0 109.996 179.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.714 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.0 m -46.68 -26.86 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 108.955 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.861 HG21 ' CE ' ' A' ' 72' ' ' MET . 49.2 mt -74.4 -47.96 37.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 121.687 0.756 . . . . 0.0 109.541 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 mt -50.32 -56.64 10.43 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.654 -0.654 . . . . 0.0 110.561 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.945 HG13 ' CZ ' ' A' ' 92' ' ' PHE . 17.2 t -62.34 -40.17 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.969 . . . . 0.0 110.958 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.481 ' HE2' HD12 ' A' ' 18' ' ' LEU . 6.5 tptp -71.54 -11.65 60.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.802 -1.186 . . . . 0.0 110.492 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.403 ' CB ' ' HE1' ' B' ' 26' ' ' PHE . 1.6 m -97.59 -21.83 16.85 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.191 -0.943 . . . . 0.0 109.265 179.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.445 ' O ' ' HE3' ' A' ' 124' ' ' MET . 6.6 tpp -78.56 -37.39 42.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.584 -0.697 . . . . 0.0 110.156 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.595 HD21 ' HG3' ' A' ' 109' ' ' MET . 1.3 mp -48.43 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.918 -1.114 . . . . 0.0 109.682 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER 31.62 58.07 0.31 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.652 -0.655 . . . . 0.0 112.514 179.392 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.548 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 62.5 -59.3 0.13 Allowed 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.47 -0.768 . . . . 0.0 111.753 178.155 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -155.66 8.42 0.25 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.886 -1.134 . . . . 0.0 111.752 -178.514 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' B' ' 18' ' ' ARG . 1.8 m -59.99 84.51 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.732 -1.23 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.626 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -111.93 13.55 20.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -0.954 . . . . 0.0 110.349 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.506 ' C ' ' HD3' ' B' ' 25' ' ' PRO . . . -96.24 -139.53 10.52 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.556 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 32.8 t-20 -119.78 47.58 1.03 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.196 -1.179 . . . . 0.0 110.386 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 48.5 Cg_endo -73.73 53.02 2.66 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.734 1.386 . . . . 0.0 110.268 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.521 ' CZ ' ' HE1' ' A' ' 72' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.987 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.246 0.546 . . . . 0.0 110.278 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.4 mt -48.27 -45.97 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.785 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.09 -41.66 62.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 109.738 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.564 ' OE2' ' CE1' ' A' ' 12' ' ' PHE . 1.9 tt0 -57.55 -51.51 69.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.746 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE1' ' OE2' ' A' ' 11' ' ' GLU . 21.0 m-85 -62.15 -45.07 95.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.942 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -60.17 -42.71 95.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -0.932 . . . . 0.0 109.705 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.79 -36.89 72.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.624 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . . . -75.45 -54.11 7.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.675 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.582 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 20.6 t80 -56.73 -17.15 8.0 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.417 -0.802 . . . . 0.0 109.714 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 18' ' ' LEU . 7.3 t -89.33 -56.74 3.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 112' ' ' LEU . 7.4 tt -44.31 -30.15 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -87.64 -30.73 20.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.284 -0.885 . . . . 0.0 110.535 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 22' ' ' ASP . 23.6 t0 -104.89 91.57 3.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 110.495 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -67.92 -48.5 65.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.18 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 5.2 p-10 -60.39 -41.98 94.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.44 -0.787 . . . . 0.0 110.434 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.429 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . 83.87 56.47 2.6 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 38.1 p-10 -107.45 -27.57 10.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.159 -1.201 . . . . 0.0 110.263 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 111.56 9.09 21.99 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 27.2 p -141.89 116.02 9.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -1.172 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.5 mt -94.76 106.45 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 110.149 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.86 152.03 23.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.792 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -45.97 -25.56 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.01 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -61.12 2.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 110.218 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.67 -57.66 10.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.226 -0.921 . . . . 0.0 110.07 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 ' CH2' ' B' ' 7' ' ' TRP . 29.8 tp -52.68 -38.43 60.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.34 -40.02 96.92 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -60.29 -55.44 33.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -1.145 . . . . 0.0 109.943 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.443 HG23 ' H ' ' A' ' 35' ' ' VAL . 21.2 t -48.29 -50.53 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.649 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.625 ' HE3' ' HG2' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -54.38 -38.69 66.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.917 . . . . 0.0 109.871 179.657 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HG3' ' ND2' ' A' ' 42' ' ' ASN . 2.0 ttp85 -64.25 -23.31 67.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.417 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 8.1 t -78.36 -30.23 47.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 110.656 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.74 -43.95 67.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.08 -1.013 . . . . 0.0 110.477 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.36 -16.01 0.41 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.654 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.1 mm-40 -113.2 166.0 11.87 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.832 -1.393 . . . . 0.0 110.624 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.5 ' ND2' ' HG3' ' A' ' 37' ' ' ARG . 3.8 t-20 -127.9 97.16 30.34 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.287 -0.883 . . . . 0.0 110.231 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.55 ' CD ' ' HB3' ' A' ' 36' ' ' MET . 46.6 Cg_endo -75.45 140.08 23.87 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 124.173 1.618 . . . . 0.0 110.357 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.682 HG23 ' H ' ' A' ' 46' ' ' ALA . 14.7 t -91.58 -143.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 109.917 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.58 ' N ' HG23 ' A' ' 44' ' ' THR . 11.4 tp10 -100.23 -25.96 14.08 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.252 -0.905 . . . . 0.0 110.289 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.682 ' H ' HG23 ' A' ' 44' ' ' THR . . . -73.62 -70.8 0.35 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.14 -0.975 . . . . 0.0 110.387 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.596 ' HG2' HG22 ' A' ' 44' ' ' THR . 8.2 pt-20 -49.42 -40.29 36.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.0 109.624 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 1.4 mt -58.73 -43.25 90.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.079 179.195 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -49.99 -49.29 51.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.502 -0.749 . . . . 0.0 109.095 179.084 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -29.98 68.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.292 179.076 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.491 ' CE ' ' CE ' ' A' ' 36' ' ' MET . 1.2 ttp -75.98 -55.38 5.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 2.5 tp -56.96 -44.66 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.532 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.5 OUTLIER -40.89 -70.1 0.12 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.557 -0.714 . . . . 0.0 111.128 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -35.91 -55.08 0.75 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.722 -0.612 . . . . 0.0 110.933 -179.315 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.634 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 11.3 t -75.21 -33.84 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.745 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 5.3 t0 -58.87 77.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 0.0 110.318 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -39.72 -61.28 0.85 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.504 -0.747 . . . . 0.0 110.575 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 41.0 p-10 -76.4 -18.85 58.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 110.091 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 72.32 49.27 21.08 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 17.0 p-10 -99.3 -27.41 13.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -1.154 . . . . 0.0 110.302 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.587 ' C ' HG23 ' A' ' 62' ' ' THR . . . 119.14 23.47 3.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 61' ' ' GLY . 81.2 p -155.65 140.36 17.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.181 -1.187 . . . . 0.0 110.051 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.4 mm -91.15 158.75 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.354 -0.842 . . . . 0.0 110.072 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 58.5 m-20 -133.7 163.32 29.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 0.0 110.059 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.603 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 11.4 t80 -56.35 -48.54 96.78 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.16 -0.962 . . . . 0.0 111.215 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.1 Cg_endo -68.73 -35.69 15.79 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.206 1.108 . . . . 0.0 110.293 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 6.8 tt0 -58.94 -41.23 86.89 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.304 -0.872 . . . . 0.0 110.143 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 15' ' ' ALA . 36.6 t80 -69.58 -54.85 12.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.82 -24.95 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.958 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 m -97.61 -15.31 20.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 110.479 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.563 ' SD ' HG22 ' A' ' 55' ' ' VAL . 5.8 ttp -74.59 -42.7 58.23 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.144 -0.972 . . . . 0.0 110.536 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.529 ' HE1' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -54.46 -15.37 1.65 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.326 -0.858 . . . . 0.0 110.85 -179.387 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.42 -12.84 18.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.049 -1.032 . . . . 0.0 111.278 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.9 -11.96 40.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.781 -1.199 . . . . 0.0 110.502 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.73 ' CB ' HG21 ' B' ' 8' ' ' THR . 17.7 mmtt . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 110.268 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.303 0.573 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.11 -27.7 62.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.891 . . . . 0.0 109.637 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' OE2' ' HB3' ' A' ' 75' ' ' LYS . 17.3 mt-10 -72.63 -42.43 64.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.827 . . . . 0.0 110.128 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.62 HG21 HG22 ' A' ' 142' ' ' VAL . 14.2 mt -68.69 -37.84 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.489 -0.884 . . . . 0.0 108.762 179.502 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -60.93 -27.34 68.15 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.034 178.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 1.5 mt-10 -73.72 -54.48 7.99 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.536 -0.728 . . . . 0.0 109.146 179.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.75 -28.14 32.76 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.329 -0.857 . . . . 0.0 109.235 179.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -70.44 -46.04 64.65 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.373 -0.83 . . . . 0.0 109.514 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -28.83 65.71 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.513 -0.742 . . . . 0.0 109.621 179.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.72 HG12 HG21 ' A' ' 108' ' ' VAL . 15.5 t -73.75 -39.25 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.391 -0.818 . . . . 0.0 109.677 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.587 ' HB3' HD13 ' A' ' 100' ' ' ILE . 11.1 m-85 -72.78 -32.0 65.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.859 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -85.24 54.18 3.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.305 -0.872 . . . . 0.0 110.395 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.82 -28.12 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 30.8 p-10 -85.57 -43.81 13.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.186 -0.946 . . . . 0.0 110.354 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 89.75 22.75 35.35 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 33.4 p-10 -75.73 -33.84 60.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -1.132 . . . . 0.0 109.927 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 120.84 21.13 3.28 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 2.0 m-85 -164.44 130.04 2.85 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.182 -1.187 . . . . 0.0 110.263 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 92' ' ' PHE . 29.0 mt -82.46 155.52 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.966 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -144.67 156.88 44.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.86 -38.03 21.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 0.0 110.2 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.47 -46.89 84.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 109.849 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.3 -36.26 70.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 109.861 179.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.606 HD12 HD11 ' A' ' 125' ' ' ILE . 5.7 mt -61.8 -48.4 80.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.346 -0.846 . . . . 0.0 109.822 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.8 -35.63 61.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.438 ' CD2' ' N ' ' A' ' 107' ' ' HIS . 35.2 m170 -64.0 -45.22 89.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -0.799 . . . . 0.0 110.14 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.72 HG21 HG12 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -79.21 -23.67 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.72 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.97 ' SD ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -68.01 -56.89 7.27 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 110.111 -179.971 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.417 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 7.3 m -60.93 -31.41 70.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.947 . . . . 0.0 109.691 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 38' ' ' SER . 7.1 m-20 -76.96 -4.7 45.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.856 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.79 HD11 HG12 ' B' ' 13' ' ' VAL . 7.0 mt -111.64 -44.68 3.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 110.374 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.96 -66.87 0.13 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.634 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 109' ' ' MET . 2.7 tt0 -103.25 166.94 10.14 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.171 -1.193 . . . . 0.0 111.137 -178.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.566 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.3 OUTLIER -124.47 16.79 8.93 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.733 0.777 . . . . 0.0 109.553 179.255 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.97 HD13 ' SD ' ' A' ' 109' ' ' MET . 2.8 mp 43.62 -173.23 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.66 0.743 . . . . 0.0 111.169 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.76 -146.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.505 -0.747 . . . . 0.0 109.886 179.75 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -114.06 -70.22 0.81 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.156 -0.965 . . . . 0.0 110.517 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 120' ' ' GLU . 3.8 pt-20 -55.39 -29.23 58.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 109.743 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.473 ' OE2' ' HE2' ' B' ' 19' ' ' LYS . 6.2 mt-10 -71.73 -45.74 60.81 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 108.919 178.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 117' ' ' THR . 53.1 t -54.67 -45.71 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.491 -0.756 . . . . 0.0 109.629 179.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -60.37 -59.23 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 0.0 109.373 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 68.5 mm-40 -48.41 -38.66 20.17 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.393 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -51.01 -56.1 14.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.252 -0.905 . . . . 0.0 109.462 179.503 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 105' ' ' LEU . 21.0 mm -56.35 -30.67 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.349 -0.844 . . . . 0.0 110.011 179.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 123' ' ' GLU . 5.7 ttt180 -64.99 -55.0 21.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.303 -0.873 . . . . 0.0 110.528 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 126' ' ' ARG . 2.6 tp10 -41.9 -42.89 2.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.305 -0.872 . . . . 0.0 110.371 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.21 -27.79 38.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.282 -0.886 . . . . 0.0 110.171 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.6 OUTLIER -83.36 63.86 7.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.373 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 129' ' ' ASP . 5.7 mt -43.56 -40.07 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.747 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 21.2 p30 -67.34 -32.23 73.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.551 -0.718 . . . . 0.0 110.118 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.3 66.65 1.76 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.445 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 2.9 p-10 -115.43 -27.86 7.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -1.121 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.96 16.26 8.62 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.436 ' O ' ' OD2' ' A' ' 133' ' ' ASP . 11.7 pt20 -169.95 149.78 3.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -1.131 . . . . 0.0 110.174 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 85.9 t -110.79 149.77 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 109.972 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.427 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 25.3 p-10 -120.21 -157.93 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.419 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.414 ' O ' ' C ' ' A' ' 139' ' ' GLU . 11.1 t80 -70.88 -67.22 0.52 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.358 -0.839 . . . . 0.0 110.61 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 138' ' ' TYR . 4.7 mt-10 -41.65 -62.32 0.91 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.384 -0.822 . . . . 0.0 110.351 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 141' ' ' PHE . 49.3 mt-10 -46.27 -60.29 2.4 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.21 -0.931 . . . . 0.0 110.009 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.605 ' CD1' HG23 ' A' ' 85' ' ' ILE . 24.4 t80 -42.04 -28.19 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.743 179.755 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.674 HG13 ' OG1' ' A' ' 146' ' ' THR . 38.2 t -100.87 -32.25 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.454 -0.779 . . . . 0.0 110.644 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.432 ' O ' ' CD ' ' A' ' 143' ' ' GLN . 4.7 tm0? -59.94 -18.43 45.16 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.147 -0.971 . . . . 0.0 110.404 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.3 mmm -112.58 -25.09 9.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 110.34 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.556 ' HE3' ' CB ' ' B' ' 24' ' ' ASN . 3.0 ttt -100.54 -9.34 22.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 111.118 -179.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.674 ' OG1' HG13 ' A' ' 142' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 O-C-N 120.92 -1.112 . . . . 0.0 111.174 -179.2 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.481 HG13 ' OE2' ' A' ' 47' ' ' GLU . 24.2 mm . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.833 ' HB3' HG21 ' B' ' 9' ' ' THR . 39.6 Cg_endo -67.43 173.18 9.14 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.113 1.586 . . . . 0.0 111.037 -179.281 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.8 t -126.1 79.38 1.84 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.247 -0.908 . . . . 0.0 111.452 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.671 ' O ' HG22 ' B' ' 10' ' ' VAL . 9.2 m95 53.99 -93.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.45 -0.781 . . . . 0.0 112.042 178.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.73 HG21 ' CB ' ' A' ' 75' ' ' LYS . 4.0 p -37.18 -29.17 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.266 -0.896 . . . . 0.0 110.517 -178.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.833 HG21 ' HB3' ' B' ' 5' ' ' PRO . 53.7 m -65.67 -51.29 60.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.189 -0.945 . . . . 0.0 109.697 178.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.822 HG23 HD12 ' B' ' 11' ' ' ILE . 2.7 m -63.19 -29.91 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.948 -1.095 . . . . 0.0 108.653 179.018 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.822 HD12 HG23 ' B' ' 10' ' ' VAL . 1.6 mp -72.34 -54.69 15.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.52 -0.737 . . . . 0.0 109.265 178.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' B' ' 11' ' ' ILE . 0.5 OUTLIER -42.23 -59.8 1.68 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.546 -0.721 . . . . 0.0 110.534 179.897 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.79 HG12 HD11 ' A' ' 112' ' ' LEU . 69.0 t -56.3 -50.15 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 110.403 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.533 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -56.12 -35.23 66.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.908 -1.12 . . . . 0.0 109.663 179.632 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 5.1 t -73.84 -19.9 60.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 109.866 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 1.7 tpt -75.2 -43.18 53.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.939 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.3 mp -53.31 -91.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.0 . . . . 0.0 109.699 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' B' ' 17' ' ' LEU . 5.7 ttt180 59.98 -69.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.401 0.619 . . . . 0.0 110.808 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.658 ' O ' HD21 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -176.2 -72.53 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.027 0 O-C-N 121.412 -0.805 . . . . 0.0 110.812 -179.619 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.594 ' HB2' ' CD ' ' B' ' 19' ' ' LYS . 2.2 ttt-85 -135.09 20.4 3.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.848 -1.157 . . . . 0.0 110.324 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.73 129.56 42.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.282 -0.886 . . . . 0.0 110.219 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 124' ' ' MET . 0.2 OUTLIER -130.67 -4.06 4.16 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.426 -0.796 . . . . 0.0 110.351 -179.8 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.52 -28.07 23.04 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.556 ' CB ' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER 48.89 81.81 0.25 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.081 -1.246 . . . . 0.0 109.912 -179.825 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.96 -34.94 9.85 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.901 1.474 . . . . 0.0 110.64 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.529 ' CZ ' ' HE1' ' A' ' 72' ' ' MET . 1.1 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.198 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.335 0.588 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.494 HG23 ' HZ ' ' A' ' 65' ' ' PHE . 46.8 mt -53.22 -27.73 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.343 -0.848 . . . . 0.0 109.759 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -57.4 -64.03 1.03 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.54 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -48.39 -44.42 34.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -67.2 -50.0 62.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.384 -0.822 . . . . 0.0 109.737 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -55.89 -44.0 77.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.854 179.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 41.2 mt-10 -55.38 -43.47 75.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.762 179.538 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -72.1 -50.35 28.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.401 -0.812 . . . . 0.0 109.965 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.576 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 11.2 t80 -54.29 -47.81 71.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 109.918 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -68.05 -27.77 66.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.882 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.82 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.2 tt -61.41 -37.97 85.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.394 -0.816 . . . . 0.0 110.085 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.628 ' HD1' HG21 ' A' ' 35' ' ' VAL . 44.5 m-85 -80.75 -30.03 36.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.44 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 13.7 t0 -84.73 84.25 7.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 110.49 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -73.12 -40.05 65.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.21 -0.931 . . . . 0.0 110.032 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -71.09 -33.86 70.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.086 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 65.17 1.23 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.476 ' O ' HG23 ' A' ' 26' ' ' THR . 57.7 p30 -128.62 6.59 5.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -1.159 . . . . 0.0 110.154 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.66 13.48 51.39 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 59.5 p -136.87 115.44 11.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.276 -1.132 . . . . 0.0 110.251 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.546 ' O ' HG22 ' A' ' 62' ' ' THR . 5.1 mt -88.9 124.01 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.203 -0.936 . . . . 0.0 110.355 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.4 p -99.67 172.02 7.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.332 -0.855 . . . . 0.0 110.284 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 p -56.95 -30.06 63.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.937 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -66.83 -60.44 2.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.232 -0.918 . . . . 0.0 110.05 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' O ' HG23 ' A' ' 35' ' ' VAL . 32.5 mt-10 -52.16 -55.65 19.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 110.024 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.568 HD13 ' CH2' ' B' ' 7' ' ' TRP . 27.0 tp -59.51 -37.6 78.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.05 -37.19 64.19 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.9 m -61.36 -55.36 32.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -1.136 . . . . 0.0 109.942 179.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.628 HG21 ' HD1' ' A' ' 19' ' ' PHE . 20.4 t -52.7 -46.88 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 109.643 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.467 ' HE1' ' SD ' ' A' ' 51' ' ' MET . 0.9 OUTLIER -58.63 -41.82 86.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.693 179.506 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -28.78 66.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 109.924 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -55.73 3.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.337 -0.852 . . . . 0.0 110.272 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mt -44.88 -28.18 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.129 -0.982 . . . . 0.0 110.063 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 115.98 49.89 0.45 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' NE2' ' HG3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -147.44 -174.53 4.55 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.211 -1.17 . . . . 0.0 110.359 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -161.89 84.12 1.69 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.325 -0.859 . . . . 0.0 110.256 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 46.9 Cg_endo -73.19 100.67 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.042 1.548 . . . . 0.0 110.169 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.498 HG22 ' HB2' ' A' ' 47' ' ' GLU . 5.0 t -57.07 162.39 2.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.085 -1.009 . . . . 0.0 110.239 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' ALA . 2.3 mt-10 -42.98 -65.37 0.49 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 110.269 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -40.45 -51.84 2.83 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 110.227 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.498 ' HB2' HG22 ' A' ' 44' ' ' THR . 5.9 mm-40 -63.85 -56.49 14.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.026 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 48' ' ' LEU . 5.2 mt -42.32 -42.8 3.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -0.832 . . . . 0.0 110.18 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -66.95 -41.1 87.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 0.0 110.079 179.77 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -27.42 65.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.402 -0.811 . . . . 0.0 110.186 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.467 ' SD ' ' HE1' ' A' ' 36' ' ' MET . 0.9 OUTLIER -82.54 -33.63 28.11 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.927 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 4.8 mm -80.35 -31.08 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -76.82 -13.71 59.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 110.233 179.937 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -73.42 -60.99 1.99 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 0.0 110.106 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.649 ' HB ' HD12 ' A' ' 63' ' ' ILE . 13.8 t -69.19 -25.41 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.108 -0.995 . . . . 0.0 109.808 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -49.23 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.368 -0.832 . . . . 0.0 109.98 179.787 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -70.56 -66.88 0.55 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.41 -0.806 . . . . 0.0 110.587 -179.521 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.7 p-10 -58.35 -35.75 72.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -0.924 . . . . 0.0 110.423 -179.582 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 92.0 45.83 3.78 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.465 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 15.7 p-10 -96.48 -34.23 11.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -1.17 . . . . 0.0 110.157 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.35 -2.36 5.4 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -141.5 165.37 27.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -1.213 . . . . 0.0 110.15 179.983 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.649 HD12 ' HB ' ' A' ' 55' ' ' VAL . 34.9 mm -87.07 142.75 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.076 179.864 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.498 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.1 m-20 -130.52 153.15 49.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.922 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 34.1 t80 -39.38 -51.08 4.77 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.549 -0.72 . . . . 0.0 112.344 -179.088 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.2 Cg_endo -64.9 -27.44 58.77 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.22 1.116 . . . . 0.0 111.265 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.492 ' HG3' ' CB ' ' A' ' 64' ' ' ASP . 7.3 mt-10 -73.02 -39.92 65.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.832 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.623 ' HZ ' HD12 ' B' ' 11' ' ' ILE . 36.4 t80 -63.54 -50.86 67.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 110.303 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.81 -37.26 78.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -0.874 . . . . 0.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.8 m -76.91 -14.59 59.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.285 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' HG22 ' A' ' 55' ' ' VAL . 37.0 ttp -79.27 -58.51 3.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.199 -0.938 . . . . 0.0 110.133 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.4 tpt -53.17 -16.09 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.409 -0.807 . . . . 0.0 111.013 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.92 -45.8 8.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.878 -1.139 . . . . 0.0 110.579 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -80.7 -10.07 59.75 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.158 -0.964 . . . . 0.0 110.75 -179.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.077 -1.014 . . . . 0.0 110.427 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.615 ' HA ' HD12 ' A' ' 85' ' ' ILE . 3.1 tt0 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.068 0.461 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.73 -40.98 88.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.645 179.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 7.3 pt-20 -54.41 -23.6 16.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.992 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 82' ' ' GLU . 51.8 mt -80.16 -61.42 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.9 . . . . 0.0 109.606 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 85' ' ' ILE . 0.4 OUTLIER -42.57 -30.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.583 -0.698 . . . . 0.0 109.524 179.549 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.657 ' HB3' HG21 ' B' ' 9' ' ' THR . 4.4 mm-40 -71.91 -60.6 2.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.408 -0.808 . . . . 0.0 109.264 179.029 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.65 -28.99 6.52 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.149 179.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -70.47 -47.71 59.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 109.758 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -35.19 51.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.755 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.651 HG11 HG11 ' B' ' 13' ' ' VAL . 10.6 t -67.68 -45.17 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.652 179.592 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.754 ' CE2' HD21 ' A' ' 105' ' ' LEU . 5.1 m-85 -58.78 -36.76 74.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.975 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -98.8 60.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 110.161 179.831 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -42.78 -32.88 0.66 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.309 -0.87 . . . . 0.0 110.073 179.939 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.2 p30 -77.19 -31.77 55.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.415 -0.803 . . . . 0.0 109.899 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 71.95 51.35 14.99 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.1 p-10 -97.67 -33.48 11.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -1.219 . . . . 0.0 110.014 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 131.51 0.49 4.92 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.585 ' CE2' ' OD1' ' A' ' 137' ' ' ASN . 65.1 m-85 -147.95 149.05 31.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.246 . . . . 0.0 110.595 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 92' ' ' PHE . 45.0 mt -104.44 149.28 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.117 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.418 ' H ' ' HB2' ' A' ' 104' ' ' GLU . 0.6 OUTLIER -139.91 160.46 39.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.016 179.73 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.35 -38.42 58.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.28 -38.73 92.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.109 -0.994 . . . . 0.0 109.811 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' A' ' 101' ' ' SER . 12.4 mt-10 -63.81 -47.66 79.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.286 -0.884 . . . . 0.0 109.862 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.023 HD12 HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -58.9 -34.55 71.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.322 -0.862 . . . . 0.0 109.517 179.552 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 109' ' ' MET . 16.9 ttp85 -59.42 -41.52 89.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.278 -0.889 . . . . 0.0 109.151 179.187 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -54.16 40.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.47 -0.769 . . . . 0.0 109.559 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 2.5 t -51.66 -37.02 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.21 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.921 ' HA ' HD21 ' B' ' 17' ' ' LEU . 21.0 mtt -58.72 -62.83 1.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.34 -0.85 . . . . 0.0 109.907 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 m -58.85 -31.36 68.46 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.574 179.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -76.53 -17.5 59.21 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.328 179.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.82 ' O ' HD11 ' A' ' 18' ' ' LEU . 7.0 mt -100.05 -47.68 4.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.845 . . . . 0.0 110.24 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.21 -28.52 1.23 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.791 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.573 ' HG2' ' CD1' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -109.28 134.86 51.25 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.798 -1.413 . . . . 0.0 111.248 -179.325 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 116' ' ' LEU . 6.8 tttt -117.09 78.5 1.22 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.077 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.795 HD11 ' O ' ' B' ' 17' ' ' LEU . 7.0 mp -40.69 164.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.612 0.72 . . . . 0.0 111.13 -179.062 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.06 -149.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.581 -0.699 . . . . 0.0 109.712 179.456 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -111.51 -70.33 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 110.144 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 23.4 pt-20 -47.54 -40.1 18.06 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.551 179.802 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 18.8 mt-10 -61.28 -55.6 30.04 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.338 -0.851 . . . . 0.0 109.148 179.027 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.0 t -50.05 -47.25 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.35 -0.844 . . . . 0.0 109.737 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.71 -50.19 70.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 109.631 179.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -34.55 68.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.462 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.474 ' HE3' ' O ' ' B' ' 16' ' ' MET . 6.5 ttt -56.93 -54.77 42.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.472 -0.767 . . . . 0.0 109.987 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.023 HD11 HD12 ' A' ' 105' ' ' LEU . 33.0 mm -57.64 -43.13 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 109.972 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -50.7 67.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.113 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -48.61 -38.74 21.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.383 -0.823 . . . . 0.0 110.16 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.709 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -81.24 -24.17 37.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.395 -0.816 . . . . 0.0 110.136 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.472 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -67.66 73.93 0.17 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.3 -0.875 . . . . 0.0 110.34 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 128' ' ' ALA . 2.8 mp -53.85 -45.21 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.245 -0.909 . . . . 0.0 110.275 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.464 ' OD2' ' OD2' ' A' ' 133' ' ' ASP . 2.4 p30 -77.38 -36.55 53.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.35 65.03 1.11 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.464 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 2.0 p30 -112.11 -28.75 7.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -1.13 . . . . 0.0 110.263 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 118.07 -6.11 15.41 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.462 ' N ' ' CD ' ' A' ' 135' ' ' GLN . 15.6 mp0 -144.52 169.88 17.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -1.133 . . . . 0.0 109.958 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 69.2 t -121.44 104.92 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.948 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.585 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 8.2 t30 -79.01 167.08 21.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -0.915 . . . . 0.0 110.386 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 139' ' ' GLU . 28.1 t80 -47.33 -58.82 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.334 -0.853 . . . . 0.0 110.058 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 138' ' ' TYR . 45.6 mm-40 -44.44 -42.25 6.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 109.669 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.472 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 4.5 tt0 -68.05 -54.3 19.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.813 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -45.8 -25.66 0.54 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.566 HG22 HG21 ' A' ' 85' ' ' ILE . 12.0 t -93.69 -30.5 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 0.0 109.836 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.491 ' NE2' HD13 ' A' ' 130' ' ' ILE . 8.2 mt-30 -58.49 -38.61 78.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.065 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.485 ' SD ' ' OD1' ' B' ' 24' ' ' ASN . 1.9 mmm -64.03 -55.17 24.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 0.0 109.917 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' B' ' 24' ' ' ASN . 6.1 ttm -67.44 -21.94 65.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 146' ' ' THR . 3.8 t . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 110.298 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.609 HG23 ' HD2' ' B' ' 5' ' ' PRO . 6.1 mt . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 120.772 0.32 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.609 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.2 Cg_endo -69.76 129.04 16.9 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.665 1.35 . . . . 0.0 111.085 -179.064 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.543 ' O ' ' N ' ' B' ' 8' ' ' THR . 3.8 m -86.83 95.96 10.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.494 -0.754 . . . . 0.0 110.813 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.568 ' CH2' HD13 ' A' ' 32' ' ' LEU . 13.9 m95 33.92 -87.82 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.805 -0.559 . . . . 0.0 111.92 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.543 ' N ' ' O ' ' B' ' 6' ' ' SER . 1.3 p -35.38 -38.76 0.11 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.51 -0.744 . . . . 0.0 111.011 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.657 HG21 ' HB3' ' A' ' 87' ' ' GLU . 4.3 m -57.65 -42.21 83.02 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.571 -0.851 . . . . 0.0 109.736 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' B' ' 7' ' ' TRP . 13.3 t -68.31 -36.6 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.418 -0.801 . . . . 0.0 109.698 179.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.686 ' N ' HD13 ' B' ' 11' ' ' ILE . 2.7 mm -70.0 -19.41 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.359 -0.838 . . . . 0.0 109.442 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.441 ' O ' ' SD ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.5 -57.43 3.94 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.715 0.769 . . . . 0.0 109.527 179.282 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.651 HG11 HG11 ' A' ' 91' ' ' VAL . 43.2 t -62.8 -34.36 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.0 110.76 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.498 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -69.7 -34.86 74.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.987 . . . . 0.0 110.304 -179.835 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 58.5 m -71.96 -25.8 62.01 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' B' ' 22' ' ' PHE . 0.2 OUTLIER -76.07 -37.49 58.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.305 -0.872 . . . . 0.0 110.828 -179.823 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.921 HD21 ' HA ' ' A' ' 109' ' ' MET . 4.4 mp -51.53 -19.54 1.51 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.94 -1.1 . . . . 0.0 110.509 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' B' ' 17' ' ' LEU . 0.3 OUTLIER -21.57 -72.0 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 CA-C-O 121.087 0.47 . . . . 0.0 112.127 -179.446 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.53 ' HD2' ' HG3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -154.08 -114.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 110.136 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.494 ' NH2' ' OE2' ' A' ' 120' ' ' GLU . 1.6 mtm180 -101.25 21.27 14.3 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.901 -1.124 . . . . 0.0 110.087 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 13.7 m -120.75 142.74 49.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.552 ' HZ ' HD11 ' A' ' 105' ' ' LEU . 1.2 m-85 -88.96 -63.96 1.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.452 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.58 108.71 0.72 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.546 ' HB2' ' HD3' ' B' ' 25' ' ' PRO . 5.6 m-80 -100.58 -42.03 0.22 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.221 -1.164 . . . . 0.0 111.943 -179.342 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' B' ' 24' ' ' ASN . 47.7 Cg_endo -81.78 10.81 3.33 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.089 1.047 . . . . 0.0 110.909 -179.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 109.961 179.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.248 0.547 . . . . 0.0 110.274 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.78 -48.38 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.985 . . . . 0.0 109.982 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.77 -36.77 62.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.802 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 19.4 mt-10 -60.74 -54.05 49.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 109.619 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -59.67 -43.06 94.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.83 . . . . 0.0 109.706 179.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -36.1 77.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.808 179.642 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -65.2 -42.04 93.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.329 -0.857 . . . . 0.0 109.769 179.573 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.22 -45.18 77.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.415 -0.803 . . . . 0.0 110.002 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.635 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 34.0 t80 -61.29 -29.74 70.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.0 109.813 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 m -83.95 -22.8 31.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.402 -0.811 . . . . 0.0 109.773 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.853 HD11 ' O ' ' A' ' 112' ' ' LEU . 4.1 tt -71.3 -36.06 71.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.962 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.67 ' HD1' HG21 ' A' ' 35' ' ' VAL . 53.8 m-85 -82.94 -46.05 13.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.234 -0.916 . . . . 0.0 110.053 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.461 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 17.1 t0 -72.61 101.33 3.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.0 110.215 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.92 -52.34 9.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.139 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 0.7 OUTLIER -53.43 -51.04 63.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.345 -0.847 . . . . 0.0 110.166 179.905 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.07 22.86 6.67 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 46.6 p-10 -79.83 -21.95 43.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -1.192 . . . . 0.0 110.107 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.558 ' C ' HG23 ' A' ' 26' ' ' THR . . . 97.18 33.2 6.07 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.558 HG23 ' C ' ' A' ' 25' ' ' GLY . 44.2 p -153.09 132.48 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.341 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.611 HD12 HG21 ' A' ' 63' ' ' ILE . 6.0 mt -101.06 112.63 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 109.937 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 29' ' ' THR . 51.8 p -97.98 156.92 16.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 110.169 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 28' ' ' THR . 1.9 p -44.53 -27.27 0.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.178 -0.952 . . . . 0.0 109.872 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -55.28 9.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 110.033 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' O ' ' HB ' ' A' ' 34' ' ' THR . 39.5 mt-10 -57.15 -56.09 26.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.93 . . . . 0.0 110.063 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.504 HD22 ' CD1' ' A' ' 52' ' ' ILE . 10.4 tp -57.65 -48.66 78.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 109.937 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -51.78 -39.6 47.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.825 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 52.6 m -59.43 -61.07 2.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -1.175 . . . . 0.0 109.715 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.67 HG21 ' HD1' ' A' ' 19' ' ' PHE . 13.8 t -45.25 -55.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -57.51 -26.96 62.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.809 179.559 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.0 ttm180 -74.23 -19.49 60.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.479 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 19.2 m -96.37 -38.11 10.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.275 -0.891 . . . . 0.0 110.625 -179.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 mt -45.67 -29.16 1.16 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.01 -1.056 . . . . 0.0 110.067 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 41' ' ' GLN . . . 125.17 58.63 0.17 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 2.2 mt-30 170.04 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.197 -1.178 . . . . 0.0 110.498 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.54 102.09 3.49 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.276 -0.89 . . . . 0.0 110.349 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.517 ' HB3' HD12 ' B' ' 4' ' ' ILE . 45.1 Cg_endo -73.18 135.77 23.34 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.093 1.575 . . . . 0.0 110.335 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.536 HG22 ' OE2' ' A' ' 47' ' ' GLU . 13.7 t -71.99 -161.93 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.206 -0.934 . . . . 0.0 110.224 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -84.18 -56.38 3.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.019 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.38 -51.22 11.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.016 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.536 ' OE2' HG22 ' A' ' 44' ' ' THR . 48.0 mt-10 -61.37 -52.35 65.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.865 . . . . 0.0 109.99 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.7 OUTLIER -55.56 -48.69 74.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.342 -0.848 . . . . 0.0 110.23 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -62.21 -32.82 73.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.103 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -32.59 70.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.364 -0.835 . . . . 0.0 110.093 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 3.1 mtp -78.02 -43.85 28.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.433 -0.792 . . . . 0.0 110.438 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.606 HG13 HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -70.43 -33.82 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.212 -0.93 . . . . 0.0 109.921 -179.993 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.2 m-80 -60.62 -25.87 66.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.486 -0.759 . . . . 0.0 110.743 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -77.92 -47.05 19.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 0.0 110.579 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.694 HG21 ' CE2' ' B' ' 7' ' ' TRP . 19.2 t -71.28 -40.36 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.185 -0.947 . . . . 0.0 110.091 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.486 ' OD1' HD13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -63.46 71.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.841 -179.975 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -37.94 -63.25 0.49 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.674 -0.641 . . . . 0.0 110.529 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 3.5 p30 -56.75 -38.85 73.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.102 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.98 48.72 4.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.529 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 16.7 p-10 -98.32 -40.39 8.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -1.182 . . . . 0.0 110.115 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 62' ' ' THR . . . 133.73 21.75 0.79 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.692 179.36 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 61' ' ' GLY . 36.3 p -158.06 145.63 18.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.922 -1.34 . . . . 0.0 110.405 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.611 HG21 HD12 ' A' ' 27' ' ' ILE . 10.8 mm -89.42 144.96 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.349 -0.844 . . . . 0.0 109.803 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -120.59 147.31 45.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.128 -0.982 . . . . 0.0 110.754 -179.578 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.635 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 11.8 t80 -43.85 -49.52 20.5 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.372 -0.83 . . . . 0.0 111.098 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.8 Cg_endo -68.7 -32.49 23.62 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.281 1.148 . . . . 0.0 110.539 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -65.51 -30.17 70.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -76.96 -51.18 11.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.885 . . . . 0.0 110.236 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 65' ' ' PHE . 2.7 mp -53.62 -32.38 51.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.376 -0.827 . . . . 0.0 110.214 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.8 m -78.03 -38.34 44.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 110.563 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -67.19 0.45 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.196 -0.94 . . . . 0.0 110.533 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.448 ' SD ' HG21 ' B' ' 11' ' ' ILE . 6.8 tpt -50.5 -19.87 0.99 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.353 -0.842 . . . . 0.0 110.665 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.86 -29.14 39.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.134 -0.979 . . . . 0.0 110.648 -179.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -93.68 -15.17 25.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.667 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.215 0.531 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -75.5 -46.38 32.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.981 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HG2' ' N ' ' A' ' 85' ' ' ILE . 10.2 pm0 -55.59 -23.37 26.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 110.26 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.667 HG21 HG22 ' A' ' 142' ' ' VAL . 24.3 mt -84.22 -46.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 109.203 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -34.29 69.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.459 -0.776 . . . . 0.0 109.216 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.45 ' HB3' HG21 ' B' ' 9' ' ' THR . 32.0 mt-10 -72.38 -48.77 38.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.223 178.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.54 -35.14 67.77 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.426 -0.797 . . . . 0.0 109.073 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.22 -39.45 78.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.368 -0.833 . . . . 0.0 108.825 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -58.67 -29.89 66.95 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.202 179.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.9 -50.47 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.485 -0.76 . . . . 0.0 109.555 179.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.532 ' HB3' HD13 ' A' ' 100' ' ' ILE . 61.2 m-85 -62.43 -38.49 89.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.26 55.84 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.995 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -56.2 -48.9 75.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.094 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 15.9 p-10 -57.6 -34.55 69.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 110.323 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 74.41 49.02 12.52 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.437 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 27.0 p-10 -98.28 -22.91 15.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -1.103 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.58 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 113.7 6.79 20.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.582 ' CB ' ' NE2' ' A' ' 135' ' ' GLN . 73.0 m-85 -157.71 134.98 10.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.248 -1.148 . . . . 0.0 109.841 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.532 HD13 ' HB3' ' A' ' 92' ' ' PHE . 24.9 mt -84.49 155.62 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.1 -1.0 . . . . 0.0 110.541 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 103' ' ' ALA . 4.0 t -139.22 140.56 37.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.454 -0.778 . . . . 0.0 109.72 179.691 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.15 -27.44 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.235 -0.916 . . . . 0.0 110.375 -179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -65.59 -55.58 16.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.674 179.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 38.1 mt-10 -55.08 -44.68 75.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.998 179.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.969 ' CD1' HD11 ' A' ' 125' ' ' ILE . 1.1 mt -57.37 -44.93 84.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.9 . . . . 0.0 109.655 179.733 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.2 OUTLIER -55.94 -38.29 70.11 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.053 -1.029 . . . . 0.0 109.286 179.273 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -32.24 73.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.629 -0.669 . . . . 0.0 109.539 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.448 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 26.1 t -81.15 -52.56 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.475 -0.765 . . . . 0.0 110.672 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.544 ' HG3' ' N ' ' A' ' 110' ' ' THR . 11.9 ptp -58.59 -38.6 78.28 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.981 . . . . 0.0 110.389 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.544 ' N ' ' HG3' ' A' ' 109' ' ' MET . 27.1 m -71.15 -40.09 71.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.881 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 38' ' ' SER . 36.5 m-80 -80.07 -4.45 52.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.787 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.853 ' O ' HD11 ' A' ' 18' ' ' LEU . 5.8 mt -98.23 -30.48 12.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 0.0 109.923 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.38 -53.11 0.59 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 109' ' ' MET . 22.7 tt0 -108.12 143.49 36.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -1.107 . . . . 0.0 110.173 -179.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.6 OUTLIER -120.64 18.72 11.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.945 . . . . 0.0 109.643 179.614 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.884 HD11 ' O ' ' B' ' 17' ' ' LEU . 3.4 mp 40.11 -164.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.613 0.72 . . . . 0.0 110.656 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 -172.87 2.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.462 -0.774 . . . . 0.0 109.269 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.3 -50.02 8.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 0.0 109.908 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -64.7 -32.83 74.68 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 179.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.41 ' OE1' ' HD2' ' B' ' 20' ' ' ARG . 4.8 mt-10 -69.05 -50.72 45.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.359 -0.838 . . . . 0.0 109.236 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.4 t -60.22 -42.06 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.805 179.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -66.14 -49.98 65.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 179.379 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -56.11 -25.47 45.99 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.449 -0.782 . . . . 0.0 109.139 179.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.802 ' HE2' ' CD1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.65 -57.57 6.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.567 -0.708 . . . . 0.0 109.854 179.546 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.969 HD11 ' CD1' ' A' ' 105' ' ' LEU . 24.6 mm -64.31 -24.32 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.389 -0.819 . . . . 0.0 110.003 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -76.05 -51.61 11.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.955 . . . . 0.0 110.021 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -12.39 42.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.334 -0.854 . . . . 0.0 110.053 179.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -98.4 -33.25 11.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.53 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.892 . . . . 0.0 110.121 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 128' ' ' ALA . 10.3 mt -72.74 -27.64 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p-10 -96.58 -28.12 14.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 0.0 110.296 -179.892 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.38 75.57 1.14 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 21.1 p-10 -128.1 -18.09 4.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.256 -1.144 . . . . 0.0 110.551 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.64 10.04 36.48 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.582 ' NE2' ' CB ' ' A' ' 99' ' ' TYR . 1.9 pt20 -168.94 170.27 9.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.361 -1.082 . . . . 0.0 109.484 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 35.3 t -114.87 151.95 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.943 -1.098 . . . . 0.0 110.85 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 12.6 t30 -116.77 -169.6 1.67 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.513 -0.742 . . . . 0.0 109.506 179.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.44 ' CE1' HG21 ' A' ' 142' ' ' VAL . 8.5 t80 -67.83 -52.83 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.931 -1.105 . . . . 0.0 110.061 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -46.17 -67.46 0.28 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.319 -0.863 . . . . 0.0 110.188 179.964 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' PHE . 4.8 tt0 -43.87 -59.39 2.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 109.766 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.435 ' CE1' ' CD2' ' A' ' 92' ' ' PHE . 42.9 t80 -43.48 -26.05 0.19 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.831 179.415 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.667 HG22 HG21 ' A' ' 85' ' ' ILE . 68.8 t -98.93 -30.77 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.369 -0.832 . . . . 0.0 110.639 -179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 140' ' ' GLU . 10.3 mm-40 -65.65 -40.71 92.75 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.097 -1.002 . . . . 0.0 110.584 -179.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -36.56 68.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.219 -0.926 . . . . 0.0 110.559 -179.708 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.683 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 3.7 mtt -85.0 -26.06 27.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 146' ' ' THR . 9.6 t . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.128 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.517 HD12 ' HB3' ' A' ' 43' ' ' PRO . 6.7 mm . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.04 0.448 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.68 139.07 36.25 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.543 1.286 . . . . 0.0 110.591 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.85 ' O ' HG23 ' B' ' 10' ' ' VAL . 40.9 t -73.11 -159.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.845 . . . . 0.0 110.724 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.694 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -82.3 -82.29 0.14 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.553 -0.717 . . . . 0.0 110.724 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.667 HG21 ' HG2' ' A' ' 75' ' ' LYS . 23.9 p -40.09 -34.99 0.34 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.622 -0.674 . . . . 0.0 110.42 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.45 HG21 ' HB3' ' A' ' 87' ' ' GLU . 40.1 m -59.85 -53.41 58.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 109.3 179.27 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.85 HG23 ' O ' ' B' ' 6' ' ' SER . 61.9 t -50.51 -41.85 20.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.301 -0.875 . . . . 0.0 109.124 178.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.587 ' H ' HD12 ' B' ' 11' ' ' ILE . 2.8 mp -61.95 -59.59 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.561 -0.712 . . . . 0.0 110.103 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.444 ' CD2' ' CE2' ' B' ' 26' ' ' PHE . 3.2 mm? -39.94 -50.64 2.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.497 -0.752 . . . . 0.0 110.992 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.603 HG12 HD11 ' A' ' 112' ' ' LEU . 94.8 t -56.65 -51.98 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.111 -0.993 . . . . 0.0 110.531 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.471 ' O ' HD22 ' B' ' 17' ' ' LEU . 19.3 tptt -56.02 -49.99 72.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.86 -1.15 . . . . 0.0 109.762 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.446 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.6 OUTLIER -68.74 -6.47 26.64 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 179.045 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.531 ' O ' ' HE3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -80.13 -45.2 18.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.362 -0.836 . . . . 0.0 110.548 -179.861 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.884 ' O ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -100.31 32.6 2.96 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 118.515 -1.274 . . . . 0.0 110.529 179.36 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.533 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 57.0 ttt180 -44.28 -58.95 2.61 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.56 -0.713 . . . . 0.0 109.859 179.3 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.595 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -144.59 -118.09 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.221 -0.924 . . . . 0.0 110.007 179.578 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.41 ' HD2' ' OE1' ' A' ' 120' ' ' GLU . 25.5 mtp180 -97.03 25.27 5.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.884 -1.135 . . . . 0.0 109.957 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.04 152.97 28.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.667 -179.352 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.802 ' CD1' ' HE2' ' A' ' 124' ' ' MET . 1.2 t80 -124.13 -25.64 4.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.875 . . . . 0.0 110.317 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.87 109.84 3.9 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.683 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 1.5 m-80 -81.57 156.18 70.84 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -1.178 . . . . 0.0 109.88 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' B' ' 26' ' ' PHE . 43.3 Cg_endo -74.72 -68.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.857 1.451 . . . . 0.0 110.432 -179.804 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.498 ' CD1' ' HB3' ' B' ' 24' ' ' ASN . 15.5 m-85 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.396 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.238 0.542 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.2 mt -49.91 -48.36 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.662 179.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.7 -48.75 66.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.331 -0.856 . . . . 0.0 109.565 179.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -55.12 -52.22 63.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.612 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -57.75 -45.38 85.94 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.321 -0.862 . . . . 0.0 109.427 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -33.67 57.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 109.247 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.7 -47.82 79.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.535 -0.728 . . . . 0.0 109.661 179.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -62.46 -44.32 96.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -0.85 . . . . 0.0 109.543 179.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.6 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 23.9 t80 -63.74 -35.59 81.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.378 -0.826 . . . . 0.0 109.708 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.2 m -78.1 -20.64 51.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -0.842 . . . . 0.0 109.854 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.855 HD12 ' O ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -69.5 -46.95 65.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.43 -0.794 . . . . 0.0 109.789 179.799 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 21' ' ' LYS . 75.5 m-85 -69.57 -59.31 3.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 109.939 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.46 91.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.343 -0.848 . . . . 0.0 110.247 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 19' ' ' PHE . 4.0 mmtp -77.49 -26.57 51.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.129 -0.982 . . . . 0.0 110.22 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 20.7 p-10 -97.73 -20.72 17.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.275 -0.89 . . . . 0.0 110.326 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.61 78.79 0.92 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 45.2 p-10 -139.39 8.47 2.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -1.151 . . . . 0.0 110.061 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.791 ' O ' HG23 ' A' ' 26' ' ' THR . . . 65.34 35.01 90.95 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -163.85 119.31 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.236 -1.155 . . . . 0.0 110.444 -179.903 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 19' ' ' PHE . 13.3 mt -83.18 134.4 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.086 -1.009 . . . . 0.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 20.1 p -98.82 179.98 4.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.405 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.2 p -70.89 -53.27 15.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -61.39 -48.8 79.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.217 -0.927 . . . . 0.0 110.455 -179.948 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OG1' ' A' ' 28' ' ' THR . 23.3 mt-10 -41.92 -69.81 0.12 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.208 -0.932 . . . . 0.0 109.947 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.615 HD22 ' CH2' ' B' ' 7' ' ' TRP . 22.5 tp -49.55 -32.43 12.5 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.125 -0.984 . . . . 0.0 109.07 179.386 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.74 95.04 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.769 -1.733 . . . . 0.0 108.769 179.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.1 m -54.76 -44.54 73.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.293 -1.122 . . . . 0.0 109.111 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 35' ' ' VAL . 24.8 t -64.31 -44.72 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.446 -0.784 . . . . 0.0 109.398 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.608 ' HA ' HD12 ' A' ' 39' ' ' LEU . 2.0 mmt -62.28 -34.89 77.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.315 -0.866 . . . . 0.0 109.663 179.369 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -34.31 77.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.501 179.386 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -26.58 54.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.577 -0.702 . . . . 0.0 110.386 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.608 HD12 ' HA ' ' A' ' 36' ' ' MET . 4.7 mt -69.77 -32.44 70.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.131 -0.98 . . . . 0.0 109.985 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.06 -46.98 0.7 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.382 179.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.56 -176.46 6.26 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.1 -1.235 . . . . 0.0 111.242 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 8.1 p30 -144.82 105.07 4.52 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.538 -0.726 . . . . 0.0 109.446 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.691 ' HA ' HD11 ' B' ' 4' ' ' ILE . 44.0 Cg_endo -72.23 151.49 54.81 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 O-C-N 124.054 1.555 . . . . 0.0 111.046 -179.304 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.554 HG22 ' N ' ' A' ' 45' ' ' GLU . 56.2 m -98.16 174.62 6.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.909 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.554 ' N ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -73.82 -41.83 61.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.118 -0.989 . . . . 0.0 110.451 -179.768 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.17 -48.82 74.51 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.066 -1.021 . . . . 0.0 110.281 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -64.45 -49.35 71.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.348 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.52 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 6.3 mt -52.34 -49.66 63.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.965 . . . . 0.0 110.109 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -54.73 -41.44 70.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 109.669 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.84 -25.54 62.88 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.315 -0.865 . . . . 0.0 109.464 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.436 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.4 OUTLIER -73.63 -40.92 63.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.894 179.678 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -28.5 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.293 -0.879 . . . . 0.0 109.478 179.733 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.71 -14.15 12.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.314 -0.866 . . . . 0.0 110.113 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -85.8 -49.27 8.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 111.069 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 21.7 t -69.1 -47.5 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.877 -1.14 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -45.89 89.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.388 0.613 . . . . 0.0 110.329 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -98.0 -9.07 26.7 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.186 -0.946 . . . . 0.0 110.59 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 5.7 p30 -100.65 -32.67 10.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.961 -1.087 . . . . 0.0 110.791 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 103.57 45.91 1.48 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 23.1 m120 -100.03 -19.82 16.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.119 -1.224 . . . . 0.0 110.037 179.833 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.89 -11.68 70.55 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 27' ' ' ILE . 0.6 OUTLIER -145.99 170.09 17.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.106 . . . . 0.0 110.109 -179.999 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.2 mm -89.9 124.85 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.423 -0.798 . . . . 0.0 110.493 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.535 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 4.5 m-20 -97.07 -177.43 3.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.274 -0.892 . . . . 0.0 110.639 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.61 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 17.9 t80 -68.5 -48.37 33.7 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.392 -0.817 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.9 Cg_endo -67.69 -32.58 30.04 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 O-C-N 123.294 1.155 . . . . 0.0 110.006 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE2' ' OD1' ' A' ' 64' ' ' ASP . 6.9 mt-10 -63.34 -36.65 84.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.187 -0.946 . . . . 0.0 109.105 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.727 ' HZ ' HG23 ' B' ' 11' ' ' ILE . 5.5 t80 -64.48 -58.24 6.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.779 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.01 -30.53 66.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.329 -0.857 . . . . 0.0 110.199 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 m -84.29 -21.9 30.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.182 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.45 -45.8 68.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 0.0 109.929 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.468 ' CE ' ' CE1' ' B' ' 26' ' ' PHE . 93.3 mmm -57.29 -15.0 5.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 110.222 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.26 -20.57 14.07 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.153 -0.967 . . . . 0.0 110.572 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 -27.01 20.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.026 . . . . 0.0 110.191 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.1 tptt . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.33 -179.939 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.566 ' HA ' HD12 ' A' ' 85' ' ' ILE . 5.1 tp10 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.209 0.528 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -77.38 -40.5 43.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.197 -0.94 . . . . 0.0 110.559 -179.658 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.81 -22.58 64.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 110.633 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.766 HG21 HG22 ' A' ' 142' ' ' VAL . 90.3 mt -76.62 -31.42 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.064 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -65.88 -37.25 85.64 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.346 -0.846 . . . . 0.0 109.651 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.815 ' HB3' HG21 ' B' ' 9' ' ' THR . 4.9 mt-10 -68.7 -52.58 29.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 179.356 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.432 ' HB2' HD13 ' B' ' 12' ' ' LEU . . . -55.64 -29.86 59.96 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.402 -0.811 . . . . 0.0 109.649 179.63 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -69.08 -44.37 72.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 109.333 179.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -37.99 54.24 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 109.191 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.939 HG11 HG11 ' B' ' 13' ' ' VAL . 54.9 t -63.48 -51.6 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.679 . . . . 0.0 109.995 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.778 ' HB3' HD13 ' A' ' 100' ' ' ILE . 20.1 m-85 -62.29 -34.9 77.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.168 -0.958 . . . . 0.0 109.995 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -100.46 67.32 1.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.801 . . . . 0.0 109.931 179.835 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 93' ' ' ASP . 3.0 tttp -37.45 -36.87 0.17 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.66 -0.65 . . . . 0.0 110.568 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.9 p30 -83.43 -31.78 26.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.291 -0.881 . . . . 0.0 110.088 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 75.47 33.77 51.89 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 31.4 p-10 -84.73 -31.59 23.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -1.179 . . . . 0.0 110.322 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 117.24 43.55 0.6 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 1.2 m-85 -169.4 124.26 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -1.083 . . . . 0.0 109.959 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.778 HD13 ' HB3' ' A' ' 92' ' ' PHE . 38.1 mt -110.4 116.29 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.585 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -106.02 148.61 27.53 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 109.547 179.237 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.561 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -37.9 -34.46 0.11 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.443 -0.786 . . . . 0.0 110.516 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -63.02 -50.41 70.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 0.0 109.487 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 25.1 mt-10 -55.47 -47.65 75.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.599 179.504 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.997 ' CD1' HD11 ' A' ' 125' ' ' ILE . 2.4 mt -51.11 -41.77 60.25 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.267 -0.896 . . . . 0.0 109.267 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HG2' HG21 ' A' ' 121' ' ' VAL . 1.1 mmm180 -60.43 -34.37 73.87 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.464 -0.772 . . . . 0.0 109.916 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 8.8 m170 -69.98 -22.25 63.16 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 92' ' ' PHE . 2.1 t -88.29 -45.28 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.168 -0.957 . . . . 0.0 110.715 -179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.572 ' HE1' ' HB2' ' A' ' 116' ' ' LEU . 13.1 ptp -63.56 -44.85 92.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.925 -1.109 . . . . 0.0 110.691 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.503 ' N ' ' CG ' ' A' ' 109' ' ' MET . 1.8 m -60.73 -27.77 68.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.038 -1.039 . . . . 0.0 109.928 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 5.8 m120 -82.53 -7.95 59.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.914 . . . . 0.0 110.159 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 18' ' ' LEU . 16.4 mt -114.05 -8.55 13.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.43 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.59 -59.55 0.65 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.422 -1.371 . . . . 0.0 111.148 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.515 ' HG2' HD12 ' A' ' 116' ' ' LEU . 17.8 tt0 -72.12 152.55 42.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.996 -1.296 . . . . 0.0 111.28 -178.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 116' ' ' LEU . 4.1 mtmt -132.01 68.06 1.51 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.495 -0.753 . . . . 0.0 109.77 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.572 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 3.0 mp -40.56 119.25 1.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.295 -0.878 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -50.82 177.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.277 -0.889 . . . . 0.0 110.455 -179.464 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -64.71 -52.28 57.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.107 -0.996 . . . . 0.0 110.088 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 10.6 pt-20 -59.92 -42.81 94.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.531 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.417 ' N ' ' CG ' ' A' ' 119' ' ' GLU . 1.8 mt-10 -61.66 -43.54 98.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.421 -0.8 . . . . 0.0 109.446 179.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.561 HG12 ' HB1' ' A' ' 102' ' ' ALA . 52.0 t -68.02 -48.46 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.328 -0.858 . . . . 0.0 109.596 179.453 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.21 -38.07 76.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.4 OUTLIER -68.71 -33.56 74.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.855 . . . . 0.0 109.677 179.593 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.575 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 12.0 ttt -64.25 -39.99 95.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.87 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.997 HD11 ' CD1' ' A' ' 105' ' ' LEU . 11.0 mm -74.37 -54.37 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.232 -0.917 . . . . 0.0 109.676 179.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.03 -53.38 53.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 110.145 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 7.7 tp10 -51.99 -30.05 23.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.827 . . . . 0.0 110.162 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -96.81 -25.85 15.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.392 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD2' HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -47.2 92.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.266 -0.896 . . . . 0.0 110.556 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.6 mt -80.85 -34.01 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.39 179.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.465 ' OD1' ' OD2' ' A' ' 133' ' ' ASP . 9.1 p-10 -87.46 -37.93 16.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.483 -0.761 . . . . 0.0 109.868 179.685 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.24 71.83 0.95 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 3.4 p30 -140.43 9.7 2.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -1.171 . . . . 0.0 109.93 179.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 58.13 15.12 20.71 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 15.4 mt-30 -146.64 170.18 17.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.354 -1.086 . . . . 0.0 110.341 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.512 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 54.6 t -131.47 129.91 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 109.81 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 137' ' ' ASN . 14.2 p-10 -114.01 -160.08 0.72 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.115 -0.991 . . . . 0.0 110.579 -179.462 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 139' ' ' GLU . 62.1 t80 -62.91 -63.6 1.16 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.887 . . . . 0.0 110.31 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -40.95 -67.86 0.22 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.325 -0.859 . . . . 0.0 110.311 -179.909 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 139' ' ' GLU . 12.7 tt0 -44.6 -60.91 1.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -46.08 -23.91 0.37 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.29 -0.881 . . . . 0.0 110.308 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.766 HG22 HG21 ' A' ' 85' ' ' ILE . 91.6 t -98.75 -31.67 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 110.241 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 143' ' ' GLN . 7.1 mm100 -66.2 -13.79 60.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.94 . . . . 0.0 110.263 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.409 ' HB3' ' HA2' ' B' ' 23' ' ' GLY . 0.9 OUTLIER -97.47 -20.31 17.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.261 -0.9 . . . . 0.0 110.475 -179.852 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 1.111 ' CE ' HD21 ' B' ' 12' ' ' LEU . 2.1 mtt -99.56 -11.28 21.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 110.218 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 146' ' ' THR . 2.7 t . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 110.072 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.691 HD11 ' HA ' ' A' ' 43' ' ' PRO . 16.6 mt . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.454 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.7 Cg_endo -68.64 -175.65 0.97 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.963 1.507 . . . . 0.0 110.165 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.31 -169.14 1.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.075 -1.016 . . . . 0.0 110.898 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.716 ' O ' HG22 ' B' ' 10' ' ' VAL . 0.9 OUTLIER -71.51 -77.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.579 -0.7 . . . . 0.0 110.658 -179.622 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.465 ' C ' ' O ' ' B' ' 7' ' ' TRP . 2.8 p -41.15 -25.78 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.025 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.815 HG21 ' HB3' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -63.99 -65.38 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 179.146 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.716 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.8 m -47.23 -29.87 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.154 -0.966 . . . . 0.0 109.501 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.727 HG23 ' HZ ' ' A' ' 68' ' ' PHE . 7.1 mm -75.7 -45.8 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.321 179.267 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 1.111 HD21 ' CE ' ' A' ' 145' ' ' MET . 0.9 OUTLIER -47.74 -56.51 7.19 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.542 0.687 . . . . 0.0 110.225 179.655 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.939 HG11 HG11 ' A' ' 91' ' ' VAL . 22.1 t -60.04 -51.94 67.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 110.734 -179.538 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' B' ' 14' ' ' LYS . 24.0 tptt -66.62 -14.61 62.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.926 -1.108 . . . . 0.0 109.975 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 23.3 t -77.71 -33.01 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.872 . . . . 0.0 109.962 179.738 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.67 -14.73 31.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.786 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.826 ' CD2' HD12 ' A' ' 112' ' ' LEU . 3.8 mp -73.72 51.11 0.36 Allowed 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.156 -0.965 . . . . 0.0 111.201 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.484 ' HB3' ' OG ' ' B' ' 21' ' ' SER . 0.1 OUTLIER -104.2 -107.41 0.28 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.116 -0.99 . . . . 0.0 109.817 179.426 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.494 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 0.1 OUTLIER -107.48 -70.16 0.81 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.026 -1.046 . . . . 0.0 109.513 179.677 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.48 ' HB3' ' CD ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -135.45 13.4 3.49 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.36 -0.837 . . . . 0.0 109.804 179.38 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -66.41 120.3 13.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.336 -0.853 . . . . 0.0 110.297 179.866 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.575 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -144.87 26.96 1.34 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.976 . . . . 0.0 110.953 179.965 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 144' ' ' MET . . . -118.65 -119.81 2.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.534 ' HB2' ' HA ' ' A' ' 145' ' ' MET . 5.2 t-20 -129.51 70.73 82.0 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.327 -1.102 . . . . 0.0 109.962 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.23 47.2 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.877 1.462 . . . . 0.0 110.21 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.468 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.952 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.354 0.597 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.9 mt -53.67 -45.46 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -50.33 -44.8 54.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.092 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.442 ' OE1' ' HD3' ' B' ' 18' ' ' ARG . 1.6 mt-10 -59.65 -47.12 86.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.943 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -60.64 -39.08 86.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.66 97.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.957 . . . . 0.0 109.932 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.72 -38.16 80.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.304 -0.872 . . . . 0.0 109.832 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -66.36 -51.94 52.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.247 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.549 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 15.3 t80 -62.87 -34.29 77.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.199 -0.938 . . . . 0.0 109.824 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.9 t -73.19 -19.23 61.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.836 . . . . 0.0 109.812 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.675 HD13 ' HG3' ' B' ' 14' ' ' LYS . 10.5 tt -80.76 -34.93 33.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.356 -0.84 . . . . 0.0 110.066 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.413 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 70.2 m-85 -86.4 -44.78 11.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.35 -0.844 . . . . 0.0 110.517 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -77.63 85.79 3.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.312 -0.868 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -66.84 -40.66 88.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.892 . . . . 0.0 110.124 179.848 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -57.1 -43.88 82.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.419 -0.8 . . . . 0.0 110.161 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.26 0.36 67.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 6.9 p-10 -74.84 -28.29 60.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.212 -1.169 . . . . 0.0 109.975 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.524 ' C ' HG23 ' A' ' 26' ' ' THR . . . 110.73 37.73 1.68 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 28.3 p -152.41 109.97 3.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.152 -1.204 . . . . 0.0 110.661 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.58 HD12 ' CG2' ' A' ' 63' ' ' ILE . 22.3 mt -80.73 115.12 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.196 -0.94 . . . . 0.0 109.442 179.292 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -93.64 174.65 7.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.283 -0.886 . . . . 0.0 110.228 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.578 HG22 ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -64.05 -30.13 71.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.043 179.923 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -73.0 -54.09 9.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.879 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -50.84 -69.91 0.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 109.865 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 tp -52.77 -36.51 58.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.739 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -62.08 -40.55 99.08 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 m -58.27 -51.87 67.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -1.086 . . . . 0.0 109.799 179.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 t -60.29 -47.53 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.858 . . . . 0.0 109.963 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.489 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 2.3 mmt -59.56 -43.02 93.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.12 -0.988 . . . . 0.0 109.895 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -65.56 -20.65 66.42 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.342 -0.849 . . . . 0.0 110.109 179.805 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.8 t -77.83 -57.41 3.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.891 . . . . 0.0 110.288 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mt -46.61 -25.64 0.75 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.156 -0.965 . . . . 0.0 110.071 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.83 66.11 0.56 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -137.69 -157.63 0.79 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.174 -1.192 . . . . 0.0 110.288 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 42' ' ' ASN . 18.0 t30 -147.54 62.8 7.33 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.291 -0.881 . . . . 0.0 110.082 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HG3' ' CB ' ' A' ' 36' ' ' MET . 48.7 Cg_endo -74.7 118.59 5.37 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.073 1.565 . . . . 0.0 110.559 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 46' ' ' ALA . 28.1 m -99.96 146.36 26.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.317 -0.864 . . . . 0.0 109.938 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 21.7 pt-20 -43.12 -44.75 5.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.17 -0.956 . . . . 0.0 110.0 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.474 ' H ' HG22 ' A' ' 44' ' ' THR . . . -65.31 -65.04 0.72 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 109.802 179.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -46.55 -43.24 16.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.683 179.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.578 ' HB3' HG22 ' A' ' 29' ' ' THR . 0.3 OUTLIER -51.7 -55.66 18.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.351 -0.843 . . . . 0.0 109.785 179.674 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -38.52 19.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.768 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -64.76 -33.69 76.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.416 -0.803 . . . . 0.0 110.104 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.552 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.5 OUTLIER -77.18 -37.9 52.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.587 HG13 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -68.94 -33.81 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.782 179.85 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.77 -46.93 42.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.342 -0.849 . . . . 0.0 110.603 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -59.56 -56.72 18.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 0.0 110.697 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 28.5 t -70.28 -42.77 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.023 -1.048 . . . . 0.0 110.252 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 60' ' ' ASN . 1.7 t70 -64.95 67.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -40.49 -51.5 2.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.551 -0.718 . . . . 0.0 110.886 -179.74 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 6.7 p-10 -67.47 -43.85 80.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 0.0 110.524 -179.621 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' CA ' ' OD2' ' A' ' 56' ' ' ASP . . . 92.72 49.03 2.81 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.53 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 19.2 p30 -100.08 -17.76 17.31 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.168 -1.195 . . . . 0.0 110.202 179.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.16 14.2 31.49 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.15 133.33 16.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.116 -1.226 . . . . 0.0 110.183 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.587 HD11 HG13 ' A' ' 52' ' ' ILE . 26.1 mm -84.57 156.27 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.386 -0.821 . . . . 0.0 110.218 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.549 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 15.2 t0 -129.82 169.06 15.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.04 -1.037 . . . . 0.0 110.453 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.82 ' CE2' HD11 ' A' ' 69' ' ' LEU . 51.7 t80 -61.32 -40.03 68.47 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 111.522 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.4 Cg_endo -71.91 -29.72 14.88 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 O-C-N 123.284 1.15 . . . . 0.0 110.22 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -70.48 -31.34 68.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -0.888 . . . . 0.0 109.418 179.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 23.6 t80 -72.73 -46.11 55.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.384 -0.822 . . . . 0.0 110.421 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.82 HD11 ' CE2' ' A' ' 65' ' ' PHE . 28.0 mt -66.92 -25.46 66.38 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.212 -0.93 . . . . 0.0 110.778 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.8 m -83.68 -28.62 28.22 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.1 -1.0 . . . . 0.0 110.893 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.437 ' SD ' ' HE3' ' A' ' 75' ' ' LYS . 5.5 tmm? -77.29 -47.59 19.68 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.134 -0.978 . . . . 0.0 111.046 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.602 ' HE2' ' CZ ' ' B' ' 26' ' ' PHE . 7.3 tpt -60.31 -10.89 5.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.118 -0.989 . . . . 0.0 111.102 -179.293 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.52 -36.58 8.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.938 -1.101 . . . . 0.0 110.942 -179.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.5 ttt-85 -85.18 -11.26 55.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.133 -0.979 . . . . 0.0 110.6 -179.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.746 ' HG2' HG21 ' B' ' 8' ' ' THR . 1.7 tppp? . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.002 -1.061 . . . . 0.0 110.669 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.181 0.515 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -80.41 -40.1 27.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 0.0 109.919 179.763 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -69.36 -27.64 65.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.262 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.496 HG23 ' CE2' ' A' ' 141' ' ' PHE . 80.0 mt -78.53 -36.14 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.113 -0.992 . . . . 0.0 109.957 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -64.66 -29.84 70.85 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 109.802 179.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -75.43 -50.78 14.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 109.109 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.762 ' HB2' HD22 ' B' ' 12' ' ' LEU . . . -60.57 -35.73 76.78 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.338 -0.852 . . . . 0.0 109.455 179.208 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 17.3 t80 -64.44 -56.95 10.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 109.847 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -44.31 -38.22 3.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.402 -0.812 . . . . 0.0 109.556 179.709 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.646 HG12 HG21 ' A' ' 108' ' ' VAL . 4.0 t -65.99 -35.92 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 109.826 179.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.619 ' HB3' HD13 ' A' ' 100' ' ' ILE . 9.1 m-85 -68.64 -35.68 77.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.164 -0.96 . . . . 0.0 110.474 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.464 ' OD1' HG12 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -98.82 63.59 1.4 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.21 -0.931 . . . . 0.0 110.402 -179.416 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -43.31 -28.22 0.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.277 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 27.6 p-10 -96.1 -36.98 10.8 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.19 -0.944 . . . . 0.0 110.436 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.23 44.0 14.77 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.417 ' ND2' ' OD2' ' A' ' 95' ' ' ASP . 21.7 p30 -78.17 -15.31 58.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -1.145 . . . . 0.0 110.374 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.501 ' C ' ' CG ' ' A' ' 99' ' ' TYR . . . 118.37 -8.39 13.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.501 ' CG ' ' C ' ' A' ' 98' ' ' GLY . 5.3 m-85 -148.88 163.89 36.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -1.186 . . . . 0.0 110.155 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.619 HD13 ' HB3' ' A' ' 92' ' ' PHE . 7.1 mt -113.01 126.32 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 110.133 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.1 p -106.36 153.15 22.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.835 . . . . 0.0 110.09 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.75 -37.84 9.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.05 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.44 93.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -55.52 -43.01 75.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.849 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.998 HD12 HD11 ' A' ' 125' ' ' ILE . 2.7 mt -57.92 -48.05 81.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.716 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.411 ' O ' ' OG1' ' A' ' 110' ' ' THR . 0.3 OUTLIER -50.83 -42.56 58.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.838 . . . . 0.0 109.754 179.79 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.81 -48.45 81.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 109.75 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.646 HG21 HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -74.42 -25.8 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 0.0 109.416 179.631 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.97 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.5 OUTLIER -71.04 -50.05 38.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 110.108 179.98 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -71.41 -31.67 67.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.187 179.934 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -72.55 -6.46 44.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.245 -0.909 . . . . 0.0 110.438 -179.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.72 HD11 HG12 ' B' ' 13' ' ' VAL . 6.4 mt -106.53 -44.72 4.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.106 -0.996 . . . . 0.0 110.617 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.69 -46.93 0.51 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.405 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.742 ' HG2' HD12 ' A' ' 116' ' ' LEU . 14.2 tt0 -98.48 141.67 31.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.067 -1.255 . . . . 0.0 110.659 -179.613 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 116' ' ' LEU . 3.2 ptpt -119.56 16.46 12.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 109.748 179.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.742 HD12 ' HG2' ' A' ' 114' ' ' GLU . 4.0 mp 39.45 -164.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.684 0.754 . . . . 0.0 110.842 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.16 -147.98 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.562 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -107.58 -48.56 3.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 109.969 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -67.24 -34.84 78.31 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.538 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.48 -44.68 82.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.272 -0.893 . . . . 0.0 109.097 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.0 t -53.25 -48.64 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.412 -0.805 . . . . 0.0 109.646 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -65.07 -56.24 14.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.75 -30.05 13.0 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.41 -0.806 . . . . 0.0 109.437 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.616 ' HE2' ' CD2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.61 -62.4 1.84 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.339 -0.851 . . . . 0.0 109.689 179.544 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.998 HD11 HD12 ' A' ' 105' ' ' LEU . 48.0 mm -56.33 -34.24 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -0.78 . . . . 0.0 110.258 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -66.91 -44.18 81.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 110.323 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.77 -29.66 69.67 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 0.0 110.215 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.18 -31.18 34.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -0.953 . . . . 0.0 110.015 179.799 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.476 ' HB3' ' HA2' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -65.6 106.2 1.4 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.372 -0.83 . . . . 0.0 110.483 -179.968 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.2 mm -64.3 -28.04 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' OD1' ' OD2' ' A' ' 129' ' ' ASP . 12.3 p30 -105.54 -16.43 14.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.958 179.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 64.02 59.36 8.63 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.441 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 6.3 p-10 -101.0 -23.96 14.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -1.146 . . . . 0.0 109.941 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 135' ' ' GLN . . . 131.79 -12.72 5.35 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.478 ' CG ' ' C ' ' A' ' 134' ' ' GLY . 9.7 mt-30 -151.31 161.16 43.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.152 -1.205 . . . . 0.0 110.073 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 19.3 t -105.67 157.85 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.908 179.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 1.9 p-10 -127.23 -179.54 4.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.221 -0.925 . . . . 0.0 110.445 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -61.03 -67.15 0.43 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.447 -0.783 . . . . 0.0 110.647 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 0.7 OUTLIER -45.32 -27.67 0.71 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.238 -0.914 . . . . 0.0 110.628 -179.49 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.464 ' HB2' ' ND2' ' A' ' 137' ' ' ASN . 4.2 tt0 -80.49 -52.51 7.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 69.3 t80 -54.33 -17.39 2.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.18 -0.95 . . . . 0.0 109.859 179.638 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.45 -55.3 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 110.637 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 0.5 OUTLIER -58.93 -13.79 7.36 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.118 -0.988 . . . . 0.0 110.78 -179.559 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.493 ' HG3' ' HA2' ' B' ' 23' ' ' GLY . 3.7 tpt -97.55 -27.27 14.48 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.166 -0.959 . . . . 0.0 110.582 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.8 ttt -100.49 -10.05 21.47 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.249 -0.907 . . . . 0.0 110.796 -179.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 0.0 110.967 -179.335 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.63 HG23 ' HD2' ' B' ' 5' ' ' PRO . 19.0 mm . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.63 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.0 Cg_endo -66.52 170.38 12.46 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.632 1.333 . . . . 0.0 110.436 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.512 ' O ' ' HB ' ' B' ' 9' ' ' THR . 0.1 OUTLIER -96.4 152.24 18.79 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.189 -0.945 . . . . 0.0 111.299 -178.913 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.759 ' O ' HG22 ' B' ' 10' ' ' VAL . 4.2 m95 -48.95 -66.09 0.46 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.881 . . . . 0.0 109.641 179.036 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.746 HG21 ' HG2' ' A' ' 75' ' ' LYS . 23.8 p -47.73 -24.17 0.88 Allowed 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.889 -1.132 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' B' ' 6' ' ' SER . 4.1 m -64.38 -54.97 24.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.066 -1.021 . . . . 0.0 109.639 179.37 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.759 HG22 ' O ' ' B' ' 7' ' ' TRP . 6.8 m -56.89 -33.71 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.908 -1.12 . . . . 0.0 108.687 179.44 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.525 ' N ' HD13 ' B' ' 11' ' ' ILE . 4.9 mm -77.45 -23.2 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 108.799 178.411 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.762 HD22 ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -68.5 -60.78 2.18 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.613 -0.68 . . . . 0.0 109.784 179.707 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.72 HG12 HD11 ' A' ' 112' ' ' LEU . 35.7 t -62.82 -32.84 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.371 -0.83 . . . . 0.0 110.166 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.675 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -69.35 -45.59 69.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.017 -1.052 . . . . 0.0 109.251 179.212 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 52.7 p -58.46 -35.23 71.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.418 -0.801 . . . . 0.0 109.518 179.151 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.489 ' HG2' ' HG3' ' B' ' 25' ' ' PRO . 0.0 OUTLIER -65.1 -41.97 94.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.445 -0.784 . . . . 0.0 109.582 179.477 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.97 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.2 mp -60.62 -12.82 11.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.421 -0.799 . . . . 0.0 110.038 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.56 ' C ' ' O ' ' B' ' 17' ' ' LEU . 6.4 tpt85 -18.8 -68.21 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.679 0 CA-C-O 121.489 0.661 . . . . 0.0 111.161 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.535 ' HD2' ' HG2' ' B' ' 20' ' ' ARG . 1.1 tmtm? -174.44 -104.49 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.011 179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.535 ' HG2' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -87.73 13.66 10.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.444 -1.41 . . . . 0.0 109.335 179.308 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -87.06 163.34 17.08 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.456 -0.777 . . . . 0.0 110.555 -179.542 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.616 ' CD2' ' HE2' ' A' ' 124' ' ' MET . 0.2 OUTLIER 179.81 -45.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.318 -0.864 . . . . 0.0 110.559 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.493 ' HA2' ' HG3' ' A' ' 144' ' ' MET . . . -69.91 -50.96 26.43 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.395 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -150.13 84.97 5.61 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.954 -1.321 . . . . 0.0 110.838 -179.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.489 ' HG3' ' HG2' ' B' ' 16' ' ' MET . 48.6 Cg_endo -80.84 -7.76 13.35 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.925 1.487 . . . . 0.0 110.109 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.602 ' CZ ' ' HE2' ' A' ' 72' ' ' MET . 5.9 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.316 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.327 0.584 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.4 mt -50.11 -44.92 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.3 -45.71 69.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 109.951 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.68 -51.01 66.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.208 -0.932 . . . . 0.0 109.813 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -44.84 67.63 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.229 -0.919 . . . . 0.0 109.377 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.63 -30.56 65.47 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.344 -0.847 . . . . 0.0 108.972 178.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -58.32 9.1 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.533 -0.729 . . . . 0.0 109.293 179.21 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.77 -48.41 41.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.267 -0.896 . . . . 0.0 109.336 179.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.543 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 32.3 t80 -66.51 -35.64 80.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.327 -0.858 . . . . 0.0 109.448 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -68.32 -30.34 69.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.46 -0.775 . . . . 0.0 109.528 179.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.876 HD13 ' CD ' ' B' ' 14' ' ' LYS . 6.7 tt -65.35 -46.03 81.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.684 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -73.29 -39.15 65.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.282 -0.886 . . . . 0.0 110.384 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.461 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 1.8 t0 -78.89 82.93 5.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.211 -0.931 . . . . 0.0 109.919 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -49.17 -74.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 110.359 -179.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.1 p-10 -51.76 -39.0 57.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 110.306 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.17 15.02 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.461 ' OD1' ' OD1' ' A' ' 20' ' ' ASP . 40.8 p-10 -76.64 -12.65 60.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -1.167 . . . . 0.0 110.081 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.621 ' O ' HG23 ' A' ' 26' ' ' THR . . . 89.98 42.11 5.42 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -161.49 117.36 2.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -1.131 . . . . 0.0 110.573 -179.831 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.538 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 8.1 mt -100.07 118.22 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.218 -0.926 . . . . 0.0 110.127 179.594 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.68 HG22 HG22 ' A' ' 62' ' ' THR . 20.4 p -94.92 153.88 17.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 109.806 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -46.31 -24.65 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.977 . . . . 0.0 109.942 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -78.54 -60.79 2.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.066 179.761 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 37.3 mt-10 -44.21 -56.64 3.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.511 HD22 ' CZ2' ' B' ' 7' ' ' TRP . 40.8 tp -57.39 -45.65 84.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.168 -0.958 . . . . 0.0 109.3 179.336 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -56.65 -39.56 86.24 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.27 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 15.0 m -53.28 -50.94 63.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -1.027 . . . . 0.0 109.363 179.352 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 35' ' ' VAL . 10.4 t -57.75 -39.28 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.326 -0.859 . . . . 0.0 109.261 179.246 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 13.5 mmt -61.31 -39.13 89.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 179.253 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -62.25 -30.74 71.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.381 179.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 m -65.73 -61.85 1.84 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.465 -0.772 . . . . 0.0 110.051 179.687 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.1 mt -47.92 -24.16 0.96 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.71 55.08 0.58 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.15 165.94 30.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -1.186 . . . . 0.0 110.482 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 42' ' ' ASN . 2.6 p30 -140.75 97.95 7.14 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.967 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.7 154.33 54.31 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.9 1.474 . . . . 0.0 110.485 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 45' ' ' GLU . 4.0 m -99.65 -176.74 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.664 ' H ' HG22 ' A' ' 44' ' ' THR . 1.2 tm-20 -67.45 -69.52 0.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.216 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.502 ' N ' ' OE1' ' A' ' 45' ' ' GLU . . . -47.14 -46.95 23.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 56.5 mm-40 -52.54 -58.19 7.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -0.895 . . . . 0.0 110.296 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.6 mt -48.61 -43.6 36.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.254 -0.904 . . . . 0.0 110.53 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 tp60 -63.87 -35.92 82.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 110.235 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -30.65 71.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.869 . . . . 0.0 110.12 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.9 mtp -84.15 -47.58 10.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.343 -0.848 . . . . 0.0 110.09 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 63' ' ' ILE . 10.2 mm -66.05 -30.26 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -56.5 -14.14 2.86 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.361 -0.837 . . . . 0.0 111.094 -179.504 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.38 -53.0 4.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.085 -1.009 . . . . 0.0 111.009 -179.29 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.823 HG22 ' HG3' ' A' ' 71' ' ' MET . 6.6 t -72.46 -36.69 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.093 -1.005 . . . . 0.0 111.002 -179.484 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.7 t0 -55.32 82.25 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.267 -0.896 . . . . 0.0 110.657 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.32 -58.2 3.59 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.402 -0.812 . . . . 0.0 110.65 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 30.1 p30 -63.94 -11.7 30.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.258 -0.901 . . . . 0.0 110.5 -179.708 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 61.08 46.52 94.38 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.487 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 23.1 p-10 -97.73 -32.84 11.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -1.147 . . . . 0.0 110.23 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.16 -9.42 5.66 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.68 HG22 HG22 ' A' ' 28' ' ' THR . 31.0 p -139.18 160.6 39.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 110.032 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.675 HD12 ' HB ' ' A' ' 55' ' ' VAL . 15.6 mm -84.59 159.45 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 109.92 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.543 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -126.25 173.33 9.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.093 -1.004 . . . . 0.0 110.55 -179.865 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.5 t80 -67.5 -50.77 35.53 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.322 -0.862 . . . . 0.0 111.135 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.3 Cg_endo -66.53 -39.51 16.15 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.254 1.134 . . . . 0.0 110.169 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE2' ' HB2' ' A' ' 64' ' ' ASP . 39.3 mt-10 -53.8 -39.62 65.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.527 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.73 -47.21 72.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 109.777 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 66' ' ' PRO . 18.3 mt -51.17 -30.41 16.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.997 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.9 m -93.89 -14.86 25.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.389 -0.819 . . . . 0.0 110.501 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.823 ' HG3' HG22 ' A' ' 55' ' ' VAL . 7.1 tmm? -73.18 -54.08 9.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.107 -0.995 . . . . 0.0 110.433 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.537 ' CE ' ' CE1' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -52.62 -18.12 1.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.816 . . . . 0.0 110.668 -179.604 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.45 -10.11 22.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.13 -0.981 . . . . 0.0 110.648 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.29 -34.6 9.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.119 -0.988 . . . . 0.0 110.447 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.755 ' HB3' HG21 ' B' ' 8' ' ' THR . 6.4 tptt . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.204 -0.935 . . . . 0.0 110.405 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 15.8 pt-20 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.199 0.523 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.501 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 1.1 pt-20 -72.64 -9.73 58.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.448 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 13.8 mm-40 -79.12 -28.0 42.89 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.497 -0.752 . . . . 0.0 109.91 179.48 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.661 HG23 ' CE1' ' A' ' 141' ' ' PHE . 77.8 mt -62.93 -39.42 85.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.205 -0.934 . . . . 0.0 108.6 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -65.51 -28.53 69.25 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.4 -53.39 7.72 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.22 -32.39 71.08 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.33 -0.856 . . . . 0.0 108.935 178.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -72.88 -45.99 55.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.067 178.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -55.25 -23.78 24.4 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.535 -0.728 . . . . 0.0 109.135 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.829 HG12 HG21 ' A' ' 108' ' ' VAL . 22.8 t -78.59 -44.37 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.536 -0.728 . . . . 0.0 109.735 179.462 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.587 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 57.3 m-85 -65.68 -42.28 91.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.889 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.458 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 30.9 t0 -100.13 61.47 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.524 ' CE ' ' HA ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -54.31 -48.21 71.57 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.153 -0.967 . . . . 0.0 109.534 179.867 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 10.0 p-10 -54.97 -32.15 61.34 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.799 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.29 54.63 22.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.463 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 52.6 p30 -96.57 -5.43 39.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.245 -1.15 . . . . 0.0 110.101 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 99.45 13.13 39.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 2.6 m-85 -164.74 162.97 21.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.303 -1.116 . . . . 0.0 110.04 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.573 HD13 ' HB3' ' A' ' 92' ' ' PHE . 10.7 mt -119.67 132.63 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.234 -0.916 . . . . 0.0 110.414 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -116.08 153.25 32.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 110.126 179.957 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.2 -32.64 1.31 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.709 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.95 84.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.406 -0.809 . . . . 0.0 109.494 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 5.7 mt-10 -54.49 -50.58 67.45 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.324 -0.86 . . . . 0.0 109.404 179.364 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.5 ' HG ' HD11 ' A' ' 125' ' ' ILE . 3.6 mm? -57.9 -52.86 63.77 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.302 -0.873 . . . . 0.0 109.5 179.349 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -50.89 -26.57 6.0 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.213 -0.93 . . . . 0.0 109.016 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.473 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 26.3 t60 -79.27 -25.45 42.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.564 -0.71 . . . . 0.0 109.69 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.829 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -98.8 -30.74 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.694 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 1.009 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.2 OUTLIER -73.49 -51.7 16.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.394 -0.816 . . . . 0.0 110.196 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.7 m -68.94 -23.42 64.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 110.321 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 3.6 m120 -86.85 -14.29 42.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 109.521 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.629 ' CD1' HG12 ' B' ' 13' ' ' VAL . 4.1 mt -89.24 -34.38 16.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -0.857 . . . . 0.0 110.106 179.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.22 -56.61 0.42 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.24 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.52 158.37 17.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.999 -1.295 . . . . 0.0 110.804 -179.338 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 1.2 pttt -135.52 76.17 1.6 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.533 -0.729 . . . . 0.0 109.251 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.696 HD21 ' HA ' ' B' ' 19' ' ' LYS . 4.6 mp -37.2 146.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.671 -0.643 . . . . 0.0 111.14 -179.332 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -54.58 -164.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 0.0 110.04 179.719 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 117' ' ' THR . 91.9 m-20 -83.86 -46.89 11.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.124 -0.985 . . . . 0.0 110.119 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -58.38 -53.06 62.58 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.74 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.658 ' HB3' HD23 ' A' ' 116' ' ' LEU . 67.8 mm-40 -52.85 -44.2 66.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.365 -0.834 . . . . 0.0 109.582 179.51 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 117' ' ' THR . 42.7 t -58.11 -51.19 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.851 . . . . 0.0 110.154 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -61.47 -56.38 20.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 109.88 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 1.8 mt-10 -52.65 -36.65 57.12 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.687 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.537 ' HE1' ' O ' ' B' ' 16' ' ' MET . 0.9 OUTLIER -55.28 -50.15 70.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.811 . . . . 0.0 110.098 179.718 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.5 HD11 ' HG ' ' A' ' 105' ' ' LEU . 37.1 mm -71.45 -46.0 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.22 -0.925 . . . . 0.0 110.321 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 127' ' ' GLU . 11.6 mmt180 -59.8 -55.32 35.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.26 -0.9 . . . . 0.0 110.446 -179.764 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.8 OUTLIER -43.69 -26.05 0.21 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 110.265 -179.958 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -98.59 -28.51 13.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.157 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.8 t70 -65.11 69.79 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.881 . . . . 0.0 110.371 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.6 mp -63.21 -35.77 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.471 179.66 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 35.7 p-10 -74.97 -23.74 58.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 179.668 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 72.93 57.87 5.07 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 1.9 p30 -110.04 -15.2 14.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.214 -1.168 . . . . 0.0 110.083 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 135' ' ' GLN . . . 106.68 -4.74 36.93 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 43.7 mt-30 -155.37 158.57 38.9 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.225 -1.162 . . . . 0.0 110.119 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 14.0 t -92.72 135.97 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 110.075 179.666 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.516 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 28.1 t-20 -106.72 173.21 6.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.156 -0.965 . . . . 0.0 110.416 -179.796 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -54.55 -49.88 69.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.856 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -52.99 -56.37 16.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.271 -0.893 . . . . 0.0 110.229 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 141' ' ' PHE . 48.4 mt-10 -54.22 -58.67 6.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.162 -0.962 . . . . 0.0 110.076 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.661 ' CE1' HG23 ' A' ' 85' ' ' ILE . 41.7 t80 -43.51 -27.39 0.28 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 109.739 179.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.838 ' O ' HG22 ' A' ' 146' ' ' THR . 46.9 t -91.81 -39.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 109.965 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -57.91 -14.14 5.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.362 -0.837 . . . . 0.0 110.501 -179.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.436 ' O ' ' HA2' ' B' ' 23' ' ' GLY . 2.5 mtp -107.3 -11.19 15.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.111 -0.993 . . . . 0.0 110.515 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.593 ' CE ' HD21 ' B' ' 12' ' ' LEU . 0.2 OUTLIER -99.91 -17.84 17.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.161 -0.962 . . . . 0.0 110.699 -179.708 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 142' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 O-C-N 121.163 -0.961 . . . . 0.0 110.346 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.448 HG23 ' HD2' ' B' ' 5' ' ' PRO . 19.6 mm . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.791 0.329 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.448 ' HD2' HG23 ' B' ' 4' ' ' ILE . 46.9 Cg_endo -73.81 164.64 34.16 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.062 1.559 . . . . 0.0 110.458 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -175.93 4.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.181 -0.949 . . . . 0.0 110.612 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 7' ' ' TRP . . . . . 0.718 ' O ' HG22 ' B' ' 10' ' ' VAL . 2.1 m95 -65.12 -76.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.643 0.735 . . . . 0.0 110.707 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.755 HG21 ' HB3' ' A' ' 75' ' ' LYS . 13.3 p -41.72 -25.83 0.06 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.13 -0.981 . . . . 0.0 110.591 -179.305 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.455 ' N ' ' O ' ' B' ' 7' ' ' TRP . 27.1 m -61.92 -61.68 2.32 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.01 -1.056 . . . . 0.0 109.318 178.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.718 HG22 ' O ' ' B' ' 7' ' ' TRP . 6.1 m -53.97 -27.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 109.037 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' B' ' 8' ' ' THR . 30.0 mm -74.3 -42.54 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.471 -0.768 . . . . 0.0 109.287 178.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.593 HD21 ' CE ' ' A' ' 145' ' ' MET . 0.5 OUTLIER -53.33 -60.61 3.07 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.647 -0.658 . . . . 0.0 110.053 179.855 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.629 HG12 ' CD1' ' A' ' 112' ' ' LEU . 69.3 t -56.51 -40.38 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.121 -0.987 . . . . 0.0 109.78 179.682 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.876 ' CD ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.32 -42.06 84.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.147 -0.971 . . . . 0.0 109.515 179.239 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -62.25 -31.51 72.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 109.552 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.537 ' O ' ' HE1' ' A' ' 124' ' ' MET . 0.7 OUTLIER -74.17 -27.03 60.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.497 -0.752 . . . . 0.0 109.87 179.694 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 1.009 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.3 mp -70.34 58.47 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.384 -0.822 . . . . 0.0 109.94 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.489 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 3.7 tpp180 -85.94 -70.93 0.56 Allowed 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.616 -0.677 . . . . 0.0 110.648 -179.637 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.696 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -165.48 -43.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.953 . . . . 0.0 110.216 -179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.674 ' N ' ' HG2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -162.5 3.73 0.05 OUTLIER 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.236 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.477 ' HB2' ' HE2' ' B' ' 19' ' ' LYS . 5.7 t -90.16 154.22 19.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.183 -0.948 . . . . 0.0 110.693 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.27 -42.3 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.367 -0.833 . . . . 0.0 109.958 179.535 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 144' ' ' MET . . . -59.34 104.05 0.49 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.509 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -102.48 105.86 46.06 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.114 -1.227 . . . . 0.0 110.658 -179.489 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.02 139.57 24.38 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.007 1.53 . . . . 0.0 109.524 179.286 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.537 ' CE1' ' CE ' ' A' ' 72' ' ' MET . 1.3 m-85 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.209 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.211 0.529 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -137.82 126.36 23.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 110.269 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.28 114.82 0.87 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.066 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.413 ' O ' ' OE1' ' A' ' 8' ' ' GLN . 15.6 mt -106.83 -163.15 0.89 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -0.943 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 p -80.39 -17.68 51.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.263 -0.898 . . . . 0.0 110.55 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -99.59 -45.71 5.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.204 -0.935 . . . . 0.0 110.159 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.465 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 7.8 tp10 -48.79 -45.92 40.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 40.2 mt-30 -62.74 -56.88 13.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.267 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.1 mt -49.24 -52.19 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 110.391 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -50.61 -42.02 55.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 110.313 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 29.6 tt0 -59.3 -48.2 82.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.226 -0.921 . . . . 0.0 110.308 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -66.23 -41.61 89.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -55.21 -34.77 64.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.187 -0.945 . . . . 0.0 109.44 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 49.8 mt-10 -67.55 -49.19 64.45 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.396 -0.815 . . . . 0.0 109.533 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.513 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -62.57 -43.3 99.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.365 -0.835 . . . . 0.0 109.608 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.616 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 73.9 t80 -62.0 -26.53 68.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.354 -0.841 . . . . 0.0 109.408 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.45 -35.47 23.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.46 -0.775 . . . . 0.0 109.742 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -54.35 -46.13 72.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 109.623 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.552 ' CD1' HD12 ' A' ' 32' ' ' LEU . 63.4 m-85 -70.02 -48.59 57.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.244 -0.91 . . . . 0.0 110.1 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -66.3 66.26 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.384 -0.823 . . . . 0.0 109.958 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -41.89 -51.82 4.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.369 -0.832 . . . . 0.0 110.198 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 6.6 p-10 -72.89 -41.4 64.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 109.701 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.91 45.21 3.67 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 26' ' ' THR . 33.1 p30 -96.03 -4.85 42.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -1.196 . . . . 0.0 110.342 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 26' ' ' THR . . . 87.49 28.33 24.88 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.714 HG23 ' O ' ' A' ' 25' ' ' GLY . 11.7 p -160.03 111.3 1.95 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -1.154 . . . . 0.0 110.394 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.65 HD12 ' HB ' ' A' ' 63' ' ' ILE . 14.9 mt -78.66 124.91 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.048 -1.032 . . . . 0.0 109.707 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.441 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 1.2 p -100.17 -179.9 4.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.628 -0.67 . . . . 0.0 110.136 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -70.72 -33.99 71.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.727 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.89 -50.51 41.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 109.903 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' OE2' ' OG1' ' A' ' 28' ' ' THR . 57.8 mt-10 -51.36 -70.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 109.892 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.552 HD12 ' CD1' ' A' ' 19' ' ' PHE . 15.7 tp -51.24 -33.62 28.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.199 -0.938 . . . . 0.0 109.592 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -61.58 -41.33 99.55 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.0 m -61.04 -41.84 97.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.384 -1.068 . . . . 0.0 109.813 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.8 t -65.44 -46.49 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.294 -0.879 . . . . 0.0 109.705 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -19.68 65.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.062 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 1.2 ttp180 -91.48 -17.2 26.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.9 . . . . 0.0 110.053 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.89 -43.1 13.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 110.113 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.516 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -50.96 -26.4 5.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 110.337 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.65 35.99 0.94 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.44 -166.62 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -1.151 . . . . 0.0 110.348 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 1.9 t30 -149.08 97.75 3.59 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.855 . . . . 0.0 110.094 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.728 ' HA ' HD11 ' B' ' 4' ' ' ILE . 41.9 Cg_endo -68.18 149.17 76.1 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.904 1.476 . . . . 0.0 110.574 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 52.9 m -97.58 135.2 39.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.304 -0.873 . . . . 0.0 110.425 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -44.68 -44.99 9.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.184 -0.947 . . . . 0.0 110.196 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.27 -57.28 6.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 72.1 mm-40 -55.59 -47.68 76.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.264 -0.897 . . . . 0.0 110.175 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -48.61 -62.6 1.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.986 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 tp60 -51.1 -44.02 61.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.428 -0.795 . . . . 0.0 109.942 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -64.96 -28.29 69.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.818 . . . . 0.0 109.644 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.29 -49.44 16.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.449 -0.782 . . . . 0.0 109.832 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -70.36 -10.03 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -85.78 -19.41 30.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.409 -0.807 . . . . 0.0 109.698 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -57.02 6.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.389 -0.819 . . . . 0.0 110.104 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.641 HG23 ' CD1' ' B' ' 7' ' ' TRP . 18.5 t -69.75 -31.72 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.274 -0.891 . . . . 0.0 109.862 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.494 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -59.15 79.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.428 -0.795 . . . . 0.0 110.034 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.86 -21.95 60.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.416 -0.802 . . . . 0.0 110.621 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -71.56 -38.83 70.92 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.048 -1.033 . . . . 0.0 110.434 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.21 12.93 32.42 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.1 p-10 -82.89 -44.48 15.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.395 -1.062 . . . . 0.0 110.528 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.33 11.27 9.86 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.493 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 14.2 p -138.56 143.32 39.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.354 -1.086 . . . . 0.0 109.869 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.65 ' HB ' HD12 ' A' ' 27' ' ' ILE . 15.8 mm -87.08 150.77 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.062 -1.023 . . . . 0.0 109.924 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.516 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 1.2 m-20 -129.74 165.03 22.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.14 -0.975 . . . . 0.0 110.981 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.622 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 14.5 t80 -50.81 -47.43 85.94 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.491 -0.756 . . . . 0.0 111.139 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -67.93 -40.88 8.56 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 O-C-N 123.176 1.093 . . . . 0.0 109.912 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.494 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 0.6 OUTLIER -56.68 -29.89 62.83 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.193 -0.942 . . . . 0.0 108.857 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -66.91 -63.34 1.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.543 -0.723 . . . . 0.0 109.523 178.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -48.26 -22.21 0.63 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.274 -0.891 . . . . 0.0 109.968 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.5 m -100.59 -9.99 21.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.189 -0.944 . . . . 0.0 111.357 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.584 ' HB2' HG13 ' A' ' 55' ' ' VAL . 9.5 ptm -86.05 -43.52 13.04 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.799 -1.188 . . . . 0.0 110.554 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.553 ' N ' ' HG3' ' A' ' 71' ' ' MET . 89.3 mmm -65.34 -10.04 29.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.055 -1.028 . . . . 0.0 110.539 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.0 -10.54 21.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.074 -1.016 . . . . 0.0 111.043 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.409 ' HB3' ' HE2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -98.75 -10.72 22.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.941 -1.1 . . . . 0.0 110.519 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.658 ' CB ' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER -94.93 -25.46 16.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.183 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.9 mmt -76.8 53.6 0.92 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.243 -0.91 . . . . 0.0 110.256 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -118.06 -64.2 1.32 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.07 -32.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.272 -0.893 . . . . 0.0 110.439 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -81.87 11.19 5.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.289 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.557 ' HA ' ' CG ' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -174.59 65.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.227 -0.921 . . . . 0.0 110.266 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 77.5 p -122.47 -52.23 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 109.765 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -99.82 -13.48 19.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.833 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 80' ' ' ASP . 0.3 OUTLIER -84.33 -21.57 30.91 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.501 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 14.8 pt-20 -73.17 -27.57 61.72 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.57 -0.706 . . . . 0.0 110.051 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.432 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 53.1 mt -73.98 -40.82 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.606 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -32.75 73.2 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 109.364 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.569 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 17.2 mt-10 -70.09 -56.58 6.54 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' B' ' 12' ' ' LEU . . . -48.85 -35.98 15.88 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.25 -0.906 . . . . 0.0 108.557 178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 90' ' ' ARG . 26.8 t80 -62.72 -56.09 20.76 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.628 -0.67 . . . . 0.0 109.473 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -43.03 -47.32 5.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.578 -0.701 . . . . 0.0 109.425 179.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.912 HG11 HG11 ' B' ' 13' ' ' VAL . 41.2 t -51.08 -49.41 28.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.363 -0.836 . . . . 0.0 109.359 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.755 ' HB3' HD13 ' A' ' 100' ' ' ILE . 54.8 m-85 -68.85 -44.66 72.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.297 -0.877 . . . . 0.0 110.38 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.486 ' HA ' ' OE2' ' A' ' 104' ' ' GLU . 34.2 t0 -92.28 60.9 3.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.062 -1.024 . . . . 0.0 110.39 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.3 -46.84 62.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.284 -0.885 . . . . 0.0 110.301 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 6.5 p30 -66.04 -26.0 67.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.319 -0.863 . . . . 0.0 110.384 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 67.52 50.99 39.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -96.97 -18.41 19.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.191 -1.182 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.542 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 109.4 24.63 5.84 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -169.92 158.75 7.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.308 -1.113 . . . . 0.0 110.139 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.755 HD13 ' HB3' ' A' ' 92' ' ' PHE . 34.4 mt -117.04 148.91 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 110.033 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 102' ' ' ALA . 19.3 t -127.75 146.73 50.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.958 . . . . 0.0 109.876 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.18 -29.54 0.25 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 109.975 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.68 -56.08 14.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.384 -0.823 . . . . 0.0 109.598 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.486 ' OE2' ' HA ' ' A' ' 93' ' ' ASP . 15.7 mt-10 -53.54 -38.13 63.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 0.0 109.707 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.052 HD12 HD11 ' A' ' 125' ' ' ILE . 1.4 mt -69.87 -39.2 76.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.436 -0.79 . . . . 0.0 109.607 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.0 ttp85 -62.58 -34.17 76.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.304 -0.872 . . . . 0.0 109.415 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -66.49 -51.51 55.91 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.362 -0.836 . . . . 0.0 109.449 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.502 HG21 HG12 ' A' ' 91' ' ' VAL . 28.3 t -57.89 -37.42 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.524 -0.735 . . . . 0.0 109.506 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.889 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -52.1 -64.07 0.94 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.609 -0.682 . . . . 0.0 110.77 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.471 HG23 ' HG2' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -64.22 -15.35 59.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.516 ' OD1' ' HA ' ' A' ' 39' ' ' LEU . 0.9 OUTLIER -79.09 -19.63 50.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.016 . . . . 0.0 109.565 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' B' ' 14' ' ' LYS . 15.8 mt -107.28 -27.03 10.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.484 -0.76 . . . . 0.0 109.862 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.415 ' O ' ' HE3' ' A' ' 115' ' ' LYS . . . 147.57 -74.32 0.29 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.735 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.436 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 1.8 tt0 -71.68 149.0 45.91 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.241 -1.152 . . . . 0.0 111.332 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.471 ' HG2' HG23 ' A' ' 110' ' ' THR . 0.7 OUTLIER -130.48 81.98 2.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.522 -0.736 . . . . 0.0 109.302 179.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.664 HD21 ' O ' ' B' ' 19' ' ' LYS . 8.0 mp -36.71 143.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.588 -0.695 . . . . 0.0 111.083 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -58.02 -153.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 110.072 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.539 ' H ' HG22 ' A' ' 117' ' ' THR . 1.2 m-20 -98.8 -66.0 0.93 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.892 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' ASP . 15.1 mt-10 -44.39 -47.46 9.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.608 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.56 -54.8 43.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.369 -0.832 . . . . 0.0 109.317 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' A' ' 116' ' ' LEU . 39.1 t -55.47 -39.59 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 109.678 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.58 -44.52 86.41 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.375 -0.828 . . . . 0.0 109.719 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -70.59 -36.7 73.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.353 -0.842 . . . . 0.0 109.678 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.417 ' HG2' ' CE2' ' B' ' 22' ' ' PHE . 24.4 ttt -56.76 -37.45 71.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -0.826 . . . . 0.0 109.788 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.052 HD11 HD12 ' A' ' 105' ' ' LEU . 27.5 mm -82.38 -31.23 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 110.084 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -36.67 80.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 110.248 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -30.44 69.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.87 . . . . 0.0 110.061 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -82.96 -29.24 29.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 110.031 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -63.68 72.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.908 . . . . 0.0 110.342 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 3.4 mt -58.05 -21.93 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 109.893 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 35.6 p-10 -98.78 -17.16 18.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.83 61.21 3.61 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 1.6 p30 -111.03 2.87 18.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -1.191 . . . . 0.0 110.098 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.481 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 85.32 -1.67 88.44 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 86.3 mt-30 -153.83 168.28 26.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.156 -1.202 . . . . 0.0 110.221 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.801 HG23 HG23 ' A' ' 125' ' ' ILE . 50.4 t -100.0 143.15 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -0.912 . . . . 0.0 110.075 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.5 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 32.7 t30 -111.2 -173.74 2.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 0.0 110.332 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -69.84 -52.86 21.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.348 -0.845 . . . . 0.0 110.5 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -45.24 -52.66 9.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.263 -0.898 . . . . 0.0 110.195 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -56.24 -58.89 6.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 110.022 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.421 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 20.4 t80 -46.39 -25.16 0.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 145' ' ' MET . 38.3 t -99.99 -54.03 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.299 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.77 -24.31 0.36 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.201 -0.937 . . . . 0.0 110.312 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmm -83.93 -23.83 30.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.266 -0.896 . . . . 0.0 110.313 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.735 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -100.16 -11.49 20.41 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.269 -0.894 . . . . 0.0 110.51 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 142' ' ' VAL . 82.4 p -90.96 -39.28 12.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 110.136 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 148' ' ' LYS . . . -77.48 52.87 1.0 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.411 -0.806 . . . . 0.0 110.267 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.221 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 121.232 0.539 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.25 -170.21 2.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.052 -1.03 . . . . 0.0 110.137 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.503 ' O ' ' HB ' ' B' ' 4' ' ' ILE . 13.1 tp -152.05 65.51 0.84 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.214 -0.928 . . . . 0.0 109.781 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.744 HG23 ' HD2' ' B' ' 5' ' ' PRO . 5.6 mt 57.24 152.48 0.07 OUTLIER Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.613 -0.679 . . . . 0.0 110.528 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.744 ' HD2' HG23 ' B' ' 4' ' ' ILE . 42.6 Cg_endo -70.12 132.46 22.81 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.958 1.504 . . . . 0.0 110.112 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 12.3 p -69.46 -167.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.325 -0.86 . . . . 0.0 110.799 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.727 ' O ' HG22 ' B' ' 10' ' ' VAL . 5.4 m95 -73.11 -77.71 0.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.536 -0.728 . . . . 0.0 110.707 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.658 HG21 ' CB ' ' A' ' 75' ' ' LYS . 20.5 p -40.87 -26.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.964 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.569 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 84.0 m -61.36 -63.55 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 110.001 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.727 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.6 m -50.79 -27.45 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.431 HG12 ' O ' ' B' ' 7' ' ' TRP . 15.0 mm -79.09 -24.79 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.468 -0.77 . . . . 0.0 109.327 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 1.4 mt -68.99 -49.76 55.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.576 -0.702 . . . . 0.0 110.087 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.912 HG11 HG11 ' A' ' 91' ' ' VAL . 97.5 t -67.53 -40.11 83.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.38 -0.825 . . . . 0.0 110.36 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.656 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -64.95 -45.74 84.48 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.918 -1.114 . . . . 0.0 109.506 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.461 ' HB3' ' ND2' ' B' ' 24' ' ' ASN . 4.7 t -57.67 -36.88 72.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.324 -0.86 . . . . 0.0 108.9 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' B' ' 13' ' ' VAL . 2.9 mmt -60.04 -34.47 73.43 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 108.833 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.889 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.3 mp -72.59 56.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.651 -0.655 . . . . 0.0 109.418 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -83.66 0.22 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.69 . . . . 0.0 110.289 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.664 ' O ' HD21 ' A' ' 116' ' ' LEU . 9.0 tmtt? -133.39 -85.03 0.45 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.61 -1.306 . . . . 0.0 110.387 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.534 ' N ' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -142.3 23.91 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.871 -1.143 . . . . 0.0 110.115 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.46 178.86 4.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.497 -0.752 . . . . 0.0 109.583 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.601 ' HZ ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -137.57 148.25 45.74 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.375 -179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.79 146.08 17.63 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.735 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 8.8 m120 -119.26 134.83 23.71 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.224 -1.162 . . . . 0.0 110.304 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 26' ' ' PHE . 46.0 Cg_endo -72.41 -44.38 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.024 1.539 . . . . 0.0 110.048 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' B' ' 25' ' ' PRO . 1.6 m-30 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.42 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.266 0.555 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.77 -22.39 43.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -56.81 101.24 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.328 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.968 HD11 ' CB ' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -133.17 -174.38 3.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 110.04 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.641 ' O ' HD12 ' A' ' 9' ' ' ILE . 6.7 t -135.14 -5.2 2.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -0.946 . . . . 0.0 111.0 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.33 -43.52 11.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.968 -1.082 . . . . 0.0 110.507 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.968 ' CB ' HD11 ' A' ' 4' ' ' LEU . 0.8 OUTLIER -64.0 -63.01 1.27 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.213 -0.929 . . . . 0.0 110.234 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 13.6 pt20 -48.59 -39.38 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.177 -0.952 . . . . 0.0 109.836 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.641 HD12 ' O ' ' A' ' 5' ' ' THR . 12.7 mt -67.32 -29.76 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.464 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -62.51 -55.78 24.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.315 -0.866 . . . . 0.0 109.634 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.534 ' HG3' ' N ' ' A' ' 12' ' ' PHE . 13.1 pt-20 -56.94 -34.67 68.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.954 . . . . 0.0 109.389 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.534 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 13.8 m-85 -73.6 -46.01 49.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.28 -0.888 . . . . 0.0 109.358 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 17' ' ' SER . 32.6 tptt -60.27 -44.07 95.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.287 -0.883 . . . . 0.0 109.212 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.32 -44.3 75.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.179 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.92 -56.69 18.94 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.42 -0.8 . . . . 0.0 109.531 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.548 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 15.2 t80 -55.81 -45.53 78.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.218 -0.926 . . . . 0.0 109.439 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -61.78 -38.49 88.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -0.76 . . . . 0.0 109.254 179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.573 ' O ' HD23 ' A' ' 18' ' ' LEU . 10.1 tt -59.09 -27.74 65.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.495 -0.753 . . . . 0.0 109.624 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CE1' HD22 ' A' ' 18' ' ' LEU . 4.7 m-85 -90.81 -49.87 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.505 -0.747 . . . . 0.0 109.823 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.95 76.99 1.67 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.5 -0.75 . . . . 0.0 110.228 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -52.27 -69.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.908 . . . . 0.0 110.183 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 6.8 p-10 -45.29 -29.19 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 54.83 6.04 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.467 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 2.0 p-10 -106.68 -34.17 7.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.179 -1.189 . . . . 0.0 110.185 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.56 7.79 6.1 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 32.0 p -141.85 117.62 10.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.217 -1.167 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.835 ' O ' HG22 ' A' ' 62' ' ' THR . 16.5 mt -76.87 128.67 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 110.336 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.603 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.5 OUTLIER -95.16 161.59 14.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.411 -0.806 . . . . 0.0 110.264 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.489 HG23 HG13 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -58.56 -39.23 79.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.0 110.4 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 31' ' ' GLU . 3.7 tmtt? -65.66 -52.87 48.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.0 110.275 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 30' ' ' LYS . 10.1 mt-10 -43.15 -61.37 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 109.903 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.7 tp -56.25 -37.98 70.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.92 . . . . 0.0 109.668 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.51 -40.29 98.5 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 m -58.34 -41.63 85.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -1.061 . . . . 0.0 109.625 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.18 -53.2 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.7 mtt -55.66 -31.13 62.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.207 -0.933 . . . . 0.0 109.731 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -74.27 -25.61 59.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 109.82 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.507 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -76.58 -47.36 22.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.209 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mt -56.31 -53.02 62.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 110.254 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.44 58.93 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.511 ' OE1' ' N ' ' A' ' 42' ' ' ASN . 1.5 mm-40 -139.33 -169.76 2.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.158 -1.201 . . . . 0.0 110.233 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 13.7 m120 -143.85 75.85 15.78 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.25 -0.906 . . . . 0.0 110.438 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.574 ' HA ' HD11 ' B' ' 4' ' ' ILE . 47.3 Cg_endo -74.27 119.76 5.95 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.013 1.533 . . . . 0.0 110.274 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 m -76.36 154.31 35.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.283 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.34 -49.24 72.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.54 -54.3 47.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.321 -0.862 . . . . 0.0 110.143 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -56.64 -34.83 67.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -0.906 . . . . 0.0 110.042 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.0 mt -55.78 -54.3 46.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.063 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -31.0 69.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 109.775 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.12 -41.51 77.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 110.068 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.447 ' CE ' ' CD1' ' B' ' 7' ' ' TRP . 1.9 ttp -73.6 -38.93 64.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.245 -0.91 . . . . 0.0 110.023 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.489 HG13 HG23 ' A' ' 29' ' ' THR . 5.5 mm -66.18 -25.1 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.75 0.72 22.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.295 -0.878 . . . . 0.0 110.187 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.77 -13.18 25.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.313 -0.867 . . . . 0.0 110.079 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 57' ' ' ALA . 16.3 t -113.63 -35.12 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.168 -0.958 . . . . 0.0 110.226 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -45.44 89.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.474 -0.766 . . . . 0.0 110.371 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -85.63 -31.44 22.58 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.236 -0.915 . . . . 0.0 110.754 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 29.4 p-10 -83.13 -39.98 20.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.029 -1.044 . . . . 0.0 110.425 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 108.54 24.12 6.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' CG ' ' OD2' ' A' ' 58' ' ' ASP . 19.9 p-10 -95.12 -14.57 24.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -1.151 . . . . 0.0 110.177 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.82 -63.76 0.3 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.835 HG22 ' O ' ' A' ' 27' ' ' ILE . 1.3 p -76.54 165.02 25.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -1.115 . . . . 0.0 110.171 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.701 ' HB ' HD12 ' A' ' 27' ' ' ILE . 20.6 mm -90.81 149.8 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.548 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 24.6 t0 -115.3 162.36 17.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.933 . . . . 0.0 110.659 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.666 ' O ' HD12 ' A' ' 69' ' ' LEU . 74.3 t80 -49.23 -46.16 76.5 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 0.0 111.333 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -69.93 -39.63 5.97 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.285 1.15 . . . . 0.0 110.406 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 57' ' ' ALA . 1.9 mt-10 -57.58 -27.07 62.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.965 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.729 ' CZ ' HD13 ' B' ' 11' ' ' ILE . 45.4 t80 -83.27 -40.99 18.83 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.374 -0.829 . . . . 0.0 110.411 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -67.62 -15.78 63.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.275 -0.891 . . . . 0.0 110.819 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 p -100.23 -41.19 7.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.059 -1.026 . . . . 0.0 110.924 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.438 ' HG2' ' HA ' ' A' ' 68' ' ' PHE . 3.3 ppp? -66.49 -34.45 77.96 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.27 -0.894 . . . . 0.0 111.227 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.613 ' SD ' HG21 ' B' ' 11' ' ' ILE . 13.2 tpt -66.67 -9.4 35.62 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.128 -0.983 . . . . 0.0 111.077 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.6 -9.85 13.19 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.978 -1.076 . . . . 0.0 111.11 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.441 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 1.8 ttm180 -97.1 -32.79 11.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.98 -1.075 . . . . 0.0 110.741 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.648 ' HB3' HG21 ' B' ' 8' ' ' THR . 0.6 OUTLIER -90.49 27.81 1.63 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.049 -1.032 . . . . 0.0 110.695 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.498 ' HE1' ' HE1' ' A' ' 72' ' ' MET . 0.0 OUTLIER -100.52 -79.67 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.074 -1.016 . . . . 0.0 110.627 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.34 55.45 3.42 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.232 -0.918 . . . . 0.0 110.702 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 74' ' ' ARG . 0.4 OUTLIER -104.88 -50.95 3.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.116 -0.99 . . . . 0.0 110.224 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 80' ' ' ASP . 2.9 t -165.14 -37.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.087 -1.008 . . . . 0.0 110.392 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.429 ' N ' HG23 ' A' ' 79' ' ' THR . 0.4 OUTLIER -85.27 83.51 7.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.21 -0.931 . . . . 0.0 110.234 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.8 p -79.56 -71.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.277 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.848 ' HA ' HD12 ' A' ' 85' ' ' ILE . 28.5 mt-10 -85.52 -10.06 56.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 110.445 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 36.1 mt-10 -66.95 -56.69 9.1 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.197 -0.94 . . . . 0.0 110.417 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 55.9 tt0 -53.07 -28.51 25.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -0.93 . . . . 0.0 110.508 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.848 HD12 ' HA ' ' A' ' 82' ' ' GLU . 72.9 mt -66.78 -28.35 42.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.133 -0.98 . . . . 0.0 109.21 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 3.9 ttt-85 -66.52 -30.26 70.55 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.641 -0.662 . . . . 0.0 109.539 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.749 ' HB3' HG21 ' B' ' 9' ' ' THR . 8.3 mt-10 -73.59 -48.99 28.52 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.343 -0.848 . . . . 0.0 109.496 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.441 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.62 -30.75 71.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -66.46 -49.91 65.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -31.49 69.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.383 -0.823 . . . . 0.0 109.544 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.496 HG11 HG21 ' B' ' 13' ' ' VAL . 11.6 t -61.06 -47.5 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.373 -0.829 . . . . 0.0 109.631 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.493 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 45.0 m-85 -67.96 -31.71 71.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.851 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 94' ' ' LYS . 7.2 t0 -80.77 55.35 2.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.2 -0.938 . . . . 0.0 110.173 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 93' ' ' ASP . 2.5 tmtt? -42.73 -32.28 0.58 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.33 -0.857 . . . . 0.0 110.538 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 4.8 p30 -90.08 -31.07 17.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.172 -0.955 . . . . 0.0 110.342 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.535 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 84.15 20.13 59.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 48.5 p30 -75.04 -15.33 60.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.042 -1.269 . . . . 0.0 109.97 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.568 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 92.79 33.17 7.56 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 33.5 m-85 -161.92 107.21 1.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -1.123 . . . . 0.0 110.233 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mt -69.19 124.98 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 110.11 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.56 161.94 17.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.973 . . . . 0.0 110.164 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.93 -37.28 66.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.101 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.5 -53.15 60.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -0.841 . . . . 0.0 110.033 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 24.0 mt-10 -56.19 -39.68 72.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.801 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.92 HD12 HD11 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -60.27 -38.5 83.76 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.301 -0.874 . . . . 0.0 109.486 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -36.78 82.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.556 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -64.99 -52.58 55.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 109.76 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.489 HG11 ' CE1' ' A' ' 92' ' ' PHE . 1.1 t -61.84 -28.58 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 109.159 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.769 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.0 OUTLIER -67.51 -59.22 3.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.398 -0.814 . . . . 0.0 109.845 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -29.07 70.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.89 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 38' ' ' SER . 3.0 m120 -77.76 -6.52 54.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.422 -0.799 . . . . 0.0 110.064 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.566 ' CD1' HG12 ' B' ' 13' ' ' VAL . 12.7 mt -117.5 7.97 12.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -0.925 . . . . 0.0 110.869 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.16 -68.33 0.24 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.256 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 109' ' ' MET . 26.8 tt0 -92.03 161.91 14.58 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.046 -1.267 . . . . 0.0 111.532 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.0 OUTLIER -141.62 82.82 1.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.64 -0.663 . . . . 0.0 109.489 179.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.552 ' H ' HD12 ' A' ' 116' ' ' LEU . 6.3 mp -38.29 140.11 0.33 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.451 -0.781 . . . . 0.0 111.1 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.701 HG22 ' H ' ' A' ' 118' ' ' ASP . 2.6 m -52.24 -171.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.427 -0.796 . . . . 0.0 110.08 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.701 ' H ' HG22 ' A' ' 117' ' ' THR . 31.8 m-20 -83.21 -54.4 5.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 110.228 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -30.26 65.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 109.704 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.436 ' HG2' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -73.62 -52.9 11.83 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.211 -0.931 . . . . 0.0 108.929 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.421 HG22 ' CE ' ' A' ' 109' ' ' MET . 40.4 t -57.85 -34.67 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.423 -0.798 . . . . 0.0 109.466 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -62.17 -44.15 97.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.433 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 5.6 mm-40 -69.43 -29.15 66.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.399 -0.813 . . . . 0.0 109.519 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.623 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 10.2 ttt -65.94 -44.46 85.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.531 -0.731 . . . . 0.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.92 HD11 HD12 ' A' ' 105' ' ' LEU . 17.7 mm -75.98 -49.59 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.274 -0.891 . . . . 0.0 109.785 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -56.61 -47.83 78.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.89 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 5.5 mm-40 -61.73 -43.89 97.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.792 . . . . 0.0 109.917 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.25 -32.17 72.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.884 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.513 ' HB3' ' HA2' ' A' ' 132' ' ' GLY . 5.3 m-20 -71.6 100.69 2.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.384 -0.823 . . . . 0.0 110.051 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.445 HG13 ' OE1' ' A' ' 143' ' ' GLN . 40.0 mm -51.74 -36.53 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.217 -0.927 . . . . 0.0 110.243 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.416 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 17.3 p-10 -99.45 -25.1 14.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.295 -0.878 . . . . 0.0 110.383 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 69.62 51.91 23.3 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 5.7 p30 -85.46 -23.85 27.65 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.185 -1.185 . . . . 0.0 110.21 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 142.17 -10.26 2.51 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.28 166.58 10.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.028 -1.278 . . . . 0.0 110.698 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 140' ' ' GLU . 2.9 t -102.54 154.43 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.397 -0.814 . . . . 0.0 109.871 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.436 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 17.0 p-10 -123.27 -145.71 0.35 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.186 -0.946 . . . . 0.0 110.399 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.85 -68.81 0.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 110.618 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -45.3 -46.28 12.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.219 -0.926 . . . . 0.0 110.653 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.436 ' HB3' HG13 ' A' ' 136' ' ' VAL . 35.7 mt-10 -61.02 -57.08 14.09 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.462 ' CE2' HG23 ' A' ' 85' ' ' ILE . 71.0 t80 -50.74 -20.71 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.241 -0.912 . . . . 0.0 110.164 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 85' ' ' ILE . 73.2 t -93.9 -58.72 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.207 -0.933 . . . . 0.0 110.436 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.445 ' OE1' HG13 ' A' ' 130' ' ' ILE . 40.3 tt0 -42.12 -30.38 0.29 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.217 -0.927 . . . . 0.0 110.176 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.461 ' O ' ' N ' ' B' ' 24' ' ' ASN . 64.9 mtp -69.51 -30.96 68.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 110.052 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 142' ' ' VAL . 23.5 ttm -94.13 -28.66 15.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.355 -0.841 . . . . 0.0 110.391 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.408 ' OG1' ' HA ' ' A' ' 143' ' ' GLN . 73.2 p -88.78 29.99 0.97 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.411 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 148' ' ' LYS . . . -72.93 54.4 0.37 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.298 -0.876 . . . . 0.0 110.348 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.197 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.254 0.55 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -152.77 143.72 22.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.168 -0.957 . . . . 0.0 110.538 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.495 ' O ' ' O ' ' B' ' 4' ' ' ILE . 0.1 OUTLIER -156.99 -48.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.955 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.851 HG23 ' HD2' ' B' ' 5' ' ' PRO . 12.0 mt 55.97 152.38 0.06 OUTLIER Pre-proline 0 N--CA 1.486 1.34 0 O-C-N 121.596 -0.69 . . . . 0.0 110.481 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.851 ' HD2' HG23 ' B' ' 4' ' ' ILE . 42.5 Cg_endo -71.68 139.64 34.3 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.642 1.338 . . . . 0.0 110.24 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.534 ' O ' ' N ' ' B' ' 8' ' ' THR . 46.4 t -90.33 64.09 5.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.306 -0.871 . . . . 0.0 111.036 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.486 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.3 OUTLIER 51.3 -85.43 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.209 -0.932 . . . . 0.0 110.659 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.648 HG21 ' HB3' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -43.46 -40.55 3.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.158 -0.964 . . . . 0.0 109.657 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.749 HG21 ' HB3' ' A' ' 87' ' ' GLU . 84.3 m -51.3 -53.5 35.18 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.438 -0.789 . . . . 0.0 109.51 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' B' ' 5' ' ' PRO . 18.6 t -52.79 -38.56 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.342 -0.849 . . . . 0.0 109.632 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.729 HD13 ' CZ ' ' A' ' 68' ' ' PHE . 12.1 mt -73.48 -25.77 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.281 -0.887 . . . . 0.0 109.727 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -48.69 65.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.4 -0.813 . . . . 0.0 109.668 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.566 HG12 ' CD1' ' A' ' 112' ' ' LEU . 86.4 t -63.77 -48.18 87.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.5 -0.75 . . . . 0.0 110.449 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.43 ' HD2' ' O ' ' B' ' 14' ' ' LYS . 30.4 tptt -54.98 -39.24 68.79 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.956 -1.09 . . . . 0.0 109.599 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 1.7 t -59.45 -40.07 85.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 109.61 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.509 ' CE ' ' HG3' ' B' ' 25' ' ' PRO . 0.2 OUTLIER -64.71 -27.85 69.19 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.39 -0.819 . . . . 0.0 110.087 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.769 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.3 mp -76.0 60.37 1.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.406 -0.808 . . . . 0.0 110.23 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -133.01 67.7 1.53 Allowed 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.53 -0.731 . . . . 0.0 111.36 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.552 ' CD ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER 60.97 -62.71 0.07 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.395 0.617 . . . . 0.0 111.478 178.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' B' ' 18' ' ' ARG . 1.2 ptm180 -143.79 4.35 1.31 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 111.023 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' B' ' 18' ' ' ARG . 23.0 m -64.23 86.59 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.815 -1.178 . . . . 0.0 109.893 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.623 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -126.43 -10.57 6.31 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.341 -0.849 . . . . 0.0 110.526 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' B' ' 24' ' ' ASN . . . -110.61 122.2 6.15 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 144' ' ' MET . 9.3 t-20 40.74 77.43 0.43 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.403 -1.057 . . . . 0.0 110.839 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.509 ' HG3' ' CE ' ' B' ' 16' ' ' MET . 47.7 Cg_endo -77.36 -9.71 17.53 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.0 1.526 . . . . 0.0 110.143 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.569 ' CZ ' ' HE2' ' A' ' 72' ' ' MET . 72.2 m-85 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.213 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.181 0.515 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -44.39 -31.71 1.14 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.128 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -99.9 139.39 35.64 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.354 -0.841 . . . . 0.0 110.16 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.98 149.62 46.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.142 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.924 ' O ' HD12 ' A' ' 9' ' ' ILE . 9.5 t -55.78 135.52 51.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 7' ' ' GLU . 0.7 OUTLIER -99.15 -58.11 2.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.142 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 6' ' ' GLU . 3.0 tt0 -42.93 -65.34 0.49 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.256 -0.902 . . . . 0.0 110.194 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 7' ' ' GLU . 73.7 mm-40 -44.18 -61.11 1.6 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.251 -0.906 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.924 HD12 ' O ' ' A' ' 5' ' ' THR . 48.2 mt -59.08 -48.85 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.6 -45.41 38.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.842 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 2.8 tt0 -57.25 -56.81 17.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 109.85 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 9.0 m-85 -53.95 -33.07 55.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.337 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 3.7 tttp -64.25 -43.08 96.0 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.328 -0.858 . . . . 0.0 109.199 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 16.0 mt-10 -53.41 -49.5 67.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 109.61 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . . . -64.99 -52.0 58.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.362 -0.836 . . . . 0.0 109.573 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.422 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 65.4 t80 -54.66 -40.83 69.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.601 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -71.82 -25.79 62.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.383 -0.823 . . . . 0.0 109.565 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.712 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.7 tt -62.42 -39.64 93.94 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.364 -0.835 . . . . 0.0 109.706 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.464 ' CD1' HD12 ' A' ' 32' ' ' LEU . 49.8 m-85 -86.06 -27.66 24.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.382 -0.824 . . . . 0.0 110.305 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -92.19 100.12 12.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.171 -0.956 . . . . 0.0 110.394 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.37 -70.31 0.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.031 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.3 p-10 -52.69 -21.61 4.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 110.049 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.5 37.24 93.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 19.8 p-10 -80.09 -36.49 35.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.108 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.577 ' C ' HG23 ' A' ' 26' ' ' THR . . . 128.51 25.55 1.03 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.577 HG23 ' C ' ' A' ' 25' ' ' GLY . 70.2 p -157.49 126.8 5.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.071 -1.252 . . . . 0.0 110.323 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.54 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 18.1 mt -97.55 122.12 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.141 -0.974 . . . . 0.0 110.015 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.8 p -90.46 175.86 6.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.811 . . . . 0.0 110.022 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.5 p -69.59 -28.92 66.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 110.175 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -77.11 -50.77 12.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.096 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -48.24 -67.44 0.27 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.321 -0.862 . . . . 0.0 109.916 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.464 HD12 ' CD1' ' A' ' 19' ' ' PHE . 22.5 tp -55.57 -43.62 76.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 109.794 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.43 -41.73 17.77 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.3 m -66.0 -54.87 20.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -1.066 . . . . 0.0 109.935 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 35' ' ' VAL . 16.0 t -49.4 -39.0 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 109.801 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.464 ' HG3' ' HG3' ' A' ' 43' ' ' PRO . 5.2 mmt -62.74 -46.67 87.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.849 . . . . 0.0 109.274 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -51.8 -27.24 11.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -0.867 . . . . 0.0 109.394 179.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -50.1 47.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.849 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 mt -54.55 -31.11 55.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.041 -1.037 . . . . 0.0 110.331 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.32 2.64 2.92 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.945 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.484 ' HG2' HG12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -130.71 158.12 40.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.811 -1.405 . . . . 0.0 110.94 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 5.7 t-20 -123.15 98.73 41.5 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.441 -0.787 . . . . 0.0 110.094 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HG3' ' HG3' ' A' ' 36' ' ' MET . 43.0 Cg_endo -71.88 112.85 3.49 Favored 'Trans proline' 0 C--N 1.296 -2.232 0 O-C-N 124.148 1.604 . . . . 0.0 110.32 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.618 HG22 ' HG3' ' A' ' 47' ' ' GLU . 1.8 t -64.25 -166.59 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -0.865 . . . . 0.0 110.677 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.447 ' N ' ' OG1' ' A' ' 44' ' ' THR . 0.1 OUTLIER -70.99 -60.94 1.96 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.424 -0.798 . . . . 0.0 110.219 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.56 -55.46 4.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.948 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.618 ' HG3' HG22 ' A' ' 44' ' ' THR . 2.2 mm-40 -55.68 -57.66 11.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.165 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 48' ' ' LEU . 17.6 mt -45.53 -65.02 0.6 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.342 -0.849 . . . . 0.0 110.357 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 tp60 -50.54 -25.29 3.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 110.325 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.12 -39.17 55.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.976 . . . . 0.0 110.081 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.571 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 1.7 mmm -80.67 -32.11 36.13 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.286 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 mm -70.09 -36.77 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.073 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 56' ' ' ASP . 0.7 OUTLIER -54.19 -67.87 0.23 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.327 -0.858 . . . . 0.0 110.701 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 53' ' ' ASN . 27.1 mt-10 -41.17 -40.33 1.53 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.42 -0.8 . . . . 0.0 110.656 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.764 HG21 ' CD1' ' B' ' 7' ' ' TRP . 48.8 t -83.55 -16.29 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.928 . . . . 0.0 110.412 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ASN . 33.7 t0 -66.04 66.78 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.246 -0.909 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' HA ' ' NH2' ' A' ' 74' ' ' ARG . . . -41.74 -44.24 3.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.367 -0.833 . . . . 0.0 110.385 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.49 -35.68 34.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.33 -0.856 . . . . 0.0 110.039 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.439 ' HA2' ' OD2' ' A' ' 56' ' ' ASP . . . 92.42 28.45 12.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 24.7 p30 -95.41 -32.63 12.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.327 -1.102 . . . . 0.0 110.318 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 62' ' ' THR . . . 117.12 30.96 1.81 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -157.53 147.57 20.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -1.192 . . . . 0.0 110.106 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.55 HD12 ' CG1' ' A' ' 55' ' ' VAL . 6.9 mm -97.39 124.84 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.335 -0.853 . . . . 0.0 110.14 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -107.76 169.84 8.35 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.233 -0.917 . . . . 0.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.622 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 11.0 t80 -58.69 -47.75 98.14 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.27 -0.894 . . . . 0.0 110.895 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.0 Cg_endo -68.09 -37.02 15.58 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 O-C-N 123.263 1.138 . . . . 0.0 109.648 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' A' ' 57' ' ' ALA . 5.1 tt0 -60.87 -34.07 74.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.303 -0.873 . . . . 0.0 109.029 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.527 ' O ' ' HG3' ' A' ' 71' ' ' MET . 5.7 t80 -63.83 -51.5 64.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.464 -0.773 . . . . 0.0 109.258 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 69' ' ' LEU . 6.2 mp -62.79 -15.2 52.74 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.247 -0.908 . . . . 0.0 109.419 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -90.81 -50.77 5.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 110.594 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.527 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -58.26 -24.97 61.13 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.054 -1.029 . . . . 0.0 109.68 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.471 ' N ' ' HE2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -65.53 -13.83 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 109.88 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 77' ' ' LYS . . . -115.31 -14.76 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 110.238 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.551 ' NH2' ' HA ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -86.81 -29.06 22.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.242 -0.911 . . . . 0.0 110.175 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HG2' HG21 ' B' ' 8' ' ' THR . 32.1 tptt -80.43 -14.12 58.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.138 -0.976 . . . . 0.0 109.959 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 53.1 mtt -100.16 4.18 44.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 110.408 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 73' ' ' ALA . 10.5 mttp -100.86 -2.88 30.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.135 -0.978 . . . . 0.0 110.297 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.864 ' O ' HG23 ' A' ' 79' ' ' THR . 0.7 OUTLIER -92.63 -55.15 3.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.281 -0.887 . . . . 0.0 109.754 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.864 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER 175.66 -96.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.608 -0.683 . . . . 0.0 109.305 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.575 ' HA ' ' CG ' ' A' ' 83' ' ' GLU . 13.0 m-20 33.27 75.22 0.05 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.383 -0.823 . . . . 0.0 111.489 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.43 -72.1 0.53 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.743 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -101.24 -9.44 21.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.315 -0.866 . . . . 0.0 110.828 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.575 ' CG ' ' HA ' ' A' ' 80' ' ' ASP . 6.9 pt-20 -76.18 -25.63 55.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.944 -1.098 . . . . 0.0 110.509 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 10.4 pt-20 -69.43 -37.21 77.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.157 -0.965 . . . . 0.0 110.31 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.509 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 20.6 mt -68.76 -37.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.108 -0.995 . . . . 0.0 109.011 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.67 -26.25 61.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' B' ' 9' ' ' THR . 1.1 mt-10 -73.16 -58.44 3.31 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.464 -0.773 . . . . 0.0 109.185 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.87 -29.17 62.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.026 . . . . 0.0 109.2 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 4.7 t80 -64.81 -49.27 71.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.317 -0.864 . . . . 0.0 109.127 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -33.37 42.53 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.492 -0.755 . . . . 0.0 109.241 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.788 HG11 HG21 ' B' ' 13' ' ' VAL . 41.3 t -72.61 -33.25 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.533 -0.729 . . . . 0.0 110.361 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.632 ' HB3' HD13 ' A' ' 100' ' ' ILE . 23.5 m-85 -75.29 -57.7 3.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.034 -1.041 . . . . 0.0 110.011 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 96' ' ' GLY . 20.6 t0 -84.53 53.41 2.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 110.437 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 93' ' ' ASP . 3.6 mtmt -46.39 -26.56 0.86 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.074 -1.016 . . . . 0.0 108.895 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 1.3 t0 -66.66 -35.55 80.43 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 67.37 35.29 87.23 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.49 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 33.2 p-10 -91.66 -24.12 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.043 -1.269 . . . . 0.0 109.741 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.544 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 120.65 15.93 4.75 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 2.9 m-85 -161.25 150.24 16.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.161 -1.199 . . . . 0.0 110.672 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 92' ' ' PHE . 9.7 mt -107.86 131.84 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.379 -0.826 . . . . 0.0 110.273 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 102' ' ' ALA . 20.2 p -115.13 145.94 41.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.111 -0.993 . . . . 0.0 110.008 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.1 -28.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.35 -0.844 . . . . 0.0 110.043 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -69.44 -51.28 37.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.295 -0.878 . . . . 0.0 109.619 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.16 -39.12 71.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.24 -0.913 . . . . 0.0 109.454 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.552 HD13 HD11 ' A' ' 125' ' ' ILE . 1.2 mt -70.07 -36.34 74.87 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.437 -0.79 . . . . 0.0 109.785 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 17.3 ttt85 -66.36 -29.87 70.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.744 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -76.36 -33.6 58.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.806 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.767 HG21 HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -79.85 -37.52 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.352 -0.842 . . . . 0.0 109.582 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.526 ' HG3' ' N ' ' A' ' 110' ' ' THR . 6.1 ptp -68.14 -36.48 79.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.526 ' N ' ' HG3' ' A' ' 109' ' ' MET . 68.1 m -70.18 -39.76 75.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.327 -0.858 . . . . 0.0 109.631 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -72.5 -14.48 61.67 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.355 -0.841 . . . . 0.0 109.437 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.732 HD11 HG12 ' B' ' 13' ' ' VAL . 10.1 mt -86.57 -46.86 9.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.403 -0.81 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.29 -9.88 0.83 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.836 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp10 -127.65 150.48 49.72 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.734 -1.45 . . . . 0.0 110.857 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 116' ' ' LEU . 2.2 mttp -132.2 74.58 1.59 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.421 -0.8 . . . . 0.0 109.454 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.68 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.4 mp -38.64 144.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.482 -0.761 . . . . 0.0 110.652 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -57.47 -144.61 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.559 -0.713 . . . . 0.0 110.57 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 117' ' ' THR . 8.2 m-20 -111.71 -38.58 4.83 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.019 -1.051 . . . . 0.0 111.212 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 4.8 pt-20 -70.87 -32.17 69.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.996 -1.065 . . . . 0.0 110.46 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.538 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 12.0 pt-20 -78.41 -40.47 35.9 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.13 -0.981 . . . . 0.0 109.4 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.625 HG23 ' HB3' ' A' ' 116' ' ' LEU . 9.7 t -63.37 -36.25 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.211 -0.931 . . . . 0.0 109.423 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.25 -48.4 65.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 0.0 109.434 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 2.3 mm-40 -63.25 -19.63 64.73 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.39 -0.819 . . . . 0.0 109.407 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.88 -56.95 4.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -0.836 . . . . 0.0 109.791 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.552 HD11 HD13 ' A' ' 105' ' ' LEU . 22.8 mm -61.5 -43.5 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 109.483 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -64.21 -37.54 87.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.436 -0.79 . . . . 0.0 110.007 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 17.2 tp10 -70.9 -15.64 62.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.783 . . . . 0.0 110.111 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -94.57 -42.04 9.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 110.358 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD2' ' CG ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -56.03 80.59 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.442 -0.786 . . . . 0.0 110.361 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 128' ' ' ALA . 13.0 mt -50.31 -41.41 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.099 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 12.0 p-10 -80.39 -34.91 35.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.424 -0.798 . . . . 0.0 110.048 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.92 68.16 1.14 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 3.0 p30 -117.3 -14.15 10.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.157 -1.202 . . . . 0.0 110.186 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.76 5.39 29.4 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 11.1 pt20 -170.05 169.26 8.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.225 -1.162 . . . . 0.0 110.445 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 26.0 t -100.34 159.1 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.212 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.568 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 57.5 t30 -128.63 173.3 10.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.257 -0.902 . . . . 0.0 110.243 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.492 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 38.4 t80 -55.71 -61.95 2.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 0.0 110.087 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.36 -31.73 15.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.43 -50.88 8.92 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.182 -0.949 . . . . 0.0 110.248 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.573 ' CE1' ' CD2' ' A' ' 92' ' ' PHE . 63.3 t80 -54.93 -17.78 4.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.995 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 146' ' ' THR . 14.7 t -97.4 -36.68 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.346 -0.846 . . . . 0.0 110.261 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -11.47 60.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.21 -0.931 . . . . 0.0 110.425 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.487 ' HE3' ' HB3' ' A' ' 144' ' ' MET . 17.8 mmm -91.75 -25.69 18.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.174 -0.954 . . . . 0.0 110.267 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.465 ' SD ' HG12 ' A' ' 85' ' ' ILE . 6.5 mtp -98.79 -30.28 12.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.226 -0.921 . . . . 0.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 142' ' ' VAL . 35.0 p -85.83 19.9 2.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.72 53.84 1.9 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.367 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.235 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 1' ' ' VAL . 23.5 m . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.304 0.573 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.551 ' O ' ' CB ' ' B' ' 3' ' ' LEU . 21.6 mttp -68.94 118.66 12.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.287 -0.883 . . . . 0.0 110.408 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.591 ' O ' ' HB ' ' B' ' 4' ' ' ILE . 2.6 mt 160.55 94.85 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.833 HG23 ' HD2' ' B' ' 5' ' ' PRO . 10.6 mt 62.23 153.31 0.11 Allowed Pre-proline 0 N--CA 1.49 1.558 0 CA-C-O 121.006 0.432 . . . . 0.0 110.423 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.833 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.5 Cg_endo -66.71 -164.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 124.06 1.558 . . . . 0.0 110.996 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.429 ' C ' ' SD ' ' A' ' 51' ' ' MET . 0.1 OUTLIER -115.65 -148.89 0.44 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.311 -0.868 . . . . 0.0 110.797 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.764 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -91.7 -74.49 0.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 110.778 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.464 HG21 ' HG2' ' A' ' 75' ' ' LYS . 14.3 p -44.28 -43.25 7.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 110.094 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 87' ' ' GLU . 17.1 m -45.18 -54.03 7.43 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 109.777 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.03 -38.66 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.247 -0.908 . . . . 0.0 109.343 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.504 ' N ' HD13 ' B' ' 11' ' ' ILE . 5.3 mm -67.72 -39.27 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.361 -0.837 . . . . 0.0 109.957 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' B' ' 9' ' ' THR . 12.7 mt -52.63 -56.09 17.82 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.347 -0.845 . . . . 0.0 109.958 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.788 HG21 HG11 ' A' ' 91' ' ' VAL . 73.4 t -54.51 -54.7 19.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 110.33 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.515 ' O ' HD22 ' B' ' 17' ' ' LEU . 3.7 tptt -55.71 -41.67 74.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.809 -1.182 . . . . 0.0 109.71 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 17.8 t -72.91 -6.0 42.27 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 109.865 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.579 ' SD ' ' CD1' ' B' ' 22' ' ' PHE . 35.0 tpp -83.97 -45.13 13.48 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.256 -0.902 . . . . 0.0 110.138 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.734 HD13 ' H ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -96.06 33.67 1.68 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 118.383 -1.327 . . . . 0.0 110.234 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.415 ' HG2' ' N ' ' B' ' 19' ' ' LYS . 1.5 ttt85 -42.5 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.49 0.662 . . . . 0.0 109.992 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.586 ' HD2' ' CG ' ' B' ' 20' ' ' ARG . 2.9 tmtm? -103.69 -84.66 0.47 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.141 -0.974 . . . . 0.0 110.387 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.586 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.4 OUTLIER -146.1 12.41 1.24 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.697 -1.252 . . . . 0.0 110.021 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.53 174.06 6.04 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.351 -0.843 . . . . 0.0 110.775 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.579 ' CD1' ' SD ' ' B' ' 16' ' ' MET . 0.2 OUTLIER -130.32 66.15 1.51 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.47 -0.769 . . . . 0.0 110.061 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.29 -173.97 13.24 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.447 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 0.4 OUTLIER -176.71 118.59 0.28 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.369 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -79.74 35.69 0.58 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.829 1.437 . . . . 0.0 111.216 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.432 ' CD1' ' OD1' ' B' ' 24' ' ' ASN . 8.3 m-85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.901 -1.125 . . . . 0.0 110.388 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.214 0.53 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 2' ' ' ASP . 9.2 t70 -126.53 25.22 6.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.245 -0.909 . . . . 0.0 110.248 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -98.19 106.31 18.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.272 -0.892 . . . . 0.0 110.205 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.493 ' C ' HG23 ' A' ' 5' ' ' THR . 1.1 tt -114.26 41.95 2.18 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.255 -0.903 . . . . 0.0 110.396 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.517 ' HB ' ' NE2' ' A' ' 8' ' ' GLN . 69.5 p -149.55 39.79 0.81 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.237 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -45.01 70.18 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.484 -0.76 . . . . 0.0 110.19 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.98 -66.5 0.38 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.517 ' NE2' ' HB ' ' A' ' 5' ' ' THR . 4.5 mt-30 -49.1 -58.39 5.03 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.255 -0.903 . . . . 0.0 110.122 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.9 mt -55.7 -54.45 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.191 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.72 -48.63 10.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.166 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.98 -49.01 74.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -0.926 . . . . 0.0 110.048 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.438 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 20.9 m-30 -63.69 -40.53 97.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.915 . . . . 0.0 110.112 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -54.91 -52.23 63.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.163 -0.961 . . . . 0.0 109.769 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 9.3 tp10 -60.04 -30.55 69.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.543 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -69.28 -50.47 46.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.466 -0.771 . . . . 0.0 110.155 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.474 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 16.9 t80 -63.15 -36.93 85.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.607 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.2 m -75.36 -15.32 60.48 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.331 -0.856 . . . . 0.0 109.4 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.859 HD11 ' O ' ' A' ' 112' ' ' LEU . 7.8 tt -74.21 -48.27 30.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.449 -0.782 . . . . 0.0 110.096 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.549 ' HB3' HG23 ' A' ' 27' ' ' ILE . 54.5 m-85 -69.57 -47.37 63.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.293 -0.879 . . . . 0.0 109.988 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 25' ' ' GLY . 4.4 t0 -57.55 95.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.13 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 8.2 mmtp -52.44 -56.08 17.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.175 -0.953 . . . . 0.0 110.15 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 18.6 p-10 -76.62 -33.78 58.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.84 . . . . 0.0 110.328 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . 95.06 41.34 4.06 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 32.3 p-10 -97.09 8.98 43.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.153 -1.204 . . . . 0.0 110.308 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 26' ' ' THR . . . 74.07 38.28 47.98 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 25' ' ' GLY . 21.7 p -156.52 111.38 2.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.173 -1.192 . . . . 0.0 110.293 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.848 HD12 HG21 ' A' ' 63' ' ' ILE . 17.5 mt -86.85 123.14 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.085 -1.009 . . . . 0.0 110.365 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -100.43 164.87 11.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.4 -0.812 . . . . 0.0 109.543 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.556 HG21 ' NE2' ' A' ' 49' ' ' GLN . 18.7 p -65.75 -25.11 67.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.984 -1.073 . . . . 0.0 109.885 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.36 -45.0 49.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 109.994 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 35' ' ' VAL . 46.6 mt-10 -63.25 -66.16 0.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 109.992 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 tp -47.74 -45.03 28.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 110.06 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -47.28 -54.89 9.5 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 59.3 m -61.08 -36.32 79.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.406 -1.055 . . . . 0.0 110.036 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 31' ' ' GLU . 19.3 t -62.69 -43.94 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.92 . . . . 0.0 110.084 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.428 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 12.5 mmm -66.48 -28.72 68.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.283 -0.886 . . . . 0.0 110.041 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 tpt85 -72.5 -29.43 63.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.324 -0.86 . . . . 0.0 110.245 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -58.39 -48.9 79.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 110.555 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.643 HD23 HG23 ' A' ' 108' ' ' VAL . 2.6 mt -57.25 -23.47 48.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.182 -0.949 . . . . 0.0 110.2 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.403 ' O ' ' OE1' ' A' ' 41' ' ' GLN . . . 106.34 70.87 0.76 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.403 ' OE1' ' O ' ' A' ' 40' ' ' GLY . 13.7 mm100 -153.26 -172.14 4.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.233 -1.157 . . . . 0.0 110.153 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.05 78.88 45.91 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.207 -0.933 . . . . 0.0 110.533 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HG3' ' HB2' ' A' ' 36' ' ' MET . 44.0 Cg_endo -72.22 135.69 25.33 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.074 1.565 . . . . 0.0 110.228 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.1 m -97.98 146.1 25.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.216 -0.927 . . . . 0.0 110.237 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -49.42 -47.55 47.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.15 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.47 -48.21 74.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.951 . . . . 0.0 110.193 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.22 -32.79 74.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.951 . . . . 0.0 110.247 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 48' ' ' LEU . 8.9 mt -61.07 -51.04 70.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 110.406 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.556 ' NE2' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -62.92 -36.91 84.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.336 -0.852 . . . . 0.0 110.203 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -71.15 -32.05 68.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 109.871 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.635 ' CE ' ' CD1' ' B' ' 7' ' ' TRP . 3.9 mmm -69.47 -36.03 76.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 109.965 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.895 HG12 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -89.69 -12.05 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 109.626 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.67 -37.17 72.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.0 110.254 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.04 -32.48 15.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.409 -0.807 . . . . 0.0 110.464 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.78 HG12 HD12 ' A' ' 63' ' ' ILE . 15.6 t -69.74 -31.51 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.093 -1.005 . . . . 0.0 110.231 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 57' ' ' ALA . 42.4 t0 -76.84 49.41 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.127 -0.983 . . . . 0.0 110.217 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 56' ' ' ASP . . . -44.05 -29.82 0.65 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 110.377 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.453 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 2.7 t0 -61.93 -61.83 2.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.725 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.18 25.19 3.92 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 54.8 p30 -99.04 -14.62 19.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.943 -1.327 . . . . 0.0 110.112 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 105.75 -34.42 5.78 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.515 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 12.7 p -106.44 161.06 14.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.157 -1.202 . . . . 0.0 110.414 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.895 HD11 HG12 ' A' ' 52' ' ' ILE . 25.6 mm -86.44 144.29 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.295 -0.878 . . . . 0.0 110.578 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 6.7 t70 -122.25 165.42 16.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.489 -0.757 . . . . 0.0 110.046 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.616 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 14.8 t80 -59.07 -43.35 97.24 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.235 -0.916 . . . . 0.0 111.625 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.4 Cg_endo -72.82 -30.31 11.53 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.37 1.194 . . . . 0.0 110.555 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 64' ' ' ASP . 17.0 mt-10 -68.64 -44.39 74.25 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.081 -1.012 . . . . 0.0 109.534 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CD1' ' HE3' ' A' ' 71' ' ' MET . 33.9 t80 -61.02 -45.23 95.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 0.0 110.036 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.3 mt -59.6 -36.28 75.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.192 -0.942 . . . . 0.0 110.421 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -71.79 -26.91 62.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.249 -0.907 . . . . 0.0 110.576 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.593 ' HE2' HG22 ' A' ' 55' ' ' VAL . 2.2 tmm? -71.5 -62.26 1.47 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 110.555 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.599 ' HE1' ' CE1' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -50.46 -20.47 1.14 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.222 -0.924 . . . . 0.0 110.157 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.4 -21.69 20.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.191 -0.943 . . . . 0.0 110.268 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtt85 -98.36 -20.07 17.38 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.194 -0.941 . . . . 0.0 110.503 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.575 ' HG2' HG21 ' B' ' 8' ' ' THR . 1.9 tptm -76.92 -35.88 57.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.933 . . . . 0.0 109.927 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.679 ' HE1' ' CD1' ' B' ' 26' ' ' PHE . 15.4 mtt -90.11 42.21 1.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.0 109.888 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -96.86 -51.05 4.41 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.358 -0.839 . . . . 0.0 110.258 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 47.7 t0 -177.19 59.09 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 110.394 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.41 -81.65 0.29 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.513 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 3.8 m-20 -94.23 90.9 6.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.326 -0.859 . . . . 0.0 110.152 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 m -86.57 -62.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.176 -0.953 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -100.44 -9.75 21.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.285 -0.884 . . . . 0.0 110.564 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.513 ' HG2' ' HA ' ' A' ' 80' ' ' ASP . 3.9 pt-20 -84.79 -9.74 57.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.142 -0.973 . . . . 0.0 110.469 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -85.49 -27.36 25.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.084 -1.01 . . . . 0.0 110.088 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.618 HD13 HG21 ' A' ' 146' ' ' THR . 5.3 mt -73.25 -38.0 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.082 -1.011 . . . . 0.0 109.024 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -57.2 -31.46 65.49 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.451 ' HB3' HG23 ' B' ' 9' ' ' THR . 0.5 OUTLIER -67.69 -58.89 3.87 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.556 -0.715 . . . . 0.0 109.293 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.17 -30.09 48.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 109.426 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -74.34 -31.49 62.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -0.888 . . . . 0.0 109.216 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.47 -22.42 64.56 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.534 -0.729 . . . . 0.0 109.467 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.783 HG12 HG21 ' A' ' 108' ' ' VAL . 23.6 t -91.12 -28.75 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 0.0 110.476 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.649 ' HB3' HD13 ' A' ' 100' ' ' ILE . 4.0 m-85 -77.92 -30.05 50.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.076 -1.015 . . . . 0.0 109.964 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -96.36 63.27 2.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.315 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ASP . 5.6 mmpp? -41.12 -28.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.512 -0.742 . . . . 0.0 110.079 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.5 ' HB2' ' OD1' ' A' ' 97' ' ' ASN . 7.9 m-20 -82.96 -39.47 21.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.357 -0.839 . . . . 0.0 109.686 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 77.23 26.61 61.41 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 95' ' ' ASP . 5.9 p-10 -86.65 -44.18 12.05 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -1.22 . . . . 0.0 109.931 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.591 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 143.62 27.61 0.13 Allowed Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.827 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 41.3 m-85 -161.2 136.92 7.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.924 -1.339 . . . . 0.0 110.174 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.649 HD13 ' HB3' ' A' ' 92' ' ' PHE . 11.1 mt -101.0 123.24 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.257 -0.902 . . . . 0.0 109.969 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 61.8 p -105.19 140.61 38.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.201 -0.937 . . . . 0.0 110.205 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.38 -34.81 0.87 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.383 -0.823 . . . . 0.0 109.999 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.6 -51.04 70.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.855 . . . . 0.0 109.761 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -57.08 -43.1 81.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.78 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.819 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -58.94 -37.35 76.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.768 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 1.8 ttt-85 -61.35 -37.38 83.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 0.6 OUTLIER -63.82 -44.32 93.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.459 -0.775 . . . . 0.0 109.808 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.783 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -82.62 -28.67 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.442 -0.786 . . . . 0.0 109.284 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.623 ' HA ' HD21 ' B' ' 17' ' ' LEU . 31.7 ttm -65.51 -57.06 9.15 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.578 -0.701 . . . . 0.0 110.14 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.682 HG23 ' HB3' ' A' ' 115' ' ' LYS . 5.8 m -67.53 -32.4 73.16 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.248 -0.907 . . . . 0.0 110.316 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 6.4 m120 -76.81 1.79 16.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.002 -1.061 . . . . 0.0 109.29 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.888 ' CD1' HG12 ' B' ' 13' ' ' VAL . 7.0 mt -111.75 4.37 18.41 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.372 -0.83 . . . . 0.0 110.601 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.76 -75.97 0.41 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.609 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.1 tp10 -94.6 154.27 17.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -1.133 . . . . 0.0 111.099 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.682 ' HB3' HG23 ' A' ' 110' ' ' THR . 1.3 pttm -129.45 74.43 1.58 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.641 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.9 mp -34.27 154.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.391 0.615 . . . . 0.0 110.965 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.81 -144.23 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.299 -0.876 . . . . 0.0 110.097 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -108.53 -59.34 1.88 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.218 -0.926 . . . . 0.0 110.139 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -48.87 -45.24 40.75 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.069 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.31 -50.58 73.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.89 . . . . 0.0 109.924 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.605 HG22 ' CE ' ' A' ' 109' ' ' MET . 43.5 t -57.64 -38.26 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.86 -45.61 70.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.902 . . . . 0.0 109.796 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 1.8 tt0 -64.84 -23.18 67.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.456 -0.778 . . . . 0.0 109.89 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.42 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 1.8 ttt -73.06 -43.79 61.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.843 . . . . 0.0 109.945 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.819 HD11 ' CD1' ' A' ' 105' ' ' LEU . 45.0 mm -69.93 -42.13 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 110.185 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.507 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 33.9 mtt-85 -66.25 -44.55 83.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.266 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 123' ' ' GLU . 7.6 mm-40 -48.19 -32.15 6.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.392 -0.818 . . . . 0.0 110.25 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -100.69 -30.57 11.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.847 . . . . 0.0 110.162 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -56.72 83.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.343 -0.848 . . . . 0.0 110.613 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -65.28 -42.35 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.231 -0.918 . . . . 0.0 109.579 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 29.9 p-10 -70.68 -33.5 70.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 109.844 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 87.02 56.55 2.17 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.456 ' OD2' ' OD2' ' A' ' 131' ' ' ASP . 25.7 p30 -112.98 0.12 14.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -1.211 . . . . 0.0 109.864 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.455 ' C ' ' HG3' ' A' ' 135' ' ' GLN . . . 76.71 -1.72 61.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 100' ' ' ILE . 33.0 mt-30 -139.55 138.52 36.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.142 -1.21 . . . . 0.0 110.25 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 125' ' ' ILE . 20.2 t -89.37 154.74 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.108 -0.995 . . . . 0.0 109.724 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.45 ' OD1' ' HG3' ' A' ' 139' ' ' GLU . 55.9 p30 -130.09 -142.32 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 110.581 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.71 -68.58 0.69 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.391 -0.818 . . . . 0.0 110.697 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -46.74 -25.06 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.23 -0.919 . . . . 0.0 110.792 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.46 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 38.0 mt-10 -83.13 -61.09 1.95 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.008 . . . . 0.0 109.726 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.515 ' CE1' HG23 ' A' ' 85' ' ' ILE . 35.4 t80 -51.23 -19.52 1.25 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 110.29 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 144' ' ' MET . 55.5 t -100.93 -70.21 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.264 -0.898 . . . . 0.0 111.455 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.811 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -39.74 -24.73 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.103 -0.998 . . . . 0.0 111.787 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.52 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 77.7 mmm -88.62 -39.25 14.21 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.745 -1.222 . . . . 0.0 111.395 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.39 -9.69 21.96 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.989 -1.069 . . . . 0.0 111.895 -178.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.618 HG21 HD13 ' A' ' 85' ' ' ILE . 1.3 p -120.47 -26.4 5.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.721 -1.237 . . . . 0.0 111.06 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -7.85 72.87 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.85 0 CA-C-O 121.677 0.751 . . . . 0.0 112.27 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 146' ' ' THR . 4.4 ptmt . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.271 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' B' ' 2' ' ' LYS . 5.6 m . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.337 0.589 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.526 ' O ' HD22 ' B' ' 3' ' ' LEU . 0.0 OUTLIER 56.29 90.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.381 -0.824 . . . . 0.0 110.934 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.526 HD22 ' O ' ' B' ' 2' ' ' LYS . 0.6 OUTLIER -127.07 -17.83 4.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.987 HD13 ' HD2' ' B' ' 5' ' ' PRO . 0.2 OUTLIER -51.44 143.05 20.03 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.987 ' HD2' HD13 ' B' ' 4' ' ' ILE . 38.5 Cg_endo -65.9 -155.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.825 1.434 . . . . 0.0 110.176 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.424 ' O ' HG23 ' B' ' 10' ' ' VAL . 6.6 m -121.94 -147.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.933 -1.104 . . . . 0.0 111.333 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.764 ' CD1' HG21 ' A' ' 55' ' ' VAL . 4.8 m95 -81.91 -76.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.547 0.689 . . . . 0.0 111.282 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.575 HG21 ' HG2' ' A' ' 75' ' ' LYS . 30.2 p -43.86 -42.82 5.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.811 . . . . 0.0 110.3 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.525 HG21 ' CB ' ' B' ' 5' ' ' PRO . 53.6 m -46.29 -41.41 13.13 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 109.292 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 6' ' ' SER . 46.2 t -69.32 -41.06 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.359 -0.838 . . . . 0.0 109.863 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.5 ' N ' HD13 ' B' ' 11' ' ' ILE . 5.6 mm -72.76 -25.69 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.248 -0.907 . . . . 0.0 109.874 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.636 HD13 ' CD2' ' B' ' 26' ' ' PHE . 1.3 mm? -65.97 -53.41 39.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.694 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.888 HG12 ' CD1' ' A' ' 112' ' ' LEU . 53.2 t -61.02 -48.9 86.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.152 -0.968 . . . . 0.0 109.766 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -35.69 43.17 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.844 -1.16 . . . . 0.0 108.965 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 5.3 t -65.24 -34.85 79.33 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.514 -0.741 . . . . 0.0 109.365 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.421 ' HG3' ' CE1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -57.32 -43.81 83.65 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.401 -0.812 . . . . 0.0 109.518 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 109' ' ' MET . 4.1 mp -58.16 -94.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 109.688 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 58.15 -76.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.518 -0.739 . . . . 0.0 110.6 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER 175.63 107.59 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.887 -0.508 . . . . 0.0 110.842 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.7 OUTLIER 40.16 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.464 -0.773 . . . . 0.0 110.947 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.518 ' N ' ' O ' ' B' ' 19' ' ' LYS . 2.2 m -107.62 141.16 39.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.983 -1.073 . . . . 0.0 110.29 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.605 ' HE2' HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -142.21 12.67 1.99 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.196 -0.94 . . . . 0.0 110.208 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' B' ' 24' ' ' ASN . . . -77.96 -61.44 2.53 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 145' ' ' MET . 1.8 m-80 55.4 69.06 2.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.3 -1.118 . . . . 0.0 110.068 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.45 62.47 4.43 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 O-C-N 123.967 1.509 . . . . 0.0 110.04 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.679 ' CD1' ' HE1' ' A' ' 76' ' ' MET . 1.1 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.189 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.249 0.547 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 59.07 95.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.207 -0.933 . . . . 0.0 110.146 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -98.16 84.75 3.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.7 118.55 26.18 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.351 -0.843 . . . . 0.0 110.273 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 p -104.33 95.43 5.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.288 -0.882 . . . . 0.0 110.324 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.51 -32.47 67.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.122 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -52.55 61.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 109.943 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -53.19 59.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.711 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.5 mp -54.07 -39.58 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.45 -51.82 65.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.484 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -48.91 -49.11 41.53 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.363 -0.835 . . . . 0.0 109.256 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -60.59 -44.79 95.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.386 -0.821 . . . . 0.0 109.345 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 10.6 tptm -57.26 -36.6 71.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.368 -0.833 . . . . 0.0 109.227 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -52.56 64.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.604 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.61 -41.88 64.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.282 -0.886 . . . . 0.0 109.492 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 31.8 t80 -65.62 -43.66 88.87 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.491 -0.756 . . . . 0.0 109.509 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -69.87 -25.35 63.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 109.615 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.692 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.3 tt -67.47 -42.29 83.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.447 -0.783 . . . . 0.0 109.798 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.515 ' HA ' HG21 ' A' ' 35' ' ' VAL . 24.9 m-85 -73.16 -39.22 65.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 109.762 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER -62.94 89.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.412 -0.805 . . . . 0.0 110.226 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -88.33 30.66 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.224 -0.922 . . . . 0.0 110.133 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 9.4 p-10 -143.65 -41.53 0.29 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.241 -0.912 . . . . 0.0 110.325 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 102.93 90.94 2.17 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 24.1 p-10 -164.07 -43.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.195 -1.179 . . . . 0.0 110.409 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.4 17.65 6.53 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -143.85 119.52 10.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.194 -1.18 . . . . 0.0 110.351 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 5.9 mt -82.09 115.97 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.083 -1.011 . . . . 0.0 109.943 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 31' ' ' GLU . 9.0 p -80.35 -174.29 4.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.678 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.0 -49.88 26.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.159 -0.963 . . . . 0.0 110.179 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' GLU . 4.8 ttmt -68.32 -40.9 81.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.484 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.2 mt-10 -43.98 -48.78 8.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.13 -0.981 . . . . 0.0 109.594 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.608 HD23 HD21 ' A' ' 48' ' ' LEU . 24.0 tp -71.39 -34.52 70.46 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.314 -0.867 . . . . 0.0 109.366 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -59.45 -46.81 93.32 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 99.5 m -58.71 -54.35 48.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -1.094 . . . . 0.0 109.159 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 31' ' ' GLU . 16.8 t -56.76 -35.47 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.37 -0.831 . . . . 0.0 109.363 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.0 mmt -63.56 -49.56 72.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.461 -0.774 . . . . 0.0 109.697 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -54.09 -30.46 48.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.876 . . . . 0.0 109.5 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.446 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 1.3 m -54.96 -50.17 69.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.439 -0.788 . . . . 0.0 110.132 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.1 mt -52.15 -36.64 52.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.109 -0.995 . . . . 0.0 109.673 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 117.45 64.87 0.33 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 40' ' ' GLY . 6.3 mt-30 -156.81 -166.28 2.06 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.227 -1.161 . . . . 0.0 110.376 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -126.6 82.0 67.51 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.224 -0.922 . . . . 0.0 110.667 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.9 102.58 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.908 1.478 . . . . 0.0 110.438 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.511 ' CG2' ' HG3' ' A' ' 47' ' ' GLU . 11.4 t -79.63 172.09 14.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.187 -0.946 . . . . 0.0 110.084 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -78.78 -25.67 44.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.158 -0.964 . . . . 0.0 110.482 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.09 -65.43 0.7 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.034 -1.041 . . . . 0.0 110.178 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HG3' ' CG2' ' A' ' 44' ' ' THR . 0.9 OUTLIER -52.7 -44.96 66.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 109.879 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.608 HD21 HD23 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -50.96 -42.94 60.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.353 -0.842 . . . . 0.0 109.907 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -45.64 92.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.423 -0.798 . . . . 0.0 109.8 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.76 -13.97 62.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 110.062 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.617 ' HE1' ' CA ' ' B' ' 7' ' ' TRP . 2.4 mmm -94.26 -46.37 7.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.52 HG13 HD11 ' A' ' 63' ' ' ILE . 1.2 tp -60.69 -37.96 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.242 -0.911 . . . . 0.0 110.035 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.408 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.8 OUTLIER -51.11 -29.78 14.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 110.284 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -65.24 -56.33 13.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.024 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.668 HG22 ' HG3' ' A' ' 71' ' ' MET . 15.2 t -70.78 -14.49 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.126 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.4 77.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 110.384 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . . . -56.9 -63.81 1.08 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 0.0 110.32 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 7.0 p-10 -66.4 -43.9 84.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.97 . . . . 0.0 110.191 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.68 41.09 1.64 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 34.9 p-10 -99.51 -42.72 6.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.093 -1.239 . . . . 0.0 110.27 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.526 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 136.23 -14.34 4.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 22.0 p -118.36 160.89 20.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.135 -1.215 . . . . 0.0 110.538 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.52 HD11 HG13 ' A' ' 52' ' ' ILE . 8.0 mm -97.85 152.63 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 109.905 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.453 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 2.0 m-20 -131.57 148.22 52.6 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.188 -0.945 . . . . 0.0 110.535 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.911 ' O ' HD12 ' A' ' 69' ' ' LEU . 37.6 t80 -40.58 -51.22 6.8 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.281 -0.887 . . . . 0.0 111.172 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.9 Cg_endo -66.09 -33.07 42.14 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.325 1.171 . . . . 0.0 110.04 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' HG2' ' CB ' ' A' ' 57' ' ' ALA . 3.2 mt-10 -69.84 -30.03 67.42 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.312 -0.868 . . . . 0.0 109.467 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.678 ' HZ ' HG23 ' B' ' 11' ' ' ILE . 56.8 t80 -65.54 -54.71 24.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.468 -0.77 . . . . 0.0 109.978 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.911 HD12 ' O ' ' A' ' 65' ' ' PHE . 1.3 mp -53.6 -48.75 68.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.383 -0.823 . . . . 0.0 110.066 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -27.99 69.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 110.247 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.668 ' HG3' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -61.88 -60.41 3.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.42 -0.8 . . . . 0.0 111.023 -179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.648 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 41.1 mmm -51.5 -16.51 0.61 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.101 -1.0 . . . . 0.0 111.076 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.73 -9.37 54.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.808 -1.182 . . . . 0.0 110.452 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 9.4 ttt85 -95.78 -42.62 8.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.094 -1.004 . . . . 0.0 111.375 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.614 ' CB ' HG21 ' B' ' 8' ' ' THR . 4.8 mmtp -69.22 -26.24 64.71 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.088 -1.007 . . . . 0.0 111.04 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 72' ' ' MET . 19.8 mmt -65.72 -27.39 68.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.205 -0.934 . . . . 0.0 110.754 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 71.4 1.44 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -0.968 . . . . 0.0 110.168 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 5.3 t70 -144.16 -55.44 0.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.025 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 7.3 t -178.06 33.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.386 -0.821 . . . . 0.0 110.081 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' THR . 1.6 t70 -179.82 71.82 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.372 -0.83 . . . . 0.0 109.823 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 t -83.31 -64.96 1.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.384 -0.823 . . . . 0.0 110.518 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HG2' ' OG1' ' A' ' 146' ' ' THR . 0.2 OUTLIER -85.58 -25.51 26.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.372 -0.83 . . . . 0.0 110.593 -179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.456 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -59.84 -15.37 20.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.05 -1.032 . . . . 0.0 109.919 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' HG2' ' CD2' ' B' ' 12' ' ' LEU . 10.8 tt0 -68.63 -33.83 74.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.497 -0.752 . . . . 0.0 110.561 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.542 ' CD1' ' HB ' ' A' ' 146' ' ' THR . 49.9 mt -60.61 -30.53 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.214 -0.929 . . . . 0.0 109.174 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -63.41 -33.57 75.83 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.737 -0.602 . . . . 0.0 110.21 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.874 ' HB3' HG21 ' B' ' 9' ' ' THR . 1.2 mp0 -73.25 -48.06 37.98 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.105 -0.997 . . . . 0.0 109.901 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -60.83 -27.68 68.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.032 . . . . 0.0 109.948 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.582 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 64.4 t80 -70.21 -49.13 53.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.929 -1.107 . . . . 0.0 108.949 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -52.12 -30.19 25.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.484 -0.76 . . . . 0.0 109.078 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.658 HG12 HG21 ' A' ' 108' ' ' VAL . 40.8 t -69.34 -47.79 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.498 -0.751 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.575 ' HB3' ' CD1' ' A' ' 100' ' ' ILE . 52.2 m-85 -62.4 -43.48 98.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.917 -1.115 . . . . 0.0 110.263 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -68.41 58.03 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 0.0 110.096 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 92' ' ' PHE . 7.2 tttm -40.89 -62.53 0.8 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.393 -0.817 . . . . 0.0 110.515 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 30.2 p-10 -63.64 -41.43 98.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.207 -0.933 . . . . 0.0 110.214 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 100.07 40.36 3.08 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 99' ' ' TYR . 30.6 p-10 -99.08 -21.07 16.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.233 -1.157 . . . . 0.0 110.265 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.56 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 101.36 33.87 4.69 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.56 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 53.3 m-85 -159.22 149.27 19.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.312 -1.111 . . . . 0.0 110.113 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 92' ' ' PHE . 11.5 mt -116.55 153.78 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.125 -0.985 . . . . 0.0 110.543 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 102' ' ' ALA . 12.0 t -145.8 154.18 41.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.437 -0.789 . . . . 0.0 109.76 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.42 -28.81 0.6 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.173 -0.955 . . . . 0.0 110.083 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.5 -51.34 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.803 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 92' ' ' PHE . 21.1 mt-10 -58.77 -35.91 73.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.879 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.026 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -65.16 -41.15 94.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.611 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.457 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 1.5 tpp180 -64.33 -24.13 67.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -79.28 -31.68 43.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.45 -0.781 . . . . 0.0 110.217 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.658 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -85.4 -30.62 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.266 -0.897 . . . . 0.0 109.995 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.689 ' HA ' HD21 ' B' ' 17' ' ' LEU . 5.0 ptp -74.41 -40.9 61.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.525 ' N ' ' HG3' ' A' ' 109' ' ' MET . 93.9 m -71.62 -23.45 61.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.134 -0.979 . . . . 0.0 109.62 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 38' ' ' SER . 22.3 m-20 -84.98 -8.48 58.72 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.194 -0.941 . . . . 0.0 109.848 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.692 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.4 mt -97.78 -38.29 9.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -0.829 . . . . 0.0 110.316 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.74 -26.99 1.18 Allowed Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.586 -1.292 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 109' ' ' MET . 21.1 tt0 -113.56 166.02 11.93 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.887 -1.361 . . . . 0.0 110.826 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -146.12 72.19 1.29 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.493 -0.754 . . . . 0.0 109.234 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 116' ' ' LEU . 2.9 mp -36.47 148.09 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.466 0.65 . . . . 0.0 111.16 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -56.46 -157.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.524 -0.735 . . . . 0.0 110.01 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 117' ' ' THR . 0.3 OUTLIER -95.47 -68.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.03 -1.044 . . . . 0.0 110.312 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -43.5 -46.27 6.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.012 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -59.79 -52.11 66.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.714 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 117' ' ' THR . 83.0 t -60.18 -38.26 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 0.0 110.175 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -66.27 -63.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.0 109.875 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 122' ' ' ASP . 13.3 mm-40 -46.11 -26.57 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.365 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.705 ' HE2' ' CD2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.44 -55.12 17.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.499 -0.751 . . . . 0.0 110.183 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.026 HD11 ' CD1' ' A' ' 105' ' ' LEU . 44.5 mm -62.85 -22.58 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.414 -0.804 . . . . 0.0 110.244 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.408 ' C ' ' HD3' ' A' ' 126' ' ' ARG . 0.1 OUTLIER -81.43 -38.98 25.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.194 -0.941 . . . . 0.0 110.158 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.34 -7.04 33.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.284 -0.885 . . . . 0.0 110.057 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.905 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -112.89 -32.09 6.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.19 -0.944 . . . . 0.0 110.334 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.94 83.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.313 -0.867 . . . . 0.0 110.513 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 128' ' ' ALA . 0.9 OUTLIER -61.67 -28.94 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 0.0 109.461 179.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -85.53 -25.24 26.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.611 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.68 57.59 7.87 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 18.2 p-10 -120.88 -28.15 4.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -1.126 . . . . 0.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.404 ' C ' ' OE1' ' A' ' 135' ' ' GLN . . . 126.37 9.04 4.69 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.154 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.486 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 1.6 pm0 -165.14 166.86 18.73 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.931 -1.335 . . . . 0.0 110.381 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 24.1 t -110.1 168.42 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 110.413 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.466 ' N ' HG12 ' A' ' 136' ' ' VAL . 13.7 t-20 -141.91 173.34 11.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.382 -0.824 . . . . 0.0 109.694 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 139' ' ' GLU . 12.3 t80 -53.31 -56.89 13.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.107 -0.996 . . . . 0.0 109.965 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 2.8 tt0 -44.08 -47.87 8.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -69.51 -57.09 5.66 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.319 -0.863 . . . . 0.0 110.324 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 45.7 t80 -51.96 -19.76 1.99 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.291 -0.881 . . . . 0.0 110.326 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.957 HG13 HG21 ' A' ' 146' ' ' THR . 44.6 t -97.86 -43.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.212 -0.93 . . . . 0.0 110.483 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -65.32 -9.89 28.2 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.041 -1.037 . . . . 0.0 110.146 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.496 ' HE2' ' CD1' ' A' ' 130' ' ' ILE . 2.2 ttm -92.8 -37.96 12.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.669 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.46 -62.17 1.28 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.211 -0.93 . . . . 0.0 111.198 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.957 HG21 HG13 ' A' ' 142' ' ' VAL . 15.2 t -76.53 50.38 0.66 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.151 -0.968 . . . . 0.0 111.151 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.91 51.12 1.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.134 -0.978 . . . . 0.0 109.953 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.276 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.531 ' CG1' ' HD2' ' B' ' 2' ' ' LYS . 8.3 p . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.202 0.525 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.531 ' HD2' ' CG1' ' B' ' 1' ' ' VAL . 0.1 OUTLIER -66.74 111.71 3.85 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.243 -0.911 . . . . 0.0 109.899 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mt -136.05 -62.97 0.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 110.81 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.768 HG23 ' HD2' ' B' ' 5' ' ' PRO . 81.5 mt -140.6 148.82 54.77 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.127 -0.983 . . . . 0.0 110.899 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.768 ' HD2' HG23 ' B' ' 4' ' ' ILE . 49.5 Cg_endo -74.78 -157.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 124.148 1.604 . . . . 0.0 109.403 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.546 ' CB ' ' OG1' ' B' ' 9' ' ' THR . 0.2 OUTLIER -123.47 -175.04 3.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.975 -1.078 . . . . 0.0 110.648 179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 1.007 ' O ' HG22 ' B' ' 10' ' ' VAL . 0.0 OUTLIER -80.35 -79.1 0.15 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.565 -0.709 . . . . 0.0 111.094 -179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.858 ' O ' HD13 ' B' ' 12' ' ' LEU . 6.6 p -45.16 -23.74 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.866 -1.146 . . . . 0.0 110.043 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.874 HG21 ' HB3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -63.46 -60.19 3.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.072 -1.017 . . . . 0.0 109.154 178.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 1.007 HG22 ' O ' ' B' ' 7' ' ' TRP . 32.9 m -48.89 -28.36 2.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.736 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.678 HG23 ' HZ ' ' A' ' 68' ' ' PHE . 6.8 mm -79.77 -33.8 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.858 HD13 ' O ' ' B' ' 8' ' ' THR . 4.2 mp -60.39 -60.96 2.99 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.673 -0.642 . . . . 0.0 109.989 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.576 ' O ' HD13 ' B' ' 17' ' ' LEU . 78.6 t -60.14 -38.88 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -67.53 -21.78 65.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.83 -1.168 . . . . 0.0 110.214 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.44 -36.68 33.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.516 ' HG2' ' HA ' ' B' ' 13' ' ' VAL . 0.2 OUTLIER -75.19 -20.65 59.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.226 -0.921 . . . . 0.0 110.255 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.689 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.3 mp -75.69 1.83 13.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.177 -0.952 . . . . 0.0 110.514 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' B' ' 17' ' ' LEU . 14.2 ttm180 -35.61 -69.71 0.1 Allowed 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.208 0.527 . . . . 0.0 110.782 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' B' ' 20' ' ' ARG . 0.1 OUTLIER -154.0 -69.1 0.14 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.084 -1.01 . . . . 0.0 110.362 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.555 ' HA ' ' HG3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -133.42 12.29 4.15 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 109.841 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 4.5 t -80.84 142.41 33.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.421 -0.799 . . . . 0.0 110.175 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.705 ' CD2' ' HE2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -143.88 -33.8 0.41 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.343 -0.848 . . . . 0.0 110.411 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.486 ' HA2' ' HG2' ' A' ' 144' ' ' MET . . . -64.9 -100.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -112.56 101.66 53.01 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.207 -1.172 . . . . 0.0 110.543 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -78.15 -18.9 12.47 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.126 1.593 . . . . 0.0 110.215 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.648 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 34.9 m-85 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.362 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.255 0.55 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -102.32 -88.53 0.39 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.307 -0.871 . . . . 0.0 110.218 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -74.89 102.44 4.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.226 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.4 mt -65.95 166.65 11.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -0.912 . . . . 0.0 110.219 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.5 p -130.02 9.1 5.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 110.063 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 7' ' ' GLU . 14.6 mt-10 -57.79 -22.0 44.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' GLU . 8.1 pt-20 -42.21 -45.26 4.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.38 -0.825 . . . . 0.0 109.957 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -62.2 -42.4 99.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.905 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.9 mt -66.28 -35.86 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.82 88.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.274 -0.892 . . . . 0.0 109.834 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 33.2 tp10 -64.62 -52.41 57.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.611 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -56.11 -31.19 63.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -37.33 83.33 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.302 -0.874 . . . . 0.0 109.211 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 17.0 mm-40 -58.33 -48.85 79.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 109.438 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.09 -51.56 69.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 109.648 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.613 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 25.4 t80 -52.58 -28.31 20.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -28.1 38.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.422 -0.799 . . . . 0.0 109.885 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.8 tt -63.66 -43.32 97.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.893 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.21 -41.0 50.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.41 -0.806 . . . . 0.0 110.333 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.74 100.03 2.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.039 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -86.13 -29.0 23.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.146 -0.971 . . . . 0.0 110.168 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.5 -33.35 54.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.12 12.49 58.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 29.7 p-10 -83.91 -27.83 28.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -1.177 . . . . 0.0 110.23 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' HG23 ' A' ' 26' ' ' THR . . . 102.99 37.71 3.08 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.551 HG23 ' C ' ' A' ' 25' ' ' GLY . 81.9 p -153.02 113.13 3.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.383 -1.069 . . . . 0.0 110.139 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.687 HD12 ' HB ' ' A' ' 63' ' ' ILE . 30.5 mt -82.83 116.24 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.42 176.27 6.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.6 p -63.41 -35.52 80.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 110.06 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.19 -56.33 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -0.828 . . . . 0.0 110.295 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 30' ' ' LYS . 44.4 mt-10 -43.35 -64.8 0.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.166 -0.959 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.76 -37.15 75.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 109.938 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.77 -42.82 91.89 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 m -62.29 -47.69 83.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -1.17 . . . . 0.0 110.017 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 t -55.69 -29.74 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.688 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -31.57 60.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.916 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.14 -18.01 58.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 110.101 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.7 m -77.3 -51.48 10.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.46 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.71 -18.26 29.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.126 -0.984 . . . . 0.0 110.171 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.25 69.96 0.97 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.497 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 5.3 mm-40 -142.23 -162.74 1.46 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.278 -1.13 . . . . 0.0 109.831 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -159.58 88.46 2.0 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.128 -0.982 . . . . 0.0 110.767 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.46 127.47 13.3 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.095 1.577 . . . . 0.0 110.039 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 46' ' ' ALA . 6.2 t -86.36 30.29 0.71 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.124 -0.985 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 44' ' ' THR . 0.3 OUTLIER 67.05 -57.37 0.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.327 -0.858 . . . . 0.0 110.302 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 44' ' ' THR . . . -51.34 -40.02 58.24 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.324 -0.86 . . . . 0.0 109.927 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.53 -52.42 39.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.698 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.56 -57.52 3.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.407 -0.808 . . . . 0.0 110.064 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.5 mm-40 -55.74 -47.89 76.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.73 -36.65 72.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.456 -0.778 . . . . 0.0 109.759 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 mtp -75.86 -47.03 27.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.433 -0.792 . . . . 0.0 109.534 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.6 mm -66.06 -30.11 48.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.416 -0.802 . . . . 0.0 109.972 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.4 m-80 -72.26 -16.61 61.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.181 -0.95 . . . . 0.0 110.029 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -87.48 -49.35 7.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 110.377 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.784 HG22 ' SD ' ' A' ' 71' ' ' MET . 21.9 t -72.25 -13.74 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.114 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.06 79.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.089 -1.007 . . . . 0.0 110.264 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -63.88 -39.37 94.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.163 -0.96 . . . . 0.0 110.666 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 37.8 p-10 -93.73 -32.12 14.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.16 -0.962 . . . . 0.0 110.793 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 97.61 38.71 4.11 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -99.81 -8.96 23.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -1.13 . . . . 0.0 110.322 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.44 -1.55 82.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' A' ' 26' ' ' THR . 24.4 p -138.76 146.35 41.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -1.201 . . . . 0.0 110.376 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.719 HD12 ' CG1' ' A' ' 55' ' ' VAL . 48.4 mm -77.54 138.38 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.34 -0.85 . . . . 0.0 110.33 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 9.1 t0 -111.43 169.31 8.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 110.792 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 15.9 t80 -55.08 -45.46 99.84 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.35 -0.844 . . . . 0.0 111.41 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.4 Cg_endo -71.12 -46.36 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.233 1.122 . . . . 0.0 110.166 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 71' ' ' MET . 29.3 mt-10 -56.97 -33.77 67.41 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 109.87 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CZ ' HD13 ' B' ' 11' ' ' ILE . 47.1 t80 -67.65 -56.08 10.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.184 -0.948 . . . . 0.0 110.633 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 65' ' ' PHE . 1.2 mp -51.65 -61.5 2.21 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.358 -0.839 . . . . 0.0 110.995 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.5 m -51.92 -58.37 6.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.33 -0.856 . . . . 0.0 111.35 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.784 ' SD ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -43.74 -68.9 0.16 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.164 -0.96 . . . . 0.0 111.372 -178.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.621 ' SD ' HG22 ' B' ' 8' ' ' THR . 7.7 mmm -37.8 -28.16 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.257 -0.902 . . . . 0.0 110.908 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' MET . . . -92.81 -41.46 10.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.092 -1.005 . . . . 0.0 111.271 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -67.21 -19.16 65.51 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.905 -1.122 . . . . 0.0 110.771 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HB3' HG21 ' B' ' 8' ' ' THR . 0.8 OUTLIER -80.3 -36.12 34.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.044 -1.035 . . . . 0.0 110.257 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.9 mtt -84.17 48.32 1.46 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 109.863 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 3.0 mttp -161.23 94.82 1.01 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.597 -0.689 . . . . 0.0 109.405 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.672 ' O ' HG23 ' A' ' 79' ' ' THR . 6.1 m-20 60.76 69.91 0.65 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.609 -0.682 . . . . 0.0 109.918 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -178.7 -54.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.592 -0.692 . . . . 0.0 109.526 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' OD1' ' HG3' ' A' ' 75' ' ' LYS . 9.0 p-10 -176.42 81.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 0.0 110.122 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 1.9 m -100.81 -31.26 11.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.351 -0.843 . . . . 0.0 110.021 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.77 -29.99 19.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.753 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 9.6 tt0 -68.24 -42.87 79.08 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.256 -0.903 . . . . 0.0 109.312 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 81' ' ' SER . 3.2 pt-20 -52.87 -26.98 16.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.513 -0.742 . . . . 0.0 110.246 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.496 HG13 ' HG3' ' A' ' 84' ' ' GLU . 81.6 mt -79.15 -47.94 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.961 -1.087 . . . . 0.0 109.02 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -63.12 -30.54 71.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.361 -0.837 . . . . 0.0 108.804 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' OE1' ' OG1' ' B' ' 9' ' ' THR . 51.7 mt-10 -73.05 -49.48 28.42 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.74 ' HB2' HD13 ' B' ' 12' ' ' LEU . . . -57.14 -36.35 70.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.335 -0.853 . . . . 0.0 109.423 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 7.2 t80 -67.46 -43.99 79.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.937 . . . . 0.0 109.397 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -35.69 50.71 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.434 -0.791 . . . . 0.0 109.236 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.609 HG12 HG21 ' A' ' 108' ' ' VAL . 4.0 t -67.53 -41.52 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.744 ' CE1' HG11 ' A' ' 108' ' ' VAL . 28.5 m-85 -74.19 -33.21 63.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.958 . . . . 0.0 109.957 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.532 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -81.26 58.15 3.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.883 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -39.58 -62.82 0.64 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.58 -0.7 . . . . 0.0 110.492 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 19.2 p-10 -66.47 -38.61 87.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.327 -0.858 . . . . 0.0 110.284 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.66 52.47 3.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -99.15 -13.34 19.81 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.333 -1.098 . . . . 0.0 110.136 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 105.78 20.37 9.47 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 13.9 m-85 -158.35 157.4 32.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -1.083 . . . . 0.0 109.906 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 6.1 mt -120.02 135.28 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.075 -1.015 . . . . 0.0 110.448 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 p -121.06 154.01 36.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.64 -34.05 4.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.31 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.31 96.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.943 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.532 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 23.1 mt-10 -60.95 -47.52 86.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 110.065 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.832 HD12 HD11 ' A' ' 125' ' ' ILE . 1.1 mt -61.5 -35.66 78.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.279 -0.888 . . . . 0.0 109.495 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 109' ' ' MET . 8.2 ttp180 -55.94 -43.02 77.03 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.312 -0.868 . . . . 0.0 109.044 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.66 -57.8 11.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.475 -0.766 . . . . 0.0 109.724 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.744 HG11 ' CE1' ' A' ' 92' ' ' PHE . 2.5 t -60.64 -21.87 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.398 -0.814 . . . . 0.0 109.855 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 1.022 ' HA ' HD21 ' B' ' 17' ' ' LEU . 4.0 mtt -64.32 -65.01 0.73 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.294 -0.879 . . . . 0.0 110.921 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.0 m -63.97 -9.44 15.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.074 -1.016 . . . . 0.0 110.455 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -95.94 -1.57 48.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.107 -0.996 . . . . 0.0 110.782 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.846 ' CD1' HG12 ' B' ' 13' ' ' VAL . 11.9 mt -133.22 -0.19 3.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 111.8 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.97 -90.5 0.13 Allowed Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.113 -1.518 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.419 ' HG2' HD12 ' A' ' 116' ' ' LEU . 1.4 pm0 -116.41 -176.85 3.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -1.063 . . . . 0.0 110.573 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -127.09 17.3 7.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.281 -0.887 . . . . 0.0 110.291 179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.9 HD23 ' HG2' ' A' ' 120' ' ' GLU . 4.7 mp 50.17 174.77 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.674 -0.642 . . . . 0.0 110.287 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -87.85 -166.29 1.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.989 . . . . 0.0 109.873 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.454 ' H ' HG22 ' A' ' 117' ' ' THR . 23.4 t70 -80.84 -51.96 8.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.827 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 2.1 mt-10 -61.08 -41.33 96.44 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.581 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.9 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.3 OUTLIER -62.2 -44.25 97.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.326 -0.859 . . . . 0.0 109.664 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 117' ' ' THR . 39.2 t -62.06 -46.32 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -66.07 -40.13 90.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.706 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 0.6 OUTLIER -64.52 -33.58 76.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.822 . . . . 0.0 109.548 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.606 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 3.0 ttt -64.85 -41.62 95.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.399 -0.813 . . . . 0.0 109.921 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.832 HD11 HD12 ' A' ' 105' ' ' LEU . 14.5 mm -84.45 -17.59 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.005 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -76.03 -39.42 55.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 110.064 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.527 ' N ' ' HD2' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -69.04 -23.5 64.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.166 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.455 ' HA ' ' SD ' ' A' ' 144' ' ' MET . . . -95.86 -24.68 16.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.17 -0.957 . . . . 0.0 110.703 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -72.24 80.6 0.99 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.084 -1.01 . . . . 0.0 110.679 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 mt -82.32 -20.65 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 0.0 109.552 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -94.46 -13.72 25.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.406 -0.809 . . . . 0.0 109.78 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.03 80.93 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -139.36 7.02 2.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.334 -1.098 . . . . 0.0 110.16 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 74.55 14.12 81.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 134' ' ' GLY . 0.9 OUTLIER -164.81 164.58 21.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.316 -1.108 . . . . 0.0 110.187 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 22.9 t -106.45 169.77 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.112 -0.992 . . . . 0.0 109.7 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.469 ' N ' HG12 ' A' ' 136' ' ' VAL . 9.1 t-20 -128.34 179.64 5.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.155 -0.966 . . . . 0.0 110.351 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.577 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 9.1 t80 -62.54 -56.27 19.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.84 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -44.74 -60.36 2.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 110.123 179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 137' ' ' ASN . 53.9 mt-10 -44.63 -46.33 10.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.4 t80 -58.26 -28.9 65.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -0.943 . . . . 0.0 109.994 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 139' ' ' GLU . 9.4 t -100.41 -33.85 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -0.792 . . . . 0.0 110.705 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 2.8 tp60 -73.22 -9.43 58.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.05 -1.031 . . . . 0.0 110.595 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.465 ' O ' ' O ' ' B' ' 23' ' ' GLY . 30.0 mtp -106.55 -18.63 13.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.094 -1.004 . . . . 0.0 110.813 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' B' ' 23' ' ' GLY . 20.7 ttm -99.92 -54.51 2.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.127 -0.983 . . . . 0.0 110.637 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 146' ' ' THR . 10.2 t -155.89 90.19 1.2 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.229 -0.92 . . . . 0.0 110.444 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.24 53.66 0.66 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.281 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.27 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.701 ' O ' HG13 ' B' ' 1' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.197 0.522 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.44 ' HG2' ' C ' ' B' ' 1' ' ' VAL . 1.3 mtmt -131.41 153.65 49.48 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 110.373 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 44.8 mt -110.94 -68.69 0.91 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.476 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.696 HG23 ' HD2' ' B' ' 5' ' ' PRO . 33.6 mm -56.92 149.83 41.95 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.835 . . . . 0.0 109.371 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.696 ' HD2' HG23 ' B' ' 4' ' ' ILE . 39.5 Cg_endo -65.49 -172.47 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.578 1.304 . . . . 0.0 110.856 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.493 ' O ' ' N ' ' B' ' 8' ' ' THR . 57.0 p -119.76 60.54 0.85 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.059 -1.025 . . . . 0.0 111.394 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.626 ' CE2' HG21 ' A' ' 55' ' ' VAL . 1.0 OUTLIER 58.06 -82.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.039 -1.038 . . . . 0.0 110.864 178.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.671 HG23 ' HE1' ' A' ' 71' ' ' MET . 1.0 OUTLIER -46.14 -46.13 17.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.487 ' OG1' ' OE1' ' A' ' 87' ' ' GLU . 22.3 m -46.61 -35.79 6.26 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.227 -0.92 . . . . 0.0 109.914 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.21 -41.41 58.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.477 -0.765 . . . . 0.0 109.547 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.569 HD12 ' HG2' ' A' ' 72' ' ' MET . 12.5 mt -72.26 -20.19 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 109.637 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.74 HD13 ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -72.6 -59.96 2.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.369 -0.832 . . . . 0.0 109.735 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.846 HG12 ' CD1' ' A' ' 112' ' ' LEU . 43.4 t -56.02 -41.7 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.717 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.504 ' HG3' HD13 ' A' ' 18' ' ' LEU . 1.6 tmtm? -62.29 -43.97 97.61 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 120.88 -1.138 . . . . 0.0 109.568 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' B' ' 12' ' ' LEU . 14.5 m -53.0 -35.59 59.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.58 -0.7 . . . . 0.0 110.041 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.531 ' SD ' ' CD1' ' B' ' 22' ' ' PHE . 0.1 OUTLIER -70.67 -34.3 71.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.946 . . . . 0.0 109.951 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 1.022 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.5 mp -71.5 57.2 0.26 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.25 -0.906 . . . . 0.0 110.02 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -114.73 -86.28 0.6 Allowed 'General case' 0 C--N 1.278 -2.507 0 O-C-N 121.406 -0.809 . . . . 0.0 110.679 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' B' ' 20' ' ' ARG . 0.6 OUTLIER -153.77 94.9 1.82 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.791 -1.193 . . . . 0.0 110.53 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' B' ' 19' ' ' LYS . 10.3 tmm_? 64.67 7.0 3.52 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.437 -0.79 . . . . 0.0 110.407 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' B' ' 25' ' ' PRO . 0.1 OUTLIER -69.24 138.27 53.84 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.296 -0.877 . . . . 0.0 110.923 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.606 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -176.29 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.233 -0.917 . . . . 0.0 110.21 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 144' ' ' MET . . . -64.39 -80.87 0.13 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -142.05 75.27 20.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.092 -1.24 . . . . 0.0 110.406 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.482 ' HB3' ' OG ' ' B' ' 21' ' ' SER . 50.6 Cg_endo -79.66 11.7 2.64 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.053 1.554 . . . . 0.0 110.716 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.33 -179.71 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.202 0.525 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.32 106.91 14.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.947 . . . . 0.0 110.329 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -98.66 89.82 4.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.243 -0.911 . . . . 0.0 110.056 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 4' ' ' LEU . 12.4 mt -125.49 129.33 49.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 110.459 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.943 HG22 ' HG2' ' A' ' 7' ' ' GLU . 18.7 m -113.97 105.68 13.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.344 -0.848 . . . . 0.0 110.25 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 7' ' ' GLU . 13.0 pt-20 -65.18 -44.7 87.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.239 -0.913 . . . . 0.0 110.503 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.943 ' HG2' HG22 ' A' ' 5' ' ' THR . 6.9 pt-20 -45.98 -45.98 16.05 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.069 -1.02 . . . . 0.0 109.816 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.71 -53.98 52.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.819 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 mt -56.96 -46.75 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.838 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.69 -45.95 74.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.683 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -42.26 97.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.308 -0.87 . . . . 0.0 109.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -66.54 -43.61 84.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.712 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -60.21 -40.58 90.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.603 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 1.6 mm-40 -61.98 -43.41 98.9 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.219 -0.925 . . . . 0.0 109.556 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.71 -47.48 69.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.881 . . . . 0.0 109.836 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.543 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 75.0 t80 -63.45 -40.42 97.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.613 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.9 t -72.82 -28.04 62.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 0.0 109.52 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.635 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.1 tt -62.97 -41.06 99.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 109.657 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.795 ' HA ' HG21 ' A' ' 35' ' ' VAL . 27.0 m-85 -78.27 -10.88 59.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -0.793 . . . . 0.0 110.76 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 6.5 t0 -102.36 114.88 29.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.037 -1.039 . . . . 0.0 110.321 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.518 ' N ' ' OE2' ' A' ' 31' ' ' GLU . 5.3 tptp -97.52 29.24 3.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.261 -0.9 . . . . 0.0 110.524 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -153.68 -38.85 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.082 -1.011 . . . . 0.0 110.368 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 89.84 47.22 4.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -104.45 2.51 31.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.291 -1.123 . . . . 0.0 110.199 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.844 ' O ' HG23 ' A' ' 26' ' ' THR . . . 73.36 33.82 58.35 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -169.25 120.58 0.72 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.269 -1.136 . . . . 0.0 110.222 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.647 HD12 ' HB ' ' A' ' 63' ' ' ILE . 28.7 mt -97.56 124.47 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.172 -0.955 . . . . 0.0 110.189 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -84.68 -171.56 3.7 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.389 -0.819 . . . . 0.0 110.206 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.486 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -78.0 -34.09 50.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.882 . . . . 0.0 109.937 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -48.83 19.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.289 -0.882 . . . . 0.0 110.042 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 21' ' ' LYS . 43.2 tt0 -45.33 -59.76 2.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.91 . . . . 0.0 109.608 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.735 HD13 ' CH2' ' B' ' 7' ' ' TRP . 10.8 tp -60.76 -34.95 75.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.36 -0.838 . . . . 0.0 109.535 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.06 86.7 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.5 m -65.9 -51.07 61.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.344 -1.092 . . . . 0.0 109.543 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.795 HG21 ' HA ' ' A' ' 19' ' ' PHE . 48.9 t -52.54 -41.99 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.206 -0.934 . . . . 0.0 109.452 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.528 ' HE1' ' CE ' ' A' ' 51' ' ' MET . 4.8 mtt -64.74 -37.54 87.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.38 -0.825 . . . . 0.0 109.42 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -30.8 68.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 110.159 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.5 m -61.54 -34.01 74.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.259 -0.9 . . . . 0.0 110.446 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mt -82.39 -3.11 54.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 110.224 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 86.57 86.07 1.07 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 0.8 OUTLIER -167.14 175.06 7.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -1.143 . . . . 0.0 110.143 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 11.7 p30 -139.63 84.31 15.96 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 0.0 110.291 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 44.0 Cg_endo -70.46 105.48 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.055 1.555 . . . . 0.0 110.496 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.449 ' HB ' ' OE2' ' A' ' 47' ' ' GLU . 8.9 m -61.18 150.82 33.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 110.058 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -49.43 -51.49 35.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.072 -1.018 . . . . 0.0 110.225 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.62 88.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.356 -0.84 . . . . 0.0 110.205 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -65.06 -50.98 64.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.0 110.211 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -50.33 -48.88 55.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -57.7 -36.81 72.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -0.875 . . . . 0.0 109.733 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 47' ' ' GLU . 5.5 m-20 -65.85 -46.98 76.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 109.949 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.57 ' HG3' HD12 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -67.93 -36.68 80.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.945 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 52' ' ' ILE . 5.5 mm -65.63 -26.66 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 109.732 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.39 -9.15 58.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.306 -0.871 . . . . 0.0 110.046 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -75.3 -22.53 57.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 110.124 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 57' ' ' ALA . 12.1 t -113.8 -48.42 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.187 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 55' ' ' VAL . 13.8 t0 -42.26 89.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.695 -0.628 . . . . 0.0 110.478 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -93.12 -9.56 39.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.404 -0.81 . . . . 0.0 110.637 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -78.24 -31.58 49.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.055 -1.028 . . . . 0.0 110.421 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.82 -16.28 18.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 3.5 p30 -77.58 -93.72 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.321 -1.105 . . . . 0.0 110.106 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 165.7 46.0 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.451 ' HB ' HG22 ' A' ' 26' ' ' THR . 2.8 p -143.28 141.8 31.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.289 -1.124 . . . . 0.0 110.204 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.647 ' HB ' HD12 ' A' ' 27' ' ' ILE . 11.9 mm -92.09 129.42 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.26 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.543 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 9.5 t0 -117.18 179.9 3.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.723 ' O ' HD12 ' A' ' 69' ' ' LEU . 17.1 t80 -67.15 -43.14 44.3 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 0.0 111.307 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.3 Cg_endo -71.77 -35.54 7.45 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.348 1.183 . . . . 0.0 110.25 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.9 -28.44 67.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.107 -0.996 . . . . 0.0 109.141 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' HZ ' HD12 ' B' ' 11' ' ' ILE . 18.8 t80 -69.77 -53.24 19.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.602 -0.686 . . . . 0.0 110.317 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 65' ' ' PHE . 1.5 mt -67.89 -17.66 64.55 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.284 -0.885 . . . . 0.0 110.513 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 m -78.29 -42.52 30.67 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.125 -0.984 . . . . 0.0 110.617 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -72.66 -42.22 64.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.149 -0.97 . . . . 0.0 110.572 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 76' ' ' MET . 0.0 OUTLIER -64.2 -9.46 17.17 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.487 -0.758 . . . . 0.0 111.231 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.31 -19.27 17.14 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.012 -1.055 . . . . 0.0 111.379 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.63 -20.85 15.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.979 -1.076 . . . . 0.0 111.02 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER -99.45 29.39 4.04 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.009 -1.057 . . . . 0.0 110.5 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 72' ' ' MET . 2.6 mmt -100.67 -42.41 6.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.202 -0.937 . . . . 0.0 110.709 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -119.64 71.96 0.9 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.125 -0.984 . . . . 0.0 110.523 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.12 -84.85 0.55 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 0.0 109.96 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 81' ' ' SER . 48.1 m -161.5 -54.72 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.467 -0.771 . . . . 0.0 109.845 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -65.48 80.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.756 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 79' ' ' THR . 4.2 t -94.79 -37.85 11.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.354 -0.841 . . . . 0.0 110.275 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.57 -25.74 35.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.859 . . . . 0.0 109.943 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.69 -15.61 59.75 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.888 . . . . 0.0 109.982 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.716 ' CG ' HD11 ' B' ' 12' ' ' LEU . 19.5 tt0 -81.83 -38.34 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 109.968 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.546 HG23 ' CE1' ' A' ' 141' ' ' PHE . 16.7 mt -67.49 -33.83 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.232 -0.917 . . . . 0.0 109.081 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -60.17 -27.19 66.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.563 -0.71 . . . . 0.0 109.091 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.512 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 1.2 mt-10 -74.76 -56.71 4.5 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.466 -0.771 . . . . 0.0 109.231 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.43 -28.85 67.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 109.567 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.439 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 15.9 t80 -69.65 -47.87 61.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.02 -1.05 . . . . 0.0 108.968 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.4 tpp85 -47.53 -36.47 10.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.496 -0.752 . . . . 0.0 109.019 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.757 HG12 HG21 ' A' ' 108' ' ' VAL . 54.5 t -74.2 -33.56 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.535 -0.728 . . . . 0.0 110.285 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.563 ' CE2' HG22 ' B' ' 13' ' ' VAL . 16.1 m-85 -80.35 -31.29 37.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.128 -0.982 . . . . 0.0 110.287 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 96' ' ' GLY . 10.9 t0 -100.04 62.83 1.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.209 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -43.17 -33.01 0.82 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.78 -31.93 61.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.385 -0.822 . . . . 0.0 109.655 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 69.37 13.61 68.02 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 23.6 p-10 -69.45 -38.84 77.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -1.12 . . . . 0.0 110.324 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 139.19 -30.27 2.46 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 33.9 m-85 -107.29 156.78 18.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -1.127 . . . . 0.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' A' ' 92' ' ' PHE . 11.4 mt -124.13 145.52 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.897 . . . . 0.0 110.018 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -124.96 147.78 48.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.168 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.29 -31.1 0.93 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.665 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.79 -47.08 79.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.359 -0.838 . . . . 0.0 109.395 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 10.0 mt-10 -54.99 -50.07 69.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.199 -0.938 . . . . 0.0 109.261 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.523 ' O ' ' CG ' ' A' ' 109' ' ' MET . 1.6 mm? -57.39 -52.79 63.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.328 -0.857 . . . . 0.0 109.185 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -45.96 -26.67 0.75 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.421 -0.8 . . . . 0.0 109.453 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.411 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -80.89 -34.59 33.43 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.373 -0.829 . . . . 0.0 110.21 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.757 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -89.57 -27.55 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 109.946 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.949 ' HA ' HD21 ' B' ' 17' ' ' LEU . 2.4 mmm -63.5 -49.5 73.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 110.659 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 m -77.82 -17.24 57.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.0 110.58 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 2.0 m120 -85.81 -3.39 58.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.089 -1.007 . . . . 0.0 109.968 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.893 ' CD1' HG12 ' B' ' 13' ' ' VAL . 5.4 mt -102.19 -42.75 5.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 110.426 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 162.67 -36.55 0.34 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.465 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 1.7 tp10 -109.7 147.0 33.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.991 -1.299 . . . . 0.0 110.828 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.514 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -119.93 74.68 1.04 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.547 -0.72 . . . . 0.0 109.282 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.634 HD23 ' O ' ' B' ' 19' ' ' LYS . 6.8 mp -38.46 160.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.687 -0.633 . . . . 0.0 110.709 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -60.69 -146.42 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.435 -0.791 . . . . 0.0 109.366 179.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.476 ' H ' HG22 ' A' ' 117' ' ' THR . 8.1 m-20 -122.3 -60.28 1.57 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.238 -0.914 . . . . 0.0 109.929 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.65 -35.65 63.72 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 9.7 mm-40 -67.31 -56.11 11.12 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.295 -0.878 . . . . 0.0 109.08 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.461 ' O ' ' HB3' ' A' ' 124' ' ' MET . 87.4 t -43.66 -36.36 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 121.361 -0.837 . . . . 0.0 109.606 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.51 -51.86 52.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -58.25 -32.49 68.41 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.403 -0.811 . . . . 0.0 109.113 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.518 ' HE3' ' O ' ' B' ' 21' ' ' SER . 11.0 ttt -59.49 -44.75 93.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.495 -0.753 . . . . 0.0 109.636 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.498 HG23 HG23 ' A' ' 136' ' ' VAL . 20.3 mm -71.72 -31.61 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 109.714 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 45.8 ttt85 -62.62 -42.76 99.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.289 -0.882 . . . . 0.0 109.98 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.9 -37.52 63.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.77 -25.83 27.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 0.0 110.142 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 134' ' ' GLY . 2.6 m-20 -57.64 99.54 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.859 . . . . 0.0 110.483 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 35.3 mm -74.79 -39.13 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.244 -0.91 . . . . 0.0 109.886 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 8.0 p-10 -90.4 -17.57 27.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.34 -0.85 . . . . 0.0 109.984 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.95 55.98 3.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 6.4 p30 -113.04 0.66 15.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.335 -1.097 . . . . 0.0 110.23 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.503 ' N ' ' OD2' ' A' ' 129' ' ' ASP . . . 76.16 8.53 85.3 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -142.66 147.46 35.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.192 -1.181 . . . . 0.0 110.406 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.498 HG23 HG23 ' A' ' 125' ' ' ILE . 39.7 t -100.9 152.0 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.34 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.564 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 62.5 t30 -122.65 158.47 29.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.324 -0.86 . . . . 0.0 110.12 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -45.8 -54.95 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.77 -41.02 56.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.301 -0.875 . . . . 0.0 109.916 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 144' ' ' MET . 9.2 mt-10 -70.87 -47.31 59.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.379 -0.826 . . . . 0.0 110.021 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.546 ' CE1' HG23 ' A' ' 85' ' ' ILE . 47.5 t80 -60.79 -17.95 52.38 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.299 -0.875 . . . . 0.0 109.968 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.43 ' O ' HG22 ' A' ' 146' ' ' THR . 46.9 t -100.19 -47.75 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.456 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.912 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 17.7 tp60 -61.89 -26.86 68.42 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.172 -0.955 . . . . 0.0 110.23 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 17.8 mmm -82.62 -18.32 41.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.551 ' CE ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -99.33 -56.86 2.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 146' ' ' THR . 6.8 t -105.1 63.48 0.7 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.226 -0.921 . . . . 0.0 110.274 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.912 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -96.15 30.32 2.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.218 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 147' ' ' ALA . 1.9 tptp . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.151 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.656 ' O ' HG13 ' B' ' 1' ' ' VAL . 14.7 p . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.626 ' C ' HD12 ' B' ' 3' ' ' LEU . 9.5 ttpt -141.0 140.56 34.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.873 . . . . 0.0 110.238 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.626 HD12 ' C ' ' B' ' 2' ' ' LYS . 5.1 mp -145.59 -48.54 0.22 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.972 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.57 HD12 ' HG3' ' A' ' 51' ' ' MET . 11.0 pt -43.17 155.29 0.29 Allowed Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.281 -0.887 . . . . 0.0 110.746 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.36 153.16 50.35 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.09 1.574 . . . . 0.0 110.013 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.501 ' O ' ' HB ' ' B' ' 9' ' ' THR . 8.6 m -71.19 142.05 50.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.944 ' O ' HG22 ' B' ' 10' ' ' VAL . 6.8 m95 -36.29 -66.01 0.24 Allowed 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.764 0.793 . . . . 0.0 110.555 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.536 HG21 ' HG2' ' A' ' 75' ' ' LYS . 10.8 p -45.38 -23.65 0.22 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.464 -0.773 . . . . 0.0 111.043 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.512 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 91.5 m -70.41 -56.65 6.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.886 -1.134 . . . . 0.0 109.87 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.944 HG22 ' O ' ' B' ' 7' ' ' TRP . 32.7 m -53.16 -27.4 13.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.281 -0.887 . . . . 0.0 109.193 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.501 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 26.0 mm -75.46 -30.57 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.447 -0.783 . . . . 0.0 109.61 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.716 HD11 ' CG ' ' A' ' 84' ' ' GLU . 9.9 mt -65.91 -60.47 2.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 110.034 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.893 HG12 ' CD1' ' A' ' 112' ' ' LEU . 41.1 t -52.95 -39.01 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.626 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -64.74 -47.62 77.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.963 -1.085 . . . . 0.0 109.226 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 50.2 m -50.97 -31.27 17.38 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.403 -0.811 . . . . 0.0 109.738 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mmt -79.87 -27.18 40.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.354 -0.841 . . . . 0.0 109.956 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.949 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.9 mp -80.04 54.47 1.92 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.344 -0.848 . . . . 0.0 109.88 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -72.58 0.57 Allowed 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.679 -0.638 . . . . 0.0 110.355 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.634 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -150.3 -60.28 0.19 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.944 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.561 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -156.64 17.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 110.208 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.518 ' O ' ' HE3' ' A' ' 124' ' ' MET . 0.3 OUTLIER -93.04 -162.1 0.9 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.217 -0.927 . . . . 0.0 110.42 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.445 ' CE2' ' HE2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -174.21 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.231 -0.918 . . . . 0.0 110.523 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.09 -155.76 22.69 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.551 ' CB ' ' CE ' ' A' ' 145' ' ' MET . 3.3 m-20 -178.96 117.07 0.23 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 110.206 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.04 52.61 3.5 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.935 1.492 . . . . 0.0 110.397 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.456 ' CD2' ' HE2' ' A' ' 76' ' ' MET . 4.8 m-85 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.251 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.263 0.554 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.44 168.33 19.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.208 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.16 132.97 45.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -0.891 . . . . 0.0 110.37 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mt -77.94 122.57 25.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.263 -0.898 . . . . 0.0 110.177 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 47.84 85.95 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.214 -0.929 . . . . 0.0 110.251 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -100.31 -24.16 14.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.307 -0.871 . . . . 0.0 110.237 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 8' ' ' GLN . 7.0 pt-20 -58.03 -34.6 70.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 109.953 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.536 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -70.2 -34.87 73.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.246 -0.908 . . . . 0.0 109.36 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 98.5 mt -75.2 -34.98 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.366 -0.834 . . . . 0.0 109.712 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.22 -62.46 1.85 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 109.654 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 12' ' ' PHE . 11.4 pt-20 -56.94 -38.23 72.63 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.162 -0.961 . . . . 0.0 109.058 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.688 ' CD2' ' CZ ' ' A' ' 68' ' ' PHE . 1.8 m-85 -57.91 -45.66 86.14 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.358 -0.839 . . . . 0.0 109.019 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -41.33 66.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 109.18 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -53.36 -49.21 67.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.713 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' B' ' 14' ' ' LYS . . . -59.28 -52.85 63.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 109.783 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 2.3 t80 -60.59 -35.6 76.49 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.614 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -67.06 -28.22 68.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.509 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.844 HD11 ' O ' ' A' ' 112' ' ' LEU . 8.4 tt -68.7 -41.81 78.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.499 -0.751 . . . . 0.0 109.881 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -74.28 -57.88 3.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -64.97 129.93 41.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.375 -0.828 . . . . 0.0 110.54 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.78 -48.5 5.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.246 -0.909 . . . . 0.0 110.157 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.2 p-10 -75.04 -35.05 61.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.78 42.34 5.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 34.8 p-10 -90.76 -28.12 18.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -1.156 . . . . 0.0 110.057 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.712 ' O ' HG23 ' A' ' 26' ' ' THR . . . 112.74 31.0 2.64 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 25' ' ' GLY . 11.1 p -159.73 125.24 4.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -1.135 . . . . 0.0 110.533 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.699 HD12 ' HB ' ' A' ' 63' ' ' ILE . 17.9 mt -91.97 119.22 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.21 -0.931 . . . . 0.0 109.999 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.6 p -100.17 172.91 6.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.92 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.436 HG21 HE22 ' A' ' 49' ' ' GLN . 3.6 p -64.43 -18.24 64.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.13 -0.981 . . . . 0.0 109.899 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -49.76 17.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.395 -0.816 . . . . 0.0 110.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.64 ' O ' HG23 ' A' ' 35' ' ' VAL . 20.9 mt-10 -67.21 -50.37 61.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 110.365 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.737 HD22 ' CD1' ' A' ' 52' ' ' ILE . 13.1 tp -59.75 -51.47 69.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.287 -0.883 . . . . 0.0 110.347 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.14 -49.35 24.68 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.8 m -56.26 -47.4 78.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.229 -1.159 . . . . 0.0 110.576 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 31' ' ' GLU . 11.4 t -62.77 -45.26 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 0.0 110.293 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.538 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 16.2 mmm -64.24 -39.64 94.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 110.405 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.94 -15.91 61.55 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.099 -1.001 . . . . 0.0 110.237 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 39' ' ' LEU . 32.2 t -75.0 -46.05 37.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.292 -0.88 . . . . 0.0 111.058 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 38' ' ' SER . 1.9 mt -45.76 -27.31 0.8 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.914 -1.116 . . . . 0.0 109.823 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.93 -32.34 2.9 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.08 -178.59 2.46 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.135 -1.215 . . . . 0.0 110.684 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -131.07 93.88 29.35 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.252 -0.905 . . . . 0.0 110.317 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.579 ' HB3' HD13 ' B' ' 4' ' ' ILE . 45.4 Cg_endo -73.16 115.97 4.54 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.004 1.529 . . . . 0.0 110.302 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.23 164.94 23.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 110.239 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 42.9 mt-10 -61.07 -42.23 98.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.276 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.12 74.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.208 -0.933 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 51' ' ' MET . 4.6 mm-40 -66.65 -32.92 74.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 110.042 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 48' ' ' LEU . 13.0 mt -60.37 -52.16 66.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 0.0 110.123 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -62.91 -42.39 99.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 110.107 179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -68.89 -15.41 63.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 110.012 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.509 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 1.2 mtp -86.9 -42.94 12.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.14 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.737 ' CD1' HD22 ' A' ' 32' ' ' LEU . 1.1 mp -80.27 -11.15 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.078 -1.014 . . . . 0.0 109.731 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -83.43 -18.58 38.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 110.856 -179.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.6 ' HG3' HG23 ' A' ' 55' ' ' VAL . 21.8 pt-20 -94.48 -18.93 21.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.036 -1.04 . . . . 0.0 110.988 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.685 HG21 ' CD1' ' B' ' 7' ' ' TRP . 50.6 t -99.1 -31.57 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.95 -1.094 . . . . 0.0 110.061 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -47.16 89.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.539 -0.726 . . . . 0.0 110.539 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.12 -49.63 71.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.451 -0.781 . . . . 0.0 110.172 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 14.8 p-10 -75.69 -37.91 59.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.26 -0.9 . . . . 0.0 110.063 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.42 45.78 2.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 36.0 p-10 -98.5 -38.72 9.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.274 -1.133 . . . . 0.0 110.141 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 127.6 -8.09 6.95 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p -135.79 148.52 48.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.216 -1.167 . . . . 0.0 110.189 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.699 ' HB ' HD12 ' A' ' 27' ' ' ILE . 31.8 mm -82.14 140.06 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.122 -0.986 . . . . 0.0 109.91 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.45 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -114.46 157.66 22.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.066 -1.021 . . . . 0.0 110.797 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.598 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 52.8 t80 -48.9 -50.34 62.41 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.443 -0.786 . . . . 0.0 111.187 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.9 Cg_endo -64.39 -32.27 60.87 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.258 1.136 . . . . 0.0 110.344 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 71' ' ' MET . 7.1 tt0 -59.97 -35.46 75.02 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.124 -0.985 . . . . 0.0 109.291 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.688 ' CZ ' ' CD2' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -76.98 -48.78 17.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.9 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.1 mm? -43.09 -45.28 5.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 110.625 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.31 -37.44 14.91 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.073 -1.017 . . . . 0.0 110.762 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -44.04 -38.91 3.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.191 -0.943 . . . . 0.0 110.72 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.655 ' HE2' ' CE1' ' B' ' 26' ' ' PHE . 5.7 tpt -74.65 -9.76 58.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.136 -0.977 . . . . 0.0 110.542 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.4 -10.83 19.88 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.248 -0.908 . . . . 0.0 110.579 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -99.61 -49.64 4.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.067 -1.021 . . . . 0.0 110.407 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.686 ' CB ' HG21 ' B' ' 8' ' ' THR . 20.2 mmtt -46.45 -36.88 7.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.904 . . . . 0.0 110.504 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.5 mtm -94.07 58.57 2.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.23 -0.919 . . . . 0.0 110.473 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 42.8 tttm -154.67 81.89 1.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 110.128 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER 66.94 54.18 0.79 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 110.252 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 78' ' ' ASP . 4.3 m -165.31 -68.75 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.204 -0.935 . . . . 0.0 110.411 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.491 ' HB3' ' CG ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -129.03 93.71 3.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.172 -0.955 . . . . 0.0 110.33 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.7 t -100.64 -54.73 2.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.204 -0.935 . . . . 0.0 110.365 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.59 -9.82 21.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 0.0 110.763 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -79.66 -17.04 54.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.044 -1.035 . . . . 0.0 110.409 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' CG ' ' HB3' ' A' ' 80' ' ' ASP . 16.0 mt-10 -81.26 -22.71 38.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.026 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.465 HG23 ' HE1' ' A' ' 141' ' ' PHE . 59.8 mt -79.09 -44.14 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.859 . . . . 0.0 110.039 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.474 ' CD ' ' OH ' ' A' ' 138' ' ' TYR . 5.4 ttp180 -55.55 -34.94 65.16 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.529 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 1.061 ' HB3' HG21 ' B' ' 9' ' ' THR . 14.1 mt-10 -71.16 -47.55 57.02 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.437 -0.789 . . . . 0.0 109.893 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.55 ' HB2' HD22 ' B' ' 12' ' ' LEU . . . -64.92 -29.05 69.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.041 -1.037 . . . . 0.0 109.828 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.01 -39.37 83.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 109.511 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -67.44 -37.95 83.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.39 -0.819 . . . . 0.0 109.503 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.635 HG12 HG21 ' A' ' 108' ' ' VAL . 11.7 t -58.51 -44.62 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.414 -0.804 . . . . 0.0 109.704 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.42 ' CE1' HG11 ' A' ' 108' ' ' VAL . 20.4 m-85 -66.47 -30.58 70.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.613 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 94' ' ' LYS . 11.6 t0 -91.42 58.47 3.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.406 -0.809 . . . . 0.0 110.092 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 93' ' ' ASP . 2.3 mmmm -43.46 -32.3 0.86 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -0.962 . . . . 0.0 110.142 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.0 p30 -83.44 -34.13 25.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.181 -0.949 . . . . 0.0 110.109 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 81.39 42.41 9.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 38.2 p30 -100.07 -17.72 17.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -1.197 . . . . 0.0 110.167 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 102.59 27.96 6.53 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 94.4 m-85 -156.95 146.65 20.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -1.08 . . . . 0.0 110.004 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 80.3 mt -119.74 111.98 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.16 -0.963 . . . . 0.0 110.411 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 37.4 t -95.89 149.18 21.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.22 -31.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.168 -0.958 . . . . 0.0 109.947 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.56 -51.62 64.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.855 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 93' ' ' ASP . 28.3 mt-10 -53.39 -38.89 63.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.67 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.997 HD12 HD11 ' A' ' 125' ' ' ILE . 1.2 mt -59.85 -44.57 94.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.376 -0.827 . . . . 0.0 109.711 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.518 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.0 OUTLIER -65.8 -20.78 66.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 109.619 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -81.77 -32.56 31.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.422 -0.799 . . . . 0.0 109.847 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.635 HG21 HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -83.17 -34.14 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.93 . . . . 0.0 109.789 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.902 ' HA ' HD21 ' B' ' 17' ' ' LEU . 11.2 ptp -79.42 -35.85 39.93 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.155 -0.965 . . . . 0.0 109.561 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.476 ' N ' ' HG3' ' A' ' 109' ' ' MET . 19.6 m -68.97 -30.52 68.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 108.802 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -85.91 -19.53 30.38 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.433 -0.792 . . . . 0.0 108.97 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.844 ' O ' HD11 ' A' ' 18' ' ' LEU . 9.5 mt -84.46 -32.38 24.06 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.535 -0.728 . . . . 0.0 110.122 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 138.98 -39.87 1.51 Allowed Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.495 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 109' ' ' MET . 2.1 tt0 -94.23 157.59 15.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.995 -1.297 . . . . 0.0 110.709 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 116' ' ' LEU . 1.8 pttt -135.86 73.21 1.46 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.565 -0.709 . . . . 0.0 109.205 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.651 HD21 ' O ' ' B' ' 17' ' ' LEU . 3.3 mp -38.79 145.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.593 -0.692 . . . . 0.0 110.794 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -56.47 -156.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 110.387 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -97.75 -48.82 5.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.224 -0.922 . . . . 0.0 110.149 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -65.31 -33.05 75.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.047 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.524 ' CG ' ' HB3' ' B' ' 20' ' ' ARG . 2.5 tt0 -66.16 -47.25 74.64 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.61 0.719 . . . . 0.0 109.33 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 116' ' ' LEU . 19.0 t -65.0 -42.15 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.519 -0.738 . . . . 0.0 110.387 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -62.99 -65.14 0.73 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.952 . . . . 0.0 109.827 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 122' ' ' ASP . 2.0 mm-40 -44.42 -30.19 0.81 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.381 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.544 ' HE2' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -62.91 -61.75 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 110.205 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.997 HD11 HD12 ' A' ' 105' ' ' LEU . 30.3 mm -59.55 -39.02 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 127' ' ' GLU . 2.8 mtt180 -60.09 -53.2 60.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.859 . . . . 0.0 110.355 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -43.3 -32.65 0.83 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.94 -26.93 13.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 110.146 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.3 OUTLIER -71.49 64.65 0.43 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.3 -0.875 . . . . 0.0 110.352 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.8 mt -63.15 -32.01 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 21.0 p-10 -77.01 -28.83 55.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.248 -0.907 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.85 64.74 1.99 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 20.4 p-10 -114.43 -23.0 9.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -1.135 . . . . 0.0 110.185 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 115.5 -6.7 20.67 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 99' ' ' TYR . 3.3 pt20 -158.38 163.17 37.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.29 -1.124 . . . . 0.0 110.022 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 137' ' ' ASN . 61.6 t -90.76 168.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.192 -0.942 . . . . 0.0 110.649 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.524 ' N ' HG12 ' A' ' 136' ' ' VAL . 15.4 t-20 -133.06 177.35 7.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.481 -0.762 . . . . 0.0 109.976 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.474 ' OH ' ' CD ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -56.05 -69.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.152 -0.967 . . . . 0.0 110.771 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 17.2 pt-20 -43.36 -39.08 2.99 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.146 -0.971 . . . . 0.0 110.692 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 139' ' ' GLU . 57.6 mt-10 -66.5 -60.21 2.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.168 -0.957 . . . . 0.0 110.211 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.465 ' HE1' HG23 ' A' ' 85' ' ' ILE . 26.6 t80 -46.98 -22.23 0.3 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.231 -0.918 . . . . 0.0 110.35 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.29 -44.01 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 0.0 110.753 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -56.44 -18.19 10.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.179 -0.95 . . . . 0.0 110.631 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.2 mmm -112.58 -10.15 13.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.151 -0.968 . . . . 0.0 110.263 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.451 ' HG2' HG12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -98.17 -9.58 25.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.938 . . . . 0.0 110.211 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p -90.95 -55.23 3.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.259 -0.901 . . . . 0.0 110.35 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 148' ' ' LYS . . . -90.18 57.49 3.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.37 -0.831 . . . . 0.0 110.341 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.259 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.601 HG23 ' HG2' ' B' ' 2' ' ' LYS . 3.1 m . . . . . 0 N--CA 1.5 2.053 0 CA-C-O 121.01 0.433 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.601 ' HG2' HG23 ' B' ' 1' ' ' VAL . 0.0 OUTLIER -146.68 31.17 0.97 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.947 -1.095 . . . . 0.0 110.237 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' B' ' 4' ' ' ILE . 0.3 OUTLIER -113.96 -6.27 13.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.844 . . . . 0.0 109.467 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.597 ' CG1' ' HD2' ' B' ' 5' ' ' PRO . 1.0 OUTLIER -38.92 156.0 0.13 Allowed Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.592 -0.693 . . . . 0.0 109.933 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.597 ' HD2' ' CG1' ' B' ' 4' ' ' ILE . 38.1 Cg_endo -64.24 151.55 84.95 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.528 1.278 . . . . 0.0 110.473 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.444 ' O ' ' CE ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -74.65 -52.36 11.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.482 -0.761 . . . . 0.0 111.759 -178.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.685 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -172.04 -76.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.82 -1.175 . . . . 0.0 110.754 -178.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.686 HG21 ' CB ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -46.11 -48.06 17.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 0.0 109.677 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 1.061 HG21 ' HB3' ' A' ' 87' ' ' GLU . 4.8 m -44.65 -51.65 8.94 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.391 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.415 HG21 ' HE1' ' A' ' 36' ' ' MET . 35.2 t -51.36 -43.08 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.263 -0.898 . . . . 0.0 108.958 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.504 HG21 ' SD ' ' A' ' 72' ' ' MET . 15.5 mm -66.36 -27.5 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.139 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -63.9 -58.71 5.94 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.623 -0.673 . . . . 0.0 109.964 179.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.868 ' O ' HD13 ' B' ' 17' ' ' LEU . 54.3 t -60.39 -39.22 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.936 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.641 ' CG ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -62.12 -61.29 2.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.087 -1.008 . . . . 0.0 109.722 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 74.5 m -60.74 -18.88 57.3 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.43 -0.794 . . . . 0.0 109.875 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.514 ' O ' ' CG ' ' B' ' 19' ' ' LYS . 6.2 ttt -80.1 -18.45 49.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.902 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.2 mp -73.76 -50.32 21.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.248 -0.907 . . . . 0.0 110.58 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.462 ' O ' ' CG ' ' B' ' 18' ' ' ARG . 0.6 OUTLIER -65.44 60.21 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.605 -0.684 . . . . 0.0 110.4 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' B' ' 16' ' ' MET . 0.0 OUTLIER -179.98 120.54 0.06 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.524 ' HB3' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -73.01 20.53 0.08 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.662 -0.649 . . . . 0.0 112.086 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.544 ' O ' ' HE2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -128.64 175.67 8.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.934 -1.104 . . . . 0.0 109.76 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.425 ' CD1' ' HE2' ' A' ' 124' ' ' MET . 0.6 OUTLIER -112.12 177.88 4.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.023 -1.048 . . . . 0.0 110.069 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.52 140.73 0.06 OUTLIER Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.502 ' ND2' ' HD2' ' B' ' 25' ' ' PRO . 0.4 OUTLIER -121.88 140.15 31.51 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.26 . . . . 0.0 110.948 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.502 ' HD2' ' ND2' ' B' ' 24' ' ' ASN . 44.3 Cg_endo -72.25 55.99 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.046 1.551 . . . . 0.0 109.655 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.655 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 1.4 m-85 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.924 -1.036 . . . . 0.0 110.286 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.212 0.53 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 18.4 p-10 -115.84 43.9 2.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.245 -0.909 . . . . 0.0 110.27 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -99.97 66.52 1.36 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.285 -0.884 . . . . 0.0 110.078 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 57.2 mt -142.44 109.97 5.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.952 . . . . 0.0 110.218 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.17 -160.54 0.74 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.306 -0.872 . . . . 0.0 110.198 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -73.66 -21.9 60.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.15 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.618 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -66.43 -68.83 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.056 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -45.23 -54.1 7.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 109.67 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.1 mt -50.93 -42.34 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.202 -0.937 . . . . 0.0 109.381 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -50.6 -45.32 57.33 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.358 -0.839 . . . . 0.0 109.266 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -57.3 -48.47 78.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.33 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -53.86 -46.24 71.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.307 -0.871 . . . . 0.0 109.379 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -57.81 -46.37 84.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.883 . . . . 0.0 109.289 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -60.09 -44.9 94.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.3 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB3' ' HE2' ' A' ' 68' ' ' PHE . . . -60.76 -45.17 95.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.383 -0.823 . . . . 0.0 109.557 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.515 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 7.2 t80 -62.97 -22.27 66.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.942 . . . . 0.0 109.074 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.51 -47.68 9.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.522 -0.736 . . . . 0.0 109.588 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.858 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.2 tt -47.66 -41.12 21.61 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.321 -0.862 . . . . 0.0 109.504 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 31' ' ' GLU . 41.0 m-85 -79.89 -46.16 17.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 0.0 109.884 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.503 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 39.5 t0 -80.46 101.94 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.451 -0.78 . . . . 0.0 110.154 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 4.32 51.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.29 -0.881 . . . . 0.0 110.431 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -97.08 -37.8 10.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.149 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.33 27.95 10.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 10.3 p30 -102.67 -17.03 15.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -1.169 . . . . 0.0 110.195 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 91.07 22.55 32.37 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 14.1 p -138.3 122.72 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.216 -1.167 . . . . 0.0 110.468 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.5 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 13.4 mt -89.3 114.63 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.124 -0.985 . . . . 0.0 110.137 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -93.46 155.73 17.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.714 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.567 ' O ' HD13 ' A' ' 48' ' ' LEU . 32.0 p -54.9 -22.71 15.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 110.039 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -43.62 63.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.88 . . . . 0.0 109.972 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.503 ' OE2' ' HA ' ' A' ' 20' ' ' ASP . 17.0 mt-10 -64.5 -56.68 12.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 0.0 110.093 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.859 HD23 ' CD2' ' A' ' 48' ' ' LEU . 11.5 tp -54.54 -36.37 64.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 109.858 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.28 -40.91 99.62 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 m -58.49 -53.07 62.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -1.119 . . . . 0.0 109.819 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 35' ' ' VAL . 12.0 t -56.93 -53.9 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.603 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.504 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -50.76 -41.01 56.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 109.736 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 2.1 mtm180 -62.91 -27.81 69.62 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 0.0 109.886 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -79.41 -59.54 2.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.821 . . . . 0.0 110.933 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 mt -44.04 -37.54 3.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.131 -0.981 . . . . 0.0 110.082 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.08 64.85 0.16 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.539 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -144.82 -168.23 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -1.178 . . . . 0.0 110.119 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 2.5 m120 -155.1 57.75 1.75 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.062 -1.024 . . . . 0.0 110.578 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 50.1 Cg_endo -80.35 135.73 10.86 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.907 1.477 . . . . 0.0 110.061 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 45' ' ' GLU . 5.1 m -97.26 163.36 12.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.206 -0.933 . . . . 0.0 110.067 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 3.2 mt-10 -43.05 -54.92 4.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 109.997 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.56 -55.43 33.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.338 -0.851 . . . . 0.0 110.043 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HG3' ' HB ' ' A' ' 44' ' ' THR . 21.3 mt-10 -47.46 -44.46 25.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 109.72 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.859 ' CD2' HD23 ' A' ' 32' ' ' LEU . 15.1 mt -55.8 -43.44 76.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.358 -0.839 . . . . 0.0 109.912 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' OE1' HG21 ' A' ' 29' ' ' THR . 5.6 tp60 -54.9 -41.42 70.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 109.441 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.06 -42.94 91.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.447 -0.783 . . . . 0.0 109.648 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.569 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.3 OUTLIER -74.95 -49.44 20.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 109.765 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.481 HG22 ' HB2' ' A' ' 56' ' ' ASP . 7.3 mm -52.4 -25.2 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.624 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -30.59 67.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.345 -0.847 . . . . 0.0 110.185 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' OE1' ' HA ' ' A' ' 51' ' ' MET . 1.3 mp0 -70.24 -25.63 63.47 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 110.062 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.832 HG22 ' SD ' ' A' ' 71' ' ' MET . 5.6 t -108.07 -28.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 52' ' ' ILE . 19.2 t0 -63.85 72.17 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.312 -0.867 . . . . 0.0 110.323 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -68.65 -35.69 77.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 110.415 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 24.3 p30 -82.44 -20.15 37.56 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.141 -0.975 . . . . 0.0 110.489 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 81.07 26.49 52.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.523 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 31.8 p-10 -89.66 -30.44 18.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -1.179 . . . . 0.0 110.09 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 113.92 -24.23 12.1 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.523 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 80.7 p -112.65 157.27 21.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -1.215 . . . . 0.0 110.393 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.581 HD12 ' CG1' ' A' ' 55' ' ' VAL . 10.2 mm -95.72 144.28 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.369 -0.832 . . . . 0.0 110.144 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 75.8 m-20 -110.67 160.68 16.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 109.975 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 33.0 t80 -52.4 -47.73 92.11 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.289 -0.882 . . . . 0.0 111.271 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -69.42 -41.82 4.34 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.203 1.107 . . . . 0.0 110.163 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 2.9 tt0 -55.6 -45.15 77.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 110.114 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.423 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 16.3 t80 -61.0 -47.35 86.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 110.118 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 65' ' ' PHE . 85.4 mt -57.41 -23.05 47.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.232 -0.917 . . . . 0.0 110.156 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.3 m -90.1 -21.7 22.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.258 -0.901 . . . . 0.0 111.012 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.832 ' SD ' HG22 ' A' ' 55' ' ' VAL . 3.1 ttp -75.48 -45.37 38.82 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.959 -1.088 . . . . 0.0 109.905 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.594 ' HE1' ' HE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -53.91 -17.27 2.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.39 -0.819 . . . . 0.0 110.907 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.02 -11.69 15.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.936 -1.102 . . . . 0.0 111.324 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -96.53 -36.23 10.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.817 -1.177 . . . . 0.0 110.678 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.709 ' HB3' HG21 ' B' ' 8' ' ' THR . 8.9 tttp -91.69 25.94 2.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.239 -0.913 . . . . 0.0 110.535 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.56 ' HE1' ' CD2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -100.27 -32.64 10.77 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.035 . . . . 0.0 110.453 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -134.44 72.71 1.47 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.237 -0.914 . . . . 0.0 110.176 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER 168.82 104.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.259 -0.901 . . . . 0.0 110.024 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 3.9 m 68.93 104.62 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.429 -0.795 . . . . 0.0 110.261 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 79' ' ' THR . 1.5 t70 71.74 74.02 0.17 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.458 -0.776 . . . . 0.0 110.552 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.4 m -107.06 -46.83 3.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.855 . . . . 0.0 109.738 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -90.48 -34.34 15.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.873 . . . . 0.0 109.513 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.31 -24.64 67.72 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.214 -0.929 . . . . 0.0 108.987 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 25.3 tt0 -55.57 -36.92 67.37 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.509 -0.745 . . . . 0.0 109.605 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.661 HG23 ' SD ' ' A' ' 145' ' ' MET . 78.1 mt -70.4 -44.96 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.269 -0.895 . . . . 0.0 109.025 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -54.98 -28.71 53.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.484 -0.76 . . . . 0.0 109.132 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 4.2 mt-10 -69.61 -58.9 3.37 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.471 -0.768 . . . . 0.0 109.445 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.35 -31.39 54.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 0.0 109.247 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 17.1 t80 -63.72 -45.05 91.7 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -60.82 -34.89 75.23 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.778 ' CG1' HG21 ' B' ' 13' ' ' VAL . 24.7 t -71.49 -42.1 72.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.584 ' CE2' HG22 ' B' ' 13' ' ' VAL . 9.6 m-85 -72.25 -34.57 68.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 108.76 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 96' ' ' GLY . 14.5 t0 -95.24 61.28 2.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.56 -0.713 . . . . 0.0 109.791 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.538 ' CE ' ' HA ' ' A' ' 94' ' ' LYS . 2.1 mmpt? -43.36 -28.02 0.3 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.16 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' OD2' ' CG ' ' A' ' 97' ' ' ASN . 49.7 t0 -67.89 -41.31 82.93 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 73.11 -0.17 48.53 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.421 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 28.5 p-10 -73.01 -24.07 60.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.117 -1.225 . . . . 0.0 110.117 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.463 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 115.21 35.44 1.33 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 0.4 OUTLIER -158.51 105.38 1.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.257 -1.143 . . . . 0.0 110.231 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 92' ' ' PHE . 7.2 mt -81.37 135.47 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.248 -0.907 . . . . 0.0 110.026 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -129.29 148.84 51.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.01 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.87 -30.95 1.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 109.848 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.3 -42.5 79.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.599 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -61.57 -43.64 98.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.386 -0.821 . . . . 0.0 109.953 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.053 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -59.76 -42.64 93.71 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.323 -0.86 . . . . 0.0 109.363 179.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -36.88 74.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 109.799 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.44 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -65.15 -44.39 88.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.823 . . . . 0.0 109.843 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.481 HG21 HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -74.0 -33.62 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.803 . . . . 0.0 109.417 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.52 ' SD ' HD21 ' B' ' 17' ' ' LEU . 0.1 OUTLIER -60.82 -65.61 0.66 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 110.174 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m -51.92 -32.84 34.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.116 -0.99 . . . . 0.0 109.507 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 9.6 m120 -77.68 -20.65 53.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 109.547 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.861 HD11 HG12 ' B' ' 13' ' ' VAL . 2.5 mt -85.05 -40.41 16.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.511 -0.743 . . . . 0.0 110.168 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.26 -47.39 0.55 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.656 ' HG2' HD12 ' A' ' 116' ' ' LEU . 31.1 tt0 -94.0 165.18 12.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.143 -1.21 . . . . 0.0 111.043 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 116' ' ' LEU . 4.0 ptpp? -140.67 62.82 1.48 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.503 -0.748 . . . . 0.0 109.358 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.882 HD21 ' HA ' ' B' ' 19' ' ' LYS . 1.6 mp -38.34 140.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.696 -0.628 . . . . 0.0 110.467 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.662 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -50.85 -173.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.37 -0.831 . . . . 0.0 110.478 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 119' ' ' GLU . 20.1 t70 -86.34 -62.32 1.54 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.026 -1.046 . . . . 0.0 110.361 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.555 ' HA ' ' OD2' ' A' ' 122' ' ' ASP . 3.2 tt0 -44.11 -49.61 8.86 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 109.916 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.95 -55.33 36.0 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 117' ' ' THR . 46.3 t -49.52 -43.6 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.556 -0.715 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.555 ' OD2' ' HA ' ' A' ' 119' ' ' GLU . 9.4 p30 -68.75 -22.53 64.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.757 -1.214 . . . . 0.0 109.966 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 40.1 mm-40 -80.56 -27.82 37.4 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.351 -0.843 . . . . 0.0 108.867 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -43.6 79.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.594 -0.691 . . . . 0.0 109.419 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.053 HD11 ' CD1' ' A' ' 105' ' ' LEU . 41.5 mm -67.66 -43.49 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.0 109.691 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.471 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 6.7 mmm-85 -56.98 -39.43 74.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -59.45 -28.59 67.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.355 -0.841 . . . . 0.0 109.996 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB2' ' HD2' ' B' ' 22' ' ' PHE . . . -99.25 -18.25 17.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.378 -0.827 . . . . 0.0 110.022 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 126' ' ' ARG . 1.2 m-20 -59.12 98.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.244 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 mm -67.38 -44.61 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.325 -0.859 . . . . 0.0 110.049 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 19.2 p-10 -90.07 -19.2 24.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 110.093 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 79.23 64.08 1.97 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.514 ' OD2' ' NE2' ' A' ' 135' ' ' GLN . 31.1 p-10 -116.04 -34.73 4.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -1.155 . . . . 0.0 110.143 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 118.34 19.5 4.62 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.514 ' NE2' ' OD2' ' A' ' 133' ' ' ASP . 3.9 pp0? -160.21 159.01 31.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.173 -1.192 . . . . 0.0 110.434 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 87.2 t -114.9 108.59 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -80.69 -173.25 4.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.212 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.429 ' O ' ' C ' ' A' ' 139' ' ' GLU . 25.5 t80 -67.66 -67.18 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 110.311 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 138' ' ' TYR . 2.3 tt0 -42.85 -27.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.772 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 144' ' ' MET . 1.6 tt0 -80.94 -53.15 6.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 110.356 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 69.5 t80 -58.26 -18.31 25.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.072 -1.017 . . . . 0.0 109.748 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 66.5 t -99.75 -62.67 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.345 -0.847 . . . . 0.0 110.568 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -52.53 -18.96 1.95 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.254 -0.904 . . . . 0.0 110.489 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.484 ' HB3' ' O ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -97.81 -20.94 17.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.128 -0.983 . . . . 0.0 110.165 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.661 ' SD ' HG23 ' A' ' 85' ' ' ILE . 8.2 ttm -100.78 -26.37 13.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.355 -0.841 . . . . 0.0 110.746 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.631 HG23 ' O ' ' A' ' 146' ' ' THR . 4.7 t -164.04 92.62 0.68 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.907 -1.121 . . . . 0.0 110.888 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.38 47.0 0.99 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.292 -0.88 . . . . 0.0 110.201 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.312 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.809 HG13 ' N ' ' B' ' 2' ' ' LYS . 2.1 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.025 0.44 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.809 ' N ' HG13 ' B' ' 1' ' ' VAL . 0.0 OUTLIER 64.83 64.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.959 -1.088 . . . . 0.0 110.054 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 7.2 tp -172.23 -26.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 111.318 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.904 HG22 ' CD ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -97.8 -177.16 0.58 Allowed Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 120.867 -1.145 . . . . 0.0 109.483 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.904 ' CD ' HG22 ' B' ' 4' ' ' ILE . 46.4 Cg_endo -83.03 -158.16 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.559 1.294 . . . . 0.0 110.534 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.524 ' O ' ' N ' ' B' ' 8' ' ' THR . 2.4 p -136.93 56.2 1.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.98 -1.075 . . . . 0.0 111.047 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.811 ' O ' HG22 ' B' ' 10' ' ' VAL . 3.0 m95 54.03 -82.15 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.253 -0.904 . . . . 0.0 111.05 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 75' ' ' LYS . 7.1 p -41.31 -25.12 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.844 -1.16 . . . . 0.0 110.633 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.496 ' N ' ' O ' ' B' ' 7' ' ' TRP . 50.6 m -64.18 -53.47 48.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 109.638 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.811 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.5 m -58.59 -26.34 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.296 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' B' ' 15' ' ' SER . 2.9 mt -75.05 -33.13 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.266 -0.897 . . . . 0.0 109.078 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mt -59.47 -59.57 5.23 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 110.125 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.861 HG12 HD11 ' A' ' 112' ' ' LEU . 61.8 t -62.66 -40.47 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 110.939 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -63.43 -31.0 72.04 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.965 -1.084 . . . . 0.0 110.072 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 0.5 OUTLIER -76.4 -24.23 54.05 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.363 -0.836 . . . . 0.0 110.092 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.589 ' HE1' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.67 -17.62 40.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.272 -0.892 . . . . 0.0 111.301 -179.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 19' ' ' LYS . 0.3 OUTLIER -78.79 -109.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.406 -1.434 . . . . 0.0 110.081 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.475 ' C ' ' HG3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 58.58 -72.64 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.131 -0.98 . . . . 0.0 110.821 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.882 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -172.94 90.62 0.09 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.348 -0.845 . . . . 0.0 112.256 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 123' ' ' GLU . 0.7 OUTLIER 62.1 4.67 1.25 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.534 -1.354 . . . . 0.0 110.829 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.5 ' O ' ' O ' ' B' ' 16' ' ' MET . 12.1 t -66.01 119.04 10.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.945 -1.097 . . . . 0.0 110.23 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.656 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -152.57 53.68 0.78 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.095 -1.003 . . . . 0.0 110.221 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.45 -136.23 6.42 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 145' ' ' MET . 2.0 m120 -130.51 65.17 75.45 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.247 -1.149 . . . . 0.0 110.637 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.27 42.26 1.29 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.937 1.493 . . . . 0.0 111.024 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.594 ' HE2' ' HE1' ' A' ' 72' ' ' MET . 5.7 m-85 . . . . . 0 N--CA 1.498 1.927 0 O-C-N 121.074 -1.016 . . . . 0.0 110.293 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.158 0.504 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.65 178.29 1.94 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -0.932 . . . . 0.0 110.333 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.442 ' O ' HD23 ' A' ' 4' ' ' LEU . 32.9 mt-30 -53.07 -176.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.245 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 59.3 mt -122.67 125.04 44.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.908 . . . . 0.0 110.178 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.521 HG23 ' N ' ' A' ' 6' ' ' GLU . 5.2 t -43.05 -40.45 3.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.381 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.521 ' N ' HG23 ' A' ' 5' ' ' THR . 0.9 OUTLIER -45.9 -25.18 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.0 110.405 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 4.2 mt-10 -68.27 -61.11 1.99 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.127 -0.983 . . . . 0.0 109.929 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 7' ' ' GLU . 1.8 mp0 -44.24 -55.93 4.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.733 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.9 mt -56.97 -43.85 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.682 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.88 -51.81 62.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.682 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.511 ' OE2' ' CD ' ' B' ' 18' ' ' ARG . 16.9 tt0 -56.9 -45.98 82.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.674 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -63.04 -41.34 99.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -61.4 -41.19 96.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.401 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 7.6 tt0 -63.18 -48.07 79.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.249 -0.907 . . . . 0.0 109.258 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' HB1' ' HZ ' ' A' ' 68' ' ' PHE . . . -62.5 -46.44 88.44 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.4 -0.813 . . . . 0.0 109.395 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 65' ' ' PHE . 41.0 t80 -61.26 -38.43 86.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.338 -0.851 . . . . 0.0 109.0 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 14' ' ' GLU . 77.5 p -75.19 -35.55 61.52 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.539 -0.725 . . . . 0.0 109.365 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.693 HD13 ' HG3' ' B' ' 14' ' ' LYS . 1.1 tt -50.16 -44.86 52.83 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.815 . . . . 0.0 109.217 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CE1' HG11 ' B' ' 10' ' ' VAL . 52.7 m-85 -76.83 -51.53 11.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.431 -0.793 . . . . 0.0 109.472 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 46.0 t0 -77.17 78.2 3.71 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.509 -0.744 . . . . 0.0 110.009 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -68.22 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 19.6 p-10 -51.64 -27.52 11.66 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.431 -0.793 . . . . 0.0 110.293 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.447 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 80.21 18.61 71.37 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 53.6 p30 -62.24 -12.47 20.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -1.191 . . . . 0.0 109.962 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 86.98 29.39 23.23 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 4.2 p -152.61 118.57 5.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.268 -1.137 . . . . 0.0 110.601 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.547 HD12 ' CB ' ' A' ' 63' ' ' ILE . 10.7 mt -94.22 120.12 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.163 -0.96 . . . . 0.0 110.172 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.53 164.76 11.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.353 -0.842 . . . . 0.0 109.984 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.554 ' O ' HD13 ' A' ' 48' ' ' LEU . 38.6 p -56.63 -29.31 62.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.992 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -69.51 -60.83 2.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.803 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -49.06 -57.53 6.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -0.888 . . . . 0.0 110.14 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 32' ' ' LEU . 22.9 tp -52.86 -41.96 64.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.781 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.528 ' HA2' ' HG3' ' A' ' 43' ' ' PRO . . . -58.39 -34.88 76.63 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.7 m -62.85 -56.92 13.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -1.11 . . . . 0.0 110.035 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 35' ' ' VAL . 16.4 t -53.71 -32.71 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.334 -0.854 . . . . 0.0 109.883 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -27.28 59.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 109.956 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 1.4 ttp180 -76.73 -21.67 54.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -0.955 . . . . 0.0 110.121 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.96 -33.71 59.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -0.922 . . . . 0.0 110.357 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.505 HD22 HG13 ' A' ' 91' ' ' VAL . 4.5 mt -74.94 -44.1 50.41 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.229 -0.919 . . . . 0.0 110.231 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.16 78.76 0.08 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -176.45 -174.51 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.259 -1.142 . . . . 0.0 110.283 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -142.55 93.43 6.97 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.0 110.315 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.528 ' HG3' ' HA2' ' A' ' 33' ' ' GLY . 44.5 Cg_endo -74.61 90.92 1.01 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 124.092 1.575 . . . . 0.0 110.297 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.29 145.86 52.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 110.428 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -49.07 -64.79 0.7 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.24 -0.913 . . . . 0.0 110.573 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -43.84 -51.14 7.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.939 -1.101 . . . . 0.0 110.046 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -65.13 -35.21 80.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 109.876 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 29' ' ' THR . 11.0 mt -62.38 -47.68 83.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 110.09 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -57.48 -44.85 85.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.875 . . . . 0.0 109.821 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.17 -27.15 69.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.419 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.571 ' SD ' HG21 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -74.66 -54.13 8.0 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.493 -0.754 . . . . 0.0 110.129 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.761 HG12 HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -70.16 -13.08 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.253 -0.904 . . . . 0.0 109.753 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.46 -24.74 63.81 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.187 -0.946 . . . . 0.0 109.212 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.85 -47.89 13.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.519 -0.738 . . . . 0.0 109.962 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.661 HG21 ' CE2' ' B' ' 7' ' ' TRP . 88.3 t -69.6 -18.09 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.651 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' ALA . 17.2 t0 -67.68 57.78 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.021 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -43.36 -55.58 4.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.178 -0.952 . . . . 0.0 110.256 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 6.9 p-10 -64.1 -44.15 93.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.86 35.39 3.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.473 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 6.9 p-10 -98.64 -44.93 6.25 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -1.207 . . . . 0.0 110.137 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.448 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . 142.15 -54.88 0.6 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.28 156.56 19.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.252 -1.146 . . . . 0.0 110.701 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.761 HD11 HG12 ' A' ' 52' ' ' ILE . 7.9 mm -90.39 142.93 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.413 -0.805 . . . . 0.0 109.378 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' OD1' ' HD2' ' A' ' 66' ' ' PRO . 0.8 OUTLIER -108.64 176.82 4.98 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.031 -1.043 . . . . 0.0 110.809 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.636 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 4.1 t80 -66.99 -45.2 52.92 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.495 -0.753 . . . . 0.0 111.372 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.8 Cg_endo -69.02 -37.81 10.38 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.203 1.107 . . . . 0.0 109.938 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.93 -41.66 64.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.293 -0.88 . . . . 0.0 109.218 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.401 ' HZ ' ' HB1' ' A' ' 15' ' ' ALA . 16.3 t80 -64.51 -50.33 67.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.462 -0.774 . . . . 0.0 109.748 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -51.44 -26.29 7.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.84 . . . . 0.0 110.574 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 34.8 m -98.4 -20.4 17.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 111.167 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.449 ' CE ' ' HB2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -78.99 -30.69 44.47 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.958 -1.089 . . . . 0.0 110.861 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.633 ' HE1' ' CE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -77.09 -9.08 58.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.192 -0.942 . . . . 0.0 110.839 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.58 -16.55 8.84 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.867 -1.145 . . . . 0.0 111.405 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -99.94 -9.91 22.25 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.883 -1.136 . . . . 0.0 110.491 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HB3' HG21 ' B' ' 8' ' ' THR . 6.5 tptt -95.41 10.29 36.92 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.29 -0.881 . . . . 0.0 110.618 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.25 -7.83 31.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.162 -0.962 . . . . 0.0 110.245 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -147.35 69.43 1.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 109.935 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 79' ' ' THR . 39.7 t0 -148.77 -47.61 0.15 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.248 -0.907 . . . . 0.0 110.416 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.774 HG23 ' O ' ' A' ' 78' ' ' ASP . 1.4 p -162.24 -37.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 110.415 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 3.6 m-20 -100.24 71.54 1.59 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 110.222 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.456 ' O ' ' OE2' ' A' ' 84' ' ' GLU . 16.0 t -85.84 -53.25 5.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.943 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.51 -20.24 16.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.39 -0.819 . . . . 0.0 110.237 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -67.42 -40.11 85.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.716 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' OE2' ' O ' ' A' ' 81' ' ' SER . 17.9 pt-20 -51.8 -31.79 28.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 109.911 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.665 HG21 HG22 ' A' ' 142' ' ' VAL . 62.2 mt -78.78 -50.84 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.155 -0.966 . . . . 0.0 109.313 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 14.9 ttm180 -49.38 -40.6 36.49 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 109.5 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.774 ' HB3' HG21 ' B' ' 9' ' ' THR . 26.4 mt-10 -69.06 -52.77 25.06 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.292 -0.88 . . . . 0.0 109.581 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.33 -27.04 44.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.07 -1.019 . . . . 0.0 109.071 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' HB3' ' O ' ' A' ' 86' ' ' ARG . 83.3 t80 -69.75 -45.58 67.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 0.0 109.112 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -56.61 -37.47 70.71 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.591 -0.693 . . . . 0.0 109.36 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.619 HG12 HG21 ' A' ' 108' ' ' VAL . 82.1 t -64.92 -41.07 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.503 -0.748 . . . . 0.0 109.748 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.774 ' HE1' HG22 ' B' ' 13' ' ' VAL . 5.0 m-85 -66.42 -31.34 72.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.0 109.37 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.511 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 3.8 t0 -91.13 59.92 4.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.479 -0.763 . . . . 0.0 109.986 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -38.96 -39.8 0.58 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.441 -0.787 . . . . 0.0 110.794 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.0 p-10 -86.58 -35.06 19.68 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 0.0 110.121 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.505 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 82.55 44.6 7.27 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -94.64 -23.61 17.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -1.197 . . . . 0.0 110.177 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.564 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 114.88 29.32 2.64 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 41.8 m-85 -160.62 150.59 17.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.174 -1.192 . . . . 0.0 110.039 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.574 HD13 ' HB3' ' A' ' 92' ' ' PHE . 9.0 mt -119.06 118.09 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 102' ' ' ALA . 2.0 t -105.33 145.88 30.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 110.147 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.953 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -43.87 -33.03 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.811 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.13 -48.15 82.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 109.546 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 39.6 mt-10 -55.77 -41.27 73.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.882 . . . . 0.0 109.492 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.027 ' CD1' HD11 ' A' ' 125' ' ' ILE . 7.7 mt -59.74 -44.67 93.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 109.601 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.408 ' NH1' ' HD3' ' A' ' 115' ' ' LYS . 1.2 ttm180 -57.5 -39.35 76.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.381 -0.825 . . . . 0.0 109.592 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -63.5 -50.8 68.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 109.554 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.619 HG21 HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -63.76 -25.27 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 108.898 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.865 ' SD ' HD13 ' A' ' 116' ' ' LEU . 2.6 mtm -69.13 -65.37 0.72 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.672 -0.643 . . . . 0.0 109.988 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -51.99 -28.88 18.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -78.55 -10.5 59.75 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.277 -0.889 . . . . 0.0 109.337 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.687 HD11 HG12 ' B' ' 13' ' ' VAL . 13.8 mt -107.34 -48.5 3.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.356 -0.84 . . . . 0.0 110.479 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.58 -59.5 0.18 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.548 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 109' ' ' MET . 2.7 tp10 -99.76 159.23 15.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.934 -1.333 . . . . 0.0 110.819 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.562 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 1.1 pttp -123.57 1.91 8.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.375 -0.828 . . . . 0.0 110.012 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.865 HD13 ' SD ' ' A' ' 109' ' ' MET . 4.8 mp 48.11 175.81 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.56 0.695 . . . . 0.0 110.969 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.666 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.46 178.91 6.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.138 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -50.97 9.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.96 -1.087 . . . . 0.0 110.065 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -56.79 -46.11 81.76 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 109.491 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -58.91 -52.8 64.18 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.375 -0.828 . . . . 0.0 109.409 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.953 HG12 ' HB1' ' A' ' 102' ' ' ALA . 41.3 t -50.84 -41.41 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.857 . . . . 0.0 109.669 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 1.1 m-20 -70.95 -38.83 72.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.398 -0.813 . . . . 0.0 110.029 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -68.84 -23.73 64.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -0.866 . . . . 0.0 110.05 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.686 ' HE3' ' CD1' ' B' ' 22' ' ' PHE . 22.3 ttt -74.4 -56.21 5.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.882 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.027 HD11 ' CD1' ' A' ' 105' ' ' LEU . 31.2 mm -60.68 -52.82 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.0 109.712 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 122' ' ' ASP . 1.5 mtp85 -50.33 -52.89 32.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 110.1 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 15.3 mm-40 -53.33 -29.04 31.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.342 -0.849 . . . . 0.0 110.193 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.54 -19.23 24.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 110.343 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.43 70.43 3.82 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.0 110.262 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.6 mt -63.57 -41.22 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.968 . . . . 0.0 109.766 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 9.7 p30 -63.55 -36.29 83.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.332 -0.855 . . . . 0.0 110.03 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 95.48 74.19 1.22 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.458 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -133.44 2.17 3.5 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.229 -1.159 . . . . 0.0 109.976 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.508 ' O ' ' CG ' ' A' ' 135' ' ' GLN . . . 71.66 4.71 58.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.508 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 68.1 mt-30 -156.63 168.81 26.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.163 . . . . 0.0 109.773 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 140' ' ' GLU . 14.7 t -107.16 131.47 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 109.953 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 11.6 t30 -100.39 -152.98 0.43 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 0.0 110.23 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.458 ' OH ' ' HG3' ' A' ' 86' ' ' ARG . 12.1 t80 -74.54 -69.45 0.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.245 -0.909 . . . . 0.0 110.087 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 143' ' ' GLN . 1.4 tt0 -46.95 -44.4 19.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.187 -0.946 . . . . 0.0 109.875 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.457 ' HB3' HG13 ' A' ' 136' ' ' VAL . 11.5 mt-10 -53.78 -60.56 3.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.795 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 140' ' ' GLU . 5.1 t80 -42.96 -33.0 0.71 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 110.017 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.665 HG22 HG21 ' A' ' 85' ' ' ILE . 37.8 t -100.09 -17.11 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.374 -0.829 . . . . 0.0 110.726 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.776 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 13.7 tt0 -77.9 -27.97 49.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.173 -0.954 . . . . 0.0 110.621 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -93.51 -11.05 32.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.524 ' O ' ' HB2' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -100.6 -24.78 14.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 110.436 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.0 p -122.93 -26.83 4.34 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.921 -1.112 . . . . 0.0 110.661 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -100.22 63.11 1.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.142 -0.974 . . . . 0.0 110.141 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 147' ' ' ALA . 18.7 tttp . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.383 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.758 HG13 ' N ' ' B' ' 2' ' ' LYS . 1.6 p . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.105 0.479 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.758 ' N ' HG13 ' B' ' 1' ' ' VAL . 0.0 OUTLIER 55.79 110.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.177 -0.952 . . . . 0.0 109.803 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.665 HD23 ' C ' ' B' ' 2' ' ' LYS . 0.2 OUTLIER -175.06 -34.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.736 -1.228 . . . . 0.0 110.457 -179.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.571 HG21 ' SD ' ' A' ' 51' ' ' MET . 12.5 mt -147.13 122.6 5.35 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 109.595 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.508 ' O ' ' HB ' ' B' ' 9' ' ' THR . 44.1 Cg_endo -70.87 66.39 2.42 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.98 1.516 . . . . 0.0 111.602 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.482 ' C ' ' O ' ' B' ' 5' ' ' PRO . 42.4 m 31.56 -147.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.533 0.682 . . . . 0.0 111.874 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.661 ' CE2' HG21 ' A' ' 55' ' ' VAL . 2.0 m95 -108.7 -73.87 0.67 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.886 0.851 . . . . 0.0 110.842 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.529 ' HA ' HD12 ' B' ' 11' ' ' ILE . 2.6 p -44.83 -36.59 3.34 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.498 -0.751 . . . . 0.0 110.288 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.774 HG21 ' HB3' ' A' ' 87' ' ' GLU . 2.6 m -44.91 -53.84 7.15 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.695 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.465 HG23 ' H ' ' B' ' 10' ' ' VAL . 4.7 t -57.46 -40.12 72.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.53 HG21 ' HG2' ' A' ' 72' ' ' MET . 47.1 mt -72.75 -19.72 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.539 -0.726 . . . . 0.0 109.635 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 8' ' ' THR . 0.2 OUTLIER -73.36 -50.16 23.42 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.647 0.737 . . . . 0.0 109.768 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.774 HG22 ' HE1' ' A' ' 92' ' ' PHE . 89.1 t -64.91 -47.06 89.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.475 -0.766 . . . . 0.0 110.575 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.693 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -65.86 -32.76 74.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.066 -1.021 . . . . 0.0 109.802 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 34.2 t -78.23 -13.68 59.76 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.6 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' B' ' 12' ' ' LEU . 0.0 OUTLIER -79.67 -42.18 25.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.162 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.621 HD21 ' CG ' ' A' ' 109' ' ' MET . 9.3 mp -44.98 -57.32 3.89 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.918 -1.114 . . . . 0.0 109.057 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.511 ' CD ' ' OE2' ' A' ' 11' ' ' GLU . 3.6 tpt85 16.38 75.24 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.528 ' O ' ' CG ' ' B' ' 19' ' ' LYS . 2.0 tptm 44.62 73.76 0.15 Allowed 'General case' 0 C--N 1.283 -2.308 0 O-C-N 121.273 -0.892 . . . . 0.0 112.883 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.691 ' H ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER 47.86 13.73 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.683 0 O-C-N 120.8 -1.187 . . . . 0.0 112.092 177.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' B' ' 18' ' ' ARG . 5.1 m -112.74 115.45 28.55 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 119.956 -1.715 . . . . 0.0 110.468 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.686 ' CD1' ' HE3' ' A' ' 124' ' ' MET . 0.9 OUTLIER -58.16 -35.32 71.38 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.167 -1.013 . . . . 0.0 108.779 179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.54 147.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.595 ' N ' ' HD3' ' B' ' 25' ' ' PRO . 1.8 p-10 -134.97 43.09 0.87 Allowed Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.479 -1.013 . . . . 0.0 110.73 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' B' ' 24' ' ' ASN . 55.2 Cg_endo -77.96 26.64 0.49 Allowed 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 123.481 1.253 . . . . 0.0 111.189 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.633 ' CE2' ' HE1' ' A' ' 72' ' ' MET . 15.5 m-85 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 110.354 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.309 0.576 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -103.84 21.91 15.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.204 -0.935 . . . . 0.0 110.271 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -170.58 2.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 110.198 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.498 HD13 ' HA ' ' A' ' 4' ' ' LEU . 2.6 mm? -108.41 -171.95 1.96 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.443 ' O ' HD12 ' A' ' 9' ' ' ILE . 0.9 OUTLIER -97.35 94.4 7.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.278 -0.889 . . . . 0.0 110.226 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -96.79 -33.42 11.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.186 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.86 -47.41 80.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.263 -0.898 . . . . 0.0 110.167 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -66.5 -45.52 79.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 110.111 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 12' ' ' PHE . 47.2 mt -66.44 -40.05 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.997 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.33 -62.35 1.78 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 109.714 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.494 ' CA ' ' OE1' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -48.64 -41.48 31.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.609 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.8 m-30 -52.49 -46.78 66.74 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.214 -0.929 . . . . 0.0 109.153 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -57.34 -34.52 68.86 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.329 -0.857 . . . . 0.0 109.172 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 1.7 tt0 -56.84 -51.01 70.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.397 -0.814 . . . . 0.0 109.794 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' CA ' ' HD2' ' B' ' 14' ' ' LYS . . . -60.01 -45.39 92.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.19 -0.943 . . . . 0.0 109.566 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.584 ' CZ ' ' O ' ' A' ' 64' ' ' ASP . 1.7 t80 -64.62 -45.43 86.89 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 109.841 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m -64.29 -31.33 72.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.809 . . . . 0.0 109.706 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.622 HD21 ' O ' ' A' ' 112' ' ' LEU . 9.7 tt -61.9 -45.9 91.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.447 -0.783 . . . . 0.0 110.041 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.737 ' HA ' HG21 ' A' ' 35' ' ' VAL . 26.4 m-85 -71.42 -27.13 63.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.287 -0.883 . . . . 0.0 110.245 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.8 120.8 26.48 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.262 -0.899 . . . . 0.0 110.346 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.44 -37.09 60.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.237 -0.914 . . . . 0.0 110.304 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 17.6 p-10 -92.09 -40.9 10.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.307 -0.871 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.98 48.58 2.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 44.8 p-10 -104.69 -7.72 19.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.225 -1.162 . . . . 0.0 110.1 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 26' ' ' THR . . . 89.71 35.78 7.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 25' ' ' GLY . 20.0 p -155.68 107.73 2.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.292 -1.122 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 mt -95.3 119.48 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.137 -0.977 . . . . 0.0 110.326 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.684 HG22 HG22 ' A' ' 62' ' ' THR . 12.7 p -100.08 174.46 6.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.179 -0.951 . . . . 0.0 110.231 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.764 HG21 ' OE1' ' A' ' 49' ' ' GLN . 74.9 p -59.09 -31.91 69.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -55.33 9.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.153 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 39.5 mt-10 -55.02 -69.76 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.06 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 31' ' ' GLU . 12.6 tp -44.94 -41.84 7.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.761 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.21 -41.99 93.12 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 2.5 m -61.07 -50.78 71.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -1.113 . . . . 0.0 109.886 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.737 HG21 ' HA ' ' A' ' 19' ' ' PHE . 12.4 t -57.92 -42.27 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 mmt -61.07 -42.34 98.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.29 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 34' ' ' THR . 3.0 tpt180 -53.04 -40.82 64.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.242 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 40' ' ' GLY . 68.3 m -71.77 -44.22 64.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.553 -0.717 . . . . 0.0 109.461 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.754 ' CD2' HD21 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -43.5 -26.24 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.38 -0.825 . . . . 0.0 109.69 179.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.476 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 107.85 37.91 2.12 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' B' ' 3' ' ' LEU . 10.5 mm-40 -145.98 165.64 28.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.31 -1.112 . . . . 0.0 110.535 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -126.84 88.89 53.43 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 109.64 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.06 160.81 46.52 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.113 1.586 . . . . 0.0 110.93 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 45' ' ' GLU . 94.9 m -99.64 164.3 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.476 -0.765 . . . . 0.0 109.879 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -69.03 -69.95 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.16 -0.963 . . . . 0.0 110.073 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -43.33 -54.14 4.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.974 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.409 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 69.1 mm-40 -54.54 -41.39 69.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.014 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 51' ' ' MET . 3.4 mt -55.4 -42.7 74.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 0.0 109.906 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.764 ' OE1' HG21 ' A' ' 29' ' ' THR . 45.4 tp60 -67.36 -24.32 65.69 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.274 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -71.51 -46.98 58.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 109.974 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.496 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 24.7 ptm -73.21 -35.41 66.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 109.724 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.565 HG13 HG22 ' A' ' 29' ' ' THR . 7.8 mm -62.32 -32.46 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 109.529 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.24 -21.06 56.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.831 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.17 -37.99 87.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 110.154 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.535 HG13 ' HE2' ' A' ' 71' ' ' MET . 11.5 t -91.86 -31.8 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 110.176 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.1 71.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.261 -0.9 . . . . 0.0 110.034 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.27 -17.17 61.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.0 110.638 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 3.6 p30 -100.43 -31.87 11.09 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.143 -0.973 . . . . 0.0 110.609 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.54 42.48 4.82 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.422 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 12.6 m120 -84.03 -15.77 46.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.195 -1.179 . . . . 0.0 110.076 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 62' ' ' THR . . . 101.67 -8.41 56.39 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.684 HG22 HG22 ' A' ' 28' ' ' THR . 2.9 p -158.23 168.46 26.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -1.133 . . . . 0.0 110.156 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.573 HG22 ' CZ ' ' A' ' 16' ' ' PHE . 30.2 mm -82.82 136.07 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.385 -0.822 . . . . 0.0 109.943 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.584 ' O ' ' CZ ' ' A' ' 16' ' ' PHE . 2.5 m-20 -114.27 174.01 6.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.307 -0.871 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.599 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 48.2 t80 -59.4 -49.85 90.37 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.404 -0.81 . . . . 0.0 111.714 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.1 Cg_endo -65.27 -38.37 27.28 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.169 1.089 . . . . 0.0 110.268 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -53.19 -33.9 54.66 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.136 -0.977 . . . . 0.0 109.335 179.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.549 ' HB2' ' CE1' ' A' ' 16' ' ' PHE . 21.9 t80 -78.05 -39.26 42.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 110.345 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 65' ' ' PHE . 2.3 mm? -55.49 -30.09 59.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.871 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.57 -63.21 1.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.041 -1.037 . . . . 0.0 111.37 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.535 ' HE2' HG13 ' A' ' 55' ' ' VAL . 2.1 tmm? -44.32 -37.92 3.6 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.068 -1.02 . . . . 0.0 111.548 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.731 ' HE1' ' CZ ' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -67.08 -8.56 31.48 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.039 -1.038 . . . . 0.0 111.317 -179.014 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.97 -9.34 9.66 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.664 -1.273 . . . . 0.0 111.687 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -17.32 30.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.78 -1.2 . . . . 0.0 111.4 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -100.42 -8.3 23.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.922 -1.111 . . . . 0.0 111.314 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.563 ' HE2' ' CE2' ' B' ' 26' ' ' PHE . 2.3 mtt -100.42 26.16 6.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 0.0 110.989 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' A' ' 76' ' ' MET . 3.1 mptt -156.49 85.97 1.0 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.13 -0.981 . . . . 0.0 110.529 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -162.61 -106.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.276 -0.89 . . . . 0.0 109.984 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.462 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -142.79 6.35 1.6 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.88 -1.138 . . . . 0.0 110.543 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 79' ' ' THR . 85.1 m-20 -141.64 63.44 1.43 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.4 p -101.81 -32.61 10.17 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.428 -0.795 . . . . 0.0 109.455 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -67.62 -23.36 65.35 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.498 -0.751 . . . . 0.0 109.566 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -73.88 -34.95 64.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.067 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 31.9 mt-10 -69.08 -19.94 64.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.146 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 82' ' ' GLU . 40.7 mt -70.85 -39.42 75.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 109.053 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.528 ' HD2' ' HE3' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -57.72 -27.72 63.22 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.426 -0.796 . . . . 0.0 108.959 178.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 5.4 mt-10 -70.94 -57.67 4.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.393 -0.817 . . . . 0.0 109.431 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.524 ' CB ' HD22 ' B' ' 12' ' ' LEU . . . -54.88 -27.54 43.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.046 -1.034 . . . . 0.0 109.173 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -66.15 -52.67 46.21 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.73 -34.53 12.28 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.306 -0.871 . . . . 0.0 109.155 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.96 HG12 HG21 ' A' ' 108' ' ' VAL . 72.0 t -67.52 -42.73 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.442 -0.786 . . . . 0.0 109.59 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.675 ' HB3' HD13 ' A' ' 100' ' ' ILE . 56.5 m-85 -76.37 -24.13 54.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 96' ' ' GLY . 3.7 t0 -100.23 67.51 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.497 -0.752 . . . . 0.0 110.144 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -39.01 -44.83 1.14 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.595 -0.69 . . . . 0.0 110.351 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.64 -22.92 34.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 109.882 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 63.18 51.56 54.13 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -99.85 -26.21 14.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -1.155 . . . . 0.0 110.166 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 122.08 18.81 3.4 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -153.35 130.99 11.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -1.145 . . . . 0.0 110.098 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.675 HD13 ' HB3' ' A' ' 92' ' ' PHE . 22.2 mt -103.95 157.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 110.419 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.8 OUTLIER -140.33 147.3 39.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.397 -0.814 . . . . 0.0 109.704 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.16 -30.9 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.869 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.49 -45.02 73.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.311 -0.868 . . . . 0.0 109.592 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 20.7 mt-10 -63.32 -47.53 81.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.257 -0.902 . . . . 0.0 109.555 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.944 HD13 HD11 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -61.39 -39.28 90.12 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.286 -0.884 . . . . 0.0 109.634 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.477 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 1.4 tmt_? -60.47 -29.05 68.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.359 -0.838 . . . . 0.0 109.823 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -31.78 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 110.048 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.96 HG21 HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -74.15 -36.71 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.979 . . . . 0.0 109.554 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.79 ' CB ' HD21 ' B' ' 17' ' ' LEU . 21.5 ptp -73.26 -39.99 64.98 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.566 ' N ' ' HG3' ' A' ' 109' ' ' MET . 87.1 m -69.54 -27.38 65.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.116 -0.99 . . . . 0.0 109.47 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -89.75 -13.14 37.39 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.42 -0.8 . . . . 0.0 109.302 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.754 HD21 ' CD2' ' A' ' 39' ' ' LEU . 9.2 mt -93.89 -32.65 13.83 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.449 -0.782 . . . . 0.0 110.006 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.05 -63.82 0.33 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.267 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 109' ' ' MET . 1.8 tt0 -94.11 156.1 16.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.114 -1.227 . . . . 0.0 110.679 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 116' ' ' LEU . 9.8 pttt -124.53 13.03 8.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' B' ' 17' ' ' LEU . 1.0 OUTLIER 40.66 -164.1 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.512 0.672 . . . . 0.0 110.56 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -166.28 1.3 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.387 -0.82 . . . . 0.0 109.567 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.436 ' O ' ' OD2' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -97.17 -59.56 1.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.094 -1.004 . . . . 0.0 109.694 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 4.5 pt-20 -58.91 -30.29 67.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.515 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 9.2 tp10 -69.83 -48.17 59.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.403 -0.811 . . . . 0.0 109.321 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 t -57.28 -42.12 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.432 -0.793 . . . . 0.0 109.64 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 118' ' ' ASP . 14.4 m-20 -69.2 -41.17 77.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.858 . . . . 0.0 109.89 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 2.4 mt-10 -64.08 -31.01 72.04 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 110.007 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.608 ' HE1' ' HA ' ' B' ' 17' ' ' LEU . 1.0 OUTLIER -69.6 -42.05 74.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.176 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.944 HD11 HD13 ' A' ' 105' ' ' LEU . 35.0 mm -74.52 -23.88 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.472 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -74.44 -40.16 62.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.23 -0.919 . . . . 0.0 110.552 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.79 -8.96 58.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 110.266 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.476 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -101.26 -30.53 11.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.305 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.97 101.37 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.109 -0.994 . . . . 0.0 110.285 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.476 HD12 ' O ' ' A' ' 128' ' ' ALA . 1.2 mp -67.81 -27.37 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.197 -0.939 . . . . 0.0 109.813 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 41.6 p-10 -103.38 -25.48 13.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 110.032 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.63 72.38 1.27 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -130.61 -0.83 4.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -1.168 . . . . 0.0 110.145 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.07 -2.7 75.9 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' A' ' 100' ' ' ILE . 40.9 mt-30 -142.54 160.7 39.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -1.226 . . . . 0.0 110.2 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 97.1 t -107.59 120.05 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.182 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 98' ' ' GLY . 10.4 t-20 -81.31 166.44 20.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.884 . . . . 0.0 110.15 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -57.7 -48.97 78.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.106 -0.996 . . . . 0.0 110.155 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -53.2 -30.67 38.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 109.934 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.84 -52.63 7.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.306 -0.871 . . . . 0.0 109.813 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.413 ' CE2' HG23 ' A' ' 85' ' ' ILE . 65.9 t80 -49.75 -21.79 1.2 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.2 -0.938 . . . . 0.0 109.593 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 146' ' ' THR . 17.1 t -94.04 -62.28 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.437 -0.789 . . . . 0.0 110.255 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -43.84 -49.55 8.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.877 . . . . 0.0 110.267 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 3.7 tpt -59.05 -19.14 41.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.869 . . . . 0.0 110.556 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 1.057 ' HE2' ' HB2' ' B' ' 24' ' ' ASN . 2.7 mtt -99.61 -24.63 14.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.168 -0.958 . . . . 0.0 110.501 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 142' ' ' VAL . 1.4 t -129.85 63.78 1.52 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.147 -0.97 . . . . 0.0 110.344 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.02 37.9 1.47 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.423 ' HD2' ' OXT' ' A' ' 148' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.21 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 77.7 t . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.274 0.559 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.528 ' HE3' ' HD2' ' A' ' 86' ' ' ARG . 4.5 mptt -94.38 105.86 17.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.229 -0.919 . . . . 0.0 110.127 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.499 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.1 mt -145.56 -51.36 0.25 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.136 -0.977 . . . . 0.0 110.477 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.659 HG23 ' HD2' ' B' ' 5' ' ' PRO . 20.0 mt -135.45 148.21 65.03 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.316 -0.865 . . . . 0.0 109.881 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.659 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.8 Cg_endo -65.27 122.63 10.41 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.843 1.444 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.526 ' O ' ' N ' ' B' ' 8' ' ' THR . 17.8 m -78.93 79.68 5.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.834 . . . . 0.0 111.015 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.406 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER 50.35 -86.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.329 -0.857 . . . . 0.0 111.106 179.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.526 ' N ' ' O ' ' B' ' 6' ' ' SER . 10.3 p -43.31 -30.05 0.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 110.733 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' B' ' 5' ' ' PRO . 83.8 m -64.86 -47.29 78.43 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.694 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.547 HG12 ' HZ ' ' A' ' 19' ' ' PHE . 5.5 t -61.39 -46.88 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.721 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' B' ' 15' ' ' SER . 76.4 mt -58.96 -30.27 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.165 -0.959 . . . . 0.0 109.488 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.618 ' HG ' ' CE2' ' B' ' 26' ' ' PHE . 3.2 tt -63.73 -56.81 12.79 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.436 -0.79 . . . . 0.0 110.26 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.666 HG21 HG11 ' A' ' 91' ' ' VAL . 67.2 t -54.38 -40.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.149 -0.969 . . . . 0.0 110.576 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.516 ' HD2' ' CA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -72.9 -44.06 61.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.944 -1.097 . . . . 0.0 109.661 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.436 ' HA ' ' HE2' ' B' ' 14' ' ' LYS . 20.7 p -67.26 -7.87 27.5 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.368 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.496 ' HB2' ' O ' ' B' ' 12' ' ' LEU . 2.0 ttt -93.15 -60.31 1.83 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.897 . . . . 0.0 110.871 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.944 HD22 ' O ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -102.51 91.88 4.42 Favored 'General case' 0 C--O 1.204 -1.315 0 CA-C-O 123.768 1.746 . . . . 0.0 110.667 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.462 ' HG3' ' N ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -124.87 -35.72 2.65 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.137 -0.977 . . . . 0.0 109.763 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.489 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 1.5 tmtm? -137.44 -72.46 0.43 Allowed 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.201 -0.937 . . . . 0.0 110.558 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.449 ' CG ' ' HD2' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -161.23 23.54 0.13 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.138 -0.976 . . . . 0.0 109.501 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.446 ' O ' ' SD ' ' A' ' 124' ' ' MET . 3.6 m -100.97 166.42 10.83 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.65 -0.656 . . . . 0.0 110.903 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.576 ' CD1' ' HG2' ' A' ' 124' ' ' MET . 0.4 OUTLIER -153.63 16.45 0.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.367 -0.833 . . . . 0.0 110.37 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.39 126.34 6.22 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 1.057 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 2.2 m-80 -112.83 135.36 21.62 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.177 -1.19 . . . . 0.0 110.951 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -81.46 11.85 2.92 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.027 1.541 . . . . 0.0 110.015 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.731 ' CZ ' ' HE1' ' A' ' 72' ' ' MET . 3.3 m-85 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.179 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.161 0.505 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -104.31 -55.82 2.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 110.292 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -74.27 -164.35 0.25 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -0.976 . . . . 0.0 110.267 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 5' ' ' THR . 3.2 mt -89.1 99.08 12.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.438 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 4' ' ' LEU . 64.0 p 40.46 65.34 0.78 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.41 -0.806 . . . . 0.0 110.47 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -100.18 -34.68 9.93 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.479 -0.763 . . . . 0.0 110.22 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 6.7 mm-40 -49.71 -68.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.333 -0.855 . . . . 0.0 110.442 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 35.4 mt-30 -41.81 -54.09 3.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.877 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 5' ' ' THR . 58.1 mt -57.33 -38.64 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 109.671 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -58.33 -39.39 79.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.588 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 26.4 mt-10 -60.23 -56.11 25.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -56.82 -36.12 69.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 109.466 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -42.66 98.37 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.294 -0.879 . . . . 0.0 109.045 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 17' ' ' SER . 4.7 tp10 -51.1 -45.26 61.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.403 -0.811 . . . . 0.0 109.149 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.86 -49.18 73.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 109.273 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.853 ' CE1' HD11 ' A' ' 27' ' ' ILE . 21.6 t80 -56.45 -29.38 61.6 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.418 -0.801 . . . . 0.0 109.744 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 3.6 t -68.83 -46.67 67.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 0.0 110.0 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.815 HD13 ' HG3' ' B' ' 14' ' ' LYS . 10.4 tt -55.03 -36.9 65.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 109.629 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 62.4 m-85 -79.38 -52.71 7.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.323 -0.86 . . . . 0.0 110.004 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -68.52 111.58 4.81 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.451 -0.78 . . . . 0.0 110.305 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -90.34 -44.15 9.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -0.841 . . . . 0.0 110.178 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 22.3 p30 -72.68 -16.48 61.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.288 -0.882 . . . . 0.0 110.244 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 64.48 65.78 2.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 21.9 p30 -130.95 -33.13 1.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -1.127 . . . . 0.0 110.235 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.587 ' C ' HG23 ' A' ' 26' ' ' THR . . . 114.33 38.39 1.12 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 25' ' ' GLY . 67.3 p -155.39 103.35 2.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -1.119 . . . . 0.0 110.453 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.853 HD11 ' CE1' ' A' ' 16' ' ' PHE . 9.8 mt -88.98 110.77 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.067 -1.02 . . . . 0.0 110.0 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.928 HG22 HG22 ' A' ' 62' ' ' THR . 59.4 p -100.79 177.39 4.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.8 p -57.65 -19.92 29.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.026 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -73.78 -55.66 5.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.214 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HG2' ' HG3' ' A' ' 21' ' ' LYS . 6.1 mt-10 -64.25 -59.84 3.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.499 HD13 ' CH2' ' B' ' 7' ' ' TRP . 7.7 tp -62.98 -25.36 68.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 110.239 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.47 -35.95 55.29 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -71.58 -46.11 60.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.233 -1.157 . . . . 0.0 110.48 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.5 -40.98 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.204 -0.935 . . . . 0.0 110.394 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.508 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 6.9 mmm -69.26 -31.96 70.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 110.36 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.6 tpt180 -79.35 -20.54 47.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.464 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 68.0 m -70.7 -44.59 66.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 110.692 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.44 -36.1 21.37 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.09 -1.006 . . . . 0.0 110.368 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.26 32.8 0.66 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -120.69 -169.58 1.84 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.2 -1.177 . . . . 0.0 110.28 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -143.9 72.13 16.85 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.263 -0.898 . . . . 0.0 110.215 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.508 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 47.3 Cg_endo -74.22 105.51 2.05 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.035 1.545 . . . . 0.0 110.309 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.4 m -53.98 153.43 4.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.172 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 8.7 tm-20 -65.42 -43.34 90.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 109.956 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.02 -63.15 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.91 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -52.0 -36.44 49.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 5.2 mt -58.52 -50.49 73.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.902 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.502 ' O ' HG22 ' A' ' 52' ' ' ILE . 5.3 tp60 -54.01 -35.68 62.15 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.8 -34.39 69.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.352 -0.843 . . . . 0.0 109.545 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.401 ' HE3' ' CD1' ' B' ' 7' ' ' TRP . 0.2 OUTLIER -70.03 -26.17 63.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.488 -0.758 . . . . 0.0 110.104 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.623 HG13 HD11 ' A' ' 63' ' ' ILE . 1.2 tp -78.62 -41.23 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.986 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.434 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -54.56 -21.77 11.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -57.21 6.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.858 . . . . 0.0 110.068 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.679 ' HB ' HD12 ' A' ' 63' ' ' ILE . 17.1 t -71.69 -23.06 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.152 -0.968 . . . . 0.0 109.926 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -56.18 83.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.353 -0.842 . . . . 0.0 110.364 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -64.08 -71.31 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.096 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 26.2 p-10 -48.22 -42.02 29.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 101.7 41.61 2.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 1.6 p-10 -98.88 -44.34 6.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.118 -1.225 . . . . 0.0 110.077 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 143.48 -47.24 0.8 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.149 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.928 HG22 HG22 ' A' ' 28' ' ' THR . 26.5 p -94.16 158.59 15.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.208 -1.172 . . . . 0.0 110.895 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.679 HD12 ' HB ' ' A' ' 55' ' ' VAL . 12.4 mm -93.07 135.12 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.348 -0.845 . . . . 0.0 110.146 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.487 ' OD1' ' HD2' ' A' ' 66' ' ' PRO . 2.3 t70 -107.24 168.34 9.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.11 -0.994 . . . . 0.0 110.424 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.622 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 t80 -56.02 -44.82 99.88 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.397 -0.814 . . . . 0.0 111.245 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -70.26 -31.59 18.02 Favored 'Trans proline' 0 N--CA 1.482 0.83 0 O-C-N 123.298 1.157 . . . . 0.0 110.269 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.509 ' OE2' ' N ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -63.7 -34.55 78.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 109.341 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -71.61 -42.04 68.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.486 -0.759 . . . . 0.0 109.779 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 mt -58.16 -34.76 70.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.373 -0.829 . . . . 0.0 110.06 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -76.86 -33.74 57.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.881 . . . . 0.0 110.435 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.561 ' SD ' HG22 ' A' ' 55' ' ' VAL . 42.1 ttp -64.84 -63.68 1.06 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.296 -0.877 . . . . 0.0 110.569 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.517 ' SD ' HG22 ' B' ' 8' ' ' THR . 9.9 tpt -54.4 -16.5 2.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.141 -0.974 . . . . 0.0 110.677 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.21 -33.02 14.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.068 -1.02 . . . . 0.0 110.662 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.423 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 1.7 tpt180 -98.64 -9.95 24.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.159 -0.963 . . . . 0.0 110.371 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER -83.68 -20.79 32.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.218 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.442 ' HE2' ' CE ' ' A' ' 72' ' ' MET . 2.1 ttm -94.09 48.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 110.296 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 2.1 mtmt -135.53 70.7 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.263 -0.898 . . . . 0.0 110.107 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 77' ' ' LYS . 7.8 t0 64.02 28.99 14.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.888 . . . . 0.0 109.98 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 2.9 p -132.36 78.5 1.81 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 109.908 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER 67.58 37.07 3.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.89 . . . . 0.0 110.05 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -83.88 -65.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 109.809 179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.51 ' HA ' HD12 ' A' ' 85' ' ' ILE . 1.0 OUTLIER -66.79 -37.1 83.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.378 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -67.04 -29.48 69.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.244 -0.91 . . . . 0.0 109.349 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.565 ' OE2' HD23 ' B' ' 12' ' ' LEU . 20.9 tt0 -61.71 -26.72 68.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.439 -0.788 . . . . 0.0 109.608 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 82' ' ' GLU . 65.3 mt -69.64 -36.79 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.464 -0.894 . . . . 0.0 108.86 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 89' ' ' PHE . 16.0 ttt180 -59.21 -36.85 76.12 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.562 0.696 . . . . 0.0 109.124 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.615 ' HB3' HG21 ' B' ' 9' ' ' THR . 6.0 mm-40 -67.09 -54.17 23.95 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.403 -0.811 . . . . 0.0 109.421 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.36 -31.28 21.65 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.136 -0.978 . . . . 0.0 108.83 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.46 ' HB3' ' O ' ' A' ' 86' ' ' ARG . 82.3 t80 -68.16 -67.1 0.49 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.418 -0.801 . . . . 0.0 109.912 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -45.25 -35.81 3.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.758 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.661 HG12 HG21 ' A' ' 108' ' ' VAL . 25.2 t -56.87 -50.39 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 109.344 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.629 ' CE1' HG11 ' A' ' 108' ' ' VAL . 25.3 m-85 -60.97 -31.62 71.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.672 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -98.77 62.2 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.373 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -43.42 -34.29 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.91 . . . . 0.0 110.067 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.4 p30 -77.08 -41.87 40.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 84.51 52.46 3.54 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.7 p-10 -100.06 -33.83 10.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.182 -1.187 . . . . 0.0 110.115 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.587 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 125.03 22.92 1.87 Allowed Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.577 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 85.9 m-85 -157.25 141.2 16.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.985 -1.303 . . . . 0.0 110.676 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 135' ' ' GLN . 6.3 mt -109.58 143.96 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.861 . . . . 0.0 110.153 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -139.6 152.3 46.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.145 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.39 -27.03 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.887 . . . . 0.0 109.867 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -68.92 -47.75 64.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.562 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 6.9 mt-10 -63.79 -43.63 95.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.467 -0.771 . . . . 0.0 109.806 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.666 HD13 HD11 ' A' ' 125' ' ' ILE . 2.6 mt -67.58 -34.8 77.77 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.378 -0.826 . . . . 0.0 109.581 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.474 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 43.0 ttp180 -66.87 -27.94 67.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.292 -0.88 . . . . 0.0 109.752 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.67 -23.41 31.77 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.292 -0.88 . . . . 0.0 109.953 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.661 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -91.34 -29.12 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 109.97 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.555 ' HA ' ' CD2' ' B' ' 17' ' ' LEU . 21.9 ptp -76.84 -34.38 57.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 110.338 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.521 ' N ' ' HG3' ' A' ' 109' ' ' MET . 5.4 m -76.66 -28.65 56.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.052 -1.03 . . . . 0.0 109.65 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 38' ' ' SER . 2.3 m120 -82.7 -23.46 34.09 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.355 -0.84 . . . . 0.0 109.917 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.793 ' CD1' HG12 ' B' ' 13' ' ' VAL . 2.0 mt -82.84 -28.69 29.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.831 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.67 -64.24 0.39 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 109' ' ' MET . 4.1 tt0 -108.01 144.81 34.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -1.17 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.512 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 0.2 OUTLIER -119.36 22.33 11.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.855 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.747 HD11 ' C ' ' B' ' 17' ' ' LEU . 5.1 mp 46.9 -176.59 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.566 -0.709 . . . . 0.0 110.687 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.89 -143.59 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.232 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.11 -51.0 2.12 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.169 -0.957 . . . . 0.0 110.178 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -60.93 -38.47 85.93 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 109.519 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.59 -52.87 59.05 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.294 -0.879 . . . . 0.0 109.298 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 125' ' ' ILE . 41.4 t -47.18 -42.22 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.273 -0.892 . . . . 0.0 109.74 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.63 -63.71 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.808 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -48.12 -24.8 1.22 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.397 -0.814 . . . . 0.0 109.732 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.445 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -70.1 -44.08 69.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.779 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.666 HD11 HD13 ' A' ' 105' ' ' LEU . 25.9 mm -78.62 -25.39 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.365 -0.834 . . . . 0.0 110.102 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.25 -69.84 0.37 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.279 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -47.49 -25.37 1.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -0.966 . . . . 0.0 110.19 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -78.24 -49.99 12.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 128' ' ' ALA . 34.7 t0 -41.95 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.487 -0.758 . . . . 0.0 110.547 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . 3.3 mp -75.37 -47.46 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.909 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.407 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 16.2 p-10 -77.23 -18.31 57.78 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.404 -0.81 . . . . 0.0 109.987 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.413 ' HA2' ' CG ' ' A' ' 129' ' ' ASP . . . 76.94 56.49 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 31.1 p30 -107.77 -8.51 16.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.08 17.31 56.27 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 10.2 pt20 -168.44 150.63 5.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -1.133 . . . . 0.0 109.95 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 13.0 t -89.37 125.68 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.173 -0.955 . . . . 0.0 110.435 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 9.6 t30 -93.8 -173.72 3.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.279 -0.888 . . . . 0.0 110.243 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 89' ' ' PHE . 64.1 t80 -69.85 -56.54 6.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.181 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.68 -58.49 4.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.843 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' OE1' HD12 ' A' ' 130' ' ' ILE . 36.3 mt-10 -52.11 -45.45 64.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.317 -0.864 . . . . 0.0 109.883 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -57.86 -26.69 62.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 0.0 109.942 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.33 -39.8 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.835 . . . . 0.0 110.347 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -56.01 -46.88 78.62 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.215 -0.928 . . . . 0.0 110.062 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 77.5 mmm -63.51 -27.47 69.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.36 -0.837 . . . . 0.0 110.308 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.54 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 3.9 mtt -90.18 -34.76 15.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.195 -0.941 . . . . 0.0 110.639 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 146' ' ' THR . 9.7 t -170.7 96.13 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.026 -1.046 . . . . 0.0 110.138 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.26 54.0 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 110.223 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.296 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.241 0.544 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.53 -148.93 0.35 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 110.223 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' B' ' 3' ' ' LEU . 0.7 OUTLIER -111.96 4.11 17.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 22.3 mt -105.86 147.76 35.31 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.342 -0.848 . . . . 0.0 109.708 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' B' ' 4' ' ' ILE . 39.6 Cg_endo -65.43 149.2 88.24 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.639 1.336 . . . . 0.0 110.272 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.576 ' O ' ' N ' ' B' ' 8' ' ' THR . 45.2 m -94.08 92.03 7.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.278 -0.889 . . . . 0.0 111.542 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.513 ' CE2' HG21 ' A' ' 55' ' ' VAL . 1.8 m95 37.48 -86.98 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.614 -0.679 . . . . 0.0 111.313 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.596 HG21 ' HG2' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -42.83 -48.62 5.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.247 -0.908 . . . . 0.0 109.802 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 87' ' ' GLU . 41.2 m -45.79 -37.76 6.41 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.378 -0.826 . . . . 0.0 109.218 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.462 ' H ' HG23 ' B' ' 10' ' ' VAL . 5.7 t -67.94 -42.03 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.71 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.495 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 9.7 mm -69.47 -26.73 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.785 . . . . 0.0 110.177 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.565 HD23 ' OE2' ' A' ' 84' ' ' GLU . 1.3 mm? -67.55 -56.52 9.14 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.392 -0.817 . . . . 0.0 110.138 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.793 HG12 ' CD1' ' A' ' 112' ' ' LEU . 9.6 t -57.31 -39.98 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.309 -0.869 . . . . 0.0 110.341 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.815 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.01 -32.28 72.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.767 -1.208 . . . . 0.0 109.596 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -41.57 89.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.339 -0.85 . . . . 0.0 109.239 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 7.2 mtt -75.12 -25.96 58.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.905 . . . . 0.0 109.753 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.747 ' C ' HD11 ' A' ' 116' ' ' LEU . 5.6 mp -81.25 49.94 1.35 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.375 -0.828 . . . . 0.0 109.697 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.512 ' N ' HD11 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -126.12 -73.5 0.62 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.247 -0.908 . . . . 0.0 111.714 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -158.67 90.64 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.105 -0.997 . . . . 0.0 111.177 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' B' ' 20' ' ' ARG . 19.6 ttp180 59.94 5.2 0.7 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.211 -0.931 . . . . 0.0 110.911 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.25 84.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.851 -1.156 . . . . 0.0 110.233 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.75 54.38 1.95 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 110.35 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.97 -111.7 0.64 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 145' ' ' MET . 1.2 t-20 -128.35 73.4 80.12 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.27 -1.135 . . . . 0.0 110.044 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.74 -2.26 10.6 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.127 1.593 . . . . 0.0 110.548 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.513 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 22.9 m-85 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.133 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.167 0.508 . . . . 0.0 110.179 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 1' ' ' ALA . 1.7 t70 -43.61 154.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.123 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' LEU . 4.2 tt0 -88.61 49.08 1.72 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 110.262 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 3' ' ' GLN . 6.6 mt -55.85 -162.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.157 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.456 ' CB ' ' HG3' ' A' ' 8' ' ' GLN . 15.1 p -133.19 127.38 33.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.963 . . . . 0.0 110.398 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.55 -43.62 54.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.86 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -50.12 -53.82 24.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 109.644 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.456 ' HG3' ' CB ' ' A' ' 5' ' ' THR . 4.5 mt-30 -50.09 -52.44 34.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.54 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.3 mt -53.32 -48.69 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.277 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 14' ' ' GLU . . . -56.46 -38.38 71.6 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.287 -0.883 . . . . 0.0 109.101 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -54.07 -52.42 60.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.411 -0.805 . . . . 0.0 109.184 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.555 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 34.4 m-85 -63.32 -40.48 97.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.237 -0.915 . . . . 0.0 109.13 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -55.89 -44.0 77.77 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.466 -0.771 . . . . 0.0 108.94 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 59.7 mt-10 -56.87 -46.38 81.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.451 -0.781 . . . . 0.0 109.032 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.579 ' HB2' ' HD2' ' B' ' 14' ' ' LYS . . . -67.62 -51.66 47.48 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.322 -0.861 . . . . 0.0 109.281 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.598 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 19.8 t80 -45.12 -34.02 2.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.415 -0.803 . . . . 0.0 108.845 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.9 p -81.73 -32.58 31.51 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.627 -0.671 . . . . 0.0 109.215 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.748 ' O ' HD23 ' A' ' 18' ' ' LEU . 6.8 tt -49.74 -34.78 20.01 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.322 -0.862 . . . . 0.0 109.177 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.452 ' HA ' HG21 ' A' ' 35' ' ' VAL . 57.7 m-85 -82.61 -46.02 13.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.447 -0.783 . . . . 0.0 109.853 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.0 103.65 2.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 109.951 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -91.45 -31.21 16.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 110.454 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 29.9 p-10 -75.02 -46.59 34.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.299 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 108.94 45.65 1.01 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 49.1 p30 -115.73 -18.17 10.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -1.179 . . . . 0.0 110.009 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 91.69 5.42 66.69 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 16.7 p -120.14 116.24 25.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -1.141 . . . . 0.0 110.484 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.732 HD12 ' HB ' ' A' ' 63' ' ' ILE . 14.2 mt -90.84 124.33 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 109.877 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.414 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 7.8 p -100.3 178.36 4.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -63.12 -32.54 73.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 110.105 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 26.5 tptt -71.52 -54.4 10.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.273 -0.892 . . . . 0.0 110.308 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 41.3 mt-10 -49.41 -61.98 1.8 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 0.0 110.153 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.439 HD22 ' CZ2' ' B' ' 7' ' ' TRP . 35.5 tp -57.32 -31.5 65.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.97 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' HA2' HD11 ' A' ' 48' ' ' LEU . . . -67.03 -28.12 73.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.9 m -73.72 -52.08 14.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -1.101 . . . . 0.0 109.828 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.452 HG21 ' HA ' ' A' ' 19' ' ' PHE . 43.2 t -63.07 -35.37 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.947 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.5 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 4.1 mmt -66.26 -35.71 81.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.273 -0.892 . . . . 0.0 109.938 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.37 -24.4 60.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 110.117 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -76.15 -32.57 59.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.36 -0.837 . . . . 0.0 110.677 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 mt -53.81 -49.46 68.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.127 -0.983 . . . . 0.0 110.405 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 142.15 47.38 0.05 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 40' ' ' GLY . 6.4 mm-40 -153.15 -167.4 2.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -1.127 . . . . 0.0 110.233 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -140.28 82.98 15.99 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.23 -0.919 . . . . 0.0 110.428 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 49.7 Cg_endo -76.79 148.63 28.76 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.978 1.515 . . . . 0.0 109.99 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.44 ' HB ' ' OE2' ' A' ' 47' ' ' GLU . 53.9 m -100.11 133.52 44.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.974 . . . . 0.0 110.227 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -42.34 -42.92 3.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.327 -0.858 . . . . 0.0 110.169 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' H ' HG22 ' A' ' 44' ' ' THR . . . -57.23 -54.4 47.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 109.742 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.44 ' OE2' ' HB ' ' A' ' 44' ' ' THR . 2.4 mt-10 -52.19 -38.02 56.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.369 -0.832 . . . . 0.0 109.681 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -56.7 -50.78 71.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.889 . . . . 0.0 109.724 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -50.77 -45.1 58.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.528 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.83 -23.58 66.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.439 -0.788 . . . . 0.0 109.537 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 2.2 mtp -86.92 -49.38 7.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 0.0 110.083 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 tp -57.47 -29.22 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.734 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -71.78 -5.29 33.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 110.474 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 51' ' ' MET . 2.4 mt-10 -86.95 -55.57 3.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 110.19 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 57' ' ' ALA . 38.9 t -70.25 -21.85 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 110.294 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 1.2 m-20 -66.89 64.01 0.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.185 -0.947 . . . . 0.0 110.389 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -51.5 -21.34 2.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.198 -0.939 . . . . 0.0 110.23 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' CG ' ' OD1' ' A' ' 60' ' ' ASN . 1.5 p30 -100.38 -32.44 10.83 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.34 -0.85 . . . . 0.0 110.418 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 91.71 52.82 2.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.436 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 5.7 m120 -99.25 -32.61 11.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.179 -1.189 . . . . 0.0 109.945 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.87 -14.3 12.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.4 p -139.66 165.14 28.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -1.07 . . . . 0.0 109.999 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.732 ' HB ' HD12 ' A' ' 27' ' ' ILE . 10.1 mm -96.83 165.89 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.319 -0.863 . . . . 0.0 110.102 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.541 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 35.2 m-20 -140.24 179.55 6.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.124 -0.985 . . . . 0.0 110.513 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.621 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 24.5 t80 -63.2 -44.27 83.15 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.33 -0.857 . . . . 0.0 111.52 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_endo -70.85 -36.04 8.51 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.359 1.189 . . . . 0.0 110.248 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 5.7 mt-10 -64.09 -29.32 70.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.393 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -50.77 23.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.0 mm? -50.52 -50.6 52.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 0.0 110.449 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.56 HG22 ' HG3' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -60.79 -64.21 1.03 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.232 -0.917 . . . . 0.0 110.805 -179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' HB2' ' A' ' 75' ' ' LYS . 9.7 tpt -43.02 -62.27 1.07 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.042 -1.037 . . . . 0.0 110.696 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.555 ' HG3' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -39.16 -32.55 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.393 -0.817 . . . . 0.0 110.748 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 77' ' ' LYS . . . -104.09 -48.26 3.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.164 -0.96 . . . . 0.0 110.474 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.56 ' HG3' HG22 ' A' ' 70' ' ' THR . 4.7 mtp180 -49.93 -67.39 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.256 -0.902 . . . . 0.0 110.438 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.75 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.0 OUTLIER -42.45 -44.94 4.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.375 -0.828 . . . . 0.0 110.42 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.0 mtt -98.47 48.13 0.99 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.313 -0.867 . . . . 0.0 110.325 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -128.86 -3.25 5.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.16 -0.963 . . . . 0.0 110.416 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -103.77 -75.52 0.61 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.247 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 p -142.79 -36.89 0.38 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.272 -0.892 . . . . 0.0 110.445 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.29 80.09 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.24 -0.912 . . . . 0.0 110.311 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.0 t -113.55 -48.89 2.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.904 . . . . 0.0 110.058 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -89.76 -18.31 26.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.52 -24.46 66.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.883 . . . . 0.0 109.678 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' HB3' ' CD1' ' B' ' 12' ' ' LEU . 9.2 mm-40 -67.7 -15.84 63.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.729 HG23 ' CE1' ' A' ' 141' ' ' PHE . 97.2 mt -70.68 -36.94 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.443 -0.785 . . . . 0.0 109.466 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 20.4 ttm-85 -59.71 -44.36 93.74 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.504 -0.747 . . . . 0.0 109.61 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 6.1 mm-40 -64.42 -51.6 62.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.286 -0.884 . . . . 0.0 109.609 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.826 ' HB2' HD22 ' B' ' 12' ' ' LEU . . . -60.39 -32.56 71.42 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.228 -0.92 . . . . 0.0 109.547 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.478 ' CE2' ' CG ' ' A' ' 138' ' ' TYR . 38.9 t80 -64.32 -43.12 95.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -29.04 70.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.834 . . . . 0.0 109.549 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.625 HG11 HG21 ' B' ' 13' ' ' VAL . 28.5 t -66.94 -51.94 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 0.0 110.209 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.706 ' CE1' HD23 ' A' ' 105' ' ' LEU . 11.8 m-85 -69.73 -29.71 67.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.199 -0.938 . . . . 0.0 110.013 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 94' ' ' LYS . 32.7 t0 -81.84 51.42 1.72 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 110.185 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -43.82 -30.37 0.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.214 -0.929 . . . . 0.0 110.259 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.95 -41.14 52.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.922 . . . . 0.0 110.119 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.98 -25.07 29.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.423 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 23.8 p-10 -51.03 -41.66 59.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.238 -1.154 . . . . 0.0 110.328 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 119.02 60.13 0.27 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 1.9 m-85 -169.73 136.09 1.55 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.271 -1.135 . . . . 0.0 109.967 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 21.8 mt -112.49 106.47 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.175 -0.953 . . . . 0.0 110.58 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 102' ' ' ALA . 45.0 t -94.54 149.76 20.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.181 -0.95 . . . . 0.0 109.513 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.38 -27.25 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 0.0 109.827 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -71.95 -44.76 63.06 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 0.0 109.464 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 107' ' ' HIS . 21.6 mt-10 -60.94 -41.45 96.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 109.565 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.97 HD12 HD11 ' A' ' 125' ' ' ILE . 1.2 mt -58.34 -44.59 88.77 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.349 -0.844 . . . . 0.0 109.364 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.541 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.0 OUTLIER -58.26 -35.87 72.4 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.318 -0.864 . . . . 0.0 109.197 179.232 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.443 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 46.4 t60 -55.72 -52.67 63.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.43 -0.794 . . . . 0.0 109.173 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.623 HG21 HG12 ' A' ' 91' ' ' VAL . 1.5 t -74.3 -35.51 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.537 -0.727 . . . . 0.0 109.227 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.596 ' HE1' ' HB2' ' A' ' 116' ' ' LEU . 10.8 ttm -49.73 -60.69 2.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.553 -0.717 . . . . 0.0 110.608 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.546 HG23 ' HE2' ' A' ' 115' ' ' LYS . 12.1 m -78.34 -17.45 56.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.314 -0.866 . . . . 0.0 110.68 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.537 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 17.7 m-20 -75.56 -14.78 60.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.002 . . . . 0.0 110.056 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' B' ' 14' ' ' LYS . 3.1 mt -101.21 -52.7 3.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.627 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.74 -18.97 0.18 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.273 -1.441 . . . . 0.0 110.87 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 35.8 tp10 -108.1 155.99 19.79 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.843 -1.387 . . . . 0.0 111.112 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.546 ' HE2' HG23 ' A' ' 110' ' ' THR . 2.2 mttm -131.25 64.36 1.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.611 -0.68 . . . . 0.0 109.521 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.596 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 1.8 mp -36.18 151.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.485 0.66 . . . . 0.0 111.126 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.563 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -61.87 -174.48 0.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.778 . . . . 0.0 110.152 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.87 -59.5 2.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.208 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.88 -42.75 37.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 109.605 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -61.61 -53.7 52.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.545 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 117' ' ' THR . 53.0 t -57.81 -41.11 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 109.921 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -61.63 -58.24 8.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.334 -0.854 . . . . 0.0 109.845 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -54.81 -37.59 66.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.308 -0.87 . . . . 0.0 109.706 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.551 ' O ' ' CD2' ' B' ' 22' ' ' PHE . 9.4 ttt -52.42 -44.14 65.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.911 . . . . 0.0 109.515 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.97 HD11 HD12 ' A' ' 105' ' ' LEU . 38.7 mm -78.44 -53.08 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.066 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -44.11 -68.52 0.19 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.83 . . . . 0.0 110.636 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 126' ' ' ARG . 1.3 tp10 -39.02 -53.93 1.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.535 -0.728 . . . . 0.0 110.755 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.582 ' HB3' HG22 ' A' ' 136' ' ' VAL . . . -58.92 -34.88 72.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 110.382 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.456 ' OD2' ' N ' ' A' ' 135' ' ' GLN . 1.6 t0 -65.78 68.45 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.434 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -60.07 -42.36 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.27 -0.894 . . . . 0.0 109.908 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.6 -35.97 78.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.382 -0.824 . . . . 0.0 110.195 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.53 71.92 1.24 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.0 p30 -121.71 -25.29 5.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.308 -1.113 . . . . 0.0 110.089 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 129.6 -20.6 5.18 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.456 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 16.0 pt20 -154.6 170.23 22.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -1.154 . . . . 0.0 110.26 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 128' ' ' ALA . 46.5 t -79.49 164.44 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.252 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.427 ' N ' HG12 ' A' ' 136' ' ' VAL . 12.5 t-20 -133.4 173.18 11.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.305 -0.872 . . . . 0.0 110.112 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.478 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -57.38 -68.22 0.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.261 -0.899 . . . . 0.0 110.26 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 143' ' ' GLN . 10.3 mm-40 -40.81 -53.26 2.9 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.447 -0.783 . . . . 0.0 110.023 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 141' ' ' PHE . 50.3 mt-10 -55.41 -57.86 10.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 109.505 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.729 ' CE1' HG23 ' A' ' 85' ' ' ILE . 3.7 t80 -43.62 -27.38 0.3 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.429 -0.794 . . . . 0.0 109.5 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 144' ' ' MET . 73.9 t -99.56 -64.39 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 139' ' ' GLU . 28.5 tp60 -43.07 -24.74 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.306 -0.871 . . . . 0.0 110.604 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 142' ' ' VAL . 1.8 tpt -84.31 -32.66 24.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 111.025 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.9 mtp -100.66 -11.42 20.01 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.017 -1.052 . . . . 0.0 111.947 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 146' ' ' THR . 9.0 t -156.06 88.84 1.11 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.705 -1.247 . . . . 0.0 111.175 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 148' ' ' LYS . . . -100.35 34.09 2.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.013 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 147' ' ' ALA . 7.9 tptp . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.136 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' B' ' 2' ' ' LYS . 12.8 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.241 0.543 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' B' ' 1' ' ' VAL . 5.3 mttt -160.62 157.15 26.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.975 . . . . 0.0 110.44 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 9.1 mt -107.31 -17.09 14.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.862 . . . . 0.0 109.269 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.893 HG23 ' HD2' ' B' ' 5' ' ' PRO . 22.1 mt -146.62 157.38 48.04 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.893 ' HD2' HG23 ' B' ' 4' ' ' ILE . 36.0 Cg_endo -59.38 114.61 2.11 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.303 1.159 . . . . 0.0 109.858 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.538 ' O ' ' N ' ' B' ' 8' ' ' THR . 13.5 t -78.34 90.07 4.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.573 -0.704 . . . . 0.0 112.303 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.481 ' O ' ' N ' ' B' ' 10' ' ' VAL . 8.7 m95 43.99 -86.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.59 -0.694 . . . . 0.0 112.229 177.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.75 HG21 ' HG2' ' A' ' 75' ' ' LYS . 63.1 p -38.57 -46.96 1.25 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.537 -0.727 . . . . 0.0 110.945 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 97.5 m -48.87 -36.9 18.09 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.242 -0.911 . . . . 0.0 109.276 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' B' ' 7' ' ' TRP . 60.5 t -73.05 -43.07 59.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.37 -0.831 . . . . 0.0 109.844 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 46.7 mt -70.94 -21.82 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 109.974 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.826 HD22 ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -72.53 -50.62 24.46 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.625 HG21 HG11 ' A' ' 91' ' ' VAL . 42.7 t -71.14 -39.01 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.124 -0.985 . . . . 0.0 110.446 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.714 ' HA ' HD13 ' A' ' 112' ' ' LEU . 2.7 tmtt? -59.64 -47.54 85.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.775 -1.203 . . . . 0.0 109.263 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 35.0 p -53.52 -48.85 68.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.451 -0.781 . . . . 0.0 109.228 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 10.6 ttm -54.82 -27.7 43.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.314 -0.866 . . . . 0.0 109.872 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.697 HD22 ' CD1' ' A' ' 112' ' ' LEU . 7.0 mp -79.71 49.51 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.249 -0.907 . . . . 0.0 110.574 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -96.6 -83.06 0.39 Allowed 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.331 -0.856 . . . . 0.0 109.769 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -140.44 -41.14 0.42 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.365 -0.835 . . . . 0.0 109.475 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' B' ' 21' ' ' SER . 2.4 ttt-85 -149.63 -41.53 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' B' ' 22' ' ' PHE . 26.8 t 29.73 -126.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.093 0.473 . . . . 0.0 111.32 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 124' ' ' MET . 1.5 m-85 61.99 57.74 2.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 110.519 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.468 ' C ' ' HD2' ' B' ' 25' ' ' PRO . . . -142.99 -165.01 10.46 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.721 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 39.0 p-10 -107.1 -2.83 0.11 Allowed Pre-proline 0 CA--C 1.569 1.697 0 O-C-N 121.28 -1.129 . . . . 0.0 112.974 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 48.0 Cg_endo -73.46 76.92 2.63 Favored 'Trans proline' 0 N--CA 1.485 0.971 0 O-C-N 122.304 0.634 . . . . 0.0 110.498 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.431 ' CE2' ' HG ' ' B' ' 12' ' ' LEU . 12.8 t80 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.228 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.252 0.549 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 6.4 t0 178.64 121.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.323 -0.861 . . . . 0.0 110.222 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -55.82 107.35 0.34 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 110.246 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 5' ' ' THR . 0.5 OUTLIER -51.3 132.07 28.69 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.227 -0.921 . . . . 0.0 110.38 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.604 ' O ' HD12 ' A' ' 9' ' ' ILE . 3.0 p -151.29 107.53 3.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.29 -0.881 . . . . 0.0 110.172 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 7' ' ' GLU . 1.5 tp10 -67.47 -52.81 34.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 110.695 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -43.77 -70.11 0.12 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.105 -0.997 . . . . 0.0 110.45 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.66 -58.09 4.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.211 -0.931 . . . . 0.0 110.464 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.604 HD12 ' O ' ' A' ' 5' ' ' THR . 97.7 mt -44.7 -50.02 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.226 -0.921 . . . . 0.0 110.296 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -49.84 -51.31 40.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 12' ' ' PHE . 9.5 tm-20 -51.58 -45.46 63.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 110.089 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CD1' ' OE1' ' A' ' 11' ' ' GLU . 18.8 m-30 -55.2 -44.42 75.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 110.014 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -53.68 -49.77 67.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.936 . . . . 0.0 109.803 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.47 -47.18 66.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 110.083 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -60.96 -46.55 90.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.4 -0.813 . . . . 0.0 110.235 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.525 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 34.9 t80 -57.65 -45.36 85.62 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 110.041 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.0 t -70.18 -17.1 63.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.85 . . . . 0.0 110.0 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.923 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.0 tt -69.99 -55.42 9.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.976 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.46 ' N ' HD23 ' A' ' 18' ' ' LEU . 91.4 m-85 -72.43 -11.97 60.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 0.0 110.27 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 21' ' ' LYS . 25.4 t0 -97.5 69.54 2.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.815 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' ASP . 20.3 mmtt -42.47 -71.24 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.328 -0.858 . . . . 0.0 110.126 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD2' ' CG ' ' A' ' 24' ' ' ASP . 2.4 p-10 -51.95 -41.23 61.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.383 -0.823 . . . . 0.0 110.062 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.4 46.72 5.71 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.464 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 39.4 p-10 -103.23 6.79 38.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -1.202 . . . . 0.0 110.238 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.69 ' O ' HG23 ' A' ' 26' ' ' THR . . . 78.3 30.38 50.25 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 25' ' ' GLY . 10.0 p -158.12 104.09 1.87 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -1.139 . . . . 0.0 110.28 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.53 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 9.5 mt -80.6 125.52 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.227 -0.921 . . . . 0.0 109.8 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p -100.1 165.74 11.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.385 -0.822 . . . . 0.0 110.68 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.9 p -56.47 -41.69 76.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.851 . . . . 0.0 110.214 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -62.02 -53.16 59.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 110.248 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -52.02 -68.74 0.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.23 -0.919 . . . . 0.0 110.092 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.516 HD22 HD11 ' A' ' 52' ' ' ILE . 23.8 tp -49.58 -32.51 12.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.898 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.97 -53.94 36.95 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.0 m -48.12 -47.17 34.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -1.151 . . . . 0.0 109.686 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.444 ' H ' HG23 ' A' ' 35' ' ' VAL . 6.3 t -61.01 -51.49 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.352 -0.843 . . . . 0.0 109.739 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.466 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 5.2 mmt -57.88 -39.61 78.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.84 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -34.9 72.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 110.016 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 39' ' ' LEU . 1.4 m -68.07 -48.11 66.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.164 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 38' ' ' SER . 9.5 mt -44.21 -25.3 0.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.873 . . . . 0.0 110.261 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.81 50.64 0.68 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 36' ' ' MET . 0.3 OUTLIER -154.61 -163.31 1.56 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -1.127 . . . . 0.0 110.224 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -151.79 102.15 2.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.055 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.62 119.23 5.82 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.016 1.535 . . . . 0.0 110.524 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 47' ' ' GLU . 9.1 m -76.05 155.3 34.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.301 -0.874 . . . . 0.0 110.22 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -45.64 -69.64 0.13 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 110.026 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.06 -47.28 65.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.999 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' CG ' ' HB ' ' A' ' 44' ' ' THR . 13.0 mt-10 -46.35 -55.44 7.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.265 -0.897 . . . . 0.0 110.095 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.425 HD23 HD23 ' A' ' 32' ' ' LEU . 1.1 mt -53.78 -40.26 66.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.75 -34.7 77.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.974 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.2 -41.15 97.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.838 . . . . 0.0 110.156 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.8 mtp -74.7 -41.27 60.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.316 -0.865 . . . . 0.0 110.251 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.516 HD11 HD22 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -71.15 -14.84 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.197 -0.939 . . . . 0.0 109.699 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.87 -18.63 36.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.288 -0.883 . . . . 0.0 110.187 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.86 -50.95 9.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.521 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 57' ' ' ALA . 10.7 t -72.95 -22.23 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.175 -0.953 . . . . 0.0 110.021 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.87 86.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.363 -0.835 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -80.31 -46.11 16.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.202 -0.936 . . . . 0.0 110.436 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 12.2 p-10 -75.94 -42.5 48.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.084 -1.01 . . . . 0.0 110.409 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.53 44.92 2.22 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 27.0 p-10 -99.48 -38.2 8.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.149 -1.206 . . . . 0.0 110.383 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 128.78 0.95 6.02 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.4 p -145.85 161.77 39.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -1.127 . . . . 0.0 110.072 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 26' ' ' THR . 17.2 mm -86.69 152.21 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.185 -0.947 . . . . 0.0 110.518 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.525 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 29.6 m-20 -127.35 -173.15 2.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 110.542 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.763 ' CE1' HD11 ' A' ' 69' ' ' LEU . 5.0 t80 -74.39 -42.07 5.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.418 -0.801 . . . . 0.0 111.326 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -72.94 -24.57 17.41 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.274 1.144 . . . . 0.0 110.395 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 3.5 mt-10 -70.82 -32.43 69.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.394 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -77.41 -33.81 54.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.893 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.763 HD11 ' CE1' ' A' ' 65' ' ' PHE . 85.1 mt -72.75 -26.91 61.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.339 -0.851 . . . . 0.0 111.21 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 p -89.32 -34.77 16.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.902 -1.124 . . . . 0.0 111.227 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.419 ' HE1' HG23 ' B' ' 8' ' ' THR . 0.3 OUTLIER -74.59 -39.24 62.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.137 -0.977 . . . . 0.0 111.022 -179.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.844 ' SD ' HG21 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -63.87 -22.11 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.05 -1.031 . . . . 0.0 110.879 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -94.94 -9.72 33.24 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.928 -1.107 . . . . 0.0 110.882 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 27.0 tpt180 -82.36 -46.88 13.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.161 -0.962 . . . . 0.0 110.747 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.62 -21.24 35.16 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 110.683 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.556 ' SD ' ' HE3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -100.51 63.19 1.08 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.17 -0.956 . . . . 0.0 110.468 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -168.34 69.25 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.238 -0.914 . . . . 0.0 110.467 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 79' ' ' THR . 0.8 OUTLIER 65.72 71.98 0.42 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 78' ' ' ASP . 17.6 p -158.66 -100.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.276 -0.89 . . . . 0.0 110.25 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.535 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -124.27 80.86 1.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.048 -1.033 . . . . 0.0 109.856 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.9 m -96.12 -43.67 7.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.367 -0.833 . . . . 0.0 109.442 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.53 -31.59 69.53 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.434 -0.792 . . . . 0.0 109.402 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.05 -39.3 34.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.468 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 80' ' ' ASP . 6.0 mm-40 -72.61 -27.0 61.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.622 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.77 -26.19 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.404 ' HG2' ' OH ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -68.96 -29.1 67.26 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.39 0.614 . . . . 0.0 109.444 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.907 ' HB3' HG21 ' B' ' 9' ' ' THR . 24.7 mt-10 -76.57 -47.79 21.36 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.281 -0.887 . . . . 0.0 109.199 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.579 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -57.97 -33.88 69.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.083 -1.01 . . . . 0.0 108.86 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -66.76 -48.09 70.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.432 -0.792 . . . . 0.0 109.464 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -52.69 -30.89 34.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.387 -0.821 . . . . 0.0 109.573 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 63.7 t -67.72 -53.18 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.818 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.669 ' CB ' HD13 ' A' ' 100' ' ' ILE . 67.0 m-85 -63.02 -15.02 55.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.135 -0.978 . . . . 0.0 109.989 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -100.04 65.01 1.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 110.436 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -40.97 -72.05 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.383 -0.823 . . . . 0.0 110.486 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 2.1 p30 -61.03 -28.44 69.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.01 50.13 7.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -99.73 -7.27 25.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.294 -1.121 . . . . 0.0 110.357 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.7 29.58 8.62 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.417 ' CD1' ' CD ' ' A' ' 135' ' ' GLN . 0.9 OUTLIER -161.31 143.19 11.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -1.139 . . . . 0.0 110.081 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.669 HD13 ' CB ' ' A' ' 92' ' ' PHE . 17.3 mt -118.71 158.26 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.522 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 102' ' ' ALA . 23.2 p -148.07 155.76 41.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.387 -0.82 . . . . 0.0 109.927 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.1 -43.1 3.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.332 -0.855 . . . . 0.0 110.205 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.78 -51.09 68.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.839 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 92' ' ' PHE . 17.9 mt-10 -58.74 -47.75 83.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 0.0 109.959 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.0 HD12 ' CD1' ' A' ' 125' ' ' ILE . 2.1 mt -62.62 -33.92 75.99 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.271 -0.893 . . . . 0.0 109.696 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -61.63 -34.07 75.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.248 -0.908 . . . . 0.0 109.431 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 10.0 t-80 -68.26 -43.67 77.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.402 -0.812 . . . . 0.0 109.588 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.675 HG13 HD12 ' A' ' 112' ' ' LEU . 1.2 t -64.16 -34.42 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 109.896 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.991 ' HA ' HD21 ' B' ' 17' ' ' LEU . 4.8 mtt -53.63 -70.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.608 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.6 m -55.38 -16.78 3.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.898 . . . . 0.0 110.554 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 9.0 m120 -94.67 -6.49 43.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.103 -0.998 . . . . 0.0 110.392 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.923 ' O ' HD11 ' A' ' 18' ' ' LEU . 9.6 mt -132.06 6.95 4.28 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.037 -1.04 . . . . 0.0 111.686 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.3 -93.34 0.13 Allowed Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.404 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' CG ' ' N ' ' A' ' 115' ' ' LYS . 15.3 tt0 -136.53 166.07 24.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -1.076 . . . . 0.0 110.408 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -103.6 118.66 37.23 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.641 ' N ' HD12 ' A' ' 116' ' ' LEU . 9.3 mp -64.83 155.31 34.4 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 121.446 -0.784 . . . . 0.0 110.336 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.637 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -49.09 178.8 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.365 -0.835 . . . . 0.0 109.274 179.436 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -72.79 -57.23 4.24 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.89 -1.131 . . . . 0.0 110.263 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.97 -49.01 31.91 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.195 -0.94 . . . . 0.0 109.669 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -57.69 -60.51 3.58 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 108.978 179.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 117' ' ' THR . 79.1 t -47.32 -44.58 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.299 -0.876 . . . . 0.0 109.416 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -50.53 71.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.292 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.569 ' HB3' ' HG3' ' B' ' 20' ' ' ARG . 0.2 OUTLIER -57.83 -31.24 66.44 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.183 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.571 ' SD ' HD13 ' A' ' 105' ' ' LEU . 9.3 ttt -60.1 -43.85 95.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.475 -0.766 . . . . 0.0 109.294 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.0 ' CD1' HD12 ' A' ' 105' ' ' LEU . 37.6 mm -84.87 -27.12 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.923 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -45.06 78.47 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.315 -0.866 . . . . 0.0 110.314 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.08 -36.18 82.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.339 -0.851 . . . . 0.0 110.165 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.23 -32.45 58.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.381 -0.824 . . . . 0.0 110.124 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.04 63.65 0.68 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.75 -58.85 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.524 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 1.7 p30 -55.07 -36.13 65.27 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.582 -0.698 . . . . 0.0 109.784 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 98.48 69.17 0.93 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.412 ' OD2' ' CG ' ' A' ' 131' ' ' ASP . 3.2 m-20 -121.89 -4.59 9.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -1.192 . . . . 0.0 110.133 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.55 -9.88 63.56 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.42 ' CB ' ' O ' ' A' ' 100' ' ' ILE . 2.8 pt20 -142.97 168.02 20.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -1.147 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 140' ' ' GLU . 5.2 t -112.82 155.76 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.203 -0.936 . . . . 0.0 110.243 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.431 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 17.6 p-10 -125.79 -144.81 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.335 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.404 ' OH ' ' HG2' ' A' ' 86' ' ' ARG . 1.1 t80 -80.15 -70.08 0.54 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.277 -0.89 . . . . 0.0 110.547 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 143' ' ' GLN . 26.4 mt-10 -43.03 -38.43 2.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.201 -0.937 . . . . 0.0 110.429 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.536 ' HB3' HG13 ' A' ' 136' ' ' VAL . 32.8 mt-10 -68.54 -62.26 1.47 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.271 -0.893 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -51.93 -22.1 3.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.3 -0.875 . . . . 0.0 110.645 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.56 -52.56 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.102 -0.999 . . . . 0.0 110.838 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.466 ' CB ' ' O ' ' A' ' 139' ' ' GLU . 4.5 tp60 -57.84 -13.03 3.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.267 -0.895 . . . . 0.0 110.832 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.8 mmm -99.34 -18.21 17.64 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.001 -1.062 . . . . 0.0 110.765 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.0 mtp -100.49 -69.25 0.78 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.041 -1.037 . . . . 0.0 110.836 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -117.39 70.72 0.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.942 . . . . 0.0 110.373 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.18 53.06 0.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.102 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.0 mttt . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.269 -179.892 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.197 0.523 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.95 126.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.267 -0.896 . . . . 0.0 110.474 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.59 ' O ' HD12 ' B' ' 3' ' ' LEU . 0.9 OUTLIER -114.0 31.35 6.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.3 -0.875 . . . . 0.0 110.147 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 6.7 mt -107.11 132.3 21.03 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.121 -0.987 . . . . 0.0 110.329 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.73 -176.45 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.081 1.569 . . . . 0.0 110.928 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.427 ' OG ' ' OE2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -106.4 178.65 4.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.329 -0.857 . . . . 0.0 110.501 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.52 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -54.11 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.415 -0.803 . . . . 0.0 110.911 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.478 ' HA ' HD12 ' B' ' 11' ' ' ILE . 55.9 p -44.82 -50.58 10.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 110.151 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.907 HG21 ' HB3' ' A' ' 87' ' ' GLU . 37.9 m -44.01 -50.37 8.34 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.444 -0.785 . . . . 0.0 109.633 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 24.9 t -57.22 -34.83 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.191 -0.943 . . . . 0.0 109.233 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.844 HG21 ' SD ' ' A' ' 72' ' ' MET . 18.4 mt -74.08 -30.49 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 108.722 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -58.38 8.62 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.543 -0.723 . . . . 0.0 109.378 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.609 ' CG1' ' CD1' ' A' ' 112' ' ' LEU . 81.0 t -59.12 -51.19 75.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.554 -0.716 . . . . 0.0 110.373 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.448 ' HG3' HD13 ' A' ' 18' ' ' LEU . 2.4 tmtm? -51.6 -58.57 5.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.025 -1.047 . . . . 0.0 109.878 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -51.15 -25.95 6.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.403 -0.811 . . . . 0.0 110.194 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.49 ' O ' ' HB2' ' B' ' 21' ' ' SER . 6.3 tpp -70.88 -32.78 69.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.991 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.9 mp -64.68 -102.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.965 -1.084 . . . . 0.0 109.838 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.567 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 55.32 -72.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.505 -0.747 . . . . 0.0 110.85 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -173.43 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.321 -0.862 . . . . 0.0 110.952 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.569 ' HG3' ' HB3' ' A' ' 123' ' ' GLU . 7.0 tmm_? 73.97 -7.1 1.69 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.892 -1.13 . . . . 0.0 110.297 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' B' ' 16' ' ' MET . 36.0 m -46.79 116.09 1.24 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.045 -1.034 . . . . 0.0 109.779 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -148.51 -32.84 0.24 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.174 -0.954 . . . . 0.0 111.282 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' B' ' 22' ' ' PHE . . . -54.81 -111.41 0.01 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.46 ' OD1' ' OXT' ' B' ' 26' ' ' PHE . 4.8 t30 -116.42 96.23 47.4 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.24 -1.153 . . . . 0.0 110.242 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.5 -18.45 20.08 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.099 1.579 . . . . 0.0 110.337 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.539 ' CE2' ' HE2' ' A' ' 76' ' ' MET . 46.0 m-85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.285 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.195 0.521 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -135.97 18.95 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.201 -0.937 . . . . 0.0 110.294 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.87 77.25 2.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 110.238 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 mt -78.22 -164.06 0.5 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.296 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -118.85 12.37 12.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.307 -0.871 . . . . 0.0 110.18 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 1.2 tm-20 -72.28 -40.21 67.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.23 -0.919 . . . . 0.0 110.39 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.658 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.5 mt-10 -41.38 -70.05 0.12 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.341 -0.85 . . . . 0.0 110.134 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -46.56 -50.07 17.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.1 -1.0 . . . . 0.0 109.235 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 21.6 mt -53.63 -38.4 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.3 -0.875 . . . . 0.0 108.751 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.03 -46.95 65.22 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.284 -0.885 . . . . 0.0 108.806 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.475 ' CD ' ' HD2' ' B' ' 18' ' ' ARG . 6.0 tt0 -53.69 -53.9 45.47 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.217 -0.927 . . . . 0.0 108.819 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -55.57 -40.27 71.75 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.373 -0.829 . . . . 0.0 108.856 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -59.43 -40.38 86.55 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 17' ' ' SER . 8.3 tt0 -49.61 -55.12 14.72 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.453 -0.78 . . . . 0.0 108.95 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.05 -55.99 24.82 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.506 -0.878 . . . . 0.0 108.76 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.547 ' HD1' HD11 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -49.1 -26.85 2.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 3.2 m -87.85 -36.33 17.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.541 -0.724 . . . . 0.0 109.113 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.763 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.8 tt -47.98 -34.61 9.55 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.389 -0.819 . . . . 0.0 109.376 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.751 ' HA ' HG21 ' A' ' 35' ' ' VAL . 73.4 m-85 -81.8 -28.66 33.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.824 . . . . 0.0 109.986 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 5.0 t0 -87.36 81.54 7.84 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.213 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -52.56 -56.97 11.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 110.374 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.42 ' OD1' ' CG ' ' A' ' 24' ' ' ASP . 3.0 p30 -59.16 -41.17 87.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.335 -0.853 . . . . 0.0 110.373 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.86 57.6 1.7 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 35.5 p-10 -114.33 10.4 17.11 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.231 -1.158 . . . . 0.0 110.293 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.97 15.18 73.96 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 1.2 p -141.72 116.6 9.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -1.225 . . . . 0.0 110.275 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.547 HD11 ' HD1' ' A' ' 16' ' ' PHE . 13.4 mt -92.27 112.92 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.149 -0.97 . . . . 0.0 109.738 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.482 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 18.8 p -75.95 -160.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.237 -0.915 . . . . 0.0 110.354 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.408 ' O ' HD22 ' A' ' 48' ' ' LEU . 22.0 p -88.82 -45.4 9.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 110.543 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.549 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 21.5 pttt -71.63 -25.87 62.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.026 -1.046 . . . . 0.0 110.574 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.797 ' O ' HG23 ' A' ' 35' ' ' VAL . 47.2 mt-10 -63.15 -44.67 94.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.031 -1.043 . . . . 0.0 109.491 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 48' ' ' LEU . 2.9 tp -67.35 -48.18 68.25 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.332 -0.855 . . . . 0.0 109.649 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.81 -44.96 49.36 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.8 m -61.17 -57.15 13.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.353 -1.086 . . . . 0.0 109.736 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 31' ' ' GLU . 21.4 t -50.42 -40.46 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.213 -0.929 . . . . 0.0 109.655 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 32' ' ' LEU . 4.7 mmt -60.82 -47.57 85.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.268 -0.895 . . . . 0.0 109.412 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.456 ' NE ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -47.79 -38.23 15.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.395 179.224 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -63.04 -45.27 93.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.564 -0.71 . . . . 0.0 110.705 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 3.1 mt -57.88 -34.47 69.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.165 -0.959 . . . . 0.0 110.455 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.37 63.65 0.32 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.456 ' O ' ' NE ' ' A' ' 37' ' ' ARG . 1.9 pt20 -160.75 -175.66 5.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.309 -1.112 . . . . 0.0 109.922 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -131.12 95.08 25.94 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.068 -1.02 . . . . 0.0 110.624 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HG3' ' HB2' ' A' ' 36' ' ' MET . 47.2 Cg_endo -75.34 123.49 7.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.041 1.548 . . . . 0.0 110.177 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.421 ' HB ' ' HG3' ' A' ' 47' ' ' GLU . 17.4 m -94.98 168.5 10.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' N ' HG22 ' A' ' 44' ' ' THR . 37.9 tt0 -57.44 -56.45 21.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.121 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.37 -55.26 16.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 0.0 110.258 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' A' ' 44' ' ' THR . 2.6 mm-40 -51.23 -52.86 40.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 110.006 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 32' ' ' LEU . 9.0 mt -46.61 -64.28 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.81 -34.81 63.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.419 -0.801 . . . . 0.0 110.075 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.55 -33.91 69.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 110.285 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.517 ' O ' ' NE1' ' B' ' 7' ' ' TRP . 9.8 mtp -81.17 -34.59 32.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -0.85 . . . . 0.0 110.023 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 10.9 mm -74.53 -36.62 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -0.867 . . . . 0.0 109.76 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -68.04 -20.39 64.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.394 -0.816 . . . . 0.0 110.135 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.04 -42.67 66.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.364 -0.835 . . . . 0.0 110.383 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 57' ' ' ALA . 8.7 t -83.8 -51.04 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -41.76 90.56 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.658 -0.651 . . . . 0.0 110.428 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -83.36 -36.43 24.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.462 -0.774 . . . . 0.0 110.747 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' OD2' ' CG ' ' A' ' 60' ' ' ASN . 6.5 p-10 -72.17 -48.26 44.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.032 -1.042 . . . . 0.0 110.535 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.89 35.94 1.09 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 29.2 p-10 -98.56 -46.02 5.88 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.016 -1.285 . . . . 0.0 110.314 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 118.43 13.69 6.75 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.5 p -144.4 141.44 29.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.16 -1.2 . . . . 0.0 110.538 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.546 ' HB ' HD12 ' A' ' 27' ' ' ILE . 35.4 mm -85.21 142.25 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.219 -0.925 . . . . 0.0 109.902 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -121.81 -175.66 3.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.075 -1.015 . . . . 0.0 110.593 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.613 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.6 t80 -65.97 -45.99 63.96 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.416 -0.802 . . . . 0.0 111.54 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.2 Cg_endo -68.62 -38.86 10.01 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 O-C-N 123.092 1.048 . . . . 0.0 110.395 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -60.61 -30.46 69.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.112 -0.992 . . . . 0.0 109.274 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CG ' ' HB2' ' A' ' 16' ' ' PHE . 4.1 t80 -69.92 -46.02 66.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.54 -0.725 . . . . 0.0 109.902 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.0 mm? -53.78 -53.05 57.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.353 -0.842 . . . . 0.0 110.303 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 71' ' ' MET . 1.5 p -66.04 -63.56 1.05 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.269 -0.895 . . . . 0.0 110.708 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.46 ' HG3' HG13 ' A' ' 55' ' ' VAL . 6.8 tmm? -40.51 -36.87 0.62 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.848 ' SD ' HG21 ' B' ' 11' ' ' ILE . 7.0 tpt -61.76 -12.1 15.33 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.224 -0.922 . . . . 0.0 110.702 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.02 -10.01 4.82 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.04 -1.037 . . . . 0.0 111.223 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -24.61 15.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.998 -1.064 . . . . 0.0 110.363 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.653 ' HB3' HG21 ' B' ' 8' ' ' THR . 2.1 tppm? -85.12 -15.58 43.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.215 -0.928 . . . . 0.0 110.414 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 10.4 mtm -99.2 -9.22 23.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 110.391 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 16.8 mmtm -110.34 51.71 0.75 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 109.996 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 79' ' ' THR . 5.3 t70 -178.71 98.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.293 -0.879 . . . . 0.0 110.196 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 2.1 m 64.92 24.94 12.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.248 -0.907 . . . . 0.0 110.352 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -155.17 59.94 0.65 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.26 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 m -83.52 -59.49 2.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 110.118 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -100.35 -25.65 14.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 110.317 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 3.6 tt0 -55.29 -43.47 74.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 110.069 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' HG3' HD12 ' B' ' 12' ' ' LEU . 19.3 tp10 -45.79 -50.21 14.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.345 -0.847 . . . . 0.0 110.495 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.5 mt -70.76 -38.53 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.109 -0.994 . . . . 0.0 109.397 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 31.5 ttt180 -58.84 -30.64 67.84 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.367 -0.833 . . . . 0.0 109.916 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.615 ' HB3' HG21 ' B' ' 9' ' ' THR . 76.9 mm-40 -74.07 -55.33 6.24 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.273 -0.892 . . . . 0.0 109.665 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.42 -29.69 49.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 0.0 109.149 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -71.89 -34.5 69.2 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.159 -0.963 . . . . 0.0 109.083 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -63.84 -27.32 69.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.445 -0.784 . . . . 0.0 109.197 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.422 HG12 HG21 ' A' ' 108' ' ' VAL . 17.1 t -75.31 -43.98 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.517 -0.739 . . . . 0.0 110.151 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.519 ' CZ ' HG22 ' B' ' 13' ' ' VAL . 24.1 m-85 -67.01 -35.92 80.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.157 -0.965 . . . . 0.0 110.338 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -73.29 54.66 0.43 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.326 -0.859 . . . . 0.0 110.502 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 93' ' ' ASP . 13.4 tppt? -41.65 -46.63 3.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.0 110.288 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 21.4 p-10 -87.97 -26.78 22.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.56 47.55 12.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 31.6 p-10 -94.41 -22.35 18.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -1.121 . . . . 0.0 110.099 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.482 ' C ' ' CD2' ' A' ' 99' ' ' TYR . . . 110.76 15.23 11.23 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD2' ' C ' ' A' ' 98' ' ' GLY . 91.2 m-85 -150.72 137.73 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.307 -1.113 . . . . 0.0 110.181 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' GLN . 7.1 mt -101.71 150.74 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.13 -0.981 . . . . 0.0 110.14 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -138.48 146.78 42.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.295 -0.878 . . . . 0.0 110.151 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -44.88 -29.08 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.93 . . . . 0.0 109.843 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.75 79.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -0.843 . . . . 0.0 109.664 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.412 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 7.6 mt-10 -61.85 -45.03 95.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.494 ' CD1' HD11 ' A' ' 125' ' ' ILE . 1.5 mt -66.1 -38.09 87.37 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.354 -0.841 . . . . 0.0 109.267 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.493 ' HG2' ' NH2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -55.62 -35.83 66.3 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.406 -0.809 . . . . 0.0 109.084 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -71.03 -47.6 57.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.5 -0.75 . . . . 0.0 109.363 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG21 HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -60.5 -23.51 28.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.381 -0.824 . . . . 0.0 109.024 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.948 ' HA ' HD21 ' B' ' 17' ' ' LEU . 5.1 mtt -69.28 -63.51 1.05 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.503 -0.748 . . . . 0.0 109.812 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.3 m -56.94 -30.37 63.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.191 -0.943 . . . . 0.0 109.236 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 12.5 m120 -74.77 -17.79 60.58 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.459 -0.776 . . . . 0.0 109.671 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.875 HD11 HG12 ' B' ' 13' ' ' VAL . 3.9 mt -95.41 -48.08 6.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.328 -0.858 . . . . 0.0 110.212 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.09 -30.12 0.22 Allowed Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.529 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 109' ' ' MET . 29.4 tt0 -125.05 171.22 10.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.873 -1.369 . . . . 0.0 110.941 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -144.98 75.7 1.46 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.798 HD21 ' CA ' ' B' ' 19' ' ' LYS . 2.4 mp -34.79 156.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.641 0.734 . . . . 0.0 111.494 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -57.1 -150.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.0 110.387 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.517 ' H ' HG22 ' A' ' 117' ' ' THR . 1.4 p-10 -109.76 -53.89 2.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.236 -0.915 . . . . 0.0 110.38 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.35 -44.46 84.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.019 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.93 -42.13 97.44 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.829 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.42 HG23 ' HB3' ' A' ' 116' ' ' LEU . 71.8 t -64.62 -40.31 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.947 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -60.28 -45.19 94.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -61.47 -38.07 85.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 109.582 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -54.06 -49.25 69.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.162 -0.961 . . . . 0.0 109.681 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' CD1' ' A' ' 105' ' ' LEU . 37.5 mm -70.16 -26.48 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -70.14 -26.51 63.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.902 . . . . 0.0 109.917 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -71.46 -44.5 64.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.867 . . . . 0.0 110.064 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.853 ' HB2' ' HD2' ' B' ' 22' ' ' PHE . . . -71.44 -33.41 69.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.381 -0.824 . . . . 0.0 110.049 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -60.44 75.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.33 -0.857 . . . . 0.0 110.4 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 128' ' ' ALA . 21.5 mt -72.16 -31.34 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.968 . . . . 0.0 110.232 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 34.8 p-10 -83.94 -27.13 28.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.148 -0.97 . . . . 0.0 110.275 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 89.94 71.17 1.24 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 4.0 p30 -126.57 -23.37 3.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.244 -1.151 . . . . 0.0 110.468 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 104.63 -0.78 42.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 4.8 pt20 -151.18 166.67 30.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 110.204 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 53.3 t -110.68 151.77 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -131.95 -164.92 1.51 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.143 -0.973 . . . . 0.0 110.397 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.752 ' CE1' HG21 ' A' ' 142' ' ' VAL . 9.2 t80 -62.13 -65.82 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.229 -0.919 . . . . 0.0 110.72 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -41.87 -50.02 4.46 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.216 -0.927 . . . . 0.0 110.677 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -63.96 -59.99 3.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.965 . . . . 0.0 110.394 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.423 ' CE1' ' HE2' ' A' ' 92' ' ' PHE . 50.1 t80 -51.75 -20.57 2.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 110.523 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.752 HG21 ' CE1' ' A' ' 138' ' ' TYR . 41.6 t -100.51 -60.28 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.179 -0.951 . . . . 0.0 110.791 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 142' ' ' VAL . 9.5 tt0 -40.36 -45.82 2.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.31 -0.869 . . . . 0.0 110.762 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.445 ' O ' ' OD1' ' B' ' 24' ' ' ASN . 3.7 mmt -66.59 -26.8 67.28 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 110.419 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.485 ' N ' ' O ' ' A' ' 142' ' ' VAL . 19.9 mmm -96.07 -45.99 6.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.079 -1.013 . . . . 0.0 110.937 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.467 HG21 HG13 ' A' ' 142' ' ' VAL . 34.5 p -84.98 38.36 0.71 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.116 -0.99 . . . . 0.0 110.984 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 148' ' ' LYS . . . -94.36 20.63 7.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -0.942 . . . . 0.0 110.141 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 147' ' ' ALA . 13.1 tptt . . . . . 0 N--CA 1.501 2.11 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.806 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.475 ' O ' HG13 ' B' ' 1' ' ' VAL . 2.4 p . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.232 0.539 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.1 -159.21 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.358 -0.839 . . . . 0.0 110.298 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.718 HD12 HG12 ' B' ' 4' ' ' ILE . 0.3 OUTLIER -165.6 -29.46 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.17 -0.956 . . . . 0.0 111.433 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.718 HG12 HD12 ' B' ' 3' ' ' LEU . 35.1 mm -100.1 146.91 32.74 Favored Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 120.926 -1.109 . . . . 0.0 110.829 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.672 ' HD2' HG23 ' B' ' 4' ' ' ILE . 42.3 Cg_endo -69.1 -157.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.936 1.493 . . . . 0.0 111.035 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' B' ' 7' ' ' TRP . 55.7 p -132.67 57.81 1.78 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.062 -1.024 . . . . 0.0 111.449 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.517 ' NE1' ' O ' ' A' ' 51' ' ' MET . 0.7 OUTLIER 64.27 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.972 -1.08 . . . . 0.0 111.575 178.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 75' ' ' LYS . 0.8 OUTLIER -46.33 -46.91 18.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 110.393 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 87' ' ' GLU . 26.0 m -45.83 -40.24 9.55 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.151 -0.968 . . . . 0.0 109.483 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.442 HG12 ' HZ ' ' A' ' 19' ' ' PHE . 10.2 t -66.03 -44.04 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.528 -0.733 . . . . 0.0 110.061 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.848 HG21 ' SD ' ' A' ' 72' ' ' MET . 51.7 mt -69.39 -25.29 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.288 -0.883 . . . . 0.0 109.907 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.532 HD23 ' C ' ' B' ' 12' ' ' LEU . 4.8 tt -67.08 -49.57 64.61 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 110.34 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.875 HG12 HD11 ' A' ' 112' ' ' LEU . 47.9 t -65.13 -46.96 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 110.561 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.649 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -58.61 -33.71 70.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.842 -1.161 . . . . 0.0 109.688 179.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 0.1 OUTLIER -63.95 -43.89 94.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.409 ' O ' ' N ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -59.18 -32.43 69.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.332 -0.855 . . . . 0.0 110.114 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.948 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.4 mp -69.4 58.65 0.12 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.161 -0.962 . . . . 0.0 110.345 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' B' ' 20' ' ' ARG . 3.0 ttp180 -123.84 76.22 1.42 Allowed 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.891 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.798 ' CA ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER 62.74 -57.77 0.15 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.605 -0.684 . . . . 0.0 111.042 179.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' B' ' 18' ' ' ARG . 0.7 OUTLIER -166.9 22.61 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.24 -0.913 . . . . 0.0 110.38 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' B' ' 18' ' ' ARG . 66.2 m -74.8 126.55 31.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.188 -0.945 . . . . 0.0 110.363 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.853 ' HD2' ' HB2' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -145.11 -40.64 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.118 -0.989 . . . . 0.0 110.913 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' B' ' 22' ' ' PHE . . . -46.37 -99.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 145' ' ' MET . 80.5 m-20 -138.3 88.11 15.23 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.144 -1.209 . . . . 0.0 110.719 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.63 -12.28 18.43 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.847 1.446 . . . . 0.0 110.036 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.642 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 5.5 m-30 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.269 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.231 0.538 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -131.1 57.79 1.74 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.23 -0.919 . . . . 0.0 110.21 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 -100.04 116.76 32.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.266 -0.896 . . . . 0.0 110.322 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 mt -95.02 128.02 41.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.212 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.443 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 1.6 t -126.94 69.28 1.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.252 -0.905 . . . . 0.0 110.24 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -99.94 -35.74 9.63 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 8' ' ' GLN . 5.7 tp10 -51.62 -65.12 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 110.556 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.554 ' CG ' ' N ' ' A' ' 9' ' ' ILE . 12.8 pt20 -43.49 -47.33 7.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.138 -0.976 . . . . 0.0 109.983 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.554 ' N ' ' CG ' ' A' ' 8' ' ' GLN . 83.8 mt -67.02 -50.43 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.023 -1.048 . . . . 0.0 109.375 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.47 64.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 109.303 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 37.8 tt0 -58.84 -52.95 63.54 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.401 -0.812 . . . . 0.0 109.478 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.567 ' CE2' ' HG3' ' A' ' 72' ' ' MET . 1.6 m-85 -53.23 -43.67 67.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.349 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -59.53 -41.69 90.57 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.765 . . . . 0.0 109.525 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -49.52 77.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.311 -0.868 . . . . 0.0 109.487 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.84 83.94 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.351 -0.843 . . . . 0.0 109.355 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.509 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 38.8 t80 -61.29 -21.68 64.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.501 -0.749 . . . . 0.0 109.575 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -89.64 -31.39 17.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.451 -0.781 . . . . 0.0 109.694 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.924 HD13 ' HG3' ' B' ' 14' ' ' LYS . 10.4 tt -61.33 -44.72 96.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.866 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 74.8 m-85 -74.27 -47.38 35.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 110.193 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -67.18 73.0 0.11 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 19' ' ' PHE . 9.3 mmtt -64.89 -8.99 17.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 110.389 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -93.83 -29.55 15.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.351 -0.843 . . . . 0.0 110.167 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.11 33.61 44.51 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 23.5 p30 -104.81 -15.56 15.16 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.19 -1.182 . . . . 0.0 110.176 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 26' ' ' THR . . . 93.61 31.0 8.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 25' ' ' GLY . 24.7 p -156.02 118.3 4.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -1.155 . . . . 0.0 110.29 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.656 HD12 ' CG2' ' A' ' 63' ' ' ILE . 7.3 mt -92.9 125.74 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.014 -1.054 . . . . 0.0 110.093 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.1 p -100.5 -175.65 2.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.501 -0.749 . . . . 0.0 109.462 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.649 ' O ' HD22 ' A' ' 48' ' ' LEU . 2.9 p -76.13 -22.54 55.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.007 . . . . 0.0 109.822 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -73.03 -46.21 53.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 110.234 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.42 -62.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.473 ' HG ' ' HE3' ' A' ' 36' ' ' MET . 34.5 tp -54.88 -30.15 57.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.013 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.655 ' CA ' HD21 ' A' ' 48' ' ' LEU . . . -68.67 -32.33 74.38 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.1 m -71.88 -59.8 2.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -1.129 . . . . 0.0 110.16 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 35' ' ' VAL . 25.7 t -50.79 -46.34 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.955 . . . . 0.0 110.167 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.594 ' HE1' ' SD ' ' A' ' 51' ' ' MET . 0.3 OUTLIER -58.77 -47.59 84.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.259 -0.901 . . . . 0.0 110.098 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -24.95 58.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.883 . . . . 0.0 110.124 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.402 ' O ' ' CG ' ' A' ' 111' ' ' ASN . 36.3 t -77.98 -34.27 51.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.881 . . . . 0.0 110.513 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.58 HD12 ' HA ' ' A' ' 36' ' ' MET . 3.5 mt -53.97 -42.85 69.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.186 -0.946 . . . . 0.0 110.276 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.49 51.21 0.06 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.98 -162.13 1.49 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -1.127 . . . . 0.0 110.225 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.54 70.92 14.1 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.82 118.71 5.84 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.913 1.48 . . . . 0.0 110.243 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 3.1 m -82.02 152.62 26.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.888 . . . . 0.0 110.42 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -48.65 -53.74 17.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.275 -0.891 . . . . 0.0 110.019 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.41 -42.19 66.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.827 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 44' ' ' THR . 4.2 mm-40 -59.5 -52.11 66.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.861 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.655 HD21 ' CA ' ' A' ' 33' ' ' GLY . 1.7 mt -44.29 -57.21 3.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.903 . . . . 0.0 109.946 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.69 -45.47 28.43 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 109.597 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.04 -39.42 78.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.484 -0.76 . . . . 0.0 109.668 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.594 ' SD ' ' HE1' ' A' ' 36' ' ' MET . 1.6 ttp -74.96 -51.03 14.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 109.64 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 52' ' ' ILE . 1.9 mm -47.95 -24.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.226 -0.921 . . . . 0.0 109.221 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.22 -14.78 59.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 110.204 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -79.59 -8.42 59.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.253 -0.905 . . . . 0.0 110.428 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.695 HG23 ' CD1' ' B' ' 7' ' ' TRP . 54.9 t -118.34 -53.86 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.062 -1.024 . . . . 0.0 110.675 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -19.27 82.6 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 CA-C-O 121.459 0.647 . . . . 0.0 112.014 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.77 -60.88 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.455 -0.778 . . . . 0.0 109.927 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 13.6 p30 -68.32 -21.61 64.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.9 . . . . 0.0 109.988 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 72.11 48.0 28.05 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -97.18 -44.96 6.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.171 -1.194 . . . . 0.0 110.181 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . 139.32 -2.11 2.52 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.84 -1.172 . . . . 0.0 110.392 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 166.33 30.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.833 -1.392 . . . . 0.0 110.759 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.656 ' CG2' HD12 ' A' ' 27' ' ' ILE . 10.5 mm -101.68 122.38 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.459 -0.775 . . . . 0.0 110.037 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.509 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 p30 -110.03 -179.64 3.85 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.021 -1.049 . . . . 0.0 110.754 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.661 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.5 t80 -63.31 -39.55 51.13 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.287 -0.883 . . . . 0.0 112.121 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.7 Cg_endo -69.47 -29.82 24.61 Favored 'Trans proline' 0 C--N 1.32 -0.952 0 O-C-N 123.078 1.041 . . . . 0.0 109.973 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 71' ' ' MET . 23.8 mt-10 -75.2 -30.66 60.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 109.309 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.735 ' HZ ' HD12 ' B' ' 11' ' ' ILE . 10.5 t80 -66.96 -42.64 84.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.471 -0.768 . . . . 0.0 109.762 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.644 HD11 ' CE1' ' A' ' 65' ' ' PHE . 4.7 mt -70.11 -32.06 69.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.83 . . . . 0.0 110.326 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -87.73 -43.25 12.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.954 . . . . 0.0 110.557 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -59.78 -32.92 71.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.118 -0.989 . . . . 0.0 110.263 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.658 ' HE1' ' CE2' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -69.13 -11.95 61.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.882 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.77 -35.27 5.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.385 -0.822 . . . . 0.0 110.051 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -68.42 -41.14 80.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 110.135 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.86 -26.1 67.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.389 -0.82 . . . . 0.0 110.145 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 72' ' ' MET . 1.4 mtt -86.0 -12.17 51.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.857 . . . . 0.0 110.202 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -115.41 58.69 0.72 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.245 -0.91 . . . . 0.0 110.112 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -147.22 -63.69 0.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 110.2 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.5 m -155.46 -43.43 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.897 . . . . 0.0 110.176 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -85.84 98.18 10.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.279 -0.888 . . . . 0.0 110.271 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m -102.18 -51.9 3.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.304 -0.872 . . . . 0.0 110.02 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -100.14 -11.13 20.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.383 -0.823 . . . . 0.0 110.128 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 1.8 mm-40 -66.85 -9.88 42.28 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 0.0 109.929 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.407 ' OE1' ' SD ' ' A' ' 76' ' ' MET . 40.8 mt-10 -76.4 -30.28 57.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.261 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.773 ' CD1' HG21 ' A' ' 146' ' ' THR . 75.1 mt -75.82 -32.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -36.82 84.09 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.438 -0.789 . . . . 0.0 109.623 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.763 ' HB3' HG21 ' B' ' 9' ' ' THR . 5.7 mm-40 -69.32 -45.58 69.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.82 ' HB2' HD11 ' B' ' 12' ' ' LEU . . . -60.62 -34.77 74.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.143 -0.973 . . . . 0.0 110.066 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 29.5 t80 -68.44 -40.93 80.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 109.653 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -60.85 -29.7 69.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 109.343 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.548 HG12 HG21 ' A' ' 108' ' ' VAL . 65.6 t -72.79 -55.06 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.006 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.679 ' HB3' HD13 ' A' ' 100' ' ' ILE . 37.5 m-85 -53.62 -29.87 40.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.258 -0.901 . . . . 0.0 109.975 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -100.44 67.14 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.459 -0.776 . . . . 0.0 110.101 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -41.36 -25.95 0.05 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.399 -0.813 . . . . 0.0 110.415 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.5 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 15.7 p-10 -102.09 -41.69 6.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 109.961 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.22 49.86 5.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 42.0 p-10 -92.18 -23.55 19.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 124.95 26.33 1.39 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.57 ' CZ ' ' OD1' ' A' ' 137' ' ' ASN . 1.1 m-85 -170.52 158.22 6.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.974 -1.309 . . . . 0.0 110.617 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.679 HD13 ' HB3' ' A' ' 92' ' ' PHE . 10.0 mt -126.97 120.19 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.271 -0.893 . . . . 0.0 110.28 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -101.38 145.91 28.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -0.988 . . . . 0.0 109.802 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.84 -31.89 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.875 . . . . 0.0 109.726 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.1 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.343 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 101' ' ' SER . 7.4 mt-10 -60.49 -48.6 81.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.442 -0.786 . . . . 0.0 109.367 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.865 HD11 ' HZ ' ' B' ' 22' ' ' PHE . 0.3 OUTLIER -59.04 -41.95 89.06 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.298 -0.876 . . . . 0.0 108.912 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.433 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 18.7 ttp180 -51.62 -36.7 46.91 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -60.11 -56.08 26.06 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.548 HG21 HG12 ' A' ' 91' ' ' VAL . 2.5 t -59.78 -34.73 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.333 -0.855 . . . . 0.0 108.792 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.873 ' HA ' HD21 ' B' ' 17' ' ' LEU . 3.7 mtt -57.35 -69.42 0.16 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.652 -0.655 . . . . 0.0 110.829 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.536 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 93.7 m -55.57 -21.68 18.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.062 -1.024 . . . . 0.0 109.876 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 38' ' ' SER . 57.1 m-20 -84.34 -10.32 57.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.169 -0.957 . . . . 0.0 109.801 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.914 HD11 HG12 ' B' ' 13' ' ' VAL . 6.8 mt -108.94 -40.37 5.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.304 -0.872 . . . . 0.0 110.549 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 167.12 -64.71 0.2 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.355 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.415 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 1.2 tp10 -107.93 171.45 7.39 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.201 -1.176 . . . . 0.0 110.841 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.593 ' HA ' ' CG ' ' A' ' 109' ' ' MET . 1.3 mptp? -130.29 5.38 4.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 0.0 110.698 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.683 HD21 ' HA ' ' B' ' 19' ' ' LYS . 1.4 mp 57.08 152.91 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.073 0 O-C-N 121.599 -0.688 . . . . 0.0 110.469 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.585 HG22 ' H ' ' A' ' 118' ' ' ASP . 1.2 m -60.72 -151.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.02 -1.05 . . . . 0.0 109.478 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.585 ' H ' HG22 ' A' ' 117' ' ' THR . 6.7 p-10 -113.38 -33.4 5.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.0 110.173 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -71.21 -45.2 63.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 109.97 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 124' ' ' MET . 12.6 pt-20 -68.71 -35.79 77.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.627 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.574 HG23 ' HB3' ' A' ' 116' ' ' LEU . 23.3 t -63.14 -37.3 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.871 . . . . 0.0 109.575 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.19 -47.8 40.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 1.2 tp10 -67.22 -30.91 70.96 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.359 -0.838 . . . . 0.0 109.268 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.567 ' CG ' ' HA ' ' B' ' 21' ' ' SER . 1.5 ttt -61.18 -46.32 90.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.496 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.669 HD11 ' CD1' ' A' ' 105' ' ' LEU . 22.0 mm -70.79 -56.62 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 0.0 109.821 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 127' ' ' GLU . 7.5 mtp85 -53.93 -62.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.377 -0.827 . . . . 0.0 110.014 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 8.7 tp10 -42.07 -28.13 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.403 -0.811 . . . . 0.0 110.191 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.503 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -90.98 -34.45 15.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.902 . . . . 0.0 110.026 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -57.75 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.38 -0.825 . . . . 0.0 110.587 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -52.04 -34.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.174 -0.954 . . . . 0.0 109.618 179.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 47.5 p-10 -94.48 -16.91 22.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 110.108 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 61.37 79.07 0.14 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 8.8 p30 -123.33 5.39 9.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -1.15 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.14 15.44 66.96 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.563 ' HG3' ' CE1' ' A' ' 99' ' ' TYR . 6.1 pt20 -169.74 169.41 8.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -1.155 . . . . 0.0 109.99 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 9.8 t -116.63 159.16 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.119 -0.988 . . . . 0.0 110.418 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.57 ' OD1' ' CZ ' ' A' ' 99' ' ' TYR . 1.2 t30 -123.56 -167.18 1.58 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.369 -0.832 . . . . 0.0 110.014 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.516 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 1.7 t80 -74.73 -64.32 1.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.184 -0.948 . . . . 0.0 109.993 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -44.36 -48.5 9.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 109.913 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 144' ' ' MET . 3.4 tt0 -55.58 -56.19 23.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.34 -0.85 . . . . 0.0 110.229 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -51.87 -19.71 1.88 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.4 t -96.46 -70.32 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.062 -1.024 . . . . 0.0 110.883 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -45.36 -48.59 13.34 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.1 -1.0 . . . . 0.0 110.794 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.515 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 11.8 tpt -72.26 -10.38 59.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.722 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.1 tpp -100.69 -47.83 4.71 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.95 -1.094 . . . . 0.0 111.044 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.773 HG21 ' CD1' ' A' ' 85' ' ' ILE . 1.7 t -141.41 85.17 1.95 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.106 -0.996 . . . . 0.0 110.344 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.22 52.95 0.61 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.455 -0.778 . . . . 0.0 110.651 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.184 179.695 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.44 HG13 ' N ' ' B' ' 2' ' ' LYS . 11.6 p . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 121.144 0.497 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.44 ' N ' HG13 ' B' ' 1' ' ' VAL . 0.1 OUTLIER -84.39 -85.34 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.021 . . . . 0.0 110.129 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' B' ' 3' ' ' LEU . 0.3 OUTLIER -50.46 -20.66 1.19 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.197 -0.939 . . . . 0.0 110.45 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.658 HG23 ' HD2' ' B' ' 5' ' ' PRO . 84.4 mt -112.66 150.18 42.32 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.317 -0.865 . . . . 0.0 110.052 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.658 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.0 Cg_endo -62.91 124.55 14.23 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.641 1.337 . . . . 0.0 110.217 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 1.009 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.3 OUTLIER -58.13 170.19 0.71 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.678 0.751 . . . . 0.0 111.25 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.695 ' CD1' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -56.13 -80.06 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.448 0.642 . . . . 0.0 110.383 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' B' ' 11' ' ' ILE . 38.7 p -45.21 -40.69 7.55 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.413 -0.805 . . . . 0.0 109.755 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 87' ' ' GLU . 94.4 m -49.92 -48.17 51.85 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.233 -0.917 . . . . 0.0 109.177 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 1.009 HG23 ' O ' ' B' ' 6' ' ' SER . 15.8 t -61.06 -29.42 45.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.387 -0.821 . . . . 0.0 109.246 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.735 HD12 ' HZ ' ' A' ' 68' ' ' PHE . 26.5 mm -77.73 -55.18 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.66 -0.65 . . . . 0.0 111.441 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 88' ' ' ALA . 3.9 pp -56.88 -33.03 66.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.188 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.914 HG12 HD11 ' A' ' 112' ' ' LEU . 24.2 t -67.09 -50.33 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.952 -1.093 . . . . 0.0 108.755 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.924 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -62.07 -24.45 67.1 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.205 -0.935 . . . . 0.0 108.633 178.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' B' ' 18' ' ' ARG . 1.4 p -75.38 -27.52 59.14 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.434 0.635 . . . . 0.0 109.36 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.496 ' O ' ' N ' ' B' ' 18' ' ' ARG . 8.4 mtt -73.31 -32.29 64.51 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.412 -0.805 . . . . 0.0 108.968 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.873 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.0 mp -67.76 58.8 0.06 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.518 -0.739 . . . . 0.0 109.229 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' B' ' 16' ' ' MET . 5.7 mtm180 -84.47 -80.99 0.19 Allowed 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.769 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.683 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -176.82 -67.31 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.052 -1.03 . . . . 0.0 111.472 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.53 ' N ' ' CD ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -87.83 -21.73 24.88 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.373 -0.829 . . . . 0.0 112.074 -178.156 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.567 ' HA ' ' CG ' ' A' ' 124' ' ' MET . 4.0 m -163.71 -175.0 3.91 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.453 -1.404 . . . . 0.0 112.554 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.865 ' HZ ' HD11 ' A' ' 105' ' ' LEU . 11.3 m-85 -78.78 -85.83 0.07 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.418 0.628 . . . . 0.0 110.567 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.45 -151.55 21.83 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.526 ' N ' ' HD2' ' B' ' 25' ' ' PRO . 0.1 OUTLIER 176.93 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.201 -1.176 . . . . 0.0 110.681 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' B' ' 24' ' ' ASN . 42.6 Cg_endo -69.45 111.3 2.71 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.764 1.402 . . . . 0.0 110.195 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.658 ' CE2' ' HE1' ' A' ' 72' ' ' MET . 2.1 t80 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.243 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.335 0.588 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.54 9.87 23.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 4' ' ' LEU . 3.6 tt0 -97.29 149.61 21.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.256 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' GLN . 1.9 mt 55.5 108.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.852 ' O ' HD12 ' A' ' 9' ' ' ILE . 10.2 t -104.23 -1.17 27.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.287 -0.883 . . . . 0.0 110.419 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -100.19 -9.84 22.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.269 -0.895 . . . . 0.0 110.46 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -68.61 -69.09 0.35 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.184 -0.947 . . . . 0.0 110.373 -179.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -50.83 41.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.539 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.852 HD12 ' O ' ' A' ' 5' ' ' THR . 61.7 mt -60.16 -35.86 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.528 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 6' ' ' GLU . . . -55.35 -56.27 22.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 110.144 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -55.72 -47.61 76.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.083 -1.011 . . . . 0.0 109.958 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -58.91 -41.82 88.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.0 109.43 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -62.1 -31.4 71.84 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.244 -0.91 . . . . 0.0 108.923 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 11' ' ' GLU . 6.3 tp10 -57.62 -53.45 58.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.499 -0.75 . . . . 0.0 109.166 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -51.7 -55.58 18.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 109.219 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.536 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 86.5 t80 -52.99 -36.28 60.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.495 -0.753 . . . . 0.0 109.366 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.2 t -76.05 -26.95 57.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.567 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.8 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.1 tt -58.8 -44.16 90.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 109.901 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -75.22 -25.91 58.53 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.216 -0.927 . . . . 0.0 110.281 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.72 106.08 14.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.233 -0.917 . . . . 0.0 110.1 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -99.66 5.87 45.73 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.216 -0.927 . . . . 0.0 110.49 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.8 p30 -116.65 -51.68 2.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.155 -0.966 . . . . 0.0 110.397 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 22' ' ' ASP . . . 114.08 39.87 1.02 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 13.6 p30 -111.65 -16.14 13.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.137 -1.214 . . . . 0.0 110.233 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.54 -1.18 81.39 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 68.3 p -118.46 108.94 15.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.18 -1.188 . . . . 0.0 110.37 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 17.9 mt -77.82 124.49 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.289 -0.882 . . . . 0.0 109.966 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.414 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 1.1 p -97.35 -178.79 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.374 -0.829 . . . . 0.0 110.316 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.757 HG21 ' NE2' ' A' ' 49' ' ' GLN . 40.6 p -73.59 -33.8 64.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.122 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -43.83 86.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 0.0 110.23 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' OE2' ' OG1' ' A' ' 28' ' ' THR . 53.6 mt-10 -60.06 -60.21 4.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.459 HD23 ' CD2' ' A' ' 48' ' ' LEU . 3.7 tp -58.73 -32.37 69.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.89 -33.26 86.77 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.1 m -71.94 -47.93 48.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.261 -1.141 . . . . 0.0 110.14 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.63 -55.57 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.266 -0.896 . . . . 0.0 110.566 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.533 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 3.8 mmt -55.47 -36.44 66.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 110.179 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -64.11 -33.04 74.87 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -44.63 81.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 0.0 110.689 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 91' ' ' VAL . 10.7 mt -47.83 -37.96 14.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.006 -1.059 . . . . 0.0 109.923 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.74 17.27 19.55 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.492 ' OE1' HD12 ' B' ' 3' ' ' LEU . 87.0 mm-40 -82.05 -131.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.122 -1.222 . . . . 0.0 110.182 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.541 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 7.6 p30 -159.05 58.28 1.22 Allowed Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.95 -1.094 . . . . 0.0 110.627 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 49.4 Cg_endo -82.87 83.14 2.02 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.931 1.49 . . . . 0.0 110.186 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 45' ' ' GLU . 2.7 m -50.0 176.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.144 -0.972 . . . . 0.0 110.297 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' H ' HG22 ' A' ' 44' ' ' THR . 3.8 mm-40 -70.13 -59.54 2.83 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.267 -0.896 . . . . 0.0 110.075 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -44.2 -36.23 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.872 . . . . 0.0 109.844 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -70.71 -38.74 73.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.904 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.459 ' CD2' HD23 ' A' ' 32' ' ' LEU . 12.1 mt -55.78 -54.71 41.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.915 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.757 ' NE2' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -60.1 -40.4 89.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.631 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.453 ' O ' ' OE1' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -63.98 -36.35 83.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 109.578 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.49 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -66.93 -47.01 73.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.908 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -63.56 -30.42 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 109.335 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.27 -16.99 61.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.705 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -72.72 -57.17 4.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.498 -0.751 . . . . 0.0 110.379 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.675 HG23 ' CD1' ' B' ' 7' ' ' TRP . 37.6 t -71.33 -29.83 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.913 -1.117 . . . . 0.0 109.936 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -48.67 88.47 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.347 -0.846 . . . . 0.0 110.565 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -69.06 -27.4 65.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.321 -0.862 . . . . 0.0 110.452 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 60' ' ' ASN . 8.6 p-10 -95.85 -41.91 8.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.216 -0.927 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.83 47.67 1.46 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 18.8 p-10 -98.46 -44.07 6.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -1.137 . . . . 0.0 110.24 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.57 6.66 5.05 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.14 154.99 41.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.121 -1.223 . . . . 0.0 110.35 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.0 mm -97.07 166.18 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.274 -0.891 . . . . 0.0 110.122 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' C ' ' CE1' ' A' ' 16' ' ' PHE . 4.8 t0 -148.11 169.94 18.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.125 -0.984 . . . . 0.0 110.568 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.659 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 19.9 t80 -59.39 -41.24 86.03 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.849 . . . . 0.0 111.961 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -68.73 -23.88 35.45 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 O-C-N 123.142 1.075 . . . . 0.0 110.473 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.58 -36.27 29.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -62.01 -42.91 99.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.411 -0.806 . . . . 0.0 110.239 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.62 -34.6 58.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.197 -0.939 . . . . 0.0 110.543 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.5 m -74.56 -12.44 60.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.062 -1.024 . . . . 0.0 110.768 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.9 tmm? -98.6 -43.68 6.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.045 -1.035 . . . . 0.0 110.76 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.503 ' CE ' ' CE ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -60.81 -10.89 6.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.167 -0.958 . . . . 0.0 110.784 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.01 -17.23 28.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.055 -1.028 . . . . 0.0 110.927 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -97.05 -18.33 19.44 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.961 -1.087 . . . . 0.0 110.72 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.948 ' HG3' HG21 ' B' ' 8' ' ' THR . 17.8 mmtp -92.39 -28.42 16.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.073 -1.017 . . . . 0.0 110.537 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.543 ' HE1' ' CE2' ' B' ' 26' ' ' PHE . 5.0 ttm -98.03 61.31 1.5 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.19 -0.944 . . . . 0.0 110.304 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -110.58 -56.62 2.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 110.295 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 1.2 t0 177.51 -41.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.219 -0.926 . . . . 0.0 110.43 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.4 m -49.06 -81.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.203 -0.935 . . . . 0.0 110.425 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 80' ' ' ASP . 6.0 p-10 -77.9 100.61 6.45 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.197 -0.939 . . . . 0.0 110.44 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.2 p -121.81 -32.97 3.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 0.0 109.786 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -99.14 -21.61 16.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.979 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -72.73 -35.57 67.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.791 ' HG2' HD12 ' B' ' 12' ' ' LEU . 8.3 tt0 -70.26 -42.09 72.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.83 . . . . 0.0 110.168 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.675 HG23 ' CE2' ' A' ' 141' ' ' PHE . 46.5 mt -68.63 -26.79 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.45 -0.782 . . . . 0.0 109.718 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -66.9 -49.69 64.79 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.465 -0.772 . . . . 0.0 109.709 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.4 mt-10 -59.53 -48.83 80.15 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.301 -0.875 . . . . 0.0 109.695 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -56.07 -31.63 63.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.588 ' CE2' ' HA ' ' A' ' 138' ' ' TYR . 4.7 t80 -67.99 -63.85 0.98 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.133 -0.98 . . . . 0.0 109.682 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' PHE . 3.9 mmt85 -41.34 -32.75 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.656 -0.653 . . . . 0.0 109.826 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.674 HG12 HG21 ' A' ' 108' ' ' VAL . 71.4 t -65.5 -47.02 88.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.353 -0.842 . . . . 0.0 109.465 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.624 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 43.9 m-85 -68.94 -18.44 64.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.309 -0.869 . . . . 0.0 110.028 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.522 ' HA ' ' OE2' ' A' ' 104' ' ' GLU . 1.9 t0 -96.98 60.68 1.74 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.334 -0.854 . . . . 0.0 110.478 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -42.07 -61.26 1.19 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.261 -0.899 . . . . 0.0 110.278 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 9.4 p30 -55.28 -28.97 57.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 110.143 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 74.81 42.84 30.02 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.0 p30 -100.13 -48.96 4.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -1.181 . . . . 0.0 110.262 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 148.66 -33.7 1.17 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -95.61 153.98 17.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.146 -1.208 . . . . 0.0 110.314 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.486 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 17.0 mt -121.27 127.52 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.259 -0.901 . . . . 0.0 110.251 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.0 p -111.28 164.13 13.22 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.352 -0.842 . . . . 0.0 109.998 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.699 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -55.95 -33.71 65.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.175 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.93 -46.53 89.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.011 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.522 ' OE2' ' HA ' ' A' ' 93' ' ' ASP . 14.3 mt-10 -58.89 -50.06 75.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.749 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.442 ' HG ' HD11 ' A' ' 125' ' ' ILE . 2.5 mm? -55.61 -42.72 75.26 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.215 -0.928 . . . . 0.0 109.748 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -18.65 65.34 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.205 -0.934 . . . . 0.0 109.339 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.459 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 1.7 m80 -82.52 -30.15 29.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.759 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.674 HG21 HG12 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -83.92 -41.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.306 -0.871 . . . . 0.0 109.647 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 1.056 ' HE2' HD13 ' A' ' 116' ' ' LEU . 16.8 mtt -44.35 -70.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 110.292 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.4 m -49.35 -46.38 46.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.445 -0.784 . . . . 0.0 109.935 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 5.2 m120 -59.04 -16.04 16.6 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.405 -0.809 . . . . 0.0 109.74 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.8 ' O ' HD11 ' A' ' 18' ' ' LEU . 8.1 mt -106.74 -45.89 4.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.34 -0.85 . . . . 0.0 110.537 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.98 -62.51 0.24 Allowed Glycine 0 N--CA 1.496 2.682 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.772 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 109' ' ' MET . 59.6 tt0 -81.75 172.04 13.85 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.109 -1.23 . . . . 0.0 110.831 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.48 ' N ' ' CG ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -154.61 75.49 0.98 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.592 -0.693 . . . . 0.0 109.593 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.056 HD13 ' HE2' ' A' ' 109' ' ' MET . 2.4 mp -36.26 138.55 0.2 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.7 -0.625 . . . . 0.0 110.63 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.547 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -54.63 -165.16 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.251 -0.905 . . . . 0.0 110.18 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.46 ' H ' HG22 ' A' ' 117' ' ' THR . 0.9 OUTLIER -83.56 -56.69 3.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.254 -0.904 . . . . 0.0 110.288 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -56.85 -25.34 56.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 110.067 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 14.7 mm-40 -78.12 -44.18 26.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 108.971 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.699 HG12 ' HB1' ' A' ' 102' ' ' ALA . 15.2 t -57.69 -36.72 55.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.676 -0.64 . . . . 0.0 109.902 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.87 -51.01 20.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.981 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -58.89 -22.71 59.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.892 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.404 ' CE ' ' O ' ' B' ' 21' ' ' SER . 0.0 OUTLIER -75.8 -47.24 26.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -0.901 . . . . 0.0 110.108 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.442 HD11 ' HG ' ' A' ' 105' ' ' LEU . 11.7 mm -76.94 -33.46 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.209 -0.932 . . . . 0.0 110.055 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 ttp85 -64.49 -45.38 87.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 0.0 110.211 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.79 -20.09 65.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.2 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.956 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -85.81 -35.2 20.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.38 64.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.279 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.956 HD12 ' O ' ' A' ' 128' ' ' ALA . 1.5 mp -46.97 -28.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.257 -0.902 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 13.3 p-10 -88.99 -28.17 20.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.915 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.8 73.03 1.28 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 135' ' ' GLN . 18.2 p-10 -127.34 -29.22 2.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.267 -1.137 . . . . 0.0 110.255 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.12 -8.32 12.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.431 ' O ' ' OD2' ' A' ' 133' ' ' ASP . 9.4 pt20 -159.43 169.01 24.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.189 -1.183 . . . . 0.0 110.417 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.642 HG13 ' HB3' ' A' ' 140' ' ' GLU . 24.9 t -113.27 159.29 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.239 -0.913 . . . . 0.0 110.497 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.464 ' OD1' ' OE2' ' A' ' 140' ' ' GLU . 10.3 p-10 -122.26 -173.38 2.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.192 -0.943 . . . . 0.0 110.325 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.588 ' HA ' ' CE2' ' A' ' 89' ' ' PHE . 6.2 t80 -57.51 -69.37 0.17 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.218 -0.926 . . . . 0.0 110.655 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.7 OUTLIER -41.0 -53.06 3.05 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.298 -0.876 . . . . 0.0 110.382 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.642 ' HB3' HG13 ' A' ' 136' ' ' VAL . 8.5 mt-10 -52.79 -62.32 1.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.934 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.675 ' CE2' HG23 ' A' ' 85' ' ' ILE . 37.8 t80 -41.79 -27.51 0.11 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.266 -0.896 . . . . 0.0 109.756 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' GLU . 96.2 t -95.19 -37.7 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.367 -0.833 . . . . 0.0 110.194 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.593 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -68.4 -9.48 48.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.119 -0.988 . . . . 0.0 109.872 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.474 ' O ' ' OD1' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -94.08 -23.15 18.09 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.364 -0.835 . . . . 0.0 110.42 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.5 mmt -100.61 -68.71 0.8 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.972 . . . . 0.0 111.105 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.453 ' H ' HG22 ' A' ' 146' ' ' THR . 5.3 t -92.43 61.66 3.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.221 -0.924 . . . . 0.0 110.797 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -99.7 40.41 1.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 110.23 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.268 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 82.6 t . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -93.98 139.19 31.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 0.0 110.039 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.505 HD13 ' C ' ' B' ' 3' ' ' LEU . 0.7 OUTLIER -170.61 68.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 110.495 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.519 HG23 ' HD2' ' B' ' 5' ' ' PRO . 14.1 mt -112.89 142.36 27.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 109.823 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.775 ' HB2' HG13 ' B' ' 10' ' ' VAL . 44.7 Cg_endo -71.24 103.88 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.893 1.47 . . . . 0.0 109.891 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.529 ' O ' ' N ' ' B' ' 8' ' ' THR . 23.1 t -62.13 71.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.561 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.78 ' O ' HG22 ' B' ' 10' ' ' VAL . 4.2 m95 50.74 -86.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.871 . . . . 0.0 110.648 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.948 HG21 ' HG3' ' A' ' 75' ' ' LYS . 40.4 p -41.78 -24.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.715 -1.241 . . . . 0.0 110.42 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.531 HG21 ' HA ' ' B' ' 5' ' ' PRO . 85.6 m -70.58 -51.47 28.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 109.941 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.78 HG22 ' O ' ' B' ' 7' ' ' TRP . 3.8 m -56.38 -28.31 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.85 -1.156 . . . . 0.0 108.849 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.45 ' N ' HD13 ' B' ' 11' ' ' ILE . 7.1 mm -75.8 -28.38 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.448 -0.783 . . . . 0.0 109.322 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.791 HD12 ' HG2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -66.08 -57.61 7.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.57 -0.706 . . . . 0.0 110.331 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.696 HG12 ' CD1' ' A' ' 112' ' ' LEU . 42.4 t -60.35 -40.71 84.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.387 -0.82 . . . . 0.0 110.952 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.459 ' O ' ' CD ' ' B' ' 14' ' ' LYS . 1.2 tmtt? -63.07 -29.08 70.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.369 -1.457 . . . . 0.0 108.744 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' B' ' 11' ' ' ILE . 1.5 p -83.39 -15.96 47.77 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.563 ' HE2' ' CE1' ' A' ' 141' ' ' PHE . 73.1 mmm -71.64 -47.2 56.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.555 -0.716 . . . . 0.0 110.578 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.771 HD13 ' H ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -99.97 37.8 1.57 Allowed 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 117.724 -1.59 . . . . 0.0 109.619 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.52 ' HG2' ' N ' ' B' ' 19' ' ' LYS . 47.7 ttp180 -48.19 -78.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.159 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.805 ' O ' HD21 ' A' ' 116' ' ' LEU . 8.6 tmtt? -104.91 -73.65 0.67 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 111.047 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.494 ' HG2' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -151.82 15.45 0.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.998 -1.063 . . . . 0.0 110.572 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.404 ' O ' ' CE ' ' A' ' 124' ' ' MET . 3.4 m -127.34 -173.36 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.111 -0.993 . . . . 0.0 110.176 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' B' ' 16' ' ' MET . 2.6 m-85 -92.91 -55.39 3.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.189 -0.944 . . . . 0.0 110.307 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' B' ' 24' ' ' ASN . . . 145.97 176.92 20.26 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.542 ' CB ' ' HD3' ' B' ' 25' ' ' PRO . 0.1 OUTLIER 174.17 -52.39 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.458 -1.025 . . . . 0.0 110.117 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 24' ' ' ASN . 48.9 Cg_endo -82.62 72.94 5.76 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.792 1.417 . . . . 0.0 110.404 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.543 ' CE2' ' HE1' ' A' ' 76' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.172 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.288 0.566 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 7.0 p-10 -154.77 40.19 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.173 -0.954 . . . . 0.0 110.188 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.422 ' N ' ' OE1' ' A' ' 3' ' ' GLN . 8.5 mp0 -74.68 151.89 39.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.082 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.83 164.19 17.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.039 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.7 p -113.55 40.94 2.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.191 -0.943 . . . . 0.0 110.135 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 7' ' ' GLU . 1.3 tp10 -48.15 -46.96 35.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.463 -0.773 . . . . 0.0 110.308 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.615 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.2 mm-40 -41.1 -62.37 0.84 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.367 -0.833 . . . . 0.0 110.226 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -45.82 -56.15 5.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.159 -0.963 . . . . 0.0 109.575 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 10' ' ' ALA . 67.1 mt -53.13 -43.88 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.795 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -44.19 -60.19 2.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.913 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 5.0 tm-20 -52.5 -55.4 22.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 109.755 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -53.26 -30.07 36.4 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.162 -0.961 . . . . 0.0 109.277 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' SER . 17.9 ttmt -64.83 -37.05 86.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.309 -0.869 . . . . 0.0 109.089 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 11' ' ' GLU . 3.1 mm-40 -61.36 -46.36 90.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.508 -0.745 . . . . 0.0 109.363 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 -48.74 80.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -0.839 . . . . 0.0 109.587 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.509 ' CE1' ' C ' ' A' ' 64' ' ' ASP . 55.3 t80 -62.78 -39.68 94.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.413 -0.804 . . . . 0.0 109.508 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -70.8 -30.27 66.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -0.801 . . . . 0.0 109.319 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.817 HD11 ' O ' ' A' ' 112' ' ' LEU . 9.5 tt -59.46 -44.18 93.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.427 -0.796 . . . . 0.0 109.702 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -69.87 -52.76 22.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.278 -0.888 . . . . 0.0 109.963 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -67.28 108.42 2.73 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.398 -0.814 . . . . 0.0 110.239 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -84.8 2.26 43.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.288 -0.883 . . . . 0.0 110.402 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.57 -68.65 0.9 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.157 -0.965 . . . . 0.0 110.694 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.27 35.24 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 60.0 p30 -94.12 -10.14 34.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -1.16 . . . . 0.0 110.039 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.554 ' C ' HG23 ' A' ' 26' ' ' THR . . . 81.37 30.39 37.22 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.554 HG23 ' C ' ' A' ' 25' ' ' GLY . 77.7 p -152.76 124.44 7.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.137 -1.214 . . . . 0.0 110.709 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.573 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 4.2 mt -92.36 120.7 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.23 -0.919 . . . . 0.0 109.758 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -100.17 171.21 7.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 110.359 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.1 p -61.94 -33.44 74.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 110.033 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -70.01 -59.21 3.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 110.276 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.404 ' OE1' ' HA ' ' A' ' 20' ' ' ASP . 52.7 mt-10 -49.2 -66.63 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 109.881 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.3 tp -48.98 -43.95 40.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.749 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.05 -43.25 49.61 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 83.0 m -60.68 -48.57 81.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -1.137 . . . . 0.0 110.06 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 35' ' ' VAL . 4.2 t -64.6 -43.37 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.804 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 29.9 mmm -70.97 -24.6 62.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 109.882 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.09 -21.18 47.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.88 . . . . 0.0 110.14 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 39' ' ' LEU . 50.8 m -85.9 -40.89 15.45 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.255 -0.903 . . . . 0.0 110.771 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.43 HD23 HG22 ' A' ' 108' ' ' VAL . 2.4 mt -44.13 -32.23 1.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.924 -1.11 . . . . 0.0 109.799 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 41' ' ' GLN . . . 128.62 67.24 0.12 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER 179.55 -172.2 0.17 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.372 -1.075 . . . . 0.0 110.231 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -138.33 92.03 12.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.938 . . . . 0.0 110.666 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.74 126.48 11.43 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.088 1.573 . . . . 0.0 109.885 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 m -94.38 161.72 14.12 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.207 -0.933 . . . . 0.0 110.581 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.0 -60.69 3.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.022 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.35 -43.96 23.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.7 -42.35 74.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 0.0 109.873 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -64.22 -34.97 79.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.83 -41.16 83.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.866 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -67.17 -24.8 65.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.384 -0.823 . . . . 0.0 109.827 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.0 mtp -77.59 -45.96 23.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 109.791 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -64.46 -35.11 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 109.845 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.37 -15.07 56.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -81.42 -33.32 32.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 110.225 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.608 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 4.4 t -103.26 -14.12 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.184 -0.948 . . . . 0.0 110.256 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 12.4 t0 -60.07 80.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 0.0 109.901 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -93.14 -15.83 25.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.901 . . . . 0.0 110.368 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.3 -40.37 21.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.199 -0.938 . . . . 0.0 110.135 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.19 13.54 30.86 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 27.6 p-10 -88.04 -46.89 8.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -1.096 . . . . 0.0 110.263 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 131.38 -21.68 4.52 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 36.0 p -116.6 169.63 9.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -1.184 . . . . 0.0 110.148 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.573 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 11.2 mm -94.62 138.66 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.888 . . . . 0.0 110.001 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.542 ' CB ' ' HD2' ' A' ' 66' ' ' PRO . 5.1 m-20 -117.48 171.91 7.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.972 . . . . 0.0 110.695 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.659 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.2 t80 -62.97 -38.82 46.5 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 111.674 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.7 Cg_endo -70.08 -24.54 28.1 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 O-C-N 123.075 1.04 . . . . 0.0 109.589 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.52 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 3.2 mt-10 -69.49 -33.61 73.1 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.414 -0.804 . . . . 0.0 108.922 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.614 ' HZ ' HG23 ' B' ' 11' ' ' ILE . 2.0 t80 -68.4 -48.21 65.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.54 -0.725 . . . . 0.0 109.571 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 3.2 mm? -55.91 -36.72 68.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 110.371 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 2.7 m -87.33 -25.45 23.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.125 -0.984 . . . . 0.0 110.61 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.526 ' HE2' ' N ' ' A' ' 72' ' ' MET . 2.2 ttp -63.07 -61.49 2.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.937 . . . . 0.0 110.209 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.671 ' CE ' ' CZ ' ' B' ' 26' ' ' PHE . 2.0 tpt -47.23 -32.27 4.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.267 -0.896 . . . . 0.0 110.632 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.38 -11.23 46.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.935 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 70' ' ' THR . 0.4 OUTLIER -99.29 -10.96 21.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.99 -1.069 . . . . 0.0 110.397 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.544 ' CB ' HG21 ' B' ' 8' ' ' THR . 2.2 mptp? -100.1 -22.75 15.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 0.0 110.455 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 32.7 mtt -99.54 60.15 1.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.107 -0.996 . . . . 0.0 110.269 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.72 -36.0 0.4 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.317 -0.864 . . . . 0.0 110.137 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' C ' ' OG1' ' A' ' 79' ' ' THR . 7.8 t70 -172.88 66.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -171.68 99.05 0.18 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 110.324 -179.725 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 79' ' ' THR . 43.8 m-20 60.22 104.53 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.423 -0.798 . . . . 0.0 110.703 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.438 ' O ' ' OE2' ' A' ' 84' ' ' GLU . 43.4 t -102.23 -49.15 3.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.648 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -98.56 -20.35 17.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.456 -0.777 . . . . 0.0 109.587 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.56 -47.57 69.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.498 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' B' ' 26' ' ' PHE . 17.3 pt-20 -47.59 -33.07 6.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.526 -0.734 . . . . 0.0 110.128 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.676 HG21 HG22 ' A' ' 142' ' ' VAL . 63.9 mt -76.32 -39.93 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.18 -0.95 . . . . 0.0 109.074 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -32.47 67.64 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HB3' HG23 ' B' ' 9' ' ' THR . 0.2 OUTLIER -67.01 -62.02 1.64 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.681 ' CB ' HD22 ' B' ' 12' ' ' LEU . . . -51.93 -30.13 23.18 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.538 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.51 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 59.0 t80 -71.92 -50.56 28.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.475 -0.766 . . . . 0.0 109.598 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.74 -47.18 77.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.0 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.54 HG11 HG21 ' B' ' 13' ' ' VAL . 0.9 OUTLIER -49.19 -45.46 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.567 -0.708 . . . . 0.0 109.29 179.087 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.561 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 17.3 m-85 -71.91 -36.69 70.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 0.0 109.964 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 94' ' ' LYS . 15.7 t0 -75.13 55.49 0.74 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.198 -0.939 . . . . 0.0 110.197 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' ASP . 9.0 tttp -40.71 -66.02 0.36 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.37 -0.831 . . . . 0.0 110.532 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 21.6 p-10 -61.48 -43.35 99.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 0.0 110.231 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 93.97 44.82 3.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 32.5 p-10 -87.23 -28.9 22.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.187 -1.184 . . . . 0.0 110.169 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.563 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 121.49 15.34 4.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 50.8 m-85 -151.76 152.41 32.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.141 -1.211 . . . . 0.0 110.178 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 9.2 mt -104.98 118.91 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.922 . . . . 0.0 110.149 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 102' ' ' ALA . 12.4 t -105.52 141.97 36.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.848 . . . . 0.0 110.338 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -42.96 -33.85 0.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.313 -0.867 . . . . 0.0 109.833 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -55.16 -55.64 28.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 109.612 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 49.0 mt-10 -54.38 -48.4 71.56 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.352 -0.842 . . . . 0.0 109.764 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.711 HD13 HD11 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -58.72 -37.36 75.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.624 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 22.6 tpt85 -60.79 -41.24 95.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.307 -0.871 . . . . 0.0 109.44 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -57.99 -44.4 87.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.783 . . . . 0.0 109.422 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.587 HG11 ' CG1' ' B' ' 13' ' ' VAL . 5.9 t -73.19 -29.08 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.553 -0.717 . . . . 0.0 109.65 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.987 ' HA ' HD21 ' B' ' 17' ' ' LEU . 2.3 mtt -55.37 -69.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 110.7 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.6 m -64.85 -10.09 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.38 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.0 m-20 -94.87 -6.68 42.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.295 -0.878 . . . . 0.0 110.159 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.817 ' O ' HD11 ' A' ' 18' ' ' LEU . 10.1 mt -107.44 -30.57 8.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 110.354 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 147.47 -51.87 0.56 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.507 ' HG2' HD12 ' A' ' 116' ' ' LEU . 23.0 tt0 -107.66 149.31 28.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -1.121 . . . . 0.0 109.7 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -123.62 19.17 9.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.895 . . . . 0.0 109.827 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.019 HD11 ' O ' ' B' ' 17' ' ' LEU . 3.5 mp 42.54 -166.51 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.55 0.69 . . . . 0.0 110.549 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.2 -144.65 0.3 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.514 -0.741 . . . . 0.0 109.144 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -117.64 -70.64 0.78 Allowed 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.07 -1.018 . . . . 0.0 110.274 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -48.45 -40.98 28.07 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 109.398 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 121' ' ' VAL . 41.7 mm-40 -60.08 -53.48 57.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 109.282 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 120' ' ' GLU . 70.8 t -44.59 -41.52 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.418 -0.801 . . . . 0.0 109.844 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 35.8 m-20 -63.43 -60.81 2.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.856 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.45 ' HA ' ' OE1' ' A' ' 123' ' ' GLU . 4.0 tp10 -50.24 -40.98 49.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.795 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.449 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 4.5 ttt -51.7 -47.28 63.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.833 . . . . 0.0 109.841 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.711 HD11 HD13 ' A' ' 105' ' ' LEU . 48.9 mm -75.72 -39.02 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.932 . . . . 0.0 109.996 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -65.42 -26.7 68.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 110.275 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.42 -41.59 98.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 110.125 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.92 -27.04 23.6 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.317 -0.864 . . . . 0.0 110.335 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.651 ' OD2' HG22 ' A' ' 125' ' ' ILE . 1.7 m-20 -58.89 88.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.328 -0.858 . . . . 0.0 110.567 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.2 mp -61.82 -41.54 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.196 -0.94 . . . . 0.0 109.422 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 35.4 p30 -82.66 -17.94 42.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.422 -0.799 . . . . 0.0 110.053 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 66.02 67.86 1.86 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 30.5 p-10 -118.25 1.84 11.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -1.11 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.86 -9.44 74.27 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 99' ' ' TYR . 1.4 pt20 -137.71 147.72 45.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -1.106 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.49 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 4.0 t -104.08 146.08 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.209 -0.932 . . . . 0.0 110.155 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.455 ' OD1' ' HG3' ' A' ' 140' ' ' GLU . 33.7 p-10 -103.46 -161.09 0.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 139' ' ' GLU . 14.8 t80 -71.81 -63.45 1.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.074 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -44.12 -56.58 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 110.009 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 136' ' ' VAL . 68.4 mt-10 -47.52 -61.38 1.95 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 6.0 t80 -44.68 -26.97 0.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.288 -0.882 . . . . 0.0 110.282 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.676 HG22 HG21 ' A' ' 85' ' ' ILE . 76.8 t -99.48 -45.95 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.201 -0.937 . . . . 0.0 110.163 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.828 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 7.7 tp60 -46.48 -34.7 4.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.363 -0.836 . . . . 0.0 110.45 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.5 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -86.02 -19.82 29.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.582 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 3.7 mtt -84.86 -47.32 10.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.996 -1.065 . . . . 0.0 110.489 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.9 p -83.09 -43.06 16.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.063 -1.023 . . . . 0.0 110.319 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -87.0 57.22 4.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.023 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.199 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' B' ' 2' ' ' LYS . 5.6 m . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.311 0.577 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' B' ' 1' ' ' VAL . 22.9 mmtp 60.6 17.44 7.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.943 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' B' ' 3' ' ' LEU . 23.1 mt -144.25 -69.03 0.31 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.561 -0.712 . . . . 0.0 109.632 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.838 HG23 ' HD2' ' B' ' 5' ' ' PRO . 17.2 mm -62.98 152.73 82.92 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.379 -0.826 . . . . 0.0 109.776 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.838 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.1 Cg_endo -66.37 116.46 4.06 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.79 1.416 . . . . 0.0 110.289 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 10' ' ' VAL . 3.0 m -53.2 179.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.848 . . . . 0.0 111.04 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.608 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -68.27 -66.14 0.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.596 0.713 . . . . 0.0 110.241 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.544 HG21 ' CB ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -53.99 -38.86 65.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 110.083 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 87' ' ' GLU . 49.1 m -49.06 -42.05 37.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.96 . . . . 0.0 108.982 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 6' ' ' SER . 47.3 t -65.76 -50.36 71.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.42 -0.8 . . . . 0.0 109.382 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.614 HG23 ' HZ ' ' A' ' 68' ' ' PHE . 9.2 mm -59.45 -27.12 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.427 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -65.14 -57.05 9.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.454 -0.779 . . . . 0.0 110.533 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.661 HG12 HD11 ' A' ' 112' ' ' LEU . 67.6 t -65.86 -30.57 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.945 . . . . 0.0 110.122 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.685 ' CG ' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -68.36 -47.27 67.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.92 . . . . 0.0 109.918 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' B' ' 18' ' ' ARG . 8.3 m -63.28 -29.85 71.09 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 110.131 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 11.6 ttm -68.22 -40.09 82.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.992 . . . . 0.0 109.95 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 1.019 ' O ' HD11 ' A' ' 116' ' ' LEU . 3.7 mp -56.19 -16.69 5.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.277 -0.889 . . . . 0.0 110.199 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.501 ' C ' ' O ' ' B' ' 17' ' ' LEU . 52.3 ttt180 -29.73 -78.34 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 121.032 0.444 . . . . 0.0 111.291 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.503 ' HD3' ' C ' ' B' ' 19' ' ' LYS . 1.8 tmtp? -143.18 -119.83 0.09 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.272 -0.893 . . . . 0.0 109.575 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.488 ' N ' ' CD ' ' B' ' 19' ' ' LYS . 0.2 OUTLIER -99.94 8.74 43.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.691 -1.255 . . . . 0.0 110.043 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.41 -178.09 1.04 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.362 -0.836 . . . . 0.0 110.13 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.449 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.3 OUTLIER -176.66 -46.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.884 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 144' ' ' MET . . . -72.02 80.8 0.58 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.2 134.57 21.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.294 -1.121 . . . . 0.0 110.586 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.51 72.62 4.26 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 124.066 1.561 . . . . 0.0 110.316 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.671 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.498 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.207 0.527 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -72.43 88.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 110.173 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.498 ' NE2' ' OE1' ' A' ' 6' ' ' GLU . 2.7 mm-40 -99.27 -156.8 0.56 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.248 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 3' ' ' GLN . 12.0 mt 55.93 160.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.293 -0.879 . . . . 0.0 110.305 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 47.58 48.14 17.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.278 -0.889 . . . . 0.0 110.464 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' OE1' ' NE2' ' A' ' 3' ' ' GLN . 4.4 tt0 -100.37 -20.19 15.94 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.466 -0.771 . . . . 0.0 110.157 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -56.67 -53.26 59.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 110.245 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.498 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 24.1 mt-30 -56.53 -35.44 68.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.164 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.85 -32.96 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.925 . . . . 0.0 110.038 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.72 -44.14 70.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.937 . . . . 0.0 110.224 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 12' ' ' PHE . 4.6 pt-20 -65.06 -31.15 72.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.522 ' N ' ' HG2' ' A' ' 11' ' ' GLU . 19.9 m-30 -65.53 -44.1 87.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.844 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 17' ' ' SER . 0.4 OUTLIER -59.97 -43.59 95.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.179 -0.95 . . . . 0.0 109.36 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -61.54 -40.17 93.72 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.27 -0.894 . . . . 0.0 109.263 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.68 -52.07 54.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 0.0 109.489 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.536 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 7.6 t80 -58.38 -26.16 62.89 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.356 -0.84 . . . . 0.0 108.992 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -76.57 -34.82 58.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.512 -0.743 . . . . 0.0 109.32 179.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.787 HD11 ' O ' ' A' ' 112' ' ' LEU . 8.1 tt -59.14 -45.47 90.86 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.371 -0.83 . . . . 0.0 109.575 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' LYS . 41.8 m-85 -74.1 -49.71 22.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.378 -0.826 . . . . 0.0 109.589 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 21' ' ' LYS . 8.2 t0 -67.95 71.31 0.15 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.484 -0.76 . . . . 0.0 109.893 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -41.3 -41.73 2.0 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.429 -0.795 . . . . 0.0 110.36 -179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 13.0 p-10 -85.3 -43.1 14.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.099 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.5 32.16 6.13 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 46.2 p-10 -81.6 -2.53 50.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -1.193 . . . . 0.0 110.014 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 26' ' ' THR . . . 82.98 29.01 35.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 25' ' ' GLY . 13.4 p -154.98 118.73 4.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -1.113 . . . . 0.0 110.265 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.554 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 7.8 mt -90.45 124.63 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.951 . . . . 0.0 110.002 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.01 168.17 10.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 110.285 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.7 p -61.41 -28.42 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.96 -44.92 60.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.165 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -61.38 -60.65 3.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.976 . . . . 0.0 110.1 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.563 HD13 ' CH2' ' B' ' 7' ' ' TRP . 2.9 tp -59.31 -29.42 67.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.875 . . . . 0.0 110.189 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.99 -40.0 84.52 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.5 m -69.65 -50.71 41.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -1.157 . . . . 0.0 110.094 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 38' ' ' SER . 21.3 t -60.41 -42.72 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.177 -0.952 . . . . 0.0 110.327 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.52 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 2.6 mmt -66.84 -42.14 86.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 109.737 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -67.73 -14.04 62.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 110.112 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -72.11 -58.18 3.65 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.189 -0.944 . . . . 0.0 110.623 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 mt -45.94 -28.59 1.17 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.12 -0.987 . . . . 0.0 110.736 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.502 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . 118.79 58.6 0.27 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.21 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 40' ' ' GLY . 64.7 mm-40 -131.9 -162.07 1.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.248 . . . . 0.0 109.928 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.548 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 1.3 t-20 -147.1 49.95 0.87 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.186 -0.947 . . . . 0.0 110.492 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 42' ' ' ASN . 46.1 Cg_endo -74.0 73.74 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.086 1.572 . . . . 0.0 110.462 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 43' ' ' PRO . 10.9 t -54.06 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.18 -0.95 . . . . 0.0 110.556 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -66.9 -58.65 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.337 -0.852 . . . . 0.0 110.351 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -42.71 -42.82 3.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 109.835 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' OE1' HD11 ' B' ' 4' ' ' ILE . 10.6 mm-40 -71.15 -41.16 70.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.491 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 mt -52.74 -59.16 4.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.806 . . . . 0.0 109.95 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -53.94 -41.26 67.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.409 -0.807 . . . . 0.0 109.882 179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -61.51 -41.13 96.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 110.101 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.49 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -73.97 -44.31 55.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 4.5 mm -61.67 -30.68 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.439 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.4 OUTLIER -73.79 -2.25 22.75 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.367 -0.833 . . . . 0.0 110.403 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.7 OUTLIER -85.29 -31.18 23.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.183 -0.948 . . . . 0.0 110.578 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 71' ' ' MET . 13.0 t -108.05 -46.34 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.126 -0.984 . . . . 0.0 110.495 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -45.57 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 110.663 -179.302 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -85.64 -3.35 58.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.371 -0.83 . . . . 0.0 110.161 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.64 -53.94 4.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.176 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 112.71 22.22 5.8 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 17.4 p-10 -87.65 -46.21 9.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -1.169 . . . . 0.0 110.18 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.92 -0.59 11.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.6 p -134.31 149.89 50.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -1.214 . . . . 0.0 110.206 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.554 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 12.0 mm -90.41 144.55 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.065 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 48.3 m-20 -119.85 169.19 10.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.252 -0.905 . . . . 0.0 110.358 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.668 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.4 t80 -63.19 -38.58 42.68 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 111.598 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.3 Cg_endo -69.78 -26.62 27.32 Favored 'Trans proline' 0 C--N 1.321 -0.881 0 O-C-N 123.025 1.013 . . . . 0.0 109.656 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 71' ' ' MET . 10.6 mt-10 -76.41 -36.46 58.03 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 108.728 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 72' ' ' MET . 3.7 t80 -61.97 -41.33 97.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.507 -0.746 . . . . 0.0 109.986 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.28 -49.1 68.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.254 -0.904 . . . . 0.0 110.16 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -59.0 3.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 110.392 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.566 ' HB2' HG13 ' A' ' 55' ' ' VAL . 5.3 ppp? -48.77 -30.45 5.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.271 -0.893 . . . . 0.0 110.716 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.546 ' HE2' ' CE ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -68.7 -9.99 53.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.019 -1.051 . . . . 0.0 110.54 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.41 -12.93 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.125 -0.984 . . . . 0.0 111.195 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -78.71 -15.79 58.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.962 -1.087 . . . . 0.0 110.766 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -100.19 -40.42 7.57 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.071 -1.018 . . . . 0.0 110.391 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.586 ' HE1' ' CE1' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -98.64 62.84 1.41 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 110.463 -179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -129.95 -31.95 1.89 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.416 -0.803 . . . . 0.0 110.379 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.83 -94.78 0.37 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.253 -0.904 . . . . 0.0 110.419 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.63 HG22 ' O ' ' A' ' 79' ' ' THR . 89.9 m -130.97 30.62 4.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.161 -0.962 . . . . 0.0 110.42 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.06 35.73 4.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.006 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.5 m -104.45 -35.25 7.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.809 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 1.4 mt-10 -69.84 -25.2 63.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.364 -0.835 . . . . 0.0 109.716 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' OE1' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -65.56 -57.92 7.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.295 -0.878 . . . . 0.0 109.548 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.541 ' OE1' ' CG ' ' A' ' 76' ' ' MET . 24.5 mt-10 -45.52 -27.9 0.83 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.557 -0.714 . . . . 0.0 110.383 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.888 HG21 HG22 ' A' ' 142' ' ' VAL . 47.8 mt -66.37 -43.29 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 121.011 -1.056 . . . . 0.0 108.988 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 ttm105 -58.54 -46.91 85.84 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.812 ' HB3' HG21 ' B' ' 9' ' ' THR . 2.9 mt-10 -67.65 -50.77 56.23 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.225 -0.922 . . . . 0.0 108.869 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' B' ' 13' ' ' VAL . . . -56.35 -40.0 73.77 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 141' ' ' PHE . 11.8 t80 -66.43 -40.08 89.28 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.482 ' NH1' ' O ' ' B' ' 3' ' ' LEU . 10.8 ttt180 -58.85 -45.63 89.64 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.917 HG11 HG11 ' B' ' 13' ' ' VAL . 21.4 t -48.29 -46.73 13.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.71 ' CE2' HD21 ' A' ' 105' ' ' LEU . 4.8 m-85 -71.58 -31.85 67.41 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.005 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 11.0 t0 -101.23 63.47 0.99 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.442 -0.786 . . . . 0.0 109.975 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.528 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 34.0 pttt -55.46 -25.38 36.22 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.149 -0.969 . . . . 0.0 110.508 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.528 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 11.8 p-10 -86.58 -40.33 15.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 110.371 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 93' ' ' ASP . . . 85.95 50.49 3.9 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.448 ' OD1' ' OD2' ' A' ' 95' ' ' ASP . 15.1 p-10 -96.2 -24.88 16.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.196 -1.179 . . . . 0.0 110.283 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 118.99 -7.87 12.77 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CE1' ' OD1' ' A' ' 137' ' ' ASN . 98.3 m-85 -136.86 151.83 49.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.286 -1.126 . . . . 0.0 110.152 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.514 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 8.7 mt -103.38 134.0 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.18 -0.95 . . . . 0.0 110.09 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 102' ' ' ALA . 37.6 t -112.2 136.54 51.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 110.234 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.39 -27.12 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.305 -0.872 . . . . 0.0 109.932 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -63.49 -59.65 4.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.357 -0.839 . . . . 0.0 109.671 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 89.4 mt-10 -48.16 -38.85 19.06 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.263 -0.898 . . . . 0.0 109.414 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.71 HD21 ' CE2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -54.91 -52.67 62.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.384 179.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.413 ' O ' ' OG1' ' A' ' 110' ' ' THR . 5.2 ttm105 -48.65 -47.97 40.09 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.251 -0.906 . . . . 0.0 109.377 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 14.0 m170 -52.95 -53.31 51.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.4 -0.812 . . . . 0.0 109.169 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.52 HG21 HG12 ' A' ' 91' ' ' VAL . 21.7 t -64.49 -41.63 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 108.943 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.787 ' HA ' HD21 ' B' ' 17' ' ' LEU . 33.6 ttm -51.81 -48.73 63.73 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.717 -0.614 . . . . 0.0 109.937 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -79.83 -32.18 40.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.232 -0.917 . . . . 0.0 110.253 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -72.81 -14.92 61.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.983 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.02 HD11 HG12 ' B' ' 13' ' ' VAL . 10.5 mt -99.35 -48.84 4.65 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.189 -0.944 . . . . 0.0 109.949 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 148.81 -31.67 1.21 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.777 ' HB3' HD23 ' B' ' 17' ' ' LEU . 5.2 tp10 -79.73 156.52 27.48 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.02 -1.282 . . . . 0.0 110.661 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.539 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.1 OUTLIER -137.17 51.83 1.94 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.776 HD12 ' HG2' ' A' ' 114' ' ' GLU . 0.2 OUTLIER -36.31 153.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.566 0.698 . . . . 0.0 110.923 -179.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 118' ' ' ASP . 2.0 m -57.67 -169.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.497 -0.752 . . . . 0.0 109.699 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.691 ' H ' HG22 ' A' ' 117' ' ' THR . 0.4 OUTLIER -99.05 -67.28 0.85 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.162 -0.961 . . . . 0.0 109.924 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -47.19 -36.97 9.4 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.762 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.8 -54.67 35.48 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.229 -0.92 . . . . 0.0 109.052 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 124' ' ' MET . 7.7 t -47.01 -48.83 7.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -60.97 -50.4 73.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 109.818 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 1.5 tp10 -59.01 -31.4 68.78 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.295 -0.878 . . . . 0.0 109.519 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -58.05 -51.2 70.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.334 -0.854 . . . . 0.0 109.855 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.846 HG23 HG23 ' A' ' 136' ' ' VAL . 2.7 mp -68.74 -24.44 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.212 -0.93 . . . . 0.0 110.006 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.414 ' NH1' ' HB2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.09 -42.05 89.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.133 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HB2' ' NH1' ' A' ' 126' ' ' ARG . 13.3 tt0 -71.34 -29.61 65.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.905 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.61 -20.45 50.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.01 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.67 68.17 0.39 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.193 -0.942 . . . . 0.0 110.111 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 mt -54.02 -31.58 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 0.0 110.306 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -89.53 -31.99 17.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.3 -0.875 . . . . 0.0 110.38 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.79 97.14 0.92 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 135' ' ' GLN . 1.2 p-10 -148.43 -38.12 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.186 -1.185 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 133.82 -1.74 4.33 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.485 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -161.22 169.73 21.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -1.235 . . . . 0.0 110.092 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.846 HG23 HG23 ' A' ' 125' ' ' ILE . 55.3 t -93.81 139.16 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.219 -0.926 . . . . 0.0 110.076 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 19.1 t30 -102.42 178.96 4.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.274 -0.891 . . . . 0.0 110.694 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.445 ' O ' ' C ' ' A' ' 139' ' ' GLU . 47.1 t80 -67.3 -68.21 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.432 -0.793 . . . . 0.0 110.298 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 140' ' ' GLU . 2.9 pt-20 -40.93 -29.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.428 -0.795 . . . . 0.0 110.094 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 3.9 mt-10 -71.62 -59.19 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.418 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.804 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.6 t80 -42.48 -29.04 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 109.377 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.888 HG22 HG21 ' A' ' 85' ' ' ILE . 45.3 t -99.81 -40.29 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.505 -0.747 . . . . 0.0 110.456 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.62 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 10.7 tt0 -63.16 -12.8 30.37 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.16 -0.962 . . . . 0.0 110.599 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.9 mtp -95.54 -21.73 18.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 109.96 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.609 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 2.6 mtt -100.88 -13.38 18.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.362 -0.836 . . . . 0.0 110.462 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 148' ' ' LYS . 72.1 p -118.89 -54.65 2.23 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.173 -0.954 . . . . 0.0 111.057 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -66.87 57.6 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.172 -0.955 . . . . 0.0 110.288 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 146' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.174 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.258 0.551 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.74 144.42 34.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.424 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.482 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 71.4 mt -114.69 -9.23 12.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.329 -0.857 . . . . 0.0 110.145 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.547 HG22 ' HD2' ' B' ' 5' ' ' PRO . 0.7 OUTLIER -97.83 142.78 25.1 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.33 -0.856 . . . . 0.0 109.56 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' B' ' 4' ' ' ILE . 48.2 Cg_endo -73.99 49.15 1.86 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.825 1.434 . . . . 0.0 111.282 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.472 ' C ' ' O ' ' B' ' 5' ' ' PRO . 10.3 m 32.72 -139.59 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.597 -0.69 . . . . 0.0 111.574 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.563 ' CH2' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -117.4 -74.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 110.265 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.588 ' HA ' HD12 ' B' ' 11' ' ' ILE . 0.6 OUTLIER -45.06 -41.7 7.9 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.803 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.812 HG21 ' HB3' ' A' ' 87' ' ' GLU . 31.4 m -51.06 -54.72 22.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.332 -0.855 . . . . 0.0 109.7 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 5' ' ' PRO . 40.6 t -47.69 -39.69 7.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.163 -0.961 . . . . 0.0 108.683 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' B' ' 8' ' ' THR . 55.0 mt -67.5 -21.81 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 0.0 109.369 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' B' ' 9' ' ' THR . 0.4 OUTLIER -71.0 -55.48 8.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.495 -0.753 . . . . 0.0 109.904 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 1.02 HG12 HD11 ' A' ' 112' ' ' LEU . 68.1 t -54.57 -40.99 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.807 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' B' ' 14' ' ' LYS . 1.2 tptm -67.24 -40.7 86.35 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.023 -1.048 . . . . 0.0 109.518 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 71.2 m -59.67 -27.76 66.68 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.354 -0.841 . . . . 0.0 109.474 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.482 ' O ' ' N ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -72.54 -38.96 67.86 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.29 -0.881 . . . . 0.0 109.375 179.257 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.787 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.8 mp -67.64 59.6 0.06 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.369 -0.832 . . . . 0.0 109.874 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' B' ' 16' ' ' MET . 0.1 OUTLIER -90.03 -77.88 0.38 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.376 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.464 ' HA ' HD21 ' A' ' 116' ' ' LEU . 10.3 tmtt? -162.75 -68.51 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.97 -1.082 . . . . 0.0 110.45 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.98 7.95 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 110.167 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.473 ' O ' ' CE ' ' A' ' 124' ' ' MET . 0.3 OUTLIER -103.7 159.79 15.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 109.639 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 0.1 OUTLIER -131.67 -34.22 1.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.158 -0.964 . . . . 0.0 110.386 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.37 171.09 33.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.609 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER -158.46 112.93 1.69 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.192 -1.181 . . . . 0.0 110.443 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.27 96.03 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.943 1.496 . . . . 0.0 110.468 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.586 ' CE1' ' HE1' ' A' ' 76' ' ' MET . 1.4 m-85 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.89 -1.053 . . . . 0.0 110.565 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.217 0.532 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -139.09 7.2 2.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.441 ' O ' ' HG3' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -88.87 152.07 21.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.248 -0.908 . . . . 0.0 110.165 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.805 ' HB2' HD11 ' A' ' 9' ' ' ILE . 0.9 OUTLIER -113.39 -150.56 0.47 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.923 . . . . 0.0 110.236 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.601 ' C ' HD12 ' A' ' 9' ' ' ILE . 9.7 p -87.08 119.58 27.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 7' ' ' GLU . 1.3 mp0 -52.15 -58.67 5.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -0.851 . . . . 0.0 110.489 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -42.16 -62.46 0.93 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.225 -0.922 . . . . 0.0 110.423 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.477 ' HB2' ' OG1' ' A' ' 5' ' ' THR . 35.6 mt-30 -54.64 -47.15 73.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.337 -0.852 . . . . 0.0 110.447 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.805 HD11 ' HB2' ' A' ' 4' ' ' LEU . 23.3 mt -63.23 -51.48 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -42.65 -50.18 5.46 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.235 -0.916 . . . . 0.0 109.98 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -58.03 -52.53 65.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.885 . . . . 0.0 109.555 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 8.5 m-85 -56.9 -39.82 75.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.303 -0.873 . . . . 0.0 109.716 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' O ' ' OG ' ' A' ' 17' ' ' SER . 3.7 tttt -63.29 -41.74 99.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.288 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.506 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 4.5 tp10 -58.23 -28.87 65.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 109.276 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -72.17 -60.87 2.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.528 -0.732 . . . . 0.0 109.769 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.534 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 21.7 t80 -52.61 -33.23 45.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.21 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 14' ' ' GLU . 2.6 p -69.47 -39.3 77.79 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.487 -0.758 . . . . 0.0 109.26 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.833 HD11 ' O ' ' A' ' 112' ' ' LEU . 1.4 tt -52.48 -36.86 55.91 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.423 -0.798 . . . . 0.0 108.965 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.556 ' CD1' HD12 ' A' ' 32' ' ' LEU . 67.0 m-85 -84.14 -45.94 12.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.578 -0.701 . . . . 0.0 109.902 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' OD2' ' HA2' ' A' ' 23' ' ' GLY . 13.5 t0 -77.49 88.15 3.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.847 . . . . 0.0 110.013 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -71.92 -13.35 61.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.251 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 21.8 p-10 -111.16 -5.73 14.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.472 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' ' OD2' ' A' ' 20' ' ' ASP . . . 52.97 57.51 14.41 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 8.0 p-10 -111.92 -41.46 4.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -1.143 . . . . 0.0 110.183 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.467 ' C ' ' CG2' ' A' ' 26' ' ' THR . . . 123.55 18.96 2.9 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.467 ' CG2' ' C ' ' A' ' 25' ' ' GLY . 7.6 p -149.53 107.59 3.73 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.198 -1.178 . . . . 0.0 110.344 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.702 HD12 ' HB ' ' A' ' 63' ' ' ILE . 16.0 mt -88.7 118.53 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.128 -0.983 . . . . 0.0 110.091 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.1 p -93.73 153.34 18.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.335 -0.853 . . . . 0.0 109.986 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 p -45.39 -28.04 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.097 -1.002 . . . . 0.0 109.964 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -66.68 -62.08 1.63 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.098 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -45.1 -66.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 109.911 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.556 HD12 ' CD1' ' A' ' 19' ' ' PHE . 11.9 tp -51.44 -38.29 52.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.705 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.17 -43.03 97.41 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -58.81 -49.57 77.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -1.063 . . . . 0.0 109.782 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -53.72 -47.82 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 0.0 109.723 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.467 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 9.0 mmt -61.55 -34.7 76.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 109.862 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -20.52 64.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 110.152 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.6 m -83.19 -54.35 5.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 110.379 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 mt -45.03 -31.91 1.49 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.23 -0.919 . . . . 0.0 110.057 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.7 27.02 3.68 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -109.9 -175.82 2.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -1.164 . . . . 0.0 110.262 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -146.36 75.64 12.43 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.273 -0.892 . . . . 0.0 110.489 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' A' ' 36' ' ' MET . 44.1 Cg_endo -72.33 149.1 50.35 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.992 1.522 . . . . 0.0 110.08 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.647 HG23 ' H ' ' A' ' 47' ' ' GLU . 7.2 t -90.54 -157.69 0.5 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.131 -0.981 . . . . 0.0 110.456 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -94.1 -44.95 7.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.314 -0.866 . . . . 0.0 110.173 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.78 84.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.178 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.647 ' H ' HG23 ' A' ' 44' ' ' THR . 51.6 mm-40 -64.72 -56.51 13.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 110.32 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 48' ' ' LEU . 14.2 mt -47.52 -45.23 26.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.144 -0.973 . . . . 0.0 110.196 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -63.21 -39.76 95.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.805 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.45 -42.86 74.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.412 ' O ' ' NE1' ' B' ' 7' ' ' TRP . 4.6 mtp -66.12 -34.46 78.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.393 -0.817 . . . . 0.0 109.602 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.544 HD13 HD11 ' A' ' 63' ' ' ILE . 7.1 mm -71.91 -36.31 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 0.7 OUTLIER -54.48 -52.05 63.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.387 -0.821 . . . . 0.0 109.977 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -43.57 -57.44 3.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.357 -0.84 . . . . 0.0 109.949 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.814 HG22 ' HG3' ' A' ' 71' ' ' MET . 15.3 t -74.23 -31.11 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -0.925 . . . . 0.0 109.811 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.546 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 30.4 t70 -64.66 71.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 110.059 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -66.65 -25.24 66.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.239 -0.913 . . . . 0.0 110.389 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -75.75 -49.86 16.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.076 -1.015 . . . . 0.0 110.29 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.69 25.39 5.99 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 8.7 p30 -99.86 -32.47 10.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.211 -1.17 . . . . 0.0 110.332 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.11 9.76 10.35 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.8 p -131.09 142.07 50.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -1.13 . . . . 0.0 109.814 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.731 HD12 ' HB ' ' A' ' 55' ' ' VAL . 9.7 mm -88.03 143.03 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.219 -0.925 . . . . 0.0 110.279 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.534 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 1.6 m-20 -118.69 170.88 8.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.319 -0.863 . . . . 0.0 110.142 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.3 t80 -60.94 -50.6 84.17 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.108 -0.995 . . . . 0.0 111.26 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.0 Cg_endo -66.03 -25.61 51.45 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 O-C-N 123.2 1.105 . . . . 0.0 110.511 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 71' ' ' MET . 34.9 mt-10 -71.6 -34.02 69.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.132 -0.98 . . . . 0.0 109.819 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -74.51 -58.95 2.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 0.0 110.223 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.1 mt -48.98 -42.72 38.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 110.299 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 9.7 m -70.66 -30.17 66.7 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.197 -0.94 . . . . 0.0 110.421 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.814 ' HG3' HG22 ' A' ' 55' ' ' VAL . 4.0 tmm? -65.14 -63.69 1.04 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.744 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.642 ' SD ' HG22 ' B' ' 8' ' ' THR . 37.3 mmm -52.31 -19.31 2.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.995 -1.066 . . . . 0.0 110.22 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 70' ' ' THR . . . -74.36 -20.84 59.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.57 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -91.64 -25.75 19.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.081 -1.012 . . . . 0.0 110.762 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.878 ' HG3' HG21 ' B' ' 8' ' ' THR . 53.1 mmtt -81.17 -11.52 59.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 110.584 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.622 ' CE ' ' CD2' ' B' ' 26' ' ' PHE . 0.6 OUTLIER -98.69 8.65 44.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.112 -0.992 . . . . 0.0 110.389 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 1.6 ttpt -66.28 -68.24 0.39 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 110.039 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 7.0 t70 -178.44 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.323 -0.861 . . . . 0.0 110.203 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.0 -75.9 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.25 -0.907 . . . . 0.0 110.295 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -85.61 99.94 11.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.284 -0.885 . . . . 0.0 110.321 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -125.77 -33.76 2.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.828 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.62 -11.94 19.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -0.838 . . . . 0.0 110.547 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -79.61 -25.16 41.54 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.108 -0.995 . . . . 0.0 110.402 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -78.02 -27.29 48.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.182 -0.949 . . . . 0.0 110.117 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.54 HG23 ' CE1' ' A' ' 141' ' ' PHE . 92.6 mt -76.9 -39.24 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.96 . . . . 0.0 109.929 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 51.5 ttp180 -62.79 -35.6 80.38 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 110.038 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.916 ' HB3' HG21 ' B' ' 9' ' ' THR . 19.6 mm-40 -69.35 -47.46 64.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 0.0 109.666 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.957 ' HB2' ' CD1' ' B' ' 12' ' ' LEU . . . -60.86 -33.59 73.31 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.113 -0.992 . . . . 0.0 109.897 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.11 -45.83 90.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.579 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 2.4 mtt180 -63.65 -26.94 68.9 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.411 -0.805 . . . . 0.0 109.759 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.803 HG11 HG21 ' B' ' 13' ' ' VAL . 41.2 t -63.84 -59.08 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 110.153 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.467 ' CE2' ' SD ' ' B' ' 16' ' ' MET . 22.7 m-85 -56.63 -32.16 65.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.08 -1.013 . . . . 0.0 110.059 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.47 ' OD1' HG12 ' A' ' 100' ' ' ILE . 3.1 m-20 -90.45 61.48 4.98 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.708 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.537 ' HG3' ' N ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -45.14 -23.38 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.422 -0.799 . . . . 0.0 110.407 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.537 ' N ' ' HG3' ' A' ' 94' ' ' LYS . 35.2 p-10 -96.91 -31.14 12.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 80.09 51.83 4.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 32.6 p-10 -97.94 -14.34 20.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -1.15 . . . . 0.0 110.428 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 99.42 18.56 23.35 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 52.1 m-85 -158.08 157.03 32.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.247 -1.149 . . . . 0.0 110.088 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.47 HG12 ' OD1' ' A' ' 93' ' ' ASP . 21.5 mt -128.42 130.77 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -0.99 . . . . 0.0 110.689 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 102' ' ' ALA . 30.9 t -116.82 151.56 36.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.837 . . . . 0.0 109.583 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.05 -26.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -72.35 -43.67 63.73 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.286 -0.884 . . . . 0.0 110.143 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 14.8 mt-10 -63.48 -33.03 74.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.006 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.987 ' CD1' HD11 ' A' ' 125' ' ' ILE . 3.8 mt -70.95 -43.61 67.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.879 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 -62.7 -26.04 68.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 109.559 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -75.0 -39.89 60.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.0 109.942 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.622 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -76.86 -33.56 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.35 -0.844 . . . . 0.0 109.377 179.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.667 ' HA ' HD21 ' B' ' 17' ' ' LEU . 3.2 mtm -54.92 -69.6 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.546 -0.721 . . . . 0.0 110.081 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -47.77 -29.05 2.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.194 -0.941 . . . . 0.0 109.714 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -85.44 -17.3 36.96 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.408 -0.808 . . . . 0.0 109.85 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.886 HD11 HG13 ' B' ' 13' ' ' VAL . 1.3 mt -94.31 -25.36 17.04 Favored 'General case' 0 C--O 1.199 -1.582 0 O-C-N 121.168 -0.957 . . . . 0.0 110.694 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.0 -50.73 0.66 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.285 -1.436 . . . . 0.0 111.214 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -117.05 158.94 23.32 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.864 -1.374 . . . . 0.0 111.549 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 115' ' ' LYS . 8.0 tmtt? -131.43 73.74 1.56 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.697 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.6 mp -33.75 153.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.628 0.728 . . . . 0.0 111.682 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.3 -146.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.536 -0.727 . . . . 0.0 110.375 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 119' ' ' GLU . 24.4 m-20 -98.79 -68.52 0.8 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.381 -0.825 . . . . 0.0 110.33 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -42.3 -47.85 4.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.432 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 124' ' ' MET . 3.3 mm-40 -60.61 -48.17 82.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -0.952 . . . . 0.0 109.89 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 124' ' ' MET . 55.0 t -65.52 -38.76 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.072 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -67.99 -65.3 0.71 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 109.753 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 4.7 mt-10 -46.67 -26.13 0.86 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.391 -0.818 . . . . 0.0 109.52 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.485 ' HG2' ' CE1' ' B' ' 22' ' ' PHE . 18.7 ttt -66.37 -57.04 8.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.969 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.987 HD11 ' CD1' ' A' ' 105' ' ' LEU . 48.2 mm -61.5 -50.48 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.929 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -54.25 -25.88 25.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.178 -0.951 . . . . 0.0 109.933 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -70.92 -44.7 65.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.396 -0.815 . . . . 0.0 110.077 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -71.37 -32.09 68.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.442 -0.786 . . . . 0.0 110.062 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -57.07 80.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.81 . . . . 0.0 110.384 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.581 HD12 ' HG3' ' A' ' 140' ' ' GLU . 1.9 mt -76.48 -37.75 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.932 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 14.6 p-10 -78.57 -31.48 47.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.056 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.61 65.75 0.97 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 26.3 p30 -124.44 -14.88 6.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -1.132 . . . . 0.0 110.46 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 90.54 17.72 51.37 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -163.23 169.78 18.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.332 -1.099 . . . . 0.0 110.019 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 137' ' ' ASN . 41.1 t -112.56 168.35 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.222 -0.924 . . . . 0.0 110.614 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.484 ' OD1' ' HB2' ' A' ' 140' ' ' GLU . 17.2 p-10 -152.18 -155.1 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -69.63 -69.44 0.34 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.295 -0.878 . . . . 0.0 110.717 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 140' ' ' GLU . 8.5 tt0 -46.19 -63.87 0.89 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.128 -0.982 . . . . 0.0 110.423 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.581 ' HG3' HD12 ' A' ' 130' ' ' ILE . 7.1 tt0 -41.46 -57.4 2.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.236 -0.915 . . . . 0.0 110.53 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.54 ' CE1' HG23 ' A' ' 85' ' ' ILE . 12.0 t80 -49.19 -28.88 4.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.237 -0.914 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.505 HG22 HG21 ' A' ' 85' ' ' ILE . 18.6 t -99.96 -38.35 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.234 -0.916 . . . . 0.0 110.607 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -33.69 69.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.201 -0.937 . . . . 0.0 110.794 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.538 ' HB2' HD11 ' A' ' 130' ' ' ILE . 10.0 tpp -88.3 -18.26 28.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.145 -0.972 . . . . 0.0 110.747 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.639 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 2.0 ttt -92.69 -9.8 39.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.0 110.101 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.6 p -106.82 -70.24 0.8 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 110.939 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.13 -125.22 0.17 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.245 -0.91 . . . . 0.0 110.271 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? . . . . . 0 C--N 1.288 -2.071 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.21 -179.688 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.473 ' O ' HG13 ' B' ' 1' ' ' VAL . 2.3 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.311 0.576 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.47 ' N ' ' CD ' ' B' ' 2' ' ' LYS . 0.4 OUTLIER -83.89 176.98 8.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.899 . . . . 0.0 110.292 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 mp -107.79 6.45 27.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 110.238 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 9.0 mt -87.41 145.56 37.82 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 109.779 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.599 ' HB2' HG23 ' B' ' 10' ' ' VAL . 40.3 Cg_endo -67.99 124.69 12.11 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.871 1.459 . . . . 0.0 110.325 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.527 ' O ' ' N ' ' B' ' 8' ' ' THR . 68.8 m -75.92 75.03 2.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.332 -0.855 . . . . 0.0 111.226 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.412 ' NE1' ' O ' ' A' ' 51' ' ' MET . 0.4 OUTLIER 53.93 -83.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.206 -0.934 . . . . 0.0 110.941 179.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.878 HG21 ' HG3' ' A' ' 75' ' ' LYS . 71.6 p -46.12 -46.81 17.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.38 -0.825 . . . . 0.0 110.017 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.916 HG21 ' HB3' ' A' ' 87' ' ' GLU . 52.7 m -52.1 -43.82 64.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.406 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.599 HG23 ' HB2' ' B' ' 5' ' ' PRO . 61.3 t -58.54 -27.38 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.259 -0.9 . . . . 0.0 108.879 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.564 HG21 ' HE2' ' A' ' 72' ' ' MET . 35.3 mm -78.16 -64.76 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.628 -0.67 . . . . 0.0 110.558 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.957 ' CD1' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -46.7 -45.39 19.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.132 -0.98 . . . . 0.0 110.485 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.886 HG13 HD11 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -60.44 -51.86 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 120.914 -1.116 . . . . 0.0 109.402 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.541 ' N ' HG12 ' B' ' 13' ' ' VAL . 0.0 OUTLIER -60.1 -33.04 71.56 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.993 -1.067 . . . . 0.0 109.055 178.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 6.1 t -62.69 -47.07 85.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.421 -0.799 . . . . 0.0 109.286 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.467 ' SD ' ' CE2' ' A' ' 92' ' ' PHE . 10.7 ttm -51.52 -35.88 42.47 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.389 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.816 HD22 HD13 ' A' ' 112' ' ' LEU . 7.1 mp -70.68 57.51 0.19 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.464 -0.773 . . . . 0.0 109.906 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.513 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 69.4 ttt-85 -122.46 -54.76 1.86 Allowed 'General case' 0 C--N 1.288 -2.069 0 O-C-N 121.404 -0.81 . . . . 0.0 111.128 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -138.74 -126.76 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.88 -1.138 . . . . 0.0 110.133 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.509 ' N ' ' HG2' ' B' ' 19' ' ' LYS . 5.0 ptp180 -119.87 41.15 3.24 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.026 -1.046 . . . . 0.0 109.918 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 8.4 t -121.52 148.7 44.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.401 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.56 ' CZ ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -117.7 -10.87 10.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.89 152.29 31.42 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.639 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 0.6 OUTLIER -148.63 127.5 6.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.096 -1.238 . . . . 0.0 110.146 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.65 57.04 2.96 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.896 1.472 . . . . 0.0 110.279 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.622 ' CD2' ' CE ' ' A' ' 76' ' ' MET . 2.9 m-85 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.32 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.193 0.52 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -100.17 65.79 1.27 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.569 ' O ' ' C ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -75.4 57.18 0.9 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.279 -0.888 . . . . 0.0 110.233 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.569 ' C ' ' O ' ' A' ' 3' ' ' GLN . 10.4 mt -1.89 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.026 0 CA-C-O 121.211 0.529 . . . . 0.0 112.351 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 t -108.35 -15.47 14.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.224 -0.923 . . . . 0.0 110.183 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.743 ' HA ' HD12 ' A' ' 9' ' ' ILE . 16.6 tt0 -57.8 -29.82 65.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.893 . . . . 0.0 110.084 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -43.5 -48.03 7.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.796 179.897 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -46.02 82.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.239 -0.913 . . . . 0.0 109.365 179.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.743 HD12 ' HA ' ' A' ' 6' ' ' GLU . 14.7 mt -66.52 -52.48 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.376 -0.827 . . . . 0.0 109.352 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.88 -39.6 74.64 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -57.91 -49.27 77.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.442 -0.786 . . . . 0.0 109.251 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.568 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 17.6 m-85 -61.07 -37.4 82.55 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.291 -0.881 . . . . 0.0 109.189 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 10.7 ttpt -57.23 -42.19 80.96 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.309 -0.869 . . . . 0.0 109.073 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.21 -42.35 99.27 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.469 -0.769 . . . . 0.0 109.165 179.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.15 -47.99 77.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.485 -0.759 . . . . 0.0 109.297 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -54.78 -27.74 43.79 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.401 -0.812 . . . . 0.0 109.156 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 t -84.05 -37.24 22.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.462 -0.774 . . . . 0.0 109.395 179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.545 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.4 tt -51.01 -36.65 40.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.418 -0.801 . . . . 0.0 109.244 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.442 ' HA ' HG21 ' A' ' 35' ' ' VAL . 86.2 m-85 -82.72 -39.78 21.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.734 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -74.86 92.33 2.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.454 -0.779 . . . . 0.0 110.058 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -65.3 -31.92 73.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 110.32 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 12.4 p-10 -90.38 -29.66 17.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.355 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.44 70.79 1.22 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 9.1 p-10 -120.21 -24.59 5.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -1.156 . . . . 0.0 110.061 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.81 -8.68 11.67 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 50.9 p -134.83 127.93 31.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -1.128 . . . . 0.0 110.222 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.684 HD12 ' CB ' ' A' ' 63' ' ' ILE . 16.4 mt -94.06 133.37 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.914 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 p -90.53 -171.35 3.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.899 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 p -83.59 -35.58 24.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.006 . . . . 0.0 109.957 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -68.52 -35.67 77.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -56.88 -55.56 32.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.19 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.62 HD13 ' CH2' ' B' ' 7' ' ' TRP . 24.6 tp -58.92 -39.73 82.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.208 -0.932 . . . . 0.0 110.253 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -56.25 -43.38 89.3 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.0 m -63.42 -56.5 15.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -1.176 . . . . 0.0 110.032 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 35' ' ' VAL . 11.7 t -55.79 -26.94 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.795 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 2.4 mmt -69.71 -41.15 75.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.247 -0.908 . . . . 0.0 109.766 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -65.81 -29.41 69.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.996 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' A' ' 39' ' ' LEU . 1.0 OUTLIER -56.39 -55.67 30.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.13 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.486 ' CD2' HG13 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -54.87 -39.23 68.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.8 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 126.77 55.86 0.14 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.534 ' HB3' ' CD1' ' B' ' 4' ' ' ILE . 40.3 mt-30 -142.35 153.92 44.23 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.169 -1.195 . . . . 0.0 110.346 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -117.76 80.31 13.9 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.227 -0.921 . . . . 0.0 110.473 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.27 146.38 40.3 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.977 1.514 . . . . 0.0 110.224 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 45' ' ' GLU . 9.6 t -100.04 -153.81 0.45 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.204 -0.935 . . . . 0.0 110.412 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.504 ' N ' HG23 ' A' ' 44' ' ' THR . 45.3 tt0 -87.18 -52.28 5.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -0.907 . . . . 0.0 110.406 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.5 76.04 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.236 -0.915 . . . . 0.0 110.305 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' LEU . 37.8 mt-10 -63.67 -55.2 25.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.295 -0.878 . . . . 0.0 110.328 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' GLU . 15.0 mt -43.81 -52.73 6.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.124 -0.985 . . . . 0.0 109.963 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -59.96 -36.19 76.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.79 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.28 -42.04 76.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.879 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.472 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 0.1 OUTLIER -67.91 -36.18 79.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 179.457 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 5.4 mm -73.31 -21.48 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.477 -0.764 . . . . 0.0 109.905 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -66.3 -54.68 21.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 110.501 -179.904 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 53' ' ' ASN . 2.6 tp10 -41.09 -35.32 0.54 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.46 -0.775 . . . . 0.0 110.598 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.671 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 10.5 t -96.68 -34.97 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.18 -0.95 . . . . 0.0 110.284 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 40.5 t0 -49.46 88.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.48 -0.762 . . . . 0.0 110.729 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -80.02 -32.36 39.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.224 -0.922 . . . . 0.0 110.38 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -76.13 -47.38 24.6 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.17 -0.956 . . . . 0.0 110.448 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.55 0.13 9.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 18.7 p30 -88.77 -32.49 17.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.113 -1.228 . . . . 0.0 110.357 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 114.44 -28.64 8.1 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 p -70.3 151.47 45.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.154 -1.204 . . . . 0.0 110.359 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.684 ' CB ' HD12 ' A' ' 27' ' ' ILE . 9.1 mm -102.46 122.9 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' C ' ' HD2' ' A' ' 66' ' ' PRO . 21.4 t0 -99.23 157.69 16.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.58 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 40.4 t80 -48.81 -45.65 72.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.711 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 50.0 Cg_endo -74.64 -37.34 2.35 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 123.347 1.183 . . . . 0.0 109.815 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 57' ' ' ALA . 4.2 tt0 -51.74 -49.07 63.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.505 -0.747 . . . . 0.0 110.199 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.13 -45.61 69.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.282 -0.886 . . . . 0.0 110.21 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -59.85 -12.59 7.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 0.0 110.607 -179.731 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.8 m -95.43 -43.21 8.1 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -0.988 . . . . 0.0 110.865 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -62.87 -39.81 95.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.089 -1.007 . . . . 0.0 110.993 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.568 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 9.3 tpt -61.49 -9.74 6.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.131 -0.981 . . . . 0.0 111.127 -179.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.81 -18.43 15.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.984 -1.072 . . . . 0.0 111.089 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.94 -23.7 14.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.986 -1.071 . . . . 0.0 110.896 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HG2' HG21 ' B' ' 8' ' ' THR . 15.8 tttt -97.98 41.12 1.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.043 -1.036 . . . . 0.0 110.638 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.1 mmt -100.27 -91.76 0.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.154 -0.966 . . . . 0.0 110.332 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.473 ' O ' ' CG ' ' A' ' 77' ' ' LYS . 15.4 tttt -101.72 37.52 1.81 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.137 -0.977 . . . . 0.0 110.271 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.424 ' O ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -105.53 -28.12 10.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 110.243 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 78' ' ' ASP . 4.2 m -164.21 -35.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.263 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -111.39 61.61 0.61 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.931 . . . . 0.0 110.287 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.411 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 1.1 t -94.31 -63.25 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.281 -0.887 . . . . 0.0 110.088 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.688 ' HA ' HD12 ' A' ' 85' ' ' ILE . 1.4 pt-20 -87.81 -22.46 24.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.412 -0.805 . . . . 0.0 110.052 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.88 -46.83 61.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 109.793 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 81' ' ' SER . 17.5 pt-20 -58.48 -20.71 47.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 110.152 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.688 HD12 ' HA ' ' A' ' 82' ' ' GLU . 73.2 mt -69.79 -45.23 77.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.136 -0.978 . . . . 0.0 109.015 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 89' ' ' PHE . 58.3 ttt180 -56.89 -31.94 65.38 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.46 -56.42 6.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.39 -0.819 . . . . 0.0 109.306 179.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' B' ' 12' ' ' LEU . . . -54.58 -22.41 13.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.196 -0.94 . . . . 0.0 108.982 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CZ ' ' HB2' ' A' ' 138' ' ' TYR . 84.1 t80 -71.41 -63.73 1.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.375 -0.828 . . . . 0.0 109.482 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -49.25 -38.34 26.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.383 -0.823 . . . . 0.0 109.076 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.694 HG12 HG21 ' A' ' 108' ' ' VAL . 18.6 t -63.78 -35.06 71.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.559 -0.713 . . . . 0.0 109.592 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.741 ' CE1' HG13 ' B' ' 13' ' ' VAL . 2.4 m-85 -72.74 -36.83 67.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.291 -0.881 . . . . 0.0 109.307 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 104' ' ' GLU . 3.6 t70 -99.91 62.19 1.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.757 . . . . 0.0 109.964 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' ASP . 7.7 tmtm? -42.64 -54.52 3.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 109.874 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.483 ' OD2' ' HG3' ' A' ' 104' ' ' GLU . 1.1 p30 -58.53 -27.32 64.41 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.533 -0.729 . . . . 0.0 109.913 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 60.86 59.24 10.5 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 34.3 p-10 -98.02 -41.95 7.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.201 -1.176 . . . . 0.0 110.556 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 162.96 -43.58 0.34 Allowed Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.295 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 15.0 m-85 -123.2 166.55 15.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.269 . . . . 0.0 110.904 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 100' ' ' ILE . 9.6 mt -102.69 84.33 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.34 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.414 ' HB2' ' OE1' ' A' ' 135' ' ' GLN . 0.2 OUTLIER -73.96 161.45 30.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.077 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.28 -19.4 3.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.922 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.84 -33.34 46.08 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.29 -0.881 . . . . 0.0 109.205 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -67.51 -42.47 82.74 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.54 -0.725 . . . . 0.0 109.254 179.178 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.054 HD12 HD11 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -63.08 -42.23 99.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.331 -0.855 . . . . 0.0 109.163 178.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -62.47 -26.82 68.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.593 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.462 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -69.95 -48.68 57.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.441 -0.787 . . . . 0.0 109.968 179.718 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.694 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -74.13 -30.88 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.286 -0.884 . . . . 0.0 109.455 179.47 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.814 ' HA ' HD21 ' B' ' 17' ' ' LEU . 2.4 ttm -52.04 -70.34 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.652 -0.655 . . . . 0.0 110.922 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.7 m -51.77 -26.76 10.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.14 -0.975 . . . . 0.0 110.337 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.48 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 8.7 m120 -72.33 -18.39 61.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.333 -0.855 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.873 HD12 HD22 ' B' ' 17' ' ' LEU . 10.2 mt -98.87 -48.84 4.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 110.423 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.42 -58.0 0.21 Allowed Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.768 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -90.89 162.21 14.89 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.964 -1.315 . . . . 0.0 111.299 -178.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.99 72.92 1.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.58 -0.7 . . . . 0.0 109.52 179.39 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 116' ' ' LEU . 4.6 mp -33.8 150.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.614 0.721 . . . . 0.0 111.525 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 118' ' ' ASP . 1.1 m -59.18 -147.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 109.82 179.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.545 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -113.13 -49.65 2.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 179.816 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.65 -51.76 66.13 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.073 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.55 ' CG ' ' N ' ' A' ' 121' ' ' VAL . 10.1 pt-20 -61.01 -44.67 97.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.55 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 73.4 t -60.36 -39.38 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.349 -0.844 . . . . 0.0 109.673 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.67 -53.54 56.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 109.725 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -57.09 -25.62 59.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.602 ' HG3' ' HA ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -64.05 -49.21 73.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.353 -0.842 . . . . 0.0 109.47 179.259 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.054 HD11 HD12 ' A' ' 105' ' ' LEU . 28.8 mm -73.27 -35.83 47.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.711 -0.618 . . . . 0.0 110.247 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.409 ' HA ' ' OD2' ' A' ' 129' ' ' ASP . 3.4 tmm_? -68.94 -22.74 64.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.204 -0.935 . . . . 0.0 110.063 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.57 -34.31 67.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 110.242 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -93.34 -26.4 17.3 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.356 -0.84 . . . . 0.0 110.233 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 126' ' ' ARG . 85.9 m-20 -45.5 90.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.323 -0.861 . . . . 0.0 110.661 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.5 mt -82.96 -40.82 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.158 -0.964 . . . . 0.0 109.521 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 35.2 p-10 -76.54 -24.47 53.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.929 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.477 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.99 35.05 19.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 15.9 p-10 -89.38 -15.97 32.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -1.113 . . . . 0.0 110.244 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 135' ' ' GLN . . . 97.78 9.63 54.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 134' ' ' GLY . 68.6 mt-30 -157.08 153.4 27.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.217 -1.167 . . . . 0.0 110.275 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 25.1 t -90.83 113.33 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.262 -0.899 . . . . 0.0 110.023 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -87.93 176.07 7.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.935 . . . . 0.0 110.557 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 5.2 t80 -57.08 -63.63 1.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.245 -0.91 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.6 OUTLIER -41.79 -49.34 4.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 0.0 109.989 179.891 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.443 ' HG2' HD12 ' A' ' 130' ' ' ILE . 3.0 mt-10 -57.08 -57.87 10.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 0.0 109.932 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.449 ' O ' ' SD ' ' A' ' 145' ' ' MET . 10.0 t80 -47.5 -24.47 0.85 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.275 -0.891 . . . . 0.0 109.962 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.498 HG13 HG21 ' A' ' 146' ' ' THR . 42.5 t -99.66 -39.4 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 110.409 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -65.89 -9.89 33.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.925 . . . . 0.0 110.797 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.465 ' CE ' ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -98.17 -26.13 14.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.029 -1.045 . . . . 0.0 110.704 -179.746 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' SD ' ' O ' ' A' ' 141' ' ' PHE . 6.5 mtp -100.48 -34.67 9.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 110.762 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.498 HG21 HG13 ' A' ' 142' ' ' VAL . 69.0 p -71.69 -29.08 64.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 0.0 110.35 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -82.25 53.78 2.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.187 -0.945 . . . . 0.0 110.482 -179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.239 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.789 HG23 ' O ' ' B' ' 1' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.116 0.484 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.677 ' O ' HD22 ' B' ' 3' ' ' LEU . 8.1 tptp -156.39 -130.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.963 -1.086 . . . . 0.0 111.035 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.677 HD22 ' O ' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -174.43 94.43 0.08 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.623 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' B' ' 3' ' ' LEU . 15.9 mm 65.36 133.41 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.24 -160.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.083 1.57 . . . . 0.0 111.243 -178.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 10.5 p -123.03 -179.17 4.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.402 -0.811 . . . . 0.0 110.911 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.671 ' CD1' ' CG2' ' A' ' 55' ' ' VAL . 22.5 m95 -59.1 -71.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.561 0.696 . . . . 0.0 111.075 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.577 HG21 ' HG2' ' A' ' 75' ' ' LYS . 65.8 p -39.88 -28.17 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.737 -0.602 . . . . 0.0 110.493 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.459 ' N ' ' O ' ' B' ' 7' ' ' TRP . 1.1 m -61.66 -50.11 73.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.678 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 t -63.89 -33.69 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.529 -0.732 . . . . 0.0 110.09 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.586 ' N ' HD13 ' B' ' 11' ' ' ILE . 3.8 mm -74.18 -31.89 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.261 -0.899 . . . . 0.0 109.979 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.482 ' O ' ' OG ' ' B' ' 15' ' ' SER . 0.4 OUTLIER -62.55 -52.45 63.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.852 . . . . 0.0 110.093 179.741 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.741 HG13 ' CE1' ' A' ' 92' ' ' PHE . 78.2 t -67.81 -43.78 85.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.669 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.425 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -59.52 -49.74 76.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.737 -1.227 . . . . 0.0 109.692 179.453 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' B' ' 12' ' ' LEU . 3.5 p -50.67 -42.27 56.46 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.42 ' SD ' ' HG3' ' B' ' 25' ' ' PRO . 26.2 tpp -73.12 -13.93 61.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 109.69 179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.873 HD22 HD12 ' A' ' 112' ' ' LEU . 2.9 mp -89.94 62.44 5.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 110.142 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 ttp85 -118.31 -74.4 0.61 Allowed 'General case' 0 C--N 1.285 -2.205 0 O-C-N 121.364 -0.835 . . . . 0.0 111.022 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.534 ' HD2' ' HB2' ' B' ' 20' ' ' ARG . 2.3 tmtm? -138.04 -75.45 0.39 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.081 -1.012 . . . . 0.0 110.952 -178.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.602 ' HA ' ' HG3' ' A' ' 124' ' ' MET . 1.0 OUTLIER -140.09 -4.21 1.36 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.714 -1.241 . . . . 0.0 111.31 -179.655 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -53.12 141.14 23.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.026 -1.046 . . . . 0.0 110.684 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -170.88 137.54 1.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.402 -0.811 . . . . 0.0 110.189 179.581 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.465 ' HA3' ' CE ' ' A' ' 144' ' ' MET . . . 126.11 -87.2 0.35 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.537 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 3.0 p30 -131.41 50.43 5.96 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.237 -1.155 . . . . 0.0 110.338 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 45.3 Cg_endo -73.48 -6.14 18.27 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.055 1.555 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.518 ' CZ ' ' HE1' ' A' ' 72' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.278 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.282 0.563 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.74 160.69 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 110.127 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -99.4 133.42 43.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 110.134 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mp -79.19 151.22 31.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.429 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.79 56.45 1.82 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.48 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.42 -26.17 13.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 110.086 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -54.02 -57.65 10.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 110.332 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -54.58 -53.07 59.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.179 -0.951 . . . . 0.0 110.303 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 10' ' ' ALA . 53.7 mt -57.44 -59.21 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -42.56 -46.18 4.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 110.051 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.82 -54.76 33.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.015 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CD2' HD23 ' A' ' 69' ' ' LEU . 21.4 m-85 -61.13 -42.91 99.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.97 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -58.58 -34.05 70.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.185 -0.947 . . . . 0.0 109.344 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -61.78 -44.67 96.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.381 -0.825 . . . . 0.0 109.49 179.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -66.43 -52.1 49.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.462 -0.774 . . . . 0.0 110.08 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.6 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 35.7 t80 -63.73 -12.23 33.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.811 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.3 m -92.76 -25.99 17.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.882 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.729 HD13 ' HG3' ' B' ' 14' ' ' LYS . 7.1 tt -77.67 -30.39 51.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.603 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 47.5 m-85 -80.01 -56.71 4.05 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.335 -0.853 . . . . 0.0 110.686 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -62.84 82.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.165 -0.96 . . . . 0.0 110.213 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -88.86 21.25 3.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.235 -179.973 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 23' ' ' GLY . 7.4 p-10 -140.1 18.68 2.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.944 . . . . 0.0 110.459 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.9 75.76 0.15 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.449 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 1.8 t0 -132.66 -26.7 1.78 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -1.134 . . . . 0.0 110.685 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.68 -21.4 29.88 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 0.8 OUTLIER -119.27 118.8 32.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -1.101 . . . . 0.0 109.874 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.502 HD12 HG21 ' A' ' 63' ' ' ILE . 12.3 mt -79.34 126.17 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.121 -0.987 . . . . 0.0 109.606 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 77.8 p -90.16 -157.68 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.795 . . . . 0.0 110.386 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.49 HG22 HG13 ' A' ' 52' ' ' ILE . 77.8 p -94.16 -33.43 13.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.843 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 31' ' ' GLU . 13.0 ptpt -74.68 -31.07 61.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.121 -0.987 . . . . 0.0 110.288 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 30' ' ' LYS . 14.9 mt-10 -58.17 -66.35 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.118 -0.988 . . . . 0.0 109.47 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.625 HD22 ' CZ2' ' B' ' 7' ' ' TRP . 58.1 tp -56.75 -35.45 68.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.168 -0.958 . . . . 0.0 109.25 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.81 -37.14 93.83 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 96.6 m -59.44 -47.13 86.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.348 -1.089 . . . . 0.0 109.441 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 35' ' ' VAL . 14.7 t -70.93 -37.35 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.592 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.654 ' HA ' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -69.19 -44.74 71.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.385 -0.822 . . . . 0.0 109.775 179.549 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -62.57 -29.77 70.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.973 179.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.43 ' O ' ' CG ' ' A' ' 111' ' ' ASN . 3.3 t -79.1 -21.67 46.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 110.014 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 36' ' ' MET . 4.3 mt -68.13 -32.01 71.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.36 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.07 -60.63 0.44 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -172.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -1.199 . . . . 0.0 110.714 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 54.7 m-80 -137.1 98.88 10.16 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.431 -0.793 . . . . 0.0 109.826 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 44.3 Cg_endo -71.61 124.04 9.95 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 123.965 1.508 . . . . 0.0 110.464 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -93.08 167.22 11.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.3 -37.08 71.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 0.0 110.108 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.07 64.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.238 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.486 ' OE1' HD12 ' B' ' 4' ' ' ILE . 20.9 mt-10 -66.78 -38.55 86.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.087 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 48' ' ' LEU . 12.2 mt -62.08 -39.72 93.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.087 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -43.89 86.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.334 -0.854 . . . . 0.0 109.696 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.18 -38.03 89.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.35 -0.844 . . . . 0.0 109.652 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.595 ' HE1' ' CG ' ' B' ' 7' ' ' TRP . 7.4 mmm -67.26 -42.31 84.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.668 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.49 HG13 HG22 ' A' ' 29' ' ' THR . 4.4 mm -70.16 -19.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.35 -0.844 . . . . 0.0 109.625 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.11 -16.21 41.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.269 -0.894 . . . . 0.0 110.02 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -71.31 -31.01 66.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.42 -0.8 . . . . 0.0 110.241 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 57' ' ' ALA . 20.4 t -92.02 -37.09 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.163 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.427 ' HA ' ' OE2' ' A' ' 67' ' ' GLU . 1.4 t70 -46.68 87.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.674 -0.641 . . . . 0.0 110.555 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -99.05 -26.78 14.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 0.0 110.203 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 3.1 p-10 -73.96 -43.27 58.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -0.962 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 58' ' ' ASP . . . 114.17 27.4 3.43 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 21.8 p-10 -99.53 -40.16 7.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.098 -1.236 . . . . 0.0 110.102 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 123.43 -46.76 1.07 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.2 p -95.31 166.5 11.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -1.217 . . . . 0.0 110.479 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 26' ' ' THR . 16.4 mm -88.69 142.24 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.3 -0.875 . . . . 0.0 109.894 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.2 m-20 -121.2 147.34 45.74 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.982 -1.073 . . . . 0.0 110.863 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.62 ' O ' HD12 ' A' ' 69' ' ' LEU . 89.7 t80 -41.61 -50.78 9.44 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.453 -0.78 . . . . 0.0 111.546 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.0 Cg_endo -66.35 -43.36 8.38 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 O-C-N 123.252 1.133 . . . . 0.0 110.773 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' OE2' ' HA ' ' A' ' 56' ' ' ASP . 43.4 tt0 -60.93 -36.82 80.32 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.208 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 13.0 t80 -62.56 -45.83 91.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.997 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 65' ' ' PHE . 2.7 mt -61.94 -29.91 70.55 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.319 -0.863 . . . . 0.0 110.726 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 1.7 p -79.4 -33.41 42.75 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.154 -0.966 . . . . 0.0 111.347 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.477 ' HG3' HG13 ' A' ' 55' ' ' VAL . 9.1 tmm? -69.05 -43.27 75.0 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.962 -1.087 . . . . 0.0 110.975 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.482 ' HE2' ' CE1' ' B' ' 26' ' ' PHE . 10.7 tpt -58.66 -10.85 2.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.189 -0.944 . . . . 0.0 111.12 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.95 -9.81 16.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.865 -1.147 . . . . 0.0 111.236 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 4.1 ttt180 -94.4 -43.49 8.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.961 -1.087 . . . . 0.0 110.686 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -64.82 -8.84 16.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.317 -0.864 . . . . 0.0 110.486 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 72' ' ' MET . 1.3 mmt -99.27 41.56 1.14 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.98 . . . . 0.0 110.113 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.489 ' CE ' ' O ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -178.01 30.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -127.22 -62.82 1.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.935 . . . . 0.0 110.344 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.14 -41.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.127 -0.983 . . . . 0.0 110.638 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.76 76.31 6.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.178 -0.951 . . . . 0.0 110.177 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.7 t -110.91 -48.93 3.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.979 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -99.98 -25.29 14.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 110.187 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -72.08 -17.94 61.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -0.972 . . . . 0.0 109.509 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -70.11 -23.23 63.0 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.455 -0.778 . . . . 0.0 109.871 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.6 mt -64.88 -28.99 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.2 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.1 -32.32 73.71 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.616 -0.677 . . . . 0.0 109.807 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.799 ' HB3' HG21 ' B' ' 9' ' ' THR . 13.9 mt-10 -74.16 -47.61 34.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.863 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.52 67.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.005 -1.059 . . . . 0.0 109.405 179.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CE1' ' OD2' ' A' ' 93' ' ' ASP . 11.8 t80 -71.44 -46.43 60.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -52.91 -32.35 44.95 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.436 -0.79 . . . . 0.0 109.321 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.666 HG12 HG21 ' A' ' 108' ' ' VAL . 20.7 t -71.27 -43.09 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.543 -0.723 . . . . 0.0 109.85 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.617 ' HB3' HD13 ' A' ' 100' ' ' ILE . 19.6 m-85 -66.58 -28.26 68.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.237 -0.914 . . . . 0.0 109.797 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.551 ' OD2' ' CE1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -88.03 62.29 6.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.388 -0.82 . . . . 0.0 109.788 179.788 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -36.29 -32.74 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.703 -0.623 . . . . 0.0 110.968 -179.553 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 12.5 p30 -111.23 -39.15 4.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.171 -0.956 . . . . 0.0 110.389 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 92.09 55.22 1.75 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 99' ' ' TYR . 52.1 p30 -97.29 0.24 47.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.178 -1.189 . . . . 0.0 110.175 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 93.68 12.56 56.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.452 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -154.14 142.31 20.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.359 -1.083 . . . . 0.0 110.03 -179.944 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 92' ' ' PHE . 5.7 mt -101.51 116.8 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.238 -0.914 . . . . 0.0 110.119 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 t -98.97 142.03 30.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.288 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.02 -35.73 3.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.832 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -58.82 -49.77 76.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 109.538 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.61 -50.02 66.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.816 . . . . 0.0 109.704 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.815 ' CD1' HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -59.32 -41.08 88.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.835 . . . . 0.0 109.397 179.468 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 13.2 ttt180 -56.08 -27.7 54.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.311 -0.868 . . . . 0.0 109.403 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.13 -42.5 37.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 109.619 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.666 HG21 HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -70.06 -26.89 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.292 179.588 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 1.011 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.5 OUTLIER -64.33 -64.8 0.79 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.361 -0.837 . . . . 0.0 110.155 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.18 -33.44 63.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.903 -179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 38' ' ' SER . 77.5 m-20 -75.31 -18.52 60.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 110.174 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.691 HD11 HG12 ' B' ' 13' ' ' VAL . 4.3 mt -92.41 -41.36 10.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 110.268 179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.32 -36.75 0.81 Allowed Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.251 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 3.4 tp10 -116.09 158.24 23.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.915 -1.344 . . . . 0.0 110.981 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -139.24 83.09 1.93 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.149 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' B' ' 19' ' ' LYS . 6.3 mp -38.34 140.76 0.28 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.591 -0.693 . . . . 0.0 111.074 -179.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -54.35 -168.52 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.541 -0.724 . . . . 0.0 109.497 179.327 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -74.95 -68.71 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.057 -1.027 . . . . 0.0 110.211 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.46 -45.16 12.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.308 -0.87 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.14 -44.28 92.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 110.049 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 117' ' ' THR . 20.1 t -61.05 -40.44 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.99 -29.21 69.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.249 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -74.63 -30.61 61.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.159 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.5 ' HE1' ' CE2' ' B' ' 22' ' ' PHE . 0.1 OUTLIER -70.41 -51.26 30.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.136 -0.977 . . . . 0.0 110.248 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.815 HD11 ' CD1' ' A' ' 105' ' ' LEU . 49.8 mm -64.56 -41.26 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.25 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -27.11 67.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 110.221 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.5 OUTLIER -69.29 -21.04 63.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.88 -35.76 8.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.931 . . . . 0.0 110.271 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.412 ' CG ' ' HA2' ' A' ' 132' ' ' GLY . 5.1 t0 -43.11 105.6 0.05 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.317 -0.864 . . . . 0.0 110.411 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 130' ' ' ILE . 23.4 mm -74.99 -33.97 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.251 -0.906 . . . . 0.0 109.928 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' A' ' 133' ' ' ASP . 7.1 p-10 -103.72 -21.98 13.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 0.0 109.989 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.412 ' HA2' ' CG ' ' A' ' 129' ' ' ASP . . . 81.09 70.41 1.34 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 19.3 p-10 -120.68 -10.96 9.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.186 -1.185 . . . . 0.0 110.406 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.77 12.13 30.99 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HG2' ' OD2' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -164.59 147.35 8.75 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.188 -1.183 . . . . 0.0 110.168 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 11.7 t -99.98 143.15 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 110.338 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 4.1 t30 -105.32 -168.23 1.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 109.89 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.415 ' CE1' HG21 ' A' ' 142' ' ' VAL . 41.1 t80 -76.06 -48.46 20.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.27 -41.29 65.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.314 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.9 -52.23 38.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.274 -0.891 . . . . 0.0 110.33 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -57.0 -17.32 9.37 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.326 -0.859 . . . . 0.0 110.631 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.564 ' O ' HG22 ' A' ' 146' ' ' THR . 37.3 t -100.26 -70.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.07 -1.019 . . . . 0.0 111.006 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.443 ' C ' ' O ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -39.82 -37.14 0.51 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.257 -0.902 . . . . 0.0 110.7 -179.487 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.6 mmm -62.75 -29.09 70.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.154 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.473 ' HA ' ' HB2' ' B' ' 24' ' ' ASN . 0.1 OUTLIER -100.4 -30.86 11.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.333 -0.854 . . . . 0.0 110.653 -179.898 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.6 t -102.45 57.66 0.79 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.096 -1.003 . . . . 0.0 110.525 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -97.39 57.4 1.41 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.048 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.243 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.402 ' O ' HG12 ' B' ' 1' ' ' VAL . 84.9 t . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 120.903 0.382 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.97 -22.84 1.18 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.947 -1.095 . . . . 0.0 111.621 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' B' ' 4' ' ' ILE . 10.9 tp -153.91 -72.44 0.13 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.561 -1.337 . . . . 0.0 111.411 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.761 HG23 ' HD2' ' B' ' 5' ' ' PRO . 7.8 mt -39.13 147.61 0.29 Allowed Pre-proline 0 N--CA 1.506 2.358 0 O-C-N 121.101 -0.999 . . . . 0.0 110.096 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.761 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.9 Cg_endo -65.31 -176.35 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.844 1.444 . . . . 0.0 110.662 -179.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.472 ' O ' ' N ' ' B' ' 8' ' ' THR . 28.9 t -126.96 64.06 1.3 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.14 -0.975 . . . . 0.0 111.384 -178.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.625 ' CZ2' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER 58.09 -83.12 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.207 -0.933 . . . . 0.0 111.188 178.688 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.472 ' N ' ' O ' ' B' ' 6' ' ' SER . 12.0 p -43.6 -42.79 5.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.992 . . . . 0.0 110.25 -179.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.799 HG21 ' HB3' ' A' ' 87' ' ' GLU . 3.8 m -52.41 -44.39 65.36 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.177 -0.952 . . . . 0.0 109.209 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.71 -37.43 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.337 -0.852 . . . . 0.0 109.381 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.583 ' N ' HD13 ' B' ' 11' ' ' ILE . 4.2 mm -71.38 -25.0 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -0.797 . . . . 0.0 109.499 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' B' ' 9' ' ' THR . 2.0 mp -67.38 -60.31 2.69 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.336 -0.853 . . . . 0.0 109.645 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.691 HG12 HD11 ' A' ' 112' ' ' LEU . 72.7 t -57.77 -37.79 61.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.348 -0.845 . . . . 0.0 109.99 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.729 ' HG3' HD13 ' A' ' 18' ' ' LEU . 2.4 ttpt -59.41 -45.1 92.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.028 -1.045 . . . . 0.0 109.467 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' B' ' 18' ' ' ARG . 1.6 m -62.79 -26.28 68.64 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.339 -0.85 . . . . 0.0 109.537 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.533 ' HA ' ' HB2' ' B' ' 21' ' ' SER . 0.0 OUTLIER -70.54 -32.37 69.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.891 . . . . 0.0 109.748 179.663 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 1.011 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.9 mp -73.65 -5.56 41.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.297 -0.877 . . . . 0.0 110.489 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.9 OUTLIER -44.21 -56.45 4.1 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.152 -0.968 . . . . 0.0 109.468 179.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.548 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -171.72 -68.65 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.605 0.717 . . . . 0.0 109.271 179.699 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.503 ' HB3' ' CD ' ' B' ' 19' ' ' LYS . 0.8 OUTLIER -129.51 14.67 6.03 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.073 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' B' ' 16' ' ' MET . 20.0 m -48.3 145.29 3.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.637 -0.664 . . . . 0.0 110.761 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.5 ' CE2' ' HE1' ' A' ' 124' ' ' MET . 0.1 OUTLIER 171.67 -34.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.495 -0.753 . . . . 0.0 109.912 179.665 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.29 -128.82 0.03 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.643 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 43.9 t30 -131.76 34.42 0.26 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.988 -1.301 . . . . 0.0 111.723 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 51.3 Cg_endo -76.33 56.65 5.09 Favored 'Trans proline' 0 N--CA 1.481 0.788 0 O-C-N 123.185 1.097 . . . . 0.0 110.472 179.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.256 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.216 0.531 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.554 ' OD1' HG21 ' A' ' 5' ' ' THR . 11.9 p30 -164.63 144.61 7.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.307 -0.87 . . . . 0.0 110.19 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 4' ' ' LEU . 6.6 mt-30 -87.86 171.15 10.58 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.264 -0.897 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 3' ' ' GLN . 25.1 mt 42.08 71.91 0.19 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.342 -0.849 . . . . 0.0 110.193 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 5' ' ' THR . 7.7 t -150.41 95.06 2.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.2 -0.938 . . . . 0.0 110.536 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.23 -23.85 18.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.131 -0.98 . . . . 0.0 110.026 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -61.76 -39.81 92.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.302 -0.874 . . . . 0.0 110.306 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 8.2 mm100 -71.19 -59.49 2.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.061 -1.025 . . . . 0.0 109.814 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mt -48.1 -43.88 11.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 109.432 179.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -54.01 -47.38 71.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.384 -0.822 . . . . 0.0 109.491 179.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 1.4 mt-10 -49.49 -54.19 19.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.507 179.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -59.46 -38.92 82.03 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.144 -0.973 . . . . 0.0 109.389 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 10.3 ttpt -53.54 -43.62 68.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.285 -0.884 . . . . 0.0 109.173 179.165 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -56.87 -48.32 78.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 108.888 178.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.21 -54.16 50.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.412 -0.805 . . . . 0.0 109.292 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 65' ' ' PHE . 55.7 t80 -50.71 -35.64 32.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.813 . . . . 0.0 109.126 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.15 -29.39 48.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.598 -0.689 . . . . 0.0 109.396 179.258 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.616 HD11 ' O ' ' A' ' 112' ' ' LEU . 3.6 tt -53.04 -50.75 63.65 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.391 -0.818 . . . . 0.0 109.365 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 45.0 m-85 -69.72 -28.03 65.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.393 179.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.515 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 16.0 t0 -87.23 66.15 9.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.516 -0.74 . . . . 0.0 110.14 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -45.25 -32.03 1.77 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.146 -0.971 . . . . 0.0 110.324 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 11.8 p-10 -89.72 -7.19 55.09 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.348 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 20' ' ' ASP . . . 47.98 71.26 0.59 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 35.9 p-10 -116.9 -34.28 4.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -1.147 . . . . 0.0 109.977 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 128.76 -0.51 6.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 21.2 p -142.4 128.28 19.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -1.159 . . . . 0.0 110.615 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.556 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 10.7 mt -91.96 129.65 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.214 -0.929 . . . . 0.0 110.054 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 p -99.64 -163.81 1.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 110.136 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 48' ' ' LEU . 4.5 p -91.2 -38.03 12.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.111 -0.993 . . . . 0.0 110.049 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -66.85 -33.39 75.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.994 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' OE2' ' HA ' ' A' ' 20' ' ' ASP . 2.1 mt-10 -67.05 -64.25 0.89 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 109.88 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.511 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 21.5 tp -52.85 -36.85 59.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 109.843 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.7 92.33 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.1 m -63.88 -52.86 58.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -1.094 . . . . 0.0 109.822 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 19' ' ' PHE . 26.3 t -52.75 -43.66 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.732 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.5 ' HE1' ' SD ' ' A' ' 51' ' ' MET . 32.2 mtt -64.18 -38.51 91.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.638 179.676 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.24 -16.37 63.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.848 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -79.0 -63.0 1.52 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.314 -0.866 . . . . 0.0 110.603 -179.879 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.472 ' O ' ' HE2' ' A' ' 94' ' ' LYS . 1.4 mt -43.48 -41.68 4.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.094 -1.004 . . . . 0.0 109.924 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' A' ' 41' ' ' GLN . . . 134.12 61.91 0.07 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.481 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' B' ' 4' ' ' ILE . 7.7 mt-30 -157.34 -176.36 5.91 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.125 -1.221 . . . . 0.0 109.974 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -144.17 97.44 5.24 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.109 -0.995 . . . . 0.0 110.612 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.843 ' HA ' HD11 ' B' ' 4' ' ' ILE . 49.2 Cg_endo -76.39 137.23 18.51 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.015 1.534 . . . . 0.0 110.539 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 47' ' ' GLU . 24.1 m -87.75 142.91 27.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 109.87 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -42.21 -64.2 0.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 0.0 110.27 179.994 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.71 -52.15 42.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 110.092 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 2.8 mm-40 -50.21 -53.05 30.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.308 -0.87 . . . . 0.0 109.985 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -44.94 -51.64 9.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 110.13 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 40.1 tp60 -57.4 -32.71 67.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -0.822 . . . . 0.0 109.999 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -68.0 -38.67 82.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 109.906 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.576 ' HE3' ' O ' ' B' ' 6' ' ' SER . 2.0 ttp -81.55 -27.5 34.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.398 -0.814 . . . . 0.0 110.246 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 mm -78.29 -29.9 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.302 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -77.55 0.96 20.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.18 -0.95 . . . . 0.0 110.017 179.807 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.56 -44.68 11.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.294 -0.878 . . . . 0.0 109.669 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.852 HG13 ' HG3' ' A' ' 71' ' ' MET . 41.0 t -79.72 -20.26 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 109.928 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -51.4 87.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.347 -0.846 . . . . 0.0 110.152 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -87.01 -47.22 9.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.259 -0.901 . . . . 0.0 111.062 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 21.2 p-10 -57.46 -45.94 84.2 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.023 -1.048 . . . . 0.0 110.828 -179.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 120.16 18.24 4.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 61' ' ' GLY . 32.8 p-10 -96.24 -46.01 6.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -1.23 . . . . 0.0 110.239 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . 134.6 -43.8 1.23 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.54 168.48 16.39 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.258 -1.142 . . . . 0.0 110.51 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.556 ' HB ' ' CG1' ' A' ' 27' ' ' ILE . 11.4 mm -92.76 143.76 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.283 -0.886 . . . . 0.0 110.109 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -117.95 163.69 16.19 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.088 -1.008 . . . . 0.0 110.379 -179.982 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 44.9 t80 -59.24 -50.7 86.21 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.269 -0.894 . . . . 0.0 110.483 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.5 Cg_endo -69.02 -29.2 27.81 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 O-C-N 123.393 1.207 . . . . 0.0 109.517 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' HG3' ' HB3' ' A' ' 57' ' ' ALA . 5.9 tt0 -67.75 -31.21 70.97 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.475 -0.766 . . . . 0.0 109.06 178.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.413 ' CZ ' HG13 ' B' ' 11' ' ' ILE . 5.6 t80 -70.06 -53.75 16.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.538 -0.726 . . . . 0.0 109.889 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -54.01 -35.52 62.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.387 -0.82 . . . . 0.0 110.333 -179.966 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 71' ' ' MET . 1.3 m -78.04 -53.7 7.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.23 -0.919 . . . . 0.0 110.712 -179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.852 ' HG3' HG13 ' A' ' 55' ' ' VAL . 5.7 tmm? -41.24 -42.69 2.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.226 -0.921 . . . . 0.0 110.553 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.55 ' HE1' ' CZ ' ' B' ' 26' ' ' PHE . 0.1 OUTLIER -51.24 -17.83 0.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.311 -0.868 . . . . 0.0 110.681 -179.741 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.48 -35.86 10.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.016 -1.052 . . . . 0.0 110.925 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -31.65 54.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.066 -1.022 . . . . 0.0 110.742 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HB3' HG21 ' B' ' 8' ' ' THR . 0.1 OUTLIER -64.23 -51.03 65.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 -179.789 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 6.9 mtt -82.62 51.57 1.9 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.375 -0.828 . . . . 0.0 110.75 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -113.11 20.93 15.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.172 -0.955 . . . . 0.0 109.983 179.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' C ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -138.82 77.34 1.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.861 . . . . 0.0 110.067 179.918 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.425 ' OG1' ' C ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 42.85 35.98 0.8 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.251 -0.905 . . . . 0.0 110.25 -179.922 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.75 76.98 3.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.251 -0.906 . . . . 0.0 110.24 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -115.04 -52.24 2.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 85' ' ' ILE . 19.7 mt-10 -100.06 -10.43 21.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.169 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 87' ' ' GLU . 7.3 tt0 -74.52 -44.52 50.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.096 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -61.64 -23.56 66.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.488 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.545 HG23 ' CE2' ' A' ' 141' ' ' PHE . 67.2 mt -78.43 -45.48 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.927 . . . . 0.0 109.816 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -53.89 -36.66 62.91 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 109.705 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.55 ' HB3' ' CG2' ' B' ' 9' ' ' THR . 0.3 OUTLIER -69.83 -52.22 26.84 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.213 -0.929 . . . . 0.0 109.542 179.494 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.69 -35.3 65.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.093 -1.005 . . . . 0.0 109.036 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' HB2' ' CD2' ' A' ' 141' ' ' PHE . 63.3 t80 -67.28 -47.59 70.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.508 -0.745 . . . . 0.0 109.668 179.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -46.42 71.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.404 -0.81 . . . . 0.0 109.328 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.629 HG11 HG21 ' B' ' 13' ' ' VAL . 1.5 t -51.09 -48.94 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.415 -0.803 . . . . 0.0 109.418 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.52 ' HB3' HD13 ' A' ' 100' ' ' ILE . 30.6 m-85 -57.05 -38.3 73.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.131 -0.981 . . . . 0.0 110.124 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.432 ' OD1' HG12 ' A' ' 100' ' ' ILE . 68.2 m-20 -89.54 59.75 4.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.545 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 0.8 OUTLIER -52.18 -34.37 44.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.952 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 9.9 p-10 -74.02 -41.83 61.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.924 . . . . 0.0 110.112 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.69 35.08 5.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.431 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 33.5 p-10 -94.65 3.09 55.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -1.197 . . . . 0.0 110.257 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.574 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 68.23 37.72 86.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 12.8 m-85 -165.27 142.61 5.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -1.113 . . . . 0.0 110.24 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 92' ' ' PHE . 9.7 mt -107.7 126.53 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.667 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 103' ' ' ALA . 2.8 t -117.76 147.83 42.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.825 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.15 -27.73 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.268 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -70.73 -43.98 67.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.855 . . . . 0.0 109.799 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 101' ' ' SER . 42.8 mt-10 -61.31 -40.21 93.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.923 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.054 ' CD1' HD11 ' A' ' 125' ' ' ILE . 2.4 mt -63.34 -44.37 95.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.405 -0.81 . . . . 0.0 109.81 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.8 ttp85 -53.87 -37.08 63.33 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.067 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.545 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -60.55 -60.94 3.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.397 -0.814 . . . . 0.0 109.573 179.292 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.68 -35.15 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.368 -0.832 . . . . 0.0 109.464 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.946 ' HA ' HD21 ' B' ' 17' ' ' LEU . 5.6 mtt -50.89 -65.42 0.56 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 110.395 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -63.5 -33.21 75.09 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 110.354 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.12 -8.37 49.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.105 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.916 HD11 HG12 ' B' ' 13' ' ' VAL . 10.1 mt -109.38 -50.88 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 110.471 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.06 -59.24 0.16 Allowed Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.585 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -105.87 154.76 20.1 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.055 -1.262 . . . . 0.0 110.626 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 116' ' ' LEU . 6.9 ptpp? -123.48 21.97 9.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.878 . . . . 0.0 110.15 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 115' ' ' LYS . 6.6 mp 41.03 -164.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.547 -0.721 . . . . 0.0 110.575 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 118' ' ' ASP . 1.1 m -96.49 -146.59 0.29 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.433 -0.792 . . . . 0.0 109.178 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.513 ' H ' HG22 ' A' ' 117' ' ' THR . 26.1 t70 -115.4 -54.51 2.53 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.127 -0.983 . . . . 0.0 109.963 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -31.35 72.54 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 109.517 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -69.93 -45.26 67.9 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.298 -0.876 . . . . 0.0 109.298 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.2 t -61.99 -45.73 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.367 -0.833 . . . . 0.0 110.082 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.29 -39.99 92.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 109.782 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 4.5 tt0 -71.71 -31.15 66.42 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.403 -0.81 . . . . 0.0 109.559 179.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.502 ' HB2' ' HA ' ' B' ' 20' ' ' ARG . 1.4 ttt -61.33 -34.59 75.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.332 -0.855 . . . . 0.0 109.603 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.054 HD11 ' CD1' ' A' ' 105' ' ' LEU . 35.2 mm -80.56 -63.52 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.446 -0.784 . . . . 0.0 110.816 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.06 -30.33 10.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.181 -0.949 . . . . 0.0 110.938 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 11.8 mt-10 -74.78 -29.96 61.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.103 -0.998 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -88.11 -28.66 21.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.311 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.6 90.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.263 -0.898 . . . . 0.0 110.148 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 128' ' ' ALA . 49.3 mm -59.75 -40.93 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 0.0 109.959 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -84.55 -28.79 26.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.414 -0.804 . . . . 0.0 110.092 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.7 76.65 0.97 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.1 p30 -135.42 8.78 3.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.216 -1.167 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.47 13.28 73.67 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -169.42 163.05 10.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.247 -1.149 . . . . 0.0 110.412 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 87.5 t -108.38 142.9 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.111 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.47 ' OD1' ' CE1' ' A' ' 99' ' ' TYR . 4.6 t30 -110.45 -159.04 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.273 -0.892 . . . . 0.0 110.106 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 139' ' ' GLU . 30.2 t80 -72.61 -63.02 1.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 109.691 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 143' ' ' GLN . 43.1 mt-10 -42.98 -50.11 5.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.324 -0.86 . . . . 0.0 109.787 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.444 ' HB3' HG13 ' A' ' 136' ' ' VAL . 48.8 mt-10 -55.67 -60.46 3.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 109.634 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 30.5 t80 -41.55 -28.14 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.538 -0.727 . . . . 0.0 109.537 179.157 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 140' ' ' GLU . 78.7 t -100.37 -28.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.559 -0.713 . . . . 0.0 110.535 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -66.04 -13.14 59.45 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.06 -1.025 . . . . 0.0 110.343 -179.792 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -103.63 -23.72 13.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.103 -0.998 . . . . 0.0 110.608 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.889 ' HE2' ' H ' ' B' ' 24' ' ' ASN . 8.5 mtt -90.8 -32.64 16.02 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.17 -0.956 . . . . 0.0 109.806 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 146' ' ' THR . 8.4 t -170.53 95.71 0.23 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.362 -0.836 . . . . 0.0 110.156 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.24 39.48 1.02 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.201 -0.937 . . . . 0.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.1 mttt . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.247 179.956 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.217 0.532 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' B' ' 3' ' ' LEU . 3.3 pttt -148.86 166.3 28.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.94 . . . . 0.0 110.541 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.677 HD23 ' O ' ' B' ' 3' ' ' LEU . 5.0 tt -178.04 62.15 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.379 -0.826 . . . . 0.0 109.243 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.843 HD11 ' HA ' ' A' ' 43' ' ' PRO . 15.9 mt -29.46 146.39 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 122.12 -0.362 . . . . 0.0 111.18 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.638 ' HD2' HG23 ' B' ' 4' ' ' ILE . 43.6 Cg_endo -74.06 151.77 44.94 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.954 1.502 . . . . 0.0 109.973 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.576 ' O ' ' HE3' ' A' ' 51' ' ' MET . 13.4 m -62.9 -55.36 26.75 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 110.432 -179.533 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.55 ' CD1' ' HE3' ' A' ' 51' ' ' MET . 0.0 OUTLIER 169.9 -76.25 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.315 -0.866 . . . . 0.0 109.552 -179.725 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.546 HG21 ' HB3' ' A' ' 75' ' ' LYS . 25.7 p -53.2 -27.75 23.3 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.758 . . . . 0.0 109.878 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.55 ' CG2' ' HB3' ' A' ' 87' ' ' GLU . 79.4 m -58.86 -52.18 66.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.925 -1.109 . . . . 0.0 108.464 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.439 ' H ' HG23 ' B' ' 10' ' ' VAL . 15.5 t -50.79 -43.69 25.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.593 ' N ' ' CD1' ' B' ' 11' ' ' ILE . 0.8 OUTLIER -59.57 -54.28 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.758 0.79 . . . . 0.0 109.584 179.408 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' B' ' 11' ' ' ILE . 0.6 OUTLIER -40.66 -66.85 0.28 Allowed 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.657 -0.652 . . . . 0.0 110.779 -179.831 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.916 HG12 HD11 ' A' ' 112' ' ' LEU . 62.1 t -46.13 -43.45 5.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.643 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.543 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -59.05 -50.01 75.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.91 -1.119 . . . . 0.0 110.277 179.652 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.76 -28.95 37.68 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.357 -0.839 . . . . 0.0 109.89 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.492 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -72.6 -31.17 64.98 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.244 -0.91 . . . . 0.0 110.593 -179.871 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.946 HD21 ' HA ' ' A' ' 109' ' ' MET . 4.6 mp -67.2 57.64 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.071 -1.018 . . . . 0.0 110.699 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.572 ' HG3' ' CD ' ' B' ' 19' ' ' LYS . 2.0 ttp180 -91.96 -110.38 0.1 Allowed 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.478 -0.764 . . . . 0.0 109.141 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.572 ' CD ' ' HG3' ' B' ' 18' ' ' ARG . 3.0 mptt -126.53 -94.4 0.46 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.741 -1.225 . . . . 0.0 109.114 178.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.502 ' HA ' ' HB2' ' A' ' 124' ' ' MET . 0.0 OUTLIER -105.33 3.02 29.4 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.274 -0.891 . . . . 0.0 109.31 178.943 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 6.9 m -84.07 -176.07 6.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 0.0 109.712 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.625 ' HE2' HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -151.7 -150.72 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.017 . . . . 0.0 111.186 179.712 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.45 ' HA2' ' SD ' ' B' ' 16' ' ' MET . . . -43.85 156.05 0.21 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.889 ' H ' ' HE2' ' A' ' 145' ' ' MET . 34.8 m120 -150.17 168.1 11.68 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.457 -1.025 . . . . 0.0 110.217 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' B' ' 24' ' ' ASN . 39.7 Cg_endo -65.78 73.22 0.32 Allowed 'Trans proline' 0 N--CA 1.488 1.149 0 O-C-N 123.637 1.335 . . . . 0.0 110.041 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.55 ' CZ ' ' HE1' ' A' ' 72' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.715 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.758 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.214 0.531 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.428 ' OD1' ' C ' ' A' ' 2' ' ' ASP . 43.9 t0 -133.87 -100.53 0.25 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 109.896 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -99.72 -176.68 3.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 109.805 179.621 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 3' ' ' GLN . 0.9 OUTLIER 61.28 136.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.079 -1.013 . . . . 0.0 109.978 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.604 HG23 ' HB2' ' A' ' 8' ' ' GLN . 2.2 t -68.72 146.62 52.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.155 -0.966 . . . . 0.0 110.418 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 7' ' ' GLU . 1.6 mp0 -86.88 -41.4 14.03 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.335 -0.853 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 3.5 tp10 -42.78 -46.81 5.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 109.999 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.604 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -59.71 -54.82 41.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.818 179.767 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 10' ' ' ALA . 88.6 mt -50.08 -59.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 9' ' ' ILE . . . -44.97 -52.7 8.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.198 -0.939 . . . . 0.0 109.514 179.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.537 ' HG2' ' CD1' ' A' ' 12' ' ' PHE . 1.2 tt0 -52.49 -48.1 66.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -0.834 . . . . 0.0 109.313 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.537 ' CD1' ' HG2' ' A' ' 11' ' ' GLU . 18.9 m-30 -55.84 -47.46 77.22 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.359 -0.838 . . . . 0.0 109.904 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -48.86 -42.64 37.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.588 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -53.63 56.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.345 -0.847 . . . . 0.0 109.619 179.439 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' A' ' 19' ' ' PHE . . . -54.2 -40.85 67.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.829 . . . . 0.0 109.861 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -66.8 -30.05 70.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.823 . . . . 0.0 109.831 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -78.43 -20.22 51.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.639 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.481 HD12 ' HE2' ' B' ' 14' ' ' LYS . 6.4 tt -76.72 -46.33 25.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.384 -0.822 . . . . 0.0 110.05 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' HA ' HG21 ' A' ' 35' ' ' VAL . 69.5 m-85 -72.1 -22.77 61.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.0 110.161 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.487 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 0.8 OUTLIER -95.44 83.78 3.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.038 179.907 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 13.2 mmtt -44.71 -35.8 2.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 3.1 p30 -97.93 -24.52 15.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 110.328 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 67.86 31.21 75.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 41.9 p-10 -79.27 -0.75 33.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -1.191 . . . . 0.0 110.111 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 26' ' ' THR . . . 87.0 27.0 29.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 25' ' ' GLY . 18.4 p -156.51 97.41 1.74 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -1.089 . . . . 0.0 109.894 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.778 HD12 HG21 ' A' ' 63' ' ' ILE . 18.8 mt -85.32 112.32 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.033 . . . . 0.0 109.978 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.429 ' OG1' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -75.79 -163.72 0.3 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.313 -0.867 . . . . 0.0 109.783 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 p -80.45 -56.09 4.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.947 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -37.98 66.13 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.44 -0.788 . . . . 0.0 110.494 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 18.9 mt-10 -48.86 -68.49 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.048 -1.033 . . . . 0.0 109.653 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD21 ' CE ' ' A' ' 51' ' ' MET . 56.0 tp -47.28 -39.33 14.27 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.309 -0.87 . . . . 0.0 109.141 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.93 -42.39 96.75 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.611 -1.796 . . . . 0.0 108.611 179.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.532 HG23 HH12 ' A' ' 37' ' ' ARG . 22.6 m -52.53 -42.97 64.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.362 -1.081 . . . . 0.0 109.249 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.602 HG21 ' HA ' ' A' ' 19' ' ' PHE . 13.3 t -66.91 -46.96 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.398 -0.814 . . . . 0.0 109.599 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.472 ' CE ' ' HG2' ' B' ' 5' ' ' PRO . 4.8 mmt -67.13 -29.8 69.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 109.658 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.532 HH12 HG23 ' A' ' 34' ' ' THR . 2.4 ttp-105 -68.46 -35.13 77.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.771 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 m -84.12 -14.35 50.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 110.064 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -83.17 -32.91 26.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 110.103 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.65 -62.93 0.18 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.555 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -100.3 175.42 5.72 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.038 -1.272 . . . . 0.0 111.315 -178.959 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -134.52 100.06 12.69 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.602 -0.686 . . . . 0.0 109.529 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' B' ' 4' ' ' ILE . 43.6 Cg_endo -69.97 162.74 41.02 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 O-C-N 124.065 1.56 . . . . 0.0 111.072 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.495 ' O ' HD12 ' A' ' 48' ' ' LEU . 4.2 t -96.93 -149.95 0.33 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.385 -0.822 . . . . 0.0 110.725 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 38.1 mt-10 -94.22 -57.33 2.54 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 0.0 110.88 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 47' ' ' GLU . . . -43.56 -70.54 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.035 -1.041 . . . . 0.0 110.409 -179.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 46' ' ' ALA . 6.0 mm-40 -44.78 -42.9 8.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.077 -1.015 . . . . 0.0 109.486 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 44' ' ' THR . 5.7 mt -57.22 -47.39 81.44 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -46.28 -43.28 15.57 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.38 179.436 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.45 -30.32 64.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.432 -0.792 . . . . 0.0 109.571 179.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.584 ' O ' ' CD1' ' B' ' 7' ' ' TRP . 1.2 mmm -74.72 -36.71 62.68 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.403 -0.811 . . . . 0.0 109.497 179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.603 HG13 HD11 ' A' ' 63' ' ' ILE . 1.5 tp -78.1 -43.75 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.273 -0.892 . . . . 0.0 110.327 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.505 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -43.43 -26.1 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.257 -0.902 . . . . 0.0 110.331 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 52' ' ' ILE . 15.6 mm-40 -67.9 -51.43 47.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 110.213 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.7 HG22 ' HG3' ' A' ' 71' ' ' MET . 14.8 t -80.61 -33.38 13.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.96 82.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.348 -0.845 . . . . 0.0 110.168 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -62.77 -69.25 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.398 -0.814 . . . . 0.0 110.816 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 47.1 p-10 -59.02 -16.88 20.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.252 -0.905 . . . . 0.0 110.675 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 69.47 43.8 67.54 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 31.4 p-10 -94.76 -31.84 13.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.326 -1.102 . . . . 0.0 110.478 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 62' ' ' THR . . . 120.51 24.09 2.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 61' ' ' GLY . 3.4 p -161.05 142.66 11.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -1.14 . . . . 0.0 110.247 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.778 HG21 HD12 ' A' ' 27' ' ' ILE . 14.1 mm -82.4 134.03 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.196 -0.94 . . . . 0.0 110.011 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -105.96 160.62 15.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 110.319 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 23.6 t80 -56.62 -50.36 88.35 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.554 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.9 Cg_endo -69.97 -31.3 19.85 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.397 1.209 . . . . 0.0 109.974 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' O ' ' OG1' ' A' ' 70' ' ' THR . 8.9 mt-10 -64.41 -34.03 77.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.32 -0.863 . . . . 0.0 110.073 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -75.45 -53.58 8.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.21 -0.932 . . . . 0.0 109.673 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mp -49.82 -29.78 8.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.883 . . . . 0.0 109.913 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.8 OUTLIER -74.59 -47.89 29.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -0.849 . . . . 0.0 110.028 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.7 ' HG3' HG22 ' A' ' 55' ' ' VAL . 8.0 mmm -50.39 -47.45 56.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.135 -0.978 . . . . 0.0 109.572 179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.861 ' CE ' HG21 ' B' ' 11' ' ' ILE . 6.1 tpt -42.19 -26.81 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.48 -0.763 . . . . 0.0 110.498 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 71' ' ' MET . . . -107.52 -21.07 13.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.193 -0.942 . . . . 0.0 110.957 -179.145 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.46 -26.01 33.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.074 -1.016 . . . . 0.0 110.394 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HB3' HG21 ' B' ' 8' ' ' THR . 2.6 tptm -100.31 23.01 10.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 110.292 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.488 ' CG ' ' O ' ' A' ' 72' ' ' MET . 19.1 mmt -100.29 -29.76 12.26 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.219 -0.926 . . . . 0.0 110.901 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -127.93 76.85 1.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.065 -1.022 . . . . 0.0 110.649 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' HG23 ' A' ' 79' ' ' THR . 0.2 OUTLIER -124.45 -79.18 0.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.758 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 78' ' ' ASP . 1.9 p -152.06 -52.67 0.12 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.344 -0.847 . . . . 0.0 109.779 179.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -83.96 85.75 7.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 110.061 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -98.46 -36.78 9.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.601 179.806 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -79.37 -35.08 41.41 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.495 -0.753 . . . . 0.0 109.64 179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -63.89 -13.17 43.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.406 -0.809 . . . . 0.0 109.51 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.529 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 3.2 mt-10 -71.28 -45.47 63.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.513 -0.742 . . . . 0.0 110.582 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.696 HG21 HG22 ' A' ' 142' ' ' VAL . 27.3 mt -73.74 -21.73 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 110.198 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -71.83 -53.45 13.25 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.159 -0.963 . . . . 0.0 110.298 -179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.831 ' HG3' HG23 ' B' ' 9' ' ' THR . 7.8 pt-20 -62.37 -40.27 95.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.012 -1.055 . . . . 0.0 110.333 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -58.89 -37.31 76.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.504 -1.372 . . . . 0.0 108.358 178.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -65.49 -44.04 88.31 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -43.52 71.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.53 -0.731 . . . . 0.0 109.046 178.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.903 HG12 HG21 ' A' ' 108' ' ' VAL . 30.4 t -53.29 -48.57 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -0.785 . . . . 0.0 108.989 179.03 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.945 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 42.9 m-85 -66.59 -35.56 80.49 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 109.228 178.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.472 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 23.6 t0 -86.9 60.02 5.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.765 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 93' ' ' ASP . 10.2 ttpt -39.51 -50.07 2.15 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.521 -0.737 . . . . 0.0 110.252 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 10.2 p-10 -65.25 -36.56 84.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 109.652 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.453 ' HA2' ' OD2' ' A' ' 93' ' ' ASP . . . 83.41 45.41 6.52 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.374 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 52.6 p-10 -100.22 -20.71 15.8 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.058 -1.26 . . . . 0.0 110.273 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 99' ' ' TYR . . . 109.28 22.08 6.99 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.577 ' CD1' ' O ' ' A' ' 98' ' ' GLY . 24.4 m-85 -143.57 142.66 31.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.363 -1.08 . . . . 0.0 109.98 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 6.3 mt -113.69 96.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.498 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.2 m -90.68 152.45 20.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -0.918 . . . . 0.0 109.775 179.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.18 -40.55 11.38 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.63 -47.4 79.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.387 -0.821 . . . . 0.0 109.59 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 25.8 mt-10 -61.06 -53.66 54.38 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.304 -0.872 . . . . 0.0 109.828 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.643 HD13 HD11 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -59.34 -29.53 67.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.465 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.4 ttt-85 -70.82 -22.88 62.29 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.343 -0.848 . . . . 0.0 108.87 178.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 9.0 m80 -79.81 -46.23 17.32 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.576 -0.702 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.903 HG21 HG12 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -67.03 -20.73 27.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.365 -0.834 . . . . 0.0 108.857 179.144 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.595 ' HG3' HD21 ' B' ' 17' ' ' LEU . 0.3 OUTLIER -68.77 -52.07 34.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.599 -0.688 . . . . 0.0 109.956 179.638 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -35.37 73.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.894 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -74.16 -12.66 60.65 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.16 -0.962 . . . . 0.0 109.345 179.429 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.623 HD11 HG12 ' B' ' 13' ' ' VAL . 8.9 mt -94.64 -51.42 4.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.432 -0.792 . . . . 0.0 109.754 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.57 -59.93 0.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 20.8 tp10 -96.76 160.6 14.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.201 -1.176 . . . . 0.0 110.949 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -133.94 81.9 1.95 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.325 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.617 ' H ' HD12 ' A' ' 116' ' ' LEU . 6.5 mp -37.27 150.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.573 0.701 . . . . 0.0 111.268 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.79 -148.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.502 -0.749 . . . . 0.0 110.012 179.759 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.99 -44.86 5.36 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.331 -0.855 . . . . 0.0 110.135 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.493 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 17.5 pt-20 -64.89 -42.36 94.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.76 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.493 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 11.1 mm-40 -63.3 -40.72 98.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.579 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 125' ' ' ILE . 40.5 t -64.89 -45.37 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.273 -0.892 . . . . 0.0 109.699 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -63.53 -35.56 80.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.436 -0.79 . . . . 0.0 109.708 179.643 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 124' ' ' MET . 45.5 mt-10 -72.87 -54.48 8.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.0 109.566 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.626 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 25.1 ttt -42.38 -43.37 3.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.476 -0.765 . . . . 0.0 109.904 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.643 HD11 HD13 ' A' ' 105' ' ' LEU . 15.3 mm -76.33 -60.27 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 0.0 109.961 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -47.84 -55.03 10.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.27 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.512 ' OE2' ' CZ ' ' B' ' 20' ' ' ARG . 46.2 mt-10 -52.51 -21.6 3.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 0.0 110.388 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.559 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -93.28 -34.95 13.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.215 -0.928 . . . . 0.0 110.328 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.433 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 5.2 m-20 -68.43 66.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 110.237 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 128' ' ' ALA . 2.5 mp -46.43 -42.82 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.004 . . . . 0.0 109.88 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -70.89 -29.41 65.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.467 -0.77 . . . . 0.0 110.189 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.92 95.45 0.28 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 29.5 p-10 -144.72 -37.76 0.29 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -1.116 . . . . 0.0 110.236 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 121.49 9.44 7.11 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -165.59 149.8 8.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -1.102 . . . . 0.0 110.271 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.474 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 3.5 t -103.19 116.38 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 109.823 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.37 -155.03 0.3 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.345 -0.847 . . . . 0.0 110.603 -179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 139' ' ' GLU . 58.5 t80 -75.24 -60.62 2.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 138' ' ' TYR . 1.5 tt0 -42.72 -56.83 3.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 143' ' ' GLN . 2.6 mt-10 -55.23 -55.62 29.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.903 . . . . 0.0 109.85 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -45.22 -28.8 0.84 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.376 -0.827 . . . . 0.0 109.626 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.806 HG12 ' HB2' ' A' ' 147' ' ' ALA . 24.3 t -98.94 -24.02 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.411 -0.806 . . . . 0.0 109.806 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.739 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -59.0 -30.58 68.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 109.917 179.797 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.0 mmm -92.0 -9.58 42.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.316 -0.865 . . . . 0.0 109.844 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.529 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.2 OUTLIER -98.56 -69.76 0.75 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.388 -179.828 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 t -156.69 56.75 0.55 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.963 -1.086 . . . . 0.0 110.866 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.806 ' HB2' HG12 ' A' ' 142' ' ' VAL . . . -100.42 38.5 1.49 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.108 -0.995 . . . . 0.0 110.251 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.235 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.428 ' O ' HG12 ' B' ' 1' ' ' VAL . 41.5 t . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.229 0.538 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -107.39 141.17 39.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.339 -0.851 . . . . 0.0 110.842 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.77 25.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 110.053 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.652 HG21 ' HB3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -64.69 147.6 97.71 Favored Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 121.169 -0.957 . . . . 0.0 110.656 -179.662 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.583 ' HB2' ' CB ' ' B' ' 9' ' ' THR . 48.1 Cg_endo -72.26 -155.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 124.334 1.702 . . . . 0.0 111.144 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.537 ' O ' ' N ' ' B' ' 8' ' ' THR . 5.0 t -130.18 73.8 1.55 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.245 -0.91 . . . . 0.0 111.214 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.714 ' O ' HG22 ' B' ' 10' ' ' VAL . 0.8 OUTLIER 46.96 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.698 0 O-C-N 121.49 -0.756 . . . . 0.0 111.848 178.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.858 ' HA ' HD12 ' B' ' 11' ' ' ILE . 21.6 p -38.99 -26.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 110.798 -179.016 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.831 HG23 ' HG3' ' A' ' 87' ' ' GLU . 15.8 m -64.92 -65.81 0.62 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.076 -1.015 . . . . 0.0 109.996 179.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.714 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.0 m -46.68 -26.86 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 108.955 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.861 HG21 ' CE ' ' A' ' 72' ' ' MET . 49.2 mt -74.4 -47.96 37.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-O 121.687 0.756 . . . . 0.0 109.541 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 mt -50.32 -56.64 10.43 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.654 -0.654 . . . . 0.0 110.561 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.945 HG13 ' CZ ' ' A' ' 92' ' ' PHE . 17.2 t -62.34 -40.17 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.969 . . . . 0.0 110.958 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.481 ' HE2' HD12 ' A' ' 18' ' ' LEU . 6.5 tptp -71.54 -11.65 60.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.802 -1.186 . . . . 0.0 110.492 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.403 ' CB ' ' HE1' ' B' ' 26' ' ' PHE . 1.6 m -97.59 -21.83 16.85 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.191 -0.943 . . . . 0.0 109.265 179.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.445 ' O ' ' HE3' ' A' ' 124' ' ' MET . 6.6 tpp -78.56 -37.39 42.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.584 -0.697 . . . . 0.0 110.156 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.595 HD21 ' HG3' ' A' ' 109' ' ' MET . 1.3 mp -48.43 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.918 -1.114 . . . . 0.0 109.682 179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER 31.62 58.07 0.31 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.652 -0.655 . . . . 0.0 112.514 179.392 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.548 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER 62.5 -59.3 0.13 Allowed 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.47 -0.768 . . . . 0.0 111.753 178.155 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -155.66 8.42 0.25 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.886 -1.134 . . . . 0.0 111.752 -178.514 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' B' ' 18' ' ' ARG . 1.8 m -59.99 84.51 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.732 -1.23 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.626 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -111.93 13.55 20.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -0.954 . . . . 0.0 110.349 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.506 ' C ' ' HD3' ' B' ' 25' ' ' PRO . . . -96.24 -139.53 10.52 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.556 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 32.8 t-20 -119.78 47.58 1.03 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.196 -1.179 . . . . 0.0 110.386 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' B' ' 24' ' ' ASN . 48.5 Cg_endo -73.73 53.02 2.66 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.734 1.386 . . . . 0.0 110.268 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.481 ' HE2' ' HE1' ' A' ' 76' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.987 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.228 0.537 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -174.29 105.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.234 -0.916 . . . . 0.0 110.188 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -100.05 164.23 12.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.346 -0.846 . . . . 0.0 110.29 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.89 ' O ' HG23 ' A' ' 5' ' ' THR . 0.9 OUTLIER -57.86 132.08 52.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 110.158 179.867 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -168.94 -40.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.388 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 1.2 mt-10 -99.48 -22.41 15.51 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.145 -0.972 . . . . 0.0 110.456 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.604 ' HB2' HD23 ' A' ' 4' ' ' LEU . 1.2 mp0 -43.31 -56.25 3.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -0.905 . . . . 0.0 110.391 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 0.2 OUTLIER -62.99 -67.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 110.278 -179.848 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 57.4 mt -48.27 -45.97 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.785 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 6' ' ' GLU . . . -52.09 -41.66 62.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 109.738 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.564 ' OE2' ' CE1' ' A' ' 12' ' ' PHE . 1.9 tt0 -57.55 -51.51 69.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.746 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE1' ' OE2' ' A' ' 11' ' ' GLU . 21.0 m-85 -62.15 -45.07 95.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.942 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -60.17 -42.71 95.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -0.932 . . . . 0.0 109.705 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.79 -36.89 72.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.624 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . . . -75.45 -54.11 7.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.675 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.582 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 20.6 t80 -56.73 -17.15 8.0 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.417 -0.802 . . . . 0.0 109.714 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 18' ' ' LEU . 7.3 t -89.33 -56.74 3.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 112' ' ' LEU . 7.4 tt -44.31 -30.15 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -87.64 -30.73 20.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.284 -0.885 . . . . 0.0 110.535 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -104.89 91.57 3.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 110.495 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -67.92 -48.5 65.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.18 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 24' ' ' ASP . 5.2 p-10 -60.39 -41.98 94.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.44 -0.787 . . . . 0.0 110.434 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' N ' ' CG ' ' A' ' 22' ' ' ASP . . . 83.87 56.47 2.6 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 38.1 p-10 -107.45 -27.57 10.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.159 -1.201 . . . . 0.0 110.263 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . 111.56 9.09 21.99 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 27.2 p -141.89 116.02 9.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -1.172 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 5.5 mt -94.76 106.45 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 110.149 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.86 152.03 23.88 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.792 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -45.97 -25.56 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.01 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -61.12 2.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 110.218 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.67 -57.66 10.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.226 -0.921 . . . . 0.0 110.07 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 ' CH2' ' B' ' 7' ' ' TRP . 29.8 tp -52.68 -38.43 60.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.34 -40.02 96.92 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -60.29 -55.44 33.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -1.145 . . . . 0.0 109.943 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.443 HG23 ' H ' ' A' ' 35' ' ' VAL . 21.2 t -48.29 -50.53 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.649 179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.625 ' HE3' ' HG2' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -54.38 -38.69 66.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.917 . . . . 0.0 109.871 179.657 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HG3' ' ND2' ' A' ' 42' ' ' ASN . 2.0 ttp85 -64.25 -23.31 67.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.417 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 8.1 t -78.36 -30.23 47.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 110.656 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.74 -43.95 67.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.08 -1.013 . . . . 0.0 110.477 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.36 -16.01 0.41 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.654 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.1 mm-40 -113.2 166.0 11.87 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.832 -1.393 . . . . 0.0 110.624 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.5 ' ND2' ' HG3' ' A' ' 37' ' ' ARG . 3.8 t-20 -127.9 97.16 30.34 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.287 -0.883 . . . . 0.0 110.231 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.55 ' CD ' ' HB3' ' A' ' 36' ' ' MET . 46.6 Cg_endo -75.45 140.08 23.87 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 124.173 1.618 . . . . 0.0 110.357 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.682 HG23 ' H ' ' A' ' 46' ' ' ALA . 14.7 t -91.58 -143.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 109.917 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.58 ' N ' HG23 ' A' ' 44' ' ' THR . 11.4 tp10 -100.23 -25.96 14.08 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.252 -0.905 . . . . 0.0 110.289 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.682 ' H ' HG23 ' A' ' 44' ' ' THR . . . -73.62 -70.8 0.35 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.14 -0.975 . . . . 0.0 110.387 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.596 ' HG2' HG22 ' A' ' 44' ' ' THR . 8.2 pt-20 -49.42 -40.29 36.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.0 109.624 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 1.4 mt -58.73 -43.25 90.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.237 -0.914 . . . . 0.0 109.079 179.195 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -49.99 -49.29 51.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.502 -0.749 . . . . 0.0 109.095 179.084 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -29.98 68.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.292 179.076 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.491 ' CE ' ' CE ' ' A' ' 36' ' ' MET . 1.2 ttp -75.98 -55.38 5.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.532 ' CG2' ' N ' ' A' ' 53' ' ' ASN . 2.5 tp -56.96 -44.66 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.532 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 0.5 OUTLIER -40.89 -70.1 0.12 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.557 -0.714 . . . . 0.0 111.128 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -35.91 -55.08 0.75 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.722 -0.612 . . . . 0.0 110.933 -179.315 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.634 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 11.3 t -75.21 -33.84 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.745 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 5.3 t0 -58.87 77.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 0.0 110.318 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -39.72 -61.28 0.85 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.504 -0.747 . . . . 0.0 110.575 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 41.0 p-10 -76.4 -18.85 58.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 0.0 110.091 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 72.32 49.27 21.08 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 17.0 p-10 -99.3 -27.41 13.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -1.154 . . . . 0.0 110.302 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.587 ' C ' HG23 ' A' ' 62' ' ' THR . . . 119.14 23.47 3.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 61' ' ' GLY . 81.2 p -155.65 140.36 17.05 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.181 -1.187 . . . . 0.0 110.051 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.4 mm -91.15 158.75 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.354 -0.842 . . . . 0.0 110.072 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 58.5 m-20 -133.7 163.32 29.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.187 -0.946 . . . . 0.0 110.059 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.603 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 11.4 t80 -56.35 -48.54 96.78 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.16 -0.962 . . . . 0.0 111.215 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.1 Cg_endo -68.73 -35.69 15.79 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.206 1.108 . . . . 0.0 110.293 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 6.8 tt0 -58.94 -41.23 86.89 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.304 -0.872 . . . . 0.0 110.143 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 15' ' ' ALA . 36.6 t80 -69.58 -54.85 12.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.82 -24.95 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.958 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 m -97.61 -15.31 20.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 110.479 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.563 ' SD ' HG22 ' A' ' 55' ' ' VAL . 5.8 ttp -74.59 -42.7 58.23 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.144 -0.972 . . . . 0.0 110.536 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.489 ' SD ' HG21 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -54.46 -15.37 1.65 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.326 -0.858 . . . . 0.0 110.85 -179.387 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.42 -12.84 18.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.049 -1.032 . . . . 0.0 111.278 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.9 -11.96 40.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.781 -1.199 . . . . 0.0 110.502 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.73 ' CB ' HG21 ' B' ' 8' ' ' THR . 17.7 mmtt -98.39 -34.91 10.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 110.268 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.484 ' HE1' ' HG3' ' A' ' 72' ' ' MET . 0.2 OUTLIER -91.35 53.18 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.082 -179.975 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.751 ' O ' HG23 ' A' ' 79' ' ' THR . 0.9 OUTLIER -133.91 78.59 1.77 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 110.679 -179.719 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 77' ' ' LYS . 3.4 p30 37.85 44.89 0.63 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.494 -0.753 . . . . 0.0 110.781 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 77' ' ' LYS . 18.9 p -142.49 -37.57 0.38 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.236 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.476 ' O ' ' OE2' ' A' ' 84' ' ' GLU . 7.4 t0 -153.19 71.91 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 110.168 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.4 p -106.92 -38.05 6.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 109.735 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -82.28 -37.69 25.5 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.441 -0.787 . . . . 0.0 109.82 179.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.47 ' HB3' ' OD1' ' A' ' 80' ' ' ASP . 1.7 tt0 -72.11 -27.7 62.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.891 . . . . 0.0 109.637 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' OE2' ' HB3' ' A' ' 75' ' ' LYS . 17.3 mt-10 -72.63 -42.43 64.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.827 . . . . 0.0 110.128 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.62 HG21 HG22 ' A' ' 142' ' ' VAL . 14.2 mt -68.69 -37.84 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.489 -0.884 . . . . 0.0 108.762 179.502 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -60.93 -27.34 68.15 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.034 178.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 1.5 mt-10 -73.72 -54.48 7.99 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.536 -0.728 . . . . 0.0 109.146 179.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.75 -28.14 32.76 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.329 -0.857 . . . . 0.0 109.235 179.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -70.44 -46.04 64.65 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.373 -0.83 . . . . 0.0 109.514 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -28.83 65.71 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.513 -0.742 . . . . 0.0 109.621 179.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.72 HG12 HG21 ' A' ' 108' ' ' VAL . 15.5 t -73.75 -39.25 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.391 -0.818 . . . . 0.0 109.677 179.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.587 ' HB3' HD13 ' A' ' 100' ' ' ILE . 11.1 m-85 -72.78 -32.0 65.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.859 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -85.24 54.18 3.01 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.305 -0.872 . . . . 0.0 110.395 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.82 -28.12 2.42 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 30.8 p-10 -85.57 -43.81 13.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.186 -0.946 . . . . 0.0 110.354 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 89.75 22.75 35.35 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 33.4 p-10 -75.73 -33.84 60.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -1.132 . . . . 0.0 109.927 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 120.84 21.13 3.28 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 2.0 m-85 -164.44 130.04 2.85 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.182 -1.187 . . . . 0.0 110.263 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 92' ' ' PHE . 29.0 mt -82.46 155.52 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.966 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -144.67 156.88 44.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.86 -38.03 21.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -0.931 . . . . 0.0 110.2 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.47 -46.89 84.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 109.849 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.3 -36.26 70.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 109.861 179.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.606 HD12 HD11 ' A' ' 125' ' ' ILE . 5.7 mt -61.8 -48.4 80.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.346 -0.846 . . . . 0.0 109.822 179.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.8 -35.63 61.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.438 ' CD2' ' N ' ' A' ' 107' ' ' HIS . 35.2 m170 -64.0 -45.22 89.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -0.799 . . . . 0.0 110.14 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.72 HG21 HG12 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -79.21 -23.67 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.72 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.97 ' SD ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -68.01 -56.89 7.27 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 110.111 -179.971 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.417 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 7.3 m -60.93 -31.41 70.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.947 . . . . 0.0 109.691 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 38' ' ' SER . 7.1 m-20 -76.96 -4.7 45.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.856 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.79 HD11 HG12 ' B' ' 13' ' ' VAL . 7.0 mt -111.64 -44.68 3.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 110.374 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.96 -66.87 0.13 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.634 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 109' ' ' MET . 2.7 tt0 -103.25 166.94 10.14 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.171 -1.193 . . . . 0.0 111.137 -178.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.566 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 0.3 OUTLIER -124.47 16.79 8.93 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.733 0.777 . . . . 0.0 109.553 179.255 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.97 HD13 ' SD ' ' A' ' 109' ' ' MET . 2.8 mp 43.62 -173.23 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.66 0.743 . . . . 0.0 111.169 179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.76 -146.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.505 -0.747 . . . . 0.0 109.886 179.75 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -114.06 -70.22 0.81 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.156 -0.965 . . . . 0.0 110.517 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 120' ' ' GLU . 3.8 pt-20 -55.39 -29.23 58.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 109.743 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.473 ' OE2' ' HE2' ' B' ' 19' ' ' LYS . 6.2 mt-10 -71.73 -45.74 60.81 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 108.919 178.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 117' ' ' THR . 53.1 t -54.67 -45.71 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.491 -0.756 . . . . 0.0 109.629 179.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -60.37 -59.23 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 0.0 109.373 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 68.5 mm-40 -48.41 -38.66 20.17 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.393 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' B' ' 20' ' ' ARG . 0.0 OUTLIER -51.01 -56.1 14.18 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.252 -0.905 . . . . 0.0 109.462 179.503 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 105' ' ' LEU . 21.0 mm -56.35 -30.67 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.349 -0.844 . . . . 0.0 110.011 179.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 123' ' ' GLU . 5.7 ttt180 -64.99 -55.0 21.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.303 -0.873 . . . . 0.0 110.528 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 126' ' ' ARG . 2.6 tp10 -41.9 -42.89 2.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.305 -0.872 . . . . 0.0 110.371 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.21 -27.79 38.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.282 -0.886 . . . . 0.0 110.171 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 0.6 OUTLIER -83.36 63.86 7.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 110.373 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 129' ' ' ASP . 5.7 mt -43.56 -40.07 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.747 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 21.2 p30 -67.34 -32.23 73.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.551 -0.718 . . . . 0.0 110.118 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 77.3 66.65 1.76 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.435 ' OD2' ' HG3' ' A' ' 135' ' ' GLN . 2.9 p-10 -115.43 -27.86 7.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -1.121 . . . . 0.0 110.231 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.96 16.26 8.62 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.435 ' HG3' ' OD2' ' A' ' 133' ' ' ASP . 11.7 pt20 -169.95 149.78 3.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -1.131 . . . . 0.0 110.174 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 85.9 t -110.79 149.77 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.277 -0.889 . . . . 0.0 109.972 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.427 ' OD1' ' CG ' ' A' ' 140' ' ' GLU . 25.3 p-10 -120.21 -157.93 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.419 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.414 ' O ' ' C ' ' A' ' 139' ' ' GLU . 11.1 t80 -70.88 -67.22 0.52 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.358 -0.839 . . . . 0.0 110.61 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 138' ' ' TYR . 4.7 mt-10 -41.65 -62.32 0.91 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.384 -0.822 . . . . 0.0 110.351 -179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 141' ' ' PHE . 49.3 mt-10 -46.27 -60.29 2.4 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.21 -0.931 . . . . 0.0 110.009 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.605 ' CD1' HG23 ' A' ' 85' ' ' ILE . 24.4 t80 -42.04 -28.19 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 0.0 109.743 179.755 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.674 HG13 ' OG1' ' A' ' 146' ' ' THR . 38.2 t -100.87 -32.25 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.454 -0.779 . . . . 0.0 110.644 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.678 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 4.7 tm0? -59.94 -18.43 45.16 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.147 -0.971 . . . . 0.0 110.404 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.3 mmm -112.58 -25.09 9.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 110.34 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.556 ' HE3' ' CB ' ' B' ' 24' ' ' ASN . 3.0 ttt -100.54 -9.34 22.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 111.118 -179.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.674 ' OG1' HG13 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -134.31 -30.73 1.14 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.92 -1.112 . . . . 0.0 111.174 -179.2 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -77.06 54.28 1.03 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.129 -0.982 . . . . 0.0 110.461 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.239 179.949 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' B' ' 2' ' ' LYS . 5.9 p . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.207 0.527 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' B' ' 1' ' ' VAL . 0.0 OUTLIER 58.69 -91.97 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.407 -0.808 . . . . 0.0 110.786 179.71 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' B' ' 4' ' ' ILE . 3.2 mp -97.68 -43.71 7.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.098 -1.001 . . . . 0.0 110.861 -179.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.481 HG13 ' OE2' ' A' ' 47' ' ' GLU . 24.2 mm -41.79 139.95 1.51 Allowed Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.243 -0.911 . . . . 0.0 109.947 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.833 ' HB3' HG21 ' B' ' 9' ' ' THR . 39.6 Cg_endo -67.43 173.18 9.14 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.113 1.586 . . . . 0.0 111.037 -179.281 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.8 t -126.1 79.38 1.84 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.247 -0.908 . . . . 0.0 111.452 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.671 ' O ' HG22 ' B' ' 10' ' ' VAL . 9.2 m95 53.99 -93.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.45 -0.781 . . . . 0.0 112.042 178.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.73 HG21 ' CB ' ' A' ' 75' ' ' LYS . 4.0 p -37.18 -29.17 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.266 -0.896 . . . . 0.0 110.517 -178.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.833 HG21 ' HB3' ' B' ' 5' ' ' PRO . 53.7 m -65.67 -51.29 60.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.189 -0.945 . . . . 0.0 109.697 178.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.822 HG23 HD12 ' B' ' 11' ' ' ILE . 2.7 m -63.19 -29.91 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.948 -1.095 . . . . 0.0 108.653 179.018 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.822 HD12 HG23 ' B' ' 10' ' ' VAL . 1.6 mp -72.34 -54.69 15.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.52 -0.737 . . . . 0.0 109.265 178.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' B' ' 11' ' ' ILE . 0.5 OUTLIER -42.23 -59.8 1.68 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.546 -0.721 . . . . 0.0 110.534 179.897 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.79 HG12 HD11 ' A' ' 112' ' ' LEU . 69.0 t -56.3 -50.15 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 110.403 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.533 ' HA ' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -56.12 -35.23 66.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.908 -1.12 . . . . 0.0 109.663 179.632 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 5.1 t -73.84 -19.9 60.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 109.866 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 1.7 tpt -75.2 -43.18 53.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.939 HD21 ' HA ' ' A' ' 109' ' ' MET . 5.3 mp -53.31 -91.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.0 . . . . 0.0 109.699 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' B' ' 17' ' ' LEU . 5.7 ttt180 59.98 -69.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.401 0.619 . . . . 0.0 110.808 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.658 ' O ' HD21 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -176.2 -72.53 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.027 0 O-C-N 121.412 -0.805 . . . . 0.0 110.812 -179.619 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.594 ' HB2' ' CD ' ' B' ' 19' ' ' LYS . 2.2 ttt-85 -135.09 20.4 3.45 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.848 -1.157 . . . . 0.0 110.324 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.73 129.56 42.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.282 -0.886 . . . . 0.0 110.219 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 124' ' ' MET . 0.2 OUTLIER -130.67 -4.06 4.16 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.426 -0.796 . . . . 0.0 110.351 -179.8 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.52 -28.07 23.04 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.556 ' CB ' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER 48.89 81.81 0.25 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.081 -1.246 . . . . 0.0 109.912 -179.825 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.96 -34.94 9.85 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.901 1.474 . . . . 0.0 110.64 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.445 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 1.1 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.198 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.276 0.56 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 11.3 t70 179.7 -35.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.381 -0.824 . . . . 0.0 109.971 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.403 ' O ' ' CB ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -51.23 124.33 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 110.061 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.403 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER 64.62 124.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.937 -179.816 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 5' ' ' THR . 7.4 t -84.02 100.66 11.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 110.472 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -96.45 -45.24 6.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 109.983 179.693 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.809 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 13.6 mt-10 -41.87 -69.95 0.12 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.379 -0.825 . . . . 0.0 110.16 179.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -44.8 -63.71 0.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 179.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 5' ' ' THR . 46.8 mt -53.22 -27.73 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.343 -0.848 . . . . 0.0 109.759 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -57.4 -64.03 1.03 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.54 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -48.39 -44.42 34.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -67.2 -50.0 62.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.384 -0.822 . . . . 0.0 109.737 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -55.89 -44.0 77.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.854 179.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 41.2 mt-10 -55.38 -43.47 75.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.762 179.538 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 18' ' ' LEU . . . -72.1 -50.35 28.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.401 -0.812 . . . . 0.0 109.965 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.576 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 11.2 t80 -54.29 -47.81 71.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 109.918 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -68.05 -27.77 66.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.882 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.82 HD11 ' O ' ' A' ' 112' ' ' LEU . 10.2 tt -61.41 -37.97 85.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.394 -0.816 . . . . 0.0 110.085 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.628 ' HD1' HG21 ' A' ' 35' ' ' VAL . 44.5 m-85 -80.75 -30.03 36.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -84.73 84.25 7.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 110.49 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -73.12 -40.05 65.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.21 -0.931 . . . . 0.0 110.032 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -71.09 -33.86 70.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.086 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.94 65.17 1.23 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.476 ' O ' HG23 ' A' ' 26' ' ' THR . 57.7 p30 -128.62 6.59 5.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -1.159 . . . . 0.0 110.154 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.66 13.48 51.39 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 59.5 p -136.87 115.44 11.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.276 -1.132 . . . . 0.0 110.251 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.546 ' O ' HG22 ' A' ' 62' ' ' THR . 5.1 mt -88.9 124.01 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.203 -0.936 . . . . 0.0 110.355 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.4 p -99.67 172.02 7.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.332 -0.855 . . . . 0.0 110.284 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 p -56.95 -30.06 63.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.937 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -66.83 -60.44 2.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.232 -0.918 . . . . 0.0 110.05 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' O ' HG23 ' A' ' 35' ' ' VAL . 32.5 mt-10 -52.16 -55.65 19.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 110.024 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.568 HD13 ' CH2' ' B' ' 7' ' ' TRP . 27.0 tp -59.51 -37.6 78.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.05 -37.19 64.19 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.9 m -61.36 -55.36 32.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -1.136 . . . . 0.0 109.942 179.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.628 HG21 ' HD1' ' A' ' 19' ' ' PHE . 20.4 t -52.7 -46.88 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 109.643 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.467 ' HE1' ' SD ' ' A' ' 51' ' ' MET . 0.9 OUTLIER -58.63 -41.82 86.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.693 179.506 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -28.78 66.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 109.924 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -55.73 3.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.337 -0.852 . . . . 0.0 110.272 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mt -44.88 -28.18 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.129 -0.982 . . . . 0.0 110.063 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . 115.98 49.89 0.45 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.487 ' NE2' ' HG3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -147.44 -174.53 4.55 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.211 -1.17 . . . . 0.0 110.359 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -161.89 84.12 1.69 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.325 -0.859 . . . . 0.0 110.256 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . 46.9 Cg_endo -73.19 100.67 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.042 1.548 . . . . 0.0 110.169 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.498 HG22 ' HB2' ' A' ' 47' ' ' GLU . 5.0 t -57.07 162.39 2.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.085 -1.009 . . . . 0.0 110.239 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' ALA . 2.3 mt-10 -42.98 -65.37 0.49 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 110.269 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' GLU . . . -40.45 -51.84 2.83 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.393 -0.817 . . . . 0.0 110.227 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' HB2' HG22 ' A' ' 44' ' ' THR . 5.9 mm-40 -63.85 -56.49 14.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.026 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 48' ' ' LEU . 5.2 mt -42.32 -42.8 3.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -0.832 . . . . 0.0 110.18 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -66.95 -41.1 87.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 0.0 110.079 179.77 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -27.42 65.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.402 -0.811 . . . . 0.0 110.186 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.467 ' SD ' ' HE1' ' A' ' 36' ' ' MET . 0.9 OUTLIER -82.54 -33.63 28.11 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.927 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 4.8 mm -80.35 -31.08 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -76.82 -13.71 59.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 110.233 179.937 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -73.42 -60.99 1.99 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 0.0 110.106 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.649 ' HB ' HD12 ' A' ' 63' ' ' ILE . 13.8 t -69.19 -25.41 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.108 -0.995 . . . . 0.0 109.808 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -49.23 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.368 -0.832 . . . . 0.0 109.98 179.787 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -70.56 -66.88 0.55 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.41 -0.806 . . . . 0.0 110.587 -179.521 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 25.7 p-10 -58.35 -35.75 72.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.222 -0.924 . . . . 0.0 110.423 -179.582 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 92.0 45.83 3.78 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.465 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 15.7 p-10 -96.48 -34.23 11.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -1.17 . . . . 0.0 110.157 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.35 -2.36 5.4 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -141.5 165.37 27.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -1.213 . . . . 0.0 110.15 179.983 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.649 HD12 ' HB ' ' A' ' 55' ' ' VAL . 34.9 mm -87.07 142.75 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.076 179.864 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.498 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.1 m-20 -130.52 153.15 49.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.922 . . . . 0.0 110.644 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 34.1 t80 -39.38 -51.08 4.77 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.549 -0.72 . . . . 0.0 112.344 -179.088 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.2 Cg_endo -64.9 -27.44 58.77 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.22 1.116 . . . . 0.0 111.265 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.492 ' HG3' ' CB ' ' A' ' 64' ' ' ASP . 7.3 mt-10 -73.02 -39.92 65.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 109.832 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.623 ' HZ ' HD12 ' B' ' 11' ' ' ILE . 36.4 t80 -63.54 -50.86 67.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 110.303 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.81 -37.26 78.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -0.874 . . . . 0.0 110.262 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.8 m -76.91 -14.59 59.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.285 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' HG22 ' A' ' 55' ' ' VAL . 37.0 ttp -79.27 -58.51 3.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.199 -0.938 . . . . 0.0 110.133 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.494 ' O ' ' HG3' ' A' ' 76' ' ' MET . 3.4 tpt -53.17 -16.09 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.409 -0.807 . . . . 0.0 111.013 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.92 -45.8 8.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.878 -1.139 . . . . 0.0 110.579 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -80.7 -10.07 59.75 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.158 -0.964 . . . . 0.0 110.75 -179.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -84.19 -14.83 49.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.077 -1.014 . . . . 0.0 110.427 -179.729 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.494 ' HG3' ' O ' ' A' ' 72' ' ' MET . 15.2 mtt -99.83 60.72 1.11 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.101 -1.0 . . . . 0.0 110.111 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.5 ' O ' ' CG ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -159.66 90.7 0.95 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.261 -0.899 . . . . 0.0 110.176 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 3.3 m-20 61.41 79.56 0.25 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 179.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.445 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -170.26 -51.69 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.319 -0.863 . . . . 0.0 110.423 -179.947 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 79' ' ' THR . 47.4 m-20 -154.97 91.28 1.35 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.211 -0.93 . . . . 0.0 110.468 -179.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 82' ' ' GLU . 93.8 p -74.02 -68.96 0.47 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.615 ' HA ' HD12 ' A' ' 85' ' ' ILE . 3.1 tt0 -100.03 -10.47 21.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 110.077 179.753 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -66.73 -40.98 88.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.645 179.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 85' ' ' ILE . 7.3 pt-20 -54.41 -23.6 16.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.992 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 82' ' ' GLU . 51.8 mt -80.16 -61.42 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.9 . . . . 0.0 109.606 179.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 85' ' ' ILE . 0.4 OUTLIER -42.57 -30.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.583 -0.698 . . . . 0.0 109.524 179.549 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.657 ' HB3' HG21 ' B' ' 9' ' ' THR . 4.4 mm-40 -71.91 -60.6 2.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.408 -0.808 . . . . 0.0 109.264 179.029 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.65 -28.99 6.52 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.149 179.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -70.47 -47.71 59.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 109.758 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -35.19 51.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.755 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.651 HG11 HG11 ' B' ' 13' ' ' VAL . 10.6 t -67.68 -45.17 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.652 179.592 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.754 ' CE2' HD21 ' A' ' 105' ' ' LEU . 5.1 m-85 -58.78 -36.76 74.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.975 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -98.8 60.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 110.161 179.831 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -42.78 -32.88 0.66 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.309 -0.87 . . . . 0.0 110.073 179.939 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 3.2 p30 -77.19 -31.77 55.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.415 -0.803 . . . . 0.0 109.899 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 71.95 51.35 14.99 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 17.1 p-10 -97.67 -33.48 11.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -1.219 . . . . 0.0 110.014 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 131.51 0.49 4.92 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.585 ' CE2' ' OD1' ' A' ' 137' ' ' ASN . 65.1 m-85 -147.95 149.05 31.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.246 . . . . 0.0 110.595 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 92' ' ' PHE . 45.0 mt -104.44 149.28 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.117 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.418 ' H ' ' HB2' ' A' ' 104' ' ' GLU . 0.6 OUTLIER -139.91 160.46 39.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.016 179.73 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.35 -38.42 58.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.28 -38.73 92.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.109 -0.994 . . . . 0.0 109.811 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' A' ' 101' ' ' SER . 12.4 mt-10 -63.81 -47.66 79.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.286 -0.884 . . . . 0.0 109.862 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.023 HD12 HD11 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -58.9 -34.55 71.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.322 -0.862 . . . . 0.0 109.517 179.552 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 109' ' ' MET . 16.9 ttp85 -59.42 -41.52 89.7 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.278 -0.889 . . . . 0.0 109.151 179.187 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -54.16 40.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.47 -0.769 . . . . 0.0 109.559 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 2.5 t -51.66 -37.02 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.21 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.921 ' HA ' HD21 ' B' ' 17' ' ' LEU . 21.0 mtt -58.72 -62.83 1.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.34 -0.85 . . . . 0.0 109.907 179.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 m -58.85 -31.36 68.46 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.259 -0.901 . . . . 0.0 109.574 179.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -76.53 -17.5 59.21 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.328 179.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.82 ' O ' HD11 ' A' ' 18' ' ' LEU . 7.0 mt -100.05 -47.68 4.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.845 . . . . 0.0 110.24 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 149.21 -28.52 1.23 Allowed Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.791 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.573 ' HG2' ' CD1' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -109.28 134.86 51.25 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.798 -1.413 . . . . 0.0 111.248 -179.325 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 116' ' ' LEU . 6.8 tttt -117.09 78.5 1.22 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.077 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.795 HD11 ' O ' ' B' ' 17' ' ' LEU . 7.0 mp -40.69 164.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.612 0.72 . . . . 0.0 111.13 -179.062 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.06 -149.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.581 -0.699 . . . . 0.0 109.712 179.456 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -111.51 -70.33 0.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 110.144 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 120' ' ' GLU . 23.4 pt-20 -47.54 -40.1 18.06 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.551 179.802 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 119' ' ' GLU . 18.8 mt-10 -61.28 -55.6 30.04 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.338 -0.851 . . . . 0.0 109.148 179.027 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.0 t -50.05 -47.25 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.35 -0.844 . . . . 0.0 109.737 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.71 -50.19 70.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 109.631 179.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.28 -34.55 68.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.462 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.474 ' HE3' ' O ' ' B' ' 16' ' ' MET . 6.5 ttt -56.93 -54.77 42.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.472 -0.767 . . . . 0.0 109.987 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.023 HD11 HD12 ' A' ' 105' ' ' LEU . 33.0 mm -57.64 -43.13 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 109.972 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -50.7 67.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.113 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -48.61 -38.74 21.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.383 -0.823 . . . . 0.0 110.16 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.709 ' O ' HD12 ' A' ' 130' ' ' ILE . . . -81.24 -24.17 37.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.395 -0.816 . . . . 0.0 110.136 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.472 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -67.66 73.93 0.17 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.3 -0.875 . . . . 0.0 110.34 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 128' ' ' ALA . 2.8 mp -53.85 -45.21 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.245 -0.909 . . . . 0.0 110.275 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 2.4 p30 -77.38 -36.55 53.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 110.314 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.427 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.35 65.03 1.11 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.0 p30 -112.11 -28.75 7.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.279 -1.13 . . . . 0.0 110.263 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 118.07 -6.11 15.41 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.462 ' N ' ' CD ' ' A' ' 135' ' ' GLN . 15.6 mp0 -144.52 169.88 17.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -1.133 . . . . 0.0 109.958 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 69.2 t -121.44 104.92 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.948 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.585 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 8.2 t30 -79.01 167.08 21.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -0.915 . . . . 0.0 110.386 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 139' ' ' GLU . 28.1 t80 -47.33 -58.82 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.334 -0.853 . . . . 0.0 110.058 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 138' ' ' TYR . 45.6 mm-40 -44.44 -42.25 6.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 109.669 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.472 ' OE2' ' HA ' ' A' ' 129' ' ' ASP . 4.5 tt0 -68.05 -54.3 19.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.813 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -45.8 -25.66 0.54 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.566 HG22 HG21 ' A' ' 85' ' ' ILE . 12.0 t -93.69 -30.5 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 0.0 109.836 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.602 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 8.2 mt-30 -58.49 -38.61 78.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.065 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.485 ' SD ' ' OD1' ' B' ' 24' ' ' ASN . 1.9 mmm -64.03 -55.17 24.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 0.0 109.917 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' B' ' 24' ' ' ASN . 6.1 ttm -67.44 -21.94 65.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 146' ' ' THR . 3.8 t -168.92 90.79 0.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 110.298 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -93.67 58.52 2.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 110.121 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.193 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.717 HG22 ' O ' ' B' ' 1' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.252 0.549 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.87 -125.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.291 -0.881 . . . . 0.0 110.042 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.497 HD23 ' OE1' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -90.7 -69.6 0.72 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.044 -1.035 . . . . 0.0 110.25 179.931 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.609 HG23 ' HD2' ' B' ' 5' ' ' PRO . 6.1 mt 57.01 147.64 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.414 -0.804 . . . . 0.0 110.203 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.609 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.2 Cg_endo -69.76 129.04 16.9 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.665 1.35 . . . . 0.0 111.085 -179.064 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.543 ' O ' ' N ' ' B' ' 8' ' ' THR . 3.8 m -86.83 95.96 10.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.494 -0.754 . . . . 0.0 110.813 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.568 ' CH2' HD13 ' A' ' 32' ' ' LEU . 13.9 m95 33.92 -87.82 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.805 -0.559 . . . . 0.0 111.92 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.543 ' N ' ' O ' ' B' ' 6' ' ' SER . 1.3 p -35.38 -38.76 0.11 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.51 -0.744 . . . . 0.0 111.011 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.657 HG21 ' HB3' ' A' ' 87' ' ' GLU . 4.3 m -57.65 -42.21 83.02 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.571 -0.851 . . . . 0.0 109.736 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' B' ' 7' ' ' TRP . 13.3 t -68.31 -36.6 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.418 -0.801 . . . . 0.0 109.698 179.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.686 ' N ' HD13 ' B' ' 11' ' ' ILE . 2.7 mm -70.0 -19.41 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.359 -0.838 . . . . 0.0 109.442 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.441 ' O ' ' SD ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.5 -57.43 3.94 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.715 0.769 . . . . 0.0 109.527 179.282 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.651 HG11 HG11 ' A' ' 91' ' ' VAL . 43.2 t -62.8 -34.36 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.0 110.76 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.498 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -69.7 -34.86 74.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.987 . . . . 0.0 110.304 -179.835 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 58.5 m -71.96 -25.8 62.01 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' B' ' 22' ' ' PHE . 0.2 OUTLIER -76.07 -37.49 58.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.305 -0.872 . . . . 0.0 110.828 -179.823 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.921 HD21 ' HA ' ' A' ' 109' ' ' MET . 4.4 mp -51.53 -19.54 1.51 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.94 -1.1 . . . . 0.0 110.509 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' B' ' 17' ' ' LEU . 0.3 OUTLIER -21.57 -72.0 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 CA-C-O 121.087 0.47 . . . . 0.0 112.127 -179.446 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.53 ' HD2' ' HG3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -154.08 -114.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 110.136 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.494 ' NH2' ' OE2' ' A' ' 120' ' ' GLU . 1.6 mtm180 -101.25 21.27 14.3 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.901 -1.124 . . . . 0.0 110.087 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 13.7 m -120.75 142.74 49.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.552 ' HZ ' HD11 ' A' ' 105' ' ' LEU . 1.2 m-85 -88.96 -63.96 1.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 110.452 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.58 108.71 0.72 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.546 ' HB2' ' HD3' ' B' ' 25' ' ' PRO . 5.6 m-80 -100.58 -42.03 0.22 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.221 -1.164 . . . . 0.0 111.943 -179.342 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' B' ' 24' ' ' ASN . 47.7 Cg_endo -81.78 10.81 3.33 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.089 1.047 . . . . 0.0 110.909 -179.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 109.961 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.195 0.521 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -113.2 -11.83 13.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.276 -0.89 . . . . 0.0 110.206 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.443 ' O ' ' CB ' ' A' ' 4' ' ' LEU . 54.0 mm-40 -73.72 99.92 3.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.136 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 0.8 OUTLIER 65.11 97.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.878 . . . . 0.0 110.224 179.953 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.3 m -101.36 128.69 47.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.276 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.669 ' HA ' HD12 ' A' ' 9' ' ' ILE . 6.8 pt-20 -63.8 -39.17 93.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 110.213 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -47.54 -52.93 15.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.093 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -60.1 -44.09 95.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.975 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 6' ' ' GLU . 82.5 mt -59.78 -48.38 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.985 . . . . 0.0 109.982 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.77 -36.77 62.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 109.802 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 19.4 mt-10 -60.74 -54.05 49.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 109.619 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -59.67 -43.06 94.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.83 . . . . 0.0 109.706 179.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 -36.1 77.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.808 179.642 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -65.2 -42.04 93.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.329 -0.857 . . . . 0.0 109.769 179.573 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.22 -45.18 77.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.415 -0.803 . . . . 0.0 110.002 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.635 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 34.0 t80 -61.29 -29.74 70.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.0 109.813 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 m -83.95 -22.8 31.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.402 -0.811 . . . . 0.0 109.773 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.853 HD11 ' O ' ' A' ' 112' ' ' LEU . 4.1 tt -71.3 -36.06 71.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.962 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.67 ' HD1' HG21 ' A' ' 35' ' ' VAL . 53.8 m-85 -82.94 -46.05 13.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.234 -0.916 . . . . 0.0 110.053 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.461 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 17.1 t0 -72.61 101.33 3.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.0 110.215 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.92 -52.34 9.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.0 110.139 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.43 -51.04 63.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.345 -0.847 . . . . 0.0 110.166 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.07 22.86 6.67 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 46.6 p-10 -79.83 -21.95 43.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -1.192 . . . . 0.0 110.107 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.558 ' C ' HG23 ' A' ' 26' ' ' THR . . . 97.18 33.2 6.07 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.558 HG23 ' C ' ' A' ' 25' ' ' GLY . 44.2 p -153.09 132.48 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.341 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.611 HD12 HG21 ' A' ' 63' ' ' ILE . 6.0 mt -101.06 112.63 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.26 -0.9 . . . . 0.0 109.937 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 29' ' ' THR . 51.8 p -97.98 156.92 16.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.868 . . . . 0.0 110.169 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 28' ' ' THR . 1.9 p -44.53 -27.27 0.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.178 -0.952 . . . . 0.0 109.872 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -55.28 9.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 110.033 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' O ' ' HB ' ' A' ' 34' ' ' THR . 39.5 mt-10 -57.15 -56.09 26.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.93 . . . . 0.0 110.063 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.504 HD22 ' CD1' ' A' ' 52' ' ' ILE . 10.4 tp -57.65 -48.66 78.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 109.937 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -51.78 -39.6 47.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.825 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 52.6 m -59.43 -61.07 2.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -1.175 . . . . 0.0 109.715 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.67 HG21 ' HD1' ' A' ' 19' ' ' PHE . 13.8 t -45.25 -55.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -57.51 -26.96 62.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.809 179.559 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.0 ttm180 -74.23 -19.49 60.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.479 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 19.2 m -96.37 -38.11 10.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.275 -0.891 . . . . 0.0 110.625 -179.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 mt -45.67 -29.16 1.16 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.01 -1.056 . . . . 0.0 110.067 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 41' ' ' GLN . . . 125.17 58.63 0.17 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 2.2 mt-30 170.04 -175.11 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.197 -1.178 . . . . 0.0 110.498 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.54 102.09 3.49 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.276 -0.89 . . . . 0.0 110.349 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.517 ' HB3' HD12 ' B' ' 4' ' ' ILE . 45.1 Cg_endo -73.18 135.77 23.34 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.093 1.575 . . . . 0.0 110.335 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.536 HG22 ' OE2' ' A' ' 47' ' ' GLU . 13.7 t -71.99 -161.93 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.206 -0.934 . . . . 0.0 110.224 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -84.18 -56.38 3.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.019 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.38 -51.22 11.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.016 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.536 ' OE2' HG22 ' A' ' 44' ' ' THR . 48.0 mt-10 -61.37 -52.35 65.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.865 . . . . 0.0 109.99 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.7 OUTLIER -55.56 -48.69 74.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.342 -0.848 . . . . 0.0 110.23 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -62.21 -32.82 73.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.103 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -32.59 70.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.364 -0.835 . . . . 0.0 110.093 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 3.1 mtp -78.02 -43.85 28.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.433 -0.792 . . . . 0.0 110.438 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.606 HG13 HD11 ' A' ' 63' ' ' ILE . 0.7 OUTLIER -70.43 -33.82 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.212 -0.93 . . . . 0.0 109.921 -179.993 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 1.2 m-80 -60.62 -25.87 66.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.486 -0.759 . . . . 0.0 110.743 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -77.92 -47.05 19.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 0.0 110.579 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.694 HG21 ' CE2' ' B' ' 7' ' ' TRP . 19.2 t -71.28 -40.36 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.185 -0.947 . . . . 0.0 110.091 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.486 ' OD1' HD13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -63.46 71.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.841 -179.975 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -37.94 -63.25 0.49 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.674 -0.641 . . . . 0.0 110.529 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 3.5 p30 -56.75 -38.85 73.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.102 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.98 48.72 4.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.529 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 16.7 p-10 -98.32 -40.39 8.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -1.182 . . . . 0.0 110.115 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 62' ' ' THR . . . 133.73 21.75 0.79 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.692 179.36 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 61' ' ' GLY . 36.3 p -158.06 145.63 18.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.922 -1.34 . . . . 0.0 110.405 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.611 HG21 HD12 ' A' ' 27' ' ' ILE . 10.8 mm -89.42 144.96 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.349 -0.844 . . . . 0.0 109.803 179.583 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -120.59 147.31 45.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.128 -0.982 . . . . 0.0 110.754 -179.578 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.635 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 11.8 t80 -43.85 -49.52 20.5 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.372 -0.83 . . . . 0.0 111.098 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.8 Cg_endo -68.7 -32.49 23.62 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.281 1.148 . . . . 0.0 110.539 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -65.51 -30.17 70.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -76.96 -51.18 11.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.885 . . . . 0.0 110.236 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 65' ' ' PHE . 2.7 mp -53.62 -32.38 51.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.376 -0.827 . . . . 0.0 110.214 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.8 m -78.03 -38.34 44.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 110.563 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -67.19 0.45 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.196 -0.94 . . . . 0.0 110.533 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.518 ' HE1' ' CD2' ' B' ' 12' ' ' LEU . 6.8 tpt -50.5 -19.87 0.99 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.353 -0.842 . . . . 0.0 110.665 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.86 -29.14 39.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.134 -0.979 . . . . 0.0 110.648 -179.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -93.68 -15.17 25.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.667 ' HG2' HG21 ' B' ' 8' ' ' THR . 0.2 OUTLIER -100.77 40.52 1.26 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 110.419 -179.845 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 72' ' ' MET . 9.9 mmt -100.22 -36.56 9.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.158 -0.964 . . . . 0.0 110.325 -179.827 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.92 51.12 0.54 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.289 -0.882 . . . . 0.0 110.369 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -120.31 -89.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 110.259 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.5 p -93.16 -16.85 24.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 110.378 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.508 ' OD1' ' HB2' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -123.99 100.91 6.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.0 110.359 -179.662 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.467 ' HA ' ' OE2' ' A' ' 84' ' ' GLU . 1.6 t -114.15 -59.33 2.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.587 179.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -100.68 -9.9 21.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.904 179.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.508 ' HB2' ' OD1' ' A' ' 80' ' ' ASP . 69.6 mt-10 -75.5 -46.38 32.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.981 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HG2' ' N ' ' A' ' 85' ' ' ILE . 10.2 pm0 -55.59 -23.37 26.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 110.26 179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.667 HG21 HG22 ' A' ' 142' ' ' VAL . 24.3 mt -84.22 -46.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 109.203 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.68 -34.29 69.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.459 -0.776 . . . . 0.0 109.216 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.45 ' HB3' HG21 ' B' ' 9' ' ' THR . 32.0 mt-10 -72.38 -48.77 38.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.223 178.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.54 -35.14 67.77 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.426 -0.797 . . . . 0.0 109.073 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.22 -39.45 78.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.368 -0.833 . . . . 0.0 108.825 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -58.67 -29.89 66.95 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.202 179.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.9 -50.47 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.485 -0.76 . . . . 0.0 109.555 179.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.532 ' HB3' HD13 ' A' ' 100' ' ' ILE . 61.2 m-85 -62.43 -38.49 89.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.26 55.84 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.995 179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -56.2 -48.9 75.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.094 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 15.9 p-10 -57.6 -34.55 69.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.367 -0.833 . . . . 0.0 110.323 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 74.41 49.02 12.52 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.437 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 27.0 p-10 -98.28 -22.91 15.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -1.103 . . . . 0.0 110.263 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.58 ' O ' ' CG ' ' A' ' 99' ' ' TYR . . . 113.7 6.79 20.91 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.582 ' CB ' ' NE2' ' A' ' 135' ' ' GLN . 73.0 m-85 -157.71 134.98 10.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.248 -1.148 . . . . 0.0 109.841 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.532 HD13 ' HB3' ' A' ' 92' ' ' PHE . 24.9 mt -84.49 155.62 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.1 -1.0 . . . . 0.0 110.541 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 103' ' ' ALA . 4.0 t -139.22 140.56 37.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.454 -0.778 . . . . 0.0 109.72 179.691 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -41.15 -27.44 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.235 -0.916 . . . . 0.0 110.375 -179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 101' ' ' SER . . . -65.59 -55.58 16.87 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.674 179.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 38.1 mt-10 -55.08 -44.68 75.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.998 179.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.969 ' CD1' HD11 ' A' ' 125' ' ' ILE . 1.1 mt -57.37 -44.93 84.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.9 . . . . 0.0 109.655 179.733 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HA ' ' HG2' ' A' ' 109' ' ' MET . 0.2 OUTLIER -55.94 -38.29 70.11 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.053 -1.029 . . . . 0.0 109.286 179.273 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 -32.24 73.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.629 -0.669 . . . . 0.0 109.539 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.448 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 26.1 t -81.15 -52.56 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.475 -0.765 . . . . 0.0 110.672 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.544 ' HG3' ' N ' ' A' ' 110' ' ' THR . 11.9 ptp -58.59 -38.6 78.28 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.981 . . . . 0.0 110.389 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.544 ' N ' ' HG3' ' A' ' 109' ' ' MET . 27.1 m -71.15 -40.09 71.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.18 -0.95 . . . . 0.0 109.881 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 38' ' ' SER . 36.5 m-80 -80.07 -4.45 52.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.787 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.853 ' O ' HD11 ' A' ' 18' ' ' LEU . 5.8 mt -98.23 -30.48 12.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 0.0 109.923 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.38 -53.11 0.59 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 109' ' ' MET . 22.7 tt0 -108.12 143.49 36.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -1.107 . . . . 0.0 110.173 -179.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.6 OUTLIER -120.64 18.72 11.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.945 . . . . 0.0 109.643 179.614 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.884 HD11 ' O ' ' B' ' 17' ' ' LEU . 3.4 mp 40.11 -164.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.613 0.72 . . . . 0.0 110.656 179.708 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 -172.87 2.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.462 -0.774 . . . . 0.0 109.269 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.3 -50.02 8.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 0.0 109.908 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -64.7 -32.83 74.68 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 179.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.41 ' OE1' ' HD2' ' B' ' 20' ' ' ARG . 4.8 mt-10 -69.05 -50.72 45.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.359 -0.838 . . . . 0.0 109.236 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.4 t -60.22 -42.06 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.805 179.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -66.14 -49.98 65.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 179.379 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -56.11 -25.47 45.99 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.449 -0.782 . . . . 0.0 109.139 179.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.802 ' HE2' ' CD1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.65 -57.57 6.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.567 -0.708 . . . . 0.0 109.854 179.546 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.969 HD11 ' CD1' ' A' ' 105' ' ' LEU . 24.6 mm -64.31 -24.32 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.389 -0.819 . . . . 0.0 110.003 179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -76.05 -51.61 11.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.955 . . . . 0.0 110.021 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -12.39 42.22 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.334 -0.854 . . . . 0.0 110.053 179.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -98.4 -33.25 11.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.53 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.892 . . . . 0.0 110.121 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 128' ' ' ALA . 10.3 mt -72.74 -27.64 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 23.4 p-10 -96.58 -28.12 14.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 0.0 110.296 -179.892 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 82.38 75.57 1.14 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 21.1 p-10 -128.1 -18.09 4.21 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.256 -1.144 . . . . 0.0 110.551 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.64 10.04 36.48 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.582 ' NE2' ' CB ' ' A' ' 99' ' ' TYR . 1.9 pt20 -168.94 170.27 9.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.361 -1.082 . . . . 0.0 109.484 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 35.3 t -114.87 151.95 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.943 -1.098 . . . . 0.0 110.85 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 98' ' ' GLY . 12.6 t30 -116.77 -169.6 1.67 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.513 -0.742 . . . . 0.0 109.506 179.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.44 ' CE1' HG21 ' A' ' 142' ' ' VAL . 8.5 t80 -67.83 -52.83 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.931 -1.105 . . . . 0.0 110.061 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -46.17 -67.46 0.28 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.319 -0.863 . . . . 0.0 110.188 179.964 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' PHE . 4.8 tt0 -43.87 -59.39 2.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.193 -0.942 . . . . 0.0 109.766 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.435 ' CE1' ' CD2' ' A' ' 92' ' ' PHE . 42.9 t80 -43.48 -26.05 0.19 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.831 179.415 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.667 HG22 HG21 ' A' ' 85' ' ' ILE . 68.8 t -98.93 -30.77 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.369 -0.832 . . . . 0.0 110.639 -179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 140' ' ' GLU . 10.3 mm-40 -65.65 -40.71 92.75 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.097 -1.002 . . . . 0.0 110.584 -179.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -36.56 68.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.219 -0.926 . . . . 0.0 110.559 -179.708 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.683 ' HE3' ' HB2' ' B' ' 24' ' ' ASN . 3.7 mtt -85.0 -26.06 27.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.197 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 146' ' ' THR . 9.6 t -170.05 96.87 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.128 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.44 49.53 1.39 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.349 -0.844 . . . . 0.0 110.362 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.9 pttp . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.241 179.941 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' B' ' 2' ' ' LYS . 24.8 t . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 121.167 0.508 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' B' ' 1' ' ' VAL . 3.9 mtmp? 54.47 103.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.036 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' B' ' 4' ' ' ILE . 2.1 mt -123.71 -90.13 0.58 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.146 -0.971 . . . . 0.0 110.062 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.53 ' O ' ' O ' ' B' ' 3' ' ' LEU . 6.7 mm 56.09 136.04 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.662 -0.649 . . . . 0.0 110.704 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.68 139.07 36.25 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.543 1.286 . . . . 0.0 110.591 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.85 ' O ' HG23 ' B' ' 10' ' ' VAL . 40.9 t -73.11 -159.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.845 . . . . 0.0 110.724 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.694 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -82.3 -82.29 0.14 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.553 -0.717 . . . . 0.0 110.724 -179.616 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.667 HG21 ' HG2' ' A' ' 75' ' ' LYS . 23.9 p -40.09 -34.99 0.34 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.622 -0.674 . . . . 0.0 110.42 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.45 HG21 ' HB3' ' A' ' 87' ' ' GLU . 40.1 m -59.85 -53.41 58.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 109.3 179.27 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.85 HG23 ' O ' ' B' ' 6' ' ' SER . 61.9 t -50.51 -41.85 20.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.301 -0.875 . . . . 0.0 109.124 178.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.587 ' H ' HD12 ' B' ' 11' ' ' ILE . 2.8 mp -61.95 -59.59 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.561 -0.712 . . . . 0.0 110.103 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.518 ' CD2' ' HE1' ' A' ' 72' ' ' MET . 3.2 mm? -39.94 -50.64 2.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.497 -0.752 . . . . 0.0 110.992 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.603 HG12 HD11 ' A' ' 112' ' ' LEU . 94.8 t -56.65 -51.98 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.111 -0.993 . . . . 0.0 110.531 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.471 ' O ' HD22 ' B' ' 17' ' ' LEU . 19.3 tptt -56.02 -49.99 72.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.86 -1.15 . . . . 0.0 109.762 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.446 ' O ' ' ND2' ' B' ' 24' ' ' ASN . 0.6 OUTLIER -68.74 -6.47 26.64 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 179.045 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.531 ' O ' ' HE3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -80.13 -45.2 18.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.362 -0.836 . . . . 0.0 110.548 -179.861 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.884 ' O ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -100.31 32.6 2.96 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 118.515 -1.274 . . . . 0.0 110.529 179.36 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.533 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 57.0 ttt180 -44.28 -58.95 2.61 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.56 -0.713 . . . . 0.0 109.859 179.3 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.595 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -144.59 -118.09 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.221 -0.924 . . . . 0.0 110.007 179.578 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.41 ' HD2' ' OE1' ' A' ' 120' ' ' GLU . 25.5 mtp180 -97.03 25.27 5.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.884 -1.135 . . . . 0.0 109.957 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.04 152.97 28.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.667 -179.352 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.802 ' CD1' ' HE2' ' A' ' 124' ' ' MET . 1.2 t80 -124.13 -25.64 4.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.875 . . . . 0.0 110.317 179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.87 109.84 3.9 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.683 ' HB2' ' HE3' ' A' ' 145' ' ' MET . 1.5 m-80 -81.57 156.18 70.84 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -1.178 . . . . 0.0 109.88 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' B' ' 26' ' ' PHE . 43.3 Cg_endo -74.72 -68.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.857 1.451 . . . . 0.0 110.432 -179.804 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.498 ' CD1' ' HB3' ' B' ' 24' ' ' ASN . 15.5 m-85 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.396 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.145 0.497 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 3' ' ' GLN . 3.3 m-20 -113.74 -40.59 3.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.301 -0.874 . . . . 0.0 110.254 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 2' ' ' ASP . 28.2 mm-40 -42.98 107.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 5' ' ' THR . 9.7 mt -102.76 133.14 48.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.276 -0.89 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 4' ' ' LEU . 7.4 p 44.46 99.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.471 -0.768 . . . . 0.0 110.656 179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.5 mt-10 -82.39 -39.48 22.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.319 -0.863 . . . . 0.0 109.992 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.59 -57.76 11.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.926 179.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -49.48 -45.47 46.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.794 179.658 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.611 HD12 ' HA ' ' A' ' 6' ' ' GLU . 40.2 mt -49.91 -48.36 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.662 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.7 -48.75 66.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.331 -0.856 . . . . 0.0 109.565 179.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -55.12 -52.22 63.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.612 179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -57.75 -45.38 85.94 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.321 -0.862 . . . . 0.0 109.427 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -33.67 57.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 109.247 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.7 -47.82 79.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.535 -0.728 . . . . 0.0 109.661 179.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -62.46 -44.32 96.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -0.85 . . . . 0.0 109.543 179.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.6 ' CZ ' ' N ' ' A' ' 65' ' ' PHE . 23.9 t80 -63.74 -35.59 81.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.378 -0.826 . . . . 0.0 109.708 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.2 m -78.1 -20.64 51.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.354 -0.842 . . . . 0.0 109.854 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.855 HD12 ' O ' ' A' ' 112' ' ' LEU . 0.4 OUTLIER -69.5 -46.95 65.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.43 -0.794 . . . . 0.0 109.789 179.799 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' A' ' 21' ' ' LYS . 75.5 m-85 -69.57 -59.31 3.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 109.939 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.46 91.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.343 -0.848 . . . . 0.0 110.247 179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 19' ' ' PHE . 4.0 mmtp -77.49 -26.57 51.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.129 -0.982 . . . . 0.0 110.22 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 20.7 p-10 -97.73 -20.72 17.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.275 -0.89 . . . . 0.0 110.326 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.61 78.79 0.92 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 45.2 p-10 -139.39 8.47 2.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -1.151 . . . . 0.0 110.061 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.791 ' O ' HG23 ' A' ' 26' ' ' THR . . . 65.34 35.01 90.95 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -163.85 119.31 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.236 -1.155 . . . . 0.0 110.444 -179.903 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 19' ' ' PHE . 13.3 mt -83.18 134.4 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.086 -1.009 . . . . 0.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.459 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 20.1 p -98.82 179.98 4.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.405 ' O ' HD13 ' A' ' 48' ' ' LEU . 1.2 p -70.89 -53.27 15.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -61.39 -48.8 79.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.217 -0.927 . . . . 0.0 110.455 -179.948 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OG1' ' A' ' 28' ' ' THR . 23.3 mt-10 -41.92 -69.81 0.12 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.208 -0.932 . . . . 0.0 109.947 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.615 HD22 ' CH2' ' B' ' 7' ' ' TRP . 22.5 tp -49.55 -32.43 12.5 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.125 -0.984 . . . . 0.0 109.07 179.386 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.74 95.04 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.769 -1.733 . . . . 0.0 108.769 179.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.1 m -54.76 -44.54 73.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.293 -1.122 . . . . 0.0 109.111 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 35' ' ' VAL . 24.8 t -64.31 -44.72 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.446 -0.784 . . . . 0.0 109.398 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.608 ' HA ' HD12 ' A' ' 39' ' ' LEU . 2.0 mmt -62.28 -34.89 77.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.315 -0.866 . . . . 0.0 109.663 179.369 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -34.31 77.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.501 179.386 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -26.58 54.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.577 -0.702 . . . . 0.0 110.386 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.608 HD12 ' HA ' ' A' ' 36' ' ' MET . 4.7 mt -69.77 -32.44 70.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.131 -0.98 . . . . 0.0 109.985 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.06 -46.98 0.7 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.382 179.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.56 -176.46 6.26 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.1 -1.235 . . . . 0.0 111.242 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 8.1 p30 -144.82 105.07 4.52 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.538 -0.726 . . . . 0.0 109.446 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.691 ' HA ' HD11 ' B' ' 4' ' ' ILE . 44.0 Cg_endo -72.23 151.49 54.81 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 O-C-N 124.054 1.555 . . . . 0.0 111.046 -179.304 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.554 HG22 ' N ' ' A' ' 45' ' ' GLU . 56.2 m -98.16 174.62 6.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.909 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.554 ' N ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -73.82 -41.83 61.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.118 -0.989 . . . . 0.0 110.451 -179.768 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.17 -48.82 74.51 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.066 -1.021 . . . . 0.0 110.281 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -64.45 -49.35 71.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.348 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.52 ' HG ' ' HB2' ' A' ' 43' ' ' PRO . 6.3 mt -52.34 -49.66 63.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.965 . . . . 0.0 110.109 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -54.73 -41.44 70.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 109.669 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -70.84 -25.54 62.88 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.315 -0.865 . . . . 0.0 109.464 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.436 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.4 OUTLIER -73.63 -40.92 63.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.894 179.678 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -28.5 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.293 -0.879 . . . . 0.0 109.478 179.733 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.71 -14.15 12.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.314 -0.866 . . . . 0.0 110.113 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -85.8 -49.27 8.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 111.069 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 57' ' ' ALA . 21.7 t -69.1 -47.5 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.877 -1.14 . . . . 0.0 109.503 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -45.89 89.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.388 0.613 . . . . 0.0 110.329 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -98.0 -9.07 26.7 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.186 -0.946 . . . . 0.0 110.59 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 5.7 p30 -100.65 -32.67 10.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.961 -1.087 . . . . 0.0 110.791 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 103.57 45.91 1.48 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' OD1' ' CG ' ' A' ' 58' ' ' ASP . 23.1 m120 -100.03 -19.82 16.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.119 -1.224 . . . . 0.0 110.037 179.833 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.89 -11.68 70.55 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 27' ' ' ILE . 0.6 OUTLIER -145.99 170.09 17.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.106 . . . . 0.0 110.109 -179.999 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.2 mm -89.9 124.85 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.423 -0.798 . . . . 0.0 110.493 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.535 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 4.5 m-20 -97.07 -177.43 3.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.274 -0.892 . . . . 0.0 110.639 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.61 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 17.9 t80 -68.5 -48.37 33.7 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.392 -0.817 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.9 Cg_endo -67.69 -32.58 30.04 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 O-C-N 123.294 1.155 . . . . 0.0 110.006 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' OE2' ' OD1' ' A' ' 64' ' ' ASP . 6.9 mt-10 -63.34 -36.65 84.4 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.187 -0.946 . . . . 0.0 109.105 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.727 ' HZ ' HG23 ' B' ' 11' ' ' ILE . 5.5 t80 -64.48 -58.24 6.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.779 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.01 -30.53 66.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.329 -0.857 . . . . 0.0 110.199 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 m -84.29 -21.9 30.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.182 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -69.45 -45.8 68.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 0.0 109.929 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.513 ' HE2' ' CE1' ' B' ' 26' ' ' PHE . 93.3 mmm -57.29 -15.0 5.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 110.222 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.26 -20.57 14.07 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.153 -0.967 . . . . 0.0 110.572 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 -27.01 20.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.026 . . . . 0.0 110.191 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -99.85 -34.2 10.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.33 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -98.13 60.77 1.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -0.934 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 7.6 ttpp -98.13 -39.04 9.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.095 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 1.1 t70 176.07 -29.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.294 -0.879 . . . . 0.0 110.107 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -43.13 -73.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.257 -0.902 . . . . 0.0 110.579 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.479 ' O ' ' OE1' ' A' ' 84' ' ' GLU . 41.6 p-10 -102.19 115.12 29.89 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.197 -0.94 . . . . 0.0 110.651 -179.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.15 -42.69 3.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.465 179.376 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.566 ' HA ' HD12 ' A' ' 85' ' ' ILE . 5.1 tp10 -100.64 -11.97 19.58 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.456 -0.777 . . . . 0.0 110.035 179.594 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 80' ' ' ASP . 5.1 tm-20 -77.38 -40.5 43.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.197 -0.94 . . . . 0.0 110.559 -179.658 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.479 ' OE1' ' O ' ' A' ' 80' ' ' ASP . 11.2 pt-20 -68.81 -22.58 64.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.933 . . . . 0.0 110.633 -179.762 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.766 HG21 HG22 ' A' ' 142' ' ' VAL . 90.3 mt -76.62 -31.42 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.064 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -65.88 -37.25 85.64 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.346 -0.846 . . . . 0.0 109.651 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.815 ' HB3' HG21 ' B' ' 9' ' ' THR . 4.9 mt-10 -68.7 -52.58 29.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 179.356 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.432 ' HB2' HD13 ' B' ' 12' ' ' LEU . . . -55.64 -29.86 59.96 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.402 -0.811 . . . . 0.0 109.649 179.63 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -69.08 -44.37 72.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 109.333 179.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -37.99 54.24 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 109.191 179.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.939 HG11 HG11 ' B' ' 13' ' ' VAL . 54.9 t -63.48 -51.6 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.679 . . . . 0.0 109.995 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.778 ' HB3' HD13 ' A' ' 100' ' ' ILE . 20.1 m-85 -62.29 -34.9 77.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.168 -0.958 . . . . 0.0 109.995 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -100.46 67.32 1.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.801 . . . . 0.0 109.931 179.835 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 93' ' ' ASP . 3.0 tttp -37.45 -36.87 0.17 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.66 -0.65 . . . . 0.0 110.568 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 1.9 p30 -83.43 -31.78 26.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.291 -0.881 . . . . 0.0 110.088 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 93' ' ' ASP . . . 75.47 33.77 51.89 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 98' ' ' GLY . 31.4 p-10 -84.73 -31.59 23.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -1.179 . . . . 0.0 110.322 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 97' ' ' ASN . . . 117.24 43.55 0.6 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -169.4 124.26 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -1.083 . . . . 0.0 109.959 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.778 HD13 ' HB3' ' A' ' 92' ' ' PHE . 38.1 mt -110.4 116.29 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.585 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -106.02 148.61 27.53 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.297 -0.877 . . . . 0.0 109.547 179.237 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.561 ' HB1' HG12 ' A' ' 121' ' ' VAL . . . -37.9 -34.46 0.11 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.443 -0.786 . . . . 0.0 110.516 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -63.02 -50.41 70.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 0.0 109.487 179.339 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 25.1 mt-10 -55.47 -47.65 75.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.599 179.504 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.997 ' CD1' HD11 ' A' ' 125' ' ' ILE . 2.4 mt -51.11 -41.77 60.25 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.267 -0.896 . . . . 0.0 109.267 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HG2' HG21 ' A' ' 121' ' ' VAL . 1.1 mmm180 -60.43 -34.37 73.87 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.464 -0.772 . . . . 0.0 109.916 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 8.8 m170 -69.98 -22.25 63.16 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 92' ' ' PHE . 2.1 t -88.29 -45.28 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.168 -0.957 . . . . 0.0 110.715 -179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.572 ' HE1' ' HB2' ' A' ' 116' ' ' LEU . 13.1 ptp -63.56 -44.85 92.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.925 -1.109 . . . . 0.0 110.691 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.503 ' N ' ' CG ' ' A' ' 109' ' ' MET . 1.8 m -60.73 -27.77 68.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.038 -1.039 . . . . 0.0 109.928 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 107' ' ' HIS . 5.8 m120 -82.53 -7.95 59.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.914 . . . . 0.0 110.159 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 18' ' ' LEU . 16.4 mt -114.05 -8.55 13.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.43 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 125.59 -59.55 0.65 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.422 -1.371 . . . . 0.0 111.148 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.515 ' HG2' HD12 ' A' ' 116' ' ' LEU . 17.8 tt0 -72.12 152.55 42.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.996 -1.296 . . . . 0.0 111.28 -178.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 116' ' ' LEU . 4.1 mtmt -132.01 68.06 1.51 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.495 -0.753 . . . . 0.0 109.77 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.572 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 3.0 mp -40.56 119.25 1.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.295 -0.878 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -50.82 177.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.277 -0.889 . . . . 0.0 110.455 -179.464 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -64.71 -52.28 57.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.107 -0.996 . . . . 0.0 110.088 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 10.6 pt-20 -59.92 -42.81 94.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.531 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.417 ' N ' ' CG ' ' A' ' 119' ' ' GLU . 1.8 mt-10 -61.66 -43.54 98.66 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.421 -0.8 . . . . 0.0 109.446 179.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.561 HG12 ' HB1' ' A' ' 102' ' ' ALA . 52.0 t -68.02 -48.46 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.328 -0.858 . . . . 0.0 109.596 179.453 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.21 -38.07 76.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 0.4 OUTLIER -68.71 -33.56 74.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.331 -0.855 . . . . 0.0 109.677 179.593 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.575 ' HG2' ' CD2' ' B' ' 22' ' ' PHE . 12.0 ttt -64.25 -39.99 95.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.87 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.997 HD11 ' CD1' ' A' ' 105' ' ' LEU . 11.0 mm -74.37 -54.37 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.232 -0.917 . . . . 0.0 109.676 179.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.03 -53.38 53.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 110.145 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 7.7 tp10 -51.99 -30.05 23.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.827 . . . . 0.0 110.162 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -96.81 -25.85 15.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.392 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.516 ' OD2' HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -47.2 92.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.266 -0.896 . . . . 0.0 110.556 -179.947 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.6 mt -80.85 -34.01 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.39 179.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.46 ' OD2' ' OD2' ' A' ' 133' ' ' ASP . 9.1 p-10 -87.46 -37.93 16.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.483 -0.761 . . . . 0.0 109.868 179.685 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.24 71.83 0.95 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 3.4 p30 -140.43 9.7 2.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -1.171 . . . . 0.0 109.93 179.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 135' ' ' GLN . . . 58.13 15.12 20.71 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 15.4 mt-30 -146.64 170.18 17.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.354 -1.086 . . . . 0.0 110.341 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.512 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 54.6 t -131.47 129.91 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 109.81 179.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 137' ' ' ASN . 14.2 p-10 -114.01 -160.08 0.72 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.115 -0.991 . . . . 0.0 110.579 -179.462 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.44 ' O ' ' C ' ' A' ' 139' ' ' GLU . 62.1 t80 -62.91 -63.6 1.16 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.887 . . . . 0.0 110.31 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -40.95 -67.86 0.22 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.325 -0.859 . . . . 0.0 110.311 -179.909 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 139' ' ' GLU . 12.7 tt0 -44.6 -60.91 1.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.156 -0.965 . . . . 0.0 110.066 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -46.08 -23.91 0.37 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.29 -0.881 . . . . 0.0 110.308 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.766 HG22 HG21 ' A' ' 85' ' ' ILE . 91.6 t -98.75 -31.67 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 110.241 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 143' ' ' GLN . 7.1 mm100 -66.2 -13.79 60.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.94 . . . . 0.0 110.263 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.409 ' HB3' ' HA2' ' B' ' 23' ' ' GLY . 0.9 OUTLIER -97.47 -20.31 17.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.261 -0.9 . . . . 0.0 110.475 -179.852 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 1.111 ' CE ' HD21 ' B' ' 12' ' ' LEU . 2.1 mtt -99.56 -11.28 21.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 110.218 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 146' ' ' THR . 2.7 t -164.95 84.42 0.39 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 110.072 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.551 ' O ' ' CG ' ' A' ' 148' ' ' LYS . . . -99.1 8.04 45.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.032 -1.043 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.551 ' CG ' ' O ' ' A' ' 147' ' ' ALA . 2.2 mttm . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.161 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.539 HG23 ' N ' ' B' ' 2' ' ' LYS . 16.3 m . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 121.109 0.481 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.539 ' N ' HG23 ' B' ' 1' ' ' VAL . 3.4 pttp -170.91 63.12 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.232 -0.917 . . . . 0.0 110.346 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' B' ' 3' ' ' LEU . 3.3 mm? -90.25 16.19 9.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 0.0 109.788 179.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.691 HD11 ' HA ' ' A' ' 43' ' ' PRO . 16.6 mt -40.89 141.27 0.98 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.591 -0.693 . . . . 0.0 110.086 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.454 ' HD2' HG23 ' B' ' 4' ' ' ILE . 40.7 Cg_endo -68.64 -175.65 0.97 Allowed 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.963 1.507 . . . . 0.0 110.165 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.31 -169.14 1.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.075 -1.016 . . . . 0.0 110.898 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.716 ' O ' HG22 ' B' ' 10' ' ' VAL . 0.9 OUTLIER -71.51 -77.52 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.579 -0.7 . . . . 0.0 110.658 -179.622 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.465 ' C ' ' O ' ' B' ' 7' ' ' TRP . 2.8 p -41.15 -25.78 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.025 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.815 HG21 ' HB3' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -63.99 -65.38 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 179.146 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.716 HG22 ' O ' ' B' ' 7' ' ' TRP . 4.8 m -47.23 -29.87 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.154 -0.966 . . . . 0.0 109.501 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.727 HG23 ' HZ ' ' A' ' 68' ' ' PHE . 7.1 mm -75.7 -45.8 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.321 179.267 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 1.111 HD21 ' CE ' ' A' ' 145' ' ' MET . 0.9 OUTLIER -47.74 -56.51 7.19 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.542 0.687 . . . . 0.0 110.225 179.655 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.939 HG11 HG11 ' A' ' 91' ' ' VAL . 22.1 t -60.04 -51.94 67.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 110.734 -179.538 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' B' ' 14' ' ' LYS . 24.0 tptt -66.62 -14.61 62.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.926 -1.108 . . . . 0.0 109.975 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' B' ' 11' ' ' ILE . 23.3 t -77.71 -33.01 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.872 . . . . 0.0 109.962 179.738 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.67 -14.73 31.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.252 -0.905 . . . . 0.0 110.786 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.826 ' CD2' HD12 ' A' ' 112' ' ' LEU . 3.8 mp -73.72 51.11 0.36 Allowed 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.156 -0.965 . . . . 0.0 111.201 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.484 ' HB3' ' OG ' ' B' ' 21' ' ' SER . 0.1 OUTLIER -104.2 -107.41 0.28 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.116 -0.99 . . . . 0.0 109.817 179.426 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.494 ' C ' ' CD ' ' B' ' 19' ' ' LYS . 0.1 OUTLIER -107.48 -70.16 0.81 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.026 -1.046 . . . . 0.0 109.513 179.677 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.48 ' HB3' ' CD ' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -135.45 13.4 3.49 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.36 -0.837 . . . . 0.0 109.804 179.38 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -66.41 120.3 13.11 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.336 -0.853 . . . . 0.0 110.297 179.866 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.575 ' CD2' ' HG2' ' A' ' 124' ' ' MET . 0.1 OUTLIER -144.87 26.96 1.34 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.976 . . . . 0.0 110.953 179.965 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 144' ' ' MET . . . -118.65 -119.81 2.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.534 ' HB2' ' HA ' ' A' ' 145' ' ' MET . 5.2 t-20 -129.51 70.73 82.0 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.327 -1.102 . . . . 0.0 109.962 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.23 47.2 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.877 1.462 . . . . 0.0 110.21 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.513 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.952 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.344 0.592 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 4' ' ' LEU . 12.0 p30 -69.33 -118.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.217 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.509 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 7.7 pt20 -62.52 74.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.992 -1.068 . . . . 0.0 110.411 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.8 ' C ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -41.69 167.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -0.859 . . . . 0.0 110.898 179.57 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.777 ' HB ' HD22 ' A' ' 4' ' ' LEU . 73.6 m 43.67 68.59 0.5 Allowed 'General case' 0 C--N 1.311 -1.09 0 O-C-N 121.44 -0.788 . . . . 0.0 110.926 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -99.59 -26.03 14.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.401 -0.812 . . . . 0.0 109.753 179.426 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 18.0 mt-10 -69.33 -63.34 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.831 . . . . 0.0 110.124 179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -45.9 -54.5 8.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 109.923 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.706 HD12 ' O ' ' A' ' 5' ' ' THR . 84.9 mt -53.67 -45.46 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -50.33 -44.8 54.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.092 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.442 ' OE1' ' HD3' ' B' ' 18' ' ' ARG . 1.6 mt-10 -59.65 -47.12 86.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.943 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -60.64 -39.08 86.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.66 97.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.957 . . . . 0.0 109.932 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -59.72 -38.16 80.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.304 -0.872 . . . . 0.0 109.832 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -66.36 -51.94 52.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 110.247 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.549 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 15.3 t80 -62.87 -34.29 77.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.199 -0.938 . . . . 0.0 109.824 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.9 t -73.19 -19.23 61.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.836 . . . . 0.0 109.812 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.675 HD13 ' HG3' ' B' ' 14' ' ' LYS . 10.5 tt -80.76 -34.93 33.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.356 -0.84 . . . . 0.0 110.066 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.413 ' CE2' ' CD1' ' B' ' 11' ' ' ILE . 70.2 m-85 -86.4 -44.78 11.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.35 -0.844 . . . . 0.0 110.517 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -77.63 85.79 3.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.312 -0.868 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -66.84 -40.66 88.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.892 . . . . 0.0 110.124 179.848 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -57.1 -43.88 82.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.419 -0.8 . . . . 0.0 110.161 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.26 0.36 67.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 6.9 p-10 -74.84 -28.29 60.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.212 -1.169 . . . . 0.0 109.975 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.524 ' C ' HG23 ' A' ' 26' ' ' THR . . . 110.73 37.73 1.68 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 63' ' ' ILE . 28.3 p -152.41 109.97 3.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.152 -1.204 . . . . 0.0 110.661 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.58 HD12 ' CG2' ' A' ' 63' ' ' ILE . 22.3 mt -80.73 115.12 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.196 -0.94 . . . . 0.0 109.442 179.292 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -93.64 174.65 7.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.283 -0.886 . . . . 0.0 110.228 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.578 HG22 ' HB3' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -64.05 -30.13 71.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.043 179.923 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -73.0 -54.09 9.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.879 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -50.84 -69.91 0.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 109.865 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 tp -52.77 -36.51 58.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.739 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -62.08 -40.55 99.08 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 m -58.27 -51.87 67.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -1.086 . . . . 0.0 109.799 179.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.9 t -60.29 -47.53 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.858 . . . . 0.0 109.963 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.489 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 2.3 mmt -59.56 -43.02 93.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.12 -0.988 . . . . 0.0 109.895 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -65.56 -20.65 66.42 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.342 -0.849 . . . . 0.0 110.109 179.805 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.8 t -77.83 -57.41 3.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.891 . . . . 0.0 110.288 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mt -46.61 -25.64 0.75 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.156 -0.965 . . . . 0.0 110.071 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.83 66.11 0.56 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -137.69 -157.63 0.79 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.174 -1.192 . . . . 0.0 110.288 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 42' ' ' ASN . 18.0 t30 -147.54 62.8 7.33 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.291 -0.881 . . . . 0.0 110.082 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HG3' ' CB ' ' A' ' 36' ' ' MET . 48.7 Cg_endo -74.7 118.59 5.37 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.073 1.565 . . . . 0.0 110.559 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 46' ' ' ALA . 28.1 m -99.96 146.36 26.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.317 -0.864 . . . . 0.0 109.938 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 21.7 pt-20 -43.12 -44.75 5.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.17 -0.956 . . . . 0.0 110.0 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.474 ' H ' HG22 ' A' ' 44' ' ' THR . . . -65.31 -65.04 0.72 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.233 -0.917 . . . . 0.0 109.802 179.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' CD ' ' HB2' ' B' ' 2' ' ' LYS . 1.1 mm-40 -46.55 -43.24 16.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.683 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.578 ' HB3' HG22 ' A' ' 29' ' ' THR . 0.3 OUTLIER -51.7 -55.66 18.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.351 -0.843 . . . . 0.0 109.785 179.674 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -38.52 19.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.768 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -64.76 -33.69 76.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.416 -0.803 . . . . 0.0 110.104 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.552 ' SD ' ' CD1' ' B' ' 7' ' ' TRP . 0.5 OUTLIER -77.18 -37.9 52.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.587 HG13 HD11 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -68.94 -33.81 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.782 179.85 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.77 -46.93 42.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.342 -0.849 . . . . 0.0 110.603 -179.624 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -59.56 -56.72 18.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 0.0 110.697 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' B' ' 7' ' ' TRP . 28.5 t -70.28 -42.77 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.023 -1.048 . . . . 0.0 110.252 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 60' ' ' ASN . 1.7 t70 -64.95 67.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -40.49 -51.5 2.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.551 -0.718 . . . . 0.0 110.886 -179.74 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 6.7 p-10 -67.47 -43.85 80.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 0.0 110.524 -179.621 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' CA ' ' OD2' ' A' ' 56' ' ' ASP . . . 92.72 49.03 2.81 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.53 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 19.2 p30 -100.08 -17.76 17.31 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.168 -1.195 . . . . 0.0 110.202 179.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.16 14.2 31.49 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.15 133.33 16.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.116 -1.226 . . . . 0.0 110.183 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.587 HD11 HG13 ' A' ' 52' ' ' ILE . 26.1 mm -84.57 156.27 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.386 -0.821 . . . . 0.0 110.218 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.549 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 15.2 t0 -129.82 169.06 15.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.04 -1.037 . . . . 0.0 110.453 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.82 ' CE2' HD11 ' A' ' 69' ' ' LEU . 51.7 t80 -61.32 -40.03 68.47 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 111.522 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.4 Cg_endo -71.91 -29.72 14.88 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 O-C-N 123.284 1.15 . . . . 0.0 110.22 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -70.48 -31.34 68.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -0.888 . . . . 0.0 109.418 179.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CZ ' ' HB1' ' A' ' 15' ' ' ALA . 23.6 t80 -72.73 -46.11 55.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.384 -0.822 . . . . 0.0 110.421 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.82 HD11 ' CE2' ' A' ' 65' ' ' PHE . 28.0 mt -66.92 -25.46 66.38 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.212 -0.93 . . . . 0.0 110.778 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.8 m -83.68 -28.62 28.22 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.1 -1.0 . . . . 0.0 110.893 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.437 ' SD ' ' HE3' ' A' ' 75' ' ' LYS . 5.5 tmm? -77.29 -47.59 19.68 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.134 -0.978 . . . . 0.0 111.046 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.609 ' HE2' ' HZ ' ' B' ' 26' ' ' PHE . 7.3 tpt -60.31 -10.89 5.25 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.118 -0.989 . . . . 0.0 111.102 -179.293 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.52 -36.58 8.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.938 -1.101 . . . . 0.0 110.942 -179.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.5 ttt-85 -85.18 -11.26 55.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.133 -0.979 . . . . 0.0 110.6 -179.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.746 ' HG2' HG21 ' B' ' 8' ' ' THR . 1.7 tppp? -100.39 -12.82 19.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.002 -1.061 . . . . 0.0 110.669 -179.786 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.63 -36.8 9.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.114 -0.991 . . . . 0.0 110.643 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -9.05 21.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.093 -1.004 . . . . 0.0 110.447 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -80.48 -87.91 0.07 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.11 -0.993 . . . . 0.0 110.376 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -155.08 -107.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 -179.86 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.468 ' N ' ' OG1' ' A' ' 79' ' ' THR . 1.0 OUTLIER 42.23 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.004 -1.06 . . . . 0.0 110.263 -179.964 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.496 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 74.3 m -125.05 -42.53 2.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 110.004 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -100.3 -20.97 15.62 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.363 -0.836 . . . . 0.0 110.154 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -80.41 -40.1 27.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 0.0 109.919 179.763 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 80' ' ' ASP . 22.8 pt-20 -69.36 -27.64 65.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.262 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.496 ' CD1' ' O ' ' A' ' 81' ' ' SER . 80.0 mt -78.53 -36.14 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.113 -0.992 . . . . 0.0 109.957 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -64.66 -29.84 70.85 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 109.802 179.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -75.43 -50.78 14.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.215 -0.928 . . . . 0.0 109.109 179.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.762 ' HB2' HD22 ' B' ' 12' ' ' LEU . . . -60.57 -35.73 76.78 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.338 -0.852 . . . . 0.0 109.455 179.208 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 17.3 t80 -64.44 -56.95 10.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.0 109.847 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -44.31 -38.22 3.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.402 -0.812 . . . . 0.0 109.556 179.709 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.646 HG12 HG21 ' A' ' 108' ' ' VAL . 4.0 t -65.99 -35.92 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 109.826 179.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.619 ' HB3' HD13 ' A' ' 100' ' ' ILE . 9.1 m-85 -68.64 -35.68 77.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.164 -0.96 . . . . 0.0 110.474 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.464 ' OD1' HG12 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -98.82 63.59 1.4 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.21 -0.931 . . . . 0.0 110.402 -179.416 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -43.31 -28.22 0.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.277 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 96' ' ' GLY . 27.6 p-10 -96.1 -36.98 10.8 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.19 -0.944 . . . . 0.0 110.436 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . 77.23 44.0 14.77 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.417 ' ND2' ' OD2' ' A' ' 95' ' ' ASP . 21.7 p30 -78.17 -15.31 58.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -1.145 . . . . 0.0 110.374 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.501 ' C ' ' CG ' ' A' ' 99' ' ' TYR . . . 118.37 -8.39 13.76 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.501 ' CG ' ' C ' ' A' ' 98' ' ' GLY . 5.3 m-85 -148.88 163.89 36.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -1.186 . . . . 0.0 110.155 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.619 HD13 ' HB3' ' A' ' 92' ' ' PHE . 7.1 mt -113.01 126.32 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 110.133 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.1 p -106.36 153.15 22.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.835 . . . . 0.0 110.09 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -46.75 -37.84 9.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.05 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.44 93.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -55.52 -43.01 75.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.849 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.998 HD12 HD11 ' A' ' 125' ' ' ILE . 2.7 mt -57.92 -48.05 81.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.716 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.411 ' O ' ' OG1' ' A' ' 110' ' ' THR . 0.3 OUTLIER -50.83 -42.56 58.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.838 . . . . 0.0 109.754 179.79 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.81 -48.45 81.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 109.75 179.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.646 HG21 HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -74.42 -25.8 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 0.0 109.416 179.631 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.97 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.5 OUTLIER -71.04 -50.05 38.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 110.108 179.98 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -71.41 -31.67 67.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.187 179.934 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -72.55 -6.46 44.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.245 -0.909 . . . . 0.0 110.438 -179.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.72 HD11 HG12 ' B' ' 13' ' ' VAL . 6.4 mt -106.53 -44.72 4.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.106 -0.996 . . . . 0.0 110.617 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.69 -46.93 0.51 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.405 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.742 ' HG2' HD12 ' A' ' 116' ' ' LEU . 14.2 tt0 -98.48 141.67 31.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.067 -1.255 . . . . 0.0 110.659 -179.613 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 116' ' ' LEU . 3.2 ptpt -119.56 16.46 12.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 109.748 179.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.742 HD12 ' HG2' ' A' ' 114' ' ' GLU . 4.0 mp 39.45 -164.48 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.684 0.754 . . . . 0.0 110.842 179.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.16 -147.98 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.562 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -107.58 -48.56 3.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 109.969 179.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -67.24 -34.84 78.31 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.538 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.48 -44.68 82.01 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.272 -0.893 . . . . 0.0 109.097 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.0 t -53.25 -48.64 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.412 -0.805 . . . . 0.0 109.646 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -65.07 -56.24 14.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.75 -30.05 13.0 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.41 -0.806 . . . . 0.0 109.437 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.616 ' HE2' ' CD2' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.61 -62.4 1.84 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.339 -0.851 . . . . 0.0 109.689 179.544 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.998 HD11 HD12 ' A' ' 105' ' ' LEU . 48.0 mm -56.33 -34.24 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -0.78 . . . . 0.0 110.258 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -66.91 -44.18 81.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 110.323 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.77 -29.66 69.67 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 0.0 110.215 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.18 -31.18 34.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -0.953 . . . . 0.0 110.015 179.799 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.476 ' HB3' ' HA2' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -65.6 106.2 1.4 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.372 -0.83 . . . . 0.0 110.483 -179.968 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.2 mm -64.3 -28.04 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 12.3 p30 -105.54 -16.43 14.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.958 179.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 129' ' ' ASP . . . 64.02 59.36 8.63 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.441 ' N ' ' OD2' ' A' ' 129' ' ' ASP . 6.3 p-10 -101.0 -23.96 14.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -1.146 . . . . 0.0 109.941 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 135' ' ' GLN . . . 131.79 -12.72 5.35 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.478 ' CG ' ' C ' ' A' ' 134' ' ' GLY . 9.7 mt-30 -151.31 161.16 43.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.152 -1.205 . . . . 0.0 110.073 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 19.3 t -105.67 157.85 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.908 179.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 1.9 p-10 -127.23 -179.54 4.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.221 -0.925 . . . . 0.0 110.445 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -61.03 -67.15 0.43 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.447 -0.783 . . . . 0.0 110.647 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 0.7 OUTLIER -45.32 -27.67 0.71 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.238 -0.914 . . . . 0.0 110.628 -179.49 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.464 ' HB2' ' ND2' ' A' ' 137' ' ' ASN . 4.2 tt0 -80.49 -52.51 7.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 69.3 t80 -54.33 -17.39 2.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.18 -0.95 . . . . 0.0 109.859 179.638 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.45 -55.3 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 110.637 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 139' ' ' GLU . 0.5 OUTLIER -58.93 -13.79 7.36 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.118 -0.988 . . . . 0.0 110.78 -179.559 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.493 ' HG3' ' HA2' ' B' ' 23' ' ' GLY . 3.7 tpt -97.55 -27.27 14.48 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.166 -0.959 . . . . 0.0 110.582 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.8 ttt -100.49 -10.05 21.47 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.249 -0.907 . . . . 0.0 110.796 -179.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 p -106.54 -53.21 2.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.076 -1.015 . . . . 0.0 110.967 -179.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 148' ' ' LYS . . . -81.65 45.3 0.87 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.214 -0.929 . . . . 0.0 110.639 -179.517 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.251 179.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 1' ' ' VAL . 27.6 m . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.244 0.545 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.466 ' O ' ' CB ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -69.81 85.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 110.03 179.817 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' B' ' 3' ' ' LEU . 8.9 tp 69.07 21.16 7.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.225 -0.922 . . . . 0.0 110.361 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.63 HG23 ' HD2' ' B' ' 5' ' ' PRO . 19.0 mm -92.5 148.89 37.22 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 179.55 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.63 ' HD2' HG23 ' B' ' 4' ' ' ILE . 38.0 Cg_endo -66.52 170.38 12.46 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.632 1.333 . . . . 0.0 110.436 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.512 ' O ' ' HB ' ' B' ' 9' ' ' THR . 0.1 OUTLIER -96.4 152.24 18.79 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.189 -0.945 . . . . 0.0 111.299 -178.913 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.759 ' O ' HG22 ' B' ' 10' ' ' VAL . 4.2 m95 -48.95 -66.09 0.46 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.291 -0.881 . . . . 0.0 109.641 179.036 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.746 HG21 ' HG2' ' A' ' 75' ' ' LYS . 23.8 p -47.73 -24.17 0.88 Allowed 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.889 -1.132 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' B' ' 6' ' ' SER . 4.1 m -64.38 -54.97 24.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.066 -1.021 . . . . 0.0 109.639 179.37 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.759 HG22 ' O ' ' B' ' 7' ' ' TRP . 6.8 m -56.89 -33.71 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.908 -1.12 . . . . 0.0 108.687 179.44 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.525 ' N ' HD13 ' B' ' 11' ' ' ILE . 4.9 mm -77.45 -23.2 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 108.799 178.411 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.762 HD22 ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -68.5 -60.78 2.18 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.613 -0.68 . . . . 0.0 109.784 179.707 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.72 HG12 HD11 ' A' ' 112' ' ' LEU . 35.7 t -62.82 -32.84 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.371 -0.83 . . . . 0.0 110.166 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.675 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -69.35 -45.59 69.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.017 -1.052 . . . . 0.0 109.251 179.212 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 52.7 p -58.46 -35.23 71.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.418 -0.801 . . . . 0.0 109.518 179.151 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.489 ' HG2' ' HG3' ' B' ' 25' ' ' PRO . 0.0 OUTLIER -65.1 -41.97 94.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.445 -0.784 . . . . 0.0 109.582 179.477 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.97 HD21 ' HA ' ' A' ' 109' ' ' MET . 6.2 mp -60.62 -12.82 11.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.421 -0.799 . . . . 0.0 110.038 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.56 ' C ' ' O ' ' B' ' 17' ' ' LEU . 6.4 tpt85 -18.8 -68.21 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.679 0 CA-C-O 121.489 0.661 . . . . 0.0 111.161 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.535 ' HD2' ' HG2' ' B' ' 20' ' ' ARG . 1.1 tmtm? -174.44 -104.49 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.011 179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.535 ' HG2' ' HD2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -87.73 13.66 10.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.444 -1.41 . . . . 0.0 109.335 179.308 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -87.06 163.34 17.08 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.456 -0.777 . . . . 0.0 110.555 -179.542 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.616 ' CD2' ' HE2' ' A' ' 124' ' ' MET . 0.2 OUTLIER 179.81 -45.29 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.318 -0.864 . . . . 0.0 110.559 -179.994 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.493 ' HA2' ' HG3' ' A' ' 144' ' ' MET . . . -69.91 -50.96 26.43 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.395 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -150.13 84.97 5.61 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.954 -1.321 . . . . 0.0 110.838 -179.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.489 ' HG3' ' HG2' ' B' ' 16' ' ' MET . 48.6 Cg_endo -80.84 -7.76 13.35 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.925 1.487 . . . . 0.0 110.109 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.609 ' HZ ' ' HE2' ' A' ' 72' ' ' MET . 5.9 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.316 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.216 0.531 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -152.99 -43.37 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -0.899 . . . . 0.0 110.264 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -99.78 -155.72 0.52 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.235 -0.916 . . . . 0.0 110.091 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 37.3 mt -69.35 -174.6 0.69 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 110.124 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 t -129.27 -5.54 4.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.14 -0.975 . . . . 0.0 110.5 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 7' ' ' GLU . 48.8 tt0 -96.12 -22.18 17.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.117 -0.989 . . . . 0.0 110.139 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -42.86 -63.94 0.71 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.995 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -46.81 -66.6 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 109.964 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.4 mt -50.11 -44.92 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.3 -45.71 69.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 109.951 179.713 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.68 -51.01 66.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.208 -0.932 . . . . 0.0 109.813 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -44.84 67.63 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.229 -0.919 . . . . 0.0 109.377 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.63 -30.56 65.47 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.344 -0.847 . . . . 0.0 108.972 178.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -58.32 9.1 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.533 -0.729 . . . . 0.0 109.293 179.21 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.77 -48.41 41.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.267 -0.896 . . . . 0.0 109.336 179.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.543 ' CZ ' ' C ' ' A' ' 64' ' ' ASP . 32.3 t80 -66.51 -35.64 80.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.327 -0.858 . . . . 0.0 109.448 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -68.32 -30.34 69.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.46 -0.775 . . . . 0.0 109.528 179.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.876 HD13 ' CD ' ' B' ' 14' ' ' LYS . 6.7 tt -65.35 -46.03 81.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.684 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -73.29 -39.15 65.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.282 -0.886 . . . . 0.0 110.384 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -78.89 82.93 5.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.211 -0.931 . . . . 0.0 109.919 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.8 mmtm -49.17 -74.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 110.359 -179.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.1 p-10 -51.76 -39.0 57.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 110.306 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.17 15.02 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.451 ' OD2' ' OG1' ' A' ' 26' ' ' THR . 40.8 p-10 -76.64 -12.65 60.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -1.167 . . . . 0.0 110.081 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.621 ' O ' HG23 ' A' ' 26' ' ' THR . . . 89.98 42.11 5.42 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -161.49 117.36 2.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -1.131 . . . . 0.0 110.573 -179.831 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.538 ' CG1' ' HB ' ' A' ' 63' ' ' ILE . 8.1 mt -100.07 118.22 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.218 -0.926 . . . . 0.0 110.127 179.594 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.68 HG22 HG22 ' A' ' 62' ' ' THR . 20.4 p -94.92 153.88 17.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 109.806 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -46.31 -24.65 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.138 -0.977 . . . . 0.0 109.942 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -78.54 -60.79 2.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.066 179.761 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 37.3 mt-10 -44.21 -56.64 3.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.511 HD22 ' CZ2' ' B' ' 7' ' ' TRP . 40.8 tp -57.39 -45.65 84.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.168 -0.958 . . . . 0.0 109.3 179.336 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 36' ' ' MET . . . -56.65 -39.56 86.24 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.27 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 31' ' ' GLU . 15.0 m -53.28 -50.94 63.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -1.027 . . . . 0.0 109.363 179.352 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 35' ' ' VAL . 10.4 t -57.75 -39.28 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.326 -0.859 . . . . 0.0 109.261 179.246 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 13.5 mmt -61.31 -39.13 89.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 179.253 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -62.25 -30.74 71.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.381 179.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 m -65.73 -61.85 1.84 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.465 -0.772 . . . . 0.0 110.051 179.687 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.1 mt -47.92 -24.16 0.96 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.71 55.08 0.58 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.15 165.94 30.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -1.186 . . . . 0.0 110.482 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 42' ' ' ASN . 2.6 p30 -140.75 97.95 7.14 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.967 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.7 154.33 54.31 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.9 1.474 . . . . 0.0 110.485 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 45' ' ' GLU . 4.0 m -99.65 -176.74 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.664 ' H ' HG22 ' A' ' 44' ' ' THR . 1.2 tm-20 -67.45 -69.52 0.31 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.216 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.502 ' N ' ' OE1' ' A' ' 45' ' ' GLU . . . -47.14 -46.95 23.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 56.5 mm-40 -52.54 -58.19 7.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -0.895 . . . . 0.0 110.296 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.6 mt -48.61 -43.6 36.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.254 -0.904 . . . . 0.0 110.53 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.0 tp60 -63.87 -35.92 82.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 110.235 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -30.65 71.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.869 . . . . 0.0 110.12 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.9 mtp -84.15 -47.58 10.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.343 -0.848 . . . . 0.0 110.09 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 63' ' ' ILE . 10.2 mm -66.05 -30.26 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.275 -0.891 . . . . 0.0 110.145 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -56.5 -14.14 2.86 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.361 -0.837 . . . . 0.0 111.094 -179.504 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.38 -53.0 4.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.085 -1.009 . . . . 0.0 111.009 -179.29 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.823 HG22 ' HG3' ' A' ' 71' ' ' MET . 6.6 t -72.46 -36.69 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.093 -1.005 . . . . 0.0 111.002 -179.484 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.7 t0 -55.32 82.25 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.267 -0.896 . . . . 0.0 110.657 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.32 -58.2 3.59 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.402 -0.812 . . . . 0.0 110.65 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 59' ' ' GLY . 30.1 p30 -63.94 -11.7 30.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.258 -0.901 . . . . 0.0 110.5 -179.708 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.507 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . 61.08 46.52 94.38 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 23.1 p-10 -97.73 -32.84 11.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.25 -1.147 . . . . 0.0 110.23 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.16 -9.42 5.66 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.68 HG22 HG22 ' A' ' 28' ' ' THR . 31.0 p -139.18 160.6 39.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 110.032 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.675 HD12 ' HB ' ' A' ' 55' ' ' VAL . 15.6 mm -84.59 159.45 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 109.92 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.543 ' C ' ' CZ ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -126.25 173.33 9.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.093 -1.004 . . . . 0.0 110.55 -179.865 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 7.5 t80 -67.5 -50.77 35.53 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.322 -0.862 . . . . 0.0 111.135 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.3 Cg_endo -66.53 -39.51 16.15 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.254 1.134 . . . . 0.0 110.169 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.425 ' OE2' ' HB2' ' A' ' 64' ' ' ASP . 39.3 mt-10 -53.8 -39.62 65.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.527 179.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -66.73 -47.21 72.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 109.777 179.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 66' ' ' PRO . 18.3 mt -51.17 -30.41 16.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.997 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.9 m -93.89 -14.86 25.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.389 -0.819 . . . . 0.0 110.501 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.823 ' HG3' HG22 ' A' ' 55' ' ' VAL . 7.1 tmm? -73.18 -54.08 9.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.107 -0.995 . . . . 0.0 110.433 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.537 ' CE ' ' CE1' ' B' ' 26' ' ' PHE . 0.0 OUTLIER -52.62 -18.12 1.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -0.816 . . . . 0.0 110.668 -179.604 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.45 -10.11 22.58 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.13 -0.981 . . . . 0.0 110.648 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.29 -34.6 9.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.119 -0.988 . . . . 0.0 110.447 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.755 ' HB3' HG21 ' B' ' 8' ' ' THR . 6.4 tptt -97.54 -49.77 4.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.204 -0.935 . . . . 0.0 110.405 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.615 ' HE3' ' CG ' ' B' ' 26' ' ' PHE . 4.2 mmm -77.33 54.29 1.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.355 -0.84 . . . . 0.0 110.562 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -102.25 -56.62 2.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.377 -0.827 . . . . 0.0 110.074 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 79' ' ' THR . 0.7 OUTLIER -178.36 -33.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.306 -0.871 . . . . 0.0 110.186 179.95 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -42.49 -45.81 4.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.969 . . . . 0.0 110.153 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.535 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 5.9 p-10 -144.68 70.24 1.28 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.257 -0.902 . . . . 0.0 109.807 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.1 p -109.42 -32.43 7.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.749 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 15.8 pt-20 -79.05 -37.34 39.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.372 -0.83 . . . . 0.0 109.884 179.567 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.501 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 1.1 pt-20 -72.64 -9.73 58.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.372 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 80' ' ' ASP . 13.8 mm-40 -79.12 -28.0 42.89 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.497 -0.752 . . . . 0.0 109.91 179.48 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.661 HG23 ' CE1' ' A' ' 141' ' ' PHE . 77.8 mt -62.93 -39.42 85.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.205 -0.934 . . . . 0.0 108.6 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -65.51 -28.53 69.25 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -77.4 -53.39 7.72 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.22 -32.39 71.08 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.33 -0.856 . . . . 0.0 108.935 178.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -72.88 -45.99 55.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.067 178.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -55.25 -23.78 24.4 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.535 -0.728 . . . . 0.0 109.135 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.829 HG12 HG21 ' A' ' 108' ' ' VAL . 22.8 t -78.59 -44.37 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.536 -0.728 . . . . 0.0 109.735 179.462 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.587 ' CZ ' HG13 ' B' ' 13' ' ' VAL . 57.3 m-85 -65.68 -42.28 91.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.889 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.458 ' OD1' ' OD1' ' A' ' 95' ' ' ASP . 30.9 t0 -100.13 61.47 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.272 -0.892 . . . . 0.0 110.184 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.524 ' CE ' ' HA ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -54.31 -48.21 71.57 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.153 -0.967 . . . . 0.0 109.534 179.867 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 97' ' ' ASN . 10.0 p-10 -54.97 -32.15 61.34 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.799 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.29 54.63 22.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.463 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 52.6 p30 -96.57 -5.43 39.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.245 -1.15 . . . . 0.0 110.101 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 99' ' ' TYR . . . 99.45 13.13 39.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 2.6 m-85 -164.74 162.97 21.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.303 -1.116 . . . . 0.0 110.04 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.573 HD13 ' HB3' ' A' ' 92' ' ' PHE . 10.7 mt -119.67 132.63 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.234 -0.916 . . . . 0.0 110.414 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -116.08 153.25 32.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 110.126 179.957 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -44.2 -32.64 1.31 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.709 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.95 84.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.406 -0.809 . . . . 0.0 109.494 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 100' ' ' ILE . 5.7 mt-10 -54.49 -50.58 67.45 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.324 -0.86 . . . . 0.0 109.404 179.364 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.5 ' HG ' HD11 ' A' ' 125' ' ' ILE . 3.6 mm? -57.9 -52.86 63.77 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.302 -0.873 . . . . 0.0 109.5 179.349 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -50.89 -26.57 6.0 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.213 -0.93 . . . . 0.0 109.016 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.473 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 26.3 t60 -79.27 -25.45 42.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.564 -0.71 . . . . 0.0 109.69 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.829 HG21 HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -98.8 -30.74 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.315 -0.866 . . . . 0.0 109.812 179.694 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 1.009 ' HA ' HD21 ' B' ' 17' ' ' LEU . 0.2 OUTLIER -73.49 -51.7 16.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.394 -0.816 . . . . 0.0 110.196 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.7 m -68.94 -23.42 64.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 110.321 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 3.6 m120 -86.85 -14.29 42.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 109.521 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.629 ' CD1' HG12 ' B' ' 13' ' ' VAL . 4.1 mt -89.24 -34.38 16.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -0.857 . . . . 0.0 110.106 179.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.22 -56.61 0.42 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.24 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.52 158.37 17.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.999 -1.295 . . . . 0.0 110.804 -179.338 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 1.2 pttt -135.52 76.17 1.6 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.533 -0.729 . . . . 0.0 109.251 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.696 HD21 ' HA ' ' B' ' 19' ' ' LYS . 4.6 mp -37.2 146.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.671 -0.643 . . . . 0.0 111.14 -179.332 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -54.58 -164.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 0.0 110.04 179.719 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 117' ' ' THR . 91.9 m-20 -83.86 -46.89 11.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.124 -0.985 . . . . 0.0 110.119 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -58.38 -53.06 62.58 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.74 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.658 ' HB3' HD23 ' A' ' 116' ' ' LEU . 67.8 mm-40 -52.85 -44.2 66.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.365 -0.834 . . . . 0.0 109.582 179.51 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 117' ' ' THR . 42.7 t -58.11 -51.19 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.851 . . . . 0.0 110.154 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -61.47 -56.38 20.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 109.88 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 1.8 mt-10 -52.65 -36.65 57.12 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.687 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.537 ' HE1' ' O ' ' B' ' 16' ' ' MET . 0.9 OUTLIER -55.28 -50.15 70.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.811 . . . . 0.0 110.098 179.718 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.5 HD11 ' HG ' ' A' ' 105' ' ' LEU . 37.1 mm -71.45 -46.0 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.22 -0.925 . . . . 0.0 110.321 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 127' ' ' GLU . 11.6 mmt180 -59.8 -55.32 35.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.26 -0.9 . . . . 0.0 110.446 -179.764 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 123' ' ' GLU . 0.8 OUTLIER -43.69 -26.05 0.21 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 110.265 -179.958 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -98.59 -28.51 13.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.157 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 1.8 t70 -65.11 69.79 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.881 . . . . 0.0 110.371 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 128' ' ' ALA . 1.6 mp -63.21 -35.77 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.471 179.66 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 35.7 p-10 -74.97 -23.74 58.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.831 179.668 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.456 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 72.93 57.87 5.07 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 135' ' ' GLN . 1.9 p30 -110.04 -15.2 14.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.214 -1.168 . . . . 0.0 110.083 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 135' ' ' GLN . . . 106.68 -4.74 36.93 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 43.7 mt-30 -155.37 158.57 38.9 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.225 -1.162 . . . . 0.0 110.119 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 14.0 t -92.72 135.97 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 110.075 179.666 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.516 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 28.1 t-20 -106.72 173.21 6.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.156 -0.965 . . . . 0.0 110.416 -179.796 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -54.55 -49.88 69.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.856 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -52.99 -56.37 16.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.271 -0.893 . . . . 0.0 110.229 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 141' ' ' PHE . 48.4 mt-10 -54.22 -58.67 6.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.162 -0.962 . . . . 0.0 110.076 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.661 ' CE1' HG23 ' A' ' 85' ' ' ILE . 41.7 t80 -43.51 -27.39 0.28 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 109.739 179.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.838 ' O ' HG22 ' A' ' 146' ' ' THR . 46.9 t -91.81 -39.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 109.965 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 2.6 tt0 -57.91 -14.14 5.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.362 -0.837 . . . . 0.0 110.501 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.436 ' O ' ' HA2' ' B' ' 23' ' ' GLY . 2.5 mtp -107.3 -11.19 15.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.111 -0.993 . . . . 0.0 110.515 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.593 ' CE ' HD21 ' B' ' 12' ' ' LEU . 0.2 OUTLIER -99.91 -17.84 17.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.161 -0.962 . . . . 0.0 110.699 -179.708 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 142' ' ' VAL . 0.4 OUTLIER -122.56 21.63 10.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.163 -0.961 . . . . 0.0 110.346 -179.947 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -100.31 46.66 0.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 0.0 110.354 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.124 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.456 ' O ' HG22 ' B' ' 1' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.311 0.577 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -65.39 -86.01 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.311 -0.868 . . . . 0.0 110.382 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.414 HD23 ' O ' ' B' ' 3' ' ' LEU . 1.0 OUTLIER 61.59 37.74 15.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 110.574 179.829 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.448 HG23 ' HD2' ' B' ' 5' ' ' PRO . 19.6 mm -142.37 139.49 17.71 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.146 -0.971 . . . . 0.0 110.453 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.448 ' HD2' HG23 ' B' ' 4' ' ' ILE . 46.9 Cg_endo -73.81 164.64 34.16 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 124.062 1.559 . . . . 0.0 110.458 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.42 -175.93 4.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.181 -0.949 . . . . 0.0 110.612 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 7' ' ' TRP . . . . . 0.718 ' O ' HG22 ' B' ' 10' ' ' VAL . 2.1 m95 -65.12 -76.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.643 0.735 . . . . 0.0 110.707 -179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.755 HG21 ' HB3' ' A' ' 75' ' ' LYS . 13.3 p -41.72 -25.83 0.06 Allowed 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.13 -0.981 . . . . 0.0 110.591 -179.305 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.455 ' N ' ' O ' ' B' ' 7' ' ' TRP . 27.1 m -61.92 -61.68 2.32 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.01 -1.056 . . . . 0.0 109.318 178.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.718 HG22 ' O ' ' B' ' 7' ' ' TRP . 6.1 m -53.97 -27.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 109.037 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' B' ' 8' ' ' THR . 30.0 mm -74.3 -42.54 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.471 -0.768 . . . . 0.0 109.287 178.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.593 HD21 ' CE ' ' A' ' 145' ' ' MET . 0.5 OUTLIER -53.33 -60.61 3.07 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.647 -0.658 . . . . 0.0 110.053 179.855 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.629 HG12 ' CD1' ' A' ' 112' ' ' LEU . 69.3 t -56.51 -40.38 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.121 -0.987 . . . . 0.0 109.78 179.682 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.876 ' CD ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -67.32 -42.06 84.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.147 -0.971 . . . . 0.0 109.515 179.239 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -62.25 -31.51 72.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 109.552 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.537 ' O ' ' HE1' ' A' ' 124' ' ' MET . 0.7 OUTLIER -74.17 -27.03 60.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.497 -0.752 . . . . 0.0 109.87 179.694 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 1.009 HD21 ' HA ' ' A' ' 109' ' ' MET . 3.3 mp -70.34 58.47 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.384 -0.822 . . . . 0.0 109.94 179.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.489 ' HB3' ' HD3' ' B' ' 19' ' ' LYS . 3.7 tpp180 -85.94 -70.93 0.56 Allowed 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.616 -0.677 . . . . 0.0 110.648 -179.637 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.696 ' HA ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -165.48 -43.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.953 . . . . 0.0 110.216 -179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.674 ' N ' ' HG2' ' B' ' 19' ' ' LYS . 0.0 OUTLIER -162.5 3.73 0.05 OUTLIER 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.236 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.477 ' HB2' ' HE2' ' B' ' 19' ' ' LYS . 5.7 t -90.16 154.22 19.92 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.183 -0.948 . . . . 0.0 110.693 -179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.27 -42.3 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.367 -0.833 . . . . 0.0 109.958 179.535 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 144' ' ' MET . . . -59.34 104.05 0.49 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.509 ' HB2' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -102.48 105.86 46.06 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.114 -1.227 . . . . 0.0 110.658 -179.489 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.02 139.57 24.38 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.007 1.53 . . . . 0.0 109.524 179.286 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.615 ' CG ' ' HE3' ' A' ' 76' ' ' MET . 1.3 m-85 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.209 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_